<SEC-DOCUMENT>0000816956-23-000007.txt : 20230427
<SEC-HEADER>0000816956-23-000007.hdr.sgml : 20230427
<ACCEPTANCE-DATETIME>20230427112243
ACCESSION NUMBER:		0000816956-23-000007
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		69
CONFORMED PERIOD OF REPORT:	20230331
FILED AS OF DATE:		20230427
DATE AS OF CHANGE:		20230427

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CONMED Corp
		CENTRAL INDEX KEY:			0000816956
		STANDARD INDUSTRIAL CLASSIFICATION:	ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
		IRS NUMBER:				160977505
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-39218
		FILM NUMBER:		23853314

	BUSINESS ADDRESS:	
		STREET 1:		11311 CONCEPT BOULEVARD
		CITY:			LARGO
		STATE:			FL
		ZIP:			33773
		BUSINESS PHONE:		727-214-2974

	MAIL ADDRESS:	
		STREET 1:		11311 CONCEPT BOULEVARD
		CITY:			LARGO
		STATE:			FL
		ZIP:			33773

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CONMED CORP
		DATE OF NAME CHANGE:	19920703
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>cnmd-20230331.htm
<DESCRIPTION>10-Q
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2023 Workiva--><!--r:30a13273-0e0a-49c8-aa2d-31e213cf1b75,g:3b97619f-d09a-4ff4-909a-c708e7b90654,d:952e7af9c0b94e65995973e7f212f399--><html xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns="http://www.w3.org/1999/xhtml" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:country="http://xbrl.sec.gov/country/2022" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:cnmd="http://www.conmed.com/20230331" xmlns:srt="http://fasb.org/srt/2022" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dei="http://xbrl.sec.gov/dei/2022" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>cnmd-20230331</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80L2ZyYWc6YzgxZTUxYzgwYzJhNGI0OGExOGMyZjg1OWZmN2Y1MTMvdGFibGU6MWJkZjE3ZGQ2ZDllNGIwY2EzOGY3ZDBlYmMwYTA2NzgvdGFibGVyYW5nZToxYmRmMTdkZDZkOWU0YjBjYTM4ZjdkMGViYzBhMDY3OF8xLTEtMS0xLTQ1OTE5_cafab1a3-113a-457b-9f08-b1f164fffbf8">0000816956</ix:nonNumeric><ix:nonNumeric contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331" name="dei:CurrentFiscalYearEndDate" format="ixt:date-month-day" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80L2ZyYWc6YzgxZTUxYzgwYzJhNGI0OGExOGMyZjg1OWZmN2Y1MTMvdGFibGU6MWJkZjE3ZGQ2ZDllNGIwY2EzOGY3ZDBlYmMwYTA2NzgvdGFibGVyYW5nZToxYmRmMTdkZDZkOWU0YjBjYTM4ZjdkMGViYzBhMDY3OF8yLTEtMS0xLTQ1OTE5_5200d9fb-0a76-4d0c-975b-4dbd24716100">12/31</ix:nonNumeric><ix:nonNumeric contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80L2ZyYWc6YzgxZTUxYzgwYzJhNGI0OGExOGMyZjg1OWZmN2Y1MTMvdGFibGU6MWJkZjE3ZGQ2ZDllNGIwY2EzOGY3ZDBlYmMwYTA2NzgvdGFibGVyYW5nZToxYmRmMTdkZDZkOWU0YjBjYTM4ZjdkMGViYzBhMDY3OF8zLTEtMS0xLTQ1OTE5_2204abe0-879e-48c8-9f1f-dca716ae8b8f">2023</ix:nonNumeric><ix:nonNumeric contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331" name="dei:DocumentFiscalPeriodFocus" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80L2ZyYWc6YzgxZTUxYzgwYzJhNGI0OGExOGMyZjg1OWZmN2Y1MTMvdGFibGU6MWJkZjE3ZGQ2ZDllNGIwY2EzOGY3ZDBlYmMwYTA2NzgvdGFibGVyYW5nZToxYmRmMTdkZDZkOWU0YjBjYTM4ZjdkMGViYzBhMDY3OF80LTEtMS0xLTQ1OTE5_38bdf91e-1ad4-429a-8525-8bf8fe365b27">Q1</ix:nonNumeric><ix:nonNumeric contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331" name="dei:AmendmentFlag" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80L2ZyYWc6YzgxZTUxYzgwYzJhNGI0OGExOGMyZjg1OWZmN2Y1MTMvdGFibGU6MWJkZjE3ZGQ2ZDllNGIwY2EzOGY3ZDBlYmMwYTA2NzgvdGFibGVyYW5nZToxYmRmMTdkZDZkOWU0YjBjYTM4ZjdkMGViYzBhMDY3OF81LTEtMS0xLTQ1OTE5_ce6d63af-64d0-442e-9f66-62a9c64080aa">FALSE</ix:nonNumeric><ix:nonNumeric contextRef="i9500a5ee8dbe4d23aa9c46ebdd25a0c8_D20220101-20220331" name="us-gaap:AccountingStandardsUpdateExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yMi9mcmFnOjRlZjhhMzg3NWQzNDQxMzNhYTVkM2YxMjA4ZjZhNzVmL3RhYmxlOjQ1NzViM2U2MDFhMDQ4MTY5Y2FjMDM2ZjcwZWRhNWJmL3RhYmxlcmFuZ2U6NDU3NWIzZTYwMWEwNDgxNjljYWMwMzZmNzBlZGE1YmZfMTItMC0xLTEtNDY0MDU_bc705460-c49b-465b-9afe-4187d60ffe68">http://fasb.org/us-gaap/2022#AccountingStandardsUpdate202006Member</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="cnmd-20230331.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i38a5d384f48a4effaeb956206898d5b3_I20230424"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-04-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="i9500a5ee8dbe4d23aa9c46ebdd25a0c8_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="i738c2d1dacaf436faf03cc46ab9cef23_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie4f63720d8b244a68941932992cd9f4d_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iab594279d9ab4ade89e55f698f81cb18_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id7b8c6548e4e406d84526eb06077992a_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if120f3461d36460aad6ccdf8d2faa0ba_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7467bf1c44a741c2a174d8fda8ebb019_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaca150a4def842dc82f49cd1d16f8299_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7a1eaccdf00242e8a344de7091fb416e_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ida5b0e90904045df9a5437b94848a04d_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idd1e8990d17d4c29a09ce497b0e3d5e9_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8faa12cfbcc746b48b96bb341f53eff6_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i92319359f0d94bf68894ee4109dfcf00_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9127d3c9a72c45de99f25a116340aff0_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i506e9fffe4144fdfa3c8d262ff65a801_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i991a26c35f3a4004a04b9c93216cb10b_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if8bf9b92b9754cb49ead7853527c0c87_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icb342dd07ae648ba88c184ef672faf7e_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia00f7e8577d7414dae3eec75b3959321_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2f463e4994b14c1bb3ce927524a1bdc7_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iee31e42803274180ade2d654c9f2c44a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i51431cd2971e460797df867a2da93b0e_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia4bed28ea4b04a1d9fca88fa74e6040c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2cfecd0f3dbb4727931bba8cc920743d_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4afaa0ad2d10419c84dae15a77c31488_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if2f0b0e837ae40e3bd5d07cc3ec663d4_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia66bff082e1642cd80c9ac67a0cc60fe_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5142ed70f8b347f2864cd50f2a21c01c_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate202006Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7fb909d76a5f4b7aa413e5dfa01ad54c_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate202006Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie301d028eb864cd3856cc78cb6269b1a_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate202006Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i441ac12b39534fb9b34b6a58c4e4cc39_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2335e528dd1244098fa2557c3aebbd19_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0539b1c96151418c99ad4f945625ba30_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib861e1905d064d5684a5172a6232ad41_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i522db0d27185495b938d0c8f18f5032f_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4730ada3cec445989c807f4fe004727c_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8c4d1dfe88414ef2adffd18a83334e37_D20220613-20220613"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cnmd:In2BonesGlobalIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-06-13</xbrli:startDate><xbrli:endDate>2022-06-13</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idc097ffbb7114253bc28bc94208a57fb_I20220613"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cnmd:In2BonesGlobalIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-13</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6d95bd83592e4caeac97181946e4d405_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cnmd:In2BonesGlobalIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i462c25545d8940a2ae0be682fa065b8b_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cnmd:In2BonesGlobalIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic28eb29cc995481fb7071df752f6760f_D20220809-20220809"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cnmd:BiorezIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-08-09</xbrli:startDate><xbrli:endDate>2022-08-09</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9d6ba56ca73740b9b3923d912000da47_I20220809"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cnmd:BiorezIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-08-09</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i26071f490d464a14b2bf24e3e1f2c752_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cnmd:OrthopedicSurgeryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7bdef281f49841f698c6ef3a3ead6753_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cnmd:GeneralSurgeryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i124749441acd44cf9c0bac450334222b_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib7fbf46a701d40e5bf879057f949e772_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cnmd:OrthopedicSurgeryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i85ba684d41a74bceaee45a7efb4e3287_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cnmd:GeneralSurgeryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9f3ae93344eb48b2b3f68003d7aaf3fd_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i39a257b7bdcf459488a0a70dadb1fc48_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cnmd:OrthopedicSurgeryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i66fa55845df14909875423110e9c3562_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cnmd:GeneralSurgeryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibeb105be0cd24a989e5a9543869dcd19_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i95feeaee74ee430ab557bd6fd0a89121_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cnmd:OrthopedicSurgeryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i025adf098383419fa26b51488aa4067f_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cnmd:GeneralSurgeryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0a8d168c31ea4928b8a1a43a06a6984a_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i576a3464c09a4584a1729cd84cc4164b_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cnmd:OrthopedicSurgeryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i05787a350f674333ac2b6243c86c128a_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cnmd:GeneralSurgeryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i602945d302db4233b3e192e2980d335f_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia1a88893879046bd89e1f186cac411ec_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cnmd:OrthopedicSurgeryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4ed292675fb142ab9e142e12e6a19a99_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cnmd:GeneralSurgeryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i26a828941a804f3f9109a0c00250ec1d_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i25c81b50fa704ad899e54ae63e120282_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cnmd:OrthopedicSurgeryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">cnmd:AmericasexcludingtheUnitedStatesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4422e467d9714c3d8fbf4438109765ab_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cnmd:GeneralSurgeryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">cnmd:AmericasexcludingtheUnitedStatesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i768d975a616147ad9d2d2288a48b11ed_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">cnmd:AmericasexcludingtheUnitedStatesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4f4ed95789924cb587cec5440c300f1a_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cnmd:OrthopedicSurgeryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">cnmd:AmericasexcludingtheUnitedStatesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1872a8b90120412d810e0a86ab85c148_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cnmd:GeneralSurgeryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">cnmd:AmericasexcludingtheUnitedStatesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib413a484ed8047a49dbd503cf4a21f59_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">cnmd:AmericasexcludingtheUnitedStatesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6a0f37b7e82e470ebf61b3f06c22aac2_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cnmd:OrthopedicSurgeryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if48f7914ec3d45beaf647b856037592a_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cnmd:GeneralSurgeryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia61d13e27f12498686a84bca47df5ec7_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cnmd:OrthopedicSurgeryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i60341eeb4343409c94899251a17bdde1_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cnmd:GeneralSurgeryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i256914f8655049ea8697187612d438ac_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cnmd:OrthopedicSurgeryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredAtPointInTimeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia6458bd1547344efa30ce73c2612539c_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredAtPointInTimeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cnmd:GeneralSurgeryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6d99ddc9cc5b4e6aab3f7115cf38a715_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredAtPointInTimeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ied376a94006741e6b0f863abd74791a1_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cnmd:OrthopedicSurgeryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredAtPointInTimeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib2980943d7fd4938b59d54c6c50f48a6_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredAtPointInTimeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cnmd:GeneralSurgeryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if9e3065b9a6e471ab072cbee433e2b01_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredAtPointInTimeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i19f0084e35914599aa701fa76539508d_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cnmd:OrthopedicSurgeryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredOverTimeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if322af949b2348ebaf2b896bd9ee2e61_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cnmd:GeneralSurgeryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredOverTimeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i75c95aec633641d7b8b7c07c7fdff0c3_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredOverTimeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idb37c3470f1c4ee4a3ca9416c789d079_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cnmd:OrthopedicSurgeryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredOverTimeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i72ad5ca858ec41a8b22fc48fcb8a2b67_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cnmd:GeneralSurgeryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredOverTimeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i147ce8278590475d95f2b007ce8b8910_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredOverTimeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4fbeeede3b5841dfb8ff0fc8fb92f3d3_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i87efb4b5e77145eaa953edbc2ad43a74_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5dcb85ddc4a34ec7a3176651d0eaccbe_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icc4b560884714e249aae5d9872c326ea_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i949433cde8d541d0b3051510dc518334_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1d229bbf0e07481b86b9acbec2af77ef_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idd1ea00148744dfd850e020220bf03f5_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7606ff56051a4e0e8d0a3acff90b86be_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i27c9aa8186434e5993cdaaed802e058d_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6fdde14e95954ed59a9518497036382d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia9d784369a924cdc9cf0e77dbb1d00de_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibc00334b78294a0783fda260135f6549_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie696fef447f64ccc8a668daaade9cd9b_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icfac919075cc429fb858404f3c669d73_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iae81127123e340fbb32267cb782ca25e_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iededad20ecc44fd2bb270dd062e6d769_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i21089d5235814c6ab121525210fd30c8_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie69d0166e9554b6d85184883bd783cfe_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib8cab3c62ed442529813f178f35898bc_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibeb90d75f39f491cacb945863ad49c07_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i50ba6b690edd40ac98d62cd0bd0b088a_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib9cb6638855042dcace6138a16b438ef_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i717c6c4879334aaf8b31721fd327e132_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0d7ec65a949147fa901cc819f74ad4ea_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i808450fedc2a4fb9bae456706bfd3a2f_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">cnmd:RevenuesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1e788e10ae614e408a862f260845ff94_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">cnmd:RevenuesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2e7e8a5239c24bf8943da6f26a1c8fc5_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6241041cc28b4b86aab309ebee334dd7_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i80aea042b5874dd49071f7d95c6d3e55_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i05c39c1786d348b380be8f3ab5ee62a6_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic37b157fcb074cfaaf336217f5e69f47_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4455b5d88e18472f9babbe0ea7158f8f_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3f7daa7f8baa47d29e9879c6f43c37e0_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9b6c7563dc904e9d8280dedc024d298d_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1aa96a8c12644da9a3f724a2ff7bae28_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9d03c70b7871426aa4315ec3afbc74b6_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic5ba3db9a3fd46c9a33db4ff90f454ca_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i88547f770c9e4da1886319e36a385937_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1b64b61d3f3b4bdfacdd2afc2e367b87_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cnmd:In2BonesGlobalIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="ibfc06ce8169a4d33886f8243da232e5b_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cnmd:BiorezIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i517939c1b1424d2a82601fc769d01674_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">cnmd:MeasurementInputRevenueVolatilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cnmd:In2BonesGlobalIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i82c6f94346114193ae96a1af52315fc4_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">cnmd:MeasurementInputRevenueVolatilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cnmd:BiorezIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ice84e4caa93743c5af0f4b86f25100ee_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cnmd:In2BonesGlobalIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic59ba63fc4b34daa82e9ac6f2499169a_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cnmd:BiorezIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibc813fbabc244729a87811be824caa94_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cnmd:BiorezIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1c3351caf2af4528b8145dc927d3396a_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cnmd:In2BonesGlobalIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i259d409a7f7547048e55cae0b6ae73bc_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cnmd:BiorezIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iedfdc8f66b2f411eba07af9d70f8fc00_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ide2cf996936344b29f9f89e17e70e4cf_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cnmd:CustomerandDistributorRelationshipsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4d83f76b6b11441d8c3ab802aea5f214_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cnmd:CustomerandDistributorRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie37eab970dd24bbc96548816db1cb2e7_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cnmd:CustomerandDistributorRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i58ab77cab7774f0abbd0ec4142cdd537_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cnmd:SalesrepresentationmarketingandpromotionalrightsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i64c256aebff14314a4a652aca23bb503_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cnmd:SalesrepresentationmarketingandpromotionalrightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifdfb609f174b4aff8460fb861d91811c_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cnmd:SalesrepresentationmarketingandpromotionalrightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i91d9eb56eaa944dea8c761cea88d5b5c_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7c64eb13dae8441284872536e8e2fd72_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i133dcfdb14dd4cd893d74ce7e88ebdac_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifeb04f4ad743475cb77f3692c078bd59_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cnmd:PatentsAndOtherIntangibleAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1e96e744b1b74f8aa08027bb20d925e8_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cnmd:PatentsAndOtherIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i28feeea45b68471f9fa287ac91c55448_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cnmd:PatentsAndOtherIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id242550a03e34bc39903baf6836b46df_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksAndTradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9b68c90bafb04105bba9266879cc57f9_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksAndTradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1252040e498e429c840f44af12d910cb_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">cnmd:ExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie545f13df7334e93a19c1ff77d2eb84e_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">cnmd:ReductionofRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7c9501d6daae4d25a09881fd7407a2f6_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iee16a97278a34fe6b541169cf414845b_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i77a44de4154e4f80aabef63885392692_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i76b7788d670549fab9bb3750f7a0c4ec_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia3deab346b25408c987cad57798b899f_I20190129"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cnmd:A2.625PercentConvertibleNotesDue2024Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-01-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie736fe11e175439d9773dbf983dad1c9_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cnmd:A2.625PercentConvertibleNotesDue2024Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie383611c595342b7bcfa70c8d97dc2b2_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cnmd:A2.625PercentConvertibleNotesDue2024Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9439f4c05d684bd2b8c31654eba4d05f_I20220606"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cnmd:A2250PercentConvertibleNotesDue2027Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-06</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2d6a32f6a1f64e998b122bbbc261a999_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cnmd:A2250PercentConvertibleNotesDue2027Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibf5d8099c676486794c460824796bb9a_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cnmd:A2250PercentConvertibleNotesDue2027Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0dc2d8a4965f4bf786ec6493bd6eea66_I20210716"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cnmd:AmendedAndRestatedSeniorCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-07-16</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibbe0c9555d2a40d18fa14506df884584_I20210716"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cnmd:AmendedAndRestatedSeniorCreditAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-07-16</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i33405b42e96c4b0797d76ca71cdcc742_D20220606-20220606"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cnmd:AmendedAndRestatedSeniorCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-06-06</xbrli:startDate><xbrli:endDate>2022-06-06</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i04f774d345914aff9bbced40761489cc_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LongTermDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cnmd:AmendedAndRestatedSeniorCreditAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic7e449aedd59496caf4a7c096a050bf9_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">cnmd:AdjustedTermSOFRInterestRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LongTermDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cnmd:AmendedAndRestatedSeniorCreditAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if29e0d4f562843b3816062f7f565bb17_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LongTermDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cnmd:AmendedAndRestatedSeniorCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:FederalFundsEffectiveSwapRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4e265365e2db4e6b9a43fef2da7662e0_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">cnmd:AdjustedTermSOFRMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LongTermDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cnmd:AmendedAndRestatedSeniorCreditAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic2773d0e28ec4c6e93f203b0cb250c6b_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cnmd:AmendedAndRestatedSeniorCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8e5340b37c9c4826a451adea29a1d1d0_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cnmd:AmendedAndRestatedSeniorCreditAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic751565b186d4ab8b25554beae97197d_D20190129-20190129"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cnmd:A2.625PercentConvertibleNotesDue2024Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-29</xbrli:startDate><xbrli:endDate>2019-01-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2dbc31bae66544e8ad4c1dd3147f68c4_I20190129"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cnmd:A2.625PercentConvertibleNotesDue2024Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:OptionIndexedToIssuersEquityTypeAxis">us-gaap:CallOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-01-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idfc03df5461f46f685bf90bc12673743_D20220606-20220606"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cnmd:A2.625PercentConvertibleNotesDue2024Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-06-06</xbrli:startDate><xbrli:endDate>2022-06-06</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i10eb0e0f69c44d6b8a5dcbb6bec8e099_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cnmd:A2.625PercentConvertibleNotesDue2024Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifa15bf919650442ab2cfd3f7e7f70be6_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cnmd:A2.625PercentConvertibleNotesDue2024Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id1b284d79bb1490fa07cbd99bd8692dd_D20220606-20220606"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cnmd:A2250PercentConvertibleNotesDue2027Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-06-06</xbrli:startDate><xbrli:endDate>2022-06-06</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i82b966a7802b4350a629c26252c5e157_I20220606"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cnmd:A2250PercentConvertibleNotesDue2027Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:OptionIndexedToIssuersEquityTypeAxis">us-gaap:CallOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-06</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ief4e99def0364c889fba657b34e2c8bd_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cnmd:A2250PercentConvertibleNotesDue2027Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4ff9b47cc6de4e7f8d64f0b08302c5da_D20190129-20190129"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cnmd:A2.625PercentConvertibleNotesDue2024Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="cnmd:IndexedTransactionTypeAxis">us-gaap:WarrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-29</xbrli:startDate><xbrli:endDate>2019-01-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i588b04626e27426a9be89a521d673e93_D20220606-20220606"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cnmd:A2250PercentConvertibleNotesDue2027Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="cnmd:IndexedTransactionTypeAxis">us-gaap:WarrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-06-06</xbrli:startDate><xbrli:endDate>2022-06-06</xbrli:endDate></xbrli:period></xbrli:context><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yMi9mcmFnOjRlZjhhMzg3NWQzNDQxMzNhYTVkM2YxMjA4ZjZhNzVmL3RhYmxlOjQ1NzViM2U2MDFhMDQ4MTY5Y2FjMDM2ZjcwZWRhNWJmL3RhYmxlcmFuZ2U6NDU3NWIzZTYwMWEwNDgxNjljYWMwMzZmNzBlZGE1YmZfMTItMy0xLTEtNDY0MDU_cfef9874-6ec2-42b5-801c-7abe9a1e0261 id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yMi9mcmFnOjRlZjhhMzg3NWQzNDQxMzNhYTVkM2YxMjA4ZjZhNzVmL3RhYmxlOjQ1NzViM2U2MDFhMDQ4MTY5Y2FjMDM2ZjcwZWRhNWJmL3RhYmxlcmFuZ2U6NDU3NWIzZTYwMWEwNDgxNjljYWMwMzZmNzBlZGE1YmZfMTItNC0xLTEtNDY0MDU_800b98f9-a0f2-47d2-ab38-b018d0a13d2c id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yMi9mcmFnOjRlZjhhMzg3NWQzNDQxMzNhYTVkM2YxMjA4ZjZhNzVmL3RhYmxlOjQ1NzViM2U2MDFhMDQ4MTY5Y2FjMDM2ZjcwZWRhNWJmL3RhYmxlcmFuZ2U6NDU3NWIzZTYwMWEwNDgxNjljYWMwMzZmNzBlZGE1YmZfMTItNy0xLTEtNDY0MDU_9abb2f00-e46a-4479-b6e5-b85487673102" linkRole="http://www.xbrl.org/2003/role/link" toRefs="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yMi9mcmFnOjRlZjhhMzg3NWQzNDQxMzNhYTVkM2YxMjA4ZjZhNzVmL3RhYmxlOjQ1NzViM2U2MDFhMDQ4MTY5Y2FjMDM2ZjcwZWRhNWJmL3RhYmxlcmFuZ2U6NDU3NWIzZTYwMWEwNDgxNjljYWMwMzZmNzBlZGE1YmZfMTMtMC0xLTEtNDY0MDE_046f1bcf-28f6-4ffe-8b0c-3932efd1e841" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80Ni9mcmFnOjFiNzYzYzFhMzFiMTRhNjU5MGJkMjUwMDIzMGQzNjM1L3RhYmxlOmNjNzJlOTI1MjlkNTRhNmU4OTYzZDEzZTQ2Y2NmZDlhL3RhYmxlcmFuZ2U6Y2M3MmU5MjUyOWQ1NGE2ZTg5NjNkMTNlNDZjY2ZkOWFfNC01LTEtMS00NTkxOQ_ba7fab8b-5212-4892-9579-36104468ce0a id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80Ni9mcmFnOjFiNzYzYzFhMzFiMTRhNjU5MGJkMjUwMDIzMGQzNjM1L3RhYmxlOmNjNzJlOTI1MjlkNTRhNmU4OTYzZDEzZTQ2Y2NmZDlhL3RhYmxlcmFuZ2U6Y2M3MmU5MjUyOWQ1NGE2ZTg5NjNkMTNlNDZjY2ZkOWFfNC0xLTEtMS00NTkxOQ_0fe84469-858a-4e69-9a3a-893fcb2bafa5 id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80Ni9mcmFnOjFiNzYzYzFhMzFiMTRhNjU5MGJkMjUwMDIzMGQzNjM1L3RhYmxlOmNjNzJlOTI1MjlkNTRhNmU4OTYzZDEzZTQ2Y2NmZDlhL3RhYmxlcmFuZ2U6Y2M3MmU5MjUyOWQ1NGE2ZTg5NjNkMTNlNDZjY2ZkOWFfNC03LTEtMS00NTkxOQ_896695cd-bd46-44cc-9447-3e80d5cd0dcc id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80Ni9mcmFnOjFiNzYzYzFhMzFiMTRhNjU5MGJkMjUwMDIzMGQzNjM1L3RhYmxlOmQ5NDdhNTllYzVhNzQyNmQ4YzQyMGIwNTIzMjA5ZTc1L3RhYmxlcmFuZ2U6ZDk0N2E1OWVjNWE3NDI2ZDhjNDIwYjA1MjMyMDllNzVfNC01LTEtMS00NTkxOQ_65231fba-6cdc-4ada-a5c3-462933774344 id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80Ni9mcmFnOjFiNzYzYzFhMzFiMTRhNjU5MGJkMjUwMDIzMGQzNjM1L3RhYmxlOmQ5NDdhNTllYzVhNzQyNmQ4YzQyMGIwNTIzMjA5ZTc1L3RhYmxlcmFuZ2U6ZDk0N2E1OWVjNWE3NDI2ZDhjNDIwYjA1MjMyMDllNzVfNC0zLTEtMS00NTkxOQ_a8dbf427-756e-4143-9d45-1ba70ee2c003 id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80Ni9mcmFnOjFiNzYzYzFhMzFiMTRhNjU5MGJkMjUwMDIzMGQzNjM1L3RhYmxlOmQ5NDdhNTllYzVhNzQyNmQ4YzQyMGIwNTIzMjA5ZTc1L3RhYmxlcmFuZ2U6ZDk0N2E1OWVjNWE3NDI2ZDhjNDIwYjA1MjMyMDllNzVfNC0xLTEtMS00NTkxOQ_545a0e5f-0ef0-4299-9610-97f8b53813b3 id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80Ni9mcmFnOjFiNzYzYzFhMzFiMTRhNjU5MGJkMjUwMDIzMGQzNjM1L3RhYmxlOmNjNzJlOTI1MjlkNTRhNmU4OTYzZDEzZTQ2Y2NmZDlhL3RhYmxlcmFuZ2U6Y2M3MmU5MjUyOWQ1NGE2ZTg5NjNkMTNlNDZjY2ZkOWFfNC0zLTEtMS00NTkxOQ_38630875-cff5-42ad-91c7-b88c3d7d6be9 id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80Ni9mcmFnOjFiNzYzYzFhMzFiMTRhNjU5MGJkMjUwMDIzMGQzNjM1L3RhYmxlOmQ5NDdhNTllYzVhNzQyNmQ4YzQyMGIwNTIzMjA5ZTc1L3RhYmxlcmFuZ2U6ZDk0N2E1OWVjNWE3NDI2ZDhjNDIwYjA1MjMyMDllNzVfNC03LTEtMS00NTkxOQ_22c7109f-9951-4b46-948d-23c9ee7c3f75" linkRole="http://www.xbrl.org/2003/role/link" toRefs="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80Ni9mcmFnOjFiNzYzYzFhMzFiMTRhNjU5MGJkMjUwMDIzMGQzNjM1L3RleHRyZWdpb246MWI3NjNjMWEzMWIxNGE2NTkwYmQyNTAwMjMwZDM2MzVfNDY0_2ad6ae1a-986b-44b2-9137-8872e5ce3b1e" order="1"></ix:relationship></ix:resources></ix:header></div><div id="i952e7af9c0b94e65995973e7f212f399_1"></div><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Washington, D.C. 20549</span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xL2ZyYWc6ZDQ1ZTBmNGE4MWFkNDZkYmFiZTE5OWM1YWQwZGQyOGMvdGV4dHJlZ2lvbjpkNDVlMGY0YTgxYWQ0NmRiYWJlMTk5YzVhZDBkZDI4Y18yMTMy_f48550c0-6aaa-4b90-9e8e-3bf342d1d356">10-Q</ix:nonNumeric> </span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331" name="dei:DocumentQuarterlyReport" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xL2ZyYWc6ZDQ1ZTBmNGE4MWFkNDZkYmFiZTE5OWM1YWQwZGQyOGMvdGV4dHJlZ2lvbjpkNDVlMGY0YTgxYWQ0NmRiYWJlMTk5YzVhZDBkZDI4Y18yMTMz_be82009f-f646-46b7-8862-257dcfb35cd3">&#9746;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">or</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331" name="dei:DocumentTransitionReport" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xL2ZyYWc6ZDQ1ZTBmNGE4MWFkNDZkYmFiZTE5OWM1YWQwZGQyOGMvdGV4dHJlZ2lvbjpkNDVlMGY0YTgxYWQ0NmRiYWJlMTk5YzVhZDBkZDI4Y18yMTM0_ae9e8725-29e1-455f-aeb3-013725e398bf">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">For the quarterly period ended</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Commission File Number</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xL2ZyYWc6ZDQ1ZTBmNGE4MWFkNDZkYmFiZTE5OWM1YWQwZGQyOGMvdGFibGU6ZGVjMTgxZWUzYWQ5NDY1YTkwYzJjOGYxNmY5MDRlMDEvdGFibGVyYW5nZTpkZWMxODFlZTNhZDk0NjVhOTBjMmM4ZjE2ZjkwNGUwMV8xLTAtMS0xLTQ1OTE5_7406e8d5-16dd-425a-9eb4-f40e72d258cc">March 31, 2023</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xL2ZyYWc6ZDQ1ZTBmNGE4MWFkNDZkYmFiZTE5OWM1YWQwZGQyOGMvdGFibGU6ZGVjMTgxZWUzYWQ5NDY1YTkwYzJjOGYxNmY5MDRlMDEvdGFibGVyYW5nZTpkZWMxODFlZTNhZDk0NjVhOTBjMmM4ZjE2ZjkwNGUwMV8xLTEtMS0xLTQ1OTE5_2da4261b-26af-4d01-858c-4b58a6af1098">001-39218</ix:nonNumeric></span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xL2ZyYWc6ZDQ1ZTBmNGE4MWFkNDZkYmFiZTE5OWM1YWQwZGQyOGMvdGV4dHJlZ2lvbjpkNDVlMGY0YTgxYWQ0NmRiYWJlMTk5YzVhZDBkZDI4Y18yMTM1_b5f28d12-06aa-47a2-88d0-3d4832cbeaf0">CONMED CORPORATION</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(Exact name of the registrant as specified in its charter)</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.912%"><tr><td style="width:1.0%"></td><td style="width:26.867%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.493%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.704%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.536%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xL2ZyYWc6ZDQ1ZTBmNGE4MWFkNDZkYmFiZTE5OWM1YWQwZGQyOGMvdGFibGU6NGU3M2IwMzAwMGZmNDk2NThlM2JmNzQ2M2E2MmJlNGIvdGFibGVyYW5nZTo0ZTczYjAzMDAwZmY0OTY1OGUzYmY3NDYzYTYyYmU0Yl8wLTAtMS0xLTQ1OTE5_bde80e9b-a498-4548-b9ff-55d7b3ab04dc">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xL2ZyYWc6ZDQ1ZTBmNGE4MWFkNDZkYmFiZTE5OWM1YWQwZGQyOGMvdGFibGU6NGU3M2IwMzAwMGZmNDk2NThlM2JmNzQ2M2E2MmJlNGIvdGFibGVyYW5nZTo0ZTczYjAzMDAwZmY0OTY1OGUzYmY3NDYzYTYyYmU0Yl8wLTMtMS0xLTQ1OTE5_8d54d40c-cec1-4afc-aa1d-d64cff8113e2">16-0977505</ix:nonNumeric></span></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(State or other jurisdiction of incorporation or organization)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(I.R.S. Employer Identification No.)</span></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xL2ZyYWc6ZDQ1ZTBmNGE4MWFkNDZkYmFiZTE5OWM1YWQwZGQyOGMvdGFibGU6NGU3M2IwMzAwMGZmNDk2NThlM2JmNzQ2M2E2MmJlNGIvdGFibGVyYW5nZTo0ZTczYjAzMDAwZmY0OTY1OGUzYmY3NDYzYTYyYmU0Yl8zLTAtMS0xLTQ1OTE5_1ae161cf-83d8-4e62-bc5f-d7677802bb8e">11311 Concept Blvd</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xL2ZyYWc6ZDQ1ZTBmNGE4MWFkNDZkYmFiZTE5OWM1YWQwZGQyOGMvdGFibGU6NGU3M2IwMzAwMGZmNDk2NThlM2JmNzQ2M2E2MmJlNGIvdGFibGVyYW5nZTo0ZTczYjAzMDAwZmY0OTY1OGUzYmY3NDYzYTYyYmU0Yl8zLTEtMS0xLTQ1OTE5_e039a080-354b-4cb6-bdef-5707699e6756">Largo,</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xL2ZyYWc6ZDQ1ZTBmNGE4MWFkNDZkYmFiZTE5OWM1YWQwZGQyOGMvdGFibGU6NGU3M2IwMzAwMGZmNDk2NThlM2JmNzQ2M2E2MmJlNGIvdGFibGVyYW5nZTo0ZTczYjAzMDAwZmY0OTY1OGUzYmY3NDYzYTYyYmU0Yl8zLTItMS0xLTQ1OTE5_2dfacf78-ea8c-44e7-a009-23466fe2643e">Florida</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xL2ZyYWc6ZDQ1ZTBmNGE4MWFkNDZkYmFiZTE5OWM1YWQwZGQyOGMvdGFibGU6NGU3M2IwMzAwMGZmNDk2NThlM2JmNzQ2M2E2MmJlNGIvdGFibGVyYW5nZTo0ZTczYjAzMDAwZmY0OTY1OGUzYmY3NDYzYTYyYmU0Yl8zLTMtMS0xLTQ1OTE5_39a35538-dadc-469d-810a-cc1e4461f310">33773</ix:nonNumeric></span></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(Address of principal executive offices)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(Zip Code)</span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(<ix:nonNumeric contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xL2ZyYWc6ZDQ1ZTBmNGE4MWFkNDZkYmFiZTE5OWM1YWQwZGQyOGMvdGV4dHJlZ2lvbjpkNDVlMGY0YTgxYWQ0NmRiYWJlMTk5YzVhZDBkZDI4Y18yMTM5_5b32bc0d-9606-4d07-bed0-f17d227e0361">727</ix:nonNumeric>) <ix:nonNumeric contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xL2ZyYWc6ZDQ1ZTBmNGE4MWFkNDZkYmFiZTE5OWM1YWQwZGQyOGMvdGV4dHJlZ2lvbjpkNDVlMGY0YTgxYWQ0NmRiYWJlMTk5YzVhZDBkZDI4Y18yMTM2_5253fd87-89f1-47fe-a261-ebd54b60413f">392-6464</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(Registrant's telephone number, including area code)</span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Act</span></div><div style="margin-bottom:1pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:32.135%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.282%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.283%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Title of each class</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Trading Symbol</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xL2ZyYWc6ZDQ1ZTBmNGE4MWFkNDZkYmFiZTE5OWM1YWQwZGQyOGMvdGFibGU6MTY5Y2YzNTUxNTUxNGYyZGE1NWNmYmU5MDliODk4MDYvdGFibGVyYW5nZToxNjljZjM1NTE1NTE0ZjJkYTU1Y2ZiZTkwOWI4OTgwNl8xLTAtMS0xLTQ1OTE5_f71ebb9d-4a03-4051-81c8-c95fb0320080">Common Stock, $0.01 par value</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xL2ZyYWc6ZDQ1ZTBmNGE4MWFkNDZkYmFiZTE5OWM1YWQwZGQyOGMvdGFibGU6MTY5Y2YzNTUxNTUxNGYyZGE1NWNmYmU5MDliODk4MDYvdGFibGVyYW5nZToxNjljZjM1NTE1NTE0ZjJkYTU1Y2ZiZTkwOWI4OTgwNl8xLTEtMS0xLTQ1OTE5_90f46dfd-f5ab-4b1e-b392-94268eea34c2">CNMD</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331" name="dei:SecurityExchangeName" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xL2ZyYWc6ZDQ1ZTBmNGE4MWFkNDZkYmFiZTE5OWM1YWQwZGQyOGMvdGFibGU6MTY5Y2YzNTUxNTUxNGYyZGE1NWNmYmU5MDliODk4MDYvdGFibGVyYW5nZToxNjljZjM1NTE1NTE0ZjJkYTU1Y2ZiZTkwOWI4OTgwNl8xLTItMS0xLTQ1OTE5_fd890ce5-ee6b-4933-a521-1ccc3059745c">NYSE</ix:nonNumeric></span></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports) and (2) has been subject to such filing requirements for the past 90 days.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331" name="dei:EntityCurrentReportingStatus" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xL2ZyYWc6ZDQ1ZTBmNGE4MWFkNDZkYmFiZTE5OWM1YWQwZGQyOGMvdGV4dHJlZ2lvbjpkNDVlMGY0YTgxYWQ0NmRiYWJlMTk5YzVhZDBkZDI4Y18yMTM3_239420f0-de38-44c3-8733-b72225a75f8f">Yes</ix:nonNumeric> </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;No </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9744;</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).&#160;&#160;</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331" name="dei:EntityInteractiveDataCurrent" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xL2ZyYWc6ZDQ1ZTBmNGE4MWFkNDZkYmFiZTE5OWM1YWQwZGQyOGMvdGV4dHJlZ2lvbjpkNDVlMGY0YTgxYWQ0NmRiYWJlMTk5YzVhZDBkZDI4Y18yMTQw_749357b6-c59e-4318-bf66-9e94f927baa0">Yes</ix:nonNumeric> </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;No </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company or an emerging growth company.&#160;&#160;See the definitions of "large accelerated filer", "accelerated filer", "smaller reporting company" and "emerging growth company" in Rule 12b-2 of the Exchange Act (Check one).</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331" name="dei:EntityFilerCategory" format="ixt-sec:entityfilercategoryen" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xL2ZyYWc6ZDQ1ZTBmNGE4MWFkNDZkYmFiZTE5OWM1YWQwZGQyOGMvdGV4dHJlZ2lvbjpkNDVlMGY0YTgxYWQ0NmRiYWJlMTk5YzVhZDBkZDI4Y18yMTQx_ef9c28d7-6503-4075-8ec9-1218c6485615">Large accelerated filer</ix:nonNumeric> </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Accelerated filer </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9744;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Non-accelerated filer </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9744;</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Smaller reporting company </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331" name="dei:EntitySmallBusiness" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xL2ZyYWc6ZDQ1ZTBmNGE4MWFkNDZkYmFiZTE5OWM1YWQwZGQyOGMvdGV4dHJlZ2lvbjpkNDVlMGY0YTgxYWQ0NmRiYWJlMTk5YzVhZDBkZDI4Y18yMTQy_1241cfdf-a1e5-4210-a4a4-6e49d6af38c7">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Emerging growth company </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xL2ZyYWc6ZDQ1ZTBmNGE4MWFkNDZkYmFiZTE5OWM1YWQwZGQyOGMvdGV4dHJlZ2lvbjpkNDVlMGY0YTgxYWQ0NmRiYWJlMTk5YzVhZDBkZDI4Y18yMTM4_31cab8c1-9f0d-44d7-8880-36334d5c4fc7">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9744;</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Yes </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331" name="dei:EntityShellCompany" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xL2ZyYWc6ZDQ1ZTBmNGE4MWFkNDZkYmFiZTE5OWM1YWQwZGQyOGMvdGV4dHJlZ2lvbjpkNDVlMGY0YTgxYWQ0NmRiYWJlMTk5YzVhZDBkZDI4Y18yMTMx_7d26485b-eda3-47bd-90c9-0ab247cea248">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> No </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9746;</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The number of shares outstanding of registrant's common stock, as of April&#160;24, 2023 is <ix:nonFraction unitRef="shares" contextRef="i38a5d384f48a4effaeb956206898d5b3_I20230424" decimals="INF" name="dei:EntityCommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xL2ZyYWc6ZDQ1ZTBmNGE4MWFkNDZkYmFiZTE5OWM1YWQwZGQyOGMvdGV4dHJlZ2lvbjpkNDVlMGY0YTgxYWQ0NmRiYWJlMTk5YzVhZDBkZDI4Y18yMTIy_30632e80-226c-451a-89a0-11290a8b7c22">30,575,290</ix:nonFraction> shares.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i952e7af9c0b94e65995973e7f212f399_7"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONMED CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUARTERLY REPORT ON FORM 10-Q</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FOR THE QUARTER ENDED MARCH&#160;31, 2023 </span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.830%"><tr><td style="width:1.0%"></td><td style="width:12.065%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:78.189%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.446%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">PART I FINANCIAL INFORMATION</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Item Number</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Page</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i952e7af9c0b94e65995973e7f212f399_13">Item 1.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i952e7af9c0b94e65995973e7f212f399_13">Financial Statements (unaudited)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i952e7af9c0b94e65995973e7f212f399_16">&#8211; Consolidated Condensed Statements of Comprehensive Income for the three months ended March 31, 2023 and 2022</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i952e7af9c0b94e65995973e7f212f399_16">1</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i952e7af9c0b94e65995973e7f212f399_19">&#8211; Consolidated Condensed Balance Sheets as of March 31, 2023 and December 31, 2022</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i952e7af9c0b94e65995973e7f212f399_19">2</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i952e7af9c0b94e65995973e7f212f399_22">&#8211; Consolidated Condensed Statements of Shareholders' Equity for the three months ended March 31, 2023 and 2022</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i952e7af9c0b94e65995973e7f212f399_22">3</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i952e7af9c0b94e65995973e7f212f399_25">&#8211;  Consolidated Condensed Statements of Cash Flows for the three months ended March 31, 2023 and 2022</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i952e7af9c0b94e65995973e7f212f399_25">4</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i952e7af9c0b94e65995973e7f212f399_28">&#8211; Notes to Consolidated Condensed Financial Statements</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i952e7af9c0b94e65995973e7f212f399_28">5</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i952e7af9c0b94e65995973e7f212f399_79">Item 2.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i952e7af9c0b94e65995973e7f212f399_79">Management's Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i952e7af9c0b94e65995973e7f212f399_79">19</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i952e7af9c0b94e65995973e7f212f399_88">Item 3.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i952e7af9c0b94e65995973e7f212f399_88">Quantitative and Qualitative Disclosures About Market Risk&#160;</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i952e7af9c0b94e65995973e7f212f399_88">25</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i952e7af9c0b94e65995973e7f212f399_91">Item 4.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i952e7af9c0b94e65995973e7f212f399_91">Controls and Procedures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i952e7af9c0b94e65995973e7f212f399_91">25</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">PART II OTHER INFORMATION</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i952e7af9c0b94e65995973e7f212f399_97">Item 1.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i952e7af9c0b94e65995973e7f212f399_97">Legal Proceedings</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i952e7af9c0b94e65995973e7f212f399_97">25</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i952e7af9c0b94e65995973e7f212f399_103">Item 6.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i952e7af9c0b94e65995973e7f212f399_103">Exhibits</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i952e7af9c0b94e65995973e7f212f399_103">26</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i952e7af9c0b94e65995973e7f212f399_106">Signatures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i952e7af9c0b94e65995973e7f212f399_106">27</a></span></div></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i952e7af9c0b94e65995973e7f212f399_10"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline" href="#i952e7af9c0b94e65995973e7f212f399_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART I&#160;FINANCIAL INFORMATION</span></div><div id="i952e7af9c0b94e65995973e7f212f399_13"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1.</span></div><div id="i952e7af9c0b94e65995973e7f212f399_16"></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONMED CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED CONDENSED STATEMENTS OF COMPREHENSIVE INCOME</span></div><div style="text-align:center;text-indent:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited, in thousands except per share amounts)</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:79.455%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.259%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net sales</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xNi9mcmFnOmFjZDYxZTMzYzQxNjRlMTJhNGEzMTk5ZDMxMDFkYTczL3RhYmxlOjRkY2I5OTAzYjAzYzQ2NThhY2I4MGM3ZmY2NDFkZjkwL3RhYmxlcmFuZ2U6NGRjYjk5MDNiMDNjNDY1OGFjYjgwYzdmZjY0MWRmOTBfMy0xLTEtMS00NTkxOQ_5b817f06-9d27-4e49-bca4-da5b8937383f">295,468</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9500a5ee8dbe4d23aa9c46ebdd25a0c8_D20220101-20220331" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xNi9mcmFnOmFjZDYxZTMzYzQxNjRlMTJhNGEzMTk5ZDMxMDFkYTczL3RhYmxlOjRkY2I5OTAzYjAzYzQ2NThhY2I4MGM3ZmY2NDFkZjkwL3RhYmxlcmFuZ2U6NGRjYjk5MDNiMDNjNDY1OGFjYjgwYzdmZjY0MWRmOTBfMy0zLTEtMS00NTkxOQ_8fff1772-445d-46cc-ae10-8ae119ac96fa">242,327</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331" decimals="-3" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xNi9mcmFnOmFjZDYxZTMzYzQxNjRlMTJhNGEzMTk5ZDMxMDFkYTczL3RhYmxlOjRkY2I5OTAzYjAzYzQ2NThhY2I4MGM3ZmY2NDFkZjkwL3RhYmxlcmFuZ2U6NGRjYjk5MDNiMDNjNDY1OGFjYjgwYzdmZjY0MWRmOTBfNS0xLTEtMS00NTkxOQ_6a90ea9d-6ab7-4e03-a94e-1587be8d4ee1">140,147</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9500a5ee8dbe4d23aa9c46ebdd25a0c8_D20220101-20220331" decimals="-3" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xNi9mcmFnOmFjZDYxZTMzYzQxNjRlMTJhNGEzMTk5ZDMxMDFkYTczL3RhYmxlOjRkY2I5OTAzYjAzYzQ2NThhY2I4MGM3ZmY2NDFkZjkwL3RhYmxlcmFuZ2U6NGRjYjk5MDNiMDNjNDY1OGFjYjgwYzdmZjY0MWRmOTBfNS0zLTEtMS00NTkxOQ_26d42139-bb76-4e8b-bfb5-f7702befe3c5">106,336</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331" decimals="-3" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xNi9mcmFnOmFjZDYxZTMzYzQxNjRlMTJhNGEzMTk5ZDMxMDFkYTczL3RhYmxlOjRkY2I5OTAzYjAzYzQ2NThhY2I4MGM3ZmY2NDFkZjkwL3RhYmxlcmFuZ2U6NGRjYjk5MDNiMDNjNDY1OGFjYjgwYzdmZjY0MWRmOTBfNy0xLTEtMS00NTkxOQ_fc116f42-b9fc-4e41-94b2-eb345161cc53">155,321</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9500a5ee8dbe4d23aa9c46ebdd25a0c8_D20220101-20220331" decimals="-3" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xNi9mcmFnOmFjZDYxZTMzYzQxNjRlMTJhNGEzMTk5ZDMxMDFkYTczL3RhYmxlOjRkY2I5OTAzYjAzYzQ2NThhY2I4MGM3ZmY2NDFkZjkwL3RhYmxlcmFuZ2U6NGRjYjk5MDNiMDNjNDY1OGFjYjgwYzdmZjY0MWRmOTBfNy0zLTEtMS00NTkxOQ_bcae1fbd-9978-4167-adab-4e35597e8f0e">135,991</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling and administrative expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331" decimals="-3" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xNi9mcmFnOmFjZDYxZTMzYzQxNjRlMTJhNGEzMTk5ZDMxMDFkYTczL3RhYmxlOjRkY2I5OTAzYjAzYzQ2NThhY2I4MGM3ZmY2NDFkZjkwL3RhYmxlcmFuZ2U6NGRjYjk5MDNiMDNjNDY1OGFjYjgwYzdmZjY0MWRmOTBfOS0xLTEtMS00NTkxOQ_12928f2d-6fed-44c2-a75f-c3d38d564dd7">130,083</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9500a5ee8dbe4d23aa9c46ebdd25a0c8_D20220101-20220331" decimals="-3" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xNi9mcmFnOmFjZDYxZTMzYzQxNjRlMTJhNGEzMTk5ZDMxMDFkYTczL3RhYmxlOjRkY2I5OTAzYjAzYzQ2NThhY2I4MGM3ZmY2NDFkZjkwL3RhYmxlcmFuZ2U6NGRjYjk5MDNiMDNjNDY1OGFjYjgwYzdmZjY0MWRmOTBfOS0zLTEtMS00NTkxOQ_6308b315-6563-49ff-89d6-485019755c5f">102,875</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xNi9mcmFnOmFjZDYxZTMzYzQxNjRlMTJhNGEzMTk5ZDMxMDFkYTczL3RhYmxlOjRkY2I5OTAzYjAzYzQ2NThhY2I4MGM3ZmY2NDFkZjkwL3RhYmxlcmFuZ2U6NGRjYjk5MDNiMDNjNDY1OGFjYjgwYzdmZjY0MWRmOTBfMTEtMS0xLTEtNDU5MTk_9586201a-c7a4-432a-9577-f860a0a92926">12,539</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9500a5ee8dbe4d23aa9c46ebdd25a0c8_D20220101-20220331" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xNi9mcmFnOmFjZDYxZTMzYzQxNjRlMTJhNGEzMTk5ZDMxMDFkYTczL3RhYmxlOjRkY2I5OTAzYjAzYzQ2NThhY2I4MGM3ZmY2NDFkZjkwL3RhYmxlcmFuZ2U6NGRjYjk5MDNiMDNjNDY1OGFjYjgwYzdmZjY0MWRmOTBfMTEtMy0xLTEtNDU5MTk_45fbf05d-f5ba-4691-ac35-768d5e88a734">10,672</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;   Operating expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xNi9mcmFnOmFjZDYxZTMzYzQxNjRlMTJhNGEzMTk5ZDMxMDFkYTczL3RhYmxlOjRkY2I5OTAzYjAzYzQ2NThhY2I4MGM3ZmY2NDFkZjkwL3RhYmxlcmFuZ2U6NGRjYjk5MDNiMDNjNDY1OGFjYjgwYzdmZjY0MWRmOTBfMTMtMS0xLTEtNDU5MTk_e9862010-477b-47fd-84ce-21b37c2c3c91">142,622</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9500a5ee8dbe4d23aa9c46ebdd25a0c8_D20220101-20220331" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xNi9mcmFnOmFjZDYxZTMzYzQxNjRlMTJhNGEzMTk5ZDMxMDFkYTczL3RhYmxlOjRkY2I5OTAzYjAzYzQ2NThhY2I4MGM3ZmY2NDFkZjkwL3RhYmxlcmFuZ2U6NGRjYjk5MDNiMDNjNDY1OGFjYjgwYzdmZjY0MWRmOTBfMTMtMy0xLTEtNDU5MTk_7fdb89c6-c219-4449-8536-7efc7c11fa55">113,547</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xNi9mcmFnOmFjZDYxZTMzYzQxNjRlMTJhNGEzMTk5ZDMxMDFkYTczL3RhYmxlOjRkY2I5OTAzYjAzYzQ2NThhY2I4MGM3ZmY2NDFkZjkwL3RhYmxlcmFuZ2U6NGRjYjk5MDNiMDNjNDY1OGFjYjgwYzdmZjY0MWRmOTBfMTUtMS0xLTEtNDU5MTk_49f5e232-85ef-487f-9246-7bf91c1d6994">12,699</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9500a5ee8dbe4d23aa9c46ebdd25a0c8_D20220101-20220331" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xNi9mcmFnOmFjZDYxZTMzYzQxNjRlMTJhNGEzMTk5ZDMxMDFkYTczL3RhYmxlOjRkY2I5OTAzYjAzYzQ2NThhY2I4MGM3ZmY2NDFkZjkwL3RhYmxlcmFuZ2U6NGRjYjk5MDNiMDNjNDY1OGFjYjgwYzdmZjY0MWRmOTBfMTUtMy0xLTEtNDU5MTk_9d4b4739-2941-4c64-b36a-fcbf7556b85f">22,444</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331" decimals="-3" name="us-gaap:InterestExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xNi9mcmFnOmFjZDYxZTMzYzQxNjRlMTJhNGEzMTk5ZDMxMDFkYTczL3RhYmxlOjRkY2I5OTAzYjAzYzQ2NThhY2I4MGM3ZmY2NDFkZjkwL3RhYmxlcmFuZ2U6NGRjYjk5MDNiMDNjNDY1OGFjYjgwYzdmZjY0MWRmOTBfMTctMS0xLTEtNDU5MTk_88df49be-182c-41ec-848a-1b51bfc785ed">10,255</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9500a5ee8dbe4d23aa9c46ebdd25a0c8_D20220101-20220331" decimals="-3" name="us-gaap:InterestExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xNi9mcmFnOmFjZDYxZTMzYzQxNjRlMTJhNGEzMTk5ZDMxMDFkYTczL3RhYmxlOjRkY2I5OTAzYjAzYzQ2NThhY2I4MGM3ZmY2NDFkZjkwL3RhYmxlcmFuZ2U6NGRjYjk5MDNiMDNjNDY1OGFjYjgwYzdmZjY0MWRmOTBfMTctMy0xLTEtNDU5MTk_58323b14-4e41-4aa1-b6b9-dac963a33af8">4,998</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income before income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xNi9mcmFnOmFjZDYxZTMzYzQxNjRlMTJhNGEzMTk5ZDMxMDFkYTczL3RhYmxlOjRkY2I5OTAzYjAzYzQ2NThhY2I4MGM3ZmY2NDFkZjkwL3RhYmxlcmFuZ2U6NGRjYjk5MDNiMDNjNDY1OGFjYjgwYzdmZjY0MWRmOTBfMjEtMS0xLTEtNDU5MTk_fad1f127-1d32-44e1-968f-ad4257fb519b">2,444</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9500a5ee8dbe4d23aa9c46ebdd25a0c8_D20220101-20220331" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xNi9mcmFnOmFjZDYxZTMzYzQxNjRlMTJhNGEzMTk5ZDMxMDFkYTczL3RhYmxlOjRkY2I5OTAzYjAzYzQ2NThhY2I4MGM3ZmY2NDFkZjkwL3RhYmxlcmFuZ2U6NGRjYjk5MDNiMDNjNDY1OGFjYjgwYzdmZjY0MWRmOTBfMjEtMy0xLTEtNDU5MTk_a4807550-3314-4496-b9a8-853f115fb3f8">17,446</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xNi9mcmFnOmFjZDYxZTMzYzQxNjRlMTJhNGEzMTk5ZDMxMDFkYTczL3RhYmxlOjRkY2I5OTAzYjAzYzQ2NThhY2I4MGM3ZmY2NDFkZjkwL3RhYmxlcmFuZ2U6NGRjYjk5MDNiMDNjNDY1OGFjYjgwYzdmZjY0MWRmOTBfMjMtMS0xLTEtNDU5MTk_2f858b17-7b08-4717-ba0c-42a52c4b9ac5">625</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9500a5ee8dbe4d23aa9c46ebdd25a0c8_D20220101-20220331" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xNi9mcmFnOmFjZDYxZTMzYzQxNjRlMTJhNGEzMTk5ZDMxMDFkYTczL3RhYmxlOjRkY2I5OTAzYjAzYzQ2NThhY2I4MGM3ZmY2NDFkZjkwL3RhYmxlcmFuZ2U6NGRjYjk5MDNiMDNjNDY1OGFjYjgwYzdmZjY0MWRmOTBfMjMtMy0xLTEtNDU5MTk_dc698c9e-0759-4526-8547-1ba02fc6ff18">2,471</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xNi9mcmFnOmFjZDYxZTMzYzQxNjRlMTJhNGEzMTk5ZDMxMDFkYTczL3RhYmxlOjRkY2I5OTAzYjAzYzQ2NThhY2I4MGM3ZmY2NDFkZjkwL3RhYmxlcmFuZ2U6NGRjYjk5MDNiMDNjNDY1OGFjYjgwYzdmZjY0MWRmOTBfMjUtMS0xLTEtNDU5MTk_52bc8723-ce15-4869-99a1-c957420817a9">1,819</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9500a5ee8dbe4d23aa9c46ebdd25a0c8_D20220101-20220331" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xNi9mcmFnOmFjZDYxZTMzYzQxNjRlMTJhNGEzMTk5ZDMxMDFkYTczL3RhYmxlOjRkY2I5OTAzYjAzYzQ2NThhY2I4MGM3ZmY2NDFkZjkwL3RhYmxlcmFuZ2U6NGRjYjk5MDNiMDNjNDY1OGFjYjgwYzdmZjY0MWRmOTBfMjUtMy0xLTEtNDU5MTk_39bcecab-fea0-4320-9c5c-faffe4b3104a">14,975</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive income</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xNi9mcmFnOmFjZDYxZTMzYzQxNjRlMTJhNGEzMTk5ZDMxMDFkYTczL3RhYmxlOjRkY2I5OTAzYjAzYzQ2NThhY2I4MGM3ZmY2NDFkZjkwL3RhYmxlcmFuZ2U6NGRjYjk5MDNiMDNjNDY1OGFjYjgwYzdmZjY0MWRmOTBfMjctMS0xLTEtNDU5MTk_8cfacbc8-22d0-497d-a2be-045abede9880">4,695</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9500a5ee8dbe4d23aa9c46ebdd25a0c8_D20220101-20220331" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xNi9mcmFnOmFjZDYxZTMzYzQxNjRlMTJhNGEzMTk5ZDMxMDFkYTczL3RhYmxlOjRkY2I5OTAzYjAzYzQ2NThhY2I4MGM3ZmY2NDFkZjkwL3RhYmxlcmFuZ2U6NGRjYjk5MDNiMDNjNDY1OGFjYjgwYzdmZjY0MWRmOTBfMjctMy0xLTEtNDU5MTk_38d9b8e8-1541-4ed5-a640-7c14c1e36f05">16,415</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Per share data:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xNi9mcmFnOmFjZDYxZTMzYzQxNjRlMTJhNGEzMTk5ZDMxMDFkYTczL3RhYmxlOjRkY2I5OTAzYjAzYzQ2NThhY2I4MGM3ZmY2NDFkZjkwL3RhYmxlcmFuZ2U6NGRjYjk5MDNiMDNjNDY1OGFjYjgwYzdmZjY0MWRmOTBfMzMtMS0xLTEtNDU5MTk_fedbdebc-45cf-4886-a307-c8f318bb24b4">0.06</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i9500a5ee8dbe4d23aa9c46ebdd25a0c8_D20220101-20220331" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xNi9mcmFnOmFjZDYxZTMzYzQxNjRlMTJhNGEzMTk5ZDMxMDFkYTczL3RhYmxlOjRkY2I5OTAzYjAzYzQ2NThhY2I4MGM3ZmY2NDFkZjkwL3RhYmxlcmFuZ2U6NGRjYjk5MDNiMDNjNDY1OGFjYjgwYzdmZjY0MWRmOTBfMzMtMy0xLTEtNDU5MTk_5a4d84ed-4a91-4371-bfa1-e9d6594f1af5">0.51</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xNi9mcmFnOmFjZDYxZTMzYzQxNjRlMTJhNGEzMTk5ZDMxMDFkYTczL3RhYmxlOjRkY2I5OTAzYjAzYzQ2NThhY2I4MGM3ZmY2NDFkZjkwL3RhYmxlcmFuZ2U6NGRjYjk5MDNiMDNjNDY1OGFjYjgwYzdmZjY0MWRmOTBfMzQtMS0xLTEtNDU5MTk_8f10e1c5-7b05-42cb-a7cd-9d14585d95b8">0.06</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i9500a5ee8dbe4d23aa9c46ebdd25a0c8_D20220101-20220331" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xNi9mcmFnOmFjZDYxZTMzYzQxNjRlMTJhNGEzMTk5ZDMxMDFkYTczL3RhYmxlOjRkY2I5OTAzYjAzYzQ2NThhY2I4MGM3ZmY2NDFkZjkwL3RhYmxlcmFuZ2U6NGRjYjk5MDNiMDNjNDY1OGFjYjgwYzdmZjY0MWRmOTBfMzQtMy0xLTEtNDU5MTk_4b5c531f-e3e5-4ad8-a979-8ff95fd9663b">0.47</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common shares</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xNi9mcmFnOmFjZDYxZTMzYzQxNjRlMTJhNGEzMTk5ZDMxMDFkYTczL3RhYmxlOjRkY2I5OTAzYjAzYzQ2NThhY2I4MGM3ZmY2NDFkZjkwL3RhYmxlcmFuZ2U6NGRjYjk5MDNiMDNjNDY1OGFjYjgwYzdmZjY0MWRmOTBfMzctMS0xLTEtNDU5MTk_d1f16651-0082-4096-bf1f-729359412c6b">30,511</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9500a5ee8dbe4d23aa9c46ebdd25a0c8_D20220101-20220331" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xNi9mcmFnOmFjZDYxZTMzYzQxNjRlMTJhNGEzMTk5ZDMxMDFkYTczL3RhYmxlOjRkY2I5OTAzYjAzYzQ2NThhY2I4MGM3ZmY2NDFkZjkwL3RhYmxlcmFuZ2U6NGRjYjk5MDNiMDNjNDY1OGFjYjgwYzdmZjY0MWRmOTBfMzctMy0xLTEtNDU5MTk_74c9c9a8-7ade-4740-aca1-ee6b7f6130e8">29,428</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xNi9mcmFnOmFjZDYxZTMzYzQxNjRlMTJhNGEzMTk5ZDMxMDFkYTczL3RhYmxlOjRkY2I5OTAzYjAzYzQ2NThhY2I4MGM3ZmY2NDFkZjkwL3RhYmxlcmFuZ2U6NGRjYjk5MDNiMDNjNDY1OGFjYjgwYzdmZjY0MWRmOTBfMzgtMS0xLTEtNDU5MTk_6de1cfad-6f5d-473c-8939-a94e62aa92d2">31,204</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9500a5ee8dbe4d23aa9c46ebdd25a0c8_D20220101-20220331" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xNi9mcmFnOmFjZDYxZTMzYzQxNjRlMTJhNGEzMTk5ZDMxMDFkYTczL3RhYmxlOjRkY2I5OTAzYjAzYzQ2NThhY2I4MGM3ZmY2NDFkZjkwL3RhYmxlcmFuZ2U6NGRjYjk5MDNiMDNjNDY1OGFjYjgwYzdmZjY0MWRmOTBfMzgtMy0xLTEtNDU5MTk_134bb95d-766e-4f72-bd52-033fa2a603d5">35,155</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;See notes to consolidated condensed financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1</span></div></div></div><div id="i952e7af9c0b94e65995973e7f212f399_19"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline" href="#i952e7af9c0b94e65995973e7f212f399_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONMED CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED CONDENSED BALANCE SHEETS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited, in thousands except share and per share amounts)</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:70.894%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.536%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.537%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ASSETS</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i738c2d1dacaf436faf03cc46ab9cef23_I20230331" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xOS9mcmFnOjZmYmQzMDlmMGUwYjQ2NGNhNjhhMmFhMjdjYWIzOGM3L3RhYmxlOjJiODJlMWQ5NDE0ZjQ2NmQ5NTg3YWU2M2NjODQ3YWYzL3RhYmxlcmFuZ2U6MmI4MmUxZDk0MTRmNDY2ZDk1ODdhZTYzY2M4NDdhZjNfMy0xLTEtMS00NTkxOQ_a13aa0a7-4620-4c1c-a3fb-bdd867f38541">26,494</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4f63720d8b244a68941932992cd9f4d_I20221231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xOS9mcmFnOjZmYmQzMDlmMGUwYjQ2NGNhNjhhMmFhMjdjYWIzOGM3L3RhYmxlOjJiODJlMWQ5NDE0ZjQ2NmQ5NTg3YWU2M2NjODQ3YWYzL3RhYmxlcmFuZ2U6MmI4MmUxZDk0MTRmNDY2ZDk1ODdhZTYzY2M4NDdhZjNfMy0zLTEtMS00NTkxOQ_8efafadf-4c22-4f0b-b03b-d8d3e7a6e19d">28,942</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i738c2d1dacaf436faf03cc46ab9cef23_I20230331" decimals="-3" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xOS9mcmFnOjZmYmQzMDlmMGUwYjQ2NGNhNjhhMmFhMjdjYWIzOGM3L3RhYmxlOjJiODJlMWQ5NDE0ZjQ2NmQ5NTg3YWU2M2NjODQ3YWYzL3RhYmxlcmFuZ2U6MmI4MmUxZDk0MTRmNDY2ZDk1ODdhZTYzY2M4NDdhZjNfNC0xLTEtMS00NTkxOQ_ff92e64f-433c-47a3-9881-23d860f61805">213,182</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4f63720d8b244a68941932992cd9f4d_I20221231" decimals="-3" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xOS9mcmFnOjZmYmQzMDlmMGUwYjQ2NGNhNjhhMmFhMjdjYWIzOGM3L3RhYmxlOjJiODJlMWQ5NDE0ZjQ2NmQ5NTg3YWU2M2NjODQ3YWYzL3RhYmxlcmFuZ2U6MmI4MmUxZDk0MTRmNDY2ZDk1ODdhZTYzY2M4NDdhZjNfNC0zLTEtMS00NTkxOQ_af188eee-e872-4018-85c9-6ea293083096">191,345</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i738c2d1dacaf436faf03cc46ab9cef23_I20230331" decimals="-3" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xOS9mcmFnOjZmYmQzMDlmMGUwYjQ2NGNhNjhhMmFhMjdjYWIzOGM3L3RhYmxlOjJiODJlMWQ5NDE0ZjQ2NmQ5NTg3YWU2M2NjODQ3YWYzL3RhYmxlcmFuZ2U6MmI4MmUxZDk0MTRmNDY2ZDk1ODdhZTYzY2M4NDdhZjNfNS0xLTEtMS00NTkxOQ_fcf5a4dc-696b-4a77-9771-a1d84bc583d7">335,370</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4f63720d8b244a68941932992cd9f4d_I20221231" decimals="-3" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xOS9mcmFnOjZmYmQzMDlmMGUwYjQ2NGNhNjhhMmFhMjdjYWIzOGM3L3RhYmxlOjJiODJlMWQ5NDE0ZjQ2NmQ5NTg3YWU2M2NjODQ3YWYzL3RhYmxlcmFuZ2U6MmI4MmUxZDk0MTRmNDY2ZDk1ODdhZTYzY2M4NDdhZjNfNS0zLTEtMS00NTkxOQ_aa148661-35e8-4769-98e9-bd6e920ff9d3">332,320</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i738c2d1dacaf436faf03cc46ab9cef23_I20230331" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xOS9mcmFnOjZmYmQzMDlmMGUwYjQ2NGNhNjhhMmFhMjdjYWIzOGM3L3RhYmxlOjJiODJlMWQ5NDE0ZjQ2NmQ5NTg3YWU2M2NjODQ3YWYzL3RhYmxlcmFuZ2U6MmI4MmUxZDk0MTRmNDY2ZDk1ODdhZTYzY2M4NDdhZjNfNi0xLTEtMS00NTkxOQ_db928a05-e44d-40cf-adad-d4f112322898">35,042</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4f63720d8b244a68941932992cd9f4d_I20221231" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xOS9mcmFnOjZmYmQzMDlmMGUwYjQ2NGNhNjhhMmFhMjdjYWIzOGM3L3RhYmxlOjJiODJlMWQ5NDE0ZjQ2NmQ5NTg3YWU2M2NjODQ3YWYzL3RhYmxlcmFuZ2U6MmI4MmUxZDk0MTRmNDY2ZDk1ODdhZTYzY2M4NDdhZjNfNi0zLTEtMS00NTkxOQ_88513d7c-1258-4d8d-b5d2-e52dc518d274">28,619</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i738c2d1dacaf436faf03cc46ab9cef23_I20230331" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xOS9mcmFnOjZmYmQzMDlmMGUwYjQ2NGNhNjhhMmFhMjdjYWIzOGM3L3RhYmxlOjJiODJlMWQ5NDE0ZjQ2NmQ5NTg3YWU2M2NjODQ3YWYzL3RhYmxlcmFuZ2U6MmI4MmUxZDk0MTRmNDY2ZDk1ODdhZTYzY2M4NDdhZjNfNy0xLTEtMS00NTkxOQ_87448efa-988b-4d0e-aa34-c2bf3d8bf91a">610,088</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4f63720d8b244a68941932992cd9f4d_I20221231" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xOS9mcmFnOjZmYmQzMDlmMGUwYjQ2NGNhNjhhMmFhMjdjYWIzOGM3L3RhYmxlOjJiODJlMWQ5NDE0ZjQ2NmQ5NTg3YWU2M2NjODQ3YWYzL3RhYmxlcmFuZ2U6MmI4MmUxZDk0MTRmNDY2ZDk1ODdhZTYzY2M4NDdhZjNfNy0zLTEtMS00NTkxOQ_20c9de7b-1574-46b9-b992-b122d3dff11d">581,226</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment, net</span></td><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i738c2d1dacaf436faf03cc46ab9cef23_I20230331" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xOS9mcmFnOjZmYmQzMDlmMGUwYjQ2NGNhNjhhMmFhMjdjYWIzOGM3L3RhYmxlOjJiODJlMWQ5NDE0ZjQ2NmQ5NTg3YWU2M2NjODQ3YWYzL3RhYmxlcmFuZ2U6MmI4MmUxZDk0MTRmNDY2ZDk1ODdhZTYzY2M4NDdhZjNfOC0xLTEtMS00NTkxOQ_302c4a52-c7df-40b9-8856-681396b42043">115,356</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4f63720d8b244a68941932992cd9f4d_I20221231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xOS9mcmFnOjZmYmQzMDlmMGUwYjQ2NGNhNjhhMmFhMjdjYWIzOGM3L3RhYmxlOjJiODJlMWQ5NDE0ZjQ2NmQ5NTg3YWU2M2NjODQ3YWYzL3RhYmxlcmFuZ2U6MmI4MmUxZDk0MTRmNDY2ZDk1ODdhZTYzY2M4NDdhZjNfOC0zLTEtMS00NTkxOQ_22ebac39-ef06-4023-a267-ad49c220a22d">115,611</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i738c2d1dacaf436faf03cc46ab9cef23_I20230331" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xOS9mcmFnOjZmYmQzMDlmMGUwYjQ2NGNhNjhhMmFhMjdjYWIzOGM3L3RhYmxlOjJiODJlMWQ5NDE0ZjQ2NmQ5NTg3YWU2M2NjODQ3YWYzL3RhYmxlcmFuZ2U6MmI4MmUxZDk0MTRmNDY2ZDk1ODdhZTYzY2M4NDdhZjNfOS0xLTEtMS00NTkxOQ_e8cb2012-21f2-425c-aa6b-363ae45fc36a">815,499</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4f63720d8b244a68941932992cd9f4d_I20221231" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xOS9mcmFnOjZmYmQzMDlmMGUwYjQ2NGNhNjhhMmFhMjdjYWIzOGM3L3RhYmxlOjJiODJlMWQ5NDE0ZjQ2NmQ5NTg3YWU2M2NjODQ3YWYzL3RhYmxlcmFuZ2U6MmI4MmUxZDk0MTRmNDY2ZDk1ODdhZTYzY2M4NDdhZjNfOS0zLTEtMS00NTkxOQ_825d160e-876f-41fc-8b3f-a369246361ca">815,429</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i738c2d1dacaf436faf03cc46ab9cef23_I20230331" decimals="-3" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xOS9mcmFnOjZmYmQzMDlmMGUwYjQ2NGNhNjhhMmFhMjdjYWIzOGM3L3RhYmxlOjJiODJlMWQ5NDE0ZjQ2NmQ5NTg3YWU2M2NjODQ3YWYzL3RhYmxlcmFuZ2U6MmI4MmUxZDk0MTRmNDY2ZDk1ODdhZTYzY2M4NDdhZjNfMTAtMS0xLTEtNDU5MTk_50e9bed2-a3aa-4bde-b09e-e5c9de73fb6b">673,538</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4f63720d8b244a68941932992cd9f4d_I20221231" decimals="-3" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xOS9mcmFnOjZmYmQzMDlmMGUwYjQ2NGNhNjhhMmFhMjdjYWIzOGM3L3RhYmxlOjJiODJlMWQ5NDE0ZjQ2NmQ5NTg3YWU2M2NjODQ3YWYzL3RhYmxlcmFuZ2U6MmI4MmUxZDk0MTRmNDY2ZDk1ODdhZTYzY2M4NDdhZjNfMTAtMy0xLTEtNDU5MTk_4f787109-b36b-485d-897e-58a06d3404c0">681,799</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i738c2d1dacaf436faf03cc46ab9cef23_I20230331" decimals="-3" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xOS9mcmFnOjZmYmQzMDlmMGUwYjQ2NGNhNjhhMmFhMjdjYWIzOGM3L3RhYmxlOjJiODJlMWQ5NDE0ZjQ2NmQ5NTg3YWU2M2NjODQ3YWYzL3RhYmxlcmFuZ2U6MmI4MmUxZDk0MTRmNDY2ZDk1ODdhZTYzY2M4NDdhZjNfMTEtMS0xLTEtNDU5MTk_d12f7439-a0e0-4db7-8051-f1ddbbf48c1e">105,639</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4f63720d8b244a68941932992cd9f4d_I20221231" decimals="-3" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xOS9mcmFnOjZmYmQzMDlmMGUwYjQ2NGNhNjhhMmFhMjdjYWIzOGM3L3RhYmxlOjJiODJlMWQ5NDE0ZjQ2NmQ5NTg3YWU2M2NjODQ3YWYzL3RhYmxlcmFuZ2U6MmI4MmUxZDk0MTRmNDY2ZDk1ODdhZTYzY2M4NDdhZjNfMTEtMy0xLTEtNDU5MTk_30b72539-3f72-4882-9160-6f09f31e00ef">103,527</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i738c2d1dacaf436faf03cc46ab9cef23_I20230331" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xOS9mcmFnOjZmYmQzMDlmMGUwYjQ2NGNhNjhhMmFhMjdjYWIzOGM3L3RhYmxlOjJiODJlMWQ5NDE0ZjQ2NmQ5NTg3YWU2M2NjODQ3YWYzL3RhYmxlcmFuZ2U6MmI4MmUxZDk0MTRmNDY2ZDk1ODdhZTYzY2M4NDdhZjNfMTItMS0xLTEtNDU5MTk_a46364ff-7600-4eec-87a0-de49def71153">2,320,120</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4f63720d8b244a68941932992cd9f4d_I20221231" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xOS9mcmFnOjZmYmQzMDlmMGUwYjQ2NGNhNjhhMmFhMjdjYWIzOGM3L3RhYmxlOjJiODJlMWQ5NDE0ZjQ2NmQ5NTg3YWU2M2NjODQ3YWYzL3RhYmxlcmFuZ2U6MmI4MmUxZDk0MTRmNDY2ZDk1ODdhZTYzY2M4NDdhZjNfMTItMy0xLTEtNDU5MTk_0fa11369-f086-472f-9901-2356df9292be">2,297,592</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">LIABILITIES AND SHAREHOLDERS' EQUITY</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of long-term debt</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i738c2d1dacaf436faf03cc46ab9cef23_I20230331" decimals="-3" name="us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xOS9mcmFnOjZmYmQzMDlmMGUwYjQ2NGNhNjhhMmFhMjdjYWIzOGM3L3RhYmxlOjJiODJlMWQ5NDE0ZjQ2NmQ5NTg3YWU2M2NjODQ3YWYzL3RhYmxlcmFuZ2U6MmI4MmUxZDk0MTRmNDY2ZDk1ODdhZTYzY2M4NDdhZjNfMTktMS0xLTEtNDU5MTk_e511dbec-e50e-47f5-9a05-3527b0178116">69,693</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4f63720d8b244a68941932992cd9f4d_I20221231" decimals="-3" name="us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xOS9mcmFnOjZmYmQzMDlmMGUwYjQ2NGNhNjhhMmFhMjdjYWIzOGM3L3RhYmxlOjJiODJlMWQ5NDE0ZjQ2NmQ5NTg3YWU2M2NjODQ3YWYzL3RhYmxlcmFuZ2U6MmI4MmUxZDk0MTRmNDY2ZDk1ODdhZTYzY2M4NDdhZjNfMTktMy0xLTEtNDU5MTk_b7ae1e88-a8c5-4348-888d-bf9c1eb912c5">69,746</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i738c2d1dacaf436faf03cc46ab9cef23_I20230331" decimals="-3" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xOS9mcmFnOjZmYmQzMDlmMGUwYjQ2NGNhNjhhMmFhMjdjYWIzOGM3L3RhYmxlOjJiODJlMWQ5NDE0ZjQ2NmQ5NTg3YWU2M2NjODQ3YWYzL3RhYmxlcmFuZ2U6MmI4MmUxZDk0MTRmNDY2ZDk1ODdhZTYzY2M4NDdhZjNfMjAtMS0xLTEtNDU5MTk_c2976494-ae93-4289-a194-84beb6c27375">76,680</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4f63720d8b244a68941932992cd9f4d_I20221231" decimals="-3" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xOS9mcmFnOjZmYmQzMDlmMGUwYjQ2NGNhNjhhMmFhMjdjYWIzOGM3L3RhYmxlOjJiODJlMWQ5NDE0ZjQ2NmQ5NTg3YWU2M2NjODQ3YWYzL3RhYmxlcmFuZ2U6MmI4MmUxZDk0MTRmNDY2ZDk1ODdhZTYzY2M4NDdhZjNfMjAtMy0xLTEtNDU5MTk_a7e7f095-b370-427a-a546-9c6b59b531b7">73,393</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued compensation and benefits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i738c2d1dacaf436faf03cc46ab9cef23_I20230331" decimals="-3" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xOS9mcmFnOjZmYmQzMDlmMGUwYjQ2NGNhNjhhMmFhMjdjYWIzOGM3L3RhYmxlOjJiODJlMWQ5NDE0ZjQ2NmQ5NTg3YWU2M2NjODQ3YWYzL3RhYmxlcmFuZ2U6MmI4MmUxZDk0MTRmNDY2ZDk1ODdhZTYzY2M4NDdhZjNfMjEtMS0xLTEtNDU5MTk_5dfb8714-4ad0-4826-afa1-875b9fe9278f">49,378</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4f63720d8b244a68941932992cd9f4d_I20221231" decimals="-3" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xOS9mcmFnOjZmYmQzMDlmMGUwYjQ2NGNhNjhhMmFhMjdjYWIzOGM3L3RhYmxlOjJiODJlMWQ5NDE0ZjQ2NmQ5NTg3YWU2M2NjODQ3YWYzL3RhYmxlcmFuZ2U6MmI4MmUxZDk0MTRmNDY2ZDk1ODdhZTYzY2M4NDdhZjNfMjEtMy0xLTEtNDU5MTk_7e4fe6d9-b103-4391-bf61-d499358b243c">54,733</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i738c2d1dacaf436faf03cc46ab9cef23_I20230331" decimals="-3" name="us-gaap:OtherLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xOS9mcmFnOjZmYmQzMDlmMGUwYjQ2NGNhNjhhMmFhMjdjYWIzOGM3L3RhYmxlOjJiODJlMWQ5NDE0ZjQ2NmQ5NTg3YWU2M2NjODQ3YWYzL3RhYmxlcmFuZ2U6MmI4MmUxZDk0MTRmNDY2ZDk1ODdhZTYzY2M4NDdhZjNfMjItMS0xLTEtNDU5MTk_713895b9-4f38-4c6e-888b-89909879a401">124,935</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4f63720d8b244a68941932992cd9f4d_I20221231" decimals="-3" name="us-gaap:OtherLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xOS9mcmFnOjZmYmQzMDlmMGUwYjQ2NGNhNjhhMmFhMjdjYWIzOGM3L3RhYmxlOjJiODJlMWQ5NDE0ZjQ2NmQ5NTg3YWU2M2NjODQ3YWYzL3RhYmxlcmFuZ2U6MmI4MmUxZDk0MTRmNDY2ZDk1ODdhZTYzY2M4NDdhZjNfMjItMy0xLTEtNDU5MTk_9ddbc2c2-14bd-4c33-a7d8-92d9338036ea">98,680</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i738c2d1dacaf436faf03cc46ab9cef23_I20230331" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xOS9mcmFnOjZmYmQzMDlmMGUwYjQ2NGNhNjhhMmFhMjdjYWIzOGM3L3RhYmxlOjJiODJlMWQ5NDE0ZjQ2NmQ5NTg3YWU2M2NjODQ3YWYzL3RhYmxlcmFuZ2U6MmI4MmUxZDk0MTRmNDY2ZDk1ODdhZTYzY2M4NDdhZjNfMjMtMS0xLTEtNDU5MTk_5bf6f19c-3cc0-4e2b-bf96-350ca3326226">320,686</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4f63720d8b244a68941932992cd9f4d_I20221231" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xOS9mcmFnOjZmYmQzMDlmMGUwYjQ2NGNhNjhhMmFhMjdjYWIzOGM3L3RhYmxlOjJiODJlMWQ5NDE0ZjQ2NmQ5NTg3YWU2M2NjODQ3YWYzL3RhYmxlcmFuZ2U6MmI4MmUxZDk0MTRmNDY2ZDk1ODdhZTYzY2M4NDdhZjNfMjMtMy0xLTEtNDU5MTk_0d8fbe5c-8f5d-454c-94b9-411c1e0096f3">296,552</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i738c2d1dacaf436faf03cc46ab9cef23_I20230331" decimals="-3" name="us-gaap:LongTermDebtAndCapitalLeaseObligations" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xOS9mcmFnOjZmYmQzMDlmMGUwYjQ2NGNhNjhhMmFhMjdjYWIzOGM3L3RhYmxlOjJiODJlMWQ5NDE0ZjQ2NmQ5NTg3YWU2M2NjODQ3YWYzL3RhYmxlcmFuZ2U6MmI4MmUxZDk0MTRmNDY2ZDk1ODdhZTYzY2M4NDdhZjNfMjUtMS0xLTEtNDU5MTk_7d69aeaf-dc3c-4956-a3bd-0b5c22debf27">995,276</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4f63720d8b244a68941932992cd9f4d_I20221231" decimals="-3" name="us-gaap:LongTermDebtAndCapitalLeaseObligations" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xOS9mcmFnOjZmYmQzMDlmMGUwYjQ2NGNhNjhhMmFhMjdjYWIzOGM3L3RhYmxlOjJiODJlMWQ5NDE0ZjQ2NmQ5NTg3YWU2M2NjODQ3YWYzL3RhYmxlcmFuZ2U6MmI4MmUxZDk0MTRmNDY2ZDk1ODdhZTYzY2M4NDdhZjNfMjUtMy0xLTEtNDU5MTk_eccba8ec-2d50-4e77-9ea3-d285e61fb215">985,076</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i738c2d1dacaf436faf03cc46ab9cef23_I20230331" decimals="-3" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xOS9mcmFnOjZmYmQzMDlmMGUwYjQ2NGNhNjhhMmFhMjdjYWIzOGM3L3RhYmxlOjJiODJlMWQ5NDE0ZjQ2NmQ5NTg3YWU2M2NjODQ3YWYzL3RhYmxlcmFuZ2U6MmI4MmUxZDk0MTRmNDY2ZDk1ODdhZTYzY2M4NDdhZjNfMjYtMS0xLTEtNDU5MTk_e551bc33-91d3-4122-89a5-bdd645b2af06">65,546</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4f63720d8b244a68941932992cd9f4d_I20221231" decimals="-3" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xOS9mcmFnOjZmYmQzMDlmMGUwYjQ2NGNhNjhhMmFhMjdjYWIzOGM3L3RhYmxlOjJiODJlMWQ5NDE0ZjQ2NmQ5NTg3YWU2M2NjODQ3YWYzL3RhYmxlcmFuZ2U6MmI4MmUxZDk0MTRmNDY2ZDk1ODdhZTYzY2M4NDdhZjNfMjYtMy0xLTEtNDU5MTk_4504a92c-481b-4904-b0a9-4838e16039dc">66,725</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i738c2d1dacaf436faf03cc46ab9cef23_I20230331" decimals="-3" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xOS9mcmFnOjZmYmQzMDlmMGUwYjQ2NGNhNjhhMmFhMjdjYWIzOGM3L3RhYmxlOjJiODJlMWQ5NDE0ZjQ2NmQ5NTg3YWU2M2NjODQ3YWYzL3RhYmxlcmFuZ2U6MmI4MmUxZDk0MTRmNDY2ZDk1ODdhZTYzY2M4NDdhZjNfMjctMS0xLTEtNDU5MTk_503fede5-d8f8-42a9-944f-0756193c842f">186,159</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4f63720d8b244a68941932992cd9f4d_I20221231" decimals="-3" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xOS9mcmFnOjZmYmQzMDlmMGUwYjQ2NGNhNjhhMmFhMjdjYWIzOGM3L3RhYmxlOjJiODJlMWQ5NDE0ZjQ2NmQ5NTg3YWU2M2NjODQ3YWYzL3RhYmxlcmFuZ2U6MmI4MmUxZDk0MTRmNDY2ZDk1ODdhZTYzY2M4NDdhZjNfMjctMy0xLTEtNDU5MTk_d9cdf3b6-f383-4642-b564-178d5ae2a384">203,694</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i738c2d1dacaf436faf03cc46ab9cef23_I20230331" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xOS9mcmFnOjZmYmQzMDlmMGUwYjQ2NGNhNjhhMmFhMjdjYWIzOGM3L3RhYmxlOjJiODJlMWQ5NDE0ZjQ2NmQ5NTg3YWU2M2NjODQ3YWYzL3RhYmxlcmFuZ2U6MmI4MmUxZDk0MTRmNDY2ZDk1ODdhZTYzY2M4NDdhZjNfMjgtMS0xLTEtNDU5MTk_36c73de1-7fb8-469e-b13b-4bc87a898abc">1,567,667</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4f63720d8b244a68941932992cd9f4d_I20221231" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xOS9mcmFnOjZmYmQzMDlmMGUwYjQ2NGNhNjhhMmFhMjdjYWIzOGM3L3RhYmxlOjJiODJlMWQ5NDE0ZjQ2NmQ5NTg3YWU2M2NjODQ3YWYzL3RhYmxlcmFuZ2U6MmI4MmUxZDk0MTRmNDY2ZDk1ODdhZTYzY2M4NDdhZjNfMjgtMy0xLTEtNDU5MTk_9e894a3e-993e-45cf-b807-2f5c3f4e2948">1,552,047</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commitments and contingencies</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="i738c2d1dacaf436faf03cc46ab9cef23_I20230331" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xOS9mcmFnOjZmYmQzMDlmMGUwYjQ2NGNhNjhhMmFhMjdjYWIzOGM3L3RhYmxlOjJiODJlMWQ5NDE0ZjQ2NmQ5NTg3YWU2M2NjODQ3YWYzL3RhYmxlcmFuZ2U6MmI4MmUxZDk0MTRmNDY2ZDk1ODdhZTYzY2M4NDdhZjNfMzAtMS0xLTEtNDU5MTk_a0712a66-018c-4e18-8472-c6834c5446bf"></ix:nonFraction></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="ie4f63720d8b244a68941932992cd9f4d_I20221231" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xOS9mcmFnOjZmYmQzMDlmMGUwYjQ2NGNhNjhhMmFhMjdjYWIzOGM3L3RhYmxlOjJiODJlMWQ5NDE0ZjQ2NmQ5NTg3YWU2M2NjODQ3YWYzL3RhYmxlcmFuZ2U6MmI4MmUxZDk0MTRmNDY2ZDk1ODdhZTYzY2M4NDdhZjNfMzAtMy0xLTEtNDU5MTk_4276d678-b3e5-4f73-9db6-8b7c1ae70233"></ix:nonFraction></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shareholders' equity:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preferred stock, par value $<ix:nonFraction unitRef="usdPerShare" contextRef="i738c2d1dacaf436faf03cc46ab9cef23_I20230331" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xOS9mcmFnOjZmYmQzMDlmMGUwYjQ2NGNhNjhhMmFhMjdjYWIzOGM3L3RhYmxlOjJiODJlMWQ5NDE0ZjQ2NmQ5NTg3YWU2M2NjODQ3YWYzL3RhYmxlcmFuZ2U6MmI4MmUxZDk0MTRmNDY2ZDk1ODdhZTYzY2M4NDdhZjNfMzMtMC0xLTEtNDU5MTkvdGV4dHJlZ2lvbjpiOTRmMjkxOTcyZjY0ZTZjYjdlYjZlYmJkOTQxZTcxMF8zMQ_6e702358-3047-4064-b878-02ea2ead4d32"><ix:nonFraction unitRef="usdPerShare" contextRef="ie4f63720d8b244a68941932992cd9f4d_I20221231" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xOS9mcmFnOjZmYmQzMDlmMGUwYjQ2NGNhNjhhMmFhMjdjYWIzOGM3L3RhYmxlOjJiODJlMWQ5NDE0ZjQ2NmQ5NTg3YWU2M2NjODQ3YWYzL3RhYmxlcmFuZ2U6MmI4MmUxZDk0MTRmNDY2ZDk1ODdhZTYzY2M4NDdhZjNfMzMtMC0xLTEtNDU5MTkvdGV4dHJlZ2lvbjpiOTRmMjkxOTcyZjY0ZTZjYjdlYjZlYmJkOTQxZTcxMF8zMQ_9f10ac3b-5ea5-4d56-b981-5d371057e63a">0.01</ix:nonFraction></ix:nonFraction> per share;</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">authorized <ix:nonFraction unitRef="shares" contextRef="i738c2d1dacaf436faf03cc46ab9cef23_I20230331" decimals="INF" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xOS9mcmFnOjZmYmQzMDlmMGUwYjQ2NGNhNjhhMmFhMjdjYWIzOGM3L3RhYmxlOjJiODJlMWQ5NDE0ZjQ2NmQ5NTg3YWU2M2NjODQ3YWYzL3RhYmxlcmFuZ2U6MmI4MmUxZDk0MTRmNDY2ZDk1ODdhZTYzY2M4NDdhZjNfMzQtMC0xLTEtNDU5MTkvdGV4dHJlZ2lvbjoxNGQ0ZDYyNWY5NWU0ZjQ5OTZiNDEyMGFjYWFjZDBmMV8xNQ_bf67e8a6-ed35-4f72-a8c7-685671344693"><ix:nonFraction unitRef="shares" contextRef="ie4f63720d8b244a68941932992cd9f4d_I20221231" decimals="INF" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xOS9mcmFnOjZmYmQzMDlmMGUwYjQ2NGNhNjhhMmFhMjdjYWIzOGM3L3RhYmxlOjJiODJlMWQ5NDE0ZjQ2NmQ5NTg3YWU2M2NjODQ3YWYzL3RhYmxlcmFuZ2U6MmI4MmUxZDk0MTRmNDY2ZDk1ODdhZTYzY2M4NDdhZjNfMzQtMC0xLTEtNDU5MTkvdGV4dHJlZ2lvbjoxNGQ0ZDYyNWY5NWU0ZjQ5OTZiNDEyMGFjYWFjZDBmMV8xNQ_c45c8f07-c6f2-4fa3-b6ef-d4ece7644a17">500,000</ix:nonFraction></ix:nonFraction> shares; <ix:nonFraction unitRef="shares" contextRef="i738c2d1dacaf436faf03cc46ab9cef23_I20230331" decimals="INF" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xOS9mcmFnOjZmYmQzMDlmMGUwYjQ2NGNhNjhhMmFhMjdjYWIzOGM3L3RhYmxlOjJiODJlMWQ5NDE0ZjQ2NmQ5NTg3YWU2M2NjODQ3YWYzL3RhYmxlcmFuZ2U6MmI4MmUxZDk0MTRmNDY2ZDk1ODdhZTYzY2M4NDdhZjNfMzQtMC0xLTEtNDU5MTkvdGV4dHJlZ2lvbjoxNGQ0ZDYyNWY5NWU0ZjQ5OTZiNDEyMGFjYWFjZDBmMV8yNg_3a42d8a7-8258-4b68-ac73-260076b3d8f9"><ix:nonFraction unitRef="shares" contextRef="ie4f63720d8b244a68941932992cd9f4d_I20221231" decimals="INF" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xOS9mcmFnOjZmYmQzMDlmMGUwYjQ2NGNhNjhhMmFhMjdjYWIzOGM3L3RhYmxlOjJiODJlMWQ5NDE0ZjQ2NmQ5NTg3YWU2M2NjODQ3YWYzL3RhYmxlcmFuZ2U6MmI4MmUxZDk0MTRmNDY2ZDk1ODdhZTYzY2M4NDdhZjNfMzQtMC0xLTEtNDU5MTkvdGV4dHJlZ2lvbjoxNGQ0ZDYyNWY5NWU0ZjQ5OTZiNDEyMGFjYWFjZDBmMV8yNg_d04c94ba-4e9b-4d15-89f8-0c5743edb716">none</ix:nonFraction></ix:nonFraction> outstanding</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i738c2d1dacaf436faf03cc46ab9cef23_I20230331" decimals="-3" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xOS9mcmFnOjZmYmQzMDlmMGUwYjQ2NGNhNjhhMmFhMjdjYWIzOGM3L3RhYmxlOjJiODJlMWQ5NDE0ZjQ2NmQ5NTg3YWU2M2NjODQ3YWYzL3RhYmxlcmFuZ2U6MmI4MmUxZDk0MTRmNDY2ZDk1ODdhZTYzY2M4NDdhZjNfMzQtMS0xLTEtNDU5MTk_5b6ac0d2-3554-4356-b609-5e97740ee5df">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4f63720d8b244a68941932992cd9f4d_I20221231" decimals="-3" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xOS9mcmFnOjZmYmQzMDlmMGUwYjQ2NGNhNjhhMmFhMjdjYWIzOGM3L3RhYmxlOjJiODJlMWQ5NDE0ZjQ2NmQ5NTg3YWU2M2NjODQ3YWYzL3RhYmxlcmFuZ2U6MmI4MmUxZDk0MTRmNDY2ZDk1ODdhZTYzY2M4NDdhZjNfMzQtMy0xLTEtNDU5MTk_bcbede60-e326-45f8-925c-baa71b5f7aa1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock, par value $<ix:nonFraction unitRef="usdPerShare" contextRef="ie4f63720d8b244a68941932992cd9f4d_I20221231" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xOS9mcmFnOjZmYmQzMDlmMGUwYjQ2NGNhNjhhMmFhMjdjYWIzOGM3L3RhYmxlOjJiODJlMWQ5NDE0ZjQ2NmQ5NTg3YWU2M2NjODQ3YWYzL3RhYmxlcmFuZ2U6MmI4MmUxZDk0MTRmNDY2ZDk1ODdhZTYzY2M4NDdhZjNfMzUtMC0xLTEtNDU5MTkvdGV4dHJlZ2lvbjo0OTU4NWE4NTg2MjA0MGQ1OWQ1OTg1NmI0OGFmYjA1N18yOA_2b496b3a-8bd6-4343-ae9a-cfd6583d0f54"><ix:nonFraction unitRef="usdPerShare" contextRef="i738c2d1dacaf436faf03cc46ab9cef23_I20230331" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xOS9mcmFnOjZmYmQzMDlmMGUwYjQ2NGNhNjhhMmFhMjdjYWIzOGM3L3RhYmxlOjJiODJlMWQ5NDE0ZjQ2NmQ5NTg3YWU2M2NjODQ3YWYzL3RhYmxlcmFuZ2U6MmI4MmUxZDk0MTRmNDY2ZDk1ODdhZTYzY2M4NDdhZjNfMzUtMC0xLTEtNDU5MTkvdGV4dHJlZ2lvbjo0OTU4NWE4NTg2MjA0MGQ1OWQ1OTg1NmI0OGFmYjA1N18yOA_492e4eed-b41d-4132-a8ab-e837bbe93627">0.01</ix:nonFraction></ix:nonFraction> per share;</span></div><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie4f63720d8b244a68941932992cd9f4d_I20221231" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xOS9mcmFnOjZmYmQzMDlmMGUwYjQ2NGNhNjhhMmFhMjdjYWIzOGM3L3RhYmxlOjJiODJlMWQ5NDE0ZjQ2NmQ5NTg3YWU2M2NjODQ3YWYzL3RhYmxlcmFuZ2U6MmI4MmUxZDk0MTRmNDY2ZDk1ODdhZTYzY2M4NDdhZjNfMzUtMC0xLTEtNDU5MTkvdGV4dHJlZ2lvbjo0OTU4NWE4NTg2MjA0MGQ1OWQ1OTg1NmI0OGFmYjA1N180Mg_21cb1922-c405-4c00-8242-9483c41245b5"><ix:nonFraction unitRef="shares" contextRef="i738c2d1dacaf436faf03cc46ab9cef23_I20230331" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xOS9mcmFnOjZmYmQzMDlmMGUwYjQ2NGNhNjhhMmFhMjdjYWIzOGM3L3RhYmxlOjJiODJlMWQ5NDE0ZjQ2NmQ5NTg3YWU2M2NjODQ3YWYzL3RhYmxlcmFuZ2U6MmI4MmUxZDk0MTRmNDY2ZDk1ODdhZTYzY2M4NDdhZjNfMzUtMC0xLTEtNDU5MTkvdGV4dHJlZ2lvbjo0OTU4NWE4NTg2MjA0MGQ1OWQ1OTg1NmI0OGFmYjA1N180Mg_5d306bca-c609-41d3-b07e-5a7081003fab">100,000,000</ix:nonFraction></ix:nonFraction> shares authorized; <ix:nonFraction unitRef="shares" contextRef="i738c2d1dacaf436faf03cc46ab9cef23_I20230331" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xOS9mcmFnOjZmYmQzMDlmMGUwYjQ2NGNhNjhhMmFhMjdjYWIzOGM3L3RhYmxlOjJiODJlMWQ5NDE0ZjQ2NmQ5NTg3YWU2M2NjODQ3YWYzL3RhYmxlcmFuZ2U6MmI4MmUxZDk0MTRmNDY2ZDk1ODdhZTYzY2M4NDdhZjNfMzUtMC0xLTEtNDU5MTkvdGV4dHJlZ2lvbjo0OTU4NWE4NTg2MjA0MGQ1OWQ1OTg1NmI0OGFmYjA1N182NA_79cbe940-7f21-4845-a6b1-5b3cd79e1fae"><ix:nonFraction unitRef="shares" contextRef="ie4f63720d8b244a68941932992cd9f4d_I20221231" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xOS9mcmFnOjZmYmQzMDlmMGUwYjQ2NGNhNjhhMmFhMjdjYWIzOGM3L3RhYmxlOjJiODJlMWQ5NDE0ZjQ2NmQ5NTg3YWU2M2NjODQ3YWYzL3RhYmxlcmFuZ2U6MmI4MmUxZDk0MTRmNDY2ZDk1ODdhZTYzY2M4NDdhZjNfMzUtMC0xLTEtNDU5MTkvdGV4dHJlZ2lvbjo0OTU4NWE4NTg2MjA0MGQ1OWQ1OTg1NmI0OGFmYjA1N182NA_ce095b10-3fdb-4a85-8fc8-a9eae4106375">31,299,194</ix:nonFraction></ix:nonFraction> shares</span></div><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">issued in 2023 and 2022, respectively</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i738c2d1dacaf436faf03cc46ab9cef23_I20230331" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xOS9mcmFnOjZmYmQzMDlmMGUwYjQ2NGNhNjhhMmFhMjdjYWIzOGM3L3RhYmxlOjJiODJlMWQ5NDE0ZjQ2NmQ5NTg3YWU2M2NjODQ3YWYzL3RhYmxlcmFuZ2U6MmI4MmUxZDk0MTRmNDY2ZDk1ODdhZTYzY2M4NDdhZjNfMzUtMS0xLTEtNDU5MTk_46239911-8b83-434c-a4ee-237da56c6744">313</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4f63720d8b244a68941932992cd9f4d_I20221231" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xOS9mcmFnOjZmYmQzMDlmMGUwYjQ2NGNhNjhhMmFhMjdjYWIzOGM3L3RhYmxlOjJiODJlMWQ5NDE0ZjQ2NmQ5NTg3YWU2M2NjODQ3YWYzL3RhYmxlcmFuZ2U6MmI4MmUxZDk0MTRmNDY2ZDk1ODdhZTYzY2M4NDdhZjNfMzUtMy0xLTEtNDU5MTk_2e1bfb21-4d82-4f56-a05e-10b0fca1f77a">313</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Paid-in capital</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i738c2d1dacaf436faf03cc46ab9cef23_I20230331" decimals="-3" name="us-gaap:AdditionalPaidInCapital" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xOS9mcmFnOjZmYmQzMDlmMGUwYjQ2NGNhNjhhMmFhMjdjYWIzOGM3L3RhYmxlOjJiODJlMWQ5NDE0ZjQ2NmQ5NTg3YWU2M2NjODQ3YWYzL3RhYmxlcmFuZ2U6MmI4MmUxZDk0MTRmNDY2ZDk1ODdhZTYzY2M4NDdhZjNfMzYtMS0xLTEtNDU5MTk_310f1375-a92c-44d0-a107-01c32710a8b0">419,517</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4f63720d8b244a68941932992cd9f4d_I20221231" decimals="-3" name="us-gaap:AdditionalPaidInCapital" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xOS9mcmFnOjZmYmQzMDlmMGUwYjQ2NGNhNjhhMmFhMjdjYWIzOGM3L3RhYmxlOjJiODJlMWQ5NDE0ZjQ2NmQ5NTg3YWU2M2NjODQ3YWYzL3RhYmxlcmFuZ2U6MmI4MmUxZDk0MTRmNDY2ZDk1ODdhZTYzY2M4NDdhZjNfMzYtMy0xLTEtNDU5MTk_9438378c-7266-4d0c-9a0a-a5279f4d1358">413,235</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Retained earnings</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i738c2d1dacaf436faf03cc46ab9cef23_I20230331" decimals="-3" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xOS9mcmFnOjZmYmQzMDlmMGUwYjQ2NGNhNjhhMmFhMjdjYWIzOGM3L3RhYmxlOjJiODJlMWQ5NDE0ZjQ2NmQ5NTg3YWU2M2NjODQ3YWYzL3RhYmxlcmFuZ2U6MmI4MmUxZDk0MTRmNDY2ZDk1ODdhZTYzY2M4NDdhZjNfMzctMS0xLTEtNDU5MTk_9642f08a-edbb-4fd4-b035-a4e3ef52bf3c">408,337</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4f63720d8b244a68941932992cd9f4d_I20221231" decimals="-3" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xOS9mcmFnOjZmYmQzMDlmMGUwYjQ2NGNhNjhhMmFhMjdjYWIzOGM3L3RhYmxlOjJiODJlMWQ5NDE0ZjQ2NmQ5NTg3YWU2M2NjODQ3YWYzL3RhYmxlcmFuZ2U6MmI4MmUxZDk0MTRmNDY2ZDk1ODdhZTYzY2M4NDdhZjNfMzctMy0xLTEtNDU5MTk_77734a21-2cca-4b00-8172-322ffc887a2e">412,631</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i738c2d1dacaf436faf03cc46ab9cef23_I20230331" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xOS9mcmFnOjZmYmQzMDlmMGUwYjQ2NGNhNjhhMmFhMjdjYWIzOGM3L3RhYmxlOjJiODJlMWQ5NDE0ZjQ2NmQ5NTg3YWU2M2NjODQ3YWYzL3RhYmxlcmFuZ2U6MmI4MmUxZDk0MTRmNDY2ZDk1ODdhZTYzY2M4NDdhZjNfMzgtMS0xLTEtNDU5MTk_15bf5e44-1b29-42ff-9ffe-40bafa673dff">54,982</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie4f63720d8b244a68941932992cd9f4d_I20221231" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xOS9mcmFnOjZmYmQzMDlmMGUwYjQ2NGNhNjhhMmFhMjdjYWIzOGM3L3RhYmxlOjJiODJlMWQ5NDE0ZjQ2NmQ5NTg3YWU2M2NjODQ3YWYzL3RhYmxlcmFuZ2U6MmI4MmUxZDk0MTRmNDY2ZDk1ODdhZTYzY2M4NDdhZjNfMzgtMy0xLTEtNDU5MTk_316f4f17-f01a-40c9-aad8-6c744fc888a9">57,858</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: <ix:nonFraction unitRef="shares" contextRef="i738c2d1dacaf436faf03cc46ab9cef23_I20230331" decimals="INF" name="us-gaap:TreasuryStockCommonShares" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xOS9mcmFnOjZmYmQzMDlmMGUwYjQ2NGNhNjhhMmFhMjdjYWIzOGM3L3RhYmxlOjJiODJlMWQ5NDE0ZjQ2NmQ5NTg3YWU2M2NjODQ3YWYzL3RhYmxlcmFuZ2U6MmI4MmUxZDk0MTRmNDY2ZDk1ODdhZTYzY2M4NDdhZjNfMzktMC0xLTEtNDU5MTkvdGV4dHJlZ2lvbjowYjI5M2ZjZmMxYTI0YjQ4YmNiN2EwNGY2MzhhYmRhNV8xMA_7e0cb0ca-de33-480f-9b29-f41c32cb7b94">738,718</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="ie4f63720d8b244a68941932992cd9f4d_I20221231" decimals="INF" name="us-gaap:TreasuryStockCommonShares" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xOS9mcmFnOjZmYmQzMDlmMGUwYjQ2NGNhNjhhMmFhMjdjYWIzOGM3L3RhYmxlOjJiODJlMWQ5NDE0ZjQ2NmQ5NTg3YWU2M2NjODQ3YWYzL3RhYmxlcmFuZ2U6MmI4MmUxZDk0MTRmNDY2ZDk1ODdhZTYzY2M4NDdhZjNfMzktMC0xLTEtNDU5MTkvdGV4dHJlZ2lvbjowYjI5M2ZjZmMxYTI0YjQ4YmNiN2EwNGY2MzhhYmRhNV8xNw_1109599f-fb44-4086-b182-ef49e17ef257">811,532</ix:nonFraction> shares of common stock </span></div><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">in treasury, at cost, in 2023 and 2022, respectively</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i738c2d1dacaf436faf03cc46ab9cef23_I20230331" decimals="-3" name="us-gaap:TreasuryStockCommonValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xOS9mcmFnOjZmYmQzMDlmMGUwYjQ2NGNhNjhhMmFhMjdjYWIzOGM3L3RhYmxlOjJiODJlMWQ5NDE0ZjQ2NmQ5NTg3YWU2M2NjODQ3YWYzL3RhYmxlcmFuZ2U6MmI4MmUxZDk0MTRmNDY2ZDk1ODdhZTYzY2M4NDdhZjNfMzktMS0xLTEtNDU5MTk_c3c13cdd-7218-4fb7-954d-f15004834d01">20,732</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie4f63720d8b244a68941932992cd9f4d_I20221231" decimals="-3" name="us-gaap:TreasuryStockCommonValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xOS9mcmFnOjZmYmQzMDlmMGUwYjQ2NGNhNjhhMmFhMjdjYWIzOGM3L3RhYmxlOjJiODJlMWQ5NDE0ZjQ2NmQ5NTg3YWU2M2NjODQ3YWYzL3RhYmxlcmFuZ2U6MmI4MmUxZDk0MTRmNDY2ZDk1ODdhZTYzY2M4NDdhZjNfMzktMy0xLTEtNDU5MTk_e408fdf7-2e62-4399-82ac-c9e2644906f0">22,776</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total shareholders&#8217; equity</span></td><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i738c2d1dacaf436faf03cc46ab9cef23_I20230331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xOS9mcmFnOjZmYmQzMDlmMGUwYjQ2NGNhNjhhMmFhMjdjYWIzOGM3L3RhYmxlOjJiODJlMWQ5NDE0ZjQ2NmQ5NTg3YWU2M2NjODQ3YWYzL3RhYmxlcmFuZ2U6MmI4MmUxZDk0MTRmNDY2ZDk1ODdhZTYzY2M4NDdhZjNfNDAtMS0xLTEtNDU5MTk_c1105b79-d15b-4e7e-8845-eecfad2ce60e">752,453</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4f63720d8b244a68941932992cd9f4d_I20221231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xOS9mcmFnOjZmYmQzMDlmMGUwYjQ2NGNhNjhhMmFhMjdjYWIzOGM3L3RhYmxlOjJiODJlMWQ5NDE0ZjQ2NmQ5NTg3YWU2M2NjODQ3YWYzL3RhYmxlcmFuZ2U6MmI4MmUxZDk0MTRmNDY2ZDk1ODdhZTYzY2M4NDdhZjNfNDAtMy0xLTEtNDU5MTk_237d135a-51de-46a8-9111-75706acad71f">745,545</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities and shareholders&#8217; equity</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i738c2d1dacaf436faf03cc46ab9cef23_I20230331" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xOS9mcmFnOjZmYmQzMDlmMGUwYjQ2NGNhNjhhMmFhMjdjYWIzOGM3L3RhYmxlOjJiODJlMWQ5NDE0ZjQ2NmQ5NTg3YWU2M2NjODQ3YWYzL3RhYmxlcmFuZ2U6MmI4MmUxZDk0MTRmNDY2ZDk1ODdhZTYzY2M4NDdhZjNfNDEtMS0xLTEtNDU5MTk_8c1134aa-f9ee-4ff9-9aa8-f85e8d382b1d">2,320,120</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4f63720d8b244a68941932992cd9f4d_I20221231" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xOS9mcmFnOjZmYmQzMDlmMGUwYjQ2NGNhNjhhMmFhMjdjYWIzOGM3L3RhYmxlOjJiODJlMWQ5NDE0ZjQ2NmQ5NTg3YWU2M2NjODQ3YWYzL3RhYmxlcmFuZ2U6MmI4MmUxZDk0MTRmNDY2ZDk1ODdhZTYzY2M4NDdhZjNfNDEtMy0xLTEtNDU5MTk_10038cee-57bf-4dda-8ca0-8c0f27ee584d">2,297,592</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;See notes to consolidated condensed financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</span></div></div></div><div id="i952e7af9c0b94e65995973e7f212f399_22"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline" href="#i952e7af9c0b94e65995973e7f212f399_7">Table of Contents</a></span></div></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONMED CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED CONDENSED STATEMENTS OF SHAREHOLDERS' EQUITY</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited, in thousands except per share amounts)</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:35.996%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.498%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.524%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.111%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.111%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.803%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.111%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.046%"></td><td style="width:0.1%"></td></tr><tr style="height:26pt"><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">Paid-in<br/>Capital</span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">Retained<br/>Earnings</span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">Accumulated<br/>Other<br/>Comprehensive<br/>Loss</span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">Treasury<br/>Stock</span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">Shareholders&#8217;<br/>Equity</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Balance at December&#160;31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iab594279d9ab4ade89e55f698f81cb18_I20221231" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yMi9mcmFnOjRlZjhhMzg3NWQzNDQxMzNhYTVkM2YxMjA4ZjZhNzVmL3RhYmxlOmI0Y2Q1OTkwNjlkNDQ2ZTdhMTViNjM5ZTU2NWVlMDhmL3RhYmxlcmFuZ2U6YjRjZDU5OTA2OWQ0NDZlN2ExNWI2MzllNTY1ZWUwOGZfMi0xLTEtMS00NTkxOQ_3753a616-3589-4c3d-b86b-e6133170fb8e">31,299</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab594279d9ab4ade89e55f698f81cb18_I20221231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yMi9mcmFnOjRlZjhhMzg3NWQzNDQxMzNhYTVkM2YxMjA4ZjZhNzVmL3RhYmxlOmI0Y2Q1OTkwNjlkNDQ2ZTdhMTViNjM5ZTU2NWVlMDhmL3RhYmxlcmFuZ2U6YjRjZDU5OTA2OWQ0NDZlN2ExNWI2MzllNTY1ZWUwOGZfMi0yLTEtMS00NTkxOQ_c5c3895a-434b-4ef6-a381-dfcdc6ccf872">313</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7b8c6548e4e406d84526eb06077992a_I20221231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yMi9mcmFnOjRlZjhhMzg3NWQzNDQxMzNhYTVkM2YxMjA4ZjZhNzVmL3RhYmxlOmI0Y2Q1OTkwNjlkNDQ2ZTdhMTViNjM5ZTU2NWVlMDhmL3RhYmxlcmFuZ2U6YjRjZDU5OTA2OWQ0NDZlN2ExNWI2MzllNTY1ZWUwOGZfMi0zLTEtMS00NTkxOQ_9fda8863-4f81-41d5-bd22-e3b51a5e63a1">413,235</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if120f3461d36460aad6ccdf8d2faa0ba_I20221231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yMi9mcmFnOjRlZjhhMzg3NWQzNDQxMzNhYTVkM2YxMjA4ZjZhNzVmL3RhYmxlOmI0Y2Q1OTkwNjlkNDQ2ZTdhMTViNjM5ZTU2NWVlMDhmL3RhYmxlcmFuZ2U6YjRjZDU5OTA2OWQ0NDZlN2ExNWI2MzllNTY1ZWUwOGZfMi00LTEtMS00NTkxOQ_e8156402-bc7e-497f-ae91-dca0c2b1c7ef">412,631</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7467bf1c44a741c2a174d8fda8ebb019_I20221231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yMi9mcmFnOjRlZjhhMzg3NWQzNDQxMzNhYTVkM2YxMjA4ZjZhNzVmL3RhYmxlOmI0Y2Q1OTkwNjlkNDQ2ZTdhMTViNjM5ZTU2NWVlMDhmL3RhYmxlcmFuZ2U6YjRjZDU5OTA2OWQ0NDZlN2ExNWI2MzllNTY1ZWUwOGZfMi01LTEtMS00NTkxOQ_fc637e5a-0a7e-424d-b28f-0d1932a82192">57,858</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaca150a4def842dc82f49cd1d16f8299_I20221231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yMi9mcmFnOjRlZjhhMzg3NWQzNDQxMzNhYTVkM2YxMjA4ZjZhNzVmL3RhYmxlOmI0Y2Q1OTkwNjlkNDQ2ZTdhMTViNjM5ZTU2NWVlMDhmL3RhYmxlcmFuZ2U6YjRjZDU5OTA2OWQ0NDZlN2ExNWI2MzllNTY1ZWUwOGZfMi02LTEtMS00NTkxOQ_3c6da392-c3a4-4d37-b072-aabe418ba05a">22,776</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4f63720d8b244a68941932992cd9f4d_I20221231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yMi9mcmFnOjRlZjhhMzg3NWQzNDQxMzNhYTVkM2YxMjA4ZjZhNzVmL3RhYmxlOmI0Y2Q1OTkwNjlkNDQ2ZTdhMTViNjM5ZTU2NWVlMDhmL3RhYmxlcmFuZ2U6YjRjZDU5OTA2OWQ0NDZlN2ExNWI2MzllNTY1ZWUwOGZfMi03LTEtMS00NTkxOQ_196cadce-8db0-4332-ab6e-b99b36672546">745,545</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Common stock issued under employee plans</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a1eaccdf00242e8a344de7091fb416e_D20230101-20230331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yMi9mcmFnOjRlZjhhMzg3NWQzNDQxMzNhYTVkM2YxMjA4ZjZhNzVmL3RhYmxlOmI0Y2Q1OTkwNjlkNDQ2ZTdhMTViNjM5ZTU2NWVlMDhmL3RhYmxlcmFuZ2U6YjRjZDU5OTA2OWQ0NDZlN2ExNWI2MzllNTY1ZWUwOGZfMy0zLTEtMS00NTkxOQ_31b27049-d905-4103-8274-40717f7a5e09">556</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida5b0e90904045df9a5437b94848a04d_D20230101-20230331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yMi9mcmFnOjRlZjhhMzg3NWQzNDQxMzNhYTVkM2YxMjA4ZjZhNzVmL3RhYmxlOmI0Y2Q1OTkwNjlkNDQ2ZTdhMTViNjM5ZTU2NWVlMDhmL3RhYmxlcmFuZ2U6YjRjZDU5OTA2OWQ0NDZlN2ExNWI2MzllNTY1ZWUwOGZfMy02LTEtMS00NTkxOQ_ee4d1bda-f7fe-4c4c-88fc-8895f7147dd2">2,044</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yMi9mcmFnOjRlZjhhMzg3NWQzNDQxMzNhYTVkM2YxMjA4ZjZhNzVmL3RhYmxlOmI0Y2Q1OTkwNjlkNDQ2ZTdhMTViNjM5ZTU2NWVlMDhmL3RhYmxlcmFuZ2U6YjRjZDU5OTA2OWQ0NDZlN2ExNWI2MzllNTY1ZWUwOGZfMy03LTEtMS00NTkxOQ_2f73f4ca-cb21-4c9f-aa07-eb3c7d3b0499">2,600</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a1eaccdf00242e8a344de7091fb416e_D20230101-20230331" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yMi9mcmFnOjRlZjhhMzg3NWQzNDQxMzNhYTVkM2YxMjA4ZjZhNzVmL3RhYmxlOmI0Y2Q1OTkwNjlkNDQ2ZTdhMTViNjM5ZTU2NWVlMDhmL3RhYmxlcmFuZ2U6YjRjZDU5OTA2OWQ0NDZlN2ExNWI2MzllNTY1ZWUwOGZfNC0zLTEtMS00NTkxOQ_f1e61d3b-1d51-437e-8a75-858098ea50b6">5,726</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yMi9mcmFnOjRlZjhhMzg3NWQzNDQxMzNhYTVkM2YxMjA4ZjZhNzVmL3RhYmxlOmI0Y2Q1OTkwNjlkNDQ2ZTdhMTViNjM5ZTU2NWVlMDhmL3RhYmxlcmFuZ2U6YjRjZDU5OTA2OWQ0NDZlN2ExNWI2MzllNTY1ZWUwOGZfNC03LTEtMS00NTkxOQ_068acb60-982a-4dc4-8d48-925d8841e94c">5,726</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Dividends on common stock ($<ix:nonFraction unitRef="usdPerShare" contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331" decimals="2" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yMi9mcmFnOjRlZjhhMzg3NWQzNDQxMzNhYTVkM2YxMjA4ZjZhNzVmL3RhYmxlOmI0Y2Q1OTkwNjlkNDQ2ZTdhMTViNjM5ZTU2NWVlMDhmL3RhYmxlcmFuZ2U6YjRjZDU5OTA2OWQ0NDZlN2ExNWI2MzllNTY1ZWUwOGZfNS0wLTEtMS00NTkxOS90ZXh0cmVnaW9uOmQ0MTVkMGI2NmYyYTQ3MmQ5YmViOWMyMjYwZjUyODU2XzMx_ad241424-5689-44bd-b209-bc7733036cac">0.20</ix:nonFraction> per share)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idd1e8990d17d4c29a09ce497b0e3d5e9_D20230101-20230331" decimals="-3" name="us-gaap:DividendsCommonStockCash" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yMi9mcmFnOjRlZjhhMzg3NWQzNDQxMzNhYTVkM2YxMjA4ZjZhNzVmL3RhYmxlOmI0Y2Q1OTkwNjlkNDQ2ZTdhMTViNjM5ZTU2NWVlMDhmL3RhYmxlcmFuZ2U6YjRjZDU5OTA2OWQ0NDZlN2ExNWI2MzllNTY1ZWUwOGZfNS00LTEtMS00NTkxOQ_d2fc999a-d0be-4d0d-850b-6b72ffc36080">6,113</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331" decimals="-3" name="us-gaap:DividendsCommonStockCash" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yMi9mcmFnOjRlZjhhMzg3NWQzNDQxMzNhYTVkM2YxMjA4ZjZhNzVmL3RhYmxlOmI0Y2Q1OTkwNjlkNDQ2ZTdhMTViNjM5ZTU2NWVlMDhmL3RhYmxlcmFuZ2U6YjRjZDU5OTA2OWQ0NDZlN2ExNWI2MzllNTY1ZWUwOGZfNS03LTEtMS00NTkxOQ_e571afaa-fc7c-42b4-9351-4724052971e1">6,113</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Comprehensive income:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Cash flow hedging gain, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8faa12cfbcc746b48b96bb341f53eff6_D20230101-20230331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yMi9mcmFnOjRlZjhhMzg3NWQzNDQxMzNhYTVkM2YxMjA4ZjZhNzVmL3RhYmxlOmI0Y2Q1OTkwNjlkNDQ2ZTdhMTViNjM5ZTU2NWVlMDhmL3RhYmxlcmFuZ2U6YjRjZDU5OTA2OWQ0NDZlN2ExNWI2MzllNTY1ZWUwOGZfMTAtNS0xLTEtNDU5MTk_de13a84d-502f-4f84-9156-15e766dc9055">877</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Pension liability, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8faa12cfbcc746b48b96bb341f53eff6_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yMi9mcmFnOjRlZjhhMzg3NWQzNDQxMzNhYTVkM2YxMjA4ZjZhNzVmL3RhYmxlOmI0Y2Q1OTkwNjlkNDQ2ZTdhMTViNjM5ZTU2NWVlMDhmL3RhYmxlcmFuZ2U6YjRjZDU5OTA2OWQ0NDZlN2ExNWI2MzllNTY1ZWUwOGZfMTEtNS0xLTEtNDU5MTk_c828d914-8d64-4a45-9a5b-30b8ef1f6a1a">403</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Foreign currency translation adjustments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8faa12cfbcc746b48b96bb341f53eff6_D20230101-20230331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yMi9mcmFnOjRlZjhhMzg3NWQzNDQxMzNhYTVkM2YxMjA4ZjZhNzVmL3RhYmxlOmI0Y2Q1OTkwNjlkNDQ2ZTdhMTViNjM5ZTU2NWVlMDhmL3RhYmxlcmFuZ2U6YjRjZDU5OTA2OWQ0NDZlN2ExNWI2MzllNTY1ZWUwOGZfMTItNS0xLTEtNDU5MTk_e6cf437f-a0f5-40dd-8597-ae4049160400">1,596</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd1e8990d17d4c29a09ce497b0e3d5e9_D20230101-20230331" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yMi9mcmFnOjRlZjhhMzg3NWQzNDQxMzNhYTVkM2YxMjA4ZjZhNzVmL3RhYmxlOmI0Y2Q1OTkwNjlkNDQ2ZTdhMTViNjM5ZTU2NWVlMDhmL3RhYmxlcmFuZ2U6YjRjZDU5OTA2OWQ0NDZlN2ExNWI2MzllNTY1ZWUwOGZfMTMtNC0xLTEtNDU5MTk_31142bde-3a3f-46aa-a244-0a9792d2802f">1,819</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Total comprehensive income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yMi9mcmFnOjRlZjhhMzg3NWQzNDQxMzNhYTVkM2YxMjA4ZjZhNzVmL3RhYmxlOmI0Y2Q1OTkwNjlkNDQ2ZTdhMTViNjM5ZTU2NWVlMDhmL3RhYmxlcmFuZ2U6YjRjZDU5OTA2OWQ0NDZlN2ExNWI2MzllNTY1ZWUwOGZfMTQtNy0xLTEtNDU5MTk_c593cbe2-804c-4b97-9e9c-bc040fdc33ab">4,695</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Balance at March&#160;31, 2023</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i92319359f0d94bf68894ee4109dfcf00_I20230331" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yMi9mcmFnOjRlZjhhMzg3NWQzNDQxMzNhYTVkM2YxMjA4ZjZhNzVmL3RhYmxlOmI0Y2Q1OTkwNjlkNDQ2ZTdhMTViNjM5ZTU2NWVlMDhmL3RhYmxlcmFuZ2U6YjRjZDU5OTA2OWQ0NDZlN2ExNWI2MzllNTY1ZWUwOGZfMTYtMS0xLTEtNDU5MTk_46b2963b-f06a-4331-bc10-b548af173f3b">31,299</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92319359f0d94bf68894ee4109dfcf00_I20230331" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yMi9mcmFnOjRlZjhhMzg3NWQzNDQxMzNhYTVkM2YxMjA4ZjZhNzVmL3RhYmxlOmI0Y2Q1OTkwNjlkNDQ2ZTdhMTViNjM5ZTU2NWVlMDhmL3RhYmxlcmFuZ2U6YjRjZDU5OTA2OWQ0NDZlN2ExNWI2MzllNTY1ZWUwOGZfMTYtMi0xLTEtNDU5MTk_cda5522b-6616-4d0a-b589-a8d2486f735c">313</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9127d3c9a72c45de99f25a116340aff0_I20230331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yMi9mcmFnOjRlZjhhMzg3NWQzNDQxMzNhYTVkM2YxMjA4ZjZhNzVmL3RhYmxlOmI0Y2Q1OTkwNjlkNDQ2ZTdhMTViNjM5ZTU2NWVlMDhmL3RhYmxlcmFuZ2U6YjRjZDU5OTA2OWQ0NDZlN2ExNWI2MzllNTY1ZWUwOGZfMTYtMy0xLTEtNDU5MTk_ae02ef6d-2235-4bb8-9ac6-11c855d644b5">419,517</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i506e9fffe4144fdfa3c8d262ff65a801_I20230331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yMi9mcmFnOjRlZjhhMzg3NWQzNDQxMzNhYTVkM2YxMjA4ZjZhNzVmL3RhYmxlOmI0Y2Q1OTkwNjlkNDQ2ZTdhMTViNjM5ZTU2NWVlMDhmL3RhYmxlcmFuZ2U6YjRjZDU5OTA2OWQ0NDZlN2ExNWI2MzllNTY1ZWUwOGZfMTYtNC0xLTEtNDU5MTk_0be247f8-3fe6-4b66-9c42-ecdd74f1290e">408,337</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i991a26c35f3a4004a04b9c93216cb10b_I20230331" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yMi9mcmFnOjRlZjhhMzg3NWQzNDQxMzNhYTVkM2YxMjA4ZjZhNzVmL3RhYmxlOmI0Y2Q1OTkwNjlkNDQ2ZTdhMTViNjM5ZTU2NWVlMDhmL3RhYmxlcmFuZ2U6YjRjZDU5OTA2OWQ0NDZlN2ExNWI2MzllNTY1ZWUwOGZfMTYtNS0xLTEtNDU5MTk_364ba74d-3a82-4a37-8127-c713d5818db3">54,982</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if8bf9b92b9754cb49ead7853527c0c87_I20230331" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yMi9mcmFnOjRlZjhhMzg3NWQzNDQxMzNhYTVkM2YxMjA4ZjZhNzVmL3RhYmxlOmI0Y2Q1OTkwNjlkNDQ2ZTdhMTViNjM5ZTU2NWVlMDhmL3RhYmxlcmFuZ2U6YjRjZDU5OTA2OWQ0NDZlN2ExNWI2MzllNTY1ZWUwOGZfMTYtNi0xLTEtNDU5MTk_938b4cac-0114-412b-b8a6-447e1748429c">20,732</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i738c2d1dacaf436faf03cc46ab9cef23_I20230331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yMi9mcmFnOjRlZjhhMzg3NWQzNDQxMzNhYTVkM2YxMjA4ZjZhNzVmL3RhYmxlOmI0Y2Q1OTkwNjlkNDQ2ZTdhMTViNjM5ZTU2NWVlMDhmL3RhYmxlcmFuZ2U6YjRjZDU5OTA2OWQ0NDZlN2ExNWI2MzllNTY1ZWUwOGZfMTYtNy0xLTEtNDU5MTk_599ce202-87cd-44fb-9063-4d639d049e2f">752,453</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:35.996%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.498%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.524%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.111%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.111%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.803%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.111%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.046%"></td><td style="width:0.1%"></td></tr><tr style="height:26pt"><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">Paid-in<br/>Capital</span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">Retained<br/>Earnings</span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">Accumulated<br/>Other<br/>Comprehensive<br/>Loss</span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">Treasury<br/>Stock</span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">Shareholders&#8217;<br/>Equity</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Balance at December&#160;31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="icb342dd07ae648ba88c184ef672faf7e_I20211231" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yMi9mcmFnOjRlZjhhMzg3NWQzNDQxMzNhYTVkM2YxMjA4ZjZhNzVmL3RhYmxlOjQ1NzViM2U2MDFhMDQ4MTY5Y2FjMDM2ZjcwZWRhNWJmL3RhYmxlcmFuZ2U6NDU3NWIzZTYwMWEwNDgxNjljYWMwMzZmNzBlZGE1YmZfMi0xLTEtMS00NTkxOQ_7e1c581e-6503-44bc-9078-5f1fc12330c4">31,299</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb342dd07ae648ba88c184ef672faf7e_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yMi9mcmFnOjRlZjhhMzg3NWQzNDQxMzNhYTVkM2YxMjA4ZjZhNzVmL3RhYmxlOjQ1NzViM2U2MDFhMDQ4MTY5Y2FjMDM2ZjcwZWRhNWJmL3RhYmxlcmFuZ2U6NDU3NWIzZTYwMWEwNDgxNjljYWMwMzZmNzBlZGE1YmZfMi0yLTEtMS00NTkxOQ_40fa39fe-b474-4abc-b34a-a5838f4fafb2">313</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia00f7e8577d7414dae3eec75b3959321_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yMi9mcmFnOjRlZjhhMzg3NWQzNDQxMzNhYTVkM2YxMjA4ZjZhNzVmL3RhYmxlOjQ1NzViM2U2MDFhMDQ4MTY5Y2FjMDM2ZjcwZWRhNWJmL3RhYmxlcmFuZ2U6NDU3NWIzZTYwMWEwNDgxNjljYWMwMzZmNzBlZGE1YmZfMi0zLTEtMS00NTkxOQ_a8be4574-4e32-49d2-9786-bfa93cecb8ef">396,771</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f463e4994b14c1bb3ce927524a1bdc7_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yMi9mcmFnOjRlZjhhMzg3NWQzNDQxMzNhYTVkM2YxMjA4ZjZhNzVmL3RhYmxlOjQ1NzViM2U2MDFhMDQ4MTY5Y2FjMDM2ZjcwZWRhNWJmL3RhYmxlcmFuZ2U6NDU3NWIzZTYwMWEwNDgxNjljYWMwMzZmNzBlZGE1YmZfMi00LTEtMS00NTkxOQ_ab024462-7c7b-4aa5-b509-1ed900365018">496,605</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iee31e42803274180ade2d654c9f2c44a_I20211231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yMi9mcmFnOjRlZjhhMzg3NWQzNDQxMzNhYTVkM2YxMjA4ZjZhNzVmL3RhYmxlOjQ1NzViM2U2MDFhMDQ4MTY5Y2FjMDM2ZjcwZWRhNWJmL3RhYmxlcmFuZ2U6NDU3NWIzZTYwMWEwNDgxNjljYWMwMzZmNzBlZGE1YmZfMi01LTEtMS00NTkxOQ_9a5fb60e-0c63-494c-981c-7302aa237e8f">54,203</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i51431cd2971e460797df867a2da93b0e_I20211231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yMi9mcmFnOjRlZjhhMzg3NWQzNDQxMzNhYTVkM2YxMjA4ZjZhNzVmL3RhYmxlOjQ1NzViM2U2MDFhMDQ4MTY5Y2FjMDM2ZjcwZWRhNWJmL3RhYmxlcmFuZ2U6NDU3NWIzZTYwMWEwNDgxNjljYWMwMzZmNzBlZGE1YmZfMi02LTEtMS00NTkxOQ_09a09c3f-7022-4e09-ab6a-b11a00a3acf2">54,051</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia4bed28ea4b04a1d9fca88fa74e6040c_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yMi9mcmFnOjRlZjhhMzg3NWQzNDQxMzNhYTVkM2YxMjA4ZjZhNzVmL3RhYmxlOjQ1NzViM2U2MDFhMDQ4MTY5Y2FjMDM2ZjcwZWRhNWJmL3RhYmxlcmFuZ2U6NDU3NWIzZTYwMWEwNDgxNjljYWMwMzZmNzBlZGE1YmZfMi03LTEtMS00NTkxOQ_6169c302-e8ee-4085-b580-473ef6002cd2">785,435</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Common stock issued under employee plans</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2cfecd0f3dbb4727931bba8cc920743d_D20220101-20220331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yMi9mcmFnOjRlZjhhMzg3NWQzNDQxMzNhYTVkM2YxMjA4ZjZhNzVmL3RhYmxlOjQ1NzViM2U2MDFhMDQ4MTY5Y2FjMDM2ZjcwZWRhNWJmL3RhYmxlcmFuZ2U6NDU3NWIzZTYwMWEwNDgxNjljYWMwMzZmNzBlZGE1YmZfMy0zLTEtMS00NTkxOQ_665b8cb9-6fe9-47eb-b5af-231139d5293c">2,232</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4afaa0ad2d10419c84dae15a77c31488_D20220101-20220331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yMi9mcmFnOjRlZjhhMzg3NWQzNDQxMzNhYTVkM2YxMjA4ZjZhNzVmL3RhYmxlOjQ1NzViM2U2MDFhMDQ4MTY5Y2FjMDM2ZjcwZWRhNWJmL3RhYmxlcmFuZ2U6NDU3NWIzZTYwMWEwNDgxNjljYWMwMzZmNzBlZGE1YmZfMy02LTEtMS00NTkxOQ_101adba3-4f24-406e-b054-d0c25a9374b2">4,020</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9500a5ee8dbe4d23aa9c46ebdd25a0c8_D20220101-20220331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yMi9mcmFnOjRlZjhhMzg3NWQzNDQxMzNhYTVkM2YxMjA4ZjZhNzVmL3RhYmxlOjQ1NzViM2U2MDFhMDQ4MTY5Y2FjMDM2ZjcwZWRhNWJmL3RhYmxlcmFuZ2U6NDU3NWIzZTYwMWEwNDgxNjljYWMwMzZmNzBlZGE1YmZfMy03LTEtMS00NTkxOQ_01f0b8a3-4a64-4617-8991-66a271431a78">6,252</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2cfecd0f3dbb4727931bba8cc920743d_D20220101-20220331" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yMi9mcmFnOjRlZjhhMzg3NWQzNDQxMzNhYTVkM2YxMjA4ZjZhNzVmL3RhYmxlOjQ1NzViM2U2MDFhMDQ4MTY5Y2FjMDM2ZjcwZWRhNWJmL3RhYmxlcmFuZ2U6NDU3NWIzZTYwMWEwNDgxNjljYWMwMzZmNzBlZGE1YmZfNC0zLTEtMS00NTkxOQ_a16748a5-03cf-4093-9107-80e762972189">4,463</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9500a5ee8dbe4d23aa9c46ebdd25a0c8_D20220101-20220331" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yMi9mcmFnOjRlZjhhMzg3NWQzNDQxMzNhYTVkM2YxMjA4ZjZhNzVmL3RhYmxlOjQ1NzViM2U2MDFhMDQ4MTY5Y2FjMDM2ZjcwZWRhNWJmL3RhYmxlcmFuZ2U6NDU3NWIzZTYwMWEwNDgxNjljYWMwMzZmNzBlZGE1YmZfNC03LTEtMS00NTkxOQ_91b3d675-40c8-415d-9212-fd7c8d793300">4,463</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Dividends on common stock ($<ix:nonFraction unitRef="usdPerShare" contextRef="i9500a5ee8dbe4d23aa9c46ebdd25a0c8_D20220101-20220331" decimals="2" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yMi9mcmFnOjRlZjhhMzg3NWQzNDQxMzNhYTVkM2YxMjA4ZjZhNzVmL3RhYmxlOjQ1NzViM2U2MDFhMDQ4MTY5Y2FjMDM2ZjcwZWRhNWJmL3RhYmxlcmFuZ2U6NDU3NWIzZTYwMWEwNDgxNjljYWMwMzZmNzBlZGE1YmZfNS0wLTEtMS00NTkxOS90ZXh0cmVnaW9uOjNiMjhjNDlhODUwOTQwNjBhM2JlNDllYWQyMmJkMGU2XzMx_e2bb8d4c-47b3-493f-97ca-d8fed258b29a">0.20</ix:nonFraction> per share)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if2f0b0e837ae40e3bd5d07cc3ec663d4_D20220101-20220331" decimals="-3" name="us-gaap:DividendsCommonStockCash" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yMi9mcmFnOjRlZjhhMzg3NWQzNDQxMzNhYTVkM2YxMjA4ZjZhNzVmL3RhYmxlOjQ1NzViM2U2MDFhMDQ4MTY5Y2FjMDM2ZjcwZWRhNWJmL3RhYmxlcmFuZ2U6NDU3NWIzZTYwMWEwNDgxNjljYWMwMzZmNzBlZGE1YmZfNS00LTEtMS00NTkxOQ_646bc4be-0106-47fe-a65b-72c98c4889ac">5,899</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9500a5ee8dbe4d23aa9c46ebdd25a0c8_D20220101-20220331" decimals="-3" name="us-gaap:DividendsCommonStockCash" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yMi9mcmFnOjRlZjhhMzg3NWQzNDQxMzNhYTVkM2YxMjA4ZjZhNzVmL3RhYmxlOjQ1NzViM2U2MDFhMDQ4MTY5Y2FjMDM2ZjcwZWRhNWJmL3RhYmxlcmFuZ2U6NDU3NWIzZTYwMWEwNDgxNjljYWMwMzZmNzBlZGE1YmZfNS03LTEtMS00NTkxOQ_3bcab615-6535-40b6-aaae-fab0ed8ed5e3">5,899</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Comprehensive income (loss):</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Cash flow hedging gain, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia66bff082e1642cd80c9ac67a0cc60fe_D20220101-20220331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yMi9mcmFnOjRlZjhhMzg3NWQzNDQxMzNhYTVkM2YxMjA4ZjZhNzVmL3RhYmxlOjQ1NzViM2U2MDFhMDQ4MTY5Y2FjMDM2ZjcwZWRhNWJmL3RhYmxlcmFuZ2U6NDU3NWIzZTYwMWEwNDgxNjljYWMwMzZmNzBlZGE1YmZfNy01LTEtMS00NTkxOQ_0721bca2-4ce6-4a43-9cca-84c1fbc92c76">1,082</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Pension liability, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia66bff082e1642cd80c9ac67a0cc60fe_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yMi9mcmFnOjRlZjhhMzg3NWQzNDQxMzNhYTVkM2YxMjA4ZjZhNzVmL3RhYmxlOjQ1NzViM2U2MDFhMDQ4MTY5Y2FjMDM2ZjcwZWRhNWJmL3RhYmxlcmFuZ2U6NDU3NWIzZTYwMWEwNDgxNjljYWMwMzZmNzBlZGE1YmZfOC01LTEtMS00NTkxOQ_90089a43-d00c-4f5c-a303-1cdfad83d715">521</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Foreign currency translation adjustments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia66bff082e1642cd80c9ac67a0cc60fe_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yMi9mcmFnOjRlZjhhMzg3NWQzNDQxMzNhYTVkM2YxMjA4ZjZhNzVmL3RhYmxlOjQ1NzViM2U2MDFhMDQ4MTY5Y2FjMDM2ZjcwZWRhNWJmL3RhYmxlcmFuZ2U6NDU3NWIzZTYwMWEwNDgxNjljYWMwMzZmNzBlZGE1YmZfOS01LTEtMS00NTkxOQ_b8568d8c-cd22-4778-be5f-d6b55965b716">163</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2f0b0e837ae40e3bd5d07cc3ec663d4_D20220101-20220331" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yMi9mcmFnOjRlZjhhMzg3NWQzNDQxMzNhYTVkM2YxMjA4ZjZhNzVmL3RhYmxlOjQ1NzViM2U2MDFhMDQ4MTY5Y2FjMDM2ZjcwZWRhNWJmL3RhYmxlcmFuZ2U6NDU3NWIzZTYwMWEwNDgxNjljYWMwMzZmNzBlZGE1YmZfMTAtNC0xLTEtNDU5MTk_40606f2e-e953-4c43-aa26-4bfffb7f1069">14,975</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Total comprehensive income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9500a5ee8dbe4d23aa9c46ebdd25a0c8_D20220101-20220331" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yMi9mcmFnOjRlZjhhMzg3NWQzNDQxMzNhYTVkM2YxMjA4ZjZhNzVmL3RhYmxlOjQ1NzViM2U2MDFhMDQ4MTY5Y2FjMDM2ZjcwZWRhNWJmL3RhYmxlcmFuZ2U6NDU3NWIzZTYwMWEwNDgxNjljYWMwMzZmNzBlZGE1YmZfMTEtNy0xLTEtNDU5MTk_46756733-5bb6-41fd-9854-a9b9d88a8aaf">16,415</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yMi9mcmFnOjRlZjhhMzg3NWQzNDQxMzNhYTVkM2YxMjA4ZjZhNzVmL3RhYmxlOjQ1NzViM2U2MDFhMDQ4MTY5Y2FjMDM2ZjcwZWRhNWJmL3RhYmxlcmFuZ2U6NDU3NWIzZTYwMWEwNDgxNjljYWMwMzZmNzBlZGE1YmZfMTItMC0xLTEtNDY0MDU_bc705460-c49b-465b-9afe-4187d60ffe68"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Cumulative effect of change in accounting principle</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.52pt;font-weight:400;line-height:100%;position:relative;top:-2.97pt;vertical-align:baseline">(1)</span></span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5142ed70f8b347f2864cd50f2a21c01c_I20220331" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yMi9mcmFnOjRlZjhhMzg3NWQzNDQxMzNhYTVkM2YxMjA4ZjZhNzVmL3RhYmxlOjQ1NzViM2U2MDFhMDQ4MTY5Y2FjMDM2ZjcwZWRhNWJmL3RhYmxlcmFuZ2U6NDU3NWIzZTYwMWEwNDgxNjljYWMwMzZmNzBlZGE1YmZfMTItMy0xLTEtNDY0MDU_cfef9874-6ec2-42b5-801c-7abe9a1e0261">37,911</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fb909d76a5f4b7aa413e5dfa01ad54c_I20220331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yMi9mcmFnOjRlZjhhMzg3NWQzNDQxMzNhYTVkM2YxMjA4ZjZhNzVmL3RhYmxlOjQ1NzViM2U2MDFhMDQ4MTY5Y2FjMDM2ZjcwZWRhNWJmL3RhYmxlcmFuZ2U6NDU3NWIzZTYwMWEwNDgxNjljYWMwMzZmNzBlZGE1YmZfMTItNC0xLTEtNDY0MDU_800b98f9-a0f2-47d2-ab38-b018d0a13d2c">20,791</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie301d028eb864cd3856cc78cb6269b1a_I20220331" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yMi9mcmFnOjRlZjhhMzg3NWQzNDQxMzNhYTVkM2YxMjA4ZjZhNzVmL3RhYmxlOjQ1NzViM2U2MDFhMDQ4MTY5Y2FjMDM2ZjcwZWRhNWJmL3RhYmxlcmFuZ2U6NDU3NWIzZTYwMWEwNDgxNjljYWMwMzZmNzBlZGE1YmZfMTItNy0xLTEtNDY0MDU_9abb2f00-e46a-4479-b6e5-b85487673102">17,120</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Balance at March&#160;31, 2022</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i441ac12b39534fb9b34b6a58c4e4cc39_I20220331" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yMi9mcmFnOjRlZjhhMzg3NWQzNDQxMzNhYTVkM2YxMjA4ZjZhNzVmL3RhYmxlOjQ1NzViM2U2MDFhMDQ4MTY5Y2FjMDM2ZjcwZWRhNWJmL3RhYmxlcmFuZ2U6NDU3NWIzZTYwMWEwNDgxNjljYWMwMzZmNzBlZGE1YmZfMTItMS0xLTEtNDU5MTk_0fa9320c-dd5d-4dd5-a33b-f4875ff77049">31,299</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i441ac12b39534fb9b34b6a58c4e4cc39_I20220331" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yMi9mcmFnOjRlZjhhMzg3NWQzNDQxMzNhYTVkM2YxMjA4ZjZhNzVmL3RhYmxlOjQ1NzViM2U2MDFhMDQ4MTY5Y2FjMDM2ZjcwZWRhNWJmL3RhYmxlcmFuZ2U6NDU3NWIzZTYwMWEwNDgxNjljYWMwMzZmNzBlZGE1YmZfMTItMi0xLTEtNDU5MTk_20415283-93ca-4244-b7d7-0e55273c1703">313</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2335e528dd1244098fa2557c3aebbd19_I20220331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yMi9mcmFnOjRlZjhhMzg3NWQzNDQxMzNhYTVkM2YxMjA4ZjZhNzVmL3RhYmxlOjQ1NzViM2U2MDFhMDQ4MTY5Y2FjMDM2ZjcwZWRhNWJmL3RhYmxlcmFuZ2U6NDU3NWIzZTYwMWEwNDgxNjljYWMwMzZmNzBlZGE1YmZfMTItMy0xLTEtNDU5MTk_8b4edf9a-04e1-42ed-bf51-251205dc3f9b">365,555</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0539b1c96151418c99ad4f945625ba30_I20220331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yMi9mcmFnOjRlZjhhMzg3NWQzNDQxMzNhYTVkM2YxMjA4ZjZhNzVmL3RhYmxlOjQ1NzViM2U2MDFhMDQ4MTY5Y2FjMDM2ZjcwZWRhNWJmL3RhYmxlcmFuZ2U6NDU3NWIzZTYwMWEwNDgxNjljYWMwMzZmNzBlZGE1YmZfMTItNC0xLTEtNDU5MTk_42f25fce-ddbb-469f-99ae-18752df64e64">526,472</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib861e1905d064d5684a5172a6232ad41_I20220331" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yMi9mcmFnOjRlZjhhMzg3NWQzNDQxMzNhYTVkM2YxMjA4ZjZhNzVmL3RhYmxlOjQ1NzViM2U2MDFhMDQ4MTY5Y2FjMDM2ZjcwZWRhNWJmL3RhYmxlcmFuZ2U6NDU3NWIzZTYwMWEwNDgxNjljYWMwMzZmNzBlZGE1YmZfMTItNS0xLTEtNDU5MTk_ea700c4c-b41f-4e76-a3c2-3dc557fd241f">52,763</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i522db0d27185495b938d0c8f18f5032f_I20220331" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yMi9mcmFnOjRlZjhhMzg3NWQzNDQxMzNhYTVkM2YxMjA4ZjZhNzVmL3RhYmxlOjQ1NzViM2U2MDFhMDQ4MTY5Y2FjMDM2ZjcwZWRhNWJmL3RhYmxlcmFuZ2U6NDU3NWIzZTYwMWEwNDgxNjljYWMwMzZmNzBlZGE1YmZfMTItNi0xLTEtNDU5MTk_e8f64641-93e8-478a-8927-807f0797c4f8">50,031</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4730ada3cec445989c807f4fe004727c_I20220331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yMi9mcmFnOjRlZjhhMzg3NWQzNDQxMzNhYTVkM2YxMjA4ZjZhNzVmL3RhYmxlOjQ1NzViM2U2MDFhMDQ4MTY5Y2FjMDM2ZjcwZWRhNWJmL3RhYmxlcmFuZ2U6NDU3NWIzZTYwMWEwNDgxNjljYWMwMzZmNzBlZGE1YmZfMTItNy0xLTEtNDU5MTk_57084aaa-00bc-4b31-a88f-aa32d3a252ae">789,546</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="24" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><ix:footnote id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yMi9mcmFnOjRlZjhhMzg3NWQzNDQxMzNhYTVkM2YxMjA4ZjZhNzVmL3RhYmxlOjQ1NzViM2U2MDFhMDQ4MTY5Y2FjMDM2ZjcwZWRhNWJmL3RhYmxlcmFuZ2U6NDU3NWIzZTYwMWEwNDgxNjljYWMwMzZmNzBlZGE1YmZfMTMtMC0xLTEtNDY0MDE_046f1bcf-28f6-4ffe-8b0c-3932efd1e841" footnoteRole="http://www.xbrl.org/2003/role/footnote"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.52pt;font-weight:400;line-height:100%;position:relative;top:-2.97pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">We recorded the cumulative impact of adopting Accounting Standards Update (ASU) 2020-06, Debt&#8212;Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging&#8212;Contracts in Entity&#8217;s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity&#8217;s Own Equity in 2022.</span></ix:footnote></div></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See notes to consolidated condensed financial statements.</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</span></div></div></div><div id="i952e7af9c0b94e65995973e7f212f399_25"></div><hr style="page-break-after:always"/><div style="min-height:31.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline" href="#i952e7af9c0b94e65995973e7f212f399_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONMED CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED CONDENSED STATEMENTS OF CASH FLOWS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited, in thousands)</span></div><div style="margin-bottom:1pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"></td><td style="width:77.808%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.076%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.079%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flows from operating activities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yNS9mcmFnOjcwZjRjY2U0NjVlOTQ2MWJhN2NkZWRiMzAzNmJjNDE2L3RhYmxlOjcxNTQ4MjkxNjM4ZTQ4OTNhNzNlMWNhZDUwODYxYTRmL3RhYmxlcmFuZ2U6NzE1NDgyOTE2MzhlNDg5M2E3M2UxY2FkNTA4NjFhNGZfNC0xLTEtMS00NTkxOQ_46cea407-de0c-4301-be46-0462f0b2e392">1,819</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9500a5ee8dbe4d23aa9c46ebdd25a0c8_D20220101-20220331" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yNS9mcmFnOjcwZjRjY2U0NjVlOTQ2MWJhN2NkZWRiMzAzNmJjNDE2L3RhYmxlOjcxNTQ4MjkxNjM4ZTQ4OTNhNzNlMWNhZDUwODYxYTRmL3RhYmxlcmFuZ2U6NzE1NDgyOTE2MzhlNDg5M2E3M2UxY2FkNTA4NjFhNGZfNC0zLTEtMS00NTkxOQ_441b1315-5ce7-4dca-9a0a-0f189f3f1900">14,975</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments to reconcile net income to net cash provided by (used in) operating activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331" decimals="-3" name="us-gaap:Depreciation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yNS9mcmFnOjcwZjRjY2U0NjVlOTQ2MWJhN2NkZWRiMzAzNmJjNDE2L3RhYmxlOjcxNTQ4MjkxNjM4ZTQ4OTNhNzNlMWNhZDUwODYxYTRmL3RhYmxlcmFuZ2U6NzE1NDgyOTE2MzhlNDg5M2E3M2UxY2FkNTA4NjFhNGZfNi0xLTEtMS00NTkxOQ_66fa278a-9548-40e1-a497-2b0102f38239">4,057</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9500a5ee8dbe4d23aa9c46ebdd25a0c8_D20220101-20220331" decimals="-3" name="us-gaap:Depreciation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yNS9mcmFnOjcwZjRjY2U0NjVlOTQ2MWJhN2NkZWRiMzAzNmJjNDE2L3RhYmxlOjcxNTQ4MjkxNjM4ZTQ4OTNhNzNlMWNhZDUwODYxYTRmL3RhYmxlcmFuZ2U6NzE1NDgyOTE2MzhlNDg5M2E3M2UxY2FkNTA4NjFhNGZfNi0zLTEtMS00NTkxOQ_e132ec5e-579f-40f3-8599-c20bcb6f923c">4,032</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of deferred debt issuance costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331" decimals="-3" name="us-gaap:AmortizationOfFinancingCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yNS9mcmFnOjcwZjRjY2U0NjVlOTQ2MWJhN2NkZWRiMzAzNmJjNDE2L3RhYmxlOjcxNTQ4MjkxNjM4ZTQ4OTNhNzNlMWNhZDUwODYxYTRmL3RhYmxlcmFuZ2U6NzE1NDgyOTE2MzhlNDg5M2E3M2UxY2FkNTA4NjFhNGZfOC0xLTEtMS00NTkxOQ_5c649ec3-a93f-460a-b65a-2eb8e7a9d7f3">1,506</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9500a5ee8dbe4d23aa9c46ebdd25a0c8_D20220101-20220331" decimals="-3" name="us-gaap:AmortizationOfFinancingCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yNS9mcmFnOjcwZjRjY2U0NjVlOTQ2MWJhN2NkZWRiMzAzNmJjNDE2L3RhYmxlOjcxNTQ4MjkxNjM4ZTQ4OTNhNzNlMWNhZDUwODYxYTRmL3RhYmxlcmFuZ2U6NzE1NDgyOTE2MzhlNDg5M2E3M2UxY2FkNTA4NjFhNGZfOC0zLTEtMS00NTkxOQ_3469dd9d-e57d-449d-8f6a-c33024fdbd46">880</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331" decimals="-3" name="us-gaap:OtherAmortizationOfDeferredCharges" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yNS9mcmFnOjcwZjRjY2U0NjVlOTQ2MWJhN2NkZWRiMzAzNmJjNDE2L3RhYmxlOjcxNTQ4MjkxNjM4ZTQ4OTNhNzNlMWNhZDUwODYxYTRmL3RhYmxlcmFuZ2U6NzE1NDgyOTE2MzhlNDg5M2E3M2UxY2FkNTA4NjFhNGZfOS0xLTEtMS00NTkxOQ_a0c1a194-77f9-46b4-9d7e-ab5d616472cb">13,877</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9500a5ee8dbe4d23aa9c46ebdd25a0c8_D20220101-20220331" decimals="-3" name="us-gaap:OtherAmortizationOfDeferredCharges" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yNS9mcmFnOjcwZjRjY2U0NjVlOTQ2MWJhN2NkZWRiMzAzNmJjNDE2L3RhYmxlOjcxNTQ4MjkxNjM4ZTQ4OTNhNzNlMWNhZDUwODYxYTRmL3RhYmxlcmFuZ2U6NzE1NDgyOTE2MzhlNDg5M2E3M2UxY2FkNTA4NjFhNGZfOS0zLTEtMS00NTkxOQ_bd5b9e33-d6f3-4d4e-a934-489276f05668">12,799</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yNS9mcmFnOjcwZjRjY2U0NjVlOTQ2MWJhN2NkZWRiMzAzNmJjNDE2L3RhYmxlOjcxNTQ4MjkxNjM4ZTQ4OTNhNzNlMWNhZDUwODYxYTRmL3RhYmxlcmFuZ2U6NzE1NDgyOTE2MzhlNDg5M2E3M2UxY2FkNTA4NjFhNGZfMTAtMS0xLTEtNDU5MTk_89efdcfc-2aab-49e2-bf8f-62b91240d726">5,726</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9500a5ee8dbe4d23aa9c46ebdd25a0c8_D20220101-20220331" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yNS9mcmFnOjcwZjRjY2U0NjVlOTQ2MWJhN2NkZWRiMzAzNmJjNDE2L3RhYmxlOjcxNTQ4MjkxNjM4ZTQ4OTNhNzNlMWNhZDUwODYxYTRmL3RhYmxlcmFuZ2U6NzE1NDgyOTE2MzhlNDg5M2E3M2UxY2FkNTA4NjFhNGZfMTAtMy0xLTEtNDU5MTk_a9893305-97d5-4334-b0db-1b87247abd03">4,463</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yNS9mcmFnOjcwZjRjY2U0NjVlOTQ2MWJhN2NkZWRiMzAzNmJjNDE2L3RhYmxlOjcxNTQ4MjkxNjM4ZTQ4OTNhNzNlMWNhZDUwODYxYTRmL3RhYmxlcmFuZ2U6NzE1NDgyOTE2MzhlNDg5M2E3M2UxY2FkNTA4NjFhNGZfMTItMS0xLTEtNDU5MTk_61569f80-fbed-41c0-9705-715448982e97">1,140</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9500a5ee8dbe4d23aa9c46ebdd25a0c8_D20220101-20220331" decimals="-3" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yNS9mcmFnOjcwZjRjY2U0NjVlOTQ2MWJhN2NkZWRiMzAzNmJjNDE2L3RhYmxlOjcxNTQ4MjkxNjM4ZTQ4OTNhNzNlMWNhZDUwODYxYTRmL3RhYmxlcmFuZ2U6NzE1NDgyOTE2MzhlNDg5M2E3M2UxY2FkNTA4NjFhNGZfMTItMy0xLTEtNDU5MTk_ac2bac26-2918-4359-8f4d-3d2a57773257">177</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash adjustment to fair value of contingent consideration liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yNS9mcmFnOjcwZjRjY2U0NjVlOTQ2MWJhN2NkZWRiMzAzNmJjNDE2L3RhYmxlOjcxNTQ4MjkxNjM4ZTQ4OTNhNzNlMWNhZDUwODYxYTRmL3RhYmxlcmFuZ2U6NzE1NDgyOTE2MzhlNDg5M2E3M2UxY2FkNTA4NjFhNGZfMTMtMS0xLTEtNDk3ODY_f1f759bd-56bd-445e-9031-7d9b67b4d1b0">4,436</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9500a5ee8dbe4d23aa9c46ebdd25a0c8_D20220101-20220331" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yNS9mcmFnOjcwZjRjY2U0NjVlOTQ2MWJhN2NkZWRiMzAzNmJjNDE2L3RhYmxlOjcxNTQ4MjkxNjM4ZTQ4OTNhNzNlMWNhZDUwODYxYTRmL3RhYmxlcmFuZ2U6NzE1NDgyOTE2MzhlNDg5M2E3M2UxY2FkNTA4NjFhNGZfMTMtMy0xLTEtNDk3OTY_40bc3e0e-3231-4f0c-a3d6-7c901e0bade9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase (decrease) in cash flows from changes in assets and liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yNS9mcmFnOjcwZjRjY2U0NjVlOTQ2MWJhN2NkZWRiMzAzNmJjNDE2L3RhYmxlOjcxNTQ4MjkxNjM4ZTQ4OTNhNzNlMWNhZDUwODYxYTRmL3RhYmxlcmFuZ2U6NzE1NDgyOTE2MzhlNDg5M2E3M2UxY2FkNTA4NjFhNGZfMTctMS0xLTEtNDU5MTk_6c65ceee-a5bd-474c-b54a-346db64d024a">20,666</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9500a5ee8dbe4d23aa9c46ebdd25a0c8_D20220101-20220331" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yNS9mcmFnOjcwZjRjY2U0NjVlOTQ2MWJhN2NkZWRiMzAzNmJjNDE2L3RhYmxlOjcxNTQ4MjkxNjM4ZTQ4OTNhNzNlMWNhZDUwODYxYTRmL3RhYmxlcmFuZ2U6NzE1NDgyOTE2MzhlNDg5M2E3M2UxY2FkNTA4NjFhNGZfMTctMy0xLTEtNDU5MTk_28dee48a-66ab-4ebe-ac1c-0506bbcfeb0b">163</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331" decimals="-3" name="us-gaap:IncreaseDecreaseInInventories" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yNS9mcmFnOjcwZjRjY2U0NjVlOTQ2MWJhN2NkZWRiMzAzNmJjNDE2L3RhYmxlOjcxNTQ4MjkxNjM4ZTQ4OTNhNzNlMWNhZDUwODYxYTRmL3RhYmxlcmFuZ2U6NzE1NDgyOTE2MzhlNDg5M2E3M2UxY2FkNTA4NjFhNGZfMTgtMS0xLTEtNDU5MTk_1e53e0f7-a806-4b5b-9318-0d4eeb3d6866">3,016</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9500a5ee8dbe4d23aa9c46ebdd25a0c8_D20220101-20220331" decimals="-3" name="us-gaap:IncreaseDecreaseInInventories" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yNS9mcmFnOjcwZjRjY2U0NjVlOTQ2MWJhN2NkZWRiMzAzNmJjNDE2L3RhYmxlOjcxNTQ4MjkxNjM4ZTQ4OTNhNzNlMWNhZDUwODYxYTRmL3RhYmxlcmFuZ2U6NzE1NDgyOTE2MzhlNDg5M2E3M2UxY2FkNTA4NjFhNGZfMTgtMy0xLTEtNDU5MTk_2fd8db4a-a2a0-422e-adc7-e0d79f5e488d">21,857</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsPayable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yNS9mcmFnOjcwZjRjY2U0NjVlOTQ2MWJhN2NkZWRiMzAzNmJjNDE2L3RhYmxlOjcxNTQ4MjkxNjM4ZTQ4OTNhNzNlMWNhZDUwODYxYTRmL3RhYmxlcmFuZ2U6NzE1NDgyOTE2MzhlNDg5M2E3M2UxY2FkNTA4NjFhNGZfMTktMS0xLTEtNDU5MTk_6cd6b2e8-792d-4eb2-9625-7abbdcdbb293">2,699</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9500a5ee8dbe4d23aa9c46ebdd25a0c8_D20220101-20220331" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsPayable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yNS9mcmFnOjcwZjRjY2U0NjVlOTQ2MWJhN2NkZWRiMzAzNmJjNDE2L3RhYmxlOjcxNTQ4MjkxNjM4ZTQ4OTNhNzNlMWNhZDUwODYxYTRmL3RhYmxlcmFuZ2U6NzE1NDgyOTE2MzhlNDg5M2E3M2UxY2FkNTA4NjFhNGZfMTktMy0xLTEtNDU5MTk_33bf515d-c430-461d-8cf3-7ff41a0a2334">9,205</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued compensation and benefits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yNS9mcmFnOjcwZjRjY2U0NjVlOTQ2MWJhN2NkZWRiMzAzNmJjNDE2L3RhYmxlOjcxNTQ4MjkxNjM4ZTQ4OTNhNzNlMWNhZDUwODYxYTRmL3RhYmxlcmFuZ2U6NzE1NDgyOTE2MzhlNDg5M2E3M2UxY2FkNTA4NjFhNGZfMjAtMS0xLTEtNDU5MTk_2bdc492b-11a0-4b3c-9328-0a766b55fee7">5,722</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9500a5ee8dbe4d23aa9c46ebdd25a0c8_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yNS9mcmFnOjcwZjRjY2U0NjVlOTQ2MWJhN2NkZWRiMzAzNmJjNDE2L3RhYmxlOjcxNTQ4MjkxNjM4ZTQ4OTNhNzNlMWNhZDUwODYxYTRmL3RhYmxlcmFuZ2U6NzE1NDgyOTE2MzhlNDg5M2E3M2UxY2FkNTA4NjFhNGZfMjAtMy0xLTEtNDU5MTk_088790cc-8656-41e4-aa04-c3223065748f">14,966</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331" decimals="-3" name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yNS9mcmFnOjcwZjRjY2U0NjVlOTQ2MWJhN2NkZWRiMzAzNmJjNDE2L3RhYmxlOjcxNTQ4MjkxNjM4ZTQ4OTNhNzNlMWNhZDUwODYxYTRmL3RhYmxlcmFuZ2U6NzE1NDgyOTE2MzhlNDg5M2E3M2UxY2FkNTA4NjFhNGZfMjEtMS0xLTEtNDU5MTk_5f660f18-ac9a-451d-ae25-de44666b7507">11,372</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9500a5ee8dbe4d23aa9c46ebdd25a0c8_D20220101-20220331" decimals="-3" name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yNS9mcmFnOjcwZjRjY2U0NjVlOTQ2MWJhN2NkZWRiMzAzNmJjNDE2L3RhYmxlOjcxNTQ4MjkxNjM4ZTQ4OTNhNzNlMWNhZDUwODYxYTRmL3RhYmxlcmFuZ2U6NzE1NDgyOTE2MzhlNDg5M2E3M2UxY2FkNTA4NjFhNGZfMjEtMy0xLTEtNDU5MTk_e8e8a0f7-33d4-4495-979a-799368f593b3">6,129</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331" decimals="-3" name="us-gaap:IncreaseDecreaseInOtherOperatingLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yNS9mcmFnOjcwZjRjY2U0NjVlOTQ2MWJhN2NkZWRiMzAzNmJjNDE2L3RhYmxlOjcxNTQ4MjkxNjM4ZTQ4OTNhNzNlMWNhZDUwODYxYTRmL3RhYmxlcmFuZ2U6NzE1NDgyOTE2MzhlNDg5M2E3M2UxY2FkNTA4NjFhNGZfMjItMS0xLTEtNDU5MTk_abc8bbee-2738-43fe-b219-5bd91d08ee5b">3,949</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9500a5ee8dbe4d23aa9c46ebdd25a0c8_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInOtherOperatingLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yNS9mcmFnOjcwZjRjY2U0NjVlOTQ2MWJhN2NkZWRiMzAzNmJjNDE2L3RhYmxlOjcxNTQ4MjkxNjM4ZTQ4OTNhNzNlMWNhZDUwODYxYTRmL3RhYmxlcmFuZ2U6NzE1NDgyOTE2MzhlNDg5M2E3M2UxY2FkNTA4NjFhNGZfMjItMy0xLTEtNDU5MTk_698a2747-eb61-40be-9d1e-0acdab5bbd07">3,088</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash (used in) provided by operating activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yNS9mcmFnOjcwZjRjY2U0NjVlOTQ2MWJhN2NkZWRiMzAzNmJjNDE2L3RhYmxlOjcxNTQ4MjkxNjM4ZTQ4OTNhNzNlMWNhZDUwODYxYTRmL3RhYmxlcmFuZ2U6NzE1NDgyOTE2MzhlNDg5M2E3M2UxY2FkNTA4NjFhNGZfMjMtMS0xLTEtNDU5MTk_a751d81b-4311-4db4-b66c-79027d09fa1c">3,847</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9500a5ee8dbe4d23aa9c46ebdd25a0c8_D20220101-20220331" decimals="-3" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yNS9mcmFnOjcwZjRjY2U0NjVlOTQ2MWJhN2NkZWRiMzAzNmJjNDE2L3RhYmxlOjcxNTQ4MjkxNjM4ZTQ4OTNhNzNlMWNhZDUwODYxYTRmL3RhYmxlcmFuZ2U6NzE1NDgyOTE2MzhlNDg5M2E3M2UxY2FkNTA4NjFhNGZfMjMtMy0xLTEtNDU5MTk_b872d88c-9427-4887-80e9-754586594d79">328</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flows from investing activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases of property, plant and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yNS9mcmFnOjcwZjRjY2U0NjVlOTQ2MWJhN2NkZWRiMzAzNmJjNDE2L3RhYmxlOjcxNTQ4MjkxNjM4ZTQ4OTNhNzNlMWNhZDUwODYxYTRmL3RhYmxlcmFuZ2U6NzE1NDgyOTE2MzhlNDg5M2E3M2UxY2FkNTA4NjFhNGZfMjctMS0xLTEtNDU5MTk_8202d7c3-b0f6-43b8-9be8-93a70d4a5a6e">4,254</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9500a5ee8dbe4d23aa9c46ebdd25a0c8_D20220101-20220331" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yNS9mcmFnOjcwZjRjY2U0NjVlOTQ2MWJhN2NkZWRiMzAzNmJjNDE2L3RhYmxlOjcxNTQ4MjkxNjM4ZTQ4OTNhNzNlMWNhZDUwODYxYTRmL3RhYmxlcmFuZ2U6NzE1NDgyOTE2MzhlNDg5M2E3M2UxY2FkNTA4NjFhNGZfMjctMy0xLTEtNDU5MTk_8c856c85-ca15-4ff2-843e-e6e112a27f8d">3,687</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash used in investing activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yNS9mcmFnOjcwZjRjY2U0NjVlOTQ2MWJhN2NkZWRiMzAzNmJjNDE2L3RhYmxlOjcxNTQ4MjkxNjM4ZTQ4OTNhNzNlMWNhZDUwODYxYTRmL3RhYmxlcmFuZ2U6NzE1NDgyOTE2MzhlNDg5M2E3M2UxY2FkNTA4NjFhNGZfMjktMS0xLTEtNDU5MTk_034948b3-24e0-4181-81fc-e6e387b5119c">4,254</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9500a5ee8dbe4d23aa9c46ebdd25a0c8_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yNS9mcmFnOjcwZjRjY2U0NjVlOTQ2MWJhN2NkZWRiMzAzNmJjNDE2L3RhYmxlOjcxNTQ4MjkxNjM4ZTQ4OTNhNzNlMWNhZDUwODYxYTRmL3RhYmxlcmFuZ2U6NzE1NDgyOTE2MzhlNDg5M2E3M2UxY2FkNTA4NjFhNGZfMjktMy0xLTEtNDU5MTk_d0788c0d-6dcb-48b2-b922-1107c93f34c0">3,687</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flows from financing activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments on term loan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331" decimals="-3" name="us-gaap:RepaymentsOfSeniorDebt" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yNS9mcmFnOjcwZjRjY2U0NjVlOTQ2MWJhN2NkZWRiMzAzNmJjNDE2L3RhYmxlOjcxNTQ4MjkxNjM4ZTQ4OTNhNzNlMWNhZDUwODYxYTRmL3RhYmxlcmFuZ2U6NzE1NDgyOTE2MzhlNDg5M2E3M2UxY2FkNTA4NjFhNGZfMzItMS0xLTEtNDU5MTk_4d9dfe41-4a3e-49d2-adb2-825e65cb33d7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9500a5ee8dbe4d23aa9c46ebdd25a0c8_D20220101-20220331" decimals="-3" name="us-gaap:RepaymentsOfSeniorDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yNS9mcmFnOjcwZjRjY2U0NjVlOTQ2MWJhN2NkZWRiMzAzNmJjNDE2L3RhYmxlOjcxNTQ4MjkxNjM4ZTQ4OTNhNzNlMWNhZDUwODYxYTRmL3RhYmxlcmFuZ2U6NzE1NDgyOTE2MzhlNDg5M2E3M2UxY2FkNTA4NjFhNGZfMzItMy0xLTEtNDU5MTk_3122051a-814f-4271-8c1b-edbc03114dad">2,981</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments on revolving line of credit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331" decimals="-3" name="us-gaap:RepaymentsOfLinesOfCredit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yNS9mcmFnOjcwZjRjY2U0NjVlOTQ2MWJhN2NkZWRiMzAzNmJjNDE2L3RhYmxlOjcxNTQ4MjkxNjM4ZTQ4OTNhNzNlMWNhZDUwODYxYTRmL3RhYmxlcmFuZ2U6NzE1NDgyOTE2MzhlNDg5M2E3M2UxY2FkNTA4NjFhNGZfMzQtMS0xLTEtNDU5MTk_78b1b8ee-d47e-41b4-87bc-57c79642cd4e">164,000</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9500a5ee8dbe4d23aa9c46ebdd25a0c8_D20220101-20220331" decimals="-3" name="us-gaap:RepaymentsOfLinesOfCredit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yNS9mcmFnOjcwZjRjY2U0NjVlOTQ2MWJhN2NkZWRiMzAzNmJjNDE2L3RhYmxlOjcxNTQ4MjkxNjM4ZTQ4OTNhNzNlMWNhZDUwODYxYTRmL3RhYmxlcmFuZ2U6NzE1NDgyOTE2MzhlNDg5M2E3M2UxY2FkNTA4NjFhNGZfMzQtMy0xLTEtNDU5MTk_595cdc2b-9d0a-436f-ae8a-bd78c99ffb79">99,000</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from revolving line of credit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331" decimals="-3" name="us-gaap:ProceedsFromLinesOfCredit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yNS9mcmFnOjcwZjRjY2U0NjVlOTQ2MWJhN2NkZWRiMzAzNmJjNDE2L3RhYmxlOjcxNTQ4MjkxNjM4ZTQ4OTNhNzNlMWNhZDUwODYxYTRmL3RhYmxlcmFuZ2U6NzE1NDgyOTE2MzhlNDg5M2E3M2UxY2FkNTA4NjFhNGZfMzUtMS0xLTEtNDU5MTk_acd9d8aa-05aa-4335-987a-7f5df11656fc">173,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9500a5ee8dbe4d23aa9c46ebdd25a0c8_D20220101-20220331" decimals="-3" name="us-gaap:ProceedsFromLinesOfCredit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yNS9mcmFnOjcwZjRjY2U0NjVlOTQ2MWJhN2NkZWRiMzAzNmJjNDE2L3RhYmxlOjcxNTQ4MjkxNjM4ZTQ4OTNhNzNlMWNhZDUwODYxYTRmL3RhYmxlcmFuZ2U6NzE1NDgyOTE2MzhlNDg5M2E3M2UxY2FkNTA4NjFhNGZfMzUtMy0xLTEtNDU5MTk_61340a18-1d19-434f-822b-4155c344fe99">110,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments related to contingent consideration</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331" decimals="-3" name="cnmd:PaymentsForContingentConsideration" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yNS9mcmFnOjcwZjRjY2U0NjVlOTQ2MWJhN2NkZWRiMzAzNmJjNDE2L3RhYmxlOjcxNTQ4MjkxNjM4ZTQ4OTNhNzNlMWNhZDUwODYxYTRmL3RhYmxlcmFuZ2U6NzE1NDgyOTE2MzhlNDg5M2E3M2UxY2FkNTA4NjFhNGZfMzgtMS0xLTEtNDU5MTk_68e2af89-c578-43f8-903a-b2697cef6ee8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9500a5ee8dbe4d23aa9c46ebdd25a0c8_D20220101-20220331" decimals="-3" name="cnmd:PaymentsForContingentConsideration" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yNS9mcmFnOjcwZjRjY2U0NjVlOTQ2MWJhN2NkZWRiMzAzNmJjNDE2L3RhYmxlOjcxNTQ4MjkxNjM4ZTQ4OTNhNzNlMWNhZDUwODYxYTRmL3RhYmxlcmFuZ2U6NzE1NDgyOTE2MzhlNDg5M2E3M2UxY2FkNTA4NjFhNGZfMzgtMy0xLTEtNDU5MTk_9bde5fe7-9018-4ca2-b8f9-4fbe2596a3fc">798</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividends paid on common stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331" decimals="-3" name="us-gaap:PaymentsOfDividendsCommonStock" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yNS9mcmFnOjcwZjRjY2U0NjVlOTQ2MWJhN2NkZWRiMzAzNmJjNDE2L3RhYmxlOjcxNTQ4MjkxNjM4ZTQ4OTNhNzNlMWNhZDUwODYxYTRmL3RhYmxlcmFuZ2U6NzE1NDgyOTE2MzhlNDg5M2E3M2UxY2FkNTA4NjFhNGZfNDAtMS0xLTEtNDU5MTk_e2621935-ce2b-41fe-be66-7dc0548a1487">6,098</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9500a5ee8dbe4d23aa9c46ebdd25a0c8_D20220101-20220331" decimals="-3" name="us-gaap:PaymentsOfDividendsCommonStock" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yNS9mcmFnOjcwZjRjY2U0NjVlOTQ2MWJhN2NkZWRiMzAzNmJjNDE2L3RhYmxlOjcxNTQ4MjkxNjM4ZTQ4OTNhNzNlMWNhZDUwODYxYTRmL3RhYmxlcmFuZ2U6NzE1NDgyOTE2MzhlNDg5M2E3M2UxY2FkNTA4NjFhNGZfNDAtMy0xLTEtNDU5MTk_2d0185e3-bdfc-4237-9999-80aad5986aee">5,874</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331" decimals="-3" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yNS9mcmFnOjcwZjRjY2U0NjVlOTQ2MWJhN2NkZWRiMzAzNmJjNDE2L3RhYmxlOjcxNTQ4MjkxNjM4ZTQ4OTNhNzNlMWNhZDUwODYxYTRmL3RhYmxlcmFuZ2U6NzE1NDgyOTE2MzhlNDg5M2E3M2UxY2FkNTA4NjFhNGZfNDUtMS0xLTEtNDU5MTk_062340a4-1c5f-4603-90be-227ecd274f3d">2,448</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9500a5ee8dbe4d23aa9c46ebdd25a0c8_D20220101-20220331" decimals="-3" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yNS9mcmFnOjcwZjRjY2U0NjVlOTQ2MWJhN2NkZWRiMzAzNmJjNDE2L3RhYmxlOjcxNTQ4MjkxNjM4ZTQ4OTNhNzNlMWNhZDUwODYxYTRmL3RhYmxlcmFuZ2U6NzE1NDgyOTE2MzhlNDg5M2E3M2UxY2FkNTA4NjFhNGZfNDUtMy0xLTEtNDU5MTk_2b09fbeb-12b5-49d1-9379-068cb3a7715b">6,142</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by financing activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331" decimals="-3" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yNS9mcmFnOjcwZjRjY2U0NjVlOTQ2MWJhN2NkZWRiMzAzNmJjNDE2L3RhYmxlOjcxNTQ4MjkxNjM4ZTQ4OTNhNzNlMWNhZDUwODYxYTRmL3RhYmxlcmFuZ2U6NzE1NDgyOTE2MzhlNDg5M2E3M2UxY2FkNTA4NjFhNGZfNDYtMS0xLTEtNDU5MTk_f99bf387-033f-48d8-ad09-cdc090d02bcd">5,350</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9500a5ee8dbe4d23aa9c46ebdd25a0c8_D20220101-20220331" decimals="-3" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yNS9mcmFnOjcwZjRjY2U0NjVlOTQ2MWJhN2NkZWRiMzAzNmJjNDE2L3RhYmxlOjcxNTQ4MjkxNjM4ZTQ4OTNhNzNlMWNhZDUwODYxYTRmL3RhYmxlcmFuZ2U6NzE1NDgyOTE2MzhlNDg5M2E3M2UxY2FkNTA4NjFhNGZfNDYtMy0xLTEtNDU5MTk_b99dc40b-b1c0-42f9-bca8-16cdb3c559d8">7,489</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:6pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of exchange rate changes on cash and cash equivalents</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331" decimals="-3" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yNS9mcmFnOjcwZjRjY2U0NjVlOTQ2MWJhN2NkZWRiMzAzNmJjNDE2L3RhYmxlOjcxNTQ4MjkxNjM4ZTQ4OTNhNzNlMWNhZDUwODYxYTRmL3RhYmxlcmFuZ2U6NzE1NDgyOTE2MzhlNDg5M2E3M2UxY2FkNTA4NjFhNGZfNDgtMS0xLTEtNDU5MTk_84c10c27-874c-40e3-87f3-2f2cd03f65c3">303</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9500a5ee8dbe4d23aa9c46ebdd25a0c8_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yNS9mcmFnOjcwZjRjY2U0NjVlOTQ2MWJhN2NkZWRiMzAzNmJjNDE2L3RhYmxlOjcxNTQ4MjkxNjM4ZTQ4OTNhNzNlMWNhZDUwODYxYTRmL3RhYmxlcmFuZ2U6NzE1NDgyOTE2MzhlNDg5M2E3M2UxY2FkNTA4NjFhNGZfNDgtMy0xLTEtNDU5MTk_00dc31fc-463f-4c5c-a80d-9ea850e0a744">113</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:5pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net (decrease) increase in cash and cash equivalents</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yNS9mcmFnOjcwZjRjY2U0NjVlOTQ2MWJhN2NkZWRiMzAzNmJjNDE2L3RhYmxlOjcxNTQ4MjkxNjM4ZTQ4OTNhNzNlMWNhZDUwODYxYTRmL3RhYmxlcmFuZ2U6NzE1NDgyOTE2MzhlNDg5M2E3M2UxY2FkNTA4NjFhNGZfNTAtMS0xLTEtNDU5MTk_1ebf8eca-828b-4369-94db-5c7cfa8f02da">2,448</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9500a5ee8dbe4d23aa9c46ebdd25a0c8_D20220101-20220331" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yNS9mcmFnOjcwZjRjY2U0NjVlOTQ2MWJhN2NkZWRiMzAzNmJjNDE2L3RhYmxlOjcxNTQ4MjkxNjM4ZTQ4OTNhNzNlMWNhZDUwODYxYTRmL3RhYmxlcmFuZ2U6NzE1NDgyOTE2MzhlNDg5M2E3M2UxY2FkNTA4NjFhNGZfNTAtMy0xLTEtNDU5MTk_da4c3d00-337e-4a2e-bf58-0bec0c467503">4,017</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:6pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents at beginning of period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4f63720d8b244a68941932992cd9f4d_I20221231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yNS9mcmFnOjcwZjRjY2U0NjVlOTQ2MWJhN2NkZWRiMzAzNmJjNDE2L3RhYmxlOjcxNTQ4MjkxNjM4ZTQ4OTNhNzNlMWNhZDUwODYxYTRmL3RhYmxlcmFuZ2U6NzE1NDgyOTE2MzhlNDg5M2E3M2UxY2FkNTA4NjFhNGZfNTItMS0xLTEtNDU5MTk_c0322c41-181d-453d-8f70-e1f71335902c">28,942</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia4bed28ea4b04a1d9fca88fa74e6040c_I20211231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yNS9mcmFnOjcwZjRjY2U0NjVlOTQ2MWJhN2NkZWRiMzAzNmJjNDE2L3RhYmxlOjcxNTQ4MjkxNjM4ZTQ4OTNhNzNlMWNhZDUwODYxYTRmL3RhYmxlcmFuZ2U6NzE1NDgyOTE2MzhlNDg5M2E3M2UxY2FkNTA4NjFhNGZfNTItMy0xLTEtNDU5MTk_d306aee0-ecd3-4244-9456-a28d08feadc2">20,847</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:6pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents at end of period</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i738c2d1dacaf436faf03cc46ab9cef23_I20230331" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yNS9mcmFnOjcwZjRjY2U0NjVlOTQ2MWJhN2NkZWRiMzAzNmJjNDE2L3RhYmxlOjcxNTQ4MjkxNjM4ZTQ4OTNhNzNlMWNhZDUwODYxYTRmL3RhYmxlcmFuZ2U6NzE1NDgyOTE2MzhlNDg5M2E3M2UxY2FkNTA4NjFhNGZfNTQtMS0xLTEtNDU5MTk_c74b973b-b328-4125-80b4-64f1ec7aaeba">26,494</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4730ada3cec445989c807f4fe004727c_I20220331" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yNS9mcmFnOjcwZjRjY2U0NjVlOTQ2MWJhN2NkZWRiMzAzNmJjNDE2L3RhYmxlOjcxNTQ4MjkxNjM4ZTQ4OTNhNzNlMWNhZDUwODYxYTRmL3RhYmxlcmFuZ2U6NzE1NDgyOTE2MzhlNDg5M2E3M2UxY2FkNTA4NjFhNGZfNTQtMy0xLTEtNDU5MTk_eb369318-5471-49c3-a611-87dc5156a3ff">24,864</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:6pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Non-cash investing and financing activities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividends payable</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i738c2d1dacaf436faf03cc46ab9cef23_I20230331" decimals="-3" name="us-gaap:DividendsPayableCurrentAndNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yNS9mcmFnOjcwZjRjY2U0NjVlOTQ2MWJhN2NkZWRiMzAzNmJjNDE2L3RhYmxlOjcxNTQ4MjkxNjM4ZTQ4OTNhNzNlMWNhZDUwODYxYTRmL3RhYmxlcmFuZ2U6NzE1NDgyOTE2MzhlNDg5M2E3M2UxY2FkNTA4NjFhNGZfNTgtMS0xLTEtNDU5MTk_819ce9ad-546a-4c22-a25e-494fe5396d7a">6,113</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4730ada3cec445989c807f4fe004727c_I20220331" decimals="-3" name="us-gaap:DividendsPayableCurrentAndNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yNS9mcmFnOjcwZjRjY2U0NjVlOTQ2MWJhN2NkZWRiMzAzNmJjNDE2L3RhYmxlOjcxNTQ4MjkxNjM4ZTQ4OTNhNzNlMWNhZDUwODYxYTRmL3RhYmxlcmFuZ2U6NzE1NDgyOTE2MzhlNDg5M2E3M2UxY2FkNTA4NjFhNGZfNTgtMy0xLTEtNDU5MTk_29af72fd-f129-4b57-8451-9b59c18bb56b">5,899</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See notes to consolidated condensed financial statements.</span></div><div style="height:31.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</span></div></div></div><div id="i952e7af9c0b94e65995973e7f212f399_28"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline" href="#i952e7af9c0b94e65995973e7f212f399_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONMED CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED CONDENSED FINANCIAL STATEMENTS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited, in thousands except per share amounts)</span></div><div><span><br/></span></div><div id="i952e7af9c0b94e65995973e7f212f399_31"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Note 1 &#8211; <ix:nonNumeric contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331" name="us-gaap:NatureOfOperations" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8zMS9mcmFnOmE2ZjMwNWRjMDU3ODRmMTNhZDE5OWNiOTFlYTY5YjMyL3RleHRyZWdpb246YTZmMzA1ZGMwNTc4NGYxM2FkMTk5Y2I5MWVhNjliMzJfNDAw_0c749cfc-d871-4e00-9596-aa1909dbbbd5" continuedAt="i2eba0542dc1b4d9197089240a9828c81" escape="true">Operations</ix:nonNumeric></span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i2eba0542dc1b4d9197089240a9828c81">CONMED Corporation (&#8220;CONMED&#8221;, the &#8220;Company&#8221;, &#8220;we&#8221; or &#8220;us&#8221;) is a medical technology company that provides devices and equipment for surgical procedures.&#160;&#160;The Company&#8217;s products are used by surgeons and other healthcare professionals in a variety of specialties including orthopedics, general surgery, gynecology, thoracic surgery and gastroenterology.</ix:continuation></span></div><div><span><br/></span></div><div id="i952e7af9c0b94e65995973e7f212f399_34"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Note 2 - <ix:nonNumeric contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331" name="us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8zNC9mcmFnOjZmMjkyZWRhZTllNjQwNjZiY2I5YjA4YThiZWU1Y2M4L3RleHRyZWdpb246NmYyOTJlZGFlOWU2NDA2NmJjYjliMDhhOGJlZTVjYzhfMjEzNw_315dec16-ed34-40f1-8024-a0c351714569" continuedAt="i0b1a942461cc47d9bef5127a64a6a1cd" escape="true">Interim Financial Information</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i0b1a942461cc47d9bef5127a64a6a1cd"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying unaudited consolidated condensed financial statements have been prepared in accordance with generally accepted accounting principles for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X.  Accordingly, they do not include all of the information and footnotes required by generally accepted accounting principles for annual financial statements.  The information herein reflects all normal recurring material adjustments, which are, in the opinion of management, necessary to fairly present the results for the periods presented.  The consolidated condensed financial statements herein consist of all wholly-owned domestic and foreign subsidiaries with all significant intercompany transactions eliminated.  Results for the period ended March&#160;31, 2023 are not necessarily indicative of the results that may be expected for the year ending December&#160;31, 2023.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The consolidated condensed financial statements and notes thereto should be read in conjunction with the consolidated financial statements and notes for the year ended December&#160;31, 2022 included in our Annual Report on Form 10-K.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><ix:nonNumeric contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331" name="us-gaap:UseOfEstimates" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8zNC9mcmFnOjZmMjkyZWRhZTllNjQwNjZiY2I5YjA4YThiZWU1Y2M4L3RleHRyZWdpb246NmYyOTJlZGFlOWU2NDA2NmJjYjliMDhhOGJlZTVjYzhfMjE0Mw_a8f3dd6f-90ad-4374-b19b-ea42b9c9273c" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Preparation of the consolidated condensed financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated condensed financial statements and the reported amounts of revenue and expenses during the reporting period.</span></div></ix:nonNumeric><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While there has been uncertainty and disruption in the global economy and financial markets, we are not aware of any specific event or circumstance that would require an update to our estimates or judgments or a revision of the carrying value of our assets or liabilities as of&#160;April&#160;27, 2023, the date of issuance of this Quarterly Report on Form 10-Q.  These estimates may change, as new events occur and additional information is obtained. Actual results could differ materially from these estimates under different assumptions or conditions.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div id="i952e7af9c0b94e65995973e7f212f399_37"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Note 3 &#8211; <ix:nonNumeric contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331" name="us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8zNy9mcmFnOjdlNWRhZTUxNTExNDRjMzY5N2RlMDA5MDgwNjY3YTA2L3RleHRyZWdpb246N2U1ZGFlNTE1MTE0NGMzNjk3ZGUwMDkwODA2NjdhMDZfNDE4Ng_bcac3751-91b6-4f5f-9afd-382716ed266c" continuedAt="i5dbda354d98c4e50b3eab9e69832ace5" escape="true"><ix:nonNumeric contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8zNy9mcmFnOjdlNWRhZTUxNTExNDRjMzY5N2RlMDA5MDgwNjY3YTA2L3RleHRyZWdpb246N2U1ZGFlNTE1MTE0NGMzNjk3ZGUwMDkwODA2NjdhMDZfNDE5MQ_7b348b7e-5c39-4bd8-9f58-651560123308" continuedAt="ifa73739af4c843239c1cd3e6473a6827" escape="true">New Accounting Pronouncements</ix:nonNumeric></ix:nonNumeric></span></div><ix:continuation id="i5dbda354d98c4e50b3eab9e69832ace5"><ix:continuation id="ifa73739af4c843239c1cd3e6473a6827"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recently Issued Accounting Standards, Not Yet Adopted</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2020, the Financial Accounting Standards Board ("FASB") issued ASU 2020-04, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting, which provides optional guidance if certain criteria are met for entities that have contracts, hedging relationships, and other transactions that reference LIBOR or other reference rates expected to be discontinued as a result of reference rate reform.  This ASU is effective as of March 12, 2020 through December 31, 2022 and was extended through December 31, 2024 by ASU 2022-06, Reference Rate Reform (Topic 848): Deferral of the Sunset Date of Topic 848.  The Company has not adopted these ASUs as of March&#160;31, 2023.  Our seventh amended and restated senior credit agreement includes language to address the change from LIBOR to SOFR, an alternative base rate, therefore we do not believe reference rate reform will have a significant impact on our consolidated financial statements.</span></div></ix:continuation></ix:continuation><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div id="i952e7af9c0b94e65995973e7f212f399_40"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Note 4 - <ix:nonNumeric contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331" name="us-gaap:BusinessCombinationDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80MC9mcmFnOjFlZWQxODUxMjFhMzQwZmFhN2QyYTdhOGJkZmYxMzQ2L3RleHRyZWdpb246MWVlZDE4NTEyMWEzNDBmYWE3ZDJhN2E4YmRmZjEzNDZfMzk3Mw_f222374b-9064-4c02-bbce-ce8cce3da413" continuedAt="i1d6ab855b55c4b3793bd41054cd2d81b" escape="true">Business Combinations</ix:nonNumeric></span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i1d6ab855b55c4b3793bd41054cd2d81b" continuedAt="i75563030c9814f7ab7bf2c45c8e0e569">On June&#160;13, 2022, we acquired In2Bones Global, Inc. ("In2Bones") and all of its stock (the "In2Bones Acquisition") for an aggregate upfront payment of $<ix:nonFraction unitRef="usd" contextRef="i8c4d1dfe88414ef2adffd18a83334e37_D20220613-20220613" decimals="-5" name="us-gaap:BusinessCombinationConsiderationTransferred1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80MC9mcmFnOjFlZWQxODUxMjFhMzQwZmFhN2QyYTdhOGJkZmYxMzQ2L3RleHRyZWdpb246MWVlZDE4NTEyMWEzNDBmYWE3ZDJhN2E4YmRmZjEzNDZfMTc3_582856af-6279-4226-b48d-28b344f69388">145.2</ix:nonFraction>&#160;million in cash.  In addition, there are potential earn-out payments to In2Bones&#8217; equity holders in an amount up to $<ix:nonFraction unitRef="usd" contextRef="idc097ffbb7114253bc28bc94208a57fb_I20220613" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80MC9mcmFnOjFlZWQxODUxMjFhMzQwZmFhN2QyYTdhOGJkZmYxMzQ2L3RleHRyZWdpb246MWVlZDE4NTEyMWEzNDBmYWE3ZDJhN2E4YmRmZjEzNDZfMjg4_4d4e9cfc-2f45-4fa8-8226-999954178a32">110.0</ix:nonFraction>&#160;million based on the achievement of certain revenue targets for In2Bones products during the sixteen (16) successive quarters commencing on July 1, 2022.  In2Bones is a global developer, manufacturer and distributor of medical devices for the treatment of disorders and injuries of the upper (hand, wrist and elbow) and lower (foot </ix:continuation></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline" href="#i952e7af9c0b94e65995973e7f212f399_7">Table of Contents</a></span></div></div><ix:continuation id="i75563030c9814f7ab7bf2c45c8e0e569"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and ankle) extremities.  The In2Bones Acquisition was funded through a combination of cash on hand and long-term borrowings as further described in Note 11.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">We recorded $<ix:nonFraction unitRef="usd" contextRef="i6d95bd83592e4caeac97181946e4d405_D20230101-20230331" decimals="-5" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80MC9mcmFnOjFlZWQxODUxMjFhMzQwZmFhN2QyYTdhOGJkZmYxMzQ2L3RleHRyZWdpb246MWVlZDE4NTEyMWEzNDBmYWE3ZDJhN2E4YmRmZjEzNDZfNTQ5NzU1ODIzNTU2_87cd9c54-6502-487a-872c-16914057564e">11.8</ix:nonFraction>&#160;million in net sales for In2Bones during the three months ended March&#160;31, 2023.  Earnings recorded in the consolidated condensed statement of comprehensive income for the three months ended March&#160;31, 2023 were not material.  We also believe the proforma information is immaterial for disclosure for the three months ended March&#160;31, 2022.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">During the three months ended March&#160;31, 2023, we incurred costs for the amortization of inventory step-up to fair value of $<ix:nonFraction unitRef="usd" contextRef="i462c25545d8940a2ae0be682fa065b8b_D20230101-20230331" decimals="-5" name="cnmd:AmortizationOfInventoryStepUpAdjustments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80MC9mcmFnOjFlZWQxODUxMjFhMzQwZmFhN2QyYTdhOGJkZmYxMzQ2L3RleHRyZWdpb246MWVlZDE4NTEyMWEzNDBmYWE3ZDJhN2E4YmRmZjEzNDZfMjc0ODc3OTA3ODA4MQ_4f7291c9-6022-4e7f-8d39-8a3709c36710">2.1</ix:nonFraction> million related to the In2Bones acquisition which are recorded in cost of sales.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August&#160;9, 2022, we acquired Biorez, Inc. ("Biorez") and all of its stock (the "Biorez Acquisition") for an aggregate upfront payment of $<ix:nonFraction unitRef="usd" contextRef="ic28eb29cc995481fb7071df752f6760f_D20220809-20220809" decimals="-5" name="us-gaap:BusinessCombinationConsiderationTransferred1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80MC9mcmFnOjFlZWQxODUxMjFhMzQwZmFhN2QyYTdhOGJkZmYxMzQ2L3RleHRyZWdpb246MWVlZDE4NTEyMWEzNDBmYWE3ZDJhN2E4YmRmZjEzNDZfOTAw_0ca67fe0-a607-479d-84b8-d9fd306544b2">85.5</ix:nonFraction>&#160;million in cash.  We paid $<ix:nonFraction unitRef="usd" contextRef="ic28eb29cc995481fb7071df752f6760f_D20220809-20220809" decimals="-5" name="us-gaap:PaymentsToAcquireBusinessesGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80MC9mcmFnOjFlZWQxODUxMjFhMzQwZmFhN2QyYTdhOGJkZmYxMzQ2L3RleHRyZWdpb246MWVlZDE4NTEyMWEzNDBmYWE3ZDJhN2E4YmRmZjEzNDZfOTIx_63e4679c-4902-4a38-bb80-d182de2aa3b8">83.8</ix:nonFraction>&#160;million as of March&#160;31, 2023, with a $<ix:nonFraction unitRef="usd" contextRef="ic28eb29cc995481fb7071df752f6760f_D20220809-20220809" decimals="-5" name="cnmd:BusinessCombinationPurchasePriceAdjustmentHoldback" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80MC9mcmFnOjFlZWQxODUxMjFhMzQwZmFhN2QyYTdhOGJkZmYxMzQ2L3RleHRyZWdpb246MWVlZDE4NTEyMWEzNDBmYWE3ZDJhN2E4YmRmZjEzNDZfOTQ1_7f9ec1e4-c2d1-478f-b0b1-50d2e0351141">1.7</ix:nonFraction>&#160;million holdback, pursuant to the merger agreement for the Biorez Acquisition.  In addition, there are potential earn-out payments to Biorez&#8217; equity holders in an amount up to $<ix:nonFraction unitRef="usd" contextRef="i9d6ba56ca73740b9b3923d912000da47_I20220809" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80MC9mcmFnOjFlZWQxODUxMjFhMzQwZmFhN2QyYTdhOGJkZmYxMzQ2L3RleHRyZWdpb246MWVlZDE4NTEyMWEzNDBmYWE3ZDJhN2E4YmRmZjEzNDZfMTE0Mg_611c9c9f-957e-489e-a1e7-f4e84a356501">165.0</ix:nonFraction>&#160;million based on the achievement of certain revenue targets for Biorez products during the sixteen (16) successive quarters commencing on October 1, 2022.  Biorez is a medical device start-up focused on advancing the healing of soft tissue using its proprietary BioBrace</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> implant technology.  The Biorez Acquisition was funded through a combination of cash on hand and long-term borrowings.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">Net sales and earnings for Biorez were immaterial for the three months ended March&#160;31, 2023. We also believe the proforma information is immaterial for disclosure for the three months ended March&#160;31, 2022.  </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">The allocation of purchase price for these acquisitions is preliminary and therefore subject to adjustment during the measurement adjustment periods.</span></div></ix:continuation><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div id="i952e7af9c0b94e65995973e7f212f399_43"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Note 5 - <ix:nonNumeric contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331" name="us-gaap:RevenueFromContractWithCustomerTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80My9mcmFnOjQ4M2E3ZjM0NDExZDQzNGI5M2MzM2VmNTk1ZGY3ZTQxL3RleHRyZWdpb246NDgzYTdmMzQ0MTFkNDM0YjkzYzMzZWY1OTVkZjdlNDFfNTEx_9c769563-bfce-4ea7-b92b-1a923c67b87a" continuedAt="i54cf0cdcfb594018b2dc81b4e2dea604" escape="true">Revenues</ix:nonNumeric></span></div><ix:continuation id="i54cf0cdcfb594018b2dc81b4e2dea604" continuedAt="i91eff369bfce44b0856c4ecffb7cb10d"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><ix:nonNumeric contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331" name="us-gaap:DisaggregationOfRevenueTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80My9mcmFnOjQ4M2E3ZjM0NDExZDQzNGI5M2MzM2VmNTk1ZGY3ZTQxL3RleHRyZWdpb246NDgzYTdmMzQ0MTFkNDM0YjkzYzMzZWY1OTVkZjdlNDFfNTE4_0531c479-09b4-4589-b080-3a1e861d5eb5" escape="true"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables present revenue disaggregated by primary geographic market where the products are sold, by product line and timing of revenue recognition: </span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:31.209%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.581%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Orthopedic Surgery</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">General Surgery</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Orthopedic Surgery</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">General Surgery</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Primary Geographic Markets</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26071f490d464a14b2bf24e3e1f2c752_D20230101-20230331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80My9mcmFnOjQ4M2E3ZjM0NDExZDQzNGI5M2MzM2VmNTk1ZGY3ZTQxL3RhYmxlOjY0YTlkZDAzN2E3OTRjNmRiZmNmYTY3YmQ2MGQ0YjQyL3RhYmxlcmFuZ2U6NjRhOWRkMDM3YTc5NGM2ZGJmY2ZhNjdiZDYwZDRiNDJfNC0xLTEtMS00NTkxOQ_ade2c10c-c0c2-49af-9557-c1715c60db07">48,944</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7bdef281f49841f698c6ef3a3ead6753_D20230101-20230331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80My9mcmFnOjQ4M2E3ZjM0NDExZDQzNGI5M2MzM2VmNTk1ZGY3ZTQxL3RhYmxlOjY0YTlkZDAzN2E3OTRjNmRiZmNmYTY3YmQ2MGQ0YjQyL3RhYmxlcmFuZ2U6NjRhOWRkMDM3YTc5NGM2ZGJmY2ZhNjdiZDYwZDRiNDJfNC0zLTEtMS00NTkxOQ_f3b4c58e-01a9-40f3-9b6c-fcd13ac32f28">115,645</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i124749441acd44cf9c0bac450334222b_D20230101-20230331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80My9mcmFnOjQ4M2E3ZjM0NDExZDQzNGI5M2MzM2VmNTk1ZGY3ZTQxL3RhYmxlOjY0YTlkZDAzN2E3OTRjNmRiZmNmYTY3YmQ2MGQ0YjQyL3RhYmxlcmFuZ2U6NjRhOWRkMDM3YTc5NGM2ZGJmY2ZhNjdiZDYwZDRiNDJfNC01LTEtMS00NTkxOQ_1bfafdff-6a8f-4b6b-b6b7-c3367a82d231">164,589</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib7fbf46a701d40e5bf879057f949e772_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80My9mcmFnOjQ4M2E3ZjM0NDExZDQzNGI5M2MzM2VmNTk1ZGY3ZTQxL3RhYmxlOjY0YTlkZDAzN2E3OTRjNmRiZmNmYTY3YmQ2MGQ0YjQyL3RhYmxlcmFuZ2U6NjRhOWRkMDM3YTc5NGM2ZGJmY2ZhNjdiZDYwZDRiNDJfNC03LTEtMS00NTkxOQ_2f44d90f-93f9-455c-92ea-96b505c907c4">37,947</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i85ba684d41a74bceaee45a7efb4e3287_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80My9mcmFnOjQ4M2E3ZjM0NDExZDQzNGI5M2MzM2VmNTk1ZGY3ZTQxL3RhYmxlOjY0YTlkZDAzN2E3OTRjNmRiZmNmYTY3YmQ2MGQ0YjQyL3RhYmxlcmFuZ2U6NjRhOWRkMDM3YTc5NGM2ZGJmY2ZhNjdiZDYwZDRiNDJfNC05LTEtMS00NTkxOQ_9724b15f-5d06-436d-a9ec-41afd58e0b4c">93,280</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f3ae93344eb48b2b3f68003d7aaf3fd_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80My9mcmFnOjQ4M2E3ZjM0NDExZDQzNGI5M2MzM2VmNTk1ZGY3ZTQxL3RhYmxlOjY0YTlkZDAzN2E3OTRjNmRiZmNmYTY3YmQ2MGQ0YjQyL3RhYmxlcmFuZ2U6NjRhOWRkMDM3YTc5NGM2ZGJmY2ZhNjdiZDYwZDRiNDJfNC0xMS0xLTEtNDU5MTk_367e9daa-865d-4466-9ed4-c89407ec5b8a">131,227</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe, Middle East &amp; Africa</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39a257b7bdcf459488a0a70dadb1fc48_D20230101-20230331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80My9mcmFnOjQ4M2E3ZjM0NDExZDQzNGI5M2MzM2VmNTk1ZGY3ZTQxL3RhYmxlOjY0YTlkZDAzN2E3OTRjNmRiZmNmYTY3YmQ2MGQ0YjQyL3RhYmxlcmFuZ2U6NjRhOWRkMDM3YTc5NGM2ZGJmY2ZhNjdiZDYwZDRiNDJfNS0xLTEtMS00NTkxOQ_9bfbae11-b84d-415d-8f50-621ada46bddc">33,120</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i66fa55845df14909875423110e9c3562_D20230101-20230331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80My9mcmFnOjQ4M2E3ZjM0NDExZDQzNGI5M2MzM2VmNTk1ZGY3ZTQxL3RhYmxlOjY0YTlkZDAzN2E3OTRjNmRiZmNmYTY3YmQ2MGQ0YjQyL3RhYmxlcmFuZ2U6NjRhOWRkMDM3YTc5NGM2ZGJmY2ZhNjdiZDYwZDRiNDJfNS0zLTEtMS00NTkxOQ_cb2de3de-03f7-40cf-8fb6-7ec5ddc64f9f">22,896</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibeb105be0cd24a989e5a9543869dcd19_D20230101-20230331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80My9mcmFnOjQ4M2E3ZjM0NDExZDQzNGI5M2MzM2VmNTk1ZGY3ZTQxL3RhYmxlOjY0YTlkZDAzN2E3OTRjNmRiZmNmYTY3YmQ2MGQ0YjQyL3RhYmxlcmFuZ2U6NjRhOWRkMDM3YTc5NGM2ZGJmY2ZhNjdiZDYwZDRiNDJfNS01LTEtMS00NTkxOQ_c6808e0c-27dd-4612-b23b-6649ce85be1d">56,016</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95feeaee74ee430ab557bd6fd0a89121_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80My9mcmFnOjQ4M2E3ZjM0NDExZDQzNGI5M2MzM2VmNTk1ZGY3ZTQxL3RhYmxlOjY0YTlkZDAzN2E3OTRjNmRiZmNmYTY3YmQ2MGQ0YjQyL3RhYmxlcmFuZ2U6NjRhOWRkMDM3YTc5NGM2ZGJmY2ZhNjdiZDYwZDRiNDJfNS03LTEtMS00NTkxOQ_23ffa528-5bcf-476f-94d9-03f8cd888716">29,980</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i025adf098383419fa26b51488aa4067f_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80My9mcmFnOjQ4M2E3ZjM0NDExZDQzNGI5M2MzM2VmNTk1ZGY3ZTQxL3RhYmxlOjY0YTlkZDAzN2E3OTRjNmRiZmNmYTY3YmQ2MGQ0YjQyL3RhYmxlcmFuZ2U6NjRhOWRkMDM3YTc5NGM2ZGJmY2ZhNjdiZDYwZDRiNDJfNS05LTEtMS00NTkxOQ_844786f4-001d-4ee6-b0bb-bc67e9d37c2f">20,326</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0a8d168c31ea4928b8a1a43a06a6984a_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80My9mcmFnOjQ4M2E3ZjM0NDExZDQzNGI5M2MzM2VmNTk1ZGY3ZTQxL3RhYmxlOjY0YTlkZDAzN2E3OTRjNmRiZmNmYTY3YmQ2MGQ0YjQyL3RhYmxlcmFuZ2U6NjRhOWRkMDM3YTc5NGM2ZGJmY2ZhNjdiZDYwZDRiNDJfNS0xMS0xLTEtNDU5MTk_7e9a96cc-ba2e-47b6-9279-a6bb3ced5e69">50,306</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia Pacific</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i576a3464c09a4584a1729cd84cc4164b_D20230101-20230331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80My9mcmFnOjQ4M2E3ZjM0NDExZDQzNGI5M2MzM2VmNTk1ZGY3ZTQxL3RhYmxlOjY0YTlkZDAzN2E3OTRjNmRiZmNmYTY3YmQ2MGQ0YjQyL3RhYmxlcmFuZ2U6NjRhOWRkMDM3YTc5NGM2ZGJmY2ZhNjdiZDYwZDRiNDJfNi0xLTEtMS00NTkxOQ_75c1babe-6c25-4515-8207-89e1998fb597">30,121</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05787a350f674333ac2b6243c86c128a_D20230101-20230331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80My9mcmFnOjQ4M2E3ZjM0NDExZDQzNGI5M2MzM2VmNTk1ZGY3ZTQxL3RhYmxlOjY0YTlkZDAzN2E3OTRjNmRiZmNmYTY3YmQ2MGQ0YjQyL3RhYmxlcmFuZ2U6NjRhOWRkMDM3YTc5NGM2ZGJmY2ZhNjdiZDYwZDRiNDJfNi0zLTEtMS00NTkxOQ_e0d970d2-3009-4a8c-9d1a-09285047d1de">15,986</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i602945d302db4233b3e192e2980d335f_D20230101-20230331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80My9mcmFnOjQ4M2E3ZjM0NDExZDQzNGI5M2MzM2VmNTk1ZGY3ZTQxL3RhYmxlOjY0YTlkZDAzN2E3OTRjNmRiZmNmYTY3YmQ2MGQ0YjQyL3RhYmxlcmFuZ2U6NjRhOWRkMDM3YTc5NGM2ZGJmY2ZhNjdiZDYwZDRiNDJfNi01LTEtMS00NTkxOQ_6d4e85ab-8a47-4a04-a969-5d208973c455">46,107</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1a88893879046bd89e1f186cac411ec_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80My9mcmFnOjQ4M2E3ZjM0NDExZDQzNGI5M2MzM2VmNTk1ZGY3ZTQxL3RhYmxlOjY0YTlkZDAzN2E3OTRjNmRiZmNmYTY3YmQ2MGQ0YjQyL3RhYmxlcmFuZ2U6NjRhOWRkMDM3YTc5NGM2ZGJmY2ZhNjdiZDYwZDRiNDJfNi03LTEtMS00NTkxOQ_6a46ea97-af16-429c-a431-86c2d998cab9">23,418</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ed292675fb142ab9e142e12e6a19a99_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80My9mcmFnOjQ4M2E3ZjM0NDExZDQzNGI5M2MzM2VmNTk1ZGY3ZTQxL3RhYmxlOjY0YTlkZDAzN2E3OTRjNmRiZmNmYTY3YmQ2MGQ0YjQyL3RhYmxlcmFuZ2U6NjRhOWRkMDM3YTc5NGM2ZGJmY2ZhNjdiZDYwZDRiNDJfNi05LTEtMS00NTkxOQ_6f7e7269-2341-4efb-9903-3d0e095b5680">12,954</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26a828941a804f3f9109a0c00250ec1d_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80My9mcmFnOjQ4M2E3ZjM0NDExZDQzNGI5M2MzM2VmNTk1ZGY3ZTQxL3RhYmxlOjY0YTlkZDAzN2E3OTRjNmRiZmNmYTY3YmQ2MGQ0YjQyL3RhYmxlcmFuZ2U6NjRhOWRkMDM3YTc5NGM2ZGJmY2ZhNjdiZDYwZDRiNDJfNi0xMS0xLTEtNDU5MTk_9521251a-c66a-4b7c-9677-dff42898d4f3">36,372</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Americas (excluding the United States)</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i25c81b50fa704ad899e54ae63e120282_D20230101-20230331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80My9mcmFnOjQ4M2E3ZjM0NDExZDQzNGI5M2MzM2VmNTk1ZGY3ZTQxL3RhYmxlOjY0YTlkZDAzN2E3OTRjNmRiZmNmYTY3YmQ2MGQ0YjQyL3RhYmxlcmFuZ2U6NjRhOWRkMDM3YTc5NGM2ZGJmY2ZhNjdiZDYwZDRiNDJfNy0xLTEtMS00NTkxOQ_56c83131-819d-4a5d-8581-185bd0a569ce">18,990</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4422e467d9714c3d8fbf4438109765ab_D20230101-20230331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80My9mcmFnOjQ4M2E3ZjM0NDExZDQzNGI5M2MzM2VmNTk1ZGY3ZTQxL3RhYmxlOjY0YTlkZDAzN2E3OTRjNmRiZmNmYTY3YmQ2MGQ0YjQyL3RhYmxlcmFuZ2U6NjRhOWRkMDM3YTc5NGM2ZGJmY2ZhNjdiZDYwZDRiNDJfNy0zLTEtMS00NTkxOQ_eb9f0d22-235e-419f-8a2a-3a9112bfdbed">9,766</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i768d975a616147ad9d2d2288a48b11ed_D20230101-20230331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80My9mcmFnOjQ4M2E3ZjM0NDExZDQzNGI5M2MzM2VmNTk1ZGY3ZTQxL3RhYmxlOjY0YTlkZDAzN2E3OTRjNmRiZmNmYTY3YmQ2MGQ0YjQyL3RhYmxlcmFuZ2U6NjRhOWRkMDM3YTc5NGM2ZGJmY2ZhNjdiZDYwZDRiNDJfNy01LTEtMS00NTkxOQ_2e9ef980-489d-4c14-a8b8-c77f14db2dab">28,756</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4f4ed95789924cb587cec5440c300f1a_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80My9mcmFnOjQ4M2E3ZjM0NDExZDQzNGI5M2MzM2VmNTk1ZGY3ZTQxL3RhYmxlOjY0YTlkZDAzN2E3OTRjNmRiZmNmYTY3YmQ2MGQ0YjQyL3RhYmxlcmFuZ2U6NjRhOWRkMDM3YTc5NGM2ZGJmY2ZhNjdiZDYwZDRiNDJfNy03LTEtMS00NTkxOQ_bdbb8f2a-3522-41cd-9f17-be15765a948c">16,172</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1872a8b90120412d810e0a86ab85c148_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80My9mcmFnOjQ4M2E3ZjM0NDExZDQzNGI5M2MzM2VmNTk1ZGY3ZTQxL3RhYmxlOjY0YTlkZDAzN2E3OTRjNmRiZmNmYTY3YmQ2MGQ0YjQyL3RhYmxlcmFuZ2U6NjRhOWRkMDM3YTc5NGM2ZGJmY2ZhNjdiZDYwZDRiNDJfNy05LTEtMS00NTkxOQ_b5323961-0766-484b-b1f6-8f5d8abe28cb">8,250</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib413a484ed8047a49dbd503cf4a21f59_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80My9mcmFnOjQ4M2E3ZjM0NDExZDQzNGI5M2MzM2VmNTk1ZGY3ZTQxL3RhYmxlOjY0YTlkZDAzN2E3OTRjNmRiZmNmYTY3YmQ2MGQ0YjQyL3RhYmxlcmFuZ2U6NjRhOWRkMDM3YTc5NGM2ZGJmY2ZhNjdiZDYwZDRiNDJfNy0xMS0xLTEtNDU5MTk_a04956ce-f17f-4fd1-ae90-422417c378dc">24,422</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 19pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total sales from contracts with customers</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a0f37b7e82e470ebf61b3f06c22aac2_D20230101-20230331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80My9mcmFnOjQ4M2E3ZjM0NDExZDQzNGI5M2MzM2VmNTk1ZGY3ZTQxL3RhYmxlOjY0YTlkZDAzN2E3OTRjNmRiZmNmYTY3YmQ2MGQ0YjQyL3RhYmxlcmFuZ2U6NjRhOWRkMDM3YTc5NGM2ZGJmY2ZhNjdiZDYwZDRiNDJfOC0xLTEtMS00NTkxOQ_b9b931cc-a630-440e-a8cf-4798266e56bd">131,175</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if48f7914ec3d45beaf647b856037592a_D20230101-20230331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80My9mcmFnOjQ4M2E3ZjM0NDExZDQzNGI5M2MzM2VmNTk1ZGY3ZTQxL3RhYmxlOjY0YTlkZDAzN2E3OTRjNmRiZmNmYTY3YmQ2MGQ0YjQyL3RhYmxlcmFuZ2U6NjRhOWRkMDM3YTc5NGM2ZGJmY2ZhNjdiZDYwZDRiNDJfOC0zLTEtMS00NTkxOQ_ded439e6-41fd-476d-8766-fe096145128b">164,293</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80My9mcmFnOjQ4M2E3ZjM0NDExZDQzNGI5M2MzM2VmNTk1ZGY3ZTQxL3RhYmxlOjY0YTlkZDAzN2E3OTRjNmRiZmNmYTY3YmQ2MGQ0YjQyL3RhYmxlcmFuZ2U6NjRhOWRkMDM3YTc5NGM2ZGJmY2ZhNjdiZDYwZDRiNDJfOC01LTEtMS00NTkxOQ_80c41819-f463-41f3-b17a-025e7f88676c">295,468</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia61d13e27f12498686a84bca47df5ec7_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80My9mcmFnOjQ4M2E3ZjM0NDExZDQzNGI5M2MzM2VmNTk1ZGY3ZTQxL3RhYmxlOjY0YTlkZDAzN2E3OTRjNmRiZmNmYTY3YmQ2MGQ0YjQyL3RhYmxlcmFuZ2U6NjRhOWRkMDM3YTc5NGM2ZGJmY2ZhNjdiZDYwZDRiNDJfOC03LTEtMS00NTkxOQ_b01fd066-bf1e-42d3-8bb6-4a0d2980d5a1">107,517</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i60341eeb4343409c94899251a17bdde1_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80My9mcmFnOjQ4M2E3ZjM0NDExZDQzNGI5M2MzM2VmNTk1ZGY3ZTQxL3RhYmxlOjY0YTlkZDAzN2E3OTRjNmRiZmNmYTY3YmQ2MGQ0YjQyL3RhYmxlcmFuZ2U6NjRhOWRkMDM3YTc5NGM2ZGJmY2ZhNjdiZDYwZDRiNDJfOC05LTEtMS00NTkxOQ_9d1fa249-17f6-4869-aa38-d75f959ba334">134,810</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9500a5ee8dbe4d23aa9c46ebdd25a0c8_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80My9mcmFnOjQ4M2E3ZjM0NDExZDQzNGI5M2MzM2VmNTk1ZGY3ZTQxL3RhYmxlOjY0YTlkZDAzN2E3OTRjNmRiZmNmYTY3YmQ2MGQ0YjQyL3RhYmxlcmFuZ2U6NjRhOWRkMDM3YTc5NGM2ZGJmY2ZhNjdiZDYwZDRiNDJfOC0xMS0xLTEtNDU5MTk_5d77896d-4c05-4d82-bcdd-d489c59d522d">242,327</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Timing of Revenue Recognition</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goods transferred at a point in time</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i256914f8655049ea8697187612d438ac_D20230101-20230331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80My9mcmFnOjQ4M2E3ZjM0NDExZDQzNGI5M2MzM2VmNTk1ZGY3ZTQxL3RhYmxlOjY0YTlkZDAzN2E3OTRjNmRiZmNmYTY3YmQ2MGQ0YjQyL3RhYmxlcmFuZ2U6NjRhOWRkMDM3YTc5NGM2ZGJmY2ZhNjdiZDYwZDRiNDJfMTEtMS0xLTEtNDU5MTk_8f6d2153-b88c-4120-ab3f-898ae099f917">121,122</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia6458bd1547344efa30ce73c2612539c_D20230101-20230331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80My9mcmFnOjQ4M2E3ZjM0NDExZDQzNGI5M2MzM2VmNTk1ZGY3ZTQxL3RhYmxlOjY0YTlkZDAzN2E3OTRjNmRiZmNmYTY3YmQ2MGQ0YjQyL3RhYmxlcmFuZ2U6NjRhOWRkMDM3YTc5NGM2ZGJmY2ZhNjdiZDYwZDRiNDJfMTEtMy0xLTEtNDU5MTk_7685c892-2cc4-4024-b715-c3fffc1bdded">162,590</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d99ddc9cc5b4e6aab3f7115cf38a715_D20230101-20230331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80My9mcmFnOjQ4M2E3ZjM0NDExZDQzNGI5M2MzM2VmNTk1ZGY3ZTQxL3RhYmxlOjY0YTlkZDAzN2E3OTRjNmRiZmNmYTY3YmQ2MGQ0YjQyL3RhYmxlcmFuZ2U6NjRhOWRkMDM3YTc5NGM2ZGJmY2ZhNjdiZDYwZDRiNDJfMTEtNS0xLTEtNDU5MTk_71e475a0-2b4e-41c7-8e6b-e16ad9cca612">283,712</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied376a94006741e6b0f863abd74791a1_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80My9mcmFnOjQ4M2E3ZjM0NDExZDQzNGI5M2MzM2VmNTk1ZGY3ZTQxL3RhYmxlOjY0YTlkZDAzN2E3OTRjNmRiZmNmYTY3YmQ2MGQ0YjQyL3RhYmxlcmFuZ2U6NjRhOWRkMDM3YTc5NGM2ZGJmY2ZhNjdiZDYwZDRiNDJfMTEtNy0xLTEtNDU5MTk_78db3841-edb6-4f83-a19f-eb8d55e0b0c4">98,204</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib2980943d7fd4938b59d54c6c50f48a6_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80My9mcmFnOjQ4M2E3ZjM0NDExZDQzNGI5M2MzM2VmNTk1ZGY3ZTQxL3RhYmxlOjY0YTlkZDAzN2E3OTRjNmRiZmNmYTY3YmQ2MGQ0YjQyL3RhYmxlcmFuZ2U6NjRhOWRkMDM3YTc5NGM2ZGJmY2ZhNjdiZDYwZDRiNDJfMTEtOS0xLTEtNDU5MTk_3bf76de2-35f4-49e5-a3cc-f16357cce9ec">133,322</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if9e3065b9a6e471ab072cbee433e2b01_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80My9mcmFnOjQ4M2E3ZjM0NDExZDQzNGI5M2MzM2VmNTk1ZGY3ZTQxL3RhYmxlOjY0YTlkZDAzN2E3OTRjNmRiZmNmYTY3YmQ2MGQ0YjQyL3RhYmxlcmFuZ2U6NjRhOWRkMDM3YTc5NGM2ZGJmY2ZhNjdiZDYwZDRiNDJfMTEtMTEtMS0xLTQ1OTE5_e2e7989a-d2c7-4d55-9aab-8fdb5b04dd10">231,526</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Services transferred over time</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i19f0084e35914599aa701fa76539508d_D20230101-20230331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80My9mcmFnOjQ4M2E3ZjM0NDExZDQzNGI5M2MzM2VmNTk1ZGY3ZTQxL3RhYmxlOjY0YTlkZDAzN2E3OTRjNmRiZmNmYTY3YmQ2MGQ0YjQyL3RhYmxlcmFuZ2U6NjRhOWRkMDM3YTc5NGM2ZGJmY2ZhNjdiZDYwZDRiNDJfMTItMS0xLTEtNDU5MTk_6669bc29-c015-4bcc-bc88-6c3049cc7d34">10,053</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if322af949b2348ebaf2b896bd9ee2e61_D20230101-20230331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80My9mcmFnOjQ4M2E3ZjM0NDExZDQzNGI5M2MzM2VmNTk1ZGY3ZTQxL3RhYmxlOjY0YTlkZDAzN2E3OTRjNmRiZmNmYTY3YmQ2MGQ0YjQyL3RhYmxlcmFuZ2U6NjRhOWRkMDM3YTc5NGM2ZGJmY2ZhNjdiZDYwZDRiNDJfMTItMy0xLTEtNDU5MTk_ce8bde1c-9d4a-4816-bee9-1a5283bbcf4e">1,703</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i75c95aec633641d7b8b7c07c7fdff0c3_D20230101-20230331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80My9mcmFnOjQ4M2E3ZjM0NDExZDQzNGI5M2MzM2VmNTk1ZGY3ZTQxL3RhYmxlOjY0YTlkZDAzN2E3OTRjNmRiZmNmYTY3YmQ2MGQ0YjQyL3RhYmxlcmFuZ2U6NjRhOWRkMDM3YTc5NGM2ZGJmY2ZhNjdiZDYwZDRiNDJfMTItNS0xLTEtNDU5MTk_e8db20f3-ca4f-4e75-88ee-d54b6a905d81">11,756</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb37c3470f1c4ee4a3ca9416c789d079_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80My9mcmFnOjQ4M2E3ZjM0NDExZDQzNGI5M2MzM2VmNTk1ZGY3ZTQxL3RhYmxlOjY0YTlkZDAzN2E3OTRjNmRiZmNmYTY3YmQ2MGQ0YjQyL3RhYmxlcmFuZ2U6NjRhOWRkMDM3YTc5NGM2ZGJmY2ZhNjdiZDYwZDRiNDJfMTItNy0xLTEtNDU5MTk_043a83b2-0d23-45cc-9d07-1a0a17f6aad0">9,313</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i72ad5ca858ec41a8b22fc48fcb8a2b67_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80My9mcmFnOjQ4M2E3ZjM0NDExZDQzNGI5M2MzM2VmNTk1ZGY3ZTQxL3RhYmxlOjY0YTlkZDAzN2E3OTRjNmRiZmNmYTY3YmQ2MGQ0YjQyL3RhYmxlcmFuZ2U6NjRhOWRkMDM3YTc5NGM2ZGJmY2ZhNjdiZDYwZDRiNDJfMTItOS0xLTEtNDU5MTk_bc566c70-26f1-4c64-8808-6eeb454836b3">1,488</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i147ce8278590475d95f2b007ce8b8910_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80My9mcmFnOjQ4M2E3ZjM0NDExZDQzNGI5M2MzM2VmNTk1ZGY3ZTQxL3RhYmxlOjY0YTlkZDAzN2E3OTRjNmRiZmNmYTY3YmQ2MGQ0YjQyL3RhYmxlcmFuZ2U6NjRhOWRkMDM3YTc5NGM2ZGJmY2ZhNjdiZDYwZDRiNDJfMTItMTEtMS0xLTQ1OTE5_89049586-b96d-466e-9733-acf92f31ffc0">10,801</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 19pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total sales from contracts with customers</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a0f37b7e82e470ebf61b3f06c22aac2_D20230101-20230331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80My9mcmFnOjQ4M2E3ZjM0NDExZDQzNGI5M2MzM2VmNTk1ZGY3ZTQxL3RhYmxlOjY0YTlkZDAzN2E3OTRjNmRiZmNmYTY3YmQ2MGQ0YjQyL3RhYmxlcmFuZ2U6NjRhOWRkMDM3YTc5NGM2ZGJmY2ZhNjdiZDYwZDRiNDJfMTMtMS0xLTEtNDU5MTk_eabf12c9-1623-4af1-90cd-b5187f5ea9f3">131,175</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if48f7914ec3d45beaf647b856037592a_D20230101-20230331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80My9mcmFnOjQ4M2E3ZjM0NDExZDQzNGI5M2MzM2VmNTk1ZGY3ZTQxL3RhYmxlOjY0YTlkZDAzN2E3OTRjNmRiZmNmYTY3YmQ2MGQ0YjQyL3RhYmxlcmFuZ2U6NjRhOWRkMDM3YTc5NGM2ZGJmY2ZhNjdiZDYwZDRiNDJfMTMtMy0xLTEtNDU5MTk_7e38d14a-3c67-4c26-88e9-c95f514a45ca">164,293</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80My9mcmFnOjQ4M2E3ZjM0NDExZDQzNGI5M2MzM2VmNTk1ZGY3ZTQxL3RhYmxlOjY0YTlkZDAzN2E3OTRjNmRiZmNmYTY3YmQ2MGQ0YjQyL3RhYmxlcmFuZ2U6NjRhOWRkMDM3YTc5NGM2ZGJmY2ZhNjdiZDYwZDRiNDJfMTMtNS0xLTEtNDU5MTk_70f38554-929e-4ff7-a7a9-70be7f28b789">295,468</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia61d13e27f12498686a84bca47df5ec7_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80My9mcmFnOjQ4M2E3ZjM0NDExZDQzNGI5M2MzM2VmNTk1ZGY3ZTQxL3RhYmxlOjY0YTlkZDAzN2E3OTRjNmRiZmNmYTY3YmQ2MGQ0YjQyL3RhYmxlcmFuZ2U6NjRhOWRkMDM3YTc5NGM2ZGJmY2ZhNjdiZDYwZDRiNDJfMTMtNy0xLTEtNDU5MTk_5c085b32-493a-49cd-b6d4-ecb9ee204c26">107,517</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i60341eeb4343409c94899251a17bdde1_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80My9mcmFnOjQ4M2E3ZjM0NDExZDQzNGI5M2MzM2VmNTk1ZGY3ZTQxL3RhYmxlOjY0YTlkZDAzN2E3OTRjNmRiZmNmYTY3YmQ2MGQ0YjQyL3RhYmxlcmFuZ2U6NjRhOWRkMDM3YTc5NGM2ZGJmY2ZhNjdiZDYwZDRiNDJfMTMtOS0xLTEtNDU5MTk_fa9d2d42-8b7c-4a2d-b1bf-6fa83559dc9b">134,810</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9500a5ee8dbe4d23aa9c46ebdd25a0c8_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80My9mcmFnOjQ4M2E3ZjM0NDExZDQzNGI5M2MzM2VmNTk1ZGY3ZTQxL3RhYmxlOjY0YTlkZDAzN2E3OTRjNmRiZmNmYTY3YmQ2MGQ0YjQyL3RhYmxlcmFuZ2U6NjRhOWRkMDM3YTc5NGM2ZGJmY2ZhNjdiZDYwZDRiNDJfMTMtMTEtMS0xLTQ1OTE5_e5ab9265-d8ba-4911-bdfc-0ae83f56ae64">242,327</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:31.209%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.581%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><ix:nonNumeric contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331" name="us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80My9mcmFnOjQ4M2E3ZjM0NDExZDQzNGI5M2MzM2VmNTk1ZGY3ZTQxL3RleHRyZWdpb246NDgzYTdmMzQ0MTFkNDM0YjkzYzMzZWY1OTVkZjdlNDFfNTEw_a9fdbccd-3ac9-4a51-95d2-0226685f8539" escape="true"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contract liability balances related to the sale of extended warranties to customers are as follows:</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.987%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.344%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.346%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract liability</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i738c2d1dacaf436faf03cc46ab9cef23_I20230331" decimals="-3" name="us-gaap:ContractWithCustomerLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80My9mcmFnOjQ4M2E3ZjM0NDExZDQzNGI5M2MzM2VmNTk1ZGY3ZTQxL3RhYmxlOmZjZjJmZjQ5MDU4NzQxMjY5MzA3NzRlMGYwNWJiMWViL3RhYmxlcmFuZ2U6ZmNmMmZmNDkwNTg3NDEyNjkzMDc3NGUwZjA1YmIxZWJfMi0xLTEtMS00NTkxOQ_4028b1b5-5cb5-4c5f-9f4d-263741e0aa35">18,887</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4f63720d8b244a68941932992cd9f4d_I20221231" decimals="-3" name="us-gaap:ContractWithCustomerLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80My9mcmFnOjQ4M2E3ZjM0NDExZDQzNGI5M2MzM2VmNTk1ZGY3ZTQxL3RhYmxlOmZjZjJmZjQ5MDU4NzQxMjY5MzA3NzRlMGYwNWJiMWViL3RhYmxlcmFuZ2U6ZmNmMmZmNDkwNTg3NDEyNjkzMDc3NGUwZjA1YmIxZWJfMi0zLTEtMS00NTkxOQ_739fe68e-83f0-41ef-9e59-036d602de0dd">19,114</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue recognized during the three months ended March&#160;31, 2023 and March&#160;31, 2022 from amounts included in contract liabilities at the beginning of the period were $<ix:nonFraction unitRef="usd" contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331" decimals="-5" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80My9mcmFnOjQ4M2E3ZjM0NDExZDQzNGI5M2MzM2VmNTk1ZGY3ZTQxL3RleHRyZWdpb246NDgzYTdmMzQ0MTFkNDM0YjkzYzMzZWY1OTVkZjdlNDFfNDIy_278ae302-aade-443a-a413-8f2d8fe4aaf2">4.2</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i9500a5ee8dbe4d23aa9c46ebdd25a0c8_D20220101-20220331" decimals="-5" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80My9mcmFnOjQ4M2E3ZjM0NDExZDQzNGI5M2MzM2VmNTk1ZGY3ZTQxL3RleHRyZWdpb246NDgzYTdmMzQ0MTFkNDM0YjkzYzMzZWY1OTVkZjdlNDFfNDI5_6c8031d1-3b5a-43e4-b519-a9a2c49e3785">3.9</ix:nonFraction> million, respectively.  There were no material </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline" href="#i952e7af9c0b94e65995973e7f212f399_7">Table of Contents</a></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i91eff369bfce44b0856c4ecffb7cb10d">contract assets as of March&#160;31, 2023 and December&#160;31, 2022.</ix:continuation></span></div><div style="text-align:justify"><span><br/></span></div><div id="i952e7af9c0b94e65995973e7f212f399_46"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Note 6 &#8211; <ix:nonNumeric contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331" name="us-gaap:ComprehensiveIncomeNoteTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80Ni9mcmFnOjFiNzYzYzFhMzFiMTRhNjU5MGJkMjUwMDIzMGQzNjM1L3RleHRyZWdpb246MWI3NjNjMWEzMWIxNGE2NTkwYmQyNTAwMjMwZDM2MzVfNDg0_4189e999-d7cf-4820-8043-1e565b25928c" continuedAt="i7d4534ca8e8d495993e1d1283f6671b7" escape="true">Comprehensive Income</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="i7d4534ca8e8d495993e1d1283f6671b7"><ix:nonNumeric contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331" name="us-gaap:ScheduleOfComprehensiveIncomeLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80Ni9mcmFnOjFiNzYzYzFhMzFiMTRhNjU5MGJkMjUwMDIzMGQzNjM1L3RleHRyZWdpb246MWI3NjNjMWEzMWIxNGE2NTkwYmQyNTAwMjMwZDM2MzVfNDg3_3ca98132-c045-449d-81b7-ac595de007bf" escape="true"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Comprehensive income consists of the following:</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:1pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:79.747%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.113%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80Ni9mcmFnOjFiNzYzYzFhMzFiMTRhNjU5MGJkMjUwMDIzMGQzNjM1L3RhYmxlOmU4NDkzYzM2ODQwMzQ4ZDY5NmZlZjkxZjVkYjEzODEwL3RhYmxlcmFuZ2U6ZTg0OTNjMzY4NDAzNDhkNjk2ZmVmOTFmNWRiMTM4MTBfMi0xLTEtMS00NTkxOQ_f249a106-e0ab-4e14-b05e-9d4973802ff1">1,819</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9500a5ee8dbe4d23aa9c46ebdd25a0c8_D20220101-20220331" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80Ni9mcmFnOjFiNzYzYzFhMzFiMTRhNjU5MGJkMjUwMDIzMGQzNjM1L3RhYmxlOmU4NDkzYzM2ODQwMzQ4ZDY5NmZlZjkxZjVkYjEzODEwL3RhYmxlcmFuZ2U6ZTg0OTNjMzY4NDAzNDhkNjk2ZmVmOTFmNWRiMTM4MTBfMi0zLTEtMS00NTkxOQ_476c55c5-8113-4eb6-9997-23cc9c75f483">14,975</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flow hedging gain, net of income tax (income tax expense of $<ix:nonFraction unitRef="usd" contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80Ni9mcmFnOjFiNzYzYzFhMzFiMTRhNjU5MGJkMjUwMDIzMGQzNjM1L3RhYmxlOmU4NDkzYzM2ODQwMzQ4ZDY5NmZlZjkxZjVkYjEzODEwL3RhYmxlcmFuZ2U6ZTg0OTNjMzY4NDAzNDhkNjk2ZmVmOTFmNWRiMTM4MTBfNS0wLTEtMS00NTkxOS90ZXh0cmVnaW9uOjAyMjExYjMwZjY3ZjRiM2JhNzJmMGYyZjYyNTdlNDFkXzY5_192d105e-077d-4654-8931-89edb9390610">280</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i9500a5ee8dbe4d23aa9c46ebdd25a0c8_D20220101-20220331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80Ni9mcmFnOjFiNzYzYzFhMzFiMTRhNjU5MGJkMjUwMDIzMGQzNjM1L3RhYmxlOmU4NDkzYzM2ODQwMzQ4ZDY5NmZlZjkxZjVkYjEzODEwL3RhYmxlcmFuZ2U6ZTg0OTNjMzY4NDAzNDhkNjk2ZmVmOTFmNWRiMTM4MTBfNS0wLTEtMS00NTkxOS90ZXh0cmVnaW9uOjAyMjExYjMwZjY3ZjRiM2JhNzJmMGYyZjYyNTdlNDFkXzc2_4d5e762a-5bb5-41f7-9557-2c4a7ccef84c">346</ix:nonFraction> for the three months ended March 31, 2023 and 2022, respectively)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80Ni9mcmFnOjFiNzYzYzFhMzFiMTRhNjU5MGJkMjUwMDIzMGQzNjM1L3RhYmxlOmU4NDkzYzM2ODQwMzQ4ZDY5NmZlZjkxZjVkYjEzODEwL3RhYmxlcmFuZ2U6ZTg0OTNjMzY4NDAzNDhkNjk2ZmVmOTFmNWRiMTM4MTBfNS0xLTEtMS00NTkxOQ_906d882e-2191-4858-9c48-32950a5ad966">877</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9500a5ee8dbe4d23aa9c46ebdd25a0c8_D20220101-20220331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80Ni9mcmFnOjFiNzYzYzFhMzFiMTRhNjU5MGJkMjUwMDIzMGQzNjM1L3RhYmxlOmU4NDkzYzM2ODQwMzQ4ZDY5NmZlZjkxZjVkYjEzODEwL3RhYmxlcmFuZ2U6ZTg0OTNjMzY4NDAzNDhkNjk2ZmVmOTFmNWRiMTM4MTBfNS0zLTEtMS00NTkxOQ_d74e1db8-e62f-4012-81d1-6fca16b179bc">1,082</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension liability, net of income tax (income tax expense of $<ix:nonFraction unitRef="usd" contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80Ni9mcmFnOjFiNzYzYzFhMzFiMTRhNjU5MGJkMjUwMDIzMGQzNjM1L3RhYmxlOmU4NDkzYzM2ODQwMzQ4ZDY5NmZlZjkxZjVkYjEzODEwL3RhYmxlcmFuZ2U6ZTg0OTNjMzY4NDAzNDhkNjk2ZmVmOTFmNWRiMTM4MTBfNi0wLTEtMS00NTkxOS90ZXh0cmVnaW9uOjA3MzVjMWQxNDc1ZTQ1NzNiNzViMDM5OWJmN2NmMzEyXzY0_43074f28-f03b-4684-a96b-2b358485dc58">129</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i9500a5ee8dbe4d23aa9c46ebdd25a0c8_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80Ni9mcmFnOjFiNzYzYzFhMzFiMTRhNjU5MGJkMjUwMDIzMGQzNjM1L3RhYmxlOmU4NDkzYzM2ODQwMzQ4ZDY5NmZlZjkxZjVkYjEzODEwL3RhYmxlcmFuZ2U6ZTg0OTNjMzY4NDAzNDhkNjk2ZmVmOTFmNWRiMTM4MTBfNi0wLTEtMS00NTkxOS90ZXh0cmVnaW9uOjA3MzVjMWQxNDc1ZTQ1NzNiNzViMDM5OWJmN2NmMzEyXzcx_1949f657-3f18-4de8-b964-c4739d6d36f5">127</ix:nonFraction> for the three months ended March 31, 2023 and 2022, respectively)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80Ni9mcmFnOjFiNzYzYzFhMzFiMTRhNjU5MGJkMjUwMDIzMGQzNjM1L3RhYmxlOmU4NDkzYzM2ODQwMzQ4ZDY5NmZlZjkxZjVkYjEzODEwL3RhYmxlcmFuZ2U6ZTg0OTNjMzY4NDAzNDhkNjk2ZmVmOTFmNWRiMTM4MTBfNi0xLTEtMS00NTkxOQ_c16fd109-3eea-41ec-a16c-70af9186c021">403</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9500a5ee8dbe4d23aa9c46ebdd25a0c8_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80Ni9mcmFnOjFiNzYzYzFhMzFiMTRhNjU5MGJkMjUwMDIzMGQzNjM1L3RhYmxlOmU4NDkzYzM2ODQwMzQ4ZDY5NmZlZjkxZjVkYjEzODEwL3RhYmxlcmFuZ2U6ZTg0OTNjMzY4NDAzNDhkNjk2ZmVmOTFmNWRiMTM4MTBfNi0zLTEtMS00NTkxOQ_f52c1316-1ab6-40c1-8d9a-129247a80858">521</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80Ni9mcmFnOjFiNzYzYzFhMzFiMTRhNjU5MGJkMjUwMDIzMGQzNjM1L3RhYmxlOmU4NDkzYzM2ODQwMzQ4ZDY5NmZlZjkxZjVkYjEzODEwL3RhYmxlcmFuZ2U6ZTg0OTNjMzY4NDAzNDhkNjk2ZmVmOTFmNWRiMTM4MTBfNy0xLTEtMS00NTkxOQ_c57efee6-47e1-4cfc-a55f-916be8857e5a"><ix:nonFraction unitRef="usd" contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80Ni9mcmFnOjFiNzYzYzFhMzFiMTRhNjU5MGJkMjUwMDIzMGQzNjM1L3RhYmxlOmU4NDkzYzM2ODQwMzQ4ZDY5NmZlZjkxZjVkYjEzODEwL3RhYmxlcmFuZ2U6ZTg0OTNjMzY4NDAzNDhkNjk2ZmVmOTFmNWRiMTM4MTBfNy0xLTEtMS00NTkxOQ_e9f5192c-fa45-4a65-90e5-09e3b8c04e8f">1,596</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9500a5ee8dbe4d23aa9c46ebdd25a0c8_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80Ni9mcmFnOjFiNzYzYzFhMzFiMTRhNjU5MGJkMjUwMDIzMGQzNjM1L3RhYmxlOmU4NDkzYzM2ODQwMzQ4ZDY5NmZlZjkxZjVkYjEzODEwL3RhYmxlcmFuZ2U6ZTg0OTNjMzY4NDAzNDhkNjk2ZmVmOTFmNWRiMTM4MTBfNy0zLTEtMS00NTkxOQ_7f8d2fed-32be-4f79-8cde-f41b6692cd35">163</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 7.75pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive income</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80Ni9mcmFnOjFiNzYzYzFhMzFiMTRhNjU5MGJkMjUwMDIzMGQzNjM1L3RhYmxlOmU4NDkzYzM2ODQwMzQ4ZDY5NmZlZjkxZjVkYjEzODEwL3RhYmxlcmFuZ2U6ZTg0OTNjMzY4NDAzNDhkNjk2ZmVmOTFmNWRiMTM4MTBfOS0xLTEtMS00NTkxOQ_7ad8bff7-0e76-4158-b472-f11a274fcb74">4,695</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9500a5ee8dbe4d23aa9c46ebdd25a0c8_D20220101-20220331" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80Ni9mcmFnOjFiNzYzYzFhMzFiMTRhNjU5MGJkMjUwMDIzMGQzNjM1L3RhYmxlOmU4NDkzYzM2ODQwMzQ4ZDY5NmZlZjkxZjVkYjEzODEwL3RhYmxlcmFuZ2U6ZTg0OTNjMzY4NDAzNDhkNjk2ZmVmOTFmNWRiMTM4MTBfOS0zLTEtMS00NTkxOQ_1ad285a2-9512-4f73-9582-4d1ef85c8ebd">16,415</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div style="text-indent:36pt"><span><br/></span></div><ix:nonNumeric contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331" name="us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80Ni9mcmFnOjFiNzYzYzFhMzFiMTRhNjU5MGJkMjUwMDIzMGQzNjM1L3RleHRyZWdpb246MWI3NjNjMWEzMWIxNGE2NTkwYmQyNTAwMjMwZDM2MzVfNDc1_ae77f4ed-b1f6-45fc-994a-249ce8557eac" escape="true"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accumulated other comprehensive loss consists of the following:</span></div><div style="text-indent:36pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.268%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.326%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.326%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.526%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash Flow<br/>Hedging<br/>Gain (Loss)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Pension<br/>Liability</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cumulative<br/>Translation<br/>Adjustments</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated<br/>Other<br/>Comprehensive<br/>Income (Loss)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, December 31, 2022</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4fbeeede3b5841dfb8ff0fc8fb92f3d3_I20221231" decimals="-3" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80Ni9mcmFnOjFiNzYzYzFhMzFiMTRhNjU5MGJkMjUwMDIzMGQzNjM1L3RhYmxlOmQ5NDdhNTllYzVhNzQyNmQ4YzQyMGIwNTIzMjA5ZTc1L3RhYmxlcmFuZ2U6ZDk0N2E1OWVjNWE3NDI2ZDhjNDIwYjA1MjMyMDllNzVfMS0xLTEtMS00NTkxOQ_102e4f29-e02c-4f96-865f-9198b93c1033">2,497</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i87efb4b5e77145eaa953edbc2ad43a74_I20221231" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80Ni9mcmFnOjFiNzYzYzFhMzFiMTRhNjU5MGJkMjUwMDIzMGQzNjM1L3RhYmxlOmQ5NDdhNTllYzVhNzQyNmQ4YzQyMGIwNTIzMjA5ZTc1L3RhYmxlcmFuZ2U6ZDk0N2E1OWVjNWE3NDI2ZDhjNDIwYjA1MjMyMDllNzVfMS0zLTEtMS00NTkxOQ_4792c5fd-1182-4c90-ae36-f5f20da567aa">23,749</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5dcb85ddc4a34ec7a3176651d0eaccbe_I20221231" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80Ni9mcmFnOjFiNzYzYzFhMzFiMTRhNjU5MGJkMjUwMDIzMGQzNjM1L3RhYmxlOmQ5NDdhNTllYzVhNzQyNmQ4YzQyMGIwNTIzMjA5ZTc1L3RhYmxlcmFuZ2U6ZDk0N2E1OWVjNWE3NDI2ZDhjNDIwYjA1MjMyMDllNzVfMS01LTEtMS00NTkxOQ_23f0416a-9883-4c97-bdd1-b497a427548e">36,606</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7467bf1c44a741c2a174d8fda8ebb019_I20221231" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80Ni9mcmFnOjFiNzYzYzFhMzFiMTRhNjU5MGJkMjUwMDIzMGQzNjM1L3RhYmxlOmQ5NDdhNTllYzVhNzQyNmQ4YzQyMGIwNTIzMjA5ZTc1L3RhYmxlcmFuZ2U6ZDk0N2E1OWVjNWE3NDI2ZDhjNDIwYjA1MjMyMDllNzVfMS03LTEtMS00NTkxOQ_ccc56b65-8e14-43fd-95e0-966fa0388cec">57,858</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income before reclassifications, net of tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc4b560884714e249aae5d9872c326ea_D20230101-20230331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80Ni9mcmFnOjFiNzYzYzFhMzFiMTRhNjU5MGJkMjUwMDIzMGQzNjM1L3RhYmxlOmQ5NDdhNTllYzVhNzQyNmQ4YzQyMGIwNTIzMjA5ZTc1L3RhYmxlcmFuZ2U6ZDk0N2E1OWVjNWE3NDI2ZDhjNDIwYjA1MjMyMDllNzVfMy0xLTEtMS00NTkxOQ_de83e0a6-3f2c-496e-95fb-abbfa1e52ed4">1,923</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i949433cde8d541d0b3051510dc518334_D20230101-20230331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80Ni9mcmFnOjFiNzYzYzFhMzFiMTRhNjU5MGJkMjUwMDIzMGQzNjM1L3RhYmxlOmQ5NDdhNTllYzVhNzQyNmQ4YzQyMGIwNTIzMjA5ZTc1L3RhYmxlcmFuZ2U6ZDk0N2E1OWVjNWE3NDI2ZDhjNDIwYjA1MjMyMDllNzVfMy0zLTEtMS00NTkxOQ_e62c84b1-6efd-416b-9556-451fea1cf003">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1d229bbf0e07481b86b9acbec2af77ef_D20230101-20230331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80Ni9mcmFnOjFiNzYzYzFhMzFiMTRhNjU5MGJkMjUwMDIzMGQzNjM1L3RhYmxlOmQ5NDdhNTllYzVhNzQyNmQ4YzQyMGIwNTIzMjA5ZTc1L3RhYmxlcmFuZ2U6ZDk0N2E1OWVjNWE3NDI2ZDhjNDIwYjA1MjMyMDllNzVfMy01LTEtMS00NTkxOQ_f9ac2fbf-e190-4e33-9df0-4d54695ae6dd">1,596</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8faa12cfbcc746b48b96bb341f53eff6_D20230101-20230331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80Ni9mcmFnOjFiNzYzYzFhMzFiMTRhNjU5MGJkMjUwMDIzMGQzNjM1L3RhYmxlOmQ5NDdhNTllYzVhNzQyNmQ4YzQyMGIwNTIzMjA5ZTc1L3RhYmxlcmFuZ2U6ZDk0N2E1OWVjNWE3NDI2ZDhjNDIwYjA1MjMyMDllNzVfMy03LTEtMS00NTkxOQ_d4e35cc8-e172-4121-be8c-eadc60a4d3d5">3,519</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive income (loss) before tax</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">a</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icc4b560884714e249aae5d9872c326ea_D20230101-20230331" decimals="-3" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80Ni9mcmFnOjFiNzYzYzFhMzFiMTRhNjU5MGJkMjUwMDIzMGQzNjM1L3RhYmxlOmQ5NDdhNTllYzVhNzQyNmQ4YzQyMGIwNTIzMjA5ZTc1L3RhYmxlcmFuZ2U6ZDk0N2E1OWVjNWE3NDI2ZDhjNDIwYjA1MjMyMDllNzVfNC0xLTEtMS00NTkxOQ_545a0e5f-0ef0-4299-9610-97f8b53813b3">1,381</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i949433cde8d541d0b3051510dc518334_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80Ni9mcmFnOjFiNzYzYzFhMzFiMTRhNjU5MGJkMjUwMDIzMGQzNjM1L3RhYmxlOmQ5NDdhNTllYzVhNzQyNmQ4YzQyMGIwNTIzMjA5ZTc1L3RhYmxlcmFuZ2U6ZDk0N2E1OWVjNWE3NDI2ZDhjNDIwYjA1MjMyMDllNzVfNC0zLTEtMS00NTkxOQ_a8dbf427-756e-4143-9d45-1ba70ee2c003">532</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1d229bbf0e07481b86b9acbec2af77ef_D20230101-20230331" decimals="-3" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80Ni9mcmFnOjFiNzYzYzFhMzFiMTRhNjU5MGJkMjUwMDIzMGQzNjM1L3RhYmxlOmQ5NDdhNTllYzVhNzQyNmQ4YzQyMGIwNTIzMjA5ZTc1L3RhYmxlcmFuZ2U6ZDk0N2E1OWVjNWE3NDI2ZDhjNDIwYjA1MjMyMDllNzVfNC01LTEtMS00NTkxOQ_65231fba-6cdc-4ada-a5c3-462933774344">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8faa12cfbcc746b48b96bb341f53eff6_D20230101-20230331" decimals="-3" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80Ni9mcmFnOjFiNzYzYzFhMzFiMTRhNjU5MGJkMjUwMDIzMGQzNjM1L3RhYmxlOmQ5NDdhNTllYzVhNzQyNmQ4YzQyMGIwNTIzMjA5ZTc1L3RhYmxlcmFuZ2U6ZDk0N2E1OWVjNWE3NDI2ZDhjNDIwYjA1MjMyMDllNzVfNC03LTEtMS00NTkxOQ_22c7109f-9951-4b46-948d-23c9ee7c3f75">849</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc4b560884714e249aae5d9872c326ea_D20230101-20230331" decimals="-3" name="us-gaap:ReclassificationFromAociCurrentPeriodTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80Ni9mcmFnOjFiNzYzYzFhMzFiMTRhNjU5MGJkMjUwMDIzMGQzNjM1L3RhYmxlOmQ5NDdhNTllYzVhNzQyNmQ4YzQyMGIwNTIzMjA5ZTc1L3RhYmxlcmFuZ2U6ZDk0N2E1OWVjNWE3NDI2ZDhjNDIwYjA1MjMyMDllNzVfNS0xLTEtMS00NTkxOQ_549a2632-c747-416b-a4c9-d88afeba3525">335</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i949433cde8d541d0b3051510dc518334_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:ReclassificationFromAociCurrentPeriodTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80Ni9mcmFnOjFiNzYzYzFhMzFiMTRhNjU5MGJkMjUwMDIzMGQzNjM1L3RhYmxlOmQ5NDdhNTllYzVhNzQyNmQ4YzQyMGIwNTIzMjA5ZTc1L3RhYmxlcmFuZ2U6ZDk0N2E1OWVjNWE3NDI2ZDhjNDIwYjA1MjMyMDllNzVfNS0zLTEtMS00NTkxOQ_0195f0b2-c5df-446e-8ff8-ca680968a02a">129</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1d229bbf0e07481b86b9acbec2af77ef_D20230101-20230331" decimals="-3" name="us-gaap:ReclassificationFromAociCurrentPeriodTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80Ni9mcmFnOjFiNzYzYzFhMzFiMTRhNjU5MGJkMjUwMDIzMGQzNjM1L3RhYmxlOmQ5NDdhNTllYzVhNzQyNmQ4YzQyMGIwNTIzMjA5ZTc1L3RhYmxlcmFuZ2U6ZDk0N2E1OWVjNWE3NDI2ZDhjNDIwYjA1MjMyMDllNzVfNS01LTEtMS00NTkxOQ_73be34e8-503a-4044-a2ae-da735a6c1463">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8faa12cfbcc746b48b96bb341f53eff6_D20230101-20230331" decimals="-3" name="us-gaap:ReclassificationFromAociCurrentPeriodTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80Ni9mcmFnOjFiNzYzYzFhMzFiMTRhNjU5MGJkMjUwMDIzMGQzNjM1L3RhYmxlOmQ5NDdhNTllYzVhNzQyNmQ4YzQyMGIwNTIzMjA5ZTc1L3RhYmxlcmFuZ2U6ZDk0N2E1OWVjNWE3NDI2ZDhjNDIwYjA1MjMyMDllNzVfNS03LTEtMS00NTkxOQ_75d9a950-9dd9-4ec6-be66-8bae3e82fcd9">206</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:8pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net current-period other comprehensive income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc4b560884714e249aae5d9872c326ea_D20230101-20230331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80Ni9mcmFnOjFiNzYzYzFhMzFiMTRhNjU5MGJkMjUwMDIzMGQzNjM1L3RhYmxlOmQ5NDdhNTllYzVhNzQyNmQ4YzQyMGIwNTIzMjA5ZTc1L3RhYmxlcmFuZ2U6ZDk0N2E1OWVjNWE3NDI2ZDhjNDIwYjA1MjMyMDllNzVfNy0xLTEtMS00NTkxOQ_f7d5da8d-f536-4ca4-9eb9-2a2449a6ced5">877</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i949433cde8d541d0b3051510dc518334_D20230101-20230331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80Ni9mcmFnOjFiNzYzYzFhMzFiMTRhNjU5MGJkMjUwMDIzMGQzNjM1L3RhYmxlOmQ5NDdhNTllYzVhNzQyNmQ4YzQyMGIwNTIzMjA5ZTc1L3RhYmxlcmFuZ2U6ZDk0N2E1OWVjNWE3NDI2ZDhjNDIwYjA1MjMyMDllNzVfNy0zLTEtMS00NTkxOQ_02300d7a-18f1-45ed-a243-016b1069958b">403</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1d229bbf0e07481b86b9acbec2af77ef_D20230101-20230331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80Ni9mcmFnOjFiNzYzYzFhMzFiMTRhNjU5MGJkMjUwMDIzMGQzNjM1L3RhYmxlOmQ5NDdhNTllYzVhNzQyNmQ4YzQyMGIwNTIzMjA5ZTc1L3RhYmxlcmFuZ2U6ZDk0N2E1OWVjNWE3NDI2ZDhjNDIwYjA1MjMyMDllNzVfNy01LTEtMS00NTkxOQ_70dd2237-6ebc-4067-9f07-64f58224d3f9">1,596</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8faa12cfbcc746b48b96bb341f53eff6_D20230101-20230331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80Ni9mcmFnOjFiNzYzYzFhMzFiMTRhNjU5MGJkMjUwMDIzMGQzNjM1L3RhYmxlOmQ5NDdhNTllYzVhNzQyNmQ4YzQyMGIwNTIzMjA5ZTc1L3RhYmxlcmFuZ2U6ZDk0N2E1OWVjNWE3NDI2ZDhjNDIwYjA1MjMyMDllNzVfNy03LTEtMS00NTkxOQ_f57945ad-ea23-4961-96fc-d17ee1460c04">2,876</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, March 31, 2023</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd1ea00148744dfd850e020220bf03f5_I20230331" decimals="-3" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80Ni9mcmFnOjFiNzYzYzFhMzFiMTRhNjU5MGJkMjUwMDIzMGQzNjM1L3RhYmxlOmQ5NDdhNTllYzVhNzQyNmQ4YzQyMGIwNTIzMjA5ZTc1L3RhYmxlcmFuZ2U6ZDk0N2E1OWVjNWE3NDI2ZDhjNDIwYjA1MjMyMDllNzVfOS0xLTEtMS00NTkxOQ_5564b4a5-ba8b-4e5e-bdbe-565a2f1a6b2a">3,374</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7606ff56051a4e0e8d0a3acff90b86be_I20230331" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80Ni9mcmFnOjFiNzYzYzFhMzFiMTRhNjU5MGJkMjUwMDIzMGQzNjM1L3RhYmxlOmQ5NDdhNTllYzVhNzQyNmQ4YzQyMGIwNTIzMjA5ZTc1L3RhYmxlcmFuZ2U6ZDk0N2E1OWVjNWE3NDI2ZDhjNDIwYjA1MjMyMDllNzVfOS0zLTEtMS00NTkxOQ_b6126f7a-87b7-4199-b9dc-4338a987f409">23,346</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i27c9aa8186434e5993cdaaed802e058d_I20230331" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80Ni9mcmFnOjFiNzYzYzFhMzFiMTRhNjU5MGJkMjUwMDIzMGQzNjM1L3RhYmxlOmQ5NDdhNTllYzVhNzQyNmQ4YzQyMGIwNTIzMjA5ZTc1L3RhYmxlcmFuZ2U6ZDk0N2E1OWVjNWE3NDI2ZDhjNDIwYjA1MjMyMDllNzVfOS01LTEtMS00NTkxOQ_761b7f8f-1565-4ac8-91c7-d231a2847097">35,010</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i991a26c35f3a4004a04b9c93216cb10b_I20230331" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80Ni9mcmFnOjFiNzYzYzFhMzFiMTRhNjU5MGJkMjUwMDIzMGQzNjM1L3RhYmxlOmQ5NDdhNTllYzVhNzQyNmQ4YzQyMGIwNTIzMjA5ZTc1L3RhYmxlcmFuZ2U6ZDk0N2E1OWVjNWE3NDI2ZDhjNDIwYjA1MjMyMDllNzVfOS03LTEtMS00NTkxOQ_4970698e-d634-4042-bf59-50cb0bb28ae5">54,982</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div style="margin-bottom:1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.268%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.326%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.326%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.526%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash Flow<br/>Hedging<br/>Gain (Loss)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Pension<br/>Liability</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cumulative<br/>Translation<br/>Adjustments</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated<br/>Other<br/>Comprehensive<br/>Income (Loss)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, December 31, 2021</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6fdde14e95954ed59a9518497036382d_I20211231" decimals="-3" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80Ni9mcmFnOjFiNzYzYzFhMzFiMTRhNjU5MGJkMjUwMDIzMGQzNjM1L3RhYmxlOmNjNzJlOTI1MjlkNTRhNmU4OTYzZDEzZTQ2Y2NmZDlhL3RhYmxlcmFuZ2U6Y2M3MmU5MjUyOWQ1NGE2ZTg5NjNkMTNlNDZjY2ZkOWFfMS0xLTEtMS00NTkxOQ_656ff91b-6a8e-4b10-b732-3f45da70b685">3,656</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia9d784369a924cdc9cf0e77dbb1d00de_I20211231" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80Ni9mcmFnOjFiNzYzYzFhMzFiMTRhNjU5MGJkMjUwMDIzMGQzNjM1L3RhYmxlOmNjNzJlOTI1MjlkNTRhNmU4OTYzZDEzZTQ2Y2NmZDlhL3RhYmxlcmFuZ2U6Y2M3MmU5MjUyOWQ1NGE2ZTg5NjNkMTNlNDZjY2ZkOWFfMS0zLTEtMS00NTkxOQ_6c8a0c09-feed-4b03-973f-c9ad41978ed6">29,671</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibc00334b78294a0783fda260135f6549_I20211231" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80Ni9mcmFnOjFiNzYzYzFhMzFiMTRhNjU5MGJkMjUwMDIzMGQzNjM1L3RhYmxlOmNjNzJlOTI1MjlkNTRhNmU4OTYzZDEzZTQ2Y2NmZDlhL3RhYmxlcmFuZ2U6Y2M3MmU5MjUyOWQ1NGE2ZTg5NjNkMTNlNDZjY2ZkOWFfMS01LTEtMS00NTkxOQ_8655792e-0ff7-4bab-b141-0d884974a327">28,188</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iee31e42803274180ade2d654c9f2c44a_I20211231" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80Ni9mcmFnOjFiNzYzYzFhMzFiMTRhNjU5MGJkMjUwMDIzMGQzNjM1L3RhYmxlOmNjNzJlOTI1MjlkNTRhNmU4OTYzZDEzZTQ2Y2NmZDlhL3RhYmxlcmFuZ2U6Y2M3MmU5MjUyOWQ1NGE2ZTg5NjNkMTNlNDZjY2ZkOWFfMS03LTEtMS00NTkxOQ_d00b51e0-6ed6-4a3f-9f3f-75fb14f72436">54,203</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications, net of tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie696fef447f64ccc8a668daaade9cd9b_D20220101-20220331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80Ni9mcmFnOjFiNzYzYzFhMzFiMTRhNjU5MGJkMjUwMDIzMGQzNjM1L3RhYmxlOmNjNzJlOTI1MjlkNTRhNmU4OTYzZDEzZTQ2Y2NmZDlhL3RhYmxlcmFuZ2U6Y2M3MmU5MjUyOWQ1NGE2ZTg5NjNkMTNlNDZjY2ZkOWFfMy0xLTEtMS00NTkxOQ_3b3e08ed-f721-4e4c-9031-93971f7ffedf">2,460</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icfac919075cc429fb858404f3c669d73_D20220101-20220331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80Ni9mcmFnOjFiNzYzYzFhMzFiMTRhNjU5MGJkMjUwMDIzMGQzNjM1L3RhYmxlOmNjNzJlOTI1MjlkNTRhNmU4OTYzZDEzZTQ2Y2NmZDlhL3RhYmxlcmFuZ2U6Y2M3MmU5MjUyOWQ1NGE2ZTg5NjNkMTNlNDZjY2ZkOWFfMy0zLTEtMS00NTkxOQ_48742ee7-fb11-4642-83c4-c7a8bfedde15">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iae81127123e340fbb32267cb782ca25e_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80Ni9mcmFnOjFiNzYzYzFhMzFiMTRhNjU5MGJkMjUwMDIzMGQzNjM1L3RhYmxlOmNjNzJlOTI1MjlkNTRhNmU4OTYzZDEzZTQ2Y2NmZDlhL3RhYmxlcmFuZ2U6Y2M3MmU5MjUyOWQ1NGE2ZTg5NjNkMTNlNDZjY2ZkOWFfMy01LTEtMS00NTkxOQ_ab2963cd-913a-48bf-a17f-b27210260319">163</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia66bff082e1642cd80c9ac67a0cc60fe_D20220101-20220331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80Ni9mcmFnOjFiNzYzYzFhMzFiMTRhNjU5MGJkMjUwMDIzMGQzNjM1L3RhYmxlOmNjNzJlOTI1MjlkNTRhNmU4OTYzZDEzZTQ2Y2NmZDlhL3RhYmxlcmFuZ2U6Y2M3MmU5MjUyOWQ1NGE2ZTg5NjNkMTNlNDZjY2ZkOWFfMy03LTEtMS00NTkxOQ_6adf404e-f75a-4518-be30-346f78a142a6">2,297</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive income (loss) before tax</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">a</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie696fef447f64ccc8a668daaade9cd9b_D20220101-20220331" decimals="-3" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80Ni9mcmFnOjFiNzYzYzFhMzFiMTRhNjU5MGJkMjUwMDIzMGQzNjM1L3RhYmxlOmNjNzJlOTI1MjlkNTRhNmU4OTYzZDEzZTQ2Y2NmZDlhL3RhYmxlcmFuZ2U6Y2M3MmU5MjUyOWQ1NGE2ZTg5NjNkMTNlNDZjY2ZkOWFfNC0xLTEtMS00NTkxOQ_0fe84469-858a-4e69-9a3a-893fcb2bafa5">1,819</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icfac919075cc429fb858404f3c669d73_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80Ni9mcmFnOjFiNzYzYzFhMzFiMTRhNjU5MGJkMjUwMDIzMGQzNjM1L3RhYmxlOmNjNzJlOTI1MjlkNTRhNmU4OTYzZDEzZTQ2Y2NmZDlhL3RhYmxlcmFuZ2U6Y2M3MmU5MjUyOWQ1NGE2ZTg5NjNkMTNlNDZjY2ZkOWFfNC0zLTEtMS00NTkxOQ_38630875-cff5-42ad-91c7-b88c3d7d6be9">648</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae81127123e340fbb32267cb782ca25e_D20220101-20220331" decimals="-3" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80Ni9mcmFnOjFiNzYzYzFhMzFiMTRhNjU5MGJkMjUwMDIzMGQzNjM1L3RhYmxlOmNjNzJlOTI1MjlkNTRhNmU4OTYzZDEzZTQ2Y2NmZDlhL3RhYmxlcmFuZ2U6Y2M3MmU5MjUyOWQ1NGE2ZTg5NjNkMTNlNDZjY2ZkOWFfNC01LTEtMS00NTkxOQ_ba7fab8b-5212-4892-9579-36104468ce0a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia66bff082e1642cd80c9ac67a0cc60fe_D20220101-20220331" decimals="-3" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80Ni9mcmFnOjFiNzYzYzFhMzFiMTRhNjU5MGJkMjUwMDIzMGQzNjM1L3RhYmxlOmNjNzJlOTI1MjlkNTRhNmU4OTYzZDEzZTQ2Y2NmZDlhL3RhYmxlcmFuZ2U6Y2M3MmU5MjUyOWQ1NGE2ZTg5NjNkMTNlNDZjY2ZkOWFfNC03LTEtMS00NTkxOQ_896695cd-bd46-44cc-9447-3e80d5cd0dcc">1,171</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie696fef447f64ccc8a668daaade9cd9b_D20220101-20220331" decimals="-3" name="us-gaap:ReclassificationFromAociCurrentPeriodTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80Ni9mcmFnOjFiNzYzYzFhMzFiMTRhNjU5MGJkMjUwMDIzMGQzNjM1L3RhYmxlOmNjNzJlOTI1MjlkNTRhNmU4OTYzZDEzZTQ2Y2NmZDlhL3RhYmxlcmFuZ2U6Y2M3MmU5MjUyOWQ1NGE2ZTg5NjNkMTNlNDZjY2ZkOWFfNS0xLTEtMS00NTkxOQ_e9b0904f-8d3e-49dc-994d-d2e980cc09fa">441</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icfac919075cc429fb858404f3c669d73_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:ReclassificationFromAociCurrentPeriodTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80Ni9mcmFnOjFiNzYzYzFhMzFiMTRhNjU5MGJkMjUwMDIzMGQzNjM1L3RhYmxlOmNjNzJlOTI1MjlkNTRhNmU4OTYzZDEzZTQ2Y2NmZDlhL3RhYmxlcmFuZ2U6Y2M3MmU5MjUyOWQ1NGE2ZTg5NjNkMTNlNDZjY2ZkOWFfNS0zLTEtMS00NTkxOQ_c58cf232-f94f-47f7-9efc-a3a4427e1290">127</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae81127123e340fbb32267cb782ca25e_D20220101-20220331" decimals="-3" name="us-gaap:ReclassificationFromAociCurrentPeriodTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80Ni9mcmFnOjFiNzYzYzFhMzFiMTRhNjU5MGJkMjUwMDIzMGQzNjM1L3RhYmxlOmNjNzJlOTI1MjlkNTRhNmU4OTYzZDEzZTQ2Y2NmZDlhL3RhYmxlcmFuZ2U6Y2M3MmU5MjUyOWQ1NGE2ZTg5NjNkMTNlNDZjY2ZkOWFfNS01LTEtMS00NTkxOQ_122f655f-c156-433d-8d00-76a7dc957350">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia66bff082e1642cd80c9ac67a0cc60fe_D20220101-20220331" decimals="-3" name="us-gaap:ReclassificationFromAociCurrentPeriodTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80Ni9mcmFnOjFiNzYzYzFhMzFiMTRhNjU5MGJkMjUwMDIzMGQzNjM1L3RhYmxlOmNjNzJlOTI1MjlkNTRhNmU4OTYzZDEzZTQ2Y2NmZDlhL3RhYmxlcmFuZ2U6Y2M3MmU5MjUyOWQ1NGE2ZTg5NjNkMTNlNDZjY2ZkOWFfNS03LTEtMS00NTkxOQ_93f75430-f637-43cd-b3e8-5efd3515825d">314</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net current-period other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie696fef447f64ccc8a668daaade9cd9b_D20220101-20220331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80Ni9mcmFnOjFiNzYzYzFhMzFiMTRhNjU5MGJkMjUwMDIzMGQzNjM1L3RhYmxlOmNjNzJlOTI1MjlkNTRhNmU4OTYzZDEzZTQ2Y2NmZDlhL3RhYmxlcmFuZ2U6Y2M3MmU5MjUyOWQ1NGE2ZTg5NjNkMTNlNDZjY2ZkOWFfNy0xLTEtMS00NTkxOQ_6731f6ab-484b-401a-83a7-689df0653a42">1,082</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icfac919075cc429fb858404f3c669d73_D20220101-20220331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80Ni9mcmFnOjFiNzYzYzFhMzFiMTRhNjU5MGJkMjUwMDIzMGQzNjM1L3RhYmxlOmNjNzJlOTI1MjlkNTRhNmU4OTYzZDEzZTQ2Y2NmZDlhL3RhYmxlcmFuZ2U6Y2M3MmU5MjUyOWQ1NGE2ZTg5NjNkMTNlNDZjY2ZkOWFfNy0zLTEtMS00NTkxOQ_c773fe68-cd40-478c-a475-58137673b9f7">521</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iae81127123e340fbb32267cb782ca25e_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80Ni9mcmFnOjFiNzYzYzFhMzFiMTRhNjU5MGJkMjUwMDIzMGQzNjM1L3RhYmxlOmNjNzJlOTI1MjlkNTRhNmU4OTYzZDEzZTQ2Y2NmZDlhL3RhYmxlcmFuZ2U6Y2M3MmU5MjUyOWQ1NGE2ZTg5NjNkMTNlNDZjY2ZkOWFfNy01LTEtMS00NTkxOQ_2dcbd9f0-147b-4f98-9c60-cc7fe75b31f5">163</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia66bff082e1642cd80c9ac67a0cc60fe_D20220101-20220331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80Ni9mcmFnOjFiNzYzYzFhMzFiMTRhNjU5MGJkMjUwMDIzMGQzNjM1L3RhYmxlOmNjNzJlOTI1MjlkNTRhNmU4OTYzZDEzZTQ2Y2NmZDlhL3RhYmxlcmFuZ2U6Y2M3MmU5MjUyOWQ1NGE2ZTg5NjNkMTNlNDZjY2ZkOWFfNy03LTEtMS00NTkxOQ_7cb40c99-c0d0-4a32-b76c-41838b514965">1,440</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, March 31, 2022</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iededad20ecc44fd2bb270dd062e6d769_I20220331" decimals="-3" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80Ni9mcmFnOjFiNzYzYzFhMzFiMTRhNjU5MGJkMjUwMDIzMGQzNjM1L3RhYmxlOmNjNzJlOTI1MjlkNTRhNmU4OTYzZDEzZTQ2Y2NmZDlhL3RhYmxlcmFuZ2U6Y2M3MmU5MjUyOWQ1NGE2ZTg5NjNkMTNlNDZjY2ZkOWFfOS0xLTEtMS00NTkxOQ_38c52dc7-7543-4cdb-b99e-e69456daec42">4,738</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i21089d5235814c6ab121525210fd30c8_I20220331" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80Ni9mcmFnOjFiNzYzYzFhMzFiMTRhNjU5MGJkMjUwMDIzMGQzNjM1L3RhYmxlOmNjNzJlOTI1MjlkNTRhNmU4OTYzZDEzZTQ2Y2NmZDlhL3RhYmxlcmFuZ2U6Y2M3MmU5MjUyOWQ1NGE2ZTg5NjNkMTNlNDZjY2ZkOWFfOS0zLTEtMS00NTkxOQ_1221c642-8665-43b7-869f-7f24b4e90f26">29,150</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie69d0166e9554b6d85184883bd783cfe_I20220331" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80Ni9mcmFnOjFiNzYzYzFhMzFiMTRhNjU5MGJkMjUwMDIzMGQzNjM1L3RhYmxlOmNjNzJlOTI1MjlkNTRhNmU4OTYzZDEzZTQ2Y2NmZDlhL3RhYmxlcmFuZ2U6Y2M3MmU5MjUyOWQ1NGE2ZTg5NjNkMTNlNDZjY2ZkOWFfOS01LTEtMS00NTkxOQ_4c108db7-2297-4003-8348-be5da2cf58a6">28,351</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib861e1905d064d5684a5172a6232ad41_I20220331" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80Ni9mcmFnOjFiNzYzYzFhMzFiMTRhNjU5MGJkMjUwMDIzMGQzNjM1L3RhYmxlOmNjNzJlOTI1MjlkNTRhNmU4OTYzZDEzZTQ2Y2NmZDlhL3RhYmxlcmFuZ2U6Y2M3MmU5MjUyOWQ1NGE2ZTg5NjNkMTNlNDZjY2ZkOWFfOS03LTEtMS00NTkxOQ_e922f734-0e84-417c-b74c-6fde54573350">52,763</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)  <ix:footnote id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80Ni9mcmFnOjFiNzYzYzFhMzFiMTRhNjU5MGJkMjUwMDIzMGQzNjM1L3RleHRyZWdpb246MWI3NjNjMWEzMWIxNGE2NTkwYmQyNTAwMjMwZDM2MzVfNDY0_2ad6ae1a-986b-44b2-9137-8872e5ce3b1e" footnoteRole="http://www.xbrl.org/2003/role/footnote">The cash flow hedging gain (loss) and pension liability accumulated other comprehensive loss components are included in sales or cost of sales and as a component of net periodic pension cost, respectively.  Refer to Note 7 and Note 13, respectively, for further details.</ix:footnote></span></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</span></div></div></div><div id="i952e7af9c0b94e65995973e7f212f399_49"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline" href="#i952e7af9c0b94e65995973e7f212f399_7">Table of Contents</a></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Note 7 &#8211; <ix:nonNumeric contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331" name="us-gaap:DerivativesAndFairValueTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80OS9mcmFnOmIzNmU0MzJjMjM0ZDRjMTJiMmY4NzM2MTk3Yjg3MTE4L3RleHRyZWdpb246YjM2ZTQzMmMyMzRkNGMxMmIyZjg3MzYxOTdiODcxMThfNTg2NA_42377031-dfd8-4dba-8a89-17c5dd32ed17" continuedAt="i268a6c1fcf134ca0b5e272f56f3f6020" escape="true">Fair Value of Financial Instruments</ix:nonNumeric></span></div><ix:continuation id="i268a6c1fcf134ca0b5e272f56f3f6020" continuedAt="ieab33aa1532549f3965c730ab640b902"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We enter into derivative instruments for risk management purposes only.  We operate internationally and, in the normal course of business, are exposed to fluctuations in interest rates, foreign exchange rates and commodity prices.  These fluctuations can increase the costs of financing, investing and operating the business.  We use forward contracts, a type of derivative instrument, to manage certain foreign currency exposures.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">By nature, all financial instruments involve market and credit risks.  We enter into forward contracts with major investment grade financial institutions and have policies to monitor the credit risk of those counterparties.  While there can be no assurance, we do not anticipate any material non-performance by any of these counterparties.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Foreign Currency Forward Contracts.  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We hedge forecasted intercompany sales denominated in foreign currencies through the use of forward contracts.&#160;&#160;We account for these forward contracts as cash flow hedges.&#160;&#160;To the extent these forward contracts meet hedge accounting criteria, changes in their fair value are not included in current earnings but are included in accumulated other comprehensive loss.&#160;&#160;These changes in fair value will be recognized into earnings as a component of sales or cost of sales when the forecasted transaction occurs.&#160;&#160;</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also enter into forward contracts to exchange foreign currencies for United States dollars in order to hedge our currency transaction exposures on intercompany receivables designated in foreign currencies.&#160;&#160;These forward contracts settle each month at month-end, at which time we enter into new forward contracts.&#160;&#160;We have not designated these forward contracts as hedges and have not applied hedge accounting to them.&#160;&#160;</span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331" name="us-gaap:ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80OS9mcmFnOmIzNmU0MzJjMjM0ZDRjMTJiMmY4NzM2MTk3Yjg3MTE4L3RleHRyZWdpb246YjM2ZTQzMmMyMzRkNGMxMmIyZjg3MzYxOTdiODcxMThfNTg3Mw_2f9064b0-7141-4e2a-b313-12b260412530" escape="true"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the notional contract amounts for forward contracts outstanding:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:38.929%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.401%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.401%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.403%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">FASB ASC Topic 815 Designation</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward exchange contracts</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flow hedge</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8cab3c62ed442529813f178f35898bc_I20230331" decimals="-3" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80OS9mcmFnOmIzNmU0MzJjMjM0ZDRjMTJiMmY4NzM2MTk3Yjg3MTE4L3RhYmxlOmI4OWVhYmE3NzM5ZDQ2ZDlhNTZhYjJjODdhY2M5Yjc5L3RhYmxlcmFuZ2U6Yjg5ZWFiYTc3MzlkNDZkOWE1NmFiMmM4N2FjYzliNzlfMi0zLTEtMS00NTkxOQ_33606946-36b7-4c73-8596-eb6bb850ccb7">199,005</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibeb90d75f39f491cacb945863ad49c07_I20221231" decimals="-3" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80OS9mcmFnOmIzNmU0MzJjMjM0ZDRjMTJiMmY4NzM2MTk3Yjg3MTE4L3RhYmxlOmI4OWVhYmE3NzM5ZDQ2ZDlhNTZhYjJjODdhY2M5Yjc5L3RhYmxlcmFuZ2U6Yjg5ZWFiYTc3MzlkNDZkOWE1NmFiMmM4N2FjYzliNzlfMi01LTEtMS00NTkxOQ_acdbe50b-138a-4372-9c00-535b28eb6c0c">198,473</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward exchange contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-designated</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i50ba6b690edd40ac98d62cd0bd0b088a_I20230331" decimals="-3" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80OS9mcmFnOmIzNmU0MzJjMjM0ZDRjMTJiMmY4NzM2MTk3Yjg3MTE4L3RhYmxlOmI4OWVhYmE3NzM5ZDQ2ZDlhNTZhYjJjODdhY2M5Yjc5L3RhYmxlcmFuZ2U6Yjg5ZWFiYTc3MzlkNDZkOWE1NmFiMmM4N2FjYzliNzlfMy0zLTEtMS00NTkxOQ_c9475b5a-b2ce-4505-abe7-901865b9757c">98,173</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9cb6638855042dcace6138a16b438ef_I20221231" decimals="-3" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80OS9mcmFnOmIzNmU0MzJjMjM0ZDRjMTJiMmY4NzM2MTk3Yjg3MTE4L3RhYmxlOmI4OWVhYmE3NzM5ZDQ2ZDlhNTZhYjJjODdhY2M5Yjc5L3RhYmxlcmFuZ2U6Yjg5ZWFiYTc3MzlkNDZkOWE1NmFiMmM4N2FjYzliNzlfMy01LTEtMS00NTkxOQ_a2c0cabd-c83e-4784-a66b-f12c8559ad1c">81,929</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The remaining time to maturity as of March&#160;31, 2023 is within <ix:nonNumeric contextRef="i717c6c4879334aaf8b31721fd327e132_D20230101-20230331" name="us-gaap:MaximumLengthOfTimeHedgedInCashFlowHedge1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80OS9mcmFnOmIzNmU0MzJjMjM0ZDRjMTJiMmY4NzM2MTk3Yjg3MTE4L3RleHRyZWdpb246YjM2ZTQzMmMyMzRkNGMxMmIyZjg3MzYxOTdiODcxMThfMTk1MQ_288ce0f3-7298-45d4-8d5c-0b01dee4086e">two years</ix:nonNumeric> for hedge designated foreign exchange contracts and approximately <ix:nonNumeric contextRef="i0d7ec65a949147fa901cc819f74ad4ea_D20230101-20230331" name="us-gaap:MaximumLengthOfTimeHedgedInCashFlowHedge1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80OS9mcmFnOmIzNmU0MzJjMjM0ZDRjMTJiMmY4NzM2MTk3Yjg3MTE4L3RleHRyZWdpb246YjM2ZTQzMmMyMzRkNGMxMmIyZjg3MzYxOTdiODcxMThfMjAyMA_3b4736a5-97a7-4948-bbea-ab4f56c04bd7">one month</ix:nonNumeric> for non-hedge designated forward exchange contracts.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline" href="#i952e7af9c0b94e65995973e7f212f399_7">Table of Contents</a></span></div></div><ix:continuation id="ieab33aa1532549f3965c730ab640b902" continuedAt="i11aa79fd28734471803824731e5514c2"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Statement of comprehensive income presentation</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Derivatives designated as cash flow hedges</span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331" name="us-gaap:ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80OS9mcmFnOmIzNmU0MzJjMjM0ZDRjMTJiMmY4NzM2MTk3Yjg3MTE4L3RleHRyZWdpb246YjM2ZTQzMmMyMzRkNGMxMmIyZjg3MzYxOTdiODcxMThfNTg2OA_7624d797-dcb1-466d-bbd5-40804922f123" escape="true"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Foreign exchange contracts designated as cash flow hedges had the following effects on accumulated other comprehensive income (loss) ("AOCI") and net earnings on our consolidated condensed statements of comprehensive income and our consolidated condensed balance sheets:</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:27.639%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.551%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.551%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.386%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.002%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.551%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.551%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.551%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.553%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount of Gain Recognized in AOCI</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated Condensed Statements  of Comprehensive Income</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount of Gain Reclassified from AOCI</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="36" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="6" style="border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Amount of Line Item Presented</span></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivative Instrument</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Location of amount reclassified</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80OS9mcmFnOmIzNmU0MzJjMjM0ZDRjMTJiMmY4NzM2MTk3Yjg3MTE4L3RhYmxlOjYyYTFiZjIyNzdmNjRjZTQ5MTUwZTk0YmJlMTM0NWM5L3RhYmxlcmFuZ2U6NjJhMWJmMjI3N2Y2NGNlNDkxNTBlOTRiYmUxMzQ1YzlfNS0yLTEtMS00NTkxOQ_1f1493fb-552e-4779-925d-1f10aac93f57">2,538</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9500a5ee8dbe4d23aa9c46ebdd25a0c8_D20220101-20220331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80OS9mcmFnOmIzNmU0MzJjMjM0ZDRjMTJiMmY4NzM2MTk3Yjg3MTE4L3RhYmxlOjYyYTFiZjIyNzdmNjRjZTQ5MTUwZTk0YmJlMTM0NWM5L3RhYmxlcmFuZ2U6NjJhMWJmMjI3N2Y2NGNlNDkxNTBlOTRiYmUxMzQ1YzlfNS00LTEtMS00NTkxOQ_91951585-69a3-4174-89f6-b0f823aa6b4f">3,247</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Sales</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80OS9mcmFnOmIzNmU0MzJjMjM0ZDRjMTJiMmY4NzM2MTk3Yjg3MTE4L3RhYmxlOjYyYTFiZjIyNzdmNjRjZTQ5MTUwZTk0YmJlMTM0NWM5L3RhYmxlcmFuZ2U6NjJhMWJmMjI3N2Y2NGNlNDkxNTBlOTRiYmUxMzQ1YzlfNS04LTEtMS00NTkxOQ_5b817f06-9d27-4e49-bca4-da5b8937383f">295,468</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9500a5ee8dbe4d23aa9c46ebdd25a0c8_D20220101-20220331" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80OS9mcmFnOmIzNmU0MzJjMjM0ZDRjMTJiMmY4NzM2MTk3Yjg3MTE4L3RhYmxlOjYyYTFiZjIyNzdmNjRjZTQ5MTUwZTk0YmJlMTM0NWM5L3RhYmxlcmFuZ2U6NjJhMWJmMjI3N2Y2NGNlNDkxNTBlOTRiYmUxMzQ1YzlfNS05LTEtMS00NTkxOQ_8fff1772-445d-46cc-ae10-8ae119ac96fa">242,327</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i808450fedc2a4fb9bae456706bfd3a2f_D20230101-20230331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80OS9mcmFnOmIzNmU0MzJjMjM0ZDRjMTJiMmY4NzM2MTk3Yjg3MTE4L3RhYmxlOjYyYTFiZjIyNzdmNjRjZTQ5MTUwZTk0YmJlMTM0NWM5L3RhYmxlcmFuZ2U6NjJhMWJmMjI3N2Y2NGNlNDkxNTBlOTRiYmUxMzQ1YzlfNS0xMS0xLTEtNDU5MTk_27586335-02c5-4dc4-b229-1775bad13cb4">575</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e788e10ae614e408a862f260845ff94_D20220101-20220331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80OS9mcmFnOmIzNmU0MzJjMjM0ZDRjMTJiMmY4NzM2MTk3Yjg3MTE4L3RhYmxlOjYyYTFiZjIyNzdmNjRjZTQ5MTUwZTk0YmJlMTM0NWM5L3RhYmxlcmFuZ2U6NjJhMWJmMjI3N2Y2NGNlNDkxNTBlOTRiYmUxMzQ1YzlfNS0xMy0xLTEtNDU5MTk_24f7597c-614a-406d-91fe-d09ac7dc3618">1,744</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of Sales</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331" decimals="-3" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80OS9mcmFnOmIzNmU0MzJjMjM0ZDRjMTJiMmY4NzM2MTk3Yjg3MTE4L3RhYmxlOjYyYTFiZjIyNzdmNjRjZTQ5MTUwZTk0YmJlMTM0NWM5L3RhYmxlcmFuZ2U6NjJhMWJmMjI3N2Y2NGNlNDkxNTBlOTRiYmUxMzQ1YzlfNi04LTEtMS00NTkxOQ_6a90ea9d-6ab7-4e03-a94e-1587be8d4ee1">140,147</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9500a5ee8dbe4d23aa9c46ebdd25a0c8_D20220101-20220331" decimals="-3" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80OS9mcmFnOmIzNmU0MzJjMjM0ZDRjMTJiMmY4NzM2MTk3Yjg3MTE4L3RhYmxlOjYyYTFiZjIyNzdmNjRjZTQ5MTUwZTk0YmJlMTM0NWM5L3RhYmxlcmFuZ2U6NjJhMWJmMjI3N2Y2NGNlNDkxNTBlOTRiYmUxMzQ1YzlfNi05LTEtMS00NTkxOQ_26d42139-bb76-4e8b-bfb5-f7702befe3c5">106,336</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e7e8a5239c24bf8943da6f26a1c8fc5_D20230101-20230331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80OS9mcmFnOmIzNmU0MzJjMjM0ZDRjMTJiMmY4NzM2MTk3Yjg3MTE4L3RhYmxlOjYyYTFiZjIyNzdmNjRjZTQ5MTUwZTk0YmJlMTM0NWM5L3RhYmxlcmFuZ2U6NjJhMWJmMjI3N2Y2NGNlNDkxNTBlOTRiYmUxMzQ1YzlfNi0xMS0xLTEtNDU5MTk_88ca9d48-8276-4ed9-9b4c-0143cd279daf">806</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6241041cc28b4b86aab309ebee334dd7_D20220101-20220331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80OS9mcmFnOmIzNmU0MzJjMjM0ZDRjMTJiMmY4NzM2MTk3Yjg3MTE4L3RhYmxlOjYyYTFiZjIyNzdmNjRjZTQ5MTUwZTk0YmJlMTM0NWM5L3RhYmxlcmFuZ2U6NjJhMWJmMjI3N2Y2NGNlNDkxNTBlOTRiYmUxMzQ1YzlfNi0xMy0xLTEtNDU5MTk_2444cc39-9118-468f-8a51-75f0ca65cc93">75</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pre-tax gain</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80OS9mcmFnOmIzNmU0MzJjMjM0ZDRjMTJiMmY4NzM2MTk3Yjg3MTE4L3RhYmxlOjYyYTFiZjIyNzdmNjRjZTQ5MTUwZTk0YmJlMTM0NWM5L3RhYmxlcmFuZ2U6NjJhMWJmMjI3N2Y2NGNlNDkxNTBlOTRiYmUxMzQ1YzlfNy0yLTEtMS00NTkxOQ_2dbcef00-a952-4b79-a717-1f06a3bcf95c">2,538</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9500a5ee8dbe4d23aa9c46ebdd25a0c8_D20220101-20220331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80OS9mcmFnOmIzNmU0MzJjMjM0ZDRjMTJiMmY4NzM2MTk3Yjg3MTE4L3RhYmxlOjYyYTFiZjIyNzdmNjRjZTQ5MTUwZTk0YmJlMTM0NWM5L3RhYmxlcmFuZ2U6NjJhMWJmMjI3N2Y2NGNlNDkxNTBlOTRiYmUxMzQ1YzlfNy00LTEtMS00NTkxOQ_825d51da-1d2a-44b1-966c-9e00d01d9b0f">3,247</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80OS9mcmFnOmIzNmU0MzJjMjM0ZDRjMTJiMmY4NzM2MTk3Yjg3MTE4L3RhYmxlOjYyYTFiZjIyNzdmNjRjZTQ5MTUwZTk0YmJlMTM0NWM5L3RhYmxlcmFuZ2U6NjJhMWJmMjI3N2Y2NGNlNDkxNTBlOTRiYmUxMzQ1YzlfNy0xMS0xLTEtNDU5MTk_28903c45-da6d-41e3-8ad8-1e7f308405b4">1,381</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9500a5ee8dbe4d23aa9c46ebdd25a0c8_D20220101-20220331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80OS9mcmFnOmIzNmU0MzJjMjM0ZDRjMTJiMmY4NzM2MTk3Yjg3MTE4L3RhYmxlOjYyYTFiZjIyNzdmNjRjZTQ5MTUwZTk0YmJlMTM0NWM5L3RhYmxlcmFuZ2U6NjJhMWJmMjI3N2Y2NGNlNDkxNTBlOTRiYmUxMzQ1YzlfNy0xMy0xLTEtNDU5MTk_c729b947-a43e-4fde-81c8-bbde7f2ebed4">1,819</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80OS9mcmFnOmIzNmU0MzJjMjM0ZDRjMTJiMmY4NzM2MTk3Yjg3MTE4L3RhYmxlOjYyYTFiZjIyNzdmNjRjZTQ5MTUwZTk0YmJlMTM0NWM5L3RhYmxlcmFuZ2U6NjJhMWJmMjI3N2Y2NGNlNDkxNTBlOTRiYmUxMzQ1YzlfOC0yLTEtMS00NTkxOQ_3c1398ef-6fce-48cd-a1c1-df0458080d88">615</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9500a5ee8dbe4d23aa9c46ebdd25a0c8_D20220101-20220331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80OS9mcmFnOmIzNmU0MzJjMjM0ZDRjMTJiMmY4NzM2MTk3Yjg3MTE4L3RhYmxlOjYyYTFiZjIyNzdmNjRjZTQ5MTUwZTk0YmJlMTM0NWM5L3RhYmxlcmFuZ2U6NjJhMWJmMjI3N2Y2NGNlNDkxNTBlOTRiYmUxMzQ1YzlfOC00LTEtMS00NTkxOQ_ae7371ca-72f9-4e52-868d-ffe9e8fe269f">787</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80OS9mcmFnOmIzNmU0MzJjMjM0ZDRjMTJiMmY4NzM2MTk3Yjg3MTE4L3RhYmxlOjYyYTFiZjIyNzdmNjRjZTQ5MTUwZTk0YmJlMTM0NWM5L3RhYmxlcmFuZ2U6NjJhMWJmMjI3N2Y2NGNlNDkxNTBlOTRiYmUxMzQ1YzlfOC0xMS0xLTEtNDU5MTk_7fc5eb7d-1432-4b2d-9396-f9511e2ca581">335</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9500a5ee8dbe4d23aa9c46ebdd25a0c8_D20220101-20220331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80OS9mcmFnOmIzNmU0MzJjMjM0ZDRjMTJiMmY4NzM2MTk3Yjg3MTE4L3RhYmxlOjYyYTFiZjIyNzdmNjRjZTQ5MTUwZTk0YmJlMTM0NWM5L3RhYmxlcmFuZ2U6NjJhMWJmMjI3N2Y2NGNlNDkxNTBlOTRiYmUxMzQ1YzlfOC0xMy0xLTEtNDU5MTk_db6a009a-b048-403b-bc38-1cab3b9260ea">441</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net gain</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80OS9mcmFnOmIzNmU0MzJjMjM0ZDRjMTJiMmY4NzM2MTk3Yjg3MTE4L3RhYmxlOjYyYTFiZjIyNzdmNjRjZTQ5MTUwZTk0YmJlMTM0NWM5L3RhYmxlcmFuZ2U6NjJhMWJmMjI3N2Y2NGNlNDkxNTBlOTRiYmUxMzQ1YzlfOS0yLTEtMS00NTkxOQ_64562e24-dcf8-4067-9d1d-9056608fb5b3">1,923</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9500a5ee8dbe4d23aa9c46ebdd25a0c8_D20220101-20220331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80OS9mcmFnOmIzNmU0MzJjMjM0ZDRjMTJiMmY4NzM2MTk3Yjg3MTE4L3RhYmxlOjYyYTFiZjIyNzdmNjRjZTQ5MTUwZTk0YmJlMTM0NWM5L3RhYmxlcmFuZ2U6NjJhMWJmMjI3N2Y2NGNlNDkxNTBlOTRiYmUxMzQ1YzlfOS00LTEtMS00NTkxOQ_d5e6708c-f26e-4375-86bf-77c00f15c5ca">2,460</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80OS9mcmFnOmIzNmU0MzJjMjM0ZDRjMTJiMmY4NzM2MTk3Yjg3MTE4L3RhYmxlOjYyYTFiZjIyNzdmNjRjZTQ5MTUwZTk0YmJlMTM0NWM5L3RhYmxlcmFuZ2U6NjJhMWJmMjI3N2Y2NGNlNDkxNTBlOTRiYmUxMzQ1YzlfOS0xMS0xLTEtNDU5MTk_09583fb6-89a7-43d1-bacd-add499548d4c">1,046</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9500a5ee8dbe4d23aa9c46ebdd25a0c8_D20220101-20220331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80OS9mcmFnOmIzNmU0MzJjMjM0ZDRjMTJiMmY4NzM2MTk3Yjg3MTE4L3RhYmxlOjYyYTFiZjIyNzdmNjRjZTQ5MTUwZTk0YmJlMTM0NWM5L3RhYmxlcmFuZ2U6NjJhMWJmMjI3N2Y2NGNlNDkxNTBlOTRiYmUxMzQ1YzlfOS0xMy0xLTEtNDU5MTk_4a3338f6-a1a0-4c2b-bbb4-e9fc3297b95f">1,378</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:27.993%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.525%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.525%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.666%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.525%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.525%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.525%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.536%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At March&#160;31, 2023, $<ix:nonFraction unitRef="usd" contextRef="ib8cab3c62ed442529813f178f35898bc_I20230331" decimals="-5" name="us-gaap:ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80OS9mcmFnOmIzNmU0MzJjMjM0ZDRjMTJiMmY4NzM2MTk3Yjg3MTE4L3RleHRyZWdpb246YjM2ZTQzMmMyMzRkNGMxMmIyZjg3MzYxOTdiODcxMThfMjQ3NA_2b7d98ce-e880-4c57-9c99-dbb70cdac517">3.3</ix:nonFraction> million of net unrealized gains on forward contracts accounted for as cash flow hedges, and included in accumulated other comprehensive loss, are expected to be recognized in earnings in the next twelve months.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Derivatives not designated as cash flow hedges</span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331" name="us-gaap:ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80OS9mcmFnOmIzNmU0MzJjMjM0ZDRjMTJiMmY4NzM2MTk3Yjg3MTE4L3RleHRyZWdpb246YjM2ZTQzMmMyMzRkNGMxMmIyZjg3MzYxOTdiODcxMThfNTg1MQ_f32c9b4f-4c1e-4fe4-9907-2931fa923dc0" escape="true"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net gains and losses from derivative instruments not accounted for as hedges and losses on our intercompany receivables on our consolidated condensed statements of comprehensive income were:</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:44.367%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.087%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.285%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivative Instrument</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Location on Consolidated Condensed Statements of Comprehensive Income</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss on currency forward contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling and administrative expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i80aea042b5874dd49071f7d95c6d3e55_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80OS9mcmFnOmIzNmU0MzJjMjM0ZDRjMTJiMmY4NzM2MTk3Yjg3MTE4L3RhYmxlOjZmNjdjNzlhOGIyNDRiZjA4ODliYzY2MDU4YTk2ZmZiL3RhYmxlcmFuZ2U6NmY2N2M3OWE4YjI0NGJmMDg4OWJjNjYwNThhOTZmZmJfMy00LTEtMS00NTkxOQ_779f2de0-3465-4ea1-be58-0f641f5b60be">366</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i05c39c1786d348b380be8f3ab5ee62a6_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80OS9mcmFnOmIzNmU0MzJjMjM0ZDRjMTJiMmY4NzM2MTk3Yjg3MTE4L3RhYmxlOjZmNjdjNzlhOGIyNDRiZjA4ODliYzY2MDU4YTk2ZmZiL3RhYmxlcmFuZ2U6NmY2N2M3OWE4YjI0NGJmMDg4OWJjNjYwNThhOTZmZmJfMy02LTEtMS00NTkxOQ_cafe4249-fad9-4974-8a2f-2a38b42575fd">958</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net gain on currency transaction exposures</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling and administrative expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331" decimals="-3" name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80OS9mcmFnOmIzNmU0MzJjMjM0ZDRjMTJiMmY4NzM2MTk3Yjg3MTE4L3RhYmxlOjZmNjdjNzlhOGIyNDRiZjA4ODliYzY2MDU4YTk2ZmZiL3RhYmxlcmFuZ2U6NmY2N2M3OWE4YjI0NGJmMDg4OWJjNjYwNThhOTZmZmJfNC00LTEtMS00NTkxOQ_bce34d82-49d1-4504-8679-149b3281e2aa">76</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9500a5ee8dbe4d23aa9c46ebdd25a0c8_D20220101-20220331" decimals="-3" name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80OS9mcmFnOmIzNmU0MzJjMjM0ZDRjMTJiMmY4NzM2MTk3Yjg3MTE4L3RhYmxlOjZmNjdjNzlhOGIyNDRiZjA4ODliYzY2MDU4YTk2ZmZiL3RhYmxlcmFuZ2U6NmY2N2M3OWE4YjI0NGJmMDg4OWJjNjYwNThhOTZmZmJfNC02LTEtMS00NTkxOQ_b1d8b604-cc33-45eb-aa11-426780bb31d8">415</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline" href="#i952e7af9c0b94e65995973e7f212f399_7">Table of Contents</a></span></div></div><ix:continuation id="i11aa79fd28734471803824731e5514c2" continuedAt="i85e0d2a4758949e9a81eb36ef7076426"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Balance sheet presentation</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We record these forward foreign exchange contracts at fair value.  <ix:nonNumeric contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331" name="us-gaap:ScheduleOfForeignExchangeContractsStatementOfFinancialPositionTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80OS9mcmFnOmIzNmU0MzJjMjM0ZDRjMTJiMmY4NzM2MTk3Yjg3MTE4L3RleHRyZWdpb246YjM2ZTQzMmMyMzRkNGMxMmIyZjg3MzYxOTdiODcxMThfNTg0OQ_866c8c8d-500f-4f82-993b-e513ba833ec4" continuedAt="ibbeffb60303d41d382ab73741bd98e75" escape="true">The following tables summarize the fair value for forward foreign exchange contracts outstanding at March&#160;31, 2023 and December&#160;31, 2022: </ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="ibbeffb60303d41d382ab73741bd98e75"><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:35.157%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.209%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.700%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Location on Consolidated Condensed Balance Sheet</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Asset Fair Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities Fair Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net<br/>Fair<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives designated as hedged instruments:</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic37b157fcb074cfaaf336217f5e69f47_I20230331" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80OS9mcmFnOmIzNmU0MzJjMjM0ZDRjMTJiMmY4NzM2MTk3Yjg3MTE4L3RhYmxlOmNlZmI0YTUwMGI3MTQyNDY4NzhlMWYxMmU5NWU2ZTRiL3RhYmxlcmFuZ2U6Y2VmYjRhNTAwYjcxNDI0Njg3OGUxZjEyZTk1ZTZlNGJfMi0zLTEtMS00NTkxOQ_8a7439b5-bfb6-4ba7-9482-7c74a7c1a9e4">6,869</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic37b157fcb074cfaaf336217f5e69f47_I20230331" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80OS9mcmFnOmIzNmU0MzJjMjM0ZDRjMTJiMmY4NzM2MTk3Yjg3MTE4L3RhYmxlOmNlZmI0YTUwMGI3MTQyNDY4NzhlMWYxMmU5NWU2ZTRiL3RhYmxlcmFuZ2U6Y2VmYjRhNTAwYjcxNDI0Njg3OGUxZjEyZTk1ZTZlNGJfMi01LTEtMS00NTkxOQ_ce9c5ccb-9578-498f-82b3-bb9dbcfddc96">2,476</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic37b157fcb074cfaaf336217f5e69f47_I20230331" decimals="-3" name="us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80OS9mcmFnOmIzNmU0MzJjMjM0ZDRjMTJiMmY4NzM2MTk3Yjg3MTE4L3RhYmxlOmNlZmI0YTUwMGI3MTQyNDY4NzhlMWYxMmU5NWU2ZTRiL3RhYmxlcmFuZ2U6Y2VmYjRhNTAwYjcxNDI0Njg3OGUxZjEyZTk1ZTZlNGJfMi03LTEtMS00NTkxOQ_39e5758b-aedc-43b3-b70b-dd81886a9a26">4,393</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4455b5d88e18472f9babbe0ea7158f8f_I20230331" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80OS9mcmFnOmIzNmU0MzJjMjM0ZDRjMTJiMmY4NzM2MTk3Yjg3MTE4L3RhYmxlOmNlZmI0YTUwMGI3MTQyNDY4NzhlMWYxMmU5NWU2ZTRiL3RhYmxlcmFuZ2U6Y2VmYjRhNTAwYjcxNDI0Njg3OGUxZjEyZTk1ZTZlNGJfMy0zLTEtMS00NTkxOQ_59b78a69-acdd-4f21-aca4-65eaf6b8e922">485</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4455b5d88e18472f9babbe0ea7158f8f_I20230331" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80OS9mcmFnOmIzNmU0MzJjMjM0ZDRjMTJiMmY4NzM2MTk3Yjg3MTE4L3RhYmxlOmNlZmI0YTUwMGI3MTQyNDY4NzhlMWYxMmU5NWU2ZTRiL3RhYmxlcmFuZ2U6Y2VmYjRhNTAwYjcxNDI0Njg3OGUxZjEyZTk1ZTZlNGJfMy01LTEtMS00NTkxOQ_a6994e20-8344-46ef-baff-621f03b6ab9d">424</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4455b5d88e18472f9babbe0ea7158f8f_I20230331" decimals="-3" name="us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80OS9mcmFnOmIzNmU0MzJjMjM0ZDRjMTJiMmY4NzM2MTk3Yjg3MTE4L3RhYmxlOmNlZmI0YTUwMGI3MTQyNDY4NzhlMWYxMmU5NWU2ZTRiL3RhYmxlcmFuZ2U6Y2VmYjRhNTAwYjcxNDI0Njg3OGUxZjEyZTk1ZTZlNGJfMy03LTEtMS00NTkxOQ_82c84ce3-8b9b-448e-a15f-bd0803cafb66">61</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f7daa7f8baa47d29e9879c6f43c37e0_I20230331" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80OS9mcmFnOmIzNmU0MzJjMjM0ZDRjMTJiMmY4NzM2MTk3Yjg3MTE4L3RhYmxlOmNlZmI0YTUwMGI3MTQyNDY4NzhlMWYxMmU5NWU2ZTRiL3RhYmxlcmFuZ2U6Y2VmYjRhNTAwYjcxNDI0Njg3OGUxZjEyZTk1ZTZlNGJfNC0zLTEtMS00NTkxOQ_3a885de9-c761-4c48-9ed6-bf0590599121">7,354</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3f7daa7f8baa47d29e9879c6f43c37e0_I20230331" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80OS9mcmFnOmIzNmU0MzJjMjM0ZDRjMTJiMmY4NzM2MTk3Yjg3MTE4L3RhYmxlOmNlZmI0YTUwMGI3MTQyNDY4NzhlMWYxMmU5NWU2ZTRiL3RhYmxlcmFuZ2U6Y2VmYjRhNTAwYjcxNDI0Njg3OGUxZjEyZTk1ZTZlNGJfNC01LTEtMS00NTkxOQ_37fa0e6d-3b3a-44df-afc4-2b7af6f2ad1b">2,900</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f7daa7f8baa47d29e9879c6f43c37e0_I20230331" decimals="-3" name="us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80OS9mcmFnOmIzNmU0MzJjMjM0ZDRjMTJiMmY4NzM2MTk3Yjg3MTE4L3RhYmxlOmNlZmI0YTUwMGI3MTQyNDY4NzhlMWYxMmU5NWU2ZTRiL3RhYmxlcmFuZ2U6Y2VmYjRhNTAwYjcxNDI0Njg3OGUxZjEyZTk1ZTZlNGJfNC03LTEtMS00NTkxOQ_18dfc8d8-1fb3-4367-bbe5-774258b3f48d">4,454</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives not designated as hedging instruments:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b6c7563dc904e9d8280dedc024d298d_I20230331" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80OS9mcmFnOmIzNmU0MzJjMjM0ZDRjMTJiMmY4NzM2MTk3Yjg3MTE4L3RhYmxlOmNlZmI0YTUwMGI3MTQyNDY4NzhlMWYxMmU5NWU2ZTRiL3RhYmxlcmFuZ2U6Y2VmYjRhNTAwYjcxNDI0Njg3OGUxZjEyZTk1ZTZlNGJfNy0zLTEtMS00NTkxOQ_be0f4801-4783-402d-8ae6-0da32a202475">52</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9b6c7563dc904e9d8280dedc024d298d_I20230331" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80OS9mcmFnOmIzNmU0MzJjMjM0ZDRjMTJiMmY4NzM2MTk3Yjg3MTE4L3RhYmxlOmNlZmI0YTUwMGI3MTQyNDY4NzhlMWYxMmU5NWU2ZTRiL3RhYmxlcmFuZ2U6Y2VmYjRhNTAwYjcxNDI0Njg3OGUxZjEyZTk1ZTZlNGJfNy01LTEtMS00NTkxOQ_4565831c-aa77-455a-bc6f-ba278c4ed857">334</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9b6c7563dc904e9d8280dedc024d298d_I20230331" decimals="-3" sign="-" name="us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80OS9mcmFnOmIzNmU0MzJjMjM0ZDRjMTJiMmY4NzM2MTk3Yjg3MTE4L3RhYmxlOmNlZmI0YTUwMGI3MTQyNDY4NzhlMWYxMmU5NWU2ZTRiL3RhYmxlcmFuZ2U6Y2VmYjRhNTAwYjcxNDI0Njg3OGUxZjEyZTk1ZTZlNGJfNy03LTEtMS00NTkxOQ_fb4ba1b6-7eab-486e-b732-c2fe5f6364af">282</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total derivatives</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i738c2d1dacaf436faf03cc46ab9cef23_I20230331" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80OS9mcmFnOmIzNmU0MzJjMjM0ZDRjMTJiMmY4NzM2MTk3Yjg3MTE4L3RhYmxlOmNlZmI0YTUwMGI3MTQyNDY4NzhlMWYxMmU5NWU2ZTRiL3RhYmxlcmFuZ2U6Y2VmYjRhNTAwYjcxNDI0Njg3OGUxZjEyZTk1ZTZlNGJfOS0zLTEtMS00NTkxOQ_c8acb87b-afb4-444c-91cb-0a1c143d9796">7,406</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i738c2d1dacaf436faf03cc46ab9cef23_I20230331" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80OS9mcmFnOmIzNmU0MzJjMjM0ZDRjMTJiMmY4NzM2MTk3Yjg3MTE4L3RhYmxlOmNlZmI0YTUwMGI3MTQyNDY4NzhlMWYxMmU5NWU2ZTRiL3RhYmxlcmFuZ2U6Y2VmYjRhNTAwYjcxNDI0Njg3OGUxZjEyZTk1ZTZlNGJfOS01LTEtMS00NTkxOQ_18768fa5-e7ce-4ae8-be2b-b33fc68b4126">3,234</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i738c2d1dacaf436faf03cc46ab9cef23_I20230331" decimals="-3" name="us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80OS9mcmFnOmIzNmU0MzJjMjM0ZDRjMTJiMmY4NzM2MTk3Yjg3MTE4L3RhYmxlOmNlZmI0YTUwMGI3MTQyNDY4NzhlMWYxMmU5NWU2ZTRiL3RhYmxlcmFuZ2U6Y2VmYjRhNTAwYjcxNDI0Njg3OGUxZjEyZTk1ZTZlNGJfOS03LTEtMS00NTkxOQ_2f5d751f-0ea2-4380-824c-50fa49dc22fe">4,172</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:35.157%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.209%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.700%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Location on Consolidated Condensed Balance Sheet</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Asset Fair Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities Fair Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net<br/>Fair<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives designated as hedged instruments:</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1aa96a8c12644da9a3f724a2ff7bae28_I20221231" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80OS9mcmFnOmIzNmU0MzJjMjM0ZDRjMTJiMmY4NzM2MTk3Yjg3MTE4L3RhYmxlOjAzMzk3OThhZjk5MTRjNWRiNGIyOGMxNjkxMjBmMzEyL3RhYmxlcmFuZ2U6MDMzOTc5OGFmOTkxNGM1ZGI0YjI4YzE2OTEyMGYzMTJfMi0zLTEtMS00NTkxOQ_f49a6dd1-17cd-44ef-a306-430a41ffca31">6,757</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1aa96a8c12644da9a3f724a2ff7bae28_I20221231" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80OS9mcmFnOmIzNmU0MzJjMjM0ZDRjMTJiMmY4NzM2MTk3Yjg3MTE4L3RhYmxlOjAzMzk3OThhZjk5MTRjNWRiNGIyOGMxNjkxMjBmMzEyL3RhYmxlcmFuZ2U6MDMzOTc5OGFmOTkxNGM1ZGI0YjI4YzE2OTEyMGYzMTJfMi01LTEtMS00NTkxOQ_ebd64ba2-bc60-4875-be22-e933dbfe5aa4">3,121</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1aa96a8c12644da9a3f724a2ff7bae28_I20221231" decimals="-3" name="us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80OS9mcmFnOmIzNmU0MzJjMjM0ZDRjMTJiMmY4NzM2MTk3Yjg3MTE4L3RhYmxlOjAzMzk3OThhZjk5MTRjNWRiNGIyOGMxNjkxMjBmMzEyL3RhYmxlcmFuZ2U6MDMzOTc5OGFmOTkxNGM1ZGI0YjI4YzE2OTEyMGYzMTJfMi03LTEtMS00NTkxOQ_8befe2e0-af94-443c-919b-a207fdfabe3a">3,636</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d03c70b7871426aa4315ec3afbc74b6_I20221231" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80OS9mcmFnOmIzNmU0MzJjMjM0ZDRjMTJiMmY4NzM2MTk3Yjg3MTE4L3RhYmxlOjAzMzk3OThhZjk5MTRjNWRiNGIyOGMxNjkxMjBmMzEyL3RhYmxlcmFuZ2U6MDMzOTc5OGFmOTkxNGM1ZGI0YjI4YzE2OTEyMGYzMTJfMy0zLTEtMS00NTkxOQ_7750ef40-0e75-4339-a5a3-bb67e8a7d6c0">60</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9d03c70b7871426aa4315ec3afbc74b6_I20221231" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80OS9mcmFnOmIzNmU0MzJjMjM0ZDRjMTJiMmY4NzM2MTk3Yjg3MTE4L3RhYmxlOjAzMzk3OThhZjk5MTRjNWRiNGIyOGMxNjkxMjBmMzEyL3RhYmxlcmFuZ2U6MDMzOTc5OGFmOTkxNGM1ZGI0YjI4YzE2OTEyMGYzMTJfMy01LTEtMS00NTkxOQ_7cd9f132-ebff-45a3-8049-46fb77a50d28">400</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9d03c70b7871426aa4315ec3afbc74b6_I20221231" decimals="-3" sign="-" name="us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80OS9mcmFnOmIzNmU0MzJjMjM0ZDRjMTJiMmY4NzM2MTk3Yjg3MTE4L3RhYmxlOjAzMzk3OThhZjk5MTRjNWRiNGIyOGMxNjkxMjBmMzEyL3RhYmxlcmFuZ2U6MDMzOTc5OGFmOTkxNGM1ZGI0YjI4YzE2OTEyMGYzMTJfMy03LTEtMS00NTkxOQ_6f6210b6-8ff5-4d8f-8fb1-fe23ea903d17">340</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5ba3db9a3fd46c9a33db4ff90f454ca_I20221231" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80OS9mcmFnOmIzNmU0MzJjMjM0ZDRjMTJiMmY4NzM2MTk3Yjg3MTE4L3RhYmxlOjAzMzk3OThhZjk5MTRjNWRiNGIyOGMxNjkxMjBmMzEyL3RhYmxlcmFuZ2U6MDMzOTc5OGFmOTkxNGM1ZGI0YjI4YzE2OTEyMGYzMTJfNC0zLTEtMS00NTkxOQ_abf946a6-c68b-4609-a996-1667c6d29aa2">6,817</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic5ba3db9a3fd46c9a33db4ff90f454ca_I20221231" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80OS9mcmFnOmIzNmU0MzJjMjM0ZDRjMTJiMmY4NzM2MTk3Yjg3MTE4L3RhYmxlOjAzMzk3OThhZjk5MTRjNWRiNGIyOGMxNjkxMjBmMzEyL3RhYmxlcmFuZ2U6MDMzOTc5OGFmOTkxNGM1ZGI0YjI4YzE2OTEyMGYzMTJfNC01LTEtMS00NTkxOQ_86aec08f-5c29-4f37-b499-fae13090af84">3,521</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5ba3db9a3fd46c9a33db4ff90f454ca_I20221231" decimals="-3" name="us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80OS9mcmFnOmIzNmU0MzJjMjM0ZDRjMTJiMmY4NzM2MTk3Yjg3MTE4L3RhYmxlOjAzMzk3OThhZjk5MTRjNWRiNGIyOGMxNjkxMjBmMzEyL3RhYmxlcmFuZ2U6MDMzOTc5OGFmOTkxNGM1ZGI0YjI4YzE2OTEyMGYzMTJfNC03LTEtMS00NTkxOQ_915da7ea-5bd0-4a6c-807e-d5b2e4172013">3,296</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives not designated as hedging instruments:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i88547f770c9e4da1886319e36a385937_I20221231" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80OS9mcmFnOmIzNmU0MzJjMjM0ZDRjMTJiMmY4NzM2MTk3Yjg3MTE4L3RhYmxlOjAzMzk3OThhZjk5MTRjNWRiNGIyOGMxNjkxMjBmMzEyL3RhYmxlcmFuZ2U6MDMzOTc5OGFmOTkxNGM1ZGI0YjI4YzE2OTEyMGYzMTJfNy0zLTEtMS00NTkxOQ_e3cb34af-781c-45c5-b7a2-21263dae5b19">48</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i88547f770c9e4da1886319e36a385937_I20221231" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80OS9mcmFnOmIzNmU0MzJjMjM0ZDRjMTJiMmY4NzM2MTk3Yjg3MTE4L3RhYmxlOjAzMzk3OThhZjk5MTRjNWRiNGIyOGMxNjkxMjBmMzEyL3RhYmxlcmFuZ2U6MDMzOTc5OGFmOTkxNGM1ZGI0YjI4YzE2OTEyMGYzMTJfNy01LTEtMS00NTkxOQ_7450edec-aecc-406a-814f-0f0a6856c25c">395</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i88547f770c9e4da1886319e36a385937_I20221231" decimals="-3" sign="-" name="us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80OS9mcmFnOmIzNmU0MzJjMjM0ZDRjMTJiMmY4NzM2MTk3Yjg3MTE4L3RhYmxlOjAzMzk3OThhZjk5MTRjNWRiNGIyOGMxNjkxMjBmMzEyL3RhYmxlcmFuZ2U6MDMzOTc5OGFmOTkxNGM1ZGI0YjI4YzE2OTEyMGYzMTJfNy03LTEtMS00NTkxOQ_163ee873-1638-4697-8ea7-05f29b3641f6">347</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total derivatives</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4f63720d8b244a68941932992cd9f4d_I20221231" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80OS9mcmFnOmIzNmU0MzJjMjM0ZDRjMTJiMmY4NzM2MTk3Yjg3MTE4L3RhYmxlOjAzMzk3OThhZjk5MTRjNWRiNGIyOGMxNjkxMjBmMzEyL3RhYmxlcmFuZ2U6MDMzOTc5OGFmOTkxNGM1ZGI0YjI4YzE2OTEyMGYzMTJfOS0zLTEtMS00NTkxOQ_40758c4c-f4b8-40da-963a-6c538ce6c950">6,865</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie4f63720d8b244a68941932992cd9f4d_I20221231" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80OS9mcmFnOmIzNmU0MzJjMjM0ZDRjMTJiMmY4NzM2MTk3Yjg3MTE4L3RhYmxlOjAzMzk3OThhZjk5MTRjNWRiNGIyOGMxNjkxMjBmMzEyL3RhYmxlcmFuZ2U6MDMzOTc5OGFmOTkxNGM1ZGI0YjI4YzE2OTEyMGYzMTJfOS01LTEtMS00NTkxOQ_646481f6-053b-408c-95d7-e5981bf70926">3,916</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4f63720d8b244a68941932992cd9f4d_I20221231" decimals="-3" name="us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80OS9mcmFnOmIzNmU0MzJjMjM0ZDRjMTJiMmY4NzM2MTk3Yjg3MTE4L3RhYmxlOjAzMzk3OThhZjk5MTRjNWRiNGIyOGMxNjkxMjBmMzEyL3RhYmxlcmFuZ2U6MDMzOTc5OGFmOTkxNGM1ZGI0YjI4YzE2OTEyMGYzMTJfOS03LTEtMS00NTkxOQ_b153dc8e-b6d2-4206-9c91-df52fcf45721">2,949</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our forward foreign exchange contracts are subject to a master netting agreement and qualify for netting in the consolidated condensed balance sheets. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Fair Value Disclosure.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  FASB guidance defines fair value and establishes a framework for measuring fair value and related disclosure requirements.  This guidance applies when fair value measurements are required or permitted.  The guidance indicates, among other things, that a fair value measurement assumes that the transaction to sell an asset or transfer a liability occurs in the principal market for the asset or liability or, in the absence of a principal market, the most advantageous market for the asset or liability.  Fair value is defined based upon an exit price model.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Valuation Hierarchy. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> A valuation hierarchy was established for disclosure of the inputs to the valuations used to measure fair value.  This hierarchy prioritizes the inputs into three broad levels as follows.  Level 1 inputs are quoted prices (unadjusted) in active markets for identical assets or liabilities.  Level 2 inputs are quoted prices for similar assets and liabilities in active markets, quoted prices for identical or similar assets in markets that are not active, inputs other than quoted prices that are observable for the asset or liability, including interest rates, yield curves and credit risks, or inputs that are derived principally from or corroborated by observable market data through correlation.  Level 3 inputs are unobservable inputs based on our own assumptions used to measure assets and liabilities at fair value.  A financial asset or liability&#8217;s classification within the hierarchy is determined based on the lowest level input that is significant to the fair value measurement.  There have been no significant changes in the assumptions.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline" href="#i952e7af9c0b94e65995973e7f212f399_7">Table of Contents</a></span></div></div><ix:continuation id="i85e0d2a4758949e9a81eb36ef7076426" continuedAt="i45052282d9414522936dac9e09a76a32"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:107%">Valuation Techniques. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"> Assets and liabilities carried at fair value and measured on a recurring basis as of March&#160;31, 2023 consist of forward foreign exchange contracts and contingent consideration.  The Company values its forward foreign exchange contracts using quoted prices for similar assets.  The most significant assumption is quoted currency rates.  The value of the forward foreign exchange contract assets and liabilities were valued using Level 2 inputs and are listed in the table above.&#160;&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">The Company values contingent consideration from the In2Bones and Biorez acquisitions using Level 3 inputs.  The contingent consideration was recorded at fair value at the date of acquisition based on the consideration expected to be transferred, estimated as the probability-weighted future cash flows, discounted back to present value. The fair value of contingent consideration is measured using projected payment dates, discount rates, revenue volatilities and projected revenues. <ix:nonNumeric contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331" name="us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80OS9mcmFnOmIzNmU0MzJjMjM0ZDRjMTJiMmY4NzM2MTk3Yjg3MTE4L3RleHRyZWdpb246YjM2ZTQzMmMyMzRkNGMxMmIyZjg3MzYxOTdiODcxMThfNTQ5NzU1ODI0Mzgz_fc95161b-c376-40c5-b780-8d03f6f7c048" continuedAt="i68d1fe02505a4252ae8c40acfca0bf30" escape="true">The recurring Level 3 fair value measurements of contingent consideration for which the liabilities are recorded include the following significant unobservable inputs as of March&#160;31, 2023:</ix:nonNumeric></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><ix:continuation id="i68d1fe02505a4252ae8c40acfca0bf30"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:56.356%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.577%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.783%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.784%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assumptions</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unobservable Input</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">In2Bones</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Biorez</span></td></tr><tr style="height:6pt"><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i1b64b61d3f3b4bdfacdd2afc2e367b87_I20230331" decimals="INF" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80OS9mcmFnOmIzNmU0MzJjMjM0ZDRjMTJiMmY4NzM2MTk3Yjg3MTE4L3RhYmxlOmNmMTgyMDQ4OTYwOTRiOTdiYTM0MmZhM2M0NWY3OTg0L3RhYmxlcmFuZ2U6Y2YxODIwNDg5NjA5NGI5N2JhMzQyZmEzYzQ1Zjc5ODRfMy0yLTEtMS00ODQyOA_737a3f54-b238-451f-82b8-4bf5f2069229">6.52</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ibfc06ce8169a4d33886f8243da232e5b_I20230331" decimals="INF" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80OS9mcmFnOmIzNmU0MzJjMjM0ZDRjMTJiMmY4NzM2MTk3Yjg3MTE4L3RhYmxlOmNmMTgyMDQ4OTYwOTRiOTdiYTM0MmZhM2M0NWY3OTg0L3RhYmxlcmFuZ2U6Y2YxODIwNDg5NjA5NGI5N2JhMzQyZmEzYzQ1Zjc5ODRfMy0zLTEtMS00ODQyOA_08ae2196-4785-4e13-b295-2d6ab6259446">11.32</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue volatility</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i517939c1b1424d2a82601fc769d01674_I20230331" decimals="INF" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80OS9mcmFnOmIzNmU0MzJjMjM0ZDRjMTJiMmY4NzM2MTk3Yjg3MTE4L3RhYmxlOmNmMTgyMDQ4OTYwOTRiOTdiYTM0MmZhM2M0NWY3OTg0L3RhYmxlcmFuZ2U6Y2YxODIwNDg5NjA5NGI5N2JhMzQyZmEzYzQ1Zjc5ODRfNC0yLTEtMS00ODQyOA_c4b0934e-33b2-42d9-9de7-8537518332f9">13.11</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i82c6f94346114193ae96a1af52315fc4_I20230331" decimals="INF" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80OS9mcmFnOmIzNmU0MzJjMjM0ZDRjMTJiMmY4NzM2MTk3Yjg3MTE4L3RhYmxlOmNmMTgyMDQ4OTYwOTRiOTdiYTM0MmZhM2M0NWY3OTg0L3RhYmxlcmFuZ2U6Y2YxODIwNDg5NjA5NGI5N2JhMzQyZmEzYzQ1Zjc5ODRfNC0zLTEtMS00ODQyOA_463dd5d3-c6d9-41af-955d-8e261d756fa6">20.88</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Projected year of payment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023-2026</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023-2026</span></div></td></tr></table></ix:continuation></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Adjustments to the fair value of contingent consideration relate to the passage of time and changes in market assumptions.  <ix:nonNumeric contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331" name="us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80OS9mcmFnOmIzNmU0MzJjMjM0ZDRjMTJiMmY4NzM2MTk3Yjg3MTE4L3RleHRyZWdpb246YjM2ZTQzMmMyMzRkNGMxMmIyZjg3MzYxOTdiODcxMThfNTQ5NzU1ODI0Mzg0_9953aa89-0fc4-4fba-b21b-d19a3718c4a8" continuedAt="ieefc8eaf9c044a0ca89119e5dfeb2c93" escape="true">Changes in the fair value of contingent consideration liabilities for the three months ended March&#160;31, 2023 are as follows:</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><ix:continuation id="ieefc8eaf9c044a0ca89119e5dfeb2c93"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:41.443%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:27.705%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">In2Bones</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Biorez</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Location in Financial Statements</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of January 1, 2023</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ice84e4caa93743c5af0f4b86f25100ee_I20221231" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80OS9mcmFnOmIzNmU0MzJjMjM0ZDRjMTJiMmY4NzM2MTk3Yjg3MTE4L3RhYmxlOjFhMGY4YjcxMTMzMjQxZDg5OWU2MWMwMjhiOGI1Yzk0L3RhYmxlcmFuZ2U6MWEwZjhiNzExMzMyNDFkODk5ZTYxYzAyOGI4YjVjOTRfMS0xLTEtMS00Nzg5Ng_9c19332a-91de-4750-9f8b-ba6370abddc7">70,198</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic59ba63fc4b34daa82e9ac6f2499169a_I20221231" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80OS9mcmFnOmIzNmU0MzJjMjM0ZDRjMTJiMmY4NzM2MTk3Yjg3MTE4L3RhYmxlOjFhMGY4YjcxMTMzMjQxZDg5OWU2MWMwMjhiOGI1Yzk0L3RhYmxlcmFuZ2U6MWEwZjhiNzExMzMyNDFkODk5ZTYxYzAyOGI4YjVjOTRfMS0zLTEtMS00Nzg5Ng_99821960-b923-4934-b958-13228599e85a">116,234</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in fair value of contingent consideration</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d95bd83592e4caeac97181946e4d405_D20230101-20230331" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80OS9mcmFnOmIzNmU0MzJjMjM0ZDRjMTJiMmY4NzM2MTk3Yjg3MTE4L3RhYmxlOjFhMGY4YjcxMTMzMjQxZDg5OWU2MWMwMjhiOGI1Yzk0L3RhYmxlcmFuZ2U6MWEwZjhiNzExMzMyNDFkODk5ZTYxYzAyOGI4YjVjOTRfNC0xLTEtMS00NzkxMA_74bdfcd0-5992-4e1d-8858-de7033a61a07">2,637</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc813fbabc244729a87811be824caa94_D20230101-20230331" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80OS9mcmFnOmIzNmU0MzJjMjM0ZDRjMTJiMmY4NzM2MTk3Yjg3MTE4L3RhYmxlOjFhMGY4YjcxMTMzMjQxZDg5OWU2MWMwMjhiOGI1Yzk0L3RhYmxlcmFuZ2U6MWEwZjhiNzExMzMyNDFkODk5ZTYxYzAyOGI4YjVjOTRfNC0zLTEtMS00NzkxMA_b8cfd139-0168-4ff9-bf18-592b42f41b7a">1,799</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling and administrative expense</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of March 31, 2023</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1c3351caf2af4528b8145dc927d3396a_I20230331" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80OS9mcmFnOmIzNmU0MzJjMjM0ZDRjMTJiMmY4NzM2MTk3Yjg3MTE4L3RhYmxlOjFhMGY4YjcxMTMzMjQxZDg5OWU2MWMwMjhiOGI1Yzk0L3RhYmxlcmFuZ2U6MWEwZjhiNzExMzMyNDFkODk5ZTYxYzAyOGI4YjVjOTRfNS0xLTEtMS01MDkxOA_dd519bff-cf0e-49bf-a07f-e03ac60b7a94">72,835</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i259d409a7f7547048e55cae0b6ae73bc_I20230331" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80OS9mcmFnOmIzNmU0MzJjMjM0ZDRjMTJiMmY4NzM2MTk3Yjg3MTE4L3RhYmxlOjFhMGY4YjcxMTMzMjQxZDg5OWU2MWMwMjhiOGI1Yzk0L3RhYmxlcmFuZ2U6MWEwZjhiNzExMzMyNDFkODk5ZTYxYzAyOGI4YjVjOTRfNS0zLTEtMS01MDkyMg_5e2edf7e-a17d-4497-b424-4f69850f53e3">118,033</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr></table></ix:continuation></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">Contingent consideration of $<ix:nonFraction unitRef="usd" contextRef="i738c2d1dacaf436faf03cc46ab9cef23_I20230331" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80OS9mcmFnOmIzNmU0MzJjMjM0ZDRjMTJiMmY4NzM2MTk3Yjg3MTE4L3RleHRyZWdpb246YjM2ZTQzMmMyMzRkNGMxMmIyZjg3MzYxOTdiODcxMThfNTQ5NzU1ODIxMzE5_fcb73c76-883a-49a7-a765-a220e369352e">38.7</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i738c2d1dacaf436faf03cc46ab9cef23_I20230331" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80OS9mcmFnOmIzNmU0MzJjMjM0ZDRjMTJiMmY4NzM2MTk3Yjg3MTE4L3RleHRyZWdpb246YjM2ZTQzMmMyMzRkNGMxMmIyZjg3MzYxOTdiODcxMThfNTQ5NzU1ODIxMzI3_a33684f5-59ce-43af-922c-7586ce70f405">152.2</ix:nonFraction> million is included in other current liabilities and other long-term liabilities, respectively, in the consolidated condensed balance sheet at March&#160;31, 2023.  Contingent consideration of $<ix:nonFraction unitRef="usd" contextRef="ie4f63720d8b244a68941932992cd9f4d_I20221231" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80OS9mcmFnOmIzNmU0MzJjMjM0ZDRjMTJiMmY4NzM2MTk3Yjg3MTE4L3RleHRyZWdpb246YjM2ZTQzMmMyMzRkNGMxMmIyZjg3MzYxOTdiODcxMThfNTQ5NzU1ODI0NDg0_66ff6491-f2a8-41ce-bfcd-f1c785dc3404">18.6</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ie4f63720d8b244a68941932992cd9f4d_I20221231" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80OS9mcmFnOmIzNmU0MzJjMjM0ZDRjMTJiMmY4NzM2MTk3Yjg3MTE4L3RleHRyZWdpb246YjM2ZTQzMmMyMzRkNGMxMmIyZjg3MzYxOTdiODcxMThfNTQ5NzU1ODI0NTAy_53f0fc43-4a46-47d1-8a00-3a26beef22d7">167.8</ix:nonFraction> million is included in other current liabilities and other long term liabilities, respectively, in the consolidated condensed balance sheet at December 31, 2022.</span></div></ix:continuation><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"><ix:continuation id="i45052282d9414522936dac9e09a76a32">The carrying amounts reported in our consolidated condensed balance sheets for cash and cash equivalents, accounts receivable, accounts payable and variable long-term debt approximate fair value.</ix:continuation>&#160;&#160;</span></div><div style="text-align:justify"><span><br/></span></div><div id="i952e7af9c0b94e65995973e7f212f399_52"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Note 8 - <ix:nonNumeric contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331" name="us-gaap:InventoryDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV81Mi9mcmFnOjM5ZjFlZWEwYjJhOTQ0NGM4MmZjYTUzZjlkNWFlYTMyL3RleHRyZWdpb246MzlmMWVlYTBiMmE5NDQ0YzgyZmNhNTNmOWQ1YWVhMzJfODY_f88d09ef-6124-4e16-91a8-48b25e20a442" continuedAt="i19040f45cf254c3c80f38d1146761fe8" escape="true">Inventories</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i19040f45cf254c3c80f38d1146761fe8"><ix:nonNumeric contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331" name="us-gaap:ScheduleOfInventoryCurrentTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV81Mi9mcmFnOjM5ZjFlZWEwYjJhOTQ0NGM4MmZjYTUzZjlkNWFlYTMyL3RleHRyZWdpb246MzlmMWVlYTBiMmE5NDQ0YzgyZmNhNTNmOWQ1YWVhMzJfNzQ_bad91fc9-670e-4268-83c1-3362c54b20df" escape="true"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories consist of the following:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.560%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.204%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.206%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i738c2d1dacaf436faf03cc46ab9cef23_I20230331" decimals="-3" name="us-gaap:InventoryRawMaterialsNetOfReserves" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV81Mi9mcmFnOjM5ZjFlZWEwYjJhOTQ0NGM4MmZjYTUzZjlkNWFlYTMyL3RhYmxlOjA3Mjc5MDMwYTgxNzQyYzQ4ZDg5YThkZDg4MmVjYjExL3RhYmxlcmFuZ2U6MDcyNzkwMzBhODE3NDJjNDhkODlhOGRkODgyZWNiMTFfMS0xLTEtMS00NTkxOQ_7bca97ee-1a52-403e-98d4-876236272440">124,122</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4f63720d8b244a68941932992cd9f4d_I20221231" decimals="-3" name="us-gaap:InventoryRawMaterialsNetOfReserves" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV81Mi9mcmFnOjM5ZjFlZWEwYjJhOTQ0NGM4MmZjYTUzZjlkNWFlYTMyL3RhYmxlOjA3Mjc5MDMwYTgxNzQyYzQ4ZDg5YThkZDg4MmVjYjExL3RhYmxlcmFuZ2U6MDcyNzkwMzBhODE3NDJjNDhkODlhOGRkODgyZWNiMTFfMS0zLTEtMS00NTkxOQ_e5a8c8e8-8e7a-4df9-91d0-ba477de9880f">110,677</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work-in-process</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i738c2d1dacaf436faf03cc46ab9cef23_I20230331" decimals="-3" name="us-gaap:InventoryWorkInProcessNetOfReserves" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV81Mi9mcmFnOjM5ZjFlZWEwYjJhOTQ0NGM4MmZjYTUzZjlkNWFlYTMyL3RhYmxlOjA3Mjc5MDMwYTgxNzQyYzQ4ZDg5YThkZDg4MmVjYjExL3RhYmxlcmFuZ2U6MDcyNzkwMzBhODE3NDJjNDhkODlhOGRkODgyZWNiMTFfMi0xLTEtMS00NTkxOQ_21febb00-f4bd-48dd-8239-3c1b7154ba23">26,487</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4f63720d8b244a68941932992cd9f4d_I20221231" decimals="-3" name="us-gaap:InventoryWorkInProcessNetOfReserves" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV81Mi9mcmFnOjM5ZjFlZWEwYjJhOTQ0NGM4MmZjYTUzZjlkNWFlYTMyL3RhYmxlOjA3Mjc5MDMwYTgxNzQyYzQ4ZDg5YThkZDg4MmVjYjExL3RhYmxlcmFuZ2U6MDcyNzkwMzBhODE3NDJjNDhkODlhOGRkODgyZWNiMTFfMi0zLTEtMS00NTkxOQ_e0f723b5-a9e2-4489-a136-8c45b7394443">26,166</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i738c2d1dacaf436faf03cc46ab9cef23_I20230331" decimals="-3" name="us-gaap:InventoryFinishedGoodsNetOfReserves" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV81Mi9mcmFnOjM5ZjFlZWEwYjJhOTQ0NGM4MmZjYTUzZjlkNWFlYTMyL3RhYmxlOjA3Mjc5MDMwYTgxNzQyYzQ4ZDg5YThkZDg4MmVjYjExL3RhYmxlcmFuZ2U6MDcyNzkwMzBhODE3NDJjNDhkODlhOGRkODgyZWNiMTFfMy0xLTEtMS00NTkxOQ_8ae59e32-dd9a-4d46-8ddb-698ae248b5a4">184,761</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4f63720d8b244a68941932992cd9f4d_I20221231" decimals="-3" name="us-gaap:InventoryFinishedGoodsNetOfReserves" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV81Mi9mcmFnOjM5ZjFlZWEwYjJhOTQ0NGM4MmZjYTUzZjlkNWFlYTMyL3RhYmxlOjA3Mjc5MDMwYTgxNzQyYzQ4ZDg5YThkZDg4MmVjYjExL3RhYmxlcmFuZ2U6MDcyNzkwMzBhODE3NDJjNDhkODlhOGRkODgyZWNiMTFfMy0zLTEtMS00NTkxOQ_846b6f56-8e79-41cc-a817-039376b546da">195,477</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i738c2d1dacaf436faf03cc46ab9cef23_I20230331" decimals="-3" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV81Mi9mcmFnOjM5ZjFlZWEwYjJhOTQ0NGM4MmZjYTUzZjlkNWFlYTMyL3RhYmxlOjA3Mjc5MDMwYTgxNzQyYzQ4ZDg5YThkZDg4MmVjYjExL3RhYmxlcmFuZ2U6MDcyNzkwMzBhODE3NDJjNDhkODlhOGRkODgyZWNiMTFfNC0xLTEtMS00NTkxOQ_dac1c19c-0d20-4169-8921-37105c865954">335,370</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4f63720d8b244a68941932992cd9f4d_I20221231" decimals="-3" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV81Mi9mcmFnOjM5ZjFlZWEwYjJhOTQ0NGM4MmZjYTUzZjlkNWFlYTMyL3RhYmxlOjA3Mjc5MDMwYTgxNzQyYzQ4ZDg5YThkZDg4MmVjYjExL3RhYmxlcmFuZ2U6MDcyNzkwMzBhODE3NDJjNDhkODlhOGRkODgyZWNiMTFfNC0zLTEtMS00NTkxOQ_fcc66368-566d-4c25-8114-4d1cf104de14">332,320</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div id="i952e7af9c0b94e65995973e7f212f399_55"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Note 9 &#8211; <ix:nonNumeric contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331" name="us-gaap:EarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV81NS9mcmFnOjJmNDEzOTUxNDIwZjQxNmRiOTZjMjE1Y2VlNGVkMTQ3L3RleHRyZWdpb246MmY0MTM5NTE0MjBmNDE2ZGI5NmMyMTVjZWU0ZWQxNDdfNDg3Mg_3706a34e-7111-43dd-97e2-927e98fe42d9" continuedAt="ic06a2b8988de4a0780446dd9193902c5" escape="true">Earnings Per Share</ix:nonNumeric></span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ic06a2b8988de4a0780446dd9193902c5" continuedAt="iffdacb45f7bd42cf9e6863815ca461b5">Basic earnings per share (&#8220;basic EPS&#8221;) is computed by dividing net income by the weighted average number of common shares outstanding for the reporting period.  Diluted earnings per share (&#8220;diluted EPS&#8221;) gives effect to all dilutive potential shares. </ix:continuation></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline" href="#i952e7af9c0b94e65995973e7f212f399_7">Table of Contents</a></span></div></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><ix:continuation id="iffdacb45f7bd42cf9e6863815ca461b5"><ix:nonNumeric contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV81NS9mcmFnOjJmNDEzOTUxNDIwZjQxNmRiOTZjMjE1Y2VlNGVkMTQ3L3RleHRyZWdpb246MmY0MTM5NTE0MjBmNDE2ZGI5NmMyMTVjZWU0ZWQxNDdfNDg3NA_a618ffb6-a793-48e9-8889-55d47db88bee" escape="true"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the computation of basic and diluted earnings per share for the three months ended March 31, 2023 and 2022:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:25.800%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.605%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31, 2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Basic EPS</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Adjustments</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Diluted EPS</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Basic EPS</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Adjustments</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Diluted EPS</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV81NS9mcmFnOjJmNDEzOTUxNDIwZjQxNmRiOTZjMjE1Y2VlNGVkMTQ3L3RhYmxlOjlkZDhkMjk5OGFlNTQ4ZTZhYzJkYTc1MDJiZGUwMjUyL3RhYmxlcmFuZ2U6OWRkOGQyOTk4YWU1NDhlNmFjMmRhNzUwMmJkZTAyNTJfMi0xLTEtMS00NTkxOQ_0213456e-d1db-4e57-a739-0c7caca31a29">1,819</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331" decimals="-3" name="us-gaap:InterestOnConvertibleDebtNetOfTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV81NS9mcmFnOjJmNDEzOTUxNDIwZjQxNmRiOTZjMjE1Y2VlNGVkMTQ3L3RhYmxlOjlkZDhkMjk5OGFlNTQ4ZTZhYzJkYTc1MDJiZGUwMjUyL3RhYmxlcmFuZ2U6OWRkOGQyOTk4YWU1NDhlNmFjMmRhNzUwMmJkZTAyNTJfMi0zLTEtMS00NTkxOQ_7cde3f1a-49c8-4b25-bd27-de49d28cc047">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331" decimals="-3" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV81NS9mcmFnOjJmNDEzOTUxNDIwZjQxNmRiOTZjMjE1Y2VlNGVkMTQ3L3RhYmxlOjlkZDhkMjk5OGFlNTQ4ZTZhYzJkYTc1MDJiZGUwMjUyL3RhYmxlcmFuZ2U6OWRkOGQyOTk4YWU1NDhlNmFjMmRhNzUwMmJkZTAyNTJfMi01LTEtMS00NTkxOQ_0538e2c1-635f-4504-9bd3-26871e379904">1,819</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9500a5ee8dbe4d23aa9c46ebdd25a0c8_D20220101-20220331" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV81NS9mcmFnOjJmNDEzOTUxNDIwZjQxNmRiOTZjMjE1Y2VlNGVkMTQ3L3RhYmxlOjlkZDhkMjk5OGFlNTQ4ZTZhYzJkYTc1MDJiZGUwMjUyL3RhYmxlcmFuZ2U6OWRkOGQyOTk4YWU1NDhlNmFjMmRhNzUwMmJkZTAyNTJfMi03LTEtMS00NTkxOQ_7b7578b7-4c8a-4664-a19e-e118bb66eab5">14,975</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9500a5ee8dbe4d23aa9c46ebdd25a0c8_D20220101-20220331" decimals="-3" name="us-gaap:InterestOnConvertibleDebtNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV81NS9mcmFnOjJmNDEzOTUxNDIwZjQxNmRiOTZjMjE1Y2VlNGVkMTQ3L3RhYmxlOjlkZDhkMjk5OGFlNTQ4ZTZhYzJkYTc1MDJiZGUwMjUyL3RhYmxlcmFuZ2U6OWRkOGQyOTk4YWU1NDhlNmFjMmRhNzUwMmJkZTAyNTJfMi05LTEtMS00NTkxOQ_166db459-d9b8-4c4c-ac3c-e769e77c9aa3">1,715</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9500a5ee8dbe4d23aa9c46ebdd25a0c8_D20220101-20220331" decimals="-3" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV81NS9mcmFnOjJmNDEzOTUxNDIwZjQxNmRiOTZjMjE1Y2VlNGVkMTQ3L3RhYmxlOjlkZDhkMjk5OGFlNTQ4ZTZhYzJkYTc1MDJiZGUwMjUyL3RhYmxlcmFuZ2U6OWRkOGQyOTk4YWU1NDhlNmFjMmRhNzUwMmJkZTAyNTJfMi0xMS0xLTEtNDU5MTk_b445ef55-1aba-4709-8cc1-bfcd3ddf732a">16,690</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares outstanding</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV81NS9mcmFnOjJmNDEzOTUxNDIwZjQxNmRiOTZjMjE1Y2VlNGVkMTQ3L3RhYmxlOjlkZDhkMjk5OGFlNTQ4ZTZhYzJkYTc1MDJiZGUwMjUyL3RhYmxlcmFuZ2U6OWRkOGQyOTk4YWU1NDhlNmFjMmRhNzUwMmJkZTAyNTJfNC0xLTEtMS00NTkxOQ_6899eade-dc23-459a-afd7-301069a7cd91">30,511</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV81NS9mcmFnOjJmNDEzOTUxNDIwZjQxNmRiOTZjMjE1Y2VlNGVkMTQ3L3RhYmxlOjlkZDhkMjk5OGFlNTQ4ZTZhYzJkYTc1MDJiZGUwMjUyL3RhYmxlcmFuZ2U6OWRkOGQyOTk4YWU1NDhlNmFjMmRhNzUwMmJkZTAyNTJfNC01LTEtMS00NTkxOQ_18071fa5-d6b1-4c0a-92c2-08b728a25e3b">30,511</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9500a5ee8dbe4d23aa9c46ebdd25a0c8_D20220101-20220331" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV81NS9mcmFnOjJmNDEzOTUxNDIwZjQxNmRiOTZjMjE1Y2VlNGVkMTQ3L3RhYmxlOjlkZDhkMjk5OGFlNTQ4ZTZhYzJkYTc1MDJiZGUwMjUyL3RhYmxlcmFuZ2U6OWRkOGQyOTk4YWU1NDhlNmFjMmRhNzUwMmJkZTAyNTJfNC03LTEtMS00NTkxOQ_25315d7e-c075-44e0-ad04-6a033b690383">29,428</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9500a5ee8dbe4d23aa9c46ebdd25a0c8_D20220101-20220331" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV81NS9mcmFnOjJmNDEzOTUxNDIwZjQxNmRiOTZjMjE1Y2VlNGVkMTQ3L3RhYmxlOjlkZDhkMjk5OGFlNTQ4ZTZhYzJkYTc1MDJiZGUwMjUyL3RhYmxlcmFuZ2U6OWRkOGQyOTk4YWU1NDhlNmFjMmRhNzUwMmJkZTAyNTJfNC0xMS0xLTEtNDU5MTk_29c68a08-d91e-4fe7-824c-0b5a0ae04972">29,428</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV81NS9mcmFnOjJmNDEzOTUxNDIwZjQxNmRiOTZjMjE1Y2VlNGVkMTQ3L3RhYmxlOjlkZDhkMjk5OGFlNTQ4ZTZhYzJkYTc1MDJiZGUwMjUyL3RhYmxlcmFuZ2U6OWRkOGQyOTk4YWU1NDhlNmFjMmRhNzUwMmJkZTAyNTJfNi0zLTEtMS00NTkxOQ_e0e5489d-cf7a-4411-9c71-2c67effe6d3c">629</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV81NS9mcmFnOjJmNDEzOTUxNDIwZjQxNmRiOTZjMjE1Y2VlNGVkMTQ3L3RhYmxlOjlkZDhkMjk5OGFlNTQ4ZTZhYzJkYTc1MDJiZGUwMjUyL3RhYmxlcmFuZ2U6OWRkOGQyOTk4YWU1NDhlNmFjMmRhNzUwMmJkZTAyNTJfNi01LTEtMS00NTkxOQ_9ed3b468-7580-40bc-a1cb-47b1ecc337fa">629</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9500a5ee8dbe4d23aa9c46ebdd25a0c8_D20220101-20220331" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV81NS9mcmFnOjJmNDEzOTUxNDIwZjQxNmRiOTZjMjE1Y2VlNGVkMTQ3L3RhYmxlOjlkZDhkMjk5OGFlNTQ4ZTZhYzJkYTc1MDJiZGUwMjUyL3RhYmxlcmFuZ2U6OWRkOGQyOTk4YWU1NDhlNmFjMmRhNzUwMmJkZTAyNTJfNi05LTEtMS00NTkxOQ_bba2dd8c-7cdc-4a3b-b34a-37efd1159ffc">1,158</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9500a5ee8dbe4d23aa9c46ebdd25a0c8_D20220101-20220331" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV81NS9mcmFnOjJmNDEzOTUxNDIwZjQxNmRiOTZjMjE1Y2VlNGVkMTQ3L3RhYmxlOjlkZDhkMjk5OGFlNTQ4ZTZhYzJkYTc1MDJiZGUwMjUyL3RhYmxlcmFuZ2U6OWRkOGQyOTk4YWU1NDhlNmFjMmRhNzUwMmJkZTAyNTJfNi0xMS0xLTEtNDU5MTk_b4c53f44-2db3-4fb4-a580-248e50ccf0a0">1,158</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warrants</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV81NS9mcmFnOjJmNDEzOTUxNDIwZjQxNmRiOTZjMjE1Y2VlNGVkMTQ3L3RhYmxlOjlkZDhkMjk5OGFlNTQ4ZTZhYzJkYTc1MDJiZGUwMjUyL3RhYmxlcmFuZ2U6OWRkOGQyOTk4YWU1NDhlNmFjMmRhNzUwMmJkZTAyNTJfOC0zLTEtMS00NTkxOQ_b9cd1638-f97f-4b65-a88f-61fa36dbb3c2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV81NS9mcmFnOjJmNDEzOTUxNDIwZjQxNmRiOTZjMjE1Y2VlNGVkMTQ3L3RhYmxlOjlkZDhkMjk5OGFlNTQ4ZTZhYzJkYTc1MDJiZGUwMjUyL3RhYmxlcmFuZ2U6OWRkOGQyOTk4YWU1NDhlNmFjMmRhNzUwMmJkZTAyNTJfOC01LTEtMS00NTkxOQ_412e02e3-40aa-4c42-be2e-115319dcfdc8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9500a5ee8dbe4d23aa9c46ebdd25a0c8_D20220101-20220331" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV81NS9mcmFnOjJmNDEzOTUxNDIwZjQxNmRiOTZjMjE1Y2VlNGVkMTQ3L3RhYmxlOjlkZDhkMjk5OGFlNTQ4ZTZhYzJkYTc1MDJiZGUwMjUyL3RhYmxlcmFuZ2U6OWRkOGQyOTk4YWU1NDhlNmFjMmRhNzUwMmJkZTAyNTJfOC05LTEtMS00NTkxOQ_8675b4ba-cc20-4c16-ab84-fe4b5e5956a2">684</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9500a5ee8dbe4d23aa9c46ebdd25a0c8_D20220101-20220331" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV81NS9mcmFnOjJmNDEzOTUxNDIwZjQxNmRiOTZjMjE1Y2VlNGVkMTQ3L3RhYmxlOjlkZDhkMjk5OGFlNTQ4ZTZhYzJkYTc1MDJiZGUwMjUyL3RhYmxlcmFuZ2U6OWRkOGQyOTk4YWU1NDhlNmFjMmRhNzUwMmJkZTAyNTJfOC0xMS0xLTEtNDU5MTk_eb841bad-95c0-4269-97fc-0d52f3a2fcc6">684</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Convertible notes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV81NS9mcmFnOjJmNDEzOTUxNDIwZjQxNmRiOTZjMjE1Y2VlNGVkMTQ3L3RhYmxlOjlkZDhkMjk5OGFlNTQ4ZTZhYzJkYTc1MDJiZGUwMjUyL3RhYmxlcmFuZ2U6OWRkOGQyOTk4YWU1NDhlNmFjMmRhNzUwMmJkZTAyNTJfMTAtMy0xLTEtNDU5MTk_336b5da8-3b6a-4f4f-9f05-7ad5a2821382">64</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV81NS9mcmFnOjJmNDEzOTUxNDIwZjQxNmRiOTZjMjE1Y2VlNGVkMTQ3L3RhYmxlOjlkZDhkMjk5OGFlNTQ4ZTZhYzJkYTc1MDJiZGUwMjUyL3RhYmxlcmFuZ2U6OWRkOGQyOTk4YWU1NDhlNmFjMmRhNzUwMmJkZTAyNTJfMTAtNS0xLTEtNDU5MTk_b7ba9247-be73-4271-bc66-a96596e1ce51">64</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9500a5ee8dbe4d23aa9c46ebdd25a0c8_D20220101-20220331" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV81NS9mcmFnOjJmNDEzOTUxNDIwZjQxNmRiOTZjMjE1Y2VlNGVkMTQ3L3RhYmxlOjlkZDhkMjk5OGFlNTQ4ZTZhYzJkYTc1MDJiZGUwMjUyL3RhYmxlcmFuZ2U6OWRkOGQyOTk4YWU1NDhlNmFjMmRhNzUwMmJkZTAyNTJfMTAtOS0xLTEtNDU5MTk_4095547f-b9b2-4acd-a39d-0aa019b27937">3,885</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9500a5ee8dbe4d23aa9c46ebdd25a0c8_D20220101-20220331" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV81NS9mcmFnOjJmNDEzOTUxNDIwZjQxNmRiOTZjMjE1Y2VlNGVkMTQ3L3RhYmxlOjlkZDhkMjk5OGFlNTQ4ZTZhYzJkYTc1MDJiZGUwMjUyL3RhYmxlcmFuZ2U6OWRkOGQyOTk4YWU1NDhlNmFjMmRhNzUwMmJkZTAyNTJfMTAtMTEtMS0xLTQ1OTE5_e317ba1a-5eeb-44df-99e4-04caaf487c26">3,885</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV81NS9mcmFnOjJmNDEzOTUxNDIwZjQxNmRiOTZjMjE1Y2VlNGVkMTQ3L3RhYmxlOjlkZDhkMjk5OGFlNTQ4ZTZhYzJkYTc1MDJiZGUwMjUyL3RhYmxlcmFuZ2U6OWRkOGQyOTk4YWU1NDhlNmFjMmRhNzUwMmJkZTAyNTJfMTItMS0xLTEtNDU5MTk_d1f16651-0082-4096-bf1f-729359412c6b">30,511</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331" decimals="-3" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV81NS9mcmFnOjJmNDEzOTUxNDIwZjQxNmRiOTZjMjE1Y2VlNGVkMTQ3L3RhYmxlOjlkZDhkMjk5OGFlNTQ4ZTZhYzJkYTc1MDJiZGUwMjUyL3RhYmxlcmFuZ2U6OWRkOGQyOTk4YWU1NDhlNmFjMmRhNzUwMmJkZTAyNTJfMTItMy0xLTEtNDU5MTk_cb3dabc4-106c-4395-a724-66c69065dbf9">693</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV81NS9mcmFnOjJmNDEzOTUxNDIwZjQxNmRiOTZjMjE1Y2VlNGVkMTQ3L3RhYmxlOjlkZDhkMjk5OGFlNTQ4ZTZhYzJkYTc1MDJiZGUwMjUyL3RhYmxlcmFuZ2U6OWRkOGQyOTk4YWU1NDhlNmFjMmRhNzUwMmJkZTAyNTJfMTItNS0xLTEtNDU5MTk_6de1cfad-6f5d-473c-8939-a94e62aa92d2">31,204</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9500a5ee8dbe4d23aa9c46ebdd25a0c8_D20220101-20220331" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV81NS9mcmFnOjJmNDEzOTUxNDIwZjQxNmRiOTZjMjE1Y2VlNGVkMTQ3L3RhYmxlOjlkZDhkMjk5OGFlNTQ4ZTZhYzJkYTc1MDJiZGUwMjUyL3RhYmxlcmFuZ2U6OWRkOGQyOTk4YWU1NDhlNmFjMmRhNzUwMmJkZTAyNTJfMTItNy0xLTEtNDU5MTk_74c9c9a8-7ade-4740-aca1-ee6b7f6130e8">29,428</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9500a5ee8dbe4d23aa9c46ebdd25a0c8_D20220101-20220331" decimals="-3" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV81NS9mcmFnOjJmNDEzOTUxNDIwZjQxNmRiOTZjMjE1Y2VlNGVkMTQ3L3RhYmxlOjlkZDhkMjk5OGFlNTQ4ZTZhYzJkYTc1MDJiZGUwMjUyL3RhYmxlcmFuZ2U6OWRkOGQyOTk4YWU1NDhlNmFjMmRhNzUwMmJkZTAyNTJfMTItOS0xLTEtNDU5MTk_c47a710a-f346-486a-9707-6e8fac25cca3">5,727</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9500a5ee8dbe4d23aa9c46ebdd25a0c8_D20220101-20220331" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV81NS9mcmFnOjJmNDEzOTUxNDIwZjQxNmRiOTZjMjE1Y2VlNGVkMTQ3L3RhYmxlOjlkZDhkMjk5OGFlNTQ4ZTZhYzJkYTc1MDJiZGUwMjUyL3RhYmxlcmFuZ2U6OWRkOGQyOTk4YWU1NDhlNmFjMmRhNzUwMmJkZTAyNTJfMTItMTEtMS0xLTQ1OTE5_134bb95d-766e-4f72-bd52-033fa2a603d5">35,155</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EPS</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV81NS9mcmFnOjJmNDEzOTUxNDIwZjQxNmRiOTZjMjE1Y2VlNGVkMTQ3L3RhYmxlOjlkZDhkMjk5OGFlNTQ4ZTZhYzJkYTc1MDJiZGUwMjUyL3RhYmxlcmFuZ2U6OWRkOGQyOTk4YWU1NDhlNmFjMmRhNzUwMmJkZTAyNTJfMTQtMS0xLTEtNDU5MTk_94e622d1-ca5e-420e-856e-087d48e8e12b">0.06</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV81NS9mcmFnOjJmNDEzOTUxNDIwZjQxNmRiOTZjMjE1Y2VlNGVkMTQ3L3RhYmxlOjlkZDhkMjk5OGFlNTQ4ZTZhYzJkYTc1MDJiZGUwMjUyL3RhYmxlcmFuZ2U6OWRkOGQyOTk4YWU1NDhlNmFjMmRhNzUwMmJkZTAyNTJfMTQtNS0xLTEtNDU5MTk_8c639eb7-1bd4-45cf-af2e-b1e7a3b9004e">0.06</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i9500a5ee8dbe4d23aa9c46ebdd25a0c8_D20220101-20220331" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV81NS9mcmFnOjJmNDEzOTUxNDIwZjQxNmRiOTZjMjE1Y2VlNGVkMTQ3L3RhYmxlOjlkZDhkMjk5OGFlNTQ4ZTZhYzJkYTc1MDJiZGUwMjUyL3RhYmxlcmFuZ2U6OWRkOGQyOTk4YWU1NDhlNmFjMmRhNzUwMmJkZTAyNTJfMTQtNy0xLTEtNDU5MTk_be0cce94-aa43-4f37-b939-ccb6310ca410">0.51</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i9500a5ee8dbe4d23aa9c46ebdd25a0c8_D20220101-20220331" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV81NS9mcmFnOjJmNDEzOTUxNDIwZjQxNmRiOTZjMjE1Y2VlNGVkMTQ3L3RhYmxlOjlkZDhkMjk5OGFlNTQ4ZTZhYzJkYTc1MDJiZGUwMjUyL3RhYmxlcmFuZ2U6OWRkOGQyOTk4YWU1NDhlNmFjMmRhNzUwMmJkZTAyNTJfMTQtMTEtMS0xLTQ1OTE5_32c85c11-e2e3-47b5-8469-f9b682efdaed">0.47</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div></ix:nonNumeric><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:25.800%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.605%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The shares used in the calculation of diluted EPS exclude stock options and stock appreciation rights to purchase shares where the exercise price was greater than the average market price of common shares for the period and the effect of the inclusion would be anti-dilutive.  Such shares aggregated approximately <ix:nonFraction unitRef="shares" contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331" decimals="-5" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV81NS9mcmFnOjJmNDEzOTUxNDIwZjQxNmRiOTZjMjE1Y2VlNGVkMTQ3L3RleHRyZWdpb246MmY0MTM5NTE0MjBmNDE2ZGI5NmMyMTVjZWU0ZWQxNDdfOTkx_e05a498f-08d8-46b0-a991-6df14b576501">2.2</ix:nonFraction> million and <ix:nonFraction unitRef="shares" contextRef="i9500a5ee8dbe4d23aa9c46ebdd25a0c8_D20220101-20220331" decimals="-5" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV81NS9mcmFnOjJmNDEzOTUxNDIwZjQxNmRiOTZjMjE1Y2VlNGVkMTQ3L3RleHRyZWdpb246MmY0MTM5NTE0MjBmNDE2ZGI5NmMyMTVjZWU0ZWQxNDdfNTQ5NzU1ODE5NzE0_c971bdd8-393d-4901-af73-01b20e3e13f5">0.9</ix:nonFraction> million for the three months ended March&#160;31, 2023 and 2022, respectively.</span></div></ix:continuation><div id="i952e7af9c0b94e65995973e7f212f399_58"></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Note 10 &#8211; <ix:nonNumeric contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331" name="us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV81OC9mcmFnOjg3YjJhN2NmMDU0ZDQxYzJiOWFhNjQzZDdjZjUyNWI0L3RleHRyZWdpb246ODdiMmE3Y2YwNTRkNDFjMmI5YWE2NDNkN2NmNTI1YjRfMTg5Ng_bbf558df-f4bc-48ac-a340-40397438e04f" continuedAt="ieed5e9b4ff074531bed89d9c5950ca6a" escape="true">Goodwill and Other Intangible Assets</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="ieed5e9b4ff074531bed89d9c5950ca6a" continuedAt="i5eba10842ea544d38cb9e48db8057ca9"><ix:nonNumeric contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331" name="us-gaap:ScheduleOfGoodwillTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV81OC9mcmFnOjg3YjJhN2NmMDU0ZDQxYzJiOWFhNjQzZDdjZjUyNWI0L3RleHRyZWdpb246ODdiMmE3Y2YwNTRkNDFjMmI5YWE2NDNkN2NmNTI1YjRfMTkwMw_d9e055a9-5684-4f03-8527-fccfca521eca" escape="true"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The changes in the net carrying amount of goodwill for the three months ended March&#160;31, 2023 are as follows:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:84.426%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.374%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2022</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4f63720d8b244a68941932992cd9f4d_I20221231" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV81OC9mcmFnOjg3YjJhN2NmMDU0ZDQxYzJiOWFhNjQzZDdjZjUyNWI0L3RhYmxlOjA3ZGM5MDY5ZDhmNjQ2MjNhM2VmOWQ0YzE0YmNlZjg5L3RhYmxlcmFuZ2U6MDdkYzkwNjlkOGY2NDYyM2EzZWY5ZDRjMTRiY2VmODlfMC0xLTEtMS00NTkxOQ_0559e9d5-b5f2-4a77-9dfd-783b964fde59">815,429</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331" decimals="-3" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV81OC9mcmFnOjg3YjJhN2NmMDU0ZDQxYzJiOWFhNjQzZDdjZjUyNWI0L3RhYmxlOjA3ZGM5MDY5ZDhmNjQ2MjNhM2VmOWQ0YzE0YmNlZjg5L3RhYmxlcmFuZ2U6MDdkYzkwNjlkOGY2NDYyM2EzZWY5ZDRjMTRiY2VmODlfNC0xLTEtMS00NTkxOQ_74fa99e1-4e84-4873-a5b6-49c4cd6559ea">70</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of March 31, 2023</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i738c2d1dacaf436faf03cc46ab9cef23_I20230331" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV81OC9mcmFnOjg3YjJhN2NmMDU0ZDQxYzJiOWFhNjQzZDdjZjUyNWI0L3RhYmxlOjA3ZGM5MDY5ZDhmNjQ2MjNhM2VmOWQ0YzE0YmNlZjg5L3RhYmxlcmFuZ2U6MDdkYzkwNjlkOGY2NDYyM2EzZWY5ZDRjMTRiY2VmODlfNi0xLTEtMS00NTkxOQ_a51f175d-95d2-4b00-ad88-9da07af230af">815,499</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Assets and liabilities of acquired businesses are recorded at their estimated fair values as of the date of acquisition.&#160;&#160;Goodwill represents costs in excess of fair values assigned to the underlying net assets of acquired businesses.&#160;</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline" href="#i952e7af9c0b94e65995973e7f212f399_7">Table of Contents</a></span></div></div><ix:continuation id="i5eba10842ea544d38cb9e48db8057ca9"><ix:nonNumeric contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331" name="us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV81OC9mcmFnOjg3YjJhN2NmMDU0ZDQxYzJiOWFhNjQzZDdjZjUyNWI0L3RleHRyZWdpb246ODdiMmE3Y2YwNTRkNDFjMmI5YWE2NDNkN2NmNTI1YjRfMTg5NA_ed2d16eb-d3c3-4591-8e64-e4ad432add90" escape="true"><ix:nonNumeric contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331" name="us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV81OC9mcmFnOjg3YjJhN2NmMDU0ZDQxYzJiOWFhNjQzZDdjZjUyNWI0L3RleHRyZWdpb246ODdiMmE3Y2YwNTRkNDFjMmI5YWE2NDNkN2NmNTI1YjRfMTkyMA_a3a3db32-7973-448f-a7c3-73e510b009f1" escape="true"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other intangible assets consist of the following:</span></div><div style="text-align:justify;text-indent:15.75pt"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:36.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.204%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.326%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.333%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average Amortization Period (Years)</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross<br/>Carrying<br/>Amount</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross<br/>Carrying<br/>Amount</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Intangible assets with definite lives:</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="iedfdc8f66b2f411eba07af9d70f8fc00_D20230101-20230331" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV81OC9mcmFnOjg3YjJhN2NmMDU0ZDQxYzJiOWFhNjQzZDdjZjUyNWI0L3RhYmxlOmMwM2VjNmEzZTJlZDQ0NThiZDc1Yzk3MzlhYTJlMTU2L3RhYmxlcmFuZ2U6YzAzZWM2YTNlMmVkNDQ1OGJkNzVjOTczOWFhMmUxNTZfMi0xLTEtMS00NTkxOQ_54dfa4eb-c88e-48c2-8b73-fc13b6def291">22</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer and distributor relationships</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ide2cf996936344b29f9f89e17e70e4cf_D20230101-20230331" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV81OC9mcmFnOjg3YjJhN2NmMDU0ZDQxYzJiOWFhNjQzZDdjZjUyNWI0L3RhYmxlOmMwM2VjNmEzZTJlZDQ0NThiZDc1Yzk3MzlhYTJlMTU2L3RhYmxlcmFuZ2U6YzAzZWM2YTNlMmVkNDQ1OGJkNzVjOTczOWFhMmUxNTZfNC0xLTEtMS00NTkxOQ_4b6ac6bc-c28f-42b8-9587-cde42868691a">24</ix:nonNumeric></span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d83f76b6b11441d8c3ab802aea5f214_I20230331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV81OC9mcmFnOjg3YjJhN2NmMDU0ZDQxYzJiOWFhNjQzZDdjZjUyNWI0L3RhYmxlOmMwM2VjNmEzZTJlZDQ0NThiZDc1Yzk3MzlhYTJlMTU2L3RhYmxlcmFuZ2U6YzAzZWM2YTNlMmVkNDQ1OGJkNzVjOTczOWFhMmUxNTZfNC0yLTEtMS00NTkxOQ_9e62278c-2cc8-4803-9597-2f8d80867fe5">369,881</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4d83f76b6b11441d8c3ab802aea5f214_I20230331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV81OC9mcmFnOjg3YjJhN2NmMDU0ZDQxYzJiOWFhNjQzZDdjZjUyNWI0L3RhYmxlOmMwM2VjNmEzZTJlZDQ0NThiZDc1Yzk3MzlhYTJlMTU2L3RhYmxlcmFuZ2U6YzAzZWM2YTNlMmVkNDQ1OGJkNzVjOTczOWFhMmUxNTZfNC00LTEtMS00NTkxOQ_1126cca2-aeaa-4322-90c3-4b31e14f5876">175,291</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie37eab970dd24bbc96548816db1cb2e7_I20221231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV81OC9mcmFnOjg3YjJhN2NmMDU0ZDQxYzJiOWFhNjQzZDdjZjUyNWI0L3RhYmxlOmMwM2VjNmEzZTJlZDQ0NThiZDc1Yzk3MzlhYTJlMTU2L3RhYmxlcmFuZ2U6YzAzZWM2YTNlMmVkNDQ1OGJkNzVjOTczOWFhMmUxNTZfNC02LTEtMS00NTkxOQ_96b45dfa-2992-4d35-b8e6-52d1c6f0fdaf">369,854</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie37eab970dd24bbc96548816db1cb2e7_I20221231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV81OC9mcmFnOjg3YjJhN2NmMDU0ZDQxYzJiOWFhNjQzZDdjZjUyNWI0L3RhYmxlOmMwM2VjNmEzZTJlZDQ0NThiZDc1Yzk3MzlhYTJlMTU2L3RhYmxlcmFuZ2U6YzAzZWM2YTNlMmVkNDQ1OGJkNzVjOTczOWFhMmUxNTZfNC04LTEtMS00NTkxOQ_ab32845c-5945-4bc6-8872-fcd17fd3d304">170,870</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales representation, marketing and promotional rights</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i58ab77cab7774f0abbd0ec4142cdd537_D20230101-20230331" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV81OC9mcmFnOjg3YjJhN2NmMDU0ZDQxYzJiOWFhNjQzZDdjZjUyNWI0L3RhYmxlOmMwM2VjNmEzZTJlZDQ0NThiZDc1Yzk3MzlhYTJlMTU2L3RhYmxlcmFuZ2U6YzAzZWM2YTNlMmVkNDQ1OGJkNzVjOTczOWFhMmUxNTZfNi0xLTEtMS00NTkxOQ_d45b4579-bd0e-48a4-baab-3a1504145d3a">25</ix:nonNumeric></span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64c256aebff14314a4a652aca23bb503_I20230331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV81OC9mcmFnOjg3YjJhN2NmMDU0ZDQxYzJiOWFhNjQzZDdjZjUyNWI0L3RhYmxlOmMwM2VjNmEzZTJlZDQ0NThiZDc1Yzk3MzlhYTJlMTU2L3RhYmxlcmFuZ2U6YzAzZWM2YTNlMmVkNDQ1OGJkNzVjOTczOWFhMmUxNTZfNi0yLTEtMS00NTkxOQ_55b40fe3-6b43-4e32-8aa0-5de27aaf703e">149,376</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i64c256aebff14314a4a652aca23bb503_I20230331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV81OC9mcmFnOjg3YjJhN2NmMDU0ZDQxYzJiOWFhNjQzZDdjZjUyNWI0L3RhYmxlOmMwM2VjNmEzZTJlZDQ0NThiZDc1Yzk3MzlhYTJlMTU2L3RhYmxlcmFuZ2U6YzAzZWM2YTNlMmVkNDQ1OGJkNzVjOTczOWFhMmUxNTZfNi00LTEtMS00NTkxOQ_3c9a14ca-21fb-4480-afdf-b958fc3ad082">67,500</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifdfb609f174b4aff8460fb861d91811c_I20221231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV81OC9mcmFnOjg3YjJhN2NmMDU0ZDQxYzJiOWFhNjQzZDdjZjUyNWI0L3RhYmxlOmMwM2VjNmEzZTJlZDQ0NThiZDc1Yzk3MzlhYTJlMTU2L3RhYmxlcmFuZ2U6YzAzZWM2YTNlMmVkNDQ1OGJkNzVjOTczOWFhMmUxNTZfNi02LTEtMS00NTkxOQ_f23e7c62-caf4-4332-b4ec-dbd0b117d4c8">149,376</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifdfb609f174b4aff8460fb861d91811c_I20221231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV81OC9mcmFnOjg3YjJhN2NmMDU0ZDQxYzJiOWFhNjQzZDdjZjUyNWI0L3RhYmxlOmMwM2VjNmEzZTJlZDQ0NThiZDc1Yzk3MzlhYTJlMTU2L3RhYmxlcmFuZ2U6YzAzZWM2YTNlMmVkNDQ1OGJkNzVjOTczOWFhMmUxNTZfNi04LTEtMS00NTkxOQ_467a449f-f56c-4956-b77e-a4295feb4432">66,000</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed technology</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i91d9eb56eaa944dea8c761cea88d5b5c_D20230101-20230331" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV81OC9mcmFnOjg3YjJhN2NmMDU0ZDQxYzJiOWFhNjQzZDdjZjUyNWI0L3RhYmxlOmMwM2VjNmEzZTJlZDQ0NThiZDc1Yzk3MzlhYTJlMTU2L3RhYmxlcmFuZ2U6YzAzZWM2YTNlMmVkNDQ1OGJkNzVjOTczOWFhMmUxNTZfOC0xLTEtMS00NTkxOQ_0d363d07-3fe6-4120-b52d-9c39f9a67086">18</ix:nonNumeric></span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c64eb13dae8441284872536e8e2fd72_I20230331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV81OC9mcmFnOjg3YjJhN2NmMDU0ZDQxYzJiOWFhNjQzZDdjZjUyNWI0L3RhYmxlOmMwM2VjNmEzZTJlZDQ0NThiZDc1Yzk3MzlhYTJlMTU2L3RhYmxlcmFuZ2U6YzAzZWM2YTNlMmVkNDQ1OGJkNzVjOTczOWFhMmUxNTZfOC0yLTEtMS00NTkxOQ_eb9f3d8c-b804-4ee0-9ae1-90f31dc94204">320,204</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7c64eb13dae8441284872536e8e2fd72_I20230331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV81OC9mcmFnOjg3YjJhN2NmMDU0ZDQxYzJiOWFhNjQzZDdjZjUyNWI0L3RhYmxlOmMwM2VjNmEzZTJlZDQ0NThiZDc1Yzk3MzlhYTJlMTU2L3RhYmxlcmFuZ2U6YzAzZWM2YTNlMmVkNDQ1OGJkNzVjOTczOWFhMmUxNTZfOC00LTEtMS00NTkxOQ_8cd52bdf-1bfe-48cf-a286-667e761374a8">37,146</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i133dcfdb14dd4cd893d74ce7e88ebdac_I20221231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV81OC9mcmFnOjg3YjJhN2NmMDU0ZDQxYzJiOWFhNjQzZDdjZjUyNWI0L3RhYmxlOmMwM2VjNmEzZTJlZDQ0NThiZDc1Yzk3MzlhYTJlMTU2L3RhYmxlcmFuZ2U6YzAzZWM2YTNlMmVkNDQ1OGJkNzVjOTczOWFhMmUxNTZfOC02LTEtMS00NTkxOQ_968a277f-2050-44bb-86fb-de0a6c673b06">320,204</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i133dcfdb14dd4cd893d74ce7e88ebdac_I20221231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV81OC9mcmFnOjg3YjJhN2NmMDU0ZDQxYzJiOWFhNjQzZDdjZjUyNWI0L3RhYmxlOmMwM2VjNmEzZTJlZDQ0NThiZDc1Yzk3MzlhYTJlMTU2L3RhYmxlcmFuZ2U6YzAzZWM2YTNlMmVkNDQ1OGJkNzVjOTczOWFhMmUxNTZfOC04LTEtMS00NTkxOQ_68692b36-a2c7-439f-b278-a5b6faf400e5">34,675</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patents and other intangible assets</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ifeb04f4ad743475cb77f3692c078bd59_D20230101-20230331" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV81OC9mcmFnOjg3YjJhN2NmMDU0ZDQxYzJiOWFhNjQzZDdjZjUyNWI0L3RhYmxlOmMwM2VjNmEzZTJlZDQ0NThiZDc1Yzk3MzlhYTJlMTU2L3RhYmxlcmFuZ2U6YzAzZWM2YTNlMmVkNDQ1OGJkNzVjOTczOWFhMmUxNTZfMTAtMS0xLTEtNDU5MTk_d0387eaf-5085-4eaf-8503-0edcc30e1b03">16</ix:nonNumeric></span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e96e744b1b74f8aa08027bb20d925e8_I20230331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV81OC9mcmFnOjg3YjJhN2NmMDU0ZDQxYzJiOWFhNjQzZDdjZjUyNWI0L3RhYmxlOmMwM2VjNmEzZTJlZDQ0NThiZDc1Yzk3MzlhYTJlMTU2L3RhYmxlcmFuZ2U6YzAzZWM2YTNlMmVkNDQ1OGJkNzVjOTczOWFhMmUxNTZfMTAtMi0xLTEtNDU5MTk_06848c85-294c-4e9b-b8ef-e7e0fd7a5b7f">80,335</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1e96e744b1b74f8aa08027bb20d925e8_I20230331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV81OC9mcmFnOjg3YjJhN2NmMDU0ZDQxYzJiOWFhNjQzZDdjZjUyNWI0L3RhYmxlOmMwM2VjNmEzZTJlZDQ0NThiZDc1Yzk3MzlhYTJlMTU2L3RhYmxlcmFuZ2U6YzAzZWM2YTNlMmVkNDQ1OGJkNzVjOTczOWFhMmUxNTZfMTAtNC0xLTEtNDU5MTk_800dabb6-b455-4ca4-8682-46ba2fc0401d">52,865</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28feeea45b68471f9fa287ac91c55448_I20221231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV81OC9mcmFnOjg3YjJhN2NmMDU0ZDQxYzJiOWFhNjQzZDdjZjUyNWI0L3RhYmxlOmMwM2VjNmEzZTJlZDQ0NThiZDc1Yzk3MzlhYTJlMTU2L3RhYmxlcmFuZ2U6YzAzZWM2YTNlMmVkNDQ1OGJkNzVjOTczOWFhMmUxNTZfMTAtNi0xLTEtNDU5MTk_3431941c-de7a-4d2a-b12b-5a6aea439c0c">79,838</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i28feeea45b68471f9fa287ac91c55448_I20221231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV81OC9mcmFnOjg3YjJhN2NmMDU0ZDQxYzJiOWFhNjQzZDdjZjUyNWI0L3RhYmxlOmMwM2VjNmEzZTJlZDQ0NThiZDc1Yzk3MzlhYTJlMTU2L3RhYmxlcmFuZ2U6YzAzZWM2YTNlMmVkNDQ1OGJkNzVjOTczOWFhMmUxNTZfMTAtOC0xLTEtNDU5MTk_b1ffa39e-8eb4-456c-b2a6-cb606c4b9894">52,472</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Intangible assets with indefinite lives:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks and tradenames</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id242550a03e34bc39903baf6836b46df_I20230331" decimals="-3" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV81OC9mcmFnOjg3YjJhN2NmMDU0ZDQxYzJiOWFhNjQzZDdjZjUyNWI0L3RhYmxlOmMwM2VjNmEzZTJlZDQ0NThiZDc1Yzk3MzlhYTJlMTU2L3RhYmxlcmFuZ2U6YzAzZWM2YTNlMmVkNDQ1OGJkNzVjOTczOWFhMmUxNTZfMTQtMi0xLTEtNDU5MTk_e240b9e7-89a6-4329-9c50-0e7f22588278">86,544</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b68c90bafb04105bba9266879cc57f9_I20221231" decimals="-3" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV81OC9mcmFnOjg3YjJhN2NmMDU0ZDQxYzJiOWFhNjQzZDdjZjUyNWI0L3RhYmxlOmMwM2VjNmEzZTJlZDQ0NThiZDc1Yzk3MzlhYTJlMTU2L3RhYmxlcmFuZ2U6YzAzZWM2YTNlMmVkNDQ1OGJkNzVjOTczOWFhMmUxNTZfMTQtNi0xLTEtNDU5MTk_59ec6652-2aef-4100-a6c6-5330cc3072c5">86,544</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i738c2d1dacaf436faf03cc46ab9cef23_I20230331" decimals="-3" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV81OC9mcmFnOjg3YjJhN2NmMDU0ZDQxYzJiOWFhNjQzZDdjZjUyNWI0L3RhYmxlOmMwM2VjNmEzZTJlZDQ0NThiZDc1Yzk3MzlhYTJlMTU2L3RhYmxlcmFuZ2U6YzAzZWM2YTNlMmVkNDQ1OGJkNzVjOTczOWFhMmUxNTZfMTYtMi0xLTEtNDU5MTk_271fe6bc-d682-4e3e-b63a-bb9ad1353067">1,006,340</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i738c2d1dacaf436faf03cc46ab9cef23_I20230331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV81OC9mcmFnOjg3YjJhN2NmMDU0ZDQxYzJiOWFhNjQzZDdjZjUyNWI0L3RhYmxlOmMwM2VjNmEzZTJlZDQ0NThiZDc1Yzk3MzlhYTJlMTU2L3RhYmxlcmFuZ2U6YzAzZWM2YTNlMmVkNDQ1OGJkNzVjOTczOWFhMmUxNTZfMTYtNC0xLTEtNDU5MTk_58ebd87c-701c-4a47-a1c2-10fbea24d303">332,802</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4f63720d8b244a68941932992cd9f4d_I20221231" decimals="-3" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV81OC9mcmFnOjg3YjJhN2NmMDU0ZDQxYzJiOWFhNjQzZDdjZjUyNWI0L3RhYmxlOmMwM2VjNmEzZTJlZDQ0NThiZDc1Yzk3MzlhYTJlMTU2L3RhYmxlcmFuZ2U6YzAzZWM2YTNlMmVkNDQ1OGJkNzVjOTczOWFhMmUxNTZfMTYtNi0xLTEtNDU5MTk_1c58b755-473d-4191-bbdb-990a5ba69641">1,005,816</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie4f63720d8b244a68941932992cd9f4d_I20221231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV81OC9mcmFnOjg3YjJhN2NmMDU0ZDQxYzJiOWFhNjQzZDdjZjUyNWI0L3RhYmxlOmMwM2VjNmEzZTJlZDQ0NThiZDc1Yzk3MzlhYTJlMTU2L3RhYmxlcmFuZ2U6YzAzZWM2YTNlMmVkNDQ1OGJkNzVjOTczOWFhMmUxNTZfMTYtOC0xLTEtNDU5MTk_6c061d3d-6c6c-48e7-927b-f2f110adf80b">324,017</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Customer and distributor relationships, trademarks and tradenames, developed technology and patents and other intangible assets primarily represent allocations of purchase price to identifiable intangible assets of acquired businesses.  Sales representation, marketing and promotional rights represent intangible assets created under our agreement with Musculoskeletal Transplant Foundation (&#8220;MTF&#8221;).</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization expense related to intangible assets which are subject to amortization totaled $<ix:nonFraction unitRef="usd" contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV81OC9mcmFnOjg3YjJhN2NmMDU0ZDQxYzJiOWFhNjQzZDdjZjUyNWI0L3RleHRyZWdpb246ODdiMmE3Y2YwNTRkNDFjMmI5YWE2NDNkN2NmNTI1YjRfMTM5MQ_5eb31089-0211-48d6-be87-0cdd3bfbc04b">8.8</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i9500a5ee8dbe4d23aa9c46ebdd25a0c8_D20220101-20220331" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV81OC9mcmFnOjg3YjJhN2NmMDU0ZDQxYzJiOWFhNjQzZDdjZjUyNWI0L3RleHRyZWdpb246ODdiMmE3Y2YwNTRkNDFjMmI5YWE2NDNkN2NmNTI1YjRfMTM5OA_becab892-4b42-4e65-a19e-d50a9f11c627">8.0</ix:nonFraction> million for the three months ended March 31, 2023 and 2022, respectively, and is included as a reduction of revenue (for amortization related to our sales representation, marketing and promotional rights) and in selling and administrative expense (for all other intangible assets) in the consolidated condensed statements of comprehensive income.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><ix:nonNumeric contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331" name="us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV81OC9mcmFnOjg3YjJhN2NmMDU0ZDQxYzJiOWFhNjQzZDdjZjUyNWI0L3RleHRyZWdpb246ODdiMmE3Y2YwNTRkNDFjMmI5YWE2NDNkN2NmNTI1YjRfMTg4OQ_f6d39902-b204-4ae7-9c06-54b0a79b99c0" escape="true"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated intangible asset amortization expense remaining for the year ending December&#160;31, 2023 and for each of the five succeeding years is as follows:</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:1pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:57.025%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.223%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.824%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.930%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.824%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.374%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amortization included in expense</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amortization recorded as a reduction of revenue</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remaining, 2023</span></div></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1252040e498e429c840f44af12d910cb_I20230331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV81OC9mcmFnOjg3YjJhN2NmMDU0ZDQxYzJiOWFhNjQzZDdjZjUyNWI0L3RhYmxlOjk3Yzk5YWY2MjNjYzRmNWRiOTcyODNkNTA5MGVhMzc3L3RhYmxlcmFuZ2U6OTdjOTlhZjYyM2NjNGY1ZGI5NzI4M2Q1MDkwZWEzNzdfMS0xLTEtMS00NTkxOQ_d4236831-8222-470f-aace-64860a207996">21,947</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie545f13df7334e93a19c1ff77d2eb84e_I20230331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV81OC9mcmFnOjg3YjJhN2NmMDU0ZDQxYzJiOWFhNjQzZDdjZjUyNWI0L3RhYmxlOjk3Yzk5YWY2MjNjYzRmNWRiOTcyODNkNTA5MGVhMzc3L3RhYmxlcmFuZ2U6OTdjOTlhZjYyM2NjNGY1ZGI5NzI4M2Q1MDkwZWEzNzdfMS0zLTEtMS00NTkxOQ_533a5121-7235-4216-a3f0-a7275dfc579e">4,500</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i738c2d1dacaf436faf03cc46ab9cef23_I20230331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV81OC9mcmFnOjg3YjJhN2NmMDU0ZDQxYzJiOWFhNjQzZDdjZjUyNWI0L3RhYmxlOjk3Yzk5YWY2MjNjYzRmNWRiOTcyODNkNTA5MGVhMzc3L3RhYmxlcmFuZ2U6OTdjOTlhZjYyM2NjNGY1ZGI5NzI4M2Q1MDkwZWEzNzdfMS01LTEtMS00NTkxOQ_f2fbc64c-e509-42b0-9e03-e13063f97674">26,447</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1252040e498e429c840f44af12d910cb_I20230331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV81OC9mcmFnOjg3YjJhN2NmMDU0ZDQxYzJiOWFhNjQzZDdjZjUyNWI0L3RhYmxlOjk3Yzk5YWY2MjNjYzRmNWRiOTcyODNkNTA5MGVhMzc3L3RhYmxlcmFuZ2U6OTdjOTlhZjYyM2NjNGY1ZGI5NzI4M2Q1MDkwZWEzNzdfMi0xLTEtMS00NTkxOQ_7de82285-0287-42ec-8101-fbe338442c6e">28,773</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie545f13df7334e93a19c1ff77d2eb84e_I20230331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV81OC9mcmFnOjg3YjJhN2NmMDU0ZDQxYzJiOWFhNjQzZDdjZjUyNWI0L3RhYmxlOjk3Yzk5YWY2MjNjYzRmNWRiOTcyODNkNTA5MGVhMzc3L3RhYmxlcmFuZ2U6OTdjOTlhZjYyM2NjNGY1ZGI5NzI4M2Q1MDkwZWEzNzdfMi0zLTEtMS00NTkxOQ_9f5a05f2-df85-4297-aa13-d48b91eb82d0">6,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i738c2d1dacaf436faf03cc46ab9cef23_I20230331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV81OC9mcmFnOjg3YjJhN2NmMDU0ZDQxYzJiOWFhNjQzZDdjZjUyNWI0L3RhYmxlOjk3Yzk5YWY2MjNjYzRmNWRiOTcyODNkNTA5MGVhMzc3L3RhYmxlcmFuZ2U6OTdjOTlhZjYyM2NjNGY1ZGI5NzI4M2Q1MDkwZWEzNzdfMi01LTEtMS00NTkxOQ_baacee79-b928-4b5b-8838-ddec76ee090c">34,773</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1252040e498e429c840f44af12d910cb_I20230331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV81OC9mcmFnOjg3YjJhN2NmMDU0ZDQxYzJiOWFhNjQzZDdjZjUyNWI0L3RhYmxlOjk3Yzk5YWY2MjNjYzRmNWRiOTcyODNkNTA5MGVhMzc3L3RhYmxlcmFuZ2U6OTdjOTlhZjYyM2NjNGY1ZGI5NzI4M2Q1MDkwZWEzNzdfMy0xLTEtMS00NTkxOQ_34ced6c0-ddb2-44ed-9262-9ca3e0aa321b">29,563</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie545f13df7334e93a19c1ff77d2eb84e_I20230331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV81OC9mcmFnOjg3YjJhN2NmMDU0ZDQxYzJiOWFhNjQzZDdjZjUyNWI0L3RhYmxlOjk3Yzk5YWY2MjNjYzRmNWRiOTcyODNkNTA5MGVhMzc3L3RhYmxlcmFuZ2U6OTdjOTlhZjYyM2NjNGY1ZGI5NzI4M2Q1MDkwZWEzNzdfMy0zLTEtMS00NTkxOQ_dd81663b-bcbd-48b2-ab61-78f426855e1d">6,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i738c2d1dacaf436faf03cc46ab9cef23_I20230331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV81OC9mcmFnOjg3YjJhN2NmMDU0ZDQxYzJiOWFhNjQzZDdjZjUyNWI0L3RhYmxlOjk3Yzk5YWY2MjNjYzRmNWRiOTcyODNkNTA5MGVhMzc3L3RhYmxlcmFuZ2U6OTdjOTlhZjYyM2NjNGY1ZGI5NzI4M2Q1MDkwZWEzNzdfMy01LTEtMS00NTkxOQ_9cee5f14-69fe-4b3c-9c36-3d14e379d630">35,563</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1252040e498e429c840f44af12d910cb_I20230331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV81OC9mcmFnOjg3YjJhN2NmMDU0ZDQxYzJiOWFhNjQzZDdjZjUyNWI0L3RhYmxlOjk3Yzk5YWY2MjNjYzRmNWRiOTcyODNkNTA5MGVhMzc3L3RhYmxlcmFuZ2U6OTdjOTlhZjYyM2NjNGY1ZGI5NzI4M2Q1MDkwZWEzNzdfNC0xLTEtMS00NTkxOQ_4870b6d8-b60a-41a6-b562-51c5b8a51e87">29,316</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie545f13df7334e93a19c1ff77d2eb84e_I20230331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV81OC9mcmFnOjg3YjJhN2NmMDU0ZDQxYzJiOWFhNjQzZDdjZjUyNWI0L3RhYmxlOjk3Yzk5YWY2MjNjYzRmNWRiOTcyODNkNTA5MGVhMzc3L3RhYmxlcmFuZ2U6OTdjOTlhZjYyM2NjNGY1ZGI5NzI4M2Q1MDkwZWEzNzdfNC0zLTEtMS00NTkxOQ_bc68144f-987e-4898-8454-6d05bf7e15cd">6,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i738c2d1dacaf436faf03cc46ab9cef23_I20230331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV81OC9mcmFnOjg3YjJhN2NmMDU0ZDQxYzJiOWFhNjQzZDdjZjUyNWI0L3RhYmxlOjk3Yzk5YWY2MjNjYzRmNWRiOTcyODNkNTA5MGVhMzc3L3RhYmxlcmFuZ2U6OTdjOTlhZjYyM2NjNGY1ZGI5NzI4M2Q1MDkwZWEzNzdfNC01LTEtMS00NTkxOQ_1c075d9d-aefb-493d-b486-22638686920f">35,316</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1252040e498e429c840f44af12d910cb_I20230331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV81OC9mcmFnOjg3YjJhN2NmMDU0ZDQxYzJiOWFhNjQzZDdjZjUyNWI0L3RhYmxlOjk3Yzk5YWY2MjNjYzRmNWRiOTcyODNkNTA5MGVhMzc3L3RhYmxlcmFuZ2U6OTdjOTlhZjYyM2NjNGY1ZGI5NzI4M2Q1MDkwZWEzNzdfNS0xLTEtMS00NTkxOQ_1ecc9d94-4339-44a4-b9af-f32614f9db48">30,367</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie545f13df7334e93a19c1ff77d2eb84e_I20230331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV81OC9mcmFnOjg3YjJhN2NmMDU0ZDQxYzJiOWFhNjQzZDdjZjUyNWI0L3RhYmxlOjk3Yzk5YWY2MjNjYzRmNWRiOTcyODNkNTA5MGVhMzc3L3RhYmxlcmFuZ2U6OTdjOTlhZjYyM2NjNGY1ZGI5NzI4M2Q1MDkwZWEzNzdfNS0zLTEtMS00NTkxOQ_153bc3bf-753d-451f-a0bb-c1937d2d677b">6,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i738c2d1dacaf436faf03cc46ab9cef23_I20230331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV81OC9mcmFnOjg3YjJhN2NmMDU0ZDQxYzJiOWFhNjQzZDdjZjUyNWI0L3RhYmxlOjk3Yzk5YWY2MjNjYzRmNWRiOTcyODNkNTA5MGVhMzc3L3RhYmxlcmFuZ2U6OTdjOTlhZjYyM2NjNGY1ZGI5NzI4M2Q1MDkwZWEzNzdfNS01LTEtMS00NTkxOQ_97168057-59ed-4309-b208-4e6568579fc4">36,367</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1252040e498e429c840f44af12d910cb_I20230331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV81OC9mcmFnOjg3YjJhN2NmMDU0ZDQxYzJiOWFhNjQzZDdjZjUyNWI0L3RhYmxlOjk3Yzk5YWY2MjNjYzRmNWRiOTcyODNkNTA5MGVhMzc3L3RhYmxlcmFuZ2U6OTdjOTlhZjYyM2NjNGY1ZGI5NzI4M2Q1MDkwZWEzNzdfNi0xLTEtMS00NTkxOQ_acefe8d8-b2be-4d84-bdb4-9794425c3c51">33,507</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie545f13df7334e93a19c1ff77d2eb84e_I20230331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV81OC9mcmFnOjg3YjJhN2NmMDU0ZDQxYzJiOWFhNjQzZDdjZjUyNWI0L3RhYmxlOjk3Yzk5YWY2MjNjYzRmNWRiOTcyODNkNTA5MGVhMzc3L3RhYmxlcmFuZ2U6OTdjOTlhZjYyM2NjNGY1ZGI5NzI4M2Q1MDkwZWEzNzdfNi0zLTEtMS00NTkxOQ_d4252212-b47a-4dca-9078-38ffc0421cca">6,000</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i738c2d1dacaf436faf03cc46ab9cef23_I20230331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV81OC9mcmFnOjg3YjJhN2NmMDU0ZDQxYzJiOWFhNjQzZDdjZjUyNWI0L3RhYmxlOjk3Yzk5YWY2MjNjYzRmNWRiOTcyODNkNTA5MGVhMzc3L3RhYmxlcmFuZ2U6OTdjOTlhZjYyM2NjNGY1ZGI5NzI4M2Q1MDkwZWEzNzdfNi01LTEtMS00NTkxOQ_e3efc621-dc36-4c25-88c6-0480b87e5919">39,507</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</span></div></div></div><div id="i952e7af9c0b94e65995973e7f212f399_61"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline" href="#i952e7af9c0b94e65995973e7f212f399_7">Table of Contents</a></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Note 11 - <ix:nonNumeric contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331" name="us-gaap:LongTermDebtTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82MS9mcmFnOmE4ZDk2NGIzNGMzYjQ1MjdhNzA4Y2JhMDY1M2Y1YTBmL3RleHRyZWdpb246YThkOTY0YjM0YzNiNDUyN2E3MDhjYmEwNjUzZjVhMGZfMTA2MTY_86cf2054-16a6-4202-93ce-d57db650bb95" continuedAt="ieeac8f35578f4acf9459a556e0f539e7" escape="true">Long-Term Debt</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="ieeac8f35578f4acf9459a556e0f539e7" continuedAt="i75d2858fca584c5b8d63819226778ad9"><ix:nonNumeric contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331" name="us-gaap:ScheduleOfDebtInstrumentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82MS9mcmFnOmE4ZDk2NGIzNGMzYjQ1MjdhNzA4Y2JhMDY1M2Y1YTBmL3RleHRyZWdpb246YThkOTY0YjM0YzNiNDUyN2E3MDhjYmEwNjUzZjVhMGZfMTA2MDU_f39edc3c-e62a-40df-bea2-6e58548809fa" escape="true"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-term debt consists of the following:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"></td><td style="width:72.793%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.289%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.881%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revolving line of credit</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c9501d6daae4d25a09881fd7407a2f6_I20230331" decimals="-5" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82MS9mcmFnOmE4ZDk2NGIzNGMzYjQ1MjdhNzA4Y2JhMDY1M2Y1YTBmL3RhYmxlOmMzNzY3MWMxZjRkMDQ2YjFiYjQyZjM5MjY1ODBiZjZhL3RhYmxlcmFuZ2U6YzM3NjcxYzFmNGQwNDZiMWJiNDJmMzkyNjU4MGJmNmFfMS0xLTEtMS00NTkxOQ_c197a52a-b5d8-4ac4-a76f-689080e3514d">79,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee16a97278a34fe6b541169cf414845b_I20221231" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82MS9mcmFnOmE4ZDk2NGIzNGMzYjQ1MjdhNzA4Y2JhMDY1M2Y1YTBmL3RhYmxlOmMzNzY3MWMxZjRkMDQ2YjFiYjQyZjM5MjY1ODBiZjZhL3RhYmxlcmFuZ2U6YzM3NjcxYzFmNGQwNDZiMWJiNDJmMzkyNjU4MGJmNmFfMS0zLTEtMS00NTkxOQ_a0d38e8f-18ee-43c2-a436-9195ab13a093">70,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term loan, net of deferred debt issuance costs of $<ix:nonFraction unitRef="usd" contextRef="i77a44de4154e4f80aabef63885392692_I20230331" decimals="-3" name="us-gaap:UnamortizedDebtIssuanceExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82MS9mcmFnOmE4ZDk2NGIzNGMzYjQ1MjdhNzA4Y2JhMDY1M2Y1YTBmL3RhYmxlOmMzNzY3MWMxZjRkMDQ2YjFiYjQyZjM5MjY1ODBiZjZhL3RhYmxlcmFuZ2U6YzM3NjcxYzFmNGQwNDZiMWJiNDJmMzkyNjU4MGJmNmFfMi0wLTEtMS00NTkxOS90ZXh0cmVnaW9uOjIzYTJlMWM5MGNmMDRiZjRhZmE5YTkyNjlmZDgzMmI1XzU0_5469d4b9-7e1c-4580-92fb-a2654d6ebb91">678</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i76b7788d670549fab9bb3750f7a0c4ec_I20221231" decimals="-3" name="us-gaap:UnamortizedDebtIssuanceExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82MS9mcmFnOmE4ZDk2NGIzNGMzYjQ1MjdhNzA4Y2JhMDY1M2Y1YTBmL3RhYmxlOmMzNzY3MWMxZjRkMDQ2YjFiYjQyZjM5MjY1ODBiZjZhL3RhYmxlcmFuZ2U6YzM3NjcxYzFmNGQwNDZiMWJiNDJmMzkyNjU4MGJmNmFfMi0wLTEtMS00NTkxOS90ZXh0cmVnaW9uOjIzYTJlMWM5MGNmMDRiZjRhZmE5YTkyNjlmZDgzMmI1XzYx_cafe2881-ea7b-4fc9-aa49-294d9749fd92">729</ix:nonFraction> in 2023 and 2022, respectively</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i77a44de4154e4f80aabef63885392692_I20230331" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82MS9mcmFnOmE4ZDk2NGIzNGMzYjQ1MjdhNzA4Y2JhMDY1M2Y1YTBmL3RhYmxlOmMzNzY3MWMxZjRkMDQ2YjFiYjQyZjM5MjY1ODBiZjZhL3RhYmxlcmFuZ2U6YzM3NjcxYzFmNGQwNDZiMWJiNDJmMzkyNjU4MGJmNmFfMi0xLTEtMS00NTkxOQ_74808683-0c43-480c-a294-4eea4e9fd704">133,910</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76b7788d670549fab9bb3750f7a0c4ec_I20221231" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82MS9mcmFnOmE4ZDk2NGIzNGMzYjQ1MjdhNzA4Y2JhMDY1M2Y1YTBmL3RhYmxlOmMzNzY3MWMxZjRkMDQ2YjFiYjQyZjM5MjY1ODBiZjZhL3RhYmxlcmFuZ2U6YzM3NjcxYzFmNGQwNDZiMWJiNDJmMzkyNjU4MGJmNmFfMi0zLTEtMS00NTkxOQ_2e65ea47-37b9-4805-bd9d-bcbfe5cb5939">133,858</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia3deab346b25408c987cad57798b899f_I20190129" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82MS9mcmFnOmE4ZDk2NGIzNGMzYjQ1MjdhNzA4Y2JhMDY1M2Y1YTBmL3RhYmxlOmMzNzY3MWMxZjRkMDQ2YjFiYjQyZjM5MjY1ODBiZjZhL3RhYmxlcmFuZ2U6YzM3NjcxYzFmNGQwNDZiMWJiNDJmMzkyNjU4MGJmNmFfMy0wLTEtMS00NTkxOS90ZXh0cmVnaW9uOmQxYWJiMzQzOTQ1NDQxMjM4NmJmNzMwOWE2YTQzNzUzXzQ_05827e15-e81e-47fa-a025-f0f5823de8ac">2.625</ix:nonFraction>% convertible notes, net of deferred debt issuance costs of $<ix:nonFraction unitRef="usd" contextRef="ie736fe11e175439d9773dbf983dad1c9_I20230331" decimals="-3" name="us-gaap:UnamortizedDebtIssuanceExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82MS9mcmFnOmE4ZDk2NGIzNGMzYjQ1MjdhNzA4Y2JhMDY1M2Y1YTBmL3RhYmxlOmMzNzY3MWMxZjRkMDQ2YjFiYjQyZjM5MjY1ODBiZjZhL3RhYmxlcmFuZ2U6YzM3NjcxYzFmNGQwNDZiMWJiNDJmMzkyNjU4MGJmNmFfMy0wLTEtMS00NTkxOS90ZXh0cmVnaW9uOmQxYWJiMzQzOTQ1NDQxMjM4NmJmNzMwOWE2YTQzNzUzXzY1_44934d6c-0c6c-4b4b-94cc-02ad04d3d8cc">332</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="ie383611c595342b7bcfa70c8d97dc2b2_I20221231" decimals="-3" name="us-gaap:UnamortizedDebtIssuanceExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82MS9mcmFnOmE4ZDk2NGIzNGMzYjQ1MjdhNzA4Y2JhMDY1M2Y1YTBmL3RhYmxlOmMzNzY3MWMxZjRkMDQ2YjFiYjQyZjM5MjY1ODBiZjZhL3RhYmxlcmFuZ2U6YzM3NjcxYzFmNGQwNDZiMWJiNDJmMzkyNjU4MGJmNmFfMy0wLTEtMS00NTkxOS90ZXh0cmVnaW9uOmQxYWJiMzQzOTQ1NDQxMjM4NmJmNzMwOWE2YTQzNzUzXzcy_1722cb6f-8505-464b-85b0-d63833c7f401">432</ix:nonFraction> in 2023 and 2022, respectively</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie736fe11e175439d9773dbf983dad1c9_I20230331" decimals="-3" name="us-gaap:ConvertibleDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82MS9mcmFnOmE4ZDk2NGIzNGMzYjQ1MjdhNzA4Y2JhMDY1M2Y1YTBmL3RhYmxlOmMzNzY3MWMxZjRkMDQ2YjFiYjQyZjM5MjY1ODBiZjZhL3RhYmxlcmFuZ2U6YzM3NjcxYzFmNGQwNDZiMWJiNDJmMzkyNjU4MGJmNmFfMy0xLTEtMS00NTkxOQ_2e836d50-56a7-4107-bc8e-43022efafd57">69,668</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie383611c595342b7bcfa70c8d97dc2b2_I20221231" decimals="-3" name="us-gaap:ConvertibleDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82MS9mcmFnOmE4ZDk2NGIzNGMzYjQ1MjdhNzA4Y2JhMDY1M2Y1YTBmL3RhYmxlOmMzNzY3MWMxZjRkMDQ2YjFiYjQyZjM5MjY1ODBiZjZhL3RhYmxlcmFuZ2U6YzM3NjcxYzFmNGQwNDZiMWJiNDJmMzkyNjU4MGJmNmFfMy0zLTEtMS00NTkxOQ_5409ada4-057a-483e-9ad1-eef70cca83e1">69,568</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i9439f4c05d684bd2b8c31654eba4d05f_I20220606" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82MS9mcmFnOmE4ZDk2NGIzNGMzYjQ1MjdhNzA4Y2JhMDY1M2Y1YTBmL3RhYmxlOmMzNzY3MWMxZjRkMDQ2YjFiYjQyZjM5MjY1ODBiZjZhL3RhYmxlcmFuZ2U6YzM3NjcxYzFmNGQwNDZiMWJiNDJmMzkyNjU4MGJmNmFfNC0wLTEtMS00NTkxOS90ZXh0cmVnaW9uOjUxOWIxNzBmZjY0MDQxY2Y4YjRhZTMyYWY0MjA3ZmUxXzU_910e2d7d-1f9e-434c-8403-39a40cbdb228">2.250</ix:nonFraction>% convertible notes, net of deferred debt issuance costs of $<ix:nonFraction unitRef="usd" contextRef="i2d6a32f6a1f64e998b122bbbc261a999_I20230331" decimals="-3" name="us-gaap:UnamortizedDebtIssuanceExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82MS9mcmFnOmE4ZDk2NGIzNGMzYjQ1MjdhNzA4Y2JhMDY1M2Y1YTBmL3RhYmxlOmMzNzY3MWMxZjRkMDQ2YjFiYjQyZjM5MjY1ODBiZjZhL3RhYmxlcmFuZ2U6YzM3NjcxYzFmNGQwNDZiMWJiNDJmMzkyNjU4MGJmNmFfNC0wLTEtMS00NTkxOS90ZXh0cmVnaW9uOjUxOWIxNzBmZjY0MDQxY2Y4YjRhZTMyYWY0MjA3ZmUxXzY2_0835fd99-55ca-4aae-8d37-8ef4096b3922">17,771</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="ibf5d8099c676486794c460824796bb9a_I20221231" decimals="-3" name="us-gaap:UnamortizedDebtIssuanceExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82MS9mcmFnOmE4ZDk2NGIzNGMzYjQ1MjdhNzA4Y2JhMDY1M2Y1YTBmL3RhYmxlOmMzNzY3MWMxZjRkMDQ2YjFiYjQyZjM5MjY1ODBiZjZhL3RhYmxlcmFuZ2U6YzM3NjcxYzFmNGQwNDZiMWJiNDJmMzkyNjU4MGJmNmFfNC0wLTEtMS00NTkxOS90ZXh0cmVnaW9uOjUxOWIxNzBmZjY0MDQxY2Y4YjRhZTMyYWY0MjA3ZmUxXzU0OTc1NTgxMzk2Ng_f61b1081-34e2-468f-82dd-29572201d039">18,834</ix:nonFraction> in 2023 and 2022, respectively</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d6a32f6a1f64e998b122bbbc261a999_I20230331" decimals="-3" name="us-gaap:ConvertibleDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82MS9mcmFnOmE4ZDk2NGIzNGMzYjQ1MjdhNzA4Y2JhMDY1M2Y1YTBmL3RhYmxlOmMzNzY3MWMxZjRkMDQ2YjFiYjQyZjM5MjY1ODBiZjZhL3RhYmxlcmFuZ2U6YzM3NjcxYzFmNGQwNDZiMWJiNDJmMzkyNjU4MGJmNmFfNC0xLTEtMS00NTkxOQ_5173bb91-e6b0-4209-a7b6-6a0e106496cb">782,229</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf5d8099c676486794c460824796bb9a_I20221231" decimals="-3" name="us-gaap:ConvertibleDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82MS9mcmFnOmE4ZDk2NGIzNGMzYjQ1MjdhNzA4Y2JhMDY1M2Y1YTBmL3RhYmxlOmMzNzY3MWMxZjRkMDQ2YjFiYjQyZjM5MjY1ODBiZjZhL3RhYmxlcmFuZ2U6YzM3NjcxYzFmNGQwNDZiMWJiNDJmMzkyNjU4MGJmNmFfNC0zLTEtMS00NTkxOQ_b5d738c9-34fe-4e33-8818-1ec7c1d78e7a">781,166</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i738c2d1dacaf436faf03cc46ab9cef23_I20230331" decimals="-3" name="us-gaap:FinanceLeaseLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82MS9mcmFnOmE4ZDk2NGIzNGMzYjQ1MjdhNzA4Y2JhMDY1M2Y1YTBmL3RhYmxlOmMzNzY3MWMxZjRkMDQ2YjFiYjQyZjM5MjY1ODBiZjZhL3RhYmxlcmFuZ2U6YzM3NjcxYzFmNGQwNDZiMWJiNDJmMzkyNjU4MGJmNmFfNS0xLTEtMS00NTkxOQ_b59d75f3-38b8-4017-b9bc-15e11b0d3ba8">162</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4f63720d8b244a68941932992cd9f4d_I20221231" decimals="-3" name="us-gaap:FinanceLeaseLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82MS9mcmFnOmE4ZDk2NGIzNGMzYjQ1MjdhNzA4Y2JhMDY1M2Y1YTBmL3RhYmxlOmMzNzY3MWMxZjRkMDQ2YjFiYjQyZjM5MjY1ODBiZjZhL3RhYmxlcmFuZ2U6YzM3NjcxYzFmNGQwNDZiMWJiNDJmMzkyNjU4MGJmNmFfNS0zLTEtMS00NTkxOQ_945f98da-1750-4e8c-8f7e-72cf7e02f84f">230</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i738c2d1dacaf436faf03cc46ab9cef23_I20230331" decimals="-3" name="us-gaap:LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82MS9mcmFnOmE4ZDk2NGIzNGMzYjQ1MjdhNzA4Y2JhMDY1M2Y1YTBmL3RhYmxlOmMzNzY3MWMxZjRkMDQ2YjFiYjQyZjM5MjY1ODBiZjZhL3RhYmxlcmFuZ2U6YzM3NjcxYzFmNGQwNDZiMWJiNDJmMzkyNjU4MGJmNmFfNi0xLTEtMS00NTkxOQ_96fd62ff-a1f9-41a5-9d64-e41cc52f20cf">1,064,969</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4f63720d8b244a68941932992cd9f4d_I20221231" decimals="-3" name="us-gaap:LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82MS9mcmFnOmE4ZDk2NGIzNGMzYjQ1MjdhNzA4Y2JhMDY1M2Y1YTBmL3RhYmxlOmMzNzY3MWMxZjRkMDQ2YjFiYjQyZjM5MjY1ODBiZjZhL3RhYmxlcmFuZ2U6YzM3NjcxYzFmNGQwNDZiMWJiNDJmMzkyNjU4MGJmNmFfNi0zLTEtMS00NTkxOQ_f37a4357-e205-4a90-b6f1-12f5c8627828">1,054,822</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less:&#160;&#160;Current portion</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i738c2d1dacaf436faf03cc46ab9cef23_I20230331" decimals="-3" name="us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82MS9mcmFnOmE4ZDk2NGIzNGMzYjQ1MjdhNzA4Y2JhMDY1M2Y1YTBmL3RhYmxlOmMzNzY3MWMxZjRkMDQ2YjFiYjQyZjM5MjY1ODBiZjZhL3RhYmxlcmFuZ2U6YzM3NjcxYzFmNGQwNDZiMWJiNDJmMzkyNjU4MGJmNmFfNy0xLTEtMS00NTkxOQ_c8dccfe8-6c63-442d-9a42-26ded006f92e">69,693</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4f63720d8b244a68941932992cd9f4d_I20221231" decimals="-3" name="us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82MS9mcmFnOmE4ZDk2NGIzNGMzYjQ1MjdhNzA4Y2JhMDY1M2Y1YTBmL3RhYmxlOmMzNzY3MWMxZjRkMDQ2YjFiYjQyZjM5MjY1ODBiZjZhL3RhYmxlcmFuZ2U6YzM3NjcxYzFmNGQwNDZiMWJiNDJmMzkyNjU4MGJmNmFfNy0zLTEtMS00NTkxOQ_ad2ee1a2-cb54-4629-8560-0b491bce326f">69,746</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total long-term debt</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i738c2d1dacaf436faf03cc46ab9cef23_I20230331" decimals="-3" name="us-gaap:LongTermDebtAndCapitalLeaseObligations" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82MS9mcmFnOmE4ZDk2NGIzNGMzYjQ1MjdhNzA4Y2JhMDY1M2Y1YTBmL3RhYmxlOmMzNzY3MWMxZjRkMDQ2YjFiYjQyZjM5MjY1ODBiZjZhL3RhYmxlcmFuZ2U6YzM3NjcxYzFmNGQwNDZiMWJiNDJmMzkyNjU4MGJmNmFfOC0xLTEtMS00NTkxOQ_73bf9da2-6911-415f-814f-28476aae543b">995,276</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4f63720d8b244a68941932992cd9f4d_I20221231" decimals="-3" name="us-gaap:LongTermDebtAndCapitalLeaseObligations" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82MS9mcmFnOmE4ZDk2NGIzNGMzYjQ1MjdhNzA4Y2JhMDY1M2Y1YTBmL3RhYmxlOmMzNzY3MWMxZjRkMDQ2YjFiYjQyZjM5MjY1ODBiZjZhL3RhYmxlcmFuZ2U6YzM3NjcxYzFmNGQwNDZiMWJiNDJmMzkyNjU4MGJmNmFfOC0zLTEtMS00NTkxOQ_54978132-31f1-442e-9729-106f6ff18db6">985,076</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Seventh Amended and Restated Senior Credit Agreement</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On July&#160;16, 2021, we entered into a seventh amended and restated senior credit agreement consisting of: (a) a $<ix:nonFraction unitRef="usd" contextRef="i0dc2d8a4965f4bf786ec6493bd6eea66_I20210716" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82MS9mcmFnOmE4ZDk2NGIzNGMzYjQ1MjdhNzA4Y2JhMDY1M2Y1YTBmL3RleHRyZWdpb246YThkOTY0YjM0YzNiNDUyN2E3MDhjYmEwNjUzZjVhMGZfMjMw_9f9f401f-9aac-431b-b91d-26f2640bdf1f">233.5</ix:nonFraction>&#160;million term loan facility and (b) a $<ix:nonFraction unitRef="usd" contextRef="ibbe0c9555d2a40d18fa14506df884584_I20210716" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82MS9mcmFnOmE4ZDk2NGIzNGMzYjQ1MjdhNzA4Y2JhMDY1M2Y1YTBmL3RleHRyZWdpb246YThkOTY0YjM0YzNiNDUyN2E3MDhjYmEwNjUzZjVhMGZfMjYy_2817fd6e-bdbd-4caa-b40e-4ea9b570c73e">585.0</ix:nonFraction>&#160;million revolving credit facility. The revolving credit facility will terminate and the loans outstanding under the term loan facility will expire on July&#160;16, 2026. The term loan was payable in quarterly installments increasing over the term of the facility.  During 2022, we made a $<ix:nonFraction unitRef="usd" contextRef="i33405b42e96c4b0797d76ca71cdcc742_D20220606-20220606" decimals="-5" name="us-gaap:RepaymentsOfSeniorDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82MS9mcmFnOmE4ZDk2NGIzNGMzYjQ1MjdhNzA4Y2JhMDY1M2Y1YTBmL3RleHRyZWdpb246YThkOTY0YjM0YzNiNDUyN2E3MDhjYmEwNjUzZjVhMGZfNTMz_967e6757-2cca-4790-b818-53bf5476af64">90.0</ix:nonFraction>&#160;million prepayment on the term loan facility resulting in the elimination of such quarterly payments with the remaining balance due upon the expiration of the term loan facility. Proceeds from the term loan facility and borrowings under the revolving credit facility were used to repay the then existing senior credit agreement. Interest rates are at the term secured overnight financing rate plus <ix:nonFraction unitRef="number" contextRef="i04f774d345914aff9bbced40761489cc_I20230331" decimals="INF" name="cnmd:TermSOFRInterestRateSpreadAdjustment" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82MS9mcmFnOmE4ZDk2NGIzNGMzYjQ1MjdhNzA4Y2JhMDY1M2Y1YTBmL3RleHRyZWdpb246YThkOTY0YjM0YzNiNDUyN2E3MDhjYmEwNjUzZjVhMGZfMjc0ODc3OTA4NDk1OA_66537312-7bb4-4a6d-b5ec-9d32d278e4cd">0.1148</ix:nonFraction>% ("Adjusted Term SOFR") (<ix:nonFraction unitRef="number" contextRef="i04f774d345914aff9bbced40761489cc_I20230331" decimals="INF" name="cnmd:AdjustedTermSOFRInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82MS9mcmFnOmE4ZDk2NGIzNGMzYjQ1MjdhNzA4Y2JhMDY1M2Y1YTBmL3RleHRyZWdpb246YThkOTY0YjM0YzNiNDUyN2E3MDhjYmEwNjUzZjVhMGZfMTAzMQ_a7e2f22a-3e77-460b-8f76-65af5eb074d5">4.927</ix:nonFraction>% at March&#160;31, 2023) plus an interest rate margin of <ix:nonFraction unitRef="number" contextRef="ic7e449aedd59496caf4a7c096a050bf9_D20230101-20230331" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82MS9mcmFnOmE4ZDk2NGIzNGMzYjQ1MjdhNzA4Y2JhMDY1M2Y1YTBmL3RleHRyZWdpb246YThkOTY0YjM0YzNiNDUyN2E3MDhjYmEwNjUzZjVhMGZfMTA3Mw_a1710676-cf0d-4f43-b97a-51d6ca41bf3c">1.125</ix:nonFraction>% (<ix:nonFraction unitRef="number" contextRef="i04f774d345914aff9bbced40761489cc_I20230331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82MS9mcmFnOmE4ZDk2NGIzNGMzYjQ1MjdhNzA4Y2JhMDY1M2Y1YTBmL3RleHRyZWdpb246YThkOTY0YjM0YzNiNDUyN2E3MDhjYmEwNjUzZjVhMGZfMTA3Nw_d6318c58-805f-4fad-9002-560cc145228e">6.052</ix:nonFraction>% at March&#160;31, 2023). For borrowings where we elect to use the alternate base rate, the initial base rate is the greatest of (i) the Prime Rate, (ii) the Federal Funds Rate plus <ix:nonFraction unitRef="number" contextRef="if29e0d4f562843b3816062f7f565bb17_D20230101-20230331" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82MS9mcmFnOmE4ZDk2NGIzNGMzYjQ1MjdhNzA4Y2JhMDY1M2Y1YTBmL3RleHRyZWdpb246YThkOTY0YjM0YzNiNDUyN2E3MDhjYmEwNjUzZjVhMGZfMTI0NA_d209c2cf-b0a9-4331-afa7-405570df6ed0">0.50</ix:nonFraction>% or (iii) the one-month Adjusted Term SOFR plus <ix:nonFraction unitRef="number" contextRef="i4e265365e2db4e6b9a43fef2da7662e0_D20230101-20230331" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82MS9mcmFnOmE4ZDk2NGIzNGMzYjQ1MjdhNzA4Y2JhMDY1M2Y1YTBmL3RleHRyZWdpb246YThkOTY0YjM0YzNiNDUyN2E3MDhjYmEwNjUzZjVhMGZfMTI5MA_0a87e17e-ed49-469d-972d-0b2ac37b6169">1.00</ix:nonFraction>%, plus, in each case, an interest rate margin. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were $<ix:nonFraction unitRef="usd" contextRef="ic2773d0e28ec4c6e93f203b0cb250c6b_I20230331" decimals="-5" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82MS9mcmFnOmE4ZDk2NGIzNGMzYjQ1MjdhNzA4Y2JhMDY1M2Y1YTBmL3RleHRyZWdpb246YThkOTY0YjM0YzNiNDUyN2E3MDhjYmEwNjUzZjVhMGZfMTM1Mg_d6b3a299-f8bb-4e52-b694-c2f10915192e">134.6</ix:nonFraction> million in borrowings outstanding on the term loan facility as of March&#160;31, 2023.  There were $<ix:nonFraction unitRef="usd" contextRef="i7c9501d6daae4d25a09881fd7407a2f6_I20230331" decimals="-5" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82MS9mcmFnOmE4ZDk2NGIzNGMzYjQ1MjdhNzA4Y2JhMDY1M2Y1YTBmL3RleHRyZWdpb246YThkOTY0YjM0YzNiNDUyN2E3MDhjYmEwNjUzZjVhMGZfMTQyOQ_2a7ec06e-6254-40cf-a846-ee845bb0ac7f">79.0</ix:nonFraction> million in borrowings outstanding under the revolving credit facility as of March&#160;31, 2023.  Our available borrowings on the revolving credit facility at March&#160;31, 2023 were $<ix:nonFraction unitRef="usd" contextRef="i8e5340b37c9c4826a451adea29a1d1d0_I20230331" decimals="-5" name="us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82MS9mcmFnOmE4ZDk2NGIzNGMzYjQ1MjdhNzA4Y2JhMDY1M2Y1YTBmL3RleHRyZWdpb246YThkOTY0YjM0YzNiNDUyN2E3MDhjYmEwNjUzZjVhMGZfMTU3NA_cae5842d-3ff9-467f-810a-307942eeec08">504.2</ix:nonFraction> million with approximately $<ix:nonFraction unitRef="usd" contextRef="i8e5340b37c9c4826a451adea29a1d1d0_I20230331" decimals="-5" name="us-gaap:LettersOfCreditOutstandingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82MS9mcmFnOmE4ZDk2NGIzNGMzYjQ1MjdhNzA4Y2JhMDY1M2Y1YTBmL3RleHRyZWdpb246YThkOTY0YjM0YzNiNDUyN2E3MDhjYmEwNjUzZjVhMGZfMTU5Ng_00b7f4d0-b8ec-40b1-98f8-690288684b59">1.8</ix:nonFraction> million of the facility set aside for outstanding letters of credit. The carrying amounts of the term loan and revolving credit facility approximate fair value.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The seventh amended and restated senior credit agreement is collateralized by substantially all of our personal property and assets.  The seventh amended and restated senior credit agreement contains covenants and restrictions which, among other things, require the maintenance of certain financial ratios and restrict dividend payments and the incurrence of certain indebtedness and other activities, including acquisitions and dispositions.  We were in full compliance with these covenants and restrictions as of March&#160;31, 2023.  We are also required, under certain circumstances, to make mandatory prepayments from net cash proceeds from any issuance of equity and asset sales.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">2.625% Convertible Notes</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 29, 2019, we issued $<ix:nonFraction unitRef="usd" contextRef="ia3deab346b25408c987cad57798b899f_I20190129" decimals="-5" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82MS9mcmFnOmE4ZDk2NGIzNGMzYjQ1MjdhNzA4Y2JhMDY1M2Y1YTBmL3RleHRyZWdpb246YThkOTY0YjM0YzNiNDUyN2E3MDhjYmEwNjUzZjVhMGZfMjM4OQ_be705b25-d54d-4ead-8b88-8e44dac145f8">345.0</ix:nonFraction> million aggregate principal amount of <ix:nonFraction unitRef="number" contextRef="ia3deab346b25408c987cad57798b899f_I20190129" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82MS9mcmFnOmE4ZDk2NGIzNGMzYjQ1MjdhNzA4Y2JhMDY1M2Y1YTBmL3RleHRyZWdpb246YThkOTY0YjM0YzNiNDUyN2E3MDhjYmEwNjUzZjVhMGZfMjM5NQ_05827e15-e81e-47fa-a025-f0f5823de8ac">2.625</ix:nonFraction>% convertible notes due in 2024 (the "<ix:nonFraction unitRef="number" contextRef="ia3deab346b25408c987cad57798b899f_I20190129" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82MS9mcmFnOmE4ZDk2NGIzNGMzYjQ1MjdhNzA4Y2JhMDY1M2Y1YTBmL3RleHRyZWdpb246YThkOTY0YjM0YzNiNDUyN2E3MDhjYmEwNjUzZjVhMGZfMjQzNA_e389c1cd-14b2-46f3-9148-12e498c8c680">2.625</ix:nonFraction>% Notes").  Interest is payable semi-annually in arrears on February 1 and August 1 of each year, commencing August 1, 2019.  The <ix:nonFraction unitRef="number" contextRef="ia3deab346b25408c987cad57798b899f_I20190129" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82MS9mcmFnOmE4ZDk2NGIzNGMzYjQ1MjdhNzA4Y2JhMDY1M2Y1YTBmL3RleHRyZWdpb246YThkOTY0YjM0YzNiNDUyN2E3MDhjYmEwNjUzZjVhMGZfMjU2NQ_e389c1cd-14b2-46f3-9148-12e498c8c680">2.625</ix:nonFraction>% Notes will mature on February 1, 2024, unless earlier repurchased or converted.  The <ix:nonFraction unitRef="number" contextRef="ia3deab346b25408c987cad57798b899f_I20190129" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82MS9mcmFnOmE4ZDk2NGIzNGMzYjQ1MjdhNzA4Y2JhMDY1M2Y1YTBmL3RleHRyZWdpb246YThkOTY0YjM0YzNiNDUyN2E3MDhjYmEwNjUzZjVhMGZfMjY1Mw_e389c1cd-14b2-46f3-9148-12e498c8c680">2.625</ix:nonFraction>% Notes represent subordinated unsecured obligations and are convertible under certain circumstances, as defined in the indenture, into a combination of cash and CONMED common stock.&#160;&#160;The <ix:nonFraction unitRef="number" contextRef="ia3deab346b25408c987cad57798b899f_I20190129" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82MS9mcmFnOmE4ZDk2NGIzNGMzYjQ1MjdhNzA4Y2JhMDY1M2Y1YTBmL3RleHRyZWdpb246YThkOTY0YjM0YzNiNDUyN2E3MDhjYmEwNjUzZjVhMGZfMjg0Mg_e389c1cd-14b2-46f3-9148-12e498c8c680">2.625</ix:nonFraction>% Notes may be converted at an initial conversion rate of <ix:nonFraction unitRef="number" contextRef="ic751565b186d4ab8b25554beae97197d_D20190129-20190129" decimals="4" name="us-gaap:DebtInstrumentConvertibleConversionRatio1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82MS9mcmFnOmE4ZDk2NGIzNGMzYjQ1MjdhNzA4Y2JhMDY1M2Y1YTBmL3RleHRyZWdpb246YThkOTY0YjM0YzNiNDUyN2E3MDhjYmEwNjUzZjVhMGZfMjkwMQ_e08c0e7c-be03-4fae-a9ce-efe08457012d">11.2608</ix:nonFraction> shares of our common stock per $1,000 principal amount of <ix:nonFraction unitRef="number" contextRef="ia3deab346b25408c987cad57798b899f_I20190129" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82MS9mcmFnOmE4ZDk2NGIzNGMzYjQ1MjdhNzA4Y2JhMDY1M2Y1YTBmL3RleHRyZWdpb246YThkOTY0YjM0YzNiNDUyN2E3MDhjYmEwNjUzZjVhMGZfMjk1OA_e389c1cd-14b2-46f3-9148-12e498c8c680">2.625</ix:nonFraction>% Notes (equivalent to an initial conversion price of approximately $<ix:nonFraction unitRef="usdPerShare" contextRef="ia3deab346b25408c987cad57798b899f_I20190129" decimals="2" name="us-gaap:DebtInstrumentConvertibleConversionPrice1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82MS9mcmFnOmE4ZDk2NGIzNGMzYjQ1MjdhNzA4Y2JhMDY1M2Y1YTBmL3RleHRyZWdpb246YThkOTY0YjM0YzNiNDUyN2E3MDhjYmEwNjUzZjVhMGZfMzAyNw_eefcdc27-afff-49fe-838f-57b041d0ecb9">88.80</ix:nonFraction> per share of common stock).  Holders of the <ix:nonFraction unitRef="number" contextRef="ia3deab346b25408c987cad57798b899f_I20190129" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82MS9mcmFnOmE4ZDk2NGIzNGMzYjQ1MjdhNzA4Y2JhMDY1M2Y1YTBmL3RleHRyZWdpb246YThkOTY0YjM0YzNiNDUyN2E3MDhjYmEwNjUzZjVhMGZfMzA3NA_e389c1cd-14b2-46f3-9148-12e498c8c680">2.625</ix:nonFraction>% Notes may convert the <ix:nonFraction unitRef="number" contextRef="ia3deab346b25408c987cad57798b899f_I20190129" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82MS9mcmFnOmE4ZDk2NGIzNGMzYjQ1MjdhNzA4Y2JhMDY1M2Y1YTBmL3RleHRyZWdpb246YThkOTY0YjM0YzNiNDUyN2E3MDhjYmEwNjUzZjVhMGZfMzA5OQ_e389c1cd-14b2-46f3-9148-12e498c8c680">2.625</ix:nonFraction>% Notes at their option at any time on or after November 1, 2023 through the second scheduled trading day preceding the maturity date.  Holders of the <ix:nonFraction unitRef="number" contextRef="ia3deab346b25408c987cad57798b899f_I20190129" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82MS9mcmFnOmE4ZDk2NGIzNGMzYjQ1MjdhNzA4Y2JhMDY1M2Y1YTBmL3RleHRyZWdpb246YThkOTY0YjM0YzNiNDUyN2E3MDhjYmEwNjUzZjVhMGZfMzI1MQ_e389c1cd-14b2-46f3-9148-12e498c8c680">2.625</ix:nonFraction>% Notes will also have the right to convert the <ix:nonFraction unitRef="number" contextRef="ia3deab346b25408c987cad57798b899f_I20190129" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82MS9mcmFnOmE4ZDk2NGIzNGMzYjQ1MjdhNzA4Y2JhMDY1M2Y1YTBmL3RleHRyZWdpb246YThkOTY0YjM0YzNiNDUyN2E3MDhjYmEwNjUzZjVhMGZfMzMwMA_e389c1cd-14b2-46f3-9148-12e498c8c680">2.625</ix:nonFraction>% Notes prior to November 1, 2023, but only upon the occurrence of specified events.  The conversion rate is subject to anti-dilution adjustments if certain events occur.  A portion of the net proceeds from the offering of the <ix:nonFraction unitRef="number" contextRef="ia3deab346b25408c987cad57798b899f_I20190129" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82MS9mcmFnOmE4ZDk2NGIzNGMzYjQ1MjdhNzA4Y2JhMDY1M2Y1YTBmL3RleHRyZWdpb246YThkOTY0YjM0YzNiNDUyN2E3MDhjYmEwNjUzZjVhMGZfMzUyOA_e389c1cd-14b2-46f3-9148-12e498c8c680">2.625</ix:nonFraction>% Notes were used as part of the financing for the Buffalo Filter acquisition and $<ix:nonFraction unitRef="usd" contextRef="i2dbc31bae66544e8ad4c1dd3147f68c4_I20190129" decimals="-5" name="cnmd:HedgeAndWarrantTransactionsNetCashPaid" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82MS9mcmFnOmE4ZDk2NGIzNGMzYjQ1MjdhNzA4Y2JhMDY1M2Y1YTBmL3RleHRyZWdpb246YThkOTY0YjM0YzNiNDUyN2E3MDhjYmEwNjUzZjVhMGZfMzYxMQ_f9ad1e91-6d67-44e1-9cdb-7965ac7eecd5">21.0</ix:nonFraction> million were used to pay the cost of certain convertible notes hedge transactions as further described below.  </span></div></ix:continuation><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline" href="#i952e7af9c0b94e65995973e7f212f399_7">Table of Contents</a></span></div></div><ix:continuation id="i75d2858fca584c5b8d63819226778ad9" continuedAt="ifd112cafc7b449dda48d6e9690834f43"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On June 6, 2022, the Company repurchased and extinguished $<ix:nonFraction unitRef="usd" contextRef="idfc03df5461f46f685bf90bc12673743_D20220606-20220606" decimals="-5" name="us-gaap:RepaymentsOfConvertibleDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82MS9mcmFnOmE4ZDk2NGIzNGMzYjQ1MjdhNzA4Y2JhMDY1M2Y1YTBmL3RleHRyZWdpb246YThkOTY0YjM0YzNiNDUyN2E3MDhjYmEwNjUzZjVhMGZfMzc3Nw_09a11e54-adba-42ee-b26f-ff19d8a9d6fa">275.0</ix:nonFraction> million principal amount of the <ix:nonFraction unitRef="number" contextRef="ia3deab346b25408c987cad57798b899f_I20190129" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82MS9mcmFnOmE4ZDk2NGIzNGMzYjQ1MjdhNzA4Y2JhMDY1M2Y1YTBmL3RleHRyZWdpb246YThkOTY0YjM0YzNiNDUyN2E3MDhjYmEwNjUzZjVhMGZfMzgwNA_e389c1cd-14b2-46f3-9148-12e498c8c680">2.625</ix:nonFraction>% Notes for aggregate consideration consisting of $<ix:nonFraction unitRef="usd" contextRef="idfc03df5461f46f685bf90bc12673743_D20220606-20220606" decimals="-5" name="us-gaap:RepaymentsOfConvertibleDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82MS9mcmFnOmE4ZDk2NGIzNGMzYjQ1MjdhNzA4Y2JhMDY1M2Y1YTBmL3RleHRyZWdpb246YThkOTY0YjM0YzNiNDUyN2E3MDhjYmEwNjUzZjVhMGZfMzg1NQ_09a11e54-adba-42ee-b26f-ff19d8a9d6fa">275.0</ix:nonFraction> million in cash and approximately <ix:nonFraction unitRef="shares" contextRef="idfc03df5461f46f685bf90bc12673743_D20220606-20220606" decimals="-5" name="us-gaap:DebtConversionConvertedInstrumentSharesIssued1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82MS9mcmFnOmE4ZDk2NGIzNGMzYjQ1MjdhNzA4Y2JhMDY1M2Y1YTBmL3RleHRyZWdpb246YThkOTY0YjM0YzNiNDUyN2E3MDhjYmEwNjUzZjVhMGZfMzg4NA_64fe4c29-5d8d-4195-986d-2304cef69059">0.9</ix:nonFraction> million shares of the Company's common stock.  Concurrently, the Company entered into a Supplemental Indenture related to the remaining $<ix:nonFraction unitRef="usd" contextRef="ie736fe11e175439d9773dbf983dad1c9_I20230331" decimals="-5" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82MS9mcmFnOmE4ZDk2NGIzNGMzYjQ1MjdhNzA4Y2JhMDY1M2Y1YTBmL3RleHRyZWdpb246YThkOTY0YjM0YzNiNDUyN2E3MDhjYmEwNjUzZjVhMGZfNDM3Nw_6ac77d7d-6808-4a62-a40f-dd5b5e6ab66d">70.0</ix:nonFraction> million in <ix:nonFraction unitRef="number" contextRef="ia3deab346b25408c987cad57798b899f_I20190129" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82MS9mcmFnOmE4ZDk2NGIzNGMzYjQ1MjdhNzA4Y2JhMDY1M2Y1YTBmL3RleHRyZWdpb246YThkOTY0YjM0YzNiNDUyN2E3MDhjYmEwNjUzZjVhMGZfNDM4Mw_e389c1cd-14b2-46f3-9148-12e498c8c680">2.625</ix:nonFraction>% Notes, in which the Company irrevocably elected to settle the principal value of those <ix:nonFraction unitRef="number" contextRef="ia3deab346b25408c987cad57798b899f_I20190129" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82MS9mcmFnOmE4ZDk2NGIzNGMzYjQ1MjdhNzA4Y2JhMDY1M2Y1YTBmL3RleHRyZWdpb246YThkOTY0YjM0YzNiNDUyN2E3MDhjYmEwNjUzZjVhMGZfNDQ3Mw_e389c1cd-14b2-46f3-9148-12e498c8c680">2.625</ix:nonFraction>% Notes in cash. The $<ix:nonFraction unitRef="usd" contextRef="ie736fe11e175439d9773dbf983dad1c9_I20230331" decimals="-5" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82MS9mcmFnOmE4ZDk2NGIzNGMzYjQ1MjdhNzA4Y2JhMDY1M2Y1YTBmL3RleHRyZWdpb246YThkOTY0YjM0YzNiNDUyN2E3MDhjYmEwNjUzZjVhMGZfMTA5OTUxMTYzOTgzMw_6ac77d7d-6808-4a62-a40f-dd5b5e6ab66d">70.0</ix:nonFraction> million in <ix:nonFraction unitRef="number" contextRef="ia3deab346b25408c987cad57798b899f_I20190129" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82MS9mcmFnOmE4ZDk2NGIzNGMzYjQ1MjdhNzA4Y2JhMDY1M2Y1YTBmL3RleHRyZWdpb246YThkOTY0YjM0YzNiNDUyN2E3MDhjYmEwNjUzZjVhMGZfMTA5OTUxMTYzOTg0Mw_e389c1cd-14b2-46f3-9148-12e498c8c680">2.625</ix:nonFraction>% Notes are reflected in the current portion of long-term debt at March&#160;31, 2023.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended March 31, 2023 and 2022, we have recorded interest expense on the <ix:nonFraction unitRef="number" contextRef="ia3deab346b25408c987cad57798b899f_I20190129" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82MS9mcmFnOmE4ZDk2NGIzNGMzYjQ1MjdhNzA4Y2JhMDY1M2Y1YTBmL3RleHRyZWdpb246YThkOTY0YjM0YzNiNDUyN2E3MDhjYmEwNjUzZjVhMGZfNTIzNQ_e389c1cd-14b2-46f3-9148-12e498c8c680">2.625</ix:nonFraction>% Notes of $<ix:nonFraction unitRef="usd" contextRef="i10eb0e0f69c44d6b8a5dcbb6bec8e099_D20230101-20230331" decimals="-5" name="us-gaap:InterestExpenseDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82MS9mcmFnOmE4ZDk2NGIzNGMzYjQ1MjdhNzA4Y2JhMDY1M2Y1YTBmL3RleHRyZWdpb246YThkOTY0YjM0YzNiNDUyN2E3MDhjYmEwNjUzZjVhMGZfNTI0OA_03efb295-949b-44b7-81d4-79d488acc0db">0.5</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ifa15bf919650442ab2cfd3f7e7f70be6_D20220101-20220331" decimals="-5" name="us-gaap:InterestExpenseDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82MS9mcmFnOmE4ZDk2NGIzNGMzYjQ1MjdhNzA4Y2JhMDY1M2Y1YTBmL3RleHRyZWdpb246YThkOTY0YjM0YzNiNDUyN2E3MDhjYmEwNjUzZjVhMGZfNTI1NQ_603a373b-0deb-4903-9431-a2e6e83fd74c">2.3</ix:nonFraction> million, respectively, at the contractual coupon rate of <ix:nonFraction unitRef="number" contextRef="ia3deab346b25408c987cad57798b899f_I20190129" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82MS9mcmFnOmE4ZDk2NGIzNGMzYjQ1MjdhNzA4Y2JhMDY1M2Y1YTBmL3RleHRyZWdpb246YThkOTY0YjM0YzNiNDUyN2E3MDhjYmEwNjUzZjVhMGZfNTQwMw_05827e15-e81e-47fa-a025-f0f5823de8ac">2.625</ix:nonFraction>%.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">The estimated fair value of the <ix:nonFraction unitRef="number" contextRef="ia3deab346b25408c987cad57798b899f_I20190129" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82MS9mcmFnOmE4ZDk2NGIzNGMzYjQ1MjdhNzA4Y2JhMDY1M2Y1YTBmL3RleHRyZWdpb246YThkOTY0YjM0YzNiNDUyN2E3MDhjYmEwNjUzZjVhMGZfNTQ0MA_e389c1cd-14b2-46f3-9148-12e498c8c680">2.625</ix:nonFraction>% Notes was approximately $<ix:nonFraction unitRef="usd" contextRef="ie736fe11e175439d9773dbf983dad1c9_I20230331" decimals="-5" name="us-gaap:DebtInstrumentFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82MS9mcmFnOmE4ZDk2NGIzNGMzYjQ1MjdhNzA4Y2JhMDY1M2Y1YTBmL3RleHRyZWdpb246YThkOTY0YjM0YzNiNDUyN2E3MDhjYmEwNjUzZjVhMGZfNTQ2Nw_1c757f26-e735-4213-8ff8-faacba288fde">85.3</ix:nonFraction> million as of March&#160;31, 2023 based on a market approach which represents a Level 2 valuation in the fair value hierarchy.  The estimated fair value was determined based on the estimated or actual bids and offers of the <ix:nonFraction unitRef="number" contextRef="ia3deab346b25408c987cad57798b899f_I20190129" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82MS9mcmFnOmE4ZDk2NGIzNGMzYjQ1MjdhNzA4Y2JhMDY1M2Y1YTBmL3RleHRyZWdpb246YThkOTY0YjM0YzNiNDUyN2E3MDhjYmEwNjUzZjVhMGZfNTY2OQ_e389c1cd-14b2-46f3-9148-12e498c8c680">2.625</ix:nonFraction>% Notes in an over-the-counter market transaction on the last business day of the period.  </span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">2.250% Convertible Notes</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">On June 6, 2022, we issued $<ix:nonFraction unitRef="usd" contextRef="i9439f4c05d684bd2b8c31654eba4d05f_I20220606" decimals="-5" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82MS9mcmFnOmE4ZDk2NGIzNGMzYjQ1MjdhNzA4Y2JhMDY1M2Y1YTBmL3RleHRyZWdpb246YThkOTY0YjM0YzNiNDUyN2E3MDhjYmEwNjUzZjVhMGZfNTgxNg_2a5e4e9b-e215-40c7-b084-e43e5ac27656">800.0</ix:nonFraction> million aggregate principal amount of <ix:nonFraction unitRef="number" contextRef="i9439f4c05d684bd2b8c31654eba4d05f_I20220606" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82MS9mcmFnOmE4ZDk2NGIzNGMzYjQ1MjdhNzA4Y2JhMDY1M2Y1YTBmL3RleHRyZWdpb246YThkOTY0YjM0YzNiNDUyN2E3MDhjYmEwNjUzZjVhMGZfNTgyMg_910e2d7d-1f9e-434c-8403-39a40cbdb228">2.250</ix:nonFraction>% Notes.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:107%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">Interest is payable semi-annually in arrears on June 15 and December 15 of each year, commencing December 15, 2022.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:107%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">The <ix:nonFraction unitRef="number" contextRef="i9439f4c05d684bd2b8c31654eba4d05f_I20220606" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82MS9mcmFnOmE4ZDk2NGIzNGMzYjQ1MjdhNzA4Y2JhMDY1M2Y1YTBmL3RleHRyZWdpb246YThkOTY0YjM0YzNiNDUyN2E3MDhjYmEwNjUzZjVhMGZfNTk1NA_910e2d7d-1f9e-434c-8403-39a40cbdb228">2.250</ix:nonFraction>% Notes will mature on June 15, 2027, unless earlier repurchased or converted. The <ix:nonFraction unitRef="number" contextRef="i9439f4c05d684bd2b8c31654eba4d05f_I20220606" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82MS9mcmFnOmE4ZDk2NGIzNGMzYjQ1MjdhNzA4Y2JhMDY1M2Y1YTBmL3RleHRyZWdpb246YThkOTY0YjM0YzNiNDUyN2E3MDhjYmEwNjUzZjVhMGZfNjAzOA_910e2d7d-1f9e-434c-8403-39a40cbdb228">2.250</ix:nonFraction>% Notes represent subordinated unsecured obligations and are convertible under certain circumstances, as defined in the indenture, into a combination of cash and CONMED common stock, with the principal required to be paid in cash.  The <ix:nonFraction unitRef="number" contextRef="i9439f4c05d684bd2b8c31654eba4d05f_I20220606" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82MS9mcmFnOmE4ZDk2NGIzNGMzYjQ1MjdhNzA4Y2JhMDY1M2Y1YTBmL3RleHRyZWdpb246YThkOTY0YjM0YzNiNDUyN2E3MDhjYmEwNjUzZjVhMGZfNjI3NQ_910e2d7d-1f9e-434c-8403-39a40cbdb228">2.250</ix:nonFraction>% Notes may be converted at an initial conversion rate of <ix:nonFraction unitRef="number" contextRef="id1b284d79bb1490fa07cbd99bd8692dd_D20220606-20220606" decimals="4" name="us-gaap:DebtInstrumentConvertibleConversionRatio1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82MS9mcmFnOmE4ZDk2NGIzNGMzYjQ1MjdhNzA4Y2JhMDY1M2Y1YTBmL3RleHRyZWdpb246YThkOTY0YjM0YzNiNDUyN2E3MDhjYmEwNjUzZjVhMGZfNjMzNA_5898f980-76af-457f-a369-2de3f1571d29">6.8810</ix:nonFraction> shares of our common stock per $1,000 principal amount of the <ix:nonFraction unitRef="number" contextRef="i9439f4c05d684bd2b8c31654eba4d05f_I20220606" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82MS9mcmFnOmE4ZDk2NGIzNGMzYjQ1MjdhNzA4Y2JhMDY1M2Y1YTBmL3RleHRyZWdpb246YThkOTY0YjM0YzNiNDUyN2E3MDhjYmEwNjUzZjVhMGZfNjM5OQ_910e2d7d-1f9e-434c-8403-39a40cbdb228">2.250</ix:nonFraction>% Notes (equivalent to an initial conversion price of approximately $<ix:nonFraction unitRef="usdPerShare" contextRef="i9439f4c05d684bd2b8c31654eba4d05f_I20220606" decimals="2" name="us-gaap:DebtInstrumentConvertibleConversionPrice1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82MS9mcmFnOmE4ZDk2NGIzNGMzYjQ1MjdhNzA4Y2JhMDY1M2Y1YTBmL3RleHRyZWdpb246YThkOTY0YjM0YzNiNDUyN2E3MDhjYmEwNjUzZjVhMGZfNjQ2OA_2473f4ad-72c9-4d55-9a4c-07c02c2b3005">145.33</ix:nonFraction> per share of common stock).  Holders of the <ix:nonFraction unitRef="number" contextRef="i9439f4c05d684bd2b8c31654eba4d05f_I20220606" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82MS9mcmFnOmE4ZDk2NGIzNGMzYjQ1MjdhNzA4Y2JhMDY1M2Y1YTBmL3RleHRyZWdpb246YThkOTY0YjM0YzNiNDUyN2E3MDhjYmEwNjUzZjVhMGZfNjUxNQ_910e2d7d-1f9e-434c-8403-39a40cbdb228">2.250</ix:nonFraction>% Notes may convert the <ix:nonFraction unitRef="number" contextRef="i9439f4c05d684bd2b8c31654eba4d05f_I20220606" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82MS9mcmFnOmE4ZDk2NGIzNGMzYjQ1MjdhNzA4Y2JhMDY1M2Y1YTBmL3RleHRyZWdpb246YThkOTY0YjM0YzNiNDUyN2E3MDhjYmEwNjUzZjVhMGZfNjU0MA_910e2d7d-1f9e-434c-8403-39a40cbdb228">2.250</ix:nonFraction>% Notes at their option at any time on or after March 15, 2027 through the second scheduled trading day preceding the maturity date.  Holders of the <ix:nonFraction unitRef="number" contextRef="i9439f4c05d684bd2b8c31654eba4d05f_I20220606" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82MS9mcmFnOmE4ZDk2NGIzNGMzYjQ1MjdhNzA4Y2JhMDY1M2Y1YTBmL3RleHRyZWdpb246YThkOTY0YjM0YzNiNDUyN2E3MDhjYmEwNjUzZjVhMGZfNjY5MA_910e2d7d-1f9e-434c-8403-39a40cbdb228">2.250</ix:nonFraction>% Notes will also have the right to convert the <ix:nonFraction unitRef="number" contextRef="i9439f4c05d684bd2b8c31654eba4d05f_I20220606" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82MS9mcmFnOmE4ZDk2NGIzNGMzYjQ1MjdhNzA4Y2JhMDY1M2Y1YTBmL3RleHRyZWdpb246YThkOTY0YjM0YzNiNDUyN2E3MDhjYmEwNjUzZjVhMGZfNjczOQ_910e2d7d-1f9e-434c-8403-39a40cbdb228">2.250</ix:nonFraction>% Notes prior to March 15, 2027, but only upon the occurrence of specified events.  The conversion rate is subject to anti-dilution adjustments if certain events occur.  A portion of these proceeds were used to repurchase and extinguish a portion of the <ix:nonFraction unitRef="number" contextRef="ia3deab346b25408c987cad57798b899f_I20190129" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82MS9mcmFnOmE4ZDk2NGIzNGMzYjQ1MjdhNzA4Y2JhMDY1M2Y1YTBmL3RleHRyZWdpb246YThkOTY0YjM0YzNiNDUyN2E3MDhjYmEwNjUzZjVhMGZfNjk5NA_e389c1cd-14b2-46f3-9148-12e498c8c680">2.625</ix:nonFraction>% Notes, pay off our then outstanding balance on our revolving line of credit, pay down of $<ix:nonFraction unitRef="usd" contextRef="i33405b42e96c4b0797d76ca71cdcc742_D20220606-20220606" decimals="-5" name="us-gaap:RepaymentsOfSeniorDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82MS9mcmFnOmE4ZDk2NGIzNGMzYjQ1MjdhNzA4Y2JhMDY1M2Y1YTBmL3RleHRyZWdpb246YThkOTY0YjM0YzNiNDUyN2E3MDhjYmEwNjUzZjVhMGZfNzA4Ng_967e6757-2cca-4790-b818-53bf5476af64">90.0</ix:nonFraction>&#160;million of our term loan and partially pay for the In2Bones Acquisition.  In addition, approximately $<ix:nonFraction unitRef="usd" contextRef="i82b966a7802b4350a629c26252c5e157_I20220606" decimals="-5" name="cnmd:HedgeAndWarrantTransactionsNetCashPaid" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82MS9mcmFnOmE4ZDk2NGIzNGMzYjQ1MjdhNzA4Y2JhMDY1M2Y1YTBmL3RleHRyZWdpb246YThkOTY0YjM0YzNiNDUyN2E3MDhjYmEwNjUzZjVhMGZfNzE4Mg_0697605d-d91a-489b-b2f7-112c880c8e5b">115.6</ix:nonFraction> million of the proceeds were used to pay the cost of certain convertible notes hedge transactions related to the <ix:nonFraction unitRef="number" contextRef="i9439f4c05d684bd2b8c31654eba4d05f_I20220606" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82MS9mcmFnOmE4ZDk2NGIzNGMzYjQ1MjdhNzA4Y2JhMDY1M2Y1YTBmL3RleHRyZWdpb246YThkOTY0YjM0YzNiNDUyN2E3MDhjYmEwNjUzZjVhMGZfNzI5MA_910e2d7d-1f9e-434c-8403-39a40cbdb228">2.250</ix:nonFraction>% Notes.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">For the three months ended March&#160;31, 2023, we have recorded interest expense on the <ix:nonFraction unitRef="number" contextRef="i9439f4c05d684bd2b8c31654eba4d05f_I20220606" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82MS9mcmFnOmE4ZDk2NGIzNGMzYjQ1MjdhNzA4Y2JhMDY1M2Y1YTBmL3RleHRyZWdpb246YThkOTY0YjM0YzNiNDUyN2E3MDhjYmEwNjUzZjVhMGZfNzM1Nw_910e2d7d-1f9e-434c-8403-39a40cbdb228">2.250</ix:nonFraction>% Notes of</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:107%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">$<ix:nonFraction unitRef="usd" contextRef="ief4e99def0364c889fba657b34e2c8bd_D20230101-20230331" decimals="-5" name="us-gaap:InterestExpenseDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82MS9mcmFnOmE4ZDk2NGIzNGMzYjQ1MjdhNzA4Y2JhMDY1M2Y1YTBmL3RleHRyZWdpb246YThkOTY0YjM0YzNiNDUyN2E3MDhjYmEwNjUzZjVhMGZfNzM2OQ_9cffd3e1-3be5-4c2d-8285-40d269a35e48">4.5</ix:nonFraction> million at the contractual coupon rate of <ix:nonFraction unitRef="number" contextRef="i9439f4c05d684bd2b8c31654eba4d05f_I20220606" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82MS9mcmFnOmE4ZDk2NGIzNGMzYjQ1MjdhNzA4Y2JhMDY1M2Y1YTBmL3RleHRyZWdpb246YThkOTY0YjM0YzNiNDUyN2E3MDhjYmEwNjUzZjVhMGZfNzQyOA_910e2d7d-1f9e-434c-8403-39a40cbdb228">2.250</ix:nonFraction>%.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The estimated fair value of the <ix:nonFraction unitRef="number" contextRef="i9439f4c05d684bd2b8c31654eba4d05f_I20220606" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82MS9mcmFnOmE4ZDk2NGIzNGMzYjQ1MjdhNzA4Y2JhMDY1M2Y1YTBmL3RleHRyZWdpb246YThkOTY0YjM0YzNiNDUyN2E3MDhjYmEwNjUzZjVhMGZfNzQ2NQ_910e2d7d-1f9e-434c-8403-39a40cbdb228">2.250</ix:nonFraction>% Notes was approximately $<ix:nonFraction unitRef="usd" contextRef="i2d6a32f6a1f64e998b122bbbc261a999_I20230331" decimals="-5" name="us-gaap:DebtInstrumentFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82MS9mcmFnOmE4ZDk2NGIzNGMzYjQ1MjdhNzA4Y2JhMDY1M2Y1YTBmL3RleHRyZWdpb246YThkOTY0YjM0YzNiNDUyN2E3MDhjYmEwNjUzZjVhMGZfNzQ5Mg_6f2e803f-2f37-49d3-a30d-c50460610007">796.1</ix:nonFraction> million as of March&#160;31, 2023 based on a market approach which represents a Level 2 valuation in the fair value hierarchy.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The estimated fair value was determined based on the estimated or actual bids and offers of the <ix:nonFraction unitRef="number" contextRef="i9439f4c05d684bd2b8c31654eba4d05f_I20220606" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82MS9mcmFnOmE4ZDk2NGIzNGMzYjQ1MjdhNzA4Y2JhMDY1M2Y1YTBmL3RleHRyZWdpb246YThkOTY0YjM0YzNiNDUyN2E3MDhjYmEwNjUzZjVhMGZfNzY5NA_910e2d7d-1f9e-434c-8403-39a40cbdb228">2.250</ix:nonFraction>% Notes in an over-the-counter market transaction on the last business day of the period.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Convertible Notes Hedge Transactions</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">In connection with the offerings of the <ix:nonFraction unitRef="number" contextRef="ia3deab346b25408c987cad57798b899f_I20190129" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82MS9mcmFnOmE4ZDk2NGIzNGMzYjQ1MjdhNzA4Y2JhMDY1M2Y1YTBmL3RleHRyZWdpb246YThkOTY0YjM0YzNiNDUyN2E3MDhjYmEwNjUzZjVhMGZfNzg2Mw_e389c1cd-14b2-46f3-9148-12e498c8c680">2.625</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="i9439f4c05d684bd2b8c31654eba4d05f_I20220606" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82MS9mcmFnOmE4ZDk2NGIzNGMzYjQ1MjdhNzA4Y2JhMDY1M2Y1YTBmL3RleHRyZWdpb246YThkOTY0YjM0YzNiNDUyN2E3MDhjYmEwNjUzZjVhMGZfNzg3MA_910e2d7d-1f9e-434c-8403-39a40cbdb228">2.250</ix:nonFraction>% Notes, we entered into convertible notes hedge transactions with a number of financial institutions (each, an &#8220;option counterparty&#8221;).  The convertible notes hedge transactions cover, subject to anti-dilution adjustments substantially similar to those applicable to the respective Notes, the number of shares of our common stock underlying the <ix:nonFraction unitRef="number" contextRef="ia3deab346b25408c987cad57798b899f_I20190129" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82MS9mcmFnOmE4ZDk2NGIzNGMzYjQ1MjdhNzA4Y2JhMDY1M2Y1YTBmL3RleHRyZWdpb246YThkOTY0YjM0YzNiNDUyN2E3MDhjYmEwNjUzZjVhMGZfODIxNg_e389c1cd-14b2-46f3-9148-12e498c8c680">2.625</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="i9439f4c05d684bd2b8c31654eba4d05f_I20220606" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82MS9mcmFnOmE4ZDk2NGIzNGMzYjQ1MjdhNzA4Y2JhMDY1M2Y1YTBmL3RleHRyZWdpb246YThkOTY0YjM0YzNiNDUyN2E3MDhjYmEwNjUzZjVhMGZfODIyMw_910e2d7d-1f9e-434c-8403-39a40cbdb228">2.250</ix:nonFraction>% Notes.  Concurrent with entering into the convertible notes hedge transactions, we also entered into separate warrant transactions with each option counterparty whereby we sold to such option counterparty warrants to purchase, subject to customary anti-dilution adjustments, the same number of shares of our common stock.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In connection with the repurchase and extinguishment of $<ix:nonFraction unitRef="usd" contextRef="idfc03df5461f46f685bf90bc12673743_D20220606-20220606" decimals="-5" name="us-gaap:RepaymentsOfConvertibleDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82MS9mcmFnOmE4ZDk2NGIzNGMzYjQ1MjdhNzA4Y2JhMDY1M2Y1YTBmL3RleHRyZWdpb246YThkOTY0YjM0YzNiNDUyN2E3MDhjYmEwNjUzZjVhMGZfODYwNQ_09a11e54-adba-42ee-b26f-ff19d8a9d6fa">275.0</ix:nonFraction> million principal amount of the <ix:nonFraction unitRef="number" contextRef="ia3deab346b25408c987cad57798b899f_I20190129" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82MS9mcmFnOmE4ZDk2NGIzNGMzYjQ1MjdhNzA4Y2JhMDY1M2Y1YTBmL3RleHRyZWdpb246YThkOTY0YjM0YzNiNDUyN2E3MDhjYmEwNjUzZjVhMGZfODYzMg_e389c1cd-14b2-46f3-9148-12e498c8c680">2.625</ix:nonFraction>% Notes, the Company entered into agreements with the option counterparties to terminate a corresponding portion of the hedges on the <ix:nonFraction unitRef="number" contextRef="ia3deab346b25408c987cad57798b899f_I20190129" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82MS9mcmFnOmE4ZDk2NGIzNGMzYjQ1MjdhNzA4Y2JhMDY1M2Y1YTBmL3RleHRyZWdpb246YThkOTY0YjM0YzNiNDUyN2E3MDhjYmEwNjUzZjVhMGZfODc2Nw_e389c1cd-14b2-46f3-9148-12e498c8c680">2.625</ix:nonFraction>% Notes.  </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The convertible notes hedge transactions are expected generally to reduce the potential dilution upon conversion of the Notes and/or offset any cash payments we are required to make in excess of the principal amount of converted Notes, as the case may be, in the event that the market price per share of our common stock, as measured under the terms of the convertible notes hedge transactions, is greater than the strike price of the convertible notes hedge transactions, which initially corresponds to the conversion price of the Notes and is subject to anti-dilution adjustments substantially similar to those applicable to the conversion rate of the Notes.  If, however, the market price per share of our common stock, as measured under the terms of the warrant transactions, exceeds the strike price ($<ix:nonFraction unitRef="usdPerShare" contextRef="i4ff9b47cc6de4e7f8d64f0b08302c5da_D20190129-20190129" decimals="2" name="us-gaap:OptionIndexedToIssuersEquityStrikePrice1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82MS9mcmFnOmE4ZDk2NGIzNGMzYjQ1MjdhNzA4Y2JhMDY1M2Y1YTBmL3RleHRyZWdpb246YThkOTY0YjM0YzNiNDUyN2E3MDhjYmEwNjUzZjVhMGZfMTAyMDQ_c2634f69-c48c-4fa0-a1b7-8414491782e2">114.92</ix:nonFraction> for the <ix:nonFraction unitRef="number" contextRef="ia3deab346b25408c987cad57798b899f_I20190129" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82MS9mcmFnOmE4ZDk2NGIzNGMzYjQ1MjdhNzA4Y2JhMDY1M2Y1YTBmL3RleHRyZWdpb246YThkOTY0YjM0YzNiNDUyN2E3MDhjYmEwNjUzZjVhMGZfMTAyMTU_e389c1cd-14b2-46f3-9148-12e498c8c680">2.625</ix:nonFraction>% Notes and $<ix:nonFraction unitRef="usdPerShare" contextRef="i588b04626e27426a9be89a521d673e93_D20220606-20220606" decimals="2" name="us-gaap:OptionIndexedToIssuersEquityStrikePrice1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82MS9mcmFnOmE4ZDk2NGIzNGMzYjQ1MjdhNzA4Y2JhMDY1M2Y1YTBmL3RleHRyZWdpb246YThkOTY0YjM0YzNiNDUyN2E3MDhjYmEwNjUzZjVhMGZfMTAyMjg_3311f6d4-5390-4b0f-bedf-42fb50a469cd">251.53</ix:nonFraction> for the <ix:nonFraction unitRef="number" contextRef="i9439f4c05d684bd2b8c31654eba4d05f_I20220606" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82MS9mcmFnOmE4ZDk2NGIzNGMzYjQ1MjdhNzA4Y2JhMDY1M2Y1YTBmL3RleHRyZWdpb246YThkOTY0YjM0YzNiNDUyN2E3MDhjYmEwNjUzZjVhMGZfMTAyMzk_910e2d7d-1f9e-434c-8403-39a40cbdb228">2.250</ix:nonFraction>% Notes) of the warrants, there would nevertheless be dilution to the extent that such market price exceeds the strike price of the warrants, </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline" href="#i952e7af9c0b94e65995973e7f212f399_7">Table of Contents</a></span></div></div><ix:continuation id="ifd112cafc7b449dda48d6e9690834f43"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">unless we elect to settle the warrants in cash.</span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331" name="us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82MS9mcmFnOmE4ZDk2NGIzNGMzYjQ1MjdhNzA4Y2JhMDY1M2Y1YTBmL3RleHRyZWdpb246YThkOTY0YjM0YzNiNDUyN2E3MDhjYmEwNjUzZjVhMGZfMTA2MDQ_f1128968-5d7c-4f78-ace5-278c8c715b8f" escape="true"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The scheduled&#160;maturities&#160;of&#160;long-term&#160;debt outstanding at March&#160;31, 2023 are as follows:</span></div><div style="text-align:justify"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:85.263%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.537%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remaining, 2023</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i738c2d1dacaf436faf03cc46ab9cef23_I20230331" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82MS9mcmFnOmE4ZDk2NGIzNGMzYjQ1MjdhNzA4Y2JhMDY1M2Y1YTBmL3RhYmxlOjEyNmQxYjhhYWU5MjQyNGZiZDZiOTNlZTk4NTdhODQ4L3RhYmxlcmFuZ2U6MTI2ZDFiOGFhZTkyNDI0ZmJkNmI5M2VlOTg1N2E4NDhfMC0xLTEtMS00NTkxOQ_fdab4ec6-9050-41b0-a127-3a16180e31f7">70,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i738c2d1dacaf436faf03cc46ab9cef23_I20230331" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82MS9mcmFnOmE4ZDk2NGIzNGMzYjQ1MjdhNzA4Y2JhMDY1M2Y1YTBmL3RhYmxlOjEyNmQxYjhhYWU5MjQyNGZiZDZiOTNlZTk4NTdhODQ4L3RhYmxlcmFuZ2U6MTI2ZDFiOGFhZTkyNDI0ZmJkNmI5M2VlOTg1N2E4NDhfMS0xLTEtMS00NTkxOQ_167ad7e9-0b06-4c07-885d-82c2f3381f7f">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i738c2d1dacaf436faf03cc46ab9cef23_I20230331" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82MS9mcmFnOmE4ZDk2NGIzNGMzYjQ1MjdhNzA4Y2JhMDY1M2Y1YTBmL3RhYmxlOjEyNmQxYjhhYWU5MjQyNGZiZDZiOTNlZTk4NTdhODQ4L3RhYmxlcmFuZ2U6MTI2ZDFiOGFhZTkyNDI0ZmJkNmI5M2VlOTg1N2E4NDhfMi0xLTEtMS00NTkxOQ_dada981e-70f5-4453-b13d-803937ad14b4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i738c2d1dacaf436faf03cc46ab9cef23_I20230331" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82MS9mcmFnOmE4ZDk2NGIzNGMzYjQ1MjdhNzA4Y2JhMDY1M2Y1YTBmL3RhYmxlOjEyNmQxYjhhYWU5MjQyNGZiZDZiOTNlZTk4NTdhODQ4L3RhYmxlcmFuZ2U6MTI2ZDFiOGFhZTkyNDI0ZmJkNmI5M2VlOTg1N2E4NDhfMy0xLTEtMS00NTkxOQ_5aca6e55-882e-41da-acbc-0594fa97aac3">213,588</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i738c2d1dacaf436faf03cc46ab9cef23_I20230331" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82MS9mcmFnOmE4ZDk2NGIzNGMzYjQ1MjdhNzA4Y2JhMDY1M2Y1YTBmL3RhYmxlOjEyNmQxYjhhYWU5MjQyNGZiZDZiOTNlZTk4NTdhODQ4L3RhYmxlcmFuZ2U6MTI2ZDFiOGFhZTkyNDI0ZmJkNmI5M2VlOTg1N2E4NDhfNC0xLTEtMS00NTkxOQ_61c2c240-2aa9-4310-ba9e-e5c62f5f971e">800,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i738c2d1dacaf436faf03cc46ab9cef23_I20230331" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82MS9mcmFnOmE4ZDk2NGIzNGMzYjQ1MjdhNzA4Y2JhMDY1M2Y1YTBmL3RhYmxlOjEyNmQxYjhhYWU5MjQyNGZiZDZiOTNlZTk4NTdhODQ4L3RhYmxlcmFuZ2U6MTI2ZDFiOGFhZTkyNDI0ZmJkNmI5M2VlOTg1N2E4NDhfNS0xLTEtMS00NTkxOQ_a1fb455f-e700-4e1a-baf4-01f61d85218a">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">The above amounts exclude deferred debt issuance costs and financing leases.</span></div></ix:nonNumeric></ix:continuation><div style="text-align:justify"><span><br/></span></div><div id="i952e7af9c0b94e65995973e7f212f399_64"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Note 12 &#8211; <ix:nonNumeric contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331" name="us-gaap:ProductWarrantyDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82NC9mcmFnOjIwYjA5NjQxOTFlNTQzYjc5MGY4NDQ5NjE0NzNlN2Y5L3RleHRyZWdpb246MjBiMDk2NDE5MWU1NDNiNzkwZjg0NDk2MTQ3M2U3ZjlfNzA0_56e524b6-e3d3-44ac-abe1-cfdfaf35a54c" continuedAt="ibef49695da1a4df1ad3f8d20b41919e0" escape="true">Guarantees</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="ibef49695da1a4df1ad3f8d20b41919e0"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We provide warranties on certain of our products at the time of sale and sell extended warranties.  The standard warranty period for our capital equipment is generally <ix:nonNumeric contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331" name="cnmd:ProductWarrantyAccrualTerm" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82NC9mcmFnOjIwYjA5NjQxOTFlNTQzYjc5MGY4NDQ5NjE0NzNlN2Y5L3RleHRyZWdpb246MjBiMDk2NDE5MWU1NDNiNzkwZjg0NDk2MTQ3M2U3ZjlfMTk1_f9facf33-5ca0-4281-ad15-844aa4b54c16">one year</ix:nonNumeric> and our extended warranties typically vary from one to three years.  Liability under service and warranty policies is based upon a review of historical warranty and service claim experience.  Adjustments are made to accruals as claim data and historical experience warrant.</span></div><div style="text-indent:36pt"><span><br/></span></div><ix:nonNumeric contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331" name="us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82NC9mcmFnOjIwYjA5NjQxOTFlNTQzYjc5MGY4NDQ5NjE0NzNlN2Y5L3RleHRyZWdpb246MjBiMDk2NDE5MWU1NDNiNzkwZjg0NDk2MTQ3M2U3ZjlfNjg5_a8831b9c-bdc4-40bb-979c-42dd26c065dc" escape="true"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the liability for standard warranties for the three months ended March 31, are as follows:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:77.993%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.990%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of January 1,</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4f63720d8b244a68941932992cd9f4d_I20221231" decimals="-3" name="us-gaap:StandardProductWarrantyAccrual" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82NC9mcmFnOjIwYjA5NjQxOTFlNTQzYjc5MGY4NDQ5NjE0NzNlN2Y5L3RhYmxlOjZkZDAwODQ1OGY4YzQ2OGU4YzA2MjE5ZjQ2Y2IyZTVmL3RhYmxlcmFuZ2U6NmRkMDA4NDU4ZjhjNDY4ZThjMDYyMTlmNDZjYjJlNWZfMS0xLTEtMS00NTkxOQ_898ba87b-bf1f-44d4-87e1-6979eb19e675">1,944</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia4bed28ea4b04a1d9fca88fa74e6040c_I20211231" decimals="-3" name="us-gaap:StandardProductWarrantyAccrual" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82NC9mcmFnOjIwYjA5NjQxOTFlNTQzYjc5MGY4NDQ5NjE0NzNlN2Y5L3RhYmxlOjZkZDAwODQ1OGY4YzQ2OGU4YzA2MjE5ZjQ2Y2IyZTVmL3RhYmxlcmFuZ2U6NmRkMDA4NDU4ZjhjNDY4ZThjMDYyMTlmNDZjYjJlNWZfMS0zLTEtMS00NTkxOQ_76873d4c-b2ee-4c00-942b-0a05ad009d54">2,344</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for warranties</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331" decimals="-3" name="us-gaap:StandardProductWarrantyAccrualWarrantiesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82NC9mcmFnOjIwYjA5NjQxOTFlNTQzYjc5MGY4NDQ5NjE0NzNlN2Y5L3RhYmxlOjZkZDAwODQ1OGY4YzQ2OGU4YzA2MjE5ZjQ2Y2IyZTVmL3RhYmxlcmFuZ2U6NmRkMDA4NDU4ZjhjNDY4ZThjMDYyMTlmNDZjYjJlNWZfMy0xLTEtMS00NTkxOQ_e631eb9d-f721-4380-9253-28e0639ded40">115</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9500a5ee8dbe4d23aa9c46ebdd25a0c8_D20220101-20220331" decimals="-3" name="us-gaap:StandardProductWarrantyAccrualWarrantiesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82NC9mcmFnOjIwYjA5NjQxOTFlNTQzYjc5MGY4NDQ5NjE0NzNlN2Y5L3RhYmxlOjZkZDAwODQ1OGY4YzQ2OGU4YzA2MjE5ZjQ2Y2IyZTVmL3RhYmxlcmFuZ2U6NmRkMDA4NDU4ZjhjNDY4ZThjMDYyMTlmNDZjYjJlNWZfMy0zLTEtMS00NTkxOQ_4d51829c-8ff5-4398-9790-95e67577846c">197</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Claims made</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331" decimals="-3" name="us-gaap:StandardProductWarrantyAccrualPayments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82NC9mcmFnOjIwYjA5NjQxOTFlNTQzYjc5MGY4NDQ5NjE0NzNlN2Y5L3RhYmxlOjZkZDAwODQ1OGY4YzQ2OGU4YzA2MjE5ZjQ2Y2IyZTVmL3RhYmxlcmFuZ2U6NmRkMDA4NDU4ZjhjNDY4ZThjMDYyMTlmNDZjYjJlNWZfNC0xLTEtMS00NTkxOQ_a2bc5b1f-7c4d-45be-8934-d6a89c3fa74c">198</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9500a5ee8dbe4d23aa9c46ebdd25a0c8_D20220101-20220331" decimals="-3" name="us-gaap:StandardProductWarrantyAccrualPayments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82NC9mcmFnOjIwYjA5NjQxOTFlNTQzYjc5MGY4NDQ5NjE0NzNlN2Y5L3RhYmxlOjZkZDAwODQ1OGY4YzQ2OGU4YzA2MjE5ZjQ2Y2IyZTVmL3RhYmxlcmFuZ2U6NmRkMDA4NDU4ZjhjNDY4ZThjMDYyMTlmNDZjYjJlNWZfNC0zLTEtMS00NTkxOQ_696e2c52-b97d-4d67-831a-8e990e835387">187</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of March 31,</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i738c2d1dacaf436faf03cc46ab9cef23_I20230331" decimals="-3" name="us-gaap:StandardProductWarrantyAccrual" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82NC9mcmFnOjIwYjA5NjQxOTFlNTQzYjc5MGY4NDQ5NjE0NzNlN2Y5L3RhYmxlOjZkZDAwODQ1OGY4YzQ2OGU4YzA2MjE5ZjQ2Y2IyZTVmL3RhYmxlcmFuZ2U6NmRkMDA4NDU4ZjhjNDY4ZThjMDYyMTlmNDZjYjJlNWZfNi0xLTEtMS00NTkxOQ_46a58ee6-298a-4d3b-8167-e3ad1f0cf9ba">1,861</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4730ada3cec445989c807f4fe004727c_I20220331" decimals="-3" name="us-gaap:StandardProductWarrantyAccrual" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82NC9mcmFnOjIwYjA5NjQxOTFlNTQzYjc5MGY4NDQ5NjE0NzNlN2Y5L3RhYmxlOjZkZDAwODQ1OGY4YzQ2OGU4YzA2MjE5ZjQ2Y2IyZTVmL3RhYmxlcmFuZ2U6NmRkMDA4NDU4ZjhjNDY4ZThjMDYyMTlmNDZjYjJlNWZfNi0zLTEtMS00NTkxOQ_4d919fa4-e762-4c6a-bacc-9f9e1bdec6d0">2,354</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Costs associated with extended warranty repairs are recorded as incurred and amounted to $<ix:nonFraction unitRef="usd" contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331" decimals="-5" name="us-gaap:ProductWarrantyExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82NC9mcmFnOjIwYjA5NjQxOTFlNTQzYjc5MGY4NDQ5NjE0NzNlN2Y5L3RleHRyZWdpb246MjBiMDk2NDE5MWU1NDNiNzkwZjg0NDk2MTQ3M2U3ZjlfNjQ3_7862ec9b-4639-4729-86c6-756726f70d22">1.5</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i9500a5ee8dbe4d23aa9c46ebdd25a0c8_D20220101-20220331" decimals="-5" name="us-gaap:ProductWarrantyExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82NC9mcmFnOjIwYjA5NjQxOTFlNTQzYjc5MGY4NDQ5NjE0NzNlN2Y5L3RleHRyZWdpb246MjBiMDk2NDE5MWU1NDNiNzkwZjg0NDk2MTQ3M2U3ZjlfNjU0_4e853034-460f-49d4-99c9-2c8f14027a87">1.6</ix:nonFraction> million for the three months ended March 31, 2023 and 2022, respectively.</span></div></ix:continuation><div><span><br/></span></div><div id="i952e7af9c0b94e65995973e7f212f399_67"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Note 13 &#8211; <ix:nonNumeric contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331" name="us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82Ny9mcmFnOjJkYTkxMjg4ZjhkMzQzYmM5MjA0NzYwZmNkNTZlYjI1L3RleHRyZWdpb246MmRhOTEyODhmOGQzNDNiYzkyMDQ3NjBmY2Q1NmViMjVfMjI5_c651a7d9-76bf-4c98-87e8-cea00a970c20" continuedAt="i0cee9e5ef9e4499590ff4f0a925d6fc2" escape="true">Pension Plan</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="i0cee9e5ef9e4499590ff4f0a925d6fc2" continuedAt="i5d763049bf394522a15f48ab4713fdee"><ix:nonNumeric contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331" name="us-gaap:ScheduleOfNetBenefitCostsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82Ny9mcmFnOjJkYTkxMjg4ZjhkMzQzYmM5MjA0NzYwZmNkNTZlYjI1L3RleHRyZWdpb246MmRhOTEyODhmOGQzNDNiYzkyMDQ3NjBmY2Q1NmViMjVfMjM2_6ac8fdaf-26ea-4b09-82ad-1be32e5f00e0" escape="true"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net periodic pension cost consists of the following:&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:77.993%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.990%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service cost</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331" decimals="-3" name="us-gaap:DefinedBenefitPlanServiceCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82Ny9mcmFnOjJkYTkxMjg4ZjhkMzQzYmM5MjA0NzYwZmNkNTZlYjI1L3RhYmxlOmUwYmNjMzViZWRiNjQwNTQ5OGRhYmMxZWFmODIzN2JmL3RhYmxlcmFuZ2U6ZTBiY2MzNWJlZGI2NDA1NDk4ZGFiYzFlYWY4MjM3YmZfMi0xLTEtMS00NTkxOQ_06098229-fc72-481f-87c7-f0fa92290e57">194</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9500a5ee8dbe4d23aa9c46ebdd25a0c8_D20220101-20220331" decimals="-3" name="us-gaap:DefinedBenefitPlanServiceCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82Ny9mcmFnOjJkYTkxMjg4ZjhkMzQzYmM5MjA0NzYwZmNkNTZlYjI1L3RhYmxlOmUwYmNjMzViZWRiNjQwNTQ5OGRhYmMxZWFmODIzN2JmL3RhYmxlcmFuZ2U6ZTBiY2MzNWJlZGI2NDA1NDk4ZGFiYzFlYWY4MjM3YmZfMi0zLTEtMS00NTkxOQ_0a4dd57d-6f9f-451b-87b8-0c31b8499ad4">269</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost on projected benefit obligation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331" decimals="-3" name="us-gaap:DefinedBenefitPlanInterestCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82Ny9mcmFnOjJkYTkxMjg4ZjhkMzQzYmM5MjA0NzYwZmNkNTZlYjI1L3RhYmxlOmUwYmNjMzViZWRiNjQwNTQ5OGRhYmMxZWFmODIzN2JmL3RhYmxlcmFuZ2U6ZTBiY2MzNWJlZGI2NDA1NDk4ZGFiYzFlYWY4MjM3YmZfNC0xLTEtMS00NTkxOQ_932773ac-c7fd-4aa2-8428-4f72f2cd1866">911</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9500a5ee8dbe4d23aa9c46ebdd25a0c8_D20220101-20220331" decimals="-3" name="us-gaap:DefinedBenefitPlanInterestCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82Ny9mcmFnOjJkYTkxMjg4ZjhkMzQzYmM5MjA0NzYwZmNkNTZlYjI1L3RhYmxlOmUwYmNjMzViZWRiNjQwNTQ5OGRhYmMxZWFmODIzN2JmL3RhYmxlcmFuZ2U6ZTBiY2MzNWJlZGI2NDA1NDk4ZGFiYzFlYWY4MjM3YmZfNC0zLTEtMS00NTkxOQ_a35fd2ed-277c-498e-af5d-b63e27c7c638">537</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected return on plan assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331" decimals="-3" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82Ny9mcmFnOjJkYTkxMjg4ZjhkMzQzYmM5MjA0NzYwZmNkNTZlYjI1L3RhYmxlOmUwYmNjMzViZWRiNjQwNTQ5OGRhYmMxZWFmODIzN2JmL3RhYmxlcmFuZ2U6ZTBiY2MzNWJlZGI2NDA1NDk4ZGFiYzFlYWY4MjM3YmZfNi0xLTEtMS00NTkxOQ_72f7f20a-0633-4c32-9ba8-36c67c5da629">1,032</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9500a5ee8dbe4d23aa9c46ebdd25a0c8_D20220101-20220331" decimals="-3" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82Ny9mcmFnOjJkYTkxMjg4ZjhkMzQzYmM5MjA0NzYwZmNkNTZlYjI1L3RhYmxlOmUwYmNjMzViZWRiNjQwNTQ5OGRhYmMxZWFmODIzN2JmL3RhYmxlcmFuZ2U6ZTBiY2MzNWJlZGI2NDA1NDk4ZGFiYzFlYWY4MjM3YmZfNi0zLTEtMS00NTkxOQ_aa24c9bc-2346-40eb-8cf9-83c33ba277ec">1,324</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net amortization and deferral</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82Ny9mcmFnOjJkYTkxMjg4ZjhkMzQzYmM5MjA0NzYwZmNkNTZlYjI1L3RhYmxlOmUwYmNjMzViZWRiNjQwNTQ5OGRhYmMxZWFmODIzN2JmL3RhYmxlcmFuZ2U6ZTBiY2MzNWJlZGI2NDA1NDk4ZGFiYzFlYWY4MjM3YmZfOC0xLTEtMS00NTkxOQ_331e8f0a-0d03-4209-a3c1-a2c41d2dfe72">532</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9500a5ee8dbe4d23aa9c46ebdd25a0c8_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82Ny9mcmFnOjJkYTkxMjg4ZjhkMzQzYmM5MjA0NzYwZmNkNTZlYjI1L3RhYmxlOmUwYmNjMzViZWRiNjQwNTQ5OGRhYmMxZWFmODIzN2JmL3RhYmxlcmFuZ2U6ZTBiY2MzNWJlZGI2NDA1NDk4ZGFiYzFlYWY4MjM3YmZfOC0zLTEtMS00NTkxOQ_a08388c1-7e9e-4371-9ce6-447f6099f79c">648</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net periodic pension cost</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331" decimals="-3" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82Ny9mcmFnOjJkYTkxMjg4ZjhkMzQzYmM5MjA0NzYwZmNkNTZlYjI1L3RhYmxlOmUwYmNjMzViZWRiNjQwNTQ5OGRhYmMxZWFmODIzN2JmL3RhYmxlcmFuZ2U6ZTBiY2MzNWJlZGI2NDA1NDk4ZGFiYzFlYWY4MjM3YmZfMTAtMS0xLTEtNDU5MTk_e71f197a-fba7-4bad-9178-bef19dc41199">605</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9500a5ee8dbe4d23aa9c46ebdd25a0c8_D20220101-20220331" decimals="-3" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82Ny9mcmFnOjJkYTkxMjg4ZjhkMzQzYmM5MjA0NzYwZmNkNTZlYjI1L3RhYmxlOmUwYmNjMzViZWRiNjQwNTQ5OGRhYmMxZWFmODIzN2JmL3RhYmxlcmFuZ2U6ZTBiY2MzNWJlZGI2NDA1NDk4ZGFiYzFlYWY4MjM3YmZfMTAtMy0xLTEtNDU5MTk_f5300c8b-28b5-48bb-96cb-114bfe2ca0cb">130</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div></ix:continuation><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i5d763049bf394522a15f48ab4713fdee">We do not expect to make any pension contributions during 2023.  Non-service pension cost/(benefit) was immaterial for the three months ended March&#160;31, 2023 and 2022.</ix:continuation> </span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</span></div></div></div><div id="i952e7af9c0b94e65995973e7f212f399_70"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline" href="#i952e7af9c0b94e65995973e7f212f399_7">Table of Contents</a></span></div></div><div><span><br/></span></div><div id="i952e7af9c0b94e65995973e7f212f399_73"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Note 14 &#8211; <ix:nonNumeric contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331" name="us-gaap:SegmentReportingDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV83My9mcmFnOjk1ZTFhMDljODczZDQyMmVhZDA4NTYyZGI1ODA3YjgxL3RleHRyZWdpb246OTVlMWEwOWM4NzNkNDIyZWFkMDg1NjJkYjU4MDdiODFfMTIzNA_53d88b70-8ba3-4c32-83fe-ec8e339bf408" continuedAt="i016ff9297fa0430e88cdec579b5fd1bc" escape="true">Business Segment</ix:nonNumeric></span></div><ix:continuation id="i016ff9297fa0430e88cdec579b5fd1bc"><div style="margin-top:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are accounting and reporting for our business as a single operating segment entity engaged in the development, manufacturing and sale on a global basis of surgical devices and related equipment.  Our chief operating decision maker (the CEO) evaluates the various global product portfolios on a net sales basis and evaluates profitability, investment, cash flow metrics and allocates resources on a consolidated worldwide basis due to shared infrastructure and resources.  Our product lines consist of orthopedic surgery and general surgery.  Orthopedic surgery consists of sports medicine instrumentation and small bone, large bone and specialty powered surgical instruments as well as imaging systems for use in minimally invasive surgery procedures and fees related to the sales representation, promotion and marketing of sports medicine allograft tissue.  General surgery consists of a complete line of endo-mechanical instrumentation for minimally invasive laparoscopic and gastrointestinal procedures, smoke evacuation devices, a line of cardiac monitoring products as well as electrosurgical generators and related instruments.  <ix:nonNumeric contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331" name="us-gaap:ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV83My9mcmFnOjk1ZTFhMDljODczZDQyMmVhZDA4NTYyZGI1ODA3YjgxL3RleHRyZWdpb246OTVlMWEwOWM4NzNkNDIyZWFkMDg1NjJkYjU4MDdiODFfMTIzNw_472651fc-a758-4ea6-a62c-e4fc0ac2811b" continuedAt="i1633ae9661e34ef1bc15c6da721320a7" escape="true">These product lines' net sales are as follows:</ix:nonNumeric></span></div><div style="margin-top:9pt;text-align:justify"><ix:continuation id="i1633ae9661e34ef1bc15c6da721320a7"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.976%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.498%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Orthopedic surgery</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a0f37b7e82e470ebf61b3f06c22aac2_D20230101-20230331" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV83My9mcmFnOjk1ZTFhMDljODczZDQyMmVhZDA4NTYyZGI1ODA3YjgxL3RhYmxlOmQ3NTk0MjU0NzU2ZjQ3OGRiODlhOWM2NmM0ZjgyNmI5L3RhYmxlcmFuZ2U6ZDc1OTQyNTQ3NTZmNDc4ZGI4OWE5YzY2YzRmODI2YjlfMi0xLTEtMS00NTkxOQ_b10e2059-85c7-4f66-9196-84d67a408cac">131,175</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia61d13e27f12498686a84bca47df5ec7_D20220101-20220331" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV83My9mcmFnOjk1ZTFhMDljODczZDQyMmVhZDA4NTYyZGI1ODA3YjgxL3RhYmxlOmQ3NTk0MjU0NzU2ZjQ3OGRiODlhOWM2NmM0ZjgyNmI5L3RhYmxlcmFuZ2U6ZDc1OTQyNTQ3NTZmNDc4ZGI4OWE5YzY2YzRmODI2YjlfMi0zLTEtMS00NTkxOQ_a259fcac-4fa2-40d7-b46e-fd083d571334">107,517</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General surgery</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if48f7914ec3d45beaf647b856037592a_D20230101-20230331" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV83My9mcmFnOjk1ZTFhMDljODczZDQyMmVhZDA4NTYyZGI1ODA3YjgxL3RhYmxlOmQ3NTk0MjU0NzU2ZjQ3OGRiODlhOWM2NmM0ZjgyNmI5L3RhYmxlcmFuZ2U6ZDc1OTQyNTQ3NTZmNDc4ZGI4OWE5YzY2YzRmODI2YjlfMy0xLTEtMS00NTkxOQ_25343551-460b-43bd-a26a-e17e2546c3b0">164,293</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i60341eeb4343409c94899251a17bdde1_D20220101-20220331" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV83My9mcmFnOjk1ZTFhMDljODczZDQyMmVhZDA4NTYyZGI1ODA3YjgxL3RhYmxlOmQ3NTk0MjU0NzU2ZjQ3OGRiODlhOWM2NmM0ZjgyNmI5L3RhYmxlcmFuZ2U6ZDc1OTQyNTQ3NTZmNDc4ZGI4OWE5YzY2YzRmODI2YjlfMy0zLTEtMS00NTkxOQ_e71f8e70-5d53-4c11-95fa-655a08ee76fb">134,810</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated net sales</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV83My9mcmFnOjk1ZTFhMDljODczZDQyMmVhZDA4NTYyZGI1ODA3YjgxL3RhYmxlOmQ3NTk0MjU0NzU2ZjQ3OGRiODlhOWM2NmM0ZjgyNmI5L3RhYmxlcmFuZ2U6ZDc1OTQyNTQ3NTZmNDc4ZGI4OWE5YzY2YzRmODI2YjlfNC0xLTEtMS00NTkxOQ_d53976ac-7752-401d-85b0-7de2ef136ac2">295,468</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9500a5ee8dbe4d23aa9c46ebdd25a0c8_D20220101-20220331" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV83My9mcmFnOjk1ZTFhMDljODczZDQyMmVhZDA4NTYyZGI1ODA3YjgxL3RhYmxlOmQ3NTk0MjU0NzU2ZjQ3OGRiODlhOWM2NmM0ZjgyNmI5L3RhYmxlcmFuZ2U6ZDc1OTQyNTQ3NTZmNDc4ZGI4OWE5YzY2YzRmODI2YjlfNC0zLTEtMS00NTkxOQ_8323028a-8b82-4b4b-9553-c6c940deef80">242,327</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></ix:continuation></div></ix:continuation><div><span><br/></span></div><div id="i952e7af9c0b94e65995973e7f212f399_76"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Note 15 &#8211; <ix:nonNumeric contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331" name="us-gaap:LegalMattersAndContingenciesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV83Ni9mcmFnOmNiODM2MzkwODgyZDQ0MWViOGRmOWE3ZjM4ODlmMjQ0L3RleHRyZWdpb246Y2I4MzYzOTA4ODJkNDQxZWI4ZGY5YTdmMzg4OWYyNDRfMTA5MTU_d1689d91-3ec6-4b77-9358-fd50f7c79e0c" continuedAt="i2a599b9210254c10beca19ed460ca933" escape="true">Legal Proceedings</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="i2a599b9210254c10beca19ed460ca933" continuedAt="i8e06c178252841c29e045881f358b5a7"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, the Company may receive an information request, subpoena or warrant from a government agency such as the Securities and Exchange Commission, Department of Justice, Equal Employment Opportunity Commission, the Occupational Safety and Health Administration, the United States Food and Drug Administration, the Department of Labor, the Treasury Department or other federal and state agencies or foreign governments or government agencies.  These information requests, subpoenas or warrants may or may not be routine inquiries, or may begin as routine inquiries and over time develop into enforcement actions of various types.  Likewise, if we receive reports of alleged misconduct from employees and third parties, we investigate as appropriate.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Manufacturers of medical devices have been the subject of various enforcement actions relating to interactions with health care providers domestically or internationally whereby companies are claimed to have provided health care providers with inappropriate incentives to purchase their products.  Similarly, the Foreign Corrupt Practices Act ("FCPA") imposes obligations on manufacturers with respect to interactions with health care providers who may be considered government officials based on their affiliation with public hospitals.  The FCPA also requires publicly listed manufacturers to maintain accurate books and records, and maintain internal accounting controls sufficient to provide assurance that transactions are accurately recorded, lawful and in accordance with management's authorization.  The FCPA poses unique challenges both because manufacturers operate in foreign cultures in which conduct illegal under the FCPA may not be illegal in local jurisdictions, and because, in some cases, a United States manufacturer may face risks under the FCPA based on the conduct of third parties over whom the manufacturer may not have complete control.  While CONMED has not experienced any material enforcement action to date, there can be no assurance that the Company will not be subject to a material enforcement action in the future, or that the Company will not incur costs including, in the form of fees for lawyers and other consultants, that are material to the Company&#8217;s results of operations in the course of responding to a future inquiry or investigation.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Manufacturers of medical products may face exposure to significant product liability claims, as well as patent infringement and other claims incurred in the ordinary course of business.  To date, we have not experienced any claims that have been material to our financial statements or financial condition, but any such claims arising in the future could have a material adverse effect on our business, results of operations or cash flows.  We currently maintain commercial product liability insurance of $<ix:nonFraction unitRef="usd" contextRef="i738c2d1dacaf436faf03cc46ab9cef23_I20230331" decimals="-6" name="cnmd:ProductLiabilityContingencyInsuranceAmountPerIncident" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV83Ni9mcmFnOmNiODM2MzkwODgyZDQ0MWViOGRmOWE3ZjM4ODlmMjQ0L3RleHRyZWdpb246Y2I4MzYzOTA4ODJkNDQxZWI4ZGY5YTdmMzg4OWYyNDRfMjg4MQ_e9302be4-62a8-4b7e-a145-cfcc97229a1c">35</ix:nonFraction> million per incident and $<ix:nonFraction unitRef="usd" contextRef="i738c2d1dacaf436faf03cc46ab9cef23_I20230331" decimals="-6" name="cnmd:ProductLiabilityContingencyInsuranceAggregateAnnualAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV83Ni9mcmFnOmNiODM2MzkwODgyZDQ0MWViOGRmOWE3ZjM4ODlmMjQ0L3RleHRyZWdpb246Y2I4MzYzOTA4ODJkNDQxZWI4ZGY5YTdmMzg4OWYyNDRfMjkwMQ_4d71b8ad-b8c6-450a-b39b-3a1c4475c9c3">35</ix:nonFraction> million in the aggregate annually, which we believe is adequate.  This coverage is on a claims-made basis.  There can be no assurance that claims will not exceed insurance coverage, that the carriers will be solvent or that such insurance will be available to us in the future at a reasonable cost.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our operations are subject, and in the past have been subject, to a number of environmental laws and regulations governing, among other things, air emissions; wastewater discharges; the use, handling and disposal of hazardous substances and wastes; soil and groundwater remediation and employee health and safety.  Likewise, the operations of our suppliers and sterilizers are subject to similar environmental laws and regulations.  In some jurisdictions, environmental requirements may be expected to become more stringent in the future.  In the United States, certain environmental laws can impose liability for the entire cost of site restoration upon each of the parties that may have contributed to conditions at the site regardless of fault or </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline" href="#i952e7af9c0b94e65995973e7f212f399_7">Table of Contents</a></span></div></div><ix:continuation id="i8e06c178252841c29e045881f358b5a7"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the lawfulness of the party&#8217;s activities.  While we do not believe that the present costs of environmental compliance and remediation are material, there can be no assurance that future compliance or remedial obligations would not have a material adverse effect on our financial condition, results of operations or cash flows.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CONMED is defending two Georgia State Court actions.  The first action was filed in Cobb County by various employees, former employees, contract workers and others against CONMED and against a contract sterilizer (the "Cobb County Action"). The second action was filed in Douglas County against CONMED&#8217;s landlord and other allegedly related entities (the "Douglas County Action").  Plaintiffs in the lawsuits allege personal injury and related claims purportedly arising from or relating to exposure to Ethylene Oxide, a chemical used to sterilize certain products.  CONMED is defending the claims asserted directly against it and is providing indemnification for certain other defendants based on contractual provisions. </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Both actions are in their early stages.  The Company's motion to dismiss in the Cobb County action was heard on January 10, 2022, and the Court issued a ruling on June 15, 2022 dismissing 44 of the 51 plaintiffs' claims as precluded by the exclusive workers' compensation remedy, as well as one claim from a non-employee plaintiff.  As to the remaining claims that were not the subject of the motion to dismiss, CONMED believes it has strong defenses and will vigorously defend itself and all parties it is indemnifying.  As with any litigation, there are risks, including the risk that CONMED may not prevail with respect to the defense of the underlying claims, or with respect to securing adequate insurance coverage for the indemnification claims.  The Company is unable to estimate a range of possible loss at this time, and has not recorded any expense related to potential damages in connection with this matter because the Company does not believe any potential loss is probable.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">CONMED submitted the foregoing claims for insurance coverage.  One insurer is providing coverage for certain of the claims asserted directly against the Company.  CONMED litigated two lawsuits in the United States District Court for the Northern District of New York with Federal Insurance Company (&#8220;Chubb&#8221;): one involving CONMED&#8217;s claim for coverage for the indemnification claims arising from the Cobb County Action, and the other concerning CONMED&#8217;s claim for coverage for the indemnification claims arising from the Douglas County Action.  On March 10, 2022, the Court ruled in favor of CONMED with respect to coverage for the indemnification claims arising from the Cobb County Action.  Chubb's motion for reconsideration was denied, and Chubb filed a notice of appeal.  On August 9, 2022, CONMED won a similar ruling finding in its favor and against Chubb as to the coverage case concerning the Douglas County Action.  Chubb appealed that decision as well.  Chubb subsequently withdrew its appeal in connection with a favorable settlement between the parties.  There can be no assurance that Chubb will honor its obligations prospectively.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, one of CONMED&#8217;s contract sterilizers, which is defending toxic tort claims asserted by various residents in the areas around its processing facility, has placed CONMED on notice of a claim for indemnification relating to some of those claims.  CONMED is reviewing the notice, and has not at this time taken any position on the notice.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The government of Italy passed a law in late 2015 to tax medical device companies on revenue derived from sales to public hospitals.  The tax is calculated and based on provincial spending over and above certain thresholds.  Since the law was enacted, the Italian government essentially made no effort to administer or collect the tax.  A lack of interpretative guidance and complexity of the law resulted in uncertainty as to the actual amount of liability.  In September 2022, the Italian government passed a further decree which, amongst other provisions, delegated administration and collection to the provincial level for the years 2015 &#8211; 2018.  The Italy medical device tax represents variable consideration in the form of a retroactive discount potentially owed to the customer, which is ultimately the Italian government.  The Company is challenging the imposition of the medical device tax in Italy, as have many other medical device companies, on the ground that the law was never implemented properly with regulations.  While the Company is informed that its position is well-grounded in the law, there can be no assurance that the Company will prevail.  In January 2023, the Italian government postponed the due date for payment of the tax to allow time for Italian courts to rule on the constitutionality of the law.   No amounts have been remitted to date.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">From time to time, we are also subject to negligence and other claims arising out of the ordinary conduct of our business, including, for example, automobile or other accidents our employees may experience within the course of their employment or otherwise and which may, on occasion, involve potentially significant personal injuries or other exposures.  In the first quarter of 2023, the Company reached an agreement to settle one such personal injury lawsuit. The settlement is covered by the Company&#8217;s insurance coverage and did not have a material impact on our financial position or results of operations.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We record reserves sufficient to cover probable and estimable losses associated with any such pending claims.  We do not expect that the resolution of any pending claims, investigations or reports of alleged misconduct will have a material adverse effect on our financial condition, results of operations or cash flows.  There can be no assurance, however, that future claims or investigations, or the costs associated with responding to such claims, investigations or reports of misconduct, especially claims and investigations not covered by insurance, will not have a material adverse effect on our financial condition, results of operations or cash flows.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</span></div></div></div><div id="i952e7af9c0b94e65995973e7f212f399_79"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline" href="#i952e7af9c0b94e65995973e7f212f399_7">Table of Contents</a></span></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:19.837%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:57.025%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.838%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Item 2.</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION<br/>&#160;AND RESULTS OF OPERATIONS</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Forward-Looking Statements</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In this Report on Form 10-Q, we make forward-looking statements about our financial condition, results of operations and business.  Forward-looking statements are statements made by us concerning events that may or may not occur in the future.  These statements may be made directly in this document or may be &#8220;incorporated by reference&#8221; from other documents.  Such statements may be identified by the use of words such as &#8220;anticipates&#8221;, &#8220;expects&#8221;, &#8220;estimates&#8221;, &#8220;intends&#8221; and &#8220;believes&#8221; and variations thereof and other terms of similar meaning.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Forward-Looking Statements are not Guarantees of Future Performance</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Forward-looking statements involve known and unknown risks, uncertainties and other factors, including those that may cause our actual results, performance or achievements or industry results, to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements.  Such factors include those identified under &#8220;Risk Factors&#8221; in our Annual Report on Form 10-K for the year ended December&#160;31, 2022 and the following, among others:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">general economic and business conditions, including, without limitation, a potential economic downturn, supply chain challenges and constraints, including the availability and cost of materials, the effects of inflation, and increased interest rates;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">compliance with and changes in regulatory requirements;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the failure of any enterprise-wide software programs or information technology systems, or potential disruption associated with updating or implementing new software programs or information technology systems;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the risk of an information security breach, including a cybersecurity breach;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the COVID-19 global pandemic, which poses risks to our business, financial condition and results of operations as the pandemic and government and hospital responses to it, continue;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the possibility that United States or foreign regulatory and/or administrative agencies may initiate enforcement actions against us or our distributors;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the introduction and acceptance of new products;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the ability to advance our product lines, including challenges and uncertainties inherent in product research and development, and the uncertain impact, outcome and cost of ongoing and future clinical trials and market studies; </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">competition;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in customer preferences;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in technology;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">cyclical customer purchasing patterns due to budgetary, staffing and other constraints;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.15pt">environmental compliance risks, including lack of availability of sterilization with Ethylene Oxide (&#8220;EtO&#8221;) or other compliance costs associated with the use of EtO;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the quality of our management and business abilities and the judgment of our personnel, as well as our ability to attract, motivate and retain employees at all levels of the Company;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the availability, terms and deployment of capital;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">current and future levels of indebtedness and capital spending;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in foreign exchange and interest rates;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the ability to evaluate, finance and integrate acquired businesses, products and companies;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in business strategy;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the risk of a lack of allograft tissues due to reduced donations of such tissues or due to tissues not meeting the appropriate high standards for screening and/or processing of such tissues; </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the ability to defend and enforce intellectual property</span><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">,</span><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> including the risks related to theft or compromise of intellectual property in connection with our international operations;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the risk of patent, product and other litigation, as well as the cost associated with such litigation;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">trade protection measures, tariffs and other border taxes, and import or export licensing requirements; and</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">weather related events which may disrupt our operations.</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221; below and &#8220;Risk Factors&#8221; and &#8220;Business&#8221; in our Annual Report on Form 10-K for the year ended December&#160;31, 2022 for a further discussion of these factors.  You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof.  We do not undertake any obligation to publicly release any revisions to these forward-looking statements to reflect </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline" href="#i952e7af9c0b94e65995973e7f212f399_7">Table of Contents</a></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">events or circumstances after the date of this Quarterly Report on Form 10-Q or to reflect the occurrence of unanticipated events.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Overview</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CONMED Corporation (&#8220;CONMED&#8221;, the &#8220;Company&#8221;, &#8220;we&#8221; or &#8220;us&#8221;) is a medical technology company that provides devices and equipment for surgical procedures.  The Company&#8217;s products are used by surgeons and other healthcare professionals in a variety of specialties including orthopedics, general surgery, gynecology, thoracic surgery and gastroenterology.  </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our product lines consist of orthopedic surgery and general surgery.  Orthopedic surgery consists of sports medicine instrumentation and small bone, large bone and specialty powered surgical instruments as well as imaging systems for use in minimally invasive surgery procedures and service fees related to the promotion and marketing of sports medicine allograft tissue.  General surgery consists of a complete line of endo-mechanical instrumentation for minimally invasive laparoscopic and gastrointestinal procedures, smoke evacuation devices, a line of cardiac monitoring products as well as electrosurgical generators and related instruments.  These product lines as a percentage of consolidated net sales are as follows:</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:79.747%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.113%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Orthopedic surgery</span></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General surgery</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated net sales</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A significant amount of our products are used in surgical procedures with approximate</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ly </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">84% of our revenues derived from the sale of single-use products.  Our capital equipment offerings also facilitate the ongoing sale of related single-use products and accessories, thus providing us with a recurring revenue stream.  We manufacture substantially all of our products in facilities located in the United States and Mexico.  We market our products both domestically and internationally directly to customers and through distributors.  International sales approximated 44% and 46% of our</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> consolidated net sales duri</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ng the three months ended March 31, 2023 and 2022, respectively.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Business Environment </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has been and continues to be impacted by the macro-economic environment and we are experiencing higher manufacturing and operating costs caused by inflationary pressures and ongoing supply chain challenges.  We continuously work with suppliers to mitigate these impacts; however, we expect these challenges to continue through 2023.  This will likely impact our results of operations.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company has no direct operations in either Russia or Ukraine and our business is limited to selling to third party distributors.  Total revenues associated with sales to third party distributors in these countries are not material to the consolidated financial results, and we have fully reserved the outstanding accounts receivable from distributors in these territories which are not material.  We will continue to monitor and adjust our business strategy in this region as necessary.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">During the fourth quarter of 2022, we implemented a warehouse management system to increase capacity and efficiency, however this also caused significant delays in shipping and increased costs.  During the first quarter of 2023, we made significant progress and improvement with the performance of our warehouse management system and the shipping delays that existed at year-end 2022 were substantially reduced.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">However, we continue to incur certain incremental costs as a result of the implementation and there remains a risk of loss of sales and customers as a result of the shipping disruptions which occurred.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Critical Accounting Policies</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Preparation of our financial statements requires us to make estimates and assumptions which affect the reported amounts of assets, liabilities, revenues and expenses.  Note 1 to the Consolidated Financial Statements in our Annual Report on Form 10-K for the year ended December&#160;31, 2022 describes the significant accounting policies used in preparation of the Consolidated Financial Statements.  On an ongoing basis, we evaluate the critical accounting policies used to prepare our consolidated financial statements, including, but not limited to, those related to goodwill and intangible assets, contingent consideration and our pension benefit obligation.  </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline" href="#i952e7af9c0b94e65995973e7f212f399_7">Table of Contents</a></span></div></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div id="i952e7af9c0b94e65995973e7f212f399_82"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated Results of Operations</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents, as a percentage of net sales, certain categories included in our consolidated condensed statements of comprehensive income for the periods indicated:</span></div><div style="text-indent:36pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:79.747%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.113%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net sales</span></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling and administrative expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from operations</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income before income taxes</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for income taxes </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:22.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline" href="#i952e7af9c0b94e65995973e7f212f399_7">Table of Contents</a></span></div></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Net Sales</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents net sales by product line for the three months ended March 31, 2023 and 2022:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:40.016%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.060%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.060%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.060%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.060%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.208%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="15" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">% Change</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As Reported</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Impact of Foreign Currency</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Constant Currency</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Orthopedic surgery</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131.2&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107.5&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.0&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.0&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.0&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General surgery</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">164.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">134.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Net sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">295.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">242.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Single-use products</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">249.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">201.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital products</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Net sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">295.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">242.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Net sales increased 21.9% in the three months ended March&#160;31, 2023 compared to the same period a year ago as we made significant progress and improvement with the performance of our warehouse management system and the shipping delays that existed at year-end 2022 were substantially reduced in the quarter.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Further contributing to sales growth in the first quarter were $13.6&#160;million in sales from the recently acquired In2Bones and Biorez products and increases in our existing product lines. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Orthopedic surgery sales increased 22.0% in the three months ended March&#160;31, 2023 as a result of the recently acquired In2Bones and Biorez products and increases in our orthopedic product offerings. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">General surgery sales increased 21.9% in the three months ended March&#160;31, 2023 on growth in our AirSeal, Buffalo Filter and other surgical product offerings. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cost of Sales </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cost of sales increased to $140.1 million in the three months ended March&#160;31, 2023 as compared to $106.3 million in the three months ended March&#160;31, 2022.  Gross profit margins decreased 350 basis points to 52.6% in the three months ended March&#160;31, 2023 as compared to 56.1% in the three months ended March&#160;31, 2022.  Decreases in gross profit margins are driven by cost increases, inflation in raw materials, freight and other costs of production.  In addition, during the three months ended March&#160;31, 2023, we incurred costs for the amortization of inventory step-up to fair value of $2.1 million related to the In2Bones acquisition, $1.1 million in consulting fees related to a cost improvement initiative and $1.0 million in severance related to the elimination of certain positions.  </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Selling and Administrative Expense</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Selling and administrative expense increased to $130.1 million in the three months ended March&#160;31, 2023 as compared to $102.9 million in the three months ended March&#160;31, 2022.  Selling and administrative expense as a percentage of net sales increased to 44.0% in the three months ended March&#160;31, 2023 as compared to 42.5% in the three months ended March&#160;31, 2022.  The increase in selling and administrative expense as a percentage of net sales for the three months ended March&#160;31, 2023 was primarily driven by:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">$4.4&#160;million in costs related to fair value adjustments to contingent consideration;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">$4.3 million in costs related to the implementation of a new warehouse management system.  These costs mainly consisted of incremental freight, labor and travel costs as well as professional fees; and</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">$1.6 million in costs consisting of severance related to the elimination of certain positions.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">These increases are offset by lower ongoing selling and administrative expenses as a percentage of revenue as we leverage our existing selling and administrative structure.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline" href="#i952e7af9c0b94e65995973e7f212f399_7">Table of Contents</a></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Research and Development Expense</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development expense increased to $12.5 million in the three months ended March&#160;31, 2023 as compared to $10.7 million in the three months ended March&#160;31, 2022.  As a percentage of net sales, research and development expense decreased 20 basis points to 4.2% in the three months ended March&#160;31, 2023 as compared to 4.4% in the three months ended March&#160;31, 2022.  The lower spend as a percentage of sales for the three months ended March&#160;31, 2023 was mainly driven by higher sales in the three months ended March&#160;31, 2023 compared to the prior year period. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Interest Expense</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense increased to $10.3 million in the three months ended March&#160;31, 2023 from $5.0 million in the three months ended March&#160;31, 2022.   The weighted average interest rates on our borrowings increased to 3.14% in the three months ended March&#160;31, 2023 as compared to 2.22% in the three months ended March&#160;31, 2022.  The increase in interest expense in the three months ended March&#160;31, 2023 is primarily driven by the issuance of the 2.250% Notes in June 2022 as well as higher interest rates on our senior credit agreement.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Provision for Income Taxes</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company's tax provision for interim periods is determined using an estimate of its annual effective tax rate applied to its year-to-date earnings, and also adjusting for discrete items arising in that quarter. In each quarter, the Company updates its estimate of the annual effective tax rate and if the estimated annual effective tax rate changes, the Company would make a cumulative adjustment in that quarter.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income tax expense has been recorded at an effective tax rate of 25.6% for the three months ended March&#160;31, 2023 compared to an income tax expense at an effective tax rate of 14.2% for the three months ended March&#160;31, 2022.  The higher effective tax rate for the three months ended March&#160;31, 2023 as compared to the same period in the prior year was primarily the result of the lower income in 2023 incurring a higher percentage of tax expense and a reduction in discrete tax benefit relating to stock option exercises. The three months ended March 31, 2023 and 2022 included discrete income tax benefit from stock option exercises which reduced the effective tax rate by 2.4% and 9.8%, respectively. A reconciliation of the United States statutory income tax rate to our effective tax rate is included in our Annual Report on Form 10-K for the year ended December&#160;31, 2022 under Note 9 to the consolidated financial statements.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Non-GAAP Financial Measures</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net sales on a "constant currency" basis is a non-GAAP measure.  The Company analyzes net sales on a constant currency basis to better measure the comparability of results between periods.  To measure percentage sales growth in constant currency, the Company removes the impact of changes in foreign currency exchange rates that affect the comparability and trend of net sales. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because non-GAAP financial measures are not standardized, it may not be possible to compare this financial measure with other companies' non-GAAP financial measures having the same or similar names.  This adjusted financial measure should not be considered in isolation or as a substitute for reported net sales growth, the most directly comparable GAAP financial measure.  This non-GAAP financial measure is an additional way of viewing net sales that, when viewed with our GAAP results, provides a more complete understanding of our business.  The Company strongly encourages investors and shareholders to review our financial statements and publicly-filed reports in their entirety and not to rely on any single financial measure.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div id="i952e7af9c0b94e65995973e7f212f399_85"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Liquidity and Capital Resources</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our liquidity needs arise primarily from capital investments, working capital requirements and payments on indebtedness under the seventh amended and restated senior credit agreement.  We have historically met these liquidity requirements with funds generated from operations and borrowings under our revolving credit facility.  In addition, we have historically used term borrowings, including borrowings under the seventh amended and restated senior credit agreement to finance our acquisitions.  We also have the ability to raise funds through the sale of stock or we may issue debt through a private placement or public offering.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Operating cash flows</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Our net working capital position was $289.4 million at March&#160;31, 2023.&#160;&#160;Net cash used in operating activities was  $3.8 million in the three months ended March&#160;31, 2023 and net cash provided by operating activities was $0.3 million in the </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline" href="#i952e7af9c0b94e65995973e7f212f399_7">Table of Contents</a></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">three months ended March&#160;31, 2022, generated on net income of $1.8 million and $15.0 million for the three months ended March 31, 2023 and 2022, respectively.  The decrease in operating cash flows is primarily due to lower net income in the three months ended March&#160;31, 2023, compared to the prior year period.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Significant changes in assets and liabilities affecting cash flows  in the three months ended March&#160;31, 2023 include the following:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">A decrease in cash flows from accounts receivable based on the timing of sales and cash receipts;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">An increase in cash flows from accounts payable due to the timing of payments; and </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">A decrease in cash flows from accrued compensation and benefits as a result of incentive compensation payments.</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Investing cash flows</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash used in investing activities in the three months ended March&#160;31, 2023 increased $0.6 million from the same period a year ago primarily due to capital expenditures being higher at $4.3 million in the three months ended March&#160;31, 2023 compared to $3.7 million in the same period a year ago.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Financing cash flows</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash provided by financing activities in the three months ended March&#160;31, 2023 was $5.4 million compared to net cash provided by financing activities of $7.5 million during 2022.  Below is a summary of the significant financing activities impacting the change during the three months ended March&#160;31, 2023 compared to 2022:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">We had net borrowings on our revolving line of credit of $9.0 million, compared to net borrowings of $11.0 million during the three months ended March&#160;31, 2022.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">We had net payments on our term loan of $3.0 million during the three months ended March&#160;31, 2022.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">We paid $0.8 million in contingent consideration related to a prior acquisition during the three months ended March&#160;31, 2022.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">We had net cash proceeds of $3.4&#160;million related to stock issued under employee plans for the three months ended  March&#160;31, 2023 compared to $8.0&#160;million in the same period a year ago.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other Liquidity Matters</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our cash balances and cash flows generated from operations may be used to fund strategic investments, business acquisitions, working capital needs, research and development, common stock repurchases and payments of dividends to our shareholders. Management believes that cash flow from operations, including cash and cash equivalents on hand and available borrowing capacity under our seventh amended and restated senior credit agreement, will be adequate to meet our anticipated operating working capital requirements, debt service, funding of capital expenditures, dividend payments and common stock repurchases in the foreseeable future. In addition, management believes we could access capital markets, as necessary, to fund future business acquisitions.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is also being impacted by the macro-economic environment and we are experiencing higher manufacturing and operating costs caused by inflationary pressures and ongoing supply chain challenges.  We continue to monitor our spending and expenses in light of these factors. However, we may need to take further steps to reduce our costs, or to refinance our debt.  See &#8220;Item 1A. Risk Factors" in our Annual Report on Form 10-K for the year ended December&#160;31, 2022, for further discussion.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were $134.6 million in borrowings outstanding on the term loan facility as of March&#160;31, 2023.  There were $79.0 million in borrowings outstanding under the revolving credit facility as of March&#160;31, 2023.  Our available borrowings on the revolving credit facility at March&#160;31, 2023 were $504.2 million with approximately $1.8 million of the facility set aside for outstanding letters of credit.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The seventh amended and restated senior credit agreement is collateralized by substantially all of our personal property and assets.  The seventh amended and restated senior credit agreement contains covenants and restrictions which, among other things, require the maintenance of certain financial ratios and restrict dividend payments and the incurrence of certain indebtedness and other activities, including acquisitions and dispositions.  We were in full compliance with these covenants and restrictions as of March&#160;31, 2023.  We are also required, under certain circumstances, to make mandatory prepayments from net cash proceeds from any issuance of equity and asset sales.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 11 for further information on our financing agreements and outside debt obligations.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline" href="#i952e7af9c0b94e65995973e7f212f399_7">Table of Contents</a></span></div></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Board of Directors has authorized a $200.0 million share repurchase program.  Through March&#160;31, 2023, we have repurchased a total of 6.1 million shares of common stock aggregating $162.6 million under this authorization and have $37.4 million remaining available for share repurchases.  The repurchase program calls for shares to be purchased in the open market or in private transactions from time to time.  We may suspend or discontinue the share repurchase program at any time.  We have not purchased any shares of common stock under the share repurchase program during 2023.  We have financed the repurchases and may finance additional repurchases through operating cash flow and from available borrowings under our revolving credit facility.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">New accounting pronouncements</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 3 to the consolidated condensed financial statements for a discussion of new accounting pronouncements.</span></div><div><span><br/></span></div><div id="i952e7af9c0b94e65995973e7f212f399_88"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 3. Quantitative and Qualitative Disclosures About Market Risk</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There have been no significant changes in our primary market risk exposures or in how these exposures are managed during the three months ended March&#160;31, 2023.&#160;&#160;Reference is made to Item 7A. of our Annual Report on Form 10-K for the year ended December&#160;31, 2022 for a description of Qualitative and Quantitative Disclosures About Market Risk.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div id="i952e7af9c0b94e65995973e7f212f399_91"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 4.&#160;&#160;Controls and Procedures</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of the end of the period covered by this report, an evaluation was carried out by CONMED Corporation&#8217;s management, with the participation of our Chief Executive Officer and Chief Financial Officer, of the effectiveness of our disclosure controls and procedures (as defined in Rule 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934).&#160;&#160;Based upon that evaluation, our Chief Executive Officer and Chief Financial Officer concluded that these disclosure controls and procedures were effective as of the end of the period covered by this report.&#160;&#160;In addition, no change in our internal control over financial reporting (as defined in Rule 13a-15(f) and 15d-15(f) under the Securities Exchange Act of 1934) occurred during the quarter ended March&#160;31, 2023 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div id="i952e7af9c0b94e65995973e7f212f399_94"></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART II OTHER INFORMATION</span></div><div><span><br/></span></div><div id="i952e7af9c0b94e65995973e7f212f399_97"></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1. Legal Proceedings</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reference is made to Item 3 of the Company&#8217;s Annual Report on Form 10-K for the year ended December&#160;31, 2022 and to Note 15 of the Notes to Consolidated Condensed Financial Statements included in Part I of this Report for a description of certain legal matters.</span></div><div id="i952e7af9c0b94e65995973e7f212f399_100"></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline" href="#i952e7af9c0b94e65995973e7f212f399_7">Table of Contents</a></span></div></div><div style="text-align:justify"><span><br/></span></div><div id="i952e7af9c0b94e65995973e7f212f399_103"></div><div style="-sec-extract:summary"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 6.  Exhibits</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:11.052%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:86.748%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Exhibit Index</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit No.</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Description of Exhibit</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="cnmd33123ex311.htm">Certification of Curt R. Hartman pursuant to Rule 13a-14(a) or Rule 15d-14(a) of the Securities Exchange Act, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.2</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="cnmd33123ex312.htm">Certification of Todd W. Garner pursuant to Rule 13a-14(a) or Rule 15d-14(a) of the Securities Exchange Act, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="cnmd33123ex321.htm">Certifications of Curt R. Hartman and Todd W. Garner pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.INS</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.SCH</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Schema Document</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.CAL</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Calculation Linkbase Document</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.DEF</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Definition Linkbase Document</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.LAB</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Label Linkbase Document</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.PRE</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Presentation Linkbase Document</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cover Page - Interactive Data File - the cover page XBRL tags are embedded within the Inline XBRL document (included in Exhibit 101)</span></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26</span></div></div></div><div id="i952e7af9c0b94e65995973e7f212f399_106"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline" href="#i952e7af9c0b94e65995973e7f212f399_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized on the date indicated below.</span></div><div style="text-align:justify"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:4.610%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:58.197%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.893%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CONMED CORPORATION</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">By: /s/ Todd W. Garner</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Todd W. Garner</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice President and </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date:&#160;&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">April 27, 2023</span></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>2
<FILENAME>cnmd33123ex311.htm
<DESCRIPTION>EX-31.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="idfee69911ff647aaaece620a42fde9c8_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.1</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Curt R. Hartman, certify that&#58;</font></div><div style="margin-top:9pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">I have reviewed this quarterly report on Form 10-Q of CONMED Corporation&#59;</font></div><div style="margin-top:9pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-top:9pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-top:9pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-top:9pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.24pt">designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-top:9pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt">designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-top:9pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.24pt">evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-top:9pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt">disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting&#59; and</font></div><div style="margin-top:9pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-top:9pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.24pt">all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-top:9pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt">any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">April&#160;27, 2023 </font></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.228%"><tr><td style="width:1.0%"></td><td style="width:54.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:42.971%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">&#47;s&#47; Curt R. Hartman</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Curt R. Hartman</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chair of the Board, President &#38; Chief Executive Officer</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>3
<FILENAME>cnmd33123ex312.htm
<DESCRIPTION>EX-31.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="if817a32c700b497584150bc2d8322d42_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.2</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Todd W. Garner, certify that&#58;</font></div><div style="margin-top:9pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">I have reviewed this quarterly report on Form 10-Q of CONMED Corporation&#59;</font></div><div style="margin-top:9pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-top:9pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-top:9pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-top:9pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.24pt">designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-top:9pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt">designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-top:9pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.24pt">evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-top:9pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt">disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting&#59; and</font></div><div style="margin-top:9pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-top:9pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.24pt">all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-top:9pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt">any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">April&#160;27, 2023 </font></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.228%"><tr><td style="width:1.0%"></td><td style="width:54.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:42.971%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">&#47;s&#47; Todd W. Garner</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Todd W. Garner</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice President and </font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer</font></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>4
<FILENAME>cnmd33123ex321.htm
<DESCRIPTION>EX-32.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i1cc12ded234b4708b74998b0da87bb5a_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 32.1</font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATIONS</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(SUBSECTIONS (a) AND (b) OF SECTION 1350, CHAPTER 63 OF TITLE 18, UNITED STATES CODE)</font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of section 1350, chapter 63 of title 18, United States Code), each of the undersigned officers of CONMED Corporation, a Delaware corporation (the &#8220;Corporation&#8221;), does hereby certify that&#58;</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Quarterly Report on Form 10-Q for the quarter ended March&#160;31, 2023 (the &#8220;Form 10-Q&#8221;) of the Corporation fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934 and information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Corporation.</font></div><div><font><br></font></div><div><font><br></font></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:4.325%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.160%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:72.215%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">April 27, 2023</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">&#47;s&#47; Curt R. Hartman</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Curt R. Hartman</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chair of the Board, President &#38; <br>Chief Executive Officer</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">April 27, 2023</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">&#47;s&#47; Todd W. Garner</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Todd W. Garner</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice President and </font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer</font></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>5
<FILENAME>cnmd-20230331.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:30a13273-0e0a-49c8-aa2d-31e213cf1b75,g:3b97619f-d09a-4ff4-909a-c708e7b90654-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:cnmd="http://www.conmed.com/20230331" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.conmed.com/20230331">
  <xs:import namespace="http://fasb.org/srt/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/country/2022" schemaLocation="https://xbrl.sec.gov/country/2022/country-2022.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2022" schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="cnmd-20230331_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="cnmd-20230331_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="cnmd-20230331_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="cnmd-20230331_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="DocumentandEntityInformation" roleURI="http://www.conmed.com/role/DocumentandEntityInformation">
        <link:definition>0000001 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedCondensedStatementsofComprehensiveIncomeUnaudited" roleURI="http://www.conmed.com/role/ConsolidatedCondensedStatementsofComprehensiveIncomeUnaudited">
        <link:definition>0000002 - Statement - Consolidated Condensed Statements of Comprehensive Income (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedCondensedBalanceSheetsUnaudited" roleURI="http://www.conmed.com/role/ConsolidatedCondensedBalanceSheetsUnaudited">
        <link:definition>0000003 - Statement - Consolidated Condensed Balance Sheets (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedCondensedBalanceSheetsUnauditedParenthetical" roleURI="http://www.conmed.com/role/ConsolidatedCondensedBalanceSheetsUnauditedParenthetical">
        <link:definition>0000004 - Statement - Consolidated Condensed Balance Sheets (Unaudited) (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedCondensedStatementsofShareholdersEquityUnaudited" roleURI="http://www.conmed.com/role/ConsolidatedCondensedStatementsofShareholdersEquityUnaudited">
        <link:definition>0000005 - Statement - Consolidated Condensed Statements of Shareholders' Equity (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedCondensedStatementsofShareholdersEquityUnauditedParenthetical" roleURI="http://www.conmed.com/role/ConsolidatedCondensedStatementsofShareholdersEquityUnauditedParenthetical">
        <link:definition>0000006 - Statement - Consolidated Condensed Statements of Shareholders' Equity (Unaudited) (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedCondensedStatementsofCashFlowsUnaudited" roleURI="http://www.conmed.com/role/ConsolidatedCondensedStatementsofCashFlowsUnaudited">
        <link:definition>0000007 - Statement - Consolidated Condensed Statements of Cash Flows (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Operations" roleURI="http://www.conmed.com/role/Operations">
        <link:definition>0000008 - Disclosure - Operations</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InterimFinancialInformation" roleURI="http://www.conmed.com/role/InterimFinancialInformation">
        <link:definition>0000009 - Disclosure - Interim Financial Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NewAccountingPronouncements" roleURI="http://www.conmed.com/role/NewAccountingPronouncements">
        <link:definition>0000010 - Disclosure - New Accounting Pronouncements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessCombinations" roleURI="http://www.conmed.com/role/BusinessCombinations">
        <link:definition>0000011 - Disclosure - Business Combinations</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Revenues" roleURI="http://www.conmed.com/role/Revenues">
        <link:definition>0000012 - Disclosure - Revenues</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ComprehensiveIncome" roleURI="http://www.conmed.com/role/ComprehensiveIncome">
        <link:definition>0000013 - Disclosure - Comprehensive Income</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueofFinancialInstruments" roleURI="http://www.conmed.com/role/FairValueofFinancialInstruments">
        <link:definition>0000014 - Disclosure - Fair Value of Financial Instruments</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Inventories" roleURI="http://www.conmed.com/role/Inventories">
        <link:definition>0000015 - Disclosure - Inventories</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsPerShare" roleURI="http://www.conmed.com/role/EarningsPerShare">
        <link:definition>0000016 - Disclosure - Earnings Per Share</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandOtherIntangibleAssets" roleURI="http://www.conmed.com/role/GoodwillandOtherIntangibleAssets">
        <link:definition>0000017 - Disclosure - Goodwill and Other Intangible Assets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermDebt" roleURI="http://www.conmed.com/role/LongTermDebt">
        <link:definition>0000018 - Disclosure - Long Term Debt</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Guarantees" roleURI="http://www.conmed.com/role/Guarantees">
        <link:definition>0000019 - Disclosure - Guarantees</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PensionPlan" roleURI="http://www.conmed.com/role/PensionPlan">
        <link:definition>0000020 - Disclosure - Pension Plan</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessSegment" roleURI="http://www.conmed.com/role/BusinessSegment">
        <link:definition>0000021 - Disclosure - Business Segment</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LegalProceedings" roleURI="http://www.conmed.com/role/LegalProceedings">
        <link:definition>0000022 - Disclosure - Legal Proceedings</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InterimReportingPolicies" roleURI="http://www.conmed.com/role/InterimReportingPolicies">
        <link:definition>0000023 - Disclosure - Interim Reporting (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NewAccountingPronouncementsPolicies" roleURI="http://www.conmed.com/role/NewAccountingPronouncementsPolicies">
        <link:definition>0000024 - Disclosure - New Accounting Pronouncements (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenuesTables" roleURI="http://www.conmed.com/role/RevenuesTables">
        <link:definition>0000025 - Disclosure - Revenues (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ComprehensiveIncomeTables" roleURI="http://www.conmed.com/role/ComprehensiveIncomeTables">
        <link:definition>0000026 - Disclosure - Comprehensive Income (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueofFinancialInstrumentsTables" roleURI="http://www.conmed.com/role/FairValueofFinancialInstrumentsTables">
        <link:definition>0000027 - Disclosure - Fair Value of Financial Instruments (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InventoriesTables" roleURI="http://www.conmed.com/role/InventoriesTables">
        <link:definition>0000028 - Disclosure - Inventories (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsPerShareTables" roleURI="http://www.conmed.com/role/EarningsPerShareTables">
        <link:definition>0000029 - Disclosure - Earnings Per Share (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandOtherIntangibleAssetsTables" roleURI="http://www.conmed.com/role/GoodwillandOtherIntangibleAssetsTables">
        <link:definition>0000030 - Disclosure - Goodwill and Other Intangible Assets (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermDebtTables" roleURI="http://www.conmed.com/role/LongTermDebtTables">
        <link:definition>0000031 - Disclosure - Long Term Debt (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GuaranteesTables" roleURI="http://www.conmed.com/role/GuaranteesTables">
        <link:definition>0000032 - Disclosure - Guarantees (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PensionPlanTables" roleURI="http://www.conmed.com/role/PensionPlanTables">
        <link:definition>0000033 - Disclosure - Pension Plan (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessSegmentTables" roleURI="http://www.conmed.com/role/BusinessSegmentTables">
        <link:definition>0000034 - Disclosure - Business Segment (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessCombinationsDetails" roleURI="http://www.conmed.com/role/BusinessCombinationsDetails">
        <link:definition>0000035 - Disclosure - Business Combinations (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenuesDisaggregatedRevenuesDetails" roleURI="http://www.conmed.com/role/RevenuesDisaggregatedRevenuesDetails">
        <link:definition>0000036 - Disclosure - Revenues (Disaggregated Revenues) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenuesCustomerLiabilityDetails" roleURI="http://www.conmed.com/role/RevenuesCustomerLiabilityDetails">
        <link:definition>0000037 - Disclosure - Revenues (Customer Liability) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ComprehensiveIncomeDetails" roleURI="http://www.conmed.com/role/ComprehensiveIncomeDetails">
        <link:definition>0000038 - Disclosure - Comprehensive Income (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ComprehensiveIncomeAccumulatedOtherComprehensiveIncomeLossDetails" roleURI="http://www.conmed.com/role/ComprehensiveIncomeAccumulatedOtherComprehensiveIncomeLossDetails">
        <link:definition>0000039 - Disclosure - Comprehensive Income (Accumulated Other Comprehensive Income (Loss)) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueofFinancialInstrumentsAmountsRecordedInandReclassifiedFromAOCIDetails" roleURI="http://www.conmed.com/role/FairValueofFinancialInstrumentsAmountsRecordedInandReclassifiedFromAOCIDetails">
        <link:definition>0000040 - Disclosure - Fair Value of Financial Instruments (Amounts Recorded In and Reclassified From AOCI) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueofFinancialInstrumentsForeignCurrencyForwardContractsDetails" roleURI="http://www.conmed.com/role/FairValueofFinancialInstrumentsForeignCurrencyForwardContractsDetails">
        <link:definition>0000041 - Disclosure - Fair Value of Financial Instruments (Foreign Currency Forward Contracts) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueofFinancialInstrumentsContingentConsiderationDetails" roleURI="http://www.conmed.com/role/FairValueofFinancialInstrumentsContingentConsiderationDetails">
        <link:definition>0000042 - Disclosure - Fair Value of Financial Instruments (Contingent Consideration) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InventoriesDetails" roleURI="http://www.conmed.com/role/InventoriesDetails">
        <link:definition>0000043 - Disclosure - Inventories (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsPerShareDetails" roleURI="http://www.conmed.com/role/EarningsPerShareDetails">
        <link:definition>0000044 - Disclosure - Earnings Per Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandOtherIntangibleAssetsGoodwillDetails" roleURI="http://www.conmed.com/role/GoodwillandOtherIntangibleAssetsGoodwillDetails">
        <link:definition>0000045 - Disclosure - Goodwill and Other Intangible Assets (Goodwill) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandOtherIntangibleAssetsIntangibleAssetsDetails" roleURI="http://www.conmed.com/role/GoodwillandOtherIntangibleAssetsIntangibleAssetsDetails">
        <link:definition>0000046 - Disclosure - Goodwill and Other Intangible Assets (Intangible Assets) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermDebtDetails" roleURI="http://www.conmed.com/role/LongTermDebtDetails">
        <link:definition>0000047 - Disclosure - Long Term Debt (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermDebtAdditionalInformationDetails" roleURI="http://www.conmed.com/role/LongTermDebtAdditionalInformationDetails">
        <link:definition>0000048 - Disclosure - Long Term Debt Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermDebtMaturitiesofLongTermDebtDetails" roleURI="http://www.conmed.com/role/LongTermDebtMaturitiesofLongTermDebtDetails">
        <link:definition>0000049 - Disclosure - Long Term Debt Maturities of Long Term Debt (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GuaranteesDetails" roleURI="http://www.conmed.com/role/GuaranteesDetails">
        <link:definition>0000050 - Disclosure - Guarantees (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PensionPlanDetails" roleURI="http://www.conmed.com/role/PensionPlanDetails">
        <link:definition>0000051 - Disclosure - Pension Plan (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessSegmentDetails" roleURI="http://www.conmed.com/role/BusinessSegmentDetails">
        <link:definition>0000052 - Disclosure - Business Segment (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LegalProceedingsDetails" roleURI="http://www.conmed.com/role/LegalProceedingsDetails">
        <link:definition>0000053 - Disclosure - Legal Proceedings (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="cnmd_RevenuesMember" abstract="true" name="RevenuesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cnmd_ReductionofRevenueMember" abstract="true" name="ReductionofRevenueMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cnmd_HedgeAndWarrantTransactionsNetCashPaid" abstract="false" name="HedgeAndWarrantTransactionsNetCashPaid" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cnmd_BusinessCombinationPurchasePriceAdjustmentHoldback" abstract="false" name="BusinessCombinationPurchasePriceAdjustmentHoldback" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cnmd_OrthopedicSurgeryMember" abstract="true" name="OrthopedicSurgeryMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cnmd_ProductLiabilityContingencyInsuranceAggregateAnnualAmount" abstract="false" name="ProductLiabilityContingencyInsuranceAggregateAnnualAmount" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cnmd_AdjustedTermSOFRInterestRate" abstract="false" name="AdjustedTermSOFRInterestRate" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="cnmd_SalesrepresentationmarketingandpromotionalrightsMember" abstract="true" name="SalesrepresentationmarketingandpromotionalrightsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cnmd_AdjustedTermSOFRInterestRateMember" abstract="true" name="AdjustedTermSOFRInterestRateMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cnmd_ProductLiabilityContingencyInsuranceAmountPerIncident" abstract="false" name="ProductLiabilityContingencyInsuranceAmountPerIncident" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cnmd_IndexedTransactionTypeAxis" abstract="true" name="IndexedTransactionTypeAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="cnmd_A2.625PercentConvertibleNotesDue2024Member" abstract="true" name="A2.625PercentConvertibleNotesDue2024Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cnmd_AdjustedTermSOFRMember" abstract="true" name="AdjustedTermSOFRMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cnmd_In2BonesGlobalIncMember" abstract="true" name="In2BonesGlobalIncMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cnmd_BusinessAcquisitionContingentConsiderationAtFairValueRollForwardRollForward" abstract="true" name="BusinessAcquisitionContingentConsiderationAtFairValueRollForwardRollForward" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="cnmd_AmortizationOfInventoryStepUpAdjustments" abstract="false" name="AmortizationOfInventoryStepUpAdjustments" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cnmd_MeasurementInputRevenueVolatilityMember" abstract="true" name="MeasurementInputRevenueVolatilityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cnmd_BiorezIncMember" abstract="true" name="BiorezIncMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cnmd_CustomerandDistributorRelationshipsMember" abstract="true" name="CustomerandDistributorRelationshipsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cnmd_ScheduleOfFiniteLivedAndIndefiniteLivedAssetsLineItems" abstract="true" name="ScheduleOfFiniteLivedAndIndefiniteLivedAssetsLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="cnmd_AmendedAndRestatedSeniorCreditAgreementMember" abstract="true" name="AmendedAndRestatedSeniorCreditAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cnmd_AmericasexcludingtheUnitedStatesMember" abstract="true" name="AmericasexcludingtheUnitedStatesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cnmd_ExpenseMember" abstract="true" name="ExpenseMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cnmd_PaymentsForContingentConsideration" abstract="false" name="PaymentsForContingentConsideration" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cnmd_ScheduleOfFiniteLivedAndIndefiniteLivedAssetsTable" abstract="true" name="ScheduleOfFiniteLivedAndIndefiniteLivedAssetsTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="cnmd_A2250PercentConvertibleNotesDue2027Member" abstract="true" name="A2250PercentConvertibleNotesDue2027Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cnmd_ProductWarrantyAccrualTerm" abstract="false" name="ProductWarrantyAccrualTerm" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="cnmd_PatentsAndOtherIntangibleAssetsMember" abstract="true" name="PatentsAndOtherIntangibleAssetsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cnmd_TermSOFRInterestRateSpreadAdjustment" abstract="false" name="TermSOFRInterestRateSpreadAdjustment" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="cnmd_GeneralSurgeryMember" abstract="true" name="GeneralSurgeryMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cnmd_IndexedTransactionTypeDomain" abstract="true" name="IndexedTransactionTypeDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>6
<FILENAME>cnmd-20230331_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:30a13273-0e0a-49c8-aa2d-31e213cf1b75,g:3b97619f-d09a-4ff4-909a-c708e7b90654-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.conmed.com/role/ConsolidatedCondensedStatementsofComprehensiveIncomeUnaudited" xlink:type="simple" xlink:href="cnmd-20230331.xsd#ConsolidatedCondensedStatementsofComprehensiveIncomeUnaudited"/>
  <link:calculationLink xlink:role="http://www.conmed.com/role/ConsolidatedCondensedStatementsofComprehensiveIncomeUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_11c54392-25b8-430e-b885-4ef176644b52" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GrossProfit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_589a2708-19c6-4873-bed3-cecf8f9c4ef0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_11c54392-25b8-430e-b885-4ef176644b52" xlink:to="loc_us-gaap_Revenues_589a2708-19c6-4873-bed3-cecf8f9c4ef0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_16d24c1f-9cf9-4984-a10c-a8aaf55ac807" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_11c54392-25b8-430e-b885-4ef176644b52" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_16d24c1f-9cf9-4984-a10c-a8aaf55ac807" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_3c6c9603-18de-4f91-afed-cdc38fd653e9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_291812ff-f678-4180-afa0-db2000126710" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_3c6c9603-18de-4f91-afed-cdc38fd653e9" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_291812ff-f678-4180-afa0-db2000126710" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_710a1976-13e4-4192-88ae-7dd2830df97b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_3c6c9603-18de-4f91-afed-cdc38fd653e9" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_710a1976-13e4-4192-88ae-7dd2830df97b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_1a06f96f-cc13-439d-b463-e4e590be3ae2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_4aeba6f4-0f3e-4c24-a54a-be3abf75134a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_1a06f96f-cc13-439d-b463-e4e590be3ae2" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_4aeba6f4-0f3e-4c24-a54a-be3abf75134a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_88977bab-e537-47a9-886a-5b59076cd1dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_1a06f96f-cc13-439d-b463-e4e590be3ae2" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_88977bab-e537-47a9-886a-5b59076cd1dc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2913bc26-5f7a-4927-90e8-ba6800fc522c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_98da2bba-0954-41ef-ad1d-cd9922926578" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2913bc26-5f7a-4927-90e8-ba6800fc522c" xlink:to="loc_us-gaap_OperatingIncomeLoss_98da2bba-0954-41ef-ad1d-cd9922926578" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_7881a630-f3b2-40d3-ab4e-12d00ce34f30" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2913bc26-5f7a-4927-90e8-ba6800fc522c" xlink:to="loc_us-gaap_InterestExpense_7881a630-f3b2-40d3-ab4e-12d00ce34f30" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_b7a6b06c-1b63-4cf0-888b-2de156a9b722" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_ee449724-96ec-4893-bac3-c1a1c25aded6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GrossProfit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_b7a6b06c-1b63-4cf0-888b-2de156a9b722" xlink:to="loc_us-gaap_GrossProfit_ee449724-96ec-4893-bac3-c1a1c25aded6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_3bab0c36-0bfc-4c73-8e48-9a767dc75324" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_b7a6b06c-1b63-4cf0-888b-2de156a9b722" xlink:to="loc_us-gaap_OperatingExpenses_3bab0c36-0bfc-4c73-8e48-9a767dc75324" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.conmed.com/role/ConsolidatedCondensedBalanceSheetsUnaudited" xlink:type="simple" xlink:href="cnmd-20230331.xsd#ConsolidatedCondensedBalanceSheetsUnaudited"/>
  <link:calculationLink xlink:role="http://www.conmed.com/role/ConsolidatedCondensedBalanceSheetsUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_5cefdb34-ddc4-4e3a-807b-c26a678f8816" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_d4ff40b9-7120-4b89-a9e8-f424a6e52c40" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_5cefdb34-ddc4-4e3a-807b-c26a678f8816" xlink:to="loc_us-gaap_PreferredStockValue_d4ff40b9-7120-4b89-a9e8-f424a6e52c40" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_98d7c803-91b3-4802-8558-5b0da2edf4e9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_5cefdb34-ddc4-4e3a-807b-c26a678f8816" xlink:to="loc_us-gaap_CommonStockValue_98d7c803-91b3-4802-8558-5b0da2edf4e9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_6aa7c7da-a93f-463d-9a84-824a2f9bd63c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_5cefdb34-ddc4-4e3a-807b-c26a678f8816" xlink:to="loc_us-gaap_AdditionalPaidInCapital_6aa7c7da-a93f-463d-9a84-824a2f9bd63c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_853b7c5e-2994-493a-931b-c50766e67162" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_5cefdb34-ddc4-4e3a-807b-c26a678f8816" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_853b7c5e-2994-493a-931b-c50766e67162" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_3b60e48b-c06e-4b98-a7d8-05ae580b1c5f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_5cefdb34-ddc4-4e3a-807b-c26a678f8816" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_3b60e48b-c06e-4b98-a7d8-05ae580b1c5f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonValue_47859983-1c95-425e-9a6b-28270b9fa6c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockCommonValue"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_5cefdb34-ddc4-4e3a-807b-c26a678f8816" xlink:to="loc_us-gaap_TreasuryStockCommonValue_47859983-1c95-425e-9a6b-28270b9fa6c9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_21c7cb41-e22b-4c05-86de-acd9512b98d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_fae556d2-a8a0-4ee6-bc85-eb6213ad36bb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_21c7cb41-e22b-4c05-86de-acd9512b98d4" xlink:to="loc_us-gaap_Liabilities_fae556d2-a8a0-4ee6-bc85-eb6213ad36bb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_d75adb1a-9ac2-4d22-99ae-4d63861afee6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_21c7cb41-e22b-4c05-86de-acd9512b98d4" xlink:to="loc_us-gaap_StockholdersEquity_d75adb1a-9ac2-4d22-99ae-4d63861afee6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_d640e1ec-ee4f-453a-b68c-cb7cafddfa23" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_21c7cb41-e22b-4c05-86de-acd9512b98d4" xlink:to="loc_us-gaap_CommitmentsAndContingencies_d640e1ec-ee4f-453a-b68c-cb7cafddfa23" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_b4c4f4e4-201c-4bf9-b002-9cfecd6e0f08" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_57caa788-0bd1-4077-a757-2aff8724577a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_b4c4f4e4-201c-4bf9-b002-9cfecd6e0f08" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_57caa788-0bd1-4077-a757-2aff8724577a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_98d51bff-b934-4ce8-be5e-fd5e734e1b20" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_b4c4f4e4-201c-4bf9-b002-9cfecd6e0f08" xlink:to="loc_us-gaap_AccountsPayableCurrent_98d51bff-b934-4ce8-be5e-fd5e734e1b20" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_bdba16cc-c069-4c59-b6e6-e111cf124a5a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_b4c4f4e4-201c-4bf9-b002-9cfecd6e0f08" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_bdba16cc-c069-4c59-b6e6-e111cf124a5a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_0b2c7486-35b4-412b-9aef-a70239eeab22" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_b4c4f4e4-201c-4bf9-b002-9cfecd6e0f08" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_0b2c7486-35b4-412b-9aef-a70239eeab22" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_542f673f-5f3d-4c61-876b-9c0159d4ac80" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_31c60a7a-573b-4188-9307-341b61919517" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_542f673f-5f3d-4c61-876b-9c0159d4ac80" xlink:to="loc_us-gaap_AssetsCurrent_31c60a7a-573b-4188-9307-341b61919517" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_d523cfc0-3924-4b44-9881-2cf25a2fc633" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_542f673f-5f3d-4c61-876b-9c0159d4ac80" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_d523cfc0-3924-4b44-9881-2cf25a2fc633" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_bef70967-6149-4d79-b27a-1ad023844366" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_542f673f-5f3d-4c61-876b-9c0159d4ac80" xlink:to="loc_us-gaap_Goodwill_bef70967-6149-4d79-b27a-1ad023844366" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_4ad1aee9-2cc5-42df-bee7-6cf492a9b14a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_542f673f-5f3d-4c61-876b-9c0159d4ac80" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_4ad1aee9-2cc5-42df-bee7-6cf492a9b14a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_e34b4dba-7875-4ece-be57-ddb84b7180d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_542f673f-5f3d-4c61-876b-9c0159d4ac80" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_e34b4dba-7875-4ece-be57-ddb84b7180d3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_eadff24c-8c48-4685-9054-088ef248945f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_cfe4fb45-2f33-4e51-be52-7ec698bfc4cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_eadff24c-8c48-4685-9054-088ef248945f" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_cfe4fb45-2f33-4e51-be52-7ec698bfc4cf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_96b8da90-dc4c-4307-96d0-1452ad830f76" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_eadff24c-8c48-4685-9054-088ef248945f" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_96b8da90-dc4c-4307-96d0-1452ad830f76" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_0ac8053a-9642-44b5-8f5b-4f46736496d5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_eadff24c-8c48-4685-9054-088ef248945f" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_0ac8053a-9642-44b5-8f5b-4f46736496d5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_e5310b89-b5f2-4f61-ada9-a0bfc1b77e27" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_eadff24c-8c48-4685-9054-088ef248945f" xlink:to="loc_us-gaap_LiabilitiesCurrent_e5310b89-b5f2-4f61-ada9-a0bfc1b77e27" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_eec94c52-df5c-48f4-b41d-3014a8cfa2ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_bc0941b2-fc77-4822-a690-7fce5b9cd794" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_eec94c52-df5c-48f4-b41d-3014a8cfa2ba" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_bc0941b2-fc77-4822-a690-7fce5b9cd794" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_68bd7f54-d24b-44b9-a5c3-71733c1b8f04" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_eec94c52-df5c-48f4-b41d-3014a8cfa2ba" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_68bd7f54-d24b-44b9-a5c3-71733c1b8f04" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_3685f507-7482-4faa-b46f-bcf9b00aa892" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_eec94c52-df5c-48f4-b41d-3014a8cfa2ba" xlink:to="loc_us-gaap_InventoryNet_3685f507-7482-4faa-b46f-bcf9b00aa892" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_f90a9dbd-e9da-4853-bdcc-c92287f901aa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_eec94c52-df5c-48f4-b41d-3014a8cfa2ba" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_f90a9dbd-e9da-4853-bdcc-c92287f901aa" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.conmed.com/role/ConsolidatedCondensedStatementsofCashFlowsUnaudited" xlink:type="simple" xlink:href="cnmd-20230331.xsd#ConsolidatedCondensedStatementsofCashFlowsUnaudited"/>
  <link:calculationLink xlink:role="http://www.conmed.com/role/ConsolidatedCondensedStatementsofCashFlowsUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_58b19b98-21f1-4aa3-81be-2851b7af5566" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_527b2415-97d0-4c7b-8353-914da156ecb6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_58b19b98-21f1-4aa3-81be-2851b7af5566" xlink:to="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_527b2415-97d0-4c7b-8353-914da156ecb6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_PaymentsForContingentConsideration_c0783569-a625-4324-b29b-cec49ddb0ea8" xlink:href="cnmd-20230331.xsd#cnmd_PaymentsForContingentConsideration"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_58b19b98-21f1-4aa3-81be-2851b7af5566" xlink:to="loc_cnmd_PaymentsForContingentConsideration_c0783569-a625-4324-b29b-cec49ddb0ea8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLinesOfCredit_2f41b32a-7580-4101-ad7e-2251becb5031" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromLinesOfCredit"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_58b19b98-21f1-4aa3-81be-2851b7af5566" xlink:to="loc_us-gaap_ProceedsFromLinesOfCredit_2f41b32a-7580-4101-ad7e-2251becb5031" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsCommonStock_ec59e1ca-0d1b-46ff-bc3e-44f5959b8274" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDividendsCommonStock"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_58b19b98-21f1-4aa3-81be-2851b7af5566" xlink:to="loc_us-gaap_PaymentsOfDividendsCommonStock_ec59e1ca-0d1b-46ff-bc3e-44f5959b8274" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfSeniorDebt_d305bf32-32ae-4abe-ba46-759cb6061497" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfSeniorDebt"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_58b19b98-21f1-4aa3-81be-2851b7af5566" xlink:to="loc_us-gaap_RepaymentsOfSeniorDebt_d305bf32-32ae-4abe-ba46-759cb6061497" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLinesOfCredit_3867167a-3c08-49dc-813c-75309a3cabe6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfLinesOfCredit"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_58b19b98-21f1-4aa3-81be-2851b7af5566" xlink:to="loc_us-gaap_RepaymentsOfLinesOfCredit_3867167a-3c08-49dc-813c-75309a3cabe6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_99f1eb46-b316-4c95-9f4b-bf57e299bc12" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_162c68c2-1fc7-4efa-a3c5-e5056cbed9b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_99f1eb46-b316-4c95-9f4b-bf57e299bc12" xlink:to="loc_us-gaap_NetIncomeLoss_162c68c2-1fc7-4efa-a3c5-e5056cbed9b3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_5836b292-15c4-4aea-88e9-703ed7004605" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Depreciation"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_99f1eb46-b316-4c95-9f4b-bf57e299bc12" xlink:to="loc_us-gaap_Depreciation_5836b292-15c4-4aea-88e9-703ed7004605" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts_15771da9-d9f6-4ebd-a39b-d85e6b60e7ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_99f1eb46-b316-4c95-9f4b-bf57e299bc12" xlink:to="loc_us-gaap_AmortizationOfFinancingCosts_15771da9-d9f6-4ebd-a39b-d85e6b60e7ef" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAmortizationOfDeferredCharges_5a49a5e7-b46b-48f2-a19a-d4f0e7413c4b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAmortizationOfDeferredCharges"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_99f1eb46-b316-4c95-9f4b-bf57e299bc12" xlink:to="loc_us-gaap_OtherAmortizationOfDeferredCharges_5a49a5e7-b46b-48f2-a19a-d4f0e7413c4b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_720cf7a7-2c95-4384-9f89-13b22b956c2e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_99f1eb46-b316-4c95-9f4b-bf57e299bc12" xlink:to="loc_us-gaap_ShareBasedCompensation_720cf7a7-2c95-4384-9f89-13b22b956c2e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_a2fbc625-6677-4c89-971f-dad8ecc5c6a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_99f1eb46-b316-4c95-9f4b-bf57e299bc12" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_a2fbc625-6677-4c89-971f-dad8ecc5c6a8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_802c63e2-1651-4735-8641-94d770c08987" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_99f1eb46-b316-4c95-9f4b-bf57e299bc12" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_802c63e2-1651-4735-8641-94d770c08987" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_9ae5f842-0ac3-476e-afa0-cc636b3dd282" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_99f1eb46-b316-4c95-9f4b-bf57e299bc12" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_9ae5f842-0ac3-476e-afa0-cc636b3dd282" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_1783cf8e-8c64-4cea-b746-341952ad018a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:calculationArc order="9" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_99f1eb46-b316-4c95-9f4b-bf57e299bc12" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_1783cf8e-8c64-4cea-b746-341952ad018a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_090eb9dc-e2d6-43c3-9a55-c9a5bef9ebbd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_99f1eb46-b316-4c95-9f4b-bf57e299bc12" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_090eb9dc-e2d6-43c3-9a55-c9a5bef9ebbd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_79af93e1-7ad7-4a9b-a428-0f248ad19cf3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_99f1eb46-b316-4c95-9f4b-bf57e299bc12" xlink:to="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_79af93e1-7ad7-4a9b-a428-0f248ad19cf3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_85ee017c-94a1-4a6c-b5e5-49ea4a2c5992" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:calculationArc order="12" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_99f1eb46-b316-4c95-9f4b-bf57e299bc12" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_85ee017c-94a1-4a6c-b5e5-49ea4a2c5992" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_da8fed96-076f-4510-99e9-2ed6d422303b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherOperatingLiabilities"/>
    <link:calculationArc order="13" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_99f1eb46-b316-4c95-9f4b-bf57e299bc12" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_da8fed96-076f-4510-99e9-2ed6d422303b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_04f07cd4-022b-4556-b742-269e87d2cd27" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_4b3cb368-2223-4d6a-82b1-a76b593f7944" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_04f07cd4-022b-4556-b742-269e87d2cd27" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_4b3cb368-2223-4d6a-82b1-a76b593f7944" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_28ef1923-1633-42e6-b146-f35732a4583c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_bde718fb-7bbe-49dc-9d50-59b32d26091e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_28ef1923-1633-42e6-b146-f35732a4583c" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_bde718fb-7bbe-49dc-9d50-59b32d26091e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_4e8ac7ea-a1b3-4a29-a606-cf0061d76737" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_28ef1923-1633-42e6-b146-f35732a4583c" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_4e8ac7ea-a1b3-4a29-a606-cf0061d76737" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_16d35aa0-f374-48e8-a402-47195e002e42" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_28ef1923-1633-42e6-b146-f35732a4583c" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_16d35aa0-f374-48e8-a402-47195e002e42" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_5942474c-e0e8-4dc8-9be4-c506a1b8c8e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_28ef1923-1633-42e6-b146-f35732a4583c" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_5942474c-e0e8-4dc8-9be4-c506a1b8c8e0" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.conmed.com/role/ComprehensiveIncomeDetails" xlink:type="simple" xlink:href="cnmd-20230331.xsd#ComprehensiveIncomeDetails"/>
  <link:calculationLink xlink:role="http://www.conmed.com/role/ComprehensiveIncomeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_fb489bab-9b14-4dd7-8742-c460ac29753d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_c2fa8155-c372-4c5d-bfa0-0b1e519a97b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_fb489bab-9b14-4dd7-8742-c460ac29753d" xlink:to="loc_us-gaap_NetIncomeLoss_c2fa8155-c372-4c5d-bfa0-0b1e519a97b0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_b09e4ca0-c843-41c4-b4ec-cbaf63a65266" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_fb489bab-9b14-4dd7-8742-c460ac29753d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_b09e4ca0-c843-41c4-b4ec-cbaf63a65266" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_f29a9e76-c576-4ab4-a66d-d5165b9b3827" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_fb489bab-9b14-4dd7-8742-c460ac29753d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_f29a9e76-c576-4ab4-a66d-d5165b9b3827" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_9fc7a4b3-f015-45ee-ac37-bd3b04914f24" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_fb489bab-9b14-4dd7-8742-c460ac29753d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_9fc7a4b3-f015-45ee-ac37-bd3b04914f24" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.conmed.com/role/ComprehensiveIncomeAccumulatedOtherComprehensiveIncomeLossDetails" xlink:type="simple" xlink:href="cnmd-20230331.xsd#ComprehensiveIncomeAccumulatedOtherComprehensiveIncomeLossDetails"/>
  <link:calculationLink xlink:role="http://www.conmed.com/role/ComprehensiveIncomeAccumulatedOtherComprehensiveIncomeLossDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_988521c2-c4d7-43c5-8732-7c1f40ec0ddc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_4e2d293d-5207-4f54-9a2a-afe028820a19" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_988521c2-c4d7-43c5-8732-7c1f40ec0ddc" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_4e2d293d-5207-4f54-9a2a-afe028820a19" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax_f30c69f4-fa83-4634-8a3b-178a918bb036" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_988521c2-c4d7-43c5-8732-7c1f40ec0ddc" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax_f30c69f4-fa83-4634-8a3b-178a918bb036" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodTax_ecfed922-5399-4e95-9bac-1f82bc83e264" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAociCurrentPeriodTax"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_988521c2-c4d7-43c5-8732-7c1f40ec0ddc" xlink:to="loc_us-gaap_ReclassificationFromAociCurrentPeriodTax_ecfed922-5399-4e95-9bac-1f82bc83e264" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.conmed.com/role/FairValueofFinancialInstrumentsForeignCurrencyForwardContractsDetails" xlink:type="simple" xlink:href="cnmd-20230331.xsd#FairValueofFinancialInstrumentsForeignCurrencyForwardContractsDetails"/>
  <link:calculationLink xlink:role="http://www.conmed.com/role/FairValueofFinancialInstrumentsForeignCurrencyForwardContractsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet_cff712fd-5927-4300-bf70-d07124d4b71c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_16a03ea5-a23c-471b-b76e-fbbdf2e78398" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet_cff712fd-5927-4300-bf70-d07124d4b71c" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_16a03ea5-a23c-471b-b76e-fbbdf2e78398" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_fbf30724-6e29-4c18-9d33-5222377debde" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet_cff712fd-5927-4300-bf70-d07124d4b71c" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_fbf30724-6e29-4c18-9d33-5222377debde" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.conmed.com/role/InventoriesDetails" xlink:type="simple" xlink:href="cnmd-20230331.xsd#InventoriesDetails"/>
  <link:calculationLink xlink:role="http://www.conmed.com/role/InventoriesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_9afda7f8-0b19-4d59-bbc3-ccba2af23a9b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves_235de8b9-7fdf-4d92-94a1-2204f8f44fa5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_9afda7f8-0b19-4d59-bbc3-ccba2af23a9b" xlink:to="loc_us-gaap_InventoryRawMaterialsNetOfReserves_235de8b9-7fdf-4d92-94a1-2204f8f44fa5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves_f0fb40e2-a4e3-42a7-8474-796e61a5f4de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_9afda7f8-0b19-4d59-bbc3-ccba2af23a9b" xlink:to="loc_us-gaap_InventoryWorkInProcessNetOfReserves_f0fb40e2-a4e3-42a7-8474-796e61a5f4de" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_39faf80f-b405-434b-8b6e-ab9cea329770" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_9afda7f8-0b19-4d59-bbc3-ccba2af23a9b" xlink:to="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_39faf80f-b405-434b-8b6e-ab9cea329770" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.conmed.com/role/EarningsPerShareDetails" xlink:type="simple" xlink:href="cnmd-20230331.xsd#EarningsPerShareDetails"/>
  <link:calculationLink xlink:role="http://www.conmed.com/role/EarningsPerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_6e1d4b5b-a494-4616-975c-f663971a3ad6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_eed817d7-1c5b-4a16-ae8f-b5fc956ba1fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_6e1d4b5b-a494-4616-975c-f663971a3ad6" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_eed817d7-1c5b-4a16-ae8f-b5fc956ba1fc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_48dc4aa5-43ef-44b2-9b09-e1da8e75a511" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_6e1d4b5b-a494-4616-975c-f663971a3ad6" xlink:to="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_48dc4aa5-43ef-44b2-9b09-e1da8e75a511" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_98656a85-a5d4-4a05-890d-d7f27ca22025" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_9425aef9-fee2-4418-bc5b-908a8ca3c4e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_98656a85-a5d4-4a05-890d-d7f27ca22025" xlink:to="loc_us-gaap_NetIncomeLoss_9425aef9-fee2-4418-bc5b-908a8ca3c4e0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestOnConvertibleDebtNetOfTax_d16e9f1e-7023-4421-b6a8-40c0800e95c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestOnConvertibleDebtNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_98656a85-a5d4-4a05-890d-d7f27ca22025" xlink:to="loc_us-gaap_InterestOnConvertibleDebtNetOfTax_d16e9f1e-7023-4421-b6a8-40c0800e95c9" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.conmed.com/role/GoodwillandOtherIntangibleAssetsIntangibleAssetsDetails" xlink:type="simple" xlink:href="cnmd-20230331.xsd#GoodwillandOtherIntangibleAssetsIntangibleAssetsDetails"/>
  <link:calculationLink xlink:role="http://www.conmed.com/role/GoodwillandOtherIntangibleAssetsIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_7c7a7892-a139-4830-b2d4-c8a05aa4da6f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_a981e187-67cf-43f8-ad32-d65238fcab4f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_7c7a7892-a139-4830-b2d4-c8a05aa4da6f" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_a981e187-67cf-43f8-ad32-d65238fcab4f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_5dfde882-b9e7-4e3f-abe6-3043e0a81963" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_7c7a7892-a139-4830-b2d4-c8a05aa4da6f" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_5dfde882-b9e7-4e3f-abe6-3043e0a81963" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.conmed.com/role/LongTermDebtDetails" xlink:type="simple" xlink:href="cnmd-20230331.xsd#LongTermDebtDetails"/>
  <link:calculationLink xlink:role="http://www.conmed.com/role/LongTermDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities_7f2460af-62b7-45f3-ae38-d2c1c5214931" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_d2ff4442-6ec0-4911-88f3-d1237c54eb03" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities_7f2460af-62b7-45f3-ae38-d2c1c5214931" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_d2ff4442-6ec0-4911-88f3-d1237c54eb03" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_88be34bf-1294-4400-bfde-b08731622934" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities_7f2460af-62b7-45f3-ae38-d2c1c5214931" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_88be34bf-1294-4400-bfde-b08731622934" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.conmed.com/role/PensionPlanDetails" xlink:type="simple" xlink:href="cnmd-20230331.xsd#PensionPlanDetails"/>
  <link:calculationLink xlink:role="http://www.conmed.com/role/PensionPlanDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_6d38dc5b-fafa-4ba3-a32e-9c92ab7fc9c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost_4efdf70f-2be9-43bb-8bfd-f29d9b665936" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_6d38dc5b-fafa-4ba3-a32e-9c92ab7fc9c8" xlink:to="loc_us-gaap_DefinedBenefitPlanServiceCost_4efdf70f-2be9-43bb-8bfd-f29d9b665936" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost_cca0ba95-d57d-4490-afdf-508d3a852114" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_6d38dc5b-fafa-4ba3-a32e-9c92ab7fc9c8" xlink:to="loc_us-gaap_DefinedBenefitPlanInterestCost_cca0ba95-d57d-4490-afdf-508d3a852114" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_f2c39a82-c392-4cba-b3d3-6b36bd83f2e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_6d38dc5b-fafa-4ba3-a32e-9c92ab7fc9c8" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_f2c39a82-c392-4cba-b3d3-6b36bd83f2e1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_bcad360e-0fab-47d1-93d3-25cb20016e19" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_6d38dc5b-fafa-4ba3-a32e-9c92ab7fc9c8" xlink:to="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_bcad360e-0fab-47d1-93d3-25cb20016e19" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>7
<FILENAME>cnmd-20230331_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:30a13273-0e0a-49c8-aa2d-31e213cf1b75,g:3b97619f-d09a-4ff4-909a-c708e7b90654-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.conmed.com/role/ConsolidatedCondensedStatementsofShareholdersEquityUnaudited" xlink:type="simple" xlink:href="cnmd-20230331.xsd#ConsolidatedCondensedStatementsofShareholdersEquityUnaudited"/>
  <link:definitionLink xlink:role="http://www.conmed.com/role/ConsolidatedCondensedStatementsofShareholdersEquityUnaudited" xlink:type="extended" id="i9903cbb8fed54f8abe960b3c07dab0f5_ConsolidatedCondensedStatementsofShareholdersEquityUnaudited">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_cd163b1c-bdb8-4142-9e76-97723e3c744b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e5d6d0df-04b3-45db-8aa4-5c0b35caaf34" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_cd163b1c-bdb8-4142-9e76-97723e3c744b" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e5d6d0df-04b3-45db-8aa4-5c0b35caaf34" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_f9116a32-1381-46e6-850b-ee1ec733da11" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e5d6d0df-04b3-45db-8aa4-5c0b35caaf34" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_f9116a32-1381-46e6-850b-ee1ec733da11" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_f7f6afaf-0bd6-4042-b271-49b3ebda6fce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e5d6d0df-04b3-45db-8aa4-5c0b35caaf34" xlink:to="loc_us-gaap_StockholdersEquity_f7f6afaf-0bd6-4042-b271-49b3ebda6fce" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_7577e175-1739-429e-a5c6-01ee7d04aae7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e5d6d0df-04b3-45db-8aa4-5c0b35caaf34" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_7577e175-1739-429e-a5c6-01ee7d04aae7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_2dc97936-f56b-48c9-9e89-350f7df3409a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e5d6d0df-04b3-45db-8aa4-5c0b35caaf34" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_2dc97936-f56b-48c9-9e89-350f7df3409a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStockCash_700db0c5-2eb4-493d-9106-5d085b10f9bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsCommonStockCash"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e5d6d0df-04b3-45db-8aa4-5c0b35caaf34" xlink:to="loc_us-gaap_DividendsCommonStockCash_700db0c5-2eb4-493d-9106-5d085b10f9bd" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_da5e401c-8468-420c-b15e-be2851855a89" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e5d6d0df-04b3-45db-8aa4-5c0b35caaf34" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_da5e401c-8468-420c-b15e-be2851855a89" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_3d1beb47-94fa-480f-841a-30c8738bd337" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_da5e401c-8468-420c-b15e-be2851855a89" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_3d1beb47-94fa-480f-841a-30c8738bd337" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_12bcf127-e0ee-4495-87b3-7d91250558d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_da5e401c-8468-420c-b15e-be2851855a89" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_12bcf127-e0ee-4495-87b3-7d91250558d8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_816e82af-374a-4527-a906-faa12a71ffdc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_da5e401c-8468-420c-b15e-be2851855a89" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_816e82af-374a-4527-a906-faa12a71ffdc" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_a5cb1156-48b0-4c62-acfd-9780cbf1e91f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_da5e401c-8468-420c-b15e-be2851855a89" xlink:to="loc_us-gaap_NetIncomeLoss_a5cb1156-48b0-4c62-acfd-9780cbf1e91f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_ed2d19a6-0244-476c-ba75-0cf85b200d22" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_da5e401c-8468-420c-b15e-be2851855a89" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_ed2d19a6-0244-476c-ba75-0cf85b200d22" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdateExtensibleList_5c57ffc9-52ad-4ebe-b024-eef31d3ca405" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingStandardsUpdateExtensibleList"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_da5e401c-8468-420c-b15e-be2851855a89" xlink:to="loc_us-gaap_AccountingStandardsUpdateExtensibleList_5c57ffc9-52ad-4ebe-b024-eef31d3ca405" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_dc139f93-3077-499f-aacf-d9fca40d831f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_29e34551-5623-4954-91d2-72c5d5e955b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_6c507a62-8813-46fc-8a60-08981c15141a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_cd163b1c-bdb8-4142-9e76-97723e3c744b" xlink:to="loc_us-gaap_StatementTable_6c507a62-8813-46fc-8a60-08981c15141a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_506e113e-5d11-4cbd-8619-ed14ec196c05" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_6c507a62-8813-46fc-8a60-08981c15141a" xlink:to="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_506e113e-5d11-4cbd-8619-ed14ec196c05" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_506e113e-5d11-4cbd-8619-ed14ec196c05_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_506e113e-5d11-4cbd-8619-ed14ec196c05" xlink:to="loc_us-gaap_TypeOfAdoptionMember_506e113e-5d11-4cbd-8619-ed14ec196c05_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_030fe3be-5342-4f25-b2bd-72acf6cd5d02" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_506e113e-5d11-4cbd-8619-ed14ec196c05" xlink:to="loc_us-gaap_TypeOfAdoptionMember_030fe3be-5342-4f25-b2bd-72acf6cd5d02" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate202006Member_048c18d5-2ee8-4847-9d97-ab842b1dedcc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingStandardsUpdate202006Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfAdoptionMember_030fe3be-5342-4f25-b2bd-72acf6cd5d02" xlink:to="loc_us-gaap_AccountingStandardsUpdate202006Member_048c18d5-2ee8-4847-9d97-ab842b1dedcc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_a953e52d-530f-4342-afea-bb372a04ad75" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_6c507a62-8813-46fc-8a60-08981c15141a" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_a953e52d-530f-4342-afea-bb372a04ad75" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_a953e52d-530f-4342-afea-bb372a04ad75_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_a953e52d-530f-4342-afea-bb372a04ad75" xlink:to="loc_us-gaap_EquityComponentDomain_a953e52d-530f-4342-afea-bb372a04ad75_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_181a3610-8239-4d61-b606-f16404fd829b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_a953e52d-530f-4342-afea-bb372a04ad75" xlink:to="loc_us-gaap_EquityComponentDomain_181a3610-8239-4d61-b606-f16404fd829b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_0ca9fe68-f13d-4765-b1c0-9c0a47b0c9ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_181a3610-8239-4d61-b606-f16404fd829b" xlink:to="loc_us-gaap_CommonStockMember_0ca9fe68-f13d-4765-b1c0-9c0a47b0c9ab" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_b799e2b3-2aa0-4f7c-a0cd-b8f7fb89c12e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_181a3610-8239-4d61-b606-f16404fd829b" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_b799e2b3-2aa0-4f7c-a0cd-b8f7fb89c12e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_cc57f637-561e-4cab-994e-f3085260f536" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_181a3610-8239-4d61-b606-f16404fd829b" xlink:to="loc_us-gaap_RetainedEarningsMember_cc57f637-561e-4cab-994e-f3085260f536" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_0fdfcf73-ac98-43d5-abbd-c918eb975470" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_181a3610-8239-4d61-b606-f16404fd829b" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_0fdfcf73-ac98-43d5-abbd-c918eb975470" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonMember_54780045-a9d3-446d-886d-0d01b1302614" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockCommonMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_181a3610-8239-4d61-b606-f16404fd829b" xlink:to="loc_us-gaap_TreasuryStockCommonMember_54780045-a9d3-446d-886d-0d01b1302614" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.conmed.com/role/BusinessCombinationsDetails" xlink:type="simple" xlink:href="cnmd-20230331.xsd#BusinessCombinationsDetails"/>
  <link:definitionLink xlink:role="http://www.conmed.com/role/BusinessCombinationsDetails" xlink:type="extended" id="i43ceb4b502f1497a927841ee45425cbc_BusinessCombinationsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_51778b64-2021-47ea-ad6c-8a6749e94cae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_c9f2e074-d201-454e-93df-29e7b9361b45" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_51778b64-2021-47ea-ad6c-8a6749e94cae" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_c9f2e074-d201-454e-93df-29e7b9361b45" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_6a299864-53e7-410b-8bfd-e4ffee83c48c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_51778b64-2021-47ea-ad6c-8a6749e94cae" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_6a299864-53e7-410b-8bfd-e4ffee83c48c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_BusinessCombinationPurchasePriceAdjustmentHoldback_7708483a-ec9a-47c9-8ab4-7c076398af1d" xlink:href="cnmd-20230331.xsd#cnmd_BusinessCombinationPurchasePriceAdjustmentHoldback"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_51778b64-2021-47ea-ad6c-8a6749e94cae" xlink:to="loc_cnmd_BusinessCombinationPurchasePriceAdjustmentHoldback_7708483a-ec9a-47c9-8ab4-7c076398af1d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_21745974-3acc-4b14-9f95-985b8bd2f8ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_51778b64-2021-47ea-ad6c-8a6749e94cae" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_21745974-3acc-4b14-9f95-985b8bd2f8ce" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_8c0fe150-1616-4719-a546-a914c5bb9476" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_51778b64-2021-47ea-ad6c-8a6749e94cae" xlink:to="loc_us-gaap_Revenues_8c0fe150-1616-4719-a546-a914c5bb9476" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_AmortizationOfInventoryStepUpAdjustments_6ce3b691-cf23-49b0-b3d9-15bb38306139" xlink:href="cnmd-20230331.xsd#cnmd_AmortizationOfInventoryStepUpAdjustments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_51778b64-2021-47ea-ad6c-8a6749e94cae" xlink:to="loc_cnmd_AmortizationOfInventoryStepUpAdjustments_6ce3b691-cf23-49b0-b3d9-15bb38306139" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_d6796433-4cca-46bc-bac0-b7735cdfee83" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_51778b64-2021-47ea-ad6c-8a6749e94cae" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_d6796433-4cca-46bc-bac0-b7735cdfee83" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_e9c07cfa-06dd-46d3-b173-668afe4be7a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_d6796433-4cca-46bc-bac0-b7735cdfee83" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_e9c07cfa-06dd-46d3-b173-668afe4be7a1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e9c07cfa-06dd-46d3-b173-668afe4be7a1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_e9c07cfa-06dd-46d3-b173-668afe4be7a1" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e9c07cfa-06dd-46d3-b173-668afe4be7a1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_41dbb8ce-e20f-4267-8fe8-b8a88d18f79f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_e9c07cfa-06dd-46d3-b173-668afe4be7a1" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_41dbb8ce-e20f-4267-8fe8-b8a88d18f79f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_In2BonesGlobalIncMember_4e28cea9-a78a-4998-9d5c-d3082faf439a" xlink:href="cnmd-20230331.xsd#cnmd_In2BonesGlobalIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_41dbb8ce-e20f-4267-8fe8-b8a88d18f79f" xlink:to="loc_cnmd_In2BonesGlobalIncMember_4e28cea9-a78a-4998-9d5c-d3082faf439a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_BiorezIncMember_41dc97f0-3dcf-4f63-a324-434c3e8890fb" xlink:href="cnmd-20230331.xsd#cnmd_BiorezIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_41dbb8ce-e20f-4267-8fe8-b8a88d18f79f" xlink:to="loc_cnmd_BiorezIncMember_41dc97f0-3dcf-4f63-a324-434c3e8890fb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_37861e96-eaca-40aa-b390-31a719c01a25" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_d6796433-4cca-46bc-bac0-b7735cdfee83" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_37861e96-eaca-40aa-b390-31a719c01a25" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_37861e96-eaca-40aa-b390-31a719c01a25_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_37861e96-eaca-40aa-b390-31a719c01a25" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_37861e96-eaca-40aa-b390-31a719c01a25_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_5b0e2744-58fd-4ef4-8a6a-4b9040054b1c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_37861e96-eaca-40aa-b390-31a719c01a25" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_5b0e2744-58fd-4ef4-8a6a-4b9040054b1c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_5e32cc6d-f0b0-4066-ae40-13cb57298937" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfSalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_5b0e2744-58fd-4ef4-8a6a-4b9040054b1c" xlink:to="loc_us-gaap_CostOfSalesMember_5e32cc6d-f0b0-4066-ae40-13cb57298937" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.conmed.com/role/RevenuesDisaggregatedRevenuesDetails" xlink:type="simple" xlink:href="cnmd-20230331.xsd#RevenuesDisaggregatedRevenuesDetails"/>
  <link:definitionLink xlink:role="http://www.conmed.com/role/RevenuesDisaggregatedRevenuesDetails" xlink:type="extended" id="iae5ba1b46788486a81ed645b897ac604_RevenuesDisaggregatedRevenuesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_ab70c664-5232-450f-8c96-591cbe206977" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_71b691c9-c36f-4d44-8952-29bc4c23aaf4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_ab70c664-5232-450f-8c96-591cbe206977" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_71b691c9-c36f-4d44-8952-29bc4c23aaf4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_ffcf1785-da7f-4fbd-86a2-cea965e3686a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_ab70c664-5232-450f-8c96-591cbe206977" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_ffcf1785-da7f-4fbd-86a2-cea965e3686a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_f0b17322-af50-45d4-bb10-0b260d7ccd45" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_ffcf1785-da7f-4fbd-86a2-cea965e3686a" xlink:to="loc_srt_StatementGeographicalAxis_f0b17322-af50-45d4-bb10-0b260d7ccd45" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_f0b17322-af50-45d4-bb10-0b260d7ccd45_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_f0b17322-af50-45d4-bb10-0b260d7ccd45" xlink:to="loc_srt_SegmentGeographicalDomain_f0b17322-af50-45d4-bb10-0b260d7ccd45_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_31ab8852-cecd-4acc-b334-f354a1eae0f1" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_f0b17322-af50-45d4-bb10-0b260d7ccd45" xlink:to="loc_srt_SegmentGeographicalDomain_31ab8852-cecd-4acc-b334-f354a1eae0f1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_5d1a06f9-1017-4a42-bdc5-2a8abd3f1f8f" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_31ab8852-cecd-4acc-b334-f354a1eae0f1" xlink:to="loc_country_US_5d1a06f9-1017-4a42-bdc5-2a8abd3f1f8f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_AmericasexcludingtheUnitedStatesMember_09ab6f5f-96d6-40f8-be0a-2f13dd8e7248" xlink:href="cnmd-20230331.xsd#cnmd_AmericasexcludingtheUnitedStatesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_31ab8852-cecd-4acc-b334-f354a1eae0f1" xlink:to="loc_cnmd_AmericasexcludingtheUnitedStatesMember_09ab6f5f-96d6-40f8-be0a-2f13dd8e7248" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EMEAMember_ee36db4a-b9a9-4d3a-ad96-5767e2a7fcc7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EMEAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_31ab8852-cecd-4acc-b334-f354a1eae0f1" xlink:to="loc_us-gaap_EMEAMember_ee36db4a-b9a9-4d3a-ad96-5767e2a7fcc7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AsiaPacificMember_6f0f9e9a-fc7d-40bd-bc10-05568fbd8710" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_AsiaPacificMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_31ab8852-cecd-4acc-b334-f354a1eae0f1" xlink:to="loc_srt_AsiaPacificMember_6f0f9e9a-fc7d-40bd-bc10-05568fbd8710" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_ff4459d6-4c4b-4333-a8ac-bdcef0685da9" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_ffcf1785-da7f-4fbd-86a2-cea965e3686a" xlink:to="loc_srt_ProductOrServiceAxis_ff4459d6-4c4b-4333-a8ac-bdcef0685da9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_ff4459d6-4c4b-4333-a8ac-bdcef0685da9_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_ff4459d6-4c4b-4333-a8ac-bdcef0685da9" xlink:to="loc_srt_ProductsAndServicesDomain_ff4459d6-4c4b-4333-a8ac-bdcef0685da9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_dcfa34a5-fba6-4e14-8649-82f88ed34e90" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_ff4459d6-4c4b-4333-a8ac-bdcef0685da9" xlink:to="loc_srt_ProductsAndServicesDomain_dcfa34a5-fba6-4e14-8649-82f88ed34e90" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_OrthopedicSurgeryMember_2fc4b01c-bd3f-4740-b072-ac74c5485de6" xlink:href="cnmd-20230331.xsd#cnmd_OrthopedicSurgeryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_dcfa34a5-fba6-4e14-8649-82f88ed34e90" xlink:to="loc_cnmd_OrthopedicSurgeryMember_2fc4b01c-bd3f-4740-b072-ac74c5485de6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_GeneralSurgeryMember_cb95550b-cab9-4cc9-ab68-735317fa17c3" xlink:href="cnmd-20230331.xsd#cnmd_GeneralSurgeryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_dcfa34a5-fba6-4e14-8649-82f88ed34e90" xlink:to="loc_cnmd_GeneralSurgeryMember_cb95550b-cab9-4cc9-ab68-735317fa17c3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TimingOfTransferOfGoodOrServiceAxis_c9df6cb4-7e2d-41e3-b523-9a631dfb56dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TimingOfTransferOfGoodOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_ffcf1785-da7f-4fbd-86a2-cea965e3686a" xlink:to="loc_us-gaap_TimingOfTransferOfGoodOrServiceAxis_c9df6cb4-7e2d-41e3-b523-9a631dfb56dc" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain_c9df6cb4-7e2d-41e3-b523-9a631dfb56dc_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TimingOfTransferOfGoodOrServiceDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TimingOfTransferOfGoodOrServiceAxis_c9df6cb4-7e2d-41e3-b523-9a631dfb56dc" xlink:to="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain_c9df6cb4-7e2d-41e3-b523-9a631dfb56dc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain_ba1a5750-3c4d-4a4e-8ec3-cc92bf26cc33" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TimingOfTransferOfGoodOrServiceDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TimingOfTransferOfGoodOrServiceAxis_c9df6cb4-7e2d-41e3-b523-9a631dfb56dc" xlink:to="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain_ba1a5750-3c4d-4a4e-8ec3-cc92bf26cc33" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransferredAtPointInTimeMember_9c6d3da3-2c77-4a53-94ba-981efcfcd510" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransferredAtPointInTimeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain_ba1a5750-3c4d-4a4e-8ec3-cc92bf26cc33" xlink:to="loc_us-gaap_TransferredAtPointInTimeMember_9c6d3da3-2c77-4a53-94ba-981efcfcd510" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransferredOverTimeMember_dfb3a348-62f3-4256-9a1c-1ba2ddfe93d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransferredOverTimeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain_ba1a5750-3c4d-4a4e-8ec3-cc92bf26cc33" xlink:to="loc_us-gaap_TransferredOverTimeMember_dfb3a348-62f3-4256-9a1c-1ba2ddfe93d0" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.conmed.com/role/ComprehensiveIncomeAccumulatedOtherComprehensiveIncomeLossDetails" xlink:type="simple" xlink:href="cnmd-20230331.xsd#ComprehensiveIncomeAccumulatedOtherComprehensiveIncomeLossDetails"/>
  <link:definitionLink xlink:role="http://www.conmed.com/role/ComprehensiveIncomeAccumulatedOtherComprehensiveIncomeLossDetails" xlink:type="extended" id="i6d945bdb1d7b4b6c9f94117b243ef355_ComprehensiveIncomeAccumulatedOtherComprehensiveIncomeLossDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_51e50834-6009-41f1-a136-755feecb9138" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_26dc3fe5-6969-447f-9d15-a45049407c0c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AOCIAttributableToParentNetOfTaxRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_51e50834-6009-41f1-a136-755feecb9138" xlink:to="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_26dc3fe5-6969-447f-9d15-a45049407c0c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_b3eccf4a-0e16-47fd-a840-719cb44f7baa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_26dc3fe5-6969-447f-9d15-a45049407c0c" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_b3eccf4a-0e16-47fd-a840-719cb44f7baa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_2351e544-81c7-44bd-9847-843d76a34a26" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_26dc3fe5-6969-447f-9d15-a45049407c0c" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_2351e544-81c7-44bd-9847-843d76a34a26" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax_610df4da-2d5c-49ee-a1f9-71820bacaa0c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_26dc3fe5-6969-447f-9d15-a45049407c0c" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax_610df4da-2d5c-49ee-a1f9-71820bacaa0c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodTax_9b254970-5697-41f8-80ad-c6a456a85f6c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAociCurrentPeriodTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_26dc3fe5-6969-447f-9d15-a45049407c0c" xlink:to="loc_us-gaap_ReclassificationFromAociCurrentPeriodTax_9b254970-5697-41f8-80ad-c6a456a85f6c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_6fb9274d-1aea-44a9-853c-0bcae33ae344" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_26dc3fe5-6969-447f-9d15-a45049407c0c" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_6fb9274d-1aea-44a9-853c-0bcae33ae344" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_fb7a2b02-9618-4bd0-accb-6f05c1927157" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_1e1f5349-12ba-4713-91a9-0523f539b263" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_51e50834-6009-41f1-a136-755feecb9138" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_1e1f5349-12ba-4713-91a9-0523f539b263" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_eec867f8-ed7f-4062-b68b-c7bbf1fc0ba2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_1e1f5349-12ba-4713-91a9-0523f539b263" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_eec867f8-ed7f-4062-b68b-c7bbf1fc0ba2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_eec867f8-ed7f-4062-b68b-c7bbf1fc0ba2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_eec867f8-ed7f-4062-b68b-c7bbf1fc0ba2" xlink:to="loc_us-gaap_EquityComponentDomain_eec867f8-ed7f-4062-b68b-c7bbf1fc0ba2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_8a6cee34-f238-4603-98e3-9e5690503e3e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_eec867f8-ed7f-4062-b68b-c7bbf1fc0ba2" xlink:to="loc_us-gaap_EquityComponentDomain_8a6cee34-f238-4603-98e3-9e5690503e3e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_e5837ec5-e7c2-470b-8486-910d8ae3d433" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_8a6cee34-f238-4603-98e3-9e5690503e3e" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_e5837ec5-e7c2-470b-8486-910d8ae3d433" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember_b8183abc-5809-4567-a1e7-423a5c3319ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_e5837ec5-e7c2-470b-8486-910d8ae3d433" xlink:to="loc_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember_b8183abc-5809-4567-a1e7-423a5c3319ca" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_ebf5c46e-8822-4dac-8732-7cb657752f1d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_e5837ec5-e7c2-470b-8486-910d8ae3d433" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_ebf5c46e-8822-4dac-8732-7cb657752f1d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember_100d4a62-3d45-4a97-8666-6a30037d3fa7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_e5837ec5-e7c2-470b-8486-910d8ae3d433" xlink:to="loc_us-gaap_AccumulatedTranslationAdjustmentMember_100d4a62-3d45-4a97-8666-6a30037d3fa7" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.conmed.com/role/FairValueofFinancialInstrumentsAmountsRecordedInandReclassifiedFromAOCIDetails" xlink:type="simple" xlink:href="cnmd-20230331.xsd#FairValueofFinancialInstrumentsAmountsRecordedInandReclassifiedFromAOCIDetails"/>
  <link:definitionLink xlink:role="http://www.conmed.com/role/FairValueofFinancialInstrumentsAmountsRecordedInandReclassifiedFromAOCIDetails" xlink:type="extended" id="ia2468b778d1c4426987cab2ce6a2b6fb_FairValueofFinancialInstrumentsAmountsRecordedInandReclassifiedFromAOCIDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_960a2423-a66f-4fd3-9066-87797a33a489" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_bc400699-e8dd-42a3-8762-23a3d0b04095" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_960a2423-a66f-4fd3-9066-87797a33a489" xlink:to="loc_us-gaap_Revenues_bc400699-e8dd-42a3-8762-23a3d0b04095" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_556ac171-1a54-4d17-a7f3-8fd6403226f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_960a2423-a66f-4fd3-9066-87797a33a489" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_556ac171-1a54-4d17-a7f3-8fd6403226f5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_b06dd740-188e-49ca-88d2-df9e63397054" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_960a2423-a66f-4fd3-9066-87797a33a489" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_b06dd740-188e-49ca-88d2-df9e63397054" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax_f32eeb3a-55c1-4cf5-8e51-151d81442ca0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_960a2423-a66f-4fd3-9066-87797a33a489" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax_f32eeb3a-55c1-4cf5-8e51-151d81442ca0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_99ba06a9-cf87-4519-8f4c-c92368b23d67" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_960a2423-a66f-4fd3-9066-87797a33a489" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_99ba06a9-cf87-4519-8f4c-c92368b23d67" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_21493511-edad-4ddc-a97c-9fc780bc6369" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_960a2423-a66f-4fd3-9066-87797a33a489" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_21493511-edad-4ddc-a97c-9fc780bc6369" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax_62f8d06e-2f8e-47a8-9bb1-dbf61c0306ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_960a2423-a66f-4fd3-9066-87797a33a489" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax_62f8d06e-2f8e-47a8-9bb1-dbf61c0306ec" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_7831df53-1aac-4e63-81dd-2c14dc4e4814" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_960a2423-a66f-4fd3-9066-87797a33a489" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_7831df53-1aac-4e63-81dd-2c14dc4e4814" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_4d999013-8dd8-4ca9-a55b-69476797fd1b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_960a2423-a66f-4fd3-9066-87797a33a489" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_4d999013-8dd8-4ca9-a55b-69476797fd1b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_8d322d32-9237-47a6-9bc4-26cb48f449c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_4d999013-8dd8-4ca9-a55b-69476797fd1b" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_8d322d32-9237-47a6-9bc4-26cb48f449c5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_8d322d32-9237-47a6-9bc4-26cb48f449c5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_8d322d32-9237-47a6-9bc4-26cb48f449c5" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_8d322d32-9237-47a6-9bc4-26cb48f449c5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_2c8d3c94-0dc7-4306-88e8-a8c22a400dd4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_8d322d32-9237-47a6-9bc4-26cb48f449c5" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_2c8d3c94-0dc7-4306-88e8-a8c22a400dd4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_RevenuesMember_f4de6d40-9bc9-4d53-a80f-a8e8ef642a9d" xlink:href="cnmd-20230331.xsd#cnmd_RevenuesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_2c8d3c94-0dc7-4306-88e8-a8c22a400dd4" xlink:to="loc_cnmd_RevenuesMember_f4de6d40-9bc9-4d53-a80f-a8e8ef642a9d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_200cc88f-4f72-4535-8b72-d43b7c9e96f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfSalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_2c8d3c94-0dc7-4306-88e8-a8c22a400dd4" xlink:to="loc_us-gaap_CostOfSalesMember_200cc88f-4f72-4535-8b72-d43b7c9e96f2" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.conmed.com/role/FairValueofFinancialInstrumentsForeignCurrencyForwardContractsDetails" xlink:type="simple" xlink:href="cnmd-20230331.xsd#FairValueofFinancialInstrumentsForeignCurrencyForwardContractsDetails"/>
  <link:definitionLink xlink:role="http://www.conmed.com/role/FairValueofFinancialInstrumentsForeignCurrencyForwardContractsDetails" xlink:type="extended" id="i581f4e47cada4a44a79284898f19214f_FairValueofFinancialInstrumentsForeignCurrencyForwardContractsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_409d6bc2-4738-431a-90b4-ed2875dbef97" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MaximumLengthOfTimeHedgedInCashFlowHedge1_4d939dff-1c24-46f7-a815-ebf644274347" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MaximumLengthOfTimeHedgedInCashFlowHedge1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_409d6bc2-4738-431a-90b4-ed2875dbef97" xlink:to="loc_us-gaap_MaximumLengthOfTimeHedgedInCashFlowHedge1_4d939dff-1c24-46f7-a815-ebf644274347" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_d4997587-0eb4-4c16-9bda-a62ad02012f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_409d6bc2-4738-431a-90b4-ed2875dbef97" xlink:to="loc_us-gaap_DerivativeNotionalAmount_d4997587-0eb4-4c16-9bda-a62ad02012f8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months_7a50f9b7-4168-4bf4-a910-f73c9fa98501" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_409d6bc2-4738-431a-90b4-ed2875dbef97" xlink:to="loc_us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months_7a50f9b7-4168-4bf4-a910-f73c9fa98501" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments_9c4b44e3-9de2-40a6-8b5e-4750a7f59203" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_409d6bc2-4738-431a-90b4-ed2875dbef97" xlink:to="loc_us-gaap_GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments_9c4b44e3-9de2-40a6-8b5e-4750a7f59203" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_a59b271f-cbb8-4b35-944c-0b6c3764957a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_409d6bc2-4738-431a-90b4-ed2875dbef97" xlink:to="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_a59b271f-cbb8-4b35-944c-0b6c3764957a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNetByBalanceSheetClassificationAbstract_3ac5ec80-499d-48e2-aee5-94b695aed1bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssetsLiabilitiesAtFairValueNetByBalanceSheetClassificationAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_409d6bc2-4738-431a-90b4-ed2875dbef97" xlink:to="loc_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNetByBalanceSheetClassificationAbstract_3ac5ec80-499d-48e2-aee5-94b695aed1bf" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_d69bfdf3-626b-4d21-bfd2-d757aa6c5223" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNetByBalanceSheetClassificationAbstract_3ac5ec80-499d-48e2-aee5-94b695aed1bf" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_d69bfdf3-626b-4d21-bfd2-d757aa6c5223" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_de22f067-25d4-42dc-a92b-ff9c3fde402e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNetByBalanceSheetClassificationAbstract_3ac5ec80-499d-48e2-aee5-94b695aed1bf" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_de22f067-25d4-42dc-a92b-ff9c3fde402e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet_da34a15b-fa8b-4ab7-bc20-5e6f2dbfbb62" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNetByBalanceSheetClassificationAbstract_3ac5ec80-499d-48e2-aee5-94b695aed1bf" xlink:to="loc_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet_da34a15b-fa8b-4ab7-bc20-5e6f2dbfbb62" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_5094d8a6-7735-481f-81a0-159393ef71e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeLineItems_409d6bc2-4738-431a-90b4-ed2875dbef97" xlink:to="loc_us-gaap_DerivativeTable_5094d8a6-7735-481f-81a0-159393ef71e7" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_73b65725-32cf-4f1d-b76b-ea6c7d39389d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_5094d8a6-7735-481f-81a0-159393ef71e7" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_73b65725-32cf-4f1d-b76b-ea6c7d39389d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_73b65725-32cf-4f1d-b76b-ea6c7d39389d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_73b65725-32cf-4f1d-b76b-ea6c7d39389d" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_73b65725-32cf-4f1d-b76b-ea6c7d39389d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_43eed70d-f547-4ce4-8b2c-89c5c96d4a89" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_73b65725-32cf-4f1d-b76b-ea6c7d39389d" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_43eed70d-f547-4ce4-8b2c-89c5c96d4a89" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_RevenuesMember_0060033d-3e8d-4265-967d-47e61d9a9b1f" xlink:href="cnmd-20230331.xsd#cnmd_RevenuesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_43eed70d-f547-4ce4-8b2c-89c5c96d4a89" xlink:to="loc_cnmd_RevenuesMember_0060033d-3e8d-4265-967d-47e61d9a9b1f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_0ece70f9-73c3-4881-ac8d-743b75d2051f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfSalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_43eed70d-f547-4ce4-8b2c-89c5c96d4a89" xlink:to="loc_us-gaap_CostOfSalesMember_0ece70f9-73c3-4881-ac8d-743b75d2051f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_c51a6ac6-1dc0-4f3e-8beb-a2e8c3e29f80" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_5094d8a6-7735-481f-81a0-159393ef71e7" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_c51a6ac6-1dc0-4f3e-8beb-a2e8c3e29f80" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_c51a6ac6-1dc0-4f3e-8beb-a2e8c3e29f80_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_c51a6ac6-1dc0-4f3e-8beb-a2e8c3e29f80" xlink:to="loc_us-gaap_EquityComponentDomain_c51a6ac6-1dc0-4f3e-8beb-a2e8c3e29f80_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_6c34ed98-7997-477e-96a0-588559d1075f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_c51a6ac6-1dc0-4f3e-8beb-a2e8c3e29f80" xlink:to="loc_us-gaap_EquityComponentDomain_6c34ed98-7997-477e-96a0-588559d1075f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember_2ae4ee0a-6812-453c-a7b9-8cc6afbb1cbb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_6c34ed98-7997-477e-96a0-588559d1075f" xlink:to="loc_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember_2ae4ee0a-6812-453c-a7b9-8cc6afbb1cbb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_e8c72310-af4a-4a00-abb9-ae8a8dd675ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_5094d8a6-7735-481f-81a0-159393ef71e7" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_e8c72310-af4a-4a00-abb9-ae8a8dd675ed" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_e8c72310-af4a-4a00-abb9-ae8a8dd675ed_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_e8c72310-af4a-4a00-abb9-ae8a8dd675ed" xlink:to="loc_us-gaap_HedgingRelationshipDomain_e8c72310-af4a-4a00-abb9-ae8a8dd675ed_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_5364e265-5fe3-4f59-9e8c-42d4a89f07ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_e8c72310-af4a-4a00-abb9-ae8a8dd675ed" xlink:to="loc_us-gaap_HedgingRelationshipDomain_5364e265-5fe3-4f59-9e8c-42d4a89f07ad" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_803a077a-9118-4550-b873-cdee737919d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_5364e265-5fe3-4f59-9e8c-42d4a89f07ad" xlink:to="loc_us-gaap_CashFlowHedgingMember_803a077a-9118-4550-b873-cdee737919d6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_7d3f9e0d-2e53-4d07-a4ec-51493a3826e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NondesignatedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_5364e265-5fe3-4f59-9e8c-42d4a89f07ad" xlink:to="loc_us-gaap_NondesignatedMember_7d3f9e0d-2e53-4d07-a4ec-51493a3826e2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_d50fae78-2b42-44c1-83a3-6367a6b8bb52" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_5094d8a6-7735-481f-81a0-159393ef71e7" xlink:to="loc_us-gaap_HedgingDesignationAxis_d50fae78-2b42-44c1-83a3-6367a6b8bb52" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_d50fae78-2b42-44c1-83a3-6367a6b8bb52_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_d50fae78-2b42-44c1-83a3-6367a6b8bb52" xlink:to="loc_us-gaap_HedgingDesignationDomain_d50fae78-2b42-44c1-83a3-6367a6b8bb52_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_cf50b913-c806-4c58-9b30-4c9a5c19fbfd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_d50fae78-2b42-44c1-83a3-6367a6b8bb52" xlink:to="loc_us-gaap_HedgingDesignationDomain_cf50b913-c806-4c58-9b30-4c9a5c19fbfd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_fee19d30-9eee-46bb-a395-4b1707aa4114" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_cf50b913-c806-4c58-9b30-4c9a5c19fbfd" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_fee19d30-9eee-46bb-a395-4b1707aa4114" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_93c7d28b-26e3-4cde-b553-1a1226ae3049" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NondesignatedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_cf50b913-c806-4c58-9b30-4c9a5c19fbfd" xlink:to="loc_us-gaap_NondesignatedMember_93c7d28b-26e3-4cde-b553-1a1226ae3049" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_c0490205-1507-4576-8c2c-286cb956cce7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_5094d8a6-7735-481f-81a0-159393ef71e7" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_c0490205-1507-4576-8c2c-286cb956cce7" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_c0490205-1507-4576-8c2c-286cb956cce7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_c0490205-1507-4576-8c2c-286cb956cce7" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_c0490205-1507-4576-8c2c-286cb956cce7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_9fed3f46-7c7e-4f70-b96a-f26b2ff63715" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_c0490205-1507-4576-8c2c-286cb956cce7" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_9fed3f46-7c7e-4f70-b96a-f26b2ff63715" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember_1a974c80-75e1-4bf6-aba8-81e20a84f66c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_9fed3f46-7c7e-4f70-b96a-f26b2ff63715" xlink:to="loc_us-gaap_ForeignExchangeForwardMember_1a974c80-75e1-4bf6-aba8-81e20a84f66c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_cdb84b49-d648-4e4e-b446-28523a2f5f9f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_5094d8a6-7735-481f-81a0-159393ef71e7" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_cdb84b49-d648-4e4e-b446-28523a2f5f9f" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_cdb84b49-d648-4e4e-b446-28523a2f5f9f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_cdb84b49-d648-4e4e-b446-28523a2f5f9f" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_cdb84b49-d648-4e4e-b446-28523a2f5f9f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_e7d551fd-5d63-41b7-8d9d-f6ca9187af6c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_cdb84b49-d648-4e4e-b446-28523a2f5f9f" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_e7d551fd-5d63-41b7-8d9d-f6ca9187af6c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_1c4275e7-31bc-47ed-976e-e8640d8919e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_e7d551fd-5d63-41b7-8d9d-f6ca9187af6c" xlink:to="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_1c4275e7-31bc-47ed-976e-e8640d8919e4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember_7c99203d-51ea-4808-ac77-1d4fff2cbb91" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_e7d551fd-5d63-41b7-8d9d-f6ca9187af6c" xlink:to="loc_us-gaap_OtherNoncurrentLiabilitiesMember_7c99203d-51ea-4808-ac77-1d4fff2cbb91" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember_b419c42f-0b7b-4849-b8f3-aa9960d73539" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCurrentLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_e7d551fd-5d63-41b7-8d9d-f6ca9187af6c" xlink:to="loc_us-gaap_OtherCurrentLiabilitiesMember_b419c42f-0b7b-4849-b8f3-aa9960d73539" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentAssetsMember_d2cc0d2d-318e-4182-85cd-031211a5795e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncurrentAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_e7d551fd-5d63-41b7-8d9d-f6ca9187af6c" xlink:to="loc_us-gaap_OtherNoncurrentAssetsMember_d2cc0d2d-318e-4182-85cd-031211a5795e" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.conmed.com/role/FairValueofFinancialInstrumentsContingentConsiderationDetails" xlink:type="simple" xlink:href="cnmd-20230331.xsd#FairValueofFinancialInstrumentsContingentConsiderationDetails"/>
  <link:definitionLink xlink:role="http://www.conmed.com/role/FairValueofFinancialInstrumentsContingentConsiderationDetails" xlink:type="extended" id="i7383bfd4d9bf4be08ab3ce76234940fa_FairValueofFinancialInstrumentsContingentConsiderationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_dad08938-1520-4212-b865-6c9cce6d9f7d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionContingentConsiderationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_BusinessAcquisitionContingentConsiderationAtFairValueRollForwardRollForward_1d6f41bf-f46e-4433-bd79-0813589e4b21" xlink:href="cnmd-20230331.xsd#cnmd_BusinessAcquisitionContingentConsiderationAtFairValueRollForwardRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_dad08938-1520-4212-b865-6c9cce6d9f7d" xlink:to="loc_cnmd_BusinessAcquisitionContingentConsiderationAtFairValueRollForwardRollForward_1d6f41bf-f46e-4433-bd79-0813589e4b21" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_2c3ab08e-0b0f-4788-b95f-5877282c8cc2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cnmd_BusinessAcquisitionContingentConsiderationAtFairValueRollForwardRollForward_1d6f41bf-f46e-4433-bd79-0813589e4b21" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_2c3ab08e-0b0f-4788-b95f-5877282c8cc2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_0946fbb7-357f-41ca-bbe9-8bf77ae6852f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cnmd_BusinessAcquisitionContingentConsiderationAtFairValueRollForwardRollForward_1d6f41bf-f46e-4433-bd79-0813589e4b21" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_0946fbb7-357f-41ca-bbe9-8bf77ae6852f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_0992a3ac-8af9-4183-bc74-9f5f819083b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_e45b807f-4f03-4d0e-a97a-9f1b6fd3680b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_dad08938-1520-4212-b865-6c9cce6d9f7d" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_e45b807f-4f03-4d0e-a97a-9f1b6fd3680b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_7921598c-6dae-4072-bf28-9694830fbcdb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_dad08938-1520-4212-b865-6c9cce6d9f7d" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_7921598c-6dae-4072-bf28-9694830fbcdb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_48c62153-fae4-4732-a62c-8976f3d001fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_dad08938-1520-4212-b865-6c9cce6d9f7d" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_48c62153-fae4-4732-a62c-8976f3d001fc" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_aeed961c-49ed-42d2-ad22-0cbca90be9fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_dad08938-1520-4212-b865-6c9cce6d9f7d" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_aeed961c-49ed-42d2-ad22-0cbca90be9fb" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_3675b602-20a1-4b17-bda5-d7c369dbf094" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_aeed961c-49ed-42d2-ad22-0cbca90be9fb" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_3675b602-20a1-4b17-bda5-d7c369dbf094" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3675b602-20a1-4b17-bda5-d7c369dbf094_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_3675b602-20a1-4b17-bda5-d7c369dbf094" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3675b602-20a1-4b17-bda5-d7c369dbf094_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9fa1afe3-1550-4ed0-9349-88c9976de23a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_3675b602-20a1-4b17-bda5-d7c369dbf094" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9fa1afe3-1550-4ed0-9349-88c9976de23a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_In2BonesGlobalIncMember_a1939afd-0f7d-48ed-a76d-d407bfae9c4c" xlink:href="cnmd-20230331.xsd#cnmd_In2BonesGlobalIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9fa1afe3-1550-4ed0-9349-88c9976de23a" xlink:to="loc_cnmd_In2BonesGlobalIncMember_a1939afd-0f7d-48ed-a76d-d407bfae9c4c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_BiorezIncMember_c5725769-0b52-44ee-9a38-fc57fb76e3da" xlink:href="cnmd-20230331.xsd#cnmd_BiorezIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9fa1afe3-1550-4ed0-9349-88c9976de23a" xlink:to="loc_cnmd_BiorezIncMember_c5725769-0b52-44ee-9a38-fc57fb76e3da" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_54f6a094-dd96-4702-af7d-ac756593bcb6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_aeed961c-49ed-42d2-ad22-0cbca90be9fb" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_54f6a094-dd96-4702-af7d-ac756593bcb6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_54f6a094-dd96-4702-af7d-ac756593bcb6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_54f6a094-dd96-4702-af7d-ac756593bcb6" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_54f6a094-dd96-4702-af7d-ac756593bcb6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_d2968b1d-1eaf-4fa7-b66b-3ca9ad21b0eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_54f6a094-dd96-4702-af7d-ac756593bcb6" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_d2968b1d-1eaf-4fa7-b66b-3ca9ad21b0eb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_b051e87d-5bf8-41ab-9aa2-7dd5141d66f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_d2968b1d-1eaf-4fa7-b66b-3ca9ad21b0eb" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_b051e87d-5bf8-41ab-9aa2-7dd5141d66f3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_348178e0-fa86-4e75-a519-eddcc820f96c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_aeed961c-49ed-42d2-ad22-0cbca90be9fb" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_348178e0-fa86-4e75-a519-eddcc820f96c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_348178e0-fa86-4e75-a519-eddcc820f96c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_348178e0-fa86-4e75-a519-eddcc820f96c" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_348178e0-fa86-4e75-a519-eddcc820f96c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_ff47724b-59ab-41e4-b51d-90f527b1219b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_348178e0-fa86-4e75-a519-eddcc820f96c" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_ff47724b-59ab-41e4-b51d-90f527b1219b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_a6247226-5761-42dd-b41a-eddde4accf77" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_ff47724b-59ab-41e4-b51d-90f527b1219b" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_a6247226-5761-42dd-b41a-eddde4accf77" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis_3e80c63a-461b-4f0f-9502-6d0ac6c45da8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_aeed961c-49ed-42d2-ad22-0cbca90be9fb" xlink:to="loc_us-gaap_MeasurementInputTypeAxis_3e80c63a-461b-4f0f-9502-6d0ac6c45da8" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_3e80c63a-461b-4f0f-9502-6d0ac6c45da8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_3e80c63a-461b-4f0f-9502-6d0ac6c45da8" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_3e80c63a-461b-4f0f-9502-6d0ac6c45da8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_3fe66160-6d91-42bc-8437-151813cd569a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_3e80c63a-461b-4f0f-9502-6d0ac6c45da8" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_3fe66160-6d91-42bc-8437-151813cd569a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputDiscountRateMember_8d1771d9-9380-4414-96f6-9c71a38587f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputDiscountRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_3fe66160-6d91-42bc-8437-151813cd569a" xlink:to="loc_us-gaap_MeasurementInputDiscountRateMember_8d1771d9-9380-4414-96f6-9c71a38587f4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_MeasurementInputRevenueVolatilityMember_29d304f8-ac54-47dd-9f26-c8cda75e28d1" xlink:href="cnmd-20230331.xsd#cnmd_MeasurementInputRevenueVolatilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_3fe66160-6d91-42bc-8437-151813cd569a" xlink:to="loc_cnmd_MeasurementInputRevenueVolatilityMember_29d304f8-ac54-47dd-9f26-c8cda75e28d1" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.conmed.com/role/GoodwillandOtherIntangibleAssetsGoodwillDetails" xlink:type="simple" xlink:href="cnmd-20230331.xsd#GoodwillandOtherIntangibleAssetsGoodwillDetails"/>
  <link:definitionLink xlink:role="http://www.conmed.com/role/GoodwillandOtherIntangibleAssetsGoodwillDetails" xlink:type="extended" id="i59686ceb00a044188d7b93547626824c_GoodwillandOtherIntangibleAssetsGoodwillDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_67f8e162-3a52-4c0d-bb05-818d7b814004" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_5068a10a-af95-4772-99ac-d107edca1286" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_67f8e162-3a52-4c0d-bb05-818d7b814004" xlink:to="loc_us-gaap_Goodwill_5068a10a-af95-4772-99ac-d107edca1286" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_07dfbd8e-1da2-4ce3-b3e1-5081fdd09400" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_GoodwillLineItems_67f8e162-3a52-4c0d-bb05-818d7b814004" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_07dfbd8e-1da2-4ce3-b3e1-5081fdd09400" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_0b92c0ec-aba6-4293-a1a8-34bddc6684a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_07dfbd8e-1da2-4ce3-b3e1-5081fdd09400" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_0b92c0ec-aba6-4293-a1a8-34bddc6684a1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_0b92c0ec-aba6-4293-a1a8-34bddc6684a1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_0b92c0ec-aba6-4293-a1a8-34bddc6684a1" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_0b92c0ec-aba6-4293-a1a8-34bddc6684a1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b7ffd1bc-f446-4e2b-80a4-3827c8ef0582" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_0b92c0ec-aba6-4293-a1a8-34bddc6684a1" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b7ffd1bc-f446-4e2b-80a4-3827c8ef0582" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_In2BonesGlobalIncMember_b309ec37-1914-4434-9fcc-2e9cfa8601b2" xlink:href="cnmd-20230331.xsd#cnmd_In2BonesGlobalIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b7ffd1bc-f446-4e2b-80a4-3827c8ef0582" xlink:to="loc_cnmd_In2BonesGlobalIncMember_b309ec37-1914-4434-9fcc-2e9cfa8601b2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_BiorezIncMember_1634ead4-9967-424e-ade6-f5404d94be4a" xlink:href="cnmd-20230331.xsd#cnmd_BiorezIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b7ffd1bc-f446-4e2b-80a4-3827c8ef0582" xlink:to="loc_cnmd_BiorezIncMember_1634ead4-9967-424e-ade6-f5404d94be4a" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.conmed.com/role/GoodwillandOtherIntangibleAssetsIntangibleAssetsDetails" xlink:type="simple" xlink:href="cnmd-20230331.xsd#GoodwillandOtherIntangibleAssetsIntangibleAssetsDetails"/>
  <link:definitionLink xlink:role="http://www.conmed.com/role/GoodwillandOtherIntangibleAssetsIntangibleAssetsDetails" xlink:type="extended" id="i75376c618a0c4f76be4a578a65b7486e_GoodwillandOtherIntangibleAssetsIntangibleAssetsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_ScheduleOfFiniteLivedAndIndefiniteLivedAssetsLineItems_45ac5c59-8c5e-43e2-9714-d7d0e9431ff2" xlink:href="cnmd-20230331.xsd#cnmd_ScheduleOfFiniteLivedAndIndefiniteLivedAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_51d52f30-598d-4899-bac2-814b9a129051" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cnmd_ScheduleOfFiniteLivedAndIndefiniteLivedAssetsLineItems_45ac5c59-8c5e-43e2-9714-d7d0e9431ff2" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_51d52f30-598d-4899-bac2-814b9a129051" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_93b1f670-b82b-4acd-815e-51a38b1e7b67" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cnmd_ScheduleOfFiniteLivedAndIndefiniteLivedAssetsLineItems_45ac5c59-8c5e-43e2-9714-d7d0e9431ff2" xlink:to="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_93b1f670-b82b-4acd-815e-51a38b1e7b67" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_801711fe-7dea-44c5-b1a2-74447bab3c3d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cnmd_ScheduleOfFiniteLivedAndIndefiniteLivedAssetsLineItems_45ac5c59-8c5e-43e2-9714-d7d0e9431ff2" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_801711fe-7dea-44c5-b1a2-74447bab3c3d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_c2efdd89-a18e-40b1-8ce6-03a0fab47c24" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cnmd_ScheduleOfFiniteLivedAndIndefiniteLivedAssetsLineItems_45ac5c59-8c5e-43e2-9714-d7d0e9431ff2" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_c2efdd89-a18e-40b1-8ce6-03a0fab47c24" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_abc11ac4-020a-46aa-a611-1c42a8508e29" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cnmd_ScheduleOfFiniteLivedAndIndefiniteLivedAssetsLineItems_45ac5c59-8c5e-43e2-9714-d7d0e9431ff2" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_abc11ac4-020a-46aa-a611-1c42a8508e29" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_39ffa0ee-cd3d-45f4-a2b6-21babb0850b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cnmd_ScheduleOfFiniteLivedAndIndefiniteLivedAssetsLineItems_45ac5c59-8c5e-43e2-9714-d7d0e9431ff2" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_39ffa0ee-cd3d-45f4-a2b6-21babb0850b4" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_c9b8040b-369b-4873-9606-cddb5bbc1c60" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cnmd_ScheduleOfFiniteLivedAndIndefiniteLivedAssetsLineItems_45ac5c59-8c5e-43e2-9714-d7d0e9431ff2" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_c9b8040b-369b-4873-9606-cddb5bbc1c60" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_89307bf6-917f-4672-afe2-132aed28abb8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_c9b8040b-369b-4873-9606-cddb5bbc1c60" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_89307bf6-917f-4672-afe2-132aed28abb8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_7c4627f3-f6fa-407d-953b-e44ef89f6fa7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_c9b8040b-369b-4873-9606-cddb5bbc1c60" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_7c4627f3-f6fa-407d-953b-e44ef89f6fa7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_a444e54f-2cc2-4684-ab55-e027f26c871a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_c9b8040b-369b-4873-9606-cddb5bbc1c60" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_a444e54f-2cc2-4684-ab55-e027f26c871a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_980ab7e4-dde4-4f1b-9f0d-17f64287c672" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_c9b8040b-369b-4873-9606-cddb5bbc1c60" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_980ab7e4-dde4-4f1b-9f0d-17f64287c672" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_cc58178b-93c6-48d2-96a1-c0f794c16421" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_c9b8040b-369b-4873-9606-cddb5bbc1c60" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_cc58178b-93c6-48d2-96a1-c0f794c16421" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_e7117b55-124a-4684-b7dc-a5d46554a256" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_c9b8040b-369b-4873-9606-cddb5bbc1c60" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_e7117b55-124a-4684-b7dc-a5d46554a256" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_ScheduleOfFiniteLivedAndIndefiniteLivedAssetsTable_a2c62297-1f69-4c12-8dcb-c6f5270112dc" xlink:href="cnmd-20230331.xsd#cnmd_ScheduleOfFiniteLivedAndIndefiniteLivedAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_cnmd_ScheduleOfFiniteLivedAndIndefiniteLivedAssetsLineItems_45ac5c59-8c5e-43e2-9714-d7d0e9431ff2" xlink:to="loc_cnmd_ScheduleOfFiniteLivedAndIndefiniteLivedAssetsTable_a2c62297-1f69-4c12-8dcb-c6f5270112dc" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_20c6acb1-6f4a-434f-a568-abebd2a48c9b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_cnmd_ScheduleOfFiniteLivedAndIndefiniteLivedAssetsTable_a2c62297-1f69-4c12-8dcb-c6f5270112dc" xlink:to="loc_srt_RangeAxis_20c6acb1-6f4a-434f-a568-abebd2a48c9b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_20c6acb1-6f4a-434f-a568-abebd2a48c9b_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_20c6acb1-6f4a-434f-a568-abebd2a48c9b" xlink:to="loc_srt_RangeMember_20c6acb1-6f4a-434f-a568-abebd2a48c9b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_151fdc61-2e15-447f-9cef-2b7f7c735f47" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_20c6acb1-6f4a-434f-a568-abebd2a48c9b" xlink:to="loc_srt_RangeMember_151fdc61-2e15-447f-9cef-2b7f7c735f47" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_WeightedAverageMember_e227afdf-e0e5-4c51-945a-aaf3e6415204" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_WeightedAverageMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_151fdc61-2e15-447f-9cef-2b7f7c735f47" xlink:to="loc_srt_WeightedAverageMember_e227afdf-e0e5-4c51-945a-aaf3e6415204" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_19d2c225-7f8b-4f08-8661-ef431634aada" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_cnmd_ScheduleOfFiniteLivedAndIndefiniteLivedAssetsTable_a2c62297-1f69-4c12-8dcb-c6f5270112dc" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_19d2c225-7f8b-4f08-8661-ef431634aada" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_19d2c225-7f8b-4f08-8661-ef431634aada_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_19d2c225-7f8b-4f08-8661-ef431634aada" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_19d2c225-7f8b-4f08-8661-ef431634aada_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b02c3bae-9279-4ee8-99e3-c7118630c70f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_19d2c225-7f8b-4f08-8661-ef431634aada" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b02c3bae-9279-4ee8-99e3-c7118630c70f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_CustomerandDistributorRelationshipsMember_267f682a-6be4-4e46-891f-9fcdecd366a5" xlink:href="cnmd-20230331.xsd#cnmd_CustomerandDistributorRelationshipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b02c3bae-9279-4ee8-99e3-c7118630c70f" xlink:to="loc_cnmd_CustomerandDistributorRelationshipsMember_267f682a-6be4-4e46-891f-9fcdecd366a5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_SalesrepresentationmarketingandpromotionalrightsMember_34865e2c-0611-4a34-8428-54c681ea8477" xlink:href="cnmd-20230331.xsd#cnmd_SalesrepresentationmarketingandpromotionalrightsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b02c3bae-9279-4ee8-99e3-c7118630c70f" xlink:to="loc_cnmd_SalesrepresentationmarketingandpromotionalrightsMember_34865e2c-0611-4a34-8428-54c681ea8477" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_a1cbc499-7a82-405a-b038-fbf423e5d96b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b02c3bae-9279-4ee8-99e3-c7118630c70f" xlink:to="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_a1cbc499-7a82-405a-b038-fbf423e5d96b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_PatentsAndOtherIntangibleAssetsMember_eec0ee5a-0fb2-4aa5-af9b-ea6543d01436" xlink:href="cnmd-20230331.xsd#cnmd_PatentsAndOtherIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b02c3bae-9279-4ee8-99e3-c7118630c70f" xlink:to="loc_cnmd_PatentsAndOtherIntangibleAssetsMember_eec0ee5a-0fb2-4aa5-af9b-ea6543d01436" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_0e1d3310-021b-46aa-8d02-ea3286196b2a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_cnmd_ScheduleOfFiniteLivedAndIndefiniteLivedAssetsTable_a2c62297-1f69-4c12-8dcb-c6f5270112dc" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_0e1d3310-021b-46aa-8d02-ea3286196b2a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_0e1d3310-021b-46aa-8d02-ea3286196b2a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_0e1d3310-021b-46aa-8d02-ea3286196b2a" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_0e1d3310-021b-46aa-8d02-ea3286196b2a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_04a2cab7-4efe-4276-b122-246bad197bb0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_0e1d3310-021b-46aa-8d02-ea3286196b2a" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_04a2cab7-4efe-4276-b122-246bad197bb0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksAndTradeNamesMember_db673ad5-21ab-4e6c-b491-00de5c9188b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TrademarksAndTradeNamesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_04a2cab7-4efe-4276-b122-246bad197bb0" xlink:to="loc_us-gaap_TrademarksAndTradeNamesMember_db673ad5-21ab-4e6c-b491-00de5c9188b0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_4cee2229-f13d-4151-bb48-4db1fa7132fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_cnmd_ScheduleOfFiniteLivedAndIndefiniteLivedAssetsTable_a2c62297-1f69-4c12-8dcb-c6f5270112dc" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_4cee2229-f13d-4151-bb48-4db1fa7132fb" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_4cee2229-f13d-4151-bb48-4db1fa7132fb_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_4cee2229-f13d-4151-bb48-4db1fa7132fb" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_4cee2229-f13d-4151-bb48-4db1fa7132fb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_a6bec311-b65f-483e-87b7-4c8a586d84a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_4cee2229-f13d-4151-bb48-4db1fa7132fb" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_a6bec311-b65f-483e-87b7-4c8a586d84a4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_ExpenseMember_61c005ec-3346-4f14-a9b4-0dc4a6f2a3c1" xlink:href="cnmd-20230331.xsd#cnmd_ExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_a6bec311-b65f-483e-87b7-4c8a586d84a4" xlink:to="loc_cnmd_ExpenseMember_61c005ec-3346-4f14-a9b4-0dc4a6f2a3c1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_ReductionofRevenueMember_935ed502-ebac-4cf8-beb2-5a3f1032778a" xlink:href="cnmd-20230331.xsd#cnmd_ReductionofRevenueMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_a6bec311-b65f-483e-87b7-4c8a586d84a4" xlink:to="loc_cnmd_ReductionofRevenueMember_935ed502-ebac-4cf8-beb2-5a3f1032778a" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.conmed.com/role/LongTermDebtDetails" xlink:type="simple" xlink:href="cnmd-20230331.xsd#LongTermDebtDetails"/>
  <link:definitionLink xlink:role="http://www.conmed.com/role/LongTermDebtDetails" xlink:type="extended" id="i66c70820c8284a6fb2ea4aad5c9c9bf2_LongTermDebtDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_e07b63e9-ac99-4ce0-9280-41738d88dcab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_42d7de1b-63a9-4803-8c9c-4f004f8471e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_e07b63e9-ac99-4ce0-9280-41738d88dcab" xlink:to="loc_us-gaap_LongTermDebt_42d7de1b-63a9-4803-8c9c-4f004f8471e2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebt_878e6133-fb4b-4420-97c3-d23b29e42dc9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertibleDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_e07b63e9-ac99-4ce0-9280-41738d88dcab" xlink:to="loc_us-gaap_ConvertibleDebt_878e6133-fb4b-4420-97c3-d23b29e42dc9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_2d64bc02-2316-477d-a8ab-a28e601b061f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_e07b63e9-ac99-4ce0-9280-41738d88dcab" xlink:to="loc_us-gaap_FinanceLeaseLiability_2d64bc02-2316-477d-a8ab-a28e601b061f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities_4e7408f1-c84e-48c3-b6b6-6e5306576e9f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_e07b63e9-ac99-4ce0-9280-41738d88dcab" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities_4e7408f1-c84e-48c3-b6b6-6e5306576e9f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_8fef8d73-75a7-4fc1-bfff-6ff91432b699" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_e07b63e9-ac99-4ce0-9280-41738d88dcab" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_8fef8d73-75a7-4fc1-bfff-6ff91432b699" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_59a9c5e1-e634-492b-9c13-6544ef86814d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_e07b63e9-ac99-4ce0-9280-41738d88dcab" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_59a9c5e1-e634-492b-9c13-6544ef86814d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnamortizedDebtIssuanceExpense_b7eb7de8-8e3d-4b7d-a860-f65b706c18ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnamortizedDebtIssuanceExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_e07b63e9-ac99-4ce0-9280-41738d88dcab" xlink:to="loc_us-gaap_UnamortizedDebtIssuanceExpense_b7eb7de8-8e3d-4b7d-a860-f65b706c18ec" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_59edb598-09e2-407e-a6ba-2a38b0597ce1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_e07b63e9-ac99-4ce0-9280-41738d88dcab" xlink:to="loc_us-gaap_DebtInstrumentTable_59edb598-09e2-407e-a6ba-2a38b0597ce1" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_798a0692-1b2d-41d9-b9a9-902d430f90f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_59edb598-09e2-407e-a6ba-2a38b0597ce1" xlink:to="loc_us-gaap_DebtInstrumentAxis_798a0692-1b2d-41d9-b9a9-902d430f90f8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_798a0692-1b2d-41d9-b9a9-902d430f90f8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_798a0692-1b2d-41d9-b9a9-902d430f90f8" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_798a0692-1b2d-41d9-b9a9-902d430f90f8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_9ca6525c-0ed4-40b6-bd94-06b964c094ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_798a0692-1b2d-41d9-b9a9-902d430f90f8" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_9ca6525c-0ed4-40b6-bd94-06b964c094ba" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_AmendedAndRestatedSeniorCreditAgreementMember_4b684be2-32cb-430d-9a36-08ab9f3b1c12" xlink:href="cnmd-20230331.xsd#cnmd_AmendedAndRestatedSeniorCreditAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9ca6525c-0ed4-40b6-bd94-06b964c094ba" xlink:to="loc_cnmd_AmendedAndRestatedSeniorCreditAgreementMember_4b684be2-32cb-430d-9a36-08ab9f3b1c12" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_A2.625PercentConvertibleNotesDue2024Member_b0052c1c-bc51-4226-a11b-acbb54937e54" xlink:href="cnmd-20230331.xsd#cnmd_A2.625PercentConvertibleNotesDue2024Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9ca6525c-0ed4-40b6-bd94-06b964c094ba" xlink:to="loc_cnmd_A2.625PercentConvertibleNotesDue2024Member_b0052c1c-bc51-4226-a11b-acbb54937e54" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_A2250PercentConvertibleNotesDue2027Member_3dd0c15d-9507-4910-bd80-cd69362e28e3" xlink:href="cnmd-20230331.xsd#cnmd_A2250PercentConvertibleNotesDue2027Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9ca6525c-0ed4-40b6-bd94-06b964c094ba" xlink:to="loc_cnmd_A2250PercentConvertibleNotesDue2027Member_3dd0c15d-9507-4910-bd80-cd69362e28e3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_996d857e-3046-49c7-b8f0-07d70b6e4741" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_59edb598-09e2-407e-a6ba-2a38b0597ce1" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_996d857e-3046-49c7-b8f0-07d70b6e4741" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_996d857e-3046-49c7-b8f0-07d70b6e4741_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_996d857e-3046-49c7-b8f0-07d70b6e4741" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_996d857e-3046-49c7-b8f0-07d70b6e4741_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_287f5722-c2b8-4602-b706-76ccf5a3d49d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_996d857e-3046-49c7-b8f0-07d70b6e4741" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_287f5722-c2b8-4602-b706-76ccf5a3d49d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_590fdeda-eeba-40a2-980c-95eb7d4b7acb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_287f5722-c2b8-4602-b706-76ccf5a3d49d" xlink:to="loc_us-gaap_LineOfCreditMember_590fdeda-eeba-40a2-980c-95eb7d4b7acb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansPayableMember_a05fe3a8-e06d-417a-b819-d1652695e979" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LoansPayableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_287f5722-c2b8-4602-b706-76ccf5a3d49d" xlink:to="loc_us-gaap_LoansPayableMember_a05fe3a8-e06d-417a-b819-d1652695e979" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleNotesPayableMember_4f9fdbf1-8625-4b24-95e4-8ff3d54dfe8b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertibleNotesPayableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_287f5722-c2b8-4602-b706-76ccf5a3d49d" xlink:to="loc_us-gaap_ConvertibleNotesPayableMember_4f9fdbf1-8625-4b24-95e4-8ff3d54dfe8b" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.conmed.com/role/LongTermDebtAdditionalInformationDetails" xlink:type="simple" xlink:href="cnmd-20230331.xsd#LongTermDebtAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.conmed.com/role/LongTermDebtAdditionalInformationDetails" xlink:type="extended" id="i0e64673700d34719b60feab36e91f920_LongTermDebtAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_5881f14e-f9fa-484e-93c2-99346bdaed60" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_38a86f95-d3d3-4759-9565-528bbc0cd60e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5881f14e-f9fa-484e-93c2-99346bdaed60" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_38a86f95-d3d3-4759-9565-528bbc0cd60e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_5c0b9477-d9e5-481a-9bd8-aefd3b5c49e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5881f14e-f9fa-484e-93c2-99346bdaed60" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_5c0b9477-d9e5-481a-9bd8-aefd3b5c49e6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfSeniorDebt_ba9e791a-1470-45f5-9bd8-86acf39cbe74" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfSeniorDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5881f14e-f9fa-484e-93c2-99346bdaed60" xlink:to="loc_us-gaap_RepaymentsOfSeniorDebt_ba9e791a-1470-45f5-9bd8-86acf39cbe74" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_TermSOFRInterestRateSpreadAdjustment_b0bb41cf-8363-42c6-b1c2-70121f943ab8" xlink:href="cnmd-20230331.xsd#cnmd_TermSOFRInterestRateSpreadAdjustment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5881f14e-f9fa-484e-93c2-99346bdaed60" xlink:to="loc_cnmd_TermSOFRInterestRateSpreadAdjustment_b0bb41cf-8363-42c6-b1c2-70121f943ab8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_AdjustedTermSOFRInterestRate_3119da24-71aa-43c2-87f3-6b27a20e6d7e" xlink:href="cnmd-20230331.xsd#cnmd_AdjustedTermSOFRInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5881f14e-f9fa-484e-93c2-99346bdaed60" xlink:to="loc_cnmd_AdjustedTermSOFRInterestRate_3119da24-71aa-43c2-87f3-6b27a20e6d7e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_7bc7f4d0-4082-40f5-bacd-01e4d06e22b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5881f14e-f9fa-484e-93c2-99346bdaed60" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_7bc7f4d0-4082-40f5-bacd-01e4d06e22b5" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_cdc1cc6d-0d6a-4eff-8676-9c3fd10a7094" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5881f14e-f9fa-484e-93c2-99346bdaed60" xlink:to="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_cdc1cc6d-0d6a-4eff-8676-9c3fd10a7094" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_08cdcb57-89f0-471b-ac13-a3d2074c81f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5881f14e-f9fa-484e-93c2-99346bdaed60" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_08cdcb57-89f0-471b-ac13-a3d2074c81f4" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_79483b75-9657-4c77-b522-357c1860878d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5881f14e-f9fa-484e-93c2-99346bdaed60" xlink:to="loc_us-gaap_LongTermDebt_79483b75-9657-4c77-b522-357c1860878d" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_ee940826-7849-413b-b993-fbc2b702feb1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5881f14e-f9fa-484e-93c2-99346bdaed60" xlink:to="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_ee940826-7849-413b-b993-fbc2b702feb1" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LettersOfCreditOutstandingAmount_ef1e828c-50f3-4368-a566-3346104b2a2c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LettersOfCreditOutstandingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5881f14e-f9fa-484e-93c2-99346bdaed60" xlink:to="loc_us-gaap_LettersOfCreditOutstandingAmount_ef1e828c-50f3-4368-a566-3346104b2a2c" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_303b760e-2253-4cbe-9d94-f9c1151ba9c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5881f14e-f9fa-484e-93c2-99346bdaed60" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_303b760e-2253-4cbe-9d94-f9c1151ba9c0" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1_4ebfc77c-3dbd-4f0e-b086-4b8b7f9f671b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleConversionRatio1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5881f14e-f9fa-484e-93c2-99346bdaed60" xlink:to="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1_4ebfc77c-3dbd-4f0e-b086-4b8b7f9f671b" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_04776d29-7721-49d4-b1fc-436afdf56f1d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5881f14e-f9fa-484e-93c2-99346bdaed60" xlink:to="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_04776d29-7721-49d4-b1fc-436afdf56f1d" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_HedgeAndWarrantTransactionsNetCashPaid_7f51e442-60c9-483e-8484-ec653255568c" xlink:href="cnmd-20230331.xsd#cnmd_HedgeAndWarrantTransactionsNetCashPaid"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5881f14e-f9fa-484e-93c2-99346bdaed60" xlink:to="loc_cnmd_HedgeAndWarrantTransactionsNetCashPaid_7f51e442-60c9-483e-8484-ec653255568c" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfConvertibleDebt_11add576-1c2f-4a23-a741-f7406b5dc9fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfConvertibleDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5881f14e-f9fa-484e-93c2-99346bdaed60" xlink:to="loc_us-gaap_RepaymentsOfConvertibleDebt_11add576-1c2f-4a23-a741-f7406b5dc9fd" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtConversionConvertedInstrumentSharesIssued1_43e45630-216d-4ec9-a3b0-db6c1717c93d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtConversionConvertedInstrumentSharesIssued1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5881f14e-f9fa-484e-93c2-99346bdaed60" xlink:to="loc_us-gaap_DebtConversionConvertedInstrumentSharesIssued1_43e45630-216d-4ec9-a3b0-db6c1717c93d" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt_379496b4-f582-4302-a8b3-f497eae096ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpenseDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5881f14e-f9fa-484e-93c2-99346bdaed60" xlink:to="loc_us-gaap_InterestExpenseDebt_379496b4-f582-4302-a8b3-f497eae096ac" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue_89acbbed-fef1-43e9-9ba3-5cb5b20bdcc8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5881f14e-f9fa-484e-93c2-99346bdaed60" xlink:to="loc_us-gaap_DebtInstrumentFairValue_89acbbed-fef1-43e9-9ba3-5cb5b20bdcc8" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OptionIndexedToIssuersEquityStrikePrice1_c15e57eb-4f7a-412c-ab06-829028455612" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OptionIndexedToIssuersEquityStrikePrice1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5881f14e-f9fa-484e-93c2-99346bdaed60" xlink:to="loc_us-gaap_OptionIndexedToIssuersEquityStrikePrice1_c15e57eb-4f7a-412c-ab06-829028455612" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_cd942d52-7f3d-4182-842d-ee011e9acfa9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5881f14e-f9fa-484e-93c2-99346bdaed60" xlink:to="loc_us-gaap_DebtInstrumentTable_cd942d52-7f3d-4182-842d-ee011e9acfa9" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OptionIndexedToIssuersEquityTypeAxis_8c349f74-5fb9-41be-bafe-9461c3545d35" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OptionIndexedToIssuersEquityTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_cd942d52-7f3d-4182-842d-ee011e9acfa9" xlink:to="loc_us-gaap_OptionIndexedToIssuersEquityTypeAxis_8c349f74-5fb9-41be-bafe-9461c3545d35" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OptionIndexedToIssuersEquityTypeDomain_8c349f74-5fb9-41be-bafe-9461c3545d35_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OptionIndexedToIssuersEquityTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_OptionIndexedToIssuersEquityTypeAxis_8c349f74-5fb9-41be-bafe-9461c3545d35" xlink:to="loc_us-gaap_OptionIndexedToIssuersEquityTypeDomain_8c349f74-5fb9-41be-bafe-9461c3545d35_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OptionIndexedToIssuersEquityTypeDomain_d7ee1866-eae4-4a1d-8af9-042db760cf18" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OptionIndexedToIssuersEquityTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_OptionIndexedToIssuersEquityTypeAxis_8c349f74-5fb9-41be-bafe-9461c3545d35" xlink:to="loc_us-gaap_OptionIndexedToIssuersEquityTypeDomain_d7ee1866-eae4-4a1d-8af9-042db760cf18" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CallOptionMember_ddf02b87-6daa-4e77-8e8a-9c148bd5fa79" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CallOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OptionIndexedToIssuersEquityTypeDomain_d7ee1866-eae4-4a1d-8af9-042db760cf18" xlink:to="loc_us-gaap_CallOptionMember_ddf02b87-6daa-4e77-8e8a-9c148bd5fa79" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_e6c54d9d-d3a1-4568-90f7-784d1f5137e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_cd942d52-7f3d-4182-842d-ee011e9acfa9" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_e6c54d9d-d3a1-4568-90f7-784d1f5137e7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_e6c54d9d-d3a1-4568-90f7-784d1f5137e7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_e6c54d9d-d3a1-4568-90f7-784d1f5137e7" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_e6c54d9d-d3a1-4568-90f7-784d1f5137e7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_7aef8a8e-fee9-4658-9566-ff33671241c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_e6c54d9d-d3a1-4568-90f7-784d1f5137e7" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_7aef8a8e-fee9-4658-9566-ff33671241c6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansPayableMember_7aa1f2ee-1d55-4223-80c9-d075705eb594" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LoansPayableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_7aef8a8e-fee9-4658-9566-ff33671241c6" xlink:to="loc_us-gaap_LoansPayableMember_7aa1f2ee-1d55-4223-80c9-d075705eb594" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_32430897-f432-4f98-ab9b-7db9069de972" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_7aef8a8e-fee9-4658-9566-ff33671241c6" xlink:to="loc_us-gaap_LineOfCreditMember_32430897-f432-4f98-ab9b-7db9069de972" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleNotesPayableMember_f8557b88-5138-4e8d-abd0-1f3de108d698" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertibleNotesPayableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_7aef8a8e-fee9-4658-9566-ff33671241c6" xlink:to="loc_us-gaap_ConvertibleNotesPayableMember_f8557b88-5138-4e8d-abd0-1f3de108d698" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMember_8e89853b-db92-4c87-adbf-517136d8b501" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_7aef8a8e-fee9-4658-9566-ff33671241c6" xlink:to="loc_us-gaap_LongTermDebtMember_8e89853b-db92-4c87-adbf-517136d8b501" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_a9db1273-3b38-4bb4-b23f-808e0d6e9aef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_cd942d52-7f3d-4182-842d-ee011e9acfa9" xlink:to="loc_us-gaap_DebtInstrumentAxis_a9db1273-3b38-4bb4-b23f-808e0d6e9aef" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_a9db1273-3b38-4bb4-b23f-808e0d6e9aef_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_a9db1273-3b38-4bb4-b23f-808e0d6e9aef" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_a9db1273-3b38-4bb4-b23f-808e0d6e9aef_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_4eb67f49-9730-4aac-9f98-bf5ade046478" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_a9db1273-3b38-4bb4-b23f-808e0d6e9aef" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_4eb67f49-9730-4aac-9f98-bf5ade046478" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_AmendedAndRestatedSeniorCreditAgreementMember_1b8a657c-3a3e-4b6d-9907-559c3d211bbd" xlink:href="cnmd-20230331.xsd#cnmd_AmendedAndRestatedSeniorCreditAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_4eb67f49-9730-4aac-9f98-bf5ade046478" xlink:to="loc_cnmd_AmendedAndRestatedSeniorCreditAgreementMember_1b8a657c-3a3e-4b6d-9907-559c3d211bbd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_A2.625PercentConvertibleNotesDue2024Member_ac547b79-4327-4f29-9ffe-f867807b2763" xlink:href="cnmd-20230331.xsd#cnmd_A2.625PercentConvertibleNotesDue2024Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_4eb67f49-9730-4aac-9f98-bf5ade046478" xlink:to="loc_cnmd_A2.625PercentConvertibleNotesDue2024Member_ac547b79-4327-4f29-9ffe-f867807b2763" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_A2250PercentConvertibleNotesDue2027Member_5a9895b2-8595-49c3-9a53-de8b16a42cbc" xlink:href="cnmd-20230331.xsd#cnmd_A2250PercentConvertibleNotesDue2027Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_4eb67f49-9730-4aac-9f98-bf5ade046478" xlink:to="loc_cnmd_A2250PercentConvertibleNotesDue2027Member_5a9895b2-8595-49c3-9a53-de8b16a42cbc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_b917f92f-a719-44e1-92c5-cdbeca1f175c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPeriodAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_cd942d52-7f3d-4182-842d-ee011e9acfa9" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_b917f92f-a719-44e1-92c5-cdbeca1f175c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_b917f92f-a719-44e1-92c5-cdbeca1f175c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_b917f92f-a719-44e1-92c5-cdbeca1f175c" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_b917f92f-a719-44e1-92c5-cdbeca1f175c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_cb261e93-a62e-41df-a516-ec09f8e486d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_b917f92f-a719-44e1-92c5-cdbeca1f175c" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_cb261e93-a62e-41df-a516-ec09f8e486d0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_IndexedTransactionTypeAxis_3bc13cd1-2c58-42c6-a3b9-00fed73fe3cc" xlink:href="cnmd-20230331.xsd#cnmd_IndexedTransactionTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_cd942d52-7f3d-4182-842d-ee011e9acfa9" xlink:to="loc_cnmd_IndexedTransactionTypeAxis_3bc13cd1-2c58-42c6-a3b9-00fed73fe3cc" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_IndexedTransactionTypeDomain_3bc13cd1-2c58-42c6-a3b9-00fed73fe3cc_default" xlink:href="cnmd-20230331.xsd#cnmd_IndexedTransactionTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_cnmd_IndexedTransactionTypeAxis_3bc13cd1-2c58-42c6-a3b9-00fed73fe3cc" xlink:to="loc_cnmd_IndexedTransactionTypeDomain_3bc13cd1-2c58-42c6-a3b9-00fed73fe3cc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_IndexedTransactionTypeDomain_c44a172e-dd9e-4ff5-ad91-e2deab9c0771" xlink:href="cnmd-20230331.xsd#cnmd_IndexedTransactionTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_cnmd_IndexedTransactionTypeAxis_3bc13cd1-2c58-42c6-a3b9-00fed73fe3cc" xlink:to="loc_cnmd_IndexedTransactionTypeDomain_c44a172e-dd9e-4ff5-ad91-e2deab9c0771" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember_827b2d7c-a8a3-40bb-a0b7-28fef709ed3b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cnmd_IndexedTransactionTypeDomain_c44a172e-dd9e-4ff5-ad91-e2deab9c0771" xlink:to="loc_us-gaap_WarrantMember_827b2d7c-a8a3-40bb-a0b7-28fef709ed3b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_e06bfecf-709b-4072-8866-5556cdb1e44b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_cd942d52-7f3d-4182-842d-ee011e9acfa9" xlink:to="loc_us-gaap_VariableRateAxis_e06bfecf-709b-4072-8866-5556cdb1e44b" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_e06bfecf-709b-4072-8866-5556cdb1e44b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VariableRateAxis_e06bfecf-709b-4072-8866-5556cdb1e44b" xlink:to="loc_us-gaap_VariableRateDomain_e06bfecf-709b-4072-8866-5556cdb1e44b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_ddf7efb4-420e-4dd5-a384-945d63bce834" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VariableRateAxis_e06bfecf-709b-4072-8866-5556cdb1e44b" xlink:to="loc_us-gaap_VariableRateDomain_ddf7efb4-420e-4dd5-a384-945d63bce834" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_AdjustedTermSOFRInterestRateMember_900d1efe-49cc-4ef6-9343-382c43079fd8" xlink:href="cnmd-20230331.xsd#cnmd_AdjustedTermSOFRInterestRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_ddf7efb4-420e-4dd5-a384-945d63bce834" xlink:to="loc_cnmd_AdjustedTermSOFRInterestRateMember_900d1efe-49cc-4ef6-9343-382c43079fd8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FederalFundsEffectiveSwapRateMember_9c9785ae-4ba6-4a38-b8b7-cfd09f65972c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FederalFundsEffectiveSwapRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_ddf7efb4-420e-4dd5-a384-945d63bce834" xlink:to="loc_us-gaap_FederalFundsEffectiveSwapRateMember_9c9785ae-4ba6-4a38-b8b7-cfd09f65972c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_AdjustedTermSOFRMember_01d1849f-ddc7-4205-887f-d395b14b9b01" xlink:href="cnmd-20230331.xsd#cnmd_AdjustedTermSOFRMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_ddf7efb4-420e-4dd5-a384-945d63bce834" xlink:to="loc_cnmd_AdjustedTermSOFRMember_01d1849f-ddc7-4205-887f-d395b14b9b01" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.conmed.com/role/BusinessSegmentDetails" xlink:type="simple" xlink:href="cnmd-20230331.xsd#BusinessSegmentDetails"/>
  <link:definitionLink xlink:role="http://www.conmed.com/role/BusinessSegmentDetails" xlink:type="extended" id="i4016179e850a457e8a969d363de800c6_BusinessSegmentDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_04726fd6-cfaf-4d02-ada0-93f2dfae1f34" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_769a8d4e-0739-48ed-805a-35764496de6e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_04726fd6-cfaf-4d02-ada0-93f2dfae1f34" xlink:to="loc_us-gaap_Revenues_769a8d4e-0739-48ed-805a-35764496de6e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_de9d9830-dfe4-4e95-9e97-2d3b35e192f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_04726fd6-cfaf-4d02-ada0-93f2dfae1f34" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_de9d9830-dfe4-4e95-9e97-2d3b35e192f1" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_9302d79a-e092-49c9-96cc-f31c87372659" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_de9d9830-dfe4-4e95-9e97-2d3b35e192f1" xlink:to="loc_srt_ProductOrServiceAxis_9302d79a-e092-49c9-96cc-f31c87372659" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_9302d79a-e092-49c9-96cc-f31c87372659_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_9302d79a-e092-49c9-96cc-f31c87372659" xlink:to="loc_srt_ProductsAndServicesDomain_9302d79a-e092-49c9-96cc-f31c87372659_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_e9480ea5-19ae-4740-ba52-29b00d5620b8" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_9302d79a-e092-49c9-96cc-f31c87372659" xlink:to="loc_srt_ProductsAndServicesDomain_e9480ea5-19ae-4740-ba52-29b00d5620b8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_OrthopedicSurgeryMember_d2a299fe-a717-4f54-93c3-b4d8f23f9f89" xlink:href="cnmd-20230331.xsd#cnmd_OrthopedicSurgeryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_e9480ea5-19ae-4740-ba52-29b00d5620b8" xlink:to="loc_cnmd_OrthopedicSurgeryMember_d2a299fe-a717-4f54-93c3-b4d8f23f9f89" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_GeneralSurgeryMember_912a3e27-95bb-497e-a3b5-1b04785e7ec9" xlink:href="cnmd-20230331.xsd#cnmd_GeneralSurgeryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_e9480ea5-19ae-4740-ba52-29b00d5620b8" xlink:to="loc_cnmd_GeneralSurgeryMember_912a3e27-95bb-497e-a3b5-1b04785e7ec9" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://fasb.org/us-gaap/role/eedm/ExtensibleEnumerationLists" xlink:type="simple" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd#eedm"/>
  <link:definitionLink xlink:role="http://fasb.org/us-gaap/role/eedm/ExtensibleEnumerationLists" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate202006Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingStandardsUpdate202006Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfAdoptionMember" xlink:to="loc_us-gaap_AccountingStandardsUpdate202006Member" xlink:type="arc" order="1"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>8
<FILENAME>cnmd-20230331_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:30a13273-0e0a-49c8-aa2d-31e213cf1b75,g:3b97619f-d09a-4ff4-909a-c708e7b90654-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_bd4f2951-ff60-4793-b4c1-d77b6c3fc1cc_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAxis" xlink:to="lab_us-gaap_BusinessAcquisitionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_efc5b5ba-59db-48e5-adee-846b652ca5f3_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_95197d6b-494b-4790-a6f3-b64fd2cd1c0f_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Gross</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount" xlink:to="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_6558b4b1-c3a2-4dfe-8deb-0ce3e46839ed_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_cf7e88e8-69f7-4787-b7f5-afc839ebca1e_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesOutstanding" xlink:to="lab_us-gaap_PreferredStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_3323453f-cbee-47a4-8e92-075e86b0f62a_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_1e8616a6-f9e5-45e7-9c5a-e160d1e6cda6_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis" xlink:to="lab_us-gaap_DebtInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock_90cef530-eeb0-4848-ba4e-633b20f12b61_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Indefinite-Lived Intangible Assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Indefinite-Lived Intangible Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiability_a6940e37-eddf-4b08-941a-1f76c0acf84b_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiability_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiability" xlink:to="lab_us-gaap_FinanceLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfDividendsCommonStock_783590ca-30dd-4df7-9900-e1dc476e2eea_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDividendsCommonStock" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends paid on common stock</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDividendsCommonStock_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDividendsCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Ordinary Dividends, Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDividendsCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDividendsCommonStock" xlink:to="lab_us-gaap_PaymentsOfDividendsCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_2a6674ca-1871-4c41-b69f-226c0aad0fd3_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_a953b140-9768-4fe7-9f26-7c14dbea93cc_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt and Lease Obligation, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:to="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFairValue_7ea5f4f9-9ea7-4758-a84d-4d546909de2b_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Fair Value Disclosure</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFairValue_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFairValue" xlink:to="lab_us-gaap_DebtInstrumentFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_89761637-35ff-4c2f-a1d7-459fe63f4313_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid in Capital</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapital" xlink:to="lab_us-gaap_AdditionalPaidInCapital" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_ed5d903d-5e9b-41e2-9d54-5f66f5f3f970_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Basis Spread on Variable Rate</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Basis Spread on Variable Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:to="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_2dd52479-05c1-491f-b429-1e145eb05ca5_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_0cecc5d1-58c1-49ef-a5c4-050e01e222dc_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Depreciation_c18c2c8a-9e05-4ba1-ba8d-5986578e6257_terseLabel_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation</link:label>
    <link:label id="lab_us-gaap_Depreciation_label_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Depreciation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Depreciation" xlink:to="lab_us-gaap_Depreciation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MaturitiesOfLongTermDebtAbstract_13cdcedb-3d64-4d58-b0f8-bc657b0451e9_terseLabel_en-US" xlink:label="lab_us-gaap_MaturitiesOfLongTermDebtAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maturities of Long-term Debt [Abstract]</link:label>
    <link:label id="lab_us-gaap_MaturitiesOfLongTermDebtAbstract_label_en-US" xlink:label="lab_us-gaap_MaturitiesOfLongTermDebtAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maturities of Long-Term Debt [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MaturitiesOfLongTermDebtAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MaturitiesOfLongTermDebtAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MaturitiesOfLongTermDebtAbstract" xlink:to="lab_us-gaap_MaturitiesOfLongTermDebtAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_cnmd_IndexedTransactionTypeAxis_cf0777a0-0b9c-4db3-a403-d7dc1d280f91_terseLabel_en-US" xlink:label="lab_cnmd_IndexedTransactionTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indexed transaction type [Axis]</link:label>
    <link:label id="lab_cnmd_IndexedTransactionTypeAxis_label_en-US" xlink:label="lab_cnmd_IndexedTransactionTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indexed transaction type [Axis]</link:label>
    <link:label id="lab_cnmd_IndexedTransactionTypeAxis_documentation_en-US" xlink:label="lab_cnmd_IndexedTransactionTypeAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indexed transaction type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_IndexedTransactionTypeAxis" xlink:href="cnmd-20230331.xsd#cnmd_IndexedTransactionTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cnmd_IndexedTransactionTypeAxis" xlink:to="lab_cnmd_IndexedTransactionTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_8dcf4093-4f74-4616-829d-ccda7973ad15_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate, stated percentage</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Stated Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock_fd269705-ac10-4611-a59e-15c9742a46ae_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions by Acquisition, Contingent Consideration</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions by Acquisition, Contingent Consideration [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock" xlink:to="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LegalMattersAndContingenciesTextBlock_b5286c85-c10d-4941-b838-65abbc978397_terseLabel_en-US" xlink:label="lab_us-gaap_LegalMattersAndContingenciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Proceedings</link:label>
    <link:label id="lab_us-gaap_LegalMattersAndContingenciesTextBlock_label_en-US" xlink:label="lab_us-gaap_LegalMattersAndContingenciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Matters and Contingencies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LegalMattersAndContingenciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LegalMattersAndContingenciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LegalMattersAndContingenciesTextBlock" xlink:to="lab_us-gaap_LegalMattersAndContingenciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_186553d4-9665-4ed2-93e9-6a787d8de18b_totalLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net periodic pension cost</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Net Periodic Benefit Cost (Credit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:to="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:type="arc" order="1"/>
    <link:label id="lab_cnmd_TermSOFRInterestRateSpreadAdjustment_bc926d02-e147-4b12-83f2-dff3f22ab696_terseLabel_en-US" xlink:label="lab_cnmd_TermSOFRInterestRateSpreadAdjustment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term SOFR Interest Rate Spread Adjustment</link:label>
    <link:label id="lab_cnmd_TermSOFRInterestRateSpreadAdjustment_label_en-US" xlink:label="lab_cnmd_TermSOFRInterestRateSpreadAdjustment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term SOFR Interest Rate Spread Adjustment</link:label>
    <link:label id="lab_cnmd_TermSOFRInterestRateSpreadAdjustment_documentation_en-US" xlink:label="lab_cnmd_TermSOFRInterestRateSpreadAdjustment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term SOFR Interest Rate Spread Adjustment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_TermSOFRInterestRateSpreadAdjustment" xlink:href="cnmd-20230331.xsd#cnmd_TermSOFRInterestRateSpreadAdjustment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cnmd_TermSOFRInterestRateSpreadAdjustment" xlink:to="lab_cnmd_TermSOFRInterestRateSpreadAdjustment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendsPayableCurrentAndNoncurrent_7e958d02-aa71-4f16-890e-8e2c909c31d7_terseLabel_en-US" xlink:label="lab_us-gaap_DividendsPayableCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends payable</link:label>
    <link:label id="lab_us-gaap_DividendsPayableCurrentAndNoncurrent_label_en-US" xlink:label="lab_us-gaap_DividendsPayableCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableCurrentAndNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsPayableCurrentAndNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsPayableCurrentAndNoncurrent" xlink:to="lab_us-gaap_DividendsPayableCurrentAndNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_836c130e-211c-46bb-ae6a-0d1619466fac_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_a169ea90-27c4-446e-9c26-48ae5085f656_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputTypeDomain_acc516c6-492b-4a9b-b996-94ab00b29414_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input Type [Domain]</link:label>
    <link:label id="lab_us-gaap_MeasurementInputTypeDomain_label_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputTypeDomain" xlink:to="lab_us-gaap_MeasurementInputTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_04e2f674-0757-4418-b84a-5fb02249024c_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive securities excluded from computation of earnings per share (in shares)</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_2b2a8ae1-2ab2-4c9c-8302-82918dcff787_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Maturities of Long-Term Debt</link:label>
    <link:label id="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Maturities of Long-Term Debt [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FederalFundsEffectiveSwapRateMember_bb0b9bdb-dcc8-4363-84c4-8541d52372a0_terseLabel_en-US" xlink:label="lab_us-gaap_FederalFundsEffectiveSwapRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fed Funds Effective Rate Overnight Index Swap Rate [Member]</link:label>
    <link:label id="lab_us-gaap_FederalFundsEffectiveSwapRateMember_label_en-US" xlink:label="lab_us-gaap_FederalFundsEffectiveSwapRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fed Funds Effective Rate Overnight Index Swap Rate [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FederalFundsEffectiveSwapRateMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FederalFundsEffectiveSwapRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FederalFundsEffectiveSwapRateMember" xlink:to="lab_us-gaap_FederalFundsEffectiveSwapRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_b1f43cc4-3f8a-4e4b-9de8-0b14aa056478_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputDiscountRateMember_a8eabc55-bcf1-474d-ad93-538044489c01_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputDiscountRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Discount Rate</link:label>
    <link:label id="lab_us-gaap_MeasurementInputDiscountRateMember_label_en-US" xlink:label="lab_us-gaap_MeasurementInputDiscountRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Discount Rate [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputDiscountRateMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputDiscountRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputDiscountRateMember" xlink:to="lab_us-gaap_MeasurementInputDiscountRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockCommonValue_25950d98-419f-48af-8f53-d5074caae7d9_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonValue" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: 738,718 and 811,532 shares of common stock in treasury, at cost, in 2023 and 2022, respectively</link:label>
    <link:label id="lab_us-gaap_TreasuryStockCommonValue_label_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Common, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockCommonValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockCommonValue" xlink:to="lab_us-gaap_TreasuryStockCommonValue" xlink:type="arc" order="1"/>
    <link:label id="lab_cnmd_RevenuesMember_f4f9d100-2b98-4b13-9f7f-7b8ba2d75110_terseLabel_en-US" xlink:label="lab_cnmd_RevenuesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues</link:label>
    <link:label id="lab_cnmd_RevenuesMember_label_en-US" xlink:label="lab_cnmd_RevenuesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues [Member]</link:label>
    <link:label id="lab_cnmd_RevenuesMember_documentation_en-US" xlink:label="lab_cnmd_RevenuesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_RevenuesMember" xlink:href="cnmd-20230331.xsd#cnmd_RevenuesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cnmd_RevenuesMember" xlink:to="lab_cnmd_RevenuesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities_4e03a931-4358-44bc-aa0f-ef3786616f78_totalLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt and Lease Obligation, Including Current Maturities</link:label>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities_label_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt and Lease Obligation, Including Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities" xlink:to="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingDesignationDomain_acd45c12-9cc9-4b8c-8830-d6985a14aacd_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingDesignationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Domain]</link:label>
    <link:label id="lab_us-gaap_HedgingDesignationDomain_label_en-US" xlink:label="lab_us-gaap_HedgingDesignationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingDesignationDomain" xlink:to="lab_us-gaap_HedgingDesignationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_88aea729-90b6-4fb2-b982-a209f6321b4a_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument Risk [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:to="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_cnmd_ScheduleOfFiniteLivedAndIndefiniteLivedAssetsTable_0c98bce8-535f-4a6d-aaa3-32c03f1bbe5e_terseLabel_en-US" xlink:label="lab_cnmd_ScheduleOfFiniteLivedAndIndefiniteLivedAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived and Indefinite-Lived Assets [Table]</link:label>
    <link:label id="lab_cnmd_ScheduleOfFiniteLivedAndIndefiniteLivedAssetsTable_label_en-US" xlink:label="lab_cnmd_ScheduleOfFiniteLivedAndIndefiniteLivedAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived and Indefinite-Lived Assets [Table]</link:label>
    <link:label id="lab_cnmd_ScheduleOfFiniteLivedAndIndefiniteLivedAssetsTable_documentation_en-US" xlink:label="lab_cnmd_ScheduleOfFiniteLivedAndIndefiniteLivedAssetsTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived and Indefinite-Lived Assets [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_ScheduleOfFiniteLivedAndIndefiniteLivedAssetsTable" xlink:href="cnmd-20230331.xsd#cnmd_ScheduleOfFiniteLivedAndIndefiniteLivedAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cnmd_ScheduleOfFiniteLivedAndIndefiniteLivedAssetsTable" xlink:to="lab_cnmd_ScheduleOfFiniteLivedAndIndefiniteLivedAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillLineItems_7ff88d8b-1233-442f-916d-7321418a18e0_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Line Items]</link:label>
    <link:label id="lab_us-gaap_GoodwillLineItems_label_en-US" xlink:label="lab_us-gaap_GoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillLineItems" xlink:to="lab_us-gaap_GoodwillLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_04cedd02-9a71-4ce6-9db4-c15eb2c77d43_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_74fc19ab-c3c1-47e6-a0c6-e73d2a96c0cf_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock_c3f8f35b-9aa6-42b5-80cc-c8f57249b8d0_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Notional Amounts of Outstanding Derivative Positions</link:label>
    <link:label id="lab_us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Notional Amounts of Outstanding Derivative Positions [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities_36d74ade-6d81-4d64-98f3-a026b615e81b_terseLabel_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities (in shares)</link:label>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities_label_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities" xlink:to="lab_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_1d7b2c5a-67fb-4035-908c-999862796f6c_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive income:</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_72bcc673-9110-4cbc-9ef2-64114e187e45_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash (used in) provided by operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_cnmd_GeneralSurgeryMember_d9819304-3483-484d-b5df-6bf9edd2ba27_terseLabel_en-US" xlink:label="lab_cnmd_GeneralSurgeryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General Surgery</link:label>
    <link:label id="lab_cnmd_GeneralSurgeryMember_label_en-US" xlink:label="lab_cnmd_GeneralSurgeryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General Surgery [Member]</link:label>
    <link:label id="lab_cnmd_GeneralSurgeryMember_documentation_en-US" xlink:label="lab_cnmd_GeneralSurgeryMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General Surgery [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_GeneralSurgeryMember" xlink:href="cnmd-20230331.xsd#cnmd_GeneralSurgeryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cnmd_GeneralSurgeryMember" xlink:to="lab_cnmd_GeneralSurgeryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Liabilities_ccee1c0f-d78c-465a-a52e-6e111d9e3c59_totalLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_label_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_c406b674-a1aa-4328-a9de-33c0e26df123_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementGeographicalAxis_e5f60764-d8db-4ec4-ba44-0170ce50d85c_terseLabel_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:label id="lab_srt_StatementGeographicalAxis_label_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementGeographicalAxis" xlink:to="lab_srt_StatementGeographicalAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_a823e8bd-dedd-4cf1-b050-7fc4f461397d_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from investing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TechnologyBasedIntangibleAssetsMember_45f7997f-6b77-424f-94bf-a9f9793440f6_terseLabel_en-US" xlink:label="lab_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Developed technology</link:label>
    <link:label id="lab_us-gaap_TechnologyBasedIntangibleAssetsMember_label_en-US" xlink:label="lab_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Technology-Based Intangible Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:to="lab_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_f6f24835-9046-47e7-96bb-6e0003d7f772_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_6deb6f9f-295d-4b59-8a41-9bb3862f433a_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_ff206fb6-6c70-4d1e-ba3d-9c12616f5e2c_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements and Changes in Accounting Principles [Abstract]</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update and Change in Accounting Principle [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:to="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_4ba56294-1805-49f9-8eec-426ab1962542_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TransferredAtPointInTimeMember_6d2f1ac2-54f6-4bfc-afe0-2e2f81295b67_terseLabel_en-US" xlink:label="lab_us-gaap_TransferredAtPointInTimeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goods transferred at a point in time</link:label>
    <link:label id="lab_us-gaap_TransferredAtPointInTimeMember_label_en-US" xlink:label="lab_us-gaap_TransferredAtPointInTimeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transferred at Point in Time [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransferredAtPointInTimeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransferredAtPointInTimeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TransferredAtPointInTimeMember" xlink:to="lab_us-gaap_TransferredAtPointInTimeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtTextBlock_589488d7-b37c-4cb7-9940-9af5a827d84f_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtTextBlock_label_en-US" xlink:label="lab_us-gaap_LongTermDebtTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtTextBlock" xlink:to="lab_us-gaap_LongTermDebtTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StandardProductWarrantyAccrualPayments_e46f8248-1aaa-49ac-b45b-5987e1fd0b34_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StandardProductWarrantyAccrualPayments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Claims made</link:label>
    <link:label id="lab_us-gaap_StandardProductWarrantyAccrualPayments_label_en-US" xlink:label="lab_us-gaap_StandardProductWarrantyAccrualPayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Standard Product Warranty Accrual, Decrease for Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StandardProductWarrantyAccrualPayments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StandardProductWarrantyAccrualPayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StandardProductWarrantyAccrualPayments" xlink:to="lab_us-gaap_StandardProductWarrantyAccrualPayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_7d64c367-7ef2-434f-9c9e-6a0f48b6d03e_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductsAndServicesDomain_64e5e2c7-3a92-4ee7-856d-dbfe81e11a0e_terseLabel_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:label id="lab_srt_ProductsAndServicesDomain_label_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductsAndServicesDomain" xlink:to="lab_srt_ProductsAndServicesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_7cdd3424-33d5-43c4-baff-b454156e181a_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_c391d572-6785-4ac9-886a-d3188ec9f749_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_ca2a62de-530a-48ea-ad33-b3ba7ed9a0d2_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_fb3ce54f-7ae4-4906-88e7-f1d9d1cd95e7_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OptionIndexedToIssuersEquityTypeDomain_65b708fc-37c9-4f49-b0c0-60fdab501963_terseLabel_en-US" xlink:label="lab_us-gaap_OptionIndexedToIssuersEquityTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Option Indexed to Issuer's Equity, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_OptionIndexedToIssuersEquityTypeDomain_label_en-US" xlink:label="lab_us-gaap_OptionIndexedToIssuersEquityTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Option Indexed to Issuer's Equity, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OptionIndexedToIssuersEquityTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OptionIndexedToIssuersEquityTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OptionIndexedToIssuersEquityTypeDomain" xlink:to="lab_us-gaap_OptionIndexedToIssuersEquityTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_3baa9d67-687d-4140-9d86-4c8498d6c261_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Asset and Liability</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:to="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_cc3a39c0-fdf8-4f39-af27-4d6569aa61ee_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_cnmd_ProductLiabilityContingencyInsuranceAmountPerIncident_2ebb5ee1-fb2e-41de-8b7a-20925b9c41c1_terseLabel_en-US" xlink:label="lab_cnmd_ProductLiabilityContingencyInsuranceAmountPerIncident" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product liability insurance, amount per incident</link:label>
    <link:label id="lab_cnmd_ProductLiabilityContingencyInsuranceAmountPerIncident_label_en-US" xlink:label="lab_cnmd_ProductLiabilityContingencyInsuranceAmountPerIncident" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Liability Contingency, Insurance, Amount per Incident</link:label>
    <link:label id="lab_cnmd_ProductLiabilityContingencyInsuranceAmountPerIncident_documentation_en-US" xlink:label="lab_cnmd_ProductLiabilityContingencyInsuranceAmountPerIncident" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Liability Contingency, Insurance, Amount per Incident</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_ProductLiabilityContingencyInsuranceAmountPerIncident" xlink:href="cnmd-20230331.xsd#cnmd_ProductLiabilityContingencyInsuranceAmountPerIncident"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cnmd_ProductLiabilityContingencyInsuranceAmountPerIncident" xlink:to="lab_cnmd_ProductLiabilityContingencyInsuranceAmountPerIncident" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_e50f8710-5a52-486b-9b6d-39142ce52bc5_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions by Acquisition, Contingent Consideration [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions by Acquisition, Contingent Consideration [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable" xlink:to="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_cnmd_HedgeAndWarrantTransactionsNetCashPaid_7b19a929-e43a-45e4-aa01-9a9170e3ce61_terseLabel_en-US" xlink:label="lab_cnmd_HedgeAndWarrantTransactionsNetCashPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedge and warrant transactions, net cash paid</link:label>
    <link:label id="lab_cnmd_HedgeAndWarrantTransactionsNetCashPaid_label_en-US" xlink:label="lab_cnmd_HedgeAndWarrantTransactionsNetCashPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedge and Warrant Transactions, Net Cash Paid</link:label>
    <link:label id="lab_cnmd_HedgeAndWarrantTransactionsNetCashPaid_documentation_en-US" xlink:label="lab_cnmd_HedgeAndWarrantTransactionsNetCashPaid" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Up-front costs to purchase hedge instruments, net of cash received from issuance of warrants</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_HedgeAndWarrantTransactionsNetCashPaid" xlink:href="cnmd-20230331.xsd#cnmd_HedgeAndWarrantTransactionsNetCashPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cnmd_HedgeAndWarrantTransactionsNetCashPaid" xlink:to="lab_cnmd_HedgeAndWarrantTransactionsNetCashPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months_f03024aa-adbd-431e-924e-d88d25fa43d2_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Cash Flow Hedge Gain (Loss) to be Reclassified During Next 12 Months</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Cash Flow Hedge Gain (Loss) to be Reclassified During Next 12 Months</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months" xlink:to="lab_us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingStandardsUpdate202006Member_d309e58b-e422-466a-89cb-b6565b653337_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdate202006Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update 2020-06</link:label>
    <link:label id="lab_us-gaap_AccountingStandardsUpdate202006Member_label_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdate202006Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update 2020-06 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate202006Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingStandardsUpdate202006Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingStandardsUpdate202006Member" xlink:to="lab_us-gaap_AccountingStandardsUpdate202006Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNetByBalanceSheetClassificationAbstract_ba8d4683-2fce-45e2-b95b-24bbc25efd83_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNetByBalanceSheetClassificationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Assets and Liabilities at Fair Value [Abstract]</link:label>
    <link:label id="lab_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNetByBalanceSheetClassificationAbstract_label_en-US" xlink:label="lab_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNetByBalanceSheetClassificationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Assets (Liabilities), at Fair Value, Net, by Balance Sheet Classification [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNetByBalanceSheetClassificationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssetsLiabilitiesAtFairValueNetByBalanceSheetClassificationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNetByBalanceSheetClassificationAbstract" xlink:to="lab_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNetByBalanceSheetClassificationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_13aca432-9f93-47ee-937d-c9ba13e16439_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Table]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_89227435-ea02-42a9-bd85-5ee676d78b3d_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accumulated Other Comprehensive Loss</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_53fa7326-0ad6-4a57-bcde-b2728ab9b4e2_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OptionIndexedToIssuersEquityStrikePrice1_a80b8354-01a8-4b5a-b1dc-1427cd83dfa1_terseLabel_en-US" xlink:label="lab_us-gaap_OptionIndexedToIssuersEquityStrikePrice1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Option indexed to issuer's equity, strike price (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_OptionIndexedToIssuersEquityStrikePrice1_label_en-US" xlink:label="lab_us-gaap_OptionIndexedToIssuersEquityStrikePrice1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Option Indexed to Issuer's Equity, Strike Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OptionIndexedToIssuersEquityStrikePrice1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OptionIndexedToIssuersEquityStrikePrice1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OptionIndexedToIssuersEquityStrikePrice1" xlink:to="lab_us-gaap_OptionIndexedToIssuersEquityStrikePrice1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_248a369e-f513-4dad-b98f-8c2080e7e388_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureAbstract" xlink:to="lab_us-gaap_DebtDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_2e2b5a0e-4024-4fd3-ab43-5531e8c6de16_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionContingentConsiderationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Contingent Consideration [Line Items]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionContingentConsiderationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Contingent Consideration [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionContingentConsiderationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems" xlink:to="lab_us-gaap_BusinessAcquisitionContingentConsiderationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_d2f4f4c3-aa51-46b1-9e39-80415c604feb_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Per share data:</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_e869a9e9-b7f9-42a1-930d-6a3da9703c2e_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationAxis" xlink:to="lab_us-gaap_IncomeStatementLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_c063d673-4b02-4028-a384-046703d005f1_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpenseDebt_dffdab3e-bc73-423c-a6f9-d869702f32b3_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpenseDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense, Debt</link:label>
    <link:label id="lab_us-gaap_InterestExpenseDebt_label_en-US" xlink:label="lab_us-gaap_InterestExpenseDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense, Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpenseDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpenseDebt" xlink:to="lab_us-gaap_InterestExpenseDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_e4e01920-6a25-4dcd-8ed3-0ad4987e7aab_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued compensation and benefits</link:label>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee-related Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:to="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditMember_b615f987-2173-4328-84f3-a383c399346c_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit [Member]</link:label>
    <link:label id="lab_us-gaap_LineOfCreditMember_label_en-US" xlink:label="lab_us-gaap_LineOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditMember" xlink:to="lab_us-gaap_LineOfCreditMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_2b04a1d4-70f5-449f-8d42-204bab10875b_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shareholders' equity:</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityAbstract" xlink:to="lab_us-gaap_StockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_804c62a1-3b39-4616-9aa9-16cf53513c43_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expense and Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_0999d9d6-2b16-48de-b64a-c86dee3438c9_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income before income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments_90d0ccbc-021c-45ac-b40e-e10e1a0ec90d_verboseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss on Foreign Currency Derivative Instruments Not Designated as Hedging Instruments</link:label>
    <link:label id="lab_us-gaap_GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments_label_en-US" xlink:label="lab_us-gaap_GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Foreign Currency Derivative Instruments Not Designated as Hedging Instruments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments" xlink:to="lab_us-gaap_GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_5adaf034-0e9a-4cab-9d5c-fde22b3592e7_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable" xlink:to="lab_us-gaap_ScheduleOfGoodwillTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_0f2b6309-7087-42a2-a768-3a4528accc9c_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock" xlink:to="lab_us-gaap_EarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanInterestCost_00246905-ef50-4057-8921-14f27e9f27d6_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanInterestCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest cost on projected benefit obligation</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanInterestCost_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanInterestCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Interest Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanInterestCost" xlink:to="lab_us-gaap_DefinedBenefitPlanInterestCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncurrentLiabilitiesMember_796fea28-1592-453c-a3d6-bbfadf180328_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncurrent Liabilities [Member]</link:label>
    <link:label id="lab_us-gaap_OtherNoncurrentLiabilitiesMember_label_en-US" xlink:label="lab_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncurrent Liabilities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:to="lab_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants_eb73d221-f73b-4913-afa8-a89270931d44_terseLabel_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants (in shares)</link:label>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants_label_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants" xlink:to="lab_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_79c57d28-d633-4909-ae8e-74cd41a2f915_terseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive income</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_d9adbdd4-31b3-4a21-b25a-5aa70290be5e_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive income</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_3d9c399f-a047-4df8-b538-69d151ce4892_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_468c4fd2-1008-4ada-8f85-0cdb48cd3a11_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss) before reclassifications, net of tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), before Reclassifications, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesGross_7c44ad0e-1955-4e94-afd6-d9d63825b8a5_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to acquire businesses, gross</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesGross_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesGross" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_9b30522b-4b60-401e-8579-6ae79014b548_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract Type [Domain]</link:label>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_label_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeContractTypeDomain" xlink:to="lab_us-gaap_DerivativeContractTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GrossProfit_1bd9761e-f73f-4c21-95eb-d666b87300c7_totalLabel_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross profit</link:label>
    <link:label id="lab_us-gaap_GrossProfit_label_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Profit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GrossProfit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GrossProfit" xlink:to="lab_us-gaap_GrossProfit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MaximumLengthOfTimeHedgedInCashFlowHedge1_3dfa93b1-3708-4f24-8bf9-846f85d20020_terseLabel_en-US" xlink:label="lab_us-gaap_MaximumLengthOfTimeHedgedInCashFlowHedge1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum Length of Time Hedged in Cash Flow Hedge</link:label>
    <link:label id="lab_us-gaap_MaximumLengthOfTimeHedgedInCashFlowHedge1_label_en-US" xlink:label="lab_us-gaap_MaximumLengthOfTimeHedgedInCashFlowHedge1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum Length of Time Hedged in Cash Flow Hedge</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MaximumLengthOfTimeHedgedInCashFlowHedge1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MaximumLengthOfTimeHedgedInCashFlowHedge1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MaximumLengthOfTimeHedgedInCashFlowHedge1" xlink:to="lab_us-gaap_MaximumLengthOfTimeHedgedInCashFlowHedge1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_24359ce0-50e4-4fab-900b-ad947deaa44f_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_8c4310f4-3543-4215-9fc3-f873a82042d3_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation</link:label>
    <link:label id="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_label_en-US" xlink:label="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Foreign Currency Translation Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillForeignCurrencyTranslationGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:to="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedTranslationAdjustmentMember_62febb66-9dea-4821-a075-4756c5442804_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Translation Adjustments</link:label>
    <link:label id="lab_us-gaap_AccumulatedTranslationAdjustmentMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Foreign Currency Adjustment Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:to="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_d7ac580a-52b1-4700-a8b2-5ddf63de69cd_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_6f2a4d97-36ad-4e41-8356-b84983823b20_terseLabel_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension Plan</link:label>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Benefits [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:to="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EMEAMember_8c08eb46-337a-48b6-85ec-eedc7e30ce3a_terseLabel_en-US" xlink:label="lab_us-gaap_EMEAMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Europe, Middle East &amp; Africa</link:label>
    <link:label id="lab_us-gaap_EMEAMember_label_en-US" xlink:label="lab_us-gaap_EMEAMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EMEA [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EMEAMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EMEAMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EMEAMember" xlink:to="lab_us-gaap_EMEAMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleConversionRatio1_e7a9ee46-570c-4d02-94a4-bf164da81d42_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Conversion Ratio</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleConversionRatio1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Conversion Ratio</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleConversionRatio1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:to="lab_us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_b31bc0c6-ae4c-46e0-9b72-adde8fcde9e8_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_c392af3b-9a2e-4b4f-9945-f9610927764f_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_3aebf832-61e1-4efd-ab67-3a98f36127ff_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, par value (dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryRawMaterialsNetOfReserves_95577aeb-7c84-4687-acf0-b6b8e1c277aa_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Raw materials</link:label>
    <link:label id="lab_us-gaap_InventoryRawMaterialsNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Raw Materials, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:to="lab_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_4c7bf884-ecb4-4e5e-b371-66e2149f8dd7_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_fbd15cfb-6851-4c1a-8799-cc4d7b95d273_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_c052a226-e051-4cd0-b25a-2d2e9b80c054_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockCommonMember_7ff132b2-b764-44e4-b169-e4b94ff35320_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock</link:label>
    <link:label id="lab_us-gaap_TreasuryStockCommonMember_label_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Common [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockCommonMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockCommonMember" xlink:to="lab_us-gaap_TreasuryStockCommonMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_ed1f51f4-dc7d-47f9-83d7-46083d176e5e_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments for New Accounting Pronouncements [Axis]</link:label>
    <link:label id="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_label_en-US" xlink:label="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:to="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAmortizationOfDeferredCharges_283591aa-3a4a-4c20-896b-8008557179ca_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAmortizationOfDeferredCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization</link:label>
    <link:label id="lab_us-gaap_OtherAmortizationOfDeferredCharges_label_en-US" xlink:label="lab_us-gaap_OtherAmortizationOfDeferredCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Other Deferred Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAmortizationOfDeferredCharges" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAmortizationOfDeferredCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAmortizationOfDeferredCharges" xlink:to="lab_us-gaap_OtherAmortizationOfDeferredCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_67f38852-2efc-498b-b6ff-06baa023f213_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_57193a69-38f9-432f-8d6c-31218228b2e3_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockCommonShares_44031902-84db-46f9-b2ea-6ca27dbc2bf9_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock, shares (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockCommonShares_label_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Common, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockCommonShares" xlink:to="lab_us-gaap_TreasuryStockCommonShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationFromAociCurrentPeriodTax_2f7220f2-1bb8-42e2-947b-d380aa94a321_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationFromAociCurrentPeriodTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification from AOCI, Current Period, Tax</link:label>
    <link:label id="lab_us-gaap_ReclassificationFromAociCurrentPeriodTax_label_en-US" xlink:label="lab_us-gaap_ReclassificationFromAociCurrentPeriodTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification from AOCI, Current Period, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAociCurrentPeriodTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationFromAociCurrentPeriodTax" xlink:to="lab_us-gaap_ReclassificationFromAociCurrentPeriodTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_bc3ed682-8b98-4d19-8ccd-1f0a7df0ed97_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2027</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_8e13992c-4780-4d1a-a510-0a611c0578e1_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Line Items]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_ce7d3b5d-1b55-4d0b-9afe-d3550465392b_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development expense</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromLinesOfCredit_981c6284-5f1b-4da4-88cc-e7d3d1e80c53_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromLinesOfCredit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from revolving line of credit</link:label>
    <link:label id="lab_us-gaap_ProceedsFromLinesOfCredit_label_en-US" xlink:label="lab_us-gaap_ProceedsFromLinesOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Lines of Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLinesOfCredit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromLinesOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromLinesOfCredit" xlink:to="lab_us-gaap_ProceedsFromLinesOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UseOfEstimates_875af9ea-9b13-49d1-9d6b-207e5d6571c9_terseLabel_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates</link:label>
    <link:label id="lab_us-gaap_UseOfEstimates_label_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UseOfEstimates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UseOfEstimates" xlink:to="lab_us-gaap_UseOfEstimates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationDisclosureTextBlock_b3e31dfe-39bb-494f-9e2f-4169ea2e269c_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:to="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_9891210c-7c64-4e07-ae25-b90525fdc407_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Revenues_ec653164-7605-4bc6-a5b7-4f71014ea866_terseLabel_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net sales</link:label>
    <link:label id="lab_us-gaap_Revenues_label_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Revenues" xlink:to="lab_us-gaap_Revenues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_02b17df7-9198-47c3-a895-18158d2a574e_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flow hedging gain, net</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:type="arc" order="1"/>
    <link:label id="lab_cnmd_ProductWarrantyAccrualTerm_f8b10ac1-e620-4fc5-b633-9d9053506070_terseLabel_en-US" xlink:label="lab_cnmd_ProductWarrantyAccrualTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Standard warranty period (in years)</link:label>
    <link:label id="lab_cnmd_ProductWarrantyAccrualTerm_label_en-US" xlink:label="lab_cnmd_ProductWarrantyAccrualTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Warranty Accrual Term</link:label>
    <link:label id="lab_cnmd_ProductWarrantyAccrualTerm_documentation_en-US" xlink:label="lab_cnmd_ProductWarrantyAccrualTerm" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Warranty Accrual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_ProductWarrantyAccrualTerm" xlink:href="cnmd-20230331.xsd#cnmd_ProductWarrantyAccrualTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cnmd_ProductWarrantyAccrualTerm" xlink:to="lab_cnmd_ProductWarrantyAccrualTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GuaranteesAbstract_a80a6edb-3da0-4593-9bc1-a85c689913a7_terseLabel_en-US" xlink:label="lab_us-gaap_GuaranteesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantees [Abstract]</link:label>
    <link:label id="lab_us-gaap_GuaranteesAbstract_label_en-US" xlink:label="lab_us-gaap_GuaranteesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantees [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuaranteesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GuaranteesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GuaranteesAbstract" xlink:to="lab_us-gaap_GuaranteesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryFinishedGoodsNetOfReserves_ddd37bbc-ffd8-4e4c-bfc2-af5b6f50ccf6_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finished goods</link:label>
    <link:label id="lab_us-gaap_InventoryFinishedGoodsNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Finished Goods, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:to="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_cnmd_AmericasexcludingtheUnitedStatesMember_5db943f3-16c7-4fce-958d-51cf4883e2f5_terseLabel_en-US" xlink:label="lab_cnmd_AmericasexcludingtheUnitedStatesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Americas (excluding the United States)</link:label>
    <link:label id="lab_cnmd_AmericasexcludingtheUnitedStatesMember_label_en-US" xlink:label="lab_cnmd_AmericasexcludingtheUnitedStatesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Americas (excluding the United States) [Member]</link:label>
    <link:label id="lab_cnmd_AmericasexcludingtheUnitedStatesMember_documentation_en-US" xlink:label="lab_cnmd_AmericasexcludingtheUnitedStatesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Americas (excluding the United States) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_AmericasexcludingtheUnitedStatesMember" xlink:href="cnmd-20230331.xsd#cnmd_AmericasexcludingtheUnitedStatesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cnmd_AmericasexcludingtheUnitedStatesMember" xlink:to="lab_cnmd_AmericasexcludingtheUnitedStatesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_9c5fbd49-62de-4153-b1e7-d57ddd737d43_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization expense</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:to="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill_e519ba50-0c15-403d-91d4-a4c5a9066fef_totalLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets, Gross carrying amount</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Gross (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_427f7d04-4008-40d8-8970-bd0ab59948aa_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:to="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_b5fcdc0b-9a9a-4f31-a012-1f02c0679bc5_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax_47fcdda1-1849-4a54-b719-3baed4d59797_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax_ba651057-a152-47f1-9306-cc35a8ce10bf_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts reclassified from other accumulated comprehensive income (loss) before tax</link:label>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax_label_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" xlink:to="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_b107a9c0-9e6b-4e73-aa67-7c6b28ef19b9_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension Liability</link:label>
    <link:label id="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:to="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cnmd_AdjustedTermSOFRMember_25be0053-c4c9-4021-8d88-1565ba5a3eb4_terseLabel_en-US" xlink:label="lab_cnmd_AdjustedTermSOFRMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjusted Term SOFR</link:label>
    <link:label id="lab_cnmd_AdjustedTermSOFRMember_label_en-US" xlink:label="lab_cnmd_AdjustedTermSOFRMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjusted Term SOFR [Member]</link:label>
    <link:label id="lab_cnmd_AdjustedTermSOFRMember_documentation_en-US" xlink:label="lab_cnmd_AdjustedTermSOFRMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjusted Term SOFR</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_AdjustedTermSOFRMember" xlink:href="cnmd-20230331.xsd#cnmd_AdjustedTermSOFRMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cnmd_AdjustedTermSOFRMember" xlink:to="lab_cnmd_AdjustedTermSOFRMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfConvertibleDebt_84b795b5-818e-4cfc-bd0c-943a7953a7b6_terseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfConvertibleDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Convertible Debt</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfConvertibleDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfConvertibleDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Convertible Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfConvertibleDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfConvertibleDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfConvertibleDebt" xlink:to="lab_us-gaap_RepaymentsOfConvertibleDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_d5a5c7b3-15b3-4a90-89e9-b3103a4ca9d6_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets by Major Class [Axis]</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-Lived Intangible Assets [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_062227a0-2a7d-46bb-b14c-b5e122f661ba_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total shareholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_9bea189b-4606-4582-ba27-2a0c131747d0_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at period start</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_32525438-5625-41fe-a0fd-68da6486192b_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at period end</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_cnmd_AmendedAndRestatedSeniorCreditAgreementMember_881e0e72-049f-4a44-a078-21715b08d178_terseLabel_en-US" xlink:label="lab_cnmd_AmendedAndRestatedSeniorCreditAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amended and Restated Senior Credit Agreement [Member]</link:label>
    <link:label id="lab_cnmd_AmendedAndRestatedSeniorCreditAgreementMember_label_en-US" xlink:label="lab_cnmd_AmendedAndRestatedSeniorCreditAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amended and Restated Senior Credit Agreement [Member]</link:label>
    <link:label id="lab_cnmd_AmendedAndRestatedSeniorCreditAgreementMember_documentation_en-US" xlink:label="lab_cnmd_AmendedAndRestatedSeniorCreditAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amended and Restated Senior Credit Agreement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_AmendedAndRestatedSeniorCreditAgreementMember" xlink:href="cnmd-20230331.xsd#cnmd_AmendedAndRestatedSeniorCreditAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cnmd_AmendedAndRestatedSeniorCreditAgreementMember" xlink:to="lab_cnmd_AmendedAndRestatedSeniorCreditAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossLineItems_2b16e4eb-6a17-4428-b8a0-a40d260029c0_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_765590b5-8ca8-41ae-9766-ecb221bd90ec_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_ae58970e-841d-4fb8-9e5c-d418ef3fe867_negatedLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets, Accumulated amortization</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_242c78b2-5066-4dae-ae8a-8bf39b451b1b_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expenses and Other Current Assets [Member]</link:label>
    <link:label id="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_label_en-US" xlink:label="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expenses and Other Current Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:to="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_88a01d66-5e53-4a4f-8c81-e353ba83ecb2_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (decrease) in cash flows from changes in assets and liabilities:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_85b58065-866d-4fa2-9140-7959ab919d0b_verboseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_72e40dda-a968-4534-bbea-c3bd217fc3fd_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2028</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_4df00acd-3ebe-47ba-821c-870fb0f05831_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_a4ae30db-6069-45d9-b346-97e8190f7a26_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_label_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems" xlink:to="lab_us-gaap_SegmentReportingInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendsCommonStockCash_faecf8dc-4b78-4d12-8f6f-e95c2d8be007_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DividendsCommonStockCash" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends on common stock ($0.20 per share)</link:label>
    <link:label id="lab_us-gaap_DividendsCommonStockCash_label_en-US" xlink:label="lab_us-gaap_DividendsCommonStockCash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends, Common Stock, Cash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStockCash" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsCommonStockCash"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsCommonStockCash" xlink:to="lab_us-gaap_DividendsCommonStockCash" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_e554bb29-59d7-4019-bafc-6565b2677679_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_4bf5a99e-985e-465f-b122-8bcc6b7fd7d6_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock issued under employee plans</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_3c31a9bd-4e8d-4a33-accf-1a0093ea368c_periodStartLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance as of January 1, 2023</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_d370d769-cc4f-4e15-ab85-08bf5379773c_periodEndLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance as of March 31, 2023</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_cnmd_PatentsAndOtherIntangibleAssetsMember_ffad76ea-7efd-4fea-a76f-e6b5356b034c_terseLabel_en-US" xlink:label="lab_cnmd_PatentsAndOtherIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patents and other intangible assets</link:label>
    <link:label id="lab_cnmd_PatentsAndOtherIntangibleAssetsMember_label_en-US" xlink:label="lab_cnmd_PatentsAndOtherIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patents and Other Intangible Assets [Member]</link:label>
    <link:label id="lab_cnmd_PatentsAndOtherIntangibleAssetsMember_documentation_en-US" xlink:label="lab_cnmd_PatentsAndOtherIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patents and Other Intangible Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_PatentsAndOtherIntangibleAssetsMember" xlink:href="cnmd-20230331.xsd#cnmd_PatentsAndOtherIntangibleAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cnmd_PatentsAndOtherIntangibleAssetsMember" xlink:to="lab_cnmd_PatentsAndOtherIntangibleAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_37d403bd-ebaa-433a-b728-4ebe1cd8af32_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage_8d921fb4-559a-4b19-8443-c24239d2426c_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Effective Percentage</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Effective Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentQuarterlyReport_0e7b7533-5254-4382-9b2d-eebbb2be684f_terseLabel_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:label id="lab_dei_DocumentQuarterlyReport_label_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentQuarterlyReport" xlink:to="lab_dei_DocumentQuarterlyReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_36c257a3-1bf4-4c26-8590-9cdd0ea716ec_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current assets:</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_add97926-456d-4612-8c79-53dafe704d56_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement Inputs and Valuation Techniques</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement Inputs and Valuation Techniques [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_82bf34a7-d2aa-45f6-b5e5-2f6909074a0d_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_cnmd_SalesrepresentationmarketingandpromotionalrightsMember_e1de904a-2df3-4ca6-9eca-35fadb855187_terseLabel_en-US" xlink:label="lab_cnmd_SalesrepresentationmarketingandpromotionalrightsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales representation, marketing and promotional rights</link:label>
    <link:label id="lab_cnmd_SalesrepresentationmarketingandpromotionalrightsMember_label_en-US" xlink:label="lab_cnmd_SalesrepresentationmarketingandpromotionalrightsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales representation, marketing and promotional rights [Member]</link:label>
    <link:label id="lab_cnmd_SalesrepresentationmarketingandpromotionalrightsMember_documentation_en-US" xlink:label="lab_cnmd_SalesrepresentationmarketingandpromotionalrightsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales representation, marketing and promotional rights [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_SalesrepresentationmarketingandpromotionalrightsMember" xlink:href="cnmd-20230331.xsd#cnmd_SalesrepresentationmarketingandpromotionalrightsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cnmd_SalesrepresentationmarketingandpromotionalrightsMember" xlink:to="lab_cnmd_SalesrepresentationmarketingandpromotionalrightsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_81cbf102-187d-4fd1-b09c-54a8dec22891_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unamortized intangible assets, Gross carrying amount</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-Lived Intangible Assets (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OptionIndexedToIssuersEquityTypeAxis_ffdf1622-f201-4444-8e4c-8d892ef27f33_terseLabel_en-US" xlink:label="lab_us-gaap_OptionIndexedToIssuersEquityTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Option Indexed to Issuer's Equity, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_OptionIndexedToIssuersEquityTypeAxis_label_en-US" xlink:label="lab_us-gaap_OptionIndexedToIssuersEquityTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Option Indexed to Issuer's Equity, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OptionIndexedToIssuersEquityTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OptionIndexedToIssuersEquityTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OptionIndexedToIssuersEquityTypeAxis" xlink:to="lab_us-gaap_OptionIndexedToIssuersEquityTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_eb922a78-f71e-4e44-9f1f-b3b2220ed3af_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_90a96684-d1bc-41f9-b347-bb271d88a087_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable, net</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent" xlink:to="lab_us-gaap_AccountsReceivableNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_6be6df4f-8451-48ed-8862-9bca6b75a4cf_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement, Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_eb0c435f-c852-48dd-94d1-897de799c425_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:to="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TimingOfTransferOfGoodOrServiceAxis_17a7be9c-d6d0-43be-8ffc-05144ec1a607_terseLabel_en-US" xlink:label="lab_us-gaap_TimingOfTransferOfGoodOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Timing of Transfer of Good or Service [Axis]</link:label>
    <link:label id="lab_us-gaap_TimingOfTransferOfGoodOrServiceAxis_label_en-US" xlink:label="lab_us-gaap_TimingOfTransferOfGoodOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Timing of Transfer of Good or Service [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TimingOfTransferOfGoodOrServiceAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TimingOfTransferOfGoodOrServiceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TimingOfTransferOfGoodOrServiceAxis" xlink:to="lab_us-gaap_TimingOfTransferOfGoodOrServiceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_84bbf75f-e500-40c3-8951-d709a0192c72_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_4a86fd84-957a-4769-bf1f-1f9614485c47_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from operating activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_d8cfc8f5-cdc1-4ef2-926d-4e82cbfdf188_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_c40b27a3-63ef-4af2-ad6a-170284fa7bcf_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability, Current</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateDomain_bbc93b81-997d-48f9-a35d-1694b87f38c3_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:label id="lab_us-gaap_VariableRateDomain_label_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateDomain" xlink:to="lab_us-gaap_VariableRateDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_6568c020-8ce1-424d-9644-c92b4ecfda74_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortized intangible assets, Gross carrying amount</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_1fd15385-bd76-46e1-b992-03e081582319_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_1081040d-a5e6-4407-b10e-8caa693238bf_terseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling and administrative expense</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_a7fafe65-608b-4399-bcf1-b1ee9eb2f945_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update and Change in Accounting Principle [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_3752be7d-4b4f-4332-b6f3-0f3a5ece9fd4_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-cash adjustment to fair value of contingent consideration liability</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_172ffeb9-2e1e-42c4-9abd-a2c6e3d6294b_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNoteTextBlock_0505b0f7-dea3-4b06-8400-c96efcf6df8b_terseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNoteTextBlock_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss) Note [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNoteTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:to="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_a1262b80-1f5f-4e6f-a14f-0b171ba1215a_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_14e91af0-5880-417d-a177-0a8daa596e0a_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_ce7579cd-9a23-41c4-bfd4-59033787e4b5_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income from operations</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_67d672c1-9266-4d12-b0f2-674b5f24e48f_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Inventories</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInInventories" xlink:to="lab_us-gaap_IncreaseDecreaseInInventories" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_af4bcfdc-04d1-42fe-bb43-c07c96f8d8f2_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtConversionConvertedInstrumentSharesIssued1_7daf84f6-28c3-465e-8e2a-a8cc5d9a0fde_terseLabel_en-US" xlink:label="lab_us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Conversion, Converted Instrument, Shares Issued</link:label>
    <link:label id="lab_us-gaap_DebtConversionConvertedInstrumentSharesIssued1_label_en-US" xlink:label="lab_us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Conversion, Converted Instrument, Shares Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtConversionConvertedInstrumentSharesIssued1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:to="lab_us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_ab25ddbb-5069-49ac-901a-e50c3551b670_periodStartLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at period start (shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_c5948fe1-196d-41dc-871d-ca7a8741e73d_periodEndLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at period end (shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding" xlink:to="lab_us-gaap_CommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Goodwill_f4f5b8bb-ec8b-43d6-bb60-766bf4ffca61_terseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_3c76f171-77c2-47b9-bbe8-4e491669b7d9_periodStartLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_Goodwill_d849d9ba-bf85-46cc-8cce-567f0ae486a6_periodEndLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_Goodwill_label_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill" xlink:to="lab_us-gaap_Goodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherCurrentLiabilitiesMember_cf78482e-ff0f-4d9a-abff-e7f7d1ce1583_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Current Liabilities [Member]</link:label>
    <link:label id="lab_us-gaap_OtherCurrentLiabilitiesMember_label_en-US" xlink:label="lab_us-gaap_OtherCurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Current Liabilities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCurrentLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCurrentLiabilitiesMember" xlink:to="lab_us-gaap_OtherCurrentLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MovementInStandardProductWarrantyAccrualRollForward_af58a503-d13c-450e-99c1-fb6d9f33598f_terseLabel_en-US" xlink:label="lab_us-gaap_MovementInStandardProductWarrantyAccrualRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Movement in Standard Product Warranty Accrual [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_MovementInStandardProductWarrantyAccrualRollForward_label_en-US" xlink:label="lab_us-gaap_MovementInStandardProductWarrantyAccrualRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Movement in Standard Product Warranty Accrual [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MovementInStandardProductWarrantyAccrualRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MovementInStandardProductWarrantyAccrualRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MovementInStandardProductWarrantyAccrualRollForward" xlink:to="lab_us-gaap_MovementInStandardProductWarrantyAccrualRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_99d42956-4288-4904-ae39-536881cd0c1d_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to reconcile net income to net cash provided by (used in) operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_98898b02-2d25-4762-becc-1a90a52ce945_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Other Intangible Assets</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StandardProductWarrantyAccrual_637da92d-9995-432b-bfd5-b35af513a827_periodStartLabel_en-US" xlink:label="lab_us-gaap_StandardProductWarrantyAccrual" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance as of January 1,</link:label>
    <link:label id="lab_us-gaap_StandardProductWarrantyAccrual_52213755-140b-4ae9-9cef-83a8639a9d21_periodEndLabel_en-US" xlink:label="lab_us-gaap_StandardProductWarrantyAccrual" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance as of March 31,</link:label>
    <link:label id="lab_us-gaap_StandardProductWarrantyAccrual_label_en-US" xlink:label="lab_us-gaap_StandardProductWarrantyAccrual" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Standard Product Warranty Accrual</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StandardProductWarrantyAccrual" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StandardProductWarrantyAccrual"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StandardProductWarrantyAccrual" xlink:to="lab_us-gaap_StandardProductWarrantyAccrual" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_9f0aefd5-48d7-4757-947e-d5028f70231b_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision for income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_SegmentGeographicalDomain_fde7de7d-a10f-4780-9d80-2753acc8f6f2_terseLabel_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:label id="lab_srt_SegmentGeographicalDomain_label_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_SegmentGeographicalDomain" xlink:to="lab_srt_SegmentGeographicalDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_1142fb12-1677-47ee-a7d5-02ba9ea7edda_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock_af549827-3e50-46fd-aa5f-79d6ea2ae43b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in the Carrying Amount of Service and Product Warranties</link:label>
    <link:label id="lab_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Product Warranty Liability [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_446b189d-4d0c-4f35-81a5-0c4b750a0018_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, par value (dollars per share)</link:label>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_443c8555-2509-42ad-aff2-7b35ef17a85f_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_3879f0ad-e625-4fd7-9056-4d1f549ea8a5_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Paid-in Capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_6b8e26e3-a3e5-4b98-930e-1b4f0bf0865d_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationDomain" xlink:to="lab_us-gaap_BalanceSheetLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_327773c7-98cf-4ba7-9953-de89e4dd0356_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_8c250661-220c-452c-9622-6b8f929d916f_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of sales</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_label_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Goods and Services Sold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:to="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLineItems_cd0a153a-30e7-4b47-8746-567a88fbe0a8_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativeLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativeLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLineItems" xlink:to="lab_us-gaap_DerivativeLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_86f30c3f-33ab-4ab2-992c-01b751053494_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_b32e25b0-0e4a-4a1d-94a1-cb88de962ed1_totalLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted- weighted average shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet_6d7bacad-c480-4d2f-9dee-f186322b2878_totalLabel_en-US" xlink:label="lab_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Fair Value</link:label>
    <link:label id="lab_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet_label_en-US" xlink:label="lab_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Assets (Liabilities), at Fair Value, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet" xlink:to="lab_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_b374e8cc-a55a-40cf-8011-9f588b31f70f_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Inventory</link:label>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Inventory, Current [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeLiability_4e533766-386d-4f57-b8e8-0b53acfd9334_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities Fair Value</link:label>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeLiability_label_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability, Subject to Master Netting Arrangement, before Offset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:to="lab_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProductWarrantyExpense_d91d56a6-9bba-420e-aab2-75285717e808_terseLabel_en-US" xlink:label="lab_us-gaap_ProductWarrantyExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product extended warranty expense</link:label>
    <link:label id="lab_us-gaap_ProductWarrantyExpense_label_en-US" xlink:label="lab_us-gaap_ProductWarrantyExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Warranty Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductWarrantyExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductWarrantyExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductWarrantyExpense" xlink:to="lab_us-gaap_ProductWarrantyExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_1d87e45d-ad0e-40be-8dad-12e713762f7f_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, par value $0.01 per share; 100,000,000 shares authorized; 31,299,194 shares issued in 2023 and 2022, respectively</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_86bbb317-ae80-4d08-aec5-f5608db01d4d_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="lab_us-gaap_DebtInstrumentNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_bdd390f1-d6a0-4ed5-ad77-f3f44267fd2b_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_AsiaPacificMember_5c9fd7a9-f407-4c5e-b649-63d8a3ed898b_terseLabel_en-US" xlink:label="lab_srt_AsiaPacificMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asia Pacific</link:label>
    <link:label id="lab_srt_AsiaPacificMember_label_en-US" xlink:label="lab_srt_AsiaPacificMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asia Pacific [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AsiaPacificMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_AsiaPacificMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_AsiaPacificMember" xlink:to="lab_srt_AsiaPacificMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleConversionPrice1_fa1f22db-5322-4d0c-927e-f651898250a2_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Conversion price (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleConversionPrice1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Conversion Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:to="lab_us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:type="arc" order="1"/>
    <link:label id="lab_cnmd_BiorezIncMember_33fbc97d-3222-430d-a0df-8a84583e26cb_terseLabel_en-US" xlink:label="lab_cnmd_BiorezIncMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Biorez Inc</link:label>
    <link:label id="lab_cnmd_BiorezIncMember_label_en-US" xlink:label="lab_cnmd_BiorezIncMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Biorez Inc [Member]</link:label>
    <link:label id="lab_cnmd_BiorezIncMember_documentation_en-US" xlink:label="lab_cnmd_BiorezIncMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Biorez Inc</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_BiorezIncMember" xlink:href="cnmd-20230331.xsd#cnmd_BiorezIncMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cnmd_BiorezIncMember" xlink:to="lab_cnmd_BiorezIncMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock_4d6d44a6-2398-4488-9e57-15488ccd7952_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (Loss)</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProductWarrantyDisclosureTextBlock_d90835de-f684-4171-9f28-63d0136c7be6_terseLabel_en-US" xlink:label="lab_us-gaap_ProductWarrantyDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantees</link:label>
    <link:label id="lab_us-gaap_ProductWarrantyDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_ProductWarrantyDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Warranty Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductWarrantyDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductWarrantyDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductWarrantyDisclosureTextBlock" xlink:to="lab_us-gaap_ProductWarrantyDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_e237a1d9-f78b-4e5e-9ce1-d648e2a2e68f_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesAuthorized" xlink:to="lab_us-gaap_PreferredStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_549a25d0-1791-4bc1-8bab-bf38e29d2618_terseLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_25c9913a-ff69-4003-bea5-9f84ff7bf6fb_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents at beginning of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_fd37899e-12e2-4b84-b376-9209f82acf00_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents at end of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_cfaf3f7e-2f75-4dcc-8d25-771de52f2d3c_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation adjustments</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LoansPayableMember_640bef8d-9c58-4370-bb3b-4aab8822a0b3_terseLabel_en-US" xlink:label="lab_us-gaap_LoansPayableMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan Facility [Member]</link:label>
    <link:label id="lab_us-gaap_LoansPayableMember_label_en-US" xlink:label="lab_us-gaap_LoansPayableMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loans Payable [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansPayableMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LoansPayableMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LoansPayableMember" xlink:to="lab_us-gaap_LoansPayableMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cnmd_A2250PercentConvertibleNotesDue2027Member_b0e099ef-5a9c-483b-8ba3-1e54041f21bf_terseLabel_en-US" xlink:label="lab_cnmd_A2250PercentConvertibleNotesDue2027Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.250 Percent Convertible Notes Due 2027</link:label>
    <link:label id="lab_cnmd_A2250PercentConvertibleNotesDue2027Member_label_en-US" xlink:label="lab_cnmd_A2250PercentConvertibleNotesDue2027Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.250 Percent Convertible Notes Due 2027 [Member]</link:label>
    <link:label id="lab_cnmd_A2250PercentConvertibleNotesDue2027Member_documentation_en-US" xlink:label="lab_cnmd_A2250PercentConvertibleNotesDue2027Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.250 Percent Convertible Notes Due 2027</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_A2250PercentConvertibleNotesDue2027Member" xlink:href="cnmd-20230331.xsd#cnmd_A2250PercentConvertibleNotesDue2027Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cnmd_A2250PercentConvertibleNotesDue2027Member" xlink:to="lab_cnmd_A2250PercentConvertibleNotesDue2027Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_28b98e02-b691-472c-9a44-6fe824a3f5af_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignExchangeForwardMember_d0eb760c-4485-4f98-9e28-8e09f11691aa_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignExchangeForwardMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Forward Contracts</link:label>
    <link:label id="lab_us-gaap_ForeignExchangeForwardMember_label_en-US" xlink:label="lab_us-gaap_ForeignExchangeForwardMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Exchange Forward [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignExchangeForwardMember" xlink:to="lab_us-gaap_ForeignExchangeForwardMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_8f33ebbc-b26c-4fb6-9f91-7dcabd129d58_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember_79289315-63f2-4674-bc76-e8db23e1e188_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow Hedging Gain (Loss)</link:label>
    <link:label id="lab_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Net Gain (Loss) from Cash Flow Hedges Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember" xlink:to="lab_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax_5f8dd29f-bec5-4d06-9d08-6065b023f90d_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flow hedging gain, tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_35fc2438-668a-4c0a-a286-0f92a7dac18f_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Transaction Gain (Loss), before Tax</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Transaction Gain (Loss), before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:to="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TransferredOverTimeMember_6963736e-3425-4770-86fc-b1b85a7ff37a_terseLabel_en-US" xlink:label="lab_us-gaap_TransferredOverTimeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Services transferred over time</link:label>
    <link:label id="lab_us-gaap_TransferredOverTimeMember_label_en-US" xlink:label="lab_us-gaap_TransferredOverTimeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transferred over Time [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransferredOverTimeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransferredOverTimeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TransferredOverTimeMember" xlink:to="lab_us-gaap_TransferredOverTimeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_fbdf85df-3656-491e-9ffb-984f03caab0a_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationDomain" xlink:to="lab_us-gaap_IncomeStatementLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashFlowHedgingMember_de62685c-70be-4660-84a7-a1995488fd51_terseLabel_en-US" xlink:label="lab_us-gaap_CashFlowHedgingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flow hedge</link:label>
    <link:label id="lab_us-gaap_CashFlowHedgingMember_label_en-US" xlink:label="lab_us-gaap_CashFlowHedgingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow Hedging [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashFlowHedgingMember" xlink:to="lab_us-gaap_CashFlowHedgingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_202323b8-5c76-4c50-9f10-c3fe2a32682b_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_a0c2747e-56b3-497a-bfd1-fbeb717d3afe_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-lived intangible asset useful life (in years)</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_3f34e08c-b4f4-4492-b2cd-04fc1797f867_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used in investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_ec2917b0-fb53-49e4-9373-335f25279c4f_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, face amount</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Face Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFaceAmount" xlink:to="lab_us-gaap_DebtInstrumentFaceAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestOnConvertibleDebtNetOfTax_5e1c1f4d-c1cb-4714-8ed7-ca3d24af2231_terseLabel_en-US" xlink:label="lab_us-gaap_InterestOnConvertibleDebtNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest on Convertible Debt, Net of Tax</link:label>
    <link:label id="lab_us-gaap_InterestOnConvertibleDebtNetOfTax_label_en-US" xlink:label="lab_us-gaap_InterestOnConvertibleDebtNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest on Convertible Debt, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestOnConvertibleDebtNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestOnConvertibleDebtNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestOnConvertibleDebtNetOfTax" xlink:to="lab_us-gaap_InterestOnConvertibleDebtNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_4051d67c-6c71-427d-b4eb-3469214cb1e6_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net current-period other comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_cnmd_OrthopedicSurgeryMember_e36704fa-b641-4b00-8098-85c78c141698_terseLabel_en-US" xlink:label="lab_cnmd_OrthopedicSurgeryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Orthopedic Surgery</link:label>
    <link:label id="lab_cnmd_OrthopedicSurgeryMember_label_en-US" xlink:label="lab_cnmd_OrthopedicSurgeryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Orthopedic Surgery [Member]</link:label>
    <link:label id="lab_cnmd_OrthopedicSurgeryMember_documentation_en-US" xlink:label="lab_cnmd_OrthopedicSurgeryMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Orthopedic Surgery [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_OrthopedicSurgeryMember" xlink:href="cnmd-20230331.xsd#cnmd_OrthopedicSurgeryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cnmd_OrthopedicSurgeryMember" xlink:to="lab_cnmd_OrthopedicSurgeryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax_b51160e6-aab2-4640-a1dd-2339d7c1e54f_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension liability, tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_5f51debe-070c-4f03-a60a-8836e7ae9095_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_0e773315-a664-4c7a-af66-622e2db78c03_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrent_802c0cbf-f60a-4c99-9426-bea418ccedaf_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_65468704-8793-4d94-8af1-0e3225f8007a_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent" xlink:to="lab_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConvertibleDebt_0922e185-8f67-4296-92f6-4df227ba6162_terseLabel_en-US" xlink:label="lab_us-gaap_ConvertibleDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Debt</link:label>
    <link:label id="lab_us-gaap_ConvertibleDebt_label_en-US" xlink:label="lab_us-gaap_ConvertibleDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertibleDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConvertibleDebt" xlink:to="lab_us-gaap_ConvertibleDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_7bb7594d-ff39-4cda-bb16-e82e49529d9b_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued compensation and benefits</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Employee Related Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_ccec3b32-4a6a-422d-b10b-3a3ccde4f5e5_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable" xlink:to="lab_us-gaap_DisaggregationOfRevenueTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ExtendedProductWarrantyDisclosureAbstract_954e3519-e88e-4273-81f8-304f2cd0a1cd_terseLabel_en-US" xlink:label="lab_us-gaap_ExtendedProductWarrantyDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Extended Product Warranty Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_ExtendedProductWarrantyDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_ExtendedProductWarrantyDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Extended Product Warranty Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtendedProductWarrantyDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ExtendedProductWarrantyDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ExtendedProductWarrantyDisclosureAbstract" xlink:to="lab_us-gaap_ExtendedProductWarrantyDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StandardProductWarrantyAccrualWarrantiesIssued_f2f88710-8348-4d66-8d89-8685ba0ba06b_terseLabel_en-US" xlink:label="lab_us-gaap_StandardProductWarrantyAccrualWarrantiesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision for warranties</link:label>
    <link:label id="lab_us-gaap_StandardProductWarrantyAccrualWarrantiesIssued_label_en-US" xlink:label="lab_us-gaap_StandardProductWarrantyAccrualWarrantiesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Standard Product Warranty Accrual, Increase for Warranties Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StandardProductWarrantyAccrualWarrantiesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StandardProductWarrantyAccrualWarrantiesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StandardProductWarrantyAccrualWarrantiesIssued" xlink:to="lab_us-gaap_StandardProductWarrantyAccrualWarrantiesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeTable_e04e4502-e5c7-40b3-8451-56ccef980ddf_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Table]</link:label>
    <link:label id="lab_us-gaap_DerivativeTable_label_en-US" xlink:label="lab_us-gaap_DerivativeTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeTable" xlink:to="lab_us-gaap_DerivativeTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_d1ba4269-740d-40d5-a771-bbc5e38ee122_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Table]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_6e602934-c9f2-44af-8721-053d6bfa2cf4_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_97b259c9-18e4-4bff-93e7-15ca96bc7626_terseLabel_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of exchange rate changes on cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_146fbffd-18ed-475f-88bf-21a91d80805a_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_d9026937-a99b-4860-8e16-0c609ac0b651_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Estimated Amortization Expense</link:label>
    <link:label id="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:to="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cnmd_AmortizationOfInventoryStepUpAdjustments_fd58133f-141b-48cb-8350-43422beccae9_terseLabel_en-US" xlink:label="lab_cnmd_AmortizationOfInventoryStepUpAdjustments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of inventory step-up adjustments</link:label>
    <link:label id="lab_cnmd_AmortizationOfInventoryStepUpAdjustments_label_en-US" xlink:label="lab_cnmd_AmortizationOfInventoryStepUpAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of inventory step-up adjustments</link:label>
    <link:label id="lab_cnmd_AmortizationOfInventoryStepUpAdjustments_documentation_en-US" xlink:label="lab_cnmd_AmortizationOfInventoryStepUpAdjustments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of inventory step-up adjustments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_AmortizationOfInventoryStepUpAdjustments" xlink:href="cnmd-20230331.xsd#cnmd_AmortizationOfInventoryStepUpAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cnmd_AmortizationOfInventoryStepUpAdjustments" xlink:to="lab_cnmd_AmortizationOfInventoryStepUpAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMember_f52d2380-a100-41a4-945a-ac116a7c79a6_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt [Member]</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMember_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMember" xlink:to="lab_us-gaap_LongTermDebtMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_4fbb159a-aa68-4696-87eb-e441d4bd0257_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_50e745ab-1016-45e1-a4a6-b1d25e8d3357_negatedLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension liability, net of income tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain_70441f3e-a670-4066-ab7d-9198f27e13f1_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPeriodDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebt_8ea8f6ae-4a87-4c21-adcd-d6339eb4081a_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebt_label_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebt" xlink:to="lab_us-gaap_LongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_d58bff6b-4565-4926-bebd-89772ceb9bf8_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationAxis" xlink:to="lab_us-gaap_BalanceSheetLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_041477f2-dede-469b-bdf3-8b062de1afc3_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability, Noncurrent</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_2f45cf2d-1d43-418a-aeeb-3e75b3867249_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_1eacf0f0-45ab-4a36-a42d-6d8290b99379_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpenses_fe578b54-be6c-48cd-8275-7ae6a01df8eb_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">&#160; Operating expenses</link:label>
    <link:label id="lab_us-gaap_OperatingExpenses_label_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpenses" xlink:to="lab_us-gaap_OperatingExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock_bb0e8cac-fb17-4a41-8019-39c87cfeef35_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Net Sales Information by Product Line</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from External Customers by Products and Services [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock" xlink:to="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_4a0b98d0-5e8d-4b57-a84c-fe2e0b73f8d8_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_5a641914-2b45-4c48-8ad5-1a52ea8e81bf_periodStartLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_1618b979-23b2-4857-8e54-f3ae00379a5f_periodEndLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_309b3a1a-754c-4d6c-95bc-dcb4925c621b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_05f51dfd-9b6f-495f-8eaa-25f3c682574a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives Not Designated as Hedging Instruments</link:label>
    <link:label id="lab_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives Not Designated as Hedging Instruments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cnmd_AdjustedTermSOFRInterestRateMember_1882d7ba-6d65-474e-98d7-bf9de8bb2962_terseLabel_en-US" xlink:label="lab_cnmd_AdjustedTermSOFRInterestRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjusted Term SOFR Interest Rate</link:label>
    <link:label id="lab_cnmd_AdjustedTermSOFRInterestRateMember_label_en-US" xlink:label="lab_cnmd_AdjustedTermSOFRInterestRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjusted Term SOFR Interest Rate [Member]</link:label>
    <link:label id="lab_cnmd_AdjustedTermSOFRInterestRateMember_documentation_en-US" xlink:label="lab_cnmd_AdjustedTermSOFRInterestRateMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjusted Term SOFR Interest Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_AdjustedTermSOFRInterestRateMember" xlink:href="cnmd-20230331.xsd#cnmd_AdjustedTermSOFRInterestRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cnmd_AdjustedTermSOFRInterestRateMember" xlink:to="lab_cnmd_AdjustedTermSOFRInterestRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_c35714fb-dc5e-4cd6-a8d7-727aada822ba_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DesignatedAsHedgingInstrumentMember_b30db108-2c1e-458c-be77-11aa6f424b10_terseLabel_en-US" xlink:label="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives designated as hedged instruments:</link:label>
    <link:label id="lab_us-gaap_DesignatedAsHedgingInstrumentMember_label_en-US" xlink:label="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Designated as Hedging Instrument [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:to="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax_a45402cc-2243-4544-a7a0-914444f608b6_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_3baf360b-635d-4a25-bb4a-04980a60c53b_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue recognized</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Revenue Recognized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_e295fba4-c280-41e3-a386-fbe209489da8_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems" xlink:to="lab_us-gaap_BusinessAcquisitionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_5a282e18-0861-4391-88c2-aa325bd65e8e_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_36a19486-7d3e-4139-8813-3c5338ba20b3_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock_efcaac75-e7e3-496d-8765-74165bec4d90_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Net Benefit Cost</link:label>
    <link:label id="lab_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Net Benefit Costs [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfNetBenefitCostsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareDeclared_7c1483fc-ee1c-49d8-acb7-3b52a6661f5e_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends per share of common stock (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareDeclared_label_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Dividends, Per Share, Declared</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockDividendsPerShareDeclared" xlink:to="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_a0a5ee8e-56f5-44f6-897e-8557d52fa57e_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_2964ba3e-3556-4adb-9808-2fcf5ff61d7a_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_8903e2ea-ba16-4cf2-bd48-84a37ba610d6_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interim Financial Information</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfLinesOfCredit_b54adccd-209d-4ca4-979b-f9184be5fb17_negatedLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfLinesOfCredit" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments on revolving line of credit</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfLinesOfCredit_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfLinesOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Lines of Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLinesOfCredit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfLinesOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfLinesOfCredit" xlink:to="lab_us-gaap_RepaymentsOfLinesOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_cnmd_ProductLiabilityContingencyInsuranceAggregateAnnualAmount_cb28f98a-9e7b-4eed-b18c-095a3bebd1db_terseLabel_en-US" xlink:label="lab_cnmd_ProductLiabilityContingencyInsuranceAggregateAnnualAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product liability insurance, aggregate annual amount</link:label>
    <link:label id="lab_cnmd_ProductLiabilityContingencyInsuranceAggregateAnnualAmount_label_en-US" xlink:label="lab_cnmd_ProductLiabilityContingencyInsuranceAggregateAnnualAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Liability Contingency, Insurance, Aggregate Annual Amount</link:label>
    <link:label id="lab_cnmd_ProductLiabilityContingencyInsuranceAggregateAnnualAmount_documentation_en-US" xlink:label="lab_cnmd_ProductLiabilityContingencyInsuranceAggregateAnnualAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Liability Contingency, Insurance, Aggregate Annual Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_ProductLiabilityContingencyInsuranceAggregateAnnualAmount" xlink:href="cnmd-20230331.xsd#cnmd_ProductLiabilityContingencyInsuranceAggregateAnnualAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cnmd_ProductLiabilityContingencyInsuranceAggregateAnnualAmount" xlink:to="lab_cnmd_ProductLiabilityContingencyInsuranceAggregateAnnualAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_9d2bf281-0e12-49c8-9118-6bfff3b259f4_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="lab_us-gaap_DebtInstrumentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination and Asset Acquisition [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:to="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_a6ccf56e-e3f3-43db-b6ea-33f6db0d8020_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Segment</link:label>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cnmd_BusinessCombinationPurchasePriceAdjustmentHoldback_c829d529-dccb-49c9-a0a3-25a4efcc9a6e_terseLabel_en-US" xlink:label="lab_cnmd_BusinessCombinationPurchasePriceAdjustmentHoldback" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase Price Adjustment Holdback</link:label>
    <link:label id="lab_cnmd_BusinessCombinationPurchasePriceAdjustmentHoldback_label_en-US" xlink:label="lab_cnmd_BusinessCombinationPurchasePriceAdjustmentHoldback" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Purchase Price Adjustment, Holdback</link:label>
    <link:label id="lab_cnmd_BusinessCombinationPurchasePriceAdjustmentHoldback_documentation_en-US" xlink:label="lab_cnmd_BusinessCombinationPurchasePriceAdjustmentHoldback" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Purchase Price Adjustment, Holdback</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_BusinessCombinationPurchasePriceAdjustmentHoldback" xlink:href="cnmd-20230331.xsd#cnmd_BusinessCombinationPurchasePriceAdjustmentHoldback"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cnmd_BusinessCombinationPurchasePriceAdjustmentHoldback" xlink:to="lab_cnmd_BusinessCombinationPurchasePriceAdjustmentHoldback" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_fcbf851a-1fe0-44ed-8ac8-6e0197c91f51_verboseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_cnmd_ReductionofRevenueMember_6bc7905e-4f69-4928-9ab2-a9ce843a0546_terseLabel_en-US" xlink:label="lab_cnmd_ReductionofRevenueMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization recorded as a reduction of revenue</link:label>
    <link:label id="lab_cnmd_ReductionofRevenueMember_label_en-US" xlink:label="lab_cnmd_ReductionofRevenueMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reduction of Revenue [Member]</link:label>
    <link:label id="lab_cnmd_ReductionofRevenueMember_documentation_en-US" xlink:label="lab_cnmd_ReductionofRevenueMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reduction of Revenue [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_ReductionofRevenueMember" xlink:href="cnmd-20230331.xsd#cnmd_ReductionofRevenueMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cnmd_ReductionofRevenueMember" xlink:to="lab_cnmd_ReductionofRevenueMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_62fe10db-af45-439d-a523-9c7ac739533f_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LIABILITIES AND SHAREHOLDERS' EQUITY</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_cnmd_A2.625PercentConvertibleNotesDue2024Member_00218703-800f-4acc-8c1b-068aa5efc32e_terseLabel_en-US" xlink:label="lab_cnmd_A2.625PercentConvertibleNotesDue2024Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.625 Percent Convertible Notes Due 2024</link:label>
    <link:label id="lab_cnmd_A2.625PercentConvertibleNotesDue2024Member_label_en-US" xlink:label="lab_cnmd_A2.625PercentConvertibleNotesDue2024Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.625 Percent Convertible Notes Due 2024 [Member]</link:label>
    <link:label id="lab_cnmd_A2.625PercentConvertibleNotesDue2024Member_documentation_en-US" xlink:label="lab_cnmd_A2.625PercentConvertibleNotesDue2024Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.625 Percent Convertible Notes Due 2024 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_A2.625PercentConvertibleNotesDue2024Member" xlink:href="cnmd-20230331.xsd#cnmd_A2.625PercentConvertibleNotesDue2024Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cnmd_A2.625PercentConvertibleNotesDue2024Member" xlink:to="lab_cnmd_A2.625PercentConvertibleNotesDue2024Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_13c3444c-642c-4e4c-af96-8063542ba4c5_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remaining, 2023</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Remainder of Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_de2cbc27-0051-4ae4-953a-d04a63bcabdb_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average common shares:</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryNet_1ec2958c-6f35-40f2-826b-5cbe9c797a91_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_InventoryNet_e1ca6738-645e-4f20-a4d9-c4eae04803e7_totalLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total inventory</link:label>
    <link:label id="lab_us-gaap_InventoryNet_label_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNet" xlink:to="lab_us-gaap_InventoryNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_58e38088-cca6-40c9-8772-6cc2cb7f8503_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrent" xlink:to="lab_us-gaap_AccountsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets_72efe075-7c4c-4c87-b12f-be00ffb1ee72_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Operating Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_4d248bf3-bb16-4bc6-b90a-39ecaec11b15_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2027</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingRelationshipDomain_3f58a82f-af06-4cfa-95ab-000442b08947_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingRelationshipDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Domain]</link:label>
    <link:label id="lab_us-gaap_HedgingRelationshipDomain_label_en-US" xlink:label="lab_us-gaap_HedgingRelationshipDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingRelationshipDomain" xlink:to="lab_us-gaap_HedgingRelationshipDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingDesignationAxis_6b26e356-4416-4967-ba5d-afa208964cab_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingDesignationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Axis]</link:label>
    <link:label id="lab_us-gaap_HedgingDesignationAxis_label_en-US" xlink:label="lab_us-gaap_HedgingDesignationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingDesignationAxis" xlink:to="lab_us-gaap_HedgingDesignationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NatureOfOperations_e183aa78-485c-4d50-b56e-2ccf1d12fef5_terseLabel_en-US" xlink:label="lab_us-gaap_NatureOfOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operations</link:label>
    <link:label id="lab_us-gaap_NatureOfOperations_label_en-US" xlink:label="lab_us-gaap_NatureOfOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nature of Operations [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NatureOfOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NatureOfOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NatureOfOperations" xlink:to="lab_us-gaap_NatureOfOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConvertibleNotesPayableMember_92712ead-f168-45ba-ad23-2a43295de4e9_terseLabel_en-US" xlink:label="lab_us-gaap_ConvertibleNotesPayableMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Notes Payable [Member]</link:label>
    <link:label id="lab_us-gaap_ConvertibleNotesPayableMember_label_en-US" xlink:label="lab_us-gaap_ConvertibleNotesPayableMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Notes Payable [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleNotesPayableMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertibleNotesPayableMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConvertibleNotesPayableMember" xlink:to="lab_us-gaap_ConvertibleNotesPayableMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WarrantMember_9c2f410f-fde6-471c-a2ae-b81e1c2378b2_terseLabel_en-US" xlink:label="lab_us-gaap_WarrantMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrant</link:label>
    <link:label id="lab_us-gaap_WarrantMember_label_en-US" xlink:label="lab_us-gaap_WarrantMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrant [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WarrantMember" xlink:to="lab_us-gaap_WarrantMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_3eed4741-a074-42f0-a1f0-1ea76b797055_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_32ac6588-c05b-4064-9790-856e4c1dae5c_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic (shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_cfaf2adf-bcce-4b17-b58d-82bc9d509657_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic-weighted average shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_cnmd_ScheduleOfFiniteLivedAndIndefiniteLivedAssetsLineItems_929f2a5c-f4fa-41f2-b5c5-90d6d8731b53_terseLabel_en-US" xlink:label="lab_cnmd_ScheduleOfFiniteLivedAndIndefiniteLivedAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived and Indefinite-Lived Assets [Line Items]</link:label>
    <link:label id="lab_cnmd_ScheduleOfFiniteLivedAndIndefiniteLivedAssetsLineItems_label_en-US" xlink:label="lab_cnmd_ScheduleOfFiniteLivedAndIndefiniteLivedAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived and Indefinite-Lived Assets [Line Items]</link:label>
    <link:label id="lab_cnmd_ScheduleOfFiniteLivedAndIndefiniteLivedAssetsLineItems_documentation_en-US" xlink:label="lab_cnmd_ScheduleOfFiniteLivedAndIndefiniteLivedAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived and Indefinite-Lived Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_ScheduleOfFiniteLivedAndIndefiniteLivedAssetsLineItems" xlink:href="cnmd-20230331.xsd#cnmd_ScheduleOfFiniteLivedAndIndefiniteLivedAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cnmd_ScheduleOfFiniteLivedAndIndefiniteLivedAssetsLineItems" xlink:to="lab_cnmd_ScheduleOfFiniteLivedAndIndefiniteLivedAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_country_US_614a2c7a-7b08-458d-8b61-37994d7af264_terseLabel_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States</link:label>
    <link:label id="lab_country_US_label_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UNITED STATES</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_US" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_US"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_US" xlink:to="lab_country_US" xlink:type="arc" order="1"/>
    <link:label id="lab_cnmd_MeasurementInputRevenueVolatilityMember_45b7c5a6-f9e2-4c9e-a224-8f4757dfd2f4_terseLabel_en-US" xlink:label="lab_cnmd_MeasurementInputRevenueVolatilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Revenue Volatility</link:label>
    <link:label id="lab_cnmd_MeasurementInputRevenueVolatilityMember_label_en-US" xlink:label="lab_cnmd_MeasurementInputRevenueVolatilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Revenue Volatility [Member]</link:label>
    <link:label id="lab_cnmd_MeasurementInputRevenueVolatilityMember_documentation_en-US" xlink:label="lab_cnmd_MeasurementInputRevenueVolatilityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Revenue Volatility</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_MeasurementInputRevenueVolatilityMember" xlink:href="cnmd-20230331.xsd#cnmd_MeasurementInputRevenueVolatilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cnmd_MeasurementInputRevenueVolatilityMember" xlink:to="lab_cnmd_MeasurementInputRevenueVolatilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfForeignExchangeContractsStatementOfFinancialPositionTableTextBlock_686b12df-48e7-4979-a107-0c0bf39ace86_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfForeignExchangeContractsStatementOfFinancialPositionTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Fair Value for Forward Foreign Exchange Contracts</link:label>
    <link:label id="lab_us-gaap_ScheduleOfForeignExchangeContractsStatementOfFinancialPositionTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfForeignExchangeContractsStatementOfFinancialPositionTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Foreign Exchange Contracts, Statement of Financial Position [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfForeignExchangeContractsStatementOfFinancialPositionTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfForeignExchangeContractsStatementOfFinancialPositionTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfForeignExchangeContractsStatementOfFinancialPositionTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfForeignExchangeContractsStatementOfFinancialPositionTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_4afef79c-7fc1-4dc0-b686-588fcf3ede7d_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingencies" xlink:to="lab_us-gaap_CommitmentsAndContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_e7be1e2b-9ec5-4590-bb55-b93a8edca16d_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_00e8fd2e-a848-4ade-aa7e-f16e8b727dc6_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notional amount of cash flow hedges</link:label>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_label_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Notional Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeNotionalAmount" xlink:to="lab_us-gaap_DerivativeNotionalAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockValue_d91e96d9-eeea-4227-a638-df7427da133d_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, par value $.01 per share; authorized 500,000 shares; none outstanding</link:label>
    <link:label id="lab_us-gaap_PreferredStockValue_label_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockValue" xlink:to="lab_us-gaap_PreferredStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_41703803-f528-4427-8abc-5b0e64d35b37_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, after Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LettersOfCreditOutstandingAmount_7400ab33-f186-4578-893f-dcac37462ede_terseLabel_en-US" xlink:label="lab_us-gaap_LettersOfCreditOutstandingAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letters of Credit Outstanding, Amount</link:label>
    <link:label id="lab_us-gaap_LettersOfCreditOutstandingAmount_label_en-US" xlink:label="lab_us-gaap_LettersOfCreditOutstandingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letters of Credit Outstanding, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LettersOfCreditOutstandingAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LettersOfCreditOutstandingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LettersOfCreditOutstandingAmount" xlink:to="lab_us-gaap_LettersOfCreditOutstandingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_57ca3cb9-dabd-4a72-9568-2f145467c306_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Sales</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Excluding Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanServiceCost_0b4500a6-8bd8-44ce-abce-7ff600d88d65_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanServiceCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service cost</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanServiceCost_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanServiceCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Service Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanServiceCost" xlink:to="lab_us-gaap_DefinedBenefitPlanServiceCost" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_6b1b7514-5f35-40f2-8c7b-9f2a43bb320d_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTable_4a12437d-4c6a-4035-93ca-43392b98eadf_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTable_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-Term Debt Instruments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTable" xlink:to="lab_us-gaap_DebtInstrumentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_0f59f9b4-fe28-4efa-9f21-786d0205c9f8_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 3</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel3Member" xlink:to="lab_us-gaap_FairValueInputsLevel3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryWorkInProcessNetOfReserves_e0ade19e-b1ed-4992-bfef-542e00c03dfa_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Work-in-process</link:label>
    <link:label id="lab_us-gaap_InventoryWorkInProcessNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Work in Process, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:to="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_b4d55a9e-5520-460d-816e-1b9256bb214c_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_fec1eb33-96d1-4c71-b508-ed94e5312522_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingAbstract" xlink:to="lab_us-gaap_SegmentReportingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CallOptionMember_1d3ab0c2-a3d2-4558-81e9-3c71d4396cf6_terseLabel_en-US" xlink:label="lab_us-gaap_CallOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Call Option [Member]</link:label>
    <link:label id="lab_us-gaap_CallOptionMember_label_en-US" xlink:label="lab_us-gaap_CallOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Call Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CallOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CallOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CallOptionMember" xlink:to="lab_us-gaap_CallOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cnmd_In2BonesGlobalIncMember_6c17e466-80e0-4f00-97e9-94491b55bbea_terseLabel_en-US" xlink:label="lab_cnmd_In2BonesGlobalIncMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">In2Bones Global Inc</link:label>
    <link:label id="lab_cnmd_In2BonesGlobalIncMember_label_en-US" xlink:label="lab_cnmd_In2BonesGlobalIncMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">In2Bones Global Inc [Member]</link:label>
    <link:label id="lab_cnmd_In2BonesGlobalIncMember_documentation_en-US" xlink:label="lab_cnmd_In2BonesGlobalIncMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">In2Bones Global Inc</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_In2BonesGlobalIncMember" xlink:href="cnmd-20230331.xsd#cnmd_In2BonesGlobalIncMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cnmd_In2BonesGlobalIncMember" xlink:to="lab_cnmd_In2BonesGlobalIncMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_aaeae229-9ba0-4f06-ac8e-b412a4fdead6_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net amortization and deferral</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Amortization of Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:to="lab_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_b9c45adc-5bef-4539-b2a7-698b883e7408_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities and shareholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCosts_d588c225-c8ad-4c5e-9123-f9388440706a_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of deferred debt issuance costs</link:label>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCosts_label_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Debt Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfFinancingCosts" xlink:to="lab_us-gaap_AmortizationOfFinancingCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_55be9776-5a36-40c6-8d83-fd4159a93129_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeAxis" xlink:to="lab_us-gaap_LongtermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillRollForward_c8a70c34-0c80-42b2-a582-44600d4e2e9e_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_GoodwillRollForward_label_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillRollForward" xlink:to="lab_us-gaap_GoodwillRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TimingOfTransferOfGoodOrServiceDomain_476fd809-b5a3-4d42-b97c-786bfc2e09a2_terseLabel_en-US" xlink:label="lab_us-gaap_TimingOfTransferOfGoodOrServiceDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Timing of Transfer of Good or Service [Domain]</link:label>
    <link:label id="lab_us-gaap_TimingOfTransferOfGoodOrServiceDomain_label_en-US" xlink:label="lab_us-gaap_TimingOfTransferOfGoodOrServiceDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Timing of Transfer of Good or Service [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TimingOfTransferOfGoodOrServiceDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain" xlink:to="lab_us-gaap_TimingOfTransferOfGoodOrServiceDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_0476146e-a6cf-467d-854c-c6032883f695_terseLabel_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements (in shares)</link:label>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_label_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:to="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_4101a9d4-bb57-439b-90c6-ee73cdbb69da_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NondesignatedMember_c1465344-9fb8-40e6-9504-2b6f1e55ca21_terseLabel_en-US" xlink:label="lab_us-gaap_NondesignatedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives not designated as hedging instruments:</link:label>
    <link:label id="lab_us-gaap_NondesignatedMember_label_en-US" xlink:label="lab_us-gaap_NondesignatedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Not Designated as Hedging Instrument [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NondesignatedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NondesignatedMember" xlink:to="lab_us-gaap_NondesignatedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_18fee9d9-9e1d-4fef-98d3-3fb00006ec86_terseLabel_en-US" xlink:label="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive income (loss) [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_label_en-US" xlink:label="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent, Net of Tax [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AOCIAttributableToParentNetOfTaxRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:to="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_cb58db2b-346a-48bd-8c45-dfe9e68cb078_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_cnmd_CustomerandDistributorRelationshipsMember_552828c7-a4ba-4af0-9eb6-5646705b59dd_verboseLabel_en-US" xlink:label="lab_cnmd_CustomerandDistributorRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer and distributor relationships</link:label>
    <link:label id="lab_cnmd_CustomerandDistributorRelationshipsMember_label_en-US" xlink:label="lab_cnmd_CustomerandDistributorRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer and Distributor Relationships [Member]</link:label>
    <link:label id="lab_cnmd_CustomerandDistributorRelationshipsMember_documentation_en-US" xlink:label="lab_cnmd_CustomerandDistributorRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer and Distributor Relationships [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_CustomerandDistributorRelationshipsMember" xlink:href="cnmd-20230331.xsd#cnmd_CustomerandDistributorRelationshipsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cnmd_CustomerandDistributorRelationshipsMember" xlink:to="lab_cnmd_CustomerandDistributorRelationshipsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_fc1719f3-9adc-43cc-821d-5d77ecdfc282_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income Available to Common Stockholders, Diluted</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Available to Common Stockholders, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:to="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_b0ffa71a-5815-4fcc-80f2-1ce9d9e68865_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other intangible assets, net</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Net (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_5c18df7e-e02a-47fc-949a-9ae4946c9aa0_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TrademarksAndTradeNamesMember_94cc230e-65b9-42fa-bce2-c64d2b18fce6_terseLabel_en-US" xlink:label="lab_us-gaap_TrademarksAndTradeNamesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trademarks &amp; tradenames</link:label>
    <link:label id="lab_us-gaap_TrademarksAndTradeNamesMember_label_en-US" xlink:label="lab_us-gaap_TrademarksAndTradeNamesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trademarks and Trade Names [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksAndTradeNamesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TrademarksAndTradeNamesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TrademarksAndTradeNamesMember" xlink:to="lab_us-gaap_TrademarksAndTradeNamesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cnmd_IndexedTransactionTypeDomain_4046ac77-0c2e-42b9-afb2-cf020fbcbc2e_terseLabel_en-US" xlink:label="lab_cnmd_IndexedTransactionTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indexed transaction type [Domain]</link:label>
    <link:label id="lab_cnmd_IndexedTransactionTypeDomain_label_en-US" xlink:label="lab_cnmd_IndexedTransactionTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indexed transaction type [Domain]</link:label>
    <link:label id="lab_cnmd_IndexedTransactionTypeDomain_documentation_en-US" xlink:label="lab_cnmd_IndexedTransactionTypeDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indexed transaction type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_IndexedTransactionTypeDomain" xlink:href="cnmd-20230331.xsd#cnmd_IndexedTransactionTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cnmd_IndexedTransactionTypeDomain" xlink:to="lab_cnmd_IndexedTransactionTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_d8b72946-8d26-4aaa-a14a-fd3af0ee7578_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APIC, Share-Based Payment Arrangement, Increase for Cost Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_14a0f5a1-5b6a-4680-8a5d-b010e354a43b_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativesAndFairValueTextBlock_724c4620-3362-4943-b353-32da5780b411_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativesAndFairValueTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value of Financial Instruments</link:label>
    <link:label id="lab_us-gaap_DerivativesAndFairValueTextBlock_label_en-US" xlink:label="lab_us-gaap_DerivativesAndFairValueTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives and Fair Value [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesAndFairValueTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativesAndFairValueTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativesAndFairValueTextBlock" xlink:to="lab_us-gaap_DerivativesAndFairValueTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cnmd_PaymentsForContingentConsideration_400b2ac5-2efb-4e29-9854-99ff11af710a_negatedTerseLabel_en-US" xlink:label="lab_cnmd_PaymentsForContingentConsideration" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments related to contingent consideration</link:label>
    <link:label id="lab_cnmd_PaymentsForContingentConsideration_label_en-US" xlink:label="lab_cnmd_PaymentsForContingentConsideration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Contingent Consideration</link:label>
    <link:label id="lab_cnmd_PaymentsForContingentConsideration_documentation_en-US" xlink:label="lab_cnmd_PaymentsForContingentConsideration" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Contingent Consideration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_PaymentsForContingentConsideration" xlink:href="cnmd-20230331.xsd#cnmd_PaymentsForContingentConsideration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cnmd_PaymentsForContingentConsideration" xlink:to="lab_cnmd_PaymentsForContingentConsideration" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeAsset_3c9698b7-8dec-4c81-867b-930ddf9607e9_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Fair Value</link:label>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeAsset_label_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset, Subject to Master Netting Arrangement, before Offset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:to="lab_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_4293a463-849b-416c-a4fc-4e8fecb9f139_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_f0e7b24d-899a-4274-9267-9a2f293d79ba_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other, net</link:label>
    <link:label id="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from (Payments for) Other Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:to="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiability_651f7102-64ab-4955-917c-148b9238eea3_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract liability</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiability_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiability" xlink:to="lab_us-gaap_ContractWithCustomerLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductOrServiceAxis_e8858f1e-e402-4a60-84f3-f03108915986_terseLabel_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:label id="lab_srt_ProductOrServiceAxis_label_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductOrServiceAxis" xlink:to="lab_srt_ProductOrServiceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_1a4c59f3-dba7-42c6-b546-56f7594e3eb0_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected return on plan assets</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Return (Loss) on Plan Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_53ce4d3d-b161-484c-a0c6-767e1475b277_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract" xlink:to="lab_us-gaap_FairValueDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_2c9c1b49-c145-4a1f-9feb-ddb9a51f8d75_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Remaining Borrowing Capacity</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Remaining Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpense_b42e294f-eeb6-42b1-932a-8b7451d08f2b_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpense_label_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpense" xlink:to="lab_us-gaap_InterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations_fd48f370-65f5-4a8e-b767-4a3544cea37b_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations_14e750dc-b556-4d5d-bf8a-0336ada59cb9_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations_label_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt and Lease Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:to="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryDisclosureTextBlock_465475c1-d74e-4f73-9e8c-4b4873db921a_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_InventoryDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_InventoryDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryDisclosureTextBlock" xlink:to="lab_us-gaap_InventoryDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock_0339d310-e686-44cc-bab1-a09b1c1c3f09_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-Term Debt</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-Term Debt Instruments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDebtInstrumentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:to="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityAbstract_f2818120-e44f-438f-a7fa-8f7973d42f2c_terseLabel_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_EquityAbstract_label_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityAbstract" xlink:to="lab_us-gaap_EquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_cnmd_AdjustedTermSOFRInterestRate_d2838113-a165-41b3-8844-e88e929af04c_terseLabel_en-US" xlink:label="lab_cnmd_AdjustedTermSOFRInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjusted Term SOFR Interest Rate</link:label>
    <link:label id="lab_cnmd_AdjustedTermSOFRInterestRate_label_en-US" xlink:label="lab_cnmd_AdjustedTermSOFRInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjusted Term SOFR Interest Rate</link:label>
    <link:label id="lab_cnmd_AdjustedTermSOFRInterestRate_documentation_en-US" xlink:label="lab_cnmd_AdjustedTermSOFRInterestRate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjusted Term SOFR Interest Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_AdjustedTermSOFRInterestRate" xlink:href="cnmd-20230331.xsd#cnmd_AdjustedTermSOFRInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cnmd_AdjustedTermSOFRInterestRate" xlink:to="lab_cnmd_AdjustedTermSOFRInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryDisclosureAbstract_cf28b8a4-e62c-4bb1-bc52-c3971d7f1ab6_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_InventoryDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_InventoryDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryDisclosureAbstract" xlink:to="lab_us-gaap_InventoryDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_866adb6a-cf8a-4a84-bac9-c3d9026699d2_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnamortizedDebtIssuanceExpense_17fb28de-0e7b-4cc8-aef4-b038b01dd119_terseLabel_en-US" xlink:label="lab_us-gaap_UnamortizedDebtIssuanceExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unamortized Debt Issuance Expense</link:label>
    <link:label id="lab_us-gaap_UnamortizedDebtIssuanceExpense_label_en-US" xlink:label="lab_us-gaap_UnamortizedDebtIssuanceExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unamortized Debt Issuance Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnamortizedDebtIssuanceExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnamortizedDebtIssuanceExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnamortizedDebtIssuanceExpense" xlink:to="lab_us-gaap_UnamortizedDebtIssuanceExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncurrentAssetsMember_7aba0b50-79a5-42bc-ba33-37565d9a0b92_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNoncurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncurrent Assets [Member]</link:label>
    <link:label id="lab_us-gaap_OtherNoncurrentAssetsMember_label_en-US" xlink:label="lab_us-gaap_OtherNoncurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncurrent Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncurrentAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncurrentAssetsMember" xlink:to="lab_us-gaap_OtherNoncurrentAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_258fd7ce-b0cd-4b3f-bbbe-157d8dc502fb_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:to="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_d28bf13e-d1c0-4d8c-9c2b-cf0ff201c98d_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_4a374267-61cb-407b-91e7-da98fc47d29b_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remaining, 2023</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProductWarrantiesDisclosuresAbstract_580a7337-e00e-4dfb-aeef-eabfb987829c_terseLabel_en-US" xlink:label="lab_us-gaap_ProductWarrantiesDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Warranties Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_ProductWarrantiesDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_ProductWarrantiesDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Warranties Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductWarrantiesDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductWarrantiesDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductWarrantiesDisclosuresAbstract" xlink:to="lab_us-gaap_ProductWarrantiesDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_b580caf2-09d2-487b-86f6-04897944feb9_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net (decrease) increase in cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_5d2e1e39-9d0e-4989-ac85-992800d21428_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of dilutive potential securities (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted, Adjustment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:to="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_0a0b771c-a42e-48f8-a1b1-33b076255391_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability, Measurement Input</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability, Measurement Input</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_adb8cc07-ac47-4b0b-93db-6d1931e126b7_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2028</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_faeacad6-3f6f-4773-9300-3ce7737dafa8_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_ff36c185-c4f8-4194-b15f-e99c29647bf3_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Future amortization expense [Abstract]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_b76ca772-a5ed-4856-8e6b-c3cc8281884c_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_e0791c06-0a2b-4ef0-bd5a-ad82c32dec52_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_4a928276-c479-4f00-ac64-15e8ec0e60f9_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:to="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock_1fc0f63e-9f6d-4f1a-9a6a-ebad682e3c2e_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Comprehensive Income</link:label>
    <link:label id="lab_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputTypeAxis_a4337099-2b24-4bc0-8a75-c603dd4a0455_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input Type [Axis]</link:label>
    <link:label id="lab_us-gaap_MeasurementInputTypeAxis_label_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputTypeAxis" xlink:to="lab_us-gaap_MeasurementInputTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TypeOfAdoptionMember_ae144069-bb38-429b-98b0-8aa301016e79_terseLabel_en-US" xlink:label="lab_us-gaap_TypeOfAdoptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Type of Adoption [Domain]</link:label>
    <link:label id="lab_us-gaap_TypeOfAdoptionMember_label_en-US" xlink:label="lab_us-gaap_TypeOfAdoptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfAdoptionMember" xlink:to="lab_us-gaap_TypeOfAdoptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_72996e11-9b89-4ccd-ad24-aaf3c70daa5f_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_1a98e746-1009-4007-96bc-4331e7ffe96a_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASSETS</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_6dc98ccb-fee6-4495-92ea-c71db42a1653_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeDomain" xlink:to="lab_us-gaap_LongtermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_cnmd_BusinessAcquisitionContingentConsiderationAtFairValueRollForwardRollForward_6c1ad9c7-5004-4555-91b7-5f75a1cabc68_terseLabel_en-US" xlink:label="lab_cnmd_BusinessAcquisitionContingentConsiderationAtFairValueRollForwardRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration [Abstract]</link:label>
    <link:label id="lab_cnmd_BusinessAcquisitionContingentConsiderationAtFairValueRollForwardRollForward_label_en-US" xlink:label="lab_cnmd_BusinessAcquisitionContingentConsiderationAtFairValueRollForwardRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition Contingent Consideration At Fair Value Roll Forward [Roll Forward]</link:label>
    <link:label id="lab_cnmd_BusinessAcquisitionContingentConsiderationAtFairValueRollForwardRollForward_documentation_en-US" xlink:label="lab_cnmd_BusinessAcquisitionContingentConsiderationAtFairValueRollForwardRollForward" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition Contingent Consideration At Fair Value Roll Forward</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_BusinessAcquisitionContingentConsiderationAtFairValueRollForwardRollForward" xlink:href="cnmd-20230331.xsd#cnmd_BusinessAcquisitionContingentConsiderationAtFairValueRollForwardRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cnmd_BusinessAcquisitionContingentConsiderationAtFairValueRollForwardRollForward" xlink:to="lab_cnmd_BusinessAcquisitionContingentConsiderationAtFairValueRollForwardRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CompensationAndRetirementDisclosureAbstract_3c72a3fa-7cd8-4472-98ee-09ba4bc09ebd_terseLabel_en-US" xlink:label="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Benefits [Abstract]</link:label>
    <link:label id="lab_us-gaap_CompensationAndRetirementDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Benefits [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:to="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_8c3d9cb5-21d5-4943-9b6b-ff35cdc7c4fe_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_cnmd_ExpenseMember_0c20c17a-42bb-48b8-b57b-bdd736677102_terseLabel_en-US" xlink:label="lab_cnmd_ExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization included in expense</link:label>
    <link:label id="lab_cnmd_ExpenseMember_label_en-US" xlink:label="lab_cnmd_ExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expense [Member]</link:label>
    <link:label id="lab_cnmd_ExpenseMember_documentation_en-US" xlink:label="lab_cnmd_ExpenseMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_ExpenseMember" xlink:href="cnmd-20230331.xsd#cnmd_ExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cnmd_ExpenseMember" xlink:to="lab_cnmd_ExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis_07ee804b-7e80-450b-8752-479f8f210b39_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPeriodAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_fb5901fc-b1db-4d4e-99cc-085ad3906d4e_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from financing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_5ad01f70-4118-4798-bffb-70362a2a1050_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_4c948194-a09a-4602-a738-a47c8546bf5a_terseLabel_en-US" xlink:label="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-cash investing and financing activities:</link:label>
    <link:label id="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_bca415c7-227d-45a4-ad78-cd7fa4495b6b_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateAxis_9cb20994-3015-458c-a38d-c3f2c8a91000_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:label id="lab_us-gaap_VariableRateAxis_label_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateAxis" xlink:to="lab_us-gaap_VariableRateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfSeniorDebt_5ca33e58-05e9-4a16-967a-f64ec8e0e2e9_negatedLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfSeniorDebt" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments on term loan</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfSeniorDebt_c6e814fe-9b73-4d84-a530-8bdaef2a37dd_terseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfSeniorDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Senior Debt</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfSeniorDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfSeniorDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Senior Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfSeniorDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfSeniorDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfSeniorDebt" xlink:to="lab_us-gaap_RepaymentsOfSeniorDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_72271a7b-52ea-4eb3-b5d8-68801ededf48_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_fb9ed9ee-9c09-4dd3-9112-ee9075627021_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Operating Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherOperatingLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_6db1aa30-6ecc-423d-a756-c4c19f12c6d0_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of property, plant and equipment</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_d317d682-08e2-483e-8796-cec1d2a94664_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:to="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_WeightedAverageMember_cb51babd-ba3e-4319-afc8-89f2decec683_terseLabel_en-US" xlink:label="lab_srt_WeightedAverageMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average</link:label>
    <link:label id="lab_srt_WeightedAverageMember_label_en-US" xlink:label="lab_srt_WeightedAverageMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_WeightedAverageMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_WeightedAverageMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_WeightedAverageMember" xlink:to="lab_srt_WeightedAverageMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_7e94082d-e86d-4300-bd5b-75bc2567bd95_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_fca269a0-c05c-41cd-b831-cfe308b3aaaf_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Calculation of Basic and Diluted Earnings Per Share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfSalesMember_ae63fa24-7897-4243-b8ea-17f419b7dd3c_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Sales</link:label>
    <link:label id="lab_us-gaap_CostOfSalesMember_label_en-US" xlink:label="lab_us-gaap_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Sales [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfSalesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfSalesMember" xlink:to="lab_us-gaap_CostOfSalesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingStandardsUpdateExtensibleList_4226741d-ea8e-4637-8624-a6a999ce9c62_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdateExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update [Extensible Enumeration]</link:label>
    <link:label id="lab_us-gaap_AccountingStandardsUpdateExtensibleList_label_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdateExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdateExtensibleList" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingStandardsUpdateExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingStandardsUpdateExtensibleList" xlink:to="lab_us-gaap_AccountingStandardsUpdateExtensibleList" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>9
<FILENAME>cnmd-20230331_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:30a13273-0e0a-49c8-aa2d-31e213cf1b75,g:3b97619f-d09a-4ff4-909a-c708e7b90654-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.conmed.com/role/DocumentandEntityInformation" xlink:type="simple" xlink:href="cnmd-20230331.xsd#DocumentandEntityInformation"/>
  <link:presentationLink xlink:role="http://www.conmed.com/role/DocumentandEntityInformation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_baff2bc0-d087-437f-a9c7-081facaed91e" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_f96a5ba3-3cb4-40b2-a540-026943298c3e" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_baff2bc0-d087-437f-a9c7-081facaed91e" xlink:to="loc_dei_DocumentType_f96a5ba3-3cb4-40b2-a540-026943298c3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport_a4918d5a-d380-439b-9a0d-12334f4df2cf" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_baff2bc0-d087-437f-a9c7-081facaed91e" xlink:to="loc_dei_DocumentQuarterlyReport_a4918d5a-d380-439b-9a0d-12334f4df2cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_61330ac4-49bc-4216-901e-ca0cce61c0d9" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_baff2bc0-d087-437f-a9c7-081facaed91e" xlink:to="loc_dei_DocumentTransitionReport_61330ac4-49bc-4216-901e-ca0cce61c0d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_105d3328-c27a-4370-9b0e-e86025550060" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_baff2bc0-d087-437f-a9c7-081facaed91e" xlink:to="loc_dei_DocumentFiscalPeriodFocus_105d3328-c27a-4370-9b0e-e86025550060" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_735eea1b-bc48-4d0f-8c53-69b909137338" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_baff2bc0-d087-437f-a9c7-081facaed91e" xlink:to="loc_dei_DocumentPeriodEndDate_735eea1b-bc48-4d0f-8c53-69b909137338" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_fddf5436-c670-4017-b1d1-f544f648ca46" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_baff2bc0-d087-437f-a9c7-081facaed91e" xlink:to="loc_dei_CurrentFiscalYearEndDate_fddf5436-c670-4017-b1d1-f544f648ca46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_bbefd964-6a41-407c-9e72-db358a410696" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_baff2bc0-d087-437f-a9c7-081facaed91e" xlink:to="loc_dei_DocumentFiscalYearFocus_bbefd964-6a41-407c-9e72-db358a410696" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_d9e05f79-767b-498a-8e17-e3afdc9be047" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_baff2bc0-d087-437f-a9c7-081facaed91e" xlink:to="loc_dei_EntityFileNumber_d9e05f79-767b-498a-8e17-e3afdc9be047" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_fa9d210b-bc5a-4cda-8764-79cac85519eb" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_baff2bc0-d087-437f-a9c7-081facaed91e" xlink:to="loc_dei_EntityRegistrantName_fa9d210b-bc5a-4cda-8764-79cac85519eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_0d3f31d7-8492-4567-86f9-0d8102e91710" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_baff2bc0-d087-437f-a9c7-081facaed91e" xlink:to="loc_dei_EntityIncorporationStateCountryCode_0d3f31d7-8492-4567-86f9-0d8102e91710" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_2d4a362f-576d-458c-bcf6-4ebf996beab9" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_baff2bc0-d087-437f-a9c7-081facaed91e" xlink:to="loc_dei_EntityTaxIdentificationNumber_2d4a362f-576d-458c-bcf6-4ebf996beab9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_510242e5-2db0-4ccc-b809-a846013a9602" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_baff2bc0-d087-437f-a9c7-081facaed91e" xlink:to="loc_dei_EntityAddressAddressLine1_510242e5-2db0-4ccc-b809-a846013a9602" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_d0183723-2a6b-484a-9dc2-95cbeb1844fa" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_baff2bc0-d087-437f-a9c7-081facaed91e" xlink:to="loc_dei_EntityAddressCityOrTown_d0183723-2a6b-484a-9dc2-95cbeb1844fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_cbe1ba50-315c-47fb-b575-da0e09ffd424" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_baff2bc0-d087-437f-a9c7-081facaed91e" xlink:to="loc_dei_EntityAddressStateOrProvince_cbe1ba50-315c-47fb-b575-da0e09ffd424" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_f2b780e0-908e-4296-b924-23567e768a54" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_baff2bc0-d087-437f-a9c7-081facaed91e" xlink:to="loc_dei_EntityAddressPostalZipCode_f2b780e0-908e-4296-b924-23567e768a54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_e7edb092-b53c-40cd-a634-17cdef7678c9" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_baff2bc0-d087-437f-a9c7-081facaed91e" xlink:to="loc_dei_CityAreaCode_e7edb092-b53c-40cd-a634-17cdef7678c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_ea14e892-6e81-40ff-bab2-98b30082cb59" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_baff2bc0-d087-437f-a9c7-081facaed91e" xlink:to="loc_dei_LocalPhoneNumber_ea14e892-6e81-40ff-bab2-98b30082cb59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_1bfebe8f-ad72-452f-848c-299c99605523" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_baff2bc0-d087-437f-a9c7-081facaed91e" xlink:to="loc_dei_Security12bTitle_1bfebe8f-ad72-452f-848c-299c99605523" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_1567b57f-5788-494c-9398-61c6183fda67" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_baff2bc0-d087-437f-a9c7-081facaed91e" xlink:to="loc_dei_TradingSymbol_1567b57f-5788-494c-9398-61c6183fda67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_86c64c1b-5284-4935-8f6d-5625b78cd480" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_baff2bc0-d087-437f-a9c7-081facaed91e" xlink:to="loc_dei_SecurityExchangeName_86c64c1b-5284-4935-8f6d-5625b78cd480" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_a81f4760-542d-4100-bf10-a11e9e64e30f" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_baff2bc0-d087-437f-a9c7-081facaed91e" xlink:to="loc_dei_EntityCurrentReportingStatus_a81f4760-542d-4100-bf10-a11e9e64e30f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_5716ee16-fb7b-4580-9808-8cf471484718" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_baff2bc0-d087-437f-a9c7-081facaed91e" xlink:to="loc_dei_EntityInteractiveDataCurrent_5716ee16-fb7b-4580-9808-8cf471484718" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_e3edfef8-606a-4838-897d-ce98c97d5329" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_baff2bc0-d087-437f-a9c7-081facaed91e" xlink:to="loc_dei_EntityFilerCategory_e3edfef8-606a-4838-897d-ce98c97d5329" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_74055a81-51c6-47d3-ac2f-a35745939f09" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_baff2bc0-d087-437f-a9c7-081facaed91e" xlink:to="loc_dei_EntitySmallBusiness_74055a81-51c6-47d3-ac2f-a35745939f09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_d1353ffd-83f7-44f0-bfd3-276c5e68fe06" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_baff2bc0-d087-437f-a9c7-081facaed91e" xlink:to="loc_dei_EntityEmergingGrowthCompany_d1353ffd-83f7-44f0-bfd3-276c5e68fe06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_f4a177a8-d246-4bea-a28a-595a94a6e793" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_baff2bc0-d087-437f-a9c7-081facaed91e" xlink:to="loc_dei_EntityShellCompany_f4a177a8-d246-4bea-a28a-595a94a6e793" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_e85d608e-469b-4272-9ddb-923c525298a9" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_baff2bc0-d087-437f-a9c7-081facaed91e" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_e85d608e-469b-4272-9ddb-923c525298a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_75287179-c0e8-46db-a60e-d61b9ad8c988" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_baff2bc0-d087-437f-a9c7-081facaed91e" xlink:to="loc_dei_EntityCentralIndexKey_75287179-c0e8-46db-a60e-d61b9ad8c988" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_02f80711-33ca-4fc8-ae50-c16fe77d2a58" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_baff2bc0-d087-437f-a9c7-081facaed91e" xlink:to="loc_dei_AmendmentFlag_02f80711-33ca-4fc8-ae50-c16fe77d2a58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.conmed.com/role/ConsolidatedCondensedStatementsofComprehensiveIncomeUnaudited" xlink:type="simple" xlink:href="cnmd-20230331.xsd#ConsolidatedCondensedStatementsofComprehensiveIncomeUnaudited"/>
  <link:presentationLink xlink:role="http://www.conmed.com/role/ConsolidatedCondensedStatementsofComprehensiveIncomeUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_23c9f50d-e2f8-49e5-b542-d5da0d959423" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_550efd84-fafe-4d7a-82f6-499bcc6eca50" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_23c9f50d-e2f8-49e5-b542-d5da0d959423" xlink:to="loc_us-gaap_Revenues_550efd84-fafe-4d7a-82f6-499bcc6eca50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_1b6b90d0-ece7-4c6c-bc06-08a5643f7ca6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_23c9f50d-e2f8-49e5-b542-d5da0d959423" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_1b6b90d0-ece7-4c6c-bc06-08a5643f7ca6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_485918d9-86b8-482f-ae2c-bc23986f0fdf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GrossProfit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_23c9f50d-e2f8-49e5-b542-d5da0d959423" xlink:to="loc_us-gaap_GrossProfit_485918d9-86b8-482f-ae2c-bc23986f0fdf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_7b0011dc-919f-4aef-88a5-5b103c269785" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_23c9f50d-e2f8-49e5-b542-d5da0d959423" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_7b0011dc-919f-4aef-88a5-5b103c269785" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_744db8a3-b817-48a6-b081-da2684efb797" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_23c9f50d-e2f8-49e5-b542-d5da0d959423" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_744db8a3-b817-48a6-b081-da2684efb797" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_31962cf5-7eb7-45cf-b40c-d7ae803671c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_23c9f50d-e2f8-49e5-b542-d5da0d959423" xlink:to="loc_us-gaap_OperatingExpenses_31962cf5-7eb7-45cf-b40c-d7ae803671c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_3a320e64-6bc1-4613-83e4-97999f876905" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_23c9f50d-e2f8-49e5-b542-d5da0d959423" xlink:to="loc_us-gaap_OperatingIncomeLoss_3a320e64-6bc1-4613-83e4-97999f876905" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_3f495235-6a8d-427f-9361-c5988934595e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_23c9f50d-e2f8-49e5-b542-d5da0d959423" xlink:to="loc_us-gaap_InterestExpense_3f495235-6a8d-427f-9361-c5988934595e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_97808f30-935e-4efb-bdc0-4c1a0c7b66c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_23c9f50d-e2f8-49e5-b542-d5da0d959423" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_97808f30-935e-4efb-bdc0-4c1a0c7b66c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_34b15581-ddd2-4cb8-a238-526c46f81cb4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_23c9f50d-e2f8-49e5-b542-d5da0d959423" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_34b15581-ddd2-4cb8-a238-526c46f81cb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_d893ebb1-1925-45a2-a71e-6a3a2012053b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_23c9f50d-e2f8-49e5-b542-d5da0d959423" xlink:to="loc_us-gaap_NetIncomeLoss_d893ebb1-1925-45a2-a71e-6a3a2012053b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_b80f4202-35a8-4b0b-b459-11dbb15ec274" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_23c9f50d-e2f8-49e5-b542-d5da0d959423" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_b80f4202-35a8-4b0b-b459-11dbb15ec274" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_da9e2b05-d201-437f-aab9-41b7246e8ab0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_23c9f50d-e2f8-49e5-b542-d5da0d959423" xlink:to="loc_us-gaap_EarningsPerShareAbstract_da9e2b05-d201-437f-aab9-41b7246e8ab0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_ee84ad77-0007-4283-8300-9cb89a287f29" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_da9e2b05-d201-437f-aab9-41b7246e8ab0" xlink:to="loc_us-gaap_EarningsPerShareBasic_ee84ad77-0007-4283-8300-9cb89a287f29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_78169e3b-a81a-4fa6-b6bf-68f7a95cf811" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_da9e2b05-d201-437f-aab9-41b7246e8ab0" xlink:to="loc_us-gaap_EarningsPerShareDiluted_78169e3b-a81a-4fa6-b6bf-68f7a95cf811" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_535fb735-6fd8-4f38-a377-57493a7097ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_23c9f50d-e2f8-49e5-b542-d5da0d959423" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_535fb735-6fd8-4f38-a377-57493a7097ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_2f871f4f-f0e5-4e14-aa4b-dabff507a7a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_535fb735-6fd8-4f38-a377-57493a7097ec" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_2f871f4f-f0e5-4e14-aa4b-dabff507a7a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_7d81d63b-5bf3-4f99-9d91-4a8ed9f6c7b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_535fb735-6fd8-4f38-a377-57493a7097ec" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_7d81d63b-5bf3-4f99-9d91-4a8ed9f6c7b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.conmed.com/role/ConsolidatedCondensedBalanceSheetsUnaudited" xlink:type="simple" xlink:href="cnmd-20230331.xsd#ConsolidatedCondensedBalanceSheetsUnaudited"/>
  <link:presentationLink xlink:role="http://www.conmed.com/role/ConsolidatedCondensedBalanceSheetsUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_502a9062-f086-42e9-8200-973feac648c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_9bd5d4ea-1f13-4957-aca8-d82f999de73d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_502a9062-f086-42e9-8200-973feac648c9" xlink:to="loc_us-gaap_AssetsAbstract_9bd5d4ea-1f13-4957-aca8-d82f999de73d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_04ae9347-a244-41ec-9509-17c7a734f7c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_9bd5d4ea-1f13-4957-aca8-d82f999de73d" xlink:to="loc_us-gaap_AssetsCurrentAbstract_04ae9347-a244-41ec-9509-17c7a734f7c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_47d4d048-f746-44b4-870d-c90e79a76490" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_04ae9347-a244-41ec-9509-17c7a734f7c1" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_47d4d048-f746-44b4-870d-c90e79a76490" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_4b8b3e5c-a1bf-41a9-8783-e6ae260ee2c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_04ae9347-a244-41ec-9509-17c7a734f7c1" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_4b8b3e5c-a1bf-41a9-8783-e6ae260ee2c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_e73364a7-45e8-46a3-b97b-898edaaaa036" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_04ae9347-a244-41ec-9509-17c7a734f7c1" xlink:to="loc_us-gaap_InventoryNet_e73364a7-45e8-46a3-b97b-898edaaaa036" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_6ded5907-9215-4aff-ad17-ebfc0d4c2950" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_04ae9347-a244-41ec-9509-17c7a734f7c1" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_6ded5907-9215-4aff-ad17-ebfc0d4c2950" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_d5751742-448a-477e-8361-c2cbd38aba01" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_04ae9347-a244-41ec-9509-17c7a734f7c1" xlink:to="loc_us-gaap_AssetsCurrent_d5751742-448a-477e-8361-c2cbd38aba01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_3793d800-3a7c-4fdd-922c-a96743438cde" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_9bd5d4ea-1f13-4957-aca8-d82f999de73d" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_3793d800-3a7c-4fdd-922c-a96743438cde" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_cc0f454d-9039-4d6f-95be-d46c33693d5e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_9bd5d4ea-1f13-4957-aca8-d82f999de73d" xlink:to="loc_us-gaap_Goodwill_cc0f454d-9039-4d6f-95be-d46c33693d5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_a5b59a7f-a190-4f3e-81ba-9ca717591b2e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_9bd5d4ea-1f13-4957-aca8-d82f999de73d" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_a5b59a7f-a190-4f3e-81ba-9ca717591b2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_bc790ee7-c839-465f-993f-4e6f70b5a723" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_9bd5d4ea-1f13-4957-aca8-d82f999de73d" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_bc790ee7-c839-465f-993f-4e6f70b5a723" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_76270a55-a444-4eb7-a59c-d7374223a68e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_9bd5d4ea-1f13-4957-aca8-d82f999de73d" xlink:to="loc_us-gaap_Assets_76270a55-a444-4eb7-a59c-d7374223a68e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_4c857e1f-fe6f-4fa0-8e72-ec21102ffde5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_502a9062-f086-42e9-8200-973feac648c9" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_4c857e1f-fe6f-4fa0-8e72-ec21102ffde5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_ad44c1a5-e7a9-4438-9f12-2cfabbc66a48" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_4c857e1f-fe6f-4fa0-8e72-ec21102ffde5" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_ad44c1a5-e7a9-4438-9f12-2cfabbc66a48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_399e5fef-276c-4896-a72a-1009ddb095b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_ad44c1a5-e7a9-4438-9f12-2cfabbc66a48" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_399e5fef-276c-4896-a72a-1009ddb095b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_a8293d11-22dc-463e-9c9d-0d2a875fbfea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_ad44c1a5-e7a9-4438-9f12-2cfabbc66a48" xlink:to="loc_us-gaap_AccountsPayableCurrent_a8293d11-22dc-463e-9c9d-0d2a875fbfea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_f64d9deb-e6e1-4c9b-b76e-47d63cb9f9b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_ad44c1a5-e7a9-4438-9f12-2cfabbc66a48" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_f64d9deb-e6e1-4c9b-b76e-47d63cb9f9b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_572fb711-a438-4405-9e87-cb6fe51e8bf6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_ad44c1a5-e7a9-4438-9f12-2cfabbc66a48" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_572fb711-a438-4405-9e87-cb6fe51e8bf6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_ac8bc885-50a6-4b81-9b54-b26cf075ece2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_ad44c1a5-e7a9-4438-9f12-2cfabbc66a48" xlink:to="loc_us-gaap_LiabilitiesCurrent_ac8bc885-50a6-4b81-9b54-b26cf075ece2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_24ec7bd7-bef0-494b-9036-265a4e63f6ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_4c857e1f-fe6f-4fa0-8e72-ec21102ffde5" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_24ec7bd7-bef0-494b-9036-265a4e63f6ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_38d0a4d3-d020-43c3-9fed-87f172187262" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_4c857e1f-fe6f-4fa0-8e72-ec21102ffde5" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_38d0a4d3-d020-43c3-9fed-87f172187262" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_c1f5745e-c92f-4566-8943-3838c1406f25" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_4c857e1f-fe6f-4fa0-8e72-ec21102ffde5" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_c1f5745e-c92f-4566-8943-3838c1406f25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_301c648c-9c0d-4a1e-8c4b-91d7053df232" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_4c857e1f-fe6f-4fa0-8e72-ec21102ffde5" xlink:to="loc_us-gaap_Liabilities_301c648c-9c0d-4a1e-8c4b-91d7053df232" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_bbbe9df7-b6a9-4f3e-ab8d-3821ba72b33d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_4c857e1f-fe6f-4fa0-8e72-ec21102ffde5" xlink:to="loc_us-gaap_CommitmentsAndContingencies_bbbe9df7-b6a9-4f3e-ab8d-3821ba72b33d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_10499740-1081-45b4-bb01-0322e478ecf7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_4c857e1f-fe6f-4fa0-8e72-ec21102ffde5" xlink:to="loc_us-gaap_StockholdersEquityAbstract_10499740-1081-45b4-bb01-0322e478ecf7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_9ce5590f-5f20-4276-a096-a2f0dadd4149" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_10499740-1081-45b4-bb01-0322e478ecf7" xlink:to="loc_us-gaap_PreferredStockValue_9ce5590f-5f20-4276-a096-a2f0dadd4149" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_3601a186-124e-4d80-8462-9c78d850c99a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_10499740-1081-45b4-bb01-0322e478ecf7" xlink:to="loc_us-gaap_CommonStockValue_3601a186-124e-4d80-8462-9c78d850c99a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_af30432a-198f-47f4-93f1-dbab218a37ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_10499740-1081-45b4-bb01-0322e478ecf7" xlink:to="loc_us-gaap_AdditionalPaidInCapital_af30432a-198f-47f4-93f1-dbab218a37ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_ad8406cc-6308-4b49-8fe1-414ad6af38a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_10499740-1081-45b4-bb01-0322e478ecf7" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_ad8406cc-6308-4b49-8fe1-414ad6af38a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_68e52598-c7d5-475b-8f35-8772d694a814" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_10499740-1081-45b4-bb01-0322e478ecf7" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_68e52598-c7d5-475b-8f35-8772d694a814" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonValue_cfe6703d-6798-485b-98aa-81cb599e67c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockCommonValue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_10499740-1081-45b4-bb01-0322e478ecf7" xlink:to="loc_us-gaap_TreasuryStockCommonValue_cfe6703d-6798-485b-98aa-81cb599e67c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_5e45272e-a915-4de5-a2b6-ae3026cd62a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_10499740-1081-45b4-bb01-0322e478ecf7" xlink:to="loc_us-gaap_StockholdersEquity_5e45272e-a915-4de5-a2b6-ae3026cd62a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_9c7c9538-ff06-45bd-9b38-dffece9bdb10" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_4c857e1f-fe6f-4fa0-8e72-ec21102ffde5" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_9c7c9538-ff06-45bd-9b38-dffece9bdb10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.conmed.com/role/ConsolidatedCondensedBalanceSheetsUnauditedParenthetical" xlink:type="simple" xlink:href="cnmd-20230331.xsd#ConsolidatedCondensedBalanceSheetsUnauditedParenthetical"/>
  <link:presentationLink xlink:role="http://www.conmed.com/role/ConsolidatedCondensedBalanceSheetsUnauditedParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_0a42f0ba-c854-4dc0-b756-7a5521bcfdcf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_a778ef27-5421-424c-b9bd-c2982b87f328" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_0a42f0ba-c854-4dc0-b756-7a5521bcfdcf" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_a778ef27-5421-424c-b9bd-c2982b87f328" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_7c0097d2-7035-4264-aa8e-441c39eafdca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_0a42f0ba-c854-4dc0-b756-7a5521bcfdcf" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_7c0097d2-7035-4264-aa8e-441c39eafdca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_18172ad9-eb21-40c0-a21a-939da30a4c5a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_0a42f0ba-c854-4dc0-b756-7a5521bcfdcf" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_18172ad9-eb21-40c0-a21a-939da30a4c5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_017f0e3c-01b8-4805-8552-b78daf8f07cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_0a42f0ba-c854-4dc0-b756-7a5521bcfdcf" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_017f0e3c-01b8-4805-8552-b78daf8f07cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_3d41b421-d64d-401d-9d9f-31415dadae01" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_0a42f0ba-c854-4dc0-b756-7a5521bcfdcf" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_3d41b421-d64d-401d-9d9f-31415dadae01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_3a4baf47-0f5c-4c41-9f3c-ae4baa0e9cfc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_0a42f0ba-c854-4dc0-b756-7a5521bcfdcf" xlink:to="loc_us-gaap_CommonStockSharesIssued_3a4baf47-0f5c-4c41-9f3c-ae4baa0e9cfc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares_7acb2ef5-4808-4816-9917-3894ea6c18ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_0a42f0ba-c854-4dc0-b756-7a5521bcfdcf" xlink:to="loc_us-gaap_TreasuryStockCommonShares_7acb2ef5-4808-4816-9917-3894ea6c18ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.conmed.com/role/ConsolidatedCondensedStatementsofShareholdersEquityUnaudited" xlink:type="simple" xlink:href="cnmd-20230331.xsd#ConsolidatedCondensedStatementsofShareholdersEquityUnaudited"/>
  <link:presentationLink xlink:role="http://www.conmed.com/role/ConsolidatedCondensedStatementsofShareholdersEquityUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_fd61de27-9783-4d46-9f07-6c7fba80cadb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_6c507a62-8813-46fc-8a60-08981c15141a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_fd61de27-9783-4d46-9f07-6c7fba80cadb" xlink:to="loc_us-gaap_StatementTable_6c507a62-8813-46fc-8a60-08981c15141a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_506e113e-5d11-4cbd-8619-ed14ec196c05" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_6c507a62-8813-46fc-8a60-08981c15141a" xlink:to="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_506e113e-5d11-4cbd-8619-ed14ec196c05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_030fe3be-5342-4f25-b2bd-72acf6cd5d02" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_506e113e-5d11-4cbd-8619-ed14ec196c05" xlink:to="loc_us-gaap_TypeOfAdoptionMember_030fe3be-5342-4f25-b2bd-72acf6cd5d02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate202006Member_048c18d5-2ee8-4847-9d97-ab842b1dedcc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingStandardsUpdate202006Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfAdoptionMember_030fe3be-5342-4f25-b2bd-72acf6cd5d02" xlink:to="loc_us-gaap_AccountingStandardsUpdate202006Member_048c18d5-2ee8-4847-9d97-ab842b1dedcc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_a953e52d-530f-4342-afea-bb372a04ad75" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_6c507a62-8813-46fc-8a60-08981c15141a" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_a953e52d-530f-4342-afea-bb372a04ad75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_181a3610-8239-4d61-b606-f16404fd829b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_a953e52d-530f-4342-afea-bb372a04ad75" xlink:to="loc_us-gaap_EquityComponentDomain_181a3610-8239-4d61-b606-f16404fd829b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_0ca9fe68-f13d-4765-b1c0-9c0a47b0c9ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_181a3610-8239-4d61-b606-f16404fd829b" xlink:to="loc_us-gaap_CommonStockMember_0ca9fe68-f13d-4765-b1c0-9c0a47b0c9ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_b799e2b3-2aa0-4f7c-a0cd-b8f7fb89c12e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_181a3610-8239-4d61-b606-f16404fd829b" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_b799e2b3-2aa0-4f7c-a0cd-b8f7fb89c12e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_cc57f637-561e-4cab-994e-f3085260f536" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_181a3610-8239-4d61-b606-f16404fd829b" xlink:to="loc_us-gaap_RetainedEarningsMember_cc57f637-561e-4cab-994e-f3085260f536" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_0fdfcf73-ac98-43d5-abbd-c918eb975470" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_181a3610-8239-4d61-b606-f16404fd829b" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_0fdfcf73-ac98-43d5-abbd-c918eb975470" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonMember_54780045-a9d3-446d-886d-0d01b1302614" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockCommonMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_181a3610-8239-4d61-b606-f16404fd829b" xlink:to="loc_us-gaap_TreasuryStockCommonMember_54780045-a9d3-446d-886d-0d01b1302614" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_cd163b1c-bdb8-4142-9e76-97723e3c744b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_6c507a62-8813-46fc-8a60-08981c15141a" xlink:to="loc_us-gaap_StatementLineItems_cd163b1c-bdb8-4142-9e76-97723e3c744b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e5d6d0df-04b3-45db-8aa4-5c0b35caaf34" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_cd163b1c-bdb8-4142-9e76-97723e3c744b" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e5d6d0df-04b3-45db-8aa4-5c0b35caaf34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_f9116a32-1381-46e6-850b-ee1ec733da11" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e5d6d0df-04b3-45db-8aa4-5c0b35caaf34" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_f9116a32-1381-46e6-850b-ee1ec733da11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_f7f6afaf-0bd6-4042-b271-49b3ebda6fce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e5d6d0df-04b3-45db-8aa4-5c0b35caaf34" xlink:to="loc_us-gaap_StockholdersEquity_f7f6afaf-0bd6-4042-b271-49b3ebda6fce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_7577e175-1739-429e-a5c6-01ee7d04aae7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e5d6d0df-04b3-45db-8aa4-5c0b35caaf34" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_7577e175-1739-429e-a5c6-01ee7d04aae7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_2dc97936-f56b-48c9-9e89-350f7df3409a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e5d6d0df-04b3-45db-8aa4-5c0b35caaf34" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_2dc97936-f56b-48c9-9e89-350f7df3409a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStockCash_700db0c5-2eb4-493d-9106-5d085b10f9bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsCommonStockCash"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e5d6d0df-04b3-45db-8aa4-5c0b35caaf34" xlink:to="loc_us-gaap_DividendsCommonStockCash_700db0c5-2eb4-493d-9106-5d085b10f9bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_da5e401c-8468-420c-b15e-be2851855a89" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e5d6d0df-04b3-45db-8aa4-5c0b35caaf34" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_da5e401c-8468-420c-b15e-be2851855a89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_3d1beb47-94fa-480f-841a-30c8738bd337" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_da5e401c-8468-420c-b15e-be2851855a89" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_3d1beb47-94fa-480f-841a-30c8738bd337" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_12bcf127-e0ee-4495-87b3-7d91250558d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_da5e401c-8468-420c-b15e-be2851855a89" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_12bcf127-e0ee-4495-87b3-7d91250558d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_816e82af-374a-4527-a906-faa12a71ffdc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_da5e401c-8468-420c-b15e-be2851855a89" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_816e82af-374a-4527-a906-faa12a71ffdc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_a5cb1156-48b0-4c62-acfd-9780cbf1e91f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_da5e401c-8468-420c-b15e-be2851855a89" xlink:to="loc_us-gaap_NetIncomeLoss_a5cb1156-48b0-4c62-acfd-9780cbf1e91f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_ed2d19a6-0244-476c-ba75-0cf85b200d22" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_da5e401c-8468-420c-b15e-be2851855a89" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_ed2d19a6-0244-476c-ba75-0cf85b200d22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdateExtensibleList_5c57ffc9-52ad-4ebe-b024-eef31d3ca405" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingStandardsUpdateExtensibleList"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_da5e401c-8468-420c-b15e-be2851855a89" xlink:to="loc_us-gaap_AccountingStandardsUpdateExtensibleList_5c57ffc9-52ad-4ebe-b024-eef31d3ca405" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_dc139f93-3077-499f-aacf-d9fca40d831f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e5d6d0df-04b3-45db-8aa4-5c0b35caaf34" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_dc139f93-3077-499f-aacf-d9fca40d831f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_29e34551-5623-4954-91d2-72c5d5e955b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e5d6d0df-04b3-45db-8aa4-5c0b35caaf34" xlink:to="loc_us-gaap_StockholdersEquity_29e34551-5623-4954-91d2-72c5d5e955b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.conmed.com/role/ConsolidatedCondensedStatementsofShareholdersEquityUnauditedParenthetical" xlink:type="simple" xlink:href="cnmd-20230331.xsd#ConsolidatedCondensedStatementsofShareholdersEquityUnauditedParenthetical"/>
  <link:presentationLink xlink:role="http://www.conmed.com/role/ConsolidatedCondensedStatementsofShareholdersEquityUnauditedParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_7f525a42-e243-4668-ae8c-581b1d432ec4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared_d9416aca-bb8f-4c04-ac00-4561a1a2414f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_7f525a42-e243-4668-ae8c-581b1d432ec4" xlink:to="loc_us-gaap_CommonStockDividendsPerShareDeclared_d9416aca-bb8f-4c04-ac00-4561a1a2414f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.conmed.com/role/ConsolidatedCondensedStatementsofCashFlowsUnaudited" xlink:type="simple" xlink:href="cnmd-20230331.xsd#ConsolidatedCondensedStatementsofCashFlowsUnaudited"/>
  <link:presentationLink xlink:role="http://www.conmed.com/role/ConsolidatedCondensedStatementsofCashFlowsUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_a9c5a3ac-8a09-4ca0-bcb9-9c434e56e19c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_c2ef19f5-537c-4874-98d9-fc135a8e38aa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_a9c5a3ac-8a09-4ca0-bcb9-9c434e56e19c" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_c2ef19f5-537c-4874-98d9-fc135a8e38aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_f4a5d887-0935-416a-9ad2-c7afb150d43b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_c2ef19f5-537c-4874-98d9-fc135a8e38aa" xlink:to="loc_us-gaap_NetIncomeLoss_f4a5d887-0935-416a-9ad2-c7afb150d43b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_7af647d7-6a69-47ca-9ba3-0a2bf5c2d9e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_c2ef19f5-537c-4874-98d9-fc135a8e38aa" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_7af647d7-6a69-47ca-9ba3-0a2bf5c2d9e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_c79ffbf4-d142-4879-acf3-24f89d935213" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Depreciation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_7af647d7-6a69-47ca-9ba3-0a2bf5c2d9e8" xlink:to="loc_us-gaap_Depreciation_c79ffbf4-d142-4879-acf3-24f89d935213" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts_cd29ec58-1161-4ae2-8020-e290877b75e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_7af647d7-6a69-47ca-9ba3-0a2bf5c2d9e8" xlink:to="loc_us-gaap_AmortizationOfFinancingCosts_cd29ec58-1161-4ae2-8020-e290877b75e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAmortizationOfDeferredCharges_26e5a003-d764-4cf7-b466-0d82ba7dcf63" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAmortizationOfDeferredCharges"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_7af647d7-6a69-47ca-9ba3-0a2bf5c2d9e8" xlink:to="loc_us-gaap_OtherAmortizationOfDeferredCharges_26e5a003-d764-4cf7-b466-0d82ba7dcf63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_c4248130-a0a4-4ecd-a0be-d28d1111a89d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_7af647d7-6a69-47ca-9ba3-0a2bf5c2d9e8" xlink:to="loc_us-gaap_ShareBasedCompensation_c4248130-a0a4-4ecd-a0be-d28d1111a89d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_975ae5a2-b6b3-43ee-ab1a-fe1882b96053" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_7af647d7-6a69-47ca-9ba3-0a2bf5c2d9e8" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_975ae5a2-b6b3-43ee-ab1a-fe1882b96053" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_b845b63a-496a-46fa-aefc-f08904f3915f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_7af647d7-6a69-47ca-9ba3-0a2bf5c2d9e8" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_b845b63a-496a-46fa-aefc-f08904f3915f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_9c3b2017-9455-4c6e-b182-ec9a77fd3bc6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_7af647d7-6a69-47ca-9ba3-0a2bf5c2d9e8" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_9c3b2017-9455-4c6e-b182-ec9a77fd3bc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_ace9225e-baae-4a3a-b8cf-d66c033a1d12" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_9c3b2017-9455-4c6e-b182-ec9a77fd3bc6" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_ace9225e-baae-4a3a-b8cf-d66c033a1d12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_3feed10c-3d55-4624-8846-ca4354fce047" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_9c3b2017-9455-4c6e-b182-ec9a77fd3bc6" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_3feed10c-3d55-4624-8846-ca4354fce047" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_7678f036-5ab9-4cc9-8cd6-f6f8d32e492b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_9c3b2017-9455-4c6e-b182-ec9a77fd3bc6" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_7678f036-5ab9-4cc9-8cd6-f6f8d32e492b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_d92075c9-5bb5-4056-9403-5ce3cb6d79ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_9c3b2017-9455-4c6e-b182-ec9a77fd3bc6" xlink:to="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_d92075c9-5bb5-4056-9403-5ce3cb6d79ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_84c9c58e-9b43-42b7-a0d3-632d4755ec5d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_9c3b2017-9455-4c6e-b182-ec9a77fd3bc6" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_84c9c58e-9b43-42b7-a0d3-632d4755ec5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_b12b32ee-8dde-4142-a9d9-d97c86a13afa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherOperatingLiabilities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_9c3b2017-9455-4c6e-b182-ec9a77fd3bc6" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_b12b32ee-8dde-4142-a9d9-d97c86a13afa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_bc079114-717b-497f-9328-0e73ebcc2fa5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_7af647d7-6a69-47ca-9ba3-0a2bf5c2d9e8" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_bc079114-717b-497f-9328-0e73ebcc2fa5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_250e5976-b240-4c97-a08b-9a22340ea4db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_a9c5a3ac-8a09-4ca0-bcb9-9c434e56e19c" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_250e5976-b240-4c97-a08b-9a22340ea4db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_e17e202e-ea01-4129-b143-2ba7821cc9a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_250e5976-b240-4c97-a08b-9a22340ea4db" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_e17e202e-ea01-4129-b143-2ba7821cc9a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_595abe48-ff84-4f14-aeeb-1e7c12d6143a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_250e5976-b240-4c97-a08b-9a22340ea4db" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_595abe48-ff84-4f14-aeeb-1e7c12d6143a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_a3026e31-d8f9-4008-bc25-468073ffd042" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_a9c5a3ac-8a09-4ca0-bcb9-9c434e56e19c" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_a3026e31-d8f9-4008-bc25-468073ffd042" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfSeniorDebt_73fb5105-8cf0-4d0f-92f2-ac57844e9f7e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfSeniorDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_a3026e31-d8f9-4008-bc25-468073ffd042" xlink:to="loc_us-gaap_RepaymentsOfSeniorDebt_73fb5105-8cf0-4d0f-92f2-ac57844e9f7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLinesOfCredit_77177e4e-05af-445b-9145-aa6af5a9ad57" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfLinesOfCredit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_a3026e31-d8f9-4008-bc25-468073ffd042" xlink:to="loc_us-gaap_RepaymentsOfLinesOfCredit_77177e4e-05af-445b-9145-aa6af5a9ad57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLinesOfCredit_34506058-b5c2-4b2f-816d-ed3d1d7a5479" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromLinesOfCredit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_a3026e31-d8f9-4008-bc25-468073ffd042" xlink:to="loc_us-gaap_ProceedsFromLinesOfCredit_34506058-b5c2-4b2f-816d-ed3d1d7a5479" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_PaymentsForContingentConsideration_26cb70ae-14c8-4843-8b5f-e75ec5a2d46a" xlink:href="cnmd-20230331.xsd#cnmd_PaymentsForContingentConsideration"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_a3026e31-d8f9-4008-bc25-468073ffd042" xlink:to="loc_cnmd_PaymentsForContingentConsideration_26cb70ae-14c8-4843-8b5f-e75ec5a2d46a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsCommonStock_dcae5eda-7eed-4dd1-9dcc-583e282b3c03" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDividendsCommonStock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_a3026e31-d8f9-4008-bc25-468073ffd042" xlink:to="loc_us-gaap_PaymentsOfDividendsCommonStock_dcae5eda-7eed-4dd1-9dcc-583e282b3c03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_e4dc2bbb-04d6-4cc4-abc4-d22b9cdeeefb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_a3026e31-d8f9-4008-bc25-468073ffd042" xlink:to="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_e4dc2bbb-04d6-4cc4-abc4-d22b9cdeeefb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_226b938c-4b16-4c72-9f19-170439579990" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_a3026e31-d8f9-4008-bc25-468073ffd042" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_226b938c-4b16-4c72-9f19-170439579990" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_d82f66ee-873e-4093-878c-3e41f88f4abe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_a9c5a3ac-8a09-4ca0-bcb9-9c434e56e19c" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_d82f66ee-873e-4093-878c-3e41f88f4abe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_5785c0e0-e07b-4cac-a432-17ff7605a4a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_a9c5a3ac-8a09-4ca0-bcb9-9c434e56e19c" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_5785c0e0-e07b-4cac-a432-17ff7605a4a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_d9d4ac59-1617-4c3f-b780-550ce3de568b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_a9c5a3ac-8a09-4ca0-bcb9-9c434e56e19c" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_d9d4ac59-1617-4c3f-b780-550ce3de568b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_1a1a85a4-486f-4fc6-b23d-55a9d7e5378e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_a9c5a3ac-8a09-4ca0-bcb9-9c434e56e19c" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_1a1a85a4-486f-4fc6-b23d-55a9d7e5378e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_23975006-32f9-4d1a-9704-92b986eff541" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_a9c5a3ac-8a09-4ca0-bcb9-9c434e56e19c" xlink:to="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_23975006-32f9-4d1a-9704-92b986eff541" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableCurrentAndNoncurrent_12943644-6dfe-4b36-aaad-677bf7239fe1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsPayableCurrentAndNoncurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_23975006-32f9-4d1a-9704-92b986eff541" xlink:to="loc_us-gaap_DividendsPayableCurrentAndNoncurrent_12943644-6dfe-4b36-aaad-677bf7239fe1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.conmed.com/role/Operations" xlink:type="simple" xlink:href="cnmd-20230331.xsd#Operations"/>
  <link:presentationLink xlink:role="http://www.conmed.com/role/Operations" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_1eb6d418-bec7-4cba-992b-1ad61618aeee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NatureOfOperations_9d0ca3b9-31cf-408a-9ea5-49620cf35fca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NatureOfOperations"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_1eb6d418-bec7-4cba-992b-1ad61618aeee" xlink:to="loc_us-gaap_NatureOfOperations_9d0ca3b9-31cf-408a-9ea5-49620cf35fca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.conmed.com/role/InterimFinancialInformation" xlink:type="simple" xlink:href="cnmd-20230331.xsd#InterimFinancialInformation"/>
  <link:presentationLink xlink:role="http://www.conmed.com/role/InterimFinancialInformation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_434ab9c2-4679-41ff-8faf-1fcc4e26f733" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_35b6dd58-4e5f-423c-bb79-27a2d0b3dc5b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_434ab9c2-4679-41ff-8faf-1fcc4e26f733" xlink:to="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_35b6dd58-4e5f-423c-bb79-27a2d0b3dc5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.conmed.com/role/NewAccountingPronouncements" xlink:type="simple" xlink:href="cnmd-20230331.xsd#NewAccountingPronouncements"/>
  <link:presentationLink xlink:role="http://www.conmed.com/role/NewAccountingPronouncements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_d9fb2053-9070-45d2-9508-2a94e3b426a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_a31b848a-e559-43ef-9f9d-60646826d41b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_d9fb2053-9070-45d2-9508-2a94e3b426a6" xlink:to="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_a31b848a-e559-43ef-9f9d-60646826d41b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.conmed.com/role/BusinessCombinations" xlink:type="simple" xlink:href="cnmd-20230331.xsd#BusinessCombinations"/>
  <link:presentationLink xlink:role="http://www.conmed.com/role/BusinessCombinations" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_0a6e64a0-97f7-4fd3-ace3-09788b478455" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock_95db6268-76a6-488d-8fff-59f3422dc268" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_0a6e64a0-97f7-4fd3-ace3-09788b478455" xlink:to="loc_us-gaap_BusinessCombinationDisclosureTextBlock_95db6268-76a6-488d-8fff-59f3422dc268" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.conmed.com/role/Revenues" xlink:type="simple" xlink:href="cnmd-20230331.xsd#Revenues"/>
  <link:presentationLink xlink:role="http://www.conmed.com/role/Revenues" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_40e97b63-b83b-4d43-bd6f-06bfa4e6d977" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_d4da85f3-5b15-4440-965d-382f47214288" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_40e97b63-b83b-4d43-bd6f-06bfa4e6d977" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_d4da85f3-5b15-4440-965d-382f47214288" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.conmed.com/role/ComprehensiveIncome" xlink:type="simple" xlink:href="cnmd-20230331.xsd#ComprehensiveIncome"/>
  <link:presentationLink xlink:role="http://www.conmed.com/role/ComprehensiveIncome" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_a60a25d1-9190-4430-b4a1-42fb243d9c30" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNoteTextBlock_3ec426ae-620c-4e60-8bad-49e315dc606d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNoteTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_a60a25d1-9190-4430-b4a1-42fb243d9c30" xlink:to="loc_us-gaap_ComprehensiveIncomeNoteTextBlock_3ec426ae-620c-4e60-8bad-49e315dc606d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.conmed.com/role/FairValueofFinancialInstruments" xlink:type="simple" xlink:href="cnmd-20230331.xsd#FairValueofFinancialInstruments"/>
  <link:presentationLink xlink:role="http://www.conmed.com/role/FairValueofFinancialInstruments" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_a1ef0b9d-008b-4a40-ba2e-7981e03fa545" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesAndFairValueTextBlock_9430efbd-e648-4ef6-bb5f-2bdc45f54086" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativesAndFairValueTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_a1ef0b9d-008b-4a40-ba2e-7981e03fa545" xlink:to="loc_us-gaap_DerivativesAndFairValueTextBlock_9430efbd-e648-4ef6-bb5f-2bdc45f54086" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.conmed.com/role/Inventories" xlink:type="simple" xlink:href="cnmd-20230331.xsd#Inventories"/>
  <link:presentationLink xlink:role="http://www.conmed.com/role/Inventories" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract_f77a5839-94e4-4cb3-9bc4-099c6ba68366" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureTextBlock_47f96db9-0a4c-4547-9556-16527f7ce0e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_f77a5839-94e4-4cb3-9bc4-099c6ba68366" xlink:to="loc_us-gaap_InventoryDisclosureTextBlock_47f96db9-0a4c-4547-9556-16527f7ce0e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.conmed.com/role/EarningsPerShare" xlink:type="simple" xlink:href="cnmd-20230331.xsd#EarningsPerShare"/>
  <link:presentationLink xlink:role="http://www.conmed.com/role/EarningsPerShare" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_5ffbc52c-1784-4ef6-9b03-331e14c69e37" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_2bf976c4-f903-44fd-9421-f5ca72f3ea3d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_5ffbc52c-1784-4ef6-9b03-331e14c69e37" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_2bf976c4-f903-44fd-9421-f5ca72f3ea3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.conmed.com/role/GoodwillandOtherIntangibleAssets" xlink:type="simple" xlink:href="cnmd-20230331.xsd#GoodwillandOtherIntangibleAssets"/>
  <link:presentationLink xlink:role="http://www.conmed.com/role/GoodwillandOtherIntangibleAssets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_b31ffb18-854b-422a-8893-5ecb9fcdb482" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_3183eb70-debb-4085-8b5a-e9e08a01e5aa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_b31ffb18-854b-422a-8893-5ecb9fcdb482" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_3183eb70-debb-4085-8b5a-e9e08a01e5aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.conmed.com/role/LongTermDebt" xlink:type="simple" xlink:href="cnmd-20230331.xsd#LongTermDebt"/>
  <link:presentationLink xlink:role="http://www.conmed.com/role/LongTermDebt" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_9e5a5adb-5ebc-4e12-b1fb-173387aeb6d7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtTextBlock_fc8a35d2-666f-49d3-88c5-0cbd4bbb31f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_9e5a5adb-5ebc-4e12-b1fb-173387aeb6d7" xlink:to="loc_us-gaap_LongTermDebtTextBlock_fc8a35d2-666f-49d3-88c5-0cbd4bbb31f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.conmed.com/role/Guarantees" xlink:type="simple" xlink:href="cnmd-20230331.xsd#Guarantees"/>
  <link:presentationLink xlink:role="http://www.conmed.com/role/Guarantees" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuaranteesAbstract_a99d0d96-dff6-4728-b6dd-11f1859e6100" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GuaranteesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductWarrantyDisclosureTextBlock_05373956-fe7f-42eb-860f-1681c67a92b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductWarrantyDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GuaranteesAbstract_a99d0d96-dff6-4728-b6dd-11f1859e6100" xlink:to="loc_us-gaap_ProductWarrantyDisclosureTextBlock_05373956-fe7f-42eb-860f-1681c67a92b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.conmed.com/role/PensionPlan" xlink:type="simple" xlink:href="cnmd-20230331.xsd#PensionPlan"/>
  <link:presentationLink xlink:role="http://www.conmed.com/role/PensionPlan" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_8c785db3-0fda-4f51-a68f-2885777f4df2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_d4420038-ab03-4ff9-bd54-e61cf4302882" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_8c785db3-0fda-4f51-a68f-2885777f4df2" xlink:to="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_d4420038-ab03-4ff9-bd54-e61cf4302882" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.conmed.com/role/BusinessSegment" xlink:type="simple" xlink:href="cnmd-20230331.xsd#BusinessSegment"/>
  <link:presentationLink xlink:role="http://www.conmed.com/role/BusinessSegment" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_ea8f0806-defe-49c9-83b5-47fb7d327bd9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock_d9ed9461-d3aa-4d11-9362-384936cb48e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_ea8f0806-defe-49c9-83b5-47fb7d327bd9" xlink:to="loc_us-gaap_SegmentReportingDisclosureTextBlock_d9ed9461-d3aa-4d11-9362-384936cb48e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.conmed.com/role/LegalProceedings" xlink:type="simple" xlink:href="cnmd-20230331.xsd#LegalProceedings"/>
  <link:presentationLink xlink:role="http://www.conmed.com/role/LegalProceedings" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_b6a6e636-7536-41bd-b1c5-fdee140f2f9a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LegalMattersAndContingenciesTextBlock_74c1e313-7d01-43da-a8e5-799c4d48c113" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LegalMattersAndContingenciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_b6a6e636-7536-41bd-b1c5-fdee140f2f9a" xlink:to="loc_us-gaap_LegalMattersAndContingenciesTextBlock_74c1e313-7d01-43da-a8e5-799c4d48c113" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.conmed.com/role/InterimReportingPolicies" xlink:type="simple" xlink:href="cnmd-20230331.xsd#InterimReportingPolicies"/>
  <link:presentationLink xlink:role="http://www.conmed.com/role/InterimReportingPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_e4f22e69-4027-4ad5-b21e-9ff70d2ecc4f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates_c1c7950a-6d97-4be9-ae0d-c7e3cd2f1013" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UseOfEstimates"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_e4f22e69-4027-4ad5-b21e-9ff70d2ecc4f" xlink:to="loc_us-gaap_UseOfEstimates_c1c7950a-6d97-4be9-ae0d-c7e3cd2f1013" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.conmed.com/role/NewAccountingPronouncementsPolicies" xlink:type="simple" xlink:href="cnmd-20230331.xsd#NewAccountingPronouncementsPolicies"/>
  <link:presentationLink xlink:role="http://www.conmed.com/role/NewAccountingPronouncementsPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_47b718b0-a60d-41e8-a9e9-03f7f02daf8d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_a8ef9fea-319c-4670-85a3-8cb5f71e3b6e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_47b718b0-a60d-41e8-a9e9-03f7f02daf8d" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_a8ef9fea-319c-4670-85a3-8cb5f71e3b6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.conmed.com/role/RevenuesTables" xlink:type="simple" xlink:href="cnmd-20230331.xsd#RevenuesTables"/>
  <link:presentationLink xlink:role="http://www.conmed.com/role/RevenuesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_452368ad-d082-4a2a-a225-e9022ce0bdd6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_41843585-2446-42c7-84f2-009e11b42f95" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_452368ad-d082-4a2a-a225-e9022ce0bdd6" xlink:to="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_41843585-2446-42c7-84f2-009e11b42f95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_4364fe19-35c4-4bdf-a24f-f7844fbc8f3e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_452368ad-d082-4a2a-a225-e9022ce0bdd6" xlink:to="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_4364fe19-35c4-4bdf-a24f-f7844fbc8f3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.conmed.com/role/ComprehensiveIncomeTables" xlink:type="simple" xlink:href="cnmd-20230331.xsd#ComprehensiveIncomeTables"/>
  <link:presentationLink xlink:role="http://www.conmed.com/role/ComprehensiveIncomeTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_72a7152c-2176-4daa-ad15-c77f878461f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock_041a54a3-4cb0-4b42-b42a-8cf696660512" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_72a7152c-2176-4daa-ad15-c77f878461f8" xlink:to="loc_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock_041a54a3-4cb0-4b42-b42a-8cf696660512" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_e743de2f-bf42-47f6-a24e-b9d979a578c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_72a7152c-2176-4daa-ad15-c77f878461f8" xlink:to="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_e743de2f-bf42-47f6-a24e-b9d979a578c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.conmed.com/role/FairValueofFinancialInstrumentsTables" xlink:type="simple" xlink:href="cnmd-20230331.xsd#FairValueofFinancialInstrumentsTables"/>
  <link:presentationLink xlink:role="http://www.conmed.com/role/FairValueofFinancialInstrumentsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_423585fe-0315-43f2-af9d-73f92b397cb8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock_b7fb88a3-bc4f-49a1-85e9-b0bd07489278" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_423585fe-0315-43f2-af9d-73f92b397cb8" xlink:to="loc_us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock_b7fb88a3-bc4f-49a1-85e9-b0bd07489278" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock_504406a9-be1e-48ca-9ca4-37490be1c5fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_423585fe-0315-43f2-af9d-73f92b397cb8" xlink:to="loc_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock_504406a9-be1e-48ca-9ca4-37490be1c5fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_5801b82a-f7ac-4139-95a3-77cd94a5413b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_423585fe-0315-43f2-af9d-73f92b397cb8" xlink:to="loc_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_5801b82a-f7ac-4139-95a3-77cd94a5413b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfForeignExchangeContractsStatementOfFinancialPositionTableTextBlock_44b8f59c-b321-4842-83e4-819a0712b733" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfForeignExchangeContractsStatementOfFinancialPositionTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_423585fe-0315-43f2-af9d-73f92b397cb8" xlink:to="loc_us-gaap_ScheduleOfForeignExchangeContractsStatementOfFinancialPositionTableTextBlock_44b8f59c-b321-4842-83e4-819a0712b733" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_52042e98-695a-4c5b-887c-70c86730dc2c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_423585fe-0315-43f2-af9d-73f92b397cb8" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_52042e98-695a-4c5b-887c-70c86730dc2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock_f80bc365-b4ad-4322-a1d8-eb46fc7fdc70" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_423585fe-0315-43f2-af9d-73f92b397cb8" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock_f80bc365-b4ad-4322-a1d8-eb46fc7fdc70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.conmed.com/role/InventoriesTables" xlink:type="simple" xlink:href="cnmd-20230331.xsd#InventoriesTables"/>
  <link:presentationLink xlink:role="http://www.conmed.com/role/InventoriesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract_aff3dae3-91ce-484f-9b3e-c032a55cf4fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_b98bec0b-4e3f-40ab-816c-54b417c36e6f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_aff3dae3-91ce-484f-9b3e-c032a55cf4fa" xlink:to="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_b98bec0b-4e3f-40ab-816c-54b417c36e6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.conmed.com/role/EarningsPerShareTables" xlink:type="simple" xlink:href="cnmd-20230331.xsd#EarningsPerShareTables"/>
  <link:presentationLink xlink:role="http://www.conmed.com/role/EarningsPerShareTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_fd52864b-4269-48cd-84a1-f7d3e8051975" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_0399ad27-329e-4570-842a-9d35b5566790" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_fd52864b-4269-48cd-84a1-f7d3e8051975" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_0399ad27-329e-4570-842a-9d35b5566790" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.conmed.com/role/GoodwillandOtherIntangibleAssetsTables" xlink:type="simple" xlink:href="cnmd-20230331.xsd#GoodwillandOtherIntangibleAssetsTables"/>
  <link:presentationLink xlink:role="http://www.conmed.com/role/GoodwillandOtherIntangibleAssetsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_d76236fc-37cb-4f89-a2ac-e7a3e792387f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock_d79b0d4a-2827-4929-a3d4-357531d6a3d5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_d76236fc-37cb-4f89-a2ac-e7a3e792387f" xlink:to="loc_us-gaap_ScheduleOfGoodwillTextBlock_d79b0d4a-2827-4929-a3d4-357531d6a3d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_0c61e131-9244-46a6-9559-3752c00c6b21" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_d76236fc-37cb-4f89-a2ac-e7a3e792387f" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_0c61e131-9244-46a6-9559-3752c00c6b21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock_44d4d836-be16-4e08-8160-92921ff02270" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_d76236fc-37cb-4f89-a2ac-e7a3e792387f" xlink:to="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock_44d4d836-be16-4e08-8160-92921ff02270" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_e39cafc6-f7a9-4693-8920-6b033bd1e871" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_d76236fc-37cb-4f89-a2ac-e7a3e792387f" xlink:to="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_e39cafc6-f7a9-4693-8920-6b033bd1e871" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.conmed.com/role/LongTermDebtTables" xlink:type="simple" xlink:href="cnmd-20230331.xsd#LongTermDebtTables"/>
  <link:presentationLink xlink:role="http://www.conmed.com/role/LongTermDebtTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_f4ed0038-88cc-49a6-84f7-1cc536aba4dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock_9491cd77-6d1f-472b-9fbb-5eb9576065a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDebtInstrumentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_f4ed0038-88cc-49a6-84f7-1cc536aba4dc" xlink:to="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock_9491cd77-6d1f-472b-9fbb-5eb9576065a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_8f7fc26f-cec9-4ea9-b1e5-909b56c7ddd0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_f4ed0038-88cc-49a6-84f7-1cc536aba4dc" xlink:to="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_8f7fc26f-cec9-4ea9-b1e5-909b56c7ddd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.conmed.com/role/GuaranteesTables" xlink:type="simple" xlink:href="cnmd-20230331.xsd#GuaranteesTables"/>
  <link:presentationLink xlink:role="http://www.conmed.com/role/GuaranteesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuaranteesAbstract_6a3fef89-87ea-4188-9f29-f8ef851f699e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GuaranteesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock_9cb098ed-df42-4894-821b-38ef63c54cb9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GuaranteesAbstract_6a3fef89-87ea-4188-9f29-f8ef851f699e" xlink:to="loc_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock_9cb098ed-df42-4894-821b-38ef63c54cb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.conmed.com/role/PensionPlanTables" xlink:type="simple" xlink:href="cnmd-20230331.xsd#PensionPlanTables"/>
  <link:presentationLink xlink:role="http://www.conmed.com/role/PensionPlanTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_432c2e5e-305f-42b0-af6c-93791d9cd3ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock_39b60111-3fef-484a-aabd-b0dd0f94ffea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfNetBenefitCostsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_432c2e5e-305f-42b0-af6c-93791d9cd3ea" xlink:to="loc_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock_39b60111-3fef-484a-aabd-b0dd0f94ffea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.conmed.com/role/BusinessSegmentTables" xlink:type="simple" xlink:href="cnmd-20230331.xsd#BusinessSegmentTables"/>
  <link:presentationLink xlink:role="http://www.conmed.com/role/BusinessSegmentTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_d97afd5d-6e2e-4c3b-87c7-4d85ceb0b1ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock_dc6b8d6d-5aae-43ab-b467-0f56566d7635" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_d97afd5d-6e2e-4c3b-87c7-4d85ceb0b1ea" xlink:to="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock_dc6b8d6d-5aae-43ab-b467-0f56566d7635" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.conmed.com/role/BusinessCombinationsDetails" xlink:type="simple" xlink:href="cnmd-20230331.xsd#BusinessCombinationsDetails"/>
  <link:presentationLink xlink:role="http://www.conmed.com/role/BusinessCombinationsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_879def6a-8230-4f59-a487-bcc82306c8c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_d6796433-4cca-46bc-bac0-b7735cdfee83" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_879def6a-8230-4f59-a487-bcc82306c8c1" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_d6796433-4cca-46bc-bac0-b7735cdfee83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_e9c07cfa-06dd-46d3-b173-668afe4be7a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_d6796433-4cca-46bc-bac0-b7735cdfee83" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_e9c07cfa-06dd-46d3-b173-668afe4be7a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_41dbb8ce-e20f-4267-8fe8-b8a88d18f79f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_e9c07cfa-06dd-46d3-b173-668afe4be7a1" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_41dbb8ce-e20f-4267-8fe8-b8a88d18f79f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_In2BonesGlobalIncMember_4e28cea9-a78a-4998-9d5c-d3082faf439a" xlink:href="cnmd-20230331.xsd#cnmd_In2BonesGlobalIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_41dbb8ce-e20f-4267-8fe8-b8a88d18f79f" xlink:to="loc_cnmd_In2BonesGlobalIncMember_4e28cea9-a78a-4998-9d5c-d3082faf439a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_BiorezIncMember_41dc97f0-3dcf-4f63-a324-434c3e8890fb" xlink:href="cnmd-20230331.xsd#cnmd_BiorezIncMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_41dbb8ce-e20f-4267-8fe8-b8a88d18f79f" xlink:to="loc_cnmd_BiorezIncMember_41dc97f0-3dcf-4f63-a324-434c3e8890fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_37861e96-eaca-40aa-b390-31a719c01a25" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_d6796433-4cca-46bc-bac0-b7735cdfee83" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_37861e96-eaca-40aa-b390-31a719c01a25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_5b0e2744-58fd-4ef4-8a6a-4b9040054b1c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_37861e96-eaca-40aa-b390-31a719c01a25" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_5b0e2744-58fd-4ef4-8a6a-4b9040054b1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_5e32cc6d-f0b0-4066-ae40-13cb57298937" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfSalesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_5b0e2744-58fd-4ef4-8a6a-4b9040054b1c" xlink:to="loc_us-gaap_CostOfSalesMember_5e32cc6d-f0b0-4066-ae40-13cb57298937" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_51778b64-2021-47ea-ad6c-8a6749e94cae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_d6796433-4cca-46bc-bac0-b7735cdfee83" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_51778b64-2021-47ea-ad6c-8a6749e94cae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_c9f2e074-d201-454e-93df-29e7b9361b45" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_51778b64-2021-47ea-ad6c-8a6749e94cae" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_c9f2e074-d201-454e-93df-29e7b9361b45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_6a299864-53e7-410b-8bfd-e4ffee83c48c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_51778b64-2021-47ea-ad6c-8a6749e94cae" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_6a299864-53e7-410b-8bfd-e4ffee83c48c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_BusinessCombinationPurchasePriceAdjustmentHoldback_7708483a-ec9a-47c9-8ab4-7c076398af1d" xlink:href="cnmd-20230331.xsd#cnmd_BusinessCombinationPurchasePriceAdjustmentHoldback"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_51778b64-2021-47ea-ad6c-8a6749e94cae" xlink:to="loc_cnmd_BusinessCombinationPurchasePriceAdjustmentHoldback_7708483a-ec9a-47c9-8ab4-7c076398af1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_21745974-3acc-4b14-9f95-985b8bd2f8ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_51778b64-2021-47ea-ad6c-8a6749e94cae" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_21745974-3acc-4b14-9f95-985b8bd2f8ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_8c0fe150-1616-4719-a546-a914c5bb9476" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_51778b64-2021-47ea-ad6c-8a6749e94cae" xlink:to="loc_us-gaap_Revenues_8c0fe150-1616-4719-a546-a914c5bb9476" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_AmortizationOfInventoryStepUpAdjustments_6ce3b691-cf23-49b0-b3d9-15bb38306139" xlink:href="cnmd-20230331.xsd#cnmd_AmortizationOfInventoryStepUpAdjustments"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_51778b64-2021-47ea-ad6c-8a6749e94cae" xlink:to="loc_cnmd_AmortizationOfInventoryStepUpAdjustments_6ce3b691-cf23-49b0-b3d9-15bb38306139" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.conmed.com/role/RevenuesDisaggregatedRevenuesDetails" xlink:type="simple" xlink:href="cnmd-20230331.xsd#RevenuesDisaggregatedRevenuesDetails"/>
  <link:presentationLink xlink:role="http://www.conmed.com/role/RevenuesDisaggregatedRevenuesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_1cd26006-ef5e-4312-9beb-5aa1b73f9e92" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_ffcf1785-da7f-4fbd-86a2-cea965e3686a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_1cd26006-ef5e-4312-9beb-5aa1b73f9e92" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_ffcf1785-da7f-4fbd-86a2-cea965e3686a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_f0b17322-af50-45d4-bb10-0b260d7ccd45" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_ffcf1785-da7f-4fbd-86a2-cea965e3686a" xlink:to="loc_srt_StatementGeographicalAxis_f0b17322-af50-45d4-bb10-0b260d7ccd45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_31ab8852-cecd-4acc-b334-f354a1eae0f1" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_f0b17322-af50-45d4-bb10-0b260d7ccd45" xlink:to="loc_srt_SegmentGeographicalDomain_31ab8852-cecd-4acc-b334-f354a1eae0f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_5d1a06f9-1017-4a42-bdc5-2a8abd3f1f8f" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_31ab8852-cecd-4acc-b334-f354a1eae0f1" xlink:to="loc_country_US_5d1a06f9-1017-4a42-bdc5-2a8abd3f1f8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_AmericasexcludingtheUnitedStatesMember_09ab6f5f-96d6-40f8-be0a-2f13dd8e7248" xlink:href="cnmd-20230331.xsd#cnmd_AmericasexcludingtheUnitedStatesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_31ab8852-cecd-4acc-b334-f354a1eae0f1" xlink:to="loc_cnmd_AmericasexcludingtheUnitedStatesMember_09ab6f5f-96d6-40f8-be0a-2f13dd8e7248" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EMEAMember_ee36db4a-b9a9-4d3a-ad96-5767e2a7fcc7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EMEAMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_31ab8852-cecd-4acc-b334-f354a1eae0f1" xlink:to="loc_us-gaap_EMEAMember_ee36db4a-b9a9-4d3a-ad96-5767e2a7fcc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AsiaPacificMember_6f0f9e9a-fc7d-40bd-bc10-05568fbd8710" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_AsiaPacificMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_31ab8852-cecd-4acc-b334-f354a1eae0f1" xlink:to="loc_srt_AsiaPacificMember_6f0f9e9a-fc7d-40bd-bc10-05568fbd8710" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_ff4459d6-4c4b-4333-a8ac-bdcef0685da9" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_ffcf1785-da7f-4fbd-86a2-cea965e3686a" xlink:to="loc_srt_ProductOrServiceAxis_ff4459d6-4c4b-4333-a8ac-bdcef0685da9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_dcfa34a5-fba6-4e14-8649-82f88ed34e90" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_ff4459d6-4c4b-4333-a8ac-bdcef0685da9" xlink:to="loc_srt_ProductsAndServicesDomain_dcfa34a5-fba6-4e14-8649-82f88ed34e90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_OrthopedicSurgeryMember_2fc4b01c-bd3f-4740-b072-ac74c5485de6" xlink:href="cnmd-20230331.xsd#cnmd_OrthopedicSurgeryMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_dcfa34a5-fba6-4e14-8649-82f88ed34e90" xlink:to="loc_cnmd_OrthopedicSurgeryMember_2fc4b01c-bd3f-4740-b072-ac74c5485de6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_GeneralSurgeryMember_cb95550b-cab9-4cc9-ab68-735317fa17c3" xlink:href="cnmd-20230331.xsd#cnmd_GeneralSurgeryMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_dcfa34a5-fba6-4e14-8649-82f88ed34e90" xlink:to="loc_cnmd_GeneralSurgeryMember_cb95550b-cab9-4cc9-ab68-735317fa17c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TimingOfTransferOfGoodOrServiceAxis_c9df6cb4-7e2d-41e3-b523-9a631dfb56dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TimingOfTransferOfGoodOrServiceAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_ffcf1785-da7f-4fbd-86a2-cea965e3686a" xlink:to="loc_us-gaap_TimingOfTransferOfGoodOrServiceAxis_c9df6cb4-7e2d-41e3-b523-9a631dfb56dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain_ba1a5750-3c4d-4a4e-8ec3-cc92bf26cc33" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TimingOfTransferOfGoodOrServiceDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TimingOfTransferOfGoodOrServiceAxis_c9df6cb4-7e2d-41e3-b523-9a631dfb56dc" xlink:to="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain_ba1a5750-3c4d-4a4e-8ec3-cc92bf26cc33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransferredAtPointInTimeMember_9c6d3da3-2c77-4a53-94ba-981efcfcd510" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransferredAtPointInTimeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain_ba1a5750-3c4d-4a4e-8ec3-cc92bf26cc33" xlink:to="loc_us-gaap_TransferredAtPointInTimeMember_9c6d3da3-2c77-4a53-94ba-981efcfcd510" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransferredOverTimeMember_dfb3a348-62f3-4256-9a1c-1ba2ddfe93d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransferredOverTimeMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain_ba1a5750-3c4d-4a4e-8ec3-cc92bf26cc33" xlink:to="loc_us-gaap_TransferredOverTimeMember_dfb3a348-62f3-4256-9a1c-1ba2ddfe93d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_ab70c664-5232-450f-8c96-591cbe206977" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_ffcf1785-da7f-4fbd-86a2-cea965e3686a" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_ab70c664-5232-450f-8c96-591cbe206977" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_71b691c9-c36f-4d44-8952-29bc4c23aaf4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_ab70c664-5232-450f-8c96-591cbe206977" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_71b691c9-c36f-4d44-8952-29bc4c23aaf4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.conmed.com/role/RevenuesCustomerLiabilityDetails" xlink:type="simple" xlink:href="cnmd-20230331.xsd#RevenuesCustomerLiabilityDetails"/>
  <link:presentationLink xlink:role="http://www.conmed.com/role/RevenuesCustomerLiabilityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_a401ed28-a001-4edf-a771-463616481479" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_49496fef-a295-4535-80a6-9f447ab2763d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_a401ed28-a001-4edf-a771-463616481479" xlink:to="loc_us-gaap_ContractWithCustomerLiability_49496fef-a295-4535-80a6-9f447ab2763d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_bc8f883a-1046-4455-b5bb-62d677df6ed1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_a401ed28-a001-4edf-a771-463616481479" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_bc8f883a-1046-4455-b5bb-62d677df6ed1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.conmed.com/role/ComprehensiveIncomeDetails" xlink:type="simple" xlink:href="cnmd-20230331.xsd#ComprehensiveIncomeDetails"/>
  <link:presentationLink xlink:role="http://www.conmed.com/role/ComprehensiveIncomeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_2d113354-cf87-41e7-bd6b-3584f149601e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_ef46365a-51c8-4501-a3d1-e1779c816e1f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_2d113354-cf87-41e7-bd6b-3584f149601e" xlink:to="loc_us-gaap_NetIncomeLoss_ef46365a-51c8-4501-a3d1-e1779c816e1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_d488c5a9-7196-499a-976d-9ef60b15dd7c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_2d113354-cf87-41e7-bd6b-3584f149601e" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_d488c5a9-7196-499a-976d-9ef60b15dd7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_b47bd002-310c-423f-bd43-2573d86d79f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_2d113354-cf87-41e7-bd6b-3584f149601e" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_b47bd002-310c-423f-bd43-2573d86d79f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_6346f787-e281-4935-8646-fb5065fd9c5c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_2d113354-cf87-41e7-bd6b-3584f149601e" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_6346f787-e281-4935-8646-fb5065fd9c5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_e27c32f4-a3e5-4c6b-8d4e-d1b1c794423f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_2d113354-cf87-41e7-bd6b-3584f149601e" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_e27c32f4-a3e5-4c6b-8d4e-d1b1c794423f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax_2628121e-d2ff-43a1-afb6-d17c75f57d3b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_2d113354-cf87-41e7-bd6b-3584f149601e" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax_2628121e-d2ff-43a1-afb6-d17c75f57d3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax_222eea35-9c89-414b-94f1-d573ed11ad9c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_2d113354-cf87-41e7-bd6b-3584f149601e" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax_222eea35-9c89-414b-94f1-d573ed11ad9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.conmed.com/role/ComprehensiveIncomeAccumulatedOtherComprehensiveIncomeLossDetails" xlink:type="simple" xlink:href="cnmd-20230331.xsd#ComprehensiveIncomeAccumulatedOtherComprehensiveIncomeLossDetails"/>
  <link:presentationLink xlink:role="http://www.conmed.com/role/ComprehensiveIncomeAccumulatedOtherComprehensiveIncomeLossDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_22014d31-6f89-4cb4-8842-edfe2cc0ab99" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_1e1f5349-12ba-4713-91a9-0523f539b263" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_22014d31-6f89-4cb4-8842-edfe2cc0ab99" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_1e1f5349-12ba-4713-91a9-0523f539b263" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_eec867f8-ed7f-4062-b68b-c7bbf1fc0ba2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_1e1f5349-12ba-4713-91a9-0523f539b263" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_eec867f8-ed7f-4062-b68b-c7bbf1fc0ba2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_8a6cee34-f238-4603-98e3-9e5690503e3e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_eec867f8-ed7f-4062-b68b-c7bbf1fc0ba2" xlink:to="loc_us-gaap_EquityComponentDomain_8a6cee34-f238-4603-98e3-9e5690503e3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_e5837ec5-e7c2-470b-8486-910d8ae3d433" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_8a6cee34-f238-4603-98e3-9e5690503e3e" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_e5837ec5-e7c2-470b-8486-910d8ae3d433" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember_b8183abc-5809-4567-a1e7-423a5c3319ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_e5837ec5-e7c2-470b-8486-910d8ae3d433" xlink:to="loc_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember_b8183abc-5809-4567-a1e7-423a5c3319ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_ebf5c46e-8822-4dac-8732-7cb657752f1d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_e5837ec5-e7c2-470b-8486-910d8ae3d433" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_ebf5c46e-8822-4dac-8732-7cb657752f1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember_100d4a62-3d45-4a97-8666-6a30037d3fa7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_e5837ec5-e7c2-470b-8486-910d8ae3d433" xlink:to="loc_us-gaap_AccumulatedTranslationAdjustmentMember_100d4a62-3d45-4a97-8666-6a30037d3fa7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_51e50834-6009-41f1-a136-755feecb9138" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_1e1f5349-12ba-4713-91a9-0523f539b263" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_51e50834-6009-41f1-a136-755feecb9138" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_26dc3fe5-6969-447f-9d15-a45049407c0c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AOCIAttributableToParentNetOfTaxRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_51e50834-6009-41f1-a136-755feecb9138" xlink:to="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_26dc3fe5-6969-447f-9d15-a45049407c0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_b3eccf4a-0e16-47fd-a840-719cb44f7baa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_26dc3fe5-6969-447f-9d15-a45049407c0c" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_b3eccf4a-0e16-47fd-a840-719cb44f7baa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_2351e544-81c7-44bd-9847-843d76a34a26" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_26dc3fe5-6969-447f-9d15-a45049407c0c" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_2351e544-81c7-44bd-9847-843d76a34a26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax_610df4da-2d5c-49ee-a1f9-71820bacaa0c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_26dc3fe5-6969-447f-9d15-a45049407c0c" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax_610df4da-2d5c-49ee-a1f9-71820bacaa0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodTax_9b254970-5697-41f8-80ad-c6a456a85f6c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAociCurrentPeriodTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_26dc3fe5-6969-447f-9d15-a45049407c0c" xlink:to="loc_us-gaap_ReclassificationFromAociCurrentPeriodTax_9b254970-5697-41f8-80ad-c6a456a85f6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_6fb9274d-1aea-44a9-853c-0bcae33ae344" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_26dc3fe5-6969-447f-9d15-a45049407c0c" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_6fb9274d-1aea-44a9-853c-0bcae33ae344" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_fb7a2b02-9618-4bd0-accb-6f05c1927157" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_26dc3fe5-6969-447f-9d15-a45049407c0c" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_fb7a2b02-9618-4bd0-accb-6f05c1927157" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.conmed.com/role/FairValueofFinancialInstrumentsAmountsRecordedInandReclassifiedFromAOCIDetails" xlink:type="simple" xlink:href="cnmd-20230331.xsd#FairValueofFinancialInstrumentsAmountsRecordedInandReclassifiedFromAOCIDetails"/>
  <link:presentationLink xlink:role="http://www.conmed.com/role/FairValueofFinancialInstrumentsAmountsRecordedInandReclassifiedFromAOCIDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_c010e410-fad4-4d0d-ac85-5844b10eeeb1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_4d999013-8dd8-4ca9-a55b-69476797fd1b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_c010e410-fad4-4d0d-ac85-5844b10eeeb1" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_4d999013-8dd8-4ca9-a55b-69476797fd1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_8d322d32-9237-47a6-9bc4-26cb48f449c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_4d999013-8dd8-4ca9-a55b-69476797fd1b" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_8d322d32-9237-47a6-9bc4-26cb48f449c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_2c8d3c94-0dc7-4306-88e8-a8c22a400dd4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_8d322d32-9237-47a6-9bc4-26cb48f449c5" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_2c8d3c94-0dc7-4306-88e8-a8c22a400dd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_RevenuesMember_f4de6d40-9bc9-4d53-a80f-a8e8ef642a9d" xlink:href="cnmd-20230331.xsd#cnmd_RevenuesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_2c8d3c94-0dc7-4306-88e8-a8c22a400dd4" xlink:to="loc_cnmd_RevenuesMember_f4de6d40-9bc9-4d53-a80f-a8e8ef642a9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_200cc88f-4f72-4535-8b72-d43b7c9e96f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfSalesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_2c8d3c94-0dc7-4306-88e8-a8c22a400dd4" xlink:to="loc_us-gaap_CostOfSalesMember_200cc88f-4f72-4535-8b72-d43b7c9e96f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_960a2423-a66f-4fd3-9066-87797a33a489" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_4d999013-8dd8-4ca9-a55b-69476797fd1b" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_960a2423-a66f-4fd3-9066-87797a33a489" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_bc400699-e8dd-42a3-8762-23a3d0b04095" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_960a2423-a66f-4fd3-9066-87797a33a489" xlink:to="loc_us-gaap_Revenues_bc400699-e8dd-42a3-8762-23a3d0b04095" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_556ac171-1a54-4d17-a7f3-8fd6403226f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_960a2423-a66f-4fd3-9066-87797a33a489" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_556ac171-1a54-4d17-a7f3-8fd6403226f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_b06dd740-188e-49ca-88d2-df9e63397054" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_960a2423-a66f-4fd3-9066-87797a33a489" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_b06dd740-188e-49ca-88d2-df9e63397054" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax_f32eeb3a-55c1-4cf5-8e51-151d81442ca0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_960a2423-a66f-4fd3-9066-87797a33a489" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax_f32eeb3a-55c1-4cf5-8e51-151d81442ca0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_99ba06a9-cf87-4519-8f4c-c92368b23d67" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_960a2423-a66f-4fd3-9066-87797a33a489" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_99ba06a9-cf87-4519-8f4c-c92368b23d67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_21493511-edad-4ddc-a97c-9fc780bc6369" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_960a2423-a66f-4fd3-9066-87797a33a489" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_21493511-edad-4ddc-a97c-9fc780bc6369" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax_62f8d06e-2f8e-47a8-9bb1-dbf61c0306ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_960a2423-a66f-4fd3-9066-87797a33a489" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax_62f8d06e-2f8e-47a8-9bb1-dbf61c0306ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_7831df53-1aac-4e63-81dd-2c14dc4e4814" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_960a2423-a66f-4fd3-9066-87797a33a489" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_7831df53-1aac-4e63-81dd-2c14dc4e4814" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.conmed.com/role/FairValueofFinancialInstrumentsForeignCurrencyForwardContractsDetails" xlink:type="simple" xlink:href="cnmd-20230331.xsd#FairValueofFinancialInstrumentsForeignCurrencyForwardContractsDetails"/>
  <link:presentationLink xlink:role="http://www.conmed.com/role/FairValueofFinancialInstrumentsForeignCurrencyForwardContractsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_a9410336-5047-4d70-9b15-8c84ececb4ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_5094d8a6-7735-481f-81a0-159393ef71e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_a9410336-5047-4d70-9b15-8c84ececb4ee" xlink:to="loc_us-gaap_DerivativeTable_5094d8a6-7735-481f-81a0-159393ef71e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_73b65725-32cf-4f1d-b76b-ea6c7d39389d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_5094d8a6-7735-481f-81a0-159393ef71e7" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_73b65725-32cf-4f1d-b76b-ea6c7d39389d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_43eed70d-f547-4ce4-8b2c-89c5c96d4a89" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_73b65725-32cf-4f1d-b76b-ea6c7d39389d" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_43eed70d-f547-4ce4-8b2c-89c5c96d4a89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_RevenuesMember_0060033d-3e8d-4265-967d-47e61d9a9b1f" xlink:href="cnmd-20230331.xsd#cnmd_RevenuesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_43eed70d-f547-4ce4-8b2c-89c5c96d4a89" xlink:to="loc_cnmd_RevenuesMember_0060033d-3e8d-4265-967d-47e61d9a9b1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_0ece70f9-73c3-4881-ac8d-743b75d2051f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfSalesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_43eed70d-f547-4ce4-8b2c-89c5c96d4a89" xlink:to="loc_us-gaap_CostOfSalesMember_0ece70f9-73c3-4881-ac8d-743b75d2051f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_c51a6ac6-1dc0-4f3e-8beb-a2e8c3e29f80" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_5094d8a6-7735-481f-81a0-159393ef71e7" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_c51a6ac6-1dc0-4f3e-8beb-a2e8c3e29f80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_6c34ed98-7997-477e-96a0-588559d1075f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_c51a6ac6-1dc0-4f3e-8beb-a2e8c3e29f80" xlink:to="loc_us-gaap_EquityComponentDomain_6c34ed98-7997-477e-96a0-588559d1075f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember_2ae4ee0a-6812-453c-a7b9-8cc6afbb1cbb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_6c34ed98-7997-477e-96a0-588559d1075f" xlink:to="loc_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember_2ae4ee0a-6812-453c-a7b9-8cc6afbb1cbb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_e8c72310-af4a-4a00-abb9-ae8a8dd675ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_5094d8a6-7735-481f-81a0-159393ef71e7" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_e8c72310-af4a-4a00-abb9-ae8a8dd675ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_5364e265-5fe3-4f59-9e8c-42d4a89f07ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_e8c72310-af4a-4a00-abb9-ae8a8dd675ed" xlink:to="loc_us-gaap_HedgingRelationshipDomain_5364e265-5fe3-4f59-9e8c-42d4a89f07ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_803a077a-9118-4550-b873-cdee737919d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_5364e265-5fe3-4f59-9e8c-42d4a89f07ad" xlink:to="loc_us-gaap_CashFlowHedgingMember_803a077a-9118-4550-b873-cdee737919d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_7d3f9e0d-2e53-4d07-a4ec-51493a3826e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NondesignatedMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_5364e265-5fe3-4f59-9e8c-42d4a89f07ad" xlink:to="loc_us-gaap_NondesignatedMember_7d3f9e0d-2e53-4d07-a4ec-51493a3826e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_d50fae78-2b42-44c1-83a3-6367a6b8bb52" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_5094d8a6-7735-481f-81a0-159393ef71e7" xlink:to="loc_us-gaap_HedgingDesignationAxis_d50fae78-2b42-44c1-83a3-6367a6b8bb52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_cf50b913-c806-4c58-9b30-4c9a5c19fbfd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_d50fae78-2b42-44c1-83a3-6367a6b8bb52" xlink:to="loc_us-gaap_HedgingDesignationDomain_cf50b913-c806-4c58-9b30-4c9a5c19fbfd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_fee19d30-9eee-46bb-a395-4b1707aa4114" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_cf50b913-c806-4c58-9b30-4c9a5c19fbfd" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_fee19d30-9eee-46bb-a395-4b1707aa4114" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_93c7d28b-26e3-4cde-b553-1a1226ae3049" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NondesignatedMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_cf50b913-c806-4c58-9b30-4c9a5c19fbfd" xlink:to="loc_us-gaap_NondesignatedMember_93c7d28b-26e3-4cde-b553-1a1226ae3049" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_c0490205-1507-4576-8c2c-286cb956cce7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_5094d8a6-7735-481f-81a0-159393ef71e7" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_c0490205-1507-4576-8c2c-286cb956cce7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_9fed3f46-7c7e-4f70-b96a-f26b2ff63715" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_c0490205-1507-4576-8c2c-286cb956cce7" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_9fed3f46-7c7e-4f70-b96a-f26b2ff63715" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember_1a974c80-75e1-4bf6-aba8-81e20a84f66c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_9fed3f46-7c7e-4f70-b96a-f26b2ff63715" xlink:to="loc_us-gaap_ForeignExchangeForwardMember_1a974c80-75e1-4bf6-aba8-81e20a84f66c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_cdb84b49-d648-4e4e-b446-28523a2f5f9f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_5094d8a6-7735-481f-81a0-159393ef71e7" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_cdb84b49-d648-4e4e-b446-28523a2f5f9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_e7d551fd-5d63-41b7-8d9d-f6ca9187af6c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_cdb84b49-d648-4e4e-b446-28523a2f5f9f" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_e7d551fd-5d63-41b7-8d9d-f6ca9187af6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_1c4275e7-31bc-47ed-976e-e8640d8919e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_e7d551fd-5d63-41b7-8d9d-f6ca9187af6c" xlink:to="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_1c4275e7-31bc-47ed-976e-e8640d8919e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember_7c99203d-51ea-4808-ac77-1d4fff2cbb91" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_e7d551fd-5d63-41b7-8d9d-f6ca9187af6c" xlink:to="loc_us-gaap_OtherNoncurrentLiabilitiesMember_7c99203d-51ea-4808-ac77-1d4fff2cbb91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember_b419c42f-0b7b-4849-b8f3-aa9960d73539" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCurrentLiabilitiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_e7d551fd-5d63-41b7-8d9d-f6ca9187af6c" xlink:to="loc_us-gaap_OtherCurrentLiabilitiesMember_b419c42f-0b7b-4849-b8f3-aa9960d73539" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentAssetsMember_d2cc0d2d-318e-4182-85cd-031211a5795e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncurrentAssetsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_e7d551fd-5d63-41b7-8d9d-f6ca9187af6c" xlink:to="loc_us-gaap_OtherNoncurrentAssetsMember_d2cc0d2d-318e-4182-85cd-031211a5795e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_409d6bc2-4738-431a-90b4-ed2875dbef97" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLineItems"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_5094d8a6-7735-481f-81a0-159393ef71e7" xlink:to="loc_us-gaap_DerivativeLineItems_409d6bc2-4738-431a-90b4-ed2875dbef97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MaximumLengthOfTimeHedgedInCashFlowHedge1_4d939dff-1c24-46f7-a815-ebf644274347" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MaximumLengthOfTimeHedgedInCashFlowHedge1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_409d6bc2-4738-431a-90b4-ed2875dbef97" xlink:to="loc_us-gaap_MaximumLengthOfTimeHedgedInCashFlowHedge1_4d939dff-1c24-46f7-a815-ebf644274347" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_d4997587-0eb4-4c16-9bda-a62ad02012f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_409d6bc2-4738-431a-90b4-ed2875dbef97" xlink:to="loc_us-gaap_DerivativeNotionalAmount_d4997587-0eb4-4c16-9bda-a62ad02012f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months_7a50f9b7-4168-4bf4-a910-f73c9fa98501" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_409d6bc2-4738-431a-90b4-ed2875dbef97" xlink:to="loc_us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months_7a50f9b7-4168-4bf4-a910-f73c9fa98501" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments_9c4b44e3-9de2-40a6-8b5e-4750a7f59203" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_409d6bc2-4738-431a-90b4-ed2875dbef97" xlink:to="loc_us-gaap_GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments_9c4b44e3-9de2-40a6-8b5e-4750a7f59203" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_a59b271f-cbb8-4b35-944c-0b6c3764957a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_409d6bc2-4738-431a-90b4-ed2875dbef97" xlink:to="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_a59b271f-cbb8-4b35-944c-0b6c3764957a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNetByBalanceSheetClassificationAbstract_3ac5ec80-499d-48e2-aee5-94b695aed1bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssetsLiabilitiesAtFairValueNetByBalanceSheetClassificationAbstract"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_409d6bc2-4738-431a-90b4-ed2875dbef97" xlink:to="loc_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNetByBalanceSheetClassificationAbstract_3ac5ec80-499d-48e2-aee5-94b695aed1bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_d69bfdf3-626b-4d21-bfd2-d757aa6c5223" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNetByBalanceSheetClassificationAbstract_3ac5ec80-499d-48e2-aee5-94b695aed1bf" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_d69bfdf3-626b-4d21-bfd2-d757aa6c5223" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_de22f067-25d4-42dc-a92b-ff9c3fde402e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNetByBalanceSheetClassificationAbstract_3ac5ec80-499d-48e2-aee5-94b695aed1bf" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_de22f067-25d4-42dc-a92b-ff9c3fde402e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet_da34a15b-fa8b-4ab7-bc20-5e6f2dbfbb62" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNetByBalanceSheetClassificationAbstract_3ac5ec80-499d-48e2-aee5-94b695aed1bf" xlink:to="loc_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet_da34a15b-fa8b-4ab7-bc20-5e6f2dbfbb62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.conmed.com/role/FairValueofFinancialInstrumentsContingentConsiderationDetails" xlink:type="simple" xlink:href="cnmd-20230331.xsd#FairValueofFinancialInstrumentsContingentConsiderationDetails"/>
  <link:presentationLink xlink:role="http://www.conmed.com/role/FairValueofFinancialInstrumentsContingentConsiderationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_f004b1c5-c8ac-48d6-8a50-5153e22b973f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_aeed961c-49ed-42d2-ad22-0cbca90be9fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_f004b1c5-c8ac-48d6-8a50-5153e22b973f" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_aeed961c-49ed-42d2-ad22-0cbca90be9fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_3675b602-20a1-4b17-bda5-d7c369dbf094" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_aeed961c-49ed-42d2-ad22-0cbca90be9fb" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_3675b602-20a1-4b17-bda5-d7c369dbf094" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9fa1afe3-1550-4ed0-9349-88c9976de23a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_3675b602-20a1-4b17-bda5-d7c369dbf094" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9fa1afe3-1550-4ed0-9349-88c9976de23a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_In2BonesGlobalIncMember_a1939afd-0f7d-48ed-a76d-d407bfae9c4c" xlink:href="cnmd-20230331.xsd#cnmd_In2BonesGlobalIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9fa1afe3-1550-4ed0-9349-88c9976de23a" xlink:to="loc_cnmd_In2BonesGlobalIncMember_a1939afd-0f7d-48ed-a76d-d407bfae9c4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_BiorezIncMember_c5725769-0b52-44ee-9a38-fc57fb76e3da" xlink:href="cnmd-20230331.xsd#cnmd_BiorezIncMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9fa1afe3-1550-4ed0-9349-88c9976de23a" xlink:to="loc_cnmd_BiorezIncMember_c5725769-0b52-44ee-9a38-fc57fb76e3da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_54f6a094-dd96-4702-af7d-ac756593bcb6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_aeed961c-49ed-42d2-ad22-0cbca90be9fb" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_54f6a094-dd96-4702-af7d-ac756593bcb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_d2968b1d-1eaf-4fa7-b66b-3ca9ad21b0eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_54f6a094-dd96-4702-af7d-ac756593bcb6" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_d2968b1d-1eaf-4fa7-b66b-3ca9ad21b0eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_b051e87d-5bf8-41ab-9aa2-7dd5141d66f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_d2968b1d-1eaf-4fa7-b66b-3ca9ad21b0eb" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_b051e87d-5bf8-41ab-9aa2-7dd5141d66f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_348178e0-fa86-4e75-a519-eddcc820f96c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_aeed961c-49ed-42d2-ad22-0cbca90be9fb" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_348178e0-fa86-4e75-a519-eddcc820f96c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_ff47724b-59ab-41e4-b51d-90f527b1219b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_348178e0-fa86-4e75-a519-eddcc820f96c" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_ff47724b-59ab-41e4-b51d-90f527b1219b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_a6247226-5761-42dd-b41a-eddde4accf77" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_ff47724b-59ab-41e4-b51d-90f527b1219b" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_a6247226-5761-42dd-b41a-eddde4accf77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis_3e80c63a-461b-4f0f-9502-6d0ac6c45da8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_aeed961c-49ed-42d2-ad22-0cbca90be9fb" xlink:to="loc_us-gaap_MeasurementInputTypeAxis_3e80c63a-461b-4f0f-9502-6d0ac6c45da8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_3fe66160-6d91-42bc-8437-151813cd569a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_3e80c63a-461b-4f0f-9502-6d0ac6c45da8" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_3fe66160-6d91-42bc-8437-151813cd569a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputDiscountRateMember_8d1771d9-9380-4414-96f6-9c71a38587f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputDiscountRateMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_3fe66160-6d91-42bc-8437-151813cd569a" xlink:to="loc_us-gaap_MeasurementInputDiscountRateMember_8d1771d9-9380-4414-96f6-9c71a38587f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_MeasurementInputRevenueVolatilityMember_29d304f8-ac54-47dd-9f26-c8cda75e28d1" xlink:href="cnmd-20230331.xsd#cnmd_MeasurementInputRevenueVolatilityMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_3fe66160-6d91-42bc-8437-151813cd569a" xlink:to="loc_cnmd_MeasurementInputRevenueVolatilityMember_29d304f8-ac54-47dd-9f26-c8cda75e28d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_dad08938-1520-4212-b865-6c9cce6d9f7d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionContingentConsiderationLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_aeed961c-49ed-42d2-ad22-0cbca90be9fb" xlink:to="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_dad08938-1520-4212-b865-6c9cce6d9f7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_BusinessAcquisitionContingentConsiderationAtFairValueRollForwardRollForward_1d6f41bf-f46e-4433-bd79-0813589e4b21" xlink:href="cnmd-20230331.xsd#cnmd_BusinessAcquisitionContingentConsiderationAtFairValueRollForwardRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_dad08938-1520-4212-b865-6c9cce6d9f7d" xlink:to="loc_cnmd_BusinessAcquisitionContingentConsiderationAtFairValueRollForwardRollForward_1d6f41bf-f46e-4433-bd79-0813589e4b21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_2c3ab08e-0b0f-4788-b95f-5877282c8cc2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cnmd_BusinessAcquisitionContingentConsiderationAtFairValueRollForwardRollForward_1d6f41bf-f46e-4433-bd79-0813589e4b21" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_2c3ab08e-0b0f-4788-b95f-5877282c8cc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_0946fbb7-357f-41ca-bbe9-8bf77ae6852f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cnmd_BusinessAcquisitionContingentConsiderationAtFairValueRollForwardRollForward_1d6f41bf-f46e-4433-bd79-0813589e4b21" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_0946fbb7-357f-41ca-bbe9-8bf77ae6852f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_0992a3ac-8af9-4183-bc74-9f5f819083b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cnmd_BusinessAcquisitionContingentConsiderationAtFairValueRollForwardRollForward_1d6f41bf-f46e-4433-bd79-0813589e4b21" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_0992a3ac-8af9-4183-bc74-9f5f819083b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_e45b807f-4f03-4d0e-a97a-9f1b6fd3680b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_dad08938-1520-4212-b865-6c9cce6d9f7d" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_e45b807f-4f03-4d0e-a97a-9f1b6fd3680b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_7921598c-6dae-4072-bf28-9694830fbcdb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_dad08938-1520-4212-b865-6c9cce6d9f7d" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_7921598c-6dae-4072-bf28-9694830fbcdb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_48c62153-fae4-4732-a62c-8976f3d001fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_dad08938-1520-4212-b865-6c9cce6d9f7d" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_48c62153-fae4-4732-a62c-8976f3d001fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.conmed.com/role/InventoriesDetails" xlink:type="simple" xlink:href="cnmd-20230331.xsd#InventoriesDetails"/>
  <link:presentationLink xlink:role="http://www.conmed.com/role/InventoriesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract_538de06d-4bc0-4efc-b097-12c9c537bf7b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves_c899cf75-b504-419a-8626-7f69705c28bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_538de06d-4bc0-4efc-b097-12c9c537bf7b" xlink:to="loc_us-gaap_InventoryRawMaterialsNetOfReserves_c899cf75-b504-419a-8626-7f69705c28bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves_0ce4a6b1-9572-4f5a-a2e0-967096664a10" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_538de06d-4bc0-4efc-b097-12c9c537bf7b" xlink:to="loc_us-gaap_InventoryWorkInProcessNetOfReserves_0ce4a6b1-9572-4f5a-a2e0-967096664a10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_804a68f6-f710-48fa-81d7-4beda149842d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_538de06d-4bc0-4efc-b097-12c9c537bf7b" xlink:to="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_804a68f6-f710-48fa-81d7-4beda149842d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_2c35da48-998d-4042-8911-d2c2f3359f34" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_538de06d-4bc0-4efc-b097-12c9c537bf7b" xlink:to="loc_us-gaap_InventoryNet_2c35da48-998d-4042-8911-d2c2f3359f34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.conmed.com/role/EarningsPerShareDetails" xlink:type="simple" xlink:href="cnmd-20230331.xsd#EarningsPerShareDetails"/>
  <link:presentationLink xlink:role="http://www.conmed.com/role/EarningsPerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_f36f263f-674c-4c7c-8c8b-db929216aa03" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_74b26a31-04c7-4f45-a41c-1b243d0a168a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_f36f263f-674c-4c7c-8c8b-db929216aa03" xlink:to="loc_us-gaap_NetIncomeLoss_74b26a31-04c7-4f45-a41c-1b243d0a168a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestOnConvertibleDebtNetOfTax_94a4a7af-70ce-4aab-9734-e46aa9af3d99" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestOnConvertibleDebtNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_f36f263f-674c-4c7c-8c8b-db929216aa03" xlink:to="loc_us-gaap_InterestOnConvertibleDebtNetOfTax_94a4a7af-70ce-4aab-9734-e46aa9af3d99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_702e5ac1-df80-481d-88ce-85d73c8a2a30" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_f36f263f-674c-4c7c-8c8b-db929216aa03" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_702e5ac1-df80-481d-88ce-85d73c8a2a30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_9ae26ba3-e834-4035-9ad9-6f17ece0cf7d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_f36f263f-674c-4c7c-8c8b-db929216aa03" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_9ae26ba3-e834-4035-9ad9-6f17ece0cf7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_9341011a-d8f0-4eb0-a20c-425d500de999" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_f36f263f-674c-4c7c-8c8b-db929216aa03" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_9341011a-d8f0-4eb0-a20c-425d500de999" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants_e5c82305-2a29-4e70-8c62-266fada13398" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_f36f263f-674c-4c7c-8c8b-db929216aa03" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants_e5c82305-2a29-4e70-8c62-266fada13398" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities_5e2c419b-d076-4020-9407-2c0bdb6c3386" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_f36f263f-674c-4c7c-8c8b-db929216aa03" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities_5e2c419b-d076-4020-9407-2c0bdb6c3386" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_ee935609-8b94-4d01-b732-01dfcc258d31" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_f36f263f-674c-4c7c-8c8b-db929216aa03" xlink:to="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_ee935609-8b94-4d01-b732-01dfcc258d31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_9e47cf5a-1fd9-4a70-899b-cd56cfe1a0d5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_f36f263f-674c-4c7c-8c8b-db929216aa03" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_9e47cf5a-1fd9-4a70-899b-cd56cfe1a0d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_b5d1f0da-f499-41eb-93e4-b12197597395" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_f36f263f-674c-4c7c-8c8b-db929216aa03" xlink:to="loc_us-gaap_EarningsPerShareBasic_b5d1f0da-f499-41eb-93e4-b12197597395" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_763a552f-1702-44a0-b968-320405226adc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_f36f263f-674c-4c7c-8c8b-db929216aa03" xlink:to="loc_us-gaap_EarningsPerShareDiluted_763a552f-1702-44a0-b968-320405226adc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_cf5d5007-9f8a-473c-9de1-75d56a55db42" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_f36f263f-674c-4c7c-8c8b-db929216aa03" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_cf5d5007-9f8a-473c-9de1-75d56a55db42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.conmed.com/role/GoodwillandOtherIntangibleAssetsGoodwillDetails" xlink:type="simple" xlink:href="cnmd-20230331.xsd#GoodwillandOtherIntangibleAssetsGoodwillDetails"/>
  <link:presentationLink xlink:role="http://www.conmed.com/role/GoodwillandOtherIntangibleAssetsGoodwillDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_25f3467e-3d92-4d56-b557-f28183f346ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_f132e840-0aaa-475b-a129-8f4ef3f34a30" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_25f3467e-3d92-4d56-b557-f28183f346ea" xlink:to="loc_us-gaap_GoodwillRollForward_f132e840-0aaa-475b-a129-8f4ef3f34a30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_f2fb513b-b919-47de-911d-7ad584ea27d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_f132e840-0aaa-475b-a129-8f4ef3f34a30" xlink:to="loc_us-gaap_Goodwill_f2fb513b-b919-47de-911d-7ad584ea27d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_d19ff7d1-7bf4-4066-882e-e0c73e421c50" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillForeignCurrencyTranslationGainLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_f132e840-0aaa-475b-a129-8f4ef3f34a30" xlink:to="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_d19ff7d1-7bf4-4066-882e-e0c73e421c50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_205968aa-6f1d-4cee-b07f-23f245a9ce4e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_f132e840-0aaa-475b-a129-8f4ef3f34a30" xlink:to="loc_us-gaap_Goodwill_205968aa-6f1d-4cee-b07f-23f245a9ce4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_07dfbd8e-1da2-4ce3-b3e1-5081fdd09400" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_25f3467e-3d92-4d56-b557-f28183f346ea" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_07dfbd8e-1da2-4ce3-b3e1-5081fdd09400" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_0b92c0ec-aba6-4293-a1a8-34bddc6684a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_07dfbd8e-1da2-4ce3-b3e1-5081fdd09400" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_0b92c0ec-aba6-4293-a1a8-34bddc6684a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b7ffd1bc-f446-4e2b-80a4-3827c8ef0582" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_0b92c0ec-aba6-4293-a1a8-34bddc6684a1" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b7ffd1bc-f446-4e2b-80a4-3827c8ef0582" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_In2BonesGlobalIncMember_b309ec37-1914-4434-9fcc-2e9cfa8601b2" xlink:href="cnmd-20230331.xsd#cnmd_In2BonesGlobalIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b7ffd1bc-f446-4e2b-80a4-3827c8ef0582" xlink:to="loc_cnmd_In2BonesGlobalIncMember_b309ec37-1914-4434-9fcc-2e9cfa8601b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_BiorezIncMember_1634ead4-9967-424e-ade6-f5404d94be4a" xlink:href="cnmd-20230331.xsd#cnmd_BiorezIncMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b7ffd1bc-f446-4e2b-80a4-3827c8ef0582" xlink:to="loc_cnmd_BiorezIncMember_1634ead4-9967-424e-ade6-f5404d94be4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_67f8e162-3a52-4c0d-bb05-818d7b814004" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_07dfbd8e-1da2-4ce3-b3e1-5081fdd09400" xlink:to="loc_us-gaap_GoodwillLineItems_67f8e162-3a52-4c0d-bb05-818d7b814004" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_5068a10a-af95-4772-99ac-d107edca1286" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_67f8e162-3a52-4c0d-bb05-818d7b814004" xlink:to="loc_us-gaap_Goodwill_5068a10a-af95-4772-99ac-d107edca1286" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.conmed.com/role/GoodwillandOtherIntangibleAssetsIntangibleAssetsDetails" xlink:type="simple" xlink:href="cnmd-20230331.xsd#GoodwillandOtherIntangibleAssetsIntangibleAssetsDetails"/>
  <link:presentationLink xlink:role="http://www.conmed.com/role/GoodwillandOtherIntangibleAssetsIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_75a4ec40-9d3a-4e94-8562-eb599dfca4a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_ScheduleOfFiniteLivedAndIndefiniteLivedAssetsTable_a2c62297-1f69-4c12-8dcb-c6f5270112dc" xlink:href="cnmd-20230331.xsd#cnmd_ScheduleOfFiniteLivedAndIndefiniteLivedAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_75a4ec40-9d3a-4e94-8562-eb599dfca4a7" xlink:to="loc_cnmd_ScheduleOfFiniteLivedAndIndefiniteLivedAssetsTable_a2c62297-1f69-4c12-8dcb-c6f5270112dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_20c6acb1-6f4a-434f-a568-abebd2a48c9b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cnmd_ScheduleOfFiniteLivedAndIndefiniteLivedAssetsTable_a2c62297-1f69-4c12-8dcb-c6f5270112dc" xlink:to="loc_srt_RangeAxis_20c6acb1-6f4a-434f-a568-abebd2a48c9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_151fdc61-2e15-447f-9cef-2b7f7c735f47" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_20c6acb1-6f4a-434f-a568-abebd2a48c9b" xlink:to="loc_srt_RangeMember_151fdc61-2e15-447f-9cef-2b7f7c735f47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_WeightedAverageMember_e227afdf-e0e5-4c51-945a-aaf3e6415204" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_WeightedAverageMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_151fdc61-2e15-447f-9cef-2b7f7c735f47" xlink:to="loc_srt_WeightedAverageMember_e227afdf-e0e5-4c51-945a-aaf3e6415204" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_19d2c225-7f8b-4f08-8661-ef431634aada" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cnmd_ScheduleOfFiniteLivedAndIndefiniteLivedAssetsTable_a2c62297-1f69-4c12-8dcb-c6f5270112dc" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_19d2c225-7f8b-4f08-8661-ef431634aada" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b02c3bae-9279-4ee8-99e3-c7118630c70f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_19d2c225-7f8b-4f08-8661-ef431634aada" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b02c3bae-9279-4ee8-99e3-c7118630c70f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_CustomerandDistributorRelationshipsMember_267f682a-6be4-4e46-891f-9fcdecd366a5" xlink:href="cnmd-20230331.xsd#cnmd_CustomerandDistributorRelationshipsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b02c3bae-9279-4ee8-99e3-c7118630c70f" xlink:to="loc_cnmd_CustomerandDistributorRelationshipsMember_267f682a-6be4-4e46-891f-9fcdecd366a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_SalesrepresentationmarketingandpromotionalrightsMember_34865e2c-0611-4a34-8428-54c681ea8477" xlink:href="cnmd-20230331.xsd#cnmd_SalesrepresentationmarketingandpromotionalrightsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b02c3bae-9279-4ee8-99e3-c7118630c70f" xlink:to="loc_cnmd_SalesrepresentationmarketingandpromotionalrightsMember_34865e2c-0611-4a34-8428-54c681ea8477" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_a1cbc499-7a82-405a-b038-fbf423e5d96b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b02c3bae-9279-4ee8-99e3-c7118630c70f" xlink:to="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_a1cbc499-7a82-405a-b038-fbf423e5d96b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_PatentsAndOtherIntangibleAssetsMember_eec0ee5a-0fb2-4aa5-af9b-ea6543d01436" xlink:href="cnmd-20230331.xsd#cnmd_PatentsAndOtherIntangibleAssetsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b02c3bae-9279-4ee8-99e3-c7118630c70f" xlink:to="loc_cnmd_PatentsAndOtherIntangibleAssetsMember_eec0ee5a-0fb2-4aa5-af9b-ea6543d01436" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_0e1d3310-021b-46aa-8d02-ea3286196b2a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cnmd_ScheduleOfFiniteLivedAndIndefiniteLivedAssetsTable_a2c62297-1f69-4c12-8dcb-c6f5270112dc" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_0e1d3310-021b-46aa-8d02-ea3286196b2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_04a2cab7-4efe-4276-b122-246bad197bb0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_0e1d3310-021b-46aa-8d02-ea3286196b2a" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_04a2cab7-4efe-4276-b122-246bad197bb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksAndTradeNamesMember_db673ad5-21ab-4e6c-b491-00de5c9188b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TrademarksAndTradeNamesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_04a2cab7-4efe-4276-b122-246bad197bb0" xlink:to="loc_us-gaap_TrademarksAndTradeNamesMember_db673ad5-21ab-4e6c-b491-00de5c9188b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_4cee2229-f13d-4151-bb48-4db1fa7132fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cnmd_ScheduleOfFiniteLivedAndIndefiniteLivedAssetsTable_a2c62297-1f69-4c12-8dcb-c6f5270112dc" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_4cee2229-f13d-4151-bb48-4db1fa7132fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_a6bec311-b65f-483e-87b7-4c8a586d84a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_4cee2229-f13d-4151-bb48-4db1fa7132fb" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_a6bec311-b65f-483e-87b7-4c8a586d84a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_ExpenseMember_61c005ec-3346-4f14-a9b4-0dc4a6f2a3c1" xlink:href="cnmd-20230331.xsd#cnmd_ExpenseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_a6bec311-b65f-483e-87b7-4c8a586d84a4" xlink:to="loc_cnmd_ExpenseMember_61c005ec-3346-4f14-a9b4-0dc4a6f2a3c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_ReductionofRevenueMember_935ed502-ebac-4cf8-beb2-5a3f1032778a" xlink:href="cnmd-20230331.xsd#cnmd_ReductionofRevenueMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_a6bec311-b65f-483e-87b7-4c8a586d84a4" xlink:to="loc_cnmd_ReductionofRevenueMember_935ed502-ebac-4cf8-beb2-5a3f1032778a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_ScheduleOfFiniteLivedAndIndefiniteLivedAssetsLineItems_45ac5c59-8c5e-43e2-9714-d7d0e9431ff2" xlink:href="cnmd-20230331.xsd#cnmd_ScheduleOfFiniteLivedAndIndefiniteLivedAssetsLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cnmd_ScheduleOfFiniteLivedAndIndefiniteLivedAssetsTable_a2c62297-1f69-4c12-8dcb-c6f5270112dc" xlink:to="loc_cnmd_ScheduleOfFiniteLivedAndIndefiniteLivedAssetsLineItems_45ac5c59-8c5e-43e2-9714-d7d0e9431ff2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_51d52f30-598d-4899-bac2-814b9a129051" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cnmd_ScheduleOfFiniteLivedAndIndefiniteLivedAssetsLineItems_45ac5c59-8c5e-43e2-9714-d7d0e9431ff2" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_51d52f30-598d-4899-bac2-814b9a129051" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_93b1f670-b82b-4acd-815e-51a38b1e7b67" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cnmd_ScheduleOfFiniteLivedAndIndefiniteLivedAssetsLineItems_45ac5c59-8c5e-43e2-9714-d7d0e9431ff2" xlink:to="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_93b1f670-b82b-4acd-815e-51a38b1e7b67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_801711fe-7dea-44c5-b1a2-74447bab3c3d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cnmd_ScheduleOfFiniteLivedAndIndefiniteLivedAssetsLineItems_45ac5c59-8c5e-43e2-9714-d7d0e9431ff2" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_801711fe-7dea-44c5-b1a2-74447bab3c3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_c2efdd89-a18e-40b1-8ce6-03a0fab47c24" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cnmd_ScheduleOfFiniteLivedAndIndefiniteLivedAssetsLineItems_45ac5c59-8c5e-43e2-9714-d7d0e9431ff2" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_c2efdd89-a18e-40b1-8ce6-03a0fab47c24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_abc11ac4-020a-46aa-a611-1c42a8508e29" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cnmd_ScheduleOfFiniteLivedAndIndefiniteLivedAssetsLineItems_45ac5c59-8c5e-43e2-9714-d7d0e9431ff2" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_abc11ac4-020a-46aa-a611-1c42a8508e29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_39ffa0ee-cd3d-45f4-a2b6-21babb0850b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cnmd_ScheduleOfFiniteLivedAndIndefiniteLivedAssetsLineItems_45ac5c59-8c5e-43e2-9714-d7d0e9431ff2" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_39ffa0ee-cd3d-45f4-a2b6-21babb0850b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_c9b8040b-369b-4873-9606-cddb5bbc1c60" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cnmd_ScheduleOfFiniteLivedAndIndefiniteLivedAssetsLineItems_45ac5c59-8c5e-43e2-9714-d7d0e9431ff2" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_c9b8040b-369b-4873-9606-cddb5bbc1c60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_89307bf6-917f-4672-afe2-132aed28abb8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_c9b8040b-369b-4873-9606-cddb5bbc1c60" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_89307bf6-917f-4672-afe2-132aed28abb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_7c4627f3-f6fa-407d-953b-e44ef89f6fa7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_c9b8040b-369b-4873-9606-cddb5bbc1c60" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_7c4627f3-f6fa-407d-953b-e44ef89f6fa7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_a444e54f-2cc2-4684-ab55-e027f26c871a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_c9b8040b-369b-4873-9606-cddb5bbc1c60" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_a444e54f-2cc2-4684-ab55-e027f26c871a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_980ab7e4-dde4-4f1b-9f0d-17f64287c672" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_c9b8040b-369b-4873-9606-cddb5bbc1c60" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_980ab7e4-dde4-4f1b-9f0d-17f64287c672" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_cc58178b-93c6-48d2-96a1-c0f794c16421" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_c9b8040b-369b-4873-9606-cddb5bbc1c60" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_cc58178b-93c6-48d2-96a1-c0f794c16421" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_e7117b55-124a-4684-b7dc-a5d46554a256" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_c9b8040b-369b-4873-9606-cddb5bbc1c60" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_e7117b55-124a-4684-b7dc-a5d46554a256" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.conmed.com/role/LongTermDebtDetails" xlink:type="simple" xlink:href="cnmd-20230331.xsd#LongTermDebtDetails"/>
  <link:presentationLink xlink:role="http://www.conmed.com/role/LongTermDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_897186fd-6e31-404f-9668-876f554df2e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_59edb598-09e2-407e-a6ba-2a38b0597ce1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_897186fd-6e31-404f-9668-876f554df2e8" xlink:to="loc_us-gaap_DebtInstrumentTable_59edb598-09e2-407e-a6ba-2a38b0597ce1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_798a0692-1b2d-41d9-b9a9-902d430f90f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_59edb598-09e2-407e-a6ba-2a38b0597ce1" xlink:to="loc_us-gaap_DebtInstrumentAxis_798a0692-1b2d-41d9-b9a9-902d430f90f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_9ca6525c-0ed4-40b6-bd94-06b964c094ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_798a0692-1b2d-41d9-b9a9-902d430f90f8" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_9ca6525c-0ed4-40b6-bd94-06b964c094ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_AmendedAndRestatedSeniorCreditAgreementMember_4b684be2-32cb-430d-9a36-08ab9f3b1c12" xlink:href="cnmd-20230331.xsd#cnmd_AmendedAndRestatedSeniorCreditAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9ca6525c-0ed4-40b6-bd94-06b964c094ba" xlink:to="loc_cnmd_AmendedAndRestatedSeniorCreditAgreementMember_4b684be2-32cb-430d-9a36-08ab9f3b1c12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_A2.625PercentConvertibleNotesDue2024Member_b0052c1c-bc51-4226-a11b-acbb54937e54" xlink:href="cnmd-20230331.xsd#cnmd_A2.625PercentConvertibleNotesDue2024Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9ca6525c-0ed4-40b6-bd94-06b964c094ba" xlink:to="loc_cnmd_A2.625PercentConvertibleNotesDue2024Member_b0052c1c-bc51-4226-a11b-acbb54937e54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_A2250PercentConvertibleNotesDue2027Member_3dd0c15d-9507-4910-bd80-cd69362e28e3" xlink:href="cnmd-20230331.xsd#cnmd_A2250PercentConvertibleNotesDue2027Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9ca6525c-0ed4-40b6-bd94-06b964c094ba" xlink:to="loc_cnmd_A2250PercentConvertibleNotesDue2027Member_3dd0c15d-9507-4910-bd80-cd69362e28e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_996d857e-3046-49c7-b8f0-07d70b6e4741" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_59edb598-09e2-407e-a6ba-2a38b0597ce1" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_996d857e-3046-49c7-b8f0-07d70b6e4741" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_287f5722-c2b8-4602-b706-76ccf5a3d49d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_996d857e-3046-49c7-b8f0-07d70b6e4741" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_287f5722-c2b8-4602-b706-76ccf5a3d49d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_590fdeda-eeba-40a2-980c-95eb7d4b7acb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_287f5722-c2b8-4602-b706-76ccf5a3d49d" xlink:to="loc_us-gaap_LineOfCreditMember_590fdeda-eeba-40a2-980c-95eb7d4b7acb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansPayableMember_a05fe3a8-e06d-417a-b819-d1652695e979" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LoansPayableMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_287f5722-c2b8-4602-b706-76ccf5a3d49d" xlink:to="loc_us-gaap_LoansPayableMember_a05fe3a8-e06d-417a-b819-d1652695e979" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleNotesPayableMember_4f9fdbf1-8625-4b24-95e4-8ff3d54dfe8b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertibleNotesPayableMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_287f5722-c2b8-4602-b706-76ccf5a3d49d" xlink:to="loc_us-gaap_ConvertibleNotesPayableMember_4f9fdbf1-8625-4b24-95e4-8ff3d54dfe8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_e07b63e9-ac99-4ce0-9280-41738d88dcab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_59edb598-09e2-407e-a6ba-2a38b0597ce1" xlink:to="loc_us-gaap_DebtInstrumentLineItems_e07b63e9-ac99-4ce0-9280-41738d88dcab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_42d7de1b-63a9-4803-8c9c-4f004f8471e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_e07b63e9-ac99-4ce0-9280-41738d88dcab" xlink:to="loc_us-gaap_LongTermDebt_42d7de1b-63a9-4803-8c9c-4f004f8471e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebt_878e6133-fb4b-4420-97c3-d23b29e42dc9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertibleDebt"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_e07b63e9-ac99-4ce0-9280-41738d88dcab" xlink:to="loc_us-gaap_ConvertibleDebt_878e6133-fb4b-4420-97c3-d23b29e42dc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_2d64bc02-2316-477d-a8ab-a28e601b061f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_e07b63e9-ac99-4ce0-9280-41738d88dcab" xlink:to="loc_us-gaap_FinanceLeaseLiability_2d64bc02-2316-477d-a8ab-a28e601b061f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities_4e7408f1-c84e-48c3-b6b6-6e5306576e9f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_e07b63e9-ac99-4ce0-9280-41738d88dcab" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities_4e7408f1-c84e-48c3-b6b6-6e5306576e9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_8fef8d73-75a7-4fc1-bfff-6ff91432b699" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_e07b63e9-ac99-4ce0-9280-41738d88dcab" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_8fef8d73-75a7-4fc1-bfff-6ff91432b699" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_59a9c5e1-e634-492b-9c13-6544ef86814d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_e07b63e9-ac99-4ce0-9280-41738d88dcab" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_59a9c5e1-e634-492b-9c13-6544ef86814d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnamortizedDebtIssuanceExpense_b7eb7de8-8e3d-4b7d-a860-f65b706c18ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnamortizedDebtIssuanceExpense"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_e07b63e9-ac99-4ce0-9280-41738d88dcab" xlink:to="loc_us-gaap_UnamortizedDebtIssuanceExpense_b7eb7de8-8e3d-4b7d-a860-f65b706c18ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.conmed.com/role/LongTermDebtAdditionalInformationDetails" xlink:type="simple" xlink:href="cnmd-20230331.xsd#LongTermDebtAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.conmed.com/role/LongTermDebtAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_8745ac7d-376b-4fd8-bfdd-ca125c47cbbd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_cd942d52-7f3d-4182-842d-ee011e9acfa9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_8745ac7d-376b-4fd8-bfdd-ca125c47cbbd" xlink:to="loc_us-gaap_DebtInstrumentTable_cd942d52-7f3d-4182-842d-ee011e9acfa9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OptionIndexedToIssuersEquityTypeAxis_8c349f74-5fb9-41be-bafe-9461c3545d35" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OptionIndexedToIssuersEquityTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_cd942d52-7f3d-4182-842d-ee011e9acfa9" xlink:to="loc_us-gaap_OptionIndexedToIssuersEquityTypeAxis_8c349f74-5fb9-41be-bafe-9461c3545d35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OptionIndexedToIssuersEquityTypeDomain_d7ee1866-eae4-4a1d-8af9-042db760cf18" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OptionIndexedToIssuersEquityTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OptionIndexedToIssuersEquityTypeAxis_8c349f74-5fb9-41be-bafe-9461c3545d35" xlink:to="loc_us-gaap_OptionIndexedToIssuersEquityTypeDomain_d7ee1866-eae4-4a1d-8af9-042db760cf18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CallOptionMember_ddf02b87-6daa-4e77-8e8a-9c148bd5fa79" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CallOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OptionIndexedToIssuersEquityTypeDomain_d7ee1866-eae4-4a1d-8af9-042db760cf18" xlink:to="loc_us-gaap_CallOptionMember_ddf02b87-6daa-4e77-8e8a-9c148bd5fa79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_e6c54d9d-d3a1-4568-90f7-784d1f5137e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_cd942d52-7f3d-4182-842d-ee011e9acfa9" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_e6c54d9d-d3a1-4568-90f7-784d1f5137e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_7aef8a8e-fee9-4658-9566-ff33671241c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_e6c54d9d-d3a1-4568-90f7-784d1f5137e7" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_7aef8a8e-fee9-4658-9566-ff33671241c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansPayableMember_7aa1f2ee-1d55-4223-80c9-d075705eb594" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LoansPayableMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_7aef8a8e-fee9-4658-9566-ff33671241c6" xlink:to="loc_us-gaap_LoansPayableMember_7aa1f2ee-1d55-4223-80c9-d075705eb594" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_32430897-f432-4f98-ab9b-7db9069de972" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_7aef8a8e-fee9-4658-9566-ff33671241c6" xlink:to="loc_us-gaap_LineOfCreditMember_32430897-f432-4f98-ab9b-7db9069de972" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleNotesPayableMember_f8557b88-5138-4e8d-abd0-1f3de108d698" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertibleNotesPayableMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_7aef8a8e-fee9-4658-9566-ff33671241c6" xlink:to="loc_us-gaap_ConvertibleNotesPayableMember_f8557b88-5138-4e8d-abd0-1f3de108d698" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMember_8e89853b-db92-4c87-adbf-517136d8b501" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_7aef8a8e-fee9-4658-9566-ff33671241c6" xlink:to="loc_us-gaap_LongTermDebtMember_8e89853b-db92-4c87-adbf-517136d8b501" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_a9db1273-3b38-4bb4-b23f-808e0d6e9aef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_cd942d52-7f3d-4182-842d-ee011e9acfa9" xlink:to="loc_us-gaap_DebtInstrumentAxis_a9db1273-3b38-4bb4-b23f-808e0d6e9aef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_4eb67f49-9730-4aac-9f98-bf5ade046478" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_a9db1273-3b38-4bb4-b23f-808e0d6e9aef" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_4eb67f49-9730-4aac-9f98-bf5ade046478" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_AmendedAndRestatedSeniorCreditAgreementMember_1b8a657c-3a3e-4b6d-9907-559c3d211bbd" xlink:href="cnmd-20230331.xsd#cnmd_AmendedAndRestatedSeniorCreditAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_4eb67f49-9730-4aac-9f98-bf5ade046478" xlink:to="loc_cnmd_AmendedAndRestatedSeniorCreditAgreementMember_1b8a657c-3a3e-4b6d-9907-559c3d211bbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_A2.625PercentConvertibleNotesDue2024Member_ac547b79-4327-4f29-9ffe-f867807b2763" xlink:href="cnmd-20230331.xsd#cnmd_A2.625PercentConvertibleNotesDue2024Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_4eb67f49-9730-4aac-9f98-bf5ade046478" xlink:to="loc_cnmd_A2.625PercentConvertibleNotesDue2024Member_ac547b79-4327-4f29-9ffe-f867807b2763" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_A2250PercentConvertibleNotesDue2027Member_5a9895b2-8595-49c3-9a53-de8b16a42cbc" xlink:href="cnmd-20230331.xsd#cnmd_A2250PercentConvertibleNotesDue2027Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_4eb67f49-9730-4aac-9f98-bf5ade046478" xlink:to="loc_cnmd_A2250PercentConvertibleNotesDue2027Member_5a9895b2-8595-49c3-9a53-de8b16a42cbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_b917f92f-a719-44e1-92c5-cdbeca1f175c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPeriodAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_cd942d52-7f3d-4182-842d-ee011e9acfa9" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_b917f92f-a719-44e1-92c5-cdbeca1f175c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_cb261e93-a62e-41df-a516-ec09f8e486d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPeriodDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_b917f92f-a719-44e1-92c5-cdbeca1f175c" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_cb261e93-a62e-41df-a516-ec09f8e486d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_IndexedTransactionTypeAxis_3bc13cd1-2c58-42c6-a3b9-00fed73fe3cc" xlink:href="cnmd-20230331.xsd#cnmd_IndexedTransactionTypeAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_cd942d52-7f3d-4182-842d-ee011e9acfa9" xlink:to="loc_cnmd_IndexedTransactionTypeAxis_3bc13cd1-2c58-42c6-a3b9-00fed73fe3cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_IndexedTransactionTypeDomain_c44a172e-dd9e-4ff5-ad91-e2deab9c0771" xlink:href="cnmd-20230331.xsd#cnmd_IndexedTransactionTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cnmd_IndexedTransactionTypeAxis_3bc13cd1-2c58-42c6-a3b9-00fed73fe3cc" xlink:to="loc_cnmd_IndexedTransactionTypeDomain_c44a172e-dd9e-4ff5-ad91-e2deab9c0771" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember_827b2d7c-a8a3-40bb-a0b7-28fef709ed3b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cnmd_IndexedTransactionTypeDomain_c44a172e-dd9e-4ff5-ad91-e2deab9c0771" xlink:to="loc_us-gaap_WarrantMember_827b2d7c-a8a3-40bb-a0b7-28fef709ed3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_e06bfecf-709b-4072-8866-5556cdb1e44b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_cd942d52-7f3d-4182-842d-ee011e9acfa9" xlink:to="loc_us-gaap_VariableRateAxis_e06bfecf-709b-4072-8866-5556cdb1e44b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_ddf7efb4-420e-4dd5-a384-945d63bce834" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateAxis_e06bfecf-709b-4072-8866-5556cdb1e44b" xlink:to="loc_us-gaap_VariableRateDomain_ddf7efb4-420e-4dd5-a384-945d63bce834" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_AdjustedTermSOFRInterestRateMember_900d1efe-49cc-4ef6-9343-382c43079fd8" xlink:href="cnmd-20230331.xsd#cnmd_AdjustedTermSOFRInterestRateMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_ddf7efb4-420e-4dd5-a384-945d63bce834" xlink:to="loc_cnmd_AdjustedTermSOFRInterestRateMember_900d1efe-49cc-4ef6-9343-382c43079fd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FederalFundsEffectiveSwapRateMember_9c9785ae-4ba6-4a38-b8b7-cfd09f65972c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FederalFundsEffectiveSwapRateMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_ddf7efb4-420e-4dd5-a384-945d63bce834" xlink:to="loc_us-gaap_FederalFundsEffectiveSwapRateMember_9c9785ae-4ba6-4a38-b8b7-cfd09f65972c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_AdjustedTermSOFRMember_01d1849f-ddc7-4205-887f-d395b14b9b01" xlink:href="cnmd-20230331.xsd#cnmd_AdjustedTermSOFRMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_ddf7efb4-420e-4dd5-a384-945d63bce834" xlink:to="loc_cnmd_AdjustedTermSOFRMember_01d1849f-ddc7-4205-887f-d395b14b9b01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_5881f14e-f9fa-484e-93c2-99346bdaed60" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_cd942d52-7f3d-4182-842d-ee011e9acfa9" xlink:to="loc_us-gaap_DebtInstrumentLineItems_5881f14e-f9fa-484e-93c2-99346bdaed60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_38a86f95-d3d3-4759-9565-528bbc0cd60e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5881f14e-f9fa-484e-93c2-99346bdaed60" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_38a86f95-d3d3-4759-9565-528bbc0cd60e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_5c0b9477-d9e5-481a-9bd8-aefd3b5c49e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5881f14e-f9fa-484e-93c2-99346bdaed60" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_5c0b9477-d9e5-481a-9bd8-aefd3b5c49e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfSeniorDebt_ba9e791a-1470-45f5-9bd8-86acf39cbe74" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfSeniorDebt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5881f14e-f9fa-484e-93c2-99346bdaed60" xlink:to="loc_us-gaap_RepaymentsOfSeniorDebt_ba9e791a-1470-45f5-9bd8-86acf39cbe74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_TermSOFRInterestRateSpreadAdjustment_b0bb41cf-8363-42c6-b1c2-70121f943ab8" xlink:href="cnmd-20230331.xsd#cnmd_TermSOFRInterestRateSpreadAdjustment"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5881f14e-f9fa-484e-93c2-99346bdaed60" xlink:to="loc_cnmd_TermSOFRInterestRateSpreadAdjustment_b0bb41cf-8363-42c6-b1c2-70121f943ab8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_AdjustedTermSOFRInterestRate_3119da24-71aa-43c2-87f3-6b27a20e6d7e" xlink:href="cnmd-20230331.xsd#cnmd_AdjustedTermSOFRInterestRate"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5881f14e-f9fa-484e-93c2-99346bdaed60" xlink:to="loc_cnmd_AdjustedTermSOFRInterestRate_3119da24-71aa-43c2-87f3-6b27a20e6d7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_7bc7f4d0-4082-40f5-bacd-01e4d06e22b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5881f14e-f9fa-484e-93c2-99346bdaed60" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_7bc7f4d0-4082-40f5-bacd-01e4d06e22b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_cdc1cc6d-0d6a-4eff-8676-9c3fd10a7094" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5881f14e-f9fa-484e-93c2-99346bdaed60" xlink:to="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_cdc1cc6d-0d6a-4eff-8676-9c3fd10a7094" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_08cdcb57-89f0-471b-ac13-a3d2074c81f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5881f14e-f9fa-484e-93c2-99346bdaed60" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_08cdcb57-89f0-471b-ac13-a3d2074c81f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_79483b75-9657-4c77-b522-357c1860878d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5881f14e-f9fa-484e-93c2-99346bdaed60" xlink:to="loc_us-gaap_LongTermDebt_79483b75-9657-4c77-b522-357c1860878d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_ee940826-7849-413b-b993-fbc2b702feb1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5881f14e-f9fa-484e-93c2-99346bdaed60" xlink:to="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_ee940826-7849-413b-b993-fbc2b702feb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LettersOfCreditOutstandingAmount_ef1e828c-50f3-4368-a566-3346104b2a2c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LettersOfCreditOutstandingAmount"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5881f14e-f9fa-484e-93c2-99346bdaed60" xlink:to="loc_us-gaap_LettersOfCreditOutstandingAmount_ef1e828c-50f3-4368-a566-3346104b2a2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_303b760e-2253-4cbe-9d94-f9c1151ba9c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5881f14e-f9fa-484e-93c2-99346bdaed60" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_303b760e-2253-4cbe-9d94-f9c1151ba9c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1_4ebfc77c-3dbd-4f0e-b086-4b8b7f9f671b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleConversionRatio1"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5881f14e-f9fa-484e-93c2-99346bdaed60" xlink:to="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1_4ebfc77c-3dbd-4f0e-b086-4b8b7f9f671b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_04776d29-7721-49d4-b1fc-436afdf56f1d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5881f14e-f9fa-484e-93c2-99346bdaed60" xlink:to="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_04776d29-7721-49d4-b1fc-436afdf56f1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_HedgeAndWarrantTransactionsNetCashPaid_7f51e442-60c9-483e-8484-ec653255568c" xlink:href="cnmd-20230331.xsd#cnmd_HedgeAndWarrantTransactionsNetCashPaid"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5881f14e-f9fa-484e-93c2-99346bdaed60" xlink:to="loc_cnmd_HedgeAndWarrantTransactionsNetCashPaid_7f51e442-60c9-483e-8484-ec653255568c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfConvertibleDebt_11add576-1c2f-4a23-a741-f7406b5dc9fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfConvertibleDebt"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5881f14e-f9fa-484e-93c2-99346bdaed60" xlink:to="loc_us-gaap_RepaymentsOfConvertibleDebt_11add576-1c2f-4a23-a741-f7406b5dc9fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtConversionConvertedInstrumentSharesIssued1_43e45630-216d-4ec9-a3b0-db6c1717c93d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtConversionConvertedInstrumentSharesIssued1"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5881f14e-f9fa-484e-93c2-99346bdaed60" xlink:to="loc_us-gaap_DebtConversionConvertedInstrumentSharesIssued1_43e45630-216d-4ec9-a3b0-db6c1717c93d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt_379496b4-f582-4302-a8b3-f497eae096ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpenseDebt"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5881f14e-f9fa-484e-93c2-99346bdaed60" xlink:to="loc_us-gaap_InterestExpenseDebt_379496b4-f582-4302-a8b3-f497eae096ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue_89acbbed-fef1-43e9-9ba3-5cb5b20bdcc8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5881f14e-f9fa-484e-93c2-99346bdaed60" xlink:to="loc_us-gaap_DebtInstrumentFairValue_89acbbed-fef1-43e9-9ba3-5cb5b20bdcc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OptionIndexedToIssuersEquityStrikePrice1_c15e57eb-4f7a-412c-ab06-829028455612" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OptionIndexedToIssuersEquityStrikePrice1"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5881f14e-f9fa-484e-93c2-99346bdaed60" xlink:to="loc_us-gaap_OptionIndexedToIssuersEquityStrikePrice1_c15e57eb-4f7a-412c-ab06-829028455612" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.conmed.com/role/LongTermDebtMaturitiesofLongTermDebtDetails" xlink:type="simple" xlink:href="cnmd-20230331.xsd#LongTermDebtMaturitiesofLongTermDebtDetails"/>
  <link:presentationLink xlink:role="http://www.conmed.com/role/LongTermDebtMaturitiesofLongTermDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_af9669f4-30ff-42aa-93f4-81dd417cd171" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MaturitiesOfLongTermDebtAbstract_525580f1-d39f-430d-861d-93f827fadd0d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MaturitiesOfLongTermDebtAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_af9669f4-30ff-42aa-93f4-81dd417cd171" xlink:to="loc_us-gaap_MaturitiesOfLongTermDebtAbstract_525580f1-d39f-430d-861d-93f827fadd0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_5f57ebd8-185d-4b7c-aa35-dc79e87c86ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MaturitiesOfLongTermDebtAbstract_525580f1-d39f-430d-861d-93f827fadd0d" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_5f57ebd8-185d-4b7c-aa35-dc79e87c86ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_1275cf83-86a5-4560-93d4-d30a6f951186" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MaturitiesOfLongTermDebtAbstract_525580f1-d39f-430d-861d-93f827fadd0d" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_1275cf83-86a5-4560-93d4-d30a6f951186" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_d9949d1c-52d7-4b05-98c0-0588972f2532" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MaturitiesOfLongTermDebtAbstract_525580f1-d39f-430d-861d-93f827fadd0d" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_d9949d1c-52d7-4b05-98c0-0588972f2532" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_b7509e45-74f7-48a4-8221-7af5ffca087b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MaturitiesOfLongTermDebtAbstract_525580f1-d39f-430d-861d-93f827fadd0d" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_b7509e45-74f7-48a4-8221-7af5ffca087b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_56d13934-3b47-4750-b42f-cf5976283743" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MaturitiesOfLongTermDebtAbstract_525580f1-d39f-430d-861d-93f827fadd0d" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_56d13934-3b47-4750-b42f-cf5976283743" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_7a5367a1-f1ab-4681-b85d-666b6ed4e606" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MaturitiesOfLongTermDebtAbstract_525580f1-d39f-430d-861d-93f827fadd0d" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_7a5367a1-f1ab-4681-b85d-666b6ed4e606" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.conmed.com/role/GuaranteesDetails" xlink:type="simple" xlink:href="cnmd-20230331.xsd#GuaranteesDetails"/>
  <link:presentationLink xlink:role="http://www.conmed.com/role/GuaranteesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuaranteesAbstract_37a9a0cc-9829-4497-a4a9-a907b1d531af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GuaranteesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_ProductWarrantyAccrualTerm_4422ceb8-d584-42d2-9518-679eadf62a2b" xlink:href="cnmd-20230331.xsd#cnmd_ProductWarrantyAccrualTerm"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GuaranteesAbstract_37a9a0cc-9829-4497-a4a9-a907b1d531af" xlink:to="loc_cnmd_ProductWarrantyAccrualTerm_4422ceb8-d584-42d2-9518-679eadf62a2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MovementInStandardProductWarrantyAccrualRollForward_c38ff86a-0ed2-4f46-a3e3-33cd07eb4024" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MovementInStandardProductWarrantyAccrualRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GuaranteesAbstract_37a9a0cc-9829-4497-a4a9-a907b1d531af" xlink:to="loc_us-gaap_MovementInStandardProductWarrantyAccrualRollForward_c38ff86a-0ed2-4f46-a3e3-33cd07eb4024" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StandardProductWarrantyAccrual_faecf106-d4f7-4784-befd-718ee28cea13" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StandardProductWarrantyAccrual"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInStandardProductWarrantyAccrualRollForward_c38ff86a-0ed2-4f46-a3e3-33cd07eb4024" xlink:to="loc_us-gaap_StandardProductWarrantyAccrual_faecf106-d4f7-4784-befd-718ee28cea13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StandardProductWarrantyAccrualWarrantiesIssued_cfd040e5-18d0-44d6-91bb-b78b49e1ac2a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StandardProductWarrantyAccrualWarrantiesIssued"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInStandardProductWarrantyAccrualRollForward_c38ff86a-0ed2-4f46-a3e3-33cd07eb4024" xlink:to="loc_us-gaap_StandardProductWarrantyAccrualWarrantiesIssued_cfd040e5-18d0-44d6-91bb-b78b49e1ac2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StandardProductWarrantyAccrualPayments_0d576655-4222-41c1-9697-d100fb14220d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StandardProductWarrantyAccrualPayments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInStandardProductWarrantyAccrualRollForward_c38ff86a-0ed2-4f46-a3e3-33cd07eb4024" xlink:to="loc_us-gaap_StandardProductWarrantyAccrualPayments_0d576655-4222-41c1-9697-d100fb14220d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StandardProductWarrantyAccrual_9109d990-52e3-4bb8-989a-ff0bad7b208c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StandardProductWarrantyAccrual"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInStandardProductWarrantyAccrualRollForward_c38ff86a-0ed2-4f46-a3e3-33cd07eb4024" xlink:to="loc_us-gaap_StandardProductWarrantyAccrual_9109d990-52e3-4bb8-989a-ff0bad7b208c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductWarrantiesDisclosuresAbstract_25281071-0d9f-41a0-a7a4-55c6c81e5c0d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductWarrantiesDisclosuresAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GuaranteesAbstract_37a9a0cc-9829-4497-a4a9-a907b1d531af" xlink:to="loc_us-gaap_ProductWarrantiesDisclosuresAbstract_25281071-0d9f-41a0-a7a4-55c6c81e5c0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtendedProductWarrantyDisclosureAbstract_e920131b-bd21-420a-a38a-a663b04e930a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ExtendedProductWarrantyDisclosureAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProductWarrantiesDisclosuresAbstract_25281071-0d9f-41a0-a7a4-55c6c81e5c0d" xlink:to="loc_us-gaap_ExtendedProductWarrantyDisclosureAbstract_e920131b-bd21-420a-a38a-a663b04e930a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductWarrantyExpense_d1cdf5ae-534b-40ef-971a-b59dc31f4bf7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductWarrantyExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ExtendedProductWarrantyDisclosureAbstract_e920131b-bd21-420a-a38a-a663b04e930a" xlink:to="loc_us-gaap_ProductWarrantyExpense_d1cdf5ae-534b-40ef-971a-b59dc31f4bf7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.conmed.com/role/PensionPlanDetails" xlink:type="simple" xlink:href="cnmd-20230331.xsd#PensionPlanDetails"/>
  <link:presentationLink xlink:role="http://www.conmed.com/role/PensionPlanDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_93748aad-a8b5-442e-bb3e-6781f523a9db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost_5e6a713e-b678-4571-ac74-e18cf99af348" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_93748aad-a8b5-442e-bb3e-6781f523a9db" xlink:to="loc_us-gaap_DefinedBenefitPlanServiceCost_5e6a713e-b678-4571-ac74-e18cf99af348" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost_8942bc5c-cd6c-47d7-8665-9841820fbc20" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_93748aad-a8b5-442e-bb3e-6781f523a9db" xlink:to="loc_us-gaap_DefinedBenefitPlanInterestCost_8942bc5c-cd6c-47d7-8665-9841820fbc20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_46017d6b-d845-490e-ba53-d054f715a6db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_93748aad-a8b5-442e-bb3e-6781f523a9db" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_46017d6b-d845-490e-ba53-d054f715a6db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_687170c9-dad7-4f8d-b3fb-124a2d035a74" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_93748aad-a8b5-442e-bb3e-6781f523a9db" xlink:to="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_687170c9-dad7-4f8d-b3fb-124a2d035a74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_e548fbd0-d232-4728-a206-240d4015e523" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_93748aad-a8b5-442e-bb3e-6781f523a9db" xlink:to="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_e548fbd0-d232-4728-a206-240d4015e523" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.conmed.com/role/BusinessSegmentDetails" xlink:type="simple" xlink:href="cnmd-20230331.xsd#BusinessSegmentDetails"/>
  <link:presentationLink xlink:role="http://www.conmed.com/role/BusinessSegmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_6358179c-15bd-4d14-8b91-104b3b5422d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_de9d9830-dfe4-4e95-9e97-2d3b35e192f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_6358179c-15bd-4d14-8b91-104b3b5422d6" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_de9d9830-dfe4-4e95-9e97-2d3b35e192f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_9302d79a-e092-49c9-96cc-f31c87372659" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_de9d9830-dfe4-4e95-9e97-2d3b35e192f1" xlink:to="loc_srt_ProductOrServiceAxis_9302d79a-e092-49c9-96cc-f31c87372659" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_e9480ea5-19ae-4740-ba52-29b00d5620b8" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_9302d79a-e092-49c9-96cc-f31c87372659" xlink:to="loc_srt_ProductsAndServicesDomain_e9480ea5-19ae-4740-ba52-29b00d5620b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_OrthopedicSurgeryMember_d2a299fe-a717-4f54-93c3-b4d8f23f9f89" xlink:href="cnmd-20230331.xsd#cnmd_OrthopedicSurgeryMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_e9480ea5-19ae-4740-ba52-29b00d5620b8" xlink:to="loc_cnmd_OrthopedicSurgeryMember_d2a299fe-a717-4f54-93c3-b4d8f23f9f89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_GeneralSurgeryMember_912a3e27-95bb-497e-a3b5-1b04785e7ec9" xlink:href="cnmd-20230331.xsd#cnmd_GeneralSurgeryMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_e9480ea5-19ae-4740-ba52-29b00d5620b8" xlink:to="loc_cnmd_GeneralSurgeryMember_912a3e27-95bb-497e-a3b5-1b04785e7ec9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_04726fd6-cfaf-4d02-ada0-93f2dfae1f34" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_de9d9830-dfe4-4e95-9e97-2d3b35e192f1" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_04726fd6-cfaf-4d02-ada0-93f2dfae1f34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_769a8d4e-0739-48ed-805a-35764496de6e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_04726fd6-cfaf-4d02-ada0-93f2dfae1f34" xlink:to="loc_us-gaap_Revenues_769a8d4e-0739-48ed-805a-35764496de6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.conmed.com/role/LegalProceedingsDetails" xlink:type="simple" xlink:href="cnmd-20230331.xsd#LegalProceedingsDetails"/>
  <link:presentationLink xlink:role="http://www.conmed.com/role/LegalProceedingsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_8d6db3aa-026b-45b6-b9ce-52174e4875e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_ProductLiabilityContingencyInsuranceAmountPerIncident_281b2e54-fb4f-4448-ac17-f7e10075e476" xlink:href="cnmd-20230331.xsd#cnmd_ProductLiabilityContingencyInsuranceAmountPerIncident"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_8d6db3aa-026b-45b6-b9ce-52174e4875e0" xlink:to="loc_cnmd_ProductLiabilityContingencyInsuranceAmountPerIncident_281b2e54-fb4f-4448-ac17-f7e10075e476" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnmd_ProductLiabilityContingencyInsuranceAggregateAnnualAmount_fbbe9d57-398c-4f53-b9b1-0429058cc668" xlink:href="cnmd-20230331.xsd#cnmd_ProductLiabilityContingencyInsuranceAggregateAnnualAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_8d6db3aa-026b-45b6-b9ce-52174e4875e0" xlink:to="loc_cnmd_ProductLiabilityContingencyInsuranceAggregateAnnualAmount_fbbe9d57-398c-4f53-b9b1-0429058cc668" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140393982610688">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Document and Entity Information - shares<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Apr. 24, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentQuarterlyReport', window );">Document Quarterly Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Mar. 31,  2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-39218<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">CONMED CORPORATION<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">16-0977505<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">11311 Concept Blvd<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Largo,<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">FL<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">33773<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">727<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">392-6464<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, $0.01 par value<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">CNMD<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30,575,290<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000816956<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentQuarterlyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an quarterly report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-Q<br> -Number 240<br> -Section 308<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentQuarterlyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140393983518160">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Condensed Statements of Comprehensive Income (Unaudited) - USD ($)<br> shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net sales</a></td>
<td class="nump">$ 295,468<span></span>
</td>
<td class="nump">$ 242,327<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of sales</a></td>
<td class="nump">140,147<span></span>
</td>
<td class="nump">106,336<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross profit</a></td>
<td class="nump">155,321<span></span>
</td>
<td class="nump">135,991<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling and administrative expense</a></td>
<td class="nump">130,083<span></span>
</td>
<td class="nump">102,875<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development expense</a></td>
<td class="nump">12,539<span></span>
</td>
<td class="nump">10,672<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">&#160; Operating expenses</a></td>
<td class="nump">142,622<span></span>
</td>
<td class="nump">113,547<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Income from operations</a></td>
<td class="nump">12,699<span></span>
</td>
<td class="nump">22,444<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="nump">10,255<span></span>
</td>
<td class="nump">4,998<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Income before income taxes</a></td>
<td class="nump">2,444<span></span>
</td>
<td class="nump">17,446<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Provision for income taxes</a></td>
<td class="nump">625<span></span>
</td>
<td class="nump">2,471<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">1,819<span></span>
</td>
<td class="nump">14,975<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest', window );">Comprehensive income</a></td>
<td class="nump">$ 4,695<span></span>
</td>
<td class="nump">$ 16,415<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Per share data:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic (in dollars per share)</a></td>
<td class="nump">$ 0.06<span></span>
</td>
<td class="nump">$ 0.51<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted (in dollars per share)</a></td>
<td class="nump">$ 0.06<span></span>
</td>
<td class="nump">$ 0.47<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract', window );"><strong>Weighted average common shares:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic (shares)</a></td>
<td class="nump">30,511<span></span>
</td>
<td class="nump">29,428<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted (shares)</a></td>
<td class="nump">31,204<span></span>
</td>
<td class="nump">35,155<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 18: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126941158&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 730<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6472174&amp;loc=d3e58812-109433<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140393983762432">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Condensed Balance Sheets (Unaudited) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 26,494<span></span>
</td>
<td class="nump">$ 28,942<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable, net</a></td>
<td class="nump">213,182<span></span>
</td>
<td class="nump">191,345<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventories</a></td>
<td class="nump">335,370<span></span>
</td>
<td class="nump">332,320<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">35,042<span></span>
</td>
<td class="nump">28,619<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">610,088<span></span>
</td>
<td class="nump">581,226<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment, net</a></td>
<td class="nump">115,356<span></span>
</td>
<td class="nump">115,611<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">815,499<span></span>
</td>
<td class="nump">815,429<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Other intangible assets, net</a></td>
<td class="nump">673,538<span></span>
</td>
<td class="nump">681,799<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other assets</a></td>
<td class="nump">105,639<span></span>
</td>
<td class="nump">103,527<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">2,320,120<span></span>
</td>
<td class="nump">2,297,592<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent', window );">Current portion of long-term debt</a></td>
<td class="nump">69,693<span></span>
</td>
<td class="nump">69,746<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">76,680<span></span>
</td>
<td class="nump">73,393<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Accrued compensation and benefits</a></td>
<td class="nump">49,378<span></span>
</td>
<td class="nump">54,733<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Other current liabilities</a></td>
<td class="nump">124,935<span></span>
</td>
<td class="nump">98,680<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">320,686<span></span>
</td>
<td class="nump">296,552<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligations', window );">Long-term debt</a></td>
<td class="nump">995,276<span></span>
</td>
<td class="nump">985,076<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilitiesNet', window );">Deferred income taxes</a></td>
<td class="nump">65,546<span></span>
</td>
<td class="nump">66,725<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other long-term liabilities</a></td>
<td class="nump">186,159<span></span>
</td>
<td class="nump">203,694<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">1,567,667<span></span>
</td>
<td class="nump">1,552,047<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Shareholders' equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock, par value $.01 per share; authorized 500,000 shares; none outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, par value $0.01 per share; 100,000,000 shares authorized; 31,299,194 shares issued in 2023 and 2022, respectively</a></td>
<td class="nump">313<span></span>
</td>
<td class="nump">313<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Paid-in capital</a></td>
<td class="nump">419,517<span></span>
</td>
<td class="nump">413,235<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained earnings</a></td>
<td class="nump">408,337<span></span>
</td>
<td class="nump">412,631<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="num">(54,982)<span></span>
</td>
<td class="num">(57,858)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonValue', window );">Less: 738,718 and 811,532 shares of common stock in treasury, at cost, in 2023 and 2022, respectively</a></td>
<td class="num">(20,732)<span></span>
</td>
<td class="num">(22,776)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total shareholders&#8217; equity</a></td>
<td class="nump">752,453<span></span>
</td>
<td class="nump">745,545<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and shareholders&#8217; equity</a></td>
<td class="nump">$ 2,320,120<span></span>
</td>
<td class="nump">$ 2,297,592<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6904-107765<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt and lease obligation, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt and lease obligation, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockCommonValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount allocated to previously issued common shares repurchased by the issuing entity and held in treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23315-112656<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.30)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockCommonValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140393982445680">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Condensed Balance Sheets (Unaudited) (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value (dollars per share)</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized (in shares)</a></td>
<td class="nump">500,000<span></span>
</td>
<td class="nump">500,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (dollars per share)</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized (in shares)</a></td>
<td class="nump">100,000,000<span></span>
</td>
<td class="nump">100,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued (in shares)</a></td>
<td class="nump">31,299,194<span></span>
</td>
<td class="nump">31,299,194<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Treasury stock, shares (in shares)</a></td>
<td class="nump">738,718<span></span>
</td>
<td class="nump">811,532<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockCommonShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of previously issued common shares repurchased by the issuing entity and held in treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockCommonShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140393984064720">
<tr>
<th class="tl" colspan="2" rowspan="1"><div style="width: 200px;"><strong>Consolidated Condensed Statements of Shareholders' Equity (Unaudited) - USD ($)<br> shares in Thousands, $ in Thousands</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Common Stock</div></th>
<th class="th"><div>Paid-in Capital</div></th>
<th class="th"><div>Retained Earnings</div></th>
<th class="th"><div>Accumulated Other Comprehensive Loss</div></th>
<th class="th"><div>Treasury Stock</div></th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance at period start (shares) at Dec. 31, 2021</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">31,299<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at period start at Dec. 31, 2021</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 785,435<span></span>
</td>
<td class="nump">$ 313<span></span>
</td>
<td class="nump">$ 396,771<span></span>
</td>
<td class="nump">$ 496,605<span></span>
</td>
<td class="num">$ (54,203)<span></span>
</td>
<td class="num">$ (54,051)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Common stock issued under employee plans</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">6,252<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,232<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,020<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">4,463<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,463<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsCommonStockCash', window );">Dividends on common stock ($0.20 per share)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(5,899)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5,899)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract', window );"><strong>Comprehensive income:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax', window );">Cash flow hedging gain, net</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,082<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,082<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax', window );">Pension liability, net of income tax</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">521<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">521<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Foreign currency translation adjustments</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(163)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(163)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">14,975<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,975<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest', window );">Comprehensive income</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 16,415<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingStandardsUpdateExtensibleList', window );">Accounting Standards Update [Extensible Enumeration]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">Accounting Standards Update 2020-06<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance at period end (shares) at Mar. 31, 2022</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">31,299<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at period end at Mar. 31, 2022</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 789,546<span></span>
</td>
<td class="nump">$ 313<span></span>
</td>
<td class="nump">365,555<span></span>
</td>
<td class="nump">526,472<span></span>
</td>
<td class="num">(52,763)<span></span>
</td>
<td class="num">(50,031)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at period end (Accounting Standards Update 2020-06) at Mar. 31, 2022</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">(17,120)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(37,911)<span></span>
</td>
<td class="nump">20,791<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance at period start (shares) at Dec. 31, 2022</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">31,299<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at period start at Dec. 31, 2022</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">745,545<span></span>
</td>
<td class="nump">$ 313<span></span>
</td>
<td class="nump">413,235<span></span>
</td>
<td class="nump">412,631<span></span>
</td>
<td class="num">(57,858)<span></span>
</td>
<td class="num">(22,776)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Common stock issued under employee plans</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">556<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,044<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">5,726<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,726<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsCommonStockCash', window );">Dividends on common stock ($0.20 per share)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(6,113)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(6,113)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract', window );"><strong>Comprehensive income:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax', window );">Cash flow hedging gain, net</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">877<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">877<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax', window );">Pension liability, net of income tax</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">403<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">403<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Foreign currency translation adjustments</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,596<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,596<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,819<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,819<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest', window );">Comprehensive income</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">4,695<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance at period end (shares) at Mar. 31, 2023</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">31,299<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at period end at Mar. 31, 2023</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 752,453<span></span>
</td>
<td class="nump">$ 313<span></span>
</td>
<td class="nump">$ 419,517<span></span>
</td>
<td class="nump">$ 408,337<span></span>
</td>
<td class="num">$ (54,982)<span></span>
</td>
<td class="num">$ (20,732)<span></span>
</td>
</tr>
<tr><td colspan="7"></td></tr>
<tr><td colspan="7"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.52pt;font-weight:400;line-height:100%;position:relative;top:-2.97pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">We recorded the cumulative impact of adopting Accounting Standards Update (ASU) 2020-06, Debt&#8212;Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging&#8212;Contracts in Entity&#8217;s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity&#8217;s Own Equity in 2022.</span></td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingStandardsUpdateExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates amendment to accounting standards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL126732908-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983955&amp;loc=SL121967933-165497<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 65<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092918&amp;loc=SL128093175-196984<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983955&amp;loc=SL121967933-165497<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 65<br> -Paragraph 3<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092918&amp;loc=SL128093175-196984<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 832<br> -SubTopic 10<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128342835&amp;loc=SL128342857-244232<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983955&amp;loc=SL122642865-165497<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 65<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092918&amp;loc=SL128093175-196984<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983955&amp;loc=SL121967933-165497<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983955&amp;loc=SL121967933-165497<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983955&amp;loc=SL120254526-165497<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(iv)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(iii)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 32: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 40: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 41: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL122150809-237846<br><br>Reference 42: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL125981372-237846<br><br>Reference 43: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 44: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 10<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128293352&amp;loc=SL126838806-209984<br><br>Reference 45: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983955&amp;loc=SL122642865-165497<br><br>Reference 46: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126986314&amp;loc=SL124402458-218513<br><br>Reference 47: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126986314&amp;loc=SL124402458-218513<br><br>Reference 48: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983955&amp;loc=SL120254526-165497<br><br>Reference 49: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL125981372-237846<br><br>Reference 50: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 10<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=128293352&amp;loc=SL126838806-209984<br><br>Reference 51: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 52: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 53: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 54: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 55: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 56: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 57: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (e)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 58: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL125981372-237846<br><br>Reference 59: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 60: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL125981372-237846<br><br>Reference 61: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL125981372-237846<br><br>Reference 62: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 10<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128293352&amp;loc=SL126838806-209984<br><br>Reference 63: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 832<br> -SubTopic 10<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=128342835&amp;loc=SL128342857-244232<br><br>Reference 64: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 65: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 66: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 67: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 68: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingStandardsUpdateExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126964447&amp;loc=d3e11149-113907<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126964447&amp;loc=d3e11178-113907<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126961718&amp;loc=d3e4534-113899<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsCommonStockCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of paid and unpaid common stock dividends declared with the form of settlement in cash.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsCommonStockCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate202006Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate202006Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140393989131136">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Condensed Statements of Shareholders' Equity (Unaudited) (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfStockholdersEquityAbstract', window );"><strong>Statement of Stockholders' Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockDividendsPerShareDeclared', window );">Dividends per share of common stock (in dollars per share)</a></td>
<td class="nump">$ 0.20<span></span>
</td>
<td class="nump">$ 0.20<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockDividendsPerShareDeclared">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate dividends declared during the period for each share of common stock outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockDividendsPerShareDeclared</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfStockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfStockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140393983265680">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Condensed Statements of Cash Flows (Unaudited) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows from operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">$ 1,819<span></span>
</td>
<td class="nump">$ 14,975<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net income to net cash provided by (used in) operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation</a></td>
<td class="nump">4,057<span></span>
</td>
<td class="nump">4,032<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCosts', window );">Amortization of deferred debt issuance costs</a></td>
<td class="nump">1,506<span></span>
</td>
<td class="nump">880<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAmortizationOfDeferredCharges', window );">Amortization</a></td>
<td class="nump">13,877<span></span>
</td>
<td class="nump">12,799<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation</a></td>
<td class="nump">5,726<span></span>
</td>
<td class="nump">4,463<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred income taxes</a></td>
<td class="num">(1,140)<span></span>
</td>
<td class="nump">177<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1', window );">Non-cash adjustment to fair value of contingent consideration liability</a></td>
<td class="nump">4,436<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Increase (decrease) in cash flows from changes in assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable</a></td>
<td class="num">(20,666)<span></span>
</td>
<td class="num">(163)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Inventories</a></td>
<td class="num">(3,016)<span></span>
</td>
<td class="num">(21,857)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Accounts payable</a></td>
<td class="nump">2,699<span></span>
</td>
<td class="nump">9,205<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities', window );">Accrued compensation and benefits</a></td>
<td class="num">(5,722)<span></span>
</td>
<td class="num">(14,966)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingAssets', window );">Other assets</a></td>
<td class="num">(11,372)<span></span>
</td>
<td class="num">(6,129)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities', window );">Other liabilities</a></td>
<td class="nump">3,949<span></span>
</td>
<td class="num">(3,088)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash (used in) provided by operating activities</a></td>
<td class="num">(3,847)<span></span>
</td>
<td class="nump">328<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash flows from investing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchases of property, plant and equipment</a></td>
<td class="num">(4,254)<span></span>
</td>
<td class="num">(3,687)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="num">(4,254)<span></span>
</td>
<td class="num">(3,687)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfSeniorDebt', window );">Payments on term loan</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(2,981)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfLinesOfCredit', window );">Payments on revolving line of credit</a></td>
<td class="num">(164,000)<span></span>
</td>
<td class="num">(99,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromLinesOfCredit', window );">Proceeds from revolving line of credit</a></td>
<td class="nump">173,000<span></span>
</td>
<td class="nump">110,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cnmd_PaymentsForContingentConsideration', window );">Payments related to contingent consideration</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(798)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfDividendsCommonStock', window );">Dividends paid on common stock</a></td>
<td class="num">(6,098)<span></span>
</td>
<td class="num">(5,874)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities', window );">Other, net</a></td>
<td class="nump">2,448<span></span>
</td>
<td class="nump">6,142<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by financing activities</a></td>
<td class="nump">5,350<span></span>
</td>
<td class="nump">7,489<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Effect of exchange rate changes on cash and cash equivalents</a></td>
<td class="nump">303<span></span>
</td>
<td class="num">(113)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net (decrease) increase in cash and cash equivalents</a></td>
<td class="num">(2,448)<span></span>
</td>
<td class="nump">4,017<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents at beginning of period</a></td>
<td class="nump">28,942<span></span>
</td>
<td class="nump">20,847<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents at end of period</a></td>
<td class="nump">26,494<span></span>
</td>
<td class="nump">24,864<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract', window );"><strong>Non-cash investing and financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsPayableCurrentAndNoncurrent', window );">Dividends payable</a></td>
<td class="nump">$ 6,113<span></span>
</td>
<td class="nump">$ 5,899<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cnmd_PaymentsForContingentConsideration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Payments for Contingent Consideration</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cnmd_PaymentsForContingentConsideration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cnmd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfFinancingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfFinancingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e7008-128479<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.1)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsPayableCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of dividends declared but unpaid on equity securities issued by the entity and outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsPayableCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAmortizationOfDeferredCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization of other deferred costs recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAmortizationOfDeferredCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDividendsCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow in the form of ordinary dividends to common shareholders of the parent entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDividendsCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromLinesOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from contractual arrangement with the lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromLinesOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromPaymentsForOtherFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLinesOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for payment of an obligation from a lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLinesOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfSeniorDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for a long-term debt where the holder has highest claim on the entity's asset in case of bankruptcy or liquidation during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfSeniorDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140393983500688">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Operations<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NatureOfOperations', window );">Operations</a></td>
<td class="text">OperationsCONMED Corporation (&#8220;CONMED&#8221;, the &#8220;Company&#8221;, &#8220;we&#8221; or &#8220;us&#8221;) is a medical technology company that provides devices and equipment for surgical procedures.&#160;&#160;The Company&#8217;s products are used by surgeons and other healthcare professionals in a variety of specialties including orthopedics, general surgery, gynecology, thoracic surgery and gastroenterology.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NatureOfOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -URI https://asc.fasb.org/topic&amp;trid=2134479<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NatureOfOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140393985857856">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Interim Financial Information<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock', window );">Interim Financial Information</a></td>
<td class="text">Interim Financial Information<div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying unaudited consolidated condensed financial statements have been prepared in accordance with generally accepted accounting principles for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X.  Accordingly, they do not include all of the information and footnotes required by generally accepted accounting principles for annual financial statements.  The information herein reflects all normal recurring material adjustments, which are, in the opinion of management, necessary to fairly present the results for the periods presented.  The consolidated condensed financial statements herein consist of all wholly-owned domestic and foreign subsidiaries with all significant intercompany transactions eliminated.  Results for the period ended March&#160;31, 2023 are not necessarily indicative of the results that may be expected for the year ending December&#160;31, 2023.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The consolidated condensed financial statements and notes thereto should be read in conjunction with the consolidated financial statements and notes for the year ended December&#160;31, 2022 included in our Annual Report on Form 10-K.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Preparation of the consolidated condensed financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated condensed financial statements and the reported amounts of revenue and expenses during the reporting period.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While there has been uncertainty and disruption in the global economy and financial markets, we are not aware of any specific event or circumstance that would require an update to our estimates or judgments or a revision of the carrying value of our assets or liabilities as of&#160;April&#160;27, 2023, the date of issuance of this Quarterly Report on Form 10-Q.  These estimates may change, as new events occur and additional information is obtained. Actual results could differ materially from these estimates under different assumptions or conditions.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -URI https://asc.fasb.org/topic&amp;trid=2122149<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -URI https://asc.fasb.org/topic&amp;trid=2197479<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140394074281824">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>New Accounting Pronouncements<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract', window );"><strong>Accounting Standards Update and Change in Accounting Principle [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock', window );">New Accounting Pronouncements</a></td>
<td class="text">New Accounting Pronouncements<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recently Issued Accounting Standards, Not Yet Adopted</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2020, the Financial Accounting Standards Board ("FASB") issued ASU 2020-04, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting, which provides optional guidance if certain criteria are met for entities that have contracts, hedging relationships, and other transactions that reference LIBOR or other reference rates expected to be discontinued as a result of reference rate reform.  This ASU is effective as of March 12, 2020 through December 31, 2022 and was extended through December 31, 2024 by ASU 2022-06, Reference Rate Reform (Topic 848): Deferral of the Sunset Date of Topic 848.  The Company has not adopted these ASUs as of March&#160;31, 2023.  Our seventh amended and restated senior credit agreement includes language to address the change from LIBOR to SOFR, an alternative base rate, therefore we do not believe reference rate reform will have a significant impact on our consolidated financial statements.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for change in accounting principle. Includes, but is not limited to, nature, reason, and method of adopting amendment to accounting standards or other change in accounting principle.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -URI https://asc.fasb.org/topic&amp;trid=2122394<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126986314&amp;loc=SL124402458-218513<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(iii)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126986314&amp;loc=SL124402458-218513<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(iv)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SAB Topic 11.M.Q2)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038215&amp;loc=d3e31137-122693<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (e)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (e)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL122150809-237846<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (e)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section S99<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=122038215&amp;loc=SL108384541-122693<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 10<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128293352&amp;loc=SL126838806-209984<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (e)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983955&amp;loc=SL121967933-165497<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL126732908-238011<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 10<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (f)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=128293352&amp;loc=SL126838806-209984<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL126732908-238011<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (e)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983955&amp;loc=SL121967933-165497<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (e)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (c)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL126732908-238011<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=120154821&amp;loc=SL120154904-197079<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=120154821&amp;loc=SL120154904-197079<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=120154821&amp;loc=SL120154904-197079<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (e)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983955&amp;loc=SL121967933-165497<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL125981372-237846<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (e)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140394067894656">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Combinations<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract', window );"><strong>Business Combination and Asset Acquisition [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationDisclosureTextBlock', window );">Business Combinations</a></td>
<td class="text">Business CombinationsOn June&#160;13, 2022, we acquired In2Bones Global, Inc. ("In2Bones") and all of its stock (the "In2Bones Acquisition") for an aggregate upfront payment of $145.2&#160;million in cash.  In addition, there are potential earn-out payments to In2Bones&#8217; equity holders in an amount up to $110.0&#160;million based on the achievement of certain revenue targets for In2Bones products during the sixteen (16) successive quarters commencing on July 1, 2022.  In2Bones is a global developer, manufacturer and distributor of medical devices for the treatment of disorders and injuries of the upper (hand, wrist and elbow) and lower (foot <div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and ankle) extremities.  The In2Bones Acquisition was funded through a combination of cash on hand and long-term borrowings as further described in Note 11.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">We recorded $11.8&#160;million in net sales for In2Bones during the three months ended March&#160;31, 2023.  Earnings recorded in the consolidated condensed statement of comprehensive income for the three months ended March&#160;31, 2023 were not material.  We also believe the proforma information is immaterial for disclosure for the three months ended March&#160;31, 2022.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">During the three months ended March&#160;31, 2023, we incurred costs for the amortization of inventory step-up to fair value of $2.1 million related to the In2Bones acquisition which are recorded in cost of sales.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August&#160;9, 2022, we acquired Biorez, Inc. ("Biorez") and all of its stock (the "Biorez Acquisition") for an aggregate upfront payment of $85.5&#160;million in cash.  We paid $83.8&#160;million as of March&#160;31, 2023, with a $1.7&#160;million holdback, pursuant to the merger agreement for the Biorez Acquisition.  In addition, there are potential earn-out payments to Biorez&#8217; equity holders in an amount up to $165.0&#160;million based on the achievement of certain revenue targets for Biorez products during the sixteen (16) successive quarters commencing on October 1, 2022.  Biorez is a medical device start-up focused on advancing the healing of soft tissue using its proprietary BioBrace</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> implant technology.  The Biorez Acquisition was funded through a combination of cash on hand and long-term borrowings.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">Net sales and earnings for Biorez were immaterial for the three months ended March&#160;31, 2023. We also believe the proforma information is immaterial for disclosure for the three months ended March&#160;31, 2022.  </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">The allocation of purchase price for these acquisitions is preliminary and therefore subject to adjustment during the measurement adjustment periods.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAndAssetAcquisitionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -URI https://asc.fasb.org/topic&amp;trid=2303972<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4946-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140393985435296">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenues<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerTextBlock', window );">Revenues</a></td>
<td class="text">Revenues<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables present revenue disaggregated by primary geographic market where the products are sold, by product line and timing of revenue recognition: </span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:31.209%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.581%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Orthopedic Surgery</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">General Surgery</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Orthopedic Surgery</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">General Surgery</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Primary Geographic Markets</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,944&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115,645&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">164,589&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,947&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93,280&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131,227&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe, Middle East &amp; Africa</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,120&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,896&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,016&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,980&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,326&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,306&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia Pacific</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,121&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,986&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,107&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,418&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,954&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,372&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Americas (excluding the United States)</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,990&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,766&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,756&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,172&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,250&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,422&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 19pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total sales from contracts with customers</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131,175&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">164,293&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">295,468&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107,517&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">134,810&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">242,327&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Timing of Revenue Recognition</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goods transferred at a point in time</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121,122&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">162,590&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">283,712&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98,204&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">133,322&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">231,526&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Services transferred over time</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,053&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,703&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,756&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,313&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,488&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,801&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 19pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total sales from contracts with customers</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131,175&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">164,293&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">295,468&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107,517&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">134,810&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">242,327&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:31.209%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.581%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr></table></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contract liability balances related to the sale of extended warranties to customers are as follows:</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.987%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.344%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.346%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract liability</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,887&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,114&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue recognized during the three months ended March&#160;31, 2023 and March&#160;31, 2022 from amounts included in contract liabilities at the beginning of the period were $4.2 million and $3.9 million, respectively.  There were no material </span></div>contract assets as of March&#160;31, 2023 and December&#160;31, 2022.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI https://asc.fasb.org/topic&amp;trid=49130388<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130551-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130556-203045<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130550-203045<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130558-203045<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140394088514528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Comprehensive Income<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNoteTextBlock', window );">Comprehensive Income</a></td>
<td class="text">Comprehensive Income<div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Comprehensive income consists of the following:</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:1pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:79.747%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.110%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.113%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,819&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,975&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flow hedging gain, net of income tax (income tax expense of $280 and $346 for the three months ended March 31, 2023 and 2022, respectively)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">877&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,082&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension liability, net of income tax (income tax expense of $129 and $127 for the three months ended March 31, 2023 and 2022, respectively)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">403&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">521&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,596&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(163)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:9pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 7.75pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive income</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,695&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,415&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accumulated other comprehensive loss consists of the following:</span></div><div style="text-indent:36pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.268%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.526%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash Flow<br/>Hedging<br/>Gain (Loss)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Pension<br/>Liability</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cumulative<br/>Translation<br/>Adjustments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated<br/>Other<br/>Comprehensive<br/>Income (Loss)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, December 31, 2022</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,497&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23,749)</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36,606)</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(57,858)</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income before reclassifications, net of tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,923&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,596&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,519&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive income (loss) before tax</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">a</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,381)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">532&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(849)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">335&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(129)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">206&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:8pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net current-period other comprehensive income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">877&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">403&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,596&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,876&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, March 31, 2023</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,374&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23,346)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35,010)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(54,982)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="margin-bottom:1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.268%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.526%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash Flow<br/>Hedging<br/>Gain (Loss)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Pension<br/>Liability</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cumulative<br/>Translation<br/>Adjustments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated<br/>Other<br/>Comprehensive<br/>Income (Loss)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, December 31, 2021</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,656&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29,671)</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28,188)</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(54,203)</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications, net of tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,460&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(163)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,297&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive income (loss) before tax</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">a</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,819)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">648&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,171)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">441&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(127)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">314&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net current-period other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,082&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">521&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(163)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,440&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, March 31, 2022</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,738&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29,150)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28,351)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(52,763)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)  The cash flow hedging gain (loss) and pension liability accumulated other comprehensive loss components are included in sales or cost of sales and as a component of net periodic pension cost, respectively.  Refer to Note 7 and Note 13, respectively, for further details.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNoteTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -URI https://asc.fasb.org/topic&amp;trid=2134417<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNoteTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140393982594416">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value of Financial Instruments<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesAndFairValueTextBlock', window );">Fair Value of Financial Instruments</a></td>
<td class="text">Fair Value of Financial Instruments<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We enter into derivative instruments for risk management purposes only.  We operate internationally and, in the normal course of business, are exposed to fluctuations in interest rates, foreign exchange rates and commodity prices.  These fluctuations can increase the costs of financing, investing and operating the business.  We use forward contracts, a type of derivative instrument, to manage certain foreign currency exposures.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">By nature, all financial instruments involve market and credit risks.  We enter into forward contracts with major investment grade financial institutions and have policies to monitor the credit risk of those counterparties.  While there can be no assurance, we do not anticipate any material non-performance by any of these counterparties.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Foreign Currency Forward Contracts.  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We hedge forecasted intercompany sales denominated in foreign currencies through the use of forward contracts.&#160;&#160;We account for these forward contracts as cash flow hedges.&#160;&#160;To the extent these forward contracts meet hedge accounting criteria, changes in their fair value are not included in current earnings but are included in accumulated other comprehensive loss.&#160;&#160;These changes in fair value will be recognized into earnings as a component of sales or cost of sales when the forecasted transaction occurs.&#160;&#160;</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also enter into forward contracts to exchange foreign currencies for United States dollars in order to hedge our currency transaction exposures on intercompany receivables designated in foreign currencies.&#160;&#160;These forward contracts settle each month at month-end, at which time we enter into new forward contracts.&#160;&#160;We have not designated these forward contracts as hedges and have not applied hedge accounting to them.&#160;&#160;</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the notional contract amounts for forward contracts outstanding:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:38.929%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.401%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.401%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.403%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">FASB ASC Topic 815 Designation</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward exchange contracts</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flow hedge</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">199,005&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">198,473&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward exchange contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-designated</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98,173&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81,929&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The remaining time to maturity as of March&#160;31, 2023 is within two years for hedge designated foreign exchange contracts and approximately one month for non-hedge designated forward exchange contracts.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Statement of comprehensive income presentation</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Derivatives designated as cash flow hedges</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Foreign exchange contracts designated as cash flow hedges had the following effects on accumulated other comprehensive income (loss) ("AOCI") and net earnings on our consolidated condensed statements of comprehensive income and our consolidated condensed balance sheets:</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:27.639%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.551%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.551%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.386%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.002%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.551%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.551%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.551%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.553%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount of Gain Recognized in AOCI</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="12" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated Condensed Statements  of Comprehensive Income</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount of Gain Reclassified from AOCI</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="36" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/><td colspan="6" style="border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Amount of Line Item Presented</span></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivative Instrument</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Location of amount reclassified</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,538&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,247&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Sales</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">295,468&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">242,327&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">575&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,744&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of Sales</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">140,147&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106,336&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">806&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pre-tax gain</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,538&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,247&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,381&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,819&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">615&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">787&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">335&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">441&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net gain</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,923&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,460&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,046&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,378&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:27.993%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.525%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.525%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.666%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.525%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.525%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.525%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.536%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr></table></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At March&#160;31, 2023, $3.3 million of net unrealized gains on forward contracts accounted for as cash flow hedges, and included in accumulated other comprehensive loss, are expected to be recognized in earnings in the next twelve months.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Derivatives not designated as cash flow hedges</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net gains and losses from derivative instruments not accounted for as hedges and losses on our intercompany receivables on our consolidated condensed statements of comprehensive income were:</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:32.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:44.367%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.087%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.285%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivative Instrument</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Location on Consolidated Condensed Statements of Comprehensive Income</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss on currency forward contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling and administrative expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(366)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(958)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net gain on currency transaction exposures</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling and administrative expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">415&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Balance sheet presentation</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We record these forward foreign exchange contracts at fair value.  The following tables summarize the fair value for forward foreign exchange contracts outstanding at March&#160;31, 2023 and December&#160;31, 2022: </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:35.157%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:31.209%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.700%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Location on Consolidated Condensed Balance Sheet</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Asset Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net<br/>Fair<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives designated as hedged instruments:</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,869&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,476)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,393&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">485&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(424)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,354&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,900)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,454&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives not designated as hedging instruments:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(334)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(282)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total derivatives</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,406&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,234)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,172&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:35.157%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:31.209%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.700%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Location on Consolidated Condensed Balance Sheet</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Asset Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net<br/>Fair<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives designated as hedged instruments:</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,757&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,121)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,636&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(400)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(340)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,817&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,521)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,296&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives not designated as hedging instruments:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(395)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(347)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total derivatives</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,865&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,916)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,949&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our forward foreign exchange contracts are subject to a master netting agreement and qualify for netting in the consolidated condensed balance sheets. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Fair Value Disclosure.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  FASB guidance defines fair value and establishes a framework for measuring fair value and related disclosure requirements.  This guidance applies when fair value measurements are required or permitted.  The guidance indicates, among other things, that a fair value measurement assumes that the transaction to sell an asset or transfer a liability occurs in the principal market for the asset or liability or, in the absence of a principal market, the most advantageous market for the asset or liability.  Fair value is defined based upon an exit price model.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Valuation Hierarchy. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> A valuation hierarchy was established for disclosure of the inputs to the valuations used to measure fair value.  This hierarchy prioritizes the inputs into three broad levels as follows.  Level 1 inputs are quoted prices (unadjusted) in active markets for identical assets or liabilities.  Level 2 inputs are quoted prices for similar assets and liabilities in active markets, quoted prices for identical or similar assets in markets that are not active, inputs other than quoted prices that are observable for the asset or liability, including interest rates, yield curves and credit risks, or inputs that are derived principally from or corroborated by observable market data through correlation.  Level 3 inputs are unobservable inputs based on our own assumptions used to measure assets and liabilities at fair value.  A financial asset or liability&#8217;s classification within the hierarchy is determined based on the lowest level input that is significant to the fair value measurement.  There have been no significant changes in the assumptions.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:107%">Valuation Techniques. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"> Assets and liabilities carried at fair value and measured on a recurring basis as of March&#160;31, 2023 consist of forward foreign exchange contracts and contingent consideration.  The Company values its forward foreign exchange contracts using quoted prices for similar assets.  The most significant assumption is quoted currency rates.  The value of the forward foreign exchange contract assets and liabilities were valued using Level 2 inputs and are listed in the table above.&#160;&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">The Company values contingent consideration from the In2Bones and Biorez acquisitions using Level 3 inputs.  The contingent consideration was recorded at fair value at the date of acquisition based on the consideration expected to be transferred, estimated as the probability-weighted future cash flows, discounted back to present value. The fair value of contingent consideration is measured using projected payment dates, discount rates, revenue volatilities and projected revenues. The recurring Level 3 fair value measurements of contingent consideration for which the liabilities are recorded include the following significant unobservable inputs as of March&#160;31, 2023:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:56.356%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.577%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.783%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.784%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assumptions</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unobservable Input</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">In2Bones</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Biorez</span></td></tr><tr style="height:6pt"><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.52%</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.32%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue volatility</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.11%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.88%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Projected year of payment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023-2026</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023-2026</span></div></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Adjustments to the fair value of contingent consideration relate to the passage of time and changes in market assumptions.  Changes in the fair value of contingent consideration liabilities for the three months ended March&#160;31, 2023 are as follows:</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:41.443%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:27.705%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">In2Bones</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Biorez</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Location in Financial Statements</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of January 1, 2023</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70,198&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116,234&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in fair value of contingent consideration</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,637&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,799&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling and administrative expense</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of March 31, 2023</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72,835&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118,033&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">Contingent consideration of $38.7 million and $152.2 million is included in other current liabilities and other long-term liabilities, respectively, in the consolidated condensed balance sheet at March&#160;31, 2023.  Contingent consideration of $18.6 million and $167.8 million is included in other current liabilities and other long term liabilities, respectively, in the consolidated condensed balance sheet at December 31, 2022.</span></div>The carrying amounts reported in our consolidated condensed balance sheets for cash and cash equivalents, accounts receivable, accounts payable and variable long-term debt approximate fair value.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativesAndFairValueTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for derivatives and fair value of assets and liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -URI https://asc.fasb.org/topic&amp;trid=2155941<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -URI https://asc.fasb.org/topic&amp;trid=2229140<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativesAndFairValueTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140394067894656">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Inventories<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryDisclosureTextBlock', window );">Inventories</a></td>
<td class="text">Inventories<div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories consist of the following:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.560%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.206%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">124,122&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110,677&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work-in-process</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,487&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,166&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">184,761&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">195,477&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">335,370&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">332,320&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -URI https://asc.fasb.org/topic&amp;trid=2126998<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140393985725536">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings Per Share<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">Earnings Per Share</a></td>
<td class="text">Earnings Per ShareBasic earnings per share (&#8220;basic EPS&#8221;) is computed by dividing net income by the weighted average number of common shares outstanding for the reporting period.  Diluted earnings per share (&#8220;diluted EPS&#8221;) gives effect to all dilutive potential shares. <div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the computation of basic and diluted earnings per share for the three months ended March 31, 2023 and 2022:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:25.800%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.605%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31, 2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Basic EPS</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Adjustments</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Diluted EPS</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Basic EPS</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Adjustments</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Diluted EPS</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,819&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,819&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,975&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,715&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,690&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares outstanding</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,511&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,511&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,428&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,428&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">629&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">629&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,158&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,158&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warrants</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">684&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">684&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Convertible notes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,885&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,885&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,511&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">693&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,204&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,428&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,727&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,155&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EPS</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.06&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.06&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.51&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.47&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:25.800%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.605%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The shares used in the calculation of diluted EPS exclude stock options and stock appreciation rights to purchase shares where the exercise price was greater than the average market price of common shares for the period and the effect of the inclusion would be anti-dilutive.  Such shares aggregated approximately 2.2 million and 0.9 million for the three months ended March&#160;31, 2023 and 2022, respectively.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109243012&amp;loc=SL65017193-207537<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -URI https://asc.fasb.org/topic&amp;trid=2144383<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140393985760352">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Other Intangible Assets<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock', window );">Goodwill and Other Intangible Assets</a></td>
<td class="text">Goodwill and Other Intangible Assets<div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The changes in the net carrying amount of goodwill for the three months ended March&#160;31, 2023 are as follows:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:84.426%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.374%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2022</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">815,429&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of March 31, 2023</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">815,499&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Assets and liabilities of acquired businesses are recorded at their estimated fair values as of the date of acquisition.&#160;&#160;Goodwill represents costs in excess of fair values assigned to the underlying net assets of acquired businesses.&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other intangible assets consist of the following:</span></div><div style="text-align:justify;text-indent:15.75pt"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:36.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.333%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average Amortization Period (Years)</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross<br/>Carrying<br/>Amount</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross<br/>Carrying<br/>Amount</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Intangible assets with definite lives:</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer and distributor relationships</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">369,881&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(175,291)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">369,854&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(170,870)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales representation, marketing and promotional rights</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149,376&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(67,500)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149,376&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(66,000)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed technology</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">320,204&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37,146)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">320,204&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34,675)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patents and other intangible assets</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80,335&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(52,865)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79,838&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(52,472)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Intangible assets with indefinite lives:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks and tradenames</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86,544&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86,544&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,006,340&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(332,802)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,005,816&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(324,017)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Customer and distributor relationships, trademarks and tradenames, developed technology and patents and other intangible assets primarily represent allocations of purchase price to identifiable intangible assets of acquired businesses.  Sales representation, marketing and promotional rights represent intangible assets created under our agreement with Musculoskeletal Transplant Foundation (&#8220;MTF&#8221;).</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization expense related to intangible assets which are subject to amortization totaled $8.8 million and $8.0 million for the three months ended March 31, 2023 and 2022, respectively, and is included as a reduction of revenue (for amortization related to our sales representation, marketing and promotional rights) and in selling and administrative expense (for all other intangible assets) in the consolidated condensed statements of comprehensive income.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated intangible asset amortization expense remaining for the year ending December&#160;31, 2023 and for each of the five succeeding years is as follows:</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:1pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:57.025%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.223%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.824%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.930%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.824%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.374%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amortization included in expense</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amortization recorded as a reduction of revenue</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remaining, 2023</span></div></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,947&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,500&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,447&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,773&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,773&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,563&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,563&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,316&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,316&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,367&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,367&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,507&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,507&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -URI https://asc.fasb.org/topic&amp;trid=2144416<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140393985696080">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long Term Debt<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtTextBlock', window );">Long-Term Debt</a></td>
<td class="text">Long-Term Debt<div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-term debt consists of the following:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"/><td style="width:72.793%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.289%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.881%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revolving line of credit</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79,000&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70,000&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term loan, net of deferred debt issuance costs of $678 and $729 in 2023 and 2022, respectively</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">133,910&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">133,858&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.625% convertible notes, net of deferred debt issuance costs of $332 and $432 in 2023 and 2022, respectively</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69,668&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69,568&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.250% convertible notes, net of deferred debt issuance costs of $17,771 and $18,834 in 2023 and 2022, respectively</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">782,229&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">781,166&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">162&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">230&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,064,969&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,054,822&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less:&#160;&#160;Current portion</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69,693&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69,746&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total long-term debt</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">995,276&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">985,076&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Seventh Amended and Restated Senior Credit Agreement</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On July&#160;16, 2021, we entered into a seventh amended and restated senior credit agreement consisting of: (a) a $233.5&#160;million term loan facility and (b) a $585.0&#160;million revolving credit facility. The revolving credit facility will terminate and the loans outstanding under the term loan facility will expire on July&#160;16, 2026. The term loan was payable in quarterly installments increasing over the term of the facility.  During 2022, we made a $90.0&#160;million prepayment on the term loan facility resulting in the elimination of such quarterly payments with the remaining balance due upon the expiration of the term loan facility. Proceeds from the term loan facility and borrowings under the revolving credit facility were used to repay the then existing senior credit agreement. Interest rates are at the term secured overnight financing rate plus 0.1148% ("Adjusted Term SOFR") (4.927% at March&#160;31, 2023) plus an interest rate margin of 1.125% (6.052% at March&#160;31, 2023). For borrowings where we elect to use the alternate base rate, the initial base rate is the greatest of (i) the Prime Rate, (ii) the Federal Funds Rate plus 0.50% or (iii) the one-month Adjusted Term SOFR plus 1.00%, plus, in each case, an interest rate margin. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were $134.6 million in borrowings outstanding on the term loan facility as of March&#160;31, 2023.  There were $79.0 million in borrowings outstanding under the revolving credit facility as of March&#160;31, 2023.  Our available borrowings on the revolving credit facility at March&#160;31, 2023 were $504.2 million with approximately $1.8 million of the facility set aside for outstanding letters of credit. The carrying amounts of the term loan and revolving credit facility approximate fair value.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The seventh amended and restated senior credit agreement is collateralized by substantially all of our personal property and assets.  The seventh amended and restated senior credit agreement contains covenants and restrictions which, among other things, require the maintenance of certain financial ratios and restrict dividend payments and the incurrence of certain indebtedness and other activities, including acquisitions and dispositions.  We were in full compliance with these covenants and restrictions as of March&#160;31, 2023.  We are also required, under certain circumstances, to make mandatory prepayments from net cash proceeds from any issuance of equity and asset sales.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">2.625% Convertible Notes</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 29, 2019, we issued $345.0 million aggregate principal amount of 2.625% convertible notes due in 2024 (the "2.625% Notes").  Interest is payable semi-annually in arrears on February 1 and August 1 of each year, commencing August 1, 2019.  The 2.625% Notes will mature on February 1, 2024, unless earlier repurchased or converted.  The 2.625% Notes represent subordinated unsecured obligations and are convertible under certain circumstances, as defined in the indenture, into a combination of cash and CONMED common stock.&#160;&#160;The 2.625% Notes may be converted at an initial conversion rate of 11.2608 shares of our common stock per $1,000 principal amount of 2.625% Notes (equivalent to an initial conversion price of approximately $88.80 per share of common stock).  Holders of the 2.625% Notes may convert the 2.625% Notes at their option at any time on or after November 1, 2023 through the second scheduled trading day preceding the maturity date.  Holders of the 2.625% Notes will also have the right to convert the 2.625% Notes prior to November 1, 2023, but only upon the occurrence of specified events.  The conversion rate is subject to anti-dilution adjustments if certain events occur.  A portion of the net proceeds from the offering of the 2.625% Notes were used as part of the financing for the Buffalo Filter acquisition and $21.0 million were used to pay the cost of certain convertible notes hedge transactions as further described below.  </span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On June 6, 2022, the Company repurchased and extinguished $275.0 million principal amount of the 2.625% Notes for aggregate consideration consisting of $275.0 million in cash and approximately 0.9 million shares of the Company's common stock.  Concurrently, the Company entered into a Supplemental Indenture related to the remaining $70.0 million in 2.625% Notes, in which the Company irrevocably elected to settle the principal value of those 2.625% Notes in cash. The $70.0 million in 2.625% Notes are reflected in the current portion of long-term debt at March&#160;31, 2023.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended March 31, 2023 and 2022, we have recorded interest expense on the 2.625% Notes of $0.5 million and $2.3 million, respectively, at the contractual coupon rate of 2.625%.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">The estimated fair value of the 2.625% Notes was approximately $85.3 million as of March&#160;31, 2023 based on a market approach which represents a Level 2 valuation in the fair value hierarchy.  The estimated fair value was determined based on the estimated or actual bids and offers of the 2.625% Notes in an over-the-counter market transaction on the last business day of the period.  </span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">2.250% Convertible Notes</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">On June 6, 2022, we issued $800.0 million aggregate principal amount of 2.250% Notes.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:107%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">Interest is payable semi-annually in arrears on June 15 and December 15 of each year, commencing December 15, 2022.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:107%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">The 2.250% Notes will mature on June 15, 2027, unless earlier repurchased or converted. The 2.250% Notes represent subordinated unsecured obligations and are convertible under certain circumstances, as defined in the indenture, into a combination of cash and CONMED common stock, with the principal required to be paid in cash.  The 2.250% Notes may be converted at an initial conversion rate of 6.8810 shares of our common stock per $1,000 principal amount of the 2.250% Notes (equivalent to an initial conversion price of approximately $145.33 per share of common stock).  Holders of the 2.250% Notes may convert the 2.250% Notes at their option at any time on or after March 15, 2027 through the second scheduled trading day preceding the maturity date.  Holders of the 2.250% Notes will also have the right to convert the 2.250% Notes prior to March 15, 2027, but only upon the occurrence of specified events.  The conversion rate is subject to anti-dilution adjustments if certain events occur.  A portion of these proceeds were used to repurchase and extinguish a portion of the 2.625% Notes, pay off our then outstanding balance on our revolving line of credit, pay down of $90.0&#160;million of our term loan and partially pay for the In2Bones Acquisition.  In addition, approximately $115.6 million of the proceeds were used to pay the cost of certain convertible notes hedge transactions related to the 2.250% Notes.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">For the three months ended March&#160;31, 2023, we have recorded interest expense on the 2.250% Notes of</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:107%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">$4.5 million at the contractual coupon rate of 2.250%.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The estimated fair value of the 2.250% Notes was approximately $796.1 million as of March&#160;31, 2023 based on a market approach which represents a Level 2 valuation in the fair value hierarchy.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The estimated fair value was determined based on the estimated or actual bids and offers of the 2.250% Notes in an over-the-counter market transaction on the last business day of the period.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Convertible Notes Hedge Transactions</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">In connection with the offerings of the 2.625% and 2.250% Notes, we entered into convertible notes hedge transactions with a number of financial institutions (each, an &#8220;option counterparty&#8221;).  The convertible notes hedge transactions cover, subject to anti-dilution adjustments substantially similar to those applicable to the respective Notes, the number of shares of our common stock underlying the 2.625% and 2.250% Notes.  Concurrent with entering into the convertible notes hedge transactions, we also entered into separate warrant transactions with each option counterparty whereby we sold to such option counterparty warrants to purchase, subject to customary anti-dilution adjustments, the same number of shares of our common stock.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In connection with the repurchase and extinguishment of $275.0 million principal amount of the 2.625% Notes, the Company entered into agreements with the option counterparties to terminate a corresponding portion of the hedges on the 2.625% Notes.  </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The convertible notes hedge transactions are expected generally to reduce the potential dilution upon conversion of the Notes and/or offset any cash payments we are required to make in excess of the principal amount of converted Notes, as the case may be, in the event that the market price per share of our common stock, as measured under the terms of the convertible notes hedge transactions, is greater than the strike price of the convertible notes hedge transactions, which initially corresponds to the conversion price of the Notes and is subject to anti-dilution adjustments substantially similar to those applicable to the conversion rate of the Notes.  If, however, the market price per share of our common stock, as measured under the terms of the warrant transactions, exceeds the strike price ($114.92 for the 2.625% Notes and $251.53 for the 2.250% Notes) of the warrants, there would nevertheless be dilution to the extent that such market price exceeds the strike price of the warrants, </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">unless we elect to settle the warrants in cash.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The scheduled&#160;maturities&#160;of&#160;long-term&#160;debt outstanding at March&#160;31, 2023 are as follows:</span></div><div style="text-align:justify"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:85.263%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.537%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remaining, 2023</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">213,588&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">800,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">The above amounts exclude deferred debt issuance costs and financing leases.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-term debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI https://asc.fasb.org/topic&amp;trid=2208564<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140393988411328">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Guarantees<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GuaranteesAbstract', window );"><strong>Guarantees [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductWarrantyDisclosureTextBlock', window );">Guarantees</a></td>
<td class="text">Guarantees<div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We provide warranties on certain of our products at the time of sale and sell extended warranties.  The standard warranty period for our capital equipment is generally one year and our extended warranties typically vary from one to three years.  Liability under service and warranty policies is based upon a review of historical warranty and service claim experience.  Adjustments are made to accruals as claim data and historical experience warrant.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the liability for standard warranties for the three months ended March 31, are as follows:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:77.993%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.987%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.990%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of January 1,</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,944&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,344&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for warranties</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">197&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Claims made</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(198)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(187)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of March 31,</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,861&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,354&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Costs associated with extended warranty repairs are recorded as incurred and amounted to $1.5 million and $1.6 million for the three months ended March 31, 2023 and 2022, respectively.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GuaranteesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GuaranteesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProductWarrantyDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for standard and extended product warranties and other product guarantee contracts, including a tabular reconciliation of the changes in the guarantor's aggregate product warranty liability for the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -URI https://asc.fasb.org/topic&amp;trid=2155896<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProductWarrantyDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140393985877744">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Pension Plan<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Retirement Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock', window );">Pension Plan</a></td>
<td class="text">Pension Plan<div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net periodic pension cost consists of the following:&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:77.993%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.987%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.990%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service cost</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">194&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">269&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost on projected benefit obligation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">911&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">537&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected return on plan assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,032)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,324)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net amortization and deferral</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">532&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">648&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net periodic pension cost</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">605&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div>We do not expect to make any pension contributions during 2023.  Non-service pension cost/(benefit) was immaterial for the three months ended March&#160;31, 2023 and 2022.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for retirement benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section S99<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=21916913&amp;loc=d3e273930-122802<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (o)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (p)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 70<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=49170846&amp;loc=d3e28014-114942<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -URI https://asc.fasb.org/topic&amp;trid=2235017<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 60<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=6414203&amp;loc=d3e39689-114964<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (q)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (r)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iii)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (l)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (r)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140393982583520">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Segment<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">Business Segment</a></td>
<td class="text">Business Segment<div style="margin-top:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are accounting and reporting for our business as a single operating segment entity engaged in the development, manufacturing and sale on a global basis of surgical devices and related equipment.  Our chief operating decision maker (the CEO) evaluates the various global product portfolios on a net sales basis and evaluates profitability, investment, cash flow metrics and allocates resources on a consolidated worldwide basis due to shared infrastructure and resources.  Our product lines consist of orthopedic surgery and general surgery.  Orthopedic surgery consists of sports medicine instrumentation and small bone, large bone and specialty powered surgical instruments as well as imaging systems for use in minimally invasive surgery procedures and fees related to the sales representation, promotion and marketing of sports medicine allograft tissue.  General surgery consists of a complete line of endo-mechanical instrumentation for minimally invasive laparoscopic and gastrointestinal procedures, smoke evacuation devices, a line of cardiac monitoring products as well as electrosurgical generators and related instruments.  These product lines' net sales are as follows:</span></div><div style="margin-top:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.976%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.498%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Orthopedic surgery</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131,175&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107,517&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General surgery</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">164,293&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">134,810&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated net sales</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">295,468&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">242,327&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 34<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8981-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8721-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 26<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8844-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8657-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8721-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -URI https://asc.fasb.org/topic&amp;trid=2134510<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140393985733824">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Legal Proceedings<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LegalMattersAndContingenciesTextBlock', window );">Legal Proceedings</a></td>
<td class="text">Legal Proceedings<div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, the Company may receive an information request, subpoena or warrant from a government agency such as the Securities and Exchange Commission, Department of Justice, Equal Employment Opportunity Commission, the Occupational Safety and Health Administration, the United States Food and Drug Administration, the Department of Labor, the Treasury Department or other federal and state agencies or foreign governments or government agencies.  These information requests, subpoenas or warrants may or may not be routine inquiries, or may begin as routine inquiries and over time develop into enforcement actions of various types.  Likewise, if we receive reports of alleged misconduct from employees and third parties, we investigate as appropriate.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Manufacturers of medical devices have been the subject of various enforcement actions relating to interactions with health care providers domestically or internationally whereby companies are claimed to have provided health care providers with inappropriate incentives to purchase their products.  Similarly, the Foreign Corrupt Practices Act ("FCPA") imposes obligations on manufacturers with respect to interactions with health care providers who may be considered government officials based on their affiliation with public hospitals.  The FCPA also requires publicly listed manufacturers to maintain accurate books and records, and maintain internal accounting controls sufficient to provide assurance that transactions are accurately recorded, lawful and in accordance with management's authorization.  The FCPA poses unique challenges both because manufacturers operate in foreign cultures in which conduct illegal under the FCPA may not be illegal in local jurisdictions, and because, in some cases, a United States manufacturer may face risks under the FCPA based on the conduct of third parties over whom the manufacturer may not have complete control.  While CONMED has not experienced any material enforcement action to date, there can be no assurance that the Company will not be subject to a material enforcement action in the future, or that the Company will not incur costs including, in the form of fees for lawyers and other consultants, that are material to the Company&#8217;s results of operations in the course of responding to a future inquiry or investigation.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Manufacturers of medical products may face exposure to significant product liability claims, as well as patent infringement and other claims incurred in the ordinary course of business.  To date, we have not experienced any claims that have been material to our financial statements or financial condition, but any such claims arising in the future could have a material adverse effect on our business, results of operations or cash flows.  We currently maintain commercial product liability insurance of $35 million per incident and $35 million in the aggregate annually, which we believe is adequate.  This coverage is on a claims-made basis.  There can be no assurance that claims will not exceed insurance coverage, that the carriers will be solvent or that such insurance will be available to us in the future at a reasonable cost.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our operations are subject, and in the past have been subject, to a number of environmental laws and regulations governing, among other things, air emissions; wastewater discharges; the use, handling and disposal of hazardous substances and wastes; soil and groundwater remediation and employee health and safety.  Likewise, the operations of our suppliers and sterilizers are subject to similar environmental laws and regulations.  In some jurisdictions, environmental requirements may be expected to become more stringent in the future.  In the United States, certain environmental laws can impose liability for the entire cost of site restoration upon each of the parties that may have contributed to conditions at the site regardless of fault or </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the lawfulness of the party&#8217;s activities.  While we do not believe that the present costs of environmental compliance and remediation are material, there can be no assurance that future compliance or remedial obligations would not have a material adverse effect on our financial condition, results of operations or cash flows.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CONMED is defending two Georgia State Court actions.  The first action was filed in Cobb County by various employees, former employees, contract workers and others against CONMED and against a contract sterilizer (the "Cobb County Action"). The second action was filed in Douglas County against CONMED&#8217;s landlord and other allegedly related entities (the "Douglas County Action").  Plaintiffs in the lawsuits allege personal injury and related claims purportedly arising from or relating to exposure to Ethylene Oxide, a chemical used to sterilize certain products.  CONMED is defending the claims asserted directly against it and is providing indemnification for certain other defendants based on contractual provisions. </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Both actions are in their early stages.  The Company's motion to dismiss in the Cobb County action was heard on January 10, 2022, and the Court issued a ruling on June 15, 2022 dismissing 44 of the 51 plaintiffs' claims as precluded by the exclusive workers' compensation remedy, as well as one claim from a non-employee plaintiff.  As to the remaining claims that were not the subject of the motion to dismiss, CONMED believes it has strong defenses and will vigorously defend itself and all parties it is indemnifying.  As with any litigation, there are risks, including the risk that CONMED may not prevail with respect to the defense of the underlying claims, or with respect to securing adequate insurance coverage for the indemnification claims.  The Company is unable to estimate a range of possible loss at this time, and has not recorded any expense related to potential damages in connection with this matter because the Company does not believe any potential loss is probable.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">CONMED submitted the foregoing claims for insurance coverage.  One insurer is providing coverage for certain of the claims asserted directly against the Company.  CONMED litigated two lawsuits in the United States District Court for the Northern District of New York with Federal Insurance Company (&#8220;Chubb&#8221;): one involving CONMED&#8217;s claim for coverage for the indemnification claims arising from the Cobb County Action, and the other concerning CONMED&#8217;s claim for coverage for the indemnification claims arising from the Douglas County Action.  On March 10, 2022, the Court ruled in favor of CONMED with respect to coverage for the indemnification claims arising from the Cobb County Action.  Chubb's motion for reconsideration was denied, and Chubb filed a notice of appeal.  On August 9, 2022, CONMED won a similar ruling finding in its favor and against Chubb as to the coverage case concerning the Douglas County Action.  Chubb appealed that decision as well.  Chubb subsequently withdrew its appeal in connection with a favorable settlement between the parties.  There can be no assurance that Chubb will honor its obligations prospectively.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, one of CONMED&#8217;s contract sterilizers, which is defending toxic tort claims asserted by various residents in the areas around its processing facility, has placed CONMED on notice of a claim for indemnification relating to some of those claims.  CONMED is reviewing the notice, and has not at this time taken any position on the notice.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The government of Italy passed a law in late 2015 to tax medical device companies on revenue derived from sales to public hospitals.  The tax is calculated and based on provincial spending over and above certain thresholds.  Since the law was enacted, the Italian government essentially made no effort to administer or collect the tax.  A lack of interpretative guidance and complexity of the law resulted in uncertainty as to the actual amount of liability.  In September 2022, the Italian government passed a further decree which, amongst other provisions, delegated administration and collection to the provincial level for the years 2015 &#8211; 2018.  The Italy medical device tax represents variable consideration in the form of a retroactive discount potentially owed to the customer, which is ultimately the Italian government.  The Company is challenging the imposition of the medical device tax in Italy, as have many other medical device companies, on the ground that the law was never implemented properly with regulations.  While the Company is informed that its position is well-grounded in the law, there can be no assurance that the Company will prevail.  In January 2023, the Italian government postponed the due date for payment of the tax to allow time for Italian courts to rule on the constitutionality of the law.   No amounts have been remitted to date.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">From time to time, we are also subject to negligence and other claims arising out of the ordinary conduct of our business, including, for example, automobile or other accidents our employees may experience within the course of their employment or otherwise and which may, on occasion, involve potentially significant personal injuries or other exposures.  In the first quarter of 2023, the Company reached an agreement to settle one such personal injury lawsuit. The settlement is covered by the Company&#8217;s insurance coverage and did not have a material impact on our financial position or results of operations.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We record reserves sufficient to cover probable and estimable losses associated with any such pending claims.  We do not expect that the resolution of any pending claims, investigations or reports of alleged misconduct will have a material adverse effect on our financial condition, results of operations or cash flows.  There can be no assurance, however, that future claims or investigations, or the costs associated with responding to such claims, investigations or reports of misconduct, especially claims and investigations not covered by insurance, will not have a material adverse effect on our financial condition, results of operations or cash flows.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LegalMattersAndContingenciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for legal proceedings, legal contingencies, litigation, regulatory and environmental matters and other contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI https://asc.fasb.org/topic&amp;trid=2127136<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LegalMattersAndContingenciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140393985754240">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Interim Reporting (Policies)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Preparation of the consolidated condensed financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated condensed financial statements and the reported amounts of revenue and expenses during the reporting period.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6191-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6161-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6143-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6061-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6132-108592<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140393985787952">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>New Accounting Pronouncements (Policies)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract', window );"><strong>Accounting Standards Update and Change in Accounting Principle [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">New Accounting Pronouncements</a></td>
<td class="text">New Accounting Pronouncements<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recently Issued Accounting Standards, Not Yet Adopted</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2020, the Financial Accounting Standards Board ("FASB") issued ASU 2020-04, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting, which provides optional guidance if certain criteria are met for entities that have contracts, hedging relationships, and other transactions that reference LIBOR or other reference rates expected to be discontinued as a result of reference rate reform.  This ASU is effective as of March 12, 2020 through December 31, 2022 and was extended through December 31, 2024 by ASU 2022-06, Reference Rate Reform (Topic 848): Deferral of the Sunset Date of Topic 848.  The Company has not adopted these ASUs as of March&#160;31, 2023.  Our seventh amended and restated senior credit agreement includes language to address the change from LIBOR to SOFR, an alternative base rate, therefore we do not believe reference rate reform will have a significant impact on our consolidated financial statements.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140393988401808">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenues (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueTableTextBlock', window );">Disaggregation of Revenue</a></td>
<td class="text"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables present revenue disaggregated by primary geographic market where the products are sold, by product line and timing of revenue recognition: </span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:31.209%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.581%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Orthopedic Surgery</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">General Surgery</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Orthopedic Surgery</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">General Surgery</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Primary Geographic Markets</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,944&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115,645&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">164,589&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,947&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93,280&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131,227&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe, Middle East &amp; Africa</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,120&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,896&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,016&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,980&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,326&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,306&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia Pacific</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,121&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,986&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,107&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,418&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,954&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,372&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Americas (excluding the United States)</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,990&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,766&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,756&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,172&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,250&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,422&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 19pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total sales from contracts with customers</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131,175&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">164,293&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">295,468&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107,517&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">134,810&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">242,327&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Timing of Revenue Recognition</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goods transferred at a point in time</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121,122&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">162,590&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">283,712&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98,204&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">133,322&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">231,526&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Services transferred over time</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,053&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,703&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,756&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,313&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,488&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,801&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 19pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total sales from contracts with customers</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131,175&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">164,293&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">295,468&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107,517&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">134,810&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">242,327&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock', window );">Contract with Customer, Asset and Liability</a></td>
<td class="text"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contract liability balances related to the sale of extended warranties to customers are as follows:</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.987%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.344%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.346%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract liability</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,887&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,114&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of receivable, contract asset, and contract liability from contract with customer. Includes, but is not limited to, change in contract asset and contract liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130551-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140393988401808">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Comprehensive Income (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock', window );">Schedule of Comprehensive Income</a></td>
<td class="text"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Comprehensive income consists of the following:</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:1pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:79.747%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.110%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.113%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,819&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,975&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flow hedging gain, net of income tax (income tax expense of $280 and $346 for the three months ended March 31, 2023 and 2022, respectively)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">877&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,082&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension liability, net of income tax (income tax expense of $129 and $127 for the three months ended March 31, 2023 and 2022, respectively)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">403&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">521&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,596&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(163)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:9pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 7.75pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive income</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,695&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,415&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock', window );">Schedule of Accumulated Other Comprehensive Loss</a></td>
<td class="text"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accumulated other comprehensive loss consists of the following:</span></div><div style="text-indent:36pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.268%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.526%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash Flow<br/>Hedging<br/>Gain (Loss)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Pension<br/>Liability</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cumulative<br/>Translation<br/>Adjustments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated<br/>Other<br/>Comprehensive<br/>Income (Loss)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, December 31, 2022</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,497&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23,749)</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36,606)</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(57,858)</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income before reclassifications, net of tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,923&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,596&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,519&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive income (loss) before tax</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">a</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,381)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">532&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(849)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">335&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(129)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">206&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:8pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net current-period other comprehensive income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">877&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">403&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,596&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,876&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, March 31, 2023</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,374&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23,346)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35,010)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(54,982)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="margin-bottom:1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.268%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.526%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash Flow<br/>Hedging<br/>Gain (Loss)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Pension<br/>Liability</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cumulative<br/>Translation<br/>Adjustments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated<br/>Other<br/>Comprehensive<br/>Income (Loss)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, December 31, 2021</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,656&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29,671)</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28,188)</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(54,203)</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications, net of tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,460&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(163)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,297&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive income (loss) before tax</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">a</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,819)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">648&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,171)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">441&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(127)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">314&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net current-period other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,082&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">521&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(163)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,440&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, March 31, 2022</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,738&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29,150)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28,351)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(52,763)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)  The cash flow hedging gain (loss) and pension liability accumulated other comprehensive loss components are included in sales or cost of sales and as a component of net periodic pension cost, respectively.  Refer to Note 7 and Note 13, respectively, for further details.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of components of comprehensive income (loss). Includes, but is not limited to, foreign currency translation adjustments, foreign currency transactions designated as economic hedges of a net investment in foreign entity, gain (loss) and prior service cost (credit) for pension plans and other postretirement benefit plans.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e526-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140393980456304">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value of Financial Instruments (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock', window );">Schedule of Notional Amounts of Outstanding Derivative Positions</a></td>
<td class="text"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the notional contract amounts for forward contracts outstanding:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:38.929%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.401%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.401%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.403%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">FASB ASC Topic 815 Designation</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward exchange contracts</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flow hedge</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">199,005&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">198,473&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward exchange contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-designated</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98,173&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81,929&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock', window );">Schedule of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (Loss)</a></td>
<td class="text"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Foreign exchange contracts designated as cash flow hedges had the following effects on accumulated other comprehensive income (loss) ("AOCI") and net earnings on our consolidated condensed statements of comprehensive income and our consolidated condensed balance sheets:</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:27.639%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.551%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.551%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.386%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.002%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.551%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.551%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.551%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.553%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount of Gain Recognized in AOCI</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="12" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated Condensed Statements  of Comprehensive Income</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount of Gain Reclassified from AOCI</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="36" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/><td colspan="6" style="border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Amount of Line Item Presented</span></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivative Instrument</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Location of amount reclassified</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,538&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,247&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Sales</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">295,468&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">242,327&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">575&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,744&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of Sales</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">140,147&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106,336&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">806&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pre-tax gain</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,538&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,247&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,381&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,819&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">615&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">787&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">335&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">441&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net gain</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,923&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,460&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,046&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,378&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock', window );">Derivatives Not Designated as Hedging Instruments</a></td>
<td class="text"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net gains and losses from derivative instruments not accounted for as hedges and losses on our intercompany receivables on our consolidated condensed statements of comprehensive income were:</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:32.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:44.367%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.087%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.285%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivative Instrument</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Location on Consolidated Condensed Statements of Comprehensive Income</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss on currency forward contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling and administrative expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(366)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(958)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net gain on currency transaction exposures</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling and administrative expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">415&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfForeignExchangeContractsStatementOfFinancialPositionTableTextBlock', window );">Schedule of Fair Value for Forward Foreign Exchange Contracts</a></td>
<td class="text">The following tables summarize the fair value for forward foreign exchange contracts outstanding at March&#160;31, 2023 and December&#160;31, 2022: <div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:35.157%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:31.209%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.700%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Location on Consolidated Condensed Balance Sheet</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Asset Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net<br/>Fair<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives designated as hedged instruments:</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,869&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,476)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,393&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">485&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(424)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,354&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,900)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,454&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives not designated as hedging instruments:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(334)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(282)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total derivatives</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,406&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,234)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,172&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:35.157%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:31.209%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.700%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Location on Consolidated Condensed Balance Sheet</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Asset Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net<br/>Fair<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives designated as hedged instruments:</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,757&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,121)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,636&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(400)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(340)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,817&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,521)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,296&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives not designated as hedging instruments:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(395)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(347)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total derivatives</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,865&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,916)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,949&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock', window );">Fair Value Measurement Inputs and Valuation Techniques</a></td>
<td class="text">The recurring Level 3 fair value measurements of contingent consideration for which the liabilities are recorded include the following significant unobservable inputs as of March&#160;31, 2023:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:56.356%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.577%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.783%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.784%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assumptions</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unobservable Input</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">In2Bones</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Biorez</span></td></tr><tr style="height:6pt"><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.52%</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.32%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue volatility</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.11%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.88%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Projected year of payment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023-2026</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023-2026</span></div></td></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock', window );">Schedule of Business Acquisitions by Acquisition, Contingent Consideration</a></td>
<td class="text">Changes in the fair value of contingent consideration liabilities for the three months ended March&#160;31, 2023 are as follows:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:41.443%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:27.705%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">In2Bones</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Biorez</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Location in Financial Statements</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of January 1, 2023</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70,198&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116,234&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in fair value of contingent consideration</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,637&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,799&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling and administrative expense</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of March 31, 2023</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72,835&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118,033&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of contingent payment arrangements including the terms that will result in payment and the accounting treatment that will be followed if such contingencies occur, including the potential impact on earnings per share if contingencies are to be settled in common stock of the entity. The description also may include the period over which amounts are expected to be paid, and changes in the amount since the previous reporting period. This also includes contingent options and commitments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of gain (loss) on derivative and nonderivative instruments designated and qualifying as cash flow hedge recorded in accumulated other comprehensive income (AOCI) and reclassified into earnings.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfForeignExchangeContractsStatementOfFinancialPositionTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the presentation of foreign exchange contracts on the statement of financial position, including the fair value amounts and location of such amounts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfForeignExchangeContractsStatementOfFinancialPositionTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the notional amounts of outstanding derivative positions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of derivative instrument not designated or qualifying as hedging instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4CC<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL109998890-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140393985767648">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Inventories (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock', window );">Schedule of Inventory</a></td>
<td class="text"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories consist of the following:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.560%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.206%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">124,122&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110,677&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work-in-process</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,487&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,166&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">184,761&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">195,477&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">335,370&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">332,320&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(c))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInventoryCurrentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140393985767648">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings Per Share (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Schedule of Calculation of Basic and Diluted Earnings Per Share</a></td>
<td class="text"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the computation of basic and diluted earnings per share for the three months ended March 31, 2023 and 2022:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:25.800%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.605%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31, 2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Basic EPS</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Adjustments</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Diluted EPS</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Basic EPS</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Adjustments</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Diluted EPS</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,819&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,819&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,975&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,715&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,690&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares outstanding</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,511&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,511&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,428&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,428&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">629&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">629&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,158&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,158&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warrants</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">684&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">684&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Convertible notes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,885&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,885&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,511&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">693&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,204&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,428&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,727&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,155&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EPS</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.06&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.06&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.51&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.47&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140393978818912">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Other Intangible Assets (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfGoodwillTextBlock', window );">Schedule of Goodwill</a></td>
<td class="text"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The changes in the net carrying amount of goodwill for the three months ended March&#160;31, 2023 are as follows:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:84.426%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.374%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2022</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">815,429&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of March 31, 2023</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">815,499&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock', window );">Schedule of Finite-Lived Intangible Assets</a></td>
<td class="text"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other intangible assets consist of the following:</span></div><div style="text-align:justify;text-indent:15.75pt"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:36.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.333%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average Amortization Period (Years)</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross<br/>Carrying<br/>Amount</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross<br/>Carrying<br/>Amount</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Intangible assets with definite lives:</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer and distributor relationships</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">369,881&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(175,291)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">369,854&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(170,870)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales representation, marketing and promotional rights</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149,376&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(67,500)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149,376&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(66,000)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed technology</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">320,204&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37,146)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">320,204&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34,675)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patents and other intangible assets</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80,335&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(52,865)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79,838&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(52,472)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Intangible assets with indefinite lives:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks and tradenames</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86,544&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86,544&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,006,340&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(332,802)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,005,816&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(324,017)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock', window );">Schedule of Indefinite-Lived Intangible Assets</a></td>
<td class="text"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other intangible assets consist of the following:</span></div><div style="text-align:justify;text-indent:15.75pt"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:36.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.333%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average Amortization Period (Years)</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross<br/>Carrying<br/>Amount</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross<br/>Carrying<br/>Amount</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Intangible assets with definite lives:</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer and distributor relationships</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">369,881&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(175,291)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">369,854&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(170,870)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales representation, marketing and promotional rights</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149,376&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(67,500)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149,376&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(66,000)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed technology</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">320,204&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37,146)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">320,204&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34,675)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patents and other intangible assets</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80,335&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(52,865)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79,838&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(52,472)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Intangible assets with indefinite lives:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks and tradenames</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86,544&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86,544&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,006,340&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(332,802)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,005,816&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(324,017)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock', window );">Schedule of Estimated Amortization Expense</a></td>
<td class="text"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated intangible asset amortization expense remaining for the year ending December&#160;31, 2023 and for each of the five succeeding years is as follows:</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:1pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:57.025%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.223%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.824%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.930%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.824%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.374%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amortization included in expense</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amortization recorded as a reduction of revenue</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remaining, 2023</span></div></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,947&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,500&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,447&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,773&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,773&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,563&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,563&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,316&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,316&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,367&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,367&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,507&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,507&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfGoodwillTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=SL108378252-109267<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfGoodwillTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance and exist in perpetuity, by either major class or business segment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b),(d)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16373-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140393985730688">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long Term Debt (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDebtInstrumentsTextBlock', window );">Schedule of Long-Term Debt</a></td>
<td class="text"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-term debt consists of the following:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"/><td style="width:72.793%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.289%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.881%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revolving line of credit</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79,000&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70,000&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term loan, net of deferred debt issuance costs of $678 and $729 in 2023 and 2022, respectively</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">133,910&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">133,858&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.625% convertible notes, net of deferred debt issuance costs of $332 and $432 in 2023 and 2022, respectively</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69,668&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69,568&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.250% convertible notes, net of deferred debt issuance costs of $17,771 and $18,834 in 2023 and 2022, respectively</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">782,229&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">781,166&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">162&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">230&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,064,969&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,054,822&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less:&#160;&#160;Current portion</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69,693&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69,746&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total long-term debt</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">995,276&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">985,076&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock', window );">Schedule of Maturities of Long-Term Debt</a></td>
<td class="text"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The scheduled&#160;maturities&#160;of&#160;long-term&#160;debt outstanding at March&#160;31, 2023 are as follows:</span></div><div style="text-align:justify"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:85.263%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.537%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remaining, 2023</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">213,588&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">800,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">The above amounts exclude deferred debt issuance costs and financing leases.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDebtInstrumentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28541-108399<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21506-112644<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69E<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495743-112612<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21521-112644<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21538-112644<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=123599511&amp;loc=d3e64711-112823<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDebtInstrumentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of maturity and sinking fund requirement for long-term debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140393983022848">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Guarantees (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GuaranteesAbstract', window );"><strong>Guarantees [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock', window );">Changes in the Carrying Amount of Service and Product Warranties</a></td>
<td class="text"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the liability for standard warranties for the three months ended March 31, are as follows:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:77.993%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.987%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.990%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of January 1,</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,944&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,344&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for warranties</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">197&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Claims made</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(198)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(187)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of March 31,</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,861&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,354&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GuaranteesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GuaranteesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the changes in the guarantor's aggregate product warranty liability, including the beginning balance of the aggregate product warranty liability, the aggregate reductions in that liability for payments made (in cash or in kind) under the warranty, the aggregate changes in the liability for accruals related to product warranties issued during the reporting period, the aggregate changes in the liability for accruals related to preexisting warranties (including adjustments related to changes in estimates), and the ending balance of the aggregate product warranty liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126907703&amp;loc=d3e12565-110249<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140393985704256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Pension Plan (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Retirement Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock', window );">Schedule of Net Benefit Cost</a></td>
<td class="text"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net periodic pension cost consists of the following:&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:77.993%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.987%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.990%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service cost</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">194&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">269&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost on projected benefit obligation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">911&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">537&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected return on plan assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,032)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,324)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net amortization and deferral</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">532&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">648&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net periodic pension cost</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">605&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net benefit costs for pension plans and/or other employee benefit plans including service cost, interest cost, expected return on plan assets, gain (loss), prior service cost or credit, transition asset or obligation, and gain (loss) recognized due to settlements or curtailments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfNetBenefitCostsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140393985809248">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Segment (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock', window );">Schedule of Net Sales Information by Product Line</a></td>
<td class="text">These product lines' net sales are as follows:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.976%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.498%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Orthopedic surgery</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131,175&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107,517&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General surgery</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">164,293&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">134,810&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated net sales</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">295,468&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">242,327&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of entity-wide revenues from external customers for each product or service or each group of similar products or services if the information is not provided as part of the reportable operating segment information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140393978773264">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Combinations (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Aug. 09, 2022</div></th>
<th class="th"><div>Jun. 13, 2022</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 295,468<span></span>
</td>
<td class="nump">$ 242,327<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=cnmd_In2BonesGlobalIncMember', window );">In2Bones Global Inc</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Business Combination, Consideration Transferred</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 145,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh', window );">Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 110,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=cnmd_In2BonesGlobalIncMember', window );">In2Bones Global Inc | Cost of Sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cnmd_AmortizationOfInventoryStepUpAdjustments', window );">Amortization of inventory step-up adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=cnmd_BiorezIncMember', window );">Biorez Inc</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Business Combination, Consideration Transferred</a></td>
<td class="nump">$ 85,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Payments to acquire businesses, gross</a></td>
<td class="nump">83,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cnmd_BusinessCombinationPurchasePriceAdjustmentHoldback', window );">Purchase Price Adjustment Holdback</a></td>
<td class="nump">1,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh', window );">Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High</a></td>
<td class="nump">$ 165,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cnmd_AmortizationOfInventoryStepUpAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortization of inventory step-up adjustments</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cnmd_AmortizationOfInventoryStepUpAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cnmd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cnmd_BusinessCombinationPurchasePriceAdjustmentHoldback">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Purchase Price Adjustment, Holdback</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cnmd_BusinessCombinationPurchasePriceAdjustmentHoldback</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cnmd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferred1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126966197&amp;loc=d3e6613-128477<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e6927-128479<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126966197&amp;loc=d3e6578-128477<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferred1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For contingent consideration arrangements recognized in connection with a business combination, this element represents an estimate of the high-end of the potential range (undiscounted) of the consideration which may be paid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e6927-128479<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=cnmd_In2BonesGlobalIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=cnmd_In2BonesGlobalIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=cnmd_BiorezIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=cnmd_BiorezIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140393983772960">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenues (Disaggregated Revenues) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net Sales</a></td>
<td class="nump">$ 295,468<span></span>
</td>
<td class="nump">$ 242,327<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TimingOfTransferOfGoodOrServiceAxis=us-gaap_TransferredAtPointInTimeMember', window );">Goods transferred at a point in time</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net Sales</a></td>
<td class="nump">283,712<span></span>
</td>
<td class="nump">231,526<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TimingOfTransferOfGoodOrServiceAxis=us-gaap_TransferredOverTimeMember', window );">Services transferred over time</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net Sales</a></td>
<td class="nump">11,756<span></span>
</td>
<td class="nump">10,801<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=cnmd_OrthopedicSurgeryMember', window );">Orthopedic Surgery</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net Sales</a></td>
<td class="nump">131,175<span></span>
</td>
<td class="nump">107,517<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=cnmd_OrthopedicSurgeryMember', window );">Orthopedic Surgery | Goods transferred at a point in time</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net Sales</a></td>
<td class="nump">121,122<span></span>
</td>
<td class="nump">98,204<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=cnmd_OrthopedicSurgeryMember', window );">Orthopedic Surgery | Services transferred over time</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net Sales</a></td>
<td class="nump">10,053<span></span>
</td>
<td class="nump">9,313<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=cnmd_GeneralSurgeryMember', window );">General Surgery</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net Sales</a></td>
<td class="nump">164,293<span></span>
</td>
<td class="nump">134,810<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=cnmd_GeneralSurgeryMember', window );">General Surgery | Goods transferred at a point in time</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net Sales</a></td>
<td class="nump">162,590<span></span>
</td>
<td class="nump">133,322<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=cnmd_GeneralSurgeryMember', window );">General Surgery | Services transferred over time</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net Sales</a></td>
<td class="nump">1,703<span></span>
</td>
<td class="nump">1,488<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net Sales</a></td>
<td class="nump">164,589<span></span>
</td>
<td class="nump">131,227<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">United States | Orthopedic Surgery</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net Sales</a></td>
<td class="nump">48,944<span></span>
</td>
<td class="nump">37,947<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">United States | General Surgery</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net Sales</a></td>
<td class="nump">115,645<span></span>
</td>
<td class="nump">93,280<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=cnmd_AmericasexcludingtheUnitedStatesMember', window );">Americas (excluding the United States)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net Sales</a></td>
<td class="nump">28,756<span></span>
</td>
<td class="nump">24,422<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=cnmd_AmericasexcludingtheUnitedStatesMember', window );">Americas (excluding the United States) | Orthopedic Surgery</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net Sales</a></td>
<td class="nump">18,990<span></span>
</td>
<td class="nump">16,172<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=cnmd_AmericasexcludingtheUnitedStatesMember', window );">Americas (excluding the United States) | General Surgery</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net Sales</a></td>
<td class="nump">9,766<span></span>
</td>
<td class="nump">8,250<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=us-gaap_EMEAMember', window );">Europe, Middle East &amp; Africa</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net Sales</a></td>
<td class="nump">56,016<span></span>
</td>
<td class="nump">50,306<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=us-gaap_EMEAMember', window );">Europe, Middle East &amp; Africa | Orthopedic Surgery</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net Sales</a></td>
<td class="nump">33,120<span></span>
</td>
<td class="nump">29,980<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=us-gaap_EMEAMember', window );">Europe, Middle East &amp; Africa | General Surgery</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net Sales</a></td>
<td class="nump">22,896<span></span>
</td>
<td class="nump">20,326<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=srt_AsiaPacificMember', window );">Asia Pacific</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net Sales</a></td>
<td class="nump">46,107<span></span>
</td>
<td class="nump">36,372<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=srt_AsiaPacificMember', window );">Asia Pacific | Orthopedic Surgery</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net Sales</a></td>
<td class="nump">30,121<span></span>
</td>
<td class="nump">23,418<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=srt_AsiaPacificMember', window );">Asia Pacific | General Surgery</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net Sales</a></td>
<td class="nump">$ 15,986<span></span>
</td>
<td class="nump">$ 12,954<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TimingOfTransferOfGoodOrServiceAxis=us-gaap_TransferredAtPointInTimeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TimingOfTransferOfGoodOrServiceAxis=us-gaap_TransferredAtPointInTimeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TimingOfTransferOfGoodOrServiceAxis=us-gaap_TransferredOverTimeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TimingOfTransferOfGoodOrServiceAxis=us-gaap_TransferredOverTimeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=cnmd_OrthopedicSurgeryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=cnmd_OrthopedicSurgeryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=cnmd_GeneralSurgeryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=cnmd_GeneralSurgeryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=cnmd_AmericasexcludingtheUnitedStatesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=cnmd_AmericasexcludingtheUnitedStatesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=us-gaap_EMEAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=us-gaap_EMEAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=srt_AsiaPacificMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=srt_AsiaPacificMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140393984116672">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenues (Customer Liability) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Contract liability</a></td>
<td class="nump">$ 18,887<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 19,114<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized', window );">Revenue recognized</a></td>
<td class="nump">$ 4,200<span></span>
</td>
<td class="nump">$ 3,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130549-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130532-203044<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityRevenueRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140393982686720">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Comprehensive Income (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">$ 1,819<span></span>
</td>
<td class="nump">$ 14,975<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax', window );">Cash flow hedging gain, net</a></td>
<td class="nump">877<span></span>
</td>
<td class="nump">1,082<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax', window );">Pension liability, net of income tax</a></td>
<td class="nump">403<span></span>
</td>
<td class="nump">521<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Foreign currency translation adjustments</a></td>
<td class="nump">1,596<span></span>
</td>
<td class="num">(163)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest', window );">Comprehensive income</a></td>
<td class="nump">4,695<span></span>
</td>
<td class="nump">16,415<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax', window );">Pension liability, tax</a></td>
<td class="nump">129<span></span>
</td>
<td class="nump">127<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax', window );">Cash flow hedging gain, tax</a></td>
<td class="nump">$ 280<span></span>
</td>
<td class="nump">$ 346<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after reclassification, of tax expense (benefit) for gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e640-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after reclassification adjustment, of tax (expense) benefit for (increase) decrease in accumulated other comprehensive income of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e640-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140393974430512">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Comprehensive Income (Accumulated Other Comprehensive Income (Loss)) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>Accumulated other comprehensive income (loss) [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated Other Comprehensive Income (Loss), Net of Tax</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">$ (57,858)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated Other Comprehensive Income (Loss), Net of Tax</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(54,982)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember', window );">Accumulated Other Comprehensive Loss</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>Accumulated other comprehensive income (loss) [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated Other Comprehensive Income (Loss), Net of Tax</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(57,858)<span></span>
</td>
<td class="num">$ (54,203)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive income (loss) before reclassifications, net of tax</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">3,519<span></span>
</td>
<td class="nump">2,297<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax', window );">Amounts reclassified from other accumulated comprehensive income (loss) before tax</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">(849)<span></span>
</td>
<td class="num">(1,171)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAociCurrentPeriodTax', window );">Reclassification from AOCI, Current Period, Tax</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">206<span></span>
</td>
<td class="nump">314<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Net current-period other comprehensive income (loss)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2,876<span></span>
</td>
<td class="nump">1,440<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated Other Comprehensive Income (Loss), Net of Tax</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(54,982)<span></span>
</td>
<td class="num">(52,763)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember', window );">Cash Flow Hedging Gain (Loss)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>Accumulated other comprehensive income (loss) [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated Other Comprehensive Income (Loss), Net of Tax</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2,497<span></span>
</td>
<td class="nump">3,656<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive income (loss) before reclassifications, net of tax</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,923<span></span>
</td>
<td class="nump">2,460<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax', window );">Amounts reclassified from other accumulated comprehensive income (loss) before tax</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">(1,381)<span></span>
</td>
<td class="num">(1,819)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAociCurrentPeriodTax', window );">Reclassification from AOCI, Current Period, Tax</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">335<span></span>
</td>
<td class="nump">441<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Net current-period other comprehensive income (loss)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">877<span></span>
</td>
<td class="nump">1,082<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated Other Comprehensive Income (Loss), Net of Tax</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">3,374<span></span>
</td>
<td class="nump">4,738<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember', window );">Pension Liability</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>Accumulated other comprehensive income (loss) [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated Other Comprehensive Income (Loss), Net of Tax</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(23,749)<span></span>
</td>
<td class="num">(29,671)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive income (loss) before reclassifications, net of tax</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax', window );">Amounts reclassified from other accumulated comprehensive income (loss) before tax</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">532<span></span>
</td>
<td class="nump">648<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAociCurrentPeriodTax', window );">Reclassification from AOCI, Current Period, Tax</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(129)<span></span>
</td>
<td class="num">(127)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Net current-period other comprehensive income (loss)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">403<span></span>
</td>
<td class="nump">521<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated Other Comprehensive Income (Loss), Net of Tax</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(23,346)<span></span>
</td>
<td class="num">(29,150)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember', window );">Cumulative Translation Adjustments</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>Accumulated other comprehensive income (loss) [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated Other Comprehensive Income (Loss), Net of Tax</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(36,606)<span></span>
</td>
<td class="num">(28,188)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive income (loss) before reclassifications, net of tax</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,596<span></span>
</td>
<td class="num">(163)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax', window );">Amounts reclassified from other accumulated comprehensive income (loss) before tax</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAociCurrentPeriodTax', window );">Reclassification from AOCI, Current Period, Tax</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Net current-period other comprehensive income (loss)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,596<span></span>
</td>
<td class="num">(163)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated Other Comprehensive Income (Loss), Net of Tax</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">$ (35,010)<span></span>
</td>
<td class="num">$ (28,351)<span></span>
</td>
</tr>
<tr><td colspan="3"></td></tr>
<tr><td colspan="3"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">The cash flow hedging gain (loss) and pension liability accumulated other comprehensive loss components are included in sales or cost of sales and as a component of net periodic pension cost, respectively.  Refer to Note 7 and Note 13, respectively, for further details.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AOCIAttributableToParentNetOfTaxRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax, before reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationFromAociCurrentPeriodTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit) of reclassification adjustment from accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e640-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL34724391-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationFromAociCurrentPeriodTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140393983021296">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value of Financial Instruments (Amounts Recorded In and Reclassified From AOCI) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net sales</a></td>
<td class="nump">$ 295,468<span></span>
</td>
<td class="nump">$ 242,327<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of sales</a></td>
<td class="nump">140,147<span></span>
</td>
<td class="nump">106,336<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax', window );">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax</a></td>
<td class="nump">2,538<span></span>
</td>
<td class="nump">3,247<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax', window );">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, Tax</a></td>
<td class="nump">615<span></span>
</td>
<td class="nump">787<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax', window );">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax</a></td>
<td class="nump">1,923<span></span>
</td>
<td class="nump">2,460<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax', window );">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax</a></td>
<td class="nump">1,381<span></span>
</td>
<td class="nump">1,819<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax', window );">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, Tax</a></td>
<td class="nump">335<span></span>
</td>
<td class="nump">441<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax', window );">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, after Tax</a></td>
<td class="nump">1,046<span></span>
</td>
<td class="nump">1,378<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=cnmd_RevenuesMember', window );">Revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax', window );">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax</a></td>
<td class="nump">575<span></span>
</td>
<td class="nump">1,744<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember', window );">Cost of Sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax', window );">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax</a></td>
<td class="nump">$ 806<span></span>
</td>
<td class="nump">$ 75<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and before reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax and reclassification, of gain (loss) from derivative instrument designated and qualifying cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=121577181&amp;loc=SL110061190-113977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5618551-113959<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before reclassification, of tax expense (benefit) for gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e640-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e689-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e689-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit) for reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e640-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=cnmd_RevenuesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=cnmd_RevenuesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140393983470080">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value of Financial Instruments (Foreign Currency Forward Contracts) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax', window );">Foreign Currency Transaction Gain (Loss), before Tax</a></td>
<td class="nump">$ 76<span></span>
</td>
<td class="nump">$ 415<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNetByBalanceSheetClassificationAbstract', window );"><strong>Derivative Assets and Liabilities at Fair Value [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Asset Fair Value</a></td>
<td class="nump">7,406<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,865<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Liabilities Fair Value</a></td>
<td class="num">(3,234)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,916)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet', window );">Net Fair Value</a></td>
<td class="nump">4,172<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,949<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember', window );">Foreign Currency Forward Contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments', window );">Loss on Foreign Currency Derivative Instruments Not Designated as Hedging Instruments</a></td>
<td class="num">(366)<span></span>
</td>
<td class="num">$ (958)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Derivatives designated as hedged instruments: | Foreign Currency Forward Contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNetByBalanceSheetClassificationAbstract', window );"><strong>Derivative Assets and Liabilities at Fair Value [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Asset Fair Value</a></td>
<td class="nump">7,354<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,817<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Liabilities Fair Value</a></td>
<td class="num">(2,900)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,521)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet', window );">Net Fair Value</a></td>
<td class="nump">4,454<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,296<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Derivatives designated as hedged instruments: | Foreign Currency Forward Contracts | Prepaid Expenses and Other Current Assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNetByBalanceSheetClassificationAbstract', window );"><strong>Derivative Assets and Liabilities at Fair Value [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Asset Fair Value</a></td>
<td class="nump">6,869<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,757<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Liabilities Fair Value</a></td>
<td class="num">(2,476)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,121)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet', window );">Net Fair Value</a></td>
<td class="nump">4,393<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,636<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Derivatives designated as hedged instruments: | Foreign Currency Forward Contracts | Other Noncurrent Liabilities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNetByBalanceSheetClassificationAbstract', window );"><strong>Derivative Assets and Liabilities at Fair Value [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Asset Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Liabilities Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(400)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet', window );">Net Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(340)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Derivatives designated as hedged instruments: | Foreign Currency Forward Contracts | Other Noncurrent Assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNetByBalanceSheetClassificationAbstract', window );"><strong>Derivative Assets and Liabilities at Fair Value [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Asset Fair Value</a></td>
<td class="nump">485<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Liabilities Fair Value</a></td>
<td class="num">(424)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet', window );">Net Fair Value</a></td>
<td class="nump">$ 61<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Derivatives not designated as hedging instruments: | Foreign Currency Forward Contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MaximumLengthOfTimeHedgedInCashFlowHedge1', window );">Maximum Length of Time Hedged in Cash Flow Hedge</a></td>
<td class="text">1 month<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional amount of cash flow hedges</a></td>
<td class="nump">$ 98,173<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">81,929<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Derivatives not designated as hedging instruments: | Foreign Currency Forward Contracts | Other Current Liabilities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNetByBalanceSheetClassificationAbstract', window );"><strong>Derivative Assets and Liabilities at Fair Value [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Asset Fair Value</a></td>
<td class="nump">52<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">48<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Liabilities Fair Value</a></td>
<td class="num">(334)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(395)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet', window );">Net Fair Value</a></td>
<td class="num">$ (282)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(347)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash flow hedge | Foreign Currency Forward Contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MaximumLengthOfTimeHedgedInCashFlowHedge1', window );">Maximum Length of Time Hedged in Cash Flow Hedge</a></td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional amount of cash flow hedges</a></td>
<td class="nump">$ 199,005<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 198,473<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months', window );">Foreign Currency Cash Flow Hedge Gain (Loss) to be Reclassified During Next 12 Months</a></td>
<td class="nump">$ 3,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair values as of the balance sheet date of the net amount of all assets and liabilities resulting from contracts that meet the criteria of being accounted for as derivative instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126966630&amp;loc=d3e41228-113958<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNetByBalanceSheetClassificationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssetsLiabilitiesAtFairValueNetByBalanceSheetClassificationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFairValueOfDerivativeAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, before effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets elected not to be offset. Excludes assets not subject to a master netting arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226052-175313<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226000-175313<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 860<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4D<br> -Subparagraph (c)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=121570589&amp;loc=SL51823488-111719<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (a),(c)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFairValueOfDerivativeAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFairValueOfDerivativeLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, before effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities elected not to be offset. Excludes liabilities not subject to a master netting arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 860<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4D<br> -Subparagraph (c)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=121570589&amp;loc=SL51823488-111719<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (a),(c)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624163-113959<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226000-175313<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226052-175313<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFairValueOfDerivativeLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payment on derivative.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5580258-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated net amount of unrealized gains or losses on foreign currency cash flow hedges at the reporting date expected to be reclassified to earnings within the next 12 months.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=121549185&amp;loc=d3e80748-113994<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of foreign currency transaction realized and unrealized gain (loss) recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=125521441&amp;loc=d3e30690-110894<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 35<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123602790&amp;loc=d3e30226-110892<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=126980362&amp;loc=d3e28228-110885<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124440516&amp;loc=d3e30840-110895<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionGainLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in earnings in the period from the increase (decrease) in fair value of foreign currency derivatives not designated as hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5618551-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MaximumLengthOfTimeHedgedInCashFlowHedge1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum length of time over which the entity is hedging its exposure to the variability in future cash flows for forecasted transactions, excluding those forecasted transactions related to the payment of variable interest on existing financial instruments, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=121549185&amp;loc=d3e80748-113994<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MaximumLengthOfTimeHedgedInCashFlowHedge1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140393983391520">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value of Financial Instruments (Contingent Consideration) (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Mar. 31, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cnmd_BusinessAcquisitionContingentConsiderationAtFairValueRollForwardRollForward', window );"><strong>Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1', window );">Non-cash adjustment to fair value of contingent consideration liability</a></td>
<td class="nump">$ 4,436<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent', window );">Business Combination, Contingent Consideration, Liability, Current</a></td>
<td class="nump">38,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 18,600<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent', window );">Business Combination, Contingent Consideration, Liability, Noncurrent</a></td>
<td class="nump">152,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 167,800<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=cnmd_In2BonesGlobalIncMember', window );">In2Bones Global Inc</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cnmd_BusinessAcquisitionContingentConsiderationAtFairValueRollForwardRollForward', window );"><strong>Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Balance as of January 1, 2023</a></td>
<td class="nump">70,198<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1', window );">Non-cash adjustment to fair value of contingent consideration liability</a></td>
<td class="nump">2,637<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Balance as of March 31, 2023</a></td>
<td class="nump">$ 72,835<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=cnmd_In2BonesGlobalIncMember', window );">In2Bones Global Inc | Fair Value, Inputs, Level 3 | Fair Value, Recurring | Measurement Input, Discount Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cnmd_BusinessAcquisitionContingentConsiderationAtFairValueRollForwardRollForward', window );"><strong>Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput', window );">Business Combination, Contingent Consideration, Liability, Measurement Input</a></td>
<td class="nump">0.0652<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=cnmd_In2BonesGlobalIncMember', window );">In2Bones Global Inc | Fair Value, Inputs, Level 3 | Fair Value, Recurring | Measurement Input, Revenue Volatility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cnmd_BusinessAcquisitionContingentConsiderationAtFairValueRollForwardRollForward', window );"><strong>Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput', window );">Business Combination, Contingent Consideration, Liability, Measurement Input</a></td>
<td class="nump">0.1311<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=cnmd_BiorezIncMember', window );">Biorez Inc</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cnmd_BusinessAcquisitionContingentConsiderationAtFairValueRollForwardRollForward', window );"><strong>Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Balance as of January 1, 2023</a></td>
<td class="nump">$ 116,234<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1', window );">Non-cash adjustment to fair value of contingent consideration liability</a></td>
<td class="nump">1,799<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Balance as of March 31, 2023</a></td>
<td class="nump">$ 118,033<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=cnmd_BiorezIncMember', window );">Biorez Inc | Fair Value, Inputs, Level 3 | Fair Value, Recurring | Measurement Input, Discount Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cnmd_BusinessAcquisitionContingentConsiderationAtFairValueRollForwardRollForward', window );"><strong>Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput', window );">Business Combination, Contingent Consideration, Liability, Measurement Input</a></td>
<td class="nump">0.1132<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=cnmd_BiorezIncMember', window );">Biorez Inc | Fair Value, Inputs, Level 3 | Fair Value, Recurring | Measurement Input, Revenue Volatility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cnmd_BusinessAcquisitionContingentConsiderationAtFairValueRollForwardRollForward', window );"><strong>Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput', window );">Business Combination, Contingent Consideration, Liability, Measurement Input</a></td>
<td class="nump">0.2088<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cnmd_BusinessAcquisitionContingentConsiderationAtFairValueRollForwardRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Acquisition Contingent Consideration At Fair Value Roll Forward</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cnmd_BusinessAcquisitionContingentConsiderationAtFairValueRollForwardRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cnmd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e7008-128479<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126966325&amp;loc=d3e6819-128478<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination, expected to be settled within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph b<br> -URI https://asc.fasb.org/extlink&amp;oid=126966325&amp;loc=d3e6819-128478<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of input used to measure contingent consideration liability from business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination, expected to be settled beyond one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph b<br> -URI https://asc.fasb.org/extlink&amp;oid=126966325&amp;loc=d3e6819-128478<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=cnmd_In2BonesGlobalIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=cnmd_In2BonesGlobalIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputDiscountRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputDiscountRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=cnmd_MeasurementInputRevenueVolatilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=cnmd_MeasurementInputRevenueVolatilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=cnmd_BiorezIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=cnmd_BiorezIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140393982930864">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Inventories (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryRawMaterialsNetOfReserves', window );">Raw materials</a></td>
<td class="nump">$ 124,122<span></span>
</td>
<td class="nump">$ 110,677<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryWorkInProcessNetOfReserves', window );">Work-in-process</a></td>
<td class="nump">26,487<span></span>
</td>
<td class="nump">26,166<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryFinishedGoodsNetOfReserves', window );">Finished goods</a></td>
<td class="nump">184,761<span></span>
</td>
<td class="nump">195,477<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Total inventory</a></td>
<td class="nump">$ 335,370<span></span>
</td>
<td class="nump">$ 332,320<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryFinishedGoodsNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI https://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryFinishedGoodsNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryRawMaterialsNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of unprocessed items to be consumed in the manufacturing or production process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI https://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryRawMaterialsNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWorkInProcessNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI https://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWorkInProcessNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140393983001856">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings Per Share (Details) - USD ($)<br> $ / shares in Units, shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">$ 1,819<span></span>
</td>
<td class="nump">$ 14,975<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestOnConvertibleDebtNetOfTax', window );">Interest on Convertible Debt, Net of Tax</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,715<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted', window );">Net Income Available to Common Stockholders, Diluted</a></td>
<td class="nump">$ 1,819<span></span>
</td>
<td class="nump">$ 16,690<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic-weighted average shares outstanding (in shares)</a></td>
<td class="nump">30,511<span></span>
</td>
<td class="nump">29,428<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements', window );">Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements (in shares)</a></td>
<td class="nump">629<span></span>
</td>
<td class="nump">1,158<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants', window );">Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">684<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities', window );">Incremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities (in shares)</a></td>
<td class="nump">64<span></span>
</td>
<td class="nump">3,885<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment', window );">Effect of dilutive potential securities (in shares)</a></td>
<td class="nump">693<span></span>
</td>
<td class="nump">5,727<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted- weighted average shares outstanding (in shares)</a></td>
<td class="nump">31,204<span></span>
</td>
<td class="nump">35,155<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic (in dollars per share)</a></td>
<td class="nump">$ 0.06<span></span>
</td>
<td class="nump">$ 0.51<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted (in dollars per share)</a></td>
<td class="nump">$ 0.06<span></span>
</td>
<td class="nump">$ 0.47<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities excluded from computation of earnings per share (in shares)</a></td>
<td class="nump">2,200<span></span>
</td>
<td class="nump">900<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of call options and warrants using the treasury stock method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 26<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1828-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1757-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1707-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of convertible debt securities using the if-converted method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1930-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e2029-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126962052&amp;loc=d3e4991-113900<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1707-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28A<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1500-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1757-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestOnConvertibleDebtNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of interest recognized on convertible debt instrument excluding interest on principal required to be paid in cash.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1505-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1930-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestOnConvertibleDebtNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities, and addition from assumption of issuance of common shares for dilutive potential common shares; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1930-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1930-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1930-109256<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1505-109256<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1930-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140393983055424">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Other Intangible Assets (Goodwill) (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Mar. 31, 2023 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Beginning balance</a></td>
<td class="nump">$ 815,429<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Foreign currency translation</a></td>
<td class="nump">70<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Ending balance</a></td>
<td class="nump">815,499<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">$ 815,499<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of foreign currency translation gain (loss) which increases (decreases) an asset representing future economic benefits from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillForeignCurrencyTranslationGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140393974122144">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Other Intangible Assets (Intangible Assets) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cnmd_ScheduleOfFiniteLivedAndIndefiniteLivedAssetsLineItems', window );"><strong>Schedule of Finite-Lived and Indefinite-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill', window );">Intangible assets, Gross carrying amount</a></td>
<td class="nump">$ 1,006,340<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,005,816<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Intangible assets, Accumulated amortization</a></td>
<td class="num">(332,802)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(324,017)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization expense</a></td>
<td class="nump">8,800<span></span>
</td>
<td class="nump">$ 8,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract', window );"><strong>Future amortization expense [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear', window );">Remaining, 2023</a></td>
<td class="nump">26,447<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">2024</a></td>
<td class="nump">34,773<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">2025</a></td>
<td class="nump">35,563<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">2026</a></td>
<td class="nump">35,316<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">2027</a></td>
<td class="nump">36,367<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive', window );">2028</a></td>
<td class="nump">39,507<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=cnmd_ExpenseMember', window );">Amortization included in expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract', window );"><strong>Future amortization expense [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear', window );">Remaining, 2023</a></td>
<td class="nump">21,947<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">2024</a></td>
<td class="nump">28,773<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">2025</a></td>
<td class="nump">29,563<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">2026</a></td>
<td class="nump">29,316<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">2027</a></td>
<td class="nump">30,367<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive', window );">2028</a></td>
<td class="nump">33,507<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=cnmd_ReductionofRevenueMember', window );">Amortization recorded as a reduction of revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract', window );"><strong>Future amortization expense [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear', window );">Remaining, 2023</a></td>
<td class="nump">4,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">2024</a></td>
<td class="nump">6,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">2025</a></td>
<td class="nump">6,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">2026</a></td>
<td class="nump">6,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">2027</a></td>
<td class="nump">6,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive', window );">2028</a></td>
<td class="nump">6,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksAndTradeNamesMember', window );">Trademarks &amp; tradenames</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cnmd_ScheduleOfFiniteLivedAndIndefiniteLivedAssetsLineItems', window );"><strong>Schedule of Finite-Lived and Indefinite-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">Unamortized intangible assets, Gross carrying amount</a></td>
<td class="nump">86,544<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">86,544<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=cnmd_CustomerandDistributorRelationshipsMember', window );">Customer and distributor relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cnmd_ScheduleOfFiniteLivedAndIndefiniteLivedAssetsLineItems', window );"><strong>Schedule of Finite-Lived and Indefinite-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Amortized intangible assets, Gross carrying amount</a></td>
<td class="nump">369,881<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">369,854<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Intangible assets, Accumulated amortization</a></td>
<td class="num">(175,291)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(170,870)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=cnmd_SalesrepresentationmarketingandpromotionalrightsMember', window );">Sales representation, marketing and promotional rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cnmd_ScheduleOfFiniteLivedAndIndefiniteLivedAssetsLineItems', window );"><strong>Schedule of Finite-Lived and Indefinite-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Amortized intangible assets, Gross carrying amount</a></td>
<td class="nump">149,376<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">149,376<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Intangible assets, Accumulated amortization</a></td>
<td class="num">(67,500)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(66,000)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember', window );">Developed technology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cnmd_ScheduleOfFiniteLivedAndIndefiniteLivedAssetsLineItems', window );"><strong>Schedule of Finite-Lived and Indefinite-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Amortized intangible assets, Gross carrying amount</a></td>
<td class="nump">320,204<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">320,204<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Intangible assets, Accumulated amortization</a></td>
<td class="num">(37,146)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(34,675)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=cnmd_PatentsAndOtherIntangibleAssetsMember', window );">Patents and other intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cnmd_ScheduleOfFiniteLivedAndIndefiniteLivedAssetsLineItems', window );"><strong>Schedule of Finite-Lived and Indefinite-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Amortized intangible assets, Gross carrying amount</a></td>
<td class="nump">80,335<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">79,838<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Intangible assets, Accumulated amortization</a></td>
<td class="num">$ (52,865)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (52,472)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_WeightedAverageMember', window );">Weighted Average</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cnmd_ScheduleOfFiniteLivedAndIndefiniteLivedAssetsLineItems', window );"><strong>Schedule of Finite-Lived and Indefinite-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Finite-lived intangible asset useful life (in years)</a></td>
<td class="text">22 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_WeightedAverageMember', window );">Weighted Average | Customer and distributor relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cnmd_ScheduleOfFiniteLivedAndIndefiniteLivedAssetsLineItems', window );"><strong>Schedule of Finite-Lived and Indefinite-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Finite-lived intangible asset useful life (in years)</a></td>
<td class="text">24 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_WeightedAverageMember', window );">Weighted Average | Sales representation, marketing and promotional rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cnmd_ScheduleOfFiniteLivedAndIndefiniteLivedAssetsLineItems', window );"><strong>Schedule of Finite-Lived and Indefinite-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Finite-lived intangible asset useful life (in years)</a></td>
<td class="text">25 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_WeightedAverageMember', window );">Weighted Average | Developed technology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cnmd_ScheduleOfFiniteLivedAndIndefiniteLivedAssetsLineItems', window );"><strong>Schedule of Finite-Lived and Indefinite-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Finite-lived intangible asset useful life (in years)</a></td>
<td class="text">18 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_WeightedAverageMember', window );">Weighted Average | Patents and other intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cnmd_ScheduleOfFiniteLivedAndIndefiniteLivedAssetsLineItems', window );"><strong>Schedule of Finite-Lived and Indefinite-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Finite-lived intangible asset useful life (in years)</a></td>
<td class="text">16 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cnmd_ScheduleOfFiniteLivedAndIndefiniteLivedAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Schedule of Finite-Lived and Indefinite-Lived Assets [Line Items]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cnmd_ScheduleOfFiniteLivedAndIndefiniteLivedAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cnmd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in remainder of current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 928<br> -SubTopic 340<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6473545&amp;loc=d3e61844-108004<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated amortization of intangible assets, excluding goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsGrossExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=cnmd_ExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=cnmd_ExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=cnmd_ReductionofRevenueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=cnmd_ReductionofRevenueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksAndTradeNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksAndTradeNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=cnmd_CustomerandDistributorRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=cnmd_CustomerandDistributorRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=cnmd_SalesrepresentationmarketingandpromotionalrightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=cnmd_SalesrepresentationmarketingandpromotionalrightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=cnmd_PatentsAndOtherIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=cnmd_PatentsAndOtherIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_WeightedAverageMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_WeightedAverageMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140393983803008">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Long Term Debt (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiability', window );">Finance Lease, Liability</a></td>
<td class="nump">$ 162<span></span>
</td>
<td class="nump">$ 230<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities', window );">Long-term Debt and Lease Obligation, Including Current Maturities</a></td>
<td class="nump">1,064,969<span></span>
</td>
<td class="nump">1,054,822<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent', window );">Current portion of long-term debt</a></td>
<td class="nump">69,693<span></span>
</td>
<td class="nump">69,746<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligations', window );">Long-term debt</a></td>
<td class="nump">995,276<span></span>
</td>
<td class="nump">985,076<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember', window );">Line of Credit [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term Debt</a></td>
<td class="nump">79,000<span></span>
</td>
<td class="nump">70,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LoansPayableMember', window );">Term Loan Facility [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term Debt</a></td>
<td class="nump">133,910<span></span>
</td>
<td class="nump">133,858<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnamortizedDebtIssuanceExpense', window );">Unamortized Debt Issuance Expense</a></td>
<td class="nump">678<span></span>
</td>
<td class="nump">729<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=cnmd_A2.625PercentConvertibleNotesDue2024Member', window );">2.625 Percent Convertible Notes Due 2024 | Convertible Notes Payable [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleDebt', window );">Convertible Debt</a></td>
<td class="nump">69,668<span></span>
</td>
<td class="nump">69,568<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnamortizedDebtIssuanceExpense', window );">Unamortized Debt Issuance Expense</a></td>
<td class="nump">332<span></span>
</td>
<td class="nump">432<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=cnmd_A2250PercentConvertibleNotesDue2027Member', window );">2.250 Percent Convertible Notes Due 2027 | Convertible Notes Payable [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleDebt', window );">Convertible Debt</a></td>
<td class="nump">782,229<span></span>
</td>
<td class="nump">781,166<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnamortizedDebtIssuanceExpense', window );">Unamortized Debt Issuance Expense</a></td>
<td class="nump">$ 17,771<span></span>
</td>
<td class="nump">$ 18,834<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Including the current and noncurrent portions, carrying amount of debt identified as being convertible into another form of financial instrument (typically the entity's common stock) as of the balance sheet date, which originally required full repayment more than twelve months after issuance or greater than the normal operating cycle of the company.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt and lease obligation, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt and lease obligation, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt and lease obligation, including portion classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnamortizedDebtIssuanceExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The remaining balance of debt issuance expenses that were capitalized and are being amortized against income over the lives of the respective bond issues. This does not include the amounts capitalized as part of the cost of the utility plant or asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnamortizedDebtIssuanceExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LoansPayableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_LoansPayableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cnmd_A2.625PercentConvertibleNotesDue2024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cnmd_A2.625PercentConvertibleNotesDue2024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleNotesPayableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleNotesPayableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cnmd_A2250PercentConvertibleNotesDue2027Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cnmd_A2250PercentConvertibleNotesDue2027Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140393979833184">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long Term Debt Additional Information (Details)<br> $ / shares in Units, shares in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Jun. 06, 2022 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Jan. 29, 2019 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Mar. 31, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jul. 16, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfSeniorDebt', window );">Repayments of Senior Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 2,981,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LoansPayableMember', window );">Term Loan Facility [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">133,910,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 133,858,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LoansPayableMember', window );">Term Loan Facility [Member] | Amended and Restated Senior Credit Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt instrument, face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 233,500,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfSeniorDebt', window );">Repayments of Senior Debt</a></td>
<td class="nump">$ 90,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term Debt, Gross</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">134,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember', window );">Line of Credit [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">79,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 70,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember', window );">Line of Credit [Member] | Amended and Restated Senior Credit Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Line of Credit Facility, Maximum Borrowing Capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 585,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity', window );">Line of Credit Facility, Remaining Borrowing Capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">504,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LettersOfCreditOutstandingAmount', window );">Letters of Credit Outstanding, Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleNotesPayableMember', window );">Convertible Notes Payable [Member] | 2.625 Percent Convertible Notes Due 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt instrument, face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 345,000,000<span></span>
</td>
<td class="nump">70,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate, stated percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.625%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionRatio1', window );">Debt Instrument, Convertible, Conversion Ratio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11.2608<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionPrice1', window );">Conversion price (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 88.80<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfConvertibleDebt', window );">Repayments of Convertible Debt</a></td>
<td class="nump">$ 275,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtConversionConvertedInstrumentSharesIssued1', window );">Debt Conversion, Converted Instrument, Shares Issued | shares</a></td>
<td class="nump">0.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpenseDebt', window );">Interest Expense, Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500,000<span></span>
</td>
<td class="nump">$ 2,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Debt Instrument, Fair Value Disclosure</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">85,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleNotesPayableMember', window );">Convertible Notes Payable [Member] | 2.625 Percent Convertible Notes Due 2024 | Warrant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OptionIndexedToIssuersEquityStrikePrice1', window );">Option indexed to issuer's equity, strike price (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 114.92<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleNotesPayableMember', window );">Convertible Notes Payable [Member] | 2.250 Percent Convertible Notes Due 2027</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt instrument, face amount</a></td>
<td class="nump">$ 800,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate, stated percentage</a></td>
<td class="nump">2.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionRatio1', window );">Debt Instrument, Convertible, Conversion Ratio</a></td>
<td class="nump">6.8810<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionPrice1', window );">Conversion price (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 145.33<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpenseDebt', window );">Interest Expense, Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Debt Instrument, Fair Value Disclosure</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 796,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleNotesPayableMember', window );">Convertible Notes Payable [Member] | 2.250 Percent Convertible Notes Due 2027 | Warrant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OptionIndexedToIssuersEquityStrikePrice1', window );">Option indexed to issuer's equity, strike price (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 251.53<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LongTermDebtMember', window );">Long-term Debt [Member] | Amended and Restated Senior Credit Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cnmd_TermSOFRInterestRateSpreadAdjustment', window );">Term SOFR Interest Rate Spread Adjustment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.1148%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cnmd_AdjustedTermSOFRInterestRate', window );">Adjusted Term SOFR Interest Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.927%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage', window );">Debt Instrument, Interest Rate, Effective Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.052%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LongTermDebtMember', window );">Long-term Debt [Member] | Amended and Restated Senior Credit Agreement [Member] | Adjusted Term SOFR Interest Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Debt Instrument, Basis Spread on Variable Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.125%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LongTermDebtMember', window );">Long-term Debt [Member] | Amended and Restated Senior Credit Agreement [Member] | Fed Funds Effective Rate Overnight Index Swap Rate [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Debt Instrument, Basis Spread on Variable Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LongTermDebtMember', window );">Long-term Debt [Member] | Amended and Restated Senior Credit Agreement [Member] | Adjusted Term SOFR</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Debt Instrument, Basis Spread on Variable Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OptionIndexedToIssuersEquityTypeAxis=us-gaap_CallOptionMember', window );">Call Option [Member] | Convertible Notes Payable [Member] | 2.625 Percent Convertible Notes Due 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cnmd_HedgeAndWarrantTransactionsNetCashPaid', window );">Hedge and warrant transactions, net cash paid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 21,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OptionIndexedToIssuersEquityTypeAxis=us-gaap_CallOptionMember', window );">Call Option [Member] | Convertible Notes Payable [Member] | 2.250 Percent Convertible Notes Due 2027</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cnmd_HedgeAndWarrantTransactionsNetCashPaid', window );">Hedge and warrant transactions, net cash paid</a></td>
<td class="nump">$ 115,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cnmd_AdjustedTermSOFRInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjusted Term SOFR Interest Rate</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cnmd_AdjustedTermSOFRInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cnmd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cnmd_HedgeAndWarrantTransactionsNetCashPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Up-front costs to purchase hedge instruments, net of cash received from issuance of warrants</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cnmd_HedgeAndWarrantTransactionsNetCashPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cnmd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cnmd_TermSOFRInterestRateSpreadAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Term SOFR Interest Rate Spread Adjustment</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cnmd_TermSOFRInterestRateSpreadAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cnmd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtConversionConvertedInstrumentSharesIssued1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued in exchange for the original debt being converted in a noncash (or part noncash) transaction. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or payments in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4332-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtConversionConvertedInstrumentSharesIssued1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage points added to the reference rate to compute the variable rate on the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentBasisSpreadOnVariableRate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleConversionPrice1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The price per share of the conversion feature embedded in the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031898-161870<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleConversionPrice1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleConversionRatio1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Ratio applied to the conversion of debt instrument into equity with equity shares divided by debt principal amount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21521-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21506-112644<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleConversionRatio1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429444&amp;loc=SL124452920-239629<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13433-108611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6036836-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429444&amp;loc=SL124452920-239629<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateEffectivePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense for debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6036836-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69F<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495745-112612<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69E<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495743-112612<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LettersOfCreditOutstandingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total amount of the contingent obligation under letters of credit outstanding as of the reporting date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LettersOfCreditOutstandingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of borrowing capacity currently available under the credit facility (current borrowing capacity less the amount of borrowings outstanding).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OptionIndexedToIssuersEquityStrikePrice1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise or strike price stated in the contract for options indexed to the issuer's equity shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126731327&amp;loc=d3e90205-114008<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109262807&amp;loc=d3e22047-110879<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OptionIndexedToIssuersEquityStrikePrice1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfConvertibleDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow from the repayment of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfConvertibleDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfSeniorDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for a long-term debt where the holder has highest claim on the entity's asset in case of bankruptcy or liquidation during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfSeniorDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LoansPayableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_LoansPayableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cnmd_AmendedAndRestatedSeniorCreditAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cnmd_AmendedAndRestatedSeniorCreditAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleNotesPayableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleNotesPayableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cnmd_A2.625PercentConvertibleNotesDue2024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cnmd_A2.625PercentConvertibleNotesDue2024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cnmd_IndexedTransactionTypeAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cnmd_IndexedTransactionTypeAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cnmd_A2250PercentConvertibleNotesDue2027Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cnmd_A2250PercentConvertibleNotesDue2027Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LongTermDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_LongTermDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=cnmd_AdjustedTermSOFRInterestRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=cnmd_AdjustedTermSOFRInterestRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_FederalFundsEffectiveSwapRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_FederalFundsEffectiveSwapRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=cnmd_AdjustedTermSOFRMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=cnmd_AdjustedTermSOFRMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OptionIndexedToIssuersEquityTypeAxis=us-gaap_CallOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OptionIndexedToIssuersEquityTypeAxis=us-gaap_CallOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140393989294112">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Long Term Debt Maturities of Long Term Debt (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Mar. 31, 2023 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MaturitiesOfLongTermDebtAbstract', window );"><strong>Maturities of Long-term Debt [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear', window );">Remaining, 2023</a></td>
<td class="nump">$ 70,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths', window );">2024</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo', window );">2025</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree', window );">2026</a></td>
<td class="nump">213,588<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour', window );">2027</a></td>
<td class="nump">800,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive', window );">2028</a></td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in remainder of current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MaturitiesOfLongTermDebtAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MaturitiesOfLongTermDebtAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140393982723744">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Guarantees (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GuaranteesAbstract', window );"><strong>Guarantees [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cnmd_ProductWarrantyAccrualTerm', window );">Standard warranty period (in years)</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MovementInStandardProductWarrantyAccrualRollForward', window );"><strong>Movement in Standard Product Warranty Accrual [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StandardProductWarrantyAccrual', window );">Balance as of January 1,</a></td>
<td class="nump">$ 1,944<span></span>
</td>
<td class="nump">$ 2,344<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StandardProductWarrantyAccrualWarrantiesIssued', window );">Provision for warranties</a></td>
<td class="nump">115<span></span>
</td>
<td class="nump">197<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StandardProductWarrantyAccrualPayments', window );">Claims made</a></td>
<td class="num">(198)<span></span>
</td>
<td class="num">(187)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StandardProductWarrantyAccrual', window );">Balance as of March 31,</a></td>
<td class="nump">1,861<span></span>
</td>
<td class="nump">2,354<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ExtendedProductWarrantyDisclosureAbstract', window );"><strong>Extended Product Warranty Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductWarrantyExpense', window );">Product extended warranty expense</a></td>
<td class="nump">$ 1,500<span></span>
</td>
<td class="nump">$ 1,600<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cnmd_ProductWarrantyAccrualTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Product Warranty Accrual Term</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cnmd_ProductWarrantyAccrualTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cnmd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ExtendedProductWarrantyDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ExtendedProductWarrantyDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GuaranteesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GuaranteesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MovementInStandardProductWarrantyAccrualRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MovementInStandardProductWarrantyAccrualRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProductWarrantyExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The expense charged against earnings for the period pertaining to standard and extended warranties on the entity's goods and services granted to customers.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph ((c)(3,4))<br> -URI https://asc.fasb.org/extlink&amp;oid=126907703&amp;loc=d3e12565-110249<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProductWarrantyExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StandardProductWarrantyAccrual">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount as of the balance sheet date of the aggregate standard product warranty liability. Does not include the balance for the extended product warranty liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (c)(1),(c)(5)<br> -URI https://asc.fasb.org/extlink&amp;oid=126907703&amp;loc=d3e12565-110249<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StandardProductWarrantyAccrual</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StandardProductWarrantyAccrualPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in the standard product warranty accrual from payments made in cash or in kind to satisfy claims under the terms of the standard product warranty. Excludes extended product warranties.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph ((c)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=126907703&amp;loc=d3e12565-110249<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StandardProductWarrantyAccrualPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StandardProductWarrantyAccrualWarrantiesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in the standard product warranty accrual from warranties issued. Excludes extended product warranties.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph ((c)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=126907703&amp;loc=d3e12565-110249<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StandardProductWarrantyAccrualWarrantiesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140393985306832">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Pension Plan (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Retirement Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanServiceCost', window );">Service cost</a></td>
<td class="nump">$ 194<span></span>
</td>
<td class="nump">$ 269<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanInterestCost', window );">Interest cost on projected benefit obligation</a></td>
<td class="nump">911<span></span>
</td>
<td class="nump">537<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets', window );">Expected return on plan assets</a></td>
<td class="num">(1,032)<span></span>
</td>
<td class="num">(1,324)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses', window );">Net amortization and deferral</a></td>
<td class="nump">532<span></span>
</td>
<td class="nump">648<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost', window );">Net periodic pension cost</a></td>
<td class="nump">$ 605<span></span>
</td>
<td class="nump">$ 130<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in net periodic benefit (cost) credit of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=SL108413299-114919<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expected return (loss) recognized in net periodic benefit (cost) credit, calculated based on expected long-term rate of return and market-related value of plan assets of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=SL108413299-114919<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanInterestCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost recognized for passage of time related to defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=SL108413299-114919<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanInterestCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of net periodic benefit cost (credit) for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanServiceCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost for actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanServiceCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140393974110352">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Segment (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net sales</a></td>
<td class="nump">$ 295,468<span></span>
</td>
<td class="nump">$ 242,327<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=cnmd_OrthopedicSurgeryMember', window );">Orthopedic Surgery</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net sales</a></td>
<td class="nump">131,175<span></span>
</td>
<td class="nump">107,517<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=cnmd_GeneralSurgeryMember', window );">General Surgery</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net sales</a></td>
<td class="nump">$ 164,293<span></span>
</td>
<td class="nump">$ 134,810<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=cnmd_OrthopedicSurgeryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=cnmd_OrthopedicSurgeryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=cnmd_GeneralSurgeryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=cnmd_GeneralSurgeryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140393985346384">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Legal Proceedings (Details)<br> $ in Millions</strong></div></th>
<th class="th">
<div>Mar. 31, 2023 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cnmd_ProductLiabilityContingencyInsuranceAmountPerIncident', window );">Product liability insurance, amount per incident</a></td>
<td class="nump">$ 35<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cnmd_ProductLiabilityContingencyInsuranceAggregateAnnualAmount', window );">Product liability insurance, aggregate annual amount</a></td>
<td class="nump">$ 35<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cnmd_ProductLiabilityContingencyInsuranceAggregateAnnualAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Product Liability Contingency, Insurance, Aggregate Annual Amount</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cnmd_ProductLiabilityContingencyInsuranceAggregateAnnualAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cnmd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cnmd_ProductLiabilityContingencyInsuranceAmountPerIncident">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Product Liability Contingency, Insurance, Amount per Incident</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cnmd_ProductLiabilityContingencyInsuranceAmountPerIncident</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cnmd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>cnmd-20230331_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:cnmd="http://www.conmed.com/20230331"
  xmlns:country="http://xbrl.sec.gov/country/2022"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2022"
  xmlns:us-gaap="http://fasb.org/us-gaap/2022"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xhtml="http://www.w3.org/1999/xhtml"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="cnmd-20230331.xsd" xlink:type="simple"/>
    <context id="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i38a5d384f48a4effaeb956206898d5b3_I20230424">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
        </entity>
        <period>
            <instant>2023-04-24</instant>
        </period>
    </context>
    <context id="i9500a5ee8dbe4d23aa9c46ebdd25a0c8_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i738c2d1dacaf436faf03cc46ab9cef23_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ie4f63720d8b244a68941932992cd9f4d_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="iab594279d9ab4ade89e55f698f81cb18_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="id7b8c6548e4e406d84526eb06077992a_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="if120f3461d36460aad6ccdf8d2faa0ba_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i7467bf1c44a741c2a174d8fda8ebb019_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="iaca150a4def842dc82f49cd1d16f8299_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i7a1eaccdf00242e8a344de7091fb416e_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ida5b0e90904045df9a5437b94848a04d_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="idd1e8990d17d4c29a09ce497b0e3d5e9_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i8faa12cfbcc746b48b96bb341f53eff6_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i92319359f0d94bf68894ee4109dfcf00_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i9127d3c9a72c45de99f25a116340aff0_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i506e9fffe4144fdfa3c8d262ff65a801_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i991a26c35f3a4004a04b9c93216cb10b_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="if8bf9b92b9754cb49ead7853527c0c87_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="icb342dd07ae648ba88c184ef672faf7e_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ia00f7e8577d7414dae3eec75b3959321_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i2f463e4994b14c1bb3ce927524a1bdc7_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iee31e42803274180ade2d654c9f2c44a_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i51431cd2971e460797df867a2da93b0e_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ia4bed28ea4b04a1d9fca88fa74e6040c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i2cfecd0f3dbb4727931bba8cc920743d_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i4afaa0ad2d10419c84dae15a77c31488_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="if2f0b0e837ae40e3bd5d07cc3ec663d4_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ia66bff082e1642cd80c9ac67a0cc60fe_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i5142ed70f8b347f2864cd50f2a21c01c_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate202006Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i7fb909d76a5f4b7aa413e5dfa01ad54c_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate202006Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ie301d028eb864cd3856cc78cb6269b1a_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate202006Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i441ac12b39534fb9b34b6a58c4e4cc39_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i2335e528dd1244098fa2557c3aebbd19_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i0539b1c96151418c99ad4f945625ba30_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ib861e1905d064d5684a5172a6232ad41_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i522db0d27185495b938d0c8f18f5032f_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i4730ada3cec445989c807f4fe004727c_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i8c4d1dfe88414ef2adffd18a83334e37_D20220613-20220613">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cnmd:In2BonesGlobalIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-06-13</startDate>
            <endDate>2022-06-13</endDate>
        </period>
    </context>
    <context id="idc097ffbb7114253bc28bc94208a57fb_I20220613">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cnmd:In2BonesGlobalIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-13</instant>
        </period>
    </context>
    <context id="i6d95bd83592e4caeac97181946e4d405_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cnmd:In2BonesGlobalIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i462c25545d8940a2ae0be682fa065b8b_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cnmd:In2BonesGlobalIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ic28eb29cc995481fb7071df752f6760f_D20220809-20220809">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cnmd:BiorezIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-08-09</startDate>
            <endDate>2022-08-09</endDate>
        </period>
    </context>
    <context id="i9d6ba56ca73740b9b3923d912000da47_I20220809">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cnmd:BiorezIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-08-09</instant>
        </period>
    </context>
    <context id="i26071f490d464a14b2bf24e3e1f2c752_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cnmd:OrthopedicSurgeryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i7bdef281f49841f698c6ef3a3ead6753_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cnmd:GeneralSurgeryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i124749441acd44cf9c0bac450334222b_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ib7fbf46a701d40e5bf879057f949e772_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cnmd:OrthopedicSurgeryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i85ba684d41a74bceaee45a7efb4e3287_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cnmd:GeneralSurgeryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i9f3ae93344eb48b2b3f68003d7aaf3fd_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i39a257b7bdcf459488a0a70dadb1fc48_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cnmd:OrthopedicSurgeryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i66fa55845df14909875423110e9c3562_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cnmd:GeneralSurgeryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ibeb105be0cd24a989e5a9543869dcd19_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i95feeaee74ee430ab557bd6fd0a89121_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cnmd:OrthopedicSurgeryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i025adf098383419fa26b51488aa4067f_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cnmd:GeneralSurgeryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i0a8d168c31ea4928b8a1a43a06a6984a_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i576a3464c09a4584a1729cd84cc4164b_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cnmd:OrthopedicSurgeryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i05787a350f674333ac2b6243c86c128a_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cnmd:GeneralSurgeryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i602945d302db4233b3e192e2980d335f_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ia1a88893879046bd89e1f186cac411ec_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cnmd:OrthopedicSurgeryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i4ed292675fb142ab9e142e12e6a19a99_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cnmd:GeneralSurgeryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i26a828941a804f3f9109a0c00250ec1d_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i25c81b50fa704ad899e54ae63e120282_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cnmd:OrthopedicSurgeryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">cnmd:AmericasexcludingtheUnitedStatesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i4422e467d9714c3d8fbf4438109765ab_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cnmd:GeneralSurgeryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">cnmd:AmericasexcludingtheUnitedStatesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i768d975a616147ad9d2d2288a48b11ed_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">cnmd:AmericasexcludingtheUnitedStatesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i4f4ed95789924cb587cec5440c300f1a_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cnmd:OrthopedicSurgeryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">cnmd:AmericasexcludingtheUnitedStatesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i1872a8b90120412d810e0a86ab85c148_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cnmd:GeneralSurgeryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">cnmd:AmericasexcludingtheUnitedStatesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ib413a484ed8047a49dbd503cf4a21f59_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">cnmd:AmericasexcludingtheUnitedStatesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i6a0f37b7e82e470ebf61b3f06c22aac2_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cnmd:OrthopedicSurgeryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="if48f7914ec3d45beaf647b856037592a_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cnmd:GeneralSurgeryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ia61d13e27f12498686a84bca47df5ec7_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cnmd:OrthopedicSurgeryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i60341eeb4343409c94899251a17bdde1_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cnmd:GeneralSurgeryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i256914f8655049ea8697187612d438ac_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cnmd:OrthopedicSurgeryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredAtPointInTimeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ia6458bd1547344efa30ce73c2612539c_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cnmd:GeneralSurgeryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredAtPointInTimeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i6d99ddc9cc5b4e6aab3f7115cf38a715_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredAtPointInTimeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ied376a94006741e6b0f863abd74791a1_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cnmd:OrthopedicSurgeryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredAtPointInTimeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ib2980943d7fd4938b59d54c6c50f48a6_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cnmd:GeneralSurgeryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredAtPointInTimeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="if9e3065b9a6e471ab072cbee433e2b01_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredAtPointInTimeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i19f0084e35914599aa701fa76539508d_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cnmd:OrthopedicSurgeryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredOverTimeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="if322af949b2348ebaf2b896bd9ee2e61_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cnmd:GeneralSurgeryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredOverTimeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i75c95aec633641d7b8b7c07c7fdff0c3_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredOverTimeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="idb37c3470f1c4ee4a3ca9416c789d079_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cnmd:OrthopedicSurgeryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredOverTimeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i72ad5ca858ec41a8b22fc48fcb8a2b67_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cnmd:GeneralSurgeryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredOverTimeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i147ce8278590475d95f2b007ce8b8910_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredOverTimeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i4fbeeede3b5841dfb8ff0fc8fb92f3d3_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i87efb4b5e77145eaa953edbc2ad43a74_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i5dcb85ddc4a34ec7a3176651d0eaccbe_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="icc4b560884714e249aae5d9872c326ea_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i949433cde8d541d0b3051510dc518334_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i1d229bbf0e07481b86b9acbec2af77ef_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="idd1ea00148744dfd850e020220bf03f5_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i7606ff56051a4e0e8d0a3acff90b86be_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i27c9aa8186434e5993cdaaed802e058d_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i6fdde14e95954ed59a9518497036382d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ia9d784369a924cdc9cf0e77dbb1d00de_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ibc00334b78294a0783fda260135f6549_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie696fef447f64ccc8a668daaade9cd9b_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="icfac919075cc429fb858404f3c669d73_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="iae81127123e340fbb32267cb782ca25e_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="iededad20ecc44fd2bb270dd062e6d769_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i21089d5235814c6ab121525210fd30c8_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ie69d0166e9554b6d85184883bd783cfe_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ib8cab3c62ed442529813f178f35898bc_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ibeb90d75f39f491cacb945863ad49c07_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i50ba6b690edd40ac98d62cd0bd0b088a_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ib9cb6638855042dcace6138a16b438ef_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i717c6c4879334aaf8b31721fd327e132_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i0d7ec65a949147fa901cc819f74ad4ea_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i808450fedc2a4fb9bae456706bfd3a2f_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">cnmd:RevenuesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i1e788e10ae614e408a862f260845ff94_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">cnmd:RevenuesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i2e7e8a5239c24bf8943da6f26a1c8fc5_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i6241041cc28b4b86aab309ebee334dd7_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i80aea042b5874dd49071f7d95c6d3e55_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i05c39c1786d348b380be8f3ab5ee62a6_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ic37b157fcb074cfaaf336217f5e69f47_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i4455b5d88e18472f9babbe0ea7158f8f_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i3f7daa7f8baa47d29e9879c6f43c37e0_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i9b6c7563dc904e9d8280dedc024d298d_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i1aa96a8c12644da9a3f724a2ff7bae28_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i9d03c70b7871426aa4315ec3afbc74b6_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ic5ba3db9a3fd46c9a33db4ff90f454ca_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i88547f770c9e4da1886319e36a385937_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i1b64b61d3f3b4bdfacdd2afc2e367b87_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cnmd:In2BonesGlobalIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ibfc06ce8169a4d33886f8243da232e5b_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cnmd:BiorezIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i517939c1b1424d2a82601fc769d01674_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cnmd:In2BonesGlobalIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">cnmd:MeasurementInputRevenueVolatilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i82c6f94346114193ae96a1af52315fc4_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cnmd:BiorezIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">cnmd:MeasurementInputRevenueVolatilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ice84e4caa93743c5af0f4b86f25100ee_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cnmd:In2BonesGlobalIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ic59ba63fc4b34daa82e9ac6f2499169a_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cnmd:BiorezIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ibc813fbabc244729a87811be824caa94_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cnmd:BiorezIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i1c3351caf2af4528b8145dc927d3396a_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cnmd:In2BonesGlobalIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i259d409a7f7547048e55cae0b6ae73bc_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cnmd:BiorezIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="iedfdc8f66b2f411eba07af9d70f8fc00_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ide2cf996936344b29f9f89e17e70e4cf_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cnmd:CustomerandDistributorRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i4d83f76b6b11441d8c3ab802aea5f214_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cnmd:CustomerandDistributorRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ie37eab970dd24bbc96548816db1cb2e7_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cnmd:CustomerandDistributorRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i58ab77cab7774f0abbd0ec4142cdd537_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cnmd:SalesrepresentationmarketingandpromotionalrightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i64c256aebff14314a4a652aca23bb503_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cnmd:SalesrepresentationmarketingandpromotionalrightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ifdfb609f174b4aff8460fb861d91811c_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cnmd:SalesrepresentationmarketingandpromotionalrightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i91d9eb56eaa944dea8c761cea88d5b5c_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i7c64eb13dae8441284872536e8e2fd72_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i133dcfdb14dd4cd893d74ce7e88ebdac_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ifeb04f4ad743475cb77f3692c078bd59_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cnmd:PatentsAndOtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i1e96e744b1b74f8aa08027bb20d925e8_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cnmd:PatentsAndOtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i28feeea45b68471f9fa287ac91c55448_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cnmd:PatentsAndOtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="id242550a03e34bc39903baf6836b46df_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksAndTradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i9b68c90bafb04105bba9266879cc57f9_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksAndTradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i1252040e498e429c840f44af12d910cb_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">cnmd:ExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ie545f13df7334e93a19c1ff77d2eb84e_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">cnmd:ReductionofRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i7c9501d6daae4d25a09881fd7407a2f6_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="iee16a97278a34fe6b541169cf414845b_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i77a44de4154e4f80aabef63885392692_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i76b7788d670549fab9bb3750f7a0c4ec_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ia3deab346b25408c987cad57798b899f_I20190129">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cnmd:A2.625PercentConvertibleNotesDue2024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-01-29</instant>
        </period>
    </context>
    <context id="ie736fe11e175439d9773dbf983dad1c9_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cnmd:A2.625PercentConvertibleNotesDue2024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ie383611c595342b7bcfa70c8d97dc2b2_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cnmd:A2.625PercentConvertibleNotesDue2024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i9439f4c05d684bd2b8c31654eba4d05f_I20220606">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cnmd:A2250PercentConvertibleNotesDue2027Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-06</instant>
        </period>
    </context>
    <context id="i2d6a32f6a1f64e998b122bbbc261a999_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cnmd:A2250PercentConvertibleNotesDue2027Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ibf5d8099c676486794c460824796bb9a_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cnmd:A2250PercentConvertibleNotesDue2027Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i0dc2d8a4965f4bf786ec6493bd6eea66_I20210716">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cnmd:AmendedAndRestatedSeniorCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-16</instant>
        </period>
    </context>
    <context id="ibbe0c9555d2a40d18fa14506df884584_I20210716">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cnmd:AmendedAndRestatedSeniorCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-16</instant>
        </period>
    </context>
    <context id="i33405b42e96c4b0797d76ca71cdcc742_D20220606-20220606">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cnmd:AmendedAndRestatedSeniorCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-06-06</startDate>
            <endDate>2022-06-06</endDate>
        </period>
    </context>
    <context id="i04f774d345914aff9bbced40761489cc_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cnmd:AmendedAndRestatedSeniorCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LongTermDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ic7e449aedd59496caf4a7c096a050bf9_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cnmd:AmendedAndRestatedSeniorCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LongTermDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">cnmd:AdjustedTermSOFRInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="if29e0d4f562843b3816062f7f565bb17_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cnmd:AmendedAndRestatedSeniorCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LongTermDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:FederalFundsEffectiveSwapRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i4e265365e2db4e6b9a43fef2da7662e0_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cnmd:AmendedAndRestatedSeniorCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LongTermDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">cnmd:AdjustedTermSOFRMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ic2773d0e28ec4c6e93f203b0cb250c6b_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cnmd:AmendedAndRestatedSeniorCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i8e5340b37c9c4826a451adea29a1d1d0_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cnmd:AmendedAndRestatedSeniorCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ic751565b186d4ab8b25554beae97197d_D20190129-20190129">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cnmd:A2.625PercentConvertibleNotesDue2024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-29</startDate>
            <endDate>2019-01-29</endDate>
        </period>
    </context>
    <context id="i2dbc31bae66544e8ad4c1dd3147f68c4_I20190129">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cnmd:A2.625PercentConvertibleNotesDue2024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:OptionIndexedToIssuersEquityTypeAxis">us-gaap:CallOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-01-29</instant>
        </period>
    </context>
    <context id="idfc03df5461f46f685bf90bc12673743_D20220606-20220606">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cnmd:A2.625PercentConvertibleNotesDue2024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-06-06</startDate>
            <endDate>2022-06-06</endDate>
        </period>
    </context>
    <context id="i10eb0e0f69c44d6b8a5dcbb6bec8e099_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cnmd:A2.625PercentConvertibleNotesDue2024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ifa15bf919650442ab2cfd3f7e7f70be6_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cnmd:A2.625PercentConvertibleNotesDue2024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="id1b284d79bb1490fa07cbd99bd8692dd_D20220606-20220606">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cnmd:A2250PercentConvertibleNotesDue2027Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-06-06</startDate>
            <endDate>2022-06-06</endDate>
        </period>
    </context>
    <context id="i82b966a7802b4350a629c26252c5e157_I20220606">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cnmd:A2250PercentConvertibleNotesDue2027Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:OptionIndexedToIssuersEquityTypeAxis">us-gaap:CallOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-06</instant>
        </period>
    </context>
    <context id="ief4e99def0364c889fba657b34e2c8bd_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cnmd:A2250PercentConvertibleNotesDue2027Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i4ff9b47cc6de4e7f8d64f0b08302c5da_D20190129-20190129">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cnmd:A2.625PercentConvertibleNotesDue2024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cnmd:IndexedTransactionTypeAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-29</startDate>
            <endDate>2019-01-29</endDate>
        </period>
    </context>
    <context id="i588b04626e27426a9be89a521d673e93_D20220606-20220606">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cnmd:A2250PercentConvertibleNotesDue2027Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cnmd:IndexedTransactionTypeAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-06-06</startDate>
            <endDate>2022-06-06</endDate>
        </period>
    </context>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <dei:EntityCentralIndexKey
      contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80L2ZyYWc6YzgxZTUxYzgwYzJhNGI0OGExOGMyZjg1OWZmN2Y1MTMvdGFibGU6MWJkZjE3ZGQ2ZDllNGIwY2EzOGY3ZDBlYmMwYTA2NzgvdGFibGVyYW5nZToxYmRmMTdkZDZkOWU0YjBjYTM4ZjdkMGViYzBhMDY3OF8xLTEtMS0xLTQ1OTE5_cafab1a3-113a-457b-9f08-b1f164fffbf8">0000816956</dei:EntityCentralIndexKey>
    <dei:CurrentFiscalYearEndDate
      contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80L2ZyYWc6YzgxZTUxYzgwYzJhNGI0OGExOGMyZjg1OWZmN2Y1MTMvdGFibGU6MWJkZjE3ZGQ2ZDllNGIwY2EzOGY3ZDBlYmMwYTA2NzgvdGFibGVyYW5nZToxYmRmMTdkZDZkOWU0YjBjYTM4ZjdkMGViYzBhMDY3OF8yLTEtMS0xLTQ1OTE5_5200d9fb-0a76-4d0c-975b-4dbd24716100">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentFiscalYearFocus
      contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80L2ZyYWc6YzgxZTUxYzgwYzJhNGI0OGExOGMyZjg1OWZmN2Y1MTMvdGFibGU6MWJkZjE3ZGQ2ZDllNGIwY2EzOGY3ZDBlYmMwYTA2NzgvdGFibGVyYW5nZToxYmRmMTdkZDZkOWU0YjBjYTM4ZjdkMGViYzBhMDY3OF8zLTEtMS0xLTQ1OTE5_2204abe0-879e-48c8-9f1f-dca716ae8b8f">2023</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus
      contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80L2ZyYWc6YzgxZTUxYzgwYzJhNGI0OGExOGMyZjg1OWZmN2Y1MTMvdGFibGU6MWJkZjE3ZGQ2ZDllNGIwY2EzOGY3ZDBlYmMwYTA2NzgvdGFibGVyYW5nZToxYmRmMTdkZDZkOWU0YjBjYTM4ZjdkMGViYzBhMDY3OF80LTEtMS0xLTQ1OTE5_38bdf91e-1ad4-429a-8525-8bf8fe365b27">Q1</dei:DocumentFiscalPeriodFocus>
    <dei:AmendmentFlag
      contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80L2ZyYWc6YzgxZTUxYzgwYzJhNGI0OGExOGMyZjg1OWZmN2Y1MTMvdGFibGU6MWJkZjE3ZGQ2ZDllNGIwY2EzOGY3ZDBlYmMwYTA2NzgvdGFibGVyYW5nZToxYmRmMTdkZDZkOWU0YjBjYTM4ZjdkMGViYzBhMDY3OF81LTEtMS0xLTQ1OTE5_ce6d63af-64d0-442e-9f66-62a9c64080aa">false</dei:AmendmentFlag>
    <us-gaap:AccountingStandardsUpdateExtensibleList
      contextRef="i9500a5ee8dbe4d23aa9c46ebdd25a0c8_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yMi9mcmFnOjRlZjhhMzg3NWQzNDQxMzNhYTVkM2YxMjA4ZjZhNzVmL3RhYmxlOjQ1NzViM2U2MDFhMDQ4MTY5Y2FjMDM2ZjcwZWRhNWJmL3RhYmxlcmFuZ2U6NDU3NWIzZTYwMWEwNDgxNjljYWMwMzZmNzBlZGE1YmZfMTItMC0xLTEtNDY0MDU_bc705460-c49b-465b-9afe-4187d60ffe68">http://fasb.org/us-gaap/2022#AccountingStandardsUpdate202006Member</us-gaap:AccountingStandardsUpdateExtensibleList>
    <dei:DocumentType
      contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xL2ZyYWc6ZDQ1ZTBmNGE4MWFkNDZkYmFiZTE5OWM1YWQwZGQyOGMvdGV4dHJlZ2lvbjpkNDVlMGY0YTgxYWQ0NmRiYWJlMTk5YzVhZDBkZDI4Y18yMTMy_f48550c0-6aaa-4b90-9e8e-3bf342d1d356">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport
      contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xL2ZyYWc6ZDQ1ZTBmNGE4MWFkNDZkYmFiZTE5OWM1YWQwZGQyOGMvdGV4dHJlZ2lvbjpkNDVlMGY0YTgxYWQ0NmRiYWJlMTk5YzVhZDBkZDI4Y18yMTMz_be82009f-f646-46b7-8862-257dcfb35cd3">true</dei:DocumentQuarterlyReport>
    <dei:DocumentTransitionReport
      contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xL2ZyYWc6ZDQ1ZTBmNGE4MWFkNDZkYmFiZTE5OWM1YWQwZGQyOGMvdGV4dHJlZ2lvbjpkNDVlMGY0YTgxYWQ0NmRiYWJlMTk5YzVhZDBkZDI4Y18yMTM0_ae9e8725-29e1-455f-aeb3-013725e398bf">false</dei:DocumentTransitionReport>
    <dei:DocumentPeriodEndDate
      contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xL2ZyYWc6ZDQ1ZTBmNGE4MWFkNDZkYmFiZTE5OWM1YWQwZGQyOGMvdGFibGU6ZGVjMTgxZWUzYWQ5NDY1YTkwYzJjOGYxNmY5MDRlMDEvdGFibGVyYW5nZTpkZWMxODFlZTNhZDk0NjVhOTBjMmM4ZjE2ZjkwNGUwMV8xLTAtMS0xLTQ1OTE5_7406e8d5-16dd-425a-9eb4-f40e72d258cc">2023-03-31</dei:DocumentPeriodEndDate>
    <dei:EntityFileNumber
      contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xL2ZyYWc6ZDQ1ZTBmNGE4MWFkNDZkYmFiZTE5OWM1YWQwZGQyOGMvdGFibGU6ZGVjMTgxZWUzYWQ5NDY1YTkwYzJjOGYxNmY5MDRlMDEvdGFibGVyYW5nZTpkZWMxODFlZTNhZDk0NjVhOTBjMmM4ZjE2ZjkwNGUwMV8xLTEtMS0xLTQ1OTE5_2da4261b-26af-4d01-858c-4b58a6af1098">001-39218</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xL2ZyYWc6ZDQ1ZTBmNGE4MWFkNDZkYmFiZTE5OWM1YWQwZGQyOGMvdGV4dHJlZ2lvbjpkNDVlMGY0YTgxYWQ0NmRiYWJlMTk5YzVhZDBkZDI4Y18yMTM1_b5f28d12-06aa-47a2-88d0-3d4832cbeaf0">CONMED CORPORATION</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xL2ZyYWc6ZDQ1ZTBmNGE4MWFkNDZkYmFiZTE5OWM1YWQwZGQyOGMvdGFibGU6NGU3M2IwMzAwMGZmNDk2NThlM2JmNzQ2M2E2MmJlNGIvdGFibGVyYW5nZTo0ZTczYjAzMDAwZmY0OTY1OGUzYmY3NDYzYTYyYmU0Yl8wLTAtMS0xLTQ1OTE5_bde80e9b-a498-4548-b9ff-55d7b3ab04dc">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xL2ZyYWc6ZDQ1ZTBmNGE4MWFkNDZkYmFiZTE5OWM1YWQwZGQyOGMvdGFibGU6NGU3M2IwMzAwMGZmNDk2NThlM2JmNzQ2M2E2MmJlNGIvdGFibGVyYW5nZTo0ZTczYjAzMDAwZmY0OTY1OGUzYmY3NDYzYTYyYmU0Yl8wLTMtMS0xLTQ1OTE5_8d54d40c-cec1-4afc-aa1d-d64cff8113e2">16-0977505</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xL2ZyYWc6ZDQ1ZTBmNGE4MWFkNDZkYmFiZTE5OWM1YWQwZGQyOGMvdGFibGU6NGU3M2IwMzAwMGZmNDk2NThlM2JmNzQ2M2E2MmJlNGIvdGFibGVyYW5nZTo0ZTczYjAzMDAwZmY0OTY1OGUzYmY3NDYzYTYyYmU0Yl8zLTAtMS0xLTQ1OTE5_1ae161cf-83d8-4e62-bc5f-d7677802bb8e">11311 Concept Blvd</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xL2ZyYWc6ZDQ1ZTBmNGE4MWFkNDZkYmFiZTE5OWM1YWQwZGQyOGMvdGFibGU6NGU3M2IwMzAwMGZmNDk2NThlM2JmNzQ2M2E2MmJlNGIvdGFibGVyYW5nZTo0ZTczYjAzMDAwZmY0OTY1OGUzYmY3NDYzYTYyYmU0Yl8zLTEtMS0xLTQ1OTE5_e039a080-354b-4cb6-bdef-5707699e6756">Largo,</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xL2ZyYWc6ZDQ1ZTBmNGE4MWFkNDZkYmFiZTE5OWM1YWQwZGQyOGMvdGFibGU6NGU3M2IwMzAwMGZmNDk2NThlM2JmNzQ2M2E2MmJlNGIvdGFibGVyYW5nZTo0ZTczYjAzMDAwZmY0OTY1OGUzYmY3NDYzYTYyYmU0Yl8zLTItMS0xLTQ1OTE5_2dfacf78-ea8c-44e7-a009-23466fe2643e">FL</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xL2ZyYWc6ZDQ1ZTBmNGE4MWFkNDZkYmFiZTE5OWM1YWQwZGQyOGMvdGFibGU6NGU3M2IwMzAwMGZmNDk2NThlM2JmNzQ2M2E2MmJlNGIvdGFibGVyYW5nZTo0ZTczYjAzMDAwZmY0OTY1OGUzYmY3NDYzYTYyYmU0Yl8zLTMtMS0xLTQ1OTE5_39a35538-dadc-469d-810a-cc1e4461f310">33773</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xL2ZyYWc6ZDQ1ZTBmNGE4MWFkNDZkYmFiZTE5OWM1YWQwZGQyOGMvdGV4dHJlZ2lvbjpkNDVlMGY0YTgxYWQ0NmRiYWJlMTk5YzVhZDBkZDI4Y18yMTM5_5b32bc0d-9606-4d07-bed0-f17d227e0361">727</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xL2ZyYWc6ZDQ1ZTBmNGE4MWFkNDZkYmFiZTE5OWM1YWQwZGQyOGMvdGV4dHJlZ2lvbjpkNDVlMGY0YTgxYWQ0NmRiYWJlMTk5YzVhZDBkZDI4Y18yMTM2_5253fd87-89f1-47fe-a261-ebd54b60413f">392-6464</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xL2ZyYWc6ZDQ1ZTBmNGE4MWFkNDZkYmFiZTE5OWM1YWQwZGQyOGMvdGFibGU6MTY5Y2YzNTUxNTUxNGYyZGE1NWNmYmU5MDliODk4MDYvdGFibGVyYW5nZToxNjljZjM1NTE1NTE0ZjJkYTU1Y2ZiZTkwOWI4OTgwNl8xLTAtMS0xLTQ1OTE5_f71ebb9d-4a03-4051-81c8-c95fb0320080">Common Stock, $0.01 par value</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xL2ZyYWc6ZDQ1ZTBmNGE4MWFkNDZkYmFiZTE5OWM1YWQwZGQyOGMvdGFibGU6MTY5Y2YzNTUxNTUxNGYyZGE1NWNmYmU5MDliODk4MDYvdGFibGVyYW5nZToxNjljZjM1NTE1NTE0ZjJkYTU1Y2ZiZTkwOWI4OTgwNl8xLTEtMS0xLTQ1OTE5_90f46dfd-f5ab-4b1e-b392-94268eea34c2">CNMD</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xL2ZyYWc6ZDQ1ZTBmNGE4MWFkNDZkYmFiZTE5OWM1YWQwZGQyOGMvdGFibGU6MTY5Y2YzNTUxNTUxNGYyZGE1NWNmYmU5MDliODk4MDYvdGFibGVyYW5nZToxNjljZjM1NTE1NTE0ZjJkYTU1Y2ZiZTkwOWI4OTgwNl8xLTItMS0xLTQ1OTE5_fd890ce5-ee6b-4933-a521-1ccc3059745c">NYSE</dei:SecurityExchangeName>
    <dei:EntityCurrentReportingStatus
      contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xL2ZyYWc6ZDQ1ZTBmNGE4MWFkNDZkYmFiZTE5OWM1YWQwZGQyOGMvdGV4dHJlZ2lvbjpkNDVlMGY0YTgxYWQ0NmRiYWJlMTk5YzVhZDBkZDI4Y18yMTM3_239420f0-de38-44c3-8733-b72225a75f8f">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xL2ZyYWc6ZDQ1ZTBmNGE4MWFkNDZkYmFiZTE5OWM1YWQwZGQyOGMvdGV4dHJlZ2lvbjpkNDVlMGY0YTgxYWQ0NmRiYWJlMTk5YzVhZDBkZDI4Y18yMTQw_749357b6-c59e-4318-bf66-9e94f927baa0">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xL2ZyYWc6ZDQ1ZTBmNGE4MWFkNDZkYmFiZTE5OWM1YWQwZGQyOGMvdGV4dHJlZ2lvbjpkNDVlMGY0YTgxYWQ0NmRiYWJlMTk5YzVhZDBkZDI4Y18yMTQx_ef9c28d7-6503-4075-8ec9-1218c6485615">Large Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xL2ZyYWc6ZDQ1ZTBmNGE4MWFkNDZkYmFiZTE5OWM1YWQwZGQyOGMvdGV4dHJlZ2lvbjpkNDVlMGY0YTgxYWQ0NmRiYWJlMTk5YzVhZDBkZDI4Y18yMTQy_1241cfdf-a1e5-4210-a4a4-6e49d6af38c7">false</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xL2ZyYWc6ZDQ1ZTBmNGE4MWFkNDZkYmFiZTE5OWM1YWQwZGQyOGMvdGV4dHJlZ2lvbjpkNDVlMGY0YTgxYWQ0NmRiYWJlMTk5YzVhZDBkZDI4Y18yMTM4_31cab8c1-9f0d-44d7-8880-36334d5c4fc7">false</dei:EntityEmergingGrowthCompany>
    <dei:EntityShellCompany
      contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xL2ZyYWc6ZDQ1ZTBmNGE4MWFkNDZkYmFiZTE5OWM1YWQwZGQyOGMvdGV4dHJlZ2lvbjpkNDVlMGY0YTgxYWQ0NmRiYWJlMTk5YzVhZDBkZDI4Y18yMTMx_7d26485b-eda3-47bd-90c9-0ab247cea248">false</dei:EntityShellCompany>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="i38a5d384f48a4effaeb956206898d5b3_I20230424"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xL2ZyYWc6ZDQ1ZTBmNGE4MWFkNDZkYmFiZTE5OWM1YWQwZGQyOGMvdGV4dHJlZ2lvbjpkNDVlMGY0YTgxYWQ0NmRiYWJlMTk5YzVhZDBkZDI4Y18yMTIy_30632e80-226c-451a-89a0-11290a8b7c22"
      unitRef="shares">30575290</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:Revenues
      contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xNi9mcmFnOmFjZDYxZTMzYzQxNjRlMTJhNGEzMTk5ZDMxMDFkYTczL3RhYmxlOjRkY2I5OTAzYjAzYzQ2NThhY2I4MGM3ZmY2NDFkZjkwL3RhYmxlcmFuZ2U6NGRjYjk5MDNiMDNjNDY1OGFjYjgwYzdmZjY0MWRmOTBfMy0xLTEtMS00NTkxOQ_5b817f06-9d27-4e49-bca4-da5b8937383f"
      unitRef="usd">295468000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i9500a5ee8dbe4d23aa9c46ebdd25a0c8_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xNi9mcmFnOmFjZDYxZTMzYzQxNjRlMTJhNGEzMTk5ZDMxMDFkYTczL3RhYmxlOjRkY2I5OTAzYjAzYzQ2NThhY2I4MGM3ZmY2NDFkZjkwL3RhYmxlcmFuZ2U6NGRjYjk5MDNiMDNjNDY1OGFjYjgwYzdmZjY0MWRmOTBfMy0zLTEtMS00NTkxOQ_8fff1772-445d-46cc-ae10-8ae119ac96fa"
      unitRef="usd">242327000</us-gaap:Revenues>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xNi9mcmFnOmFjZDYxZTMzYzQxNjRlMTJhNGEzMTk5ZDMxMDFkYTczL3RhYmxlOjRkY2I5OTAzYjAzYzQ2NThhY2I4MGM3ZmY2NDFkZjkwL3RhYmxlcmFuZ2U6NGRjYjk5MDNiMDNjNDY1OGFjYjgwYzdmZjY0MWRmOTBfNS0xLTEtMS00NTkxOQ_6a90ea9d-6ab7-4e03-a94e-1587be8d4ee1"
      unitRef="usd">140147000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i9500a5ee8dbe4d23aa9c46ebdd25a0c8_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xNi9mcmFnOmFjZDYxZTMzYzQxNjRlMTJhNGEzMTk5ZDMxMDFkYTczL3RhYmxlOjRkY2I5OTAzYjAzYzQ2NThhY2I4MGM3ZmY2NDFkZjkwL3RhYmxlcmFuZ2U6NGRjYjk5MDNiMDNjNDY1OGFjYjgwYzdmZjY0MWRmOTBfNS0zLTEtMS00NTkxOQ_26d42139-bb76-4e8b-bfb5-f7702befe3c5"
      unitRef="usd">106336000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:GrossProfit
      contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xNi9mcmFnOmFjZDYxZTMzYzQxNjRlMTJhNGEzMTk5ZDMxMDFkYTczL3RhYmxlOjRkY2I5OTAzYjAzYzQ2NThhY2I4MGM3ZmY2NDFkZjkwL3RhYmxlcmFuZ2U6NGRjYjk5MDNiMDNjNDY1OGFjYjgwYzdmZjY0MWRmOTBfNy0xLTEtMS00NTkxOQ_fc116f42-b9fc-4e41-94b2-eb345161cc53"
      unitRef="usd">155321000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i9500a5ee8dbe4d23aa9c46ebdd25a0c8_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xNi9mcmFnOmFjZDYxZTMzYzQxNjRlMTJhNGEzMTk5ZDMxMDFkYTczL3RhYmxlOjRkY2I5OTAzYjAzYzQ2NThhY2I4MGM3ZmY2NDFkZjkwL3RhYmxlcmFuZ2U6NGRjYjk5MDNiMDNjNDY1OGFjYjgwYzdmZjY0MWRmOTBfNy0zLTEtMS00NTkxOQ_bcae1fbd-9978-4167-adab-4e35597e8f0e"
      unitRef="usd">135991000</us-gaap:GrossProfit>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xNi9mcmFnOmFjZDYxZTMzYzQxNjRlMTJhNGEzMTk5ZDMxMDFkYTczL3RhYmxlOjRkY2I5OTAzYjAzYzQ2NThhY2I4MGM3ZmY2NDFkZjkwL3RhYmxlcmFuZ2U6NGRjYjk5MDNiMDNjNDY1OGFjYjgwYzdmZjY0MWRmOTBfOS0xLTEtMS00NTkxOQ_12928f2d-6fed-44c2-a75f-c3d38d564dd7"
      unitRef="usd">130083000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i9500a5ee8dbe4d23aa9c46ebdd25a0c8_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xNi9mcmFnOmFjZDYxZTMzYzQxNjRlMTJhNGEzMTk5ZDMxMDFkYTczL3RhYmxlOjRkY2I5OTAzYjAzYzQ2NThhY2I4MGM3ZmY2NDFkZjkwL3RhYmxlcmFuZ2U6NGRjYjk5MDNiMDNjNDY1OGFjYjgwYzdmZjY0MWRmOTBfOS0zLTEtMS00NTkxOQ_6308b315-6563-49ff-89d6-485019755c5f"
      unitRef="usd">102875000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xNi9mcmFnOmFjZDYxZTMzYzQxNjRlMTJhNGEzMTk5ZDMxMDFkYTczL3RhYmxlOjRkY2I5OTAzYjAzYzQ2NThhY2I4MGM3ZmY2NDFkZjkwL3RhYmxlcmFuZ2U6NGRjYjk5MDNiMDNjNDY1OGFjYjgwYzdmZjY0MWRmOTBfMTEtMS0xLTEtNDU5MTk_9586201a-c7a4-432a-9577-f860a0a92926"
      unitRef="usd">12539000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i9500a5ee8dbe4d23aa9c46ebdd25a0c8_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xNi9mcmFnOmFjZDYxZTMzYzQxNjRlMTJhNGEzMTk5ZDMxMDFkYTczL3RhYmxlOjRkY2I5OTAzYjAzYzQ2NThhY2I4MGM3ZmY2NDFkZjkwL3RhYmxlcmFuZ2U6NGRjYjk5MDNiMDNjNDY1OGFjYjgwYzdmZjY0MWRmOTBfMTEtMy0xLTEtNDU5MTk_45fbf05d-f5ba-4691-ac35-768d5e88a734"
      unitRef="usd">10672000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:OperatingExpenses
      contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xNi9mcmFnOmFjZDYxZTMzYzQxNjRlMTJhNGEzMTk5ZDMxMDFkYTczL3RhYmxlOjRkY2I5OTAzYjAzYzQ2NThhY2I4MGM3ZmY2NDFkZjkwL3RhYmxlcmFuZ2U6NGRjYjk5MDNiMDNjNDY1OGFjYjgwYzdmZjY0MWRmOTBfMTMtMS0xLTEtNDU5MTk_e9862010-477b-47fd-84ce-21b37c2c3c91"
      unitRef="usd">142622000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="i9500a5ee8dbe4d23aa9c46ebdd25a0c8_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xNi9mcmFnOmFjZDYxZTMzYzQxNjRlMTJhNGEzMTk5ZDMxMDFkYTczL3RhYmxlOjRkY2I5OTAzYjAzYzQ2NThhY2I4MGM3ZmY2NDFkZjkwL3RhYmxlcmFuZ2U6NGRjYjk5MDNiMDNjNDY1OGFjYjgwYzdmZjY0MWRmOTBfMTMtMy0xLTEtNDU5MTk_7fdb89c6-c219-4449-8536-7efc7c11fa55"
      unitRef="usd">113547000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xNi9mcmFnOmFjZDYxZTMzYzQxNjRlMTJhNGEzMTk5ZDMxMDFkYTczL3RhYmxlOjRkY2I5OTAzYjAzYzQ2NThhY2I4MGM3ZmY2NDFkZjkwL3RhYmxlcmFuZ2U6NGRjYjk5MDNiMDNjNDY1OGFjYjgwYzdmZjY0MWRmOTBfMTUtMS0xLTEtNDU5MTk_49f5e232-85ef-487f-9246-7bf91c1d6994"
      unitRef="usd">12699000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i9500a5ee8dbe4d23aa9c46ebdd25a0c8_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xNi9mcmFnOmFjZDYxZTMzYzQxNjRlMTJhNGEzMTk5ZDMxMDFkYTczL3RhYmxlOjRkY2I5OTAzYjAzYzQ2NThhY2I4MGM3ZmY2NDFkZjkwL3RhYmxlcmFuZ2U6NGRjYjk5MDNiMDNjNDY1OGFjYjgwYzdmZjY0MWRmOTBfMTUtMy0xLTEtNDU5MTk_9d4b4739-2941-4c64-b36a-fcbf7556b85f"
      unitRef="usd">22444000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InterestExpense
      contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xNi9mcmFnOmFjZDYxZTMzYzQxNjRlMTJhNGEzMTk5ZDMxMDFkYTczL3RhYmxlOjRkY2I5OTAzYjAzYzQ2NThhY2I4MGM3ZmY2NDFkZjkwL3RhYmxlcmFuZ2U6NGRjYjk5MDNiMDNjNDY1OGFjYjgwYzdmZjY0MWRmOTBfMTctMS0xLTEtNDU5MTk_88df49be-182c-41ec-848a-1b51bfc785ed"
      unitRef="usd">10255000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i9500a5ee8dbe4d23aa9c46ebdd25a0c8_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xNi9mcmFnOmFjZDYxZTMzYzQxNjRlMTJhNGEzMTk5ZDMxMDFkYTczL3RhYmxlOjRkY2I5OTAzYjAzYzQ2NThhY2I4MGM3ZmY2NDFkZjkwL3RhYmxlcmFuZ2U6NGRjYjk5MDNiMDNjNDY1OGFjYjgwYzdmZjY0MWRmOTBfMTctMy0xLTEtNDU5MTk_58323b14-4e41-4aa1-b6b9-dac963a33af8"
      unitRef="usd">4998000</us-gaap:InterestExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xNi9mcmFnOmFjZDYxZTMzYzQxNjRlMTJhNGEzMTk5ZDMxMDFkYTczL3RhYmxlOjRkY2I5OTAzYjAzYzQ2NThhY2I4MGM3ZmY2NDFkZjkwL3RhYmxlcmFuZ2U6NGRjYjk5MDNiMDNjNDY1OGFjYjgwYzdmZjY0MWRmOTBfMjEtMS0xLTEtNDU5MTk_fad1f127-1d32-44e1-968f-ad4257fb519b"
      unitRef="usd">2444000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i9500a5ee8dbe4d23aa9c46ebdd25a0c8_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xNi9mcmFnOmFjZDYxZTMzYzQxNjRlMTJhNGEzMTk5ZDMxMDFkYTczL3RhYmxlOjRkY2I5OTAzYjAzYzQ2NThhY2I4MGM3ZmY2NDFkZjkwL3RhYmxlcmFuZ2U6NGRjYjk5MDNiMDNjNDY1OGFjYjgwYzdmZjY0MWRmOTBfMjEtMy0xLTEtNDU5MTk_a4807550-3314-4496-b9a8-853f115fb3f8"
      unitRef="usd">17446000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xNi9mcmFnOmFjZDYxZTMzYzQxNjRlMTJhNGEzMTk5ZDMxMDFkYTczL3RhYmxlOjRkY2I5OTAzYjAzYzQ2NThhY2I4MGM3ZmY2NDFkZjkwL3RhYmxlcmFuZ2U6NGRjYjk5MDNiMDNjNDY1OGFjYjgwYzdmZjY0MWRmOTBfMjMtMS0xLTEtNDU5MTk_2f858b17-7b08-4717-ba0c-42a52c4b9ac5"
      unitRef="usd">625000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i9500a5ee8dbe4d23aa9c46ebdd25a0c8_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xNi9mcmFnOmFjZDYxZTMzYzQxNjRlMTJhNGEzMTk5ZDMxMDFkYTczL3RhYmxlOjRkY2I5OTAzYjAzYzQ2NThhY2I4MGM3ZmY2NDFkZjkwL3RhYmxlcmFuZ2U6NGRjYjk5MDNiMDNjNDY1OGFjYjgwYzdmZjY0MWRmOTBfMjMtMy0xLTEtNDU5MTk_dc698c9e-0759-4526-8547-1ba02fc6ff18"
      unitRef="usd">2471000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:NetIncomeLoss
      contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xNi9mcmFnOmFjZDYxZTMzYzQxNjRlMTJhNGEzMTk5ZDMxMDFkYTczL3RhYmxlOjRkY2I5OTAzYjAzYzQ2NThhY2I4MGM3ZmY2NDFkZjkwL3RhYmxlcmFuZ2U6NGRjYjk5MDNiMDNjNDY1OGFjYjgwYzdmZjY0MWRmOTBfMjUtMS0xLTEtNDU5MTk_52bc8723-ce15-4869-99a1-c957420817a9"
      unitRef="usd">1819000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i9500a5ee8dbe4d23aa9c46ebdd25a0c8_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xNi9mcmFnOmFjZDYxZTMzYzQxNjRlMTJhNGEzMTk5ZDMxMDFkYTczL3RhYmxlOjRkY2I5OTAzYjAzYzQ2NThhY2I4MGM3ZmY2NDFkZjkwL3RhYmxlcmFuZ2U6NGRjYjk5MDNiMDNjNDY1OGFjYjgwYzdmZjY0MWRmOTBfMjUtMy0xLTEtNDU5MTk_39bcecab-fea0-4320-9c5c-faffe4b3104a"
      unitRef="usd">14975000</us-gaap:NetIncomeLoss>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xNi9mcmFnOmFjZDYxZTMzYzQxNjRlMTJhNGEzMTk5ZDMxMDFkYTczL3RhYmxlOjRkY2I5OTAzYjAzYzQ2NThhY2I4MGM3ZmY2NDFkZjkwL3RhYmxlcmFuZ2U6NGRjYjk5MDNiMDNjNDY1OGFjYjgwYzdmZjY0MWRmOTBfMjctMS0xLTEtNDU5MTk_8cfacbc8-22d0-497d-a2be-045abede9880"
      unitRef="usd">4695000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i9500a5ee8dbe4d23aa9c46ebdd25a0c8_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xNi9mcmFnOmFjZDYxZTMzYzQxNjRlMTJhNGEzMTk5ZDMxMDFkYTczL3RhYmxlOjRkY2I5OTAzYjAzYzQ2NThhY2I4MGM3ZmY2NDFkZjkwL3RhYmxlcmFuZ2U6NGRjYjk5MDNiMDNjNDY1OGFjYjgwYzdmZjY0MWRmOTBfMjctMy0xLTEtNDU5MTk_38d9b8e8-1541-4ed5-a640-7c14c1e36f05"
      unitRef="usd">16415000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:EarningsPerShareBasic
      contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xNi9mcmFnOmFjZDYxZTMzYzQxNjRlMTJhNGEzMTk5ZDMxMDFkYTczL3RhYmxlOjRkY2I5OTAzYjAzYzQ2NThhY2I4MGM3ZmY2NDFkZjkwL3RhYmxlcmFuZ2U6NGRjYjk5MDNiMDNjNDY1OGFjYjgwYzdmZjY0MWRmOTBfMzMtMS0xLTEtNDU5MTk_fedbdebc-45cf-4886-a307-c8f318bb24b4"
      unitRef="usdPerShare">0.06</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i9500a5ee8dbe4d23aa9c46ebdd25a0c8_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xNi9mcmFnOmFjZDYxZTMzYzQxNjRlMTJhNGEzMTk5ZDMxMDFkYTczL3RhYmxlOjRkY2I5OTAzYjAzYzQ2NThhY2I4MGM3ZmY2NDFkZjkwL3RhYmxlcmFuZ2U6NGRjYjk5MDNiMDNjNDY1OGFjYjgwYzdmZjY0MWRmOTBfMzMtMy0xLTEtNDU5MTk_5a4d84ed-4a91-4371-bfa1-e9d6594f1af5"
      unitRef="usdPerShare">0.51</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xNi9mcmFnOmFjZDYxZTMzYzQxNjRlMTJhNGEzMTk5ZDMxMDFkYTczL3RhYmxlOjRkY2I5OTAzYjAzYzQ2NThhY2I4MGM3ZmY2NDFkZjkwL3RhYmxlcmFuZ2U6NGRjYjk5MDNiMDNjNDY1OGFjYjgwYzdmZjY0MWRmOTBfMzQtMS0xLTEtNDU5MTk_8f10e1c5-7b05-42cb-a7cd-9d14585d95b8"
      unitRef="usdPerShare">0.06</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i9500a5ee8dbe4d23aa9c46ebdd25a0c8_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xNi9mcmFnOmFjZDYxZTMzYzQxNjRlMTJhNGEzMTk5ZDMxMDFkYTczL3RhYmxlOjRkY2I5OTAzYjAzYzQ2NThhY2I4MGM3ZmY2NDFkZjkwL3RhYmxlcmFuZ2U6NGRjYjk5MDNiMDNjNDY1OGFjYjgwYzdmZjY0MWRmOTBfMzQtMy0xLTEtNDU5MTk_4b5c531f-e3e5-4ad8-a979-8ff95fd9663b"
      unitRef="usdPerShare">0.47</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xNi9mcmFnOmFjZDYxZTMzYzQxNjRlMTJhNGEzMTk5ZDMxMDFkYTczL3RhYmxlOjRkY2I5OTAzYjAzYzQ2NThhY2I4MGM3ZmY2NDFkZjkwL3RhYmxlcmFuZ2U6NGRjYjk5MDNiMDNjNDY1OGFjYjgwYzdmZjY0MWRmOTBfMzctMS0xLTEtNDU5MTk_d1f16651-0082-4096-bf1f-729359412c6b"
      unitRef="shares">30511000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i9500a5ee8dbe4d23aa9c46ebdd25a0c8_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xNi9mcmFnOmFjZDYxZTMzYzQxNjRlMTJhNGEzMTk5ZDMxMDFkYTczL3RhYmxlOjRkY2I5OTAzYjAzYzQ2NThhY2I4MGM3ZmY2NDFkZjkwL3RhYmxlcmFuZ2U6NGRjYjk5MDNiMDNjNDY1OGFjYjgwYzdmZjY0MWRmOTBfMzctMy0xLTEtNDU5MTk_74c9c9a8-7ade-4740-aca1-ee6b7f6130e8"
      unitRef="shares">29428000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xNi9mcmFnOmFjZDYxZTMzYzQxNjRlMTJhNGEzMTk5ZDMxMDFkYTczL3RhYmxlOjRkY2I5OTAzYjAzYzQ2NThhY2I4MGM3ZmY2NDFkZjkwL3RhYmxlcmFuZ2U6NGRjYjk5MDNiMDNjNDY1OGFjYjgwYzdmZjY0MWRmOTBfMzgtMS0xLTEtNDU5MTk_6de1cfad-6f5d-473c-8939-a94e62aa92d2"
      unitRef="shares">31204000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i9500a5ee8dbe4d23aa9c46ebdd25a0c8_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xNi9mcmFnOmFjZDYxZTMzYzQxNjRlMTJhNGEzMTk5ZDMxMDFkYTczL3RhYmxlOjRkY2I5OTAzYjAzYzQ2NThhY2I4MGM3ZmY2NDFkZjkwL3RhYmxlcmFuZ2U6NGRjYjk5MDNiMDNjNDY1OGFjYjgwYzdmZjY0MWRmOTBfMzgtMy0xLTEtNDU5MTk_134bb95d-766e-4f72-bd52-033fa2a603d5"
      unitRef="shares">35155000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i738c2d1dacaf436faf03cc46ab9cef23_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xOS9mcmFnOjZmYmQzMDlmMGUwYjQ2NGNhNjhhMmFhMjdjYWIzOGM3L3RhYmxlOjJiODJlMWQ5NDE0ZjQ2NmQ5NTg3YWU2M2NjODQ3YWYzL3RhYmxlcmFuZ2U6MmI4MmUxZDk0MTRmNDY2ZDk1ODdhZTYzY2M4NDdhZjNfMy0xLTEtMS00NTkxOQ_a13aa0a7-4620-4c1c-a3fb-bdd867f38541"
      unitRef="usd">26494000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ie4f63720d8b244a68941932992cd9f4d_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xOS9mcmFnOjZmYmQzMDlmMGUwYjQ2NGNhNjhhMmFhMjdjYWIzOGM3L3RhYmxlOjJiODJlMWQ5NDE0ZjQ2NmQ5NTg3YWU2M2NjODQ3YWYzL3RhYmxlcmFuZ2U6MmI4MmUxZDk0MTRmNDY2ZDk1ODdhZTYzY2M4NDdhZjNfMy0zLTEtMS00NTkxOQ_8efafadf-4c22-4f0b-b03b-d8d3e7a6e19d"
      unitRef="usd">28942000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i738c2d1dacaf436faf03cc46ab9cef23_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xOS9mcmFnOjZmYmQzMDlmMGUwYjQ2NGNhNjhhMmFhMjdjYWIzOGM3L3RhYmxlOjJiODJlMWQ5NDE0ZjQ2NmQ5NTg3YWU2M2NjODQ3YWYzL3RhYmxlcmFuZ2U6MmI4MmUxZDk0MTRmNDY2ZDk1ODdhZTYzY2M4NDdhZjNfNC0xLTEtMS00NTkxOQ_ff92e64f-433c-47a3-9881-23d860f61805"
      unitRef="usd">213182000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="ie4f63720d8b244a68941932992cd9f4d_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xOS9mcmFnOjZmYmQzMDlmMGUwYjQ2NGNhNjhhMmFhMjdjYWIzOGM3L3RhYmxlOjJiODJlMWQ5NDE0ZjQ2NmQ5NTg3YWU2M2NjODQ3YWYzL3RhYmxlcmFuZ2U6MmI4MmUxZDk0MTRmNDY2ZDk1ODdhZTYzY2M4NDdhZjNfNC0zLTEtMS00NTkxOQ_af188eee-e872-4018-85c9-6ea293083096"
      unitRef="usd">191345000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:InventoryNet
      contextRef="i738c2d1dacaf436faf03cc46ab9cef23_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xOS9mcmFnOjZmYmQzMDlmMGUwYjQ2NGNhNjhhMmFhMjdjYWIzOGM3L3RhYmxlOjJiODJlMWQ5NDE0ZjQ2NmQ5NTg3YWU2M2NjODQ3YWYzL3RhYmxlcmFuZ2U6MmI4MmUxZDk0MTRmNDY2ZDk1ODdhZTYzY2M4NDdhZjNfNS0xLTEtMS00NTkxOQ_fcf5a4dc-696b-4a77-9771-a1d84bc583d7"
      unitRef="usd">335370000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="ie4f63720d8b244a68941932992cd9f4d_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xOS9mcmFnOjZmYmQzMDlmMGUwYjQ2NGNhNjhhMmFhMjdjYWIzOGM3L3RhYmxlOjJiODJlMWQ5NDE0ZjQ2NmQ5NTg3YWU2M2NjODQ3YWYzL3RhYmxlcmFuZ2U6MmI4MmUxZDk0MTRmNDY2ZDk1ODdhZTYzY2M4NDdhZjNfNS0zLTEtMS00NTkxOQ_aa148661-35e8-4769-98e9-bd6e920ff9d3"
      unitRef="usd">332320000</us-gaap:InventoryNet>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="i738c2d1dacaf436faf03cc46ab9cef23_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xOS9mcmFnOjZmYmQzMDlmMGUwYjQ2NGNhNjhhMmFhMjdjYWIzOGM3L3RhYmxlOjJiODJlMWQ5NDE0ZjQ2NmQ5NTg3YWU2M2NjODQ3YWYzL3RhYmxlcmFuZ2U6MmI4MmUxZDk0MTRmNDY2ZDk1ODdhZTYzY2M4NDdhZjNfNi0xLTEtMS00NTkxOQ_db928a05-e44d-40cf-adad-d4f112322898"
      unitRef="usd">35042000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="ie4f63720d8b244a68941932992cd9f4d_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xOS9mcmFnOjZmYmQzMDlmMGUwYjQ2NGNhNjhhMmFhMjdjYWIzOGM3L3RhYmxlOjJiODJlMWQ5NDE0ZjQ2NmQ5NTg3YWU2M2NjODQ3YWYzL3RhYmxlcmFuZ2U6MmI4MmUxZDk0MTRmNDY2ZDk1ODdhZTYzY2M4NDdhZjNfNi0zLTEtMS00NTkxOQ_88513d7c-1258-4d8d-b5d2-e52dc518d274"
      unitRef="usd">28619000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i738c2d1dacaf436faf03cc46ab9cef23_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xOS9mcmFnOjZmYmQzMDlmMGUwYjQ2NGNhNjhhMmFhMjdjYWIzOGM3L3RhYmxlOjJiODJlMWQ5NDE0ZjQ2NmQ5NTg3YWU2M2NjODQ3YWYzL3RhYmxlcmFuZ2U6MmI4MmUxZDk0MTRmNDY2ZDk1ODdhZTYzY2M4NDdhZjNfNy0xLTEtMS00NTkxOQ_87448efa-988b-4d0e-aa34-c2bf3d8bf91a"
      unitRef="usd">610088000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="ie4f63720d8b244a68941932992cd9f4d_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xOS9mcmFnOjZmYmQzMDlmMGUwYjQ2NGNhNjhhMmFhMjdjYWIzOGM3L3RhYmxlOjJiODJlMWQ5NDE0ZjQ2NmQ5NTg3YWU2M2NjODQ3YWYzL3RhYmxlcmFuZ2U6MmI4MmUxZDk0MTRmNDY2ZDk1ODdhZTYzY2M4NDdhZjNfNy0zLTEtMS00NTkxOQ_20c9de7b-1574-46b9-b992-b122d3dff11d"
      unitRef="usd">581226000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i738c2d1dacaf436faf03cc46ab9cef23_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xOS9mcmFnOjZmYmQzMDlmMGUwYjQ2NGNhNjhhMmFhMjdjYWIzOGM3L3RhYmxlOjJiODJlMWQ5NDE0ZjQ2NmQ5NTg3YWU2M2NjODQ3YWYzL3RhYmxlcmFuZ2U6MmI4MmUxZDk0MTRmNDY2ZDk1ODdhZTYzY2M4NDdhZjNfOC0xLTEtMS00NTkxOQ_302c4a52-c7df-40b9-8856-681396b42043"
      unitRef="usd">115356000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="ie4f63720d8b244a68941932992cd9f4d_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xOS9mcmFnOjZmYmQzMDlmMGUwYjQ2NGNhNjhhMmFhMjdjYWIzOGM3L3RhYmxlOjJiODJlMWQ5NDE0ZjQ2NmQ5NTg3YWU2M2NjODQ3YWYzL3RhYmxlcmFuZ2U6MmI4MmUxZDk0MTRmNDY2ZDk1ODdhZTYzY2M4NDdhZjNfOC0zLTEtMS00NTkxOQ_22ebac39-ef06-4023-a267-ad49c220a22d"
      unitRef="usd">115611000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:Goodwill
      contextRef="i738c2d1dacaf436faf03cc46ab9cef23_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xOS9mcmFnOjZmYmQzMDlmMGUwYjQ2NGNhNjhhMmFhMjdjYWIzOGM3L3RhYmxlOjJiODJlMWQ5NDE0ZjQ2NmQ5NTg3YWU2M2NjODQ3YWYzL3RhYmxlcmFuZ2U6MmI4MmUxZDk0MTRmNDY2ZDk1ODdhZTYzY2M4NDdhZjNfOS0xLTEtMS00NTkxOQ_e8cb2012-21f2-425c-aa6b-363ae45fc36a"
      unitRef="usd">815499000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="ie4f63720d8b244a68941932992cd9f4d_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xOS9mcmFnOjZmYmQzMDlmMGUwYjQ2NGNhNjhhMmFhMjdjYWIzOGM3L3RhYmxlOjJiODJlMWQ5NDE0ZjQ2NmQ5NTg3YWU2M2NjODQ3YWYzL3RhYmxlcmFuZ2U6MmI4MmUxZDk0MTRmNDY2ZDk1ODdhZTYzY2M4NDdhZjNfOS0zLTEtMS00NTkxOQ_825d160e-876f-41fc-8b3f-a369246361ca"
      unitRef="usd">815429000</us-gaap:Goodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i738c2d1dacaf436faf03cc46ab9cef23_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xOS9mcmFnOjZmYmQzMDlmMGUwYjQ2NGNhNjhhMmFhMjdjYWIzOGM3L3RhYmxlOjJiODJlMWQ5NDE0ZjQ2NmQ5NTg3YWU2M2NjODQ3YWYzL3RhYmxlcmFuZ2U6MmI4MmUxZDk0MTRmNDY2ZDk1ODdhZTYzY2M4NDdhZjNfMTAtMS0xLTEtNDU5MTk_50e9bed2-a3aa-4bde-b09e-e5c9de73fb6b"
      unitRef="usd">673538000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="ie4f63720d8b244a68941932992cd9f4d_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xOS9mcmFnOjZmYmQzMDlmMGUwYjQ2NGNhNjhhMmFhMjdjYWIzOGM3L3RhYmxlOjJiODJlMWQ5NDE0ZjQ2NmQ5NTg3YWU2M2NjODQ3YWYzL3RhYmxlcmFuZ2U6MmI4MmUxZDk0MTRmNDY2ZDk1ODdhZTYzY2M4NDdhZjNfMTAtMy0xLTEtNDU5MTk_4f787109-b36b-485d-897e-58a06d3404c0"
      unitRef="usd">681799000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i738c2d1dacaf436faf03cc46ab9cef23_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xOS9mcmFnOjZmYmQzMDlmMGUwYjQ2NGNhNjhhMmFhMjdjYWIzOGM3L3RhYmxlOjJiODJlMWQ5NDE0ZjQ2NmQ5NTg3YWU2M2NjODQ3YWYzL3RhYmxlcmFuZ2U6MmI4MmUxZDk0MTRmNDY2ZDk1ODdhZTYzY2M4NDdhZjNfMTEtMS0xLTEtNDU5MTk_d12f7439-a0e0-4db7-8051-f1ddbbf48c1e"
      unitRef="usd">105639000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="ie4f63720d8b244a68941932992cd9f4d_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xOS9mcmFnOjZmYmQzMDlmMGUwYjQ2NGNhNjhhMmFhMjdjYWIzOGM3L3RhYmxlOjJiODJlMWQ5NDE0ZjQ2NmQ5NTg3YWU2M2NjODQ3YWYzL3RhYmxlcmFuZ2U6MmI4MmUxZDk0MTRmNDY2ZDk1ODdhZTYzY2M4NDdhZjNfMTEtMy0xLTEtNDU5MTk_30b72539-3f72-4882-9160-6f09f31e00ef"
      unitRef="usd">103527000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets
      contextRef="i738c2d1dacaf436faf03cc46ab9cef23_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xOS9mcmFnOjZmYmQzMDlmMGUwYjQ2NGNhNjhhMmFhMjdjYWIzOGM3L3RhYmxlOjJiODJlMWQ5NDE0ZjQ2NmQ5NTg3YWU2M2NjODQ3YWYzL3RhYmxlcmFuZ2U6MmI4MmUxZDk0MTRmNDY2ZDk1ODdhZTYzY2M4NDdhZjNfMTItMS0xLTEtNDU5MTk_a46364ff-7600-4eec-87a0-de49def71153"
      unitRef="usd">2320120000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="ie4f63720d8b244a68941932992cd9f4d_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xOS9mcmFnOjZmYmQzMDlmMGUwYjQ2NGNhNjhhMmFhMjdjYWIzOGM3L3RhYmxlOjJiODJlMWQ5NDE0ZjQ2NmQ5NTg3YWU2M2NjODQ3YWYzL3RhYmxlcmFuZ2U6MmI4MmUxZDk0MTRmNDY2ZDk1ODdhZTYzY2M4NDdhZjNfMTItMy0xLTEtNDU5MTk_0fa11369-f086-472f-9901-2356df9292be"
      unitRef="usd">2297592000</us-gaap:Assets>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent
      contextRef="i738c2d1dacaf436faf03cc46ab9cef23_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xOS9mcmFnOjZmYmQzMDlmMGUwYjQ2NGNhNjhhMmFhMjdjYWIzOGM3L3RhYmxlOjJiODJlMWQ5NDE0ZjQ2NmQ5NTg3YWU2M2NjODQ3YWYzL3RhYmxlcmFuZ2U6MmI4MmUxZDk0MTRmNDY2ZDk1ODdhZTYzY2M4NDdhZjNfMTktMS0xLTEtNDU5MTk_e511dbec-e50e-47f5-9a05-3527b0178116"
      unitRef="usd">69693000</us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent
      contextRef="ie4f63720d8b244a68941932992cd9f4d_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xOS9mcmFnOjZmYmQzMDlmMGUwYjQ2NGNhNjhhMmFhMjdjYWIzOGM3L3RhYmxlOjJiODJlMWQ5NDE0ZjQ2NmQ5NTg3YWU2M2NjODQ3YWYzL3RhYmxlcmFuZ2U6MmI4MmUxZDk0MTRmNDY2ZDk1ODdhZTYzY2M4NDdhZjNfMTktMy0xLTEtNDU5MTk_b7ae1e88-a8c5-4348-888d-bf9c1eb912c5"
      unitRef="usd">69746000</us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="i738c2d1dacaf436faf03cc46ab9cef23_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xOS9mcmFnOjZmYmQzMDlmMGUwYjQ2NGNhNjhhMmFhMjdjYWIzOGM3L3RhYmxlOjJiODJlMWQ5NDE0ZjQ2NmQ5NTg3YWU2M2NjODQ3YWYzL3RhYmxlcmFuZ2U6MmI4MmUxZDk0MTRmNDY2ZDk1ODdhZTYzY2M4NDdhZjNfMjAtMS0xLTEtNDU5MTk_c2976494-ae93-4289-a194-84beb6c27375"
      unitRef="usd">76680000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="ie4f63720d8b244a68941932992cd9f4d_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xOS9mcmFnOjZmYmQzMDlmMGUwYjQ2NGNhNjhhMmFhMjdjYWIzOGM3L3RhYmxlOjJiODJlMWQ5NDE0ZjQ2NmQ5NTg3YWU2M2NjODQ3YWYzL3RhYmxlcmFuZ2U6MmI4MmUxZDk0MTRmNDY2ZDk1ODdhZTYzY2M4NDdhZjNfMjAtMy0xLTEtNDU5MTk_a7e7f095-b370-427a-a546-9c6b59b531b7"
      unitRef="usd">73393000</us-gaap:AccountsPayableCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="i738c2d1dacaf436faf03cc46ab9cef23_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xOS9mcmFnOjZmYmQzMDlmMGUwYjQ2NGNhNjhhMmFhMjdjYWIzOGM3L3RhYmxlOjJiODJlMWQ5NDE0ZjQ2NmQ5NTg3YWU2M2NjODQ3YWYzL3RhYmxlcmFuZ2U6MmI4MmUxZDk0MTRmNDY2ZDk1ODdhZTYzY2M4NDdhZjNfMjEtMS0xLTEtNDU5MTk_5dfb8714-4ad0-4826-afa1-875b9fe9278f"
      unitRef="usd">49378000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="ie4f63720d8b244a68941932992cd9f4d_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xOS9mcmFnOjZmYmQzMDlmMGUwYjQ2NGNhNjhhMmFhMjdjYWIzOGM3L3RhYmxlOjJiODJlMWQ5NDE0ZjQ2NmQ5NTg3YWU2M2NjODQ3YWYzL3RhYmxlcmFuZ2U6MmI4MmUxZDk0MTRmNDY2ZDk1ODdhZTYzY2M4NDdhZjNfMjEtMy0xLTEtNDU5MTk_7e4fe6d9-b103-4391-bf61-d499358b243c"
      unitRef="usd">54733000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="i738c2d1dacaf436faf03cc46ab9cef23_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xOS9mcmFnOjZmYmQzMDlmMGUwYjQ2NGNhNjhhMmFhMjdjYWIzOGM3L3RhYmxlOjJiODJlMWQ5NDE0ZjQ2NmQ5NTg3YWU2M2NjODQ3YWYzL3RhYmxlcmFuZ2U6MmI4MmUxZDk0MTRmNDY2ZDk1ODdhZTYzY2M4NDdhZjNfMjItMS0xLTEtNDU5MTk_713895b9-4f38-4c6e-888b-89909879a401"
      unitRef="usd">124935000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="ie4f63720d8b244a68941932992cd9f4d_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xOS9mcmFnOjZmYmQzMDlmMGUwYjQ2NGNhNjhhMmFhMjdjYWIzOGM3L3RhYmxlOjJiODJlMWQ5NDE0ZjQ2NmQ5NTg3YWU2M2NjODQ3YWYzL3RhYmxlcmFuZ2U6MmI4MmUxZDk0MTRmNDY2ZDk1ODdhZTYzY2M4NDdhZjNfMjItMy0xLTEtNDU5MTk_9ddbc2c2-14bd-4c33-a7d8-92d9338036ea"
      unitRef="usd">98680000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i738c2d1dacaf436faf03cc46ab9cef23_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xOS9mcmFnOjZmYmQzMDlmMGUwYjQ2NGNhNjhhMmFhMjdjYWIzOGM3L3RhYmxlOjJiODJlMWQ5NDE0ZjQ2NmQ5NTg3YWU2M2NjODQ3YWYzL3RhYmxlcmFuZ2U6MmI4MmUxZDk0MTRmNDY2ZDk1ODdhZTYzY2M4NDdhZjNfMjMtMS0xLTEtNDU5MTk_5bf6f19c-3cc0-4e2b-bf96-350ca3326226"
      unitRef="usd">320686000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="ie4f63720d8b244a68941932992cd9f4d_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xOS9mcmFnOjZmYmQzMDlmMGUwYjQ2NGNhNjhhMmFhMjdjYWIzOGM3L3RhYmxlOjJiODJlMWQ5NDE0ZjQ2NmQ5NTg3YWU2M2NjODQ3YWYzL3RhYmxlcmFuZ2U6MmI4MmUxZDk0MTRmNDY2ZDk1ODdhZTYzY2M4NDdhZjNfMjMtMy0xLTEtNDU5MTk_0d8fbe5c-8f5d-454c-94b9-411c1e0096f3"
      unitRef="usd">296552000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligations
      contextRef="i738c2d1dacaf436faf03cc46ab9cef23_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xOS9mcmFnOjZmYmQzMDlmMGUwYjQ2NGNhNjhhMmFhMjdjYWIzOGM3L3RhYmxlOjJiODJlMWQ5NDE0ZjQ2NmQ5NTg3YWU2M2NjODQ3YWYzL3RhYmxlcmFuZ2U6MmI4MmUxZDk0MTRmNDY2ZDk1ODdhZTYzY2M4NDdhZjNfMjUtMS0xLTEtNDU5MTk_7d69aeaf-dc3c-4956-a3bd-0b5c22debf27"
      unitRef="usd">995276000</us-gaap:LongTermDebtAndCapitalLeaseObligations>
    <us-gaap:LongTermDebtAndCapitalLeaseObligations
      contextRef="ie4f63720d8b244a68941932992cd9f4d_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xOS9mcmFnOjZmYmQzMDlmMGUwYjQ2NGNhNjhhMmFhMjdjYWIzOGM3L3RhYmxlOjJiODJlMWQ5NDE0ZjQ2NmQ5NTg3YWU2M2NjODQ3YWYzL3RhYmxlcmFuZ2U6MmI4MmUxZDk0MTRmNDY2ZDk1ODdhZTYzY2M4NDdhZjNfMjUtMy0xLTEtNDU5MTk_eccba8ec-2d50-4e77-9ea3-d285e61fb215"
      unitRef="usd">985076000</us-gaap:LongTermDebtAndCapitalLeaseObligations>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="i738c2d1dacaf436faf03cc46ab9cef23_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xOS9mcmFnOjZmYmQzMDlmMGUwYjQ2NGNhNjhhMmFhMjdjYWIzOGM3L3RhYmxlOjJiODJlMWQ5NDE0ZjQ2NmQ5NTg3YWU2M2NjODQ3YWYzL3RhYmxlcmFuZ2U6MmI4MmUxZDk0MTRmNDY2ZDk1ODdhZTYzY2M4NDdhZjNfMjYtMS0xLTEtNDU5MTk_e551bc33-91d3-4122-89a5-bdd645b2af06"
      unitRef="usd">65546000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="ie4f63720d8b244a68941932992cd9f4d_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xOS9mcmFnOjZmYmQzMDlmMGUwYjQ2NGNhNjhhMmFhMjdjYWIzOGM3L3RhYmxlOjJiODJlMWQ5NDE0ZjQ2NmQ5NTg3YWU2M2NjODQ3YWYzL3RhYmxlcmFuZ2U6MmI4MmUxZDk0MTRmNDY2ZDk1ODdhZTYzY2M4NDdhZjNfMjYtMy0xLTEtNDU5MTk_4504a92c-481b-4904-b0a9-4838e16039dc"
      unitRef="usd">66725000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i738c2d1dacaf436faf03cc46ab9cef23_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xOS9mcmFnOjZmYmQzMDlmMGUwYjQ2NGNhNjhhMmFhMjdjYWIzOGM3L3RhYmxlOjJiODJlMWQ5NDE0ZjQ2NmQ5NTg3YWU2M2NjODQ3YWYzL3RhYmxlcmFuZ2U6MmI4MmUxZDk0MTRmNDY2ZDk1ODdhZTYzY2M4NDdhZjNfMjctMS0xLTEtNDU5MTk_503fede5-d8f8-42a9-944f-0756193c842f"
      unitRef="usd">186159000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="ie4f63720d8b244a68941932992cd9f4d_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xOS9mcmFnOjZmYmQzMDlmMGUwYjQ2NGNhNjhhMmFhMjdjYWIzOGM3L3RhYmxlOjJiODJlMWQ5NDE0ZjQ2NmQ5NTg3YWU2M2NjODQ3YWYzL3RhYmxlcmFuZ2U6MmI4MmUxZDk0MTRmNDY2ZDk1ODdhZTYzY2M4NDdhZjNfMjctMy0xLTEtNDU5MTk_d9cdf3b6-f383-4642-b564-178d5ae2a384"
      unitRef="usd">203694000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:Liabilities
      contextRef="i738c2d1dacaf436faf03cc46ab9cef23_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xOS9mcmFnOjZmYmQzMDlmMGUwYjQ2NGNhNjhhMmFhMjdjYWIzOGM3L3RhYmxlOjJiODJlMWQ5NDE0ZjQ2NmQ5NTg3YWU2M2NjODQ3YWYzL3RhYmxlcmFuZ2U6MmI4MmUxZDk0MTRmNDY2ZDk1ODdhZTYzY2M4NDdhZjNfMjgtMS0xLTEtNDU5MTk_36c73de1-7fb8-469e-b13b-4bc87a898abc"
      unitRef="usd">1567667000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="ie4f63720d8b244a68941932992cd9f4d_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xOS9mcmFnOjZmYmQzMDlmMGUwYjQ2NGNhNjhhMmFhMjdjYWIzOGM3L3RhYmxlOjJiODJlMWQ5NDE0ZjQ2NmQ5NTg3YWU2M2NjODQ3YWYzL3RhYmxlcmFuZ2U6MmI4MmUxZDk0MTRmNDY2ZDk1ODdhZTYzY2M4NDdhZjNfMjgtMy0xLTEtNDU5MTk_9e894a3e-993e-45cf-b807-2f5c3f4e2948"
      unitRef="usd">1552047000</us-gaap:Liabilities>
    <us-gaap:CommitmentsAndContingencies
      contextRef="i738c2d1dacaf436faf03cc46ab9cef23_I20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xOS9mcmFnOjZmYmQzMDlmMGUwYjQ2NGNhNjhhMmFhMjdjYWIzOGM3L3RhYmxlOjJiODJlMWQ5NDE0ZjQ2NmQ5NTg3YWU2M2NjODQ3YWYzL3RhYmxlcmFuZ2U6MmI4MmUxZDk0MTRmNDY2ZDk1ODdhZTYzY2M4NDdhZjNfMzAtMS0xLTEtNDU5MTk_a0712a66-018c-4e18-8472-c6834c5446bf"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="ie4f63720d8b244a68941932992cd9f4d_I20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xOS9mcmFnOjZmYmQzMDlmMGUwYjQ2NGNhNjhhMmFhMjdjYWIzOGM3L3RhYmxlOjJiODJlMWQ5NDE0ZjQ2NmQ5NTg3YWU2M2NjODQ3YWYzL3RhYmxlcmFuZ2U6MmI4MmUxZDk0MTRmNDY2ZDk1ODdhZTYzY2M4NDdhZjNfMzAtMy0xLTEtNDU5MTk_4276d678-b3e5-4f73-9db6-8b7c1ae70233"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="i738c2d1dacaf436faf03cc46ab9cef23_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xOS9mcmFnOjZmYmQzMDlmMGUwYjQ2NGNhNjhhMmFhMjdjYWIzOGM3L3RhYmxlOjJiODJlMWQ5NDE0ZjQ2NmQ5NTg3YWU2M2NjODQ3YWYzL3RhYmxlcmFuZ2U6MmI4MmUxZDk0MTRmNDY2ZDk1ODdhZTYzY2M4NDdhZjNfMzMtMC0xLTEtNDU5MTkvdGV4dHJlZ2lvbjpiOTRmMjkxOTcyZjY0ZTZjYjdlYjZlYmJkOTQxZTcxMF8zMQ_6e702358-3047-4064-b878-02ea2ead4d32"
      unitRef="usdPerShare">0.01</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="ie4f63720d8b244a68941932992cd9f4d_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xOS9mcmFnOjZmYmQzMDlmMGUwYjQ2NGNhNjhhMmFhMjdjYWIzOGM3L3RhYmxlOjJiODJlMWQ5NDE0ZjQ2NmQ5NTg3YWU2M2NjODQ3YWYzL3RhYmxlcmFuZ2U6MmI4MmUxZDk0MTRmNDY2ZDk1ODdhZTYzY2M4NDdhZjNfMzMtMC0xLTEtNDU5MTkvdGV4dHJlZ2lvbjpiOTRmMjkxOTcyZjY0ZTZjYjdlYjZlYmJkOTQxZTcxMF8zMQ_9f10ac3b-5ea5-4d56-b981-5d371057e63a"
      unitRef="usdPerShare">0.01</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="i738c2d1dacaf436faf03cc46ab9cef23_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xOS9mcmFnOjZmYmQzMDlmMGUwYjQ2NGNhNjhhMmFhMjdjYWIzOGM3L3RhYmxlOjJiODJlMWQ5NDE0ZjQ2NmQ5NTg3YWU2M2NjODQ3YWYzL3RhYmxlcmFuZ2U6MmI4MmUxZDk0MTRmNDY2ZDk1ODdhZTYzY2M4NDdhZjNfMzQtMC0xLTEtNDU5MTkvdGV4dHJlZ2lvbjoxNGQ0ZDYyNWY5NWU0ZjQ5OTZiNDEyMGFjYWFjZDBmMV8xNQ_bf67e8a6-ed35-4f72-a8c7-685671344693"
      unitRef="shares">500000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="ie4f63720d8b244a68941932992cd9f4d_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xOS9mcmFnOjZmYmQzMDlmMGUwYjQ2NGNhNjhhMmFhMjdjYWIzOGM3L3RhYmxlOjJiODJlMWQ5NDE0ZjQ2NmQ5NTg3YWU2M2NjODQ3YWYzL3RhYmxlcmFuZ2U6MmI4MmUxZDk0MTRmNDY2ZDk1ODdhZTYzY2M4NDdhZjNfMzQtMC0xLTEtNDU5MTkvdGV4dHJlZ2lvbjoxNGQ0ZDYyNWY5NWU0ZjQ5OTZiNDEyMGFjYWFjZDBmMV8xNQ_c45c8f07-c6f2-4fa3-b6ef-d4ece7644a17"
      unitRef="shares">500000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="i738c2d1dacaf436faf03cc46ab9cef23_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xOS9mcmFnOjZmYmQzMDlmMGUwYjQ2NGNhNjhhMmFhMjdjYWIzOGM3L3RhYmxlOjJiODJlMWQ5NDE0ZjQ2NmQ5NTg3YWU2M2NjODQ3YWYzL3RhYmxlcmFuZ2U6MmI4MmUxZDk0MTRmNDY2ZDk1ODdhZTYzY2M4NDdhZjNfMzQtMC0xLTEtNDU5MTkvdGV4dHJlZ2lvbjoxNGQ0ZDYyNWY5NWU0ZjQ5OTZiNDEyMGFjYWFjZDBmMV8yNg_3a42d8a7-8258-4b68-ac73-260076b3d8f9"
      unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="ie4f63720d8b244a68941932992cd9f4d_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xOS9mcmFnOjZmYmQzMDlmMGUwYjQ2NGNhNjhhMmFhMjdjYWIzOGM3L3RhYmxlOjJiODJlMWQ5NDE0ZjQ2NmQ5NTg3YWU2M2NjODQ3YWYzL3RhYmxlcmFuZ2U6MmI4MmUxZDk0MTRmNDY2ZDk1ODdhZTYzY2M4NDdhZjNfMzQtMC0xLTEtNDU5MTkvdGV4dHJlZ2lvbjoxNGQ0ZDYyNWY5NWU0ZjQ5OTZiNDEyMGFjYWFjZDBmMV8yNg_d04c94ba-4e9b-4d15-89f8-0c5743edb716"
      unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockValue
      contextRef="i738c2d1dacaf436faf03cc46ab9cef23_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xOS9mcmFnOjZmYmQzMDlmMGUwYjQ2NGNhNjhhMmFhMjdjYWIzOGM3L3RhYmxlOjJiODJlMWQ5NDE0ZjQ2NmQ5NTg3YWU2M2NjODQ3YWYzL3RhYmxlcmFuZ2U6MmI4MmUxZDk0MTRmNDY2ZDk1ODdhZTYzY2M4NDdhZjNfMzQtMS0xLTEtNDU5MTk_5b6ac0d2-3554-4356-b609-5e97740ee5df"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue
      contextRef="ie4f63720d8b244a68941932992cd9f4d_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xOS9mcmFnOjZmYmQzMDlmMGUwYjQ2NGNhNjhhMmFhMjdjYWIzOGM3L3RhYmxlOjJiODJlMWQ5NDE0ZjQ2NmQ5NTg3YWU2M2NjODQ3YWYzL3RhYmxlcmFuZ2U6MmI4MmUxZDk0MTRmNDY2ZDk1ODdhZTYzY2M4NDdhZjNfMzQtMy0xLTEtNDU5MTk_bcbede60-e326-45f8-925c-baa71b5f7aa1"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="ie4f63720d8b244a68941932992cd9f4d_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xOS9mcmFnOjZmYmQzMDlmMGUwYjQ2NGNhNjhhMmFhMjdjYWIzOGM3L3RhYmxlOjJiODJlMWQ5NDE0ZjQ2NmQ5NTg3YWU2M2NjODQ3YWYzL3RhYmxlcmFuZ2U6MmI4MmUxZDk0MTRmNDY2ZDk1ODdhZTYzY2M4NDdhZjNfMzUtMC0xLTEtNDU5MTkvdGV4dHJlZ2lvbjo0OTU4NWE4NTg2MjA0MGQ1OWQ1OTg1NmI0OGFmYjA1N18yOA_2b496b3a-8bd6-4343-ae9a-cfd6583d0f54"
      unitRef="usdPerShare">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i738c2d1dacaf436faf03cc46ab9cef23_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xOS9mcmFnOjZmYmQzMDlmMGUwYjQ2NGNhNjhhMmFhMjdjYWIzOGM3L3RhYmxlOjJiODJlMWQ5NDE0ZjQ2NmQ5NTg3YWU2M2NjODQ3YWYzL3RhYmxlcmFuZ2U6MmI4MmUxZDk0MTRmNDY2ZDk1ODdhZTYzY2M4NDdhZjNfMzUtMC0xLTEtNDU5MTkvdGV4dHJlZ2lvbjo0OTU4NWE4NTg2MjA0MGQ1OWQ1OTg1NmI0OGFmYjA1N18yOA_492e4eed-b41d-4132-a8ab-e837bbe93627"
      unitRef="usdPerShare">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="ie4f63720d8b244a68941932992cd9f4d_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xOS9mcmFnOjZmYmQzMDlmMGUwYjQ2NGNhNjhhMmFhMjdjYWIzOGM3L3RhYmxlOjJiODJlMWQ5NDE0ZjQ2NmQ5NTg3YWU2M2NjODQ3YWYzL3RhYmxlcmFuZ2U6MmI4MmUxZDk0MTRmNDY2ZDk1ODdhZTYzY2M4NDdhZjNfMzUtMC0xLTEtNDU5MTkvdGV4dHJlZ2lvbjo0OTU4NWE4NTg2MjA0MGQ1OWQ1OTg1NmI0OGFmYjA1N180Mg_21cb1922-c405-4c00-8242-9483c41245b5"
      unitRef="shares">100000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i738c2d1dacaf436faf03cc46ab9cef23_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xOS9mcmFnOjZmYmQzMDlmMGUwYjQ2NGNhNjhhMmFhMjdjYWIzOGM3L3RhYmxlOjJiODJlMWQ5NDE0ZjQ2NmQ5NTg3YWU2M2NjODQ3YWYzL3RhYmxlcmFuZ2U6MmI4MmUxZDk0MTRmNDY2ZDk1ODdhZTYzY2M4NDdhZjNfMzUtMC0xLTEtNDU5MTkvdGV4dHJlZ2lvbjo0OTU4NWE4NTg2MjA0MGQ1OWQ1OTg1NmI0OGFmYjA1N180Mg_5d306bca-c609-41d3-b07e-5a7081003fab"
      unitRef="shares">100000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="i738c2d1dacaf436faf03cc46ab9cef23_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xOS9mcmFnOjZmYmQzMDlmMGUwYjQ2NGNhNjhhMmFhMjdjYWIzOGM3L3RhYmxlOjJiODJlMWQ5NDE0ZjQ2NmQ5NTg3YWU2M2NjODQ3YWYzL3RhYmxlcmFuZ2U6MmI4MmUxZDk0MTRmNDY2ZDk1ODdhZTYzY2M4NDdhZjNfMzUtMC0xLTEtNDU5MTkvdGV4dHJlZ2lvbjo0OTU4NWE4NTg2MjA0MGQ1OWQ1OTg1NmI0OGFmYjA1N182NA_79cbe940-7f21-4845-a6b1-5b3cd79e1fae"
      unitRef="shares">31299194</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="ie4f63720d8b244a68941932992cd9f4d_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xOS9mcmFnOjZmYmQzMDlmMGUwYjQ2NGNhNjhhMmFhMjdjYWIzOGM3L3RhYmxlOjJiODJlMWQ5NDE0ZjQ2NmQ5NTg3YWU2M2NjODQ3YWYzL3RhYmxlcmFuZ2U6MmI4MmUxZDk0MTRmNDY2ZDk1ODdhZTYzY2M4NDdhZjNfMzUtMC0xLTEtNDU5MTkvdGV4dHJlZ2lvbjo0OTU4NWE4NTg2MjA0MGQ1OWQ1OTg1NmI0OGFmYjA1N182NA_ce095b10-3fdb-4a85-8fc8-a9eae4106375"
      unitRef="shares">31299194</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockValue
      contextRef="i738c2d1dacaf436faf03cc46ab9cef23_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xOS9mcmFnOjZmYmQzMDlmMGUwYjQ2NGNhNjhhMmFhMjdjYWIzOGM3L3RhYmxlOjJiODJlMWQ5NDE0ZjQ2NmQ5NTg3YWU2M2NjODQ3YWYzL3RhYmxlcmFuZ2U6MmI4MmUxZDk0MTRmNDY2ZDk1ODdhZTYzY2M4NDdhZjNfMzUtMS0xLTEtNDU5MTk_46239911-8b83-434c-a4ee-237da56c6744"
      unitRef="usd">313000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="ie4f63720d8b244a68941932992cd9f4d_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xOS9mcmFnOjZmYmQzMDlmMGUwYjQ2NGNhNjhhMmFhMjdjYWIzOGM3L3RhYmxlOjJiODJlMWQ5NDE0ZjQ2NmQ5NTg3YWU2M2NjODQ3YWYzL3RhYmxlcmFuZ2U6MmI4MmUxZDk0MTRmNDY2ZDk1ODdhZTYzY2M4NDdhZjNfMzUtMy0xLTEtNDU5MTk_2e1bfb21-4d82-4f56-a05e-10b0fca1f77a"
      unitRef="usd">313000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital
      contextRef="i738c2d1dacaf436faf03cc46ab9cef23_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xOS9mcmFnOjZmYmQzMDlmMGUwYjQ2NGNhNjhhMmFhMjdjYWIzOGM3L3RhYmxlOjJiODJlMWQ5NDE0ZjQ2NmQ5NTg3YWU2M2NjODQ3YWYzL3RhYmxlcmFuZ2U6MmI4MmUxZDk0MTRmNDY2ZDk1ODdhZTYzY2M4NDdhZjNfMzYtMS0xLTEtNDU5MTk_310f1375-a92c-44d0-a107-01c32710a8b0"
      unitRef="usd">419517000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital
      contextRef="ie4f63720d8b244a68941932992cd9f4d_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xOS9mcmFnOjZmYmQzMDlmMGUwYjQ2NGNhNjhhMmFhMjdjYWIzOGM3L3RhYmxlOjJiODJlMWQ5NDE0ZjQ2NmQ5NTg3YWU2M2NjODQ3YWYzL3RhYmxlcmFuZ2U6MmI4MmUxZDk0MTRmNDY2ZDk1ODdhZTYzY2M4NDdhZjNfMzYtMy0xLTEtNDU5MTk_9438378c-7266-4d0c-9a0a-a5279f4d1358"
      unitRef="usd">413235000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i738c2d1dacaf436faf03cc46ab9cef23_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xOS9mcmFnOjZmYmQzMDlmMGUwYjQ2NGNhNjhhMmFhMjdjYWIzOGM3L3RhYmxlOjJiODJlMWQ5NDE0ZjQ2NmQ5NTg3YWU2M2NjODQ3YWYzL3RhYmxlcmFuZ2U6MmI4MmUxZDk0MTRmNDY2ZDk1ODdhZTYzY2M4NDdhZjNfMzctMS0xLTEtNDU5MTk_9642f08a-edbb-4fd4-b035-a4e3ef52bf3c"
      unitRef="usd">408337000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="ie4f63720d8b244a68941932992cd9f4d_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xOS9mcmFnOjZmYmQzMDlmMGUwYjQ2NGNhNjhhMmFhMjdjYWIzOGM3L3RhYmxlOjJiODJlMWQ5NDE0ZjQ2NmQ5NTg3YWU2M2NjODQ3YWYzL3RhYmxlcmFuZ2U6MmI4MmUxZDk0MTRmNDY2ZDk1ODdhZTYzY2M4NDdhZjNfMzctMy0xLTEtNDU5MTk_77734a21-2cca-4b00-8172-322ffc887a2e"
      unitRef="usd">412631000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i738c2d1dacaf436faf03cc46ab9cef23_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xOS9mcmFnOjZmYmQzMDlmMGUwYjQ2NGNhNjhhMmFhMjdjYWIzOGM3L3RhYmxlOjJiODJlMWQ5NDE0ZjQ2NmQ5NTg3YWU2M2NjODQ3YWYzL3RhYmxlcmFuZ2U6MmI4MmUxZDk0MTRmNDY2ZDk1ODdhZTYzY2M4NDdhZjNfMzgtMS0xLTEtNDU5MTk_15bf5e44-1b29-42ff-9ffe-40bafa673dff"
      unitRef="usd">-54982000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="ie4f63720d8b244a68941932992cd9f4d_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xOS9mcmFnOjZmYmQzMDlmMGUwYjQ2NGNhNjhhMmFhMjdjYWIzOGM3L3RhYmxlOjJiODJlMWQ5NDE0ZjQ2NmQ5NTg3YWU2M2NjODQ3YWYzL3RhYmxlcmFuZ2U6MmI4MmUxZDk0MTRmNDY2ZDk1ODdhZTYzY2M4NDdhZjNfMzgtMy0xLTEtNDU5MTk_316f4f17-f01a-40c9-aad8-6c744fc888a9"
      unitRef="usd">-57858000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:TreasuryStockCommonShares
      contextRef="i738c2d1dacaf436faf03cc46ab9cef23_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xOS9mcmFnOjZmYmQzMDlmMGUwYjQ2NGNhNjhhMmFhMjdjYWIzOGM3L3RhYmxlOjJiODJlMWQ5NDE0ZjQ2NmQ5NTg3YWU2M2NjODQ3YWYzL3RhYmxlcmFuZ2U6MmI4MmUxZDk0MTRmNDY2ZDk1ODdhZTYzY2M4NDdhZjNfMzktMC0xLTEtNDU5MTkvdGV4dHJlZ2lvbjowYjI5M2ZjZmMxYTI0YjQ4YmNiN2EwNGY2MzhhYmRhNV8xMA_7e0cb0ca-de33-480f-9b29-f41c32cb7b94"
      unitRef="shares">738718</us-gaap:TreasuryStockCommonShares>
    <us-gaap:TreasuryStockCommonShares
      contextRef="ie4f63720d8b244a68941932992cd9f4d_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xOS9mcmFnOjZmYmQzMDlmMGUwYjQ2NGNhNjhhMmFhMjdjYWIzOGM3L3RhYmxlOjJiODJlMWQ5NDE0ZjQ2NmQ5NTg3YWU2M2NjODQ3YWYzL3RhYmxlcmFuZ2U6MmI4MmUxZDk0MTRmNDY2ZDk1ODdhZTYzY2M4NDdhZjNfMzktMC0xLTEtNDU5MTkvdGV4dHJlZ2lvbjowYjI5M2ZjZmMxYTI0YjQ4YmNiN2EwNGY2MzhhYmRhNV8xNw_1109599f-fb44-4086-b182-ef49e17ef257"
      unitRef="shares">811532</us-gaap:TreasuryStockCommonShares>
    <us-gaap:TreasuryStockCommonValue
      contextRef="i738c2d1dacaf436faf03cc46ab9cef23_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xOS9mcmFnOjZmYmQzMDlmMGUwYjQ2NGNhNjhhMmFhMjdjYWIzOGM3L3RhYmxlOjJiODJlMWQ5NDE0ZjQ2NmQ5NTg3YWU2M2NjODQ3YWYzL3RhYmxlcmFuZ2U6MmI4MmUxZDk0MTRmNDY2ZDk1ODdhZTYzY2M4NDdhZjNfMzktMS0xLTEtNDU5MTk_c3c13cdd-7218-4fb7-954d-f15004834d01"
      unitRef="usd">20732000</us-gaap:TreasuryStockCommonValue>
    <us-gaap:TreasuryStockCommonValue
      contextRef="ie4f63720d8b244a68941932992cd9f4d_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xOS9mcmFnOjZmYmQzMDlmMGUwYjQ2NGNhNjhhMmFhMjdjYWIzOGM3L3RhYmxlOjJiODJlMWQ5NDE0ZjQ2NmQ5NTg3YWU2M2NjODQ3YWYzL3RhYmxlcmFuZ2U6MmI4MmUxZDk0MTRmNDY2ZDk1ODdhZTYzY2M4NDdhZjNfMzktMy0xLTEtNDU5MTk_e408fdf7-2e62-4399-82ac-c9e2644906f0"
      unitRef="usd">22776000</us-gaap:TreasuryStockCommonValue>
    <us-gaap:StockholdersEquity
      contextRef="i738c2d1dacaf436faf03cc46ab9cef23_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xOS9mcmFnOjZmYmQzMDlmMGUwYjQ2NGNhNjhhMmFhMjdjYWIzOGM3L3RhYmxlOjJiODJlMWQ5NDE0ZjQ2NmQ5NTg3YWU2M2NjODQ3YWYzL3RhYmxlcmFuZ2U6MmI4MmUxZDk0MTRmNDY2ZDk1ODdhZTYzY2M4NDdhZjNfNDAtMS0xLTEtNDU5MTk_c1105b79-d15b-4e7e-8845-eecfad2ce60e"
      unitRef="usd">752453000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ie4f63720d8b244a68941932992cd9f4d_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xOS9mcmFnOjZmYmQzMDlmMGUwYjQ2NGNhNjhhMmFhMjdjYWIzOGM3L3RhYmxlOjJiODJlMWQ5NDE0ZjQ2NmQ5NTg3YWU2M2NjODQ3YWYzL3RhYmxlcmFuZ2U6MmI4MmUxZDk0MTRmNDY2ZDk1ODdhZTYzY2M4NDdhZjNfNDAtMy0xLTEtNDU5MTk_237d135a-51de-46a8-9111-75706acad71f"
      unitRef="usd">745545000</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i738c2d1dacaf436faf03cc46ab9cef23_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xOS9mcmFnOjZmYmQzMDlmMGUwYjQ2NGNhNjhhMmFhMjdjYWIzOGM3L3RhYmxlOjJiODJlMWQ5NDE0ZjQ2NmQ5NTg3YWU2M2NjODQ3YWYzL3RhYmxlcmFuZ2U6MmI4MmUxZDk0MTRmNDY2ZDk1ODdhZTYzY2M4NDdhZjNfNDEtMS0xLTEtNDU5MTk_8c1134aa-f9ee-4ff9-9aa8-f85e8d382b1d"
      unitRef="usd">2320120000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="ie4f63720d8b244a68941932992cd9f4d_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8xOS9mcmFnOjZmYmQzMDlmMGUwYjQ2NGNhNjhhMmFhMjdjYWIzOGM3L3RhYmxlOjJiODJlMWQ5NDE0ZjQ2NmQ5NTg3YWU2M2NjODQ3YWYzL3RhYmxlcmFuZ2U6MmI4MmUxZDk0MTRmNDY2ZDk1ODdhZTYzY2M4NDdhZjNfNDEtMy0xLTEtNDU5MTk_10038cee-57bf-4dda-8ca0-8c0f27ee584d"
      unitRef="usd">2297592000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="iab594279d9ab4ade89e55f698f81cb18_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yMi9mcmFnOjRlZjhhMzg3NWQzNDQxMzNhYTVkM2YxMjA4ZjZhNzVmL3RhYmxlOmI0Y2Q1OTkwNjlkNDQ2ZTdhMTViNjM5ZTU2NWVlMDhmL3RhYmxlcmFuZ2U6YjRjZDU5OTA2OWQ0NDZlN2ExNWI2MzllNTY1ZWUwOGZfMi0xLTEtMS00NTkxOQ_3753a616-3589-4c3d-b86b-e6133170fb8e"
      unitRef="shares">31299000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="iab594279d9ab4ade89e55f698f81cb18_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yMi9mcmFnOjRlZjhhMzg3NWQzNDQxMzNhYTVkM2YxMjA4ZjZhNzVmL3RhYmxlOmI0Y2Q1OTkwNjlkNDQ2ZTdhMTViNjM5ZTU2NWVlMDhmL3RhYmxlcmFuZ2U6YjRjZDU5OTA2OWQ0NDZlN2ExNWI2MzllNTY1ZWUwOGZfMi0yLTEtMS00NTkxOQ_c5c3895a-434b-4ef6-a381-dfcdc6ccf872"
      unitRef="usd">313000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="id7b8c6548e4e406d84526eb06077992a_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yMi9mcmFnOjRlZjhhMzg3NWQzNDQxMzNhYTVkM2YxMjA4ZjZhNzVmL3RhYmxlOmI0Y2Q1OTkwNjlkNDQ2ZTdhMTViNjM5ZTU2NWVlMDhmL3RhYmxlcmFuZ2U6YjRjZDU5OTA2OWQ0NDZlN2ExNWI2MzllNTY1ZWUwOGZfMi0zLTEtMS00NTkxOQ_9fda8863-4f81-41d5-bd22-e3b51a5e63a1"
      unitRef="usd">413235000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="if120f3461d36460aad6ccdf8d2faa0ba_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yMi9mcmFnOjRlZjhhMzg3NWQzNDQxMzNhYTVkM2YxMjA4ZjZhNzVmL3RhYmxlOmI0Y2Q1OTkwNjlkNDQ2ZTdhMTViNjM5ZTU2NWVlMDhmL3RhYmxlcmFuZ2U6YjRjZDU5OTA2OWQ0NDZlN2ExNWI2MzllNTY1ZWUwOGZfMi00LTEtMS00NTkxOQ_e8156402-bc7e-497f-ae91-dca0c2b1c7ef"
      unitRef="usd">412631000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i7467bf1c44a741c2a174d8fda8ebb019_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yMi9mcmFnOjRlZjhhMzg3NWQzNDQxMzNhYTVkM2YxMjA4ZjZhNzVmL3RhYmxlOmI0Y2Q1OTkwNjlkNDQ2ZTdhMTViNjM5ZTU2NWVlMDhmL3RhYmxlcmFuZ2U6YjRjZDU5OTA2OWQ0NDZlN2ExNWI2MzllNTY1ZWUwOGZfMi01LTEtMS00NTkxOQ_fc637e5a-0a7e-424d-b28f-0d1932a82192"
      unitRef="usd">-57858000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="iaca150a4def842dc82f49cd1d16f8299_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yMi9mcmFnOjRlZjhhMzg3NWQzNDQxMzNhYTVkM2YxMjA4ZjZhNzVmL3RhYmxlOmI0Y2Q1OTkwNjlkNDQ2ZTdhMTViNjM5ZTU2NWVlMDhmL3RhYmxlcmFuZ2U6YjRjZDU5OTA2OWQ0NDZlN2ExNWI2MzllNTY1ZWUwOGZfMi02LTEtMS00NTkxOQ_3c6da392-c3a4-4d37-b072-aabe418ba05a"
      unitRef="usd">-22776000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ie4f63720d8b244a68941932992cd9f4d_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yMi9mcmFnOjRlZjhhMzg3NWQzNDQxMzNhYTVkM2YxMjA4ZjZhNzVmL3RhYmxlOmI0Y2Q1OTkwNjlkNDQ2ZTdhMTViNjM5ZTU2NWVlMDhmL3RhYmxlcmFuZ2U6YjRjZDU5OTA2OWQ0NDZlN2ExNWI2MzllNTY1ZWUwOGZfMi03LTEtMS00NTkxOQ_196cadce-8db0-4332-ab6e-b99b36672546"
      unitRef="usd">745545000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i7a1eaccdf00242e8a344de7091fb416e_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yMi9mcmFnOjRlZjhhMzg3NWQzNDQxMzNhYTVkM2YxMjA4ZjZhNzVmL3RhYmxlOmI0Y2Q1OTkwNjlkNDQ2ZTdhMTViNjM5ZTU2NWVlMDhmL3RhYmxlcmFuZ2U6YjRjZDU5OTA2OWQ0NDZlN2ExNWI2MzllNTY1ZWUwOGZfMy0zLTEtMS00NTkxOQ_31b27049-d905-4103-8274-40717f7a5e09"
      unitRef="usd">556000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="ida5b0e90904045df9a5437b94848a04d_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yMi9mcmFnOjRlZjhhMzg3NWQzNDQxMzNhYTVkM2YxMjA4ZjZhNzVmL3RhYmxlOmI0Y2Q1OTkwNjlkNDQ2ZTdhMTViNjM5ZTU2NWVlMDhmL3RhYmxlcmFuZ2U6YjRjZDU5OTA2OWQ0NDZlN2ExNWI2MzllNTY1ZWUwOGZfMy02LTEtMS00NTkxOQ_ee4d1bda-f7fe-4c4c-88fc-8895f7147dd2"
      unitRef="usd">2044000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yMi9mcmFnOjRlZjhhMzg3NWQzNDQxMzNhYTVkM2YxMjA4ZjZhNzVmL3RhYmxlOmI0Y2Q1OTkwNjlkNDQ2ZTdhMTViNjM5ZTU2NWVlMDhmL3RhYmxlcmFuZ2U6YjRjZDU5OTA2OWQ0NDZlN2ExNWI2MzllNTY1ZWUwOGZfMy03LTEtMS00NTkxOQ_2f73f4ca-cb21-4c9f-aa07-eb3c7d3b0499"
      unitRef="usd">2600000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i7a1eaccdf00242e8a344de7091fb416e_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yMi9mcmFnOjRlZjhhMzg3NWQzNDQxMzNhYTVkM2YxMjA4ZjZhNzVmL3RhYmxlOmI0Y2Q1OTkwNjlkNDQ2ZTdhMTViNjM5ZTU2NWVlMDhmL3RhYmxlcmFuZ2U6YjRjZDU5OTA2OWQ0NDZlN2ExNWI2MzllNTY1ZWUwOGZfNC0zLTEtMS00NTkxOQ_f1e61d3b-1d51-437e-8a75-858098ea50b6"
      unitRef="usd">5726000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yMi9mcmFnOjRlZjhhMzg3NWQzNDQxMzNhYTVkM2YxMjA4ZjZhNzVmL3RhYmxlOmI0Y2Q1OTkwNjlkNDQ2ZTdhMTViNjM5ZTU2NWVlMDhmL3RhYmxlcmFuZ2U6YjRjZDU5OTA2OWQ0NDZlN2ExNWI2MzllNTY1ZWUwOGZfNC03LTEtMS00NTkxOQ_068acb60-982a-4dc4-8d48-925d8841e94c"
      unitRef="usd">5726000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yMi9mcmFnOjRlZjhhMzg3NWQzNDQxMzNhYTVkM2YxMjA4ZjZhNzVmL3RhYmxlOmI0Y2Q1OTkwNjlkNDQ2ZTdhMTViNjM5ZTU2NWVlMDhmL3RhYmxlcmFuZ2U6YjRjZDU5OTA2OWQ0NDZlN2ExNWI2MzllNTY1ZWUwOGZfNS0wLTEtMS00NTkxOS90ZXh0cmVnaW9uOmQ0MTVkMGI2NmYyYTQ3MmQ5YmViOWMyMjYwZjUyODU2XzMx_ad241424-5689-44bd-b209-bc7733036cac"
      unitRef="usdPerShare">0.20</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:DividendsCommonStockCash
      contextRef="idd1e8990d17d4c29a09ce497b0e3d5e9_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yMi9mcmFnOjRlZjhhMzg3NWQzNDQxMzNhYTVkM2YxMjA4ZjZhNzVmL3RhYmxlOmI0Y2Q1OTkwNjlkNDQ2ZTdhMTViNjM5ZTU2NWVlMDhmL3RhYmxlcmFuZ2U6YjRjZDU5OTA2OWQ0NDZlN2ExNWI2MzllNTY1ZWUwOGZfNS00LTEtMS00NTkxOQ_d2fc999a-d0be-4d0d-850b-6b72ffc36080"
      unitRef="usd">6113000</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash
      contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yMi9mcmFnOjRlZjhhMzg3NWQzNDQxMzNhYTVkM2YxMjA4ZjZhNzVmL3RhYmxlOmI0Y2Q1OTkwNjlkNDQ2ZTdhMTViNjM5ZTU2NWVlMDhmL3RhYmxlcmFuZ2U6YjRjZDU5OTA2OWQ0NDZlN2ExNWI2MzllNTY1ZWUwOGZfNS03LTEtMS00NTkxOQ_e571afaa-fc7c-42b4-9351-4724052971e1"
      unitRef="usd">6113000</us-gaap:DividendsCommonStockCash>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="i8faa12cfbcc746b48b96bb341f53eff6_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yMi9mcmFnOjRlZjhhMzg3NWQzNDQxMzNhYTVkM2YxMjA4ZjZhNzVmL3RhYmxlOmI0Y2Q1OTkwNjlkNDQ2ZTdhMTViNjM5ZTU2NWVlMDhmL3RhYmxlcmFuZ2U6YjRjZDU5OTA2OWQ0NDZlN2ExNWI2MzllNTY1ZWUwOGZfMTAtNS0xLTEtNDU5MTk_de13a84d-502f-4f84-9156-15e766dc9055"
      unitRef="usd">877000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="i8faa12cfbcc746b48b96bb341f53eff6_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yMi9mcmFnOjRlZjhhMzg3NWQzNDQxMzNhYTVkM2YxMjA4ZjZhNzVmL3RhYmxlOmI0Y2Q1OTkwNjlkNDQ2ZTdhMTViNjM5ZTU2NWVlMDhmL3RhYmxlcmFuZ2U6YjRjZDU5OTA2OWQ0NDZlN2ExNWI2MzllNTY1ZWUwOGZfMTEtNS0xLTEtNDU5MTk_c828d914-8d64-4a45-9a5b-30b8ef1f6a1a"
      unitRef="usd">-403000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i8faa12cfbcc746b48b96bb341f53eff6_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yMi9mcmFnOjRlZjhhMzg3NWQzNDQxMzNhYTVkM2YxMjA4ZjZhNzVmL3RhYmxlOmI0Y2Q1OTkwNjlkNDQ2ZTdhMTViNjM5ZTU2NWVlMDhmL3RhYmxlcmFuZ2U6YjRjZDU5OTA2OWQ0NDZlN2ExNWI2MzllNTY1ZWUwOGZfMTItNS0xLTEtNDU5MTk_e6cf437f-a0f5-40dd-8597-ae4049160400"
      unitRef="usd">1596000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:NetIncomeLoss
      contextRef="idd1e8990d17d4c29a09ce497b0e3d5e9_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yMi9mcmFnOjRlZjhhMzg3NWQzNDQxMzNhYTVkM2YxMjA4ZjZhNzVmL3RhYmxlOmI0Y2Q1OTkwNjlkNDQ2ZTdhMTViNjM5ZTU2NWVlMDhmL3RhYmxlcmFuZ2U6YjRjZDU5OTA2OWQ0NDZlN2ExNWI2MzllNTY1ZWUwOGZfMTMtNC0xLTEtNDU5MTk_31142bde-3a3f-46aa-a244-0a9792d2802f"
      unitRef="usd">1819000</us-gaap:NetIncomeLoss>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yMi9mcmFnOjRlZjhhMzg3NWQzNDQxMzNhYTVkM2YxMjA4ZjZhNzVmL3RhYmxlOmI0Y2Q1OTkwNjlkNDQ2ZTdhMTViNjM5ZTU2NWVlMDhmL3RhYmxlcmFuZ2U6YjRjZDU5OTA2OWQ0NDZlN2ExNWI2MzllNTY1ZWUwOGZfMTQtNy0xLTEtNDU5MTk_c593cbe2-804c-4b97-9e9c-bc040fdc33ab"
      unitRef="usd">4695000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i92319359f0d94bf68894ee4109dfcf00_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yMi9mcmFnOjRlZjhhMzg3NWQzNDQxMzNhYTVkM2YxMjA4ZjZhNzVmL3RhYmxlOmI0Y2Q1OTkwNjlkNDQ2ZTdhMTViNjM5ZTU2NWVlMDhmL3RhYmxlcmFuZ2U6YjRjZDU5OTA2OWQ0NDZlN2ExNWI2MzllNTY1ZWUwOGZfMTYtMS0xLTEtNDU5MTk_46b2963b-f06a-4331-bc10-b548af173f3b"
      unitRef="shares">31299000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i92319359f0d94bf68894ee4109dfcf00_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yMi9mcmFnOjRlZjhhMzg3NWQzNDQxMzNhYTVkM2YxMjA4ZjZhNzVmL3RhYmxlOmI0Y2Q1OTkwNjlkNDQ2ZTdhMTViNjM5ZTU2NWVlMDhmL3RhYmxlcmFuZ2U6YjRjZDU5OTA2OWQ0NDZlN2ExNWI2MzllNTY1ZWUwOGZfMTYtMi0xLTEtNDU5MTk_cda5522b-6616-4d0a-b589-a8d2486f735c"
      unitRef="usd">313000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i9127d3c9a72c45de99f25a116340aff0_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yMi9mcmFnOjRlZjhhMzg3NWQzNDQxMzNhYTVkM2YxMjA4ZjZhNzVmL3RhYmxlOmI0Y2Q1OTkwNjlkNDQ2ZTdhMTViNjM5ZTU2NWVlMDhmL3RhYmxlcmFuZ2U6YjRjZDU5OTA2OWQ0NDZlN2ExNWI2MzllNTY1ZWUwOGZfMTYtMy0xLTEtNDU5MTk_ae02ef6d-2235-4bb8-9ac6-11c855d644b5"
      unitRef="usd">419517000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i506e9fffe4144fdfa3c8d262ff65a801_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yMi9mcmFnOjRlZjhhMzg3NWQzNDQxMzNhYTVkM2YxMjA4ZjZhNzVmL3RhYmxlOmI0Y2Q1OTkwNjlkNDQ2ZTdhMTViNjM5ZTU2NWVlMDhmL3RhYmxlcmFuZ2U6YjRjZDU5OTA2OWQ0NDZlN2ExNWI2MzllNTY1ZWUwOGZfMTYtNC0xLTEtNDU5MTk_0be247f8-3fe6-4b66-9c42-ecdd74f1290e"
      unitRef="usd">408337000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i991a26c35f3a4004a04b9c93216cb10b_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yMi9mcmFnOjRlZjhhMzg3NWQzNDQxMzNhYTVkM2YxMjA4ZjZhNzVmL3RhYmxlOmI0Y2Q1OTkwNjlkNDQ2ZTdhMTViNjM5ZTU2NWVlMDhmL3RhYmxlcmFuZ2U6YjRjZDU5OTA2OWQ0NDZlN2ExNWI2MzllNTY1ZWUwOGZfMTYtNS0xLTEtNDU5MTk_364ba74d-3a82-4a37-8127-c713d5818db3"
      unitRef="usd">-54982000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="if8bf9b92b9754cb49ead7853527c0c87_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yMi9mcmFnOjRlZjhhMzg3NWQzNDQxMzNhYTVkM2YxMjA4ZjZhNzVmL3RhYmxlOmI0Y2Q1OTkwNjlkNDQ2ZTdhMTViNjM5ZTU2NWVlMDhmL3RhYmxlcmFuZ2U6YjRjZDU5OTA2OWQ0NDZlN2ExNWI2MzllNTY1ZWUwOGZfMTYtNi0xLTEtNDU5MTk_938b4cac-0114-412b-b8a6-447e1748429c"
      unitRef="usd">-20732000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i738c2d1dacaf436faf03cc46ab9cef23_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yMi9mcmFnOjRlZjhhMzg3NWQzNDQxMzNhYTVkM2YxMjA4ZjZhNzVmL3RhYmxlOmI0Y2Q1OTkwNjlkNDQ2ZTdhMTViNjM5ZTU2NWVlMDhmL3RhYmxlcmFuZ2U6YjRjZDU5OTA2OWQ0NDZlN2ExNWI2MzllNTY1ZWUwOGZfMTYtNy0xLTEtNDU5MTk_599ce202-87cd-44fb-9063-4d639d049e2f"
      unitRef="usd">752453000</us-gaap:StockholdersEquity>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="icb342dd07ae648ba88c184ef672faf7e_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yMi9mcmFnOjRlZjhhMzg3NWQzNDQxMzNhYTVkM2YxMjA4ZjZhNzVmL3RhYmxlOjQ1NzViM2U2MDFhMDQ4MTY5Y2FjMDM2ZjcwZWRhNWJmL3RhYmxlcmFuZ2U6NDU3NWIzZTYwMWEwNDgxNjljYWMwMzZmNzBlZGE1YmZfMi0xLTEtMS00NTkxOQ_7e1c581e-6503-44bc-9078-5f1fc12330c4"
      unitRef="shares">31299000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="icb342dd07ae648ba88c184ef672faf7e_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yMi9mcmFnOjRlZjhhMzg3NWQzNDQxMzNhYTVkM2YxMjA4ZjZhNzVmL3RhYmxlOjQ1NzViM2U2MDFhMDQ4MTY5Y2FjMDM2ZjcwZWRhNWJmL3RhYmxlcmFuZ2U6NDU3NWIzZTYwMWEwNDgxNjljYWMwMzZmNzBlZGE1YmZfMi0yLTEtMS00NTkxOQ_40fa39fe-b474-4abc-b34a-a5838f4fafb2"
      unitRef="usd">313000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ia00f7e8577d7414dae3eec75b3959321_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yMi9mcmFnOjRlZjhhMzg3NWQzNDQxMzNhYTVkM2YxMjA4ZjZhNzVmL3RhYmxlOjQ1NzViM2U2MDFhMDQ4MTY5Y2FjMDM2ZjcwZWRhNWJmL3RhYmxlcmFuZ2U6NDU3NWIzZTYwMWEwNDgxNjljYWMwMzZmNzBlZGE1YmZfMi0zLTEtMS00NTkxOQ_a8be4574-4e32-49d2-9786-bfa93cecb8ef"
      unitRef="usd">396771000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i2f463e4994b14c1bb3ce927524a1bdc7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yMi9mcmFnOjRlZjhhMzg3NWQzNDQxMzNhYTVkM2YxMjA4ZjZhNzVmL3RhYmxlOjQ1NzViM2U2MDFhMDQ4MTY5Y2FjMDM2ZjcwZWRhNWJmL3RhYmxlcmFuZ2U6NDU3NWIzZTYwMWEwNDgxNjljYWMwMzZmNzBlZGE1YmZfMi00LTEtMS00NTkxOQ_ab024462-7c7b-4aa5-b509-1ed900365018"
      unitRef="usd">496605000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="iee31e42803274180ade2d654c9f2c44a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yMi9mcmFnOjRlZjhhMzg3NWQzNDQxMzNhYTVkM2YxMjA4ZjZhNzVmL3RhYmxlOjQ1NzViM2U2MDFhMDQ4MTY5Y2FjMDM2ZjcwZWRhNWJmL3RhYmxlcmFuZ2U6NDU3NWIzZTYwMWEwNDgxNjljYWMwMzZmNzBlZGE1YmZfMi01LTEtMS00NTkxOQ_9a5fb60e-0c63-494c-981c-7302aa237e8f"
      unitRef="usd">-54203000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i51431cd2971e460797df867a2da93b0e_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yMi9mcmFnOjRlZjhhMzg3NWQzNDQxMzNhYTVkM2YxMjA4ZjZhNzVmL3RhYmxlOjQ1NzViM2U2MDFhMDQ4MTY5Y2FjMDM2ZjcwZWRhNWJmL3RhYmxlcmFuZ2U6NDU3NWIzZTYwMWEwNDgxNjljYWMwMzZmNzBlZGE1YmZfMi02LTEtMS00NTkxOQ_09a09c3f-7022-4e09-ab6a-b11a00a3acf2"
      unitRef="usd">-54051000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ia4bed28ea4b04a1d9fca88fa74e6040c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yMi9mcmFnOjRlZjhhMzg3NWQzNDQxMzNhYTVkM2YxMjA4ZjZhNzVmL3RhYmxlOjQ1NzViM2U2MDFhMDQ4MTY5Y2FjMDM2ZjcwZWRhNWJmL3RhYmxlcmFuZ2U6NDU3NWIzZTYwMWEwNDgxNjljYWMwMzZmNzBlZGE1YmZfMi03LTEtMS00NTkxOQ_6169c302-e8ee-4085-b580-473ef6002cd2"
      unitRef="usd">785435000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i2cfecd0f3dbb4727931bba8cc920743d_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yMi9mcmFnOjRlZjhhMzg3NWQzNDQxMzNhYTVkM2YxMjA4ZjZhNzVmL3RhYmxlOjQ1NzViM2U2MDFhMDQ4MTY5Y2FjMDM2ZjcwZWRhNWJmL3RhYmxlcmFuZ2U6NDU3NWIzZTYwMWEwNDgxNjljYWMwMzZmNzBlZGE1YmZfMy0zLTEtMS00NTkxOQ_665b8cb9-6fe9-47eb-b5af-231139d5293c"
      unitRef="usd">2232000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i4afaa0ad2d10419c84dae15a77c31488_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yMi9mcmFnOjRlZjhhMzg3NWQzNDQxMzNhYTVkM2YxMjA4ZjZhNzVmL3RhYmxlOjQ1NzViM2U2MDFhMDQ4MTY5Y2FjMDM2ZjcwZWRhNWJmL3RhYmxlcmFuZ2U6NDU3NWIzZTYwMWEwNDgxNjljYWMwMzZmNzBlZGE1YmZfMy02LTEtMS00NTkxOQ_101adba3-4f24-406e-b054-d0c25a9374b2"
      unitRef="usd">4020000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i9500a5ee8dbe4d23aa9c46ebdd25a0c8_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yMi9mcmFnOjRlZjhhMzg3NWQzNDQxMzNhYTVkM2YxMjA4ZjZhNzVmL3RhYmxlOjQ1NzViM2U2MDFhMDQ4MTY5Y2FjMDM2ZjcwZWRhNWJmL3RhYmxlcmFuZ2U6NDU3NWIzZTYwMWEwNDgxNjljYWMwMzZmNzBlZGE1YmZfMy03LTEtMS00NTkxOQ_01f0b8a3-4a64-4617-8991-66a271431a78"
      unitRef="usd">6252000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i2cfecd0f3dbb4727931bba8cc920743d_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yMi9mcmFnOjRlZjhhMzg3NWQzNDQxMzNhYTVkM2YxMjA4ZjZhNzVmL3RhYmxlOjQ1NzViM2U2MDFhMDQ4MTY5Y2FjMDM2ZjcwZWRhNWJmL3RhYmxlcmFuZ2U6NDU3NWIzZTYwMWEwNDgxNjljYWMwMzZmNzBlZGE1YmZfNC0zLTEtMS00NTkxOQ_a16748a5-03cf-4093-9107-80e762972189"
      unitRef="usd">4463000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i9500a5ee8dbe4d23aa9c46ebdd25a0c8_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yMi9mcmFnOjRlZjhhMzg3NWQzNDQxMzNhYTVkM2YxMjA4ZjZhNzVmL3RhYmxlOjQ1NzViM2U2MDFhMDQ4MTY5Y2FjMDM2ZjcwZWRhNWJmL3RhYmxlcmFuZ2U6NDU3NWIzZTYwMWEwNDgxNjljYWMwMzZmNzBlZGE1YmZfNC03LTEtMS00NTkxOQ_91b3d675-40c8-415d-9212-fd7c8d793300"
      unitRef="usd">4463000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="i9500a5ee8dbe4d23aa9c46ebdd25a0c8_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yMi9mcmFnOjRlZjhhMzg3NWQzNDQxMzNhYTVkM2YxMjA4ZjZhNzVmL3RhYmxlOjQ1NzViM2U2MDFhMDQ4MTY5Y2FjMDM2ZjcwZWRhNWJmL3RhYmxlcmFuZ2U6NDU3NWIzZTYwMWEwNDgxNjljYWMwMzZmNzBlZGE1YmZfNS0wLTEtMS00NTkxOS90ZXh0cmVnaW9uOjNiMjhjNDlhODUwOTQwNjBhM2JlNDllYWQyMmJkMGU2XzMx_e2bb8d4c-47b3-493f-97ca-d8fed258b29a"
      unitRef="usdPerShare">0.20</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:DividendsCommonStockCash
      contextRef="if2f0b0e837ae40e3bd5d07cc3ec663d4_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yMi9mcmFnOjRlZjhhMzg3NWQzNDQxMzNhYTVkM2YxMjA4ZjZhNzVmL3RhYmxlOjQ1NzViM2U2MDFhMDQ4MTY5Y2FjMDM2ZjcwZWRhNWJmL3RhYmxlcmFuZ2U6NDU3NWIzZTYwMWEwNDgxNjljYWMwMzZmNzBlZGE1YmZfNS00LTEtMS00NTkxOQ_646bc4be-0106-47fe-a65b-72c98c4889ac"
      unitRef="usd">5899000</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash
      contextRef="i9500a5ee8dbe4d23aa9c46ebdd25a0c8_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yMi9mcmFnOjRlZjhhMzg3NWQzNDQxMzNhYTVkM2YxMjA4ZjZhNzVmL3RhYmxlOjQ1NzViM2U2MDFhMDQ4MTY5Y2FjMDM2ZjcwZWRhNWJmL3RhYmxlcmFuZ2U6NDU3NWIzZTYwMWEwNDgxNjljYWMwMzZmNzBlZGE1YmZfNS03LTEtMS00NTkxOQ_3bcab615-6535-40b6-aaae-fab0ed8ed5e3"
      unitRef="usd">5899000</us-gaap:DividendsCommonStockCash>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="ia66bff082e1642cd80c9ac67a0cc60fe_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yMi9mcmFnOjRlZjhhMzg3NWQzNDQxMzNhYTVkM2YxMjA4ZjZhNzVmL3RhYmxlOjQ1NzViM2U2MDFhMDQ4MTY5Y2FjMDM2ZjcwZWRhNWJmL3RhYmxlcmFuZ2U6NDU3NWIzZTYwMWEwNDgxNjljYWMwMzZmNzBlZGE1YmZfNy01LTEtMS00NTkxOQ_0721bca2-4ce6-4a43-9cca-84c1fbc92c76"
      unitRef="usd">1082000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="ia66bff082e1642cd80c9ac67a0cc60fe_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yMi9mcmFnOjRlZjhhMzg3NWQzNDQxMzNhYTVkM2YxMjA4ZjZhNzVmL3RhYmxlOjQ1NzViM2U2MDFhMDQ4MTY5Y2FjMDM2ZjcwZWRhNWJmL3RhYmxlcmFuZ2U6NDU3NWIzZTYwMWEwNDgxNjljYWMwMzZmNzBlZGE1YmZfOC01LTEtMS00NTkxOQ_90089a43-d00c-4f5c-a303-1cdfad83d715"
      unitRef="usd">-521000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="ia66bff082e1642cd80c9ac67a0cc60fe_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yMi9mcmFnOjRlZjhhMzg3NWQzNDQxMzNhYTVkM2YxMjA4ZjZhNzVmL3RhYmxlOjQ1NzViM2U2MDFhMDQ4MTY5Y2FjMDM2ZjcwZWRhNWJmL3RhYmxlcmFuZ2U6NDU3NWIzZTYwMWEwNDgxNjljYWMwMzZmNzBlZGE1YmZfOS01LTEtMS00NTkxOQ_b8568d8c-cd22-4778-be5f-d6b55965b716"
      unitRef="usd">-163000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:NetIncomeLoss
      contextRef="if2f0b0e837ae40e3bd5d07cc3ec663d4_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yMi9mcmFnOjRlZjhhMzg3NWQzNDQxMzNhYTVkM2YxMjA4ZjZhNzVmL3RhYmxlOjQ1NzViM2U2MDFhMDQ4MTY5Y2FjMDM2ZjcwZWRhNWJmL3RhYmxlcmFuZ2U6NDU3NWIzZTYwMWEwNDgxNjljYWMwMzZmNzBlZGE1YmZfMTAtNC0xLTEtNDU5MTk_40606f2e-e953-4c43-aa26-4bfffb7f1069"
      unitRef="usd">14975000</us-gaap:NetIncomeLoss>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i9500a5ee8dbe4d23aa9c46ebdd25a0c8_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yMi9mcmFnOjRlZjhhMzg3NWQzNDQxMzNhYTVkM2YxMjA4ZjZhNzVmL3RhYmxlOjQ1NzViM2U2MDFhMDQ4MTY5Y2FjMDM2ZjcwZWRhNWJmL3RhYmxlcmFuZ2U6NDU3NWIzZTYwMWEwNDgxNjljYWMwMzZmNzBlZGE1YmZfMTEtNy0xLTEtNDU5MTk_46756733-5bb6-41fd-9854-a9b9d88a8aaf"
      unitRef="usd">16415000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquity
      contextRef="i5142ed70f8b347f2864cd50f2a21c01c_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yMi9mcmFnOjRlZjhhMzg3NWQzNDQxMzNhYTVkM2YxMjA4ZjZhNzVmL3RhYmxlOjQ1NzViM2U2MDFhMDQ4MTY5Y2FjMDM2ZjcwZWRhNWJmL3RhYmxlcmFuZ2U6NDU3NWIzZTYwMWEwNDgxNjljYWMwMzZmNzBlZGE1YmZfMTItMy0xLTEtNDY0MDU_cfef9874-6ec2-42b5-801c-7abe9a1e0261"
      unitRef="usd">-37911000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i7fb909d76a5f4b7aa413e5dfa01ad54c_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yMi9mcmFnOjRlZjhhMzg3NWQzNDQxMzNhYTVkM2YxMjA4ZjZhNzVmL3RhYmxlOjQ1NzViM2U2MDFhMDQ4MTY5Y2FjMDM2ZjcwZWRhNWJmL3RhYmxlcmFuZ2U6NDU3NWIzZTYwMWEwNDgxNjljYWMwMzZmNzBlZGE1YmZfMTItNC0xLTEtNDY0MDU_800b98f9-a0f2-47d2-ab38-b018d0a13d2c"
      unitRef="usd">20791000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ie301d028eb864cd3856cc78cb6269b1a_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yMi9mcmFnOjRlZjhhMzg3NWQzNDQxMzNhYTVkM2YxMjA4ZjZhNzVmL3RhYmxlOjQ1NzViM2U2MDFhMDQ4MTY5Y2FjMDM2ZjcwZWRhNWJmL3RhYmxlcmFuZ2U6NDU3NWIzZTYwMWEwNDgxNjljYWMwMzZmNzBlZGE1YmZfMTItNy0xLTEtNDY0MDU_9abb2f00-e46a-4479-b6e5-b85487673102"
      unitRef="usd">-17120000</us-gaap:StockholdersEquity>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i441ac12b39534fb9b34b6a58c4e4cc39_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yMi9mcmFnOjRlZjhhMzg3NWQzNDQxMzNhYTVkM2YxMjA4ZjZhNzVmL3RhYmxlOjQ1NzViM2U2MDFhMDQ4MTY5Y2FjMDM2ZjcwZWRhNWJmL3RhYmxlcmFuZ2U6NDU3NWIzZTYwMWEwNDgxNjljYWMwMzZmNzBlZGE1YmZfMTItMS0xLTEtNDU5MTk_0fa9320c-dd5d-4dd5-a33b-f4875ff77049"
      unitRef="shares">31299000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i441ac12b39534fb9b34b6a58c4e4cc39_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yMi9mcmFnOjRlZjhhMzg3NWQzNDQxMzNhYTVkM2YxMjA4ZjZhNzVmL3RhYmxlOjQ1NzViM2U2MDFhMDQ4MTY5Y2FjMDM2ZjcwZWRhNWJmL3RhYmxlcmFuZ2U6NDU3NWIzZTYwMWEwNDgxNjljYWMwMzZmNzBlZGE1YmZfMTItMi0xLTEtNDU5MTk_20415283-93ca-4244-b7d7-0e55273c1703"
      unitRef="usd">313000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i2335e528dd1244098fa2557c3aebbd19_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yMi9mcmFnOjRlZjhhMzg3NWQzNDQxMzNhYTVkM2YxMjA4ZjZhNzVmL3RhYmxlOjQ1NzViM2U2MDFhMDQ4MTY5Y2FjMDM2ZjcwZWRhNWJmL3RhYmxlcmFuZ2U6NDU3NWIzZTYwMWEwNDgxNjljYWMwMzZmNzBlZGE1YmZfMTItMy0xLTEtNDU5MTk_8b4edf9a-04e1-42ed-bf51-251205dc3f9b"
      unitRef="usd">365555000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i0539b1c96151418c99ad4f945625ba30_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yMi9mcmFnOjRlZjhhMzg3NWQzNDQxMzNhYTVkM2YxMjA4ZjZhNzVmL3RhYmxlOjQ1NzViM2U2MDFhMDQ4MTY5Y2FjMDM2ZjcwZWRhNWJmL3RhYmxlcmFuZ2U6NDU3NWIzZTYwMWEwNDgxNjljYWMwMzZmNzBlZGE1YmZfMTItNC0xLTEtNDU5MTk_42f25fce-ddbb-469f-99ae-18752df64e64"
      unitRef="usd">526472000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ib861e1905d064d5684a5172a6232ad41_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yMi9mcmFnOjRlZjhhMzg3NWQzNDQxMzNhYTVkM2YxMjA4ZjZhNzVmL3RhYmxlOjQ1NzViM2U2MDFhMDQ4MTY5Y2FjMDM2ZjcwZWRhNWJmL3RhYmxlcmFuZ2U6NDU3NWIzZTYwMWEwNDgxNjljYWMwMzZmNzBlZGE1YmZfMTItNS0xLTEtNDU5MTk_ea700c4c-b41f-4e76-a3c2-3dc557fd241f"
      unitRef="usd">-52763000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i522db0d27185495b938d0c8f18f5032f_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yMi9mcmFnOjRlZjhhMzg3NWQzNDQxMzNhYTVkM2YxMjA4ZjZhNzVmL3RhYmxlOjQ1NzViM2U2MDFhMDQ4MTY5Y2FjMDM2ZjcwZWRhNWJmL3RhYmxlcmFuZ2U6NDU3NWIzZTYwMWEwNDgxNjljYWMwMzZmNzBlZGE1YmZfMTItNi0xLTEtNDU5MTk_e8f64641-93e8-478a-8927-807f0797c4f8"
      unitRef="usd">-50031000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i4730ada3cec445989c807f4fe004727c_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yMi9mcmFnOjRlZjhhMzg3NWQzNDQxMzNhYTVkM2YxMjA4ZjZhNzVmL3RhYmxlOjQ1NzViM2U2MDFhMDQ4MTY5Y2FjMDM2ZjcwZWRhNWJmL3RhYmxlcmFuZ2U6NDU3NWIzZTYwMWEwNDgxNjljYWMwMzZmNzBlZGE1YmZfMTItNy0xLTEtNDU5MTk_57084aaa-00bc-4b31-a88f-aa32d3a252ae"
      unitRef="usd">789546000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yNS9mcmFnOjcwZjRjY2U0NjVlOTQ2MWJhN2NkZWRiMzAzNmJjNDE2L3RhYmxlOjcxNTQ4MjkxNjM4ZTQ4OTNhNzNlMWNhZDUwODYxYTRmL3RhYmxlcmFuZ2U6NzE1NDgyOTE2MzhlNDg5M2E3M2UxY2FkNTA4NjFhNGZfNC0xLTEtMS00NTkxOQ_46cea407-de0c-4301-be46-0462f0b2e392"
      unitRef="usd">1819000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i9500a5ee8dbe4d23aa9c46ebdd25a0c8_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yNS9mcmFnOjcwZjRjY2U0NjVlOTQ2MWJhN2NkZWRiMzAzNmJjNDE2L3RhYmxlOjcxNTQ4MjkxNjM4ZTQ4OTNhNzNlMWNhZDUwODYxYTRmL3RhYmxlcmFuZ2U6NzE1NDgyOTE2MzhlNDg5M2E3M2UxY2FkNTA4NjFhNGZfNC0zLTEtMS00NTkxOQ_441b1315-5ce7-4dca-9a0a-0f189f3f1900"
      unitRef="usd">14975000</us-gaap:NetIncomeLoss>
    <us-gaap:Depreciation
      contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yNS9mcmFnOjcwZjRjY2U0NjVlOTQ2MWJhN2NkZWRiMzAzNmJjNDE2L3RhYmxlOjcxNTQ4MjkxNjM4ZTQ4OTNhNzNlMWNhZDUwODYxYTRmL3RhYmxlcmFuZ2U6NzE1NDgyOTE2MzhlNDg5M2E3M2UxY2FkNTA4NjFhNGZfNi0xLTEtMS00NTkxOQ_66fa278a-9548-40e1-a497-2b0102f38239"
      unitRef="usd">4057000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="i9500a5ee8dbe4d23aa9c46ebdd25a0c8_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yNS9mcmFnOjcwZjRjY2U0NjVlOTQ2MWJhN2NkZWRiMzAzNmJjNDE2L3RhYmxlOjcxNTQ4MjkxNjM4ZTQ4OTNhNzNlMWNhZDUwODYxYTRmL3RhYmxlcmFuZ2U6NzE1NDgyOTE2MzhlNDg5M2E3M2UxY2FkNTA4NjFhNGZfNi0zLTEtMS00NTkxOQ_e132ec5e-579f-40f3-8599-c20bcb6f923c"
      unitRef="usd">4032000</us-gaap:Depreciation>
    <us-gaap:AmortizationOfFinancingCosts
      contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yNS9mcmFnOjcwZjRjY2U0NjVlOTQ2MWJhN2NkZWRiMzAzNmJjNDE2L3RhYmxlOjcxNTQ4MjkxNjM4ZTQ4OTNhNzNlMWNhZDUwODYxYTRmL3RhYmxlcmFuZ2U6NzE1NDgyOTE2MzhlNDg5M2E3M2UxY2FkNTA4NjFhNGZfOC0xLTEtMS00NTkxOQ_5c649ec3-a93f-460a-b65a-2eb8e7a9d7f3"
      unitRef="usd">1506000</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:AmortizationOfFinancingCosts
      contextRef="i9500a5ee8dbe4d23aa9c46ebdd25a0c8_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yNS9mcmFnOjcwZjRjY2U0NjVlOTQ2MWJhN2NkZWRiMzAzNmJjNDE2L3RhYmxlOjcxNTQ4MjkxNjM4ZTQ4OTNhNzNlMWNhZDUwODYxYTRmL3RhYmxlcmFuZ2U6NzE1NDgyOTE2MzhlNDg5M2E3M2UxY2FkNTA4NjFhNGZfOC0zLTEtMS00NTkxOQ_3469dd9d-e57d-449d-8f6a-c33024fdbd46"
      unitRef="usd">880000</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:OtherAmortizationOfDeferredCharges
      contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yNS9mcmFnOjcwZjRjY2U0NjVlOTQ2MWJhN2NkZWRiMzAzNmJjNDE2L3RhYmxlOjcxNTQ4MjkxNjM4ZTQ4OTNhNzNlMWNhZDUwODYxYTRmL3RhYmxlcmFuZ2U6NzE1NDgyOTE2MzhlNDg5M2E3M2UxY2FkNTA4NjFhNGZfOS0xLTEtMS00NTkxOQ_a0c1a194-77f9-46b4-9d7e-ab5d616472cb"
      unitRef="usd">13877000</us-gaap:OtherAmortizationOfDeferredCharges>
    <us-gaap:OtherAmortizationOfDeferredCharges
      contextRef="i9500a5ee8dbe4d23aa9c46ebdd25a0c8_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yNS9mcmFnOjcwZjRjY2U0NjVlOTQ2MWJhN2NkZWRiMzAzNmJjNDE2L3RhYmxlOjcxNTQ4MjkxNjM4ZTQ4OTNhNzNlMWNhZDUwODYxYTRmL3RhYmxlcmFuZ2U6NzE1NDgyOTE2MzhlNDg5M2E3M2UxY2FkNTA4NjFhNGZfOS0zLTEtMS00NTkxOQ_bd5b9e33-d6f3-4d4e-a934-489276f05668"
      unitRef="usd">12799000</us-gaap:OtherAmortizationOfDeferredCharges>
    <us-gaap:ShareBasedCompensation
      contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yNS9mcmFnOjcwZjRjY2U0NjVlOTQ2MWJhN2NkZWRiMzAzNmJjNDE2L3RhYmxlOjcxNTQ4MjkxNjM4ZTQ4OTNhNzNlMWNhZDUwODYxYTRmL3RhYmxlcmFuZ2U6NzE1NDgyOTE2MzhlNDg5M2E3M2UxY2FkNTA4NjFhNGZfMTAtMS0xLTEtNDU5MTk_89efdcfc-2aab-49e2-bf8f-62b91240d726"
      unitRef="usd">5726000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i9500a5ee8dbe4d23aa9c46ebdd25a0c8_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yNS9mcmFnOjcwZjRjY2U0NjVlOTQ2MWJhN2NkZWRiMzAzNmJjNDE2L3RhYmxlOjcxNTQ4MjkxNjM4ZTQ4OTNhNzNlMWNhZDUwODYxYTRmL3RhYmxlcmFuZ2U6NzE1NDgyOTE2MzhlNDg5M2E3M2UxY2FkNTA4NjFhNGZfMTAtMy0xLTEtNDU5MTk_a9893305-97d5-4334-b0db-1b87247abd03"
      unitRef="usd">4463000</us-gaap:ShareBasedCompensation>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yNS9mcmFnOjcwZjRjY2U0NjVlOTQ2MWJhN2NkZWRiMzAzNmJjNDE2L3RhYmxlOjcxNTQ4MjkxNjM4ZTQ4OTNhNzNlMWNhZDUwODYxYTRmL3RhYmxlcmFuZ2U6NzE1NDgyOTE2MzhlNDg5M2E3M2UxY2FkNTA4NjFhNGZfMTItMS0xLTEtNDU5MTk_61569f80-fbed-41c0-9705-715448982e97"
      unitRef="usd">-1140000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i9500a5ee8dbe4d23aa9c46ebdd25a0c8_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yNS9mcmFnOjcwZjRjY2U0NjVlOTQ2MWJhN2NkZWRiMzAzNmJjNDE2L3RhYmxlOjcxNTQ4MjkxNjM4ZTQ4OTNhNzNlMWNhZDUwODYxYTRmL3RhYmxlcmFuZ2U6NzE1NDgyOTE2MzhlNDg5M2E3M2UxY2FkNTA4NjFhNGZfMTItMy0xLTEtNDU5MTk_ac2bac26-2918-4359-8f4d-3d2a57773257"
      unitRef="usd">177000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yNS9mcmFnOjcwZjRjY2U0NjVlOTQ2MWJhN2NkZWRiMzAzNmJjNDE2L3RhYmxlOjcxNTQ4MjkxNjM4ZTQ4OTNhNzNlMWNhZDUwODYxYTRmL3RhYmxlcmFuZ2U6NzE1NDgyOTE2MzhlNDg5M2E3M2UxY2FkNTA4NjFhNGZfMTMtMS0xLTEtNDk3ODY_f1f759bd-56bd-445e-9031-7d9b67b4d1b0"
      unitRef="usd">4436000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="i9500a5ee8dbe4d23aa9c46ebdd25a0c8_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yNS9mcmFnOjcwZjRjY2U0NjVlOTQ2MWJhN2NkZWRiMzAzNmJjNDE2L3RhYmxlOjcxNTQ4MjkxNjM4ZTQ4OTNhNzNlMWNhZDUwODYxYTRmL3RhYmxlcmFuZ2U6NzE1NDgyOTE2MzhlNDg5M2E3M2UxY2FkNTA4NjFhNGZfMTMtMy0xLTEtNDk3OTY_40bc3e0e-3231-4f0c-a3d6-7c901e0bade9"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yNS9mcmFnOjcwZjRjY2U0NjVlOTQ2MWJhN2NkZWRiMzAzNmJjNDE2L3RhYmxlOjcxNTQ4MjkxNjM4ZTQ4OTNhNzNlMWNhZDUwODYxYTRmL3RhYmxlcmFuZ2U6NzE1NDgyOTE2MzhlNDg5M2E3M2UxY2FkNTA4NjFhNGZfMTctMS0xLTEtNDU5MTk_6c65ceee-a5bd-474c-b54a-346db64d024a"
      unitRef="usd">20666000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i9500a5ee8dbe4d23aa9c46ebdd25a0c8_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yNS9mcmFnOjcwZjRjY2U0NjVlOTQ2MWJhN2NkZWRiMzAzNmJjNDE2L3RhYmxlOjcxNTQ4MjkxNjM4ZTQ4OTNhNzNlMWNhZDUwODYxYTRmL3RhYmxlcmFuZ2U6NzE1NDgyOTE2MzhlNDg5M2E3M2UxY2FkNTA4NjFhNGZfMTctMy0xLTEtNDU5MTk_28dee48a-66ab-4ebe-ac1c-0506bbcfeb0b"
      unitRef="usd">163000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yNS9mcmFnOjcwZjRjY2U0NjVlOTQ2MWJhN2NkZWRiMzAzNmJjNDE2L3RhYmxlOjcxNTQ4MjkxNjM4ZTQ4OTNhNzNlMWNhZDUwODYxYTRmL3RhYmxlcmFuZ2U6NzE1NDgyOTE2MzhlNDg5M2E3M2UxY2FkNTA4NjFhNGZfMTgtMS0xLTEtNDU5MTk_1e53e0f7-a806-4b5b-9318-0d4eeb3d6866"
      unitRef="usd">3016000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="i9500a5ee8dbe4d23aa9c46ebdd25a0c8_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yNS9mcmFnOjcwZjRjY2U0NjVlOTQ2MWJhN2NkZWRiMzAzNmJjNDE2L3RhYmxlOjcxNTQ4MjkxNjM4ZTQ4OTNhNzNlMWNhZDUwODYxYTRmL3RhYmxlcmFuZ2U6NzE1NDgyOTE2MzhlNDg5M2E3M2UxY2FkNTA4NjFhNGZfMTgtMy0xLTEtNDU5MTk_2fd8db4a-a2a0-422e-adc7-e0d79f5e488d"
      unitRef="usd">21857000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yNS9mcmFnOjcwZjRjY2U0NjVlOTQ2MWJhN2NkZWRiMzAzNmJjNDE2L3RhYmxlOjcxNTQ4MjkxNjM4ZTQ4OTNhNzNlMWNhZDUwODYxYTRmL3RhYmxlcmFuZ2U6NzE1NDgyOTE2MzhlNDg5M2E3M2UxY2FkNTA4NjFhNGZfMTktMS0xLTEtNDU5MTk_6cd6b2e8-792d-4eb2-9625-7abbdcdbb293"
      unitRef="usd">2699000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="i9500a5ee8dbe4d23aa9c46ebdd25a0c8_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yNS9mcmFnOjcwZjRjY2U0NjVlOTQ2MWJhN2NkZWRiMzAzNmJjNDE2L3RhYmxlOjcxNTQ4MjkxNjM4ZTQ4OTNhNzNlMWNhZDUwODYxYTRmL3RhYmxlcmFuZ2U6NzE1NDgyOTE2MzhlNDg5M2E3M2UxY2FkNTA4NjFhNGZfMTktMy0xLTEtNDU5MTk_33bf515d-c430-461d-8cf3-7ff41a0a2334"
      unitRef="usd">9205000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities
      contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yNS9mcmFnOjcwZjRjY2U0NjVlOTQ2MWJhN2NkZWRiMzAzNmJjNDE2L3RhYmxlOjcxNTQ4MjkxNjM4ZTQ4OTNhNzNlMWNhZDUwODYxYTRmL3RhYmxlcmFuZ2U6NzE1NDgyOTE2MzhlNDg5M2E3M2UxY2FkNTA4NjFhNGZfMjAtMS0xLTEtNDU5MTk_2bdc492b-11a0-4b3c-9328-0a766b55fee7"
      unitRef="usd">-5722000</us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities>
    <us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities
      contextRef="i9500a5ee8dbe4d23aa9c46ebdd25a0c8_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yNS9mcmFnOjcwZjRjY2U0NjVlOTQ2MWJhN2NkZWRiMzAzNmJjNDE2L3RhYmxlOjcxNTQ4MjkxNjM4ZTQ4OTNhNzNlMWNhZDUwODYxYTRmL3RhYmxlcmFuZ2U6NzE1NDgyOTE2MzhlNDg5M2E3M2UxY2FkNTA4NjFhNGZfMjAtMy0xLTEtNDU5MTk_088790cc-8656-41e4-aa04-c3223065748f"
      unitRef="usd">-14966000</us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets
      contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yNS9mcmFnOjcwZjRjY2U0NjVlOTQ2MWJhN2NkZWRiMzAzNmJjNDE2L3RhYmxlOjcxNTQ4MjkxNjM4ZTQ4OTNhNzNlMWNhZDUwODYxYTRmL3RhYmxlcmFuZ2U6NzE1NDgyOTE2MzhlNDg5M2E3M2UxY2FkNTA4NjFhNGZfMjEtMS0xLTEtNDU5MTk_5f660f18-ac9a-451d-ae25-de44666b7507"
      unitRef="usd">11372000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets
      contextRef="i9500a5ee8dbe4d23aa9c46ebdd25a0c8_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yNS9mcmFnOjcwZjRjY2U0NjVlOTQ2MWJhN2NkZWRiMzAzNmJjNDE2L3RhYmxlOjcxNTQ4MjkxNjM4ZTQ4OTNhNzNlMWNhZDUwODYxYTRmL3RhYmxlcmFuZ2U6NzE1NDgyOTE2MzhlNDg5M2E3M2UxY2FkNTA4NjFhNGZfMjEtMy0xLTEtNDU5MTk_e8e8a0f7-33d4-4495-979a-799368f593b3"
      unitRef="usd">6129000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInOtherOperatingLiabilities
      contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yNS9mcmFnOjcwZjRjY2U0NjVlOTQ2MWJhN2NkZWRiMzAzNmJjNDE2L3RhYmxlOjcxNTQ4MjkxNjM4ZTQ4OTNhNzNlMWNhZDUwODYxYTRmL3RhYmxlcmFuZ2U6NzE1NDgyOTE2MzhlNDg5M2E3M2UxY2FkNTA4NjFhNGZfMjItMS0xLTEtNDU5MTk_abc8bbee-2738-43fe-b219-5bd91d08ee5b"
      unitRef="usd">3949000</us-gaap:IncreaseDecreaseInOtherOperatingLiabilities>
    <us-gaap:IncreaseDecreaseInOtherOperatingLiabilities
      contextRef="i9500a5ee8dbe4d23aa9c46ebdd25a0c8_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yNS9mcmFnOjcwZjRjY2U0NjVlOTQ2MWJhN2NkZWRiMzAzNmJjNDE2L3RhYmxlOjcxNTQ4MjkxNjM4ZTQ4OTNhNzNlMWNhZDUwODYxYTRmL3RhYmxlcmFuZ2U6NzE1NDgyOTE2MzhlNDg5M2E3M2UxY2FkNTA4NjFhNGZfMjItMy0xLTEtNDU5MTk_698a2747-eb61-40be-9d1e-0acdab5bbd07"
      unitRef="usd">-3088000</us-gaap:IncreaseDecreaseInOtherOperatingLiabilities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yNS9mcmFnOjcwZjRjY2U0NjVlOTQ2MWJhN2NkZWRiMzAzNmJjNDE2L3RhYmxlOjcxNTQ4MjkxNjM4ZTQ4OTNhNzNlMWNhZDUwODYxYTRmL3RhYmxlcmFuZ2U6NzE1NDgyOTE2MzhlNDg5M2E3M2UxY2FkNTA4NjFhNGZfMjMtMS0xLTEtNDU5MTk_a751d81b-4311-4db4-b66c-79027d09fa1c"
      unitRef="usd">-3847000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i9500a5ee8dbe4d23aa9c46ebdd25a0c8_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yNS9mcmFnOjcwZjRjY2U0NjVlOTQ2MWJhN2NkZWRiMzAzNmJjNDE2L3RhYmxlOjcxNTQ4MjkxNjM4ZTQ4OTNhNzNlMWNhZDUwODYxYTRmL3RhYmxlcmFuZ2U6NzE1NDgyOTE2MzhlNDg5M2E3M2UxY2FkNTA4NjFhNGZfMjMtMy0xLTEtNDU5MTk_b872d88c-9427-4887-80e9-754586594d79"
      unitRef="usd">328000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yNS9mcmFnOjcwZjRjY2U0NjVlOTQ2MWJhN2NkZWRiMzAzNmJjNDE2L3RhYmxlOjcxNTQ4MjkxNjM4ZTQ4OTNhNzNlMWNhZDUwODYxYTRmL3RhYmxlcmFuZ2U6NzE1NDgyOTE2MzhlNDg5M2E3M2UxY2FkNTA4NjFhNGZfMjctMS0xLTEtNDU5MTk_8202d7c3-b0f6-43b8-9be8-93a70d4a5a6e"
      unitRef="usd">4254000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i9500a5ee8dbe4d23aa9c46ebdd25a0c8_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yNS9mcmFnOjcwZjRjY2U0NjVlOTQ2MWJhN2NkZWRiMzAzNmJjNDE2L3RhYmxlOjcxNTQ4MjkxNjM4ZTQ4OTNhNzNlMWNhZDUwODYxYTRmL3RhYmxlcmFuZ2U6NzE1NDgyOTE2MzhlNDg5M2E3M2UxY2FkNTA4NjFhNGZfMjctMy0xLTEtNDU5MTk_8c856c85-ca15-4ff2-843e-e6e112a27f8d"
      unitRef="usd">3687000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yNS9mcmFnOjcwZjRjY2U0NjVlOTQ2MWJhN2NkZWRiMzAzNmJjNDE2L3RhYmxlOjcxNTQ4MjkxNjM4ZTQ4OTNhNzNlMWNhZDUwODYxYTRmL3RhYmxlcmFuZ2U6NzE1NDgyOTE2MzhlNDg5M2E3M2UxY2FkNTA4NjFhNGZfMjktMS0xLTEtNDU5MTk_034948b3-24e0-4181-81fc-e6e387b5119c"
      unitRef="usd">-4254000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i9500a5ee8dbe4d23aa9c46ebdd25a0c8_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yNS9mcmFnOjcwZjRjY2U0NjVlOTQ2MWJhN2NkZWRiMzAzNmJjNDE2L3RhYmxlOjcxNTQ4MjkxNjM4ZTQ4OTNhNzNlMWNhZDUwODYxYTRmL3RhYmxlcmFuZ2U6NzE1NDgyOTE2MzhlNDg5M2E3M2UxY2FkNTA4NjFhNGZfMjktMy0xLTEtNDU5MTk_d0788c0d-6dcb-48b2-b922-1107c93f34c0"
      unitRef="usd">-3687000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:RepaymentsOfSeniorDebt
      contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yNS9mcmFnOjcwZjRjY2U0NjVlOTQ2MWJhN2NkZWRiMzAzNmJjNDE2L3RhYmxlOjcxNTQ4MjkxNjM4ZTQ4OTNhNzNlMWNhZDUwODYxYTRmL3RhYmxlcmFuZ2U6NzE1NDgyOTE2MzhlNDg5M2E3M2UxY2FkNTA4NjFhNGZfMzItMS0xLTEtNDU5MTk_4d9dfe41-4a3e-49d2-adb2-825e65cb33d7"
      unitRef="usd">0</us-gaap:RepaymentsOfSeniorDebt>
    <us-gaap:RepaymentsOfSeniorDebt
      contextRef="i9500a5ee8dbe4d23aa9c46ebdd25a0c8_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yNS9mcmFnOjcwZjRjY2U0NjVlOTQ2MWJhN2NkZWRiMzAzNmJjNDE2L3RhYmxlOjcxNTQ4MjkxNjM4ZTQ4OTNhNzNlMWNhZDUwODYxYTRmL3RhYmxlcmFuZ2U6NzE1NDgyOTE2MzhlNDg5M2E3M2UxY2FkNTA4NjFhNGZfMzItMy0xLTEtNDU5MTk_3122051a-814f-4271-8c1b-edbc03114dad"
      unitRef="usd">2981000</us-gaap:RepaymentsOfSeniorDebt>
    <us-gaap:RepaymentsOfLinesOfCredit
      contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yNS9mcmFnOjcwZjRjY2U0NjVlOTQ2MWJhN2NkZWRiMzAzNmJjNDE2L3RhYmxlOjcxNTQ4MjkxNjM4ZTQ4OTNhNzNlMWNhZDUwODYxYTRmL3RhYmxlcmFuZ2U6NzE1NDgyOTE2MzhlNDg5M2E3M2UxY2FkNTA4NjFhNGZfMzQtMS0xLTEtNDU5MTk_78b1b8ee-d47e-41b4-87bc-57c79642cd4e"
      unitRef="usd">164000000</us-gaap:RepaymentsOfLinesOfCredit>
    <us-gaap:RepaymentsOfLinesOfCredit
      contextRef="i9500a5ee8dbe4d23aa9c46ebdd25a0c8_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yNS9mcmFnOjcwZjRjY2U0NjVlOTQ2MWJhN2NkZWRiMzAzNmJjNDE2L3RhYmxlOjcxNTQ4MjkxNjM4ZTQ4OTNhNzNlMWNhZDUwODYxYTRmL3RhYmxlcmFuZ2U6NzE1NDgyOTE2MzhlNDg5M2E3M2UxY2FkNTA4NjFhNGZfMzQtMy0xLTEtNDU5MTk_595cdc2b-9d0a-436f-ae8a-bd78c99ffb79"
      unitRef="usd">99000000</us-gaap:RepaymentsOfLinesOfCredit>
    <us-gaap:ProceedsFromLinesOfCredit
      contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yNS9mcmFnOjcwZjRjY2U0NjVlOTQ2MWJhN2NkZWRiMzAzNmJjNDE2L3RhYmxlOjcxNTQ4MjkxNjM4ZTQ4OTNhNzNlMWNhZDUwODYxYTRmL3RhYmxlcmFuZ2U6NzE1NDgyOTE2MzhlNDg5M2E3M2UxY2FkNTA4NjFhNGZfMzUtMS0xLTEtNDU5MTk_acd9d8aa-05aa-4335-987a-7f5df11656fc"
      unitRef="usd">173000000</us-gaap:ProceedsFromLinesOfCredit>
    <us-gaap:ProceedsFromLinesOfCredit
      contextRef="i9500a5ee8dbe4d23aa9c46ebdd25a0c8_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yNS9mcmFnOjcwZjRjY2U0NjVlOTQ2MWJhN2NkZWRiMzAzNmJjNDE2L3RhYmxlOjcxNTQ4MjkxNjM4ZTQ4OTNhNzNlMWNhZDUwODYxYTRmL3RhYmxlcmFuZ2U6NzE1NDgyOTE2MzhlNDg5M2E3M2UxY2FkNTA4NjFhNGZfMzUtMy0xLTEtNDU5MTk_61340a18-1d19-434f-822b-4155c344fe99"
      unitRef="usd">110000000</us-gaap:ProceedsFromLinesOfCredit>
    <cnmd:PaymentsForContingentConsideration
      contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yNS9mcmFnOjcwZjRjY2U0NjVlOTQ2MWJhN2NkZWRiMzAzNmJjNDE2L3RhYmxlOjcxNTQ4MjkxNjM4ZTQ4OTNhNzNlMWNhZDUwODYxYTRmL3RhYmxlcmFuZ2U6NzE1NDgyOTE2MzhlNDg5M2E3M2UxY2FkNTA4NjFhNGZfMzgtMS0xLTEtNDU5MTk_68e2af89-c578-43f8-903a-b2697cef6ee8"
      unitRef="usd">0</cnmd:PaymentsForContingentConsideration>
    <cnmd:PaymentsForContingentConsideration
      contextRef="i9500a5ee8dbe4d23aa9c46ebdd25a0c8_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yNS9mcmFnOjcwZjRjY2U0NjVlOTQ2MWJhN2NkZWRiMzAzNmJjNDE2L3RhYmxlOjcxNTQ4MjkxNjM4ZTQ4OTNhNzNlMWNhZDUwODYxYTRmL3RhYmxlcmFuZ2U6NzE1NDgyOTE2MzhlNDg5M2E3M2UxY2FkNTA4NjFhNGZfMzgtMy0xLTEtNDU5MTk_9bde5fe7-9018-4ca2-b8f9-4fbe2596a3fc"
      unitRef="usd">798000</cnmd:PaymentsForContingentConsideration>
    <us-gaap:PaymentsOfDividendsCommonStock
      contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yNS9mcmFnOjcwZjRjY2U0NjVlOTQ2MWJhN2NkZWRiMzAzNmJjNDE2L3RhYmxlOjcxNTQ4MjkxNjM4ZTQ4OTNhNzNlMWNhZDUwODYxYTRmL3RhYmxlcmFuZ2U6NzE1NDgyOTE2MzhlNDg5M2E3M2UxY2FkNTA4NjFhNGZfNDAtMS0xLTEtNDU5MTk_e2621935-ce2b-41fe-be66-7dc0548a1487"
      unitRef="usd">6098000</us-gaap:PaymentsOfDividendsCommonStock>
    <us-gaap:PaymentsOfDividendsCommonStock
      contextRef="i9500a5ee8dbe4d23aa9c46ebdd25a0c8_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yNS9mcmFnOjcwZjRjY2U0NjVlOTQ2MWJhN2NkZWRiMzAzNmJjNDE2L3RhYmxlOjcxNTQ4MjkxNjM4ZTQ4OTNhNzNlMWNhZDUwODYxYTRmL3RhYmxlcmFuZ2U6NzE1NDgyOTE2MzhlNDg5M2E3M2UxY2FkNTA4NjFhNGZfNDAtMy0xLTEtNDU5MTk_2d0185e3-bdfc-4237-9999-80aad5986aee"
      unitRef="usd">5874000</us-gaap:PaymentsOfDividendsCommonStock>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yNS9mcmFnOjcwZjRjY2U0NjVlOTQ2MWJhN2NkZWRiMzAzNmJjNDE2L3RhYmxlOjcxNTQ4MjkxNjM4ZTQ4OTNhNzNlMWNhZDUwODYxYTRmL3RhYmxlcmFuZ2U6NzE1NDgyOTE2MzhlNDg5M2E3M2UxY2FkNTA4NjFhNGZfNDUtMS0xLTEtNDU5MTk_062340a4-1c5f-4603-90be-227ecd274f3d"
      unitRef="usd">2448000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="i9500a5ee8dbe4d23aa9c46ebdd25a0c8_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yNS9mcmFnOjcwZjRjY2U0NjVlOTQ2MWJhN2NkZWRiMzAzNmJjNDE2L3RhYmxlOjcxNTQ4MjkxNjM4ZTQ4OTNhNzNlMWNhZDUwODYxYTRmL3RhYmxlcmFuZ2U6NzE1NDgyOTE2MzhlNDg5M2E3M2UxY2FkNTA4NjFhNGZfNDUtMy0xLTEtNDU5MTk_2b09fbeb-12b5-49d1-9379-068cb3a7715b"
      unitRef="usd">6142000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yNS9mcmFnOjcwZjRjY2U0NjVlOTQ2MWJhN2NkZWRiMzAzNmJjNDE2L3RhYmxlOjcxNTQ4MjkxNjM4ZTQ4OTNhNzNlMWNhZDUwODYxYTRmL3RhYmxlcmFuZ2U6NzE1NDgyOTE2MzhlNDg5M2E3M2UxY2FkNTA4NjFhNGZfNDYtMS0xLTEtNDU5MTk_f99bf387-033f-48d8-ad09-cdc090d02bcd"
      unitRef="usd">5350000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i9500a5ee8dbe4d23aa9c46ebdd25a0c8_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yNS9mcmFnOjcwZjRjY2U0NjVlOTQ2MWJhN2NkZWRiMzAzNmJjNDE2L3RhYmxlOjcxNTQ4MjkxNjM4ZTQ4OTNhNzNlMWNhZDUwODYxYTRmL3RhYmxlcmFuZ2U6NzE1NDgyOTE2MzhlNDg5M2E3M2UxY2FkNTA4NjFhNGZfNDYtMy0xLTEtNDU5MTk_b99dc40b-b1c0-42f9-bca8-16cdb3c559d8"
      unitRef="usd">7489000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yNS9mcmFnOjcwZjRjY2U0NjVlOTQ2MWJhN2NkZWRiMzAzNmJjNDE2L3RhYmxlOjcxNTQ4MjkxNjM4ZTQ4OTNhNzNlMWNhZDUwODYxYTRmL3RhYmxlcmFuZ2U6NzE1NDgyOTE2MzhlNDg5M2E3M2UxY2FkNTA4NjFhNGZfNDgtMS0xLTEtNDU5MTk_84c10c27-874c-40e3-87f3-2f2cd03f65c3"
      unitRef="usd">303000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i9500a5ee8dbe4d23aa9c46ebdd25a0c8_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yNS9mcmFnOjcwZjRjY2U0NjVlOTQ2MWJhN2NkZWRiMzAzNmJjNDE2L3RhYmxlOjcxNTQ4MjkxNjM4ZTQ4OTNhNzNlMWNhZDUwODYxYTRmL3RhYmxlcmFuZ2U6NzE1NDgyOTE2MzhlNDg5M2E3M2UxY2FkNTA4NjFhNGZfNDgtMy0xLTEtNDU5MTk_00dc31fc-463f-4c5c-a80d-9ea850e0a744"
      unitRef="usd">-113000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yNS9mcmFnOjcwZjRjY2U0NjVlOTQ2MWJhN2NkZWRiMzAzNmJjNDE2L3RhYmxlOjcxNTQ4MjkxNjM4ZTQ4OTNhNzNlMWNhZDUwODYxYTRmL3RhYmxlcmFuZ2U6NzE1NDgyOTE2MzhlNDg5M2E3M2UxY2FkNTA4NjFhNGZfNTAtMS0xLTEtNDU5MTk_1ebf8eca-828b-4369-94db-5c7cfa8f02da"
      unitRef="usd">-2448000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i9500a5ee8dbe4d23aa9c46ebdd25a0c8_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yNS9mcmFnOjcwZjRjY2U0NjVlOTQ2MWJhN2NkZWRiMzAzNmJjNDE2L3RhYmxlOjcxNTQ4MjkxNjM4ZTQ4OTNhNzNlMWNhZDUwODYxYTRmL3RhYmxlcmFuZ2U6NzE1NDgyOTE2MzhlNDg5M2E3M2UxY2FkNTA4NjFhNGZfNTAtMy0xLTEtNDU5MTk_da4c3d00-337e-4a2e-bf58-0bec0c467503"
      unitRef="usd">4017000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ie4f63720d8b244a68941932992cd9f4d_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yNS9mcmFnOjcwZjRjY2U0NjVlOTQ2MWJhN2NkZWRiMzAzNmJjNDE2L3RhYmxlOjcxNTQ4MjkxNjM4ZTQ4OTNhNzNlMWNhZDUwODYxYTRmL3RhYmxlcmFuZ2U6NzE1NDgyOTE2MzhlNDg5M2E3M2UxY2FkNTA4NjFhNGZfNTItMS0xLTEtNDU5MTk_c0322c41-181d-453d-8f70-e1f71335902c"
      unitRef="usd">28942000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ia4bed28ea4b04a1d9fca88fa74e6040c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yNS9mcmFnOjcwZjRjY2U0NjVlOTQ2MWJhN2NkZWRiMzAzNmJjNDE2L3RhYmxlOjcxNTQ4MjkxNjM4ZTQ4OTNhNzNlMWNhZDUwODYxYTRmL3RhYmxlcmFuZ2U6NzE1NDgyOTE2MzhlNDg5M2E3M2UxY2FkNTA4NjFhNGZfNTItMy0xLTEtNDU5MTk_d306aee0-ecd3-4244-9456-a28d08feadc2"
      unitRef="usd">20847000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i738c2d1dacaf436faf03cc46ab9cef23_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yNS9mcmFnOjcwZjRjY2U0NjVlOTQ2MWJhN2NkZWRiMzAzNmJjNDE2L3RhYmxlOjcxNTQ4MjkxNjM4ZTQ4OTNhNzNlMWNhZDUwODYxYTRmL3RhYmxlcmFuZ2U6NzE1NDgyOTE2MzhlNDg5M2E3M2UxY2FkNTA4NjFhNGZfNTQtMS0xLTEtNDU5MTk_c74b973b-b328-4125-80b4-64f1ec7aaeba"
      unitRef="usd">26494000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i4730ada3cec445989c807f4fe004727c_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yNS9mcmFnOjcwZjRjY2U0NjVlOTQ2MWJhN2NkZWRiMzAzNmJjNDE2L3RhYmxlOjcxNTQ4MjkxNjM4ZTQ4OTNhNzNlMWNhZDUwODYxYTRmL3RhYmxlcmFuZ2U6NzE1NDgyOTE2MzhlNDg5M2E3M2UxY2FkNTA4NjFhNGZfNTQtMy0xLTEtNDU5MTk_eb369318-5471-49c3-a611-87dc5156a3ff"
      unitRef="usd">24864000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:DividendsPayableCurrentAndNoncurrent
      contextRef="i738c2d1dacaf436faf03cc46ab9cef23_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yNS9mcmFnOjcwZjRjY2U0NjVlOTQ2MWJhN2NkZWRiMzAzNmJjNDE2L3RhYmxlOjcxNTQ4MjkxNjM4ZTQ4OTNhNzNlMWNhZDUwODYxYTRmL3RhYmxlcmFuZ2U6NzE1NDgyOTE2MzhlNDg5M2E3M2UxY2FkNTA4NjFhNGZfNTgtMS0xLTEtNDU5MTk_819ce9ad-546a-4c22-a25e-494fe5396d7a"
      unitRef="usd">6113000</us-gaap:DividendsPayableCurrentAndNoncurrent>
    <us-gaap:DividendsPayableCurrentAndNoncurrent
      contextRef="i4730ada3cec445989c807f4fe004727c_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yNS9mcmFnOjcwZjRjY2U0NjVlOTQ2MWJhN2NkZWRiMzAzNmJjNDE2L3RhYmxlOjcxNTQ4MjkxNjM4ZTQ4OTNhNzNlMWNhZDUwODYxYTRmL3RhYmxlcmFuZ2U6NzE1NDgyOTE2MzhlNDg5M2E3M2UxY2FkNTA4NjFhNGZfNTgtMy0xLTEtNDU5MTk_29af72fd-f129-4b57-8451-9b59c18bb56b"
      unitRef="usd">5899000</us-gaap:DividendsPayableCurrentAndNoncurrent>
    <us-gaap:NatureOfOperations
      contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8zMS9mcmFnOmE2ZjMwNWRjMDU3ODRmMTNhZDE5OWNiOTFlYTY5YjMyL3RleHRyZWdpb246YTZmMzA1ZGMwNTc4NGYxM2FkMTk5Y2I5MWVhNjliMzJfNDAw_0c749cfc-d871-4e00-9596-aa1909dbbbd5">OperationsCONMED Corporation (&#x201c;CONMED&#x201d;, the &#x201c;Company&#x201d;, &#x201c;we&#x201d; or &#x201c;us&#x201d;) is a medical technology company that provides devices and equipment for surgical procedures.&#160;&#160;The Company&#x2019;s products are used by surgeons and other healthcare professionals in a variety of specialties including orthopedics, general surgery, gynecology, thoracic surgery and gastroenterology.</us-gaap:NatureOfOperations>
    <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock
      contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8zNC9mcmFnOjZmMjkyZWRhZTllNjQwNjZiY2I5YjA4YThiZWU1Y2M4L3RleHRyZWdpb246NmYyOTJlZGFlOWU2NDA2NmJjYjliMDhhOGJlZTVjYzhfMjEzNw_315dec16-ed34-40f1-8024-a0c351714569">Interim Financial Information&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The accompanying unaudited consolidated condensed financial statements have been prepared in accordance with generally accepted accounting principles for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X.  Accordingly, they do not include all of the information and footnotes required by generally accepted accounting principles for annual financial statements.  The information herein reflects all normal recurring material adjustments, which are, in the opinion of management, necessary to fairly present the results for the periods presented.  The consolidated condensed financial statements herein consist of all wholly-owned domestic and foreign subsidiaries with all significant intercompany transactions eliminated.  Results for the period ended March&#160;31, 2023 are not necessarily indicative of the results that may be expected for the year ending December&#160;31, 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The consolidated condensed financial statements and notes thereto should be read in conjunction with the consolidated financial statements and notes for the year ended December&#160;31, 2022 included in our Annual Report on Form 10-K.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Use of Estimates&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Preparation of the consolidated condensed financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated condensed financial statements and the reported amounts of revenue and expenses during the reporting period.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;While there has been uncertainty and disruption in the global economy and financial markets, we are not aware of any specific event or circumstance that would require an update to our estimates or judgments or a revision of the carrying value of our assets or liabilities as of&#160;April&#160;27, 2023, the date of issuance of this Quarterly Report on Form 10-Q.  These estimates may change, as new events occur and additional information is obtained. Actual results could differ materially from these estimates under different assumptions or conditions.&lt;/span&gt;&lt;/div&gt;</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock>
    <us-gaap:UseOfEstimates
      contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8zNC9mcmFnOjZmMjkyZWRhZTllNjQwNjZiY2I5YjA4YThiZWU1Y2M4L3RleHRyZWdpb246NmYyOTJlZGFlOWU2NDA2NmJjYjliMDhhOGJlZTVjYzhfMjE0Mw_a8f3dd6f-90ad-4374-b19b-ea42b9c9273c">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Use of Estimates&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Preparation of the consolidated condensed financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated condensed financial statements and the reported amounts of revenue and expenses during the reporting period.&lt;/span&gt;&lt;/div&gt;</us-gaap:UseOfEstimates>
    <us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock
      contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8zNy9mcmFnOjdlNWRhZTUxNTExNDRjMzY5N2RlMDA5MDgwNjY3YTA2L3RleHRyZWdpb246N2U1ZGFlNTE1MTE0NGMzNjk3ZGUwMDkwODA2NjdhMDZfNDE4Ng_bcac3751-91b6-4f5f-9afd-382716ed266c">New Accounting Pronouncements&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Recently Issued Accounting Standards, Not Yet Adopted&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In March 2020, the Financial Accounting Standards Board ("FASB") issued ASU 2020-04, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting, which provides optional guidance if certain criteria are met for entities that have contracts, hedging relationships, and other transactions that reference LIBOR or other reference rates expected to be discontinued as a result of reference rate reform.  This ASU is effective as of March 12, 2020 through December 31, 2022 and was extended through December 31, 2024 by ASU 2022-06, Reference Rate Reform (Topic 848): Deferral of the Sunset Date of Topic 848.  The Company has not adopted these ASUs as of March&#160;31, 2023.  Our seventh amended and restated senior credit agreement includes language to address the change from LIBOR to SOFR, an alternative base rate, therefore we do not believe reference rate reform will have a significant impact on our consolidated financial statements.&lt;/span&gt;&lt;/div&gt;</us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock
      contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8zNy9mcmFnOjdlNWRhZTUxNTExNDRjMzY5N2RlMDA5MDgwNjY3YTA2L3RleHRyZWdpb246N2U1ZGFlNTE1MTE0NGMzNjk3ZGUwMDkwODA2NjdhMDZfNDE5MQ_7b348b7e-5c39-4bd8-9f58-651560123308">New Accounting Pronouncements&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Recently Issued Accounting Standards, Not Yet Adopted&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In March 2020, the Financial Accounting Standards Board ("FASB") issued ASU 2020-04, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting, which provides optional guidance if certain criteria are met for entities that have contracts, hedging relationships, and other transactions that reference LIBOR or other reference rates expected to be discontinued as a result of reference rate reform.  This ASU is effective as of March 12, 2020 through December 31, 2022 and was extended through December 31, 2024 by ASU 2022-06, Reference Rate Reform (Topic 848): Deferral of the Sunset Date of Topic 848.  The Company has not adopted these ASUs as of March&#160;31, 2023.  Our seventh amended and restated senior credit agreement includes language to address the change from LIBOR to SOFR, an alternative base rate, therefore we do not believe reference rate reform will have a significant impact on our consolidated financial statements.&lt;/span&gt;&lt;/div&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:BusinessCombinationDisclosureTextBlock
      contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80MC9mcmFnOjFlZWQxODUxMjFhMzQwZmFhN2QyYTdhOGJkZmYxMzQ2L3RleHRyZWdpb246MWVlZDE4NTEyMWEzNDBmYWE3ZDJhN2E4YmRmZjEzNDZfMzk3Mw_f222374b-9064-4c02-bbce-ce8cce3da413">Business CombinationsOn June&#160;13, 2022, we acquired In2Bones Global, Inc. ("In2Bones") and all of its stock (the "In2Bones Acquisition") for an aggregate upfront payment of $145.2&#160;million in cash.  In addition, there are potential earn-out payments to In2Bones&#x2019; equity holders in an amount up to $110.0&#160;million based on the achievement of certain revenue targets for In2Bones products during the sixteen (16) successive quarters commencing on July 1, 2022.  In2Bones is a global developer, manufacturer and distributor of medical devices for the treatment of disorders and injuries of the upper (hand, wrist and elbow) and lower (foot &lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;and ankle) extremities.  The In2Bones Acquisition was funded through a combination of cash on hand and long-term borrowings as further described in Note 11.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"&gt;We recorded $11.8&#160;million in net sales for In2Bones during the three months ended March&#160;31, 2023.  Earnings recorded in the consolidated condensed statement of comprehensive income for the three months ended March&#160;31, 2023 were not material.  We also believe the proforma information is immaterial for disclosure for the three months ended March&#160;31, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"&gt;During the three months ended March&#160;31, 2023, we incurred costs for the amortization of inventory step-up to fair value of $2.1 million related to the In2Bones acquisition which are recorded in cost of sales.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On August&#160;9, 2022, we acquired Biorez, Inc. ("Biorez") and all of its stock (the "Biorez Acquisition") for an aggregate upfront payment of $85.5&#160;million in cash.  We paid $83.8&#160;million as of March&#160;31, 2023, with a $1.7&#160;million holdback, pursuant to the merger agreement for the Biorez Acquisition.  In addition, there are potential earn-out payments to Biorez&#x2019; equity holders in an amount up to $165.0&#160;million based on the achievement of certain revenue targets for Biorez products during the sixteen (16) successive quarters commencing on October 1, 2022.  Biorez is a medical device start-up focused on advancing the healing of soft tissue using its proprietary BioBrace&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; implant technology.  The Biorez Acquisition was funded through a combination of cash on hand and long-term borrowings.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"&gt;Net sales and earnings for Biorez were immaterial for the three months ended March&#160;31, 2023. We also believe the proforma information is immaterial for disclosure for the three months ended March&#160;31, 2022.  &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"&gt;The allocation of purchase price for these acquisitions is preliminary and therefore subject to adjustment during the measurement adjustment periods.&lt;/span&gt;&lt;/div&gt;</us-gaap:BusinessCombinationDisclosureTextBlock>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="i8c4d1dfe88414ef2adffd18a83334e37_D20220613-20220613"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80MC9mcmFnOjFlZWQxODUxMjFhMzQwZmFhN2QyYTdhOGJkZmYxMzQ2L3RleHRyZWdpb246MWVlZDE4NTEyMWEzNDBmYWE3ZDJhN2E4YmRmZjEzNDZfMTc3_582856af-6279-4226-b48d-28b344f69388"
      unitRef="usd">145200000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh
      contextRef="idc097ffbb7114253bc28bc94208a57fb_I20220613"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80MC9mcmFnOjFlZWQxODUxMjFhMzQwZmFhN2QyYTdhOGJkZmYxMzQ2L3RleHRyZWdpb246MWVlZDE4NTEyMWEzNDBmYWE3ZDJhN2E4YmRmZjEzNDZfMjg4_4d4e9cfc-2f45-4fa8-8226-999954178a32"
      unitRef="usd">110000000</us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh>
    <us-gaap:Revenues
      contextRef="i6d95bd83592e4caeac97181946e4d405_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80MC9mcmFnOjFlZWQxODUxMjFhMzQwZmFhN2QyYTdhOGJkZmYxMzQ2L3RleHRyZWdpb246MWVlZDE4NTEyMWEzNDBmYWE3ZDJhN2E4YmRmZjEzNDZfNTQ5NzU1ODIzNTU2_87cd9c54-6502-487a-872c-16914057564e"
      unitRef="usd">11800000</us-gaap:Revenues>
    <cnmd:AmortizationOfInventoryStepUpAdjustments
      contextRef="i462c25545d8940a2ae0be682fa065b8b_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80MC9mcmFnOjFlZWQxODUxMjFhMzQwZmFhN2QyYTdhOGJkZmYxMzQ2L3RleHRyZWdpb246MWVlZDE4NTEyMWEzNDBmYWE3ZDJhN2E4YmRmZjEzNDZfMjc0ODc3OTA3ODA4MQ_4f7291c9-6022-4e7f-8d39-8a3709c36710"
      unitRef="usd">2100000</cnmd:AmortizationOfInventoryStepUpAdjustments>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="ic28eb29cc995481fb7071df752f6760f_D20220809-20220809"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80MC9mcmFnOjFlZWQxODUxMjFhMzQwZmFhN2QyYTdhOGJkZmYxMzQ2L3RleHRyZWdpb246MWVlZDE4NTEyMWEzNDBmYWE3ZDJhN2E4YmRmZjEzNDZfOTAw_0ca67fe0-a607-479d-84b8-d9fd306544b2"
      unitRef="usd">85500000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="ic28eb29cc995481fb7071df752f6760f_D20220809-20220809"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80MC9mcmFnOjFlZWQxODUxMjFhMzQwZmFhN2QyYTdhOGJkZmYxMzQ2L3RleHRyZWdpb246MWVlZDE4NTEyMWEzNDBmYWE3ZDJhN2E4YmRmZjEzNDZfOTIx_63e4679c-4902-4a38-bb80-d182de2aa3b8"
      unitRef="usd">83800000</us-gaap:PaymentsToAcquireBusinessesGross>
    <cnmd:BusinessCombinationPurchasePriceAdjustmentHoldback
      contextRef="ic28eb29cc995481fb7071df752f6760f_D20220809-20220809"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80MC9mcmFnOjFlZWQxODUxMjFhMzQwZmFhN2QyYTdhOGJkZmYxMzQ2L3RleHRyZWdpb246MWVlZDE4NTEyMWEzNDBmYWE3ZDJhN2E4YmRmZjEzNDZfOTQ1_7f9ec1e4-c2d1-478f-b0b1-50d2e0351141"
      unitRef="usd">1700000</cnmd:BusinessCombinationPurchasePriceAdjustmentHoldback>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh
      contextRef="i9d6ba56ca73740b9b3923d912000da47_I20220809"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80MC9mcmFnOjFlZWQxODUxMjFhMzQwZmFhN2QyYTdhOGJkZmYxMzQ2L3RleHRyZWdpb246MWVlZDE4NTEyMWEzNDBmYWE3ZDJhN2E4YmRmZjEzNDZfMTE0Mg_611c9c9f-957e-489e-a1e7-f4e84a356501"
      unitRef="usd">165000000</us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh>
    <us-gaap:RevenueFromContractWithCustomerTextBlock
      contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80My9mcmFnOjQ4M2E3ZjM0NDExZDQzNGI5M2MzM2VmNTk1ZGY3ZTQxL3RleHRyZWdpb246NDgzYTdmMzQ0MTFkNDM0YjkzYzMzZWY1OTVkZjdlNDFfNTEx_9c769563-bfce-4ea7-b92b-1a923c67b87a">Revenues&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables present revenue disaggregated by primary geographic market where the products are sold, by product line and timing of revenue recognition: &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.209%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.581%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Orthopedic Surgery&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;General Surgery&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Orthopedic Surgery&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;General Surgery&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Primary Geographic Markets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48,944&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;115,645&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;164,589&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,947&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;93,280&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;131,227&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Europe, Middle East &amp;amp; Africa&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,896&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56,016&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,980&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,326&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,306&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asia Pacific&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,121&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,986&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46,107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,418&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,954&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,372&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Americas (excluding the United States)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,990&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,766&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,756&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,172&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,422&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 19pt 2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total sales from contracts with customers&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;131,175&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;164,293&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;295,468&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;107,517&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;134,810&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;242,327&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Timing of Revenue Recognition&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goods transferred at a point in time&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;121,122&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;162,590&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;283,712&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;98,204&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;133,322&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;231,526&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Services transferred over time&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,053&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,703&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,756&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,313&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,488&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,801&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 19pt 2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total sales from contracts with customers&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;131,175&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;164,293&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;295,468&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;107,517&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;134,810&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;242,327&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.209%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.581%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Contract liability balances related to the sale of extended warranties to customers are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.344%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.346%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract liability&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,887&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,114&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenue recognized during the three months ended March&#160;31, 2023 and March&#160;31, 2022 from amounts included in contract liabilities at the beginning of the period were $4.2 million and $3.9 million, respectively.  There were no material &lt;/span&gt;&lt;/div&gt;contract assets as of March&#160;31, 2023 and December&#160;31, 2022.</us-gaap:RevenueFromContractWithCustomerTextBlock>
    <us-gaap:DisaggregationOfRevenueTableTextBlock
      contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80My9mcmFnOjQ4M2E3ZjM0NDExZDQzNGI5M2MzM2VmNTk1ZGY3ZTQxL3RleHRyZWdpb246NDgzYTdmMzQ0MTFkNDM0YjkzYzMzZWY1OTVkZjdlNDFfNTE4_0531c479-09b4-4589-b080-3a1e861d5eb5">&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables present revenue disaggregated by primary geographic market where the products are sold, by product line and timing of revenue recognition: &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.209%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.581%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Orthopedic Surgery&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;General Surgery&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Orthopedic Surgery&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;General Surgery&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Primary Geographic Markets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48,944&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;115,645&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;164,589&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,947&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;93,280&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;131,227&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Europe, Middle East &amp;amp; Africa&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,896&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56,016&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,980&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,326&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,306&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asia Pacific&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,121&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,986&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46,107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,418&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,954&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,372&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Americas (excluding the United States)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,990&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,766&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,756&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,172&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,422&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 19pt 2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total sales from contracts with customers&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;131,175&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;164,293&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;295,468&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;107,517&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;134,810&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;242,327&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Timing of Revenue Recognition&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goods transferred at a point in time&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;121,122&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;162,590&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;283,712&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;98,204&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;133,322&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;231,526&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Services transferred over time&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,053&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,703&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,756&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,313&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,488&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,801&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 19pt 2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total sales from contracts with customers&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;131,175&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;164,293&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;295,468&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;107,517&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;134,810&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;242,327&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DisaggregationOfRevenueTableTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i26071f490d464a14b2bf24e3e1f2c752_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80My9mcmFnOjQ4M2E3ZjM0NDExZDQzNGI5M2MzM2VmNTk1ZGY3ZTQxL3RhYmxlOjY0YTlkZDAzN2E3OTRjNmRiZmNmYTY3YmQ2MGQ0YjQyL3RhYmxlcmFuZ2U6NjRhOWRkMDM3YTc5NGM2ZGJmY2ZhNjdiZDYwZDRiNDJfNC0xLTEtMS00NTkxOQ_ade2c10c-c0c2-49af-9557-c1715c60db07"
      unitRef="usd">48944000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7bdef281f49841f698c6ef3a3ead6753_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80My9mcmFnOjQ4M2E3ZjM0NDExZDQzNGI5M2MzM2VmNTk1ZGY3ZTQxL3RhYmxlOjY0YTlkZDAzN2E3OTRjNmRiZmNmYTY3YmQ2MGQ0YjQyL3RhYmxlcmFuZ2U6NjRhOWRkMDM3YTc5NGM2ZGJmY2ZhNjdiZDYwZDRiNDJfNC0zLTEtMS00NTkxOQ_f3b4c58e-01a9-40f3-9b6c-fcd13ac32f28"
      unitRef="usd">115645000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i124749441acd44cf9c0bac450334222b_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80My9mcmFnOjQ4M2E3ZjM0NDExZDQzNGI5M2MzM2VmNTk1ZGY3ZTQxL3RhYmxlOjY0YTlkZDAzN2E3OTRjNmRiZmNmYTY3YmQ2MGQ0YjQyL3RhYmxlcmFuZ2U6NjRhOWRkMDM3YTc5NGM2ZGJmY2ZhNjdiZDYwZDRiNDJfNC01LTEtMS00NTkxOQ_1bfafdff-6a8f-4b6b-b6b7-c3367a82d231"
      unitRef="usd">164589000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib7fbf46a701d40e5bf879057f949e772_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80My9mcmFnOjQ4M2E3ZjM0NDExZDQzNGI5M2MzM2VmNTk1ZGY3ZTQxL3RhYmxlOjY0YTlkZDAzN2E3OTRjNmRiZmNmYTY3YmQ2MGQ0YjQyL3RhYmxlcmFuZ2U6NjRhOWRkMDM3YTc5NGM2ZGJmY2ZhNjdiZDYwZDRiNDJfNC03LTEtMS00NTkxOQ_2f44d90f-93f9-455c-92ea-96b505c907c4"
      unitRef="usd">37947000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i85ba684d41a74bceaee45a7efb4e3287_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80My9mcmFnOjQ4M2E3ZjM0NDExZDQzNGI5M2MzM2VmNTk1ZGY3ZTQxL3RhYmxlOjY0YTlkZDAzN2E3OTRjNmRiZmNmYTY3YmQ2MGQ0YjQyL3RhYmxlcmFuZ2U6NjRhOWRkMDM3YTc5NGM2ZGJmY2ZhNjdiZDYwZDRiNDJfNC05LTEtMS00NTkxOQ_9724b15f-5d06-436d-a9ec-41afd58e0b4c"
      unitRef="usd">93280000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9f3ae93344eb48b2b3f68003d7aaf3fd_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80My9mcmFnOjQ4M2E3ZjM0NDExZDQzNGI5M2MzM2VmNTk1ZGY3ZTQxL3RhYmxlOjY0YTlkZDAzN2E3OTRjNmRiZmNmYTY3YmQ2MGQ0YjQyL3RhYmxlcmFuZ2U6NjRhOWRkMDM3YTc5NGM2ZGJmY2ZhNjdiZDYwZDRiNDJfNC0xMS0xLTEtNDU5MTk_367e9daa-865d-4466-9ed4-c89407ec5b8a"
      unitRef="usd">131227000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i39a257b7bdcf459488a0a70dadb1fc48_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80My9mcmFnOjQ4M2E3ZjM0NDExZDQzNGI5M2MzM2VmNTk1ZGY3ZTQxL3RhYmxlOjY0YTlkZDAzN2E3OTRjNmRiZmNmYTY3YmQ2MGQ0YjQyL3RhYmxlcmFuZ2U6NjRhOWRkMDM3YTc5NGM2ZGJmY2ZhNjdiZDYwZDRiNDJfNS0xLTEtMS00NTkxOQ_9bfbae11-b84d-415d-8f50-621ada46bddc"
      unitRef="usd">33120000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i66fa55845df14909875423110e9c3562_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80My9mcmFnOjQ4M2E3ZjM0NDExZDQzNGI5M2MzM2VmNTk1ZGY3ZTQxL3RhYmxlOjY0YTlkZDAzN2E3OTRjNmRiZmNmYTY3YmQ2MGQ0YjQyL3RhYmxlcmFuZ2U6NjRhOWRkMDM3YTc5NGM2ZGJmY2ZhNjdiZDYwZDRiNDJfNS0zLTEtMS00NTkxOQ_cb2de3de-03f7-40cf-8fb6-7ec5ddc64f9f"
      unitRef="usd">22896000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ibeb105be0cd24a989e5a9543869dcd19_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80My9mcmFnOjQ4M2E3ZjM0NDExZDQzNGI5M2MzM2VmNTk1ZGY3ZTQxL3RhYmxlOjY0YTlkZDAzN2E3OTRjNmRiZmNmYTY3YmQ2MGQ0YjQyL3RhYmxlcmFuZ2U6NjRhOWRkMDM3YTc5NGM2ZGJmY2ZhNjdiZDYwZDRiNDJfNS01LTEtMS00NTkxOQ_c6808e0c-27dd-4612-b23b-6649ce85be1d"
      unitRef="usd">56016000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i95feeaee74ee430ab557bd6fd0a89121_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80My9mcmFnOjQ4M2E3ZjM0NDExZDQzNGI5M2MzM2VmNTk1ZGY3ZTQxL3RhYmxlOjY0YTlkZDAzN2E3OTRjNmRiZmNmYTY3YmQ2MGQ0YjQyL3RhYmxlcmFuZ2U6NjRhOWRkMDM3YTc5NGM2ZGJmY2ZhNjdiZDYwZDRiNDJfNS03LTEtMS00NTkxOQ_23ffa528-5bcf-476f-94d9-03f8cd888716"
      unitRef="usd">29980000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i025adf098383419fa26b51488aa4067f_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80My9mcmFnOjQ4M2E3ZjM0NDExZDQzNGI5M2MzM2VmNTk1ZGY3ZTQxL3RhYmxlOjY0YTlkZDAzN2E3OTRjNmRiZmNmYTY3YmQ2MGQ0YjQyL3RhYmxlcmFuZ2U6NjRhOWRkMDM3YTc5NGM2ZGJmY2ZhNjdiZDYwZDRiNDJfNS05LTEtMS00NTkxOQ_844786f4-001d-4ee6-b0bb-bc67e9d37c2f"
      unitRef="usd">20326000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0a8d168c31ea4928b8a1a43a06a6984a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80My9mcmFnOjQ4M2E3ZjM0NDExZDQzNGI5M2MzM2VmNTk1ZGY3ZTQxL3RhYmxlOjY0YTlkZDAzN2E3OTRjNmRiZmNmYTY3YmQ2MGQ0YjQyL3RhYmxlcmFuZ2U6NjRhOWRkMDM3YTc5NGM2ZGJmY2ZhNjdiZDYwZDRiNDJfNS0xMS0xLTEtNDU5MTk_7e9a96cc-ba2e-47b6-9279-a6bb3ced5e69"
      unitRef="usd">50306000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i576a3464c09a4584a1729cd84cc4164b_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80My9mcmFnOjQ4M2E3ZjM0NDExZDQzNGI5M2MzM2VmNTk1ZGY3ZTQxL3RhYmxlOjY0YTlkZDAzN2E3OTRjNmRiZmNmYTY3YmQ2MGQ0YjQyL3RhYmxlcmFuZ2U6NjRhOWRkMDM3YTc5NGM2ZGJmY2ZhNjdiZDYwZDRiNDJfNi0xLTEtMS00NTkxOQ_75c1babe-6c25-4515-8207-89e1998fb597"
      unitRef="usd">30121000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i05787a350f674333ac2b6243c86c128a_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80My9mcmFnOjQ4M2E3ZjM0NDExZDQzNGI5M2MzM2VmNTk1ZGY3ZTQxL3RhYmxlOjY0YTlkZDAzN2E3OTRjNmRiZmNmYTY3YmQ2MGQ0YjQyL3RhYmxlcmFuZ2U6NjRhOWRkMDM3YTc5NGM2ZGJmY2ZhNjdiZDYwZDRiNDJfNi0zLTEtMS00NTkxOQ_e0d970d2-3009-4a8c-9d1a-09285047d1de"
      unitRef="usd">15986000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i602945d302db4233b3e192e2980d335f_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80My9mcmFnOjQ4M2E3ZjM0NDExZDQzNGI5M2MzM2VmNTk1ZGY3ZTQxL3RhYmxlOjY0YTlkZDAzN2E3OTRjNmRiZmNmYTY3YmQ2MGQ0YjQyL3RhYmxlcmFuZ2U6NjRhOWRkMDM3YTc5NGM2ZGJmY2ZhNjdiZDYwZDRiNDJfNi01LTEtMS00NTkxOQ_6d4e85ab-8a47-4a04-a969-5d208973c455"
      unitRef="usd">46107000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia1a88893879046bd89e1f186cac411ec_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80My9mcmFnOjQ4M2E3ZjM0NDExZDQzNGI5M2MzM2VmNTk1ZGY3ZTQxL3RhYmxlOjY0YTlkZDAzN2E3OTRjNmRiZmNmYTY3YmQ2MGQ0YjQyL3RhYmxlcmFuZ2U6NjRhOWRkMDM3YTc5NGM2ZGJmY2ZhNjdiZDYwZDRiNDJfNi03LTEtMS00NTkxOQ_6a46ea97-af16-429c-a431-86c2d998cab9"
      unitRef="usd">23418000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4ed292675fb142ab9e142e12e6a19a99_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80My9mcmFnOjQ4M2E3ZjM0NDExZDQzNGI5M2MzM2VmNTk1ZGY3ZTQxL3RhYmxlOjY0YTlkZDAzN2E3OTRjNmRiZmNmYTY3YmQ2MGQ0YjQyL3RhYmxlcmFuZ2U6NjRhOWRkMDM3YTc5NGM2ZGJmY2ZhNjdiZDYwZDRiNDJfNi05LTEtMS00NTkxOQ_6f7e7269-2341-4efb-9903-3d0e095b5680"
      unitRef="usd">12954000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i26a828941a804f3f9109a0c00250ec1d_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80My9mcmFnOjQ4M2E3ZjM0NDExZDQzNGI5M2MzM2VmNTk1ZGY3ZTQxL3RhYmxlOjY0YTlkZDAzN2E3OTRjNmRiZmNmYTY3YmQ2MGQ0YjQyL3RhYmxlcmFuZ2U6NjRhOWRkMDM3YTc5NGM2ZGJmY2ZhNjdiZDYwZDRiNDJfNi0xMS0xLTEtNDU5MTk_9521251a-c66a-4b7c-9677-dff42898d4f3"
      unitRef="usd">36372000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i25c81b50fa704ad899e54ae63e120282_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80My9mcmFnOjQ4M2E3ZjM0NDExZDQzNGI5M2MzM2VmNTk1ZGY3ZTQxL3RhYmxlOjY0YTlkZDAzN2E3OTRjNmRiZmNmYTY3YmQ2MGQ0YjQyL3RhYmxlcmFuZ2U6NjRhOWRkMDM3YTc5NGM2ZGJmY2ZhNjdiZDYwZDRiNDJfNy0xLTEtMS00NTkxOQ_56c83131-819d-4a5d-8581-185bd0a569ce"
      unitRef="usd">18990000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4422e467d9714c3d8fbf4438109765ab_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80My9mcmFnOjQ4M2E3ZjM0NDExZDQzNGI5M2MzM2VmNTk1ZGY3ZTQxL3RhYmxlOjY0YTlkZDAzN2E3OTRjNmRiZmNmYTY3YmQ2MGQ0YjQyL3RhYmxlcmFuZ2U6NjRhOWRkMDM3YTc5NGM2ZGJmY2ZhNjdiZDYwZDRiNDJfNy0zLTEtMS00NTkxOQ_eb9f0d22-235e-419f-8a2a-3a9112bfdbed"
      unitRef="usd">9766000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i768d975a616147ad9d2d2288a48b11ed_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80My9mcmFnOjQ4M2E3ZjM0NDExZDQzNGI5M2MzM2VmNTk1ZGY3ZTQxL3RhYmxlOjY0YTlkZDAzN2E3OTRjNmRiZmNmYTY3YmQ2MGQ0YjQyL3RhYmxlcmFuZ2U6NjRhOWRkMDM3YTc5NGM2ZGJmY2ZhNjdiZDYwZDRiNDJfNy01LTEtMS00NTkxOQ_2e9ef980-489d-4c14-a8b8-c77f14db2dab"
      unitRef="usd">28756000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4f4ed95789924cb587cec5440c300f1a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80My9mcmFnOjQ4M2E3ZjM0NDExZDQzNGI5M2MzM2VmNTk1ZGY3ZTQxL3RhYmxlOjY0YTlkZDAzN2E3OTRjNmRiZmNmYTY3YmQ2MGQ0YjQyL3RhYmxlcmFuZ2U6NjRhOWRkMDM3YTc5NGM2ZGJmY2ZhNjdiZDYwZDRiNDJfNy03LTEtMS00NTkxOQ_bdbb8f2a-3522-41cd-9f17-be15765a948c"
      unitRef="usd">16172000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1872a8b90120412d810e0a86ab85c148_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80My9mcmFnOjQ4M2E3ZjM0NDExZDQzNGI5M2MzM2VmNTk1ZGY3ZTQxL3RhYmxlOjY0YTlkZDAzN2E3OTRjNmRiZmNmYTY3YmQ2MGQ0YjQyL3RhYmxlcmFuZ2U6NjRhOWRkMDM3YTc5NGM2ZGJmY2ZhNjdiZDYwZDRiNDJfNy05LTEtMS00NTkxOQ_b5323961-0766-484b-b1f6-8f5d8abe28cb"
      unitRef="usd">8250000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib413a484ed8047a49dbd503cf4a21f59_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80My9mcmFnOjQ4M2E3ZjM0NDExZDQzNGI5M2MzM2VmNTk1ZGY3ZTQxL3RhYmxlOjY0YTlkZDAzN2E3OTRjNmRiZmNmYTY3YmQ2MGQ0YjQyL3RhYmxlcmFuZ2U6NjRhOWRkMDM3YTc5NGM2ZGJmY2ZhNjdiZDYwZDRiNDJfNy0xMS0xLTEtNDU5MTk_a04956ce-f17f-4fd1-ae90-422417c378dc"
      unitRef="usd">24422000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6a0f37b7e82e470ebf61b3f06c22aac2_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80My9mcmFnOjQ4M2E3ZjM0NDExZDQzNGI5M2MzM2VmNTk1ZGY3ZTQxL3RhYmxlOjY0YTlkZDAzN2E3OTRjNmRiZmNmYTY3YmQ2MGQ0YjQyL3RhYmxlcmFuZ2U6NjRhOWRkMDM3YTc5NGM2ZGJmY2ZhNjdiZDYwZDRiNDJfOC0xLTEtMS00NTkxOQ_b9b931cc-a630-440e-a8cf-4798266e56bd"
      unitRef="usd">131175000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if48f7914ec3d45beaf647b856037592a_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80My9mcmFnOjQ4M2E3ZjM0NDExZDQzNGI5M2MzM2VmNTk1ZGY3ZTQxL3RhYmxlOjY0YTlkZDAzN2E3OTRjNmRiZmNmYTY3YmQ2MGQ0YjQyL3RhYmxlcmFuZ2U6NjRhOWRkMDM3YTc5NGM2ZGJmY2ZhNjdiZDYwZDRiNDJfOC0zLTEtMS00NTkxOQ_ded439e6-41fd-476d-8766-fe096145128b"
      unitRef="usd">164293000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80My9mcmFnOjQ4M2E3ZjM0NDExZDQzNGI5M2MzM2VmNTk1ZGY3ZTQxL3RhYmxlOjY0YTlkZDAzN2E3OTRjNmRiZmNmYTY3YmQ2MGQ0YjQyL3RhYmxlcmFuZ2U6NjRhOWRkMDM3YTc5NGM2ZGJmY2ZhNjdiZDYwZDRiNDJfOC01LTEtMS00NTkxOQ_80c41819-f463-41f3-b17a-025e7f88676c"
      unitRef="usd">295468000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia61d13e27f12498686a84bca47df5ec7_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80My9mcmFnOjQ4M2E3ZjM0NDExZDQzNGI5M2MzM2VmNTk1ZGY3ZTQxL3RhYmxlOjY0YTlkZDAzN2E3OTRjNmRiZmNmYTY3YmQ2MGQ0YjQyL3RhYmxlcmFuZ2U6NjRhOWRkMDM3YTc5NGM2ZGJmY2ZhNjdiZDYwZDRiNDJfOC03LTEtMS00NTkxOQ_b01fd066-bf1e-42d3-8bb6-4a0d2980d5a1"
      unitRef="usd">107517000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i60341eeb4343409c94899251a17bdde1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80My9mcmFnOjQ4M2E3ZjM0NDExZDQzNGI5M2MzM2VmNTk1ZGY3ZTQxL3RhYmxlOjY0YTlkZDAzN2E3OTRjNmRiZmNmYTY3YmQ2MGQ0YjQyL3RhYmxlcmFuZ2U6NjRhOWRkMDM3YTc5NGM2ZGJmY2ZhNjdiZDYwZDRiNDJfOC05LTEtMS00NTkxOQ_9d1fa249-17f6-4869-aa38-d75f959ba334"
      unitRef="usd">134810000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9500a5ee8dbe4d23aa9c46ebdd25a0c8_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80My9mcmFnOjQ4M2E3ZjM0NDExZDQzNGI5M2MzM2VmNTk1ZGY3ZTQxL3RhYmxlOjY0YTlkZDAzN2E3OTRjNmRiZmNmYTY3YmQ2MGQ0YjQyL3RhYmxlcmFuZ2U6NjRhOWRkMDM3YTc5NGM2ZGJmY2ZhNjdiZDYwZDRiNDJfOC0xMS0xLTEtNDU5MTk_5d77896d-4c05-4d82-bcdd-d489c59d522d"
      unitRef="usd">242327000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i256914f8655049ea8697187612d438ac_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80My9mcmFnOjQ4M2E3ZjM0NDExZDQzNGI5M2MzM2VmNTk1ZGY3ZTQxL3RhYmxlOjY0YTlkZDAzN2E3OTRjNmRiZmNmYTY3YmQ2MGQ0YjQyL3RhYmxlcmFuZ2U6NjRhOWRkMDM3YTc5NGM2ZGJmY2ZhNjdiZDYwZDRiNDJfMTEtMS0xLTEtNDU5MTk_8f6d2153-b88c-4120-ab3f-898ae099f917"
      unitRef="usd">121122000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia6458bd1547344efa30ce73c2612539c_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80My9mcmFnOjQ4M2E3ZjM0NDExZDQzNGI5M2MzM2VmNTk1ZGY3ZTQxL3RhYmxlOjY0YTlkZDAzN2E3OTRjNmRiZmNmYTY3YmQ2MGQ0YjQyL3RhYmxlcmFuZ2U6NjRhOWRkMDM3YTc5NGM2ZGJmY2ZhNjdiZDYwZDRiNDJfMTEtMy0xLTEtNDU5MTk_7685c892-2cc4-4024-b715-c3fffc1bdded"
      unitRef="usd">162590000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6d99ddc9cc5b4e6aab3f7115cf38a715_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80My9mcmFnOjQ4M2E3ZjM0NDExZDQzNGI5M2MzM2VmNTk1ZGY3ZTQxL3RhYmxlOjY0YTlkZDAzN2E3OTRjNmRiZmNmYTY3YmQ2MGQ0YjQyL3RhYmxlcmFuZ2U6NjRhOWRkMDM3YTc5NGM2ZGJmY2ZhNjdiZDYwZDRiNDJfMTEtNS0xLTEtNDU5MTk_71e475a0-2b4e-41c7-8e6b-e16ad9cca612"
      unitRef="usd">283712000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ied376a94006741e6b0f863abd74791a1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80My9mcmFnOjQ4M2E3ZjM0NDExZDQzNGI5M2MzM2VmNTk1ZGY3ZTQxL3RhYmxlOjY0YTlkZDAzN2E3OTRjNmRiZmNmYTY3YmQ2MGQ0YjQyL3RhYmxlcmFuZ2U6NjRhOWRkMDM3YTc5NGM2ZGJmY2ZhNjdiZDYwZDRiNDJfMTEtNy0xLTEtNDU5MTk_78db3841-edb6-4f83-a19f-eb8d55e0b0c4"
      unitRef="usd">98204000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib2980943d7fd4938b59d54c6c50f48a6_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80My9mcmFnOjQ4M2E3ZjM0NDExZDQzNGI5M2MzM2VmNTk1ZGY3ZTQxL3RhYmxlOjY0YTlkZDAzN2E3OTRjNmRiZmNmYTY3YmQ2MGQ0YjQyL3RhYmxlcmFuZ2U6NjRhOWRkMDM3YTc5NGM2ZGJmY2ZhNjdiZDYwZDRiNDJfMTEtOS0xLTEtNDU5MTk_3bf76de2-35f4-49e5-a3cc-f16357cce9ec"
      unitRef="usd">133322000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if9e3065b9a6e471ab072cbee433e2b01_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80My9mcmFnOjQ4M2E3ZjM0NDExZDQzNGI5M2MzM2VmNTk1ZGY3ZTQxL3RhYmxlOjY0YTlkZDAzN2E3OTRjNmRiZmNmYTY3YmQ2MGQ0YjQyL3RhYmxlcmFuZ2U6NjRhOWRkMDM3YTc5NGM2ZGJmY2ZhNjdiZDYwZDRiNDJfMTEtMTEtMS0xLTQ1OTE5_e2e7989a-d2c7-4d55-9aab-8fdb5b04dd10"
      unitRef="usd">231526000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i19f0084e35914599aa701fa76539508d_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80My9mcmFnOjQ4M2E3ZjM0NDExZDQzNGI5M2MzM2VmNTk1ZGY3ZTQxL3RhYmxlOjY0YTlkZDAzN2E3OTRjNmRiZmNmYTY3YmQ2MGQ0YjQyL3RhYmxlcmFuZ2U6NjRhOWRkMDM3YTc5NGM2ZGJmY2ZhNjdiZDYwZDRiNDJfMTItMS0xLTEtNDU5MTk_6669bc29-c015-4bcc-bc88-6c3049cc7d34"
      unitRef="usd">10053000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if322af949b2348ebaf2b896bd9ee2e61_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80My9mcmFnOjQ4M2E3ZjM0NDExZDQzNGI5M2MzM2VmNTk1ZGY3ZTQxL3RhYmxlOjY0YTlkZDAzN2E3OTRjNmRiZmNmYTY3YmQ2MGQ0YjQyL3RhYmxlcmFuZ2U6NjRhOWRkMDM3YTc5NGM2ZGJmY2ZhNjdiZDYwZDRiNDJfMTItMy0xLTEtNDU5MTk_ce8bde1c-9d4a-4816-bee9-1a5283bbcf4e"
      unitRef="usd">1703000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i75c95aec633641d7b8b7c07c7fdff0c3_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80My9mcmFnOjQ4M2E3ZjM0NDExZDQzNGI5M2MzM2VmNTk1ZGY3ZTQxL3RhYmxlOjY0YTlkZDAzN2E3OTRjNmRiZmNmYTY3YmQ2MGQ0YjQyL3RhYmxlcmFuZ2U6NjRhOWRkMDM3YTc5NGM2ZGJmY2ZhNjdiZDYwZDRiNDJfMTItNS0xLTEtNDU5MTk_e8db20f3-ca4f-4e75-88ee-d54b6a905d81"
      unitRef="usd">11756000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="idb37c3470f1c4ee4a3ca9416c789d079_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80My9mcmFnOjQ4M2E3ZjM0NDExZDQzNGI5M2MzM2VmNTk1ZGY3ZTQxL3RhYmxlOjY0YTlkZDAzN2E3OTRjNmRiZmNmYTY3YmQ2MGQ0YjQyL3RhYmxlcmFuZ2U6NjRhOWRkMDM3YTc5NGM2ZGJmY2ZhNjdiZDYwZDRiNDJfMTItNy0xLTEtNDU5MTk_043a83b2-0d23-45cc-9d07-1a0a17f6aad0"
      unitRef="usd">9313000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i72ad5ca858ec41a8b22fc48fcb8a2b67_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80My9mcmFnOjQ4M2E3ZjM0NDExZDQzNGI5M2MzM2VmNTk1ZGY3ZTQxL3RhYmxlOjY0YTlkZDAzN2E3OTRjNmRiZmNmYTY3YmQ2MGQ0YjQyL3RhYmxlcmFuZ2U6NjRhOWRkMDM3YTc5NGM2ZGJmY2ZhNjdiZDYwZDRiNDJfMTItOS0xLTEtNDU5MTk_bc566c70-26f1-4c64-8808-6eeb454836b3"
      unitRef="usd">1488000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i147ce8278590475d95f2b007ce8b8910_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80My9mcmFnOjQ4M2E3ZjM0NDExZDQzNGI5M2MzM2VmNTk1ZGY3ZTQxL3RhYmxlOjY0YTlkZDAzN2E3OTRjNmRiZmNmYTY3YmQ2MGQ0YjQyL3RhYmxlcmFuZ2U6NjRhOWRkMDM3YTc5NGM2ZGJmY2ZhNjdiZDYwZDRiNDJfMTItMTEtMS0xLTQ1OTE5_89049586-b96d-466e-9733-acf92f31ffc0"
      unitRef="usd">10801000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6a0f37b7e82e470ebf61b3f06c22aac2_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80My9mcmFnOjQ4M2E3ZjM0NDExZDQzNGI5M2MzM2VmNTk1ZGY3ZTQxL3RhYmxlOjY0YTlkZDAzN2E3OTRjNmRiZmNmYTY3YmQ2MGQ0YjQyL3RhYmxlcmFuZ2U6NjRhOWRkMDM3YTc5NGM2ZGJmY2ZhNjdiZDYwZDRiNDJfMTMtMS0xLTEtNDU5MTk_eabf12c9-1623-4af1-90cd-b5187f5ea9f3"
      unitRef="usd">131175000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if48f7914ec3d45beaf647b856037592a_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80My9mcmFnOjQ4M2E3ZjM0NDExZDQzNGI5M2MzM2VmNTk1ZGY3ZTQxL3RhYmxlOjY0YTlkZDAzN2E3OTRjNmRiZmNmYTY3YmQ2MGQ0YjQyL3RhYmxlcmFuZ2U6NjRhOWRkMDM3YTc5NGM2ZGJmY2ZhNjdiZDYwZDRiNDJfMTMtMy0xLTEtNDU5MTk_7e38d14a-3c67-4c26-88e9-c95f514a45ca"
      unitRef="usd">164293000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80My9mcmFnOjQ4M2E3ZjM0NDExZDQzNGI5M2MzM2VmNTk1ZGY3ZTQxL3RhYmxlOjY0YTlkZDAzN2E3OTRjNmRiZmNmYTY3YmQ2MGQ0YjQyL3RhYmxlcmFuZ2U6NjRhOWRkMDM3YTc5NGM2ZGJmY2ZhNjdiZDYwZDRiNDJfMTMtNS0xLTEtNDU5MTk_70f38554-929e-4ff7-a7a9-70be7f28b789"
      unitRef="usd">295468000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia61d13e27f12498686a84bca47df5ec7_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80My9mcmFnOjQ4M2E3ZjM0NDExZDQzNGI5M2MzM2VmNTk1ZGY3ZTQxL3RhYmxlOjY0YTlkZDAzN2E3OTRjNmRiZmNmYTY3YmQ2MGQ0YjQyL3RhYmxlcmFuZ2U6NjRhOWRkMDM3YTc5NGM2ZGJmY2ZhNjdiZDYwZDRiNDJfMTMtNy0xLTEtNDU5MTk_5c085b32-493a-49cd-b6d4-ecb9ee204c26"
      unitRef="usd">107517000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i60341eeb4343409c94899251a17bdde1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80My9mcmFnOjQ4M2E3ZjM0NDExZDQzNGI5M2MzM2VmNTk1ZGY3ZTQxL3RhYmxlOjY0YTlkZDAzN2E3OTRjNmRiZmNmYTY3YmQ2MGQ0YjQyL3RhYmxlcmFuZ2U6NjRhOWRkMDM3YTc5NGM2ZGJmY2ZhNjdiZDYwZDRiNDJfMTMtOS0xLTEtNDU5MTk_fa9d2d42-8b7c-4a2d-b1bf-6fa83559dc9b"
      unitRef="usd">134810000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9500a5ee8dbe4d23aa9c46ebdd25a0c8_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80My9mcmFnOjQ4M2E3ZjM0NDExZDQzNGI5M2MzM2VmNTk1ZGY3ZTQxL3RhYmxlOjY0YTlkZDAzN2E3OTRjNmRiZmNmYTY3YmQ2MGQ0YjQyL3RhYmxlcmFuZ2U6NjRhOWRkMDM3YTc5NGM2ZGJmY2ZhNjdiZDYwZDRiNDJfMTMtMTEtMS0xLTQ1OTE5_e5ab9265-d8ba-4911-bdfc-0ae83f56ae64"
      unitRef="usd">242327000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock
      contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80My9mcmFnOjQ4M2E3ZjM0NDExZDQzNGI5M2MzM2VmNTk1ZGY3ZTQxL3RleHRyZWdpb246NDgzYTdmMzQ0MTFkNDM0YjkzYzMzZWY1OTVkZjdlNDFfNTEw_a9fdbccd-3ac9-4a51-95d2-0226685f8539">&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Contract liability balances related to the sale of extended warranties to customers are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.344%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.346%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract liability&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,887&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,114&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock>
    <us-gaap:ContractWithCustomerLiability
      contextRef="i738c2d1dacaf436faf03cc46ab9cef23_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80My9mcmFnOjQ4M2E3ZjM0NDExZDQzNGI5M2MzM2VmNTk1ZGY3ZTQxL3RhYmxlOmZjZjJmZjQ5MDU4NzQxMjY5MzA3NzRlMGYwNWJiMWViL3RhYmxlcmFuZ2U6ZmNmMmZmNDkwNTg3NDEyNjkzMDc3NGUwZjA1YmIxZWJfMi0xLTEtMS00NTkxOQ_4028b1b5-5cb5-4c5f-9f4d-263741e0aa35"
      unitRef="usd">18887000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiability
      contextRef="ie4f63720d8b244a68941932992cd9f4d_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80My9mcmFnOjQ4M2E3ZjM0NDExZDQzNGI5M2MzM2VmNTk1ZGY3ZTQxL3RhYmxlOmZjZjJmZjQ5MDU4NzQxMjY5MzA3NzRlMGYwNWJiMWViL3RhYmxlcmFuZ2U6ZmNmMmZmNDkwNTg3NDEyNjkzMDc3NGUwZjA1YmIxZWJfMi0zLTEtMS00NTkxOQ_739fe68e-83f0-41ef-9e59-036d602de0dd"
      unitRef="usd">19114000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized
      contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80My9mcmFnOjQ4M2E3ZjM0NDExZDQzNGI5M2MzM2VmNTk1ZGY3ZTQxL3RleHRyZWdpb246NDgzYTdmMzQ0MTFkNDM0YjkzYzMzZWY1OTVkZjdlNDFfNDIy_278ae302-aade-443a-a413-8f2d8fe4aaf2"
      unitRef="usd">4200000</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized
      contextRef="i9500a5ee8dbe4d23aa9c46ebdd25a0c8_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80My9mcmFnOjQ4M2E3ZjM0NDExZDQzNGI5M2MzM2VmNTk1ZGY3ZTQxL3RleHRyZWdpb246NDgzYTdmMzQ0MTFkNDM0YjkzYzMzZWY1OTVkZjdlNDFfNDI5_6c8031d1-3b5a-43e4-b519-a9a2c49e3785"
      unitRef="usd">3900000</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <us-gaap:ComprehensiveIncomeNoteTextBlock
      contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80Ni9mcmFnOjFiNzYzYzFhMzFiMTRhNjU5MGJkMjUwMDIzMGQzNjM1L3RleHRyZWdpb246MWI3NjNjMWEzMWIxNGE2NTkwYmQyNTAwMjMwZDM2MzVfNDg0_4189e999-d7cf-4820-8043-1e565b25928c">Comprehensive Income&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Comprehensive income consists of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:79.747%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.110%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.113%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,819&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,975&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash flow hedging gain, net of income tax (income tax expense of $280 and $346 for the three months ended March 31, 2023 and 2022, respectively)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;877&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,082&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pension liability, net of income tax (income tax expense of $129 and $127 for the three months ended March 31, 2023 and 2022, respectively)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;403&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;521&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency translation adjustment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,596&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(163)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7.75pt 2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Comprehensive income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,695&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,415&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accumulated other comprehensive loss consists of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.268%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.526%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Cash Flow&lt;br/&gt;Hedging&lt;br/&gt;Gain (Loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Pension&lt;br/&gt;Liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Cumulative&lt;br/&gt;Translation&lt;br/&gt;Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Other&lt;br/&gt;Comprehensive&lt;br/&gt;Income (Loss)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance, December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,497&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(23,749)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(36,606)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(57,858)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income before reclassifications, net of tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,923&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,596&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,519&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified from accumulated other comprehensive income (loss) before tax&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;a&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,381)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;532&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(849)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;335&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(129)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:8pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net current-period other comprehensive income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;877&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;403&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,596&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,876&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance, March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,374&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(23,346)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(35,010)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(54,982)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.268%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.526%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Cash Flow&lt;br/&gt;Hedging&lt;br/&gt;Gain (Loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Pension&lt;br/&gt;Liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Cumulative&lt;br/&gt;Translation&lt;br/&gt;Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Other&lt;br/&gt;Comprehensive&lt;br/&gt;Income (Loss)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance, December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,656&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(29,671)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(28,188)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(54,203)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before reclassifications, net of tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,460&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(163)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,297&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified from accumulated other comprehensive income (loss) before tax&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;a&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,819)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;648&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,171)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;441&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(127)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;314&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net current-period other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,082&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;521&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(163)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,440&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance, March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,738&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(29,150)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(28,351)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(52,763)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(a)  The cash flow hedging gain (loss) and pension liability accumulated other comprehensive loss components are included in sales or cost of sales and as a component of net periodic pension cost, respectively.  Refer to Note 7 and Note 13, respectively, for further details.&lt;/span&gt;&lt;/div&gt;</us-gaap:ComprehensiveIncomeNoteTextBlock>
    <us-gaap:ScheduleOfComprehensiveIncomeLossTableTextBlock
      contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80Ni9mcmFnOjFiNzYzYzFhMzFiMTRhNjU5MGJkMjUwMDIzMGQzNjM1L3RleHRyZWdpb246MWI3NjNjMWEzMWIxNGE2NTkwYmQyNTAwMjMwZDM2MzVfNDg3_3ca98132-c045-449d-81b7-ac595de007bf">&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Comprehensive income consists of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:79.747%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.110%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.113%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,819&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,975&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash flow hedging gain, net of income tax (income tax expense of $280 and $346 for the three months ended March 31, 2023 and 2022, respectively)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;877&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,082&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pension liability, net of income tax (income tax expense of $129 and $127 for the three months ended March 31, 2023 and 2022, respectively)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;403&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;521&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency translation adjustment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,596&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(163)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7.75pt 2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Comprehensive income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,695&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,415&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfComprehensiveIncomeLossTableTextBlock>
    <us-gaap:NetIncomeLoss
      contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80Ni9mcmFnOjFiNzYzYzFhMzFiMTRhNjU5MGJkMjUwMDIzMGQzNjM1L3RhYmxlOmU4NDkzYzM2ODQwMzQ4ZDY5NmZlZjkxZjVkYjEzODEwL3RhYmxlcmFuZ2U6ZTg0OTNjMzY4NDAzNDhkNjk2ZmVmOTFmNWRiMTM4MTBfMi0xLTEtMS00NTkxOQ_f249a106-e0ab-4e14-b05e-9d4973802ff1"
      unitRef="usd">1819000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i9500a5ee8dbe4d23aa9c46ebdd25a0c8_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80Ni9mcmFnOjFiNzYzYzFhMzFiMTRhNjU5MGJkMjUwMDIzMGQzNjM1L3RhYmxlOmU4NDkzYzM2ODQwMzQ4ZDY5NmZlZjkxZjVkYjEzODEwL3RhYmxlcmFuZ2U6ZTg0OTNjMzY4NDAzNDhkNjk2ZmVmOTFmNWRiMTM4MTBfMi0zLTEtMS00NTkxOQ_476c55c5-8113-4eb6-9997-23cc9c75f483"
      unitRef="usd">14975000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax
      contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80Ni9mcmFnOjFiNzYzYzFhMzFiMTRhNjU5MGJkMjUwMDIzMGQzNjM1L3RhYmxlOmU4NDkzYzM2ODQwMzQ4ZDY5NmZlZjkxZjVkYjEzODEwL3RhYmxlcmFuZ2U6ZTg0OTNjMzY4NDAzNDhkNjk2ZmVmOTFmNWRiMTM4MTBfNS0wLTEtMS00NTkxOS90ZXh0cmVnaW9uOjAyMjExYjMwZjY3ZjRiM2JhNzJmMGYyZjYyNTdlNDFkXzY5_192d105e-077d-4654-8931-89edb9390610"
      unitRef="usd">280000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax
      contextRef="i9500a5ee8dbe4d23aa9c46ebdd25a0c8_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80Ni9mcmFnOjFiNzYzYzFhMzFiMTRhNjU5MGJkMjUwMDIzMGQzNjM1L3RhYmxlOmU4NDkzYzM2ODQwMzQ4ZDY5NmZlZjkxZjVkYjEzODEwL3RhYmxlcmFuZ2U6ZTg0OTNjMzY4NDAzNDhkNjk2ZmVmOTFmNWRiMTM4MTBfNS0wLTEtMS00NTkxOS90ZXh0cmVnaW9uOjAyMjExYjMwZjY3ZjRiM2JhNzJmMGYyZjYyNTdlNDFkXzc2_4d5e762a-5bb5-41f7-9557-2c4a7ccef84c"
      unitRef="usd">346000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80Ni9mcmFnOjFiNzYzYzFhMzFiMTRhNjU5MGJkMjUwMDIzMGQzNjM1L3RhYmxlOmU4NDkzYzM2ODQwMzQ4ZDY5NmZlZjkxZjVkYjEzODEwL3RhYmxlcmFuZ2U6ZTg0OTNjMzY4NDAzNDhkNjk2ZmVmOTFmNWRiMTM4MTBfNS0xLTEtMS00NTkxOQ_906d882e-2191-4858-9c48-32950a5ad966"
      unitRef="usd">877000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="i9500a5ee8dbe4d23aa9c46ebdd25a0c8_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80Ni9mcmFnOjFiNzYzYzFhMzFiMTRhNjU5MGJkMjUwMDIzMGQzNjM1L3RhYmxlOmU4NDkzYzM2ODQwMzQ4ZDY5NmZlZjkxZjVkYjEzODEwL3RhYmxlcmFuZ2U6ZTg0OTNjMzY4NDAzNDhkNjk2ZmVmOTFmNWRiMTM4MTBfNS0zLTEtMS00NTkxOQ_d74e1db8-e62f-4012-81d1-6fca16b179bc"
      unitRef="usd">1082000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax
      contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80Ni9mcmFnOjFiNzYzYzFhMzFiMTRhNjU5MGJkMjUwMDIzMGQzNjM1L3RhYmxlOmU4NDkzYzM2ODQwMzQ4ZDY5NmZlZjkxZjVkYjEzODEwL3RhYmxlcmFuZ2U6ZTg0OTNjMzY4NDAzNDhkNjk2ZmVmOTFmNWRiMTM4MTBfNi0wLTEtMS00NTkxOS90ZXh0cmVnaW9uOjA3MzVjMWQxNDc1ZTQ1NzNiNzViMDM5OWJmN2NmMzEyXzY0_43074f28-f03b-4684-a96b-2b358485dc58"
      unitRef="usd">-129000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax
      contextRef="i9500a5ee8dbe4d23aa9c46ebdd25a0c8_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80Ni9mcmFnOjFiNzYzYzFhMzFiMTRhNjU5MGJkMjUwMDIzMGQzNjM1L3RhYmxlOmU4NDkzYzM2ODQwMzQ4ZDY5NmZlZjkxZjVkYjEzODEwL3RhYmxlcmFuZ2U6ZTg0OTNjMzY4NDAzNDhkNjk2ZmVmOTFmNWRiMTM4MTBfNi0wLTEtMS00NTkxOS90ZXh0cmVnaW9uOjA3MzVjMWQxNDc1ZTQ1NzNiNzViMDM5OWJmN2NmMzEyXzcx_1949f657-3f18-4de8-b964-c4739d6d36f5"
      unitRef="usd">-127000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80Ni9mcmFnOjFiNzYzYzFhMzFiMTRhNjU5MGJkMjUwMDIzMGQzNjM1L3RhYmxlOmU4NDkzYzM2ODQwMzQ4ZDY5NmZlZjkxZjVkYjEzODEwL3RhYmxlcmFuZ2U6ZTg0OTNjMzY4NDAzNDhkNjk2ZmVmOTFmNWRiMTM4MTBfNi0xLTEtMS00NTkxOQ_c16fd109-3eea-41ec-a16c-70af9186c021"
      unitRef="usd">-403000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="i9500a5ee8dbe4d23aa9c46ebdd25a0c8_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80Ni9mcmFnOjFiNzYzYzFhMzFiMTRhNjU5MGJkMjUwMDIzMGQzNjM1L3RhYmxlOmU4NDkzYzM2ODQwMzQ4ZDY5NmZlZjkxZjVkYjEzODEwL3RhYmxlcmFuZ2U6ZTg0OTNjMzY4NDAzNDhkNjk2ZmVmOTFmNWRiMTM4MTBfNi0zLTEtMS00NTkxOQ_f52c1316-1ab6-40c1-8d9a-129247a80858"
      unitRef="usd">-521000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80Ni9mcmFnOjFiNzYzYzFhMzFiMTRhNjU5MGJkMjUwMDIzMGQzNjM1L3RhYmxlOmU4NDkzYzM2ODQwMzQ4ZDY5NmZlZjkxZjVkYjEzODEwL3RhYmxlcmFuZ2U6ZTg0OTNjMzY4NDAzNDhkNjk2ZmVmOTFmNWRiMTM4MTBfNy0xLTEtMS00NTkxOQ_c57efee6-47e1-4cfc-a55f-916be8857e5a"
      unitRef="usd">1596000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80Ni9mcmFnOjFiNzYzYzFhMzFiMTRhNjU5MGJkMjUwMDIzMGQzNjM1L3RhYmxlOmU4NDkzYzM2ODQwMzQ4ZDY5NmZlZjkxZjVkYjEzODEwL3RhYmxlcmFuZ2U6ZTg0OTNjMzY4NDAzNDhkNjk2ZmVmOTFmNWRiMTM4MTBfNy0xLTEtMS00NTkxOQ_e9f5192c-fa45-4a65-90e5-09e3b8c04e8f"
      unitRef="usd">1596000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i9500a5ee8dbe4d23aa9c46ebdd25a0c8_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80Ni9mcmFnOjFiNzYzYzFhMzFiMTRhNjU5MGJkMjUwMDIzMGQzNjM1L3RhYmxlOmU4NDkzYzM2ODQwMzQ4ZDY5NmZlZjkxZjVkYjEzODEwL3RhYmxlcmFuZ2U6ZTg0OTNjMzY4NDAzNDhkNjk2ZmVmOTFmNWRiMTM4MTBfNy0zLTEtMS00NTkxOQ_7f8d2fed-32be-4f79-8cde-f41b6692cd35"
      unitRef="usd">-163000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80Ni9mcmFnOjFiNzYzYzFhMzFiMTRhNjU5MGJkMjUwMDIzMGQzNjM1L3RhYmxlOmU4NDkzYzM2ODQwMzQ4ZDY5NmZlZjkxZjVkYjEzODEwL3RhYmxlcmFuZ2U6ZTg0OTNjMzY4NDAzNDhkNjk2ZmVmOTFmNWRiMTM4MTBfOS0xLTEtMS00NTkxOQ_7ad8bff7-0e76-4158-b472-f11a274fcb74"
      unitRef="usd">4695000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i9500a5ee8dbe4d23aa9c46ebdd25a0c8_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80Ni9mcmFnOjFiNzYzYzFhMzFiMTRhNjU5MGJkMjUwMDIzMGQzNjM1L3RhYmxlOmU4NDkzYzM2ODQwMzQ4ZDY5NmZlZjkxZjVkYjEzODEwL3RhYmxlcmFuZ2U6ZTg0OTNjMzY4NDAzNDhkNjk2ZmVmOTFmNWRiMTM4MTBfOS0zLTEtMS00NTkxOQ_1ad285a2-9512-4f73-9582-4d1ef85c8ebd"
      unitRef="usd">16415000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock
      contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80Ni9mcmFnOjFiNzYzYzFhMzFiMTRhNjU5MGJkMjUwMDIzMGQzNjM1L3RleHRyZWdpb246MWI3NjNjMWEzMWIxNGE2NTkwYmQyNTAwMjMwZDM2MzVfNDc1_ae77f4ed-b1f6-45fc-994a-249ce8557eac">&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accumulated other comprehensive loss consists of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.268%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.526%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Cash Flow&lt;br/&gt;Hedging&lt;br/&gt;Gain (Loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Pension&lt;br/&gt;Liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Cumulative&lt;br/&gt;Translation&lt;br/&gt;Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Other&lt;br/&gt;Comprehensive&lt;br/&gt;Income (Loss)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance, December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,497&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(23,749)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(36,606)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(57,858)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income before reclassifications, net of tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,923&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,596&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,519&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified from accumulated other comprehensive income (loss) before tax&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;a&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,381)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;532&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(849)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;335&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(129)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:8pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net current-period other comprehensive income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;877&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;403&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,596&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,876&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance, March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,374&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(23,346)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(35,010)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(54,982)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.268%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.526%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Cash Flow&lt;br/&gt;Hedging&lt;br/&gt;Gain (Loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Pension&lt;br/&gt;Liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Cumulative&lt;br/&gt;Translation&lt;br/&gt;Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Other&lt;br/&gt;Comprehensive&lt;br/&gt;Income (Loss)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance, December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,656&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(29,671)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(28,188)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(54,203)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before reclassifications, net of tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,460&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(163)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,297&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified from accumulated other comprehensive income (loss) before tax&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;a&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,819)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;648&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,171)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;441&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(127)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;314&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net current-period other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,082&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;521&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(163)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,440&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance, March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,738&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(29,150)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(28,351)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(52,763)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(a)  The cash flow hedging gain (loss) and pension liability accumulated other comprehensive loss components are included in sales or cost of sales and as a component of net periodic pension cost, respectively.  Refer to Note 7 and Note 13, respectively, for further details.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i4fbeeede3b5841dfb8ff0fc8fb92f3d3_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80Ni9mcmFnOjFiNzYzYzFhMzFiMTRhNjU5MGJkMjUwMDIzMGQzNjM1L3RhYmxlOmQ5NDdhNTllYzVhNzQyNmQ4YzQyMGIwNTIzMjA5ZTc1L3RhYmxlcmFuZ2U6ZDk0N2E1OWVjNWE3NDI2ZDhjNDIwYjA1MjMyMDllNzVfMS0xLTEtMS00NTkxOQ_102e4f29-e02c-4f96-865f-9198b93c1033"
      unitRef="usd">2497000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i87efb4b5e77145eaa953edbc2ad43a74_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80Ni9mcmFnOjFiNzYzYzFhMzFiMTRhNjU5MGJkMjUwMDIzMGQzNjM1L3RhYmxlOmQ5NDdhNTllYzVhNzQyNmQ4YzQyMGIwNTIzMjA5ZTc1L3RhYmxlcmFuZ2U6ZDk0N2E1OWVjNWE3NDI2ZDhjNDIwYjA1MjMyMDllNzVfMS0zLTEtMS00NTkxOQ_4792c5fd-1182-4c90-ae36-f5f20da567aa"
      unitRef="usd">-23749000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i5dcb85ddc4a34ec7a3176651d0eaccbe_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80Ni9mcmFnOjFiNzYzYzFhMzFiMTRhNjU5MGJkMjUwMDIzMGQzNjM1L3RhYmxlOmQ5NDdhNTllYzVhNzQyNmQ4YzQyMGIwNTIzMjA5ZTc1L3RhYmxlcmFuZ2U6ZDk0N2E1OWVjNWE3NDI2ZDhjNDIwYjA1MjMyMDllNzVfMS01LTEtMS00NTkxOQ_23f0416a-9883-4c97-bdd1-b497a427548e"
      unitRef="usd">-36606000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i7467bf1c44a741c2a174d8fda8ebb019_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80Ni9mcmFnOjFiNzYzYzFhMzFiMTRhNjU5MGJkMjUwMDIzMGQzNjM1L3RhYmxlOmQ5NDdhNTllYzVhNzQyNmQ4YzQyMGIwNTIzMjA5ZTc1L3RhYmxlcmFuZ2U6ZDk0N2E1OWVjNWE3NDI2ZDhjNDIwYjA1MjMyMDllNzVfMS03LTEtMS00NTkxOQ_ccc56b65-8e14-43fd-95e0-966fa0388cec"
      unitRef="usd">-57858000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="icc4b560884714e249aae5d9872c326ea_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80Ni9mcmFnOjFiNzYzYzFhMzFiMTRhNjU5MGJkMjUwMDIzMGQzNjM1L3RhYmxlOmQ5NDdhNTllYzVhNzQyNmQ4YzQyMGIwNTIzMjA5ZTc1L3RhYmxlcmFuZ2U6ZDk0N2E1OWVjNWE3NDI2ZDhjNDIwYjA1MjMyMDllNzVfMy0xLTEtMS00NTkxOQ_de83e0a6-3f2c-496e-95fb-abbfa1e52ed4"
      unitRef="usd">1923000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i949433cde8d541d0b3051510dc518334_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80Ni9mcmFnOjFiNzYzYzFhMzFiMTRhNjU5MGJkMjUwMDIzMGQzNjM1L3RhYmxlOmQ5NDdhNTllYzVhNzQyNmQ4YzQyMGIwNTIzMjA5ZTc1L3RhYmxlcmFuZ2U6ZDk0N2E1OWVjNWE3NDI2ZDhjNDIwYjA1MjMyMDllNzVfMy0zLTEtMS00NTkxOQ_e62c84b1-6efd-416b-9556-451fea1cf003"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i1d229bbf0e07481b86b9acbec2af77ef_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80Ni9mcmFnOjFiNzYzYzFhMzFiMTRhNjU5MGJkMjUwMDIzMGQzNjM1L3RhYmxlOmQ5NDdhNTllYzVhNzQyNmQ4YzQyMGIwNTIzMjA5ZTc1L3RhYmxlcmFuZ2U6ZDk0N2E1OWVjNWE3NDI2ZDhjNDIwYjA1MjMyMDllNzVfMy01LTEtMS00NTkxOQ_f9ac2fbf-e190-4e33-9df0-4d54695ae6dd"
      unitRef="usd">1596000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i8faa12cfbcc746b48b96bb341f53eff6_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80Ni9mcmFnOjFiNzYzYzFhMzFiMTRhNjU5MGJkMjUwMDIzMGQzNjM1L3RhYmxlOmQ5NDdhNTllYzVhNzQyNmQ4YzQyMGIwNTIzMjA5ZTc1L3RhYmxlcmFuZ2U6ZDk0N2E1OWVjNWE3NDI2ZDhjNDIwYjA1MjMyMDllNzVfMy03LTEtMS00NTkxOQ_d4e35cc8-e172-4121-be8c-eadc60a4d3d5"
      unitRef="usd">3519000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
      contextRef="icc4b560884714e249aae5d9872c326ea_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80Ni9mcmFnOjFiNzYzYzFhMzFiMTRhNjU5MGJkMjUwMDIzMGQzNjM1L3RhYmxlOmQ5NDdhNTllYzVhNzQyNmQ4YzQyMGIwNTIzMjA5ZTc1L3RhYmxlcmFuZ2U6ZDk0N2E1OWVjNWE3NDI2ZDhjNDIwYjA1MjMyMDllNzVfNC0xLTEtMS00NTkxOQ_545a0e5f-0ef0-4299-9610-97f8b53813b3"
      unitRef="usd">1381000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
      contextRef="i949433cde8d541d0b3051510dc518334_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80Ni9mcmFnOjFiNzYzYzFhMzFiMTRhNjU5MGJkMjUwMDIzMGQzNjM1L3RhYmxlOmQ5NDdhNTllYzVhNzQyNmQ4YzQyMGIwNTIzMjA5ZTc1L3RhYmxlcmFuZ2U6ZDk0N2E1OWVjNWE3NDI2ZDhjNDIwYjA1MjMyMDllNzVfNC0zLTEtMS00NTkxOQ_a8dbf427-756e-4143-9d45-1ba70ee2c003"
      unitRef="usd">-532000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
      contextRef="i1d229bbf0e07481b86b9acbec2af77ef_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80Ni9mcmFnOjFiNzYzYzFhMzFiMTRhNjU5MGJkMjUwMDIzMGQzNjM1L3RhYmxlOmQ5NDdhNTllYzVhNzQyNmQ4YzQyMGIwNTIzMjA5ZTc1L3RhYmxlcmFuZ2U6ZDk0N2E1OWVjNWE3NDI2ZDhjNDIwYjA1MjMyMDllNzVfNC01LTEtMS00NTkxOQ_65231fba-6cdc-4ada-a5c3-462933774344"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
      contextRef="i8faa12cfbcc746b48b96bb341f53eff6_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80Ni9mcmFnOjFiNzYzYzFhMzFiMTRhNjU5MGJkMjUwMDIzMGQzNjM1L3RhYmxlOmQ5NDdhNTllYzVhNzQyNmQ4YzQyMGIwNTIzMjA5ZTc1L3RhYmxlcmFuZ2U6ZDk0N2E1OWVjNWE3NDI2ZDhjNDIwYjA1MjMyMDllNzVfNC03LTEtMS00NTkxOQ_22c7109f-9951-4b46-948d-23c9ee7c3f75"
      unitRef="usd">849000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax>
    <us-gaap:ReclassificationFromAociCurrentPeriodTax
      contextRef="icc4b560884714e249aae5d9872c326ea_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80Ni9mcmFnOjFiNzYzYzFhMzFiMTRhNjU5MGJkMjUwMDIzMGQzNjM1L3RhYmxlOmQ5NDdhNTllYzVhNzQyNmQ4YzQyMGIwNTIzMjA5ZTc1L3RhYmxlcmFuZ2U6ZDk0N2E1OWVjNWE3NDI2ZDhjNDIwYjA1MjMyMDllNzVfNS0xLTEtMS00NTkxOQ_549a2632-c747-416b-a4c9-d88afeba3525"
      unitRef="usd">335000</us-gaap:ReclassificationFromAociCurrentPeriodTax>
    <us-gaap:ReclassificationFromAociCurrentPeriodTax
      contextRef="i949433cde8d541d0b3051510dc518334_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80Ni9mcmFnOjFiNzYzYzFhMzFiMTRhNjU5MGJkMjUwMDIzMGQzNjM1L3RhYmxlOmQ5NDdhNTllYzVhNzQyNmQ4YzQyMGIwNTIzMjA5ZTc1L3RhYmxlcmFuZ2U6ZDk0N2E1OWVjNWE3NDI2ZDhjNDIwYjA1MjMyMDllNzVfNS0zLTEtMS00NTkxOQ_0195f0b2-c5df-446e-8ff8-ca680968a02a"
      unitRef="usd">-129000</us-gaap:ReclassificationFromAociCurrentPeriodTax>
    <us-gaap:ReclassificationFromAociCurrentPeriodTax
      contextRef="i1d229bbf0e07481b86b9acbec2af77ef_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80Ni9mcmFnOjFiNzYzYzFhMzFiMTRhNjU5MGJkMjUwMDIzMGQzNjM1L3RhYmxlOmQ5NDdhNTllYzVhNzQyNmQ4YzQyMGIwNTIzMjA5ZTc1L3RhYmxlcmFuZ2U6ZDk0N2E1OWVjNWE3NDI2ZDhjNDIwYjA1MjMyMDllNzVfNS01LTEtMS00NTkxOQ_73be34e8-503a-4044-a2ae-da735a6c1463"
      unitRef="usd">0</us-gaap:ReclassificationFromAociCurrentPeriodTax>
    <us-gaap:ReclassificationFromAociCurrentPeriodTax
      contextRef="i8faa12cfbcc746b48b96bb341f53eff6_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80Ni9mcmFnOjFiNzYzYzFhMzFiMTRhNjU5MGJkMjUwMDIzMGQzNjM1L3RhYmxlOmQ5NDdhNTllYzVhNzQyNmQ4YzQyMGIwNTIzMjA5ZTc1L3RhYmxlcmFuZ2U6ZDk0N2E1OWVjNWE3NDI2ZDhjNDIwYjA1MjMyMDllNzVfNS03LTEtMS00NTkxOQ_75d9a950-9dd9-4ec6-be66-8bae3e82fcd9"
      unitRef="usd">206000</us-gaap:ReclassificationFromAociCurrentPeriodTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="icc4b560884714e249aae5d9872c326ea_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80Ni9mcmFnOjFiNzYzYzFhMzFiMTRhNjU5MGJkMjUwMDIzMGQzNjM1L3RhYmxlOmQ5NDdhNTllYzVhNzQyNmQ4YzQyMGIwNTIzMjA5ZTc1L3RhYmxlcmFuZ2U6ZDk0N2E1OWVjNWE3NDI2ZDhjNDIwYjA1MjMyMDllNzVfNy0xLTEtMS00NTkxOQ_f7d5da8d-f536-4ca4-9eb9-2a2449a6ced5"
      unitRef="usd">877000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i949433cde8d541d0b3051510dc518334_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80Ni9mcmFnOjFiNzYzYzFhMzFiMTRhNjU5MGJkMjUwMDIzMGQzNjM1L3RhYmxlOmQ5NDdhNTllYzVhNzQyNmQ4YzQyMGIwNTIzMjA5ZTc1L3RhYmxlcmFuZ2U6ZDk0N2E1OWVjNWE3NDI2ZDhjNDIwYjA1MjMyMDllNzVfNy0zLTEtMS00NTkxOQ_02300d7a-18f1-45ed-a243-016b1069958b"
      unitRef="usd">403000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i1d229bbf0e07481b86b9acbec2af77ef_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80Ni9mcmFnOjFiNzYzYzFhMzFiMTRhNjU5MGJkMjUwMDIzMGQzNjM1L3RhYmxlOmQ5NDdhNTllYzVhNzQyNmQ4YzQyMGIwNTIzMjA5ZTc1L3RhYmxlcmFuZ2U6ZDk0N2E1OWVjNWE3NDI2ZDhjNDIwYjA1MjMyMDllNzVfNy01LTEtMS00NTkxOQ_70dd2237-6ebc-4067-9f07-64f58224d3f9"
      unitRef="usd">1596000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i8faa12cfbcc746b48b96bb341f53eff6_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80Ni9mcmFnOjFiNzYzYzFhMzFiMTRhNjU5MGJkMjUwMDIzMGQzNjM1L3RhYmxlOmQ5NDdhNTllYzVhNzQyNmQ4YzQyMGIwNTIzMjA5ZTc1L3RhYmxlcmFuZ2U6ZDk0N2E1OWVjNWE3NDI2ZDhjNDIwYjA1MjMyMDllNzVfNy03LTEtMS00NTkxOQ_f57945ad-ea23-4961-96fc-d17ee1460c04"
      unitRef="usd">2876000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="idd1ea00148744dfd850e020220bf03f5_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80Ni9mcmFnOjFiNzYzYzFhMzFiMTRhNjU5MGJkMjUwMDIzMGQzNjM1L3RhYmxlOmQ5NDdhNTllYzVhNzQyNmQ4YzQyMGIwNTIzMjA5ZTc1L3RhYmxlcmFuZ2U6ZDk0N2E1OWVjNWE3NDI2ZDhjNDIwYjA1MjMyMDllNzVfOS0xLTEtMS00NTkxOQ_5564b4a5-ba8b-4e5e-bdbe-565a2f1a6b2a"
      unitRef="usd">3374000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i7606ff56051a4e0e8d0a3acff90b86be_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80Ni9mcmFnOjFiNzYzYzFhMzFiMTRhNjU5MGJkMjUwMDIzMGQzNjM1L3RhYmxlOmQ5NDdhNTllYzVhNzQyNmQ4YzQyMGIwNTIzMjA5ZTc1L3RhYmxlcmFuZ2U6ZDk0N2E1OWVjNWE3NDI2ZDhjNDIwYjA1MjMyMDllNzVfOS0zLTEtMS00NTkxOQ_b6126f7a-87b7-4199-b9dc-4338a987f409"
      unitRef="usd">-23346000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i27c9aa8186434e5993cdaaed802e058d_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80Ni9mcmFnOjFiNzYzYzFhMzFiMTRhNjU5MGJkMjUwMDIzMGQzNjM1L3RhYmxlOmQ5NDdhNTllYzVhNzQyNmQ4YzQyMGIwNTIzMjA5ZTc1L3RhYmxlcmFuZ2U6ZDk0N2E1OWVjNWE3NDI2ZDhjNDIwYjA1MjMyMDllNzVfOS01LTEtMS00NTkxOQ_761b7f8f-1565-4ac8-91c7-d231a2847097"
      unitRef="usd">-35010000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i991a26c35f3a4004a04b9c93216cb10b_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80Ni9mcmFnOjFiNzYzYzFhMzFiMTRhNjU5MGJkMjUwMDIzMGQzNjM1L3RhYmxlOmQ5NDdhNTllYzVhNzQyNmQ4YzQyMGIwNTIzMjA5ZTc1L3RhYmxlcmFuZ2U6ZDk0N2E1OWVjNWE3NDI2ZDhjNDIwYjA1MjMyMDllNzVfOS03LTEtMS00NTkxOQ_4970698e-d634-4042-bf59-50cb0bb28ae5"
      unitRef="usd">-54982000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i6fdde14e95954ed59a9518497036382d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80Ni9mcmFnOjFiNzYzYzFhMzFiMTRhNjU5MGJkMjUwMDIzMGQzNjM1L3RhYmxlOmNjNzJlOTI1MjlkNTRhNmU4OTYzZDEzZTQ2Y2NmZDlhL3RhYmxlcmFuZ2U6Y2M3MmU5MjUyOWQ1NGE2ZTg5NjNkMTNlNDZjY2ZkOWFfMS0xLTEtMS00NTkxOQ_656ff91b-6a8e-4b10-b732-3f45da70b685"
      unitRef="usd">3656000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="ia9d784369a924cdc9cf0e77dbb1d00de_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80Ni9mcmFnOjFiNzYzYzFhMzFiMTRhNjU5MGJkMjUwMDIzMGQzNjM1L3RhYmxlOmNjNzJlOTI1MjlkNTRhNmU4OTYzZDEzZTQ2Y2NmZDlhL3RhYmxlcmFuZ2U6Y2M3MmU5MjUyOWQ1NGE2ZTg5NjNkMTNlNDZjY2ZkOWFfMS0zLTEtMS00NTkxOQ_6c8a0c09-feed-4b03-973f-c9ad41978ed6"
      unitRef="usd">-29671000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="ibc00334b78294a0783fda260135f6549_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80Ni9mcmFnOjFiNzYzYzFhMzFiMTRhNjU5MGJkMjUwMDIzMGQzNjM1L3RhYmxlOmNjNzJlOTI1MjlkNTRhNmU4OTYzZDEzZTQ2Y2NmZDlhL3RhYmxlcmFuZ2U6Y2M3MmU5MjUyOWQ1NGE2ZTg5NjNkMTNlNDZjY2ZkOWFfMS01LTEtMS00NTkxOQ_8655792e-0ff7-4bab-b141-0d884974a327"
      unitRef="usd">-28188000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="iee31e42803274180ade2d654c9f2c44a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80Ni9mcmFnOjFiNzYzYzFhMzFiMTRhNjU5MGJkMjUwMDIzMGQzNjM1L3RhYmxlOmNjNzJlOTI1MjlkNTRhNmU4OTYzZDEzZTQ2Y2NmZDlhL3RhYmxlcmFuZ2U6Y2M3MmU5MjUyOWQ1NGE2ZTg5NjNkMTNlNDZjY2ZkOWFfMS03LTEtMS00NTkxOQ_d00b51e0-6ed6-4a3f-9f3f-75fb14f72436"
      unitRef="usd">-54203000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="ie696fef447f64ccc8a668daaade9cd9b_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80Ni9mcmFnOjFiNzYzYzFhMzFiMTRhNjU5MGJkMjUwMDIzMGQzNjM1L3RhYmxlOmNjNzJlOTI1MjlkNTRhNmU4OTYzZDEzZTQ2Y2NmZDlhL3RhYmxlcmFuZ2U6Y2M3MmU5MjUyOWQ1NGE2ZTg5NjNkMTNlNDZjY2ZkOWFfMy0xLTEtMS00NTkxOQ_3b3e08ed-f721-4e4c-9031-93971f7ffedf"
      unitRef="usd">2460000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="icfac919075cc429fb858404f3c669d73_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80Ni9mcmFnOjFiNzYzYzFhMzFiMTRhNjU5MGJkMjUwMDIzMGQzNjM1L3RhYmxlOmNjNzJlOTI1MjlkNTRhNmU4OTYzZDEzZTQ2Y2NmZDlhL3RhYmxlcmFuZ2U6Y2M3MmU5MjUyOWQ1NGE2ZTg5NjNkMTNlNDZjY2ZkOWFfMy0zLTEtMS00NTkxOQ_48742ee7-fb11-4642-83c4-c7a8bfedde15"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="iae81127123e340fbb32267cb782ca25e_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80Ni9mcmFnOjFiNzYzYzFhMzFiMTRhNjU5MGJkMjUwMDIzMGQzNjM1L3RhYmxlOmNjNzJlOTI1MjlkNTRhNmU4OTYzZDEzZTQ2Y2NmZDlhL3RhYmxlcmFuZ2U6Y2M3MmU5MjUyOWQ1NGE2ZTg5NjNkMTNlNDZjY2ZkOWFfMy01LTEtMS00NTkxOQ_ab2963cd-913a-48bf-a17f-b27210260319"
      unitRef="usd">-163000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="ia66bff082e1642cd80c9ac67a0cc60fe_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80Ni9mcmFnOjFiNzYzYzFhMzFiMTRhNjU5MGJkMjUwMDIzMGQzNjM1L3RhYmxlOmNjNzJlOTI1MjlkNTRhNmU4OTYzZDEzZTQ2Y2NmZDlhL3RhYmxlcmFuZ2U6Y2M3MmU5MjUyOWQ1NGE2ZTg5NjNkMTNlNDZjY2ZkOWFfMy03LTEtMS00NTkxOQ_6adf404e-f75a-4518-be30-346f78a142a6"
      unitRef="usd">2297000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
      contextRef="ie696fef447f64ccc8a668daaade9cd9b_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80Ni9mcmFnOjFiNzYzYzFhMzFiMTRhNjU5MGJkMjUwMDIzMGQzNjM1L3RhYmxlOmNjNzJlOTI1MjlkNTRhNmU4OTYzZDEzZTQ2Y2NmZDlhL3RhYmxlcmFuZ2U6Y2M3MmU5MjUyOWQ1NGE2ZTg5NjNkMTNlNDZjY2ZkOWFfNC0xLTEtMS00NTkxOQ_0fe84469-858a-4e69-9a3a-893fcb2bafa5"
      unitRef="usd">1819000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
      contextRef="icfac919075cc429fb858404f3c669d73_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80Ni9mcmFnOjFiNzYzYzFhMzFiMTRhNjU5MGJkMjUwMDIzMGQzNjM1L3RhYmxlOmNjNzJlOTI1MjlkNTRhNmU4OTYzZDEzZTQ2Y2NmZDlhL3RhYmxlcmFuZ2U6Y2M3MmU5MjUyOWQ1NGE2ZTg5NjNkMTNlNDZjY2ZkOWFfNC0zLTEtMS00NTkxOQ_38630875-cff5-42ad-91c7-b88c3d7d6be9"
      unitRef="usd">-648000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
      contextRef="iae81127123e340fbb32267cb782ca25e_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80Ni9mcmFnOjFiNzYzYzFhMzFiMTRhNjU5MGJkMjUwMDIzMGQzNjM1L3RhYmxlOmNjNzJlOTI1MjlkNTRhNmU4OTYzZDEzZTQ2Y2NmZDlhL3RhYmxlcmFuZ2U6Y2M3MmU5MjUyOWQ1NGE2ZTg5NjNkMTNlNDZjY2ZkOWFfNC01LTEtMS00NTkxOQ_ba7fab8b-5212-4892-9579-36104468ce0a"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
      contextRef="ia66bff082e1642cd80c9ac67a0cc60fe_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80Ni9mcmFnOjFiNzYzYzFhMzFiMTRhNjU5MGJkMjUwMDIzMGQzNjM1L3RhYmxlOmNjNzJlOTI1MjlkNTRhNmU4OTYzZDEzZTQ2Y2NmZDlhL3RhYmxlcmFuZ2U6Y2M3MmU5MjUyOWQ1NGE2ZTg5NjNkMTNlNDZjY2ZkOWFfNC03LTEtMS00NTkxOQ_896695cd-bd46-44cc-9447-3e80d5cd0dcc"
      unitRef="usd">1171000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax>
    <us-gaap:ReclassificationFromAociCurrentPeriodTax
      contextRef="ie696fef447f64ccc8a668daaade9cd9b_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80Ni9mcmFnOjFiNzYzYzFhMzFiMTRhNjU5MGJkMjUwMDIzMGQzNjM1L3RhYmxlOmNjNzJlOTI1MjlkNTRhNmU4OTYzZDEzZTQ2Y2NmZDlhL3RhYmxlcmFuZ2U6Y2M3MmU5MjUyOWQ1NGE2ZTg5NjNkMTNlNDZjY2ZkOWFfNS0xLTEtMS00NTkxOQ_e9b0904f-8d3e-49dc-994d-d2e980cc09fa"
      unitRef="usd">441000</us-gaap:ReclassificationFromAociCurrentPeriodTax>
    <us-gaap:ReclassificationFromAociCurrentPeriodTax
      contextRef="icfac919075cc429fb858404f3c669d73_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80Ni9mcmFnOjFiNzYzYzFhMzFiMTRhNjU5MGJkMjUwMDIzMGQzNjM1L3RhYmxlOmNjNzJlOTI1MjlkNTRhNmU4OTYzZDEzZTQ2Y2NmZDlhL3RhYmxlcmFuZ2U6Y2M3MmU5MjUyOWQ1NGE2ZTg5NjNkMTNlNDZjY2ZkOWFfNS0zLTEtMS00NTkxOQ_c58cf232-f94f-47f7-9efc-a3a4427e1290"
      unitRef="usd">-127000</us-gaap:ReclassificationFromAociCurrentPeriodTax>
    <us-gaap:ReclassificationFromAociCurrentPeriodTax
      contextRef="iae81127123e340fbb32267cb782ca25e_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80Ni9mcmFnOjFiNzYzYzFhMzFiMTRhNjU5MGJkMjUwMDIzMGQzNjM1L3RhYmxlOmNjNzJlOTI1MjlkNTRhNmU4OTYzZDEzZTQ2Y2NmZDlhL3RhYmxlcmFuZ2U6Y2M3MmU5MjUyOWQ1NGE2ZTg5NjNkMTNlNDZjY2ZkOWFfNS01LTEtMS00NTkxOQ_122f655f-c156-433d-8d00-76a7dc957350"
      unitRef="usd">0</us-gaap:ReclassificationFromAociCurrentPeriodTax>
    <us-gaap:ReclassificationFromAociCurrentPeriodTax
      contextRef="ia66bff082e1642cd80c9ac67a0cc60fe_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80Ni9mcmFnOjFiNzYzYzFhMzFiMTRhNjU5MGJkMjUwMDIzMGQzNjM1L3RhYmxlOmNjNzJlOTI1MjlkNTRhNmU4OTYzZDEzZTQ2Y2NmZDlhL3RhYmxlcmFuZ2U6Y2M3MmU5MjUyOWQ1NGE2ZTg5NjNkMTNlNDZjY2ZkOWFfNS03LTEtMS00NTkxOQ_93f75430-f637-43cd-b3e8-5efd3515825d"
      unitRef="usd">314000</us-gaap:ReclassificationFromAociCurrentPeriodTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ie696fef447f64ccc8a668daaade9cd9b_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80Ni9mcmFnOjFiNzYzYzFhMzFiMTRhNjU5MGJkMjUwMDIzMGQzNjM1L3RhYmxlOmNjNzJlOTI1MjlkNTRhNmU4OTYzZDEzZTQ2Y2NmZDlhL3RhYmxlcmFuZ2U6Y2M3MmU5MjUyOWQ1NGE2ZTg5NjNkMTNlNDZjY2ZkOWFfNy0xLTEtMS00NTkxOQ_6731f6ab-484b-401a-83a7-689df0653a42"
      unitRef="usd">1082000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="icfac919075cc429fb858404f3c669d73_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80Ni9mcmFnOjFiNzYzYzFhMzFiMTRhNjU5MGJkMjUwMDIzMGQzNjM1L3RhYmxlOmNjNzJlOTI1MjlkNTRhNmU4OTYzZDEzZTQ2Y2NmZDlhL3RhYmxlcmFuZ2U6Y2M3MmU5MjUyOWQ1NGE2ZTg5NjNkMTNlNDZjY2ZkOWFfNy0zLTEtMS00NTkxOQ_c773fe68-cd40-478c-a475-58137673b9f7"
      unitRef="usd">521000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="iae81127123e340fbb32267cb782ca25e_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80Ni9mcmFnOjFiNzYzYzFhMzFiMTRhNjU5MGJkMjUwMDIzMGQzNjM1L3RhYmxlOmNjNzJlOTI1MjlkNTRhNmU4OTYzZDEzZTQ2Y2NmZDlhL3RhYmxlcmFuZ2U6Y2M3MmU5MjUyOWQ1NGE2ZTg5NjNkMTNlNDZjY2ZkOWFfNy01LTEtMS00NTkxOQ_2dcbd9f0-147b-4f98-9c60-cc7fe75b31f5"
      unitRef="usd">-163000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ia66bff082e1642cd80c9ac67a0cc60fe_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80Ni9mcmFnOjFiNzYzYzFhMzFiMTRhNjU5MGJkMjUwMDIzMGQzNjM1L3RhYmxlOmNjNzJlOTI1MjlkNTRhNmU4OTYzZDEzZTQ2Y2NmZDlhL3RhYmxlcmFuZ2U6Y2M3MmU5MjUyOWQ1NGE2ZTg5NjNkMTNlNDZjY2ZkOWFfNy03LTEtMS00NTkxOQ_7cb40c99-c0d0-4a32-b76c-41838b514965"
      unitRef="usd">1440000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="iededad20ecc44fd2bb270dd062e6d769_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80Ni9mcmFnOjFiNzYzYzFhMzFiMTRhNjU5MGJkMjUwMDIzMGQzNjM1L3RhYmxlOmNjNzJlOTI1MjlkNTRhNmU4OTYzZDEzZTQ2Y2NmZDlhL3RhYmxlcmFuZ2U6Y2M3MmU5MjUyOWQ1NGE2ZTg5NjNkMTNlNDZjY2ZkOWFfOS0xLTEtMS00NTkxOQ_38c52dc7-7543-4cdb-b99e-e69456daec42"
      unitRef="usd">4738000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i21089d5235814c6ab121525210fd30c8_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80Ni9mcmFnOjFiNzYzYzFhMzFiMTRhNjU5MGJkMjUwMDIzMGQzNjM1L3RhYmxlOmNjNzJlOTI1MjlkNTRhNmU4OTYzZDEzZTQ2Y2NmZDlhL3RhYmxlcmFuZ2U6Y2M3MmU5MjUyOWQ1NGE2ZTg5NjNkMTNlNDZjY2ZkOWFfOS0zLTEtMS00NTkxOQ_1221c642-8665-43b7-869f-7f24b4e90f26"
      unitRef="usd">-29150000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="ie69d0166e9554b6d85184883bd783cfe_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80Ni9mcmFnOjFiNzYzYzFhMzFiMTRhNjU5MGJkMjUwMDIzMGQzNjM1L3RhYmxlOmNjNzJlOTI1MjlkNTRhNmU4OTYzZDEzZTQ2Y2NmZDlhL3RhYmxlcmFuZ2U6Y2M3MmU5MjUyOWQ1NGE2ZTg5NjNkMTNlNDZjY2ZkOWFfOS01LTEtMS00NTkxOQ_4c108db7-2297-4003-8348-be5da2cf58a6"
      unitRef="usd">-28351000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="ib861e1905d064d5684a5172a6232ad41_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80Ni9mcmFnOjFiNzYzYzFhMzFiMTRhNjU5MGJkMjUwMDIzMGQzNjM1L3RhYmxlOmNjNzJlOTI1MjlkNTRhNmU4OTYzZDEzZTQ2Y2NmZDlhL3RhYmxlcmFuZ2U6Y2M3MmU5MjUyOWQ1NGE2ZTg5NjNkMTNlNDZjY2ZkOWFfOS03LTEtMS00NTkxOQ_e922f734-0e84-417c-b74c-6fde54573350"
      unitRef="usd">-52763000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:DerivativesAndFairValueTextBlock
      contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80OS9mcmFnOmIzNmU0MzJjMjM0ZDRjMTJiMmY4NzM2MTk3Yjg3MTE4L3RleHRyZWdpb246YjM2ZTQzMmMyMzRkNGMxMmIyZjg3MzYxOTdiODcxMThfNTg2NA_42377031-dfd8-4dba-8a89-17c5dd32ed17">Fair Value of Financial Instruments&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We enter into derivative instruments for risk management purposes only.  We operate internationally and, in the normal course of business, are exposed to fluctuations in interest rates, foreign exchange rates and commodity prices.  These fluctuations can increase the costs of financing, investing and operating the business.  We use forward contracts, a type of derivative instrument, to manage certain foreign currency exposures.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;By nature, all financial instruments involve market and credit risks.  We enter into forward contracts with major investment grade financial institutions and have policies to monitor the credit risk of those counterparties.  While there can be no assurance, we do not anticipate any material non-performance by any of these counterparties.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Foreign Currency Forward Contracts.  &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We hedge forecasted intercompany sales denominated in foreign currencies through the use of forward contracts.&#160;&#160;We account for these forward contracts as cash flow hedges.&#160;&#160;To the extent these forward contracts meet hedge accounting criteria, changes in their fair value are not included in current earnings but are included in accumulated other comprehensive loss.&#160;&#160;These changes in fair value will be recognized into earnings as a component of sales or cost of sales when the forecasted transaction occurs.&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We also enter into forward contracts to exchange foreign currencies for United States dollars in order to hedge our currency transaction exposures on intercompany receivables designated in foreign currencies.&#160;&#160;These forward contracts settle each month at month-end, at which time we enter into new forward contracts.&#160;&#160;We have not designated these forward contracts as hedges and have not applied hedge accounting to them.&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the notional contract amounts for forward contracts outstanding:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:38.929%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.401%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.401%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.403%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;FASB ASC Topic 815 Designation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward exchange contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash flow hedge&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;199,005&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;198,473&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward exchange contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-designated&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;98,173&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81,929&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The remaining time to maturity as of March&#160;31, 2023 is within two years for hedge designated foreign exchange contracts and approximately one month for non-hedge designated forward exchange contracts.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Statement of comprehensive income presentation&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Derivatives designated as cash flow hedges&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Foreign exchange contracts designated as cash flow hedges had the following effects on accumulated other comprehensive income (loss) ("AOCI") and net earnings on our consolidated condensed statements of comprehensive income and our consolidated condensed balance sheets:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:27.639%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.551%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.551%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.386%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.002%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.551%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.551%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.551%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.553%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amount of Gain Recognized in AOCI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="12" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Consolidated Condensed Statements  of Comprehensive Income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amount of Gain Reclassified from AOCI&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="36" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="6" style="border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Amount of Line Item Presented&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Derivative Instrument&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Location of amount reclassified&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,538&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,247&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net Sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;295,468&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;242,327&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;575&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,744&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of Sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;140,147&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;106,336&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;806&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pre-tax gain&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,538&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,247&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,381&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,819&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;615&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;787&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;335&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;441&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net gain&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,923&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,460&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,046&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,378&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:27.993%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.525%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.525%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.666%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.525%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.525%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.525%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At March&#160;31, 2023, $3.3 million of net unrealized gains on forward contracts accounted for as cash flow hedges, and included in accumulated other comprehensive loss, are expected to be recognized in earnings in the next twelve months.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Derivatives not designated as cash flow hedges&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net gains and losses from derivative instruments not accounted for as hedges and losses on our intercompany receivables on our consolidated condensed statements of comprehensive income were:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:32.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:44.367%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.087%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.285%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Derivative Instrument&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Location on Consolidated Condensed Statements of Comprehensive Income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss on currency forward contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Selling and administrative expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(366)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(958)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net gain on currency transaction exposures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Selling and administrative expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;415&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Balance sheet presentation&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We record these forward foreign exchange contracts at fair value.  The following tables summarize the fair value for forward foreign exchange contracts outstanding at March&#160;31, 2023 and December&#160;31, 2022: &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:35.157%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.209%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.700%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Location on Consolidated Condensed Balance Sheet&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Asset Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net&lt;br/&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivatives designated as hedged instruments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,869&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,476)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,393&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;485&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(424)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,354&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,900)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,454&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivatives not designated as hedging instruments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(334)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(282)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total derivatives&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,406&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,234)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,172&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:35.157%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.209%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.700%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Location on Consolidated Condensed Balance Sheet&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Asset Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net&lt;br/&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivatives designated as hedged instruments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange contracts &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,757&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,121)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,636&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other long-term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(400)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(340)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,817&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,521)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,296&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivatives not designated as hedging instruments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(395)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(347)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total derivatives&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,865&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,916)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,949&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our forward foreign exchange contracts are subject to a master netting agreement and qualify for netting in the consolidated condensed balance sheets. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Fair Value Disclosure.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;  FASB guidance defines fair value and establishes a framework for measuring fair value and related disclosure requirements.  This guidance applies when fair value measurements are required or permitted.  The guidance indicates, among other things, that a fair value measurement assumes that the transaction to sell an asset or transfer a liability occurs in the principal market for the asset or liability or, in the absence of a principal market, the most advantageous market for the asset or liability.  Fair value is defined based upon an exit price model.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Valuation Hierarchy. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; A valuation hierarchy was established for disclosure of the inputs to the valuations used to measure fair value.  This hierarchy prioritizes the inputs into three broad levels as follows.  Level 1 inputs are quoted prices (unadjusted) in active markets for identical assets or liabilities.  Level 2 inputs are quoted prices for similar assets and liabilities in active markets, quoted prices for identical or similar assets in markets that are not active, inputs other than quoted prices that are observable for the asset or liability, including interest rates, yield curves and credit risks, or inputs that are derived principally from or corroborated by observable market data through correlation.  Level 3 inputs are unobservable inputs based on our own assumptions used to measure assets and liabilities at fair value.  A financial asset or liability&#x2019;s classification within the hierarchy is determined based on the lowest level input that is significant to the fair value measurement.  There have been no significant changes in the assumptions.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:107%"&gt;Valuation Techniques. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"&gt; Assets and liabilities carried at fair value and measured on a recurring basis as of March&#160;31, 2023 consist of forward foreign exchange contracts and contingent consideration.  The Company values its forward foreign exchange contracts using quoted prices for similar assets.  The most significant assumption is quoted currency rates.  The value of the forward foreign exchange contract assets and liabilities were valued using Level 2 inputs and are listed in the table above.&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"&gt;The Company values contingent consideration from the In2Bones and Biorez acquisitions using Level 3 inputs.  The contingent consideration was recorded at fair value at the date of acquisition based on the consideration expected to be transferred, estimated as the probability-weighted future cash flows, discounted back to present value. The fair value of contingent consideration is measured using projected payment dates, discount rates, revenue volatilities and projected revenues. The recurring Level 3 fair value measurements of contingent consideration for which the liabilities are recorded include the following significant unobservable inputs as of March&#160;31, 2023:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:56.356%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.577%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.783%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.784%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assumptions&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unobservable Input&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;In2Bones&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Biorez&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.52%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.32%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenue volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.11%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.88%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Projected year of payment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023-2026&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023-2026&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Adjustments to the fair value of contingent consideration relate to the passage of time and changes in market assumptions.  Changes in the fair value of contingent consideration liabilities for the three months ended March&#160;31, 2023 are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:41.443%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:27.705%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;In2Bones&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Biorez&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Location in Financial Statements&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of January 1, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70,198&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;116,234&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Changes in fair value of contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,637&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,799&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Selling and administrative expense&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72,835&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;118,033&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"&gt;Contingent consideration of $38.7 million and $152.2 million is included in other current liabilities and other long-term liabilities, respectively, in the consolidated condensed balance sheet at March&#160;31, 2023.  Contingent consideration of $18.6 million and $167.8 million is included in other current liabilities and other long term liabilities, respectively, in the consolidated condensed balance sheet at December 31, 2022.&lt;/span&gt;&lt;/div&gt;The carrying amounts reported in our consolidated condensed balance sheets for cash and cash equivalents, accounts receivable, accounts payable and variable long-term debt approximate fair value.</us-gaap:DerivativesAndFairValueTextBlock>
    <us-gaap:ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock
      contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80OS9mcmFnOmIzNmU0MzJjMjM0ZDRjMTJiMmY4NzM2MTk3Yjg3MTE4L3RleHRyZWdpb246YjM2ZTQzMmMyMzRkNGMxMmIyZjg3MzYxOTdiODcxMThfNTg3Mw_2f9064b0-7141-4e2a-b313-12b260412530">&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the notional contract amounts for forward contracts outstanding:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:38.929%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.401%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.401%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.403%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;FASB ASC Topic 815 Designation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward exchange contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash flow hedge&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;199,005&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;198,473&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward exchange contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-designated&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;98,173&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81,929&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock>
    <us-gaap:DerivativeNotionalAmount
      contextRef="ib8cab3c62ed442529813f178f35898bc_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80OS9mcmFnOmIzNmU0MzJjMjM0ZDRjMTJiMmY4NzM2MTk3Yjg3MTE4L3RhYmxlOmI4OWVhYmE3NzM5ZDQ2ZDlhNTZhYjJjODdhY2M5Yjc5L3RhYmxlcmFuZ2U6Yjg5ZWFiYTc3MzlkNDZkOWE1NmFiMmM4N2FjYzliNzlfMi0zLTEtMS00NTkxOQ_33606946-36b7-4c73-8596-eb6bb850ccb7"
      unitRef="usd">199005000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="ibeb90d75f39f491cacb945863ad49c07_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80OS9mcmFnOmIzNmU0MzJjMjM0ZDRjMTJiMmY4NzM2MTk3Yjg3MTE4L3RhYmxlOmI4OWVhYmE3NzM5ZDQ2ZDlhNTZhYjJjODdhY2M5Yjc5L3RhYmxlcmFuZ2U6Yjg5ZWFiYTc3MzlkNDZkOWE1NmFiMmM4N2FjYzliNzlfMi01LTEtMS00NTkxOQ_acdbe50b-138a-4372-9c00-535b28eb6c0c"
      unitRef="usd">198473000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i50ba6b690edd40ac98d62cd0bd0b088a_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80OS9mcmFnOmIzNmU0MzJjMjM0ZDRjMTJiMmY4NzM2MTk3Yjg3MTE4L3RhYmxlOmI4OWVhYmE3NzM5ZDQ2ZDlhNTZhYjJjODdhY2M5Yjc5L3RhYmxlcmFuZ2U6Yjg5ZWFiYTc3MzlkNDZkOWE1NmFiMmM4N2FjYzliNzlfMy0zLTEtMS00NTkxOQ_c9475b5a-b2ce-4505-abe7-901865b9757c"
      unitRef="usd">98173000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="ib9cb6638855042dcace6138a16b438ef_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80OS9mcmFnOmIzNmU0MzJjMjM0ZDRjMTJiMmY4NzM2MTk3Yjg3MTE4L3RhYmxlOmI4OWVhYmE3NzM5ZDQ2ZDlhNTZhYjJjODdhY2M5Yjc5L3RhYmxlcmFuZ2U6Yjg5ZWFiYTc3MzlkNDZkOWE1NmFiMmM4N2FjYzliNzlfMy01LTEtMS00NTkxOQ_a2c0cabd-c83e-4784-a66b-f12c8559ad1c"
      unitRef="usd">81929000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:MaximumLengthOfTimeHedgedInCashFlowHedge1
      contextRef="i717c6c4879334aaf8b31721fd327e132_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80OS9mcmFnOmIzNmU0MzJjMjM0ZDRjMTJiMmY4NzM2MTk3Yjg3MTE4L3RleHRyZWdpb246YjM2ZTQzMmMyMzRkNGMxMmIyZjg3MzYxOTdiODcxMThfMTk1MQ_288ce0f3-7298-45d4-8d5c-0b01dee4086e">P2Y</us-gaap:MaximumLengthOfTimeHedgedInCashFlowHedge1>
    <us-gaap:MaximumLengthOfTimeHedgedInCashFlowHedge1
      contextRef="i0d7ec65a949147fa901cc819f74ad4ea_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80OS9mcmFnOmIzNmU0MzJjMjM0ZDRjMTJiMmY4NzM2MTk3Yjg3MTE4L3RleHRyZWdpb246YjM2ZTQzMmMyMzRkNGMxMmIyZjg3MzYxOTdiODcxMThfMjAyMA_3b4736a5-97a7-4948-bbea-ab4f56c04bd7">P1M</us-gaap:MaximumLengthOfTimeHedgedInCashFlowHedge1>
    <us-gaap:ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock
      contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80OS9mcmFnOmIzNmU0MzJjMjM0ZDRjMTJiMmY4NzM2MTk3Yjg3MTE4L3RleHRyZWdpb246YjM2ZTQzMmMyMzRkNGMxMmIyZjg3MzYxOTdiODcxMThfNTg2OA_7624d797-dcb1-466d-bbd5-40804922f123">&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Foreign exchange contracts designated as cash flow hedges had the following effects on accumulated other comprehensive income (loss) ("AOCI") and net earnings on our consolidated condensed statements of comprehensive income and our consolidated condensed balance sheets:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:27.639%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.551%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.551%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.386%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.002%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.551%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.551%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.551%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.553%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amount of Gain Recognized in AOCI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="12" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Consolidated Condensed Statements  of Comprehensive Income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amount of Gain Reclassified from AOCI&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="36" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="6" style="border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Amount of Line Item Presented&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Derivative Instrument&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Location of amount reclassified&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,538&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,247&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net Sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;295,468&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;242,327&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;575&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,744&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of Sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;140,147&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;106,336&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;806&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pre-tax gain&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,538&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,247&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,381&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,819&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;615&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;787&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;335&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;441&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net gain&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,923&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,460&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,046&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,378&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80OS9mcmFnOmIzNmU0MzJjMjM0ZDRjMTJiMmY4NzM2MTk3Yjg3MTE4L3RhYmxlOjYyYTFiZjIyNzdmNjRjZTQ5MTUwZTk0YmJlMTM0NWM5L3RhYmxlcmFuZ2U6NjJhMWJmMjI3N2Y2NGNlNDkxNTBlOTRiYmUxMzQ1YzlfNS0yLTEtMS00NTkxOQ_1f1493fb-552e-4779-925d-1f10aac93f57"
      unitRef="usd">2538000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="i9500a5ee8dbe4d23aa9c46ebdd25a0c8_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80OS9mcmFnOmIzNmU0MzJjMjM0ZDRjMTJiMmY4NzM2MTk3Yjg3MTE4L3RhYmxlOjYyYTFiZjIyNzdmNjRjZTQ5MTUwZTk0YmJlMTM0NWM5L3RhYmxlcmFuZ2U6NjJhMWJmMjI3N2Y2NGNlNDkxNTBlOTRiYmUxMzQ1YzlfNS00LTEtMS00NTkxOQ_91951585-69a3-4174-89f6-b0f823aa6b4f"
      unitRef="usd">3247000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:Revenues
      contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80OS9mcmFnOmIzNmU0MzJjMjM0ZDRjMTJiMmY4NzM2MTk3Yjg3MTE4L3RhYmxlOjYyYTFiZjIyNzdmNjRjZTQ5MTUwZTk0YmJlMTM0NWM5L3RhYmxlcmFuZ2U6NjJhMWJmMjI3N2Y2NGNlNDkxNTBlOTRiYmUxMzQ1YzlfNS04LTEtMS00NTkxOQ_5b817f06-9d27-4e49-bca4-da5b8937383f"
      unitRef="usd">295468000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i9500a5ee8dbe4d23aa9c46ebdd25a0c8_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80OS9mcmFnOmIzNmU0MzJjMjM0ZDRjMTJiMmY4NzM2MTk3Yjg3MTE4L3RhYmxlOjYyYTFiZjIyNzdmNjRjZTQ5MTUwZTk0YmJlMTM0NWM5L3RhYmxlcmFuZ2U6NjJhMWJmMjI3N2Y2NGNlNDkxNTBlOTRiYmUxMzQ1YzlfNS05LTEtMS00NTkxOQ_8fff1772-445d-46cc-ae10-8ae119ac96fa"
      unitRef="usd">242327000</us-gaap:Revenues>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="i808450fedc2a4fb9bae456706bfd3a2f_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80OS9mcmFnOmIzNmU0MzJjMjM0ZDRjMTJiMmY4NzM2MTk3Yjg3MTE4L3RhYmxlOjYyYTFiZjIyNzdmNjRjZTQ5MTUwZTk0YmJlMTM0NWM5L3RhYmxlcmFuZ2U6NjJhMWJmMjI3N2Y2NGNlNDkxNTBlOTRiYmUxMzQ1YzlfNS0xMS0xLTEtNDU5MTk_27586335-02c5-4dc4-b229-1775bad13cb4"
      unitRef="usd">575000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="i1e788e10ae614e408a862f260845ff94_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80OS9mcmFnOmIzNmU0MzJjMjM0ZDRjMTJiMmY4NzM2MTk3Yjg3MTE4L3RhYmxlOjYyYTFiZjIyNzdmNjRjZTQ5MTUwZTk0YmJlMTM0NWM5L3RhYmxlcmFuZ2U6NjJhMWJmMjI3N2Y2NGNlNDkxNTBlOTRiYmUxMzQ1YzlfNS0xMy0xLTEtNDU5MTk_24f7597c-614a-406d-91fe-d09ac7dc3618"
      unitRef="usd">1744000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80OS9mcmFnOmIzNmU0MzJjMjM0ZDRjMTJiMmY4NzM2MTk3Yjg3MTE4L3RhYmxlOjYyYTFiZjIyNzdmNjRjZTQ5MTUwZTk0YmJlMTM0NWM5L3RhYmxlcmFuZ2U6NjJhMWJmMjI3N2Y2NGNlNDkxNTBlOTRiYmUxMzQ1YzlfNi04LTEtMS00NTkxOQ_6a90ea9d-6ab7-4e03-a94e-1587be8d4ee1"
      unitRef="usd">140147000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i9500a5ee8dbe4d23aa9c46ebdd25a0c8_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80OS9mcmFnOmIzNmU0MzJjMjM0ZDRjMTJiMmY4NzM2MTk3Yjg3MTE4L3RhYmxlOjYyYTFiZjIyNzdmNjRjZTQ5MTUwZTk0YmJlMTM0NWM5L3RhYmxlcmFuZ2U6NjJhMWJmMjI3N2Y2NGNlNDkxNTBlOTRiYmUxMzQ1YzlfNi05LTEtMS00NTkxOQ_26d42139-bb76-4e8b-bfb5-f7702befe3c5"
      unitRef="usd">106336000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="i2e7e8a5239c24bf8943da6f26a1c8fc5_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80OS9mcmFnOmIzNmU0MzJjMjM0ZDRjMTJiMmY4NzM2MTk3Yjg3MTE4L3RhYmxlOjYyYTFiZjIyNzdmNjRjZTQ5MTUwZTk0YmJlMTM0NWM5L3RhYmxlcmFuZ2U6NjJhMWJmMjI3N2Y2NGNlNDkxNTBlOTRiYmUxMzQ1YzlfNi0xMS0xLTEtNDU5MTk_88ca9d48-8276-4ed9-9b4c-0143cd279daf"
      unitRef="usd">806000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="i6241041cc28b4b86aab309ebee334dd7_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80OS9mcmFnOmIzNmU0MzJjMjM0ZDRjMTJiMmY4NzM2MTk3Yjg3MTE4L3RhYmxlOjYyYTFiZjIyNzdmNjRjZTQ5MTUwZTk0YmJlMTM0NWM5L3RhYmxlcmFuZ2U6NjJhMWJmMjI3N2Y2NGNlNDkxNTBlOTRiYmUxMzQ1YzlfNi0xMy0xLTEtNDU5MTk_2444cc39-9118-468f-8a51-75f0ca65cc93"
      unitRef="usd">75000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80OS9mcmFnOmIzNmU0MzJjMjM0ZDRjMTJiMmY4NzM2MTk3Yjg3MTE4L3RhYmxlOjYyYTFiZjIyNzdmNjRjZTQ5MTUwZTk0YmJlMTM0NWM5L3RhYmxlcmFuZ2U6NjJhMWJmMjI3N2Y2NGNlNDkxNTBlOTRiYmUxMzQ1YzlfNy0yLTEtMS00NTkxOQ_2dbcef00-a952-4b79-a717-1f06a3bcf95c"
      unitRef="usd">2538000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="i9500a5ee8dbe4d23aa9c46ebdd25a0c8_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80OS9mcmFnOmIzNmU0MzJjMjM0ZDRjMTJiMmY4NzM2MTk3Yjg3MTE4L3RhYmxlOjYyYTFiZjIyNzdmNjRjZTQ5MTUwZTk0YmJlMTM0NWM5L3RhYmxlcmFuZ2U6NjJhMWJmMjI3N2Y2NGNlNDkxNTBlOTRiYmUxMzQ1YzlfNy00LTEtMS00NTkxOQ_825d51da-1d2a-44b1-966c-9e00d01d9b0f"
      unitRef="usd">3247000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80OS9mcmFnOmIzNmU0MzJjMjM0ZDRjMTJiMmY4NzM2MTk3Yjg3MTE4L3RhYmxlOjYyYTFiZjIyNzdmNjRjZTQ5MTUwZTk0YmJlMTM0NWM5L3RhYmxlcmFuZ2U6NjJhMWJmMjI3N2Y2NGNlNDkxNTBlOTRiYmUxMzQ1YzlfNy0xMS0xLTEtNDU5MTk_28903c45-da6d-41e3-8ad8-1e7f308405b4"
      unitRef="usd">1381000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="i9500a5ee8dbe4d23aa9c46ebdd25a0c8_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80OS9mcmFnOmIzNmU0MzJjMjM0ZDRjMTJiMmY4NzM2MTk3Yjg3MTE4L3RhYmxlOjYyYTFiZjIyNzdmNjRjZTQ5MTUwZTk0YmJlMTM0NWM5L3RhYmxlcmFuZ2U6NjJhMWJmMjI3N2Y2NGNlNDkxNTBlOTRiYmUxMzQ1YzlfNy0xMy0xLTEtNDU5MTk_c729b947-a43e-4fde-81c8-bbde7f2ebed4"
      unitRef="usd">1819000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax
      contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80OS9mcmFnOmIzNmU0MzJjMjM0ZDRjMTJiMmY4NzM2MTk3Yjg3MTE4L3RhYmxlOjYyYTFiZjIyNzdmNjRjZTQ5MTUwZTk0YmJlMTM0NWM5L3RhYmxlcmFuZ2U6NjJhMWJmMjI3N2Y2NGNlNDkxNTBlOTRiYmUxMzQ1YzlfOC0yLTEtMS00NTkxOQ_3c1398ef-6fce-48cd-a1c1-df0458080d88"
      unitRef="usd">615000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax
      contextRef="i9500a5ee8dbe4d23aa9c46ebdd25a0c8_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80OS9mcmFnOmIzNmU0MzJjMjM0ZDRjMTJiMmY4NzM2MTk3Yjg3MTE4L3RhYmxlOjYyYTFiZjIyNzdmNjRjZTQ5MTUwZTk0YmJlMTM0NWM5L3RhYmxlcmFuZ2U6NjJhMWJmMjI3N2Y2NGNlNDkxNTBlOTRiYmUxMzQ1YzlfOC00LTEtMS00NTkxOQ_ae7371ca-72f9-4e52-868d-ffe9e8fe269f"
      unitRef="usd">787000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax
      contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80OS9mcmFnOmIzNmU0MzJjMjM0ZDRjMTJiMmY4NzM2MTk3Yjg3MTE4L3RhYmxlOjYyYTFiZjIyNzdmNjRjZTQ5MTUwZTk0YmJlMTM0NWM5L3RhYmxlcmFuZ2U6NjJhMWJmMjI3N2Y2NGNlNDkxNTBlOTRiYmUxMzQ1YzlfOC0xMS0xLTEtNDU5MTk_7fc5eb7d-1432-4b2d-9396-f9511e2ca581"
      unitRef="usd">335000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax
      contextRef="i9500a5ee8dbe4d23aa9c46ebdd25a0c8_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80OS9mcmFnOmIzNmU0MzJjMjM0ZDRjMTJiMmY4NzM2MTk3Yjg3MTE4L3RhYmxlOjYyYTFiZjIyNzdmNjRjZTQ5MTUwZTk0YmJlMTM0NWM5L3RhYmxlcmFuZ2U6NjJhMWJmMjI3N2Y2NGNlNDkxNTBlOTRiYmUxMzQ1YzlfOC0xMy0xLTEtNDU5MTk_db6a009a-b048-403b-bc38-1cab3b9260ea"
      unitRef="usd">441000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80OS9mcmFnOmIzNmU0MzJjMjM0ZDRjMTJiMmY4NzM2MTk3Yjg3MTE4L3RhYmxlOjYyYTFiZjIyNzdmNjRjZTQ5MTUwZTk0YmJlMTM0NWM5L3RhYmxlcmFuZ2U6NjJhMWJmMjI3N2Y2NGNlNDkxNTBlOTRiYmUxMzQ1YzlfOS0yLTEtMS00NTkxOQ_64562e24-dcf8-4067-9d1d-9056608fb5b3"
      unitRef="usd">1923000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="i9500a5ee8dbe4d23aa9c46ebdd25a0c8_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80OS9mcmFnOmIzNmU0MzJjMjM0ZDRjMTJiMmY4NzM2MTk3Yjg3MTE4L3RhYmxlOjYyYTFiZjIyNzdmNjRjZTQ5MTUwZTk0YmJlMTM0NWM5L3RhYmxlcmFuZ2U6NjJhMWJmMjI3N2Y2NGNlNDkxNTBlOTRiYmUxMzQ1YzlfOS00LTEtMS00NTkxOQ_d5e6708c-f26e-4375-86bf-77c00f15c5ca"
      unitRef="usd">2460000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80OS9mcmFnOmIzNmU0MzJjMjM0ZDRjMTJiMmY4NzM2MTk3Yjg3MTE4L3RhYmxlOjYyYTFiZjIyNzdmNjRjZTQ5MTUwZTk0YmJlMTM0NWM5L3RhYmxlcmFuZ2U6NjJhMWJmMjI3N2Y2NGNlNDkxNTBlOTRiYmUxMzQ1YzlfOS0xMS0xLTEtNDU5MTk_09583fb6-89a7-43d1-bacd-add499548d4c"
      unitRef="usd">1046000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="i9500a5ee8dbe4d23aa9c46ebdd25a0c8_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80OS9mcmFnOmIzNmU0MzJjMjM0ZDRjMTJiMmY4NzM2MTk3Yjg3MTE4L3RhYmxlOjYyYTFiZjIyNzdmNjRjZTQ5MTUwZTk0YmJlMTM0NWM5L3RhYmxlcmFuZ2U6NjJhMWJmMjI3N2Y2NGNlNDkxNTBlOTRiYmUxMzQ1YzlfOS0xMy0xLTEtNDU5MTk_4a3338f6-a1a0-4c2b-bbb4-e9fc3297b95f"
      unitRef="usd">1378000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months
      contextRef="ib8cab3c62ed442529813f178f35898bc_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80OS9mcmFnOmIzNmU0MzJjMjM0ZDRjMTJiMmY4NzM2MTk3Yjg3MTE4L3RleHRyZWdpb246YjM2ZTQzMmMyMzRkNGMxMmIyZjg3MzYxOTdiODcxMThfMjQ3NA_2b7d98ce-e880-4c57-9c99-dbb70cdac517"
      unitRef="usd">3300000</us-gaap:ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months>
    <us-gaap:ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock
      contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80OS9mcmFnOmIzNmU0MzJjMjM0ZDRjMTJiMmY4NzM2MTk3Yjg3MTE4L3RleHRyZWdpb246YjM2ZTQzMmMyMzRkNGMxMmIyZjg3MzYxOTdiODcxMThfNTg1MQ_f32c9b4f-4c1e-4fe4-9907-2931fa923dc0">&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net gains and losses from derivative instruments not accounted for as hedges and losses on our intercompany receivables on our consolidated condensed statements of comprehensive income were:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:32.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:44.367%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.087%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.285%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Derivative Instrument&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Location on Consolidated Condensed Statements of Comprehensive Income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss on currency forward contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Selling and administrative expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(366)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(958)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net gain on currency transaction exposures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Selling and administrative expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;415&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock>
    <us-gaap:GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments
      contextRef="i80aea042b5874dd49071f7d95c6d3e55_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80OS9mcmFnOmIzNmU0MzJjMjM0ZDRjMTJiMmY4NzM2MTk3Yjg3MTE4L3RhYmxlOjZmNjdjNzlhOGIyNDRiZjA4ODliYzY2MDU4YTk2ZmZiL3RhYmxlcmFuZ2U6NmY2N2M3OWE4YjI0NGJmMDg4OWJjNjYwNThhOTZmZmJfMy00LTEtMS00NTkxOQ_779f2de0-3465-4ea1-be58-0f641f5b60be"
      unitRef="usd">-366000</us-gaap:GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments>
    <us-gaap:GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments
      contextRef="i05c39c1786d348b380be8f3ab5ee62a6_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80OS9mcmFnOmIzNmU0MzJjMjM0ZDRjMTJiMmY4NzM2MTk3Yjg3MTE4L3RhYmxlOjZmNjdjNzlhOGIyNDRiZjA4ODliYzY2MDU4YTk2ZmZiL3RhYmxlcmFuZ2U6NmY2N2M3OWE4YjI0NGJmMDg4OWJjNjYwNThhOTZmZmJfMy02LTEtMS00NTkxOQ_cafe4249-fad9-4974-8a2f-2a38b42575fd"
      unitRef="usd">-958000</us-gaap:GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax
      contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80OS9mcmFnOmIzNmU0MzJjMjM0ZDRjMTJiMmY4NzM2MTk3Yjg3MTE4L3RhYmxlOjZmNjdjNzlhOGIyNDRiZjA4ODliYzY2MDU4YTk2ZmZiL3RhYmxlcmFuZ2U6NmY2N2M3OWE4YjI0NGJmMDg4OWJjNjYwNThhOTZmZmJfNC00LTEtMS00NTkxOQ_bce34d82-49d1-4504-8679-149b3281e2aa"
      unitRef="usd">76000</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax
      contextRef="i9500a5ee8dbe4d23aa9c46ebdd25a0c8_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80OS9mcmFnOmIzNmU0MzJjMjM0ZDRjMTJiMmY4NzM2MTk3Yjg3MTE4L3RhYmxlOjZmNjdjNzlhOGIyNDRiZjA4ODliYzY2MDU4YTk2ZmZiL3RhYmxlcmFuZ2U6NmY2N2M3OWE4YjI0NGJmMDg4OWJjNjYwNThhOTZmZmJfNC02LTEtMS00NTkxOQ_b1d8b604-cc33-45eb-aa11-426780bb31d8"
      unitRef="usd">415000</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <us-gaap:ScheduleOfForeignExchangeContractsStatementOfFinancialPositionTableTextBlock
      contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80OS9mcmFnOmIzNmU0MzJjMjM0ZDRjMTJiMmY4NzM2MTk3Yjg3MTE4L3RleHRyZWdpb246YjM2ZTQzMmMyMzRkNGMxMmIyZjg3MzYxOTdiODcxMThfNTg0OQ_866c8c8d-500f-4f82-993b-e513ba833ec4">The following tables summarize the fair value for forward foreign exchange contracts outstanding at March&#160;31, 2023 and December&#160;31, 2022: &lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:35.157%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.209%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.700%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Location on Consolidated Condensed Balance Sheet&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Asset Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net&lt;br/&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivatives designated as hedged instruments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,869&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,476)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,393&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;485&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(424)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,354&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,900)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,454&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivatives not designated as hedging instruments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(334)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(282)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total derivatives&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,406&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,234)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,172&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:35.157%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.209%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.700%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Location on Consolidated Condensed Balance Sheet&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Asset Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net&lt;br/&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivatives designated as hedged instruments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange contracts &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,757&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,121)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,636&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other long-term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(400)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(340)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,817&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,521)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,296&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivatives not designated as hedging instruments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(395)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(347)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total derivatives&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,865&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,916)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,949&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfForeignExchangeContractsStatementOfFinancialPositionTableTextBlock>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="ic37b157fcb074cfaaf336217f5e69f47_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80OS9mcmFnOmIzNmU0MzJjMjM0ZDRjMTJiMmY4NzM2MTk3Yjg3MTE4L3RhYmxlOmNlZmI0YTUwMGI3MTQyNDY4NzhlMWYxMmU5NWU2ZTRiL3RhYmxlcmFuZ2U6Y2VmYjRhNTAwYjcxNDI0Njg3OGUxZjEyZTk1ZTZlNGJfMi0zLTEtMS00NTkxOQ_8a7439b5-bfb6-4ba7-9482-7c74a7c1a9e4"
      unitRef="usd">6869000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="ic37b157fcb074cfaaf336217f5e69f47_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80OS9mcmFnOmIzNmU0MzJjMjM0ZDRjMTJiMmY4NzM2MTk3Yjg3MTE4L3RhYmxlOmNlZmI0YTUwMGI3MTQyNDY4NzhlMWYxMmU5NWU2ZTRiL3RhYmxlcmFuZ2U6Y2VmYjRhNTAwYjcxNDI0Njg3OGUxZjEyZTk1ZTZlNGJfMi01LTEtMS00NTkxOQ_ce9c5ccb-9578-498f-82b3-bb9dbcfddc96"
      unitRef="usd">2476000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet
      contextRef="ic37b157fcb074cfaaf336217f5e69f47_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80OS9mcmFnOmIzNmU0MzJjMjM0ZDRjMTJiMmY4NzM2MTk3Yjg3MTE4L3RhYmxlOmNlZmI0YTUwMGI3MTQyNDY4NzhlMWYxMmU5NWU2ZTRiL3RhYmxlcmFuZ2U6Y2VmYjRhNTAwYjcxNDI0Njg3OGUxZjEyZTk1ZTZlNGJfMi03LTEtMS00NTkxOQ_39e5758b-aedc-43b3-b70b-dd81886a9a26"
      unitRef="usd">4393000</us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i4455b5d88e18472f9babbe0ea7158f8f_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80OS9mcmFnOmIzNmU0MzJjMjM0ZDRjMTJiMmY4NzM2MTk3Yjg3MTE4L3RhYmxlOmNlZmI0YTUwMGI3MTQyNDY4NzhlMWYxMmU5NWU2ZTRiL3RhYmxlcmFuZ2U6Y2VmYjRhNTAwYjcxNDI0Njg3OGUxZjEyZTk1ZTZlNGJfMy0zLTEtMS00NTkxOQ_59b78a69-acdd-4f21-aca4-65eaf6b8e922"
      unitRef="usd">485000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i4455b5d88e18472f9babbe0ea7158f8f_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80OS9mcmFnOmIzNmU0MzJjMjM0ZDRjMTJiMmY4NzM2MTk3Yjg3MTE4L3RhYmxlOmNlZmI0YTUwMGI3MTQyNDY4NzhlMWYxMmU5NWU2ZTRiL3RhYmxlcmFuZ2U6Y2VmYjRhNTAwYjcxNDI0Njg3OGUxZjEyZTk1ZTZlNGJfMy01LTEtMS00NTkxOQ_a6994e20-8344-46ef-baff-621f03b6ab9d"
      unitRef="usd">424000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet
      contextRef="i4455b5d88e18472f9babbe0ea7158f8f_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80OS9mcmFnOmIzNmU0MzJjMjM0ZDRjMTJiMmY4NzM2MTk3Yjg3MTE4L3RhYmxlOmNlZmI0YTUwMGI3MTQyNDY4NzhlMWYxMmU5NWU2ZTRiL3RhYmxlcmFuZ2U6Y2VmYjRhNTAwYjcxNDI0Njg3OGUxZjEyZTk1ZTZlNGJfMy03LTEtMS00NTkxOQ_82c84ce3-8b9b-448e-a15f-bd0803cafb66"
      unitRef="usd">61000</us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i3f7daa7f8baa47d29e9879c6f43c37e0_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80OS9mcmFnOmIzNmU0MzJjMjM0ZDRjMTJiMmY4NzM2MTk3Yjg3MTE4L3RhYmxlOmNlZmI0YTUwMGI3MTQyNDY4NzhlMWYxMmU5NWU2ZTRiL3RhYmxlcmFuZ2U6Y2VmYjRhNTAwYjcxNDI0Njg3OGUxZjEyZTk1ZTZlNGJfNC0zLTEtMS00NTkxOQ_3a885de9-c761-4c48-9ed6-bf0590599121"
      unitRef="usd">7354000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i3f7daa7f8baa47d29e9879c6f43c37e0_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80OS9mcmFnOmIzNmU0MzJjMjM0ZDRjMTJiMmY4NzM2MTk3Yjg3MTE4L3RhYmxlOmNlZmI0YTUwMGI3MTQyNDY4NzhlMWYxMmU5NWU2ZTRiL3RhYmxlcmFuZ2U6Y2VmYjRhNTAwYjcxNDI0Njg3OGUxZjEyZTk1ZTZlNGJfNC01LTEtMS00NTkxOQ_37fa0e6d-3b3a-44df-afc4-2b7af6f2ad1b"
      unitRef="usd">2900000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet
      contextRef="i3f7daa7f8baa47d29e9879c6f43c37e0_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80OS9mcmFnOmIzNmU0MzJjMjM0ZDRjMTJiMmY4NzM2MTk3Yjg3MTE4L3RhYmxlOmNlZmI0YTUwMGI3MTQyNDY4NzhlMWYxMmU5NWU2ZTRiL3RhYmxlcmFuZ2U6Y2VmYjRhNTAwYjcxNDI0Njg3OGUxZjEyZTk1ZTZlNGJfNC03LTEtMS00NTkxOQ_18dfc8d8-1fb3-4367-bbe5-774258b3f48d"
      unitRef="usd">4454000</us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i9b6c7563dc904e9d8280dedc024d298d_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80OS9mcmFnOmIzNmU0MzJjMjM0ZDRjMTJiMmY4NzM2MTk3Yjg3MTE4L3RhYmxlOmNlZmI0YTUwMGI3MTQyNDY4NzhlMWYxMmU5NWU2ZTRiL3RhYmxlcmFuZ2U6Y2VmYjRhNTAwYjcxNDI0Njg3OGUxZjEyZTk1ZTZlNGJfNy0zLTEtMS00NTkxOQ_be0f4801-4783-402d-8ae6-0da32a202475"
      unitRef="usd">52000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i9b6c7563dc904e9d8280dedc024d298d_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80OS9mcmFnOmIzNmU0MzJjMjM0ZDRjMTJiMmY4NzM2MTk3Yjg3MTE4L3RhYmxlOmNlZmI0YTUwMGI3MTQyNDY4NzhlMWYxMmU5NWU2ZTRiL3RhYmxlcmFuZ2U6Y2VmYjRhNTAwYjcxNDI0Njg3OGUxZjEyZTk1ZTZlNGJfNy01LTEtMS00NTkxOQ_4565831c-aa77-455a-bc6f-ba278c4ed857"
      unitRef="usd">334000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet
      contextRef="i9b6c7563dc904e9d8280dedc024d298d_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80OS9mcmFnOmIzNmU0MzJjMjM0ZDRjMTJiMmY4NzM2MTk3Yjg3MTE4L3RhYmxlOmNlZmI0YTUwMGI3MTQyNDY4NzhlMWYxMmU5NWU2ZTRiL3RhYmxlcmFuZ2U6Y2VmYjRhNTAwYjcxNDI0Njg3OGUxZjEyZTk1ZTZlNGJfNy03LTEtMS00NTkxOQ_fb4ba1b6-7eab-486e-b732-c2fe5f6364af"
      unitRef="usd">-282000</us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i738c2d1dacaf436faf03cc46ab9cef23_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80OS9mcmFnOmIzNmU0MzJjMjM0ZDRjMTJiMmY4NzM2MTk3Yjg3MTE4L3RhYmxlOmNlZmI0YTUwMGI3MTQyNDY4NzhlMWYxMmU5NWU2ZTRiL3RhYmxlcmFuZ2U6Y2VmYjRhNTAwYjcxNDI0Njg3OGUxZjEyZTk1ZTZlNGJfOS0zLTEtMS00NTkxOQ_c8acb87b-afb4-444c-91cb-0a1c143d9796"
      unitRef="usd">7406000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i738c2d1dacaf436faf03cc46ab9cef23_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80OS9mcmFnOmIzNmU0MzJjMjM0ZDRjMTJiMmY4NzM2MTk3Yjg3MTE4L3RhYmxlOmNlZmI0YTUwMGI3MTQyNDY4NzhlMWYxMmU5NWU2ZTRiL3RhYmxlcmFuZ2U6Y2VmYjRhNTAwYjcxNDI0Njg3OGUxZjEyZTk1ZTZlNGJfOS01LTEtMS00NTkxOQ_18768fa5-e7ce-4ae8-be2b-b33fc68b4126"
      unitRef="usd">3234000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet
      contextRef="i738c2d1dacaf436faf03cc46ab9cef23_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80OS9mcmFnOmIzNmU0MzJjMjM0ZDRjMTJiMmY4NzM2MTk3Yjg3MTE4L3RhYmxlOmNlZmI0YTUwMGI3MTQyNDY4NzhlMWYxMmU5NWU2ZTRiL3RhYmxlcmFuZ2U6Y2VmYjRhNTAwYjcxNDI0Njg3OGUxZjEyZTk1ZTZlNGJfOS03LTEtMS00NTkxOQ_2f5d751f-0ea2-4380-824c-50fa49dc22fe"
      unitRef="usd">4172000</us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i1aa96a8c12644da9a3f724a2ff7bae28_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80OS9mcmFnOmIzNmU0MzJjMjM0ZDRjMTJiMmY4NzM2MTk3Yjg3MTE4L3RhYmxlOjAzMzk3OThhZjk5MTRjNWRiNGIyOGMxNjkxMjBmMzEyL3RhYmxlcmFuZ2U6MDMzOTc5OGFmOTkxNGM1ZGI0YjI4YzE2OTEyMGYzMTJfMi0zLTEtMS00NTkxOQ_f49a6dd1-17cd-44ef-a306-430a41ffca31"
      unitRef="usd">6757000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i1aa96a8c12644da9a3f724a2ff7bae28_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80OS9mcmFnOmIzNmU0MzJjMjM0ZDRjMTJiMmY4NzM2MTk3Yjg3MTE4L3RhYmxlOjAzMzk3OThhZjk5MTRjNWRiNGIyOGMxNjkxMjBmMzEyL3RhYmxlcmFuZ2U6MDMzOTc5OGFmOTkxNGM1ZGI0YjI4YzE2OTEyMGYzMTJfMi01LTEtMS00NTkxOQ_ebd64ba2-bc60-4875-be22-e933dbfe5aa4"
      unitRef="usd">3121000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet
      contextRef="i1aa96a8c12644da9a3f724a2ff7bae28_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80OS9mcmFnOmIzNmU0MzJjMjM0ZDRjMTJiMmY4NzM2MTk3Yjg3MTE4L3RhYmxlOjAzMzk3OThhZjk5MTRjNWRiNGIyOGMxNjkxMjBmMzEyL3RhYmxlcmFuZ2U6MDMzOTc5OGFmOTkxNGM1ZGI0YjI4YzE2OTEyMGYzMTJfMi03LTEtMS00NTkxOQ_8befe2e0-af94-443c-919b-a207fdfabe3a"
      unitRef="usd">3636000</us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i9d03c70b7871426aa4315ec3afbc74b6_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80OS9mcmFnOmIzNmU0MzJjMjM0ZDRjMTJiMmY4NzM2MTk3Yjg3MTE4L3RhYmxlOjAzMzk3OThhZjk5MTRjNWRiNGIyOGMxNjkxMjBmMzEyL3RhYmxlcmFuZ2U6MDMzOTc5OGFmOTkxNGM1ZGI0YjI4YzE2OTEyMGYzMTJfMy0zLTEtMS00NTkxOQ_7750ef40-0e75-4339-a5a3-bb67e8a7d6c0"
      unitRef="usd">60000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i9d03c70b7871426aa4315ec3afbc74b6_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80OS9mcmFnOmIzNmU0MzJjMjM0ZDRjMTJiMmY4NzM2MTk3Yjg3MTE4L3RhYmxlOjAzMzk3OThhZjk5MTRjNWRiNGIyOGMxNjkxMjBmMzEyL3RhYmxlcmFuZ2U6MDMzOTc5OGFmOTkxNGM1ZGI0YjI4YzE2OTEyMGYzMTJfMy01LTEtMS00NTkxOQ_7cd9f132-ebff-45a3-8049-46fb77a50d28"
      unitRef="usd">400000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet
      contextRef="i9d03c70b7871426aa4315ec3afbc74b6_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80OS9mcmFnOmIzNmU0MzJjMjM0ZDRjMTJiMmY4NzM2MTk3Yjg3MTE4L3RhYmxlOjAzMzk3OThhZjk5MTRjNWRiNGIyOGMxNjkxMjBmMzEyL3RhYmxlcmFuZ2U6MDMzOTc5OGFmOTkxNGM1ZGI0YjI4YzE2OTEyMGYzMTJfMy03LTEtMS00NTkxOQ_6f6210b6-8ff5-4d8f-8fb1-fe23ea903d17"
      unitRef="usd">-340000</us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="ic5ba3db9a3fd46c9a33db4ff90f454ca_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80OS9mcmFnOmIzNmU0MzJjMjM0ZDRjMTJiMmY4NzM2MTk3Yjg3MTE4L3RhYmxlOjAzMzk3OThhZjk5MTRjNWRiNGIyOGMxNjkxMjBmMzEyL3RhYmxlcmFuZ2U6MDMzOTc5OGFmOTkxNGM1ZGI0YjI4YzE2OTEyMGYzMTJfNC0zLTEtMS00NTkxOQ_abf946a6-c68b-4609-a996-1667c6d29aa2"
      unitRef="usd">6817000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="ic5ba3db9a3fd46c9a33db4ff90f454ca_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80OS9mcmFnOmIzNmU0MzJjMjM0ZDRjMTJiMmY4NzM2MTk3Yjg3MTE4L3RhYmxlOjAzMzk3OThhZjk5MTRjNWRiNGIyOGMxNjkxMjBmMzEyL3RhYmxlcmFuZ2U6MDMzOTc5OGFmOTkxNGM1ZGI0YjI4YzE2OTEyMGYzMTJfNC01LTEtMS00NTkxOQ_86aec08f-5c29-4f37-b499-fae13090af84"
      unitRef="usd">3521000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet
      contextRef="ic5ba3db9a3fd46c9a33db4ff90f454ca_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80OS9mcmFnOmIzNmU0MzJjMjM0ZDRjMTJiMmY4NzM2MTk3Yjg3MTE4L3RhYmxlOjAzMzk3OThhZjk5MTRjNWRiNGIyOGMxNjkxMjBmMzEyL3RhYmxlcmFuZ2U6MDMzOTc5OGFmOTkxNGM1ZGI0YjI4YzE2OTEyMGYzMTJfNC03LTEtMS00NTkxOQ_915da7ea-5bd0-4a6c-807e-d5b2e4172013"
      unitRef="usd">3296000</us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i88547f770c9e4da1886319e36a385937_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80OS9mcmFnOmIzNmU0MzJjMjM0ZDRjMTJiMmY4NzM2MTk3Yjg3MTE4L3RhYmxlOjAzMzk3OThhZjk5MTRjNWRiNGIyOGMxNjkxMjBmMzEyL3RhYmxlcmFuZ2U6MDMzOTc5OGFmOTkxNGM1ZGI0YjI4YzE2OTEyMGYzMTJfNy0zLTEtMS00NTkxOQ_e3cb34af-781c-45c5-b7a2-21263dae5b19"
      unitRef="usd">48000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i88547f770c9e4da1886319e36a385937_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80OS9mcmFnOmIzNmU0MzJjMjM0ZDRjMTJiMmY4NzM2MTk3Yjg3MTE4L3RhYmxlOjAzMzk3OThhZjk5MTRjNWRiNGIyOGMxNjkxMjBmMzEyL3RhYmxlcmFuZ2U6MDMzOTc5OGFmOTkxNGM1ZGI0YjI4YzE2OTEyMGYzMTJfNy01LTEtMS00NTkxOQ_7450edec-aecc-406a-814f-0f0a6856c25c"
      unitRef="usd">395000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet
      contextRef="i88547f770c9e4da1886319e36a385937_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80OS9mcmFnOmIzNmU0MzJjMjM0ZDRjMTJiMmY4NzM2MTk3Yjg3MTE4L3RhYmxlOjAzMzk3OThhZjk5MTRjNWRiNGIyOGMxNjkxMjBmMzEyL3RhYmxlcmFuZ2U6MDMzOTc5OGFmOTkxNGM1ZGI0YjI4YzE2OTEyMGYzMTJfNy03LTEtMS00NTkxOQ_163ee873-1638-4697-8ea7-05f29b3641f6"
      unitRef="usd">-347000</us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="ie4f63720d8b244a68941932992cd9f4d_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80OS9mcmFnOmIzNmU0MzJjMjM0ZDRjMTJiMmY4NzM2MTk3Yjg3MTE4L3RhYmxlOjAzMzk3OThhZjk5MTRjNWRiNGIyOGMxNjkxMjBmMzEyL3RhYmxlcmFuZ2U6MDMzOTc5OGFmOTkxNGM1ZGI0YjI4YzE2OTEyMGYzMTJfOS0zLTEtMS00NTkxOQ_40758c4c-f4b8-40da-963a-6c538ce6c950"
      unitRef="usd">6865000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="ie4f63720d8b244a68941932992cd9f4d_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80OS9mcmFnOmIzNmU0MzJjMjM0ZDRjMTJiMmY4NzM2MTk3Yjg3MTE4L3RhYmxlOjAzMzk3OThhZjk5MTRjNWRiNGIyOGMxNjkxMjBmMzEyL3RhYmxlcmFuZ2U6MDMzOTc5OGFmOTkxNGM1ZGI0YjI4YzE2OTEyMGYzMTJfOS01LTEtMS00NTkxOQ_646481f6-053b-408c-95d7-e5981bf70926"
      unitRef="usd">3916000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet
      contextRef="ie4f63720d8b244a68941932992cd9f4d_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80OS9mcmFnOmIzNmU0MzJjMjM0ZDRjMTJiMmY4NzM2MTk3Yjg3MTE4L3RhYmxlOjAzMzk3OThhZjk5MTRjNWRiNGIyOGMxNjkxMjBmMzEyL3RhYmxlcmFuZ2U6MDMzOTc5OGFmOTkxNGM1ZGI0YjI4YzE2OTEyMGYzMTJfOS03LTEtMS00NTkxOQ_b153dc8e-b6d2-4206-9c91-df52fcf45721"
      unitRef="usd">2949000</us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet>
    <us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock
      contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80OS9mcmFnOmIzNmU0MzJjMjM0ZDRjMTJiMmY4NzM2MTk3Yjg3MTE4L3RleHRyZWdpb246YjM2ZTQzMmMyMzRkNGMxMmIyZjg3MzYxOTdiODcxMThfNTQ5NzU1ODI0Mzgz_fc95161b-c376-40c5-b780-8d03f6f7c048">The recurring Level 3 fair value measurements of contingent consideration for which the liabilities are recorded include the following significant unobservable inputs as of March&#160;31, 2023:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:56.356%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.577%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.783%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.784%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assumptions&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unobservable Input&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;In2Bones&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Biorez&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.52%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.32%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenue volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.11%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.88%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Projected year of payment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023-2026&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023-2026&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput
      contextRef="i1b64b61d3f3b4bdfacdd2afc2e367b87_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80OS9mcmFnOmIzNmU0MzJjMjM0ZDRjMTJiMmY4NzM2MTk3Yjg3MTE4L3RhYmxlOmNmMTgyMDQ4OTYwOTRiOTdiYTM0MmZhM2M0NWY3OTg0L3RhYmxlcmFuZ2U6Y2YxODIwNDg5NjA5NGI5N2JhMzQyZmEzYzQ1Zjc5ODRfMy0yLTEtMS00ODQyOA_737a3f54-b238-451f-82b8-4bf5f2069229"
      unitRef="number">0.0652</us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput
      contextRef="ibfc06ce8169a4d33886f8243da232e5b_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80OS9mcmFnOmIzNmU0MzJjMjM0ZDRjMTJiMmY4NzM2MTk3Yjg3MTE4L3RhYmxlOmNmMTgyMDQ4OTYwOTRiOTdiYTM0MmZhM2M0NWY3OTg0L3RhYmxlcmFuZ2U6Y2YxODIwNDg5NjA5NGI5N2JhMzQyZmEzYzQ1Zjc5ODRfMy0zLTEtMS00ODQyOA_08ae2196-4785-4e13-b295-2d6ab6259446"
      unitRef="number">0.1132</us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput
      contextRef="i517939c1b1424d2a82601fc769d01674_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80OS9mcmFnOmIzNmU0MzJjMjM0ZDRjMTJiMmY4NzM2MTk3Yjg3MTE4L3RhYmxlOmNmMTgyMDQ4OTYwOTRiOTdiYTM0MmZhM2M0NWY3OTg0L3RhYmxlcmFuZ2U6Y2YxODIwNDg5NjA5NGI5N2JhMzQyZmEzYzQ1Zjc5ODRfNC0yLTEtMS00ODQyOA_c4b0934e-33b2-42d9-9de7-8537518332f9"
      unitRef="number">0.1311</us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput
      contextRef="i82c6f94346114193ae96a1af52315fc4_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80OS9mcmFnOmIzNmU0MzJjMjM0ZDRjMTJiMmY4NzM2MTk3Yjg3MTE4L3RhYmxlOmNmMTgyMDQ4OTYwOTRiOTdiYTM0MmZhM2M0NWY3OTg0L3RhYmxlcmFuZ2U6Y2YxODIwNDg5NjA5NGI5N2JhMzQyZmEzYzQ1Zjc5ODRfNC0zLTEtMS00ODQyOA_463dd5d3-c6d9-41af-955d-8e261d756fa6"
      unitRef="number">0.2088</us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput>
    <us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock
      contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80OS9mcmFnOmIzNmU0MzJjMjM0ZDRjMTJiMmY4NzM2MTk3Yjg3MTE4L3RleHRyZWdpb246YjM2ZTQzMmMyMzRkNGMxMmIyZjg3MzYxOTdiODcxMThfNTQ5NzU1ODI0Mzg0_9953aa89-0fc4-4fba-b21b-d19a3718c4a8">Changes in the fair value of contingent consideration liabilities for the three months ended March&#160;31, 2023 are as follows:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:41.443%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:27.705%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;In2Bones&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Biorez&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Location in Financial Statements&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of January 1, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70,198&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;116,234&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Changes in fair value of contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,637&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,799&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Selling and administrative expense&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72,835&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;118,033&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="ice84e4caa93743c5af0f4b86f25100ee_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80OS9mcmFnOmIzNmU0MzJjMjM0ZDRjMTJiMmY4NzM2MTk3Yjg3MTE4L3RhYmxlOjFhMGY4YjcxMTMzMjQxZDg5OWU2MWMwMjhiOGI1Yzk0L3RhYmxlcmFuZ2U6MWEwZjhiNzExMzMyNDFkODk5ZTYxYzAyOGI4YjVjOTRfMS0xLTEtMS00Nzg5Ng_9c19332a-91de-4750-9f8b-ba6370abddc7"
      unitRef="usd">70198000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="ic59ba63fc4b34daa82e9ac6f2499169a_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80OS9mcmFnOmIzNmU0MzJjMjM0ZDRjMTJiMmY4NzM2MTk3Yjg3MTE4L3RhYmxlOjFhMGY4YjcxMTMzMjQxZDg5OWU2MWMwMjhiOGI1Yzk0L3RhYmxlcmFuZ2U6MWEwZjhiNzExMzMyNDFkODk5ZTYxYzAyOGI4YjVjOTRfMS0zLTEtMS00Nzg5Ng_99821960-b923-4934-b958-13228599e85a"
      unitRef="usd">116234000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="i6d95bd83592e4caeac97181946e4d405_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80OS9mcmFnOmIzNmU0MzJjMjM0ZDRjMTJiMmY4NzM2MTk3Yjg3MTE4L3RhYmxlOjFhMGY4YjcxMTMzMjQxZDg5OWU2MWMwMjhiOGI1Yzk0L3RhYmxlcmFuZ2U6MWEwZjhiNzExMzMyNDFkODk5ZTYxYzAyOGI4YjVjOTRfNC0xLTEtMS00NzkxMA_74bdfcd0-5992-4e1d-8858-de7033a61a07"
      unitRef="usd">2637000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="ibc813fbabc244729a87811be824caa94_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80OS9mcmFnOmIzNmU0MzJjMjM0ZDRjMTJiMmY4NzM2MTk3Yjg3MTE4L3RhYmxlOjFhMGY4YjcxMTMzMjQxZDg5OWU2MWMwMjhiOGI1Yzk0L3RhYmxlcmFuZ2U6MWEwZjhiNzExMzMyNDFkODk5ZTYxYzAyOGI4YjVjOTRfNC0zLTEtMS00NzkxMA_b8cfd139-0168-4ff9-bf18-592b42f41b7a"
      unitRef="usd">1799000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i1c3351caf2af4528b8145dc927d3396a_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80OS9mcmFnOmIzNmU0MzJjMjM0ZDRjMTJiMmY4NzM2MTk3Yjg3MTE4L3RhYmxlOjFhMGY4YjcxMTMzMjQxZDg5OWU2MWMwMjhiOGI1Yzk0L3RhYmxlcmFuZ2U6MWEwZjhiNzExMzMyNDFkODk5ZTYxYzAyOGI4YjVjOTRfNS0xLTEtMS01MDkxOA_dd519bff-cf0e-49bf-a07f-e03ac60b7a94"
      unitRef="usd">72835000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i259d409a7f7547048e55cae0b6ae73bc_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80OS9mcmFnOmIzNmU0MzJjMjM0ZDRjMTJiMmY4NzM2MTk3Yjg3MTE4L3RhYmxlOjFhMGY4YjcxMTMzMjQxZDg5OWU2MWMwMjhiOGI1Yzk0L3RhYmxlcmFuZ2U6MWEwZjhiNzExMzMyNDFkODk5ZTYxYzAyOGI4YjVjOTRfNS0zLTEtMS01MDkyMg_5e2edf7e-a17d-4497-b424-4f69850f53e3"
      unitRef="usd">118033000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent
      contextRef="i738c2d1dacaf436faf03cc46ab9cef23_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80OS9mcmFnOmIzNmU0MzJjMjM0ZDRjMTJiMmY4NzM2MTk3Yjg3MTE4L3RleHRyZWdpb246YjM2ZTQzMmMyMzRkNGMxMmIyZjg3MzYxOTdiODcxMThfNTQ5NzU1ODIxMzE5_fcb73c76-883a-49a7-a765-a220e369352e"
      unitRef="usd">38700000</us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent
      contextRef="i738c2d1dacaf436faf03cc46ab9cef23_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80OS9mcmFnOmIzNmU0MzJjMjM0ZDRjMTJiMmY4NzM2MTk3Yjg3MTE4L3RleHRyZWdpb246YjM2ZTQzMmMyMzRkNGMxMmIyZjg3MzYxOTdiODcxMThfNTQ5NzU1ODIxMzI3_a33684f5-59ce-43af-922c-7586ce70f405"
      unitRef="usd">152200000</us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent
      contextRef="ie4f63720d8b244a68941932992cd9f4d_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80OS9mcmFnOmIzNmU0MzJjMjM0ZDRjMTJiMmY4NzM2MTk3Yjg3MTE4L3RleHRyZWdpb246YjM2ZTQzMmMyMzRkNGMxMmIyZjg3MzYxOTdiODcxMThfNTQ5NzU1ODI0NDg0_66ff6491-f2a8-41ce-bfcd-f1c785dc3404"
      unitRef="usd">18600000</us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent
      contextRef="ie4f63720d8b244a68941932992cd9f4d_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80OS9mcmFnOmIzNmU0MzJjMjM0ZDRjMTJiMmY4NzM2MTk3Yjg3MTE4L3RleHRyZWdpb246YjM2ZTQzMmMyMzRkNGMxMmIyZjg3MzYxOTdiODcxMThfNTQ5NzU1ODI0NTAy_53f0fc43-4a46-47d1-8a00-3a26beef22d7"
      unitRef="usd">167800000</us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent>
    <us-gaap:InventoryDisclosureTextBlock
      contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV81Mi9mcmFnOjM5ZjFlZWEwYjJhOTQ0NGM4MmZjYTUzZjlkNWFlYTMyL3RleHRyZWdpb246MzlmMWVlYTBiMmE5NDQ0YzgyZmNhNTNmOWQ1YWVhMzJfODY_f88d09ef-6124-4e16-91a8-48b25e20a442">Inventories&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Inventories consist of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.560%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.206%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Raw materials&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;124,122&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;110,677&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Work-in-process&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,487&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,166&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;184,761&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;195,477&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;335,370&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;332,320&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:InventoryDisclosureTextBlock>
    <us-gaap:ScheduleOfInventoryCurrentTableTextBlock
      contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV81Mi9mcmFnOjM5ZjFlZWEwYjJhOTQ0NGM4MmZjYTUzZjlkNWFlYTMyL3RleHRyZWdpb246MzlmMWVlYTBiMmE5NDQ0YzgyZmNhNTNmOWQ1YWVhMzJfNzQ_bad91fc9-670e-4268-83c1-3362c54b20df">&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Inventories consist of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.560%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.206%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Raw materials&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;124,122&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;110,677&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Work-in-process&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,487&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,166&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;184,761&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;195,477&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;335,370&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;332,320&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfInventoryCurrentTableTextBlock>
    <us-gaap:InventoryRawMaterialsNetOfReserves
      contextRef="i738c2d1dacaf436faf03cc46ab9cef23_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV81Mi9mcmFnOjM5ZjFlZWEwYjJhOTQ0NGM4MmZjYTUzZjlkNWFlYTMyL3RhYmxlOjA3Mjc5MDMwYTgxNzQyYzQ4ZDg5YThkZDg4MmVjYjExL3RhYmxlcmFuZ2U6MDcyNzkwMzBhODE3NDJjNDhkODlhOGRkODgyZWNiMTFfMS0xLTEtMS00NTkxOQ_7bca97ee-1a52-403e-98d4-876236272440"
      unitRef="usd">124122000</us-gaap:InventoryRawMaterialsNetOfReserves>
    <us-gaap:InventoryRawMaterialsNetOfReserves
      contextRef="ie4f63720d8b244a68941932992cd9f4d_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV81Mi9mcmFnOjM5ZjFlZWEwYjJhOTQ0NGM4MmZjYTUzZjlkNWFlYTMyL3RhYmxlOjA3Mjc5MDMwYTgxNzQyYzQ4ZDg5YThkZDg4MmVjYjExL3RhYmxlcmFuZ2U6MDcyNzkwMzBhODE3NDJjNDhkODlhOGRkODgyZWNiMTFfMS0zLTEtMS00NTkxOQ_e5a8c8e8-8e7a-4df9-91d0-ba477de9880f"
      unitRef="usd">110677000</us-gaap:InventoryRawMaterialsNetOfReserves>
    <us-gaap:InventoryWorkInProcessNetOfReserves
      contextRef="i738c2d1dacaf436faf03cc46ab9cef23_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV81Mi9mcmFnOjM5ZjFlZWEwYjJhOTQ0NGM4MmZjYTUzZjlkNWFlYTMyL3RhYmxlOjA3Mjc5MDMwYTgxNzQyYzQ4ZDg5YThkZDg4MmVjYjExL3RhYmxlcmFuZ2U6MDcyNzkwMzBhODE3NDJjNDhkODlhOGRkODgyZWNiMTFfMi0xLTEtMS00NTkxOQ_21febb00-f4bd-48dd-8239-3c1b7154ba23"
      unitRef="usd">26487000</us-gaap:InventoryWorkInProcessNetOfReserves>
    <us-gaap:InventoryWorkInProcessNetOfReserves
      contextRef="ie4f63720d8b244a68941932992cd9f4d_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV81Mi9mcmFnOjM5ZjFlZWEwYjJhOTQ0NGM4MmZjYTUzZjlkNWFlYTMyL3RhYmxlOjA3Mjc5MDMwYTgxNzQyYzQ4ZDg5YThkZDg4MmVjYjExL3RhYmxlcmFuZ2U6MDcyNzkwMzBhODE3NDJjNDhkODlhOGRkODgyZWNiMTFfMi0zLTEtMS00NTkxOQ_e0f723b5-a9e2-4489-a136-8c45b7394443"
      unitRef="usd">26166000</us-gaap:InventoryWorkInProcessNetOfReserves>
    <us-gaap:InventoryFinishedGoodsNetOfReserves
      contextRef="i738c2d1dacaf436faf03cc46ab9cef23_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV81Mi9mcmFnOjM5ZjFlZWEwYjJhOTQ0NGM4MmZjYTUzZjlkNWFlYTMyL3RhYmxlOjA3Mjc5MDMwYTgxNzQyYzQ4ZDg5YThkZDg4MmVjYjExL3RhYmxlcmFuZ2U6MDcyNzkwMzBhODE3NDJjNDhkODlhOGRkODgyZWNiMTFfMy0xLTEtMS00NTkxOQ_8ae59e32-dd9a-4d46-8ddb-698ae248b5a4"
      unitRef="usd">184761000</us-gaap:InventoryFinishedGoodsNetOfReserves>
    <us-gaap:InventoryFinishedGoodsNetOfReserves
      contextRef="ie4f63720d8b244a68941932992cd9f4d_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV81Mi9mcmFnOjM5ZjFlZWEwYjJhOTQ0NGM4MmZjYTUzZjlkNWFlYTMyL3RhYmxlOjA3Mjc5MDMwYTgxNzQyYzQ4ZDg5YThkZDg4MmVjYjExL3RhYmxlcmFuZ2U6MDcyNzkwMzBhODE3NDJjNDhkODlhOGRkODgyZWNiMTFfMy0zLTEtMS00NTkxOQ_846b6f56-8e79-41cc-a817-039376b546da"
      unitRef="usd">195477000</us-gaap:InventoryFinishedGoodsNetOfReserves>
    <us-gaap:InventoryNet
      contextRef="i738c2d1dacaf436faf03cc46ab9cef23_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV81Mi9mcmFnOjM5ZjFlZWEwYjJhOTQ0NGM4MmZjYTUzZjlkNWFlYTMyL3RhYmxlOjA3Mjc5MDMwYTgxNzQyYzQ4ZDg5YThkZDg4MmVjYjExL3RhYmxlcmFuZ2U6MDcyNzkwMzBhODE3NDJjNDhkODlhOGRkODgyZWNiMTFfNC0xLTEtMS00NTkxOQ_dac1c19c-0d20-4169-8921-37105c865954"
      unitRef="usd">335370000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="ie4f63720d8b244a68941932992cd9f4d_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV81Mi9mcmFnOjM5ZjFlZWEwYjJhOTQ0NGM4MmZjYTUzZjlkNWFlYTMyL3RhYmxlOjA3Mjc5MDMwYTgxNzQyYzQ4ZDg5YThkZDg4MmVjYjExL3RhYmxlcmFuZ2U6MDcyNzkwMzBhODE3NDJjNDhkODlhOGRkODgyZWNiMTFfNC0zLTEtMS00NTkxOQ_fcc66368-566d-4c25-8114-4d1cf104de14"
      unitRef="usd">332320000</us-gaap:InventoryNet>
    <us-gaap:EarningsPerShareTextBlock
      contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV81NS9mcmFnOjJmNDEzOTUxNDIwZjQxNmRiOTZjMjE1Y2VlNGVkMTQ3L3RleHRyZWdpb246MmY0MTM5NTE0MjBmNDE2ZGI5NmMyMTVjZWU0ZWQxNDdfNDg3Mg_3706a34e-7111-43dd-97e2-927e98fe42d9">Earnings Per ShareBasic earnings per share (&#x201c;basic EPS&#x201d;) is computed by dividing net income by the weighted average number of common shares outstanding for the reporting period.  Diluted earnings per share (&#x201c;diluted EPS&#x201d;) gives effect to all dilutive potential shares. &lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table sets forth the computation of basic and diluted earnings per share for the three months ended March 31, 2023 and 2022:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.800%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.605%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Basic EPS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Diluted EPS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Basic EPS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Diluted EPS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,819&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,819&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,975&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,715&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,690&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,511&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,511&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,428&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,428&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;629&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;629&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,158&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,158&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;684&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;684&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Convertible notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,885&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,885&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,511&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;693&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,204&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,428&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,727&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,155&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;EPS&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.06&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.06&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.800%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.605%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The shares used in the calculation of diluted EPS exclude stock options and stock appreciation rights to purchase shares where the exercise price was greater than the average market price of common shares for the period and the effect of the inclusion would be anti-dilutive.  Such shares aggregated approximately 2.2 million and 0.9 million for the three months ended March&#160;31, 2023 and 2022, respectively.&lt;/span&gt;&lt;/div&gt;</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
      contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV81NS9mcmFnOjJmNDEzOTUxNDIwZjQxNmRiOTZjMjE1Y2VlNGVkMTQ3L3RleHRyZWdpb246MmY0MTM5NTE0MjBmNDE2ZGI5NmMyMTVjZWU0ZWQxNDdfNDg3NA_a618ffb6-a793-48e9-8889-55d47db88bee">&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table sets forth the computation of basic and diluted earnings per share for the three months ended March 31, 2023 and 2022:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.800%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.605%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Basic EPS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Diluted EPS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Basic EPS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Diluted EPS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,819&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,819&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,975&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,715&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,690&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,511&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,511&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,428&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,428&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;629&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;629&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,158&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,158&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;684&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;684&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Convertible notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,885&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,885&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,511&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;693&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,204&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,428&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,727&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,155&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;EPS&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.06&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.06&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:NetIncomeLoss
      contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV81NS9mcmFnOjJmNDEzOTUxNDIwZjQxNmRiOTZjMjE1Y2VlNGVkMTQ3L3RhYmxlOjlkZDhkMjk5OGFlNTQ4ZTZhYzJkYTc1MDJiZGUwMjUyL3RhYmxlcmFuZ2U6OWRkOGQyOTk4YWU1NDhlNmFjMmRhNzUwMmJkZTAyNTJfMi0xLTEtMS00NTkxOQ_0213456e-d1db-4e57-a739-0c7caca31a29"
      unitRef="usd">1819000</us-gaap:NetIncomeLoss>
    <us-gaap:InterestOnConvertibleDebtNetOfTax
      contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV81NS9mcmFnOjJmNDEzOTUxNDIwZjQxNmRiOTZjMjE1Y2VlNGVkMTQ3L3RhYmxlOjlkZDhkMjk5OGFlNTQ4ZTZhYzJkYTc1MDJiZGUwMjUyL3RhYmxlcmFuZ2U6OWRkOGQyOTk4YWU1NDhlNmFjMmRhNzUwMmJkZTAyNTJfMi0zLTEtMS00NTkxOQ_7cde3f1a-49c8-4b25-bd27-de49d28cc047"
      unitRef="usd">0</us-gaap:InterestOnConvertibleDebtNetOfTax>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted
      contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV81NS9mcmFnOjJmNDEzOTUxNDIwZjQxNmRiOTZjMjE1Y2VlNGVkMTQ3L3RhYmxlOjlkZDhkMjk5OGFlNTQ4ZTZhYzJkYTc1MDJiZGUwMjUyL3RhYmxlcmFuZ2U6OWRkOGQyOTk4YWU1NDhlNmFjMmRhNzUwMmJkZTAyNTJfMi01LTEtMS00NTkxOQ_0538e2c1-635f-4504-9bd3-26871e379904"
      unitRef="usd">1819000</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:NetIncomeLoss
      contextRef="i9500a5ee8dbe4d23aa9c46ebdd25a0c8_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV81NS9mcmFnOjJmNDEzOTUxNDIwZjQxNmRiOTZjMjE1Y2VlNGVkMTQ3L3RhYmxlOjlkZDhkMjk5OGFlNTQ4ZTZhYzJkYTc1MDJiZGUwMjUyL3RhYmxlcmFuZ2U6OWRkOGQyOTk4YWU1NDhlNmFjMmRhNzUwMmJkZTAyNTJfMi03LTEtMS00NTkxOQ_7b7578b7-4c8a-4664-a19e-e118bb66eab5"
      unitRef="usd">14975000</us-gaap:NetIncomeLoss>
    <us-gaap:InterestOnConvertibleDebtNetOfTax
      contextRef="i9500a5ee8dbe4d23aa9c46ebdd25a0c8_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV81NS9mcmFnOjJmNDEzOTUxNDIwZjQxNmRiOTZjMjE1Y2VlNGVkMTQ3L3RhYmxlOjlkZDhkMjk5OGFlNTQ4ZTZhYzJkYTc1MDJiZGUwMjUyL3RhYmxlcmFuZ2U6OWRkOGQyOTk4YWU1NDhlNmFjMmRhNzUwMmJkZTAyNTJfMi05LTEtMS00NTkxOQ_166db459-d9b8-4c4c-ac3c-e769e77c9aa3"
      unitRef="usd">1715000</us-gaap:InterestOnConvertibleDebtNetOfTax>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted
      contextRef="i9500a5ee8dbe4d23aa9c46ebdd25a0c8_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV81NS9mcmFnOjJmNDEzOTUxNDIwZjQxNmRiOTZjMjE1Y2VlNGVkMTQ3L3RhYmxlOjlkZDhkMjk5OGFlNTQ4ZTZhYzJkYTc1MDJiZGUwMjUyL3RhYmxlcmFuZ2U6OWRkOGQyOTk4YWU1NDhlNmFjMmRhNzUwMmJkZTAyNTJfMi0xMS0xLTEtNDU5MTk_b445ef55-1aba-4709-8cc1-bfcd3ddf732a"
      unitRef="usd">16690000</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV81NS9mcmFnOjJmNDEzOTUxNDIwZjQxNmRiOTZjMjE1Y2VlNGVkMTQ3L3RhYmxlOjlkZDhkMjk5OGFlNTQ4ZTZhYzJkYTc1MDJiZGUwMjUyL3RhYmxlcmFuZ2U6OWRkOGQyOTk4YWU1NDhlNmFjMmRhNzUwMmJkZTAyNTJfNC0xLTEtMS00NTkxOQ_6899eade-dc23-459a-afd7-301069a7cd91"
      unitRef="shares">30511000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV81NS9mcmFnOjJmNDEzOTUxNDIwZjQxNmRiOTZjMjE1Y2VlNGVkMTQ3L3RhYmxlOjlkZDhkMjk5OGFlNTQ4ZTZhYzJkYTc1MDJiZGUwMjUyL3RhYmxlcmFuZ2U6OWRkOGQyOTk4YWU1NDhlNmFjMmRhNzUwMmJkZTAyNTJfNC01LTEtMS00NTkxOQ_18071fa5-d6b1-4c0a-92c2-08b728a25e3b"
      unitRef="shares">30511000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i9500a5ee8dbe4d23aa9c46ebdd25a0c8_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV81NS9mcmFnOjJmNDEzOTUxNDIwZjQxNmRiOTZjMjE1Y2VlNGVkMTQ3L3RhYmxlOjlkZDhkMjk5OGFlNTQ4ZTZhYzJkYTc1MDJiZGUwMjUyL3RhYmxlcmFuZ2U6OWRkOGQyOTk4YWU1NDhlNmFjMmRhNzUwMmJkZTAyNTJfNC03LTEtMS00NTkxOQ_25315d7e-c075-44e0-ad04-6a033b690383"
      unitRef="shares">29428000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i9500a5ee8dbe4d23aa9c46ebdd25a0c8_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV81NS9mcmFnOjJmNDEzOTUxNDIwZjQxNmRiOTZjMjE1Y2VlNGVkMTQ3L3RhYmxlOjlkZDhkMjk5OGFlNTQ4ZTZhYzJkYTc1MDJiZGUwMjUyL3RhYmxlcmFuZ2U6OWRkOGQyOTk4YWU1NDhlNmFjMmRhNzUwMmJkZTAyNTJfNC0xMS0xLTEtNDU5MTk_29c68a08-d91e-4fe7-824c-0b5a0ae04972"
      unitRef="shares">29428000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV81NS9mcmFnOjJmNDEzOTUxNDIwZjQxNmRiOTZjMjE1Y2VlNGVkMTQ3L3RhYmxlOjlkZDhkMjk5OGFlNTQ4ZTZhYzJkYTc1MDJiZGUwMjUyL3RhYmxlcmFuZ2U6OWRkOGQyOTk4YWU1NDhlNmFjMmRhNzUwMmJkZTAyNTJfNi0zLTEtMS00NTkxOQ_e0e5489d-cf7a-4411-9c71-2c67effe6d3c"
      unitRef="shares">629000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV81NS9mcmFnOjJmNDEzOTUxNDIwZjQxNmRiOTZjMjE1Y2VlNGVkMTQ3L3RhYmxlOjlkZDhkMjk5OGFlNTQ4ZTZhYzJkYTc1MDJiZGUwMjUyL3RhYmxlcmFuZ2U6OWRkOGQyOTk4YWU1NDhlNmFjMmRhNzUwMmJkZTAyNTJfNi01LTEtMS00NTkxOQ_9ed3b468-7580-40bc-a1cb-47b1ecc337fa"
      unitRef="shares">629000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i9500a5ee8dbe4d23aa9c46ebdd25a0c8_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV81NS9mcmFnOjJmNDEzOTUxNDIwZjQxNmRiOTZjMjE1Y2VlNGVkMTQ3L3RhYmxlOjlkZDhkMjk5OGFlNTQ4ZTZhYzJkYTc1MDJiZGUwMjUyL3RhYmxlcmFuZ2U6OWRkOGQyOTk4YWU1NDhlNmFjMmRhNzUwMmJkZTAyNTJfNi05LTEtMS00NTkxOQ_bba2dd8c-7cdc-4a3b-b34a-37efd1159ffc"
      unitRef="shares">1158000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i9500a5ee8dbe4d23aa9c46ebdd25a0c8_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV81NS9mcmFnOjJmNDEzOTUxNDIwZjQxNmRiOTZjMjE1Y2VlNGVkMTQ3L3RhYmxlOjlkZDhkMjk5OGFlNTQ4ZTZhYzJkYTc1MDJiZGUwMjUyL3RhYmxlcmFuZ2U6OWRkOGQyOTk4YWU1NDhlNmFjMmRhNzUwMmJkZTAyNTJfNi0xMS0xLTEtNDU5MTk_b4c53f44-2db3-4fb4-a580-248e50ccf0a0"
      unitRef="shares">1158000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants
      contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV81NS9mcmFnOjJmNDEzOTUxNDIwZjQxNmRiOTZjMjE1Y2VlNGVkMTQ3L3RhYmxlOjlkZDhkMjk5OGFlNTQ4ZTZhYzJkYTc1MDJiZGUwMjUyL3RhYmxlcmFuZ2U6OWRkOGQyOTk4YWU1NDhlNmFjMmRhNzUwMmJkZTAyNTJfOC0zLTEtMS00NTkxOQ_b9cd1638-f97f-4b65-a88f-61fa36dbb3c2"
      unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants>
    <us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants
      contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV81NS9mcmFnOjJmNDEzOTUxNDIwZjQxNmRiOTZjMjE1Y2VlNGVkMTQ3L3RhYmxlOjlkZDhkMjk5OGFlNTQ4ZTZhYzJkYTc1MDJiZGUwMjUyL3RhYmxlcmFuZ2U6OWRkOGQyOTk4YWU1NDhlNmFjMmRhNzUwMmJkZTAyNTJfOC01LTEtMS00NTkxOQ_412e02e3-40aa-4c42-be2e-115319dcfdc8"
      unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants>
    <us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants
      contextRef="i9500a5ee8dbe4d23aa9c46ebdd25a0c8_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV81NS9mcmFnOjJmNDEzOTUxNDIwZjQxNmRiOTZjMjE1Y2VlNGVkMTQ3L3RhYmxlOjlkZDhkMjk5OGFlNTQ4ZTZhYzJkYTc1MDJiZGUwMjUyL3RhYmxlcmFuZ2U6OWRkOGQyOTk4YWU1NDhlNmFjMmRhNzUwMmJkZTAyNTJfOC05LTEtMS00NTkxOQ_8675b4ba-cc20-4c16-ab84-fe4b5e5956a2"
      unitRef="shares">684000</us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants>
    <us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants
      contextRef="i9500a5ee8dbe4d23aa9c46ebdd25a0c8_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV81NS9mcmFnOjJmNDEzOTUxNDIwZjQxNmRiOTZjMjE1Y2VlNGVkMTQ3L3RhYmxlOjlkZDhkMjk5OGFlNTQ4ZTZhYzJkYTc1MDJiZGUwMjUyL3RhYmxlcmFuZ2U6OWRkOGQyOTk4YWU1NDhlNmFjMmRhNzUwMmJkZTAyNTJfOC0xMS0xLTEtNDU5MTk_eb841bad-95c0-4269-97fc-0d52f3a2fcc6"
      unitRef="shares">684000</us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants>
    <us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities
      contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV81NS9mcmFnOjJmNDEzOTUxNDIwZjQxNmRiOTZjMjE1Y2VlNGVkMTQ3L3RhYmxlOjlkZDhkMjk5OGFlNTQ4ZTZhYzJkYTc1MDJiZGUwMjUyL3RhYmxlcmFuZ2U6OWRkOGQyOTk4YWU1NDhlNmFjMmRhNzUwMmJkZTAyNTJfMTAtMy0xLTEtNDU5MTk_336b5da8-3b6a-4f4f-9f05-7ad5a2821382"
      unitRef="shares">64000</us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities>
    <us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities
      contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV81NS9mcmFnOjJmNDEzOTUxNDIwZjQxNmRiOTZjMjE1Y2VlNGVkMTQ3L3RhYmxlOjlkZDhkMjk5OGFlNTQ4ZTZhYzJkYTc1MDJiZGUwMjUyL3RhYmxlcmFuZ2U6OWRkOGQyOTk4YWU1NDhlNmFjMmRhNzUwMmJkZTAyNTJfMTAtNS0xLTEtNDU5MTk_b7ba9247-be73-4271-bc66-a96596e1ce51"
      unitRef="shares">64000</us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities>
    <us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities
      contextRef="i9500a5ee8dbe4d23aa9c46ebdd25a0c8_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV81NS9mcmFnOjJmNDEzOTUxNDIwZjQxNmRiOTZjMjE1Y2VlNGVkMTQ3L3RhYmxlOjlkZDhkMjk5OGFlNTQ4ZTZhYzJkYTc1MDJiZGUwMjUyL3RhYmxlcmFuZ2U6OWRkOGQyOTk4YWU1NDhlNmFjMmRhNzUwMmJkZTAyNTJfMTAtOS0xLTEtNDU5MTk_4095547f-b9b2-4acd-a39d-0aa019b27937"
      unitRef="shares">3885000</us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities>
    <us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities
      contextRef="i9500a5ee8dbe4d23aa9c46ebdd25a0c8_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV81NS9mcmFnOjJmNDEzOTUxNDIwZjQxNmRiOTZjMjE1Y2VlNGVkMTQ3L3RhYmxlOjlkZDhkMjk5OGFlNTQ4ZTZhYzJkYTc1MDJiZGUwMjUyL3RhYmxlcmFuZ2U6OWRkOGQyOTk4YWU1NDhlNmFjMmRhNzUwMmJkZTAyNTJfMTAtMTEtMS0xLTQ1OTE5_e317ba1a-5eeb-44df-99e4-04caaf487c26"
      unitRef="shares">3885000</us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV81NS9mcmFnOjJmNDEzOTUxNDIwZjQxNmRiOTZjMjE1Y2VlNGVkMTQ3L3RhYmxlOjlkZDhkMjk5OGFlNTQ4ZTZhYzJkYTc1MDJiZGUwMjUyL3RhYmxlcmFuZ2U6OWRkOGQyOTk4YWU1NDhlNmFjMmRhNzUwMmJkZTAyNTJfMTItMS0xLTEtNDU5MTk_d1f16651-0082-4096-bf1f-729359412c6b"
      unitRef="shares">30511000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV81NS9mcmFnOjJmNDEzOTUxNDIwZjQxNmRiOTZjMjE1Y2VlNGVkMTQ3L3RhYmxlOjlkZDhkMjk5OGFlNTQ4ZTZhYzJkYTc1MDJiZGUwMjUyL3RhYmxlcmFuZ2U6OWRkOGQyOTk4YWU1NDhlNmFjMmRhNzUwMmJkZTAyNTJfMTItMy0xLTEtNDU5MTk_cb3dabc4-106c-4395-a724-66c69065dbf9"
      unitRef="shares">693000</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV81NS9mcmFnOjJmNDEzOTUxNDIwZjQxNmRiOTZjMjE1Y2VlNGVkMTQ3L3RhYmxlOjlkZDhkMjk5OGFlNTQ4ZTZhYzJkYTc1MDJiZGUwMjUyL3RhYmxlcmFuZ2U6OWRkOGQyOTk4YWU1NDhlNmFjMmRhNzUwMmJkZTAyNTJfMTItNS0xLTEtNDU5MTk_6de1cfad-6f5d-473c-8939-a94e62aa92d2"
      unitRef="shares">31204000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i9500a5ee8dbe4d23aa9c46ebdd25a0c8_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV81NS9mcmFnOjJmNDEzOTUxNDIwZjQxNmRiOTZjMjE1Y2VlNGVkMTQ3L3RhYmxlOjlkZDhkMjk5OGFlNTQ4ZTZhYzJkYTc1MDJiZGUwMjUyL3RhYmxlcmFuZ2U6OWRkOGQyOTk4YWU1NDhlNmFjMmRhNzUwMmJkZTAyNTJfMTItNy0xLTEtNDU5MTk_74c9c9a8-7ade-4740-aca1-ee6b7f6130e8"
      unitRef="shares">29428000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="i9500a5ee8dbe4d23aa9c46ebdd25a0c8_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV81NS9mcmFnOjJmNDEzOTUxNDIwZjQxNmRiOTZjMjE1Y2VlNGVkMTQ3L3RhYmxlOjlkZDhkMjk5OGFlNTQ4ZTZhYzJkYTc1MDJiZGUwMjUyL3RhYmxlcmFuZ2U6OWRkOGQyOTk4YWU1NDhlNmFjMmRhNzUwMmJkZTAyNTJfMTItOS0xLTEtNDU5MTk_c47a710a-f346-486a-9707-6e8fac25cca3"
      unitRef="shares">5727000</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i9500a5ee8dbe4d23aa9c46ebdd25a0c8_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV81NS9mcmFnOjJmNDEzOTUxNDIwZjQxNmRiOTZjMjE1Y2VlNGVkMTQ3L3RhYmxlOjlkZDhkMjk5OGFlNTQ4ZTZhYzJkYTc1MDJiZGUwMjUyL3RhYmxlcmFuZ2U6OWRkOGQyOTk4YWU1NDhlNmFjMmRhNzUwMmJkZTAyNTJfMTItMTEtMS0xLTQ1OTE5_134bb95d-766e-4f72-bd52-033fa2a603d5"
      unitRef="shares">35155000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareBasic
      contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV81NS9mcmFnOjJmNDEzOTUxNDIwZjQxNmRiOTZjMjE1Y2VlNGVkMTQ3L3RhYmxlOjlkZDhkMjk5OGFlNTQ4ZTZhYzJkYTc1MDJiZGUwMjUyL3RhYmxlcmFuZ2U6OWRkOGQyOTk4YWU1NDhlNmFjMmRhNzUwMmJkZTAyNTJfMTQtMS0xLTEtNDU5MTk_94e622d1-ca5e-420e-856e-087d48e8e12b"
      unitRef="usdPerShare">0.06</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV81NS9mcmFnOjJmNDEzOTUxNDIwZjQxNmRiOTZjMjE1Y2VlNGVkMTQ3L3RhYmxlOjlkZDhkMjk5OGFlNTQ4ZTZhYzJkYTc1MDJiZGUwMjUyL3RhYmxlcmFuZ2U6OWRkOGQyOTk4YWU1NDhlNmFjMmRhNzUwMmJkZTAyNTJfMTQtNS0xLTEtNDU5MTk_8c639eb7-1bd4-45cf-af2e-b1e7a3b9004e"
      unitRef="usdPerShare">0.06</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="i9500a5ee8dbe4d23aa9c46ebdd25a0c8_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV81NS9mcmFnOjJmNDEzOTUxNDIwZjQxNmRiOTZjMjE1Y2VlNGVkMTQ3L3RhYmxlOjlkZDhkMjk5OGFlNTQ4ZTZhYzJkYTc1MDJiZGUwMjUyL3RhYmxlcmFuZ2U6OWRkOGQyOTk4YWU1NDhlNmFjMmRhNzUwMmJkZTAyNTJfMTQtNy0xLTEtNDU5MTk_be0cce94-aa43-4f37-b939-ccb6310ca410"
      unitRef="usdPerShare">0.51</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i9500a5ee8dbe4d23aa9c46ebdd25a0c8_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV81NS9mcmFnOjJmNDEzOTUxNDIwZjQxNmRiOTZjMjE1Y2VlNGVkMTQ3L3RhYmxlOjlkZDhkMjk5OGFlNTQ4ZTZhYzJkYTc1MDJiZGUwMjUyL3RhYmxlcmFuZ2U6OWRkOGQyOTk4YWU1NDhlNmFjMmRhNzUwMmJkZTAyNTJfMTQtMTEtMS0xLTQ1OTE5_32c85c11-e2e3-47b5-8469-f9b682efdaed"
      unitRef="usdPerShare">0.47</us-gaap:EarningsPerShareDiluted>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV81NS9mcmFnOjJmNDEzOTUxNDIwZjQxNmRiOTZjMjE1Y2VlNGVkMTQ3L3RleHRyZWdpb246MmY0MTM5NTE0MjBmNDE2ZGI5NmMyMTVjZWU0ZWQxNDdfOTkx_e05a498f-08d8-46b0-a991-6df14b576501"
      unitRef="shares">2200000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i9500a5ee8dbe4d23aa9c46ebdd25a0c8_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV81NS9mcmFnOjJmNDEzOTUxNDIwZjQxNmRiOTZjMjE1Y2VlNGVkMTQ3L3RleHRyZWdpb246MmY0MTM5NTE0MjBmNDE2ZGI5NmMyMTVjZWU0ZWQxNDdfNTQ5NzU1ODE5NzE0_c971bdd8-393d-4901-af73-01b20e3e13f5"
      unitRef="shares">900000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock
      contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV81OC9mcmFnOjg3YjJhN2NmMDU0ZDQxYzJiOWFhNjQzZDdjZjUyNWI0L3RleHRyZWdpb246ODdiMmE3Y2YwNTRkNDFjMmI5YWE2NDNkN2NmNTI1YjRfMTg5Ng_bbf558df-f4bc-48ac-a340-40397438e04f">Goodwill and Other Intangible Assets&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The changes in the net carrying amount of goodwill for the three months ended March&#160;31, 2023 are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.374%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;815,429&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;815,499&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Assets and liabilities of acquired businesses are recorded at their estimated fair values as of the date of acquisition.&#160;&#160;Goodwill represents costs in excess of fair values assigned to the underlying net assets of acquired businesses.&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other intangible assets consist of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:15.75pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:36.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.333%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted Average Amortization Period (Years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Intangible assets with definite lives:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer and distributor relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;369,881&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(175,291)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;369,854&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(170,870)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Sales representation, marketing and promotional rights&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;149,376&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(67,500)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;149,376&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(66,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Developed technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;320,204&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(37,146)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;320,204&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(34,675)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Patents and other intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80,335&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(52,865)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79,838&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(52,472)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Intangible assets with indefinite lives:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trademarks and tradenames&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86,544&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86,544&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,006,340&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(332,802)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,005,816&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(324,017)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Customer and distributor relationships, trademarks and tradenames, developed technology and patents and other intangible assets primarily represent allocations of purchase price to identifiable intangible assets of acquired businesses.  Sales representation, marketing and promotional rights represent intangible assets created under our agreement with Musculoskeletal Transplant Foundation (&#x201c;MTF&#x201d;).&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Amortization expense related to intangible assets which are subject to amortization totaled $8.8 million and $8.0 million for the three months ended March 31, 2023 and 2022, respectively, and is included as a reduction of revenue (for amortization related to our sales representation, marketing and promotional rights) and in selling and administrative expense (for all other intangible assets) in the consolidated condensed statements of comprehensive income.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The estimated intangible asset amortization expense remaining for the year ending December&#160;31, 2023 and for each of the five succeeding years is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:57.025%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.223%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.824%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.930%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.824%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.374%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amortization included in expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amortization recorded as a reduction of revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Remaining, 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,947&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,447&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,773&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,773&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,563&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,563&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,316&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,316&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,367&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,367&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,507&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,507&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock>
    <us-gaap:ScheduleOfGoodwillTextBlock
      contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV81OC9mcmFnOjg3YjJhN2NmMDU0ZDQxYzJiOWFhNjQzZDdjZjUyNWI0L3RleHRyZWdpb246ODdiMmE3Y2YwNTRkNDFjMmI5YWE2NDNkN2NmNTI1YjRfMTkwMw_d9e055a9-5684-4f03-8527-fccfca521eca">&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The changes in the net carrying amount of goodwill for the three months ended March&#160;31, 2023 are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.374%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;815,429&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;815,499&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfGoodwillTextBlock>
    <us-gaap:Goodwill
      contextRef="ie4f63720d8b244a68941932992cd9f4d_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV81OC9mcmFnOjg3YjJhN2NmMDU0ZDQxYzJiOWFhNjQzZDdjZjUyNWI0L3RhYmxlOjA3ZGM5MDY5ZDhmNjQ2MjNhM2VmOWQ0YzE0YmNlZjg5L3RhYmxlcmFuZ2U6MDdkYzkwNjlkOGY2NDYyM2EzZWY5ZDRjMTRiY2VmODlfMC0xLTEtMS00NTkxOQ_0559e9d5-b5f2-4a77-9dfd-783b964fde59"
      unitRef="usd">815429000</us-gaap:Goodwill>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV81OC9mcmFnOjg3YjJhN2NmMDU0ZDQxYzJiOWFhNjQzZDdjZjUyNWI0L3RhYmxlOjA3ZGM5MDY5ZDhmNjQ2MjNhM2VmOWQ0YzE0YmNlZjg5L3RhYmxlcmFuZ2U6MDdkYzkwNjlkOGY2NDYyM2EzZWY5ZDRjMTRiY2VmODlfNC0xLTEtMS00NTkxOQ_74fa99e1-4e84-4873-a5b6-49c4cd6559ea"
      unitRef="usd">70000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:Goodwill
      contextRef="i738c2d1dacaf436faf03cc46ab9cef23_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV81OC9mcmFnOjg3YjJhN2NmMDU0ZDQxYzJiOWFhNjQzZDdjZjUyNWI0L3RhYmxlOjA3ZGM5MDY5ZDhmNjQ2MjNhM2VmOWQ0YzE0YmNlZjg5L3RhYmxlcmFuZ2U6MDdkYzkwNjlkOGY2NDYyM2EzZWY5ZDRjMTRiY2VmODlfNi0xLTEtMS00NTkxOQ_a51f175d-95d2-4b00-ad88-9da07af230af"
      unitRef="usd">815499000</us-gaap:Goodwill>
    <us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock
      contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV81OC9mcmFnOjg3YjJhN2NmMDU0ZDQxYzJiOWFhNjQzZDdjZjUyNWI0L3RleHRyZWdpb246ODdiMmE3Y2YwNTRkNDFjMmI5YWE2NDNkN2NmNTI1YjRfMTg5NA_ed2d16eb-d3c3-4591-8e64-e4ad432add90">&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other intangible assets consist of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:15.75pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:36.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.333%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted Average Amortization Period (Years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Intangible assets with definite lives:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer and distributor relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;369,881&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(175,291)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;369,854&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(170,870)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Sales representation, marketing and promotional rights&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;149,376&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(67,500)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;149,376&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(66,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Developed technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;320,204&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(37,146)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;320,204&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(34,675)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Patents and other intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80,335&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(52,865)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79,838&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(52,472)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Intangible assets with indefinite lives:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trademarks and tradenames&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86,544&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86,544&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,006,340&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(332,802)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,005,816&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(324,017)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock>
    <us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock
      contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV81OC9mcmFnOjg3YjJhN2NmMDU0ZDQxYzJiOWFhNjQzZDdjZjUyNWI0L3RleHRyZWdpb246ODdiMmE3Y2YwNTRkNDFjMmI5YWE2NDNkN2NmNTI1YjRfMTkyMA_a3a3db32-7973-448f-a7c3-73e510b009f1">&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other intangible assets consist of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:15.75pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:36.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.333%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted Average Amortization Period (Years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Intangible assets with definite lives:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer and distributor relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;369,881&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(175,291)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;369,854&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(170,870)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Sales representation, marketing and promotional rights&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;149,376&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(67,500)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;149,376&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(66,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Developed technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;320,204&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(37,146)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;320,204&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(34,675)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Patents and other intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80,335&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(52,865)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79,838&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(52,472)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Intangible assets with indefinite lives:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trademarks and tradenames&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86,544&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86,544&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,006,340&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(332,802)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,005,816&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(324,017)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="iedfdc8f66b2f411eba07af9d70f8fc00_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV81OC9mcmFnOjg3YjJhN2NmMDU0ZDQxYzJiOWFhNjQzZDdjZjUyNWI0L3RhYmxlOmMwM2VjNmEzZTJlZDQ0NThiZDc1Yzk3MzlhYTJlMTU2L3RhYmxlcmFuZ2U6YzAzZWM2YTNlMmVkNDQ1OGJkNzVjOTczOWFhMmUxNTZfMi0xLTEtMS00NTkxOQ_54dfa4eb-c88e-48c2-8b73-fc13b6def291">P22Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="ide2cf996936344b29f9f89e17e70e4cf_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV81OC9mcmFnOjg3YjJhN2NmMDU0ZDQxYzJiOWFhNjQzZDdjZjUyNWI0L3RhYmxlOmMwM2VjNmEzZTJlZDQ0NThiZDc1Yzk3MzlhYTJlMTU2L3RhYmxlcmFuZ2U6YzAzZWM2YTNlMmVkNDQ1OGJkNzVjOTczOWFhMmUxNTZfNC0xLTEtMS00NTkxOQ_4b6ac6bc-c28f-42b8-9587-cde42868691a">P24Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i4d83f76b6b11441d8c3ab802aea5f214_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV81OC9mcmFnOjg3YjJhN2NmMDU0ZDQxYzJiOWFhNjQzZDdjZjUyNWI0L3RhYmxlOmMwM2VjNmEzZTJlZDQ0NThiZDc1Yzk3MzlhYTJlMTU2L3RhYmxlcmFuZ2U6YzAzZWM2YTNlMmVkNDQ1OGJkNzVjOTczOWFhMmUxNTZfNC0yLTEtMS00NTkxOQ_9e62278c-2cc8-4803-9597-2f8d80867fe5"
      unitRef="usd">369881000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i4d83f76b6b11441d8c3ab802aea5f214_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV81OC9mcmFnOjg3YjJhN2NmMDU0ZDQxYzJiOWFhNjQzZDdjZjUyNWI0L3RhYmxlOmMwM2VjNmEzZTJlZDQ0NThiZDc1Yzk3MzlhYTJlMTU2L3RhYmxlcmFuZ2U6YzAzZWM2YTNlMmVkNDQ1OGJkNzVjOTczOWFhMmUxNTZfNC00LTEtMS00NTkxOQ_1126cca2-aeaa-4322-90c3-4b31e14f5876"
      unitRef="usd">175291000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ie37eab970dd24bbc96548816db1cb2e7_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV81OC9mcmFnOjg3YjJhN2NmMDU0ZDQxYzJiOWFhNjQzZDdjZjUyNWI0L3RhYmxlOmMwM2VjNmEzZTJlZDQ0NThiZDc1Yzk3MzlhYTJlMTU2L3RhYmxlcmFuZ2U6YzAzZWM2YTNlMmVkNDQ1OGJkNzVjOTczOWFhMmUxNTZfNC02LTEtMS00NTkxOQ_96b45dfa-2992-4d35-b8e6-52d1c6f0fdaf"
      unitRef="usd">369854000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ie37eab970dd24bbc96548816db1cb2e7_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV81OC9mcmFnOjg3YjJhN2NmMDU0ZDQxYzJiOWFhNjQzZDdjZjUyNWI0L3RhYmxlOmMwM2VjNmEzZTJlZDQ0NThiZDc1Yzk3MzlhYTJlMTU2L3RhYmxlcmFuZ2U6YzAzZWM2YTNlMmVkNDQ1OGJkNzVjOTczOWFhMmUxNTZfNC04LTEtMS00NTkxOQ_ab32845c-5945-4bc6-8872-fcd17fd3d304"
      unitRef="usd">170870000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i58ab77cab7774f0abbd0ec4142cdd537_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV81OC9mcmFnOjg3YjJhN2NmMDU0ZDQxYzJiOWFhNjQzZDdjZjUyNWI0L3RhYmxlOmMwM2VjNmEzZTJlZDQ0NThiZDc1Yzk3MzlhYTJlMTU2L3RhYmxlcmFuZ2U6YzAzZWM2YTNlMmVkNDQ1OGJkNzVjOTczOWFhMmUxNTZfNi0xLTEtMS00NTkxOQ_d45b4579-bd0e-48a4-baab-3a1504145d3a">P25Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i64c256aebff14314a4a652aca23bb503_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV81OC9mcmFnOjg3YjJhN2NmMDU0ZDQxYzJiOWFhNjQzZDdjZjUyNWI0L3RhYmxlOmMwM2VjNmEzZTJlZDQ0NThiZDc1Yzk3MzlhYTJlMTU2L3RhYmxlcmFuZ2U6YzAzZWM2YTNlMmVkNDQ1OGJkNzVjOTczOWFhMmUxNTZfNi0yLTEtMS00NTkxOQ_55b40fe3-6b43-4e32-8aa0-5de27aaf703e"
      unitRef="usd">149376000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i64c256aebff14314a4a652aca23bb503_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV81OC9mcmFnOjg3YjJhN2NmMDU0ZDQxYzJiOWFhNjQzZDdjZjUyNWI0L3RhYmxlOmMwM2VjNmEzZTJlZDQ0NThiZDc1Yzk3MzlhYTJlMTU2L3RhYmxlcmFuZ2U6YzAzZWM2YTNlMmVkNDQ1OGJkNzVjOTczOWFhMmUxNTZfNi00LTEtMS00NTkxOQ_3c9a14ca-21fb-4480-afdf-b958fc3ad082"
      unitRef="usd">67500000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ifdfb609f174b4aff8460fb861d91811c_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV81OC9mcmFnOjg3YjJhN2NmMDU0ZDQxYzJiOWFhNjQzZDdjZjUyNWI0L3RhYmxlOmMwM2VjNmEzZTJlZDQ0NThiZDc1Yzk3MzlhYTJlMTU2L3RhYmxlcmFuZ2U6YzAzZWM2YTNlMmVkNDQ1OGJkNzVjOTczOWFhMmUxNTZfNi02LTEtMS00NTkxOQ_f23e7c62-caf4-4332-b4ec-dbd0b117d4c8"
      unitRef="usd">149376000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ifdfb609f174b4aff8460fb861d91811c_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV81OC9mcmFnOjg3YjJhN2NmMDU0ZDQxYzJiOWFhNjQzZDdjZjUyNWI0L3RhYmxlOmMwM2VjNmEzZTJlZDQ0NThiZDc1Yzk3MzlhYTJlMTU2L3RhYmxlcmFuZ2U6YzAzZWM2YTNlMmVkNDQ1OGJkNzVjOTczOWFhMmUxNTZfNi04LTEtMS00NTkxOQ_467a449f-f56c-4956-b77e-a4295feb4432"
      unitRef="usd">66000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i91d9eb56eaa944dea8c761cea88d5b5c_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV81OC9mcmFnOjg3YjJhN2NmMDU0ZDQxYzJiOWFhNjQzZDdjZjUyNWI0L3RhYmxlOmMwM2VjNmEzZTJlZDQ0NThiZDc1Yzk3MzlhYTJlMTU2L3RhYmxlcmFuZ2U6YzAzZWM2YTNlMmVkNDQ1OGJkNzVjOTczOWFhMmUxNTZfOC0xLTEtMS00NTkxOQ_0d363d07-3fe6-4120-b52d-9c39f9a67086">P18Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i7c64eb13dae8441284872536e8e2fd72_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV81OC9mcmFnOjg3YjJhN2NmMDU0ZDQxYzJiOWFhNjQzZDdjZjUyNWI0L3RhYmxlOmMwM2VjNmEzZTJlZDQ0NThiZDc1Yzk3MzlhYTJlMTU2L3RhYmxlcmFuZ2U6YzAzZWM2YTNlMmVkNDQ1OGJkNzVjOTczOWFhMmUxNTZfOC0yLTEtMS00NTkxOQ_eb9f3d8c-b804-4ee0-9ae1-90f31dc94204"
      unitRef="usd">320204000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i7c64eb13dae8441284872536e8e2fd72_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV81OC9mcmFnOjg3YjJhN2NmMDU0ZDQxYzJiOWFhNjQzZDdjZjUyNWI0L3RhYmxlOmMwM2VjNmEzZTJlZDQ0NThiZDc1Yzk3MzlhYTJlMTU2L3RhYmxlcmFuZ2U6YzAzZWM2YTNlMmVkNDQ1OGJkNzVjOTczOWFhMmUxNTZfOC00LTEtMS00NTkxOQ_8cd52bdf-1bfe-48cf-a286-667e761374a8"
      unitRef="usd">37146000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i133dcfdb14dd4cd893d74ce7e88ebdac_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV81OC9mcmFnOjg3YjJhN2NmMDU0ZDQxYzJiOWFhNjQzZDdjZjUyNWI0L3RhYmxlOmMwM2VjNmEzZTJlZDQ0NThiZDc1Yzk3MzlhYTJlMTU2L3RhYmxlcmFuZ2U6YzAzZWM2YTNlMmVkNDQ1OGJkNzVjOTczOWFhMmUxNTZfOC02LTEtMS00NTkxOQ_968a277f-2050-44bb-86fb-de0a6c673b06"
      unitRef="usd">320204000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i133dcfdb14dd4cd893d74ce7e88ebdac_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV81OC9mcmFnOjg3YjJhN2NmMDU0ZDQxYzJiOWFhNjQzZDdjZjUyNWI0L3RhYmxlOmMwM2VjNmEzZTJlZDQ0NThiZDc1Yzk3MzlhYTJlMTU2L3RhYmxlcmFuZ2U6YzAzZWM2YTNlMmVkNDQ1OGJkNzVjOTczOWFhMmUxNTZfOC04LTEtMS00NTkxOQ_68692b36-a2c7-439f-b278-a5b6faf400e5"
      unitRef="usd">34675000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="ifeb04f4ad743475cb77f3692c078bd59_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV81OC9mcmFnOjg3YjJhN2NmMDU0ZDQxYzJiOWFhNjQzZDdjZjUyNWI0L3RhYmxlOmMwM2VjNmEzZTJlZDQ0NThiZDc1Yzk3MzlhYTJlMTU2L3RhYmxlcmFuZ2U6YzAzZWM2YTNlMmVkNDQ1OGJkNzVjOTczOWFhMmUxNTZfMTAtMS0xLTEtNDU5MTk_d0387eaf-5085-4eaf-8503-0edcc30e1b03">P16Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i1e96e744b1b74f8aa08027bb20d925e8_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV81OC9mcmFnOjg3YjJhN2NmMDU0ZDQxYzJiOWFhNjQzZDdjZjUyNWI0L3RhYmxlOmMwM2VjNmEzZTJlZDQ0NThiZDc1Yzk3MzlhYTJlMTU2L3RhYmxlcmFuZ2U6YzAzZWM2YTNlMmVkNDQ1OGJkNzVjOTczOWFhMmUxNTZfMTAtMi0xLTEtNDU5MTk_06848c85-294c-4e9b-b8ef-e7e0fd7a5b7f"
      unitRef="usd">80335000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i1e96e744b1b74f8aa08027bb20d925e8_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV81OC9mcmFnOjg3YjJhN2NmMDU0ZDQxYzJiOWFhNjQzZDdjZjUyNWI0L3RhYmxlOmMwM2VjNmEzZTJlZDQ0NThiZDc1Yzk3MzlhYTJlMTU2L3RhYmxlcmFuZ2U6YzAzZWM2YTNlMmVkNDQ1OGJkNzVjOTczOWFhMmUxNTZfMTAtNC0xLTEtNDU5MTk_800dabb6-b455-4ca4-8682-46ba2fc0401d"
      unitRef="usd">52865000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i28feeea45b68471f9fa287ac91c55448_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV81OC9mcmFnOjg3YjJhN2NmMDU0ZDQxYzJiOWFhNjQzZDdjZjUyNWI0L3RhYmxlOmMwM2VjNmEzZTJlZDQ0NThiZDc1Yzk3MzlhYTJlMTU2L3RhYmxlcmFuZ2U6YzAzZWM2YTNlMmVkNDQ1OGJkNzVjOTczOWFhMmUxNTZfMTAtNi0xLTEtNDU5MTk_3431941c-de7a-4d2a-b12b-5a6aea439c0c"
      unitRef="usd">79838000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i28feeea45b68471f9fa287ac91c55448_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV81OC9mcmFnOjg3YjJhN2NmMDU0ZDQxYzJiOWFhNjQzZDdjZjUyNWI0L3RhYmxlOmMwM2VjNmEzZTJlZDQ0NThiZDc1Yzk3MzlhYTJlMTU2L3RhYmxlcmFuZ2U6YzAzZWM2YTNlMmVkNDQ1OGJkNzVjOTczOWFhMmUxNTZfMTAtOC0xLTEtNDU5MTk_b1ffa39e-8eb4-456c-b2a6-cb606c4b9894"
      unitRef="usd">52472000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="id242550a03e34bc39903baf6836b46df_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV81OC9mcmFnOjg3YjJhN2NmMDU0ZDQxYzJiOWFhNjQzZDdjZjUyNWI0L3RhYmxlOmMwM2VjNmEzZTJlZDQ0NThiZDc1Yzk3MzlhYTJlMTU2L3RhYmxlcmFuZ2U6YzAzZWM2YTNlMmVkNDQ1OGJkNzVjOTczOWFhMmUxNTZfMTQtMi0xLTEtNDU5MTk_e240b9e7-89a6-4329-9c50-0e7f22588278"
      unitRef="usd">86544000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i9b68c90bafb04105bba9266879cc57f9_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV81OC9mcmFnOjg3YjJhN2NmMDU0ZDQxYzJiOWFhNjQzZDdjZjUyNWI0L3RhYmxlOmMwM2VjNmEzZTJlZDQ0NThiZDc1Yzk3MzlhYTJlMTU2L3RhYmxlcmFuZ2U6YzAzZWM2YTNlMmVkNDQ1OGJkNzVjOTczOWFhMmUxNTZfMTQtNi0xLTEtNDU5MTk_59ec6652-2aef-4100-a6c6-5330cc3072c5"
      unitRef="usd">86544000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="i738c2d1dacaf436faf03cc46ab9cef23_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV81OC9mcmFnOjg3YjJhN2NmMDU0ZDQxYzJiOWFhNjQzZDdjZjUyNWI0L3RhYmxlOmMwM2VjNmEzZTJlZDQ0NThiZDc1Yzk3MzlhYTJlMTU2L3RhYmxlcmFuZ2U6YzAzZWM2YTNlMmVkNDQ1OGJkNzVjOTczOWFhMmUxNTZfMTYtMi0xLTEtNDU5MTk_271fe6bc-d682-4e3e-b63a-bb9ad1353067"
      unitRef="usd">1006340000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i738c2d1dacaf436faf03cc46ab9cef23_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV81OC9mcmFnOjg3YjJhN2NmMDU0ZDQxYzJiOWFhNjQzZDdjZjUyNWI0L3RhYmxlOmMwM2VjNmEzZTJlZDQ0NThiZDc1Yzk3MzlhYTJlMTU2L3RhYmxlcmFuZ2U6YzAzZWM2YTNlMmVkNDQ1OGJkNzVjOTczOWFhMmUxNTZfMTYtNC0xLTEtNDU5MTk_58ebd87c-701c-4a47-a1c2-10fbea24d303"
      unitRef="usd">332802000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="ie4f63720d8b244a68941932992cd9f4d_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV81OC9mcmFnOjg3YjJhN2NmMDU0ZDQxYzJiOWFhNjQzZDdjZjUyNWI0L3RhYmxlOmMwM2VjNmEzZTJlZDQ0NThiZDc1Yzk3MzlhYTJlMTU2L3RhYmxlcmFuZ2U6YzAzZWM2YTNlMmVkNDQ1OGJkNzVjOTczOWFhMmUxNTZfMTYtNi0xLTEtNDU5MTk_1c58b755-473d-4191-bbdb-990a5ba69641"
      unitRef="usd">1005816000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ie4f63720d8b244a68941932992cd9f4d_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV81OC9mcmFnOjg3YjJhN2NmMDU0ZDQxYzJiOWFhNjQzZDdjZjUyNWI0L3RhYmxlOmMwM2VjNmEzZTJlZDQ0NThiZDc1Yzk3MzlhYTJlMTU2L3RhYmxlcmFuZ2U6YzAzZWM2YTNlMmVkNDQ1OGJkNzVjOTczOWFhMmUxNTZfMTYtOC0xLTEtNDU5MTk_6c061d3d-6c6c-48e7-927b-f2f110adf80b"
      unitRef="usd">324017000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV81OC9mcmFnOjg3YjJhN2NmMDU0ZDQxYzJiOWFhNjQzZDdjZjUyNWI0L3RleHRyZWdpb246ODdiMmE3Y2YwNTRkNDFjMmI5YWE2NDNkN2NmNTI1YjRfMTM5MQ_5eb31089-0211-48d6-be87-0cdd3bfbc04b"
      unitRef="usd">8800000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i9500a5ee8dbe4d23aa9c46ebdd25a0c8_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV81OC9mcmFnOjg3YjJhN2NmMDU0ZDQxYzJiOWFhNjQzZDdjZjUyNWI0L3RleHRyZWdpb246ODdiMmE3Y2YwNTRkNDFjMmI5YWE2NDNkN2NmNTI1YjRfMTM5OA_becab892-4b42-4e65-a19e-d50a9f11c627"
      unitRef="usd">8000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock
      contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV81OC9mcmFnOjg3YjJhN2NmMDU0ZDQxYzJiOWFhNjQzZDdjZjUyNWI0L3RleHRyZWdpb246ODdiMmE3Y2YwNTRkNDFjMmI5YWE2NDNkN2NmNTI1YjRfMTg4OQ_f6d39902-b204-4ae7-9c06-54b0a79b99c0">&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The estimated intangible asset amortization expense remaining for the year ending December&#160;31, 2023 and for each of the five succeeding years is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:57.025%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.223%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.824%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.930%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.824%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.374%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amortization included in expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amortization recorded as a reduction of revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Remaining, 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,947&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,447&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,773&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,773&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,563&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,563&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,316&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,316&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,367&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,367&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,507&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,507&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
      contextRef="i1252040e498e429c840f44af12d910cb_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV81OC9mcmFnOjg3YjJhN2NmMDU0ZDQxYzJiOWFhNjQzZDdjZjUyNWI0L3RhYmxlOjk3Yzk5YWY2MjNjYzRmNWRiOTcyODNkNTA5MGVhMzc3L3RhYmxlcmFuZ2U6OTdjOTlhZjYyM2NjNGY1ZGI5NzI4M2Q1MDkwZWEzNzdfMS0xLTEtMS00NTkxOQ_d4236831-8222-470f-aace-64860a207996"
      unitRef="usd">21947000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
      contextRef="ie545f13df7334e93a19c1ff77d2eb84e_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV81OC9mcmFnOjg3YjJhN2NmMDU0ZDQxYzJiOWFhNjQzZDdjZjUyNWI0L3RhYmxlOjk3Yzk5YWY2MjNjYzRmNWRiOTcyODNkNTA5MGVhMzc3L3RhYmxlcmFuZ2U6OTdjOTlhZjYyM2NjNGY1ZGI5NzI4M2Q1MDkwZWEzNzdfMS0zLTEtMS00NTkxOQ_533a5121-7235-4216-a3f0-a7275dfc579e"
      unitRef="usd">4500000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
      contextRef="i738c2d1dacaf436faf03cc46ab9cef23_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV81OC9mcmFnOjg3YjJhN2NmMDU0ZDQxYzJiOWFhNjQzZDdjZjUyNWI0L3RhYmxlOjk3Yzk5YWY2MjNjYzRmNWRiOTcyODNkNTA5MGVhMzc3L3RhYmxlcmFuZ2U6OTdjOTlhZjYyM2NjNGY1ZGI5NzI4M2Q1MDkwZWEzNzdfMS01LTEtMS00NTkxOQ_f2fbc64c-e509-42b0-9e03-e13063f97674"
      unitRef="usd">26447000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
      contextRef="i1252040e498e429c840f44af12d910cb_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV81OC9mcmFnOjg3YjJhN2NmMDU0ZDQxYzJiOWFhNjQzZDdjZjUyNWI0L3RhYmxlOjk3Yzk5YWY2MjNjYzRmNWRiOTcyODNkNTA5MGVhMzc3L3RhYmxlcmFuZ2U6OTdjOTlhZjYyM2NjNGY1ZGI5NzI4M2Q1MDkwZWEzNzdfMi0xLTEtMS00NTkxOQ_7de82285-0287-42ec-8101-fbe338442c6e"
      unitRef="usd">28773000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
      contextRef="ie545f13df7334e93a19c1ff77d2eb84e_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV81OC9mcmFnOjg3YjJhN2NmMDU0ZDQxYzJiOWFhNjQzZDdjZjUyNWI0L3RhYmxlOjk3Yzk5YWY2MjNjYzRmNWRiOTcyODNkNTA5MGVhMzc3L3RhYmxlcmFuZ2U6OTdjOTlhZjYyM2NjNGY1ZGI5NzI4M2Q1MDkwZWEzNzdfMi0zLTEtMS00NTkxOQ_9f5a05f2-df85-4297-aa13-d48b91eb82d0"
      unitRef="usd">6000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
      contextRef="i738c2d1dacaf436faf03cc46ab9cef23_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV81OC9mcmFnOjg3YjJhN2NmMDU0ZDQxYzJiOWFhNjQzZDdjZjUyNWI0L3RhYmxlOjk3Yzk5YWY2MjNjYzRmNWRiOTcyODNkNTA5MGVhMzc3L3RhYmxlcmFuZ2U6OTdjOTlhZjYyM2NjNGY1ZGI5NzI4M2Q1MDkwZWEzNzdfMi01LTEtMS00NTkxOQ_baacee79-b928-4b5b-8838-ddec76ee090c"
      unitRef="usd">34773000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
      contextRef="i1252040e498e429c840f44af12d910cb_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV81OC9mcmFnOjg3YjJhN2NmMDU0ZDQxYzJiOWFhNjQzZDdjZjUyNWI0L3RhYmxlOjk3Yzk5YWY2MjNjYzRmNWRiOTcyODNkNTA5MGVhMzc3L3RhYmxlcmFuZ2U6OTdjOTlhZjYyM2NjNGY1ZGI5NzI4M2Q1MDkwZWEzNzdfMy0xLTEtMS00NTkxOQ_34ced6c0-ddb2-44ed-9262-9ca3e0aa321b"
      unitRef="usd">29563000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
      contextRef="ie545f13df7334e93a19c1ff77d2eb84e_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV81OC9mcmFnOjg3YjJhN2NmMDU0ZDQxYzJiOWFhNjQzZDdjZjUyNWI0L3RhYmxlOjk3Yzk5YWY2MjNjYzRmNWRiOTcyODNkNTA5MGVhMzc3L3RhYmxlcmFuZ2U6OTdjOTlhZjYyM2NjNGY1ZGI5NzI4M2Q1MDkwZWEzNzdfMy0zLTEtMS00NTkxOQ_dd81663b-bcbd-48b2-ab61-78f426855e1d"
      unitRef="usd">6000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
      contextRef="i738c2d1dacaf436faf03cc46ab9cef23_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV81OC9mcmFnOjg3YjJhN2NmMDU0ZDQxYzJiOWFhNjQzZDdjZjUyNWI0L3RhYmxlOjk3Yzk5YWY2MjNjYzRmNWRiOTcyODNkNTA5MGVhMzc3L3RhYmxlcmFuZ2U6OTdjOTlhZjYyM2NjNGY1ZGI5NzI4M2Q1MDkwZWEzNzdfMy01LTEtMS00NTkxOQ_9cee5f14-69fe-4b3c-9c36-3d14e379d630"
      unitRef="usd">35563000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
      contextRef="i1252040e498e429c840f44af12d910cb_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV81OC9mcmFnOjg3YjJhN2NmMDU0ZDQxYzJiOWFhNjQzZDdjZjUyNWI0L3RhYmxlOjk3Yzk5YWY2MjNjYzRmNWRiOTcyODNkNTA5MGVhMzc3L3RhYmxlcmFuZ2U6OTdjOTlhZjYyM2NjNGY1ZGI5NzI4M2Q1MDkwZWEzNzdfNC0xLTEtMS00NTkxOQ_4870b6d8-b60a-41a6-b562-51c5b8a51e87"
      unitRef="usd">29316000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
      contextRef="ie545f13df7334e93a19c1ff77d2eb84e_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV81OC9mcmFnOjg3YjJhN2NmMDU0ZDQxYzJiOWFhNjQzZDdjZjUyNWI0L3RhYmxlOjk3Yzk5YWY2MjNjYzRmNWRiOTcyODNkNTA5MGVhMzc3L3RhYmxlcmFuZ2U6OTdjOTlhZjYyM2NjNGY1ZGI5NzI4M2Q1MDkwZWEzNzdfNC0zLTEtMS00NTkxOQ_bc68144f-987e-4898-8454-6d05bf7e15cd"
      unitRef="usd">6000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
      contextRef="i738c2d1dacaf436faf03cc46ab9cef23_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV81OC9mcmFnOjg3YjJhN2NmMDU0ZDQxYzJiOWFhNjQzZDdjZjUyNWI0L3RhYmxlOjk3Yzk5YWY2MjNjYzRmNWRiOTcyODNkNTA5MGVhMzc3L3RhYmxlcmFuZ2U6OTdjOTlhZjYyM2NjNGY1ZGI5NzI4M2Q1MDkwZWEzNzdfNC01LTEtMS00NTkxOQ_1c075d9d-aefb-493d-b486-22638686920f"
      unitRef="usd">35316000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
      contextRef="i1252040e498e429c840f44af12d910cb_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV81OC9mcmFnOjg3YjJhN2NmMDU0ZDQxYzJiOWFhNjQzZDdjZjUyNWI0L3RhYmxlOjk3Yzk5YWY2MjNjYzRmNWRiOTcyODNkNTA5MGVhMzc3L3RhYmxlcmFuZ2U6OTdjOTlhZjYyM2NjNGY1ZGI5NzI4M2Q1MDkwZWEzNzdfNS0xLTEtMS00NTkxOQ_1ecc9d94-4339-44a4-b9af-f32614f9db48"
      unitRef="usd">30367000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
      contextRef="ie545f13df7334e93a19c1ff77d2eb84e_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV81OC9mcmFnOjg3YjJhN2NmMDU0ZDQxYzJiOWFhNjQzZDdjZjUyNWI0L3RhYmxlOjk3Yzk5YWY2MjNjYzRmNWRiOTcyODNkNTA5MGVhMzc3L3RhYmxlcmFuZ2U6OTdjOTlhZjYyM2NjNGY1ZGI5NzI4M2Q1MDkwZWEzNzdfNS0zLTEtMS00NTkxOQ_153bc3bf-753d-451f-a0bb-c1937d2d677b"
      unitRef="usd">6000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
      contextRef="i738c2d1dacaf436faf03cc46ab9cef23_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV81OC9mcmFnOjg3YjJhN2NmMDU0ZDQxYzJiOWFhNjQzZDdjZjUyNWI0L3RhYmxlOjk3Yzk5YWY2MjNjYzRmNWRiOTcyODNkNTA5MGVhMzc3L3RhYmxlcmFuZ2U6OTdjOTlhZjYyM2NjNGY1ZGI5NzI4M2Q1MDkwZWEzNzdfNS01LTEtMS00NTkxOQ_97168057-59ed-4309-b208-4e6568579fc4"
      unitRef="usd">36367000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
      contextRef="i1252040e498e429c840f44af12d910cb_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV81OC9mcmFnOjg3YjJhN2NmMDU0ZDQxYzJiOWFhNjQzZDdjZjUyNWI0L3RhYmxlOjk3Yzk5YWY2MjNjYzRmNWRiOTcyODNkNTA5MGVhMzc3L3RhYmxlcmFuZ2U6OTdjOTlhZjYyM2NjNGY1ZGI5NzI4M2Q1MDkwZWEzNzdfNi0xLTEtMS00NTkxOQ_acefe8d8-b2be-4d84-bdb4-9794425c3c51"
      unitRef="usd">33507000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
      contextRef="ie545f13df7334e93a19c1ff77d2eb84e_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV81OC9mcmFnOjg3YjJhN2NmMDU0ZDQxYzJiOWFhNjQzZDdjZjUyNWI0L3RhYmxlOjk3Yzk5YWY2MjNjYzRmNWRiOTcyODNkNTA5MGVhMzc3L3RhYmxlcmFuZ2U6OTdjOTlhZjYyM2NjNGY1ZGI5NzI4M2Q1MDkwZWEzNzdfNi0zLTEtMS00NTkxOQ_d4252212-b47a-4dca-9078-38ffc0421cca"
      unitRef="usd">6000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
      contextRef="i738c2d1dacaf436faf03cc46ab9cef23_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV81OC9mcmFnOjg3YjJhN2NmMDU0ZDQxYzJiOWFhNjQzZDdjZjUyNWI0L3RhYmxlOjk3Yzk5YWY2MjNjYzRmNWRiOTcyODNkNTA5MGVhMzc3L3RhYmxlcmFuZ2U6OTdjOTlhZjYyM2NjNGY1ZGI5NzI4M2Q1MDkwZWEzNzdfNi01LTEtMS00NTkxOQ_e3efc621-dc36-4c25-88c6-0480b87e5919"
      unitRef="usd">39507000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive>
    <us-gaap:LongTermDebtTextBlock
      contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82MS9mcmFnOmE4ZDk2NGIzNGMzYjQ1MjdhNzA4Y2JhMDY1M2Y1YTBmL3RleHRyZWdpb246YThkOTY0YjM0YzNiNDUyN2E3MDhjYmEwNjUzZjVhMGZfMTA2MTY_86cf2054-16a6-4202-93ce-d57db650bb95">Long-Term Debt&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Long-term debt consists of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.793%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.289%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.881%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revolving line of credit&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Term loan, net of deferred debt issuance costs of $678 and $729 in 2023 and 2022, respectively&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;133,910&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;133,858&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.625% convertible notes, net of deferred debt issuance costs of $332 and $432 in 2023 and 2022, respectively&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69,668&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69,568&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.250% convertible notes, net of deferred debt issuance costs of $17,771 and $18,834 in 2023 and 2022, respectively&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;782,229&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;781,166&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Financing leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;162&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;230&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,064,969&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,054,822&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less:&#160;&#160;Current portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69,693&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69,746&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;995,276&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;985,076&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Seventh Amended and Restated Senior Credit Agreement&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;On July&#160;16, 2021, we entered into a seventh amended and restated senior credit agreement consisting of: (a) a $233.5&#160;million term loan facility and (b) a $585.0&#160;million revolving credit facility. The revolving credit facility will terminate and the loans outstanding under the term loan facility will expire on July&#160;16, 2026. The term loan was payable in quarterly installments increasing over the term of the facility.  During 2022, we made a $90.0&#160;million prepayment on the term loan facility resulting in the elimination of such quarterly payments with the remaining balance due upon the expiration of the term loan facility. Proceeds from the term loan facility and borrowings under the revolving credit facility were used to repay the then existing senior credit agreement. Interest rates are at the term secured overnight financing rate plus 0.1148% ("Adjusted Term SOFR") (4.927% at March&#160;31, 2023) plus an interest rate margin of 1.125% (6.052% at March&#160;31, 2023). For borrowings where we elect to use the alternate base rate, the initial base rate is the greatest of (i) the Prime Rate, (ii) the Federal Funds Rate plus 0.50% or (iii) the one-month Adjusted Term SOFR plus 1.00%, plus, in each case, an interest rate margin. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There were $134.6 million in borrowings outstanding on the term loan facility as of March&#160;31, 2023.  There were $79.0 million in borrowings outstanding under the revolving credit facility as of March&#160;31, 2023.  Our available borrowings on the revolving credit facility at March&#160;31, 2023 were $504.2 million with approximately $1.8 million of the facility set aside for outstanding letters of credit. The carrying amounts of the term loan and revolving credit facility approximate fair value.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The seventh amended and restated senior credit agreement is collateralized by substantially all of our personal property and assets.  The seventh amended and restated senior credit agreement contains covenants and restrictions which, among other things, require the maintenance of certain financial ratios and restrict dividend payments and the incurrence of certain indebtedness and other activities, including acquisitions and dispositions.  We were in full compliance with these covenants and restrictions as of March&#160;31, 2023.  We are also required, under certain circumstances, to make mandatory prepayments from net cash proceeds from any issuance of equity and asset sales.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;2.625% Convertible Notes&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On January 29, 2019, we issued $345.0 million aggregate principal amount of 2.625% convertible notes due in 2024 (the "2.625% Notes").  Interest is payable semi-annually in arrears on February 1 and August 1 of each year, commencing August 1, 2019.  The 2.625% Notes will mature on February 1, 2024, unless earlier repurchased or converted.  The 2.625% Notes represent subordinated unsecured obligations and are convertible under certain circumstances, as defined in the indenture, into a combination of cash and CONMED common stock.&#160;&#160;The 2.625% Notes may be converted at an initial conversion rate of 11.2608 shares of our common stock per $1,000 principal amount of 2.625% Notes (equivalent to an initial conversion price of approximately $88.80 per share of common stock).  Holders of the 2.625% Notes may convert the 2.625% Notes at their option at any time on or after November 1, 2023 through the second scheduled trading day preceding the maturity date.  Holders of the 2.625% Notes will also have the right to convert the 2.625% Notes prior to November 1, 2023, but only upon the occurrence of specified events.  The conversion rate is subject to anti-dilution adjustments if certain events occur.  A portion of the net proceeds from the offering of the 2.625% Notes were used as part of the financing for the Buffalo Filter acquisition and $21.0 million were used to pay the cost of certain convertible notes hedge transactions as further described below.  &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;On June 6, 2022, the Company repurchased and extinguished $275.0 million principal amount of the 2.625% Notes for aggregate consideration consisting of $275.0 million in cash and approximately 0.9 million shares of the Company's common stock.  Concurrently, the Company entered into a Supplemental Indenture related to the remaining $70.0 million in 2.625% Notes, in which the Company irrevocably elected to settle the principal value of those 2.625% Notes in cash. The $70.0 million in 2.625% Notes are reflected in the current portion of long-term debt at March&#160;31, 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the three months ended March 31, 2023 and 2022, we have recorded interest expense on the 2.625% Notes of $0.5 million and $2.3 million, respectively, at the contractual coupon rate of 2.625%.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"&gt;The estimated fair value of the 2.625% Notes was approximately $85.3 million as of March&#160;31, 2023 based on a market approach which represents a Level 2 valuation in the fair value hierarchy.  The estimated fair value was determined based on the estimated or actual bids and offers of the 2.625% Notes in an over-the-counter market transaction on the last business day of the period.  &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;2.250% Convertible Notes&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"&gt;On June 6, 2022, we issued $800.0 million aggregate principal amount of 2.250% Notes.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:107%"&gt;  &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"&gt;Interest is payable semi-annually in arrears on June 15 and December 15 of each year, commencing December 15, 2022.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:107%"&gt;  &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"&gt;The 2.250% Notes will mature on June 15, 2027, unless earlier repurchased or converted. The 2.250% Notes represent subordinated unsecured obligations and are convertible under certain circumstances, as defined in the indenture, into a combination of cash and CONMED common stock, with the principal required to be paid in cash.  The 2.250% Notes may be converted at an initial conversion rate of 6.8810 shares of our common stock per $1,000 principal amount of the 2.250% Notes (equivalent to an initial conversion price of approximately $145.33 per share of common stock).  Holders of the 2.250% Notes may convert the 2.250% Notes at their option at any time on or after March 15, 2027 through the second scheduled trading day preceding the maturity date.  Holders of the 2.250% Notes will also have the right to convert the 2.250% Notes prior to March 15, 2027, but only upon the occurrence of specified events.  The conversion rate is subject to anti-dilution adjustments if certain events occur.  A portion of these proceeds were used to repurchase and extinguish a portion of the 2.625% Notes, pay off our then outstanding balance on our revolving line of credit, pay down of $90.0&#160;million of our term loan and partially pay for the In2Bones Acquisition.  In addition, approximately $115.6 million of the proceeds were used to pay the cost of certain convertible notes hedge transactions related to the 2.250% Notes.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"&gt;For the three months ended March&#160;31, 2023, we have recorded interest expense on the 2.250% Notes of&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:107%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"&gt;$4.5 million at the contractual coupon rate of 2.250%.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The estimated fair value of the 2.250% Notes was approximately $796.1 million as of March&#160;31, 2023 based on a market approach which represents a Level 2 valuation in the fair value hierarchy.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"&gt;  &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The estimated fair value was determined based on the estimated or actual bids and offers of the 2.250% Notes in an over-the-counter market transaction on the last business day of the period.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Convertible Notes Hedge Transactions&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"&gt;In connection with the offerings of the 2.625% and 2.250% Notes, we entered into convertible notes hedge transactions with a number of financial institutions (each, an &#x201c;option counterparty&#x201d;).  The convertible notes hedge transactions cover, subject to anti-dilution adjustments substantially similar to those applicable to the respective Notes, the number of shares of our common stock underlying the 2.625% and 2.250% Notes.  Concurrent with entering into the convertible notes hedge transactions, we also entered into separate warrant transactions with each option counterparty whereby we sold to such option counterparty warrants to purchase, subject to customary anti-dilution adjustments, the same number of shares of our common stock.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;In connection with the repurchase and extinguishment of $275.0 million principal amount of the 2.625% Notes, the Company entered into agreements with the option counterparties to terminate a corresponding portion of the hedges on the 2.625% Notes.  &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The convertible notes hedge transactions are expected generally to reduce the potential dilution upon conversion of the Notes and/or offset any cash payments we are required to make in excess of the principal amount of converted Notes, as the case may be, in the event that the market price per share of our common stock, as measured under the terms of the convertible notes hedge transactions, is greater than the strike price of the convertible notes hedge transactions, which initially corresponds to the conversion price of the Notes and is subject to anti-dilution adjustments substantially similar to those applicable to the conversion rate of the Notes.  If, however, the market price per share of our common stock, as measured under the terms of the warrant transactions, exceeds the strike price ($114.92 for the 2.625% Notes and $251.53 for the 2.250% Notes) of the warrants, there would nevertheless be dilution to the extent that such market price exceeds the strike price of the warrants, &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;unless we elect to settle the warrants in cash.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The scheduled&#160;maturities&#160;of&#160;long-term&#160;debt outstanding at March&#160;31, 2023 are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:85.263%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Remaining, 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;213,588&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;800,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2028&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;The above amounts exclude deferred debt issuance costs and financing leases.&lt;/span&gt;&lt;/div&gt;</us-gaap:LongTermDebtTextBlock>
    <us-gaap:ScheduleOfDebtInstrumentsTextBlock
      contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82MS9mcmFnOmE4ZDk2NGIzNGMzYjQ1MjdhNzA4Y2JhMDY1M2Y1YTBmL3RleHRyZWdpb246YThkOTY0YjM0YzNiNDUyN2E3MDhjYmEwNjUzZjVhMGZfMTA2MDU_f39edc3c-e62a-40df-bea2-6e58548809fa">&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Long-term debt consists of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.793%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.289%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.881%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revolving line of credit&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Term loan, net of deferred debt issuance costs of $678 and $729 in 2023 and 2022, respectively&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;133,910&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;133,858&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.625% convertible notes, net of deferred debt issuance costs of $332 and $432 in 2023 and 2022, respectively&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69,668&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69,568&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.250% convertible notes, net of deferred debt issuance costs of $17,771 and $18,834 in 2023 and 2022, respectively&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;782,229&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;781,166&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Financing leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;162&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;230&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,064,969&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,054,822&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less:&#160;&#160;Current portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69,693&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69,746&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;995,276&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;985,076&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDebtInstrumentsTextBlock>
    <us-gaap:LongTermDebt
      contextRef="i7c9501d6daae4d25a09881fd7407a2f6_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82MS9mcmFnOmE4ZDk2NGIzNGMzYjQ1MjdhNzA4Y2JhMDY1M2Y1YTBmL3RhYmxlOmMzNzY3MWMxZjRkMDQ2YjFiYjQyZjM5MjY1ODBiZjZhL3RhYmxlcmFuZ2U6YzM3NjcxYzFmNGQwNDZiMWJiNDJmMzkyNjU4MGJmNmFfMS0xLTEtMS00NTkxOQ_c197a52a-b5d8-4ac4-a76f-689080e3514d"
      unitRef="usd">79000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="iee16a97278a34fe6b541169cf414845b_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82MS9mcmFnOmE4ZDk2NGIzNGMzYjQ1MjdhNzA4Y2JhMDY1M2Y1YTBmL3RhYmxlOmMzNzY3MWMxZjRkMDQ2YjFiYjQyZjM5MjY1ODBiZjZhL3RhYmxlcmFuZ2U6YzM3NjcxYzFmNGQwNDZiMWJiNDJmMzkyNjU4MGJmNmFfMS0zLTEtMS00NTkxOQ_a0d38e8f-18ee-43c2-a436-9195ab13a093"
      unitRef="usd">70000000</us-gaap:LongTermDebt>
    <us-gaap:UnamortizedDebtIssuanceExpense
      contextRef="i77a44de4154e4f80aabef63885392692_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82MS9mcmFnOmE4ZDk2NGIzNGMzYjQ1MjdhNzA4Y2JhMDY1M2Y1YTBmL3RhYmxlOmMzNzY3MWMxZjRkMDQ2YjFiYjQyZjM5MjY1ODBiZjZhL3RhYmxlcmFuZ2U6YzM3NjcxYzFmNGQwNDZiMWJiNDJmMzkyNjU4MGJmNmFfMi0wLTEtMS00NTkxOS90ZXh0cmVnaW9uOjIzYTJlMWM5MGNmMDRiZjRhZmE5YTkyNjlmZDgzMmI1XzU0_5469d4b9-7e1c-4580-92fb-a2654d6ebb91"
      unitRef="usd">678000</us-gaap:UnamortizedDebtIssuanceExpense>
    <us-gaap:UnamortizedDebtIssuanceExpense
      contextRef="i76b7788d670549fab9bb3750f7a0c4ec_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82MS9mcmFnOmE4ZDk2NGIzNGMzYjQ1MjdhNzA4Y2JhMDY1M2Y1YTBmL3RhYmxlOmMzNzY3MWMxZjRkMDQ2YjFiYjQyZjM5MjY1ODBiZjZhL3RhYmxlcmFuZ2U6YzM3NjcxYzFmNGQwNDZiMWJiNDJmMzkyNjU4MGJmNmFfMi0wLTEtMS00NTkxOS90ZXh0cmVnaW9uOjIzYTJlMWM5MGNmMDRiZjRhZmE5YTkyNjlmZDgzMmI1XzYx_cafe2881-ea7b-4fc9-aa49-294d9749fd92"
      unitRef="usd">729000</us-gaap:UnamortizedDebtIssuanceExpense>
    <us-gaap:LongTermDebt
      contextRef="i77a44de4154e4f80aabef63885392692_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82MS9mcmFnOmE4ZDk2NGIzNGMzYjQ1MjdhNzA4Y2JhMDY1M2Y1YTBmL3RhYmxlOmMzNzY3MWMxZjRkMDQ2YjFiYjQyZjM5MjY1ODBiZjZhL3RhYmxlcmFuZ2U6YzM3NjcxYzFmNGQwNDZiMWJiNDJmMzkyNjU4MGJmNmFfMi0xLTEtMS00NTkxOQ_74808683-0c43-480c-a294-4eea4e9fd704"
      unitRef="usd">133910000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i76b7788d670549fab9bb3750f7a0c4ec_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82MS9mcmFnOmE4ZDk2NGIzNGMzYjQ1MjdhNzA4Y2JhMDY1M2Y1YTBmL3RhYmxlOmMzNzY3MWMxZjRkMDQ2YjFiYjQyZjM5MjY1ODBiZjZhL3RhYmxlcmFuZ2U6YzM3NjcxYzFmNGQwNDZiMWJiNDJmMzkyNjU4MGJmNmFfMi0zLTEtMS00NTkxOQ_2e65ea47-37b9-4805-bd9d-bcbfe5cb5939"
      unitRef="usd">133858000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ia3deab346b25408c987cad57798b899f_I20190129"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82MS9mcmFnOmE4ZDk2NGIzNGMzYjQ1MjdhNzA4Y2JhMDY1M2Y1YTBmL3RhYmxlOmMzNzY3MWMxZjRkMDQ2YjFiYjQyZjM5MjY1ODBiZjZhL3RhYmxlcmFuZ2U6YzM3NjcxYzFmNGQwNDZiMWJiNDJmMzkyNjU4MGJmNmFfMy0wLTEtMS00NTkxOS90ZXh0cmVnaW9uOmQxYWJiMzQzOTQ1NDQxMjM4NmJmNzMwOWE2YTQzNzUzXzQ_05827e15-e81e-47fa-a025-f0f5823de8ac"
      unitRef="number">0.02625</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:UnamortizedDebtIssuanceExpense
      contextRef="ie736fe11e175439d9773dbf983dad1c9_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82MS9mcmFnOmE4ZDk2NGIzNGMzYjQ1MjdhNzA4Y2JhMDY1M2Y1YTBmL3RhYmxlOmMzNzY3MWMxZjRkMDQ2YjFiYjQyZjM5MjY1ODBiZjZhL3RhYmxlcmFuZ2U6YzM3NjcxYzFmNGQwNDZiMWJiNDJmMzkyNjU4MGJmNmFfMy0wLTEtMS00NTkxOS90ZXh0cmVnaW9uOmQxYWJiMzQzOTQ1NDQxMjM4NmJmNzMwOWE2YTQzNzUzXzY1_44934d6c-0c6c-4b4b-94cc-02ad04d3d8cc"
      unitRef="usd">332000</us-gaap:UnamortizedDebtIssuanceExpense>
    <us-gaap:UnamortizedDebtIssuanceExpense
      contextRef="ie383611c595342b7bcfa70c8d97dc2b2_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82MS9mcmFnOmE4ZDk2NGIzNGMzYjQ1MjdhNzA4Y2JhMDY1M2Y1YTBmL3RhYmxlOmMzNzY3MWMxZjRkMDQ2YjFiYjQyZjM5MjY1ODBiZjZhL3RhYmxlcmFuZ2U6YzM3NjcxYzFmNGQwNDZiMWJiNDJmMzkyNjU4MGJmNmFfMy0wLTEtMS00NTkxOS90ZXh0cmVnaW9uOmQxYWJiMzQzOTQ1NDQxMjM4NmJmNzMwOWE2YTQzNzUzXzcy_1722cb6f-8505-464b-85b0-d63833c7f401"
      unitRef="usd">432000</us-gaap:UnamortizedDebtIssuanceExpense>
    <us-gaap:ConvertibleDebt
      contextRef="ie736fe11e175439d9773dbf983dad1c9_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82MS9mcmFnOmE4ZDk2NGIzNGMzYjQ1MjdhNzA4Y2JhMDY1M2Y1YTBmL3RhYmxlOmMzNzY3MWMxZjRkMDQ2YjFiYjQyZjM5MjY1ODBiZjZhL3RhYmxlcmFuZ2U6YzM3NjcxYzFmNGQwNDZiMWJiNDJmMzkyNjU4MGJmNmFfMy0xLTEtMS00NTkxOQ_2e836d50-56a7-4107-bc8e-43022efafd57"
      unitRef="usd">69668000</us-gaap:ConvertibleDebt>
    <us-gaap:ConvertibleDebt
      contextRef="ie383611c595342b7bcfa70c8d97dc2b2_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82MS9mcmFnOmE4ZDk2NGIzNGMzYjQ1MjdhNzA4Y2JhMDY1M2Y1YTBmL3RhYmxlOmMzNzY3MWMxZjRkMDQ2YjFiYjQyZjM5MjY1ODBiZjZhL3RhYmxlcmFuZ2U6YzM3NjcxYzFmNGQwNDZiMWJiNDJmMzkyNjU4MGJmNmFfMy0zLTEtMS00NTkxOQ_5409ada4-057a-483e-9ad1-eef70cca83e1"
      unitRef="usd">69568000</us-gaap:ConvertibleDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i9439f4c05d684bd2b8c31654eba4d05f_I20220606"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82MS9mcmFnOmE4ZDk2NGIzNGMzYjQ1MjdhNzA4Y2JhMDY1M2Y1YTBmL3RhYmxlOmMzNzY3MWMxZjRkMDQ2YjFiYjQyZjM5MjY1ODBiZjZhL3RhYmxlcmFuZ2U6YzM3NjcxYzFmNGQwNDZiMWJiNDJmMzkyNjU4MGJmNmFfNC0wLTEtMS00NTkxOS90ZXh0cmVnaW9uOjUxOWIxNzBmZjY0MDQxY2Y4YjRhZTMyYWY0MjA3ZmUxXzU_910e2d7d-1f9e-434c-8403-39a40cbdb228"
      unitRef="number">0.02250</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:UnamortizedDebtIssuanceExpense
      contextRef="i2d6a32f6a1f64e998b122bbbc261a999_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82MS9mcmFnOmE4ZDk2NGIzNGMzYjQ1MjdhNzA4Y2JhMDY1M2Y1YTBmL3RhYmxlOmMzNzY3MWMxZjRkMDQ2YjFiYjQyZjM5MjY1ODBiZjZhL3RhYmxlcmFuZ2U6YzM3NjcxYzFmNGQwNDZiMWJiNDJmMzkyNjU4MGJmNmFfNC0wLTEtMS00NTkxOS90ZXh0cmVnaW9uOjUxOWIxNzBmZjY0MDQxY2Y4YjRhZTMyYWY0MjA3ZmUxXzY2_0835fd99-55ca-4aae-8d37-8ef4096b3922"
      unitRef="usd">17771000</us-gaap:UnamortizedDebtIssuanceExpense>
    <us-gaap:UnamortizedDebtIssuanceExpense
      contextRef="ibf5d8099c676486794c460824796bb9a_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82MS9mcmFnOmE4ZDk2NGIzNGMzYjQ1MjdhNzA4Y2JhMDY1M2Y1YTBmL3RhYmxlOmMzNzY3MWMxZjRkMDQ2YjFiYjQyZjM5MjY1ODBiZjZhL3RhYmxlcmFuZ2U6YzM3NjcxYzFmNGQwNDZiMWJiNDJmMzkyNjU4MGJmNmFfNC0wLTEtMS00NTkxOS90ZXh0cmVnaW9uOjUxOWIxNzBmZjY0MDQxY2Y4YjRhZTMyYWY0MjA3ZmUxXzU0OTc1NTgxMzk2Ng_f61b1081-34e2-468f-82dd-29572201d039"
      unitRef="usd">18834000</us-gaap:UnamortizedDebtIssuanceExpense>
    <us-gaap:ConvertibleDebt
      contextRef="i2d6a32f6a1f64e998b122bbbc261a999_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82MS9mcmFnOmE4ZDk2NGIzNGMzYjQ1MjdhNzA4Y2JhMDY1M2Y1YTBmL3RhYmxlOmMzNzY3MWMxZjRkMDQ2YjFiYjQyZjM5MjY1ODBiZjZhL3RhYmxlcmFuZ2U6YzM3NjcxYzFmNGQwNDZiMWJiNDJmMzkyNjU4MGJmNmFfNC0xLTEtMS00NTkxOQ_5173bb91-e6b0-4209-a7b6-6a0e106496cb"
      unitRef="usd">782229000</us-gaap:ConvertibleDebt>
    <us-gaap:ConvertibleDebt
      contextRef="ibf5d8099c676486794c460824796bb9a_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82MS9mcmFnOmE4ZDk2NGIzNGMzYjQ1MjdhNzA4Y2JhMDY1M2Y1YTBmL3RhYmxlOmMzNzY3MWMxZjRkMDQ2YjFiYjQyZjM5MjY1ODBiZjZhL3RhYmxlcmFuZ2U6YzM3NjcxYzFmNGQwNDZiMWJiNDJmMzkyNjU4MGJmNmFfNC0zLTEtMS00NTkxOQ_b5d738c9-34fe-4e33-8818-1ec7c1d78e7a"
      unitRef="usd">781166000</us-gaap:ConvertibleDebt>
    <us-gaap:FinanceLeaseLiability
      contextRef="i738c2d1dacaf436faf03cc46ab9cef23_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82MS9mcmFnOmE4ZDk2NGIzNGMzYjQ1MjdhNzA4Y2JhMDY1M2Y1YTBmL3RhYmxlOmMzNzY3MWMxZjRkMDQ2YjFiYjQyZjM5MjY1ODBiZjZhL3RhYmxlcmFuZ2U6YzM3NjcxYzFmNGQwNDZiMWJiNDJmMzkyNjU4MGJmNmFfNS0xLTEtMS00NTkxOQ_b59d75f3-38b8-4017-b9bc-15e11b0d3ba8"
      unitRef="usd">162000</us-gaap:FinanceLeaseLiability>
    <us-gaap:FinanceLeaseLiability
      contextRef="ie4f63720d8b244a68941932992cd9f4d_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82MS9mcmFnOmE4ZDk2NGIzNGMzYjQ1MjdhNzA4Y2JhMDY1M2Y1YTBmL3RhYmxlOmMzNzY3MWMxZjRkMDQ2YjFiYjQyZjM5MjY1ODBiZjZhL3RhYmxlcmFuZ2U6YzM3NjcxYzFmNGQwNDZiMWJiNDJmMzkyNjU4MGJmNmFfNS0zLTEtMS00NTkxOQ_945f98da-1750-4e8c-8f7e-72cf7e02f84f"
      unitRef="usd">230000</us-gaap:FinanceLeaseLiability>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities
      contextRef="i738c2d1dacaf436faf03cc46ab9cef23_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82MS9mcmFnOmE4ZDk2NGIzNGMzYjQ1MjdhNzA4Y2JhMDY1M2Y1YTBmL3RhYmxlOmMzNzY3MWMxZjRkMDQ2YjFiYjQyZjM5MjY1ODBiZjZhL3RhYmxlcmFuZ2U6YzM3NjcxYzFmNGQwNDZiMWJiNDJmMzkyNjU4MGJmNmFfNi0xLTEtMS00NTkxOQ_96fd62ff-a1f9-41a5-9d64-e41cc52f20cf"
      unitRef="usd">1064969000</us-gaap:LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities
      contextRef="ie4f63720d8b244a68941932992cd9f4d_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82MS9mcmFnOmE4ZDk2NGIzNGMzYjQ1MjdhNzA4Y2JhMDY1M2Y1YTBmL3RhYmxlOmMzNzY3MWMxZjRkMDQ2YjFiYjQyZjM5MjY1ODBiZjZhL3RhYmxlcmFuZ2U6YzM3NjcxYzFmNGQwNDZiMWJiNDJmMzkyNjU4MGJmNmFfNi0zLTEtMS00NTkxOQ_f37a4357-e205-4a90-b6f1-12f5c8627828"
      unitRef="usd">1054822000</us-gaap:LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent
      contextRef="i738c2d1dacaf436faf03cc46ab9cef23_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82MS9mcmFnOmE4ZDk2NGIzNGMzYjQ1MjdhNzA4Y2JhMDY1M2Y1YTBmL3RhYmxlOmMzNzY3MWMxZjRkMDQ2YjFiYjQyZjM5MjY1ODBiZjZhL3RhYmxlcmFuZ2U6YzM3NjcxYzFmNGQwNDZiMWJiNDJmMzkyNjU4MGJmNmFfNy0xLTEtMS00NTkxOQ_c8dccfe8-6c63-442d-9a42-26ded006f92e"
      unitRef="usd">69693000</us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent
      contextRef="ie4f63720d8b244a68941932992cd9f4d_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82MS9mcmFnOmE4ZDk2NGIzNGMzYjQ1MjdhNzA4Y2JhMDY1M2Y1YTBmL3RhYmxlOmMzNzY3MWMxZjRkMDQ2YjFiYjQyZjM5MjY1ODBiZjZhL3RhYmxlcmFuZ2U6YzM3NjcxYzFmNGQwNDZiMWJiNDJmMzkyNjU4MGJmNmFfNy0zLTEtMS00NTkxOQ_ad2ee1a2-cb54-4629-8560-0b491bce326f"
      unitRef="usd">69746000</us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligations
      contextRef="i738c2d1dacaf436faf03cc46ab9cef23_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82MS9mcmFnOmE4ZDk2NGIzNGMzYjQ1MjdhNzA4Y2JhMDY1M2Y1YTBmL3RhYmxlOmMzNzY3MWMxZjRkMDQ2YjFiYjQyZjM5MjY1ODBiZjZhL3RhYmxlcmFuZ2U6YzM3NjcxYzFmNGQwNDZiMWJiNDJmMzkyNjU4MGJmNmFfOC0xLTEtMS00NTkxOQ_73bf9da2-6911-415f-814f-28476aae543b"
      unitRef="usd">995276000</us-gaap:LongTermDebtAndCapitalLeaseObligations>
    <us-gaap:LongTermDebtAndCapitalLeaseObligations
      contextRef="ie4f63720d8b244a68941932992cd9f4d_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82MS9mcmFnOmE4ZDk2NGIzNGMzYjQ1MjdhNzA4Y2JhMDY1M2Y1YTBmL3RhYmxlOmMzNzY3MWMxZjRkMDQ2YjFiYjQyZjM5MjY1ODBiZjZhL3RhYmxlcmFuZ2U6YzM3NjcxYzFmNGQwNDZiMWJiNDJmMzkyNjU4MGJmNmFfOC0zLTEtMS00NTkxOQ_54978132-31f1-442e-9729-106f6ff18db6"
      unitRef="usd">985076000</us-gaap:LongTermDebtAndCapitalLeaseObligations>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i0dc2d8a4965f4bf786ec6493bd6eea66_I20210716"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82MS9mcmFnOmE4ZDk2NGIzNGMzYjQ1MjdhNzA4Y2JhMDY1M2Y1YTBmL3RleHRyZWdpb246YThkOTY0YjM0YzNiNDUyN2E3MDhjYmEwNjUzZjVhMGZfMjMw_9f9f401f-9aac-431b-b91d-26f2640bdf1f"
      unitRef="usd">233500000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="ibbe0c9555d2a40d18fa14506df884584_I20210716"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82MS9mcmFnOmE4ZDk2NGIzNGMzYjQ1MjdhNzA4Y2JhMDY1M2Y1YTBmL3RleHRyZWdpb246YThkOTY0YjM0YzNiNDUyN2E3MDhjYmEwNjUzZjVhMGZfMjYy_2817fd6e-bdbd-4caa-b40e-4ea9b570c73e"
      unitRef="usd">585000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:RepaymentsOfSeniorDebt
      contextRef="i33405b42e96c4b0797d76ca71cdcc742_D20220606-20220606"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82MS9mcmFnOmE4ZDk2NGIzNGMzYjQ1MjdhNzA4Y2JhMDY1M2Y1YTBmL3RleHRyZWdpb246YThkOTY0YjM0YzNiNDUyN2E3MDhjYmEwNjUzZjVhMGZfNTMz_967e6757-2cca-4790-b818-53bf5476af64"
      unitRef="usd">90000000</us-gaap:RepaymentsOfSeniorDebt>
    <cnmd:TermSOFRInterestRateSpreadAdjustment
      contextRef="i04f774d345914aff9bbced40761489cc_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82MS9mcmFnOmE4ZDk2NGIzNGMzYjQ1MjdhNzA4Y2JhMDY1M2Y1YTBmL3RleHRyZWdpb246YThkOTY0YjM0YzNiNDUyN2E3MDhjYmEwNjUzZjVhMGZfMjc0ODc3OTA4NDk1OA_66537312-7bb4-4a6d-b5ec-9d32d278e4cd"
      unitRef="number">0.001148</cnmd:TermSOFRInterestRateSpreadAdjustment>
    <cnmd:AdjustedTermSOFRInterestRate
      contextRef="i04f774d345914aff9bbced40761489cc_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82MS9mcmFnOmE4ZDk2NGIzNGMzYjQ1MjdhNzA4Y2JhMDY1M2Y1YTBmL3RleHRyZWdpb246YThkOTY0YjM0YzNiNDUyN2E3MDhjYmEwNjUzZjVhMGZfMTAzMQ_a7e2f22a-3e77-460b-8f76-65af5eb074d5"
      unitRef="number">0.04927</cnmd:AdjustedTermSOFRInterestRate>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="ic7e449aedd59496caf4a7c096a050bf9_D20230101-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82MS9mcmFnOmE4ZDk2NGIzNGMzYjQ1MjdhNzA4Y2JhMDY1M2Y1YTBmL3RleHRyZWdpb246YThkOTY0YjM0YzNiNDUyN2E3MDhjYmEwNjUzZjVhMGZfMTA3Mw_a1710676-cf0d-4f43-b97a-51d6ca41bf3c"
      unitRef="number">0.01125</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage
      contextRef="i04f774d345914aff9bbced40761489cc_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82MS9mcmFnOmE4ZDk2NGIzNGMzYjQ1MjdhNzA4Y2JhMDY1M2Y1YTBmL3RleHRyZWdpb246YThkOTY0YjM0YzNiNDUyN2E3MDhjYmEwNjUzZjVhMGZfMTA3Nw_d6318c58-805f-4fad-9002-560cc145228e"
      unitRef="number">0.06052</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="if29e0d4f562843b3816062f7f565bb17_D20230101-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82MS9mcmFnOmE4ZDk2NGIzNGMzYjQ1MjdhNzA4Y2JhMDY1M2Y1YTBmL3RleHRyZWdpb246YThkOTY0YjM0YzNiNDUyN2E3MDhjYmEwNjUzZjVhMGZfMTI0NA_d209c2cf-b0a9-4331-afa7-405570df6ed0"
      unitRef="number">0.0050</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i4e265365e2db4e6b9a43fef2da7662e0_D20230101-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82MS9mcmFnOmE4ZDk2NGIzNGMzYjQ1MjdhNzA4Y2JhMDY1M2Y1YTBmL3RleHRyZWdpb246YThkOTY0YjM0YzNiNDUyN2E3MDhjYmEwNjUzZjVhMGZfMTI5MA_0a87e17e-ed49-469d-972d-0b2ac37b6169"
      unitRef="number">0.0100</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ic2773d0e28ec4c6e93f203b0cb250c6b_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82MS9mcmFnOmE4ZDk2NGIzNGMzYjQ1MjdhNzA4Y2JhMDY1M2Y1YTBmL3RleHRyZWdpb246YThkOTY0YjM0YzNiNDUyN2E3MDhjYmEwNjUzZjVhMGZfMTM1Mg_d6b3a299-f8bb-4e52-b694-c2f10915192e"
      unitRef="usd">134600000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:LongTermDebt
      contextRef="i7c9501d6daae4d25a09881fd7407a2f6_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82MS9mcmFnOmE4ZDk2NGIzNGMzYjQ1MjdhNzA4Y2JhMDY1M2Y1YTBmL3RleHRyZWdpb246YThkOTY0YjM0YzNiNDUyN2E3MDhjYmEwNjUzZjVhMGZfMTQyOQ_2a7ec06e-6254-40cf-a846-ee845bb0ac7f"
      unitRef="usd">79000000</us-gaap:LongTermDebt>
    <us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity
      contextRef="i8e5340b37c9c4826a451adea29a1d1d0_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82MS9mcmFnOmE4ZDk2NGIzNGMzYjQ1MjdhNzA4Y2JhMDY1M2Y1YTBmL3RleHRyZWdpb246YThkOTY0YjM0YzNiNDUyN2E3MDhjYmEwNjUzZjVhMGZfMTU3NA_cae5842d-3ff9-467f-810a-307942eeec08"
      unitRef="usd">504200000</us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity>
    <us-gaap:LettersOfCreditOutstandingAmount
      contextRef="i8e5340b37c9c4826a451adea29a1d1d0_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82MS9mcmFnOmE4ZDk2NGIzNGMzYjQ1MjdhNzA4Y2JhMDY1M2Y1YTBmL3RleHRyZWdpb246YThkOTY0YjM0YzNiNDUyN2E3MDhjYmEwNjUzZjVhMGZfMTU5Ng_00b7f4d0-b8ec-40b1-98f8-690288684b59"
      unitRef="usd">1800000</us-gaap:LettersOfCreditOutstandingAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="ia3deab346b25408c987cad57798b899f_I20190129"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82MS9mcmFnOmE4ZDk2NGIzNGMzYjQ1MjdhNzA4Y2JhMDY1M2Y1YTBmL3RleHRyZWdpb246YThkOTY0YjM0YzNiNDUyN2E3MDhjYmEwNjUzZjVhMGZfMjM4OQ_be705b25-d54d-4ead-8b88-8e44dac145f8"
      unitRef="usd">345000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ia3deab346b25408c987cad57798b899f_I20190129"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82MS9mcmFnOmE4ZDk2NGIzNGMzYjQ1MjdhNzA4Y2JhMDY1M2Y1YTBmL3RleHRyZWdpb246YThkOTY0YjM0YzNiNDUyN2E3MDhjYmEwNjUzZjVhMGZfMjM5NQ_05827e15-e81e-47fa-a025-f0f5823de8ac"
      unitRef="number">0.02625</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ia3deab346b25408c987cad57798b899f_I20190129"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82MS9mcmFnOmE4ZDk2NGIzNGMzYjQ1MjdhNzA4Y2JhMDY1M2Y1YTBmL3RleHRyZWdpb246YThkOTY0YjM0YzNiNDUyN2E3MDhjYmEwNjUzZjVhMGZfMjQzNA_e389c1cd-14b2-46f3-9148-12e498c8c680"
      unitRef="number">0.02625</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ia3deab346b25408c987cad57798b899f_I20190129"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82MS9mcmFnOmE4ZDk2NGIzNGMzYjQ1MjdhNzA4Y2JhMDY1M2Y1YTBmL3RleHRyZWdpb246YThkOTY0YjM0YzNiNDUyN2E3MDhjYmEwNjUzZjVhMGZfMjU2NQ_e389c1cd-14b2-46f3-9148-12e498c8c680"
      unitRef="number">0.02625</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ia3deab346b25408c987cad57798b899f_I20190129"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82MS9mcmFnOmE4ZDk2NGIzNGMzYjQ1MjdhNzA4Y2JhMDY1M2Y1YTBmL3RleHRyZWdpb246YThkOTY0YjM0YzNiNDUyN2E3MDhjYmEwNjUzZjVhMGZfMjY1Mw_e389c1cd-14b2-46f3-9148-12e498c8c680"
      unitRef="number">0.02625</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ia3deab346b25408c987cad57798b899f_I20190129"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82MS9mcmFnOmE4ZDk2NGIzNGMzYjQ1MjdhNzA4Y2JhMDY1M2Y1YTBmL3RleHRyZWdpb246YThkOTY0YjM0YzNiNDUyN2E3MDhjYmEwNjUzZjVhMGZfMjg0Mg_e389c1cd-14b2-46f3-9148-12e498c8c680"
      unitRef="number">0.02625</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentConvertibleConversionRatio1
      contextRef="ic751565b186d4ab8b25554beae97197d_D20190129-20190129"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82MS9mcmFnOmE4ZDk2NGIzNGMzYjQ1MjdhNzA4Y2JhMDY1M2Y1YTBmL3RleHRyZWdpb246YThkOTY0YjM0YzNiNDUyN2E3MDhjYmEwNjUzZjVhMGZfMjkwMQ_e08c0e7c-be03-4fae-a9ce-efe08457012d"
      unitRef="number">11.2608</us-gaap:DebtInstrumentConvertibleConversionRatio1>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ia3deab346b25408c987cad57798b899f_I20190129"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82MS9mcmFnOmE4ZDk2NGIzNGMzYjQ1MjdhNzA4Y2JhMDY1M2Y1YTBmL3RleHRyZWdpb246YThkOTY0YjM0YzNiNDUyN2E3MDhjYmEwNjUzZjVhMGZfMjk1OA_e389c1cd-14b2-46f3-9148-12e498c8c680"
      unitRef="number">0.02625</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1
      contextRef="ia3deab346b25408c987cad57798b899f_I20190129"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82MS9mcmFnOmE4ZDk2NGIzNGMzYjQ1MjdhNzA4Y2JhMDY1M2Y1YTBmL3RleHRyZWdpb246YThkOTY0YjM0YzNiNDUyN2E3MDhjYmEwNjUzZjVhMGZfMzAyNw_eefcdc27-afff-49fe-838f-57b041d0ecb9"
      unitRef="usdPerShare">88.80</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ia3deab346b25408c987cad57798b899f_I20190129"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82MS9mcmFnOmE4ZDk2NGIzNGMzYjQ1MjdhNzA4Y2JhMDY1M2Y1YTBmL3RleHRyZWdpb246YThkOTY0YjM0YzNiNDUyN2E3MDhjYmEwNjUzZjVhMGZfMzA3NA_e389c1cd-14b2-46f3-9148-12e498c8c680"
      unitRef="number">0.02625</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ia3deab346b25408c987cad57798b899f_I20190129"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82MS9mcmFnOmE4ZDk2NGIzNGMzYjQ1MjdhNzA4Y2JhMDY1M2Y1YTBmL3RleHRyZWdpb246YThkOTY0YjM0YzNiNDUyN2E3MDhjYmEwNjUzZjVhMGZfMzA5OQ_e389c1cd-14b2-46f3-9148-12e498c8c680"
      unitRef="number">0.02625</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ia3deab346b25408c987cad57798b899f_I20190129"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82MS9mcmFnOmE4ZDk2NGIzNGMzYjQ1MjdhNzA4Y2JhMDY1M2Y1YTBmL3RleHRyZWdpb246YThkOTY0YjM0YzNiNDUyN2E3MDhjYmEwNjUzZjVhMGZfMzI1MQ_e389c1cd-14b2-46f3-9148-12e498c8c680"
      unitRef="number">0.02625</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ia3deab346b25408c987cad57798b899f_I20190129"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82MS9mcmFnOmE4ZDk2NGIzNGMzYjQ1MjdhNzA4Y2JhMDY1M2Y1YTBmL3RleHRyZWdpb246YThkOTY0YjM0YzNiNDUyN2E3MDhjYmEwNjUzZjVhMGZfMzMwMA_e389c1cd-14b2-46f3-9148-12e498c8c680"
      unitRef="number">0.02625</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ia3deab346b25408c987cad57798b899f_I20190129"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82MS9mcmFnOmE4ZDk2NGIzNGMzYjQ1MjdhNzA4Y2JhMDY1M2Y1YTBmL3RleHRyZWdpb246YThkOTY0YjM0YzNiNDUyN2E3MDhjYmEwNjUzZjVhMGZfMzUyOA_e389c1cd-14b2-46f3-9148-12e498c8c680"
      unitRef="number">0.02625</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <cnmd:HedgeAndWarrantTransactionsNetCashPaid
      contextRef="i2dbc31bae66544e8ad4c1dd3147f68c4_I20190129"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82MS9mcmFnOmE4ZDk2NGIzNGMzYjQ1MjdhNzA4Y2JhMDY1M2Y1YTBmL3RleHRyZWdpb246YThkOTY0YjM0YzNiNDUyN2E3MDhjYmEwNjUzZjVhMGZfMzYxMQ_f9ad1e91-6d67-44e1-9cdb-7965ac7eecd5"
      unitRef="usd">21000000</cnmd:HedgeAndWarrantTransactionsNetCashPaid>
    <us-gaap:RepaymentsOfConvertibleDebt
      contextRef="idfc03df5461f46f685bf90bc12673743_D20220606-20220606"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82MS9mcmFnOmE4ZDk2NGIzNGMzYjQ1MjdhNzA4Y2JhMDY1M2Y1YTBmL3RleHRyZWdpb246YThkOTY0YjM0YzNiNDUyN2E3MDhjYmEwNjUzZjVhMGZfMzc3Nw_09a11e54-adba-42ee-b26f-ff19d8a9d6fa"
      unitRef="usd">275000000</us-gaap:RepaymentsOfConvertibleDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ia3deab346b25408c987cad57798b899f_I20190129"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82MS9mcmFnOmE4ZDk2NGIzNGMzYjQ1MjdhNzA4Y2JhMDY1M2Y1YTBmL3RleHRyZWdpb246YThkOTY0YjM0YzNiNDUyN2E3MDhjYmEwNjUzZjVhMGZfMzgwNA_e389c1cd-14b2-46f3-9148-12e498c8c680"
      unitRef="number">0.02625</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:RepaymentsOfConvertibleDebt
      contextRef="idfc03df5461f46f685bf90bc12673743_D20220606-20220606"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82MS9mcmFnOmE4ZDk2NGIzNGMzYjQ1MjdhNzA4Y2JhMDY1M2Y1YTBmL3RleHRyZWdpb246YThkOTY0YjM0YzNiNDUyN2E3MDhjYmEwNjUzZjVhMGZfMzg1NQ_09a11e54-adba-42ee-b26f-ff19d8a9d6fa"
      unitRef="usd">275000000</us-gaap:RepaymentsOfConvertibleDebt>
    <us-gaap:DebtConversionConvertedInstrumentSharesIssued1
      contextRef="idfc03df5461f46f685bf90bc12673743_D20220606-20220606"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82MS9mcmFnOmE4ZDk2NGIzNGMzYjQ1MjdhNzA4Y2JhMDY1M2Y1YTBmL3RleHRyZWdpb246YThkOTY0YjM0YzNiNDUyN2E3MDhjYmEwNjUzZjVhMGZfMzg4NA_64fe4c29-5d8d-4195-986d-2304cef69059"
      unitRef="shares">900000</us-gaap:DebtConversionConvertedInstrumentSharesIssued1>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="ie736fe11e175439d9773dbf983dad1c9_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82MS9mcmFnOmE4ZDk2NGIzNGMzYjQ1MjdhNzA4Y2JhMDY1M2Y1YTBmL3RleHRyZWdpb246YThkOTY0YjM0YzNiNDUyN2E3MDhjYmEwNjUzZjVhMGZfNDM3Nw_6ac77d7d-6808-4a62-a40f-dd5b5e6ab66d"
      unitRef="usd">70000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ia3deab346b25408c987cad57798b899f_I20190129"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82MS9mcmFnOmE4ZDk2NGIzNGMzYjQ1MjdhNzA4Y2JhMDY1M2Y1YTBmL3RleHRyZWdpb246YThkOTY0YjM0YzNiNDUyN2E3MDhjYmEwNjUzZjVhMGZfNDM4Mw_e389c1cd-14b2-46f3-9148-12e498c8c680"
      unitRef="number">0.02625</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ia3deab346b25408c987cad57798b899f_I20190129"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82MS9mcmFnOmE4ZDk2NGIzNGMzYjQ1MjdhNzA4Y2JhMDY1M2Y1YTBmL3RleHRyZWdpb246YThkOTY0YjM0YzNiNDUyN2E3MDhjYmEwNjUzZjVhMGZfNDQ3Mw_e389c1cd-14b2-46f3-9148-12e498c8c680"
      unitRef="number">0.02625</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="ie736fe11e175439d9773dbf983dad1c9_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82MS9mcmFnOmE4ZDk2NGIzNGMzYjQ1MjdhNzA4Y2JhMDY1M2Y1YTBmL3RleHRyZWdpb246YThkOTY0YjM0YzNiNDUyN2E3MDhjYmEwNjUzZjVhMGZfMTA5OTUxMTYzOTgzMw_6ac77d7d-6808-4a62-a40f-dd5b5e6ab66d"
      unitRef="usd">70000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ia3deab346b25408c987cad57798b899f_I20190129"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82MS9mcmFnOmE4ZDk2NGIzNGMzYjQ1MjdhNzA4Y2JhMDY1M2Y1YTBmL3RleHRyZWdpb246YThkOTY0YjM0YzNiNDUyN2E3MDhjYmEwNjUzZjVhMGZfMTA5OTUxMTYzOTg0Mw_e389c1cd-14b2-46f3-9148-12e498c8c680"
      unitRef="number">0.02625</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ia3deab346b25408c987cad57798b899f_I20190129"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82MS9mcmFnOmE4ZDk2NGIzNGMzYjQ1MjdhNzA4Y2JhMDY1M2Y1YTBmL3RleHRyZWdpb246YThkOTY0YjM0YzNiNDUyN2E3MDhjYmEwNjUzZjVhMGZfNTIzNQ_e389c1cd-14b2-46f3-9148-12e498c8c680"
      unitRef="number">0.02625</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:InterestExpenseDebt
      contextRef="i10eb0e0f69c44d6b8a5dcbb6bec8e099_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82MS9mcmFnOmE4ZDk2NGIzNGMzYjQ1MjdhNzA4Y2JhMDY1M2Y1YTBmL3RleHRyZWdpb246YThkOTY0YjM0YzNiNDUyN2E3MDhjYmEwNjUzZjVhMGZfNTI0OA_03efb295-949b-44b7-81d4-79d488acc0db"
      unitRef="usd">500000</us-gaap:InterestExpenseDebt>
    <us-gaap:InterestExpenseDebt
      contextRef="ifa15bf919650442ab2cfd3f7e7f70be6_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82MS9mcmFnOmE4ZDk2NGIzNGMzYjQ1MjdhNzA4Y2JhMDY1M2Y1YTBmL3RleHRyZWdpb246YThkOTY0YjM0YzNiNDUyN2E3MDhjYmEwNjUzZjVhMGZfNTI1NQ_603a373b-0deb-4903-9431-a2e6e83fd74c"
      unitRef="usd">2300000</us-gaap:InterestExpenseDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ia3deab346b25408c987cad57798b899f_I20190129"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82MS9mcmFnOmE4ZDk2NGIzNGMzYjQ1MjdhNzA4Y2JhMDY1M2Y1YTBmL3RleHRyZWdpb246YThkOTY0YjM0YzNiNDUyN2E3MDhjYmEwNjUzZjVhMGZfNTQwMw_05827e15-e81e-47fa-a025-f0f5823de8ac"
      unitRef="number">0.02625</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ia3deab346b25408c987cad57798b899f_I20190129"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82MS9mcmFnOmE4ZDk2NGIzNGMzYjQ1MjdhNzA4Y2JhMDY1M2Y1YTBmL3RleHRyZWdpb246YThkOTY0YjM0YzNiNDUyN2E3MDhjYmEwNjUzZjVhMGZfNTQ0MA_e389c1cd-14b2-46f3-9148-12e498c8c680"
      unitRef="number">0.02625</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFairValue
      contextRef="ie736fe11e175439d9773dbf983dad1c9_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82MS9mcmFnOmE4ZDk2NGIzNGMzYjQ1MjdhNzA4Y2JhMDY1M2Y1YTBmL3RleHRyZWdpb246YThkOTY0YjM0YzNiNDUyN2E3MDhjYmEwNjUzZjVhMGZfNTQ2Nw_1c757f26-e735-4213-8ff8-faacba288fde"
      unitRef="usd">85300000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ia3deab346b25408c987cad57798b899f_I20190129"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82MS9mcmFnOmE4ZDk2NGIzNGMzYjQ1MjdhNzA4Y2JhMDY1M2Y1YTBmL3RleHRyZWdpb246YThkOTY0YjM0YzNiNDUyN2E3MDhjYmEwNjUzZjVhMGZfNTY2OQ_e389c1cd-14b2-46f3-9148-12e498c8c680"
      unitRef="number">0.02625</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i9439f4c05d684bd2b8c31654eba4d05f_I20220606"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82MS9mcmFnOmE4ZDk2NGIzNGMzYjQ1MjdhNzA4Y2JhMDY1M2Y1YTBmL3RleHRyZWdpb246YThkOTY0YjM0YzNiNDUyN2E3MDhjYmEwNjUzZjVhMGZfNTgxNg_2a5e4e9b-e215-40c7-b084-e43e5ac27656"
      unitRef="usd">800000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i9439f4c05d684bd2b8c31654eba4d05f_I20220606"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82MS9mcmFnOmE4ZDk2NGIzNGMzYjQ1MjdhNzA4Y2JhMDY1M2Y1YTBmL3RleHRyZWdpb246YThkOTY0YjM0YzNiNDUyN2E3MDhjYmEwNjUzZjVhMGZfNTgyMg_910e2d7d-1f9e-434c-8403-39a40cbdb228"
      unitRef="number">0.02250</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i9439f4c05d684bd2b8c31654eba4d05f_I20220606"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82MS9mcmFnOmE4ZDk2NGIzNGMzYjQ1MjdhNzA4Y2JhMDY1M2Y1YTBmL3RleHRyZWdpb246YThkOTY0YjM0YzNiNDUyN2E3MDhjYmEwNjUzZjVhMGZfNTk1NA_910e2d7d-1f9e-434c-8403-39a40cbdb228"
      unitRef="number">0.02250</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i9439f4c05d684bd2b8c31654eba4d05f_I20220606"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82MS9mcmFnOmE4ZDk2NGIzNGMzYjQ1MjdhNzA4Y2JhMDY1M2Y1YTBmL3RleHRyZWdpb246YThkOTY0YjM0YzNiNDUyN2E3MDhjYmEwNjUzZjVhMGZfNjAzOA_910e2d7d-1f9e-434c-8403-39a40cbdb228"
      unitRef="number">0.02250</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i9439f4c05d684bd2b8c31654eba4d05f_I20220606"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82MS9mcmFnOmE4ZDk2NGIzNGMzYjQ1MjdhNzA4Y2JhMDY1M2Y1YTBmL3RleHRyZWdpb246YThkOTY0YjM0YzNiNDUyN2E3MDhjYmEwNjUzZjVhMGZfNjI3NQ_910e2d7d-1f9e-434c-8403-39a40cbdb228"
      unitRef="number">0.02250</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentConvertibleConversionRatio1
      contextRef="id1b284d79bb1490fa07cbd99bd8692dd_D20220606-20220606"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82MS9mcmFnOmE4ZDk2NGIzNGMzYjQ1MjdhNzA4Y2JhMDY1M2Y1YTBmL3RleHRyZWdpb246YThkOTY0YjM0YzNiNDUyN2E3MDhjYmEwNjUzZjVhMGZfNjMzNA_5898f980-76af-457f-a369-2de3f1571d29"
      unitRef="number">6.8810</us-gaap:DebtInstrumentConvertibleConversionRatio1>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i9439f4c05d684bd2b8c31654eba4d05f_I20220606"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82MS9mcmFnOmE4ZDk2NGIzNGMzYjQ1MjdhNzA4Y2JhMDY1M2Y1YTBmL3RleHRyZWdpb246YThkOTY0YjM0YzNiNDUyN2E3MDhjYmEwNjUzZjVhMGZfNjM5OQ_910e2d7d-1f9e-434c-8403-39a40cbdb228"
      unitRef="number">0.02250</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1
      contextRef="i9439f4c05d684bd2b8c31654eba4d05f_I20220606"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82MS9mcmFnOmE4ZDk2NGIzNGMzYjQ1MjdhNzA4Y2JhMDY1M2Y1YTBmL3RleHRyZWdpb246YThkOTY0YjM0YzNiNDUyN2E3MDhjYmEwNjUzZjVhMGZfNjQ2OA_2473f4ad-72c9-4d55-9a4c-07c02c2b3005"
      unitRef="usdPerShare">145.33</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i9439f4c05d684bd2b8c31654eba4d05f_I20220606"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82MS9mcmFnOmE4ZDk2NGIzNGMzYjQ1MjdhNzA4Y2JhMDY1M2Y1YTBmL3RleHRyZWdpb246YThkOTY0YjM0YzNiNDUyN2E3MDhjYmEwNjUzZjVhMGZfNjUxNQ_910e2d7d-1f9e-434c-8403-39a40cbdb228"
      unitRef="number">0.02250</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i9439f4c05d684bd2b8c31654eba4d05f_I20220606"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82MS9mcmFnOmE4ZDk2NGIzNGMzYjQ1MjdhNzA4Y2JhMDY1M2Y1YTBmL3RleHRyZWdpb246YThkOTY0YjM0YzNiNDUyN2E3MDhjYmEwNjUzZjVhMGZfNjU0MA_910e2d7d-1f9e-434c-8403-39a40cbdb228"
      unitRef="number">0.02250</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i9439f4c05d684bd2b8c31654eba4d05f_I20220606"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82MS9mcmFnOmE4ZDk2NGIzNGMzYjQ1MjdhNzA4Y2JhMDY1M2Y1YTBmL3RleHRyZWdpb246YThkOTY0YjM0YzNiNDUyN2E3MDhjYmEwNjUzZjVhMGZfNjY5MA_910e2d7d-1f9e-434c-8403-39a40cbdb228"
      unitRef="number">0.02250</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i9439f4c05d684bd2b8c31654eba4d05f_I20220606"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82MS9mcmFnOmE4ZDk2NGIzNGMzYjQ1MjdhNzA4Y2JhMDY1M2Y1YTBmL3RleHRyZWdpb246YThkOTY0YjM0YzNiNDUyN2E3MDhjYmEwNjUzZjVhMGZfNjczOQ_910e2d7d-1f9e-434c-8403-39a40cbdb228"
      unitRef="number">0.02250</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ia3deab346b25408c987cad57798b899f_I20190129"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82MS9mcmFnOmE4ZDk2NGIzNGMzYjQ1MjdhNzA4Y2JhMDY1M2Y1YTBmL3RleHRyZWdpb246YThkOTY0YjM0YzNiNDUyN2E3MDhjYmEwNjUzZjVhMGZfNjk5NA_e389c1cd-14b2-46f3-9148-12e498c8c680"
      unitRef="number">0.02625</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:RepaymentsOfSeniorDebt
      contextRef="i33405b42e96c4b0797d76ca71cdcc742_D20220606-20220606"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82MS9mcmFnOmE4ZDk2NGIzNGMzYjQ1MjdhNzA4Y2JhMDY1M2Y1YTBmL3RleHRyZWdpb246YThkOTY0YjM0YzNiNDUyN2E3MDhjYmEwNjUzZjVhMGZfNzA4Ng_967e6757-2cca-4790-b818-53bf5476af64"
      unitRef="usd">90000000</us-gaap:RepaymentsOfSeniorDebt>
    <cnmd:HedgeAndWarrantTransactionsNetCashPaid
      contextRef="i82b966a7802b4350a629c26252c5e157_I20220606"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82MS9mcmFnOmE4ZDk2NGIzNGMzYjQ1MjdhNzA4Y2JhMDY1M2Y1YTBmL3RleHRyZWdpb246YThkOTY0YjM0YzNiNDUyN2E3MDhjYmEwNjUzZjVhMGZfNzE4Mg_0697605d-d91a-489b-b2f7-112c880c8e5b"
      unitRef="usd">115600000</cnmd:HedgeAndWarrantTransactionsNetCashPaid>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i9439f4c05d684bd2b8c31654eba4d05f_I20220606"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82MS9mcmFnOmE4ZDk2NGIzNGMzYjQ1MjdhNzA4Y2JhMDY1M2Y1YTBmL3RleHRyZWdpb246YThkOTY0YjM0YzNiNDUyN2E3MDhjYmEwNjUzZjVhMGZfNzI5MA_910e2d7d-1f9e-434c-8403-39a40cbdb228"
      unitRef="number">0.02250</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i9439f4c05d684bd2b8c31654eba4d05f_I20220606"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82MS9mcmFnOmE4ZDk2NGIzNGMzYjQ1MjdhNzA4Y2JhMDY1M2Y1YTBmL3RleHRyZWdpb246YThkOTY0YjM0YzNiNDUyN2E3MDhjYmEwNjUzZjVhMGZfNzM1Nw_910e2d7d-1f9e-434c-8403-39a40cbdb228"
      unitRef="number">0.02250</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:InterestExpenseDebt
      contextRef="ief4e99def0364c889fba657b34e2c8bd_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82MS9mcmFnOmE4ZDk2NGIzNGMzYjQ1MjdhNzA4Y2JhMDY1M2Y1YTBmL3RleHRyZWdpb246YThkOTY0YjM0YzNiNDUyN2E3MDhjYmEwNjUzZjVhMGZfNzM2OQ_9cffd3e1-3be5-4c2d-8285-40d269a35e48"
      unitRef="usd">4500000</us-gaap:InterestExpenseDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i9439f4c05d684bd2b8c31654eba4d05f_I20220606"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82MS9mcmFnOmE4ZDk2NGIzNGMzYjQ1MjdhNzA4Y2JhMDY1M2Y1YTBmL3RleHRyZWdpb246YThkOTY0YjM0YzNiNDUyN2E3MDhjYmEwNjUzZjVhMGZfNzQyOA_910e2d7d-1f9e-434c-8403-39a40cbdb228"
      unitRef="number">0.02250</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i9439f4c05d684bd2b8c31654eba4d05f_I20220606"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82MS9mcmFnOmE4ZDk2NGIzNGMzYjQ1MjdhNzA4Y2JhMDY1M2Y1YTBmL3RleHRyZWdpb246YThkOTY0YjM0YzNiNDUyN2E3MDhjYmEwNjUzZjVhMGZfNzQ2NQ_910e2d7d-1f9e-434c-8403-39a40cbdb228"
      unitRef="number">0.02250</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i2d6a32f6a1f64e998b122bbbc261a999_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82MS9mcmFnOmE4ZDk2NGIzNGMzYjQ1MjdhNzA4Y2JhMDY1M2Y1YTBmL3RleHRyZWdpb246YThkOTY0YjM0YzNiNDUyN2E3MDhjYmEwNjUzZjVhMGZfNzQ5Mg_6f2e803f-2f37-49d3-a30d-c50460610007"
      unitRef="usd">796100000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i9439f4c05d684bd2b8c31654eba4d05f_I20220606"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82MS9mcmFnOmE4ZDk2NGIzNGMzYjQ1MjdhNzA4Y2JhMDY1M2Y1YTBmL3RleHRyZWdpb246YThkOTY0YjM0YzNiNDUyN2E3MDhjYmEwNjUzZjVhMGZfNzY5NA_910e2d7d-1f9e-434c-8403-39a40cbdb228"
      unitRef="number">0.02250</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ia3deab346b25408c987cad57798b899f_I20190129"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82MS9mcmFnOmE4ZDk2NGIzNGMzYjQ1MjdhNzA4Y2JhMDY1M2Y1YTBmL3RleHRyZWdpb246YThkOTY0YjM0YzNiNDUyN2E3MDhjYmEwNjUzZjVhMGZfNzg2Mw_e389c1cd-14b2-46f3-9148-12e498c8c680"
      unitRef="number">0.02625</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i9439f4c05d684bd2b8c31654eba4d05f_I20220606"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82MS9mcmFnOmE4ZDk2NGIzNGMzYjQ1MjdhNzA4Y2JhMDY1M2Y1YTBmL3RleHRyZWdpb246YThkOTY0YjM0YzNiNDUyN2E3MDhjYmEwNjUzZjVhMGZfNzg3MA_910e2d7d-1f9e-434c-8403-39a40cbdb228"
      unitRef="number">0.02250</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ia3deab346b25408c987cad57798b899f_I20190129"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82MS9mcmFnOmE4ZDk2NGIzNGMzYjQ1MjdhNzA4Y2JhMDY1M2Y1YTBmL3RleHRyZWdpb246YThkOTY0YjM0YzNiNDUyN2E3MDhjYmEwNjUzZjVhMGZfODIxNg_e389c1cd-14b2-46f3-9148-12e498c8c680"
      unitRef="number">0.02625</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i9439f4c05d684bd2b8c31654eba4d05f_I20220606"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82MS9mcmFnOmE4ZDk2NGIzNGMzYjQ1MjdhNzA4Y2JhMDY1M2Y1YTBmL3RleHRyZWdpb246YThkOTY0YjM0YzNiNDUyN2E3MDhjYmEwNjUzZjVhMGZfODIyMw_910e2d7d-1f9e-434c-8403-39a40cbdb228"
      unitRef="number">0.02250</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:RepaymentsOfConvertibleDebt
      contextRef="idfc03df5461f46f685bf90bc12673743_D20220606-20220606"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82MS9mcmFnOmE4ZDk2NGIzNGMzYjQ1MjdhNzA4Y2JhMDY1M2Y1YTBmL3RleHRyZWdpb246YThkOTY0YjM0YzNiNDUyN2E3MDhjYmEwNjUzZjVhMGZfODYwNQ_09a11e54-adba-42ee-b26f-ff19d8a9d6fa"
      unitRef="usd">275000000</us-gaap:RepaymentsOfConvertibleDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ia3deab346b25408c987cad57798b899f_I20190129"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82MS9mcmFnOmE4ZDk2NGIzNGMzYjQ1MjdhNzA4Y2JhMDY1M2Y1YTBmL3RleHRyZWdpb246YThkOTY0YjM0YzNiNDUyN2E3MDhjYmEwNjUzZjVhMGZfODYzMg_e389c1cd-14b2-46f3-9148-12e498c8c680"
      unitRef="number">0.02625</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ia3deab346b25408c987cad57798b899f_I20190129"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82MS9mcmFnOmE4ZDk2NGIzNGMzYjQ1MjdhNzA4Y2JhMDY1M2Y1YTBmL3RleHRyZWdpb246YThkOTY0YjM0YzNiNDUyN2E3MDhjYmEwNjUzZjVhMGZfODc2Nw_e389c1cd-14b2-46f3-9148-12e498c8c680"
      unitRef="number">0.02625</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:OptionIndexedToIssuersEquityStrikePrice1
      contextRef="i4ff9b47cc6de4e7f8d64f0b08302c5da_D20190129-20190129"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82MS9mcmFnOmE4ZDk2NGIzNGMzYjQ1MjdhNzA4Y2JhMDY1M2Y1YTBmL3RleHRyZWdpb246YThkOTY0YjM0YzNiNDUyN2E3MDhjYmEwNjUzZjVhMGZfMTAyMDQ_c2634f69-c48c-4fa0-a1b7-8414491782e2"
      unitRef="usdPerShare">114.92</us-gaap:OptionIndexedToIssuersEquityStrikePrice1>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ia3deab346b25408c987cad57798b899f_I20190129"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82MS9mcmFnOmE4ZDk2NGIzNGMzYjQ1MjdhNzA4Y2JhMDY1M2Y1YTBmL3RleHRyZWdpb246YThkOTY0YjM0YzNiNDUyN2E3MDhjYmEwNjUzZjVhMGZfMTAyMTU_e389c1cd-14b2-46f3-9148-12e498c8c680"
      unitRef="number">0.02625</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:OptionIndexedToIssuersEquityStrikePrice1
      contextRef="i588b04626e27426a9be89a521d673e93_D20220606-20220606"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82MS9mcmFnOmE4ZDk2NGIzNGMzYjQ1MjdhNzA4Y2JhMDY1M2Y1YTBmL3RleHRyZWdpb246YThkOTY0YjM0YzNiNDUyN2E3MDhjYmEwNjUzZjVhMGZfMTAyMjg_3311f6d4-5390-4b0f-bedf-42fb50a469cd"
      unitRef="usdPerShare">251.53</us-gaap:OptionIndexedToIssuersEquityStrikePrice1>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i9439f4c05d684bd2b8c31654eba4d05f_I20220606"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82MS9mcmFnOmE4ZDk2NGIzNGMzYjQ1MjdhNzA4Y2JhMDY1M2Y1YTBmL3RleHRyZWdpb246YThkOTY0YjM0YzNiNDUyN2E3MDhjYmEwNjUzZjVhMGZfMTAyMzk_910e2d7d-1f9e-434c-8403-39a40cbdb228"
      unitRef="number">0.02250</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock
      contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82MS9mcmFnOmE4ZDk2NGIzNGMzYjQ1MjdhNzA4Y2JhMDY1M2Y1YTBmL3RleHRyZWdpb246YThkOTY0YjM0YzNiNDUyN2E3MDhjYmEwNjUzZjVhMGZfMTA2MDQ_f1128968-5d7c-4f78-ace5-278c8c715b8f">&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The scheduled&#160;maturities&#160;of&#160;long-term&#160;debt outstanding at March&#160;31, 2023 are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:85.263%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Remaining, 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;213,588&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;800,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2028&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;The above amounts exclude deferred debt issuance costs and financing leases.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
      contextRef="i738c2d1dacaf436faf03cc46ab9cef23_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82MS9mcmFnOmE4ZDk2NGIzNGMzYjQ1MjdhNzA4Y2JhMDY1M2Y1YTBmL3RhYmxlOjEyNmQxYjhhYWU5MjQyNGZiZDZiOTNlZTk4NTdhODQ4L3RhYmxlcmFuZ2U6MTI2ZDFiOGFhZTkyNDI0ZmJkNmI5M2VlOTg1N2E4NDhfMC0xLTEtMS00NTkxOQ_fdab4ec6-9050-41b0-a127-3a16180e31f7"
      unitRef="usd">70000000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
      contextRef="i738c2d1dacaf436faf03cc46ab9cef23_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82MS9mcmFnOmE4ZDk2NGIzNGMzYjQ1MjdhNzA4Y2JhMDY1M2Y1YTBmL3RhYmxlOjEyNmQxYjhhYWU5MjQyNGZiZDZiOTNlZTk4NTdhODQ4L3RhYmxlcmFuZ2U6MTI2ZDFiOGFhZTkyNDI0ZmJkNmI5M2VlOTg1N2E4NDhfMS0xLTEtMS00NTkxOQ_167ad7e9-0b06-4c07-885d-82c2f3381f7f"
      unitRef="usd">0</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
      contextRef="i738c2d1dacaf436faf03cc46ab9cef23_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82MS9mcmFnOmE4ZDk2NGIzNGMzYjQ1MjdhNzA4Y2JhMDY1M2Y1YTBmL3RhYmxlOjEyNmQxYjhhYWU5MjQyNGZiZDZiOTNlZTk4NTdhODQ4L3RhYmxlcmFuZ2U6MTI2ZDFiOGFhZTkyNDI0ZmJkNmI5M2VlOTg1N2E4NDhfMi0xLTEtMS00NTkxOQ_dada981e-70f5-4453-b13d-803937ad14b4"
      unitRef="usd">0</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
      contextRef="i738c2d1dacaf436faf03cc46ab9cef23_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82MS9mcmFnOmE4ZDk2NGIzNGMzYjQ1MjdhNzA4Y2JhMDY1M2Y1YTBmL3RhYmxlOjEyNmQxYjhhYWU5MjQyNGZiZDZiOTNlZTk4NTdhODQ4L3RhYmxlcmFuZ2U6MTI2ZDFiOGFhZTkyNDI0ZmJkNmI5M2VlOTg1N2E4NDhfMy0xLTEtMS00NTkxOQ_5aca6e55-882e-41da-acbc-0594fa97aac3"
      unitRef="usd">213588000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
      contextRef="i738c2d1dacaf436faf03cc46ab9cef23_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82MS9mcmFnOmE4ZDk2NGIzNGMzYjQ1MjdhNzA4Y2JhMDY1M2Y1YTBmL3RhYmxlOjEyNmQxYjhhYWU5MjQyNGZiZDZiOTNlZTk4NTdhODQ4L3RhYmxlcmFuZ2U6MTI2ZDFiOGFhZTkyNDI0ZmJkNmI5M2VlOTg1N2E4NDhfNC0xLTEtMS00NTkxOQ_61c2c240-2aa9-4310-ba9e-e5c62f5f971e"
      unitRef="usd">800000000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
      contextRef="i738c2d1dacaf436faf03cc46ab9cef23_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82MS9mcmFnOmE4ZDk2NGIzNGMzYjQ1MjdhNzA4Y2JhMDY1M2Y1YTBmL3RhYmxlOjEyNmQxYjhhYWU5MjQyNGZiZDZiOTNlZTk4NTdhODQ4L3RhYmxlcmFuZ2U6MTI2ZDFiOGFhZTkyNDI0ZmJkNmI5M2VlOTg1N2E4NDhfNS0xLTEtMS00NTkxOQ_a1fb455f-e700-4e1a-baf4-01f61d85218a"
      unitRef="usd">0</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive>
    <us-gaap:ProductWarrantyDisclosureTextBlock
      contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82NC9mcmFnOjIwYjA5NjQxOTFlNTQzYjc5MGY4NDQ5NjE0NzNlN2Y5L3RleHRyZWdpb246MjBiMDk2NDE5MWU1NDNiNzkwZjg0NDk2MTQ3M2U3ZjlfNzA0_56e524b6-e3d3-44ac-abe1-cfdfaf35a54c">Guarantees&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We provide warranties on certain of our products at the time of sale and sell extended warranties.  The standard warranty period for our capital equipment is generally one year and our extended warranties typically vary from one to three years.  Liability under service and warranty policies is based upon a review of historical warranty and service claim experience.  Adjustments are made to accruals as claim data and historical experience warrant.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in the liability for standard warranties for the three months ended March 31, are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:77.993%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.990%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of January 1,&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,944&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,344&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Provision for warranties&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;115&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;197&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Claims made&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(198)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(187)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of March 31,&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,861&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,354&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Costs associated with extended warranty repairs are recorded as incurred and amounted to $1.5 million and $1.6 million for the three months ended March 31, 2023 and 2022, respectively.&lt;/span&gt;&lt;/div&gt;</us-gaap:ProductWarrantyDisclosureTextBlock>
    <cnmd:ProductWarrantyAccrualTerm
      contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82NC9mcmFnOjIwYjA5NjQxOTFlNTQzYjc5MGY4NDQ5NjE0NzNlN2Y5L3RleHRyZWdpb246MjBiMDk2NDE5MWU1NDNiNzkwZjg0NDk2MTQ3M2U3ZjlfMTk1_f9facf33-5ca0-4281-ad15-844aa4b54c16">P1Y</cnmd:ProductWarrantyAccrualTerm>
    <us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock
      contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82NC9mcmFnOjIwYjA5NjQxOTFlNTQzYjc5MGY4NDQ5NjE0NzNlN2Y5L3RleHRyZWdpb246MjBiMDk2NDE5MWU1NDNiNzkwZjg0NDk2MTQ3M2U3ZjlfNjg5_a8831b9c-bdc4-40bb-979c-42dd26c065dc">&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in the liability for standard warranties for the three months ended March 31, are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:77.993%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.990%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of January 1,&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,944&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,344&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Provision for warranties&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;115&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;197&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Claims made&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(198)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(187)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of March 31,&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,861&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,354&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock>
    <us-gaap:StandardProductWarrantyAccrual
      contextRef="ie4f63720d8b244a68941932992cd9f4d_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82NC9mcmFnOjIwYjA5NjQxOTFlNTQzYjc5MGY4NDQ5NjE0NzNlN2Y5L3RhYmxlOjZkZDAwODQ1OGY4YzQ2OGU4YzA2MjE5ZjQ2Y2IyZTVmL3RhYmxlcmFuZ2U6NmRkMDA4NDU4ZjhjNDY4ZThjMDYyMTlmNDZjYjJlNWZfMS0xLTEtMS00NTkxOQ_898ba87b-bf1f-44d4-87e1-6979eb19e675"
      unitRef="usd">1944000</us-gaap:StandardProductWarrantyAccrual>
    <us-gaap:StandardProductWarrantyAccrual
      contextRef="ia4bed28ea4b04a1d9fca88fa74e6040c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82NC9mcmFnOjIwYjA5NjQxOTFlNTQzYjc5MGY4NDQ5NjE0NzNlN2Y5L3RhYmxlOjZkZDAwODQ1OGY4YzQ2OGU4YzA2MjE5ZjQ2Y2IyZTVmL3RhYmxlcmFuZ2U6NmRkMDA4NDU4ZjhjNDY4ZThjMDYyMTlmNDZjYjJlNWZfMS0zLTEtMS00NTkxOQ_76873d4c-b2ee-4c00-942b-0a05ad009d54"
      unitRef="usd">2344000</us-gaap:StandardProductWarrantyAccrual>
    <us-gaap:StandardProductWarrantyAccrualWarrantiesIssued
      contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82NC9mcmFnOjIwYjA5NjQxOTFlNTQzYjc5MGY4NDQ5NjE0NzNlN2Y5L3RhYmxlOjZkZDAwODQ1OGY4YzQ2OGU4YzA2MjE5ZjQ2Y2IyZTVmL3RhYmxlcmFuZ2U6NmRkMDA4NDU4ZjhjNDY4ZThjMDYyMTlmNDZjYjJlNWZfMy0xLTEtMS00NTkxOQ_e631eb9d-f721-4380-9253-28e0639ded40"
      unitRef="usd">115000</us-gaap:StandardProductWarrantyAccrualWarrantiesIssued>
    <us-gaap:StandardProductWarrantyAccrualWarrantiesIssued
      contextRef="i9500a5ee8dbe4d23aa9c46ebdd25a0c8_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82NC9mcmFnOjIwYjA5NjQxOTFlNTQzYjc5MGY4NDQ5NjE0NzNlN2Y5L3RhYmxlOjZkZDAwODQ1OGY4YzQ2OGU4YzA2MjE5ZjQ2Y2IyZTVmL3RhYmxlcmFuZ2U6NmRkMDA4NDU4ZjhjNDY4ZThjMDYyMTlmNDZjYjJlNWZfMy0zLTEtMS00NTkxOQ_4d51829c-8ff5-4398-9790-95e67577846c"
      unitRef="usd">197000</us-gaap:StandardProductWarrantyAccrualWarrantiesIssued>
    <us-gaap:StandardProductWarrantyAccrualPayments
      contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82NC9mcmFnOjIwYjA5NjQxOTFlNTQzYjc5MGY4NDQ5NjE0NzNlN2Y5L3RhYmxlOjZkZDAwODQ1OGY4YzQ2OGU4YzA2MjE5ZjQ2Y2IyZTVmL3RhYmxlcmFuZ2U6NmRkMDA4NDU4ZjhjNDY4ZThjMDYyMTlmNDZjYjJlNWZfNC0xLTEtMS00NTkxOQ_a2bc5b1f-7c4d-45be-8934-d6a89c3fa74c"
      unitRef="usd">198000</us-gaap:StandardProductWarrantyAccrualPayments>
    <us-gaap:StandardProductWarrantyAccrualPayments
      contextRef="i9500a5ee8dbe4d23aa9c46ebdd25a0c8_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82NC9mcmFnOjIwYjA5NjQxOTFlNTQzYjc5MGY4NDQ5NjE0NzNlN2Y5L3RhYmxlOjZkZDAwODQ1OGY4YzQ2OGU4YzA2MjE5ZjQ2Y2IyZTVmL3RhYmxlcmFuZ2U6NmRkMDA4NDU4ZjhjNDY4ZThjMDYyMTlmNDZjYjJlNWZfNC0zLTEtMS00NTkxOQ_696e2c52-b97d-4d67-831a-8e990e835387"
      unitRef="usd">187000</us-gaap:StandardProductWarrantyAccrualPayments>
    <us-gaap:StandardProductWarrantyAccrual
      contextRef="i738c2d1dacaf436faf03cc46ab9cef23_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82NC9mcmFnOjIwYjA5NjQxOTFlNTQzYjc5MGY4NDQ5NjE0NzNlN2Y5L3RhYmxlOjZkZDAwODQ1OGY4YzQ2OGU4YzA2MjE5ZjQ2Y2IyZTVmL3RhYmxlcmFuZ2U6NmRkMDA4NDU4ZjhjNDY4ZThjMDYyMTlmNDZjYjJlNWZfNi0xLTEtMS00NTkxOQ_46a58ee6-298a-4d3b-8167-e3ad1f0cf9ba"
      unitRef="usd">1861000</us-gaap:StandardProductWarrantyAccrual>
    <us-gaap:StandardProductWarrantyAccrual
      contextRef="i4730ada3cec445989c807f4fe004727c_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82NC9mcmFnOjIwYjA5NjQxOTFlNTQzYjc5MGY4NDQ5NjE0NzNlN2Y5L3RhYmxlOjZkZDAwODQ1OGY4YzQ2OGU4YzA2MjE5ZjQ2Y2IyZTVmL3RhYmxlcmFuZ2U6NmRkMDA4NDU4ZjhjNDY4ZThjMDYyMTlmNDZjYjJlNWZfNi0zLTEtMS00NTkxOQ_4d919fa4-e762-4c6a-bacc-9f9e1bdec6d0"
      unitRef="usd">2354000</us-gaap:StandardProductWarrantyAccrual>
    <us-gaap:ProductWarrantyExpense
      contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82NC9mcmFnOjIwYjA5NjQxOTFlNTQzYjc5MGY4NDQ5NjE0NzNlN2Y5L3RleHRyZWdpb246MjBiMDk2NDE5MWU1NDNiNzkwZjg0NDk2MTQ3M2U3ZjlfNjQ3_7862ec9b-4639-4729-86c6-756726f70d22"
      unitRef="usd">1500000</us-gaap:ProductWarrantyExpense>
    <us-gaap:ProductWarrantyExpense
      contextRef="i9500a5ee8dbe4d23aa9c46ebdd25a0c8_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82NC9mcmFnOjIwYjA5NjQxOTFlNTQzYjc5MGY4NDQ5NjE0NzNlN2Y5L3RleHRyZWdpb246MjBiMDk2NDE5MWU1NDNiNzkwZjg0NDk2MTQ3M2U3ZjlfNjU0_4e853034-460f-49d4-99c9-2c8f14027a87"
      unitRef="usd">1600000</us-gaap:ProductWarrantyExpense>
    <us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock
      contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82Ny9mcmFnOjJkYTkxMjg4ZjhkMzQzYmM5MjA0NzYwZmNkNTZlYjI1L3RleHRyZWdpb246MmRhOTEyODhmOGQzNDNiYzkyMDQ3NjBmY2Q1NmViMjVfMjI5_c651a7d9-76bf-4c98-87e8-cea00a970c20">Pension Plan&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net periodic pension cost consists of the following:&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:77.993%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.990%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Service cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;194&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;269&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest cost on projected benefit obligation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;911&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;537&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,032)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,324)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net amortization and deferral&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;532&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;648&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net periodic pension cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;605&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;130&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;We do not expect to make any pension contributions during 2023.  Non-service pension cost/(benefit) was immaterial for the three months ended March&#160;31, 2023 and 2022.</us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock>
    <us-gaap:ScheduleOfNetBenefitCostsTableTextBlock
      contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82Ny9mcmFnOjJkYTkxMjg4ZjhkMzQzYmM5MjA0NzYwZmNkNTZlYjI1L3RleHRyZWdpb246MmRhOTEyODhmOGQzNDNiYzkyMDQ3NjBmY2Q1NmViMjVfMjM2_6ac8fdaf-26ea-4b09-82ad-1be32e5f00e0">&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net periodic pension cost consists of the following:&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:77.993%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.990%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Service cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;194&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;269&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest cost on projected benefit obligation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;911&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;537&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,032)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,324)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net amortization and deferral&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;532&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;648&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net periodic pension cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;605&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;130&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfNetBenefitCostsTableTextBlock>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82Ny9mcmFnOjJkYTkxMjg4ZjhkMzQzYmM5MjA0NzYwZmNkNTZlYjI1L3RhYmxlOmUwYmNjMzViZWRiNjQwNTQ5OGRhYmMxZWFmODIzN2JmL3RhYmxlcmFuZ2U6ZTBiY2MzNWJlZGI2NDA1NDk4ZGFiYzFlYWY4MjM3YmZfMi0xLTEtMS00NTkxOQ_06098229-fc72-481f-87c7-f0fa92290e57"
      unitRef="usd">194000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="i9500a5ee8dbe4d23aa9c46ebdd25a0c8_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82Ny9mcmFnOjJkYTkxMjg4ZjhkMzQzYmM5MjA0NzYwZmNkNTZlYjI1L3RhYmxlOmUwYmNjMzViZWRiNjQwNTQ5OGRhYmMxZWFmODIzN2JmL3RhYmxlcmFuZ2U6ZTBiY2MzNWJlZGI2NDA1NDk4ZGFiYzFlYWY4MjM3YmZfMi0zLTEtMS00NTkxOQ_0a4dd57d-6f9f-451b-87b8-0c31b8499ad4"
      unitRef="usd">269000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82Ny9mcmFnOjJkYTkxMjg4ZjhkMzQzYmM5MjA0NzYwZmNkNTZlYjI1L3RhYmxlOmUwYmNjMzViZWRiNjQwNTQ5OGRhYmMxZWFmODIzN2JmL3RhYmxlcmFuZ2U6ZTBiY2MzNWJlZGI2NDA1NDk4ZGFiYzFlYWY4MjM3YmZfNC0xLTEtMS00NTkxOQ_932773ac-c7fd-4aa2-8428-4f72f2cd1866"
      unitRef="usd">911000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="i9500a5ee8dbe4d23aa9c46ebdd25a0c8_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82Ny9mcmFnOjJkYTkxMjg4ZjhkMzQzYmM5MjA0NzYwZmNkNTZlYjI1L3RhYmxlOmUwYmNjMzViZWRiNjQwNTQ5OGRhYmMxZWFmODIzN2JmL3RhYmxlcmFuZ2U6ZTBiY2MzNWJlZGI2NDA1NDk4ZGFiYzFlYWY4MjM3YmZfNC0zLTEtMS00NTkxOQ_a35fd2ed-277c-498e-af5d-b63e27c7c638"
      unitRef="usd">537000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82Ny9mcmFnOjJkYTkxMjg4ZjhkMzQzYmM5MjA0NzYwZmNkNTZlYjI1L3RhYmxlOmUwYmNjMzViZWRiNjQwNTQ5OGRhYmMxZWFmODIzN2JmL3RhYmxlcmFuZ2U6ZTBiY2MzNWJlZGI2NDA1NDk4ZGFiYzFlYWY4MjM3YmZfNi0xLTEtMS00NTkxOQ_72f7f20a-0633-4c32-9ba8-36c67c5da629"
      unitRef="usd">1032000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="i9500a5ee8dbe4d23aa9c46ebdd25a0c8_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82Ny9mcmFnOjJkYTkxMjg4ZjhkMzQzYmM5MjA0NzYwZmNkNTZlYjI1L3RhYmxlOmUwYmNjMzViZWRiNjQwNTQ5OGRhYmMxZWFmODIzN2JmL3RhYmxlcmFuZ2U6ZTBiY2MzNWJlZGI2NDA1NDk4ZGFiYzFlYWY4MjM3YmZfNi0zLTEtMS00NTkxOQ_aa24c9bc-2346-40eb-8cf9-83c33ba277ec"
      unitRef="usd">1324000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses
      contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82Ny9mcmFnOjJkYTkxMjg4ZjhkMzQzYmM5MjA0NzYwZmNkNTZlYjI1L3RhYmxlOmUwYmNjMzViZWRiNjQwNTQ5OGRhYmMxZWFmODIzN2JmL3RhYmxlcmFuZ2U6ZTBiY2MzNWJlZGI2NDA1NDk4ZGFiYzFlYWY4MjM3YmZfOC0xLTEtMS00NTkxOQ_331e8f0a-0d03-4209-a3c1-a2c41d2dfe72"
      unitRef="usd">-532000</us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses>
    <us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses
      contextRef="i9500a5ee8dbe4d23aa9c46ebdd25a0c8_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82Ny9mcmFnOjJkYTkxMjg4ZjhkMzQzYmM5MjA0NzYwZmNkNTZlYjI1L3RhYmxlOmUwYmNjMzViZWRiNjQwNTQ5OGRhYmMxZWFmODIzN2JmL3RhYmxlcmFuZ2U6ZTBiY2MzNWJlZGI2NDA1NDk4ZGFiYzFlYWY4MjM3YmZfOC0zLTEtMS00NTkxOQ_a08388c1-7e9e-4371-9ce6-447f6099f79c"
      unitRef="usd">-648000</us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82Ny9mcmFnOjJkYTkxMjg4ZjhkMzQzYmM5MjA0NzYwZmNkNTZlYjI1L3RhYmxlOmUwYmNjMzViZWRiNjQwNTQ5OGRhYmMxZWFmODIzN2JmL3RhYmxlcmFuZ2U6ZTBiY2MzNWJlZGI2NDA1NDk4ZGFiYzFlYWY4MjM3YmZfMTAtMS0xLTEtNDU5MTk_e71f197a-fba7-4bad-9178-bef19dc41199"
      unitRef="usd">605000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="i9500a5ee8dbe4d23aa9c46ebdd25a0c8_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV82Ny9mcmFnOjJkYTkxMjg4ZjhkMzQzYmM5MjA0NzYwZmNkNTZlYjI1L3RhYmxlOmUwYmNjMzViZWRiNjQwNTQ5OGRhYmMxZWFmODIzN2JmL3RhYmxlcmFuZ2U6ZTBiY2MzNWJlZGI2NDA1NDk4ZGFiYzFlYWY4MjM3YmZfMTAtMy0xLTEtNDU5MTk_f5300c8b-28b5-48bb-96cb-114bfe2ca0cb"
      unitRef="usd">130000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:SegmentReportingDisclosureTextBlock
      contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV83My9mcmFnOjk1ZTFhMDljODczZDQyMmVhZDA4NTYyZGI1ODA3YjgxL3RleHRyZWdpb246OTVlMWEwOWM4NzNkNDIyZWFkMDg1NjJkYjU4MDdiODFfMTIzNA_53d88b70-8ba3-4c32-83fe-ec8e339bf408">Business Segment&lt;div style="margin-top:9pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We are accounting and reporting for our business as a single operating segment entity engaged in the development, manufacturing and sale on a global basis of surgical devices and related equipment.  Our chief operating decision maker (the CEO) evaluates the various global product portfolios on a net sales basis and evaluates profitability, investment, cash flow metrics and allocates resources on a consolidated worldwide basis due to shared infrastructure and resources.  Our product lines consist of orthopedic surgery and general surgery.  Orthopedic surgery consists of sports medicine instrumentation and small bone, large bone and specialty powered surgical instruments as well as imaging systems for use in minimally invasive surgery procedures and fees related to the sales representation, promotion and marketing of sports medicine allograft tissue.  General surgery consists of a complete line of endo-mechanical instrumentation for minimally invasive laparoscopic and gastrointestinal procedures, smoke evacuation devices, a line of cardiac monitoring products as well as electrosurgical generators and related instruments.  These product lines' net sales are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.976%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.498%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Orthopedic surgery&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;131,175&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;107,517&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;General surgery&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;164,293&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;134,810&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Consolidated net sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;295,468&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;242,327&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock
      contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV83My9mcmFnOjk1ZTFhMDljODczZDQyMmVhZDA4NTYyZGI1ODA3YjgxL3RleHRyZWdpb246OTVlMWEwOWM4NzNkNDIyZWFkMDg1NjJkYjU4MDdiODFfMTIzNw_472651fc-a758-4ea6-a62c-e4fc0ac2811b">These product lines' net sales are as follows:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.976%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.498%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Orthopedic surgery&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;131,175&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;107,517&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;General surgery&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;164,293&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;134,810&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Consolidated net sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;295,468&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;242,327&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock>
    <us-gaap:Revenues
      contextRef="i6a0f37b7e82e470ebf61b3f06c22aac2_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV83My9mcmFnOjk1ZTFhMDljODczZDQyMmVhZDA4NTYyZGI1ODA3YjgxL3RhYmxlOmQ3NTk0MjU0NzU2ZjQ3OGRiODlhOWM2NmM0ZjgyNmI5L3RhYmxlcmFuZ2U6ZDc1OTQyNTQ3NTZmNDc4ZGI4OWE5YzY2YzRmODI2YjlfMi0xLTEtMS00NTkxOQ_b10e2059-85c7-4f66-9196-84d67a408cac"
      unitRef="usd">131175000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ia61d13e27f12498686a84bca47df5ec7_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV83My9mcmFnOjk1ZTFhMDljODczZDQyMmVhZDA4NTYyZGI1ODA3YjgxL3RhYmxlOmQ3NTk0MjU0NzU2ZjQ3OGRiODlhOWM2NmM0ZjgyNmI5L3RhYmxlcmFuZ2U6ZDc1OTQyNTQ3NTZmNDc4ZGI4OWE5YzY2YzRmODI2YjlfMi0zLTEtMS00NTkxOQ_a259fcac-4fa2-40d7-b46e-fd083d571334"
      unitRef="usd">107517000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="if48f7914ec3d45beaf647b856037592a_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV83My9mcmFnOjk1ZTFhMDljODczZDQyMmVhZDA4NTYyZGI1ODA3YjgxL3RhYmxlOmQ3NTk0MjU0NzU2ZjQ3OGRiODlhOWM2NmM0ZjgyNmI5L3RhYmxlcmFuZ2U6ZDc1OTQyNTQ3NTZmNDc4ZGI4OWE5YzY2YzRmODI2YjlfMy0xLTEtMS00NTkxOQ_25343551-460b-43bd-a26a-e17e2546c3b0"
      unitRef="usd">164293000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i60341eeb4343409c94899251a17bdde1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV83My9mcmFnOjk1ZTFhMDljODczZDQyMmVhZDA4NTYyZGI1ODA3YjgxL3RhYmxlOmQ3NTk0MjU0NzU2ZjQ3OGRiODlhOWM2NmM0ZjgyNmI5L3RhYmxlcmFuZ2U6ZDc1OTQyNTQ3NTZmNDc4ZGI4OWE5YzY2YzRmODI2YjlfMy0zLTEtMS00NTkxOQ_e71f8e70-5d53-4c11-95fa-655a08ee76fb"
      unitRef="usd">134810000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV83My9mcmFnOjk1ZTFhMDljODczZDQyMmVhZDA4NTYyZGI1ODA3YjgxL3RhYmxlOmQ3NTk0MjU0NzU2ZjQ3OGRiODlhOWM2NmM0ZjgyNmI5L3RhYmxlcmFuZ2U6ZDc1OTQyNTQ3NTZmNDc4ZGI4OWE5YzY2YzRmODI2YjlfNC0xLTEtMS00NTkxOQ_d53976ac-7752-401d-85b0-7de2ef136ac2"
      unitRef="usd">295468000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i9500a5ee8dbe4d23aa9c46ebdd25a0c8_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV83My9mcmFnOjk1ZTFhMDljODczZDQyMmVhZDA4NTYyZGI1ODA3YjgxL3RhYmxlOmQ3NTk0MjU0NzU2ZjQ3OGRiODlhOWM2NmM0ZjgyNmI5L3RhYmxlcmFuZ2U6ZDc1OTQyNTQ3NTZmNDc4ZGI4OWE5YzY2YzRmODI2YjlfNC0zLTEtMS00NTkxOQ_8323028a-8b82-4b4b-9553-c6c940deef80"
      unitRef="usd">242327000</us-gaap:Revenues>
    <us-gaap:LegalMattersAndContingenciesTextBlock
      contextRef="iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV83Ni9mcmFnOmNiODM2MzkwODgyZDQ0MWViOGRmOWE3ZjM4ODlmMjQ0L3RleHRyZWdpb246Y2I4MzYzOTA4ODJkNDQxZWI4ZGY5YTdmMzg4OWYyNDRfMTA5MTU_d1689d91-3ec6-4b77-9358-fd50f7c79e0c">Legal Proceedings&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;From time to time, the Company may receive an information request, subpoena or warrant from a government agency such as the Securities and Exchange Commission, Department of Justice, Equal Employment Opportunity Commission, the Occupational Safety and Health Administration, the United States Food and Drug Administration, the Department of Labor, the Treasury Department or other federal and state agencies or foreign governments or government agencies.  These information requests, subpoenas or warrants may or may not be routine inquiries, or may begin as routine inquiries and over time develop into enforcement actions of various types.  Likewise, if we receive reports of alleged misconduct from employees and third parties, we investigate as appropriate.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Manufacturers of medical devices have been the subject of various enforcement actions relating to interactions with health care providers domestically or internationally whereby companies are claimed to have provided health care providers with inappropriate incentives to purchase their products.  Similarly, the Foreign Corrupt Practices Act ("FCPA") imposes obligations on manufacturers with respect to interactions with health care providers who may be considered government officials based on their affiliation with public hospitals.  The FCPA also requires publicly listed manufacturers to maintain accurate books and records, and maintain internal accounting controls sufficient to provide assurance that transactions are accurately recorded, lawful and in accordance with management's authorization.  The FCPA poses unique challenges both because manufacturers operate in foreign cultures in which conduct illegal under the FCPA may not be illegal in local jurisdictions, and because, in some cases, a United States manufacturer may face risks under the FCPA based on the conduct of third parties over whom the manufacturer may not have complete control.  While CONMED has not experienced any material enforcement action to date, there can be no assurance that the Company will not be subject to a material enforcement action in the future, or that the Company will not incur costs including, in the form of fees for lawyers and other consultants, that are material to the Company&#x2019;s results of operations in the course of responding to a future inquiry or investigation.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Manufacturers of medical products may face exposure to significant product liability claims, as well as patent infringement and other claims incurred in the ordinary course of business.  To date, we have not experienced any claims that have been material to our financial statements or financial condition, but any such claims arising in the future could have a material adverse effect on our business, results of operations or cash flows.  We currently maintain commercial product liability insurance of $35 million per incident and $35 million in the aggregate annually, which we believe is adequate.  This coverage is on a claims-made basis.  There can be no assurance that claims will not exceed insurance coverage, that the carriers will be solvent or that such insurance will be available to us in the future at a reasonable cost.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our operations are subject, and in the past have been subject, to a number of environmental laws and regulations governing, among other things, air emissions; wastewater discharges; the use, handling and disposal of hazardous substances and wastes; soil and groundwater remediation and employee health and safety.  Likewise, the operations of our suppliers and sterilizers are subject to similar environmental laws and regulations.  In some jurisdictions, environmental requirements may be expected to become more stringent in the future.  In the United States, certain environmental laws can impose liability for the entire cost of site restoration upon each of the parties that may have contributed to conditions at the site regardless of fault or &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;the lawfulness of the party&#x2019;s activities.  While we do not believe that the present costs of environmental compliance and remediation are material, there can be no assurance that future compliance or remedial obligations would not have a material adverse effect on our financial condition, results of operations or cash flows.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;CONMED is defending two Georgia State Court actions.  The first action was filed in Cobb County by various employees, former employees, contract workers and others against CONMED and against a contract sterilizer (the "Cobb County Action"). The second action was filed in Douglas County against CONMED&#x2019;s landlord and other allegedly related entities (the "Douglas County Action").  Plaintiffs in the lawsuits allege personal injury and related claims purportedly arising from or relating to exposure to Ethylene Oxide, a chemical used to sterilize certain products.  CONMED is defending the claims asserted directly against it and is providing indemnification for certain other defendants based on contractual provisions. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Both actions are in their early stages.  The Company's motion to dismiss in the Cobb County action was heard on January 10, 2022, and the Court issued a ruling on June 15, 2022 dismissing 44 of the 51 plaintiffs' claims as precluded by the exclusive workers' compensation remedy, as well as one claim from a non-employee plaintiff.  As to the remaining claims that were not the subject of the motion to dismiss, CONMED believes it has strong defenses and will vigorously defend itself and all parties it is indemnifying.  As with any litigation, there are risks, including the risk that CONMED may not prevail with respect to the defense of the underlying claims, or with respect to securing adequate insurance coverage for the indemnification claims.  The Company is unable to estimate a range of possible loss at this time, and has not recorded any expense related to potential damages in connection with this matter because the Company does not believe any potential loss is probable.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;CONMED submitted the foregoing claims for insurance coverage.  One insurer is providing coverage for certain of the claims asserted directly against the Company.  CONMED litigated two lawsuits in the United States District Court for the Northern District of New York with Federal Insurance Company (&#x201c;Chubb&#x201d;): one involving CONMED&#x2019;s claim for coverage for the indemnification claims arising from the Cobb County Action, and the other concerning CONMED&#x2019;s claim for coverage for the indemnification claims arising from the Douglas County Action.  On March 10, 2022, the Court ruled in favor of CONMED with respect to coverage for the indemnification claims arising from the Cobb County Action.  Chubb's motion for reconsideration was denied, and Chubb filed a notice of appeal.  On August 9, 2022, CONMED won a similar ruling finding in its favor and against Chubb as to the coverage case concerning the Douglas County Action.  Chubb appealed that decision as well.  Chubb subsequently withdrew its appeal in connection with a favorable settlement between the parties.  There can be no assurance that Chubb will honor its obligations prospectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition, one of CONMED&#x2019;s contract sterilizers, which is defending toxic tort claims asserted by various residents in the areas around its processing facility, has placed CONMED on notice of a claim for indemnification relating to some of those claims.  CONMED is reviewing the notice, and has not at this time taken any position on the notice.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The government of Italy passed a law in late 2015 to tax medical device companies on revenue derived from sales to public hospitals.  The tax is calculated and based on provincial spending over and above certain thresholds.  Since the law was enacted, the Italian government essentially made no effort to administer or collect the tax.  A lack of interpretative guidance and complexity of the law resulted in uncertainty as to the actual amount of liability.  In September 2022, the Italian government passed a further decree which, amongst other provisions, delegated administration and collection to the provincial level for the years 2015 &#x2013; 2018.  The Italy medical device tax represents variable consideration in the form of a retroactive discount potentially owed to the customer, which is ultimately the Italian government.  The Company is challenging the imposition of the medical device tax in Italy, as have many other medical device companies, on the ground that the law was never implemented properly with regulations.  While the Company is informed that its position is well-grounded in the law, there can be no assurance that the Company will prevail.  In January 2023, the Italian government postponed the due date for payment of the tax to allow time for Italian courts to rule on the constitutionality of the law.   No amounts have been remitted to date.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;From time to time, we are also subject to negligence and other claims arising out of the ordinary conduct of our business, including, for example, automobile or other accidents our employees may experience within the course of their employment or otherwise and which may, on occasion, involve potentially significant personal injuries or other exposures.  In the first quarter of 2023, the Company reached an agreement to settle one such personal injury lawsuit. The settlement is covered by the Company&#x2019;s insurance coverage and did not have a material impact on our financial position or results of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We record reserves sufficient to cover probable and estimable losses associated with any such pending claims.  We do not expect that the resolution of any pending claims, investigations or reports of alleged misconduct will have a material adverse effect on our financial condition, results of operations or cash flows.  There can be no assurance, however, that future claims or investigations, or the costs associated with responding to such claims, investigations or reports of misconduct, especially claims and investigations not covered by insurance, will not have a material adverse effect on our financial condition, results of operations or cash flows.&lt;/span&gt;&lt;/div&gt;</us-gaap:LegalMattersAndContingenciesTextBlock>
    <cnmd:ProductLiabilityContingencyInsuranceAmountPerIncident
      contextRef="i738c2d1dacaf436faf03cc46ab9cef23_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV83Ni9mcmFnOmNiODM2MzkwODgyZDQ0MWViOGRmOWE3ZjM4ODlmMjQ0L3RleHRyZWdpb246Y2I4MzYzOTA4ODJkNDQxZWI4ZGY5YTdmMzg4OWYyNDRfMjg4MQ_e9302be4-62a8-4b7e-a145-cfcc97229a1c"
      unitRef="usd">35000000</cnmd:ProductLiabilityContingencyInsuranceAmountPerIncident>
    <cnmd:ProductLiabilityContingencyInsuranceAggregateAnnualAmount
      contextRef="i738c2d1dacaf436faf03cc46ab9cef23_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV83Ni9mcmFnOmNiODM2MzkwODgyZDQ0MWViOGRmOWE3ZjM4ODlmMjQ0L3RleHRyZWdpb246Y2I4MzYzOTA4ODJkNDQxZWI4ZGY5YTdmMzg4OWYyNDRfMjkwMQ_4d71b8ad-b8c6-450a-b39b-3a1c4475c9c3"
      unitRef="usd">35000000</cnmd:ProductLiabilityContingencyInsuranceAggregateAnnualAmount>
    <link:footnoteLink
      xlink:role="http://www.xbrl.org/2003/role/link"
      xlink:type="extended">
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yMi9mcmFnOjRlZjhhMzg3NWQzNDQxMzNhYTVkM2YxMjA4ZjZhNzVmL3RhYmxlOjQ1NzViM2U2MDFhMDQ4MTY5Y2FjMDM2ZjcwZWRhNWJmL3RhYmxlcmFuZ2U6NDU3NWIzZTYwMWEwNDgxNjljYWMwMzZmNzBlZGE1YmZfMTItMy0xLTEtNDY0MDU_cfef9874-6ec2-42b5-801c-7abe9a1e0261"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yMi9mcmFnOjRlZjhhMzg3NWQzNDQxMzNhYTVkM2YxMjA4ZjZhNzVmL3RhYmxlOjQ1NzViM2U2MDFhMDQ4MTY5Y2FjMDM2ZjcwZWRhNWJmL3RhYmxlcmFuZ2U6NDU3NWIzZTYwMWEwNDgxNjljYWMwMzZmNzBlZGE1YmZfMTItMy0xLTEtNDY0MDU_cfef9874-6ec2-42b5-801c-7abe9a1e0261"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yMi9mcmFnOjRlZjhhMzg3NWQzNDQxMzNhYTVkM2YxMjA4ZjZhNzVmL3RhYmxlOjQ1NzViM2U2MDFhMDQ4MTY5Y2FjMDM2ZjcwZWRhNWJmL3RhYmxlcmFuZ2U6NDU3NWIzZTYwMWEwNDgxNjljYWMwMzZmNzBlZGE1YmZfMTItNy0xLTEtNDY0MDU_9abb2f00-e46a-4479-b6e5-b85487673102"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yMi9mcmFnOjRlZjhhMzg3NWQzNDQxMzNhYTVkM2YxMjA4ZjZhNzVmL3RhYmxlOjQ1NzViM2U2MDFhMDQ4MTY5Y2FjMDM2ZjcwZWRhNWJmL3RhYmxlcmFuZ2U6NDU3NWIzZTYwMWEwNDgxNjljYWMwMzZmNzBlZGE1YmZfMTItNy0xLTEtNDY0MDU_9abb2f00-e46a-4479-b6e5-b85487673102"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yMi9mcmFnOjRlZjhhMzg3NWQzNDQxMzNhYTVkM2YxMjA4ZjZhNzVmL3RhYmxlOjQ1NzViM2U2MDFhMDQ4MTY5Y2FjMDM2ZjcwZWRhNWJmL3RhYmxlcmFuZ2U6NDU3NWIzZTYwMWEwNDgxNjljYWMwMzZmNzBlZGE1YmZfMTItNC0xLTEtNDY0MDU_800b98f9-a0f2-47d2-ab38-b018d0a13d2c"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yMi9mcmFnOjRlZjhhMzg3NWQzNDQxMzNhYTVkM2YxMjA4ZjZhNzVmL3RhYmxlOjQ1NzViM2U2MDFhMDQ4MTY5Y2FjMDM2ZjcwZWRhNWJmL3RhYmxlcmFuZ2U6NDU3NWIzZTYwMWEwNDgxNjljYWMwMzZmNzBlZGE1YmZfMTItNC0xLTEtNDY0MDU_800b98f9-a0f2-47d2-ab38-b018d0a13d2c"
          xlink:type="locator"/>
        <link:footnote id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yMi9mcmFnOjRlZjhhMzg3NWQzNDQxMzNhYTVkM2YxMjA4ZjZhNzVmL3RhYmxlOjQ1NzViM2U2MDFhMDQ4MTY5Y2FjMDM2ZjcwZWRhNWJmL3RhYmxlcmFuZ2U6NDU3NWIzZTYwMWEwNDgxNjljYWMwMzZmNzBlZGE1YmZfMTMtMC0xLTEtNDY0MDE_046f1bcf-28f6-4ffe-8b0c-3932efd1e841" xlink:label="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yMi9mcmFnOjRlZjhhMzg3NWQzNDQxMzNhYTVkM2YxMjA4ZjZhNzVmL3RhYmxlOjQ1NzViM2U2MDFhMDQ4MTY5Y2FjMDM2ZjcwZWRhNWJmL3RhYmxlcmFuZ2U6NDU3NWIzZTYwMWEwNDgxNjljYWMwMzZmNzBlZGE1YmZfMTMtMC0xLTEtNDY0MDE_046f1bcf-28f6-4ffe-8b0c-3932efd1e841" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"><xhtml:span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.52pt;font-weight:400;line-height:100%;position:relative;top:-2.97pt;vertical-align:baseline">(1)</xhtml:span><xhtml:span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">We recorded the cumulative impact of adopting Accounting Standards Update (ASU) 2020-06, Debt&#x2014;Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging&#x2014;Contracts in Entity&#x2019;s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity&#x2019;s Own Equity in 2022.</xhtml:span></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yMi9mcmFnOjRlZjhhMzg3NWQzNDQxMzNhYTVkM2YxMjA4ZjZhNzVmL3RhYmxlOjQ1NzViM2U2MDFhMDQ4MTY5Y2FjMDM2ZjcwZWRhNWJmL3RhYmxlcmFuZ2U6NDU3NWIzZTYwMWEwNDgxNjljYWMwMzZmNzBlZGE1YmZfMTItMy0xLTEtNDY0MDU_cfef9874-6ec2-42b5-801c-7abe9a1e0261"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yMi9mcmFnOjRlZjhhMzg3NWQzNDQxMzNhYTVkM2YxMjA4ZjZhNzVmL3RhYmxlOjQ1NzViM2U2MDFhMDQ4MTY5Y2FjMDM2ZjcwZWRhNWJmL3RhYmxlcmFuZ2U6NDU3NWIzZTYwMWEwNDgxNjljYWMwMzZmNzBlZGE1YmZfMTMtMC0xLTEtNDY0MDE_046f1bcf-28f6-4ffe-8b0c-3932efd1e841"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yMi9mcmFnOjRlZjhhMzg3NWQzNDQxMzNhYTVkM2YxMjA4ZjZhNzVmL3RhYmxlOjQ1NzViM2U2MDFhMDQ4MTY5Y2FjMDM2ZjcwZWRhNWJmL3RhYmxlcmFuZ2U6NDU3NWIzZTYwMWEwNDgxNjljYWMwMzZmNzBlZGE1YmZfMTItNy0xLTEtNDY0MDU_9abb2f00-e46a-4479-b6e5-b85487673102"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yMi9mcmFnOjRlZjhhMzg3NWQzNDQxMzNhYTVkM2YxMjA4ZjZhNzVmL3RhYmxlOjQ1NzViM2U2MDFhMDQ4MTY5Y2FjMDM2ZjcwZWRhNWJmL3RhYmxlcmFuZ2U6NDU3NWIzZTYwMWEwNDgxNjljYWMwMzZmNzBlZGE1YmZfMTMtMC0xLTEtNDY0MDE_046f1bcf-28f6-4ffe-8b0c-3932efd1e841"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yMi9mcmFnOjRlZjhhMzg3NWQzNDQxMzNhYTVkM2YxMjA4ZjZhNzVmL3RhYmxlOjQ1NzViM2U2MDFhMDQ4MTY5Y2FjMDM2ZjcwZWRhNWJmL3RhYmxlcmFuZ2U6NDU3NWIzZTYwMWEwNDgxNjljYWMwMzZmNzBlZGE1YmZfMTItNC0xLTEtNDY0MDU_800b98f9-a0f2-47d2-ab38-b018d0a13d2c"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV8yMi9mcmFnOjRlZjhhMzg3NWQzNDQxMzNhYTVkM2YxMjA4ZjZhNzVmL3RhYmxlOjQ1NzViM2U2MDFhMDQ4MTY5Y2FjMDM2ZjcwZWRhNWJmL3RhYmxlcmFuZ2U6NDU3NWIzZTYwMWEwNDgxNjljYWMwMzZmNzBlZGE1YmZfMTMtMC0xLTEtNDY0MDE_046f1bcf-28f6-4ffe-8b0c-3932efd1e841"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80Ni9mcmFnOjFiNzYzYzFhMzFiMTRhNjU5MGJkMjUwMDIzMGQzNjM1L3RhYmxlOmNjNzJlOTI1MjlkNTRhNmU4OTYzZDEzZTQ2Y2NmZDlhL3RhYmxlcmFuZ2U6Y2M3MmU5MjUyOWQ1NGE2ZTg5NjNkMTNlNDZjY2ZkOWFfNC01LTEtMS00NTkxOQ_ba7fab8b-5212-4892-9579-36104468ce0a"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80Ni9mcmFnOjFiNzYzYzFhMzFiMTRhNjU5MGJkMjUwMDIzMGQzNjM1L3RhYmxlOmNjNzJlOTI1MjlkNTRhNmU4OTYzZDEzZTQ2Y2NmZDlhL3RhYmxlcmFuZ2U6Y2M3MmU5MjUyOWQ1NGE2ZTg5NjNkMTNlNDZjY2ZkOWFfNC01LTEtMS00NTkxOQ_ba7fab8b-5212-4892-9579-36104468ce0a"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80Ni9mcmFnOjFiNzYzYzFhMzFiMTRhNjU5MGJkMjUwMDIzMGQzNjM1L3RhYmxlOmNjNzJlOTI1MjlkNTRhNmU4OTYzZDEzZTQ2Y2NmZDlhL3RhYmxlcmFuZ2U6Y2M3MmU5MjUyOWQ1NGE2ZTg5NjNkMTNlNDZjY2ZkOWFfNC0xLTEtMS00NTkxOQ_0fe84469-858a-4e69-9a3a-893fcb2bafa5"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80Ni9mcmFnOjFiNzYzYzFhMzFiMTRhNjU5MGJkMjUwMDIzMGQzNjM1L3RhYmxlOmNjNzJlOTI1MjlkNTRhNmU4OTYzZDEzZTQ2Y2NmZDlhL3RhYmxlcmFuZ2U6Y2M3MmU5MjUyOWQ1NGE2ZTg5NjNkMTNlNDZjY2ZkOWFfNC0xLTEtMS00NTkxOQ_0fe84469-858a-4e69-9a3a-893fcb2bafa5"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80Ni9mcmFnOjFiNzYzYzFhMzFiMTRhNjU5MGJkMjUwMDIzMGQzNjM1L3RhYmxlOmQ5NDdhNTllYzVhNzQyNmQ4YzQyMGIwNTIzMjA5ZTc1L3RhYmxlcmFuZ2U6ZDk0N2E1OWVjNWE3NDI2ZDhjNDIwYjA1MjMyMDllNzVfNC0xLTEtMS00NTkxOQ_545a0e5f-0ef0-4299-9610-97f8b53813b3"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80Ni9mcmFnOjFiNzYzYzFhMzFiMTRhNjU5MGJkMjUwMDIzMGQzNjM1L3RhYmxlOmQ5NDdhNTllYzVhNzQyNmQ4YzQyMGIwNTIzMjA5ZTc1L3RhYmxlcmFuZ2U6ZDk0N2E1OWVjNWE3NDI2ZDhjNDIwYjA1MjMyMDllNzVfNC0xLTEtMS00NTkxOQ_545a0e5f-0ef0-4299-9610-97f8b53813b3"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80Ni9mcmFnOjFiNzYzYzFhMzFiMTRhNjU5MGJkMjUwMDIzMGQzNjM1L3RhYmxlOmQ5NDdhNTllYzVhNzQyNmQ4YzQyMGIwNTIzMjA5ZTc1L3RhYmxlcmFuZ2U6ZDk0N2E1OWVjNWE3NDI2ZDhjNDIwYjA1MjMyMDllNzVfNC0zLTEtMS00NTkxOQ_a8dbf427-756e-4143-9d45-1ba70ee2c003"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80Ni9mcmFnOjFiNzYzYzFhMzFiMTRhNjU5MGJkMjUwMDIzMGQzNjM1L3RhYmxlOmQ5NDdhNTllYzVhNzQyNmQ4YzQyMGIwNTIzMjA5ZTc1L3RhYmxlcmFuZ2U6ZDk0N2E1OWVjNWE3NDI2ZDhjNDIwYjA1MjMyMDllNzVfNC0zLTEtMS00NTkxOQ_a8dbf427-756e-4143-9d45-1ba70ee2c003"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80Ni9mcmFnOjFiNzYzYzFhMzFiMTRhNjU5MGJkMjUwMDIzMGQzNjM1L3RhYmxlOmNjNzJlOTI1MjlkNTRhNmU4OTYzZDEzZTQ2Y2NmZDlhL3RhYmxlcmFuZ2U6Y2M3MmU5MjUyOWQ1NGE2ZTg5NjNkMTNlNDZjY2ZkOWFfNC03LTEtMS00NTkxOQ_896695cd-bd46-44cc-9447-3e80d5cd0dcc"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80Ni9mcmFnOjFiNzYzYzFhMzFiMTRhNjU5MGJkMjUwMDIzMGQzNjM1L3RhYmxlOmNjNzJlOTI1MjlkNTRhNmU4OTYzZDEzZTQ2Y2NmZDlhL3RhYmxlcmFuZ2U6Y2M3MmU5MjUyOWQ1NGE2ZTg5NjNkMTNlNDZjY2ZkOWFfNC03LTEtMS00NTkxOQ_896695cd-bd46-44cc-9447-3e80d5cd0dcc"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80Ni9mcmFnOjFiNzYzYzFhMzFiMTRhNjU5MGJkMjUwMDIzMGQzNjM1L3RhYmxlOmQ5NDdhNTllYzVhNzQyNmQ4YzQyMGIwNTIzMjA5ZTc1L3RhYmxlcmFuZ2U6ZDk0N2E1OWVjNWE3NDI2ZDhjNDIwYjA1MjMyMDllNzVfNC03LTEtMS00NTkxOQ_22c7109f-9951-4b46-948d-23c9ee7c3f75"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80Ni9mcmFnOjFiNzYzYzFhMzFiMTRhNjU5MGJkMjUwMDIzMGQzNjM1L3RhYmxlOmQ5NDdhNTllYzVhNzQyNmQ4YzQyMGIwNTIzMjA5ZTc1L3RhYmxlcmFuZ2U6ZDk0N2E1OWVjNWE3NDI2ZDhjNDIwYjA1MjMyMDllNzVfNC03LTEtMS00NTkxOQ_22c7109f-9951-4b46-948d-23c9ee7c3f75"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80Ni9mcmFnOjFiNzYzYzFhMzFiMTRhNjU5MGJkMjUwMDIzMGQzNjM1L3RhYmxlOmNjNzJlOTI1MjlkNTRhNmU4OTYzZDEzZTQ2Y2NmZDlhL3RhYmxlcmFuZ2U6Y2M3MmU5MjUyOWQ1NGE2ZTg5NjNkMTNlNDZjY2ZkOWFfNC0zLTEtMS00NTkxOQ_38630875-cff5-42ad-91c7-b88c3d7d6be9"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80Ni9mcmFnOjFiNzYzYzFhMzFiMTRhNjU5MGJkMjUwMDIzMGQzNjM1L3RhYmxlOmNjNzJlOTI1MjlkNTRhNmU4OTYzZDEzZTQ2Y2NmZDlhL3RhYmxlcmFuZ2U6Y2M3MmU5MjUyOWQ1NGE2ZTg5NjNkMTNlNDZjY2ZkOWFfNC0zLTEtMS00NTkxOQ_38630875-cff5-42ad-91c7-b88c3d7d6be9"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80Ni9mcmFnOjFiNzYzYzFhMzFiMTRhNjU5MGJkMjUwMDIzMGQzNjM1L3RhYmxlOmQ5NDdhNTllYzVhNzQyNmQ4YzQyMGIwNTIzMjA5ZTc1L3RhYmxlcmFuZ2U6ZDk0N2E1OWVjNWE3NDI2ZDhjNDIwYjA1MjMyMDllNzVfNC01LTEtMS00NTkxOQ_65231fba-6cdc-4ada-a5c3-462933774344"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80Ni9mcmFnOjFiNzYzYzFhMzFiMTRhNjU5MGJkMjUwMDIzMGQzNjM1L3RhYmxlOmQ5NDdhNTllYzVhNzQyNmQ4YzQyMGIwNTIzMjA5ZTc1L3RhYmxlcmFuZ2U6ZDk0N2E1OWVjNWE3NDI2ZDhjNDIwYjA1MjMyMDllNzVfNC01LTEtMS00NTkxOQ_65231fba-6cdc-4ada-a5c3-462933774344"
          xlink:type="locator"/>
        <link:footnote id="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80Ni9mcmFnOjFiNzYzYzFhMzFiMTRhNjU5MGJkMjUwMDIzMGQzNjM1L3RleHRyZWdpb246MWI3NjNjMWEzMWIxNGE2NTkwYmQyNTAwMjMwZDM2MzVfNDY0_2ad6ae1a-986b-44b2-9137-8872e5ce3b1e" xlink:label="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80Ni9mcmFnOjFiNzYzYzFhMzFiMTRhNjU5MGJkMjUwMDIzMGQzNjM1L3RleHRyZWdpb246MWI3NjNjMWEzMWIxNGE2NTkwYmQyNTAwMjMwZDM2MzVfNDY0_2ad6ae1a-986b-44b2-9137-8872e5ce3b1e" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">The cash flow hedging gain (loss) and pension liability accumulated other comprehensive loss components are included in sales or cost of sales and as a component of net periodic pension cost, respectively.  Refer to Note 7 and Note 13, respectively, for further details.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80Ni9mcmFnOjFiNzYzYzFhMzFiMTRhNjU5MGJkMjUwMDIzMGQzNjM1L3RhYmxlOmNjNzJlOTI1MjlkNTRhNmU4OTYzZDEzZTQ2Y2NmZDlhL3RhYmxlcmFuZ2U6Y2M3MmU5MjUyOWQ1NGE2ZTg5NjNkMTNlNDZjY2ZkOWFfNC01LTEtMS00NTkxOQ_ba7fab8b-5212-4892-9579-36104468ce0a"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80Ni9mcmFnOjFiNzYzYzFhMzFiMTRhNjU5MGJkMjUwMDIzMGQzNjM1L3RleHRyZWdpb246MWI3NjNjMWEzMWIxNGE2NTkwYmQyNTAwMjMwZDM2MzVfNDY0_2ad6ae1a-986b-44b2-9137-8872e5ce3b1e"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80Ni9mcmFnOjFiNzYzYzFhMzFiMTRhNjU5MGJkMjUwMDIzMGQzNjM1L3RhYmxlOmNjNzJlOTI1MjlkNTRhNmU4OTYzZDEzZTQ2Y2NmZDlhL3RhYmxlcmFuZ2U6Y2M3MmU5MjUyOWQ1NGE2ZTg5NjNkMTNlNDZjY2ZkOWFfNC0xLTEtMS00NTkxOQ_0fe84469-858a-4e69-9a3a-893fcb2bafa5"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80Ni9mcmFnOjFiNzYzYzFhMzFiMTRhNjU5MGJkMjUwMDIzMGQzNjM1L3RleHRyZWdpb246MWI3NjNjMWEzMWIxNGE2NTkwYmQyNTAwMjMwZDM2MzVfNDY0_2ad6ae1a-986b-44b2-9137-8872e5ce3b1e"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80Ni9mcmFnOjFiNzYzYzFhMzFiMTRhNjU5MGJkMjUwMDIzMGQzNjM1L3RhYmxlOmQ5NDdhNTllYzVhNzQyNmQ4YzQyMGIwNTIzMjA5ZTc1L3RhYmxlcmFuZ2U6ZDk0N2E1OWVjNWE3NDI2ZDhjNDIwYjA1MjMyMDllNzVfNC0xLTEtMS00NTkxOQ_545a0e5f-0ef0-4299-9610-97f8b53813b3"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80Ni9mcmFnOjFiNzYzYzFhMzFiMTRhNjU5MGJkMjUwMDIzMGQzNjM1L3RleHRyZWdpb246MWI3NjNjMWEzMWIxNGE2NTkwYmQyNTAwMjMwZDM2MzVfNDY0_2ad6ae1a-986b-44b2-9137-8872e5ce3b1e"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80Ni9mcmFnOjFiNzYzYzFhMzFiMTRhNjU5MGJkMjUwMDIzMGQzNjM1L3RhYmxlOmQ5NDdhNTllYzVhNzQyNmQ4YzQyMGIwNTIzMjA5ZTc1L3RhYmxlcmFuZ2U6ZDk0N2E1OWVjNWE3NDI2ZDhjNDIwYjA1MjMyMDllNzVfNC0zLTEtMS00NTkxOQ_a8dbf427-756e-4143-9d45-1ba70ee2c003"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80Ni9mcmFnOjFiNzYzYzFhMzFiMTRhNjU5MGJkMjUwMDIzMGQzNjM1L3RleHRyZWdpb246MWI3NjNjMWEzMWIxNGE2NTkwYmQyNTAwMjMwZDM2MzVfNDY0_2ad6ae1a-986b-44b2-9137-8872e5ce3b1e"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80Ni9mcmFnOjFiNzYzYzFhMzFiMTRhNjU5MGJkMjUwMDIzMGQzNjM1L3RhYmxlOmNjNzJlOTI1MjlkNTRhNmU4OTYzZDEzZTQ2Y2NmZDlhL3RhYmxlcmFuZ2U6Y2M3MmU5MjUyOWQ1NGE2ZTg5NjNkMTNlNDZjY2ZkOWFfNC03LTEtMS00NTkxOQ_896695cd-bd46-44cc-9447-3e80d5cd0dcc"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80Ni9mcmFnOjFiNzYzYzFhMzFiMTRhNjU5MGJkMjUwMDIzMGQzNjM1L3RleHRyZWdpb246MWI3NjNjMWEzMWIxNGE2NTkwYmQyNTAwMjMwZDM2MzVfNDY0_2ad6ae1a-986b-44b2-9137-8872e5ce3b1e"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80Ni9mcmFnOjFiNzYzYzFhMzFiMTRhNjU5MGJkMjUwMDIzMGQzNjM1L3RhYmxlOmQ5NDdhNTllYzVhNzQyNmQ4YzQyMGIwNTIzMjA5ZTc1L3RhYmxlcmFuZ2U6ZDk0N2E1OWVjNWE3NDI2ZDhjNDIwYjA1MjMyMDllNzVfNC03LTEtMS00NTkxOQ_22c7109f-9951-4b46-948d-23c9ee7c3f75"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80Ni9mcmFnOjFiNzYzYzFhMzFiMTRhNjU5MGJkMjUwMDIzMGQzNjM1L3RleHRyZWdpb246MWI3NjNjMWEzMWIxNGE2NTkwYmQyNTAwMjMwZDM2MzVfNDY0_2ad6ae1a-986b-44b2-9137-8872e5ce3b1e"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80Ni9mcmFnOjFiNzYzYzFhMzFiMTRhNjU5MGJkMjUwMDIzMGQzNjM1L3RhYmxlOmNjNzJlOTI1MjlkNTRhNmU4OTYzZDEzZTQ2Y2NmZDlhL3RhYmxlcmFuZ2U6Y2M3MmU5MjUyOWQ1NGE2ZTg5NjNkMTNlNDZjY2ZkOWFfNC0zLTEtMS00NTkxOQ_38630875-cff5-42ad-91c7-b88c3d7d6be9"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80Ni9mcmFnOjFiNzYzYzFhMzFiMTRhNjU5MGJkMjUwMDIzMGQzNjM1L3RleHRyZWdpb246MWI3NjNjMWEzMWIxNGE2NTkwYmQyNTAwMjMwZDM2MzVfNDY0_2ad6ae1a-986b-44b2-9137-8872e5ce3b1e"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80Ni9mcmFnOjFiNzYzYzFhMzFiMTRhNjU5MGJkMjUwMDIzMGQzNjM1L3RhYmxlOmQ5NDdhNTllYzVhNzQyNmQ4YzQyMGIwNTIzMjA5ZTc1L3RhYmxlcmFuZ2U6ZDk0N2E1OWVjNWE3NDI2ZDhjNDIwYjA1MjMyMDllNzVfNC01LTEtMS00NTkxOQ_65231fba-6cdc-4ada-a5c3-462933774344"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjk1MmU3YWY5YzBiOTRlNjU5OTU5NzNlN2YyMTJmMzk5L3NlYzo5NTJlN2FmOWMwYjk0ZTY1OTk1OTczZTdmMjEyZjM5OV80Ni9mcmFnOjFiNzYzYzFhMzFiMTRhNjU5MGJkMjUwMDIzMGQzNjM1L3RleHRyZWdpb246MWI3NjNjMWEzMWIxNGE2NTkwYmQyNTAwMjMwZDM2MzVfNDY0_2ad6ae1a-986b-44b2-9137-8872e5ce3b1e"
          xlink:type="arc"/>
    </link:footnoteLink>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>64
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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M,BYX;6RMF-]SHS80Q_\5#;WI)#/7@,0OD]J>29Q>>P]WETF:WD.G#XJ1#7.
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MC,9,: /X?<.Y>A[H![3?:I;_ U!+ P04    " #36IM6?Y64Q'D&   _&@
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MR*SAVKOD8APE8X![](F? 7A\;[;J!TOH!2$=!M0I1P,2C0#L2 U/\DB;1!,
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M9G(7')N=?2^FU$+ID,,DI"/C*NE8G$RS.#1U=5D7S1EE>VX![1U4$'.<O.5
M2LH-W.;L(QAFK2,AIUP4![$;..VXG4YS^T>NU F*:#R/<-SLVACC>4#)X[Z&
MKC_M)8W9X%IRIFKY,$=,PT.EYS^Q[:G=!!P1+Z)#SYUR)!KK:FC7+=#I;F''
MOJI7Y]^\B@F.3MMJ[P1MMP)10/Q@F*XN.1\ZH9%LH%W+0%_8,C01?Z$3Q#X'
M=<[3+D'G/+WHG>Z;3RN?F+S-*X4*O@)-[SB"0,C=UXK=C1:;YL#_1F@MRN9R
MS1G -P+P?"6$?KPQWQ#VWXR6_P%02P,$%     @ TUJ;5H_42 3^ @  FPD
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MT("0+1)B=BQZD!9]2+! +KYE$$,]%C@'!SI:!U:=?B+6[A%:\94!7Q:$XI-
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M#T!LB1*/,^77YS:Q;0V[#:.O3?0:X1+DE,9AG^P]8I0,V$!:&B7!FV85 ;5
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M+[\F:E2>+52?FIJGS1?+B_([7>_Y)3Z]JKX[MFJJSZ!?F()-I%'&UZ R^+@
M%ZOJRV)U8^2V_#AW)XV1>7FYX0Q8W K [VLIS?.-?4'S?7?U/U!+ P04
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MTD7<LO-C@UE'G@7PGD_HW8(=#!]*\W\ 4$L#!!0    ( --:FU:.&#D;#P0
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M^O0Q(M-OVO[@=!NVVT8[[,KP6N'/"1LO@.^%UFY_\ 8.?W?F_P!02P,$%
M  @ TUJ;5F"FFS&:!0  ?@X  !D   !X;"]W;W)K<VAE971S+W-H965T,3$N
M>&ULO5=;;]0X%/XK1P&A(I7,K;>%=J0.[(65N AVEX?5/GB2,XFI$P?;F6GY
M]?L=9R8-M'0!H7UH)W;._7SG<WRZL>["E\R!+BM3^[.D#*%Y/!KYK.1*^=0V
M7./-RKI*!2Q=,?*-8Y5'I<J,IN/QT:A2ND[FIW'OM9N?VC887?-K1[ZM*N6N
M%FSLYBR9)+N--[HH@VR,YJ>-*O@MAS^;UPZK46\EUQ777MN:'*_.DO/)X\6!
MR$>!OS1O_."9)).EM1>R>)Z?)6,)B UG02PH_*SY*1LCAA#&AZW-I'<IBL/G
MG?5?8N[(9:D\/[7FG<Y#>9:<))3S2K4FO+&;WWB;SZ'8RZSQ\3]M.MG#@X2R
MU@=;;9410:7K[E==;NLP4#@9?T%ANE68QK@[1S'*9RJH^:FS&W(B#6OR$%.-
MV@A.U]*4M\'AK89>F"]:CQWOZ:FMEKI64BI_.@HP+0*C;&MFT9F9?L',C%[8
M.I2>?JYSSC_5'R&D/J[I+J[%]$Z#+Y1+:3;9I^EX.KO#WJS/<Q;MS;XA3U)U
M3N?> _KGV8=6>QUW_SY?^N  EW]NJT/GYN!V-S)"CWVC,CY+,".>W9J3^8-[
MDZ/QDSN2..B3.+C+^M<WZSO,O*KI][9FFLQBS:?[M&',#,KB.*?G]71AH4._
M&KM49A\;64I[R6X_>1B+J8PANR(=/ &YV07MA9*IEQJ6&1J@%&B1*@K'A0I,
M;;-R@!$UZ@IS'\34_<G!83H%\HV1WNB:,N7+%/Y)Y7FTM$]PXA L_AH;H*B5
M(5:N?@06VAGS%&R?QH-[)]/)\1-BA!.NJ+0F9^?%NL13V1;.VT8T[D\FXW3<
M^Q<"R D/DI?*2LUKWH6:L0M@05#5FNN6*2A7,/Q*FGT%&F?S-L-NWCI=%]&.
MUY>!N::]R=%#L&.6H3>@*OK0*A<DKLQ6<)*)O)4VF2OJ)F.:7EO6GA05L3V@
MI37HMF&W#ZZHVQ7 W#IVL4>Y!KKUL@T("U%7G.NL4]%P'*.5H (H/NQ2@XYU
ML41B0=?O$3QD\49$VP:>:*_$.Z#&P7X48[.TFPX7H'Z16%G;O5+UA>&'Q)?P
M4J&)[%/Z Y9N PIM%*)JA5?@S=FV*)%H-AACJ3U (;4I.^OBL2X>H7@5+:W#
MF*%V"%X,.4$+TO49JL"2#;T$:F@R2>D=HWN9I)I+Y].3(?!J\(17AC_KZ*"1
M"(^9JHX).48,'LO*GLA2^AFPC+'T?G0'I@PS:(W.,0>Y+'(<?'CR 1L]PFP%
M5BGE2 0\=(TU7S?LOYQCH#$A-5J PXP=AB0FK(RWM&0C4(Z& -%XV,-!=^C'
M_ &P:J<7?0(3F;$>N/KJ$ #79]]0K4A!R+)U+M;$AVMX8DA=T!][ .@:0P=(
M7Z%BW#SJAG>EM*.U,AA&H9)I.NG[Z=C$2D,J#(&GAL K-:(16ADV2^(0<Q$*
M*8$WS]L"!S7]=!MQ+K1U_+'GRVYY-UMV,M_#E2>'Z>%-JD2/&Z4!Z)/9 - J
MCN^-@NL@TW5_DA[WDL*.2Y5=[%/3.M\J.-M6K6(P'.)"3!U&=]VYF<+W,G9G
MZ5OX^NCP!_#U-H$?P-:OLF"7*%(_ 5O3D:X_)5\9=A<$NRN+3[\N<)6O56=,
MG)>L3#0,_-D5&J&]1^ARH!<12(BX 3?#T)5X6N [A@D?(,<'3S# C8G=XZRL
MK;'%5<>Z-[OUXS@WI9<];<9#8<=_@RI'7OJ,7;Z23O]W_I)Z86YMUI<!0Y&5
M@!G\2@^WMCP/J22>SJ!NH_$)+ZV14L09@#CZWB[?XY8B^%7Y>W!)A.@ <Q4K
M"31N#R1P[&J;^_2V3\O1X$X0YU1N/@).S$IW/>AW^\O5>7>GN!;O;F:H0:&1
M@^$55,?I\6%"KKOM=(M@FWC#6-J ^TI\!% QHB* ]W+N[Q;BH+]RSO\%4$L#
M!!0    ( --:FU; S8CIG00  #8*   9    >&PO=V]R:W-H965T<R]S:&5E
M=#$R+GAM;+U62V_C-A#^*P,U6+0 84O4.YL82++;M(>@09)M#T4/M#26B$BB
M2])QTE_?(64K#WB-GGJQR>$\OODX,^+95NE'TR):>.Z[P9P'K;7KT_G<5"WV
MPLS4&@<Z62G="TM;W<S-6J.HO5'?S7D89O->R"%8G'G9K5Z<J8WMY("W&LRF
M[X5^N<1.;<^#*-@+[F336B>8+\[6HL%[M-_6MYIV\\E++7L<C%0#:%R=!Q?1
MZ67B]+W"[Q*WYLT:7"9+I1[=YM?Z/ @=(.RPLLZ#H+\GO,*N<XX(QM\[G\$4
MTAF^7>^]_^QSIUR6PN"5ZOZ0M6W/@R* &E=BT]D[M?T%=_FDSE^E.N-_83OJ
M)GD U<98U>^,"4$OA_%?/.]X>&-0A-\QX#L#[G&/@3S*+\**Q9E66]!.F[RY
MA4_56Q,X.;A+N;>:3B79V<4=/N&P07,VM^3-R>;5SO)RM.3?L8SA1@VV-?!U
MJ+%^;S\G%!,4OH=RR8\ZO!%Z!G'$@(<\/N(OGE*+O;_X>&JPTJJ'*\*JJ02(
M7MO"E2<6-?QYL31>_M<A D;_R6'_KEU.S5I4>!Y0/QC43Q@L/OT09>'G(^B3
M"7URS/O1BSEJ>1C7WAT\M,2(ZJ@9Y=" %<N.A%YOL-1E(V6U-*)I-#;"8@W+
M%U*0KF>A0=5HL6YE146H'VEH;%O4"):\KK6J-Y4U($A@5%>ST=)+P:$$,=1@
M9>\BJ]4436.EFD&Z+CTE?!KQ76D=$E&M5.U4+.^W''[3MJ6Q51/*^XUND(!?
MXX!:=-/^05G:_6?%VUW^UZ_YW_C\#7PCY(3HWA)7!DX@*5B9)+2(HI1E2>I6
M6<+2HJ15G--A3HLR9KP(W1FAYCR'KQM-2!C<R+KN$+X*8^&3Z->?X6*E924@
MCEG$0^"<%64&:<;"* ->LI+<\)#%G(3T%V9P8:2 6U')%<&,0S*+@+"4109)
MQJ(P!QZS)"H@XJQ,$X@S%N<<+J@A*)"!'_&YZC:UKP^ZUW<)_@01Y5>&4+(\
MH_@%R].,$F01>2@83PE,PA*ZA)$X(UQ]^1:L=BUHQAZL=CUH=B1$^9XJ7L:T
MXF7*DJQPLC!G:91[O805D:.-)YQ2SN%AJJ9]N]^]5A-<*U4;H*B#6:'6E(6P
M(&"M)!6['%PMHG/+*3Q!=N$Y2TL?H(A9'CE926F%_D+I"F*OQ@EO2H3?4W/)
M"M^'4$\T6+SG*&1A&D/$\I!^(T]5R>+(B9*B<.=%&/U/3$T3L)-B*3MI7^AS
MUHG!P=?8^4ZWRM^X@^(HQ6>+OMVV0E."5KI,U1L\KM.I8,9Y8DX_MN47K+!?
M$AM39QX <>(JJB@\Z))%43+=Y&XN_$, ZHW>EZ/UTZ ?IP$>F@9NRGR8")Y6
MT:O-0*3*P94WV5$%5!\!N1RI2%RD)39R&';EY2<<-8@B-MS$.TEFG#[(7>??
M%A3Q))Z5>P$C[&:-_L71O<S<T"43;S<HFIR6'-&5'_I,S-]\RXGCQK]8#.$D
MZ.-G?9).CZ*+\2WPJCZ^J(@#2L! ARLR#6=Y&H >7RGCQJJU?QDLE:4+]<N6
M'G:HG0*=KY2R^XT+,#T5%_\"4$L#!!0    ( --:FU9$YWKN@@0  ,L+   9
M    >&PO=V]R:W-H965T<R]S:&5E=#$S+GAM;+56VV[;.!#]%4(-"AO@QB)U
M=6H;2-(6S4.[0;J7A\4^T/+8TE8279*.D[_?(2G+=M?Q;H'NBT12G#-GY@Q'
MG&RE^J)+ $.>FKK5TZ T9GTU&NFBA$;H2[F&%K\LI6J$P:E:C?1:@5@XHZ8>
M\3!,1XVHVF V<6OW:C:1&U-7+=PKHC=-(]3S#=1R.PU8L%MXJ%:EL0NCV60M
M5O 9S*_K>X6S48^RJ!IH=25;HF Y#:[9U4UL][L-OU6PU0=C8B.92_G%3NX6
MTR"TA*"&PE@$@:]'N(6ZMD!(XVN'&?0NK>'A>(?^WL6.L<R%AEM9_UXM3#D-
M\H L8"DVM7F0VP_0Q9-8O$+6VCW)UN_EZ+'8:".;SACG3=7ZMWCJ\G!@D(<O
M&/#.@#O>WI%C^588,9LHN27*[D8T.W"A.FLD5[56E,]&X=<*[<SL5C8H9FFS
M_ CDKBUD Y.1063[?51T*#<>A;^ $I&/LC6E)N_:!2R.[4?(J*?%=[1N^%G
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M+,J[]+,DW*4_2KP2":>9A1F((79\_"&<;,L[Y[9+K;_MCO^:OZZ#-&O9@E5
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M9]T&+; Q9@G&<#;>;F1^@0T,^@2!NXVI7QQZ+P[WGOV8CDO_<4/W-)Y9[1=
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M$[=%]ZEQ83^O.J?#]KB!L2)-ZL142NHC6<=&8FV"?35-7W\7&XL?)2R%%BR
M5JD"OPO3<:D)\H(>M^,QO<NK$;T?^%3%&<P1+P04Q02*VQM8<9X^E>"'XG;Z
MDI[3FY>?13AKX@#3ZR(%F(QA93U7T7LKE0A\$E2H_W<N#K1?K5 NU=NAM(Y7
M!5=,=L[Q-U59-+8S3$*;\:(83&AF:AW'/RV2X;HW?%/]8KT8RC6[HK"^Q7B/
MZ,/@J=[/+R9Q@VX;[QLZ"BPJ#>7>VE]I]VF2G]W3?4@BMLIXT+@AZ'!P,\G
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M^<U-YVC&.7C DK3VJZDG5/XVE3W"343(7D!8P ?3^,K!NR;'_-A_2FQ&2ME
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MV>3B+ $;+Q7QQ9LV'.1;X^E:$(85W</0L@%]+XSQPPLO,-[L-O\!4$L#!!0
M   ( --:FU:<0!Y"5Q   #HL   9    >&PO=V]R:W-H965T<R]S:&5E=#(R
M+GAM;+5::Z_<MA']*\2V:!)@<U^VVS1^ ->O)D4<&W7:H"CZ@2M1NXPI42&E
MNW?SZWMFAJ2DO7L=!VB^V'<E/H;S.'-FJ"=['S[$G3&#NFU=%Y^N=L/0?WU^
M'JN=:74\\[WI\*;QH=4#?H;M>>R#T35/:MWYU<7%G\];;;O5LR?\[%UX]L2/
M@[.=>1=4'-M6A\-SX_S^Z>IRE1_\PVYW STX?_:DUUOSW@S_[-\%_#HOJ]2V
M-5VTOE/!-$]7UY=?/W](XWG OZS9Q]G?BDZR\?X#_?BV?KJZ((&,,]5 *VC\
M=V->&.=H(8CQ<UIS5;:DB?._\^JO^>PXRT9'\\*['VT][)ZNOEJIVC1Z=,,_
M_/X;D\[SB-:KO(O\K]K+V$=7*U6-<?!MF@P)6MO)__HVZ6$VX:N+>R9<I0E7
M++=LQ%*^U(-^]B3XO0HT&JO1'WQ4G@WA;$=&>3\$O+68-SS[SFRU4^^"KXRI
M;;>-3\X'+$LOSZNTQ'-9XNJ>)1ZH-[X;=E&]ZFI3+^>?0YPBTU66Z?G51Q=\
MH\.9>G"Y5E<75P\^LMZ#<L8'O-Z#>]9[X=O6#O"D(2K=U>H%Q,5135=9$]5+
M&ROGXQB,^L_U)@X!CO+?4UJ031Z>WH2"Y^O8Z\H\72$ZH@DW9O7L3W^X_//%
MXX\<X6$YPL./K?YI9OJ-2ZC7P;=J0(BIP?/_:S7L#-33]KH[P,L."+O*(&J@
M-F4[@0")QI]'$X<U8GG3>]-IY8/:ZQ!T-ZB&EM5JZV],Z$CK2I.N#QA<[92.
MO,E[4XW!#F0 ,LFKVVJG81+%MHH4\FOUTO0ZL-V4;]3?$0RV@HRO?AYQD%=M
M[_R!7[[M>Q^&L;/#83&?]GE;56//0F/.>]T8C*$-OS':#3MU72.F+!E]*%/^
MB85,K=X/>H!TK[VO><;+,&Y/CE^*^9W>^" O?@!*PJ\.BQ%!>;P+JC&U"9")
MEHZTE6B)%((Q4#7PI)LID1\?ZQ2CS]0/.[C;*?/$R3YQ9J#(EL5O^J_S@]H8
M%8#7\!>L\O-H Y9=YP$;L[4=6>W.$!:=!!(?JLT-(+['>WB3(6DJ(Y(R_D92
MSHT.UH_P@$-/DG]G/YB]C;"I;=3>%&\+A@S*,[1S9@MKP*B5[^JQ2OYEV/PF
M23'L;*@5*9E%WY.4-]" W;)B,:CO@^^#Q<\S]49W8P.I$/*!-VD1$!5L@2/
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MI(Z(D.7#BV:3(&L:%!%5\)M(4*"/X'PN*.^!'P <&S_$8PGF_E.D!0@LP$8
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MZ>P)520]W&1%UC0SW-@3ARV7S$0?Y7GOBC2NI >N\,:5'%TA)Z/)W>QF=$J
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M8PBA44PIF*V$7*!XFP,C;QPV:Q\J*)X!0<@WYLQ*/G5GF6V"_^Y4"@ PY4"
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MBLF02'QMT!2[!S2:]S2X,1V3-2"?@<Q%45:$R89<E'1*N.Q)N T7.\1'P>S
MM[7X2I(T#:=)[-<JKPB=%#3_R26W!VTY7FLBE07S]NAI2OOH&0H_B%Y,PZ*H
MW)(7+C;-X_\5.RG#LDSZ\$D55FGV(P9E14.*QU1629@4!?G$)6+ZR@ ^6X8D
M!24TQ3HHRT0?. GC(@NGQ=1)>1966-'/8,R,7'=(3UJR4]J_GBZ_:>J6,BL&
M"/']-;H@TVD>TK)P4I6',4IGNB$?NR%_<S?<,MMI;CF8M_7&>>1'O.MF0&_P
M43W&?I$;CC-C\>#=<3+[LBT8/B?,#'V#AW</;ARB[?!]; '4,O+^7443^M$I
M^;%2$)JD85Y53BE)%8\^U6CF*+.5VN-OJSJ)EP6>:M$U</Y&N2NS?G$?)J=J
M$QU-DA;TQL]+@R@8JQ\JX^XXDB_[2?3-O)_G>$8;+@U&6Z-K/"FQ&+J?D;UB
MU<[/I96R..6\N,6_%:"= 7Y?*VR907$!QC\JR_\ 4$L#!!0    ( --:FU;I
M! "ZG@(  ,4%   9    >&PO=V]R:W-H965T<R]S:&5E=#,R+GAM;(54;6_:
M,!#^*Z=LFEJI:D@"E#*(!.Q=JH3:;?TP[8-)#F+5+YEM2OGW.SN0LHJR+[;/
MOGON>7*Y&VVT>; 5HH,G*90=1Y5S]3".;5&A9/92UZCH9:F-9(Y,LXIM;9"5
M(4B*..UT^K%D7$7Y*-S-33[2:R>XPKD!NY:2F>T4A=Z,HR3:7]SR5>7\19R/
M:K;".W0_ZKDA*VY12BY16:X5&%R.HTDRG':]?W#XR7%C#\[@E2RT?O#&UW(<
M=3PA%%@XC\!H>\09"N&!B,:?'6;4IO2!A^<]^J>@G;0LF,69%O>\=-4X&D10
MXI*MA;O5FR^XT]/S>(46-JRP:7S[O0B*M75:[H*)@>2JV=G3[CL<! PZKP2D
MNX T\&X2!98?F&/YR.@-&.]-:/X0I(9H(L>5+\J=,_3**<[EG]?,,.40+9Q]
M9PN!]GP4.P+VSW&Q YDV(.DK(!G<:.4J"Q]5B>6_\3$1:EFE>U;3]"3@#3.7
MD"47D';2[ 1>UJK, E[V?Y6_)@OK#/T,OX_I;&"ZQV%\@PQMS0H<1]0!%LTC
M1OF[-TF_\_X$R6Y+LGL*/9]53*V((5?@*H09,V;+U0HF4J^5 [V$.\K("P2F
M2I@;7:X+!_?D1M(XVF-Z3F8\KN<%#<'9@@ONMD 3 *RCW,R4L&G3AGOOZ2J#
M"++Y$]#_"4!U+*I02&:(MO<5- ;L,!36+RE,F6"J"*\D\1M35*LM4,A;6JZ[
M7=K3BXQV4OS(PS#P&0\()$D/DNLKF G&I:7N*!'.DNO!.:V#J_,7&9XY^02#
M?M(DZ'7A6 WC@]:2:%9A@%@H?$F:+FMOVQDU:5KSV;T9<)1XQ94%@4L*[5Q>
MT4@PS=!H#*?KT*@+[:CMP[&B.8O&.]#[4FNW-WR"=G+G?P%02P,$%     @
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M(:QM[6L'J^M"C?Z6WSX7ZO-^.">ZGMI5=5":#TH+H&A-?PYJ.QM^^:Z84.Y
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M1"7!Y+][?L.3I%*2X_AZ$!T=^ZP:UE\_JO^RF[R<S&=6\IL\^3N.Q/IR%(Q
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MWV0H^"!X6OYKRMM>EYAUJ]_T1;EA"WXYDC_:DA?W?#1[_A/TO3>F23L2TU)
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MDY_('YE4Y_O\,082 =<&ZOV*,?G<T -4ESKS_P%02P,$%     @ TUJ;5L^
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MEL79PW5.V133:UD)2+5]H';[\+A"+@ J"V;PN#Z^]C!=DZ6FMQ*TY5T,U7:
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MSA8\S2Y0WR^31#X<9 %V&Q$G_P%02P,$%     @ TUJ;5HD5D>.1!0  X2@
M !D   !X;"]W;W)K<VAE971S+W-H965T-#(N>&ULU5I1;^LF%/XK*+N:>J6N
M,3AQG"Z-U,3KUNEVJMK=[F': W%(XUW;9(#;>Z?]^('MVL%Q:+V13>E#8PCG
MX_ =./#%3)XI^\37A CP.8E3?M%;"[$Y[_=YN"8)YF=T0U+YS8JR! M99(]]
MOF$$+W.C).XCQ_'Z"8[2WG22U]VRZ81F(HY2<LL SY($LR\S$M/GBQ[LO53<
M18]KH2KZT\D&/Y)[(CYN;IDL]2N49920E$<T!8RL+GJ7\#Q OC+(6SQ$Y)EO
M/0,UE 6EGU3A>GG1<Y1')":A4!!8?CR1.8ECA23]^*,$[55]*L/MYQ?TJWSP
M<C +S,F<QK]$2[&^Z/D]L"0KG,7BCC[_0,H!#15>2&.>_P?/95NG!\*,"YJ4
MQM*#)$J+3_RY)&++ *$]!J@T0&\U<$L#]ZT&@])@D#-3#"7G(< "3R>,/@.F
M6DLT]9"3F5O+X4>IBON]8/+;2-J)Z16.&'C <48 78&K*,5I&.$87*=<L$P&
M6'!P,J>IB-)'60#RD4=+PK"*VGMP$A"!HYB_!^] E(*?US3C.%WR25](YU07
M_;!T9%8X@O8XXH(;V<N:@^_2)5GJ]GTYJ&IDZ&5D,V0$O,'L#+CP%" 'N>#C
M?0!.WKUO\6O^=AAD@ G,, $)7X/11NE6\7-S7'</[BSCLH9S&9AD(:.GPG(*
M]@4,7#*&97T>5]ELK0HJ<)<)S61C.07VFOYZN9!30J[3W]J"6W@Y:/=2):]S
MOL$AN>C)[,0)>R*]Z==?0<_YMBTB-L$"2V!:= 95= 8F].E/-/TFQ'P-\/)W
MN985[4!0L%*+[NEET84UXZ'&>!SA111'XDL;X47'7MZQ2NY/T\' ]2;]IVTB
M=QLY>HO Z/\_9&=8L3,TLM-M[IZ"#R]\R$898[)%&S%%G\.M,;O^R&F,>V[T
MK.L4&^[0#'UOJTN-':]BQSL4.W+:A?L)\G8(@D.$=A@R>M>5(6^7(6_D[Z-H
M5%$T,E)TG:(9E1R![V.ZR#>ML&W 1I"NN<DF6& )3"//K\CSCV+G\&U&QR98
M8 E,B\ZXBL[8O/IQ+$]B!&"NJ/T1IYD\E8/R---&XWAG58\<./8;B]K8:5=^
M+(%I_$"G/K@Z_]?>6O:\32;RW%&#2[-_7<FTA::SN24#8(?Y)@^]X;HZ/+=2
M!'<R^@CY[K#)D;'7SAQ90M,Y0C5'J.MV _X"M8(ZE36;3*7'#^2)Q,!M?'M'
MU*XLIZ.LOR&89RQ/IX75*0@B'N:Y] X+TLJYT;VNJ=(J6F +30]-K8+@<<@@
M:%4'644+;*'I(:JE$#1KH7]QGMU9+*W4%]W[VV+GS/&&<+S]U\Q/EO1/R? A
MU!2LY10TZZD#YZ<[:93*;?6!QC)$>_=.F\IJ;A4ML(6FQZ<6=- [CB1E4]K-
MK:(%MM#T$-6"$IH5Y<&3U*@E24$7PF9>LBHS;:'II-9"$QJ5TG0644;^W*?.
MS<:=9Z-5!6@+32>NUH!P?!P)PZ9LG%M%"VRAZ>\8:A6*S"JTLTXO\;2?PJ"'
MW$$C YC[[<J2+32=I5I=(K.Z/*!6+WO6?LX<[9SSS/YU9O,0.A35.A29=6A7
MK5["Z5/.=URW29)516@+32>I5H3(*&>V-IW_5*.;O>J:*JVB!;;0](C4 A -
MCF(W0S8UW]PJ6F +30]1K2#1P=[(O>GX6W;?./Y"%S4SD5799PM-)[66?>B5
M%WD'R41O4^-FUSK/=:M2SQ::'I9:ZJ'1<:0CJZ\GK:(%MM#T$-7"$;TB' ^=
MCOR6=(0<O_G6S.QF9U*MBLK^UMVOA+#'_ X=!_DII;@L5=56]_0N\]MIC?H9
M/)\7M^UJF.+RGSQA/D8I!S%924CG;"3S*2ONTQ4%03?Y#;,%%8(F^>.:8!D7
MU4!^OZ)4O!14!]6MQNG?4$L#!!0    ( --:FU8![IDUB@(  -(&   9
M>&PO=V]R:W-H965T<R]S:&5E=#0S+GAM;*U574_;,!3]*U:&)I &29POQMI(
MT K!PR3$QWB8]N FMXV%8V>VV\"_GYV$J!33[6$OB3_N.3[']KV>M$(^J0I
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MX<0^KF!^I-((P/N%@&Q1+LP'JHET]!]02P,$%     @ TUJ;5M+<W<Z: @
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M2VEP^KEE@;\;4-8 [U=2FMW&!FA_8,EO4$L#!!0    ( --:FU:+G+C\\@@
M )U.   9    >&PO=V]R:W-H965T<R]S:&5E=#0V+GAM;,6<86_;MA:&_PKA
M#4,+-+5$2K+<)082:^T*K+A%L]Y]&.X'Q:9MH9+H2U%).^S'CY(=T[3HXR@]
M6;XDMFR^)!^)1^\A:9W?"?FE6G&NR-<B+ZN+P4JI]9OAL)JM>)%6K\6:E_J3
MA9!%JO1;N1Q6:\G3>5NHR(?4\Z)AD6;E8'+>'OLH)^>B5GE6\H^25'51I/+;
M%<_%W<7 ']P?^)0M5ZHY,)R<K],EO^;J\_JCU.^&.Y5Y5O"RRD1))%]<#"[]
M-TG$F@+M-_Z;\;MJ[S5ING(CQ)?FS?OYQ<!K6L1S/E.-1*K_W?(IS_-&2;?C
M_UO1P:[.IN#^ZWOUMVWG=6=NTHI/1?Y'-E>KBT$\('.^2.M<?1)WO_)MA\)&
M;R;RJOU+[K;?]09D5E=*%-O"N@5%5F[^IU^W(/8*:!UW ;HM0 \+!$<*L&T!
M]M "P;9 T)+9=*7ED*0JG9Q+<4=D\VVMUKQH8;:E=?>SLCGOUTKJ3S-=3DW>
M"3&_R_*<I.6<_$>MN"3O2Y66R^PFY^2RJKBJR(O.H9?D1<)5FN7ZU1GY?)V0
M%S^^)#^2K"2_KT1=:;7J?*AT YMJAK-M8ZXVC:%'&L/(!U&J545^*>=\;I<?
MZH[M>D?O>W=%0<$/J7Q-F/^*4(\R1WNF#R].'<43N'C"9\>*6[UANW/%6CUV
M1.]:#_IYK<^!6)"W69DI?O:;'C3S]MR]U\@6^P>WY^[/W[0*>:]X4?W/=48V
M50;N*INH\Z9:IS-^,=!AI>+RE@\F/_W@1][/+IR88@F2F(4ZV*$.(/7)W@6?
MMAQ?D7=25!69I5)^R\HE20M1E\I%=*,<M<I-V+V=^#H(L\ ['][NPP);T!>6
ML](P]J-=I1:'<,<A[,OA<C:KBSI/57/A%4*J[*^T">$N%!OQ<*]59XS1V*,'
M*,!&]$7AJI0&GC]RHXAV*"(0Q>5>7PG_JF^\%7?U.>I4'\?>X;F/.J=+?^?@
M2PG8GD<.@-&NMR,PUKRM52VY=8+O.TW^O+RIE-1W;&= &6$&%$RQ!$G,XAGO
M>,;@U?.)-R9,!XZC]Z*KN'/AT"@(1@=7#EA-7R)(8A:1\8[(&"2B,00N#.,.
M!A:,1NP  ZC=%P.2F(7!]XP#\TZ!")U>R>N2",/HD 2LWA<%EIK-8L^-^J=8
M1$X6OH,%V[N[;5F ZKU9(*G9+*AA04^Q&#E9T"Z+B$6'@0)6[\T"2<UF89RO
M#[J]AD7L9,&Z+,:AUV&!:DRQU&P6QIKZL#>UC$A6SO):)TM-Y@68$EBR[UT9
M52W!4K-Q&H?KAT_D='Q,VSI%54NPU&RHQBO[L%E^@-WQNT:9^N..WX$KZHWE
M*3RU;TRU#WK,HYYG6\QB$7=-#ZS>F\53^&'?&&(?=L1';8_#!X\=M@?5"&.I
MV2R,%?9/>F&W[>F:83IVV!Y4-XRE9L_8&3M,3]IAI^VA#COL=6T/K-Z7!9::
MS<+887K2#CMM#W788=:U/;!Z;Q9/88>IL<,4ML.6[9%\)F1C>]**I/K=O-XL
M(XB%?G/+R]KI@N :^MZP4=42+#6;KC'8%)Y;?KP+HJ@SR*AJ"9::#=4X=0H[
M]0>XH*W"_D@.PLYT(5Q/;RI/8;BI,=P4GE,^9H)H=^(VZDR*3F'QWBB>PB93
M8Y,I;)./>2#:]<8N%*C6&$O-1F&L,3UIC9T6B':ML0L%JC/&4K-1&&=,3SIC
MMP/J.F,7"E1CC*5FHS#&F)XTQFX#U#7&+A2HOAA+S5[[-;Z8P;[X=YG.]?U$
M?JG(3VFQ_IFHYD"9%MRYT@ZK]5[817756&HV2>.JF?\,Z^B87GN*JI9@J=F\
MC7-GL'/_7&YM93M-^?B%==:=^(ZC, @.1CW<FM[L3E5J0]G;RP'/:$_;O3U<
MMA?=/-,&.[NIE9 Z?\E;^UVMLK5[9.-NV<#=L_$4AIL9P\V"9QC9J'/GJ&H)
MEIK-VUAY!EOY2YQQW37^+!K'L7\XL%&M_Y%:PV,CVYAZ!IOZ[]PSP[K>_\P?
MA73<P8%J_]W5>O'(.\+#.'L&._OK-.>5#FMM*S2;IN.O2.-DN&HO##TVUU(4
MHOD@S8ELMFJZ(Q_JWA)4M01+S89L<@86/T/DPTPEIJAJ"9::S=LD)@Q.3) B
M7S>-\8,Q&QU.\,.-Z8WN9*WVGDF3H@1PBO*=D2_HSO"?1:/N;!C<BMX[)UVU
M6LFD3<.D&0$\>9_P6YZ+M>ZXXK-5*7*Q_.;L-FKF@*J68*G9"$WF$-!_/ZH%
MJ*L J&H)EIK-VR0E 9R4X$2UP+$IAWK4.TS4X,;T1G>R5AO*WE9P>!;_>Z-:
M=X;_C(W\X##&PZWH3<-5:Z"CZ1$:QO('L.7_J#M=ZE'6C$#1_EZD<ZDX*:#N
ME4%52[#4;*(F7PBB9PARF,G!%%4MP5*S>9M\)(#S$:0@UUV7B#W&PL-1C9ID
M."H=C6,6'QG4)GL(X!6'[PUQ&_7]GS.<A32..C!0,P!WK<&('J%AO'T >_L_
MVA\+-F/MELMTZ=Q* $OT'E^H_AY+S?[%D,D"0N_?CV<AZG(&JEJ"I6;S-GE&
M".<96\9YB_,PI)&ZXHLZ)WFVX.1%5I)O/)752R?B$WN1Z*:LDR=JTH&E9O,T
M24<(+U<<#G_R-WG\9#U<5^_K%C79P%*S.9MD(WR&G[.&J(LCJ&H)EIK-V^0Q
M(9S'H,4)N!H: '$"-<?!4K-Y[OTT%LZ$''$";ZH;KKOW=8S[ ]NGR)="DR^%
MSY OA:CY$JI:@J5F\S;Y4@CG2VAQX\0&L!"(&ZA9%)::S=,D6R&<;#GBQD.G
MBF'EWE<I:CJ&I693-4E;.'Z&J(":Y:&J)5AJ]L,03)87P6L]6%'A1#5^?#PJ
MP$7[\L12LWF:+"Z"TRM'5'CD5"M<4=^+%E4MP5*S(9O4+GJ&]:0(-<5#54NP
MU&S>)L6+X/4DM" !5^-'0)! 3>&PU#8\AWO/[2JX7+;//ZO(K)ESWCSD:G=T
M]XRUR_;)8@?'K_PWT\V3THS,YL%M'U*YS,J*Y'RA);W7(^W=Y>99:)LW2JS;
MIX/="*5$T;Y<\73.9?,%_?E""'7_IJE@]T2ZR3]02P,$%     @ TUJ;5ILP
M"/I-!   ]A,  !D   !X;"]W;W)K<VAE971S+W-H965T-#<N>&ULK5A=;]LV
M%/TKA%8,+9!&$F5]9;:!U5[0 ,D6-,WV,.R!EFB;J"1Z)!4GPW[\2$F1+)OB
MXD(OMBC=>W@.=:_N):=[RK[Q+<8"/.=9P6?65HC=E6WS9(MSQ"_I#A?RR9JR
M' DY9!N;[QA&:>649S9TG,#.$2FL^;2Z=\_F4UJ*C!3XG@%>YCEB+Y]P1O<S
MR[5>;WPAFZU0-^SY=(<V^ &+Q]T]DR.[14E)C@M.: $87L^LG]VK!:P<*HO?
M"=[S@VN@I*PH_:8&-^G,<A0CG.%$* @D_Y[P F>90I(\_FY K79.Y7AX_8I^
M78F78E:(XP7-_B"IV,ZLR (I7J,R$U_H_C-N!/D*+Z$9KW[!OK8-I7%2<D'S
MQEDRR$E1_Z/G9B$.'-S)@ -L'.!;';S&P:N$ULPJ64LDT'S*Z!XP92W1U$6U
M-I6W5$,*]1H?!)-/B?03\UM:;,!7S'*PQ"L!WB^Q0"3C'\!'\/BP!._??0#O
M "G URTM.2I2/K6%G%8YVTDSQ:=Z"C@PQ1UBE\!S+P!TH*=Q7YC=ESAIW6'?
MW99B6\6P50PK/&\03^J\*;A@I0Q' ?Z\E0;@1N"<_Z435Z--]&@JRZ[X#B5X
M9LDTXI@]86O^XP]NX/RDDSH26$^XUPKW3.CS:U*@(L'@%LNPOP"W!*U(1L2+
M3G2-%%1(ZDOP-'<#N?A/AUI.;:#GM#8]BI.6XL1(447C1]%&HXRWFBWX;961
M#5*)?R'?79*5*9%QNR@94Z_P#HF2$4&P-CKK*?U#+4XPB8/X2(_.SI]$$.HU
M^:TFWZCIE>2.LNK#1=<@:V6F4J:.LW_")9"$O2/&.JMP$NCY!BW?X(WO8(A<
M<#)M'/LP#([8:<PBWPD'Z(4MO=!,3V6K7,,%PRF1V7N'\Q5FVLPU IV;N2.!
M]31'K>9HU$]6-*;PD<!ZPN-6>'S&]T G-3X)LC!V'.<H%#56SJ%5CYSK=+73
M,=*KZN8M106X1DGU+37&HQGMW/<R%EI?^T'?X(X:DPW<6.)'0NN+[UH(UUBH
MWQ"7#4"OFGA>[!Y'IMXN\J.!V.R*O6NN]H\%RE7%^0>G=3&]X;RLZO\OSW(/
MP+&6M7=:4<+HF/*I40CC ;Y=Y7?-I1]>!M ']Y@E*IH6M'C"DOTJP^!7*C '
MRQ*K#G "_M4\O$<O2(V,V6><_^P ' FMOUI=3^'ZXV:?L4<Y6_Q(:'WQ78/B
MFCN4P_<_F'^GW8?LH(*36-:9^<%0]G5-BFON4KXO^\(3,IYWW'5KC";>0(OJ
M=@V&:RSC,ON@[_Q_]H7?GWVC]B1CH?57J^M*W'C<[#-V.6>+'PFMOWONFAYH
M;GK>DGT-1*]$R(T4/-YR:>U<-QC8(\"N.X'&!N#[\J_![.UZPS!TCTEKS*+(
MFQQQM@\.9=2)V!UB&U)PD.&U]',N0ZF:U8=,]4#0775.LZ)"T+RZW&*48J8,
MY/,UE=G6#-313WO4-_\/4$L#!!0    ( --:FU8TZQ([30P  /.-   9
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M>\%7(BM/D)_?IC+DU0=E!8]I]KEJ]OS_4$L#!!0    ( --:FU8.+_2860(
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M;PNY9/4CM/GX6B]AA3!W5#=K@T\62K9"LK(-5@Y*0ILG?FO?PT& ZYX)<-L
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M6K_P@-\#:"8![[4F8^ P9UJ1KU<SI27>T&]=YU7[1=U^YJN]5!5-8>3@9ZE
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MY8A'HMMN^ U"'QWX?NT<O1AQ+H97K?@#4$L#!!0    ( -1:FU9B[!1D20,
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MCMQC)8QQ8K3^-8+)#^Q^ %!+ P04    " #46IM62N4=FTT$  #D(@  #P
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M-VC>07G%5;6RK/LX/@XJRFY/=]LJ=0=ECWII>#V\I#&\8/+Y'U!+ P04
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MS5!DS5!DS5!DS?Y3UG=CEG_]N[B]I[4NFT,^Z_[)3SX!4$L! A0#%     @
MTUJ;5@=!36*!    L0   !               ( !     &1O8U!R;W!S+V%P
M<"YX;6Q02P$"% ,4    " #36IM6;6$3_^\    K @  $0
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M965T-"YX;6Q02P$"% ,4    " #36IM6.(NNE0<)  !F00  &
M    @('%'   >&PO=V]R:W-H965T<R]S:&5E=#4N>&UL4$L! A0#%     @
MTUJ;5HZ\OZF  @   08  !@              ("! B8  'AL+W=O<FMS:&5E
M=',O<VAE970V+GAM;%!+ 0(4 Q0    ( --:FU:LJ ++V@8  .L=   8
M          " @;@H  !X;"]W;W)K<VAE971S+W-H965T-RYX;6Q02P$"% ,4
M    " #36IM6#5EJN^T"  !9!@  &               @('(+P  >&PO=V]R
M:W-H965T<R]S:&5E=#@N>&UL4$L! A0#%     @ TUJ;5GSD!L5D!0  - T
M !@              ("!ZS(  'AL+W=O<FMS:&5E=',O<VAE970Y+GAM;%!+
M 0(4 Q0    ( --:FU:.&#D;#P0  /H(   9              " @84X  !X
M;"]W;W)K<VAE971S+W-H965T,3 N>&UL4$L! A0#%     @ TUJ;5F"FFS&:
M!0  ?@X  !D              ("!RSP  'AL+W=O<FMS:&5E=',O<VAE970Q
M,2YX;6Q02P$"% ,4    " #36IM6P,V(Z9T$   V"@  &0
M@(&<0@  >&PO=V]R:W-H965T<R]S:&5E=#$R+GAM;%!+ 0(4 Q0    ( --:
MFU9$YWKN@@0  ,L+   9              " @7!'  !X;"]W;W)K<VAE971S
M+W-H965T,3,N>&UL4$L! A0#%     @ TUJ;5I :!GAO#0  DR@  !D
M         ("!*4P  'AL+W=O<FMS:&5E=',O<VAE970Q-"YX;6Q02P$"% ,4
M    " #36IM6UDH$>W "  !:!0  &0              @('/60  >&PO=V]R
M:W-H965T<R]S:&5E=#$U+GAM;%!+ 0(4 Q0    ( --:FU;G]1T)' 0  ,T)
M   9              " @79<  !X;"]W;W)K<VAE971S+W-H965T,38N>&UL
M4$L! A0#%     @ TUJ;5J,H=Q'C!0  80X  !D              ("!R6
M 'AL+W=O<FMS:&5E=',O<VAE970Q-RYX;6Q02P$"% ,4    " #36IM6'([4
M#-4-  "%+   &0              @('C9@  >&PO=V]R:W-H965T<R]S:&5E
M=#$X+GAM;%!+ 0(4 Q0    ( --:FU;$,4A$D0,  /0'   9
M  " @>]T  !X;"]W;W)K<VAE971S+W-H965T,3DN>&UL4$L! A0#%     @
MTUJ;5I87'/:7 @  S 4  !D              ("!MW@  'AL+W=O<FMS:&5E
M=',O<VAE970R,"YX;6Q02P$"% ,4    " #36IM67IY)0V,$  #E"0  &0
M            @(&%>P  >&PO=V]R:W-H965T<R]S:&5E=#(Q+GAM;%!+ 0(4
M Q0    ( --:FU:<0!Y"5Q   #HL   9              " @1^   !X;"]W
M;W)K<VAE971S+W-H965T,C(N>&UL4$L! A0#%     @ TUJ;5I1M?%'( @
M9P8  !D              ("!K9   'AL+W=O<FMS:&5E=',O<VAE970R,RYX
M;6Q02P$"% ,4    " #36IM6;6Z[IQ@$   %"0  &0              @(&L
MDP  >&PO=V]R:W-H965T<R]S:&5E=#(T+GAM;%!+ 0(4 Q0    ( --:FU9.
M\@YI8@0  !,*   9              " @?N7  !X;"]W;W)K<VAE971S+W-H
M965T,C4N>&UL4$L! A0#%     @ TUJ;5DO1+XRQ!   A0P  !D
M     ("!E)P  'AL+W=O<FMS:&5E=',O<VAE970R-BYX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( --:FU;,U8MMFP,  +0(   9              "
M@5>T  !X;"]W;W)K<VAE971S+W-H965T,S$N>&UL4$L! A0#%     @ TUJ;
M5ND$ +J> @  Q04  !D              ("!*;@  'AL+W=O<FMS:&5E=',O
M<VAE970S,BYX;6Q02P$"% ,4    " #36IM6A%(\5*H"  #8!0  &0
M        @('^N@  >&PO=V]R:W-H965T<R]S:&5E=#,S+GAM;%!+ 0(4 Q0
M   ( --:FU9E3),SDP(  )$%   9              " @=^]  !X;"]W;W)K
M<VAE971S+W-H965T,S0N>&UL4$L! A0#%     @ TUJ;5O]$"!VP!   :QT
M !D              ("!J<   'AL+W=O<FMS:&5E=',O<VAE970S-2YX;6Q0
M2P$"% ,4    " #36IM6$">6 U@'  #D.@  &0              @(&0Q0
M>&PO=V]R:W-H965T<R]S:&5E=#,V+GAM;%!+ 0(4 Q0    ( --:FU9_D2TU
MHP(  +,'   9              " @1_-  !X;"]W;W)K<VAE971S+W-H965T
M,S<N>&UL4$L! A0#%     @ TUJ;5I^R#_8G P  APD  !D
M ("!^<\  'AL+W=O<FMS:&5E=',O<VAE970S."YX;6Q02P$"% ,4    " #3
M6IM6&,*LF(0&  !_)0  &0              @(%7TP  >&PO=V]R:W-H965T
M<R]S:&5E=#,Y+GAM;%!+ 0(4 Q0    ( --:FU;?"(K/! 0  . 1   9
M          " @1+:  !X;"]W;W)K<VAE971S+W-H965T-# N>&UL4$L! A0#
M%     @ TUJ;5L^ K1A\!P  E#@  !D              ("!3=X  'AL+W=O
M<FMS:&5E=',O<VAE970T,2YX;6Q02P$"% ,4    " #36IM6B161XY$%  #A
M*   &0              @($ Y@  >&PO=V]R:W-H965T<R]S:&5E=#0R+GAM
M;%!+ 0(4 Q0    ( --:FU8![IDUB@(  -(&   9              " @<CK
M  !X;"]W;W)K<VAE971S+W-H965T-#,N>&UL4$L! A0#%     @ TUJ;5D>%
M^<I%!   G0X  !D              ("!B>X  'AL+W=O<FMS:&5E=',O<VAE
M970T-"YX;6Q02P$"% ,4    " #36IM6TMS=SIH"  #,!@  &0
M    @($%\P  >&PO=V]R:W-H965T<R]S:&5E=#0U+GAM;%!+ 0(4 Q0    (
M --:FU:+G+C\\@@  )U.   9              " @=;U  !X;"]W;W)K<VAE
M971S+W-H965T-#8N>&UL4$L! A0#%     @ TUJ;5ILP"/I-!   ]A,  !D
M             ("!__X  'AL+W=O<FMS:&5E=',O<VAE970T-RYX;6Q02P$"
M% ,4    " #36IM6-.L2.TT,  #SC0  &0              @(&# P$ >&PO
M=V]R:W-H965T<R]S:&5E=#0X+GAM;%!+ 0(4 Q0    ( --:FU8.+_2860(
M $\&   9              " @0<0 0!X;"]W;W)K<VAE971S+W-H965T-#DN
M>&UL4$L! A0#%     @ TUJ;5H)+9>A> P  .PL  !D              ("!
MEQ(! 'AL+W=O<FMS:&5E=',O<VAE970U,"YX;6Q02P$"% ,4    " #36IM6
MSR(B\?8"  !#"   &0              @($L%@$ >&PO=V]R:W-H965T<R]S
M:&5E=#4Q+GAM;%!+ 0(4 Q0    ( --:FU;L ,"F[P(  ,<*   9
M      " @5D9 0!X;"]W;W)K<VAE971S+W-H965T-3(N>&UL4$L! A0#%
M  @ TUJ;5O_8T@-" @  X00  !D              ("!?QP! 'AL+W=O<FMS
M:&5E=',O<VAE970U,RYX;6Q02P$"% ,4    " #46IM68NP49$D#  #4%
M#0              @ 'X'@$ >&PO<W1Y;&5S+GAM;%!+ 0(4 Q0    ( -1:
MFU:7BKL<P    !,"   +              "  6PB 0!?<F5L<R\N<F5L<U!+
M 0(4 Q0    ( -1:FU9*Y1V;300  .0B   /              "  54C 0!X
M;"]W;W)K8F]O:RYX;6Q02P$"% ,4    " #46IM6?'[I&]0!  #&'P  &@
M            @ '/)P$ >&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'-02P$"
M% ,4    " #46IM6*F32ILH!  ";'P  $P              @ ';*0$ 6T-O
F;G1E;G1?5'EP97-=+GAM;%!+!08     /0 ] *(0  #6*P$    !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.23.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>177</ContextCount>
  <ElementCount>248</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>true</FootnotesReported>
  <SegmentCount>53</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>4</UnitCount>
  <MyReports>
    <Report instance="cnmd-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.conmed.com/role/DocumentandEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="cnmd-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>0000002 - Statement - Consolidated Condensed Statements of Comprehensive Income (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.conmed.com/role/ConsolidatedCondensedStatementsofComprehensiveIncomeUnaudited</Role>
      <ShortName>Consolidated Condensed Statements of Comprehensive Income (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="cnmd-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>0000003 - Statement - Consolidated Condensed Balance Sheets (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.conmed.com/role/ConsolidatedCondensedBalanceSheetsUnaudited</Role>
      <ShortName>Consolidated Condensed Balance Sheets (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="cnmd-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>0000004 - Statement - Consolidated Condensed Balance Sheets (Unaudited) (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.conmed.com/role/ConsolidatedCondensedBalanceSheetsUnauditedParenthetical</Role>
      <ShortName>Consolidated Condensed Balance Sheets (Unaudited) (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="cnmd-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>0000005 - Statement - Consolidated Condensed Statements of Shareholders' Equity (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.conmed.com/role/ConsolidatedCondensedStatementsofShareholdersEquityUnaudited</Role>
      <ShortName>Consolidated Condensed Statements of Shareholders' Equity (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="cnmd-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>0000006 - Statement - Consolidated Condensed Statements of Shareholders' Equity (Unaudited) (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.conmed.com/role/ConsolidatedCondensedStatementsofShareholdersEquityUnauditedParenthetical</Role>
      <ShortName>Consolidated Condensed Statements of Shareholders' Equity (Unaudited) (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="cnmd-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>0000007 - Statement - Consolidated Condensed Statements of Cash Flows (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.conmed.com/role/ConsolidatedCondensedStatementsofCashFlowsUnaudited</Role>
      <ShortName>Consolidated Condensed Statements of Cash Flows (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="cnmd-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>0000008 - Disclosure - Operations</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.conmed.com/role/Operations</Role>
      <ShortName>Operations</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="cnmd-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>0000009 - Disclosure - Interim Financial Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.conmed.com/role/InterimFinancialInformation</Role>
      <ShortName>Interim Financial Information</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="cnmd-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>0000010 - Disclosure - New Accounting Pronouncements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.conmed.com/role/NewAccountingPronouncements</Role>
      <ShortName>New Accounting Pronouncements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="cnmd-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>0000011 - Disclosure - Business Combinations</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.conmed.com/role/BusinessCombinations</Role>
      <ShortName>Business Combinations</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="cnmd-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>0000012 - Disclosure - Revenues</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.conmed.com/role/Revenues</Role>
      <ShortName>Revenues</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="cnmd-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>0000013 - Disclosure - Comprehensive Income</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.conmed.com/role/ComprehensiveIncome</Role>
      <ShortName>Comprehensive Income</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="cnmd-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>0000014 - Disclosure - Fair Value of Financial Instruments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.conmed.com/role/FairValueofFinancialInstruments</Role>
      <ShortName>Fair Value of Financial Instruments</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="cnmd-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>0000015 - Disclosure - Inventories</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.conmed.com/role/Inventories</Role>
      <ShortName>Inventories</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="cnmd-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>0000016 - Disclosure - Earnings Per Share</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.conmed.com/role/EarningsPerShare</Role>
      <ShortName>Earnings Per Share</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="cnmd-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>0000017 - Disclosure - Goodwill and Other Intangible Assets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.conmed.com/role/GoodwillandOtherIntangibleAssets</Role>
      <ShortName>Goodwill and Other Intangible Assets</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="cnmd-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>0000018 - Disclosure - Long Term Debt</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.conmed.com/role/LongTermDebt</Role>
      <ShortName>Long Term Debt</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="cnmd-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>0000019 - Disclosure - Guarantees</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.conmed.com/role/Guarantees</Role>
      <ShortName>Guarantees</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="cnmd-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>0000020 - Disclosure - Pension Plan</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.conmed.com/role/PensionPlan</Role>
      <ShortName>Pension Plan</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="cnmd-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>0000021 - Disclosure - Business Segment</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.conmed.com/role/BusinessSegment</Role>
      <ShortName>Business Segment</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="cnmd-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>0000022 - Disclosure - Legal Proceedings</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.conmed.com/role/LegalProceedings</Role>
      <ShortName>Legal Proceedings</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="cnmd-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>0000023 - Disclosure - Interim Reporting (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.conmed.com/role/InterimReportingPolicies</Role>
      <ShortName>Interim Reporting (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.conmed.com/role/NewAccountingPronouncements</ParentRole>
      <Position>23</Position>
    </Report>
    <Report instance="cnmd-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>0000024 - Disclosure - New Accounting Pronouncements (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.conmed.com/role/NewAccountingPronouncementsPolicies</Role>
      <ShortName>New Accounting Pronouncements (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.conmed.com/role/NewAccountingPronouncements</ParentRole>
      <Position>24</Position>
    </Report>
    <Report instance="cnmd-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>0000025 - Disclosure - Revenues (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.conmed.com/role/RevenuesTables</Role>
      <ShortName>Revenues (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.conmed.com/role/Revenues</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="cnmd-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>0000026 - Disclosure - Comprehensive Income (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.conmed.com/role/ComprehensiveIncomeTables</Role>
      <ShortName>Comprehensive Income (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.conmed.com/role/ComprehensiveIncome</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="cnmd-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>0000027 - Disclosure - Fair Value of Financial Instruments (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.conmed.com/role/FairValueofFinancialInstrumentsTables</Role>
      <ShortName>Fair Value of Financial Instruments (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.conmed.com/role/FairValueofFinancialInstruments</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="cnmd-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>0000028 - Disclosure - Inventories (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.conmed.com/role/InventoriesTables</Role>
      <ShortName>Inventories (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.conmed.com/role/Inventories</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="cnmd-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>0000029 - Disclosure - Earnings Per Share (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.conmed.com/role/EarningsPerShareTables</Role>
      <ShortName>Earnings Per Share (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.conmed.com/role/EarningsPerShare</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="cnmd-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>0000030 - Disclosure - Goodwill and Other Intangible Assets (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.conmed.com/role/GoodwillandOtherIntangibleAssetsTables</Role>
      <ShortName>Goodwill and Other Intangible Assets (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.conmed.com/role/GoodwillandOtherIntangibleAssets</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="cnmd-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>0000031 - Disclosure - Long Term Debt (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.conmed.com/role/LongTermDebtTables</Role>
      <ShortName>Long Term Debt (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.conmed.com/role/LongTermDebt</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="cnmd-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>0000032 - Disclosure - Guarantees (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.conmed.com/role/GuaranteesTables</Role>
      <ShortName>Guarantees (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.conmed.com/role/Guarantees</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="cnmd-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>0000033 - Disclosure - Pension Plan (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.conmed.com/role/PensionPlanTables</Role>
      <ShortName>Pension Plan (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.conmed.com/role/PensionPlan</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="cnmd-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>0000034 - Disclosure - Business Segment (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.conmed.com/role/BusinessSegmentTables</Role>
      <ShortName>Business Segment (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.conmed.com/role/BusinessSegment</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="cnmd-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>0000035 - Disclosure - Business Combinations (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.conmed.com/role/BusinessCombinationsDetails</Role>
      <ShortName>Business Combinations (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.conmed.com/role/BusinessCombinations</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="cnmd-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>0000036 - Disclosure - Revenues (Disaggregated Revenues) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.conmed.com/role/RevenuesDisaggregatedRevenuesDetails</Role>
      <ShortName>Revenues (Disaggregated Revenues) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.conmed.com/role/RevenuesTables</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="cnmd-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>0000037 - Disclosure - Revenues (Customer Liability) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.conmed.com/role/RevenuesCustomerLiabilityDetails</Role>
      <ShortName>Revenues (Customer Liability) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.conmed.com/role/RevenuesTables</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="cnmd-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>0000038 - Disclosure - Comprehensive Income (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.conmed.com/role/ComprehensiveIncomeDetails</Role>
      <ShortName>Comprehensive Income (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.conmed.com/role/ComprehensiveIncomeTables</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="cnmd-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>0000039 - Disclosure - Comprehensive Income (Accumulated Other Comprehensive Income (Loss)) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.conmed.com/role/ComprehensiveIncomeAccumulatedOtherComprehensiveIncomeLossDetails</Role>
      <ShortName>Comprehensive Income (Accumulated Other Comprehensive Income (Loss)) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.conmed.com/role/ComprehensiveIncomeTables</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="cnmd-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>0000040 - Disclosure - Fair Value of Financial Instruments (Amounts Recorded In and Reclassified From AOCI) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.conmed.com/role/FairValueofFinancialInstrumentsAmountsRecordedInandReclassifiedFromAOCIDetails</Role>
      <ShortName>Fair Value of Financial Instruments (Amounts Recorded In and Reclassified From AOCI) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.conmed.com/role/FairValueofFinancialInstrumentsTables</ParentRole>
      <Position>40</Position>
    </Report>
    <Report instance="cnmd-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>0000041 - Disclosure - Fair Value of Financial Instruments (Foreign Currency Forward Contracts) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.conmed.com/role/FairValueofFinancialInstrumentsForeignCurrencyForwardContractsDetails</Role>
      <ShortName>Fair Value of Financial Instruments (Foreign Currency Forward Contracts) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.conmed.com/role/FairValueofFinancialInstrumentsTables</ParentRole>
      <Position>41</Position>
    </Report>
    <Report instance="cnmd-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>0000042 - Disclosure - Fair Value of Financial Instruments (Contingent Consideration) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.conmed.com/role/FairValueofFinancialInstrumentsContingentConsiderationDetails</Role>
      <ShortName>Fair Value of Financial Instruments (Contingent Consideration) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.conmed.com/role/FairValueofFinancialInstrumentsTables</ParentRole>
      <Position>42</Position>
    </Report>
    <Report instance="cnmd-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>0000043 - Disclosure - Inventories (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.conmed.com/role/InventoriesDetails</Role>
      <ShortName>Inventories (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.conmed.com/role/InventoriesTables</ParentRole>
      <Position>43</Position>
    </Report>
    <Report instance="cnmd-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>0000044 - Disclosure - Earnings Per Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.conmed.com/role/EarningsPerShareDetails</Role>
      <ShortName>Earnings Per Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.conmed.com/role/EarningsPerShareTables</ParentRole>
      <Position>44</Position>
    </Report>
    <Report instance="cnmd-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>0000045 - Disclosure - Goodwill and Other Intangible Assets (Goodwill) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.conmed.com/role/GoodwillandOtherIntangibleAssetsGoodwillDetails</Role>
      <ShortName>Goodwill and Other Intangible Assets (Goodwill) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.conmed.com/role/GoodwillandOtherIntangibleAssetsTables</ParentRole>
      <Position>45</Position>
    </Report>
    <Report instance="cnmd-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>0000046 - Disclosure - Goodwill and Other Intangible Assets (Intangible Assets) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.conmed.com/role/GoodwillandOtherIntangibleAssetsIntangibleAssetsDetails</Role>
      <ShortName>Goodwill and Other Intangible Assets (Intangible Assets) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.conmed.com/role/GoodwillandOtherIntangibleAssetsTables</ParentRole>
      <Position>46</Position>
    </Report>
    <Report instance="cnmd-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>0000047 - Disclosure - Long Term Debt (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.conmed.com/role/LongTermDebtDetails</Role>
      <ShortName>Long Term Debt (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.conmed.com/role/LongTermDebtTables</ParentRole>
      <Position>47</Position>
    </Report>
    <Report instance="cnmd-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>0000048 - Disclosure - Long Term Debt Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.conmed.com/role/LongTermDebtAdditionalInformationDetails</Role>
      <ShortName>Long Term Debt Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>48</Position>
    </Report>
    <Report instance="cnmd-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>0000049 - Disclosure - Long Term Debt Maturities of Long Term Debt (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.conmed.com/role/LongTermDebtMaturitiesofLongTermDebtDetails</Role>
      <ShortName>Long Term Debt Maturities of Long Term Debt (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>49</Position>
    </Report>
    <Report instance="cnmd-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>0000050 - Disclosure - Guarantees (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.conmed.com/role/GuaranteesDetails</Role>
      <ShortName>Guarantees (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.conmed.com/role/GuaranteesTables</ParentRole>
      <Position>50</Position>
    </Report>
    <Report instance="cnmd-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>0000051 - Disclosure - Pension Plan (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.conmed.com/role/PensionPlanDetails</Role>
      <ShortName>Pension Plan (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.conmed.com/role/PensionPlanTables</ParentRole>
      <Position>51</Position>
    </Report>
    <Report instance="cnmd-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>0000052 - Disclosure - Business Segment (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.conmed.com/role/BusinessSegmentDetails</Role>
      <ShortName>Business Segment (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.conmed.com/role/BusinessSegmentTables</ParentRole>
      <Position>52</Position>
    </Report>
    <Report instance="cnmd-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>0000053 - Disclosure - Legal Proceedings (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.conmed.com/role/LegalProceedingsDetails</Role>
      <ShortName>Legal Proceedings (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.conmed.com/role/LegalProceedings</ParentRole>
      <Position>53</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-Q" original="cnmd-20230331.htm">cnmd-20230331.htm</File>
    <File>cnmd-20230331.xsd</File>
    <File>cnmd-20230331_cal.xml</File>
    <File>cnmd-20230331_def.xml</File>
    <File>cnmd-20230331_lab.xml</File>
    <File>cnmd-20230331_pre.xml</File>
    <File>cnmd33123ex311.htm</File>
    <File>cnmd33123ex312.htm</File>
    <File>cnmd33123ex321.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="671">http://fasb.org/us-gaap/2022</BaseTaxonomy>
    <BaseTaxonomy items="29">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>69
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "cnmd-20230331.htm": {
   "axisCustom": 1,
   "axisStandard": 21,
   "baseTaxonomies": {
    "http://fasb.org/us-gaap/2022": 671,
    "http://xbrl.sec.gov/dei/2022": 29
   },
   "contextCount": 177,
   "dts": {
    "calculationLink": {
     "local": [
      "cnmd-20230331_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "cnmd-20230331_def.xml"
     ]
    },
    "inline": {
     "local": [
      "cnmd-20230331.htm"
     ]
    },
    "labelLink": {
     "local": [
      "cnmd-20230331_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "cnmd-20230331_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "cnmd-20230331.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd",
      "https://xbrl.sec.gov/country/2022/country-2022.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd"
     ]
    }
   },
   "elementCount": 411,
   "entityCount": 1,
   "hidden": {
    "http://fasb.org/us-gaap/2022": 1,
    "http://xbrl.sec.gov/dei/2022": 5,
    "total": 6
   },
   "keyCustom": 9,
   "keyStandard": 239,
   "memberCustom": 17,
   "memberStandard": 36,
   "nsprefix": "cnmd",
   "nsuri": "http://www.conmed.com/20230331",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cnmd-20230331.htm",
      "contextRef": "iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0000001 - Document - Document and Entity Information",
     "menuCat": "Cover",
     "order": "1",
     "role": "http://www.conmed.com/role/DocumentandEntityInformation",
     "shortName": "Document and Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cnmd-20230331.htm",
      "contextRef": "iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cnmd-20230331.htm",
      "contextRef": "iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000010 - Disclosure - New Accounting Pronouncements",
     "menuCat": "Notes",
     "order": "10",
     "role": "http://www.conmed.com/role/NewAccountingPronouncements",
     "shortName": "New Accounting Pronouncements",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cnmd-20230331.htm",
      "contextRef": "iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cnmd-20230331.htm",
      "contextRef": "iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000011 - Disclosure - Business Combinations",
     "menuCat": "Notes",
     "order": "11",
     "role": "http://www.conmed.com/role/BusinessCombinations",
     "shortName": "Business Combinations",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cnmd-20230331.htm",
      "contextRef": "iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cnmd-20230331.htm",
      "contextRef": "iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000012 - Disclosure - Revenues",
     "menuCat": "Notes",
     "order": "12",
     "role": "http://www.conmed.com/role/Revenues",
     "shortName": "Revenues",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cnmd-20230331.htm",
      "contextRef": "iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cnmd-20230331.htm",
      "contextRef": "iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ComprehensiveIncomeNoteTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000013 - Disclosure - Comprehensive Income",
     "menuCat": "Notes",
     "order": "13",
     "role": "http://www.conmed.com/role/ComprehensiveIncome",
     "shortName": "Comprehensive Income",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cnmd-20230331.htm",
      "contextRef": "iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ComprehensiveIncomeNoteTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cnmd-20230331.htm",
      "contextRef": "iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativesAndFairValueTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000014 - Disclosure - Fair Value of Financial Instruments",
     "menuCat": "Notes",
     "order": "14",
     "role": "http://www.conmed.com/role/FairValueofFinancialInstruments",
     "shortName": "Fair Value of Financial Instruments",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cnmd-20230331.htm",
      "contextRef": "iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativesAndFairValueTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cnmd-20230331.htm",
      "contextRef": "iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000015 - Disclosure - Inventories",
     "menuCat": "Notes",
     "order": "15",
     "role": "http://www.conmed.com/role/Inventories",
     "shortName": "Inventories",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cnmd-20230331.htm",
      "contextRef": "iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cnmd-20230331.htm",
      "contextRef": "iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000016 - Disclosure - Earnings Per Share",
     "menuCat": "Notes",
     "order": "16",
     "role": "http://www.conmed.com/role/EarningsPerShare",
     "shortName": "Earnings Per Share",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cnmd-20230331.htm",
      "contextRef": "iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cnmd-20230331.htm",
      "contextRef": "iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000017 - Disclosure - Goodwill and Other Intangible Assets",
     "menuCat": "Notes",
     "order": "17",
     "role": "http://www.conmed.com/role/GoodwillandOtherIntangibleAssets",
     "shortName": "Goodwill and Other Intangible Assets",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cnmd-20230331.htm",
      "contextRef": "iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cnmd-20230331.htm",
      "contextRef": "iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000018 - Disclosure - Long Term Debt",
     "menuCat": "Notes",
     "order": "18",
     "role": "http://www.conmed.com/role/LongTermDebt",
     "shortName": "Long Term Debt",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cnmd-20230331.htm",
      "contextRef": "iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cnmd-20230331.htm",
      "contextRef": "iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProductWarrantyDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000019 - Disclosure - Guarantees",
     "menuCat": "Notes",
     "order": "19",
     "role": "http://www.conmed.com/role/Guarantees",
     "shortName": "Guarantees",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cnmd-20230331.htm",
      "contextRef": "iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProductWarrantyDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnmd-20230331.htm",
      "contextRef": "iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000002 - Statement - Consolidated Condensed Statements of Comprehensive Income (Unaudited)",
     "menuCat": "Statements",
     "order": "2",
     "role": "http://www.conmed.com/role/ConsolidatedCondensedStatementsofComprehensiveIncomeUnaudited",
     "shortName": "Consolidated Condensed Statements of Comprehensive Income (Unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cnmd-20230331.htm",
      "contextRef": "iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:GrossProfit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cnmd-20230331.htm",
      "contextRef": "iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000020 - Disclosure - Pension Plan",
     "menuCat": "Notes",
     "order": "20",
     "role": "http://www.conmed.com/role/PensionPlan",
     "shortName": "Pension Plan",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cnmd-20230331.htm",
      "contextRef": "iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cnmd-20230331.htm",
      "contextRef": "iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000021 - Disclosure - Business Segment",
     "menuCat": "Notes",
     "order": "21",
     "role": "http://www.conmed.com/role/BusinessSegment",
     "shortName": "Business Segment",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cnmd-20230331.htm",
      "contextRef": "iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cnmd-20230331.htm",
      "contextRef": "iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LegalMattersAndContingenciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000022 - Disclosure - Legal Proceedings",
     "menuCat": "Notes",
     "order": "22",
     "role": "http://www.conmed.com/role/LegalProceedings",
     "shortName": "Legal Proceedings",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cnmd-20230331.htm",
      "contextRef": "iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LegalMattersAndContingenciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnmd-20230331.htm",
      "contextRef": "iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:UseOfEstimates",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000023 - Disclosure - Interim Reporting (Policies)",
     "menuCat": "Policies",
     "order": "23",
     "role": "http://www.conmed.com/role/InterimReportingPolicies",
     "shortName": "Interim Reporting (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnmd-20230331.htm",
      "contextRef": "iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:UseOfEstimates",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cnmd-20230331.htm",
      "contextRef": "iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000024 - Disclosure - New Accounting Pronouncements (Policies)",
     "menuCat": "Policies",
     "order": "24",
     "role": "http://www.conmed.com/role/NewAccountingPronouncementsPolicies",
     "shortName": "New Accounting Pronouncements (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cnmd-20230331.htm",
      "contextRef": "iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnmd-20230331.htm",
      "contextRef": "iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000025 - Disclosure - Revenues (Tables)",
     "menuCat": "Tables",
     "order": "25",
     "role": "http://www.conmed.com/role/RevenuesTables",
     "shortName": "Revenues (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnmd-20230331.htm",
      "contextRef": "iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnmd-20230331.htm",
      "contextRef": "iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfComprehensiveIncomeLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000026 - Disclosure - Comprehensive Income (Tables)",
     "menuCat": "Tables",
     "order": "26",
     "role": "http://www.conmed.com/role/ComprehensiveIncomeTables",
     "shortName": "Comprehensive Income (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnmd-20230331.htm",
      "contextRef": "iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfComprehensiveIncomeLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnmd-20230331.htm",
      "contextRef": "iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000027 - Disclosure - Fair Value of Financial Instruments (Tables)",
     "menuCat": "Tables",
     "order": "27",
     "role": "http://www.conmed.com/role/FairValueofFinancialInstrumentsTables",
     "shortName": "Fair Value of Financial Instruments (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnmd-20230331.htm",
      "contextRef": "iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnmd-20230331.htm",
      "contextRef": "iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000028 - Disclosure - Inventories (Tables)",
     "menuCat": "Tables",
     "order": "28",
     "role": "http://www.conmed.com/role/InventoriesTables",
     "shortName": "Inventories (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnmd-20230331.htm",
      "contextRef": "iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnmd-20230331.htm",
      "contextRef": "iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000029 - Disclosure - Earnings Per Share (Tables)",
     "menuCat": "Tables",
     "order": "29",
     "role": "http://www.conmed.com/role/EarningsPerShareTables",
     "shortName": "Earnings Per Share (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnmd-20230331.htm",
      "contextRef": "iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cnmd-20230331.htm",
      "contextRef": "i738c2d1dacaf436faf03cc46ab9cef23_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000003 - Statement - Consolidated Condensed Balance Sheets (Unaudited)",
     "menuCat": "Statements",
     "order": "3",
     "role": "http://www.conmed.com/role/ConsolidatedCondensedBalanceSheetsUnaudited",
     "shortName": "Consolidated Condensed Balance Sheets (Unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cnmd-20230331.htm",
      "contextRef": "i738c2d1dacaf436faf03cc46ab9cef23_I20230331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:AccountsReceivableNetCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnmd-20230331.htm",
      "contextRef": "iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000030 - Disclosure - Goodwill and Other Intangible Assets (Tables)",
     "menuCat": "Tables",
     "order": "30",
     "role": "http://www.conmed.com/role/GoodwillandOtherIntangibleAssetsTables",
     "shortName": "Goodwill and Other Intangible Assets (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnmd-20230331.htm",
      "contextRef": "iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnmd-20230331.htm",
      "contextRef": "iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000031 - Disclosure - Long Term Debt (Tables)",
     "menuCat": "Tables",
     "order": "31",
     "role": "http://www.conmed.com/role/LongTermDebtTables",
     "shortName": "Long Term Debt (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnmd-20230331.htm",
      "contextRef": "iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnmd-20230331.htm",
      "contextRef": "iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000032 - Disclosure - Guarantees (Tables)",
     "menuCat": "Tables",
     "order": "32",
     "role": "http://www.conmed.com/role/GuaranteesTables",
     "shortName": "Guarantees (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnmd-20230331.htm",
      "contextRef": "iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnmd-20230331.htm",
      "contextRef": "iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfNetBenefitCostsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000033 - Disclosure - Pension Plan (Tables)",
     "menuCat": "Tables",
     "order": "33",
     "role": "http://www.conmed.com/role/PensionPlanTables",
     "shortName": "Pension Plan (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnmd-20230331.htm",
      "contextRef": "iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfNetBenefitCostsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnmd-20230331.htm",
      "contextRef": "iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000034 - Disclosure - Business Segment (Tables)",
     "menuCat": "Tables",
     "order": "34",
     "role": "http://www.conmed.com/role/BusinessSegmentTables",
     "shortName": "Business Segment (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnmd-20230331.htm",
      "contextRef": "iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnmd-20230331.htm",
      "contextRef": "iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000035 - Disclosure - Business Combinations (Details)",
     "menuCat": "Details",
     "order": "35",
     "role": "http://www.conmed.com/role/BusinessCombinationsDetails",
     "shortName": "Business Combinations (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cnmd-20230331.htm",
      "contextRef": "i8c4d1dfe88414ef2adffd18a83334e37_D20220613-20220613",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationConsiderationTransferred1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DisaggregationOfRevenueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnmd-20230331.htm",
      "contextRef": "iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000036 - Disclosure - Revenues (Disaggregated Revenues) (Details)",
     "menuCat": "Details",
     "order": "36",
     "role": "http://www.conmed.com/role/RevenuesDisaggregatedRevenuesDetails",
     "shortName": "Revenues (Disaggregated Revenues) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DisaggregationOfRevenueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnmd-20230331.htm",
      "contextRef": "iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnmd-20230331.htm",
      "contextRef": "i738c2d1dacaf436faf03cc46ab9cef23_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ContractWithCustomerLiability",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000037 - Disclosure - Revenues (Customer Liability) (Details)",
     "menuCat": "Details",
     "order": "37",
     "role": "http://www.conmed.com/role/RevenuesCustomerLiabilityDetails",
     "shortName": "Revenues (Customer Liability) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnmd-20230331.htm",
      "contextRef": "i738c2d1dacaf436faf03cc46ab9cef23_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ContractWithCustomerLiability",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cnmd-20230331.htm",
      "contextRef": "iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000038 - Disclosure - Comprehensive Income (Details)",
     "menuCat": "Details",
     "order": "38",
     "role": "http://www.conmed.com/role/ComprehensiveIncomeDetails",
     "shortName": "Comprehensive Income (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnmd-20230331.htm",
      "contextRef": "iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cnmd-20230331.htm",
      "contextRef": "ie4f63720d8b244a68941932992cd9f4d_I20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000039 - Disclosure - Comprehensive Income (Accumulated Other Comprehensive Income (Loss)) (Details)",
     "menuCat": "Details",
     "order": "39",
     "role": "http://www.conmed.com/role/ComprehensiveIncomeAccumulatedOtherComprehensiveIncomeLossDetails",
     "shortName": "Comprehensive Income (Accumulated Other Comprehensive Income (Loss)) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnmd-20230331.htm",
      "contextRef": "i7467bf1c44a741c2a174d8fda8ebb019_I20221231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cnmd-20230331.htm",
      "contextRef": "i738c2d1dacaf436faf03cc46ab9cef23_I20230331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000004 - Statement - Consolidated Condensed Balance Sheets (Unaudited) (Parenthetical)",
     "menuCat": "Statements",
     "order": "4",
     "role": "http://www.conmed.com/role/ConsolidatedCondensedBalanceSheetsUnauditedParenthetical",
     "shortName": "Consolidated Condensed Balance Sheets (Unaudited) (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cnmd-20230331.htm",
      "contextRef": "i738c2d1dacaf436faf03cc46ab9cef23_I20230331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnmd-20230331.htm",
      "contextRef": "iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000040 - Disclosure - Fair Value of Financial Instruments (Amounts Recorded In and Reclassified From AOCI) (Details)",
     "menuCat": "Details",
     "order": "40",
     "role": "http://www.conmed.com/role/FairValueofFinancialInstrumentsAmountsRecordedInandReclassifiedFromAOCIDetails",
     "shortName": "Fair Value of Financial Instruments (Amounts Recorded In and Reclassified From AOCI) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnmd-20230331.htm",
      "contextRef": "iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnmd-20230331.htm",
      "contextRef": "iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ForeignCurrencyTransactionGainLossBeforeTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000041 - Disclosure - Fair Value of Financial Instruments (Foreign Currency Forward Contracts) (Details)",
     "menuCat": "Details",
     "order": "41",
     "role": "http://www.conmed.com/role/FairValueofFinancialInstrumentsForeignCurrencyForwardContractsDetails",
     "shortName": "Fair Value of Financial Instruments (Foreign Currency Forward Contracts) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnmd-20230331.htm",
      "contextRef": "iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ForeignCurrencyTransactionGainLossBeforeTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cnmd-20230331.htm",
      "contextRef": "iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000042 - Disclosure - Fair Value of Financial Instruments (Contingent Consideration) (Details)",
     "menuCat": "Details",
     "order": "42",
     "role": "http://www.conmed.com/role/FairValueofFinancialInstrumentsContingentConsiderationDetails",
     "shortName": "Fair Value of Financial Instruments (Contingent Consideration) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnmd-20230331.htm",
      "contextRef": "i738c2d1dacaf436faf03cc46ab9cef23_I20230331",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnmd-20230331.htm",
      "contextRef": "i738c2d1dacaf436faf03cc46ab9cef23_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryRawMaterialsNetOfReserves",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000043 - Disclosure - Inventories (Details)",
     "menuCat": "Details",
     "order": "43",
     "role": "http://www.conmed.com/role/InventoriesDetails",
     "shortName": "Inventories (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnmd-20230331.htm",
      "contextRef": "i738c2d1dacaf436faf03cc46ab9cef23_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryRawMaterialsNetOfReserves",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cnmd-20230331.htm",
      "contextRef": "iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000044 - Disclosure - Earnings Per Share (Details)",
     "menuCat": "Details",
     "order": "44",
     "role": "http://www.conmed.com/role/EarningsPerShareDetails",
     "shortName": "Earnings Per Share (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnmd-20230331.htm",
      "contextRef": "iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:InterestOnConvertibleDebtNetOfTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cnmd-20230331.htm",
      "contextRef": "ie4f63720d8b244a68941932992cd9f4d_I20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000045 - Disclosure - Goodwill and Other Intangible Assets (Goodwill) (Details)",
     "menuCat": "Details",
     "order": "45",
     "role": "http://www.conmed.com/role/GoodwillandOtherIntangibleAssetsGoodwillDetails",
     "shortName": "Goodwill and Other Intangible Assets (Goodwill) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnmd-20230331.htm",
      "contextRef": "iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:GoodwillForeignCurrencyTranslationGainLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnmd-20230331.htm",
      "contextRef": "i738c2d1dacaf436faf03cc46ab9cef23_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IntangibleAssetsGrossExcludingGoodwill",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000046 - Disclosure - Goodwill and Other Intangible Assets (Intangible Assets) (Details)",
     "menuCat": "Details",
     "order": "46",
     "role": "http://www.conmed.com/role/GoodwillandOtherIntangibleAssetsIntangibleAssetsDetails",
     "shortName": "Goodwill and Other Intangible Assets (Intangible Assets) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnmd-20230331.htm",
      "contextRef": "i738c2d1dacaf436faf03cc46ab9cef23_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IntangibleAssetsGrossExcludingGoodwill",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnmd-20230331.htm",
      "contextRef": "i738c2d1dacaf436faf03cc46ab9cef23_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FinanceLeaseLiability",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000047 - Disclosure - Long Term Debt (Details)",
     "menuCat": "Details",
     "order": "47",
     "role": "http://www.conmed.com/role/LongTermDebtDetails",
     "shortName": "Long Term Debt (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnmd-20230331.htm",
      "contextRef": "i738c2d1dacaf436faf03cc46ab9cef23_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FinanceLeaseLiability",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cnmd-20230331.htm",
      "contextRef": "iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RepaymentsOfSeniorDebt",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000048 - Disclosure - Long Term Debt Additional Information (Details)",
     "menuCat": "Details",
     "order": "48",
     "role": "http://www.conmed.com/role/LongTermDebtAdditionalInformationDetails",
     "shortName": "Long Term Debt Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnmd-20230331.htm",
      "contextRef": "i0dc2d8a4965f4bf786ec6493bd6eea66_I20210716",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentFaceAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnmd-20230331.htm",
      "contextRef": "i738c2d1dacaf436faf03cc46ab9cef23_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000049 - Disclosure - Long Term Debt Maturities of Long Term Debt (Details)",
     "menuCat": "Details",
     "order": "49",
     "role": "http://www.conmed.com/role/LongTermDebtMaturitiesofLongTermDebtDetails",
     "shortName": "Long Term Debt Maturities of Long Term Debt (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnmd-20230331.htm",
      "contextRef": "i738c2d1dacaf436faf03cc46ab9cef23_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cnmd-20230331.htm",
      "contextRef": "icb342dd07ae648ba88c184ef672faf7e_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockSharesOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000005 - Statement - Consolidated Condensed Statements of Shareholders' Equity (Unaudited)",
     "menuCat": "Statements",
     "order": "5",
     "role": "http://www.conmed.com/role/ConsolidatedCondensedStatementsofShareholdersEquityUnaudited",
     "shortName": "Consolidated Condensed Statements of Shareholders' Equity (Unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cnmd-20230331.htm",
      "contextRef": "icb342dd07ae648ba88c184ef672faf7e_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockSharesOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnmd-20230331.htm",
      "contextRef": "iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cnmd:ProductWarrantyAccrualTerm",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000050 - Disclosure - Guarantees (Details)",
     "menuCat": "Details",
     "order": "50",
     "role": "http://www.conmed.com/role/GuaranteesDetails",
     "shortName": "Guarantees (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnmd-20230331.htm",
      "contextRef": "iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cnmd:ProductWarrantyAccrualTerm",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfNetBenefitCostsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnmd-20230331.htm",
      "contextRef": "iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanServiceCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000051 - Disclosure - Pension Plan (Details)",
     "menuCat": "Details",
     "order": "51",
     "role": "http://www.conmed.com/role/PensionPlanDetails",
     "shortName": "Pension Plan (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfNetBenefitCostsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnmd-20230331.htm",
      "contextRef": "iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanServiceCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R52": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnmd-20230331.htm",
      "contextRef": "iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000052 - Disclosure - Business Segment (Details)",
     "menuCat": "Details",
     "order": "52",
     "role": "http://www.conmed.com/role/BusinessSegmentDetails",
     "shortName": "Business Segment (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnmd-20230331.htm",
      "contextRef": "i6a0f37b7e82e470ebf61b3f06c22aac2_D20230101-20230331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R53": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnmd-20230331.htm",
      "contextRef": "i738c2d1dacaf436faf03cc46ab9cef23_I20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "cnmd:ProductLiabilityContingencyInsuranceAmountPerIncident",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000053 - Disclosure - Legal Proceedings (Details)",
     "menuCat": "Details",
     "order": "53",
     "role": "http://www.conmed.com/role/LegalProceedingsDetails",
     "shortName": "Legal Proceedings (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cnmd-20230331.htm",
      "contextRef": "i738c2d1dacaf436faf03cc46ab9cef23_I20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "cnmd:ProductLiabilityContingencyInsuranceAmountPerIncident",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cnmd-20230331.htm",
      "contextRef": "iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockDividendsPerShareDeclared",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000006 - Statement - Consolidated Condensed Statements of Shareholders' Equity (Unaudited) (Parenthetical)",
     "menuCat": "Statements",
     "order": "6",
     "role": "http://www.conmed.com/role/ConsolidatedCondensedStatementsofShareholdersEquityUnauditedParenthetical",
     "shortName": "Consolidated Condensed Statements of Shareholders' Equity (Unaudited) (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cnmd-20230331.htm",
      "contextRef": "iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockDividendsPerShareDeclared",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cnmd-20230331.htm",
      "contextRef": "iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000007 - Statement - Consolidated Condensed Statements of Cash Flows (Unaudited)",
     "menuCat": "Statements",
     "order": "7",
     "role": "http://www.conmed.com/role/ConsolidatedCondensedStatementsofCashFlowsUnaudited",
     "shortName": "Consolidated Condensed Statements of Cash Flows (Unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cnmd-20230331.htm",
      "contextRef": "iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:Depreciation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cnmd-20230331.htm",
      "contextRef": "iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NatureOfOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000008 - Disclosure - Operations",
     "menuCat": "Notes",
     "order": "8",
     "role": "http://www.conmed.com/role/Operations",
     "shortName": "Operations",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cnmd-20230331.htm",
      "contextRef": "iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NatureOfOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cnmd-20230331.htm",
      "contextRef": "iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000009 - Disclosure - Interim Financial Information",
     "menuCat": "Notes",
     "order": "9",
     "role": "http://www.conmed.com/role/InterimFinancialInformation",
     "shortName": "Interim Financial Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cnmd-20230331.htm",
      "contextRef": "iaa7011af6e154d219b390f6a9a86867f_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 53,
   "tag": {
    "cnmd_A2.625PercentConvertibleNotesDue2024Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2.625 Percent Convertible Notes Due 2024 [Member]",
        "label": "2.625 Percent Convertible Notes Due 2024 [Member]",
        "terseLabel": "2.625 Percent Convertible Notes Due 2024"
       }
      }
     },
     "localname": "A2.625PercentConvertibleNotesDue2024Member",
     "nsuri": "http://www.conmed.com/20230331",
     "presentation": [
      "http://www.conmed.com/role/LongTermDebtAdditionalInformationDetails",
      "http://www.conmed.com/role/LongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cnmd_A2250PercentConvertibleNotesDue2027Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2.250 Percent Convertible Notes Due 2027",
        "label": "2.250 Percent Convertible Notes Due 2027 [Member]",
        "terseLabel": "2.250 Percent Convertible Notes Due 2027"
       }
      }
     },
     "localname": "A2250PercentConvertibleNotesDue2027Member",
     "nsuri": "http://www.conmed.com/20230331",
     "presentation": [
      "http://www.conmed.com/role/LongTermDebtAdditionalInformationDetails",
      "http://www.conmed.com/role/LongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cnmd_AdjustedTermSOFRInterestRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Adjusted Term SOFR Interest Rate",
        "label": "Adjusted Term SOFR Interest Rate",
        "terseLabel": "Adjusted Term SOFR Interest Rate"
       }
      }
     },
     "localname": "AdjustedTermSOFRInterestRate",
     "nsuri": "http://www.conmed.com/20230331",
     "presentation": [
      "http://www.conmed.com/role/LongTermDebtAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "cnmd_AdjustedTermSOFRInterestRateMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Adjusted Term SOFR Interest Rate",
        "label": "Adjusted Term SOFR Interest Rate [Member]",
        "terseLabel": "Adjusted Term SOFR Interest Rate"
       }
      }
     },
     "localname": "AdjustedTermSOFRInterestRateMember",
     "nsuri": "http://www.conmed.com/20230331",
     "presentation": [
      "http://www.conmed.com/role/LongTermDebtAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cnmd_AdjustedTermSOFRMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Adjusted Term SOFR",
        "label": "Adjusted Term SOFR [Member]",
        "terseLabel": "Adjusted Term SOFR"
       }
      }
     },
     "localname": "AdjustedTermSOFRMember",
     "nsuri": "http://www.conmed.com/20230331",
     "presentation": [
      "http://www.conmed.com/role/LongTermDebtAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cnmd_AmendedAndRestatedSeniorCreditAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amended and Restated Senior Credit Agreement [Member]",
        "label": "Amended and Restated Senior Credit Agreement [Member]",
        "terseLabel": "Amended and Restated Senior Credit Agreement [Member]"
       }
      }
     },
     "localname": "AmendedAndRestatedSeniorCreditAgreementMember",
     "nsuri": "http://www.conmed.com/20230331",
     "presentation": [
      "http://www.conmed.com/role/LongTermDebtAdditionalInformationDetails",
      "http://www.conmed.com/role/LongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cnmd_AmericasexcludingtheUnitedStatesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Americas (excluding the United States) [Member]",
        "label": "Americas (excluding the United States) [Member]",
        "terseLabel": "Americas (excluding the United States)"
       }
      }
     },
     "localname": "AmericasexcludingtheUnitedStatesMember",
     "nsuri": "http://www.conmed.com/20230331",
     "presentation": [
      "http://www.conmed.com/role/RevenuesDisaggregatedRevenuesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cnmd_AmortizationOfInventoryStepUpAdjustments": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortization of inventory step-up adjustments",
        "label": "Amortization of inventory step-up adjustments",
        "terseLabel": "Amortization of inventory step-up adjustments"
       }
      }
     },
     "localname": "AmortizationOfInventoryStepUpAdjustments",
     "nsuri": "http://www.conmed.com/20230331",
     "presentation": [
      "http://www.conmed.com/role/BusinessCombinationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cnmd_BiorezIncMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Biorez Inc",
        "label": "Biorez Inc [Member]",
        "terseLabel": "Biorez Inc"
       }
      }
     },
     "localname": "BiorezIncMember",
     "nsuri": "http://www.conmed.com/20230331",
     "presentation": [
      "http://www.conmed.com/role/BusinessCombinationsDetails",
      "http://www.conmed.com/role/FairValueofFinancialInstrumentsContingentConsiderationDetails",
      "http://www.conmed.com/role/GoodwillandOtherIntangibleAssetsGoodwillDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cnmd_BusinessAcquisitionContingentConsiderationAtFairValueRollForwardRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Acquisition Contingent Consideration At Fair Value Roll Forward",
        "label": "Business Acquisition Contingent Consideration At Fair Value Roll Forward [Roll Forward]",
        "terseLabel": "Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration [Abstract]"
       }
      }
     },
     "localname": "BusinessAcquisitionContingentConsiderationAtFairValueRollForwardRollForward",
     "nsuri": "http://www.conmed.com/20230331",
     "presentation": [
      "http://www.conmed.com/role/FairValueofFinancialInstrumentsContingentConsiderationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cnmd_BusinessCombinationPurchasePriceAdjustmentHoldback": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Purchase Price Adjustment, Holdback",
        "label": "Business Combination, Purchase Price Adjustment, Holdback",
        "terseLabel": "Purchase Price Adjustment Holdback"
       }
      }
     },
     "localname": "BusinessCombinationPurchasePriceAdjustmentHoldback",
     "nsuri": "http://www.conmed.com/20230331",
     "presentation": [
      "http://www.conmed.com/role/BusinessCombinationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cnmd_CustomerandDistributorRelationshipsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Customer and Distributor Relationships [Member]",
        "label": "Customer and Distributor Relationships [Member]",
        "verboseLabel": "Customer and distributor relationships"
       }
      }
     },
     "localname": "CustomerandDistributorRelationshipsMember",
     "nsuri": "http://www.conmed.com/20230331",
     "presentation": [
      "http://www.conmed.com/role/GoodwillandOtherIntangibleAssetsIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cnmd_ExpenseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expense [Member]",
        "label": "Expense [Member]",
        "terseLabel": "Amortization included in expense"
       }
      }
     },
     "localname": "ExpenseMember",
     "nsuri": "http://www.conmed.com/20230331",
     "presentation": [
      "http://www.conmed.com/role/GoodwillandOtherIntangibleAssetsIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cnmd_GeneralSurgeryMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "General Surgery [Member]",
        "label": "General Surgery [Member]",
        "terseLabel": "General Surgery"
       }
      }
     },
     "localname": "GeneralSurgeryMember",
     "nsuri": "http://www.conmed.com/20230331",
     "presentation": [
      "http://www.conmed.com/role/BusinessSegmentDetails",
      "http://www.conmed.com/role/RevenuesDisaggregatedRevenuesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cnmd_HedgeAndWarrantTransactionsNetCashPaid": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Up-front costs to purchase hedge instruments, net of cash received from issuance of warrants",
        "label": "Hedge and Warrant Transactions, Net Cash Paid",
        "terseLabel": "Hedge and warrant transactions, net cash paid"
       }
      }
     },
     "localname": "HedgeAndWarrantTransactionsNetCashPaid",
     "nsuri": "http://www.conmed.com/20230331",
     "presentation": [
      "http://www.conmed.com/role/LongTermDebtAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cnmd_In2BonesGlobalIncMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "In2Bones Global Inc",
        "label": "In2Bones Global Inc [Member]",
        "terseLabel": "In2Bones Global Inc"
       }
      }
     },
     "localname": "In2BonesGlobalIncMember",
     "nsuri": "http://www.conmed.com/20230331",
     "presentation": [
      "http://www.conmed.com/role/BusinessCombinationsDetails",
      "http://www.conmed.com/role/FairValueofFinancialInstrumentsContingentConsiderationDetails",
      "http://www.conmed.com/role/GoodwillandOtherIntangibleAssetsGoodwillDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cnmd_IndexedTransactionTypeAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indexed transaction type",
        "label": "Indexed transaction type [Axis]",
        "terseLabel": "Indexed transaction type [Axis]"
       }
      }
     },
     "localname": "IndexedTransactionTypeAxis",
     "nsuri": "http://www.conmed.com/20230331",
     "presentation": [
      "http://www.conmed.com/role/LongTermDebtAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cnmd_IndexedTransactionTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indexed transaction type [Domain]",
        "label": "Indexed transaction type [Domain]",
        "terseLabel": "Indexed transaction type [Domain]"
       }
      }
     },
     "localname": "IndexedTransactionTypeDomain",
     "nsuri": "http://www.conmed.com/20230331",
     "presentation": [
      "http://www.conmed.com/role/LongTermDebtAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cnmd_MeasurementInputRevenueVolatilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement Input, Revenue Volatility",
        "label": "Measurement Input, Revenue Volatility [Member]",
        "terseLabel": "Measurement Input, Revenue Volatility"
       }
      }
     },
     "localname": "MeasurementInputRevenueVolatilityMember",
     "nsuri": "http://www.conmed.com/20230331",
     "presentation": [
      "http://www.conmed.com/role/FairValueofFinancialInstrumentsContingentConsiderationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cnmd_OrthopedicSurgeryMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Orthopedic Surgery [Member]",
        "label": "Orthopedic Surgery [Member]",
        "terseLabel": "Orthopedic Surgery"
       }
      }
     },
     "localname": "OrthopedicSurgeryMember",
     "nsuri": "http://www.conmed.com/20230331",
     "presentation": [
      "http://www.conmed.com/role/BusinessSegmentDetails",
      "http://www.conmed.com/role/RevenuesDisaggregatedRevenuesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cnmd_PatentsAndOtherIntangibleAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Patents and Other Intangible Assets [Member]",
        "label": "Patents and Other Intangible Assets [Member]",
        "terseLabel": "Patents and other intangible assets"
       }
      }
     },
     "localname": "PatentsAndOtherIntangibleAssetsMember",
     "nsuri": "http://www.conmed.com/20230331",
     "presentation": [
      "http://www.conmed.com/role/GoodwillandOtherIntangibleAssetsIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cnmd_PaymentsForContingentConsideration": {
     "auth_ref": [],
     "calculation": {
      "http://www.conmed.com/role/ConsolidatedCondensedStatementsofCashFlowsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payments for Contingent Consideration",
        "label": "Payments for Contingent Consideration",
        "negatedTerseLabel": "Payments related to contingent consideration"
       }
      }
     },
     "localname": "PaymentsForContingentConsideration",
     "nsuri": "http://www.conmed.com/20230331",
     "presentation": [
      "http://www.conmed.com/role/ConsolidatedCondensedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cnmd_ProductLiabilityContingencyInsuranceAggregateAnnualAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Product Liability Contingency, Insurance, Aggregate Annual Amount",
        "label": "Product Liability Contingency, Insurance, Aggregate Annual Amount",
        "terseLabel": "Product liability insurance, aggregate annual amount"
       }
      }
     },
     "localname": "ProductLiabilityContingencyInsuranceAggregateAnnualAmount",
     "nsuri": "http://www.conmed.com/20230331",
     "presentation": [
      "http://www.conmed.com/role/LegalProceedingsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cnmd_ProductLiabilityContingencyInsuranceAmountPerIncident": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Product Liability Contingency, Insurance, Amount per Incident",
        "label": "Product Liability Contingency, Insurance, Amount per Incident",
        "terseLabel": "Product liability insurance, amount per incident"
       }
      }
     },
     "localname": "ProductLiabilityContingencyInsuranceAmountPerIncident",
     "nsuri": "http://www.conmed.com/20230331",
     "presentation": [
      "http://www.conmed.com/role/LegalProceedingsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cnmd_ProductWarrantyAccrualTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Product Warranty Accrual Term",
        "label": "Product Warranty Accrual Term",
        "terseLabel": "Standard warranty period (in years)"
       }
      }
     },
     "localname": "ProductWarrantyAccrualTerm",
     "nsuri": "http://www.conmed.com/20230331",
     "presentation": [
      "http://www.conmed.com/role/GuaranteesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "cnmd_ReductionofRevenueMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reduction of Revenue [Member]",
        "label": "Reduction of Revenue [Member]",
        "terseLabel": "Amortization recorded as a reduction of revenue"
       }
      }
     },
     "localname": "ReductionofRevenueMember",
     "nsuri": "http://www.conmed.com/20230331",
     "presentation": [
      "http://www.conmed.com/role/GoodwillandOtherIntangibleAssetsIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cnmd_RevenuesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenues [Member]",
        "label": "Revenues [Member]",
        "terseLabel": "Revenues"
       }
      }
     },
     "localname": "RevenuesMember",
     "nsuri": "http://www.conmed.com/20230331",
     "presentation": [
      "http://www.conmed.com/role/FairValueofFinancialInstrumentsAmountsRecordedInandReclassifiedFromAOCIDetails",
      "http://www.conmed.com/role/FairValueofFinancialInstrumentsForeignCurrencyForwardContractsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cnmd_SalesrepresentationmarketingandpromotionalrightsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sales representation, marketing and promotional rights [Member]",
        "label": "Sales representation, marketing and promotional rights [Member]",
        "terseLabel": "Sales representation, marketing and promotional rights"
       }
      }
     },
     "localname": "SalesrepresentationmarketingandpromotionalrightsMember",
     "nsuri": "http://www.conmed.com/20230331",
     "presentation": [
      "http://www.conmed.com/role/GoodwillandOtherIntangibleAssetsIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cnmd_ScheduleOfFiniteLivedAndIndefiniteLivedAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of Finite-Lived and Indefinite-Lived Assets [Line Items]",
        "label": "Schedule of Finite-Lived and Indefinite-Lived Assets [Line Items]",
        "terseLabel": "Schedule of Finite-Lived and Indefinite-Lived Assets [Line Items]"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedAndIndefiniteLivedAssetsLineItems",
     "nsuri": "http://www.conmed.com/20230331",
     "presentation": [
      "http://www.conmed.com/role/GoodwillandOtherIntangibleAssetsIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cnmd_ScheduleOfFiniteLivedAndIndefiniteLivedAssetsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of Finite-Lived and Indefinite-Lived Assets [Table]",
        "label": "Schedule of Finite-Lived and Indefinite-Lived Assets [Table]",
        "terseLabel": "Schedule of Finite-Lived and Indefinite-Lived Assets [Table]"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedAndIndefiniteLivedAssetsTable",
     "nsuri": "http://www.conmed.com/20230331",
     "presentation": [
      "http://www.conmed.com/role/GoodwillandOtherIntangibleAssetsIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cnmd_TermSOFRInterestRateSpreadAdjustment": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term SOFR Interest Rate Spread Adjustment",
        "label": "Term SOFR Interest Rate Spread Adjustment",
        "terseLabel": "Term SOFR Interest Rate Spread Adjustment"
       }
      }
     },
     "localname": "TermSOFRInterestRateSpreadAdjustment",
     "nsuri": "http://www.conmed.com/20230331",
     "presentation": [
      "http://www.conmed.com/role/LongTermDebtAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "country_US": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "UNITED STATES",
        "terseLabel": "United States"
       }
      }
     },
     "localname": "US",
     "nsuri": "http://xbrl.sec.gov/country/2022",
     "presentation": [
      "http://www.conmed.com/role/RevenuesDisaggregatedRevenuesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.conmed.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.conmed.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.conmed.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.conmed.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.conmed.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.conmed.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r633"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report",
        "terseLabel": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.conmed.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r634"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.conmed.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.conmed.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.conmed.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.conmed.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.conmed.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.conmed.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r631"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.conmed.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.conmed.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.conmed.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r631"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.conmed.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.conmed.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r631"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.conmed.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.conmed.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r635"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.conmed.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r631"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.conmed.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r631"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.conmed.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r631"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.conmed.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r631"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.conmed.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.conmed.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r630"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.conmed.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r632"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.conmed.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.conmed.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "srt_AsiaPacificMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Asia Pacific [Member]",
        "terseLabel": "Asia Pacific"
       }
      }
     },
     "localname": "AsiaPacificMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.conmed.com/role/RevenuesDisaggregatedRevenuesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ProductOrServiceAxis": {
     "auth_ref": [
      "r304",
      "r546",
      "r612",
      "r627",
      "r666",
      "r667",
      "r672",
      "r691"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Axis]",
        "terseLabel": "Product and Service [Axis]"
       }
      }
     },
     "localname": "ProductOrServiceAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.conmed.com/role/BusinessSegmentDetails",
      "http://www.conmed.com/role/RevenuesDisaggregatedRevenuesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ProductsAndServicesDomain": {
     "auth_ref": [
      "r304",
      "r546",
      "r612",
      "r627",
      "r666",
      "r667",
      "r672",
      "r691"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Domain]",
        "terseLabel": "Product and Service [Domain]"
       }
      }
     },
     "localname": "ProductsAndServicesDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.conmed.com/role/BusinessSegmentDetails",
      "http://www.conmed.com/role/RevenuesDisaggregatedRevenuesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r346",
      "r347",
      "r348",
      "r349",
      "r401",
      "r428",
      "r432",
      "r433",
      "r434",
      "r544",
      "r545",
      "r566",
      "r595",
      "r596",
      "r611",
      "r625",
      "r629",
      "r665",
      "r670",
      "r685",
      "r686",
      "r687",
      "r688",
      "r689"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Statistical Measurement [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.conmed.com/role/GoodwillandOtherIntangibleAssetsIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r346",
      "r347",
      "r348",
      "r349",
      "r401",
      "r428",
      "r432",
      "r433",
      "r434",
      "r544",
      "r545",
      "r566",
      "r595",
      "r596",
      "r611",
      "r625",
      "r629",
      "r665",
      "r670",
      "r685",
      "r686",
      "r687",
      "r688",
      "r689"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Domain]",
        "terseLabel": "Statistical Measurement [Domain]"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.conmed.com/role/GoodwillandOtherIntangibleAssetsIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_SegmentGeographicalDomain": {
     "auth_ref": [
      "r305",
      "r306",
      "r586",
      "r587",
      "r588",
      "r589",
      "r590",
      "r591",
      "r592",
      "r593",
      "r594",
      "r613",
      "r628",
      "r672"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Domain]",
        "terseLabel": "Geographical [Domain]"
       }
      }
     },
     "localname": "SegmentGeographicalDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.conmed.com/role/RevenuesDisaggregatedRevenuesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_StatementGeographicalAxis": {
     "auth_ref": [
      "r305",
      "r306",
      "r585",
      "r586",
      "r587",
      "r588",
      "r589",
      "r590",
      "r591",
      "r592",
      "r593",
      "r594",
      "r613",
      "r628",
      "r672"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Axis]",
        "terseLabel": "Geographical [Axis]"
       }
      }
     },
     "localname": "StatementGeographicalAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.conmed.com/role/RevenuesDisaggregatedRevenuesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_WeightedAverageMember": {
     "auth_ref": [
      "r595",
      "r596",
      "r684",
      "r686",
      "r689"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average [Member]",
        "terseLabel": "Weighted Average"
       }
      }
     },
     "localname": "WeightedAverageMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.conmed.com/role/GoodwillandOtherIntangibleAssetsIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AOCIAttributableToParentNetOfTaxRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "AOCI Attributable to Parent, Net of Tax [Roll Forward]",
        "terseLabel": "Accumulated other comprehensive income (loss) [Roll Forward]"
       }
      }
     },
     "localname": "AOCIAttributableToParentNetOfTaxRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/ComprehensiveIncomeAccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountingStandardsUpdate202006Member": {
     "auth_ref": [
      "r472",
      "r473",
      "r474",
      "r475",
      "r476",
      "r477",
      "r478",
      "r480",
      "r481",
      "r482",
      "r483"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accounting Standards Update 2020-06 Debt - Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging - Contracts in Entity's Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity's Own Equity.",
        "label": "Accounting Standards Update 2020-06 [Member]",
        "terseLabel": "Accounting Standards Update 2020-06"
       }
      }
     },
     "localname": "AccountingStandardsUpdate202006Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/ConsolidatedCondensedStatementsofShareholdersEquityUnaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountingStandardsUpdateExtensibleList": {
     "auth_ref": [
      "r194",
      "r195",
      "r196",
      "r197",
      "r198",
      "r238",
      "r239",
      "r240",
      "r312",
      "r313",
      "r317",
      "r318",
      "r319",
      "r320",
      "r323",
      "r324",
      "r435",
      "r436",
      "r437",
      "r444",
      "r445",
      "r455",
      "r456",
      "r457",
      "r472",
      "r473",
      "r474",
      "r475",
      "r476",
      "r477",
      "r478",
      "r480",
      "r481",
      "r482",
      "r483",
      "r484",
      "r497",
      "r498",
      "r499",
      "r500",
      "r501",
      "r502",
      "r506",
      "r507",
      "r520",
      "r521",
      "r525",
      "r526",
      "r527",
      "r533",
      "r535",
      "r536",
      "r537",
      "r538",
      "r539",
      "r567",
      "r568",
      "r569",
      "r570",
      "r571",
      "r572",
      "r573",
      "r574",
      "r575",
      "r576",
      "r577",
      "r578",
      "r651"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates amendment to accounting standards.",
        "label": "Accounting Standards Update [Extensible Enumeration]",
        "terseLabel": "Accounting Standards Update [Extensible Enumeration]"
       }
      }
     },
     "localname": "AccountingStandardsUpdateExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/ConsolidatedCondensedStatementsofShareholdersEquityUnaudited"
     ],
     "xbrltype": "enumerationSetItemType"
    },
    "us-gaap_AccountsPayableCurrent": {
     "auth_ref": [
      "r16",
      "r626"
     ],
     "calculation": {
      "http://www.conmed.com/role/ConsolidatedCondensedBalanceSheetsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable, Current",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "AccountsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/ConsolidatedCondensedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "auth_ref": [
      "r310",
      "r311"
     ],
     "calculation": {
      "http://www.conmed.com/role/ConsolidatedCondensedBalanceSheetsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
        "label": "Accounts Receivable, after Allowance for Credit Loss, Current",
        "terseLabel": "Accounts receivable, net"
       }
      }
     },
     "localname": "AccountsReceivableNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/ConsolidatedCondensedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember": {
     "auth_ref": [
      "r33",
      "r39",
      "r130",
      "r637",
      "r638",
      "r639"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive (income) loss related to defined benefit plans attributable to the parent.",
        "label": "Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member]",
        "terseLabel": "Pension Liability"
       }
      }
     },
     "localname": "AccumulatedDefinedBenefitPlansAdjustmentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/ComprehensiveIncomeAccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember": {
     "auth_ref": [
      "r32",
      "r39",
      "r463"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) resulting from gain (loss) from derivative instruments designated and qualifying as the effective portion of cash flow hedges, attributable to the parent.",
        "label": "Accumulated Net Gain (Loss) from Cash Flow Hedges Attributable to Parent [Member]",
        "terseLabel": "Cash Flow Hedging Gain (Loss)"
       }
      }
     },
     "localname": "AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/ComprehensiveIncomeAccumulatedOtherComprehensiveIncomeLossDetails",
      "http://www.conmed.com/role/FairValueofFinancialInstrumentsForeignCurrencyForwardContractsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Accumulated Other Comprehensive Income (Loss) [Line Items]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Line Items]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/ComprehensiveIncomeAccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r36",
      "r38",
      "r39",
      "r207",
      "r561",
      "r574",
      "r578"
     ],
     "calculation": {
      "http://www.conmed.com/role/ConsolidatedCondensedBalanceSheetsUnaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "periodEndLabel": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "periodStartLabel": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Accumulated other comprehensive loss"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/ComprehensiveIncomeAccumulatedOtherComprehensiveIncomeLossDetails",
      "http://www.conmed.com/role/ConsolidatedCondensedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossTable": {
     "auth_ref": [
      "r221",
      "r222",
      "r513",
      "r514",
      "r515",
      "r516",
      "r517",
      "r519"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about components of accumulated other comprehensive income (loss).",
        "label": "Accumulated Other Comprehensive Income (Loss) [Table]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Table]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/ComprehensiveIncomeAccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r35",
      "r39",
      "r130",
      "r539",
      "r569",
      "r570",
      "r637",
      "r638",
      "r639",
      "r648",
      "r649",
      "r650"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]",
        "terseLabel": "Accumulated Other Comprehensive Loss"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/ComprehensiveIncomeAccumulatedOtherComprehensiveIncomeLossDetails",
      "http://www.conmed.com/role/ConsolidatedCondensedStatementsofShareholdersEquityUnaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedTranslationAdjustmentMember": {
     "auth_ref": [
      "r31",
      "r39",
      "r130",
      "r222",
      "r223",
      "r514",
      "r515",
      "r516",
      "r517",
      "r519",
      "r637"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) resulting from foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to the parent.",
        "label": "Accumulated Foreign Currency Adjustment Attributable to Parent [Member]",
        "terseLabel": "Cumulative Translation Adjustments"
       }
      }
     },
     "localname": "AccumulatedTranslationAdjustmentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/ComprehensiveIncomeAccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdditionalPaidInCapital": {
     "auth_ref": [
      "r8",
      "r626"
     ],
     "calculation": {
      "http://www.conmed.com/role/ConsolidatedCondensedBalanceSheetsUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.",
        "label": "Additional Paid in Capital",
        "terseLabel": "Paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapital",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/ConsolidatedCondensedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r435",
      "r436",
      "r437",
      "r648",
      "r649",
      "r650",
      "r677"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Paid-in Capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/ConsolidatedCondensedStatementsofShareholdersEquityUnaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsForNewAccountingPronouncementsAxis": {
     "auth_ref": [
      "r194",
      "r195",
      "r196",
      "r197",
      "r198",
      "r238",
      "r239",
      "r240",
      "r242",
      "r251",
      "r312",
      "r313",
      "r317",
      "r318",
      "r319",
      "r320",
      "r323",
      "r324",
      "r435",
      "r436",
      "r437",
      "r442",
      "r443",
      "r444",
      "r445",
      "r455",
      "r456",
      "r457",
      "r472",
      "r473",
      "r474",
      "r475",
      "r476",
      "r477",
      "r478",
      "r480",
      "r481",
      "r482",
      "r483",
      "r484",
      "r497",
      "r498",
      "r499",
      "r500",
      "r501",
      "r502",
      "r506",
      "r507",
      "r520",
      "r521",
      "r525",
      "r526",
      "r527",
      "r528",
      "r533",
      "r535",
      "r536",
      "r537",
      "r538",
      "r539",
      "r548",
      "r549",
      "r550",
      "r567",
      "r568",
      "r569",
      "r570",
      "r571",
      "r572",
      "r573",
      "r574",
      "r575",
      "r576",
      "r577",
      "r578"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by amendment to accounting standards.",
        "label": "Accounting Standards Update [Axis]",
        "terseLabel": "Adjustments for New Accounting Pronouncements [Axis]"
       }
      }
     },
     "localname": "AdjustmentsForNewAccountingPronouncementsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/ConsolidatedCondensedStatementsofShareholdersEquityUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "auth_ref": [
      "r112",
      "r113",
      "r430"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.",
        "label": "APIC, Share-Based Payment Arrangement, Increase for Cost Recognition",
        "terseLabel": "Stock-based compensation"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/ConsolidatedCondensedStatementsofShareholdersEquityUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Adjustments to reconcile net income to net cash provided by (used in) operating activities:"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/ConsolidatedCondensedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AmortizationOfFinancingCosts": {
     "auth_ref": [
      "r43",
      "r374",
      "r523",
      "r643"
     ],
     "calculation": {
      "http://www.conmed.com/role/ConsolidatedCondensedStatementsofCashFlowsUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization expense attributable to debt issuance costs.",
        "label": "Amortization of Debt Issuance Costs",
        "terseLabel": "Amortization of deferred debt issuance costs"
       }
      }
     },
     "localname": "AmortizationOfFinancingCosts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/ConsolidatedCondensedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfIntangibleAssets": {
     "auth_ref": [
      "r58",
      "r75",
      "r81"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Amortization of Intangible Assets",
        "terseLabel": "Amortization expense"
       }
      }
     },
     "localname": "AmortizationOfIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/GoodwillandOtherIntangibleAssetsIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r272"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "terseLabel": "Antidilutive securities excluded from computation of earnings per share (in shares)"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/EarningsPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r171",
      "r183",
      "r206",
      "r230",
      "r291",
      "r295",
      "r300",
      "r316",
      "r350",
      "r351",
      "r352",
      "r353",
      "r354",
      "r355",
      "r356",
      "r357",
      "r358",
      "r461",
      "r464",
      "r496",
      "r626",
      "r668",
      "r669",
      "r682"
     ],
     "calculation": {
      "http://www.conmed.com/role/ConsolidatedCondensedBalanceSheetsUnaudited": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/ConsolidatedCondensedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "ASSETS"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/ConsolidatedCondensedBalanceSheetsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r201",
      "r209",
      "r230",
      "r316",
      "r350",
      "r351",
      "r352",
      "r353",
      "r354",
      "r355",
      "r356",
      "r357",
      "r358",
      "r461",
      "r464",
      "r496",
      "r626",
      "r668",
      "r669",
      "r682"
     ],
     "calculation": {
      "http://www.conmed.com/role/ConsolidatedCondensedBalanceSheetsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/ConsolidatedCondensedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "terseLabel": "Current assets:"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/ConsolidatedCondensedBalanceSheetsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location on balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Axis]",
        "terseLabel": "Balance Sheet Location [Axis]"
       }
      }
     },
     "localname": "BalanceSheetLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/FairValueofFinancialInstrumentsForeignCurrencyForwardContractsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationDomain": {
     "auth_ref": [
      "r141",
      "r145"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Domain]",
        "terseLabel": "Balance Sheet Location [Domain]"
       }
      }
     },
     "localname": "BalanceSheetLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/FairValueofFinancialInstrumentsForeignCurrencyForwardContractsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "auth_ref": [
      "r453",
      "r623",
      "r624"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.",
        "label": "Business Acquisition, Acquiree [Domain]",
        "terseLabel": "Business Acquisition, Acquiree [Domain]"
       }
      }
     },
     "localname": "BusinessAcquisitionAcquireeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/BusinessCombinationsDetails",
      "http://www.conmed.com/role/FairValueofFinancialInstrumentsContingentConsiderationDetails",
      "http://www.conmed.com/role/GoodwillandOtherIntangibleAssetsGoodwillDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "auth_ref": [
      "r116",
      "r117",
      "r453",
      "r623",
      "r624"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business combination or series of individually immaterial business combinations.",
        "label": "Business Acquisition [Axis]",
        "terseLabel": "Business Acquisition [Axis]"
       }
      }
     },
     "localname": "BusinessAcquisitionAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/BusinessCombinationsDetails",
      "http://www.conmed.com/role/FairValueofFinancialInstrumentsContingentConsiderationDetails",
      "http://www.conmed.com/role/GoodwillandOtherIntangibleAssetsGoodwillDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionContingentConsiderationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Business Acquisition, Contingent Consideration [Line Items]",
        "terseLabel": "Business Acquisition, Contingent Consideration [Line Items]"
       }
      }
     },
     "localname": "BusinessAcquisitionContingentConsiderationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/FairValueofFinancialInstrumentsContingentConsiderationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Business Acquisition [Line Items]",
        "terseLabel": "Business Acquisition [Line Items]"
       }
      }
     },
     "localname": "BusinessAcquisitionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/BusinessCombinationsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationAndAssetAcquisitionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination and Asset Acquisition [Abstract]"
       }
      }
     },
     "localname": "BusinessCombinationAndAssetAcquisitionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationConsiderationTransferred1": {
     "auth_ref": [
      "r121",
      "r122",
      "r125"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.",
        "label": "Business Combination, Consideration Transferred",
        "terseLabel": "Business Combination, Consideration Transferred"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationTransferred1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/BusinessCombinationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1": {
     "auth_ref": [
      "r460",
      "r642"
     ],
     "calculation": {
      "http://www.conmed.com/role/ConsolidatedCondensedStatementsofCashFlowsUnaudited": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.",
        "label": "Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability",
        "terseLabel": "Non-cash adjustment to fair value of contingent consideration liability"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/ConsolidatedCondensedStatementsofCashFlowsUnaudited",
      "http://www.conmed.com/role/FairValueofFinancialInstrumentsContingentConsiderationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh": {
     "auth_ref": [
      "r126"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For contingent consideration arrangements recognized in connection with a business combination, this element represents an estimate of the high-end of the potential range (undiscounted) of the consideration which may be paid.",
        "label": "Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High",
        "terseLabel": "Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/BusinessCombinationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationLiability": {
     "auth_ref": [
      "r120",
      "r123",
      "r459"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liability recognized arising from contingent consideration in a business combination.",
        "label": "Business Combination, Contingent Consideration, Liability",
        "periodEndLabel": "Balance as of March 31, 2023",
        "periodStartLabel": "Balance as of January 1, 2023"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/FairValueofFinancialInstrumentsContingentConsiderationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent": {
     "auth_ref": [
      "r120",
      "r124"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liability recognized arising from contingent consideration in a business combination, expected to be settled within one year or the normal operating cycle, if longer.",
        "label": "Business Combination, Contingent Consideration, Liability, Current",
        "terseLabel": "Business Combination, Contingent Consideration, Liability, Current"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/FairValueofFinancialInstrumentsContingentConsiderationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput": {
     "auth_ref": [
      "r492"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of input used to measure contingent consideration liability from business combination.",
        "label": "Business Combination, Contingent Consideration, Liability, Measurement Input",
        "terseLabel": "Business Combination, Contingent Consideration, Liability, Measurement Input"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationLiabilityMeasurementInput",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/FairValueofFinancialInstrumentsContingentConsiderationDetails"
     ],
     "xbrltype": "decimalItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent": {
     "auth_ref": [
      "r120",
      "r124"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liability recognized arising from contingent consideration in a business combination, expected to be settled beyond one year or the normal operating cycle, if longer.",
        "label": "Business Combination, Contingent Consideration, Liability, Noncurrent",
        "terseLabel": "Business Combination, Contingent Consideration, Liability, Noncurrent"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/FairValueofFinancialInstrumentsContingentConsiderationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationDisclosureTextBlock": {
     "auth_ref": [
      "r128",
      "r454"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).",
        "label": "Business Combination Disclosure [Text Block]",
        "terseLabel": "Business Combinations"
       }
      }
     },
     "localname": "BusinessCombinationDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/BusinessCombinations"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CallOptionMember": {
     "auth_ref": [
      "r579",
      "r580",
      "r581",
      "r582",
      "r583",
      "r584"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financial contract between two parties, the buyer and the seller of the option, where the buyer has the right but not the obligation to buy an agreed quantity of a particular commodity or financial instrument (the underlying instrument) from the seller of the option for a certain price (the strike price). Seller is obligated to sell the asset to the buyer, if the buyer exercises the option.",
        "label": "Call Option [Member]",
        "terseLabel": "Call Option [Member]"
       }
      }
     },
     "localname": "CallOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/LongTermDebtAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r55",
      "r60",
      "r63"
     ],
     "calculation": {
      "http://www.conmed.com/role/ConsolidatedCondensedBalanceSheetsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents",
        "periodEndLabel": "Cash and cash equivalents at end of period",
        "periodStartLabel": "Cash and cash equivalents at beginning of period",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/ConsolidatedCondensedBalanceSheetsUnaudited",
      "http://www.conmed.com/role/ConsolidatedCondensedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r55",
      "r164"
     ],
     "calculation": {
      "http://www.conmed.com/role/ConsolidatedCondensedStatementsofCashFlowsUnaudited": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Net (decrease) increase in cash and cash equivalents"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/ConsolidatedCondensedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashFlowHedgingMember": {
     "auth_ref": [
      "r138"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Hedge of the exposure to variability in the cash flows of a recognized asset or liability, or of a forecasted transaction, that is attributable to a particular risk.",
        "label": "Cash Flow Hedging [Member]",
        "terseLabel": "Cash flow hedge"
       }
      }
     },
     "localname": "CashFlowHedgingMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/FairValueofFinancialInstrumentsForeignCurrencyForwardContractsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract]",
        "terseLabel": "Non-cash investing and financing activities:"
       }
      }
     },
     "localname": "CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/ConsolidatedCondensedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingencies": {
     "auth_ref": [
      "r25",
      "r176",
      "r189"
     ],
     "calculation": {
      "http://www.conmed.com/role/ConsolidatedCondensedBalanceSheetsUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.",
        "label": "Commitments and Contingencies",
        "terseLabel": "Commitments and contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingencies",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/ConsolidatedCondensedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]",
        "terseLabel": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommonStockDividendsPerShareDeclared": {
     "auth_ref": [
      "r107"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate dividends declared during the period for each share of common stock outstanding.",
        "label": "Common Stock, Dividends, Per Share, Declared",
        "terseLabel": "Dividends per share of common stock (in dollars per share)"
       }
      }
     },
     "localname": "CommonStockDividendsPerShareDeclared",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/ConsolidatedCondensedStatementsofShareholdersEquityUnauditedParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r648",
      "r649",
      "r677"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common Stock"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/ConsolidatedCondensedStatementsofShareholdersEquityUnaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r7"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "terseLabel": "Common stock, par value (dollars per share)"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/ConsolidatedCondensedBalanceSheetsUnauditedParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r7"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "terseLabel": "Common stock, shares authorized (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/ConsolidatedCondensedBalanceSheetsUnauditedParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r7"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "terseLabel": "Common stock, shares issued (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/ConsolidatedCondensedBalanceSheetsUnauditedParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r7",
      "r101"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common Stock, Shares, Outstanding",
        "periodEndLabel": "Balance at period end (shares)",
        "periodStartLabel": "Balance at period start (shares)"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/ConsolidatedCondensedStatementsofShareholdersEquityUnaudited"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r7",
      "r626"
     ],
     "calculation": {
      "http://www.conmed.com/role/ConsolidatedCondensedBalanceSheetsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "terseLabel": "Common stock, par value $0.01 per share; 100,000,000 shares authorized; 31,299,194 shares issued in 2023 and 2022, respectively"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/ConsolidatedCondensedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CompensationAndRetirementDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Retirement Benefits [Abstract]",
        "terseLabel": "Retirement Benefits [Abstract]"
       }
      }
     },
     "localname": "CompensationAndRetirementDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r129",
      "r131",
      "r218",
      "r220",
      "r227",
      "r557",
      "r563"
     ],
     "calculation": {
      "http://www.conmed.com/role/ComprehensiveIncomeDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest",
        "terseLabel": "Comprehensive income",
        "totalLabel": "Comprehensive income"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/ComprehensiveIncomeDetails",
      "http://www.conmed.com/role/ConsolidatedCondensedStatementsofComprehensiveIncomeUnaudited",
      "http://www.conmed.com/role/ConsolidatedCondensedStatementsofShareholdersEquityUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNoteTextBlock": {
     "auth_ref": [
      "r49",
      "r226",
      "r556",
      "r562"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income.",
        "label": "Comprehensive Income (Loss) Note [Text Block]",
        "terseLabel": "Comprehensive Income"
       }
      }
     },
     "localname": "ComprehensiveIncomeNoteTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/ComprehensiveIncome"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock": {
     "auth_ref": [
      "r671"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of receivable, contract asset, and contract liability from contract with customer. Includes, but is not limited to, change in contract asset and contract liability.",
        "label": "Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block]",
        "terseLabel": "Contract with Customer, Asset and Liability"
       }
      }
     },
     "localname": "ContractWithCustomerAssetAndLiabilityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/RevenuesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ContractWithCustomerLiability": {
     "auth_ref": [
      "r382",
      "r383",
      "r394"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.",
        "label": "Contract with Customer, Liability",
        "terseLabel": "Contract liability"
       }
      }
     },
     "localname": "ContractWithCustomerLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/RevenuesCustomerLiabilityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityRevenueRecognized": {
     "auth_ref": [
      "r395"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.",
        "label": "Contract with Customer, Liability, Revenue Recognized",
        "terseLabel": "Revenue recognized"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityRevenueRecognized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/RevenuesCustomerLiabilityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConvertibleDebt": {
     "auth_ref": [
      "r4",
      "r174",
      "r185"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Including the current and noncurrent portions, carrying amount of debt identified as being convertible into another form of financial instrument (typically the entity's common stock) as of the balance sheet date, which originally required full repayment more than twelve months after issuance or greater than the normal operating cycle of the company.",
        "label": "Convertible Debt",
        "terseLabel": "Convertible Debt"
       }
      }
     },
     "localname": "ConvertibleDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/LongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConvertibleNotesPayableMember": {
     "auth_ref": [
      "r2",
      "r172",
      "r182",
      "r192"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Written promise to pay a note which can be exchanged for a specified quantity of securities (typically common stock), at the option of the issuer or the holder.",
        "label": "Convertible Notes Payable [Member]",
        "terseLabel": "Convertible Notes Payable [Member]"
       }
      }
     },
     "localname": "ConvertibleNotesPayableMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/LongTermDebtAdditionalInformationDetails",
      "http://www.conmed.com/role/LongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CostOfGoodsAndServicesSold": {
     "auth_ref": [
      "r45",
      "r546"
     ],
     "calculation": {
      "http://www.conmed.com/role/ConsolidatedCondensedStatementsofComprehensiveIncomeUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.",
        "label": "Cost of Goods and Services Sold",
        "terseLabel": "Cost of sales"
       }
      }
     },
     "localname": "CostOfGoodsAndServicesSold",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/ConsolidatedCondensedStatementsofComprehensiveIncomeUnaudited",
      "http://www.conmed.com/role/FairValueofFinancialInstrumentsAmountsRecordedInandReclassifiedFromAOCIDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostOfSalesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing cost of sales.",
        "label": "Cost of Sales [Member]",
        "terseLabel": "Cost of Sales"
       }
      }
     },
     "localname": "CostOfSalesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/BusinessCombinationsDetails",
      "http://www.conmed.com/role/FairValueofFinancialInstrumentsAmountsRecordedInandReclassifiedFromAOCIDetails",
      "http://www.conmed.com/role/FairValueofFinancialInstrumentsForeignCurrencyForwardContractsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtConversionConvertedInstrumentSharesIssued1": {
     "auth_ref": [
      "r61",
      "r62"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares issued in exchange for the original debt being converted in a noncash (or part noncash) transaction. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or payments in the period.",
        "label": "Debt Conversion, Converted Instrument, Shares Issued",
        "terseLabel": "Debt Conversion, Converted Instrument, Shares Issued"
       }
      }
     },
     "localname": "DebtConversionConvertedInstrumentSharesIssued1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/LongTermDebtAdditionalInformationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_DebtDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Disclosure [Abstract]",
        "terseLabel": "Debt Disclosure [Abstract]"
       }
      }
     },
     "localname": "DebtDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentAxis": {
     "auth_ref": [
      "r2",
      "r3",
      "r4",
      "r172",
      "r174",
      "r182",
      "r232",
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r372",
      "r373",
      "r374",
      "r524",
      "r606",
      "r607",
      "r608",
      "r609",
      "r610",
      "r644"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.",
        "label": "Debt Instrument [Axis]",
        "terseLabel": "Debt Instrument [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/LongTermDebtAdditionalInformationDetails",
      "http://www.conmed.com/role/LongTermDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage points added to the reference rate to compute the variable rate on the debt instrument.",
        "label": "Debt Instrument, Basis Spread on Variable Rate",
        "terseLabel": "Debt Instrument, Basis Spread on Variable Rate"
       }
      }
     },
     "localname": "DebtInstrumentBasisSpreadOnVariableRate1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/LongTermDebtAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentCarryingAmount": {
     "auth_ref": [
      "r4",
      "r174",
      "r182",
      "r376"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.",
        "label": "Long-Term Debt, Gross",
        "terseLabel": "Long-term Debt, Gross"
       }
      }
     },
     "localname": "DebtInstrumentCarryingAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/LongTermDebtAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentConvertibleConversionPrice1": {
     "auth_ref": [
      "r97",
      "r361"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The price per share of the conversion feature embedded in the debt instrument.",
        "label": "Debt Instrument, Convertible, Conversion Price",
        "terseLabel": "Conversion price (in dollars per share)"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleConversionPrice1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/LongTermDebtAdditionalInformationDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_DebtInstrumentConvertibleConversionRatio1": {
     "auth_ref": [
      "r22",
      "r102",
      "r103",
      "r105",
      "r361"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Ratio applied to the conversion of debt instrument into equity with equity shares divided by debt principal amount.",
        "label": "Debt Instrument, Convertible, Conversion Ratio",
        "terseLabel": "Debt Instrument, Convertible, Conversion Ratio"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleConversionRatio1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/LongTermDebtAdditionalInformationDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "us-gaap_DebtInstrumentFaceAmount": {
     "auth_ref": [
      "r166",
      "r168",
      "r359",
      "r524",
      "r607",
      "r608"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face (par) amount of debt instrument at time of issuance.",
        "label": "Debt Instrument, Face Amount",
        "terseLabel": "Debt instrument, face amount"
       }
      }
     },
     "localname": "DebtInstrumentFaceAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/LongTermDebtAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentFairValue": {
     "auth_ref": [
      "r367",
      "r495",
      "r607",
      "r608"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.",
        "label": "Debt Instrument, Fair Value Disclosure",
        "terseLabel": "Debt Instrument, Fair Value Disclosure"
       }
      }
     },
     "localname": "DebtInstrumentFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/LongTermDebtAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentInterestRateEffectivePercentage": {
     "auth_ref": [
      "r21",
      "r166",
      "r378",
      "r524"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium.",
        "label": "Debt Instrument, Interest Rate, Effective Percentage",
        "terseLabel": "Debt Instrument, Interest Rate, Effective Percentage"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateEffectivePercentage",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/LongTermDebtAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentInterestRateStatedPercentage": {
     "auth_ref": [
      "r21",
      "r360"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.",
        "label": "Debt Instrument, Interest Rate, Stated Percentage",
        "terseLabel": "Interest rate, stated percentage"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateStatedPercentage",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/LongTermDebtAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Instrument [Line Items]",
        "terseLabel": "Debt Instrument [Line Items]"
       }
      }
     },
     "localname": "DebtInstrumentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/LongTermDebtAdditionalInformationDetails",
      "http://www.conmed.com/role/LongTermDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "auth_ref": [
      "r23",
      "r232",
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r372",
      "r373",
      "r374",
      "r524",
      "r606",
      "r607",
      "r608",
      "r609",
      "r610",
      "r644"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.",
        "label": "Debt Instrument, Name [Domain]",
        "terseLabel": "Debt Instrument, Name [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/LongTermDebtAdditionalInformationDetails",
      "http://www.conmed.com/role/LongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPeriodAxis": {
     "auth_ref": [
      "r180"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information about timing of debt redemption features under terms of the debt agreement.",
        "label": "Debt Instrument, Redemption, Period [Axis]",
        "terseLabel": "Debt Instrument, Redemption, Period [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPeriodAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/LongTermDebtAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPeriodDomain": {
     "auth_ref": [
      "r180"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period as defined under terms of the debt agreement for debt redemption features.",
        "label": "Debt Instrument, Redemption, Period [Domain]",
        "terseLabel": "Debt Instrument, Redemption, Period [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPeriodDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/LongTermDebtAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentTable": {
     "auth_ref": [
      "r23",
      "r102",
      "r104",
      "r105",
      "r106",
      "r165",
      "r166",
      "r168",
      "r181",
      "r232",
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r372",
      "r373",
      "r374",
      "r375",
      "r524",
      "r606",
      "r607",
      "r608",
      "r609",
      "r610",
      "r644"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Schedule of Long-Term Debt Instruments [Table]",
        "terseLabel": "Schedule of Long-term Debt Instruments [Table]"
       }
      }
     },
     "localname": "DebtInstrumentTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/LongTermDebtAdditionalInformationDetails",
      "http://www.conmed.com/role/LongTermDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r58",
      "r115",
      "r441",
      "r450",
      "r451",
      "r646"
     ],
     "calculation": {
      "http://www.conmed.com/role/ConsolidatedCondensedStatementsofCashFlowsUnaudited": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Income Tax Expense (Benefit)",
        "terseLabel": "Deferred income taxes"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/ConsolidatedCondensedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxLiabilitiesNet": {
     "auth_ref": [
      "r438",
      "r439"
     ],
     "calculation": {
      "http://www.conmed.com/role/ConsolidatedCondensedBalanceSheetsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.",
        "label": "Deferred Income Tax Liabilities, Net",
        "terseLabel": "Deferred income taxes"
       }
      }
     },
     "localname": "DeferredIncomeTaxLiabilitiesNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/ConsolidatedCondensedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses": {
     "auth_ref": [
      "r398",
      "r413",
      "r424",
      "r621",
      "r622"
     ],
     "calculation": {
      "http://www.conmed.com/role/PensionPlanDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) recognized in net periodic benefit (cost) credit of defined benefit plan.",
        "label": "Defined Benefit Plan, Amortization of Gain (Loss)",
        "negatedTerseLabel": "Net amortization and deferral"
       }
      }
     },
     "localname": "DefinedBenefitPlanAmortizationOfGainsLosses",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/PensionPlanDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets": {
     "auth_ref": [
      "r398",
      "r412",
      "r423",
      "r621",
      "r622"
     ],
     "calculation": {
      "http://www.conmed.com/role/PensionPlanDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expected return (loss) recognized in net periodic benefit (cost) credit, calculated based on expected long-term rate of return and market-related value of plan assets of defined benefit plan.",
        "label": "Defined Benefit Plan, Expected Return (Loss) on Plan Assets",
        "negatedTerseLabel": "Expected return on plan assets"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedReturnOnPlanAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/PensionPlanDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanInterestCost": {
     "auth_ref": [
      "r398",
      "r400",
      "r411",
      "r422",
      "r621",
      "r622"
     ],
     "calculation": {
      "http://www.conmed.com/role/PensionPlanDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost recognized for passage of time related to defined benefit plan.",
        "label": "Defined Benefit Plan, Interest Cost",
        "terseLabel": "Interest cost on projected benefit obligation"
       }
      }
     },
     "localname": "DefinedBenefitPlanInterestCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/PensionPlanDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost": {
     "auth_ref": [
      "r409",
      "r420",
      "r621",
      "r622"
     ],
     "calculation": {
      "http://www.conmed.com/role/PensionPlanDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of net periodic benefit cost (credit) for defined benefit plan.",
        "label": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit)",
        "totalLabel": "Net periodic pension cost"
       }
      }
     },
     "localname": "DefinedBenefitPlanNetPeriodicBenefitCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/PensionPlanDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanServiceCost": {
     "auth_ref": [
      "r399",
      "r410",
      "r421",
      "r621",
      "r622"
     ],
     "calculation": {
      "http://www.conmed.com/role/PensionPlanDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost for actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.",
        "label": "Defined Benefit Plan, Service Cost",
        "terseLabel": "Service cost"
       }
      }
     },
     "localname": "DefinedBenefitPlanServiceCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/PensionPlanDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Depreciation": {
     "auth_ref": [
      "r58",
      "r86"
     ],
     "calculation": {
      "http://www.conmed.com/role/ConsolidatedCondensedStatementsofCashFlowsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.",
        "label": "Depreciation",
        "terseLabel": "Depreciation"
       }
      }
     },
     "localname": "Depreciation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/ConsolidatedCondensedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet": {
     "auth_ref": [
      "r133"
     ],
     "calculation": {
      "http://www.conmed.com/role/FairValueofFinancialInstrumentsForeignCurrencyForwardContractsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair values as of the balance sheet date of the net amount of all assets and liabilities resulting from contracts that meet the criteria of being accounted for as derivative instruments.",
        "label": "Derivative Assets (Liabilities), at Fair Value, Net",
        "totalLabel": "Net Fair Value"
       }
      }
     },
     "localname": "DerivativeAssetsLiabilitiesAtFairValueNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/FairValueofFinancialInstrumentsForeignCurrencyForwardContractsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeAssetsLiabilitiesAtFairValueNetByBalanceSheetClassificationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Derivative Assets (Liabilities), at Fair Value, Net, by Balance Sheet Classification [Abstract]",
        "terseLabel": "Derivative Assets and Liabilities at Fair Value [Abstract]"
       }
      }
     },
     "localname": "DerivativeAssetsLiabilitiesAtFairValueNetByBalanceSheetClassificationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/FairValueofFinancialInstrumentsForeignCurrencyForwardContractsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeContractTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset.",
        "label": "Derivative Contract [Domain]",
        "terseLabel": "Derivative Contract Type [Domain]"
       }
      }
     },
     "localname": "DerivativeContractTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/FairValueofFinancialInstrumentsForeignCurrencyForwardContractsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DerivativeFairValueOfDerivativeAsset": {
     "auth_ref": [
      "r28",
      "r143",
      "r169",
      "r210",
      "r601"
     ],
     "calculation": {
      "http://www.conmed.com/role/FairValueofFinancialInstrumentsForeignCurrencyForwardContractsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, before effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets elected not to be offset. Excludes assets not subject to a master netting arrangement.",
        "label": "Derivative Asset, Subject to Master Netting Arrangement, before Offset",
        "terseLabel": "Asset Fair Value"
       }
      }
     },
     "localname": "DerivativeFairValueOfDerivativeAsset",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/FairValueofFinancialInstrumentsForeignCurrencyForwardContractsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeFairValueOfDerivativeLiability": {
     "auth_ref": [
      "r28",
      "r143",
      "r169",
      "r210",
      "r601"
     ],
     "calculation": {
      "http://www.conmed.com/role/FairValueofFinancialInstrumentsForeignCurrencyForwardContractsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, before effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities elected not to be offset. Excludes liabilities not subject to a master netting arrangement.",
        "label": "Derivative Liability, Subject to Master Netting Arrangement, before Offset",
        "negatedTerseLabel": "Liabilities Fair Value"
       }
      }
     },
     "localname": "DerivativeFairValueOfDerivativeLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/FairValueofFinancialInstrumentsForeignCurrencyForwardContractsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeInstrumentRiskAxis": {
     "auth_ref": [
      "r142",
      "r144",
      "r149",
      "r150",
      "r601"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of derivative contract.",
        "label": "Derivative Instrument [Axis]",
        "terseLabel": "Derivative Instrument Risk [Axis]"
       }
      }
     },
     "localname": "DerivativeInstrumentRiskAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/FairValueofFinancialInstrumentsForeignCurrencyForwardContractsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis": {
     "auth_ref": [
      "r139",
      "r142",
      "r149"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of hedging relationship.",
        "label": "Hedging Relationship [Axis]",
        "terseLabel": "Hedging Relationship [Axis]"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/FairValueofFinancialInstrumentsForeignCurrencyForwardContractsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable": {
     "auth_ref": [
      "r139",
      "r142",
      "r149",
      "r150",
      "r153",
      "r154",
      "r469"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.",
        "label": "Derivative Instruments, Gain (Loss) [Table]",
        "terseLabel": "Derivative Instruments, Gain (Loss) [Table]"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/FairValueofFinancialInstrumentsAmountsRecordedInandReclassifiedFromAOCIDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivative Instruments, Gain (Loss) [Line Items]",
        "terseLabel": "Derivative Instruments, Gain (Loss) [Line Items]"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/FairValueofFinancialInstrumentsAmountsRecordedInandReclassifiedFromAOCIDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivative [Line Items]",
        "terseLabel": "Derivative [Line Items]"
       }
      }
     },
     "localname": "DerivativeLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/FairValueofFinancialInstrumentsForeignCurrencyForwardContractsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeNotionalAmount": {
     "auth_ref": [
      "r673",
      "r674"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nominal or face amount used to calculate payment on derivative.",
        "label": "Derivative, Notional Amount",
        "terseLabel": "Notional amount of cash flow hedges"
       }
      }
     },
     "localname": "DerivativeNotionalAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/FairValueofFinancialInstrumentsForeignCurrencyForwardContractsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeTable": {
     "auth_ref": [
      "r134",
      "r136",
      "r137",
      "r139",
      "r140",
      "r146",
      "r149",
      "r151",
      "r152",
      "r154",
      "r471"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule that describes and identifies a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item.",
        "label": "Derivative [Table]",
        "terseLabel": "Derivative [Table]"
       }
      }
     },
     "localname": "DerivativeTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/FairValueofFinancialInstrumentsForeignCurrencyForwardContractsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativesAndFairValueTextBlock": {
     "auth_ref": [
      "r161",
      "r163"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for derivatives and fair value of assets and liabilities.",
        "label": "Derivatives and Fair Value [Text Block]",
        "terseLabel": "Fair Value of Financial Instruments"
       }
      }
     },
     "localname": "DerivativesAndFairValueTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/FairValueofFinancialInstruments"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DesignatedAsHedgingInstrumentMember": {
     "auth_ref": [
      "r139"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative instrument designated as hedging instrument under Generally Accepted Accounting Principles (GAAP).",
        "label": "Designated as Hedging Instrument [Member]",
        "terseLabel": "Derivatives designated as hedged instruments:"
       }
      }
     },
     "localname": "DesignatedAsHedgingInstrumentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/FairValueofFinancialInstrumentsForeignCurrencyForwardContractsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisaggregationOfRevenueLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Disaggregation of Revenue [Line Items]",
        "terseLabel": "Disaggregation of Revenue [Line Items]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/RevenuesDisaggregatedRevenuesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTable": {
     "auth_ref": [
      "r393",
      "r612",
      "r613",
      "r614",
      "r615",
      "r616",
      "r617",
      "r618"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table]",
        "terseLabel": "Disaggregation of Revenue [Table]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/RevenuesDisaggregatedRevenuesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTableTextBlock": {
     "auth_ref": [
      "r672"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table Text Block]",
        "terseLabel": "Disaggregation of Revenue"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/RevenuesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DividendsCommonStockCash": {
     "auth_ref": [
      "r107"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of paid and unpaid common stock dividends declared with the form of settlement in cash.",
        "label": "Dividends, Common Stock, Cash",
        "negatedTerseLabel": "Dividends on common stock ($0.20 per share)"
       }
      }
     },
     "localname": "DividendsCommonStockCash",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/ConsolidatedCondensedStatementsofShareholdersEquityUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DividendsPayableCurrentAndNoncurrent": {
     "auth_ref": [
      "r3",
      "r5",
      "r173",
      "r184"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of dividends declared but unpaid on equity securities issued by the entity and outstanding.",
        "label": "Dividends Payable",
        "terseLabel": "Dividends payable"
       }
      }
     },
     "localname": "DividendsPayableCurrentAndNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/ConsolidatedCondensedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EMEAMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Regions of Europe, Middle East and Africa.",
        "label": "EMEA [Member]",
        "terseLabel": "Europe, Middle East &amp; Africa"
       }
      }
     },
     "localname": "EMEAMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/RevenuesDisaggregatedRevenuesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]",
        "terseLabel": "Per share data:"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/ConsolidatedCondensedStatementsofComprehensiveIncomeUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r228",
      "r243",
      "r244",
      "r245",
      "r246",
      "r247",
      "r254",
      "r256",
      "r269",
      "r270",
      "r271",
      "r275",
      "r482",
      "r483",
      "r558",
      "r564",
      "r602"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "terseLabel": "Basic (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/ConsolidatedCondensedStatementsofComprehensiveIncomeUnaudited",
      "http://www.conmed.com/role/EarningsPerShareDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r228",
      "r243",
      "r244",
      "r245",
      "r246",
      "r247",
      "r256",
      "r269",
      "r270",
      "r271",
      "r275",
      "r482",
      "r483",
      "r558",
      "r564",
      "r602"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "terseLabel": "Diluted (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/ConsolidatedCondensedStatementsofComprehensiveIncomeUnaudited",
      "http://www.conmed.com/role/EarningsPerShareDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "auth_ref": [
      "r272",
      "r273",
      "r274",
      "r276"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for earnings per share.",
        "label": "Earnings Per Share [Text Block]",
        "terseLabel": "Earnings Per Share"
       }
      }
     },
     "localname": "EarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/EarningsPerShare"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r512"
     ],
     "calculation": {
      "http://www.conmed.com/role/ConsolidatedCondensedStatementsofCashFlowsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations",
        "terseLabel": "Effect of exchange rate changes on cash and cash equivalents"
       }
      }
     },
     "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/ConsolidatedCondensedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeRelatedLiabilitiesCurrent": {
     "auth_ref": [
      "r19"
     ],
     "calculation": {
      "http://www.conmed.com/role/ConsolidatedCondensedBalanceSheetsUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Employee-related Liabilities, Current",
        "terseLabel": "Accrued compensation and benefits"
       }
      }
     },
     "localname": "EmployeeRelatedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/ConsolidatedCondensedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity [Abstract]",
        "terseLabel": "Equity [Abstract]"
       }
      }
     },
     "localname": "EquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r101",
      "r196",
      "r221",
      "r222",
      "r223",
      "r233",
      "r234",
      "r235",
      "r239",
      "r248",
      "r250",
      "r277",
      "r320",
      "r381",
      "r435",
      "r436",
      "r437",
      "r444",
      "r445",
      "r481",
      "r513",
      "r514",
      "r515",
      "r516",
      "r517",
      "r519",
      "r539",
      "r569",
      "r570",
      "r571"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/ComprehensiveIncomeAccumulatedOtherComprehensiveIncomeLossDetails",
      "http://www.conmed.com/role/ConsolidatedCondensedStatementsofShareholdersEquityUnaudited",
      "http://www.conmed.com/role/FairValueofFinancialInstrumentsForeignCurrencyForwardContractsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ExtendedProductWarrantyDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Extended Product Warranty Disclosure [Abstract]",
        "terseLabel": "Extended Product Warranty Disclosure [Abstract]"
       }
      }
     },
     "localname": "ExtendedProductWarrantyDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/GuaranteesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock": {
     "auth_ref": [
      "r162"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis.",
        "label": "Fair Value Measurement Inputs and Valuation Techniques [Table Text Block]",
        "terseLabel": "Fair Value Measurement Inputs and Valuation Techniques"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/FairValueofFinancialInstrumentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r367",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r489",
      "r541",
      "r542",
      "r543",
      "r607",
      "r608",
      "r619",
      "r620",
      "r621"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/FairValueofFinancialInstrumentsContingentConsiderationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByMeasurementFrequencyAxis": {
     "auth_ref": [
      "r488",
      "r489",
      "r491",
      "r492",
      "r494"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by measurement frequency.",
        "label": "Measurement Frequency [Axis]",
        "terseLabel": "Measurement Frequency [Axis]"
       }
      }
     },
     "localname": "FairValueByMeasurementFrequencyAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/FairValueofFinancialInstrumentsContingentConsiderationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]",
        "terseLabel": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "localname": "FairValueDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "auth_ref": [
      "r367",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r489",
      "r543",
      "r607",
      "r608",
      "r619",
      "r620",
      "r621"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "terseLabel": "Fair Value, Inputs, Level 3"
       }
      }
     },
     "localname": "FairValueInputsLevel3Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/FairValueofFinancialInstrumentsContingentConsiderationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementFrequencyDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement frequency.",
        "label": "Measurement Frequency [Domain]",
        "terseLabel": "Measurement Frequency [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementFrequencyDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/FairValueofFinancialInstrumentsContingentConsiderationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r367",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r541",
      "r542",
      "r543",
      "r607",
      "r608",
      "r619",
      "r620",
      "r621"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "terseLabel": "Fair Value Hierarchy and NAV [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/FairValueofFinancialInstrumentsContingentConsiderationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsRecurringMember": {
     "auth_ref": [
      "r493",
      "r494"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value.",
        "label": "Fair Value, Recurring [Member]",
        "terseLabel": "Fair Value, Recurring"
       }
      }
     },
     "localname": "FairValueMeasurementsRecurringMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/FairValueofFinancialInstrumentsContingentConsiderationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FederalFundsEffectiveSwapRateMember": {
     "auth_ref": [
      "r676"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fixed rate on U.S. dollar, constant-notional interest rate swap having its variable-rate leg referenced to Federal Funds effective rate with no additional spread over Federal Funds effective rate on that variable-rate leg.",
        "label": "Fed Funds Effective Rate Overnight Index Swap Rate [Member]",
        "terseLabel": "Fed Funds Effective Rate Overnight Index Swap Rate [Member]"
       }
      }
     },
     "localname": "FederalFundsEffectiveSwapRateMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/LongTermDebtAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FinanceLeaseLiability": {
     "auth_ref": [
      "r531",
      "r532"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease.",
        "label": "Finance Lease, Liability",
        "terseLabel": "Finance Lease, Liability"
       }
      }
     },
     "localname": "FinanceLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/LongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetUsefulLife": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Finite-Lived Intangible Asset, Useful Life",
        "terseLabel": "Finite-lived intangible asset useful life (in years)"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/GoodwillandOtherIntangibleAssetsIntangibleAssetsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": {
     "auth_ref": [
      "r204",
      "r341"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Accumulated Amortization",
        "negatedLabel": "Intangible assets, Accumulated amortization"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/GoodwillandOtherIntangibleAssetsIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": {
     "auth_ref": [
      "r82"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year One",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/GoodwillandOtherIntangibleAssetsIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in remainder of current fiscal year.",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year",
        "terseLabel": "Remaining, 2023"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/GoodwillandOtherIntangibleAssetsIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive": {
     "auth_ref": [
      "r82"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Five",
        "terseLabel": "2028"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFive",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/GoodwillandOtherIntangibleAssetsIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": {
     "auth_ref": [
      "r82"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Four",
        "terseLabel": "2027"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/GoodwillandOtherIntangibleAssetsIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": {
     "auth_ref": [
      "r82"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Three",
        "verboseLabel": "2026"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/GoodwillandOtherIntangibleAssetsIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": {
     "auth_ref": [
      "r82"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Two",
        "verboseLabel": "2025"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/GoodwillandOtherIntangibleAssetsIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r338",
      "r340",
      "r341",
      "r343",
      "r547",
      "r554"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by major type or class of finite-lived intangible assets.",
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "terseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/GoodwillandOtherIntangibleAssetsIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]",
        "terseLabel": "Future amortization expense [Abstract]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/GoodwillandOtherIntangibleAssetsIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsGross": {
     "auth_ref": [
      "r80",
      "r554"
     ],
     "calculation": {
      "http://www.conmed.com/role/GoodwillandOtherIntangibleAssetsIntangibleAssetsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IntangibleAssetsGrossExcludingGoodwill",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Gross",
        "terseLabel": "Amortized intangible assets, Gross carrying amount"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/GoodwillandOtherIntangibleAssetsIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r76",
      "r79"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.",
        "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/GoodwillandOtherIntangibleAssetsIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months": {
     "auth_ref": [
      "r155"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated net amount of unrealized gains or losses on foreign currency cash flow hedges at the reporting date expected to be reclassified to earnings within the next 12 months.",
        "label": "Foreign Currency Cash Flow Hedge Gain (Loss) to be Reclassified During Next 12 Months",
        "terseLabel": "Foreign Currency Cash Flow Hedge Gain (Loss) to be Reclassified During Next 12 Months"
       }
      }
     },
     "localname": "ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/FairValueofFinancialInstrumentsForeignCurrencyForwardContractsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForeignCurrencyTransactionGainLossBeforeTax": {
     "auth_ref": [
      "r508",
      "r509",
      "r510",
      "r511"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax of foreign currency transaction realized and unrealized gain (loss) recognized in the income statement.",
        "label": "Foreign Currency Transaction Gain (Loss), before Tax",
        "terseLabel": "Foreign Currency Transaction Gain (Loss), before Tax"
       }
      }
     },
     "localname": "ForeignCurrencyTransactionGainLossBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/FairValueofFinancialInstrumentsForeignCurrencyForwardContractsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForeignExchangeForwardMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Foreign exchange forward traded on an exchange (examples include but are not limited to the International Securities Exchange, Philadelphia Stock Exchange, or the Chicago Mercantile Exchange) for options or future contracts to buy or sell a certain currency, at a specified date, at a fixed exercise exchange rate.",
        "label": "Foreign Exchange Forward [Member]",
        "terseLabel": "Foreign Currency Forward Contracts"
       }
      }
     },
     "localname": "ForeignExchangeForwardMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/FairValueofFinancialInstrumentsForeignCurrencyForwardContractsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments": {
     "auth_ref": [
      "r142",
      "r148"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) recognized in earnings in the period from the increase (decrease) in fair value of foreign currency derivatives not designated as hedging instruments.",
        "label": "Gain (Loss) on Foreign Currency Derivative Instruments Not Designated as Hedging Instruments",
        "verboseLabel": "Loss on Foreign Currency Derivative Instruments Not Designated as Hedging Instruments"
       }
      }
     },
     "localname": "GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/FairValueofFinancialInstrumentsForeignCurrencyForwardContractsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Goodwill": {
     "auth_ref": [
      "r203",
      "r326",
      "r555",
      "r605",
      "r626",
      "r654",
      "r661"
     ],
     "calculation": {
      "http://www.conmed.com/role/ConsolidatedCondensedBalanceSheetsUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "terseLabel": "Goodwill"
       }
      }
     },
     "localname": "Goodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/ConsolidatedCondensedBalanceSheetsUnaudited",
      "http://www.conmed.com/role/GoodwillandOtherIntangibleAssetsGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill and Intangible Assets Disclosure [Abstract]",
        "terseLabel": "Goodwill and Intangible Assets Disclosure [Abstract]"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r85"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for goodwill and intangible assets.",
        "label": "Goodwill and Intangible Assets Disclosure [Text Block]",
        "terseLabel": "Goodwill and Other Intangible Assets"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/GoodwillandOtherIntangibleAssets"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillForeignCurrencyTranslationGainLoss": {
     "auth_ref": [
      "r332"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of foreign currency translation gain (loss) which increases (decreases) an asset representing future economic benefits from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Foreign Currency Translation Gain (Loss)",
        "terseLabel": "Foreign currency translation"
       }
      }
     },
     "localname": "GoodwillForeignCurrencyTranslationGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/GoodwillandOtherIntangibleAssetsGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Goodwill [Line Items]",
        "terseLabel": "Goodwill [Line Items]"
       }
      }
     },
     "localname": "GoodwillLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/GoodwillandOtherIntangibleAssetsGoodwillDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Goodwill [Roll Forward]",
        "terseLabel": "Goodwill [Roll Forward]"
       }
      }
     },
     "localname": "GoodwillRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/GoodwillandOtherIntangibleAssetsGoodwillDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GrossProfit": {
     "auth_ref": [
      "r44",
      "r230",
      "r291",
      "r294",
      "r299",
      "r302",
      "r316",
      "r350",
      "r351",
      "r352",
      "r353",
      "r354",
      "r355",
      "r356",
      "r357",
      "r358",
      "r496",
      "r604",
      "r668"
     ],
     "calculation": {
      "http://www.conmed.com/role/ConsolidatedCondensedStatementsofComprehensiveIncomeUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.",
        "label": "Gross Profit",
        "totalLabel": "Gross profit"
       }
      }
     },
     "localname": "GrossProfit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/ConsolidatedCondensedStatementsofComprehensiveIncomeUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GuaranteesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Guarantees [Abstract]",
        "terseLabel": "Guarantees [Abstract]"
       }
      }
     },
     "localname": "GuaranteesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_HedgingDesignationAxis": {
     "auth_ref": [
      "r139",
      "r469"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by designation of purpose of derivative instrument.",
        "label": "Hedging Designation [Axis]",
        "terseLabel": "Hedging Designation [Axis]"
       }
      }
     },
     "localname": "HedgingDesignationAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/FairValueofFinancialInstrumentsForeignCurrencyForwardContractsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_HedgingDesignationDomain": {
     "auth_ref": [
      "r139"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designation of purpose of derivative instrument.",
        "label": "Hedging Designation [Domain]",
        "terseLabel": "Hedging Designation [Domain]"
       }
      }
     },
     "localname": "HedgingDesignationDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/FairValueofFinancialInstrumentsForeignCurrencyForwardContractsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_HedgingRelationshipDomain": {
     "auth_ref": [
      "r139"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nature or intent of a hedge.",
        "label": "Hedging Relationship [Domain]",
        "terseLabel": "Hedging Relationship [Domain]"
       }
      }
     },
     "localname": "HedgingRelationshipDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/FairValueofFinancialInstrumentsForeignCurrencyForwardContractsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "auth_ref": [
      "r41",
      "r170",
      "r177",
      "r191",
      "r291",
      "r294",
      "r299",
      "r302",
      "r559",
      "r604"
     ],
     "calculation": {
      "http://www.conmed.com/role/ConsolidatedCondensedStatementsofComprehensiveIncomeUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "totalLabel": "Income before income taxes"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/ConsolidatedCondensedStatementsofComprehensiveIncomeUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "auth_ref": [
      "r344",
      "r345"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location in the income statement.",
        "label": "Income Statement Location [Axis]",
        "terseLabel": "Income Statement Location [Axis]"
       }
      }
     },
     "localname": "IncomeStatementLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/BusinessCombinationsDetails",
      "http://www.conmed.com/role/FairValueofFinancialInstrumentsAmountsRecordedInandReclassifiedFromAOCIDetails",
      "http://www.conmed.com/role/FairValueofFinancialInstrumentsForeignCurrencyForwardContractsDetails",
      "http://www.conmed.com/role/GoodwillandOtherIntangibleAssetsIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "auth_ref": [
      "r345"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the income statement.",
        "label": "Income Statement Location [Domain]",
        "terseLabel": "Income Statement Location [Domain]"
       }
      }
     },
     "localname": "IncomeStatementLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/BusinessCombinationsDetails",
      "http://www.conmed.com/role/FairValueofFinancialInstrumentsAmountsRecordedInandReclassifiedFromAOCIDetails",
      "http://www.conmed.com/role/FairValueofFinancialInstrumentsForeignCurrencyForwardContractsDetails",
      "http://www.conmed.com/role/GoodwillandOtherIntangibleAssetsIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r231",
      "r249",
      "r250",
      "r290",
      "r440",
      "r449",
      "r452",
      "r565"
     ],
     "calculation": {
      "http://www.conmed.com/role/ConsolidatedCondensedStatementsofComprehensiveIncomeUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "terseLabel": "Provision for income taxes"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/ConsolidatedCondensedStatementsofComprehensiveIncomeUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayable": {
     "auth_ref": [
      "r57"
     ],
     "calculation": {
      "http://www.conmed.com/role/ConsolidatedCondensedStatementsofCashFlowsUnaudited": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.",
        "label": "Increase (Decrease) in Accounts Payable",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/ConsolidatedCondensedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "auth_ref": [
      "r57"
     ],
     "calculation": {
      "http://www.conmed.com/role/ConsolidatedCondensedStatementsofCashFlowsUnaudited": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.",
        "label": "Increase (Decrease) in Accounts Receivable",
        "negatedTerseLabel": "Accounts receivable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/ConsolidatedCondensedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities": {
     "auth_ref": [
      "r57"
     ],
     "calculation": {
      "http://www.conmed.com/role/ConsolidatedCondensedStatementsofCashFlowsUnaudited": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits.",
        "label": "Increase (Decrease) in Employee Related Liabilities",
        "terseLabel": "Accrued compensation and benefits"
       }
      }
     },
     "localname": "IncreaseDecreaseInEmployeeRelatedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/ConsolidatedCondensedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInInventories": {
     "auth_ref": [
      "r57"
     ],
     "calculation": {
      "http://www.conmed.com/role/ConsolidatedCondensedStatementsofCashFlowsUnaudited": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.",
        "label": "Increase (Decrease) in Inventories",
        "negatedTerseLabel": "Inventories"
       }
      }
     },
     "localname": "IncreaseDecreaseInInventories",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/ConsolidatedCondensedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Operating Capital [Abstract]",
        "terseLabel": "Increase (decrease) in cash flows from changes in assets and liabilities:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/ConsolidatedCondensedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherOperatingAssets": {
     "auth_ref": [
      "r57"
     ],
     "calculation": {
      "http://www.conmed.com/role/ConsolidatedCondensedStatementsofCashFlowsUnaudited": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in operating assets classified as other.",
        "label": "Increase (Decrease) in Other Operating Assets",
        "negatedTerseLabel": "Other assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherOperatingAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/ConsolidatedCondensedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherOperatingLiabilities": {
     "auth_ref": [
      "r57"
     ],
     "calculation": {
      "http://www.conmed.com/role/ConsolidatedCondensedStatementsofCashFlowsUnaudited": {
       "order": 13.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in operating liabilities classified as other.",
        "label": "Increase (Decrease) in Other Operating Liabilities",
        "terseLabel": "Other liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherOperatingLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/ConsolidatedCondensedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]"
       }
      }
     },
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/ConsolidatedCondensedStatementsofShareholdersEquityUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants": {
     "auth_ref": [
      "r257",
      "r258",
      "r259",
      "r271"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of call options and warrants using the treasury stock method.",
        "label": "Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants",
        "terseLabel": "Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants (in shares)"
       }
      }
     },
     "localname": "IncrementalCommonSharesAttributableToCallOptionsAndWarrants",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/EarningsPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities": {
     "auth_ref": [
      "r265",
      "r266",
      "r271"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of convertible debt securities using the if-converted method.",
        "label": "Incremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities",
        "terseLabel": "Incremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities (in shares)"
       }
      }
     },
     "localname": "IncrementalCommonSharesAttributableToConversionOfDebtSecurities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/EarningsPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements": {
     "auth_ref": [
      "r257",
      "r258",
      "r260",
      "r271",
      "r431"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.",
        "label": "Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements",
        "terseLabel": "Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements (in shares)"
       }
      }
     },
     "localname": "IncrementalCommonSharesAttributableToShareBasedPaymentArrangements",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/EarningsPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r339",
      "r342"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type or class of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.",
        "label": "Indefinite-Lived Intangible Assets [Axis]",
        "terseLabel": "Indefinite-lived Intangible Assets by Major Class [Axis]"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/GoodwillandOtherIntangibleAssetsIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill": {
     "auth_ref": [
      "r83"
     ],
     "calculation": {
      "http://www.conmed.com/role/GoodwillandOtherIntangibleAssetsIntangibleAssetsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IntangibleAssetsGrossExcludingGoodwill",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.",
        "label": "Indefinite-Lived Intangible Assets (Excluding Goodwill)",
        "terseLabel": "Unamortized intangible assets, Gross carrying amount"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/GoodwillandOtherIntangibleAssetsIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r77",
      "r83"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of indefinite-lived intangible asset (for example, trade names, etc. but not all-inclusive), excluding goodwill. A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of the company.",
        "label": "Indefinite-Lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Indefinite-lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/GoodwillandOtherIntangibleAssetsIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IntangibleAssetsGrossExcludingGoodwill": {
     "auth_ref": [
      "r203"
     ],
     "calculation": {
      "http://www.conmed.com/role/GoodwillandOtherIntangibleAssetsIntangibleAssetsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated amortization of intangible assets, excluding goodwill.",
        "label": "Intangible Assets, Gross (Excluding Goodwill)",
        "totalLabel": "Intangible assets, Gross carrying amount"
       }
      }
     },
     "localname": "IntangibleAssetsGrossExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/GoodwillandOtherIntangibleAssetsIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwill": {
     "auth_ref": [
      "r74",
      "r78"
     ],
     "calculation": {
      "http://www.conmed.com/role/ConsolidatedCondensedBalanceSheetsUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.",
        "label": "Intangible Assets, Net (Excluding Goodwill)",
        "terseLabel": "Other intangible assets, net"
       }
      }
     },
     "localname": "IntangibleAssetsNetExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/ConsolidatedCondensedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpense": {
     "auth_ref": [
      "r167",
      "r179",
      "r224",
      "r289",
      "r522"
     ],
     "calculation": {
      "http://www.conmed.com/role/ConsolidatedCondensedStatementsofComprehensiveIncomeUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.",
        "label": "Interest Expense",
        "terseLabel": "Interest expense"
       }
      }
     },
     "localname": "InterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/ConsolidatedCondensedStatementsofComprehensiveIncomeUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpenseDebt": {
     "auth_ref": [
      "r48",
      "r372",
      "r379",
      "r609",
      "r610"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense for debt.",
        "label": "Interest Expense, Debt",
        "terseLabel": "Interest Expense, Debt"
       }
      }
     },
     "localname": "InterestExpenseDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/LongTermDebtAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestOnConvertibleDebtNetOfTax": {
     "auth_ref": [
      "r255",
      "r262",
      "r271"
     ],
     "calculation": {
      "http://www.conmed.com/role/EarningsPerShareDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax, of interest recognized on convertible debt instrument excluding interest on principal required to be paid in cash.",
        "label": "Interest on Convertible Debt, Net of Tax",
        "terseLabel": "Interest on Convertible Debt, Net of Tax"
       }
      }
     },
     "localname": "InterestOnConvertibleDebtNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/EarningsPerShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Inventory Disclosure [Abstract]",
        "terseLabel": "Inventory Disclosure [Abstract]"
       }
      }
     },
     "localname": "InventoryDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_InventoryDisclosureTextBlock": {
     "auth_ref": [
      "r325"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.",
        "label": "Inventory Disclosure [Text Block]",
        "terseLabel": "Inventories"
       }
      }
     },
     "localname": "InventoryDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/Inventories"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InventoryFinishedGoodsNetOfReserves": {
     "auth_ref": [
      "r72",
      "r598"
     ],
     "calculation": {
      "http://www.conmed.com/role/InventoriesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.",
        "label": "Inventory, Finished Goods, Net of Reserves",
        "terseLabel": "Finished goods"
       }
      }
     },
     "localname": "InventoryFinishedGoodsNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/InventoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryNet": {
     "auth_ref": [
      "r208",
      "r597",
      "r626"
     ],
     "calculation": {
      "http://www.conmed.com/role/ConsolidatedCondensedBalanceSheetsUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://www.conmed.com/role/InventoriesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.",
        "label": "Inventory, Net",
        "terseLabel": "Inventories",
        "totalLabel": "Total inventory"
       }
      }
     },
     "localname": "InventoryNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/ConsolidatedCondensedBalanceSheetsUnaudited",
      "http://www.conmed.com/role/InventoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryRawMaterialsNetOfReserves": {
     "auth_ref": [
      "r72",
      "r600"
     ],
     "calculation": {
      "http://www.conmed.com/role/InventoriesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of unprocessed items to be consumed in the manufacturing or production process.",
        "label": "Inventory, Raw Materials, Net of Reserves",
        "terseLabel": "Raw materials"
       }
      }
     },
     "localname": "InventoryRawMaterialsNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/InventoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryWorkInProcessNetOfReserves": {
     "auth_ref": [
      "r72",
      "r599"
     ],
     "calculation": {
      "http://www.conmed.com/role/InventoriesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.",
        "label": "Inventory, Work in Process, Net of Reserves",
        "terseLabel": "Work-in-process"
       }
      }
     },
     "localname": "InventoryWorkInProcessNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/InventoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LegalMattersAndContingenciesTextBlock": {
     "auth_ref": [
      "r88"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for legal proceedings, legal contingencies, litigation, regulatory and environmental matters and other contingencies.",
        "label": "Legal Matters and Contingencies [Text Block]",
        "terseLabel": "Legal Proceedings"
       }
      }
     },
     "localname": "LegalMattersAndContingenciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/LegalProceedings"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LettersOfCreditOutstandingAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total amount of the contingent obligation under letters of credit outstanding as of the reporting date.",
        "label": "Letters of Credit Outstanding, Amount",
        "terseLabel": "Letters of Credit Outstanding, Amount"
       }
      }
     },
     "localname": "LettersOfCreditOutstandingAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/LongTermDebtAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r18",
      "r230",
      "r316",
      "r350",
      "r351",
      "r352",
      "r353",
      "r354",
      "r355",
      "r356",
      "r357",
      "r358",
      "r462",
      "r464",
      "r465",
      "r496",
      "r603",
      "r668",
      "r682",
      "r683"
     ],
     "calculation": {
      "http://www.conmed.com/role/ConsolidatedCondensedBalanceSheetsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/ConsolidatedCondensedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r12",
      "r175",
      "r187",
      "r626",
      "r645",
      "r653",
      "r679"
     ],
     "calculation": {
      "http://www.conmed.com/role/ConsolidatedCondensedBalanceSheetsUnaudited": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total liabilities and shareholders\u2019 equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/ConsolidatedCondensedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "terseLabel": "LIABILITIES AND SHAREHOLDERS' EQUITY"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/ConsolidatedCondensedBalanceSheetsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r20",
      "r202",
      "r230",
      "r316",
      "r350",
      "r351",
      "r352",
      "r353",
      "r354",
      "r355",
      "r356",
      "r357",
      "r358",
      "r462",
      "r464",
      "r465",
      "r496",
      "r626",
      "r668",
      "r682",
      "r683"
     ],
     "calculation": {
      "http://www.conmed.com/role/ConsolidatedCondensedBalanceSheetsUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/ConsolidatedCondensedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "terseLabel": "Current liabilities:"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/ConsolidatedCondensedBalanceSheetsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": {
     "auth_ref": [
      "r17"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.",
        "label": "Line of Credit Facility, Maximum Borrowing Capacity",
        "terseLabel": "Line of Credit Facility, Maximum Borrowing Capacity"
       }
      }
     },
     "localname": "LineOfCreditFacilityMaximumBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/LongTermDebtAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity": {
     "auth_ref": [
      "r17"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of borrowing capacity currently available under the credit facility (current borrowing capacity less the amount of borrowings outstanding).",
        "label": "Line of Credit Facility, Remaining Borrowing Capacity",
        "terseLabel": "Line of Credit Facility, Remaining Borrowing Capacity"
       }
      }
     },
     "localname": "LineOfCreditFacilityRemainingBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/LongTermDebtAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A contractual arrangement with a lender under which borrowings can be made up to a specific amount at any point in time, and under which borrowings outstanding may be either short-term or long-term, depending upon the particulars.",
        "label": "Line of Credit [Member]",
        "terseLabel": "Line of Credit [Member]"
       }
      }
     },
     "localname": "LineOfCreditMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/LongTermDebtAdditionalInformationDetails",
      "http://www.conmed.com/role/LongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LoansPayableMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Borrowing supported by a written promise to pay an obligation.",
        "label": "Loans Payable [Member]",
        "terseLabel": "Term Loan Facility [Member]"
       }
      }
     },
     "localname": "LoansPayableMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/LongTermDebtAdditionalInformationDetails",
      "http://www.conmed.com/role/LongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LongTermDebt": {
     "auth_ref": [
      "r4",
      "r174",
      "r185",
      "r366",
      "r377",
      "r607",
      "r608"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.",
        "label": "Long-Term Debt",
        "terseLabel": "Long-term Debt"
       }
      }
     },
     "localname": "LongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/LongTermDebtAdditionalInformationDetails",
      "http://www.conmed.com/role/LongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtAndCapitalLeaseObligations": {
     "auth_ref": [
      "r4"
     ],
     "calculation": {
      "http://www.conmed.com/role/ConsolidatedCondensedBalanceSheetsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      },
      "http://www.conmed.com/role/LongTermDebtDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt and lease obligation, classified as noncurrent.",
        "label": "Long-Term Debt and Lease Obligation",
        "terseLabel": "Long-term debt",
        "verboseLabel": "Long-term debt"
       }
      }
     },
     "localname": "LongTermDebtAndCapitalLeaseObligations",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/ConsolidatedCondensedBalanceSheetsUnaudited",
      "http://www.conmed.com/role/LongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent": {
     "auth_ref": [
      "r19"
     ],
     "calculation": {
      "http://www.conmed.com/role/ConsolidatedCondensedBalanceSheetsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      },
      "http://www.conmed.com/role/LongTermDebtDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt and lease obligation, classified as current.",
        "label": "Long-Term Debt and Lease Obligation, Current",
        "terseLabel": "Current portion of long-term debt"
       }
      }
     },
     "localname": "LongTermDebtAndCapitalLeaseObligationsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/ConsolidatedCondensedBalanceSheetsUnaudited",
      "http://www.conmed.com/role/LongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities": {
     "auth_ref": [],
     "calculation": {
      "http://www.conmed.com/role/LongTermDebtDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt and lease obligation, including portion classified as current.",
        "label": "Long-Term Debt and Lease Obligation, Including Current Maturities",
        "totalLabel": "Long-term Debt and Lease Obligation, Including Current Maturities"
       }
      }
     },
     "localname": "LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/LongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths": {
     "auth_ref": [
      "r95",
      "r232",
      "r370"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year One",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/LongTermDebtMaturitiesofLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive": {
     "auth_ref": [
      "r95",
      "r232",
      "r370"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Five",
        "terseLabel": "2028"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/LongTermDebtMaturitiesofLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour": {
     "auth_ref": [
      "r95",
      "r232",
      "r370"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Four",
        "terseLabel": "2027"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/LongTermDebtMaturitiesofLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree": {
     "auth_ref": [
      "r95",
      "r232",
      "r370"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Three",
        "terseLabel": "2026"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/LongTermDebtMaturitiesofLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo": {
     "auth_ref": [
      "r95",
      "r232",
      "r370"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Two",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/LongTermDebtMaturitiesofLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear": {
     "auth_ref": [
      "r647"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in remainder of current fiscal year.",
        "label": "Long-Term Debt, Maturity, Remainder of Fiscal Year",
        "terseLabel": "Remaining, 2023"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/LongTermDebtMaturitiesofLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt arrangement having an initial term longer than one year or beyond the normal operating cycle, if longer.",
        "label": "Long-Term Debt [Member]",
        "terseLabel": "Long-term Debt [Member]"
       }
      }
     },
     "localname": "LongTermDebtMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/LongTermDebtAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LongTermDebtTextBlock": {
     "auth_ref": [
      "r98"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for long-term debt.",
        "label": "Long-Term Debt [Text Block]",
        "terseLabel": "Long-Term Debt"
       }
      }
     },
     "localname": "LongTermDebtTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/LongTermDebt"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "auth_ref": [
      "r23"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-term debt.",
        "label": "Long-Term Debt, Type [Axis]",
        "terseLabel": "Long-term Debt, Type [Axis]"
       }
      }
     },
     "localname": "LongtermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/LongTermDebtAdditionalInformationDetails",
      "http://www.conmed.com/role/LongTermDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "auth_ref": [
      "r23",
      "r96"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Long-Term Debt, Type [Domain]",
        "terseLabel": "Long-term Debt, Type [Domain]"
       }
      }
     },
     "localname": "LongtermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/LongTermDebtAdditionalInformationDetails",
      "http://www.conmed.com/role/LongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MaturitiesOfLongTermDebtAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maturities of Long-Term Debt [Abstract]",
        "terseLabel": "Maturities of Long-term Debt [Abstract]"
       }
      }
     },
     "localname": "MaturitiesOfLongTermDebtAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/LongTermDebtMaturitiesofLongTermDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_MaximumLengthOfTimeHedgedInCashFlowHedge1": {
     "auth_ref": [
      "r156"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum length of time over which the entity is hedging its exposure to the variability in future cash flows for forecasted transactions, excluding those forecasted transactions related to the payment of variable interest on existing financial instruments, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Maximum Length of Time Hedged in Cash Flow Hedge",
        "terseLabel": "Maximum Length of Time Hedged in Cash Flow Hedge"
       }
      }
     },
     "localname": "MaximumLengthOfTimeHedgedInCashFlowHedge1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/FairValueofFinancialInstrumentsForeignCurrencyForwardContractsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_MeasurementInputDiscountRateMember": {
     "auth_ref": [
      "r678"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement input using interest rate to determine present value of future cash flows.",
        "label": "Measurement Input, Discount Rate [Member]",
        "terseLabel": "Measurement Input, Discount Rate"
       }
      }
     },
     "localname": "MeasurementInputDiscountRateMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/FairValueofFinancialInstrumentsContingentConsiderationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MeasurementInputTypeAxis": {
     "auth_ref": [
      "r490"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of measurement input used to determine value of asset and liability.",
        "label": "Measurement Input Type [Axis]",
        "terseLabel": "Measurement Input Type [Axis]"
       }
      }
     },
     "localname": "MeasurementInputTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/FairValueofFinancialInstrumentsContingentConsiderationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_MeasurementInputTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement input used to determine value of asset and liability.",
        "label": "Measurement Input Type [Domain]",
        "terseLabel": "Measurement Input Type [Domain]"
       }
      }
     },
     "localname": "MeasurementInputTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/FairValueofFinancialInstrumentsContingentConsiderationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MovementInStandardProductWarrantyAccrualRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Movement in Standard Product Warranty Accrual [Roll Forward]",
        "terseLabel": "Movement in Standard Product Warranty Accrual [Roll Forward]"
       }
      }
     },
     "localname": "MovementInStandardProductWarrantyAccrualRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/GuaranteesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NatureOfOperations": {
     "auth_ref": [
      "r278",
      "r283"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward.",
        "label": "Nature of Operations [Text Block]",
        "terseLabel": "Operations"
       }
      }
     },
     "localname": "NatureOfOperations",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/Operations"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r229"
     ],
     "calculation": {
      "http://www.conmed.com/role/ConsolidatedCondensedStatementsofCashFlowsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash provided by financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/ConsolidatedCondensedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "terseLabel": "Cash flows from financing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/ConsolidatedCondensedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r229"
     ],
     "calculation": {
      "http://www.conmed.com/role/ConsolidatedCondensedStatementsofCashFlowsUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash used in investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/ConsolidatedCondensedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "terseLabel": "Cash flows from investing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/ConsolidatedCondensedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r55",
      "r56",
      "r59"
     ],
     "calculation": {
      "http://www.conmed.com/role/ConsolidatedCondensedStatementsofCashFlowsUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash (used in) provided by operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/ConsolidatedCondensedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Cash flows from operating activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/ConsolidatedCondensedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r42",
      "r59",
      "r178",
      "r190",
      "r200",
      "r216",
      "r219",
      "r223",
      "r230",
      "r238",
      "r243",
      "r244",
      "r245",
      "r246",
      "r249",
      "r250",
      "r267",
      "r291",
      "r294",
      "r299",
      "r302",
      "r316",
      "r350",
      "r351",
      "r352",
      "r353",
      "r354",
      "r355",
      "r356",
      "r357",
      "r358",
      "r483",
      "r496",
      "r604",
      "r668"
     ],
     "calculation": {
      "http://www.conmed.com/role/ComprehensiveIncomeDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      },
      "http://www.conmed.com/role/ConsolidatedCondensedStatementsofCashFlowsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.conmed.com/role/ConsolidatedCondensedStatementsofComprehensiveIncomeUnaudited": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.conmed.com/role/EarningsPerShareDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "terseLabel": "Net income",
        "totalLabel": "Net income"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/ComprehensiveIncomeDetails",
      "http://www.conmed.com/role/ConsolidatedCondensedStatementsofCashFlowsUnaudited",
      "http://www.conmed.com/role/ConsolidatedCondensedStatementsofComprehensiveIncomeUnaudited",
      "http://www.conmed.com/role/ConsolidatedCondensedStatementsofShareholdersEquityUnaudited",
      "http://www.conmed.com/role/EarningsPerShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted": {
     "auth_ref": [
      "r255",
      "r261",
      "r262",
      "r263",
      "r264",
      "r268",
      "r271"
     ],
     "calculation": {
      "http://www.conmed.com/role/EarningsPerShareDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities, and addition from assumption of issuance of common shares for dilutive potential common shares; of income (loss) available to common shareholders.",
        "label": "Net Income (Loss) Available to Common Stockholders, Diluted",
        "totalLabel": "Net Income Available to Common Stockholders, Diluted"
       }
      }
     },
     "localname": "NetIncomeLossAvailableToCommonStockholdersDiluted",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/EarningsPerShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Standards Update and Change in Accounting Principle [Abstract]",
        "terseLabel": "New Accounting Pronouncements and Changes in Accounting Principles [Abstract]"
       }
      }
     },
     "localname": "NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock": {
     "auth_ref": [
      "r199",
      "r236",
      "r237",
      "r240",
      "r241",
      "r251",
      "r252",
      "r253",
      "r314",
      "r315",
      "r321",
      "r322",
      "r446",
      "r447",
      "r448",
      "r479",
      "r485",
      "r486",
      "r487",
      "r503",
      "r504",
      "r505",
      "r529",
      "r530",
      "r534",
      "r540",
      "r551",
      "r552",
      "r553",
      "r573",
      "r574",
      "r575",
      "r576",
      "r578"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for change in accounting principle. Includes, but is not limited to, nature, reason, and method of adopting amendment to accounting standards or other change in accounting principle.",
        "label": "Accounting Standards Update and Change in Accounting Principle [Text Block]",
        "terseLabel": "New Accounting Pronouncements"
       }
      }
     },
     "localname": "NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/NewAccountingPronouncements"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "terseLabel": "New Accounting Pronouncements"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/NewAccountingPronouncementsPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NondesignatedMember": {
     "auth_ref": [
      "r139"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative instrument not designated as hedging instrument under Generally Accepted Accounting Principles (GAAP).",
        "label": "Not Designated as Hedging Instrument [Member]",
        "terseLabel": "Derivatives not designated as hedging instruments:"
       }
      }
     },
     "localname": "NondesignatedMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/FairValueofFinancialInstrumentsForeignCurrencyForwardContractsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OperatingExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://www.conmed.com/role/ConsolidatedCondensedStatementsofComprehensiveIncomeUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.",
        "label": "Operating Expenses",
        "totalLabel": "Operating expenses"
       }
      }
     },
     "localname": "OperatingExpenses",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/ConsolidatedCondensedStatementsofComprehensiveIncomeUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r291",
      "r294",
      "r299",
      "r302",
      "r604"
     ],
     "calculation": {
      "http://www.conmed.com/role/ConsolidatedCondensedStatementsofComprehensiveIncomeUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "totalLabel": "Income from operations"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/ConsolidatedCondensedStatementsofComprehensiveIncomeUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OptionIndexedToIssuersEquityStrikePrice1": {
     "auth_ref": [
      "r99",
      "r159"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Exercise or strike price stated in the contract for options indexed to the issuer's equity shares.",
        "label": "Option Indexed to Issuer's Equity, Strike Price",
        "terseLabel": "Option indexed to issuer's equity, strike price (in dollars per share)"
       }
      }
     },
     "localname": "OptionIndexedToIssuersEquityStrikePrice1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/LongTermDebtAdditionalInformationDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_OptionIndexedToIssuersEquityTypeAxis": {
     "auth_ref": [
      "r100",
      "r157",
      "r158",
      "r160"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of freestanding contracts issued by an entity that are indexed to, and potentially settled in, an entity's own stock.",
        "label": "Option Indexed to Issuer's Equity, Type [Axis]",
        "terseLabel": "Option Indexed to Issuer's Equity, Type [Axis]"
       }
      }
     },
     "localname": "OptionIndexedToIssuersEquityTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/LongTermDebtAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OptionIndexedToIssuersEquityTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of the type of freestanding contract issued by a Company that is indexed to, and potentially settled in, a Company's own stock. Specifically, the pertinent rights and privileges of the securities outstanding.",
        "label": "Option Indexed to Issuer's Equity, Type [Domain]",
        "terseLabel": "Option Indexed to Issuer's Equity, Type [Domain]"
       }
      }
     },
     "localname": "OptionIndexedToIssuersEquityTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/LongTermDebtAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]",
        "terseLabel": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": {
     "auth_ref": [
      "r0",
      "r132"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.",
        "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]",
        "terseLabel": "Interim Financial Information"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/InterimFinancialInformation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherAmortizationOfDeferredCharges": {
     "auth_ref": [
      "r46",
      "r58"
     ],
     "calculation": {
      "http://www.conmed.com/role/ConsolidatedCondensedStatementsofCashFlowsUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization of other deferred costs recognized in the income statement.",
        "label": "Amortization of Other Deferred Charges",
        "terseLabel": "Amortization"
       }
      }
     },
     "localname": "OtherAmortizationOfDeferredCharges",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/ConsolidatedCondensedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r205"
     ],
     "calculation": {
      "http://www.conmed.com/role/ConsolidatedCondensedBalanceSheetsUnaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other Assets, Noncurrent",
        "terseLabel": "Other assets"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/ConsolidatedCondensedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax": {
     "auth_ref": [
      "r39",
      "r40",
      "r222",
      "r513",
      "r515",
      "r519",
      "r637"
     ],
     "calculation": {
      "http://www.conmed.com/role/ComprehensiveIncomeAccumulatedOtherComprehensiveIncomeLossDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax, before reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), before Reclassifications, Net of Tax",
        "terseLabel": "Other comprehensive income (loss) before reclassifications, net of tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/ComprehensiveIncomeAccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax": {
     "auth_ref": [
      "r211",
      "r212"
     ],
     "calculation": {
      "http://www.conmed.com/role/ComprehensiveIncomeDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax",
        "terseLabel": "Cash flow hedging gain, net"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/ComprehensiveIncomeDetails",
      "http://www.conmed.com/role/ConsolidatedCondensedStatementsofShareholdersEquityUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax": {
     "auth_ref": [
      "r213"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after reclassification, of tax expense (benefit) for gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, Tax",
        "terseLabel": "Cash flow hedging gain, tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/ComprehensiveIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax": {
     "auth_ref": [
      "r211",
      "r212"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and before reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax",
        "terseLabel": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/FairValueofFinancialInstrumentsAmountsRecordedInandReclassifiedFromAOCIDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax": {
     "auth_ref": [
      "r211",
      "r212",
      "r466",
      "r467",
      "r470"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax and reclassification, of gain (loss) from derivative instrument designated and qualifying cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax",
        "terseLabel": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/FairValueofFinancialInstrumentsAmountsRecordedInandReclassifiedFromAOCIDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax": {
     "auth_ref": [
      "r213"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before reclassification, of tax expense (benefit) for gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, Tax",
        "terseLabel": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/FairValueofFinancialInstrumentsAmountsRecordedInandReclassifiedFromAOCIDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax": {
     "auth_ref": [
      "r212",
      "r214"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, after Tax",
        "terseLabel": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, after Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/FairValueofFinancialInstrumentsAmountsRecordedInandReclassifiedFromAOCIDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax": {
     "auth_ref": [
      "r212",
      "r214",
      "r468"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax",
        "terseLabel": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/FairValueofFinancialInstrumentsAmountsRecordedInandReclassifiedFromAOCIDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax": {
     "auth_ref": [
      "r213"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax expense (benefit) for reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, Tax",
        "terseLabel": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/FairValueofFinancialInstrumentsAmountsRecordedInandReclassifiedFromAOCIDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": {
     "auth_ref": [
      "r30"
     ],
     "calculation": {
      "http://www.conmed.com/role/ComprehensiveIncomeDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax",
        "terseLabel": "Foreign currency translation adjustments"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/ComprehensiveIncomeDetails",
      "http://www.conmed.com/role/ConsolidatedCondensedStatementsofShareholdersEquityUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r40",
      "r101",
      "r217",
      "r220",
      "r226",
      "r513",
      "r518",
      "r519",
      "r556",
      "r562",
      "r637",
      "r638"
     ],
     "calculation": {
      "http://www.conmed.com/role/ComprehensiveIncomeAccumulatedOtherComprehensiveIncomeLossDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), Net of Tax",
        "totalLabel": "Net current-period other comprehensive income (loss)"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/ComprehensiveIncomeAccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Comprehensive Income (Loss), Net of Tax [Abstract]",
        "terseLabel": "Comprehensive income:"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/ConsolidatedCondensedStatementsofShareholdersEquityUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax": {
     "auth_ref": [
      "r34",
      "r36"
     ],
     "calculation": {
      "http://www.conmed.com/role/ComprehensiveIncomeDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.",
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax",
        "negatedLabel": "Pension liability, net of income tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/ComprehensiveIncomeDetails",
      "http://www.conmed.com/role/ConsolidatedCondensedStatementsofShareholdersEquityUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax": {
     "auth_ref": [
      "r34",
      "r37",
      "r129"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after reclassification adjustment, of tax (expense) benefit for (increase) decrease in accumulated other comprehensive income of defined benefit plan.",
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, Tax",
        "negatedTerseLabel": "Pension liability, tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/ComprehensiveIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherCurrentLiabilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other current liabilities.",
        "label": "Other Current Liabilities [Member]",
        "terseLabel": "Other Current Liabilities [Member]"
       }
      }
     },
     "localname": "OtherCurrentLiabilitiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/FairValueofFinancialInstrumentsForeignCurrencyForwardContractsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherLiabilitiesCurrent": {
     "auth_ref": [
      "r19",
      "r626"
     ],
     "calculation": {
      "http://www.conmed.com/role/ConsolidatedCondensedBalanceSheetsUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Current",
        "terseLabel": "Other current liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/ConsolidatedCondensedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "auth_ref": [
      "r24"
     ],
     "calculation": {
      "http://www.conmed.com/role/ConsolidatedCondensedBalanceSheetsUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Noncurrent",
        "terseLabel": "Other long-term liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/ConsolidatedCondensedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNoncurrentAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other noncurrent assets.",
        "label": "Other Noncurrent Assets [Member]",
        "terseLabel": "Other Noncurrent Assets [Member]"
       }
      }
     },
     "localname": "OtherNoncurrentAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/FairValueofFinancialInstrumentsForeignCurrencyForwardContractsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherNoncurrentLiabilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other noncurrent liabilities.",
        "label": "Other Noncurrent Liabilities [Member]",
        "terseLabel": "Other Noncurrent Liabilities [Member]"
       }
      }
     },
     "localname": "OtherNoncurrentLiabilitiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/FairValueofFinancialInstrumentsForeignCurrencyForwardContractsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PaymentsOfDividendsCommonStock": {
     "auth_ref": [
      "r53"
     ],
     "calculation": {
      "http://www.conmed.com/role/ConsolidatedCondensedStatementsofCashFlowsUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow in the form of ordinary dividends to common shareholders of the parent entity.",
        "label": "Payments of Ordinary Dividends, Common Stock",
        "negatedTerseLabel": "Dividends paid on common stock"
       }
      }
     },
     "localname": "PaymentsOfDividendsCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/ConsolidatedCondensedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireBusinessesGross": {
     "auth_ref": [
      "r50",
      "r458"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.",
        "label": "Payments to Acquire Businesses, Gross",
        "terseLabel": "Payments to acquire businesses, gross"
       }
      }
     },
     "localname": "PaymentsToAcquireBusinessesGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/BusinessCombinationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r51"
     ],
     "calculation": {
      "http://www.conmed.com/role/ConsolidatedCondensedStatementsofCashFlowsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedTerseLabel": "Purchases of property, plant and equipment"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/ConsolidatedCondensedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock": {
     "auth_ref": [
      "r401",
      "r402",
      "r408",
      "r414",
      "r415",
      "r416",
      "r417",
      "r418",
      "r419",
      "r425",
      "r426",
      "r427",
      "r429",
      "r621"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for retirement benefits.",
        "label": "Retirement Benefits [Text Block]",
        "terseLabel": "Pension Plan"
       }
      }
     },
     "localname": "PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/PensionPlan"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r6",
      "r380"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.",
        "label": "Preferred Stock, Par or Stated Value Per Share",
        "terseLabel": "Preferred stock, par value (dollars per share)"
       }
      }
     },
     "localname": "PreferredStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/ConsolidatedCondensedBalanceSheetsUnauditedParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
        "label": "Preferred Stock, Shares Authorized",
        "terseLabel": "Preferred stock, shares authorized (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/ConsolidatedCondensedBalanceSheetsUnauditedParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.",
        "label": "Preferred Stock, Shares Outstanding",
        "terseLabel": "Preferred stock, shares outstanding (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/ConsolidatedCondensedBalanceSheetsUnauditedParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockValue": {
     "auth_ref": [
      "r6",
      "r626"
     ],
     "calculation": {
      "http://www.conmed.com/role/ConsolidatedCondensedBalanceSheetsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Preferred Stock, Value, Issued",
        "terseLabel": "Preferred stock, par value $.01 per share; authorized 500,000 shares; none outstanding"
       }
      }
     },
     "localname": "PreferredStockValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/ConsolidatedCondensedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "auth_ref": [
      "r636"
     ],
     "calculation": {
      "http://www.conmed.com/role/ConsolidatedCondensedBalanceSheetsUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.",
        "label": "Prepaid Expense and Other Assets, Current",
        "terseLabel": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/ConsolidatedCondensedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing prepaid expenses and other current assets.",
        "label": "Prepaid Expenses and Other Current Assets [Member]",
        "terseLabel": "Prepaid Expenses and Other Current Assets [Member]"
       }
      }
     },
     "localname": "PrepaidExpensesAndOtherCurrentAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/FairValueofFinancialInstrumentsForeignCurrencyForwardContractsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ProceedsFromLinesOfCredit": {
     "auth_ref": [
      "r52",
      "r644"
     ],
     "calculation": {
      "http://www.conmed.com/role/ConsolidatedCondensedStatementsofCashFlowsUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from contractual arrangement with the lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.",
        "label": "Proceeds from Lines of Credit",
        "terseLabel": "Proceeds from revolving line of credit"
       }
      }
     },
     "localname": "ProceedsFromLinesOfCredit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/ConsolidatedCondensedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromPaymentsForOtherFinancingActivities": {
     "auth_ref": [
      "r640",
      "r641"
     ],
     "calculation": {
      "http://www.conmed.com/role/ConsolidatedCondensedStatementsofCashFlowsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities classified as other.",
        "label": "Proceeds from (Payments for) Other Financing Activities",
        "terseLabel": "Other, net"
       }
      }
     },
     "localname": "ProceedsFromPaymentsForOtherFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/ConsolidatedCondensedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProductWarrantiesDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product Warranties Disclosures [Abstract]",
        "terseLabel": "Product Warranties Disclosures [Abstract]"
       }
      }
     },
     "localname": "ProductWarrantiesDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/GuaranteesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ProductWarrantyDisclosureTextBlock": {
     "auth_ref": [
      "r94"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for standard and extended product warranties and other product guarantee contracts, including a tabular reconciliation of the changes in the guarantor's aggregate product warranty liability for the reporting period.",
        "label": "Product Warranty Disclosure [Text Block]",
        "terseLabel": "Guarantees"
       }
      }
     },
     "localname": "ProductWarrantyDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/Guarantees"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ProductWarrantyExpense": {
     "auth_ref": [
      "r57",
      "r91"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The expense charged against earnings for the period pertaining to standard and extended warranties on the entity's goods and services granted to customers.",
        "label": "Product Warranty Expense",
        "terseLabel": "Product extended warranty expense"
       }
      }
     },
     "localname": "ProductWarrantyExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/GuaranteesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r87",
      "r188",
      "r560",
      "r626"
     ],
     "calculation": {
      "http://www.conmed.com/role/ConsolidatedCondensedBalanceSheetsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Net",
        "terseLabel": "Property, plant and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/ConsolidatedCondensedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax": {
     "auth_ref": [
      "r39",
      "r222",
      "r513",
      "r517",
      "r519",
      "r637"
     ],
     "calculation": {
      "http://www.conmed.com/role/ComprehensiveIncomeAccumulatedOtherComprehensiveIncomeLossDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax of reclassification adjustments of other comprehensive income (loss).",
        "label": "Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax",
        "negatedTerseLabel": "Amounts reclassified from other accumulated comprehensive income (loss) before tax"
       }
      }
     },
     "localname": "ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/ComprehensiveIncomeAccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReclassificationFromAociCurrentPeriodTax": {
     "auth_ref": [
      "r37",
      "r215",
      "r221"
     ],
     "calculation": {
      "http://www.conmed.com/role/ComprehensiveIncomeAccumulatedOtherComprehensiveIncomeLossDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax expense (benefit) of reclassification adjustment from accumulated other comprehensive income (loss).",
        "label": "Reclassification from AOCI, Current Period, Tax",
        "terseLabel": "Reclassification from AOCI, Current Period, Tax"
       }
      }
     },
     "localname": "ReclassificationFromAociCurrentPeriodTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/ComprehensiveIncomeAccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfConvertibleDebt": {
     "auth_ref": [
      "r54"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow from the repayment of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.",
        "label": "Repayments of Convertible Debt",
        "terseLabel": "Repayments of Convertible Debt"
       }
      }
     },
     "localname": "RepaymentsOfConvertibleDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/LongTermDebtAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfLinesOfCredit": {
     "auth_ref": [
      "r54",
      "r644"
     ],
     "calculation": {
      "http://www.conmed.com/role/ConsolidatedCondensedStatementsofCashFlowsUnaudited": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow for payment of an obligation from a lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.",
        "label": "Repayments of Lines of Credit",
        "negatedLabel": "Payments on revolving line of credit"
       }
      }
     },
     "localname": "RepaymentsOfLinesOfCredit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/ConsolidatedCondensedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfSeniorDebt": {
     "auth_ref": [
      "r54"
     ],
     "calculation": {
      "http://www.conmed.com/role/ConsolidatedCondensedStatementsofCashFlowsUnaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for a long-term debt where the holder has highest claim on the entity's asset in case of bankruptcy or liquidation during the period.",
        "label": "Repayments of Senior Debt",
        "negatedLabel": "Payments on term loan",
        "terseLabel": "Repayments of Senior Debt"
       }
      }
     },
     "localname": "RepaymentsOfSeniorDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/ConsolidatedCondensedStatementsofCashFlowsUnaudited",
      "http://www.conmed.com/role/LongTermDebtAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "auth_ref": [
      "r114",
      "r193",
      "r690"
     ],
     "calculation": {
      "http://www.conmed.com/role/ConsolidatedCondensedStatementsofComprehensiveIncomeUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.",
        "label": "Research and Development Expense",
        "terseLabel": "Research and development expense"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/ConsolidatedCondensedStatementsofComprehensiveIncomeUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r9",
      "r107",
      "r186",
      "r573",
      "r578",
      "r626"
     ],
     "calculation": {
      "http://www.conmed.com/role/ConsolidatedCondensedBalanceSheetsUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "terseLabel": "Retained earnings"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/ConsolidatedCondensedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r196",
      "r233",
      "r234",
      "r235",
      "r239",
      "r248",
      "r250",
      "r320",
      "r435",
      "r436",
      "r437",
      "r444",
      "r445",
      "r481",
      "r569",
      "r571"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Retained Earnings"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/ConsolidatedCondensedStatementsofShareholdersEquityUnaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue from Contract with Customer [Abstract]",
        "terseLabel": "Revenue from Contract with Customer [Abstract]"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "auth_ref": [
      "r287",
      "r288",
      "r293",
      "r297",
      "r298",
      "r304",
      "r305",
      "r308",
      "r392",
      "r393",
      "r546"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.",
        "label": "Revenue from Contract with Customer, Excluding Assessed Tax",
        "terseLabel": "Net Sales"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/RevenuesDisaggregatedRevenuesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerTextBlock": {
     "auth_ref": [
      "r384",
      "r385",
      "r386",
      "r387",
      "r388",
      "r389",
      "r390",
      "r391",
      "r396",
      "r397"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.",
        "label": "Revenue from Contract with Customer [Text Block]",
        "terseLabel": "Revenues"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/Revenues"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_Revenues": {
     "auth_ref": [
      "r225",
      "r230",
      "r287",
      "r288",
      "r293",
      "r297",
      "r298",
      "r304",
      "r305",
      "r308",
      "r316",
      "r350",
      "r351",
      "r352",
      "r353",
      "r354",
      "r355",
      "r356",
      "r357",
      "r358",
      "r496",
      "r559",
      "r668"
     ],
     "calculation": {
      "http://www.conmed.com/role/ConsolidatedCondensedStatementsofComprehensiveIncomeUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).",
        "label": "Revenues",
        "terseLabel": "Net sales"
       }
      }
     },
     "localname": "Revenues",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/BusinessCombinationsDetails",
      "http://www.conmed.com/role/BusinessSegmentDetails",
      "http://www.conmed.com/role/ConsolidatedCondensedStatementsofComprehensiveIncomeUnaudited",
      "http://www.conmed.com/role/FairValueofFinancialInstrumentsAmountsRecordedInandReclassifiedFromAOCIDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock": {
     "auth_ref": [
      "r39",
      "r680",
      "r681"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of accumulated other comprehensive income (loss).",
        "label": "Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]",
        "terseLabel": "Schedule of Accumulated Other Comprehensive Loss"
       }
      }
     },
     "localname": "ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/ComprehensiveIncomeTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable": {
     "auth_ref": [
      "r127"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of information about a contingent payment arrangement including the terms that will result in payment and the accounting treatment that will be followed if such contingency occurs, including the potential impact on earnings per share if the contingency is to be settled in shares of common stock of the entity. The description also may include the period over which amounts are expected to be paid, and changes in the amount since the previous reporting period. This also includes contingent options and commitments.",
        "label": "Schedule of Business Acquisitions by Acquisition, Contingent Consideration [Table]",
        "terseLabel": "Schedule of Business Acquisitions by Acquisition, Contingent Consideration [Table]"
       }
      }
     },
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/FairValueofFinancialInstrumentsContingentConsiderationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of contingent payment arrangements including the terms that will result in payment and the accounting treatment that will be followed if such contingencies occur, including the potential impact on earnings per share if contingencies are to be settled in common stock of the entity. The description also may include the period over which amounts are expected to be paid, and changes in the amount since the previous reporting period. This also includes contingent options and commitments.",
        "label": "Schedule of Business Acquisitions by Acquisition, Contingent Consideration [Table Text Block]",
        "terseLabel": "Schedule of Business Acquisitions by Acquisition, Contingent Consideration"
       }
      }
     },
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/FairValueofFinancialInstrumentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": {
     "auth_ref": [
      "r116",
      "r117",
      "r453"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities.",
        "label": "Schedule of Business Acquisitions, by Acquisition [Table]",
        "terseLabel": "Schedule of Business Acquisitions, by Acquisition [Table]"
       }
      }
     },
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/BusinessCombinationsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock": {
     "auth_ref": [
      "r147"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of gain (loss) on derivative and nonderivative instruments designated and qualifying as cash flow hedge recorded in accumulated other comprehensive income (AOCI) and reclassified into earnings.",
        "label": "Schedule of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (Loss) [Table Text Block]",
        "terseLabel": "Schedule of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (Loss)"
       }
      }
     },
     "localname": "ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/FairValueofFinancialInstrumentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock": {
     "auth_ref": [
      "r29"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of components of comprehensive income (loss). Includes, but is not limited to, foreign currency translation adjustments, foreign currency transactions designated as economic hedges of a net investment in foreign entity, gain (loss) and prior service cost (credit) for pension plans and other postretirement benefit plans.",
        "label": "Comprehensive Income (Loss) [Table Text Block]",
        "terseLabel": "Schedule of Comprehensive Income"
       }
      }
     },
     "localname": "ScheduleOfComprehensiveIncomeLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/ComprehensiveIncomeTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDebtInstrumentsTextBlock": {
     "auth_ref": [
      "r23",
      "r102",
      "r104",
      "r105",
      "r106",
      "r165",
      "r166",
      "r168",
      "r181",
      "r607",
      "r609",
      "r647"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.",
        "label": "Schedule of Long-Term Debt Instruments [Table Text Block]",
        "terseLabel": "Schedule of Long-Term Debt"
       }
      }
     },
     "localname": "ScheduleOfDebtInstrumentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/LongTermDebtTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "auth_ref": [
      "r652"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "terseLabel": "Schedule of Calculation of Basic and Diluted Earnings Per Share"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/EarningsPerShareTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock": {
     "auth_ref": [
      "r70"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of entity-wide revenues from external customers for each product or service or each group of similar products or services if the information is not provided as part of the reportable operating segment information.",
        "label": "Revenue from External Customers by Products and Services [Table Text Block]",
        "terseLabel": "Schedule of Net Sales Information by Product Line"
       }
      }
     },
     "localname": "ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/BusinessSegmentTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock": {
     "auth_ref": [
      "r76",
      "r79"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.",
        "label": "Schedule of Finite-Lived Intangible Assets [Table Text Block]",
        "terseLabel": "Schedule of Finite-Lived Intangible Assets"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/GoodwillandOtherIntangibleAssetsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfForeignExchangeContractsStatementOfFinancialPositionTableTextBlock": {
     "auth_ref": [
      "r144"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the presentation of foreign exchange contracts on the statement of financial position, including the fair value amounts and location of such amounts.",
        "label": "Schedule of Foreign Exchange Contracts, Statement of Financial Position [Table Text Block]",
        "terseLabel": "Schedule of Fair Value for Forward Foreign Exchange Contracts"
       }
      }
     },
     "localname": "ScheduleOfForeignExchangeContractsStatementOfFinancialPositionTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/FairValueofFinancialInstrumentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfGoodwillTable": {
     "auth_ref": [
      "r327",
      "r328",
      "r329",
      "r330",
      "r331",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336",
      "r337",
      "r605"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of goodwill and the changes during the year due to acquisition, sale, impairment or for other reasons.",
        "label": "Schedule of Goodwill [Table]",
        "terseLabel": "Schedule of Goodwill [Table]"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/GoodwillandOtherIntangibleAssetsGoodwillDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfGoodwillTextBlock": {
     "auth_ref": [
      "r605",
      "r654",
      "r655",
      "r656",
      "r657",
      "r658",
      "r659",
      "r660",
      "r661",
      "r662",
      "r663",
      "r664"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.",
        "label": "Schedule of Goodwill [Table Text Block]",
        "terseLabel": "Schedule of Goodwill"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/GoodwillandOtherIntangibleAssetsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock": {
     "auth_ref": [
      "r83",
      "r84"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance and exist in perpetuity, by either major class or business segment.",
        "label": "Schedule of Indefinite-Lived Intangible Assets [Table Text Block]",
        "terseLabel": "Schedule of Indefinite-Lived Intangible Assets"
       }
      }
     },
     "localname": "ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/GoodwillandOtherIntangibleAssetsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": {
     "auth_ref": [
      "r1",
      "r13",
      "r14",
      "r15"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.",
        "label": "Schedule of Inventory, Current [Table Text Block]",
        "terseLabel": "Schedule of Inventory"
       }
      }
     },
     "localname": "ScheduleOfInventoryCurrentTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/InventoriesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock": {
     "auth_ref": [
      "r95"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of maturity and sinking fund requirement for long-term debt.",
        "label": "Schedule of Maturities of Long-Term Debt [Table Text Block]",
        "terseLabel": "Schedule of Maturities of Long-Term Debt"
       }
      }
     },
     "localname": "ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/LongTermDebtTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfNetBenefitCostsTableTextBlock": {
     "auth_ref": [
      "r110"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of net benefit costs for pension plans and/or other employee benefit plans including service cost, interest cost, expected return on plan assets, gain (loss), prior service cost or credit, transition asset or obligation, and gain (loss) recognized due to settlements or curtailments.",
        "label": "Schedule of Net Benefit Costs [Table Text Block]",
        "terseLabel": "Schedule of Net Benefit Cost"
       }
      }
     },
     "localname": "ScheduleOfNetBenefitCostsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/PensionPlanTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock": {
     "auth_ref": [
      "r135"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the notional amounts of outstanding derivative positions.",
        "label": "Schedule of Notional Amounts of Outstanding Derivative Positions [Table Text Block]",
        "terseLabel": "Schedule of Notional Amounts of Outstanding Derivative Positions"
       }
      }
     },
     "localname": "ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/FairValueofFinancialInstrumentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock": {
     "auth_ref": [
      "r148",
      "r675"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of derivative instrument not designated or qualifying as hedging instrument.",
        "label": "Derivatives Not Designated as Hedging Instruments [Table Text Block]",
        "terseLabel": "Derivatives Not Designated as Hedging Instruments"
       }
      }
     },
     "localname": "ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/FairValueofFinancialInstrumentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock": {
     "auth_ref": [
      "r93"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the changes in the guarantor's aggregate product warranty liability, including the beginning balance of the aggregate product warranty liability, the aggregate reductions in that liability for payments made (in cash or in kind) under the warranty, the aggregate changes in the liability for accruals related to product warranties issued during the reporting period, the aggregate changes in the liability for accruals related to preexisting warranties (including adjustments related to changes in estimates), and the ending balance of the aggregate product warranty liability.",
        "label": "Schedule of Product Warranty Liability [Table Text Block]",
        "terseLabel": "Changes in the Carrying Amount of Service and Product Warranties"
       }
      }
     },
     "localname": "ScheduleOfProductWarrantyLiabilityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/GuaranteesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": {
     "auth_ref": [
      "r67",
      "r68",
      "r69",
      "r73"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table]",
        "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/BusinessSegmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock": {
     "auth_ref": [
      "r79"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.",
        "label": "Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]",
        "terseLabel": "Schedule of Estimated Amortization Expense"
       }
      }
     },
     "localname": "ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/GoodwillandOtherIntangibleAssetsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentReportingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting [Abstract]",
        "terseLabel": "Segment Reporting [Abstract]"
       }
      }
     },
     "localname": "SegmentReportingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "auth_ref": [
      "r284",
      "r285",
      "r286",
      "r291",
      "r292",
      "r296",
      "r300",
      "r301",
      "r302",
      "r303",
      "r304",
      "r307",
      "r308",
      "r309"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.",
        "label": "Segment Reporting Disclosure [Text Block]",
        "terseLabel": "Business Segment"
       }
      }
     },
     "localname": "SegmentReportingDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/BusinessSegment"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentReportingInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Segment Reporting Information [Line Items]",
        "terseLabel": "Segment Reporting Information [Line Items]"
       }
      }
     },
     "localname": "SegmentReportingInformationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/BusinessSegmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r47"
     ],
     "calculation": {
      "http://www.conmed.com/role/ConsolidatedCondensedStatementsofComprehensiveIncomeUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.",
        "label": "Selling, General and Administrative Expense",
        "terseLabel": "Selling and administrative expense"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/ConsolidatedCondensedStatementsofComprehensiveIncomeUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r57"
     ],
     "calculation": {
      "http://www.conmed.com/role/ConsolidatedCondensedStatementsofCashFlowsUnaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement, Noncash Expense",
        "terseLabel": "Stock-based compensation"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/ConsolidatedCondensedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StandardProductWarrantyAccrual": {
     "auth_ref": [
      "r92"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount as of the balance sheet date of the aggregate standard product warranty liability. Does not include the balance for the extended product warranty liability.",
        "label": "Standard Product Warranty Accrual",
        "periodEndLabel": "Balance as of March 31,",
        "periodStartLabel": "Balance as of January 1,"
       }
      }
     },
     "localname": "StandardProductWarrantyAccrual",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/GuaranteesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StandardProductWarrantyAccrualPayments": {
     "auth_ref": [
      "r89"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in the standard product warranty accrual from payments made in cash or in kind to satisfy claims under the terms of the standard product warranty. Excludes extended product warranties.",
        "label": "Standard Product Warranty Accrual, Decrease for Payments",
        "negatedTerseLabel": "Claims made"
       }
      }
     },
     "localname": "StandardProductWarrantyAccrualPayments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/GuaranteesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StandardProductWarrantyAccrualWarrantiesIssued": {
     "auth_ref": [
      "r90"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in the standard product warranty accrual from warranties issued. Excludes extended product warranties.",
        "label": "Standard Product Warranty Accrual, Increase for Warranties Issued",
        "terseLabel": "Provision for warranties"
       }
      }
     },
     "localname": "StandardProductWarrantyAccrualWarrantiesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/GuaranteesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r26",
      "r101",
      "r196",
      "r221",
      "r222",
      "r223",
      "r233",
      "r234",
      "r235",
      "r239",
      "r248",
      "r250",
      "r277",
      "r320",
      "r381",
      "r435",
      "r436",
      "r437",
      "r444",
      "r445",
      "r481",
      "r513",
      "r514",
      "r515",
      "r516",
      "r517",
      "r519",
      "r539",
      "r569",
      "r570",
      "r571"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Statement, Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/ComprehensiveIncomeAccumulatedOtherComprehensiveIncomeLossDetails",
      "http://www.conmed.com/role/ConsolidatedCondensedStatementsofShareholdersEquityUnaudited",
      "http://www.conmed.com/role/FairValueofFinancialInstrumentsForeignCurrencyForwardContractsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/ConsolidatedCondensedStatementsofShareholdersEquityUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]",
        "terseLabel": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]",
        "terseLabel": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Comprehensive Income [Abstract]",
        "terseLabel": "Statement of Comprehensive Income [Abstract]"
       }
      }
     },
     "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]",
        "terseLabel": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r233",
      "r234",
      "r235",
      "r277",
      "r546"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/ConsolidatedCondensedStatementsofShareholdersEquityUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation": {
     "auth_ref": [
      "r6",
      "r7",
      "r107",
      "r111"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).",
        "label": "Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture",
        "terseLabel": "Common stock issued under employee plans"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/ConsolidatedCondensedStatementsofShareholdersEquityUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r7",
      "r10",
      "r11",
      "r71",
      "r626",
      "r645",
      "r653",
      "r679"
     ],
     "calculation": {
      "http://www.conmed.com/role/ConsolidatedCondensedBalanceSheetsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "periodEndLabel": "Balance at period end",
        "periodStartLabel": "Balance at period start",
        "totalLabel": "Total shareholders\u2019 equity"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/ConsolidatedCondensedBalanceSheetsUnaudited",
      "http://www.conmed.com/role/ConsolidatedCondensedStatementsofShareholdersEquityUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Attributable to Parent [Abstract]",
        "terseLabel": "Shareholders' equity:"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/ConsolidatedCondensedBalanceSheetsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TechnologyBasedIntangibleAssetsMember": {
     "auth_ref": [
      "r118"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Technology-based intangible assets, including, but not limited to, patented technology, unpatented technology, and developed technology rights.",
        "label": "Technology-Based Intangible Assets [Member]",
        "terseLabel": "Developed technology"
       }
      }
     },
     "localname": "TechnologyBasedIntangibleAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/GoodwillandOtherIntangibleAssetsIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TimingOfTransferOfGoodOrServiceAxis": {
     "auth_ref": [
      "r617",
      "r672"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by timing of transfer of good or service to customer.",
        "label": "Timing of Transfer of Good or Service [Axis]",
        "terseLabel": "Timing of Transfer of Good or Service [Axis]"
       }
      }
     },
     "localname": "TimingOfTransferOfGoodOrServiceAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/RevenuesDisaggregatedRevenuesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TimingOfTransferOfGoodOrServiceDomain": {
     "auth_ref": [
      "r617",
      "r672"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Timing of transfer of good or service to customer. Includes, but is not limited to, at point in time or over time.",
        "label": "Timing of Transfer of Good or Service [Domain]",
        "terseLabel": "Timing of Transfer of Good or Service [Domain]"
       }
      }
     },
     "localname": "TimingOfTransferOfGoodOrServiceDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/RevenuesDisaggregatedRevenuesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TrademarksAndTradeNamesMember": {
     "auth_ref": [
      "r119"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights acquired through registration of a trademark to gain or protect exclusive use of a business name, symbol or other device or style, or rights either acquired through registration of a business name to gain or protect exclusive use thereof.",
        "label": "Trademarks and Trade Names [Member]",
        "terseLabel": "Trademarks &amp; tradenames"
       }
      }
     },
     "localname": "TrademarksAndTradeNamesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/GoodwillandOtherIntangibleAssetsIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TransferredAtPointInTimeMember": {
     "auth_ref": [
      "r617"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract with customer in which good or service is transferred at point in time.",
        "label": "Transferred at Point in Time [Member]",
        "terseLabel": "Goods transferred at a point in time"
       }
      }
     },
     "localname": "TransferredAtPointInTimeMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/RevenuesDisaggregatedRevenuesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TransferredOverTimeMember": {
     "auth_ref": [
      "r617"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract with customer in which good or service is transferred over time.",
        "label": "Transferred over Time [Member]",
        "terseLabel": "Services transferred over time"
       }
      }
     },
     "localname": "TransferredOverTimeMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/RevenuesDisaggregatedRevenuesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockCommonMember": {
     "auth_ref": [
      "r108"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Previously issued common shares repurchased by the issuing entity and held in treasury.",
        "label": "Treasury Stock, Common [Member]",
        "terseLabel": "Treasury Stock"
       }
      }
     },
     "localname": "TreasuryStockCommonMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/ConsolidatedCondensedStatementsofShareholdersEquityUnaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockCommonShares": {
     "auth_ref": [
      "r108"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of previously issued common shares repurchased by the issuing entity and held in treasury.",
        "label": "Treasury Stock, Common, Shares",
        "terseLabel": "Treasury stock, shares (in shares)"
       }
      }
     },
     "localname": "TreasuryStockCommonShares",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/ConsolidatedCondensedBalanceSheetsUnauditedParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TreasuryStockCommonValue": {
     "auth_ref": [
      "r27",
      "r108",
      "r109"
     ],
     "calculation": {
      "http://www.conmed.com/role/ConsolidatedCondensedBalanceSheetsUnaudited": {
       "order": 6.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount allocated to previously issued common shares repurchased by the issuing entity and held in treasury.",
        "label": "Treasury Stock, Common, Value",
        "negatedTerseLabel": "Less: 738,718 and 811,532 shares of common stock in treasury, at cost, in 2023 and 2022, respectively"
       }
      }
     },
     "localname": "TreasuryStockCommonValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/ConsolidatedCondensedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TypeOfAdoptionMember": {
     "auth_ref": [
      "r194",
      "r195",
      "r196",
      "r197",
      "r198",
      "r238",
      "r239",
      "r240",
      "r242",
      "r251",
      "r312",
      "r313",
      "r317",
      "r318",
      "r319",
      "r320",
      "r323",
      "r324",
      "r435",
      "r436",
      "r437",
      "r442",
      "r443",
      "r444",
      "r445",
      "r455",
      "r456",
      "r457",
      "r472",
      "r473",
      "r474",
      "r475",
      "r476",
      "r477",
      "r478",
      "r480",
      "r481",
      "r482",
      "r483",
      "r484",
      "r497",
      "r498",
      "r499",
      "r500",
      "r501",
      "r502",
      "r506",
      "r507",
      "r520",
      "r521",
      "r525",
      "r526",
      "r527",
      "r528",
      "r533",
      "r535",
      "r536",
      "r537",
      "r538",
      "r539",
      "r548",
      "r549",
      "r550",
      "r567",
      "r568",
      "r569",
      "r570",
      "r571",
      "r572",
      "r573",
      "r574",
      "r575",
      "r576",
      "r577",
      "r578"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amendment to accounting standards.",
        "label": "Accounting Standards Update [Domain]",
        "terseLabel": "Type of Adoption [Domain]"
       }
      }
     },
     "localname": "TypeOfAdoptionMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/ConsolidatedCondensedStatementsofShareholdersEquityUnaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UnamortizedDebtIssuanceExpense": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The remaining balance of debt issuance expenses that were capitalized and are being amortized against income over the lives of the respective bond issues. This does not include the amounts capitalized as part of the cost of the utility plant or asset.",
        "label": "Unamortized Debt Issuance Expense",
        "terseLabel": "Unamortized Debt Issuance Expense"
       }
      }
     },
     "localname": "UnamortizedDebtIssuanceExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/LongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UseOfEstimates": {
     "auth_ref": [
      "r64",
      "r65",
      "r66",
      "r279",
      "r280",
      "r281",
      "r282"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "terseLabel": "Use of Estimates"
       }
      }
     },
     "localname": "UseOfEstimates",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/InterimReportingPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_VariableRateAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of variable rate.",
        "label": "Variable Rate [Axis]",
        "terseLabel": "Variable Rate [Axis]"
       }
      }
     },
     "localname": "VariableRateAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/LongTermDebtAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VariableRateDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index.",
        "label": "Variable Rate [Domain]",
        "terseLabel": "Variable Rate [Domain]"
       }
      }
     },
     "localname": "VariableRateDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/LongTermDebtAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WarrantMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount.",
        "label": "Warrant [Member]",
        "terseLabel": "Warrant"
       }
      }
     },
     "localname": "WarrantMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/LongTermDebtAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment": {
     "auth_ref": [
      "r652"
     ],
     "calculation": {
      "http://www.conmed.com/role/EarningsPerShareDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted, Adjustment",
        "terseLabel": "Effect of dilutive potential securities (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberDilutedSharesOutstandingAdjustment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/EarningsPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r255",
      "r271"
     ],
     "calculation": {
      "http://www.conmed.com/role/EarningsPerShareDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "terseLabel": "Diluted (shares)",
        "totalLabel": "Diluted- weighted average shares outstanding (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/ConsolidatedCondensedStatementsofComprehensiveIncomeUnaudited",
      "http://www.conmed.com/role/EarningsPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Number of Shares Outstanding, Diluted [Abstract]",
        "terseLabel": "Weighted average common shares:"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/ConsolidatedCondensedStatementsofComprehensiveIncomeUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r254",
      "r271"
     ],
     "calculation": {
      "http://www.conmed.com/role/EarningsPerShareDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "terseLabel": "Basic (shares)",
        "verboseLabel": "Basic-weighted average shares outstanding (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.conmed.com/role/ConsolidatedCondensedStatementsofComprehensiveIncomeUnaudited",
      "http://www.conmed.com/role/EarningsPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    }
   },
   "unitCount": 4
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "205",
   "URI": "https://asc.fasb.org/topic&trid=2122149",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "63",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "480",
   "URI": "https://asc.fasb.org/extlink&oid=126970277&loc=d3e23176-110880",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21506-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21506-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21521-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21538-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=6405834&loc=d3e23315-112656",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126964447&loc=d3e11149-113907",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126964447&loc=d3e11178-113907",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "730",
   "URI": "https://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5227-128473",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5263-128473",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=6911189&loc=d3e6408-128476",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126966197&loc=d3e6578-128477",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126966197&loc=d3e6613-128477",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126966325&loc=d3e6819-128478",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "30",
   "Subparagraph": "b",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126966325&loc=d3e6819-128478",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)(3)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "c",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "805",
   "URI": "https://asc.fasb.org/topic&trid=2303972",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569616-111683",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "810",
   "URI": "https://asc.fasb.org/topic&trid=2197479",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126966630&loc=d3e41228-113958",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579240-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5580258-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)(ii)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41638-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a),(c)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(c))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41641-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41678-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "182",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=127000641&loc=SL5629052-113961",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "25",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=121577467&loc=d3e76258-113986",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=121549185&loc=d3e80748-113994",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=121549185&loc=d3e80748-113994",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=d3e90193-114008",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=d3e90198-114008",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(a)(2)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=d3e90205-114008",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=d3e90205-114008",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "815",
   "URI": "https://asc.fasb.org/topic&trid=2229140",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "820",
   "URI": "https://asc.fasb.org/topic&trid=2155941",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=SL51823488-111719",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(b),22(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "940",
   "URI": "https://asc.fasb.org/extlink&oid=126941158&loc=d3e41242-110953",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(15)(5))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.17)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(15))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.9)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Subparagraph": "e",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(15)(5))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.(a),19)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(8))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(13))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=120401414&loc=d3e603758-122996",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "985",
   "URI": "https://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(15))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(16))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(17))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(18))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(9))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e637-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e640-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e689-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL34724391-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(5))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(210.5-03(11))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(1))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(21))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(22))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.24)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(4)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.25)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.M.Q2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=122038215&loc=d3e31137-122693",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=122038215&loc=SL108384541-122693",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "250",
   "URI": "https://asc.fasb.org/topic&trid=2122394",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1448-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1505-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1252-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1707-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1757-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "26",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1828-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1500-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1930-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1930-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1930-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1930-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1930-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e2029-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.30)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1337-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e3842-109258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "260",
   "URI": "https://asc.fasb.org/topic&trid=2144383",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226000-175313",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "275",
   "URI": "https://asc.fasb.org/topic&trid=2134479",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8657-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e526-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "26",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8844-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "34",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8981-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "280",
   "URI": "https://asc.fasb.org/topic&trid=2134510",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a),(b),(c)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=126986314&loc=SL124402458-218513",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=126986314&loc=SL124402458-218513",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(d)(1)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=126986314&loc=SL124402458-218513",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(d)(2)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=126986314&loc=SL124402458-218513",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(3)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(4)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "330",
   "URI": "https://asc.fasb.org/topic&trid=2126998",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(i),(j),(k)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=SL108378252-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(i-k)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q4)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e637-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e640-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6036836-161870",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6036836-161870",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e681-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126919976&loc=SL49130531-203044",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126919976&loc=SL49130532-203044",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130551-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669686-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130556-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130558-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130543-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130549-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130549-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130550-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "606",
   "URI": "https://asc.fasb.org/topic&trid=49130388",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123453770&loc=SL108413299-114919",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(1)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124507222&loc=d3e1436-108581",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iii)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(10))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(1)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(2)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(3)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(4)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(l)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(o)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(p)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(q)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(r)(1)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(r)(2)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(1)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(4)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=21916913&loc=d3e273930-122802",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "60",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=6414203&loc=d3e39689-114964",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "70",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=49170846&loc=d3e28014-114942",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "715",
   "URI": "https://asc.fasb.org/topic&trid=2235017",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(8))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=d3e4534-113899",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126962052&loc=d3e4991-113900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e31917-109318",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e31931-109318",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.1,2)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(3)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2(a),(d))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.1)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4946-128472",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4946-128472",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092918&loc=SL128093175-196984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092918&loc=SL128093175-196984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092918&loc=SL128093175-196984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(1)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)(1)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.3)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e7008-128479",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(3)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624181-113959",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=121577181&loc=SL110061190-113977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=d3e90205-114008",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(2)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)(2)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.8)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(2)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(4)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL126732908-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(c)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL126732908-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(c)(2)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL126732908-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(c)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL126732908-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "220",
   "URI": "https://asc.fasb.org/topic&trid=2134417",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(1)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(2)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=SL6742756-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r495": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13433-108611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r497": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL120254526-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r498": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL120254526-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r499": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(24))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r500": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r501": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r502": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r503": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r504": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r505": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(3)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r506": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL122642865-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r507": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL122642865-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r508": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=126980362&loc=d3e28228-110885",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r509": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=123602790&loc=d3e30226-110892",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r510": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=125521441&loc=d3e30690-110894",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r511": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=124440516&loc=d3e30840-110895",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r512": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r513": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r514": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r515": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r516": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r517": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r518": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r519": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r520": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "832",
   "URI": "https://asc.fasb.org/extlink&oid=128342835&loc=SL128342857-244232",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r521": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "832",
   "URI": "https://asc.fasb.org/extlink&oid=128342835&loc=SL128342857-244232",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r522": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r523": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r524": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r525": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r526": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r527": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r528": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r529": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r530": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(3)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r531": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r532": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918701-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r533": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL122150809-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r534": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL122150809-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r535": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r536": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r537": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r538": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(01)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r539": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r540": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r541": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r542": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r543": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r544": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r545": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "https://asc.fasb.org/extlink&oid=126937589&loc=SL119991595-234733",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r546": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r547": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r548": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r549": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r550": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r551": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(f)(1)",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r552": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(f)(2)",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r553": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(f)(3)",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r554": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "340",
   "Topic": "928",
   "URI": "https://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r555": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r556": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(23))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r557": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(24))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r558": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r559": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r560": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r561": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r562": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(19))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r563": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(20))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r564": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r565": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r566": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r567": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r568": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r569": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r570": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r571": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r572": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r573": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r574": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r575": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iii)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r576": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iv)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r577": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r578": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r579": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13(Column B)(Footnote 1))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611282-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r580": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13(Column C)(Footnote 1))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611282-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r581": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13(Column D)(Footnote 1))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611282-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r582": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13(Column E)(Footnote 1))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611282-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r583": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13(Column F)(Footnote 1))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611282-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r584": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13(Column G)(Footnote 1))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611282-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r585": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "310",
   "Subparagraph": "(SX 210.12-29(Footnote 4))",
   "Topic": "948",
   "URI": "https://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r586": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r587": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r588": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r589": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r590": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r591": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r592": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r593": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r594": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 2))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r595": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(c)",
   "Topic": "976",
   "URI": "https://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r596": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "978",
   "URI": "https://asc.fasb.org/extlink&oid=126945304&loc=d3e27327-108691",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r597": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r598": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r599": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(3))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3044-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r600": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r601": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226052-175313",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r602": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e4984-109258",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r603": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r604": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r605": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=122137925&loc=d3e14258-109268",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r606": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r607": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r608": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r609": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4304-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r610": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r611": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r612": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r613": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r614": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r615": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r616": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r617": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r618": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r619": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4332-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r620": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r621": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r622": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123450688&loc=d3e4587-114921",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r623": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r624": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r625": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r626": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r627": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r628": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r629": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117819544-158441",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r630": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r631": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r632": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r633": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r634": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r635": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r636": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(9))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r637": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r638": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r639": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r640": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r641": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r642": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r643": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r644": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(f))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r645": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r646": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r647": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r648": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r649": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r650": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r651": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r652": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r653": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r654": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r655": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r656": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r657": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r658": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r659": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r660": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r661": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r662": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r663": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=SL108378252-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r664": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r665": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "410",
   "URI": "https://asc.fasb.org/extlink&oid=6393242&loc=d3e13237-110859",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r666": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r667": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r668": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r669": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r670": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r671": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130551-203045",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r672": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r673": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r674": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5580258-113959",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r675": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4CC",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL109998890-113959",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r676": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=124256753&loc=SL5864739-113975",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r677": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r678": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r679": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r680": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r681": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r682": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r683": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r684": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r685": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r686": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r687": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r688": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r689": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r690": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "730",
   "Topic": "912",
   "URI": "https://asc.fasb.org/extlink&oid=6472174&loc=d3e58812-109433",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r691": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.BB)",
   "Topic": "330",
   "URI": "https://asc.fasb.org/extlink&oid=27011343&loc=d3e100047-122729",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "((a)(1),(b))",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(2)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(3)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b),(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16373-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "350",
   "URI": "https://asc.fasb.org/topic&trid=2144416",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "https://asc.fasb.org/topic&trid=2127136",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "((c)(2))",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=126907703&loc=d3e12565-110249",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "((c)(3))",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=126907703&loc=d3e12565-110249",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "((c)(3,4))",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=126907703&loc=d3e12565-110249",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1),(c)(5)",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=126907703&loc=d3e12565-110249",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=126907703&loc=d3e12565-110249",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "460",
   "URI": "https://asc.fasb.org/topic&trid=2155896",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123465755&loc=d3e1835-112601",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123465755&loc=SL6230698-112601",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6031898-161870",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "470",
   "URI": "https://asc.fasb.org/topic&trid=2208564",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "480",
   "URI": "https://asc.fasb.org/extlink&oid=109262807&loc=d3e22047-110879",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  }
 },
 "version": "2.2"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>70
<FILENAME>0000816956-23-000007-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000816956-23-000007-xbrl.zip
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M&"\DI_.O*=NA%PK3J=3D5]0$$R:9+B<8/&.N+#!O'..@#XP0,@]D[X5*SD+
M&YE(A?\@Q@K<1B4U@C!8,QVD)'.P?N3EN8*I+$!1W!JA(!+'1C+K@@F!<2-#
MM, <B)+SKRF+Y@JFHB8:V$'0@/LLI$WWQ-(H%$+42V,BC?.P./B%2HYJ0[BT
M0/E<9%PSI0P"O^"-MS@ZIN;$B<^0*[B*'C?KF^N+F)T1(AK.5:J&@R&:U$IR
M1BC&*&A'N5B ./)97<*BJXL-%B-N W*>,*-354VC.:-*:._2*I?Y4)<7+$'-
M8TC$3Z8**Q09R\%A>!$],DIC@N?$N;],%S$54H$(-SZ":Z"*,JRC(<+RM(_(
M&(:N2LK/M<8LJHN8CKH8Y;%0CN)@F";**H,-HP8)([1B9D[4Y05+D$MA*!/,
M(6T8<$.#)='.*^8<PX+-2RIPAEQ$^GI]D)MWQD&'%G*Q .)224,YBD(R2JEQ
MQ K"J%/"8:+,_"O-LWJ)%Z Q A$-<2=%Q%N(.:FE 6L2B%;(4\JG<53-A!W%
M"Q B^':EE*9IRH$)ZR$BQ!&#S1OP%3BX.?'V+]973*= 0?!$$R%YM)@18T%G
M& F8!&&P-EK/O](LL*^8BL80811)I]@8A5BD46/@IL@AB$U1<'@!IB1>@A"Y
M4]@"0S02,0.N0@?.3!#@]^$Y:@%RS<\^49T>NEZ>56@&X<QU1C[O'0P/PX=>
M/@R^_.5"+BIEC)# A/1:8N:H5VD)!*,*8$$*;A8@1'W>F>R7JD=2*% A;@06
MF$GCM2>>$*4,4Q;HZSR<"%&)]BL0$8%F:B[!S1#F+%?2!<<90XXB%/&\Y"$K
M;S-]XH*5)$99C8"G,$P\N)F C!+&*NXPFX>":I6WF0$]L@Q3\"R 2Q#%2,.T
MMYXCZB(S!$<^+W%O)=K[HA4&12JM# IXJ43!1H$MC4@X0HQQ+S"VF4O2$)F*
M4F,6(*9@W 83!9. \@)1R=/9I',OQA]"^KF4(9!YCVD@,F+"=#KVWBAFG6'2
M1Q[< JQR?FY3G ZB(LIP")91^!_23K/$Y#DV6%KOPP(L5'I64YQ2QD\ F$8E
M.$?I !4E4CT *8!#,ZJ,FW\XG7@,=EUL)N\"<VK&5F%Z@QB*9MSN]_V=)GRI
M3#.^J A^??BNG_>&.SVXP4(>%F<$X\IZS)E,.Q2BH<@%21T!K>)4SX-./:>,
MYPJDIK,.P6OMO=/.<<N", 9XN\28NP@0)?$\%2VI0.-K=4\]E<)HAI"0P"J$
M1>"4J+%>,J#[9@'(Q(MV1-/)YJ252II1+Z-GFBK+=2K +!Q'$$8:,0<Z53FB
M65*HJ --E96T$8%);"R2Q-FT30.B68OF :0JT/B.C+&.,-XL4 Z!$=?:I&W[
MT4@!U)4C-2\3CO/DB)J?0[&HO"920DPJ]& )92I8$XE56EBO0R!!X/E7I\G.
M3%6Z](VU$-QI;H(3E J&O;3*2H>D WH3(W+S4"BH$N\W:J9:*AUE$D7LTMY/
M0QT$1%@XJ;1'<EXF'RO/,QM$1A+CN3.*J^#2LEQ+2*HP$9U5AEBQ +,L+]+S
M3(<4,^F"(E)QC9CD7G.@,0BE#X'-8#0'NE2)]ULK\2"(#3Y0RQ40BV@5\(GH
M5+2:1.KIN';H IR(>^-,AT88;IN\][8_&&P5_>Y&&.0'O?1%LW@_,IT\GH.:
MO#&#PZU.__3?P1\\Q;*86Y5')W5TK"KKA5D>I(0(-ABC.0W>NG0\!S62+:(T
M-T),9ZF\!H\0\^&[#ICMEW.HYD1NW(-KYMX[8'XL.&DHED)P[%$PSMFPB'(K
M ;8SKKD];_)R#HQ,(*48V%D@3!L3P#4J21PE(LS#4J0YA\_IQVR::4:I\T%Y
M#IX368HXYAAYQ[&BE"VT#CPSZ$Y?VM@3HJV-*"#)%+9*6&T F<&U1@E>=Z&E
M_4Q0/7TI>X^#00@S)1GST2L.\B[#&I \C;STPPLFW)F \QM>^HXT?^4X7H%$
MC."G.38L( !J9*AQ,6J4[#<LHC2GQX8G)S<B'1 JA95@P(:YUN!E@6!YA4A
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MU?N1*:"'G?/=<-(OADNUV"^Z9@@/@#$8!+=J^_V.-9U.?VC[9R]/_2X^V:"
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M6L=GS?>?N%581B0R[8G,6& ZL\ZPS!OX1E-)%8T TIHO,Z'NG7W^L*N?F'$
M+-1^T$B^Y32_A\AW'6\%<A7(W0$YS1$R/ 3E;0"0H\9HQT2PWA-ND%,ER)$K
MD",5R$T%Y"[N@)R*,6(I2<88]QD3SF4F8)0I^!MKX[2(!D".D66:9@WG&>1F
MEB??71#,OK$@^/Z@QO*_'PJ1%N@>,RO4A0Y^WO0'PS05^V  =-UI\F.=?I *
MS+5+G#CO3^/>C-O]OA^L]_Q>*#[G+@SV^AU?.<E).<G&WKU( "2&@M$^$\:F
M2 #1S&@6,LR5M$!X6 AX:0TSM(S9I)SD#)']RJ"?C.-6!OTL!GV7]1+A&<$4
M GHK!1BTLIF-EF=12D1LB($Z#@:-Q#*E8N8->F8YT,P0VXE-+LQ#(V=6'1::
M$F\7_<&@=E+T8SZL&/&S,>)RV-^5HUYYS(EYS/O)\.@P%I&1S.KH4C(<9YI9
MD@5+&<<".\<I>$S.ERG!,^\Q*PH\.Q2XLN"GL>"[G-<Z$W"T/M-:JHQA(3/C
MC05;IIQK&51$X+ QY<M:S[X%SRS)F1G..X?WF%FA+C1SW0L=^/"@+.]H?#?O
MY8-A,2Y<'<Y.TE%K%9]]-CY[*8SMT N%Z:SW_/HMB6R.!5(YRDDYRN;];"\F
MFJA(?"9B\!ECCF1&\I@YZJGR7##O97*4:!DI.O..LJ*ZLT-U*^-^=N.^RX(%
M1<I2S#/!!<V8CC%3VHN,*8ZPEIP['E/FERPKR6?>N&>6,%4LN&+!\\6"=\,@
ME%M:$@WVX7/H]$_2N6\5!Y["ZN:Q*,!!;GP11.4=)[T:<.P92_K;V/C H3V?
M-%<"&(W)G#0L8Y283',ILZ@$,LAHH,8"W"-9YE3/O'>LJ._L4-_*II_/IL]O
MVS3CT4;$?1:Y-1D3&F?&49Y) =%L4,I(RA+E71:2S+Q-SRPYFAG&6ZUUF 5U
M6&BN/ :%6NWJ3./>P15+KA8#/Q]-OA[\2R]:;929H!NMWZ/&09?4&&5,2@M_
M19\IYD)&L*72$4>=+A<!DV5!9M^/5MQX=KAQ9<A/:\AW^#!8KE7:B<P!"&>,
M,9TI3D4F0W3281P-3XM_,5WF<[":?V894$6(*T+\4@CQ3L_UNZ$6BWZWUA^C
M>;]7<>$I<.&Q)-[V!Y43G: 3_7"/#3,=>2"4@.L,,6-*QDP3!D[41HT=]D)K
M5B:*X<7,^]"*#,\@&:XL^8DL^0X=UIY9)JG.B&8X8TZPS%)ALNALE)P+J]**
M"$*6@2G/O"7/+/V9&38\A_>86:$N.*<=AB(,J@40S\]FKX:^FAZ=N/]S]YBL
M4CXR;4.&%7$9P\%EBBF38<NQC4X"P?7E]"CAL[\@L&*RL\-D*RM^2BN^PV*Y
MHH1:S,9;4YDQ.+/"ZLRG$F;44&JB6EICRUI/JE1C16*KE&Z5TIV/!L_+E=7
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MT/O^R';"+,<DO];*F56(A0Y*WO2[)T4X#+U!JE=>A2<OB@P\P?F:-[1I3 N
M'S1CRYS!N\XHC>&[?I':M3X<%KD=#0W 1:M?3= _-9UX8..&B\9!C),1XH%.
M:.DS0VS($./&!A^T4B@M^19Z]ME$%>!4F/9D1XQ6F#:[F'8W1%)>6Q54!@X-
M9RQXGAG!4"8=9@X'*B)*M8G$,L.S#VHSRXBK$*D*D2:H$(]=6+"8]YA9H?ZT
MK<P(6RKON)H/X6GN,>O2 JCQH2E"S9NA6?WJ8K396\?X,P*9/8[WL/>=)X.I
M4+!"P9E#P9]<DE#!705W3YP7'V=5R KA,VXEK\T@=U52?%$32$#\]A+OFVQR
MG-S-(VV:H@>C-;AZ7*E5UPD?5"5\OI_PN;B_X#X&;WVP+F/<I3J:2F2&(IDY
M%2E6UA)FV=(:6D&SO\>LRF%7$#317'8%04\#07=+)QGF%4M''1N-,T8ESFPT
M. O:"ZY9!!_"$P3Q:I_ U**PN>&:&WEG- S^I[9"/M#U!=A<-25Z=BF("AU_
M"!W?WU]E$#$*V/&T(Y)GC#B;&>E\ICUF7'&ON563(6C?L/RG(FB/35Y45OM,
MC*:RVI^TVKMG7EKN.,4Q"S2 U1JO,J.ESE2,FD>OA: V6>VO'_#SY%8[LYRF
MFBZHI@OF:[K@8_DF^)J!5IF# !WM=@'XRVG3KY?OF,,IA)>A@HN8EW\4YUK
M,A1C&WSJ!=Y7"+ ^!H#&J&M#T8PE]QHT1\/!T/32D%YFEJJECI.B:/>7;Z=R
MBT)PG"&D2,90JJ\6@;%)HBG7#!,G@*)1M,SQ[">>JFHSOV+F$U_S7)GY],S\
M[FFKS&F7ZB9*XT/&)$.9<2F['(2546"*0BI#HY<9J2KS3YPS/4B-Z(SSHL?G
MD!<>&9^+ %T.^3V K+!Q<MAX<(\""1^PB\9G(G(/V$A=IC35F=$L" )>D'@"
M% @O$_2#1:>?#@)_@- LO'4^%V^IK/-9K/,.<\&46:O!,*40P%RB))GUG&0@
MQFB($8AZ#M;)E_&/'@SVX@C*JW)+(?SK\\]K?\)?5[^XT6<7T@[#2[M?^],6
MK]:NA^^Q/WM&N"!?%L'NA5#K]8=PVV$_ 419U\ZD/".\\:G@I:_%O&=Z+C<=
M:")\U856#U:^VK_+AS"R(E,2ZZ0_R)-6K1:A8X;YY_#':>Z'AU>8=>.'8QU9
M15]^8BPT!]#CJS^9E;'$MT?CYM^IM26$:4Z"-%$[9).+Y%IS+6F0D6 2J=:?
ML%ZZ^M%A\<7<#D)FBV".,Q.A@ZNF<VK.!TNO;HU#-^]E=\;][I!]=6!B?*ZM
M/C!48Z  E.^/#Q!8A0@H%.DJ:*69X=;5#HOD-O_U?3'*I;560HQ:/];2D0G)
M6OY\9=8>4I&IJK)\4)7?-!OUS8W:F^;NN^;N>FNGV9@A)/MJD_>:;W<VUEME
MPQL;FXT]>/5Z_>UZX\UF;>_?FYNMO9GOQ6\?>F;D<X#>Y5K>JPT/^R.XG1_4
MPID+J>)HN3\./JF=7.^6,]W^"-3K]WN=FZ9+^>I(=TUQ $!UB?-C"EXZUR\>
MH-RL"\WMF)-!6+UZ\<>5<\Y[Y4/+'_UQ^W8)\^Z0CE*RXZ\OX5#K%8ED0L3+
MM,/E@R_!<J4$RSN$9_R=1"M*LZ]^C5;P5[_[UFTQ6>%4_-1MO_T=I_1I&BL?
M==M'IG8>,=7WC3G:L;E.*0:[9\2EIZV;PAW6(.HM.6!*:SQB9G9A1V,CN)"B
MP)L#0FX-R&*5^7IX%-;W]F[ZGY^8B'FZ MD37$'RJ$;.EKP>O3OP)2PP>3,J
M"H"0FAD,PG"PZ'OP9V[X)Z%UWUI3HF>\_V_,X+!DMRZ]"/\9Y9]-9QP[59L_
M%W/GU9V,M*3*$8^]<28R*J*)B#K'A+':A4CHIYU'%D($!4I_-K_HT&X8#(O<
M06R5OECO^=L?W+AR/M+2S;W+M/31?K?=?7]1W^ATZ]L?X'?O26.[<=@X.CRL
M=[<.ZT?^J/UQYZ*Y7:=?TM)_Y\V-OSOUC^\YA,IH/_VF"Z];!]#>#Z1.&D?-
MC?>I[1=WT]+U[@Z#?IWM;QRC>FNWV]AH$WB-FQO^$-I[T29UUDBOCQKQ*B5=
MWT.HT3H^:[[_9# U!AF9,4%0QAQVF:'19M;[-"%(%6=X:8V(9:87\*#2"K@6
M%+@"BX)*@KRRA#$CE&984Z(U<5Y'YDO@(IA4P#4OP'5Q![A4 &]D? 3,(B1C
M$0%F(6HSKSP-THB M0?@4LN:D1D"KHENX)QU KGN7)D,K17!!; *VPG+M5X8
M5MLYGYIP78W\[O7 -\+P,IRL8&E2L-1X<X]/Q:A)$ Q@B5*7,6EHII7"&:'
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M>!>,]Y0R(0]*\Q90T]KAX*#;@QM"[5I K)9M_W%T:@5\_?6S5MW.=5P \C8
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MJ0LSKQ/%Q<BY>@R(670=!!(Y=@N_"+.FF"1S#\.!%72N$@JPSP_8&X/FF\O
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M\2MK%-<5*Q!8(/"%0.!=LK8S[6D@P7J;.)/))LR\Y]("%8R)LF($+PCP3?D
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M2!]T#"*RA4*#%Y%.ZE)^P%JK PP_UGYK=_O]WU_-PY_S2]A8GO&XSWAQ,<J
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M)7#.B?6$YD*6C .[ </" ;O1GD?N/3.W932E$OBCV10[EWUX.!>SI-BC$$1
M''XBRYA#":!,I*04YF9>I<#G*$X/40KEH:5]\2#S]E52YCDVRXJ 5^0]GA/\
ME=KB]\>UUF5<HY@3035#AGD@:91SY%10"$<AJ&*>*,SF4ER\@-J"R6\!M7MF
MS61,1!"=$ A(#38Z62J$\LQ&YP*Y%Z@5)O<0WN$1XFG'8TC&(LPC0=G5CUP2
M!%$!=J@(GB7C /&DJ LQK^W8@GJ+(N %]>Z'>E@PXX@WD@C"B?;&V,"3X4)2
MX2S#!?46 _5F(CAIHB+Y"/:KR[$ )B&8NH@(F*\T),FCY/D,F*QS->?D]07U
MGES "^K=<S/":4DB,< /L.1!2,VM((I:21D% "1E,V+1\&_*?Q>MPMASCQPG
M"?&H)++,4\2"!]*> H6/,_[5U3R.)17D6Q0A+\AWWV@H2H/#@2JB!3?"&:8#
M]CH1G01F-!7D6S3DF_+P10WL3G*"#(L:<:4MTH;F>@XJ8664YTD#\N$Z9O>)
MABK(MV!"7I#OGIL6BF$;@"1$S[DPVO@L,3Q%C'.1G!*%MBAX-^7?$PH#.[<6
M8>P\XHX19+5.R%I& [-44!MSV7=3%UP^ TOWRJ 5RA_TG,;DV1=NR4D46NET
M)&*IVQUTNH-85O#-*[@Q=6YC\POF,A'G$Z*@NA%/*2+ML$?,,!I3(%%SDC%D
M-,8?NGDF#@:#XU=__'%R<K+ZW?7:J]W>_A\48_9'#[[^8W+MO&'W\4Y//(FV
M^!1KO>BS](;:X"#6_/FAE=;1L1T=6K&A>UP=5%D_/[.RDV-R;"_T:Q^/@P4Y
M^&U]Y^/O.< *(RSKM8WH!O_GOS0E]'7^M7;2&AS4WG0[,!)5;C>XNU;E-JEM
M'^=QZ]=^VQDZ&+.6KW&%$<6_5]=L0,>^50WJ5W__>Y1_=/SH-_F@'[2RGT_4
M;$++!J?5-^IUO[9] A]5VNC"HS7)F91_?W6Q*Z"JQBT;M#*B;77Z@]ZPR@%4
MO?+22^S/W@/?9XVY>@:N%X#BTKF8&\+P0JM_W+:G&;;CS^-ORY67KRP#6P9V
MN:XL UL&=KFN+ -;!G:YKBP#6P9VN:XL UL&=KFN+ -;!G:YKBP#6P9VN:XL
M UL&=KFN+ -;!G:YKBP#6P9VN:XL UL&=KFN+ -;!G:YKBP#6P9VN:XL UL&
M=KFN+ -;!G:YKJP&]H^J[L3:.+SSZM!Q'W,9BI51D._:OUSOC[7+V=)O<=OD
M>W_?V&"";PH-ICDT>"?&6@Y<[=<&71B03A74;P<QCTXGQ$X??DNMCNWXEFU#
MX^"K*F9V=:9GM^KV^-V<CBKWS,93G[3"X&!RR.7"C>,C"?C\%NN@K</!];<L
MRA"SJ93Y%W[FUE9'"XR@4=ED/':&1RF,$4:QJ!(E-#%COE"Q,KGIH#?IP;'=
MC\CUHOV*;*YY_\JV3^QI?^6/2^-PU.I,&L1(%3$^/6+7CDM*]QN7ZHFO6@.8
M!7_C2(T.;H0<J%X5M'PUA 78&T70_\LN<.MJ![U\TNJ_;IY%M;*VFW$DQ]OG
M@/-1!5J[=M4*>=*5K*Y<R6^VFXW-C=J;[0_OMC^L[VYM-Q<(WZYM\L[VWUL;
MZ[M5PYL;F\T=^&UG%SYH;#9W=VK;;VMOUG?^77O[]_:GG87OSV\?.W886@#0
M]7P087#0'<+C0O_W:UM^9'O[@ !C )TZ('76ETJ]G8-M== +^M2VQ_WX:O++
MZXEZ;'6JEE4WO;[\ C%[$*9ZW^CK,?08LTHHS>@S)BSC%X^!:;4"IHF:OO2=
M4JL:ZVN_QJODVN]^]EBSBI7\I:?^_#O!U(.TU=SJJ3=0PI\<G!N?@GN<0Z\W
MZ]%*4UU]I/&L7V9E:OF.%R2]=%3QBM.*L_+P1-V>D?A1 4'0+K'6@.L.^K5-
M4#KATA"\[#G.Q^^6?8*K[.4U1NISFM?'.\(_GTEESW%2*:9L7CV^386.9S5R
M]"Z2,/=SX4\A(F]L_Z"6VMV3?BWUND>U[G',9D9GOY;/\W\#BS?V7]VGP/C<
M%MI#EI/YU56\<--Y!>(M=4V.6W:[&0?7U#:^2R^?."_-+?MZY[0TBY!>YI9]
MNT-V&6L5)L0F&8G@@1+CF,%)6F.UU%*EJB(PFU0$9C>GF8$U-*H#_'>WWU^.
M##/-G4E^#G_R^?##X1[]B)N'_[2W=]_3QJ?_'#1I\^OG3Q]:C1_K/YI'_SEL
M;FS2\_P<_GMS]SUO''[]WCQL\,_P^_9N\R"WJ_&I>?!YX^/)]L;>][W=#[/Y
M.7YLDN;&_NGV[B9M_#AHP^^B03=9@W[\OD???FWNKO/FX=N#YE^?TR2/:F,'
MX^;NU^_;[[]PZ:/E6,%X8H\X3!)RD4N$N:0).QJ9R76-ZIK,JQ+(8U8YNZ&H
M=P&D9PI(<R]17@#IH0#IQS0@<>(((P()'Q7BP5MD++8()Z)-8HD8C &0>-VH
MEUQ?_"D$<#UD;]$H6\Z@6V43ZOA6.]8Z9Y0O?Y[_\MF4.>YUO[5RNB%W6OMM
MF#<16YW?YV_5+(KA\I.I7#PP?3CC9*0GZ2H5"[Z<-^(Q+.%6M9%WGTJ!BU3Q
M;PFX_<5A+YIT;IJT-4/MI4R6Y@RY1G"-.(X$66X4H@YFBR:F*3,K:[R.A5H@
M13HG:E\$^,&X<!'@!Q+@:2H<":/1BXB$,@D$.#&DA3'(4^R\D\E0YBL!9O,J
M<O((3'A!0_ON3]V7AO>L'W6A,3\J^<TQ2"&FV.L!.P\Y>V>KWQ]6)95]MY_C
MDGZ!%RU@3?<EX$47IV4[O1V%6W;VW^1I*# [+YC=GG6!"B^YB9XA:QC K,06
M.2DLHM'IJ*P)*K'L A7XWAFVYUC>?=X&[HL7Z+GSI)\+=)'9N\CL-#5B7)H0
M3$!1J( XA]\T@"_RC&'*4W"!RY4UK?$"2>Q+\Z]<7/_%O_)H/*)*M7X9>S;&
M#._-@>WMQ\(FYH=,.S-L E0%L<1PI%0RP"8<1\ @(K).!$DD5]0[8!.LKE5Q
MNSQCN9X[G2AR_:AR/<TX7!#.1,90D(DA'GC,]@)'/-<?DPD+*37(-:TKLTB1
M$B_-N5$5J$*YZDKN[]%Q[/1_G8"\"+MG[@1D!] H_IEGX,V%"2C@-"]P:NRN
M9V"Z5"=,FYB"3QY1:QWB)E+DDDY(4F<(Y3@H"O:0J,,_"V01%1_&HI..(LN/
M(,M3-?^LT88Q+)!102#.@&0X'!PB3BO*E74!L[SMPZ\H[KRPWHUGL.VSY.Z8
MB;%P%JEEO\=?V]]97OOM+K6BY\"+KBD:/9F)443IKOV^^3U#:_PS=F)J#0JZ
MS@]=MV:8DB1"FJ0Q2BX&Q(G'@+, M@IF&6PY3:-1>;>'\%G?\9T+2!?/S$L@
M23?*<Q'9NXGL-"'R%)8JE8@:HH$0"8-TX@&Q0*U02C$JLL@NE#_UI?E=FMT.
MJH*^[5F0>(X%3[;5JWVS[6&5[2:+(70N?Y>S3+5"'*71J;5;UK7:K<%I<=,\
MFIOFSV$?VM/O@V'G6IUJ'MZ<S<^;B].SWNM9^+0*_']SD'_=ZJP?Y9JZV^F:
M6_Z>3"@I;&9^T-BXP&:^,GCFET22$L8%)*3+^^ B(H,902H8)Y7C@3A<V8JL
M^'V>,3C<E]+(A0"'U/H.E/Q'['4++MP5%TXOX,+NWA>.G6<11\0HH %/V"/+
M@D3*&TPB=C9$DP\!5:75%P@9GIL7J32X^.GN"/M@1?:B[<?:;P#0U6^_YR1_
M?BHYC*^PMI^_LOU^'/1KMA/.B/0OGZF\.>'(XBG*VZ>6^F6GR0L8LKE:K&:4
MVG>1Y6S=^\Q2^OD<<VQ]RUDL7YCU^<C>\,L,<P)S&V.0 ]8XGI /9_-1;,?Y
M<40_ZPGW4L#:C<B*;#LJ[I$3W"+&97"2!TRYS9G8ZE+.&H^W=X47NW&!Q7KN
MOO#;B761W+M)[I1#G.H0(]<629FC?:(#&?;$(RRP=,ZGZ'".,;XB/N!)Q':N
M#'X)F,56YUOL#+J]5ME??UI&<6$B"I68'R#MSU )$@6+."ED-9:(.^&0840C
M''B,C@684+FRQNJ8W(=)E$WU!1;G1V 219P?2IRG^44*,(U@"EAJ,>*4 K\(
M7J&(@S)) /70 2P#4M=7I(YY$GE^L<Z+8WOZ CT7BT4S)I/Q;C07!9OFATU?
MK_!:!.EHU$@9&K+M0Y&15"!EG0L^.$<- VRJR_L?PRJ>B\45ZT=T7!2Q?@BQ
MGJ(<C+DDB(!%S!E0#DD"TCXQI%+BQ&)+&>,K:Z9.\;VSOA;/QGUH1V\X=;*R
MVG=THU#7XN]XBO,$L]"U>73<[I[&^"%7U(SA[_-=X8)B<T.QP]ECF!0H"#?4
M(9AH0#''/#*,:H2MDM()D6)4HV.8LQG[BA_D68CY'(A)$?-%$_,ILH*U5@9[
MC[04$G$2.;(6<^09!>"60G&=1CGJ[[5S6OPCORRQ5;*4<6#4"_.-+-@>3#43
MVY.<_^O5C!1TFA\Z;<Z0$)&DS-4RD/7&(B[ E+*1"AA?SB70$"5P/BY%ZDS=
MAX44[\@""_8CN$>*8#^X8$_1CJBCMGF7E;' <]++G"("1%P9PZ1.PC#'5M9D
MG=!9UV<)_'@TUG$A!ON%N4,6F7D4X^A!4&HVP8)U7CL7(Z**Y=/:*2('\XN$
M"X8$K&,4+L>"&+Y(>?**(V0!*<BM'2%%U!]'U*<(B33:4L45BDX2Q+&+R 02
M$;8^6"><"]G28'6L]?-S@U"Q^(2D.2G%=UY^[V)1OJM*\=W'6W+KTMW/$.X>
M;GL')C%7AG\WGK@_3S_V<ZZ9<]/K;.X*VLT/[1JSQ$8)$C1QP&D(H%UP'#DI
M/9A?F*J 3;+$9[33_#Y!<7<5I27RN3PW>'CB@L2W!H4B]W>3^RF6D]-N!JT]
M,IPJQ+562.-HD!)<:"D,#\J W--9CO-K@2D/+OIC%C1IR'A-RTJNG^#@]*WZ
M.X^3V8_;R)=0$?K-5%*"5N=;[)?:SDMWN+]D_7CJ.7LW[/D#VX<'=E.VT4"/
M#T[K-1B7SJ"*L(O_.VP=YRQ++\RG_*3;V>_L:978:K>[[F'\>_'=>&;>Y7E9
M[X3-R:P4TVM^%&PV58&&Z0K*,^1@.L'^<AH9%^$'@QD/W HK8TYS1P5?#$=3
M<2<OH#NYR/9"R/:4>:6]%A+^0]X2@7A*%&G.(HJ XH1:JE(^;,CJ4B_'6<-G
MP*6>B]=[[/2^TBPI?NXE\7-O32:O^+D? I!G3UABQ@W7CB'*(T:<:((T23X#
M,M/*"4*,OS_9*G[N9PD/#[?K7^#AB>!ABJ\%K+3V." 9O$, %!0Y0RDB!"MO
M6&+<X_OSM>(++[[PY?:%IU;'=GSQA2^;+_SYN9;'CHX::.Y![!W5VEW[:_5P
ME]?3])1.Y _Q>#P#VVDG=EK=WD9T@U+Z8![\Y,=L_#$/)J3(">*61<1-H,@&
M("F:BBB%=XP%-;?2!\5E_+QMD;M+<C$W[BG.TXEA",R,(!9IPA/B5!&D/7$H
M!N<Q(X0'FW/1U8TFQ3W\Y.[A9>-#O?BMV_Z627J^KJI1UXNA]6N;["_C:.F#
M\J._<]6I[?2FFH0"K/,#UO<S/$EI1YR.$06N@"<1QY%6SB.AO#*24Q]XS$G$
M>1W6WF*<)RWGQ)>*(A5A?CAAGF))P@@?/'7(!&P19S(A&[5%+BCMC4G)Y1AE
M8Q9'EE^<%Z;7A<$+8^?@7'G'\EIS3QK;-YZ0MS ?!:D>"*D^SIZB\L$$;2W"
MPF:D8@(9K2Q2281$B!0R^5S,FUT)5<4]\VP$>OX!?46@'T6@IP^!$\:Q)1J1
M0 P(-$](4V BG CA&><I&I/33>$%$^CGYJ=9N@8_7\=2;Y2/LS;H5I W*H&=
M?SVO@?W"'$Q/0?1\YRB<17F_[?:NJ49>-N+FHAAFBT))':E-VB O5)4(2".#
M&=BD5!KE(TQPU(M8@[QXF1;6RW1KD2ZB>S?1G>)TQH4H4E0@L$#LN+<4.9V
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M8&SV3W.:_/PT>($=3))N]<&2^M;R\&]V4^<0D^/,%K-U5.L/>_O5,XYS<KL
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MJW*]U>$#OPH$9/(YD)#*733:"6X!@>CG^O.UWS)BGUT%9 :>-PH\ASM&N[N
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MS$B",*BN($"Y0XXDF3.G@[8N4NU!=NHF%<7JK!MS.DX8*+$@/S4&Q9:;X(+
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M)\2C$DCK&%$0W$EKL @Z9Q62^2O_%DY?)DX/CBG/N,*)>!XCM\Q;PXGT2IN
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MIWQ3\")P4!81G0CB(@8P93E#F$A'L#1&:%>:QZ\XYSYKGE%),'@"MI[R4.$
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MD9 G0N;:P@%$-,9(2:N"-T(Q@4N4UCIP]K/X!HI(?C0'3UKVAB4E.,,H2::
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MK:,]WCX'.;?[C>T=?F6MW3=\4E;N';9 3?MPWCIJG;7./WYKOVM];QV]AV?
M]>=[WW=V0V=GVW]O[1ZD]NY7VG[]A5.F5.ZC$%+0B =GD;;:(-#91 B,QD#4
M6'4'Y([A=5:8J023UI/D$V'<6^Q$I(HF(1-+$E.\T8B@/Q]G(AR<P'O.>]VH
M-CO3\-M.S_9\QW8;[WM#N."BR_VDO+A)W!.R8_RB?CZ+V[..UC%F+1&,"FZ
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M_[?@5H!/"7*Y6=(5O$QE1(-%\#_W0$#%M*>!! O:(&<RV829]UQ:9WQ,E-V
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MX,X@%8E'7&B,#$T.62H%#S(Z9\C:IE1SCO2][U&^2CJEM Y28<%-LLXXQY3
M25GL>?1W%0T5.2TI.>U]/_ V10KV#(I6.<23-\A:;A U/!@%NQX,!6E"S2PY
M-3L_.OAW_A%;54[*HK&ZTKL>B<]FVF=SC;74# 'V,00?/&!N+AF+T?((C*(P
MS\D&;-V0JCC])7/N@L1BQ;F/Q+G3%A.-4@"/*L04Z$W N0*Y7(#NO$M1>"<,
M,R7G:C&K-KV>DO-GLXIN9#Y@!!=[4_QG68C6,2X=%1QK;[3R-@BEC';:F)3Y
MCQA,J)GDOX^-]],,>#U)X&,.V\3^X+,=Q#\'^;CQ/V(O!W/LX96.BFC%@K>S
MX/DM2FK[T_<]N+=^\>EB9_<3:6Q_^EX_KO-&&^Z_J)_M?'U']W8_P5R_7/S?
MQ:<#+#3-K5]0U"0BKI)%%E.!$D[P"U"#MGYMDV[(W&]YBGO_GFFG(/@<A^]T
M!['_**9W5$RF2$@D2G!F0'=6++AD- LV$&\JTWO%R7"/''!N&)C8'C1 ^,,=
M=\AP#Q^I#9@'%K3/O=89_7G3.S+-)"%>&,$X=<KY9!7V&N@J>.IH97JO.#GY
M\P.B*/5.)J0%:"1< CEIX3#*67.,>94X)FN;?!XY/9KI_2IJP!>%U6^O)$NE
MPR^8U::M;QH!$(/ 2$BK$"=8@?JN<_P#R#\FFT !7-N49EW*GU;AJ_X-2\R[
M"Q*,%>\^'N_.'"/,L;'!<H1%+K;4+"+X3!"0*VR=M_ %*7A7+!7OOIJ@Y/W,
M;P,B,W&/19":NT"=]HQ(P:.S/&"12@[$$LO*_'X6#FR\O2U&].7[SM>/WQL7
MO[7WC_=P/5=XTCV^E^-$N_5S6#M</]YB^^TOW__OXLN!(3C2H (BR62!RSW2
M'#/$C.78N^ HU=G\IF+6[?U4YC<-TC*:I"5)\FB,=H12YYRGDEAC%F9^5U)B
M&6ETCQY@S40*QB A/,@8:R/2@2FD(YA11CIF*%W;)&I=*?+SYKE+(FALC)=*
M<BV5X9Y+K"E7\"AG[*+,\XK<EI'<OF!8!]+8/?P.SZ&-PX,DB2-8$\1XI&#)
M:[#I:0B(&@$V/B8!%P$&O:X9K^+HBS4(%H7\E4'P>+PW;<P+HEC.4T)1.IRK
M9@VRRDDD+8X$2VZD=VN;2M-U.B?QI JEOQCF790<K9CW\9AWYH@&$7(_'8-R
MNCCBD3&D-=&(1*\\"4I'93/SDG4BJP;N3\MZ[YL=T!^+,K=H^[%?-7-_@I90
M66/_3U[N_S2M:[::@_,*8NX#,;,57$Z8H$1BB&FG$<=$(6><1T1$0AP.S%D-
M^K2<C8Q5GOX7PZ&1)\D4Q4$[RKF5VG!B&#6&^F 2#W?5#2H.70"'3BL!AHMD
M=+"(* $:?-0>Z:0B4M3#?S!-FJ>U30#0)>+0U]!H>;<[L*W"H?HS9T1.U'N1
M^Y>!KC3J+$HOF$SNW>J$M_8T=SDK0&C'P8H4;9;Z'SN^-<RK^7;8Z\7.H&X'
MPUYST(S]RH19&'K-IO(;F8*D*2%+DLDG20ID@N0H<N*]H(EB#^A%UK'DZT8N
MR@-Q9ZY:(??$*T:*1>DG%5(L$5),ZSF)*<N94"C2G*-G#49.)H((3<)K297.
ML4] "L'7-?UI>^2ID&)!OI#BV:KL:+K,6M%_8K__IMR*\N^(B6JG.?C6[51N
MDN50AT;;4B':PA!M-I'2Z^!]BAI)+QGBG 9D+*>(RA #QC(9&LM$2L.6R'BK
MW"LKK;Y4G+UXSIYI#!-HC,12Y)W@B$MJD!82(^RX(<Y'1F4J.%OQGX[+5&Z9
M![AE6M=ZU3Y0*1RU@V6PVJ$[S%EUX^G_G"VV=&MV]^9=BU^@%X/R3ZN_5?"^
M*'C?F4V:4<PE$W+3;D,(XD0DI E/B&JNI+51<.;6-HT1ZU0M*NZ^.)9Z9I]6
M!:X5N*ZX"EV!ZP+!=;9$R2A-&$6,))*MXHB, @6:@$$L4R(Z. G@JL4Z?D'@
M>H=3J"Z+DAYR^,'3'PCQHP-R_HS?P 0]JFVU(WP9BGSKS[%?U!K5_HR=9K=7
M>UMT!:]M'?9BS%5)BSE=9=E/TB#YR(B=3NWW8>N\I&4BBT;Q9+UV%FM%0WM8
MHV9GT*W96G^TCG9B'7OC=>R7ZUAV5Z_9\3J.#^;(J6G=]*;VB_T'C'2?D@L<
M0)'5EALI$G=):1F]Y(:Y(&.TLFS#3; B]RL[>V]]W&H#=][1-R%7$U\??H+,
M<?WLP"23FQ$D9*SUB#/BD#,D("H3E1R[D$B1[<$V9ANPE/0$]-K*&SP8]S^M
M)>N+3)R"?'YQ]R4'YR+V1@@1J.4X$)TLX0++D+3F0O,[D\-_@!%V4LGW[T=S
MJMOOS?:P_5NWURL.CP&)#+_DK*&*1.:1R-[Y =5$)6#%?.YQ0-Q;BQS'.3_8
M&B<4]HH!! LM-FY*"1J32._RJ(81B(PI9:.V>Q1O_KEV!@,4!-;L !05=)6/
M ,K4UJ]UAP- J$X6F;5")A2_S2''8I3X_;39B[7N'$B4Y32N[CRS_=JI/2_.
M^6EV:O\=VA[\V#J'#_#$5JLX@ H^P'1MO\"_;Y-/'Q]4=/F2M>UA+U]6E@(!
M_+9MB/?D#L8X%@ZT&",]=U@9%93T5A$?O%><%F=I%36Z:%ZQ[NSA!9\CO&+Q
M)CNI%)5WS[-_;?S0V*U?'!BIHE1"(>IS/:+*@>.<)2_ BA?98$^2@T*);V6'
MT]YXZ3,YWD"T('Z'K4*X-LMK8JM9L$$> 2BL/_1'$Y0YWDL@=I#C@X*KVK;9
MR0,XVRK*<,,PUH:GHT<6_' YVOQ);-3^Z'5]C*%?2[UN^Z:I9K9T8V#M3_#B
M#Q@;M(_:L _:!>@?Q7*4@Q_%#LQLI%7<H'ALU,:%Y35X ="6+(QE!U>SZT<_
MS,I-YLI.5H=JZ3*)/M]1.VT-^[7[E<ACGI3B@7%A"+<I&>=\#!Q,!\*U\7Z^
MUVU"./E..[S))N&?.^\_7ZN,!W*P82MDW;%=!%16O#+^)Z2.QSO;GNWL;O'&
M-LQIZT!*P10C%"GG. *#/" GHD<F,!JHTI'[L+:)-PCLPIQ*]5_6RG4%8BC:
MM.>U7_M'[9?GV/OQ3.;1P"O>\]VMB_JG ZLB391:Q*)2B$OL<O*Q1%+8)"*(
M.Q[$VB;?,'3VR.>_9^8O3@8K879\/-@_2CX'I&I.XD6M/(0OH][]R,"KR+FQ
M,01A<CVC3=PJCXVT6&"7S-S3+.]AM_P&ND2_1(.=SE^VU\SZ1Z8.\JK)@X&U
M8HDB6 (]^(1!%4V<@;6B+!(DP#YPXA+S:YMD@\QM%_G4['Y[-Y1W*97%X"^H
M(<I/[7'C["!(1K07&FDL$NRQ#<A@3)&0V'LP!"G5.8ME XO9G+P;(6"C]AXT
MB GEY.PH:Q[9 ]*"'<C:!V@AA>I@6[ _A9GA+'R5H6*]^ &4J$'3MJZ^KC7[
MQ0^@D&3]H^A\\DOS'\5W?_2:[5C[7-S\2W/TY?L(&A&,\!Y4HW[QXT-4D$1-
MQ($G(:GFS#$-;RII4O"%<(ZH"G\>@S8_XL;60:#8>.H3<M@:Q&%ED4VY:1T6
M8 B')&/ 60V9VRX'"! H840*W4Y$[6[ALYS13!Y"%#Q24)&DB#0X'J4SEK,4
M$PU624DCKHCB48A"U+<.L-4J$A41" <@"FE"#C $A!VUGBDGB<PM0C;FG-GT
M]_5BK]>S;1<M&'(>L&7])E5EH_8<)QTO@1.[. YZ=X38\.<^_A)/<PM0'$%J
M>.YE-"Q1S!SVC@KLI;OK&8_7V>&M[?7.09!4_N4?L4>=U ]!GCMFJ3$H:><0
MCX(B)PU'GB:"#1&DR$HEC&_,1M]J8U<)\,>$\)[T^-WL.;%%J[$YVL!&K?9
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MX_EV%.I^, ^.]/ND@#,O"D6>PLVX7,OQM6Y[Y:SD$]@_&"[UEL<&]\2& %L
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M6:7_JAW #(3F4=ZT^7(0FB.Q+ C<"L):*N3J,8Q18H(;W?CA 80Y4#S9MC3
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M#1G6.B\DH%\0#,3,N)3*3L-7-]*QW)HP"R:EUR\?E-?!<0I6P0@- V&%@SD
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M]C]?-834WP7UETW'U/.U["!2M6HL&U4W-5*-G5MU@)!<1(T>HTE"M1[4'50
M\&23,150$P\%@>AB#!O&XRM*Z2+C:OG<8!XYY=/QLEQJ?HZ">8AX:_+.RCP\
M83&%2$&S6U[6[E?==7+>%Q#>H'+1P&+YAOFOAT[6QT+(B0876'LTU^#7(.G2
M;.[-%,0O'V1HHC;@F$1F*>$?RTX$:!.# 2D;&G#9+S:85CU/Q1&0=2P%:M/G
M"<$BGA)1%(-X-"I%<=WG@$0QG%9S"<M;%%_+YDHSO8\1?[U$IHFQREET+ZEA
MOF8ZG CC^*:5E\!3U6SE BBO'(SC@C9O3)5@*I?6DH+INW/&N,0RZ-Z/V6>L
M11;*8_ED]/9_-Q1;D[WA[-'5*J%>D1(JJ#@!UD8^$,JGLG:MHMPZL5HTC8>O
M(H8S?D&62V.?8G+RA!.!)D;M@2R.7)]SU0J@E%:R5"5\P@4IKT% 4[CA2(AV
MW(CWH"T0/_NI%:F\SSEH4E:VG9YM-]<H6)3EU04ZY*B,L#*RZGHF=!*8A\,9
M4F&B';)H;HV)\B@DAD)98O)[47#4M4E<(=QU&NH?Y2H8?H@\#X+P+ ,;42_5
M]\RM1ET=^ZG9G&IWU:LA+P)0Y%R ",S$KFH"&4D"J8)6H]F=76O:&'!!1J[L
M:Y\5<2&,8(FK),R7DD)73@#+5&D" K!ZA;W3+))M] 8"FX4LDMJ$Z\A&58W*
MB'Z6A62DR%@'2_LQ-4B7QRJ$6Q^U")4\A-*2K(Q%/%O\W><IC^)QH\CV)C/E
M.5;%&EI;%=M6Q>[0(UVO1;IKO-AK-=V4:4NA$.Z@K!]?,U\T^_(IHE0(@S!"
M6B^IEJH"JYW*C,2X=E_XFK+A8%AJQAF-@#UC4-.&395/!5C@// !"NHK+*BC
MM@.EXL3@4A;BR%AW"L/<TBYP;?)L"Z/:PJA'OW1]&NF2;6%42QYM851;&-46
M1CWUPJBS'>9V/IFR%;+LVLJ5?<K-;&GK>=+6$] *,FWJD+3":]D><'O-L&31
M!\*@EM/=M&IQ^0EORH(;2=BY5VXE80_XC,RNMV]G] 0DU0TU2X:]_T5+[W*\
MKD:\N'B\(W/V251[V$;WYBK"N^_$?8N[^S$HG\;I]KKZ09WN$Q"4!VC2?9+)
ME"(/<*;)N\R7>&YVGK6Q'];:>0]]1D;7WK<S>@+BZP#CE!]7-+R_D_!:L@^'
MPAA=8SN=?Z!&VT$>T9;@1ZWHVMCR.A@7]43FPF"A1[:8<+2%5G]J[HS5-;?3
M^'OCJ^[09'MJA^L=V.$^ 8%Y@+;>2=F&^7G:=N;&/D]KVSWP$1G;AMQ:4;7'
M$SZ4)Y^IT>SS*,NK=')J[WDOAO,A"B2MZ^[8L'IR)O,A'JNS<9CG$8_U"0C*
M S26WR/F55&V>&H*1^69V<U:&Q/=]R/2MTU];*76W6^CF]5TAM%=4N/VZ)GH
M0GSMP*I[/E"NVL:Y/3O?J2>4;OP0INGSH<W>'<W7EC8/0%,MP R7W]@6T.=9
M0G7H+51'"]7Q=+"PT)C[-%,\\KSP,6^%XFC@&?O3F9;&%5#&^@##MR!HW,\N
MP_<>%F_#\[IV3]\&;L/2NIK>VSF$A0[#]NX';\-J)]M.]IXF:VCN6L.N"5BQ
MVB-RYM$,)+<?.J#!(HS(C/5^UWU[)#")@QE'MY\B2L8_E-<#EO;Y/9'286W&
MFF K3WG]ZT"F/$\\F:-" K/.R=T]D%F'L8$GLJE!A+"V\$&JO$9LYC18W1>U
MW<\;]A,1)1&K?/DV/H=+Z-O;J]^VVKO!O.S=AOQT?^O?[T"V;NK;7L/?)[S-
M+N_H6U)^)J2L.=MF8A\**6^2;O+4@+@,H\7A:C'>[JF&K:6LEK+N16CU6M):
M1EI/"%SY'4]YCDU6ECM22ZC_ .E8[]U6YWM_5M(&<N40=]:T;JD%:7=V2]FK
MWP(Z>/!2]%F>ZBT^7GNHAWBHMX&O'/RI/H>H\F*S[I5H]1M8OUMD5N_=SMPE
M)G?+^O>;"0S/WD%,;J^Q3%M2?B:D;!D;H^$<&"EO&:EY$K4OMWH+CW*ZCV^X
MM*2U X"@N]^PMI1UKY1UB&1EV#L'$C]\HI)^5CF)\DF+2&:767E+BARW2&]L
MW[FG[US^PN?@Q7^"B29<G12\+'/:V'M_!E[-03DNF\-X[A_22DMS!T5SFMZB
M8NZ] 6EVG4<YH\<W$UL"N5?'M:6/9T$?1F_;F-G!$\@32F!ZS48(L;'2VG\:
M5\S6;>!&;9K-EAM[&Y9MN[';9H;=DCMZ\$+T.9ZJ>;]YE.VA/DYZ[%,_U><0
M^6SSE]JDCS9_J27E)TK*;?[24TXR:?.7]B:2]]1(J\U?VGO*.D2R:O.7VORE
M]IW[E+_4]@]L-^$Y/=D>U@$]V1[6 3W9'M8!/=D>U@$]V1[6 3W9'M8!/=D>
MU@$]N6DKLSWH,:0;_Q"-ED0;H3@-<LX*'BH8NO\'_'YC%R$1*:M:"079<,1R
M^'"<T=<*-N3*".:4A0I3IISE"NMG"BN4:QB-A? $[$8<Q0$"7X_RK)_SHJ".
M1/$0?KWB0]@9Y3H>#V@\&"K*<EAN0+VPLDFN7,/[!AG6!<&?65]\H9@68SZD
M<6@:@W@TBM.^$G(XL0+^QL8*_Q[#0S"O,4U,Y;(-$DPMAZ],?$+CCEF23!58
MTB2 9^5N_'?"\C'/NV6,;+='9JQU9(IR/V]?CV#>3G+8B!P./!WGL3\9X^["
MH0LBZN?9-9R8W*THSHMQN6=B=W_2S;+A*$PNP;[3\+#X<I1G0_I>SA&E'7:?
M!?^=Q$A5)ZGQ.W";()#?XRSG/ZK\4$$TDGJ1CHDZZ)!Q;LW>6$6W;FK]6 W%
M=/?1&HK]G_]Q#:/WZI'(!WOBR2B@BM?P+W4+FP@O0W]?%$E&5]M4)(&L84!*
MQ22A7@6[(JRLGFU)6ED4P6ZD_<W(ZW"H:7F/OCVEICG\RYUH-Y!2M61#(CB*
M\T^<)1WE]TD4L213WL8)RCBDF(SD([X>KW3N2"2[;+?W&$3R.BN(^ZB9XX-S
MQR,V;RP7/D]^H"I_TBVMJRL-_;>95&O:6C_I6J]K;C66T564=WD&5A>0:!2/
M%=%3L0!;J9RL:6N*SXH8'LEB[#H);[2-;F\+4=R<M-WKZIL-@7,]Y@U)W%\V
M<1A?"?/XBJ?8%#/ $ZC$=P=^C!+JQ(K?S]DU? U8%LP\^"S*Z>P:_(O?+O
M)?_"]V .)ZF",@=_ZRCA)"?C9^U]Z*#Q"S/"-B^A?$/9K9,-0;'$/\0$X;5Q
M"LL89RC QGRD3D:X<1&+<^6*)1,R@G\R&E1$W8UK^[O6:ZCI"CGCG_19N@,C
M#M4CKB+B\'!C$";WKV&,QRD,0RV4:9]@,*TY6,&O0/"B@3XW%Y[$PSBM5A;P
M?,S@^;++,@C$>Y2(CR/V/G'8%MA5W*>C$%8/QF@NMN[-]Q%/"[YBH@<K[YHK
M9K,KYF+%\T+0W*40-+K>UD)PC:F3+0D^*)J/X&HB&:=+/&>8BV5M9:DVEV,9
M77MS\8C=@LN9"':\VZIN:R,\MX9KAN(X!E$,M%5+X0=H+3QC!>+77MTRM/HX
M+ABYSX]K-,,4EAO-/U6 MS/: 1540Y@WU \+<6>'7!H%& V 05%+H$Z)0RZ:
MGK]J3^U^3\U4;CHPY%_0X GI[TH!,^#RZYO"9T*:P"=BP"%HZV0J#I8"9V2>
M@*2A49/2>.HH"?,SX0.!I+GBB?P^!?V21&'"8.-% 1/![X')\0H?;XGD/HE$
M[_86B40>)BH(=%*V-MV>AT='YRM8HHX'H;<!3GT!&A.\C22[!J\A2_L9[NGM
MRK=8IGUS.(=TPF68/*%3P4^:\<P;AH8?P%.9Y'R38]E2Z\JM 5O% 3)[55+$
M2R(@F,RKLE\X]1)O?%$V\=;JKS"_R)+)>/57%MIW/I*-VVBJ2]O1_'>0UT*K
MSU4?B.1291%,]B5+KMFT>/'KS)K@X-2Y/9Q?_LI%1M'=%DDCOD20A3BX/<I&
MNQ_R(!,J_>4$2"7'IV"6;(]GIX#A&OWOB_^)/=O@#HN\0/,]B_=LS[,]Q^1.
M9.A&9'K>WPXP-][<(0N^AA>B5?.O7]EORTY['X-L'T$PH4E.,N$8I$:2C4B=
MK_(UGZ207MR*L+$5*YQ0<+5VYH-VG:U=T*,;/+$.7F+<O*@Z8F<L!NRLKG%7
MA[1K;>>/"J58C/"&=8FZV]K1E!9I'>L;  G@FZ0_?I>;:W!B84)T8RWNKY]5
MO/X$U2LOGJ/HJ):^0E1H6\;937&Q_9,]&R[=B)F(F\3L,7%!VH5Q.6/0?; /
MF;B; A\LSZ[QIFEV!697WY"-%P2!T34VE"7+(E/QXD9O,J=X::!)^+I%,2E3
M1/!WF*^M_4,YR\9"+/QGDG*1ZM'P2:7L6+Z9!4]1',#DPWBLL#[,$"7O0_@]
MCR0!WN?958P>.@GFDQ3.GRL7['L#=.))RX+2UP-+$ @_G?X3E"C[CI&+QK80
ML<1#J2$*I,F0PY_ J@>JG13"05. G&*\9:*("244I!.6*#R*>$ >&XZ,]*:P
MT2B)!9/A@Y27-,[4$#^#GU-DYX[P^9(BD^$WNK>!V81Q 00*3\9C/D3'-*8)
M$%NQ*@&GB[=7G($9(?_0(1Z1RU0FHY ('U_?G#==3JV>-Z9(B(?*+X4W/!X,
M6-I'DZ;YYNMLDH2@TR\YWCI-AI-$7C)5,<:%I3P/4I1JB3@0M["4EP.06C[G
M>.D78,4=I;(AN2UN.!R@8>.%[8965E/J,Q39"Y.XZ94ZV9P;O;)4%%(:+QEW
MPQ7,J:[YI$2I<QK6WNP-AD@7:B8/"6-6[@1\72@CNLTE=B^G/FOCSFP9LJ](
M*2SOH2O6Q>=\GG*\SQ8Q%)E7-\Z"2R4;T1?X=Q@[+C"/[>*&G5#J32A3&V&>
MR00?J&5%?:3E>\E.6?Y"Y7H0P\!E.B3Q^^(1@1HVT%? UWI=]Q_DNHS$4\FT
MJQP1Q:9!G,153!&'^IS&*#<^C4D"%?"?"5U]-^9(X\-^4"QL\<UQ42^QS-$1
M4N@C'V7Y&/7YVRP?*KJF_M^*E.C<Q<8=\X /?9[/$J5"X00R(!2O)".,G6*)
M-\FZ*$[!XH@QX0AG3S<B#Q!^VQMSX2Q+U7='1^^5M]5&G(*A-\F7V L'+HGK
M7&D@)J:\0#K 3&&%$CK28/I"^MXQNKIIN3%#L1U2OI5*CZ4LF?Z L=+941<&
ME6,"[?E\C#EF<CQ)BBCAF \,-9Z*"#**+%0/XVO4$-) P9=GU3<;$FH^;7?A
M];.J.N?#[(H7Y<42H[RV4JOC]X&S8,O2>O;\N_A4FM6DQ1GQ[Y(%B*LCC!8T
M R /GU7YB$3V.P\87LI5Y%,+&'E\XN8AS<8H<=*0Y2$,'W842H2:T@<^QRN:
M(L:8)MW.DAZ$#0="6AA/)-F764]XSC$O_GGC! ;LJLQ\(IT*XK2(83- FJ;P
M.Y$;ODM8<#-2LGQI,2"K3\ZVO#06TCL&\2KU0R[B1I24'X-6$&9 3C(='JZ9
M1Y"PH-8A9BZ%,>B:,=U;"A*#O5B^GG*VJU=,'%VG?L$'UXS8[2KFZ&DWYH$$
MW@%M";R''\(<Q?:"0J*Q)8-VA$,1XFG"?'/!"0DJ9E(Y=+3R=HZ<>O0I>%',
M29%BG&=I'Q8)O :/,<&%P*&@/D7^<C&@>]X$QT1:R#E.B\9<IKKH.Z.)G\1!
M,E6C.($%B-TNXVHQ:LPQ;*[D5SQ!&A=F@1(,9T4M6Y9L]#WJQ3C\WQ>W1_I=
M^\6CYX;]$?]W$H>EN"O1KC_R LXD>'I:\QPH+:F6G'(>"@^5-XQM,CP#N1."
M?HD:@9&R_!+9H/PPYY2XWZ!5-A6_D#T=<A_$ C**M-Q(1.&M*O @2"8R]?!K
M&.DA^VU5@$=1_D)'ZPH]$N0FS.6&F0XYZ2V8?;VFF3D1MT?P<A!)E(E.X@_7
MEXUD4HR8>"-,)Z:*+ G<F24D6^6$(A:0:IS//;U>-KD)1?HX6+GUX!UI%^.8
M"Z_<=G<H&8BX6UQ.-Y),"[%S%*6@&5+\0.IWE!,,CUYL$/@OV:0_D'I$W+])
M]R,7=6)3"NGA!8<_KAYG2#E7:/6/$A:("<$7A-2J\NR?9HB.HE/G@I*(+0J@
M-O!,GU-P#B4**MQYV5 F%) G_Y/A>EVK"KB#U;DD2-"=!]>E_20V0B>RVF:&
MWB:,C7XPC*W\9';=;:\-4V&UT)ND#1"BX[SR;3\MN7AHTS*::1EFFY;1IF4\
MIIA>+J?6BWMV&G8",#C*!AGVPA(/O2%H1-%%\QKQMI#H8B!P/B)'WD29/C K
M]&K=,G?E-B&G4H1#&]/=2 YVUKAW?[Y%UI\:M?&-X HK"B[-WB06-A4J"1%.
MF3NR32]51?!4E&UG24)F8IN\?Q 9OD<S#-R@ 7([6!!DDY3RP@,.9C,*5)]R
M C))(9CBVZ_S<9"\:!#ZPFA<M$G\]WIZZ4QRQ,KC T>7SDZ*W]F3*[U@2J=?
M;1VN.*_V<+9FK7Q"E9Q#O. 3(4OR[<6%6C&/00 'C;&S*S[[E?+T=N>R/E;R
M&$9N;O%+#]?YK"Z!9KS$N%ITPV_;6/G*-"WP]>IBC0H/9068SH))5CK"=-\<
MQF.*U?L<YR;OIL$-GB\:VC(I %S@A737Y?-<I.J#B;;0B<N+S>=!U<V(1%0M
M?&O*IOB%W8C#-$EH:1ADZ4O1$W(:F=JR\EZFC?S.X4C$I6LQ&0)+3,N\@B;&
MU/+5T!UF>9<E;RHWKNN?S9&$2;6&\T%H=XKPBW!<(S0N,S_K4#P.1M?<(@J.
MQ.C53GAG@::;8Z$+W\1)V)2VC-4V04L!.Z6 YD42GC_=HR09HR0ET';M&>[O
M&8Y83+:3.P=NLK0F?1;E1(2=&A=8[?'NW?&6+%H:"P%=(@NVG(,M:)RMN$FD
M^\-0WG?RX2C)IIPN#M,;*X]NMW_=LAONED;P4[B-%!?\E#E49S6<,DQ3>R87
MDE6* ]&FSQ*\$V_$T$2T8'4F %YQ^US>W&=T+ZY0/3?OQ\%L*D29 C1SV[Z8
M(4$9%JMK!LE< 5*7[)'ST02>$@7M,^D4D0)[#T*3+NI%WFTSEZ@+YUS!1O@\
MB?E5F=Y7+7Q^M<U<!'JHVB;,H+AB2:E_!Y0IC?^_8G$B0I:E484+90$26ITV
ML4T. ^P<,"YN/@OA]3*]>,A!SE!* RB/(!Z):YGJ3N2F=)2.R%( &KJ* ]ZA
MLY3AN66.>:?:WWK3:3]6'4\)JIKAT7+:E&A"U?ZSJ2'#)>=RC1$GS+=C08 D
M5$X(G*5+CE-GF(B*'X'WU*DH48R_G/(>)<EY7SB^F8.'CB=FNXA B_ HA2]+
MN8@LR#,5L]ZS(7 T3Z_B/$OI=/"TX6 P,Q,)(X^Y\$]EK 8F.8D8XCF4< ^-
MNSD!XL%(;OC3&ML.G=\10BF+1%'\4@E),1F-,!MR@  >\&\"W-;G,EU'V$HB
MB@34%X\SR5A$K_+U%7(%#) 07)YPLS&?!^:9H5#X=W:-J!6=,GT'I1&%J[&Z
M)Y+8P8AH)Y,1L9R WD0KZF >#_V]F5V$;$4P75PA&T5[=8(8S_I15_D8%Y?*
M6_'R%[M,_._0H^6$L6AB0K USYWJ,5U8XCA;L[@R3:]W,J[S5V6\J/*FRHPV
M%#E /\NR<NA6NGJ3X\T6SJYX49W1MC*)[L97HA)?HFZ*<@4WC+HTMTC.WM:L
MKE%-G[(#V0ALV.]4*P<,.7/%+^-6U= (+L/0=2%R;"XWH6* HHY+/'?*W"Z1
M,<8JL01]AAP6]D-(TUD(>/BGS,(&^5M0^C<<(/PL4WC%M;S,I=AJ%BA^&2*8
M!AE\FY6F 'XOCP-A*5(!5@=Q0I&K2"R-!R+#4UHA4M]@;6I:5D&7B$UU+C;9
M8K/CK[!$QH,*K71NM)E$VQHSM0ZL-BV]IM$@K-&X:&)__B49'6<Y21*1"!_3
M DKX?X(B6[DS-W'U7T*_DH*6VQ1VI*PH5Q/$>3 9XHD'5)J:B5K4(1974!D:
M*-1J8\BD771&Q7U@.ITI0<?W-6E$EK,\9T9%)4[5=+H^HV'!@,'V#J+H(VV6
M)R %E8PBB0W$((I$,K<S'Y;)UK%(6XBK=7(IK3:7LLVE/ !!@N;:[QG+J53P
MF&J]L.0)2^/99#S(<E+F3/G)T+2&_4@AC(9;+5K/, %Y*<H+5@%W4S5#_4T<
M?)RA$PT3Z#6@C.D5PC!KNO*L#U*L+]RWG_2>T;">2],UKN=>YY+0:W\RG<8E
M:LY1RY-DK Q6%*;SBRMMDL7E*E@P4M1?DO6E2KTX&6T ,R>540*%<"^JVHMQ
M#J?'I H6J0KQ4*0FP7^%ZD4/L)@(_">)4U$YFM2=9_EA"&R!:6,@V@2L-&OL
M/A::+=_J1G'+JC?4-\AFXPW2ZPREP3\;&L/%E&YIHQ*P^5A9H;(DB9:&$%;"
M,B=CG1*@IQM"QF%DHIMLV9/"SZ*TYSD%DBOKR%R*-0"_A!B!68XZ0-S,&K$*
M441]P\YNFIFS9HVE^V*?:8UB1\#T'R;HX8WK?@;PAZ3\_1@V,<E$$.W(!X,3
MM0+*0 PX/;7D'Q%L(0%(J#)I-I,XTTA )Q^8LLZFI5+(,0+'OX_D9@D=,0!Y
M)]RV^A,4Q"(T'6Z>83-3J/611URXI'$A>LD!L]"Q.D?=TE7?"?J'Y"A>!'D\
M*@%+FG0BZ:8FI!L)9Q6_/?2!BU5NR]^>OO_\;<T0#!J\>98(-?X>7?;P!GR2
M?3F-O9<;1T49KY2('>-!=?.-X9J\O 6)"XDAT"'(*.P@P*I"S8#E.2*?(:_
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M_P;O!6:$U\>8GD4 AG5PR/J9_8+Q&/$7#!")OT0W18<H9YZ%V0@=J>:XG[A
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M4WY4*7@TRN-$,1P!9+.G%SA[<U?CK+ZK^=7/PBG\9S >)K_]?U!+ P04
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M,I=+EKFP9(I9&3%"Y!Q&$RU?3+VYF+]"ULJ!$4";R;LF4F'+O[E04Q/+1M7
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M_"ZTYC?PIS"D_C?,]6/T3OTG<%Q=\06D_FK9-29^OFT3'(AEX^J*VYN:_(:
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MZ18'>W\NNK^FQ\#8+ZM?>K8X_-Q-]S\L]R27ZN*_=C\I#D))IQA'#DR'Y!F
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M+%BH *5)D70@+#8_Y7H+>+=L(/!=LJN-[K:,G3>?US\B1>J__/#_4$L#!!0
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M&#A[:'+4!G6$);4QT6YE\AY+?2W.#E=#>3FY",/E!>Q.N:W+)O$H?*"XC=!
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M<J: I5$+3Z1FH40W9>(4^@DZ41]UE"IY6YDEN[!\S99.%?TT*$^Z#==Z]^R
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MHZQI<#Q2B*7DIL;=UPGBF;=$R)!2U-I*7[OPU).-LNZAY8Y1T_M(^RA!L%T
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M/"U@FBFEMW&)@C06FBPRHF2>*I3&3MNX,W*F1A%&.5@N &_5<^."<UC:<4$
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M($5*16SE"G87/3TF;74%E=;S!M2-NN!AH^\U!U.]4^!S-!4*V+$/IS8@?VI
M;E4''R^#?.7YE U>@YQ0]0I^QC,J&T#Z3ZFL1K@VQ?U$>>;ZY=/.WUXM%ZMR
M<6>*$>I?E5I&\QG<YE(KD>2DB#)(>1P9@HLAS8B$<<9)@1**<NI4-RR@;E-C
MP-UT[%-ER6O GG;_;C*9UA:"/1-]T^2OGVX[,GVF21SZA"_8_(V4:A\,_.#I
M]]=K]DPI^<$@/9^F'TZ$9]Z)O*/S7^C*4**)!U]+XZ6LMT3 L@3G'&=0T[XP
M]:5CR'"*89Y1QC3UXY0X'0]829T:HS=*@X_5DDMI2N<YUB^Q0]J.<H/C-S"9
MMM!U"C=I)'LJ:X8<@AN=4 J5/V(E<]R\$1<8CO)%G&[VW6$KS8'BI5SH'U8?
M]9/SJURUG9Y*WOWKJV6]FL4XS[)4($CR/(-(B@225!*8TP(7 @L98S9;;5H8
M66P#[00[,=&91DTA7R>MI=E+-VKJ'Q:FH2#@6E'7;;4E[K:;ZO!H#KZE;E0&
MG7; *'T##+QKO3>_,IJ#%VTNZ/F*P!X[:S?0@NVK+<6.O*MV ^-X3^UXO\>I
MB3F!^?SA[:>]'7L37GHK_OE8K\QN?J;71$DNH@3*&!40L3B!.%4)%$KI_R24
MY<2J/*2UQ*FME9JC1*/TOI-J'4F]5=SAF, *>8O3E=!X#LQ1SP:EP]E+:$A'
M.H6Y'EJW8QD7F'H/:*P&&N^HQL6NO4,;IQL]%Y?K@C0?Z9-QPW2IS7HM^ZNV
MK,OB+R3)L.%K2DW5&&4.;D@D(98))Q'A:2S<PM\LA$Z-LG=+5#5*.RXF;7"V
M7$@&1F_H1>0&N(\7@'-?'3H@$6IE:"-RW%6A PA'*T*7>_T(1B\QWRWX\EZ^
M7];U#*<YCU--'4D<<XARQB"5.861B/.8H#Q7E+ML4?=&G^(^M&RT<^.*?<AH
MG!-)2023@B.(4"XAX4D.$:8RBW"F\LRIEKH_9".P;!C(['C4&XB!"=-@T"H&
M7AC5_@)N5ZNJ9(^KYIQDM=1$&K:BS$DD A'F_MBC,N-)LPXI\/1%GL')VU2W
M=XN'QY4)L>DR<RCG69QS_=J2A$%$"8.,D!P21%D4L82@&#F%)9\5-;57>C?_
MKU$5?&G"X+R2HGH0MGOIP^ V, /X0N8>='P1C5#AQN<%C1MH?-'@HQ#CRW=X
MUG99K$I1SA]7Y3?Y6?(NCOG-#SY_%%*\U:J_6MYK@<TF_X-Z0ZN%.57[**NF
M2U77>35",E%Y@4QWJ$*O#F(,&4849HKI.4 D2I!3CF80K:9&0;M&@7IC%9"=
M6< \**;D\-HP$]4@.]/,44+;ZLZ_Z5V8N;9CN-%G<& RW)N\K4'@S=[DO=J?
MO+55YJ"B[;AW UK+ A;#"0ETJ-(Y070:M]!.2!B/RO($'?S:",-SZ2H'+5D2
MEE"]N8MA0ED"$2<<XC1*3+!T;&*H58&=W&VN"DR-OG=CS?KRLGPC 2VGQ8Y^
MAP1[8*:UQ7FDB#TW_(*'Y5F*?Z;8.S=PS@?8.8[CV0!'FKB\^=O'A:C?*"5Y
M0\??Z8,YT.A*W3 6,<($@X)S#%&:IQ CCB#.4"RR)"T2ZE3!S$+FU'A.JPP:
M?<%&X?; [<,WJ;]+=U]73>>J'\"8T?[F]]82QUVTS7S8L5U@E <FN"$ =F^_
M8P]9J&8\%A+';<UC#\%1HQZ'6_W(ZLU_/9:K)[,L7"[TIK_S+K%8H91K/DH5
MIA!)Q" 1$L.(Q8C2*,M1@5WHZ:24J1%2JR38:.GIM#N-J!W!7(W3P)3B#I$S
M8?1"$(@B3LL8E11ZS3RD@?Z+PWCO30%ML_W;^2A2+"GC60895S%$!1*0"I+"
M+,410@@3'CGU-;TL<FJ4<.2:O@%KI3U*JEI [N?6OP[(L=W[!Q@.L.BPQV<@
MA_\)@<_J^#\/P*4#@)X[_7CG2]5(>&J:@;5]P=HN!4E&LD@0O1N*B3+G_0IB
ME:509)'IX45E(8A'A\!S\JS>D/%[ [Z7=?TW4*3XIHAQDQR#X_@F2Y/.%6_\
M$[O= DWA\U5GX@V@JR;R_\;\JPD4; 8P3^L-T/<^M.O'N6-CK[,S9D=65TW
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M3;/QEX]UN9!U?<OU?K_K*/[R:>=O&W56^J=:"Z^:Y[I9W<YD%BE<Q!',:)9
MA',&"<L%3$F,$BZSA/',98<>2*^I?:_69ID6I&O#P*YEICKPSM]OMJ_R"NR9
MUVTB'1V4H:;;;L/_#),X\+=OQ/ESS_4*BW:H9+! 6HV;+186RJ-TLL##>VQ
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MDDYE(%N=V]H'RR9%A;<:>\7+VZ!O1S2!,1V8<=9PKEMW&S3;A)]6XP'V)0X
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M:CN^_Y9XV_%">!0'YHM3 .[E7@_"%VXP!>(12Z&C\HL;$(>\XWBW;T$T;N(
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M)G!(Y:;VWC?UYI2I-_=56V!<EG?:B!NPD([>RJ S:,<FSS4O S/2U54"VV*
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MW37BVQ5G_J)6/RK1M TXVJ)[%S_PGB['LXX!)V'HTX]6=8OTR0'(5OWDM]J
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MHG!3$XW344?OHG'1L'-M-"Y_.+1 VWKSH&U4MFW@V][DK+\LYW)&!"S2LLP
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MR*U ^F=0N((3*Y'BJKQQ\RE<S3])JW!^T+^(X?VZ8I^8J'0EVMS"0E M,:-
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M14R-U+^JU??$JIF\8Z+M'.D5,]*#IAL'WX;1P/Q9*Y>TV@W0%.6R\9&XZHR
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MZ33V..0(F Z'HZ9A07X!S^HNN8CZW4BP>QPJ#0O_2*=)\:?![Q0I',3>XZ.
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M_I?WKY<_U&K7XIYG'!<9 L6N!Y3 '-@<391SGL/4^=;^8.2ID4&MG$N?M"N
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M_/UY7B^%95U&71R44:_:,NIS&XUXTV6&SP0YQCT, _O081!&ZY,==:/XMC"
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MI.Q8P!"!,4GFE5V/_*"_;);B/[\MY^;A]6%K]1FQ33<%+P#,9 $013F@O.1
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MO_JQ4\"\N+'5L&@/S%ZV,T0-=J>^S?[]Q5I@G-E?DZT1R<Z*039[X2!&8K@
M!49EO'" CAGPAI'"PVB^ME?R;:T?,_AG]<1^UC>V#_K3RFRAJB=;;^NC^F/S
M]7<U_Z'^NEQLOJUGA@(--V+CJF49L5Z:V5-J;=RW-"\A@RQ+B]0WVB98FZGQ
MI/D:(__8F_#)<&/$T2 >F!R/(WFZ0E5M8<^'1<2ZGE$PBQCU$Z[+Z,%!-\-V
M+H;H]D'#^VR],X[/1V._^?']XH=:VWO2^X4\P]!G;LR0H(C8(H$LI0R@,H6
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M/EM\_9D>3-H4HGY192<V<KOWNJVP#J/[4D@?Z6<GQ9N@8Y @4U2@6!00M&+
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MYD ?JF*42T&9XWS@1]Z\$R1,OY!H(M%.3,0U$ULK%R.6[(T"$Q0G%FP"CU9
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M25#52!4=@.K=Y7LW+/U'F)WCQ"?4VK,"NE1G3U@#@=4C?5%8#CDKKEI?N#Q
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M ":/5(9<,!.MK\/#)8@0:OMLFR"PE"&Z0L&M\XDW[V'^)$$CCUAO#I]VTN\
M2G<+0BZX2$G;8J0%;3A2I!$B>*\0BF1."\.*;C[UZ6%*QDTY: ^>!O+N #4[
M5'-<6M:22RI60D@U#5]2)!!B3?CRW&'T5BO;.@%Y9^+&33,8P# -HI4.X/;
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M"UJ+0P*VAF.K1P0I-$/MK8$H5*UBKS/HF(O@@Q!2,0RJ^?3?_:GL9*#;B7*
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MQ0?>1SC8MBBZ3HV^GH%A?2;//)"7+EF=@>$A*&<AIE0_,<FEUE<<^U%XPH*
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M<W9HA7+?\WKW>-\XQ]D#@&(@$7=P"//JKZ^>75".M(?FJ )$7]L#95E#26]
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M:A*5B@&\XT@K-V6]6RB]#]*>I*AKB!T"@;L@:Z>/OM#U]BLN;S!":TV2*^'
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MG-96&1W@ZZ']V,MDLW 1:..E_9C\-HAZDZ[%A3 !)5.M+W1[]7[:XN=887>
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M]["C-M%2IVB[6)BRH#'<,"+=UW43$S@E+7#-'9<I:^-;']T_3LVX=JR-MG>
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M:3=64[$3&T:XE^CW'D:XCQRF;L'XU.R\*)G'5/NJ>JYJ1YS:G"8E$.A3'9O
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MT'ST<#-%# W1UN[ "$I84RN;!0AE8LC<VQC;MWK?F\RIAPN,")O]('JT##N
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M8?+<@FX@>+2 QK\T=W]1_Q/#&O_CW_X/4$L#!!0    ( -1:FU;1!4WH 0@
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M:*7Q&=':&H@#J$B71T^4W)DHP8G(SOO01@G* _Y\YG40[39<^9L=@FO4HW7
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M2 JU7F3=L>3:,_+EM3RQ-_\[</PG4$L! A0#%     @ U%J;5@(OEZMGC0$
MC/<2 !$              ( !     &-N;60M,C R,S S,S$N:'1M4$L! A0#
M%     @ U%J;5J8C4Y;O"P  T7X  !$              ( !EHT! &-N;60M
M,C R,S S,S$N>'-D4$L! A0#%     @ U%J;5B=6D6";&   P^4  !4
M         ( !M)D! &-N;60M,C R,S S,S%?8V%L+GAM;%!+ 0(4 Q0    (
M -1:FU9*22:_Q#H   9\ @ 5              "  8*R 0!C;FUD+3(P,C,P
M,S,Q7V1E9BYX;6Q02P$"% ,4    " #46IM6?E&*L%^W  !?HP< %0
M        @ %Y[0$ 8VYM9"TR,#(S,#,S,5]L86(N>&UL4$L! A0#%     @
MU%J;5D,LI:\[;P  HMT$ !4              ( !"Z4" &-N;60M,C R,S S
M,S%?<')E+GAM;%!+ 0(4 Q0    ( -1:FU;1!4WH 0@  /(H   2
M      "  7D4 P!C;FUD,S,Q,C-E>#,Q,2YH=&U02P$"% ,4    " #46IM6
M-F<,O?D'   B*@  $@              @ &J' , 8VYM9#,S,3(S97@S,3(N
M:'1M4$L! A0#%     @ U%J;5H@%5MD2!0  EB   !(              ( !
LTR0# &-N;60S,S$R,V5X,S(Q+FAT;5!+!08     "0 ) $H"   5*@,    !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
